{"meta":{"query_hash":"2b5dedba5d46","filters":{"venue":"European Journal of Heart Failure"},"cohort_total":788,"direct_labels_cover":2,"predictions_cover":788,"exported":788,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2b5dedba5d46","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Journal+of+Heart+Failure"},"results":[{"id":"W1484146179","doi":"10.1002/ejhf.260","title":"Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic Shock","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":792,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Medicines Company; Aarne Koskelon Säätiö; Alere","keywords":"Cardiogenic shock; Medicine; Term (time); Shock (circulatory); Heart failure; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.03833665459214959,"score_gpt":0.269779536673242,"score_spread":0.23144288208109243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1484146179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976695,0.0009568161,0.00057949935,0.000039500475,0.00043064437,0.0000752174,0.000019587502,0.000025992404,0.0002031955],"genre_scores_gemma":[0.99824554,0.000058349127,0.0013215292,0.000013608301,0.00032841615,2.4804777e-7,0.000002087385,0.000027571485,0.0000026474827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797213,0.00052432803,0.0009419556,0.00012462177,0.00029077986,0.0001462054],"domain_scores_gemma":[0.999251,0.00004507095,0.00012631816,0.00021442446,0.0000982329,0.000264923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027077845,0.00012504576,0.00041174894,0.00009279722,0.00001429068,0.000015541162,0.00013667885,0.0000623187,0.000020211597],"category_scores_gemma":[0.0001321602,0.00010705755,0.00015661029,0.00011007446,0.00003986397,0.00016790064,0.00003559013,0.0005838593,0.000008207143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014482655,0.000019312682,0.99347556,0.00003513665,0.000116403346,0.00010353124,0.00014543779,0.001677723,0.0004999028,0.0000028628647,0.003287085,0.00062257785],"study_design_scores_gemma":[0.0006446766,0.00019917001,0.98324245,0.00008341229,0.00010560843,0.00020386459,0.00012857869,0.0009155122,0.00015830019,0.000027655178,0.014193982,0.00009677566],"about_ca_topic_score_codex":0.0000014275428,"about_ca_topic_score_gemma":0.000009507954,"teacher_disagreement_score":0.010906897,"about_ca_system_score_codex":0.000025635858,"about_ca_system_score_gemma":0.000031262556,"threshold_uncertainty_score":0.43656802},"labels":[],"label_agreement":null},{"id":"W1488299655","doi":"10.1002/ejhf.299","title":"Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"CVRx","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Cardiac resynchronization therapy; Baroreflex; Randomized controlled trial; Clinical endpoint; Natriuretic peptide; Heart rate; Adverse effect; Heart rate variability; Blood pressure","score_opus":0.04068146615597442,"score_gpt":0.30963304867458186,"score_spread":0.26895158251860746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488299655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304074,0.0001238616,0.00096912007,0.004756018,0.000050331306,0.0010214786,0.0000060329194,0.000011117562,0.000021327685],"genre_scores_gemma":[0.99736637,0.00013763532,0.002236902,0.000072141316,0.00011999907,0.000005929894,0.000004284926,0.000035421217,0.00002131434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805695,0.0007433486,0.00032830416,0.00023455959,0.0004723116,0.00016454111],"domain_scores_gemma":[0.998774,0.00027180198,0.00026908968,0.00019003575,0.00039131983,0.000103739796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006288177,0.00016091223,0.0002707484,0.00017317866,0.00018026031,0.0000753383,0.000075893106,0.000030334566,0.000006745481],"category_scores_gemma":[0.00014141845,0.00008926516,0.000045335073,0.00034397052,0.0001225742,0.00038760123,0.000010092385,0.00017132428,9.776934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03505556,0.0015648756,0.81353426,0.00003081942,0.0002024093,0.0000049839678,0.0038987454,0.0095254695,0.10096615,0.000044334865,0.0031503765,0.032022025],"study_design_scores_gemma":[0.018728828,0.012907531,0.86033595,0.00012313762,0.000021915157,0.000024582383,0.00039342826,0.00042019895,0.03243367,0.000007721617,0.074423105,0.00017993522],"about_ca_topic_score_codex":0.000009270447,"about_ca_topic_score_gemma":0.0000045014795,"teacher_disagreement_score":0.07127272,"about_ca_system_score_codex":0.00010074093,"about_ca_system_score_gemma":0.00010891994,"threshold_uncertainty_score":0.36401278},"labels":[],"label_agreement":null},{"id":"W1489445210","doi":"10.1002/ejhf.75","title":"Predictors of Changes in Health Status Between and Within Patients 12 Months Post Left Ventricular Assist Device Implantation","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"ZonMw","keywords":"Medicine; Heart failure; Cardiology; Ventricular assist device; Internal medicine","score_opus":0.008534124036573883,"score_gpt":0.20932071503381774,"score_spread":0.20078659099724386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1489445210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987586,0.00027950318,0.00025799414,0.0003333495,0.0001786159,0.00011510156,0.000027093753,0.000018934094,0.000030774532],"genre_scores_gemma":[0.9985413,0.000008255212,0.0012058811,0.000078553276,0.00011510218,2.254679e-7,0.000018406412,0.00003085766,0.0000014487184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983438,0.0003912481,0.0006541763,0.000105366504,0.00028509254,0.0002202856],"domain_scores_gemma":[0.99920815,0.00007053739,0.00029819584,0.0001089389,0.000089443274,0.00022472865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010744528,0.0001287702,0.00033789902,0.0001826963,0.000031597876,0.000020615964,0.00010067565,0.000029864339,0.000016864551],"category_scores_gemma":[0.00008583213,0.00011399832,0.000041794538,0.00009231696,0.000017307337,0.00015261333,0.000022751019,0.0002512887,0.0000055346627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011138322,0.000019280706,0.99668413,0.0002313873,0.00004159118,0.0000151389395,0.00053491426,0.00064468954,0.00025583289,0.0000065300997,0.0005279095,0.0010274448],"study_design_scores_gemma":[0.000789863,0.00051400095,0.9830266,0.00028060065,0.000024343637,0.000031845855,0.00013714009,0.00021023669,0.000546227,0.0000067694396,0.014318987,0.00011336224],"about_ca_topic_score_codex":0.000013671085,"about_ca_topic_score_gemma":0.00012619043,"teacher_disagreement_score":0.013791078,"about_ca_system_score_codex":0.00004415867,"about_ca_system_score_gemma":0.000022529412,"threshold_uncertainty_score":0.46487167},"labels":[],"label_agreement":null},{"id":"W1493840214","doi":"10.1002/ejhf.58","title":"Ageing is a Risk Factor in Imatinib Mesylate Cardiotoxicity","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Cardiotoxicity; Imatinib mesylate; Medicine; Imatinib; Heart failure; Pharmacology; Tyrosine kinase; Tyrosine-kinase inhibitor; Cardiomyopathy; Internal medicine; Cancer; Chemotherapy","score_opus":0.012721174352402026,"score_gpt":0.2529556180842846,"score_spread":0.24023444373188255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493840214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948535,0.0002463815,0.00013781458,0.0029306666,0.00014524993,0.00015734091,0.000014178312,0.000021162452,0.0014937181],"genre_scores_gemma":[0.98953587,0.000046771955,0.009256921,0.00048169098,0.00043850177,4.31549e-7,0.0000010886736,0.00004736297,0.00019136052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978034,0.000688407,0.0006258362,0.00018761095,0.00039964626,0.0002950872],"domain_scores_gemma":[0.998894,0.00009952387,0.00033397326,0.00032082762,0.000109445755,0.00024224623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011246345,0.00019486918,0.00055252825,0.00019490143,0.00006065886,0.000029391176,0.00013132638,0.000038770857,0.00039801857],"category_scores_gemma":[0.00040496778,0.00014916937,0.000280017,0.00016689286,0.000040217805,0.0001271605,0.00005007174,0.00074604753,0.00023288828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010917824,0.00068489625,0.65317696,0.00043460508,0.0013725698,0.01060608,0.009230076,0.0004167499,0.08488531,0.000019919456,0.110802524,0.1272785],"study_design_scores_gemma":[0.009393105,0.0011247084,0.7911064,0.0008136864,0.00016769547,0.0017901722,0.0001463,0.0002558088,0.0071995016,0.000025635718,0.18773623,0.00024072482],"about_ca_topic_score_codex":0.000020122581,"about_ca_topic_score_gemma":0.0000088121005,"teacher_disagreement_score":0.13792944,"about_ca_system_score_codex":0.00028365117,"about_ca_system_score_gemma":0.00013291641,"threshold_uncertainty_score":0.608295},"labels":[],"label_agreement":null},{"id":"W1543680891","doi":"10.1016/j.ejheart.2007.12.006","title":"Efficacy and Tolerability of Adding an Angiotensin Receptor Blocker in Patients with Heart Failure Already Receiving an Angiotensin-Converting Inhibitor Plus Aldosterone Antagonist, With or Without a Beta Blocker. Findings from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM)-Added Trial","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Medical Research Group; McMaster Children's Hospital; McMaster University Medical Centre","funders":"","keywords":"Spironolactone; Medicine; Candesartan; Beta blocker; Discontinuation; Heart failure; Angiotensin receptor; Tolerability; Internal medicine; Aldosterone; Hyperkalemia; ACE inhibitor; Placebo; Calcium channel blocker; Angiotensin II; Angiotensin-converting enzyme; Adverse effect; Blood pressure","score_opus":0.03276913259568871,"score_gpt":0.2856124967044748,"score_spread":0.2528433641087861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543680891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857829,0.00006073154,0.000010136092,0.012120148,0.0001026264,0.0018697714,0.000030079995,0.000021666616,0.00000189154],"genre_scores_gemma":[0.95746166,0.000012599254,0.042021744,0.000119824974,0.00024554197,0.0000069983394,0.000057902853,0.000065405,0.000008328169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951189,0.0013370647,0.0015377932,0.00068342965,0.0008126273,0.0005101976],"domain_scores_gemma":[0.9979955,0.00017489553,0.0005957783,0.0005618448,0.00034014884,0.0003318329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002259751,0.0004861524,0.0015284574,0.0003726726,0.00017614418,0.00006106405,0.00013852365,0.00012132981,0.000038056707],"category_scores_gemma":[0.00014934572,0.00031932013,0.00010985827,0.000601059,0.00038493186,0.0006304704,0.000102427904,0.00084217906,6.6374577e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016181914,0.0011377403,0.9650546,0.00005696233,0.00017053983,0.00009890569,0.0028930232,0.000045215893,0.010468197,7.523677e-7,0.0037612226,0.00013094605],"study_design_scores_gemma":[0.048652723,0.0066648005,0.9371665,0.0015314681,0.00022882392,0.00021318963,0.0015117386,0.00017210895,0.0018297589,7.53349e-7,0.0017052972,0.00032284504],"about_ca_topic_score_codex":0.0014058395,"about_ca_topic_score_gemma":0.0041324478,"teacher_disagreement_score":0.042011607,"about_ca_system_score_codex":0.0002661799,"about_ca_system_score_gemma":0.0003758451,"threshold_uncertainty_score":0.9999259},"labels":[],"label_agreement":null},{"id":"W1551880861","doi":"10.1002/ejhf.207","title":"Acute Heart Failure in Elderly Patients: Worse Outcomes and Differential Utility of Standard Prognostic Variables. Insights from the PROTECT Trial","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institute of General Medical Sciences; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Hazard ratio; Confidence interval; Internal medicine; Placebo; Clinical endpoint; Randomized controlled trial; Proportional hazards model; Blood pressure; Cohort; Cardiology","score_opus":0.011271729465045467,"score_gpt":0.23721128476663442,"score_spread":0.22593955530158896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551880861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97511196,0.00008435916,0.0005050489,0.022383228,0.00030604532,0.001506108,0.00002164491,0.000021677544,0.000059950944],"genre_scores_gemma":[0.9899894,0.000009765271,0.009335735,0.00024794534,0.00031287302,0.000008975251,0.0000182441,0.000036839927,0.000040203482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662113,0.0011294507,0.0009877587,0.00029632956,0.0006614649,0.000303843],"domain_scores_gemma":[0.9984061,0.00037768265,0.00034712342,0.0004121603,0.00024236951,0.00021455168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088554627,0.00030937555,0.0009096976,0.00017801198,0.00010877181,0.00007050851,0.00017620069,0.000066937195,0.00016087189],"category_scores_gemma":[0.000594135,0.00017637994,0.00024959835,0.00020975084,0.00014209702,0.00019278226,0.000116342446,0.00058212277,0.00001343951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03564751,0.0024850462,0.80252326,0.00023533842,0.0016574676,0.0002616548,0.002973407,0.0000055721935,0.0020557386,0.00017074523,0.14256513,0.009419139],"study_design_scores_gemma":[0.07522887,0.007696558,0.5365046,0.0007676916,0.0007657186,0.000032576645,0.00024669277,0.0000305554,0.00029353017,0.00014611306,0.37802678,0.00026026496],"about_ca_topic_score_codex":0.000028007247,"about_ca_topic_score_gemma":0.00009215635,"teacher_disagreement_score":0.2660186,"about_ca_system_score_codex":0.00003692815,"about_ca_system_score_gemma":0.00009870797,"threshold_uncertainty_score":0.7192565},"labels":[],"label_agreement":null},{"id":"W1552874299","doi":"10.1002/ejhf.263","title":"April 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Trypanosoma species research and implications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Alcohol consumption; Cardiology; Prospective cohort study; Excessive alcohol consumption; Alcohol","score_opus":0.0430388856282454,"score_gpt":0.3143186079386805,"score_spread":0.27127972231043507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1552874299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7011849,0.003486871,0.00065605383,0.26070204,0.000382097,0.00029074366,0.000018015335,0.000060166545,0.033219114],"genre_scores_gemma":[0.9730891,0.00004580247,0.017635863,0.0010104908,0.0011191753,6.7010217e-7,0.0000052882597,0.000033759323,0.0070598233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987427,0.00017465917,0.000305796,0.00009701446,0.00045730645,0.00022251456],"domain_scores_gemma":[0.99846995,0.000026594844,0.00011026514,0.00026817498,0.00046668318,0.0006583417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021635754,0.00008500648,0.00020560574,0.000105884246,0.000058726026,0.000026421205,0.00014744747,0.0000165254,0.0002649349],"category_scores_gemma":[0.0003959901,0.00006239867,0.00010973792,0.00016438254,0.000073063056,0.00011752396,0.00007476612,0.0003203428,0.0012512095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017707542,0.000058032256,0.0044509927,0.000008754482,0.00002623378,0.00025404582,0.00012305619,0.0000027068475,0.03531649,0.00003384573,0.9589557,0.00059308094],"study_design_scores_gemma":[0.0014949711,0.0007104578,0.09795669,0.00005362345,0.000013401818,0.0036499966,0.00012421477,0.0000046953464,0.0008596319,0.000015040746,0.89506406,0.00005322272],"about_ca_topic_score_codex":0.000001187431,"about_ca_topic_score_gemma":0.000002741857,"teacher_disagreement_score":0.27190423,"about_ca_system_score_codex":0.00010216114,"about_ca_system_score_gemma":0.00020092157,"threshold_uncertainty_score":0.99952644},"labels":[],"label_agreement":null},{"id":"W1553852627","doi":"10.1093/eurjhf/hfr039","title":"Which Components of Heart Failure Programmes are Effective? A Systematic Review and Meta-Analysis of the Outcomes of Structured Telephone Support or Telemonitoring as the Primary Component of Chronic Heart Failure Management in 8323 Patients: Abridged Cochrane Review","year":2011,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":382,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Meta-analysis; Component (thermodynamics); Management of heart failure; Intensive care medicine; Systematic review; MEDLINE; Cardiology; Internal medicine","score_opus":0.033671897802129924,"score_gpt":0.3125810653389437,"score_spread":0.2789091675368138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553852627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096646853,0.975698,0.000004678445,0.008275899,0.00013413066,0.01474379,0.00013621144,0.00001749827,0.00002334086],"genre_scores_gemma":[0.0130987335,0.98083,0.004735613,0.00053636444,0.000063804946,0.00022958733,0.000152173,0.00017519172,0.00017851795],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98634964,0.004760682,0.005800525,0.0006701178,0.0018374576,0.00058159785],"domain_scores_gemma":[0.99019057,0.00055958895,0.0059699826,0.0018998432,0.0011206984,0.00025931004],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005209611,0.0011633312,0.017185466,0.00096312776,0.00010878283,0.000029012073,0.00089638337,0.00015526189,0.00025018994],"category_scores_gemma":[0.0004837891,0.0005436965,0.004547365,0.0024494072,0.00030391794,0.00017248123,0.0005408609,0.0010698606,0.000010616298],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092293274,0.0010265138,0.002511021,0.87298733,0.108439535,0.00005690085,0.00015184609,0.000002824067,0.00001509894,0.000008935044,0.013549943,0.001157763],"study_design_scores_gemma":[0.001857415,0.0012581226,0.014792965,0.25896358,0.46747828,0.000268296,0.00011928135,4.3222235e-7,0.000021912263,9.049558e-7,0.25485253,0.0003862964],"about_ca_topic_score_codex":0.000046783076,"about_ca_topic_score_gemma":0.00010475056,"teacher_disagreement_score":0.61402375,"about_ca_system_score_codex":0.00027016632,"about_ca_system_score_gemma":0.00026574812,"threshold_uncertainty_score":0.99970144},"labels":[],"label_agreement":null},{"id":"W1573414423","doi":"10.1002/ejhf.179","title":"Diabetes, Impaired Fasting Glucose, and Heart Failure: Its not All About the Sugar","year":2014,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Heart failure; Diabetes mellitus; Internal medicine; Cardiology; Impaired fasting glucose; Impaired glucose tolerance; Sugar; Endocrinology; Type 2 diabetes; Biochemistry","score_opus":0.019693416570205815,"score_gpt":0.2289007813113428,"score_spread":0.209207364741137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1573414423","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042304926,0.0045374725,0.000073453586,0.9510861,0.0012843485,0.00043295542,0.000021004002,0.000076307646,0.0001834323],"genre_scores_gemma":[0.14649506,0.00037648669,0.0025505023,0.8258138,0.022657536,0.000003379792,0.00009970421,0.00039117612,0.0016123923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951762,0.0015901644,0.0010074475,0.00044390524,0.0011203315,0.0006619759],"domain_scores_gemma":[0.9975964,0.0003055025,0.00056636764,0.00069000846,0.00047255898,0.00036915878],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027608166,0.00057541503,0.0013049118,0.0003185615,0.0002636169,0.00021092339,0.00029863624,0.00030070386,0.00020972214],"category_scores_gemma":[0.00049444917,0.00035350572,0.001302553,0.00020778093,0.00017149115,0.00013819334,0.00013156491,0.0043799356,0.00027696096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030335557,0.000017836022,0.0046406724,0.00020639553,0.00074143504,0.0006746069,0.00013054325,0.000007763823,0.0026515943,7.703275e-7,0.99031943,0.0005786264],"study_design_scores_gemma":[0.001701048,0.00062891707,0.028382251,0.0008183964,0.00078952394,0.0054330626,0.00006403781,0.0000143643265,0.00039777558,9.023102e-7,0.9614215,0.00034824986],"about_ca_topic_score_codex":0.0000048512957,"about_ca_topic_score_gemma":0.0000027809656,"teacher_disagreement_score":0.12527233,"about_ca_system_score_codex":0.00007670483,"about_ca_system_score_gemma":0.00015228946,"threshold_uncertainty_score":0.9998917},"labels":[],"label_agreement":null},{"id":"W1582824580","doi":"10.1002/ejhf.23","title":"Effect of Comorbidities on Outcomes and Angiotensin Converting Enzyme Inhibitor Effects in Patients with Predominantly Left Ventricular Dysfunction and Heart Failure","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Enalapril; Asymptomatic; Internal medicine; Cardiology; Comorbidity; Diabetes mellitus; ACE inhibitor; Ejection fraction; Angina; Angiotensin-converting enzyme; Myocardial infarction; Blood pressure; Endocrinology","score_opus":0.003511081184670133,"score_gpt":0.20162475201264718,"score_spread":0.19811367082797704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582824580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925047,0.00014662088,0.00005545283,0.0065520443,0.00011968877,0.0005875027,0.0000013265716,0.000014990484,0.000017655351],"genre_scores_gemma":[0.99674505,0.000004209721,0.0028040293,0.00025383662,0.00010893577,0.0000012594103,0.0000056861477,0.000034838264,0.000042182564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980096,0.0007155739,0.0004454571,0.00020849868,0.0003862728,0.0002345838],"domain_scores_gemma":[0.9990329,0.00029794607,0.00021870492,0.00017381272,0.00011483293,0.00016177751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010786732,0.0002552481,0.00072112784,0.00029683072,0.000066210145,0.000028424636,0.000039313727,0.000043600816,0.0000089159685],"category_scores_gemma":[0.00023267476,0.00016025215,0.00010666305,0.0001030966,0.000107851505,0.0001510937,0.000042406926,0.0002768623,0.000007679646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001329142,0.0002204037,0.9760658,0.00043505614,0.0001750097,0.00021029606,0.00023643584,0.000015477419,0.0011672296,0.000020899635,0.018695662,0.0014285669],"study_design_scores_gemma":[0.017122043,0.018268425,0.9153372,0.0018781858,0.00033716252,0.00019469085,0.000071279705,0.000031813066,0.008284569,0.0000027977883,0.038280454,0.00019135809],"about_ca_topic_score_codex":0.00000519364,"about_ca_topic_score_gemma":0.0000052044434,"teacher_disagreement_score":0.060728602,"about_ca_system_score_codex":0.000037245725,"about_ca_system_score_gemma":0.000017271781,"threshold_uncertainty_score":0.6534893},"labels":[],"label_agreement":null},{"id":"W1589920342","doi":"10.1002/ejhf.65","title":"Proteomic Biomarkers of Recovered Heart Function","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of Alberta; University of British Columbia Hospital; St. Paul's Hospital; BC Centre for Disease Control; Prevention of Organ Failure","funders":"Novartis Pharma; Astellas Pharma; Genome British Columbia; St. Paul's Foundation; Canadian Institutes of Health Research; Genome Canada","keywords":"Medicine; Heart failure; Heart transplantation; Biomarker; Internal medicine; Cohort; Cardiology","score_opus":0.01583958283337479,"score_gpt":0.26366797132042163,"score_spread":0.24782838848704686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589920342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96182007,0.00013968811,0.019470576,0.016243681,0.00062558125,0.00024882835,0.000006621459,0.000024905008,0.0014200542],"genre_scores_gemma":[0.83586353,0.000013572687,0.16298467,0.0005565922,0.00038132333,3.374511e-7,0.0000040008676,0.00002667622,0.00016929755],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984448,0.0005803303,0.00050475146,0.000099045974,0.00024410458,0.00012697444],"domain_scores_gemma":[0.9992506,0.000075469165,0.00023071207,0.0001559324,0.00016095382,0.00012633056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016553082,0.000102179045,0.0003373115,0.0001560954,0.000039376537,0.000011585316,0.000060941013,0.000026647685,0.00014609398],"category_scores_gemma":[0.00014753833,0.00007557744,0.00021508416,0.00012338051,0.00004264975,0.00010179967,0.000007610019,0.00022026607,0.00004078277],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028286343,0.00014823931,0.14086963,0.00039321356,0.00035603734,0.00007231056,0.00034882472,0.000034810724,0.7728877,0.000105391955,0.07011493,0.01184029],"study_design_scores_gemma":[0.0038080197,0.0025421898,0.6413766,0.0005967465,0.00024146412,0.0013722185,0.00010682221,0.00002234966,0.018855644,0.00006720228,0.33088186,0.00012885606],"about_ca_topic_score_codex":0.0000026443302,"about_ca_topic_score_gemma":7.390775e-7,"teacher_disagreement_score":0.754032,"about_ca_system_score_codex":0.000015114498,"about_ca_system_score_gemma":0.000052117524,"threshold_uncertainty_score":0.30819586},"labels":[],"label_agreement":null},{"id":"W1596067399","doi":"10.1002/ejhf.115","title":"Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Servier; University of Glasgow; Pfizer; Amgen","keywords":"Medicine; Heart failure; Ejection fraction; Enalapril; Internal medicine; Cardiology; Natriuretic peptide; Randomized controlled trial; Clinical trial; Angiotensin-converting enzyme; Blood pressure","score_opus":0.03191936138850019,"score_gpt":0.3154298619205974,"score_spread":0.2835105005320972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596067399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994804,0.00003597663,0.00004394856,0.0039130677,0.000052412386,0.0010717738,0.000042177962,0.000006475833,0.000030119909],"genre_scores_gemma":[0.9952422,0.000014288518,0.0044916337,0.00006430977,0.00013632004,0.000004453235,0.000015392108,0.00002044958,0.000010968718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779147,0.00046924734,0.00085225224,0.00026195878,0.00037649358,0.00024855265],"domain_scores_gemma":[0.99889237,0.00009740438,0.00035160832,0.00024780727,0.0001389904,0.0002717956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073385687,0.00028665227,0.0011084565,0.00022403417,0.000027822589,0.000018872755,0.00005565749,0.000041178857,0.000016536282],"category_scores_gemma":[0.00014948493,0.00018568375,0.00010926336,0.00023055906,0.00008311447,0.00009957301,0.000033979268,0.0001769431,0.0000029443472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016106857,0.002059821,0.9772269,0.00005811405,0.00013075052,0.000079694175,0.0004902345,0.00003938982,0.00013976022,0.000009155406,0.0019023151,0.0017569687],"study_design_scores_gemma":[0.033176605,0.02658117,0.93019515,0.00038793893,0.0001507562,0.000036613816,0.00008617016,0.0000977057,0.00028871905,0.0000040364603,0.008865177,0.00012992571],"about_ca_topic_score_codex":0.00011702634,"about_ca_topic_score_gemma":0.0004704391,"teacher_disagreement_score":0.04703176,"about_ca_system_score_codex":0.00019132302,"about_ca_system_score_gemma":0.0000689606,"threshold_uncertainty_score":0.7571963},"labels":[],"label_agreement":null},{"id":"W1605189715","doi":"10.1002/ejhf.100","title":"Mitochondria Selective <i>S</i> -Nitrosation by Mitochondria-Targeted <i>S</i> -Nitrosothiol Protects Against Post-Infarct Heart Failure in Mouse Hearts","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Servier; Canadian Institutes of Health Research; Gates Cambridge Trust; British Heart Foundation","keywords":"Medicine; Heart failure; Myocardial infarction; Reperfusion injury; Cardiology; Ejection fraction; Mitochondrion; Infarction; Cardioprotection; Cardiac function curve; Ischemia; Internal medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.00403997209716666,"score_gpt":0.20836160981348545,"score_spread":0.20432163771631878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1605189715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96901524,0.00044183832,0.00023951927,0.027636705,0.000574182,0.0012658545,0.000034340606,0.00010456301,0.0006877787],"genre_scores_gemma":[0.97656393,0.000032775984,0.016259076,0.004725448,0.0015399825,0.000015191398,0.00010006461,0.0001805468,0.0005829588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99507207,0.0013388216,0.0012644231,0.0005869026,0.0009883808,0.0007494003],"domain_scores_gemma":[0.99727976,0.00015827786,0.0005143413,0.00056977704,0.0008812891,0.00059653365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014249483,0.0005532871,0.0011352323,0.000499163,0.00023087666,0.00012045292,0.00023265026,0.00022598848,0.00006243485],"category_scores_gemma":[0.00078343414,0.0004577459,0.00065959594,0.00062738813,0.00013946502,0.0004419907,0.00009947277,0.001965549,0.00015356347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005272324,0.00019497321,0.0028570595,0.000070269794,0.000062574276,0.00008278497,0.0004020554,0.00004341443,0.7092721,0.0000018375151,0.28631958,0.00016611516],"study_design_scores_gemma":[0.0056341263,0.0016099534,0.002162363,0.0006150115,0.00007124846,0.0012874276,0.00031362378,0.000036979327,0.5745401,0.0000071155796,0.41329208,0.0004300346],"about_ca_topic_score_codex":0.000021508722,"about_ca_topic_score_gemma":0.000023646624,"teacher_disagreement_score":0.13473205,"about_ca_system_score_codex":0.00022248585,"about_ca_system_score_gemma":0.00030071012,"threshold_uncertainty_score":0.99978745},"labels":[],"label_agreement":null},{"id":"W1608429456","doi":"10.1002/ejhf.19","title":"The Relationship between Left Ventricular Ejection Fraction and Mortality in Patients with Acute Heart Failure: Insights from the ASCEND-HF Trial","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ejection fraction; Medicine; Hazard ratio; Nesiritide; Heart failure; Internal medicine; Acute decompensated heart failure; Cardiology; Confidence interval; Proportional hazards model; Natriuretic peptide","score_opus":0.018682983839445583,"score_gpt":0.2529119177097449,"score_spread":0.23422893387029933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608429456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633422,0.0001375517,0.000113500806,0.035166673,0.00020038897,0.000981799,0.0000029669065,0.000018246612,0.000036684203],"genre_scores_gemma":[0.9972201,0.000010786076,0.0018322333,0.00021314695,0.0006056289,0.0000052114715,0.000028781067,0.0000272572,0.000056835008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765724,0.00081423525,0.0005646407,0.00020188313,0.00054322666,0.0002187631],"domain_scores_gemma":[0.99861187,0.0004887759,0.00026305206,0.000309792,0.00017099387,0.00015552259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006808204,0.00019403698,0.00033516646,0.00011093414,0.00032892358,0.00014409854,0.00009740254,0.000050187176,0.00004156739],"category_scores_gemma":[0.00019817002,0.000096764365,0.0001207423,0.00021051329,0.00007949554,0.00041339025,0.00004240486,0.0006257627,0.00007996491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009553023,0.0001161026,0.95744646,0.00000482546,0.0002548048,0.00004222463,0.00012226625,0.0000026282885,0.000019440837,0.000017742914,0.04079886,0.00021934888],"study_design_scores_gemma":[0.013418947,0.000988654,0.8471631,0.000108820925,0.00030781925,0.000022660977,0.00019814525,0.0000031492114,0.000019436917,0.00006795283,0.13761427,0.0000870899],"about_ca_topic_score_codex":0.00007024522,"about_ca_topic_score_gemma":0.00007026771,"teacher_disagreement_score":0.1102834,"about_ca_system_score_codex":0.00009001999,"about_ca_system_score_gemma":0.00005100567,"threshold_uncertainty_score":0.39459363},"labels":[],"label_agreement":null},{"id":"W1644795515","doi":"10.1002/ejhf.238","title":"Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction: Insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Myocardial infarction; Valsartan; Internal medicine; Cardiology; Heart failure; Clinical trial","score_opus":0.04707371528903156,"score_gpt":0.327602289275263,"score_spread":0.2805285739862315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1644795515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537274,0.0002703045,0.000030380419,0.04328634,0.0019176507,0.0005450983,0.000025131885,0.000018409399,0.0001792636],"genre_scores_gemma":[0.99128586,0.0002658699,0.00057758915,0.00419544,0.0035141215,0.000007212874,0.000015086639,0.00004368045,0.0000951246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936055,0.0030596142,0.0016485817,0.0003524498,0.0009789238,0.00035492406],"domain_scores_gemma":[0.99786663,0.0005654986,0.00038036247,0.0003990992,0.00033232378,0.00045607827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033310293,0.00029929524,0.0012137478,0.0003483427,0.00009753124,0.00019202755,0.00023056682,0.00015496572,0.000049494247],"category_scores_gemma":[0.0011218976,0.00019301147,0.00038563056,0.0003674196,0.00037661075,0.00035584747,0.00018561447,0.0017890193,0.00006978175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015697546,0.00018388272,0.954687,0.0000059880063,0.0006348887,0.00070125796,0.0016674607,0.0000022107754,0.000115133604,0.000006887587,0.024433238,0.0018644906],"study_design_scores_gemma":[0.022434076,0.0012063155,0.84881485,0.00010067217,0.00017920333,0.0002486425,0.0006592572,0.000027386382,0.0000061731603,0.000048353046,0.12610888,0.00016617044],"about_ca_topic_score_codex":0.000085101965,"about_ca_topic_score_gemma":0.000023047864,"teacher_disagreement_score":0.105872154,"about_ca_system_score_codex":0.00012612014,"about_ca_system_score_gemma":0.0003976295,"threshold_uncertainty_score":0.7870779},"labels":[],"label_agreement":null},{"id":"W1697884774","doi":"10.1002/ejhf.85","title":"Relationship between Heart Rate and Mortality and Morbidity in the Irbesartan Patients with Heart Failure and Preserved Systolic Function Trial (I-Preserve)","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Heart failure; Cardiology; Ejection fraction; Internal medicine; Atrial fibrillation; Irbesartan; Sinus rhythm; Heart rate; Blood pressure","score_opus":0.046047590719771894,"score_gpt":0.28165069940941284,"score_spread":0.23560310868964096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1697884774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869529,0.00033518847,0.00007700457,0.011766266,0.0000784193,0.0007160588,0.0000076810875,0.000014055695,0.000052425963],"genre_scores_gemma":[0.9980678,0.000012723047,0.00058904954,0.00057708006,0.00068384,0.000003534053,0.00001246886,0.00003232444,0.000021194848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99471235,0.0035094442,0.00064049644,0.000289784,0.0005490273,0.00029886965],"domain_scores_gemma":[0.99850386,0.00037581977,0.00017472854,0.0004133935,0.00019360673,0.00033858186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064789047,0.00021686798,0.0006520959,0.00015085327,0.00024038997,0.000108137945,0.000082383674,0.000078082274,0.000008744429],"category_scores_gemma":[0.00055682426,0.00013852264,0.00012496738,0.00023420448,0.00013094749,0.0003415038,0.00005334301,0.00083118357,0.0000064959668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012421333,0.00006405954,0.98966837,0.00015794524,0.000059693848,0.000015455356,0.00017655826,0.0000062140257,0.00004796127,0.00001399454,0.008496341,0.00005126628],"study_design_scores_gemma":[0.015504893,0.002094925,0.9278921,0.00020731954,0.00023422114,0.00018267219,0.00017709778,0.000012727404,0.000006691775,0.000039063765,0.053523693,0.00012458098],"about_ca_topic_score_codex":0.00008982744,"about_ca_topic_score_gemma":0.00015570014,"teacher_disagreement_score":0.06177626,"about_ca_system_score_codex":0.000026215403,"about_ca_system_score_gemma":0.0000943683,"threshold_uncertainty_score":0.5648789},"labels":[],"label_agreement":null},{"id":"W1704899953","doi":"10.1002/ejhf.274","title":"Changes in N-Terminal Pro-B-Type Natriuretic Peptide Levels and Outcomes in Heart Failure with Preserved Ejection Fraction: An Analysis of the I-Preserve Study","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Interquartile range; Internal medicine; Hazard ratio; Cardiology; Natriuretic peptide; Confidence interval; Proportional hazards model; Heart failure with preserved ejection fraction","score_opus":0.04650908930617137,"score_gpt":0.3054133375954731,"score_spread":0.25890424828930175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1704899953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97418904,0.00008099999,0.000011497924,0.024803078,0.00007428458,0.0007772072,0.0000026744126,0.000012313937,0.000048910548],"genre_scores_gemma":[0.9955561,0.0000034264763,0.0038859625,0.00013549085,0.000096988,0.000005319772,0.0000033616561,0.000027781363,0.0002855777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971989,0.0010439052,0.00058546435,0.0002690339,0.00065681845,0.0002458918],"domain_scores_gemma":[0.99870104,0.0000632139,0.00027849176,0.00042680843,0.00032496176,0.00020548655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018786907,0.00022794654,0.00077822484,0.00077969476,0.000055952867,0.000048091082,0.00016119659,0.000042819054,0.000055771852],"category_scores_gemma":[0.00019100403,0.00013672149,0.00012488411,0.0011098239,0.0000713018,0.00033935017,0.00009690869,0.00047324027,0.0000040700234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005083721,0.0007505216,0.99249434,0.00003983636,0.0004929437,0.00035766093,0.0012283718,0.00026026828,0.00038596574,0.0000021205342,0.0034202882,0.000059299542],"study_design_scores_gemma":[0.004121255,0.004373349,0.96977425,0.0002038799,0.00093950884,0.00016722553,0.0071339444,0.00013338424,0.00014287898,0.000003921326,0.012877823,0.0001285873],"about_ca_topic_score_codex":0.0001374925,"about_ca_topic_score_gemma":0.0068510305,"teacher_disagreement_score":0.024667587,"about_ca_system_score_codex":0.0001080535,"about_ca_system_score_gemma":0.0001154091,"threshold_uncertainty_score":0.55753404},"labels":[],"label_agreement":null},{"id":"W1810606235","doi":"10.1002/ejhf.332","title":"Signature of Circulating microRNAs in Patients with Acute Heart Failure","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Novartis Pharma; Nederlandse Federatie van Universitair Medische Centra; ZonMw; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Exacerbation; Cohort; microRNA; COPD; Internal medicine; Cohort study; Cardiology; Oncology; Gene","score_opus":0.0063852511982745224,"score_gpt":0.21226219252429346,"score_spread":0.20587694132601894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1810606235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810195,0.00039305078,0.00032083446,0.0009143262,0.000085612744,0.00012828354,0.000013868686,0.000003886421,0.000038187653],"genre_scores_gemma":[0.9863592,0.0000012820781,0.013243015,0.000107860644,0.0001865027,3.6314378e-7,0.00003992875,0.000040695264,0.000021146641],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854594,0.00031554129,0.0004583552,0.00018574046,0.0002953097,0.00019913357],"domain_scores_gemma":[0.9987631,0.000009009247,0.00034553558,0.00024964503,0.00046470502,0.00016804627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004919682,0.00016620195,0.00024926817,0.000112933776,0.000027713635,0.000021293286,0.0001872168,0.00006912257,0.000011992278],"category_scores_gemma":[0.00009735942,0.00013612495,0.000115237555,0.00015664102,0.000073803414,0.000019528492,0.00006904945,0.00024532585,0.0000068927798],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068458286,0.00022249356,0.11739315,0.00003480264,0.00019352697,0.00006372877,0.0002279946,0.0023033107,0.79822296,0.000006386445,0.08047385,0.00017320385],"study_design_scores_gemma":[0.014099613,0.0037437656,0.60235035,0.0008641269,0.00022009487,0.000768345,0.0005411102,0.000032624637,0.1371914,0.000033806045,0.23923053,0.0009242211],"about_ca_topic_score_codex":0.0000011846269,"about_ca_topic_score_gemma":0.000003913771,"teacher_disagreement_score":0.66103154,"about_ca_system_score_codex":0.000027470383,"about_ca_system_score_gemma":0.0001459517,"threshold_uncertainty_score":0.5551014},"labels":[],"label_agreement":null},{"id":"W1822976210","doi":"10.1002/ejhf.235","title":"Loop Diuretic Dose Adjustments after a Hospitalization for Heart Failure: Insights From ASCEND-HF","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Diuretic; Medicine; Heart failure; Loop diuretic; Loop (graph theory); Internal medicine; Cardiology","score_opus":0.01816045104009309,"score_gpt":0.25657355555854067,"score_spread":0.23841310451844758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1822976210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88682055,0.0033186576,0.003834485,0.101989135,0.0013027862,0.0020535395,0.000036700898,0.00014413657,0.0004999928],"genre_scores_gemma":[0.92249936,0.000023489709,0.07298363,0.0021194525,0.001196625,0.000016900429,0.00008157307,0.00011101121,0.00096794195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973515,0.0003635294,0.00079932,0.0003634604,0.00071137917,0.0004108057],"domain_scores_gemma":[0.9980022,0.00006158324,0.0002672562,0.0004438495,0.000535585,0.0006895817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005072676,0.00037139066,0.0006571945,0.00029524553,0.0000926426,0.000104726256,0.0001633176,0.00007924511,0.00019124946],"category_scores_gemma":[0.00018518814,0.00028170997,0.0003769605,0.00025978684,0.00007312659,0.00040868082,0.00008459386,0.00031072117,0.00041961815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013011696,0.0007242174,0.021521421,0.00008950826,0.00052165374,0.00079572544,0.0013528491,0.000027567763,0.002092507,0.00011675479,0.9705574,0.00089920824],"study_design_scores_gemma":[0.00938851,0.0026927977,0.032313317,0.00049137813,0.00058164535,0.00018706087,0.00058075646,0.00005454134,0.00086549314,0.00013251494,0.952415,0.00029696675],"about_ca_topic_score_codex":0.000009767261,"about_ca_topic_score_gemma":0.000022250211,"teacher_disagreement_score":0.099869676,"about_ca_system_score_codex":0.00013953923,"about_ca_system_score_gemma":0.00018598298,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W1826470798","doi":"10.1002/ejhf.172","title":"A Prediction Model for Sudden Cardiac Death in Patients with Heart Failure and Preserved Ejection Fraction","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Bristol-Myers Squibb; U.S. Department of Veterans Affairs","keywords":"Medicine; Heart failure; Ejection fraction; Cardiology; Internal medicine; Sudden cardiac death; Stroke volume","score_opus":0.012727278487881542,"score_gpt":0.2157984303839532,"score_spread":0.20307115189607164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1826470798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98205143,0.0000672984,0.015421441,0.0016592965,0.00024241525,0.00045792005,0.00001107576,0.000028473502,0.000060664253],"genre_scores_gemma":[0.9914451,0.000014055074,0.007831359,0.00011447557,0.00042905632,0.0000033383603,0.000024046438,0.00004233588,0.00009620773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985901,0.00030739993,0.0003591058,0.00019459843,0.0003743634,0.0001744343],"domain_scores_gemma":[0.99912834,0.0000389942,0.00014331224,0.00018539318,0.00033468113,0.00016927934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009995918,0.00015052677,0.00040017182,0.0002320855,0.000091974776,0.00003714199,0.000034561886,0.000057214304,0.000009403764],"category_scores_gemma":[0.00013194402,0.00010986479,0.00024498257,0.00012242947,0.000025083908,0.00028905817,0.000015749873,0.00036677098,0.0000044667872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087225105,0.000090773974,0.973567,0.00004861438,0.0001265743,0.0000020074433,0.00006760468,0.0013261216,0.00040710246,0.00000385729,0.023241393,0.00024667662],"study_design_scores_gemma":[0.00468223,0.0014227849,0.86187375,0.0001818112,0.00020119955,0.00004962102,0.00012849146,0.0032349154,0.000097075856,0.0000066016473,0.12801564,0.000105893225],"about_ca_topic_score_codex":0.000007925322,"about_ca_topic_score_gemma":0.0000087460685,"teacher_disagreement_score":0.111693285,"about_ca_system_score_codex":0.00006835242,"about_ca_system_score_gemma":0.00004699227,"threshold_uncertainty_score":0.44801563},"labels":[],"label_agreement":null},{"id":"W1828972162","doi":"10.1002/ejhf.346","title":"Is Heart Rate a Risk Marker in Patients with Chronic Heart Failure and Concomitant Atrial Fibrillation? Results from the MAGGIC Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Auckland; University of Glasgow","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Ejection fraction; Atrial fibrillation; Hazard ratio; Heart rate; Sinus rhythm; Heart failure with preserved ejection fraction; Proportional hazards model; Ivabradine; Blood pressure; Confidence interval","score_opus":0.04862225412323212,"score_gpt":0.3050113154973389,"score_spread":0.2563890613741068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1828972162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057027875,0.9756272,0.000012578954,0.016258514,0.0001573136,0.0014660859,0.00072347786,0.000017835195,0.00003419708],"genre_scores_gemma":[0.00920624,0.97790146,0.00553023,0.0015708714,0.004498267,0.000006424018,0.0005744655,0.0003226651,0.00038940317],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98612833,0.008800592,0.0024496205,0.0007492868,0.0013117275,0.0005604698],"domain_scores_gemma":[0.9953715,0.00072957145,0.0013007497,0.0012498,0.0007242926,0.00062407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010519017,0.0007449273,0.0065184715,0.0004898741,0.00019474034,0.00016651282,0.00024341574,0.00021743275,0.00025339233],"category_scores_gemma":[0.00046154432,0.0003877254,0.005224516,0.0012148457,0.00014954786,0.00020411394,0.000121131096,0.0019809809,0.00015528823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028456608,0.00013691987,0.036389355,0.0022038694,0.28858933,0.000854364,0.0009368542,0.00031708344,8.158199e-7,0.0000014901107,0.6356596,0.03206472],"study_design_scores_gemma":[0.004761332,0.00082977273,0.019358061,0.0011758162,0.14348306,0.00039067215,0.000041403386,0.0000071787413,1.1305404e-7,0.0000016997079,0.8296454,0.00030548722],"about_ca_topic_score_codex":0.00016296562,"about_ca_topic_score_gemma":0.00018588989,"teacher_disagreement_score":0.19398585,"about_ca_system_score_codex":0.000277651,"about_ca_system_score_gemma":0.0015732651,"threshold_uncertainty_score":0.9998575},"labels":[],"label_agreement":null},{"id":"W1846633084","doi":"10.1002/ejhf.258","title":"Twenty-Four-Hour Heart Rate Lowering with Ivabradine in Chronic Heart Failure: Insights from the SHIFT Holter Substudy","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Daiichi-Sankyo; Servier; Sanofi; Pfizer; Amgen","keywords":"Ivabradine; Heart failure; Medicine; Cardiology; Internal medicine; Heart rate; Blood pressure","score_opus":0.024636093832789488,"score_gpt":0.2507080357951383,"score_spread":0.2260719419623488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1846633084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9374068,0.0041572857,0.00022887142,0.057109624,0.00035846475,0.00052870525,0.0000046010714,0.00004615636,0.00015953196],"genre_scores_gemma":[0.991482,0.000058500074,0.0023033402,0.0037055404,0.0022318675,0.0000036441197,0.000009584459,0.00012566088,0.000079819896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99506056,0.0017919719,0.0009907515,0.00044552307,0.0010345215,0.00067667256],"domain_scores_gemma":[0.9976469,0.00015175663,0.00022762346,0.0008387777,0.0003214594,0.0008134581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034834705,0.00042600607,0.0010794192,0.00025247384,0.00018171912,0.00014167574,0.00030690554,0.00008268153,0.00009838915],"category_scores_gemma":[0.00015062917,0.00026049273,0.0004301443,0.0006182276,0.0001411205,0.0004223714,0.000106517036,0.0016485758,0.00042260796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030649954,0.00093246327,0.30064335,0.00028353903,0.001816968,0.013932924,0.012056078,0.0023996471,0.039278314,0.000036175825,0.62441874,0.0011367712],"study_design_scores_gemma":[0.0064257993,0.0019221202,0.36778134,0.00084269594,0.00015787242,0.002149132,0.00087950507,0.000026172844,0.0010031204,0.000016011614,0.61850876,0.0002874912],"about_ca_topic_score_codex":0.00012561047,"about_ca_topic_score_gemma":0.0004280342,"teacher_disagreement_score":0.06713798,"about_ca_system_score_codex":0.0003240597,"about_ca_system_score_gemma":0.0010280593,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W1870916828","doi":"10.1002/ejhf.29","title":"Analysing Recurrent Hospitalizations in Heart Failure: A Review of Statistical Methodology, with Application to CHARM-Preserved","year":2013,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Medical Research Council; National Institute for Health and Care Research; AstraZeneca","keywords":"Heart failure; Candesartan; Medicine; Hazard ratio; Confidence interval; Internal medicine; Proportional hazards model; Placebo; Cardiology; Blood pressure; Angiotensin II","score_opus":0.0712695524200134,"score_gpt":0.3777123776398205,"score_spread":0.30644282521980715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1870916828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001540801,0.9505031,0.017658658,0.028482081,0.000082412225,0.0031253407,0.000030163119,0.000023079643,0.00007975127],"genre_scores_gemma":[0.000025863246,0.6835428,0.3154403,0.00041590296,0.00018506404,0.000060304046,0.00015418658,0.000084329506,0.000091241105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938091,0.0025737407,0.0021232974,0.0004629717,0.000636334,0.0003945535],"domain_scores_gemma":[0.99707407,0.00030770476,0.00094606355,0.00068835955,0.00054996583,0.0004338167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030965817,0.00051060336,0.003353417,0.0010441558,0.000053721156,0.00003580652,0.000293042,0.00008990657,0.00033400746],"category_scores_gemma":[0.00062740553,0.00033931763,0.00056738313,0.0015144047,0.00008812975,0.00014203842,0.00013154138,0.0007383664,0.00018679074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008752591,0.0006686168,0.00038778805,0.078731515,0.001207637,0.00027961418,0.00014144609,0.000009503794,0.000027661754,0.00032231797,0.6672335,0.25090283],"study_design_scores_gemma":[0.00063112914,0.0011536762,0.00016558022,0.09547397,0.002352375,0.0003580758,0.00004669477,0.000004120819,0.0000026520092,0.000004772515,0.89956784,0.00023910978],"about_ca_topic_score_codex":0.000015064039,"about_ca_topic_score_gemma":0.000022209864,"teacher_disagreement_score":0.29778165,"about_ca_system_score_codex":0.00018556016,"about_ca_system_score_gemma":0.00034920438,"threshold_uncertainty_score":0.9999059},"labels":[],"label_agreement":null},{"id":"W1884258305","doi":"10.1002/ejhf.257","title":"March 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Dilated cardiomyopathy; Muscle hypertrophy; Fibrosis; Internal medicine; Cardiomyopathy; Cardiology; Pressure overload; Agonist; Pathological; Receptor; Endocrinology; Cardiac hypertrophy","score_opus":0.028865158177398313,"score_gpt":0.2886084764163644,"score_spread":0.25974331823896607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1884258305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7498778,0.0036388661,0.00007366669,0.23018575,0.00051005866,0.00017666799,0.000004887279,0.00004159287,0.015490673],"genre_scores_gemma":[0.9550759,0.00005765228,0.035227675,0.0011379592,0.0010361964,3.53668e-7,0.0000047946196,0.000040235544,0.007419224],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988456,0.00019254624,0.0003053176,0.00010354325,0.00036886768,0.00018415837],"domain_scores_gemma":[0.9990185,0.000021847465,0.00012222998,0.00018740523,0.00022965316,0.00042036915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007093037,0.00011142448,0.00025911955,0.00006785235,0.00004255115,0.000014288398,0.00008277645,0.000018954996,0.00023949161],"category_scores_gemma":[0.00008914987,0.0000766376,0.00012823116,0.00008534967,0.000059430055,0.00005604222,0.000052352054,0.00025984787,0.00083989336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026782762,0.0001118877,0.018136792,0.000018720732,0.000044080054,0.0020387524,0.0002742831,0.0000039583724,0.002640357,0.000008355492,0.97588086,0.0005740998],"study_design_scores_gemma":[0.00337649,0.0014469154,0.011508294,0.00019846679,0.000047939327,0.0075215707,0.00028588186,0.0000034952898,0.0008781388,0.0000085951515,0.9746483,0.00007594113],"about_ca_topic_score_codex":0.0000015056978,"about_ca_topic_score_gemma":0.0000017158465,"teacher_disagreement_score":0.22904779,"about_ca_system_score_codex":0.000113761416,"about_ca_system_score_gemma":0.00011677639,"threshold_uncertainty_score":0.9999381},"labels":[],"label_agreement":null},{"id":"W1894962606","doi":"10.1002/ejhf.406","title":"September 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiac resynchronization therapy; Clinical trial; Internal medicine; Cardiology; Intensive care medicine; Ejection fraction","score_opus":0.03447618825392765,"score_gpt":0.2979085704181113,"score_spread":0.26343238216418363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1894962606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80040914,0.004522796,0.00024027788,0.011490138,0.00064671505,0.00008379805,0.000004227403,0.0000434613,0.18255948],"genre_scores_gemma":[0.9835154,0.000015403408,0.0052208807,0.0006138135,0.0010768366,1.1789963e-7,0.000001208023,0.00002278853,0.009533571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990394,0.0001206654,0.000288978,0.00008264165,0.0003399643,0.00012836848],"domain_scores_gemma":[0.9990563,0.00003081512,0.00013422362,0.000145741,0.00037613572,0.00025678615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007440968,0.00008907955,0.00034101144,0.00007270091,0.000045636672,0.000017911163,0.000016742855,0.00001408849,0.00002836338],"category_scores_gemma":[0.0001621138,0.000064881,0.00017699922,0.00009983956,0.000039841427,0.000089321795,0.000044999502,0.00015370209,0.0007514083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014407985,0.000010336306,0.0292207,0.000008036142,0.00006375279,0.00016908659,0.00030896126,0.000034094173,0.0007722699,0.000004611415,0.96917397,0.000090097565],"study_design_scores_gemma":[0.001431193,0.0002742761,0.021221703,0.00009602304,0.000049058035,0.009203494,0.00021373811,0.0000016359219,0.00018470845,0.0000051382435,0.96725535,0.00006367031],"about_ca_topic_score_codex":5.429155e-7,"about_ca_topic_score_gemma":8.464587e-7,"teacher_disagreement_score":0.18310627,"about_ca_system_score_codex":0.000053616935,"about_ca_system_score_gemma":0.000058756807,"threshold_uncertainty_score":0.96580845},"labels":[],"label_agreement":null},{"id":"W1911692366","doi":"10.1002/ejhf.320","title":"Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels?","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Hartstichting","keywords":"Medicine; Heart failure; N-terminal pro-Brain Natriuretic Peptide; Internal medicine; Cardiology; Natriuretic peptide; Brain natriuretic peptide; Terminal (telecommunication); Acute decompensated heart failure","score_opus":0.03620697080987763,"score_gpt":0.3119333362592158,"score_spread":0.2757263654493382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1911692366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90857935,0.00034963392,0.00015180532,0.08785179,0.00030422295,0.0024404526,0.000022887456,0.000050923074,0.00024893743],"genre_scores_gemma":[0.98546803,0.000018373586,0.011857462,0.0008403771,0.0003487081,0.000043318247,0.000038298112,0.000106346546,0.0012790988],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500394,0.0015045179,0.0013321878,0.0005068158,0.0008074945,0.0008450394],"domain_scores_gemma":[0.9979241,0.00029687185,0.00052283553,0.0005428027,0.00030734407,0.00040604288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002509157,0.0006006418,0.0009597715,0.00040413957,0.000253858,0.00013112249,0.00037458524,0.0000791419,0.00010851294],"category_scores_gemma":[0.00031822672,0.00030478573,0.00033454056,0.00054803153,0.00018461437,0.00061565585,0.0001864589,0.0010406809,0.00012853023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008976213,0.0062439507,0.66748405,0.00039023825,0.003356901,0.009492059,0.10286639,0.0013024855,0.0015753028,0.00055729056,0.18907247,0.008682678],"study_design_scores_gemma":[0.051534053,0.010085776,0.32265812,0.002588434,0.00082109385,0.0015659847,0.007283841,0.0015306318,0.00038958818,0.0001155761,0.6003717,0.001055196],"about_ca_topic_score_codex":0.000022925546,"about_ca_topic_score_gemma":0.00019234433,"teacher_disagreement_score":0.41129923,"about_ca_system_score_codex":0.00047275954,"about_ca_system_score_gemma":0.00032044022,"threshold_uncertainty_score":0.9999404},"labels":[],"label_agreement":null},{"id":"W1938743611","doi":"10.1002/ejhf.301","title":"June 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Atrial fibrillation; Heart failure; Epidemiology; Internal medicine; Intensive care medicine; Cardiology; Emergency medicine","score_opus":0.026903058526322444,"score_gpt":0.2748117513555577,"score_spread":0.24790869282923525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1938743611","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3552359,0.0029759316,0.0005912227,0.62116647,0.001669944,0.0006008639,0.0000052934365,0.00013398456,0.017620388],"genre_scores_gemma":[0.871743,0.000053405693,0.08799609,0.0027342557,0.0016578708,0.0000015095832,0.000010697116,0.00008124672,0.03572193],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849886,0.00022119517,0.0004186517,0.00013932353,0.00047010792,0.00025188032],"domain_scores_gemma":[0.99877185,0.000019934016,0.00015722225,0.00026412297,0.00026053097,0.0005263729],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001077113,0.0001571846,0.00035782836,0.00014143833,0.000051495575,0.000024613904,0.000104419734,0.000022453918,0.00023196233],"category_scores_gemma":[0.00010658313,0.000112326445,0.00016895674,0.00014990415,0.00004690816,0.00013456243,0.00008272481,0.00023291692,0.0014572958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026511107,0.00011461822,0.006843757,0.000017914737,0.00009240153,0.0015824449,0.00026471756,0.0000074532104,0.0010394051,0.000026996786,0.9891852,0.0005599412],"study_design_scores_gemma":[0.0035382367,0.0009882373,0.004568682,0.00013069245,0.000108194006,0.001997566,0.0001719886,0.000006685253,0.00040681893,0.000011284644,0.9879721,0.00009950767],"about_ca_topic_score_codex":0.0000017937509,"about_ca_topic_score_gemma":0.00000744502,"teacher_disagreement_score":0.6184322,"about_ca_system_score_codex":0.00012705992,"about_ca_system_score_gemma":0.00009999225,"threshold_uncertainty_score":0.9993202},"labels":[],"label_agreement":null},{"id":"W1964524529","doi":"10.1002/ejhf.46","title":"Evidence-Based Co-Medication in Heart Failure: Necessary or Bystander?","year":2013,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Aspirin; Myocardial infarction; Internal medicine; Bystander effect; Cardiology; Intensive care medicine","score_opus":0.04787576308118812,"score_gpt":0.29003803347784796,"score_spread":0.24216227039665983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964524529","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024570418,0.0015838919,0.00029453306,0.9935927,0.0004895563,0.0011933274,0.000010939999,0.00007867116,0.00029937548],"genre_scores_gemma":[0.03755017,0.0005496518,0.06518288,0.8759298,0.011686421,0.00004954468,0.0003619377,0.00044595377,0.008243692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99365044,0.0015797334,0.0017079939,0.00060364365,0.0016556554,0.00080253754],"domain_scores_gemma":[0.99702597,0.0004887334,0.00076867605,0.00086413114,0.00042800768,0.00042445734],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002338247,0.00071104825,0.0014794114,0.0011541605,0.00012444342,0.00017900273,0.00045499048,0.0003951125,0.0031544121],"category_scores_gemma":[0.0004294864,0.0004972692,0.0005736608,0.0005117999,0.00018395556,0.0005846497,0.00007979501,0.003500136,0.0014112464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027803695,0.00016913434,0.0032565165,0.0005776567,0.00019895156,0.006347835,0.000097642434,0.000008040796,0.00035879717,0.0000017727496,0.9878634,0.00084217696],"study_design_scores_gemma":[0.0037810926,0.0018819978,0.0035924036,0.00699974,0.00036730914,0.0011479045,0.0001538875,0.00002054254,0.00016347862,0.000006694498,0.98145753,0.00042742628],"about_ca_topic_score_codex":0.000022469345,"about_ca_topic_score_gemma":0.000020487694,"teacher_disagreement_score":0.117662914,"about_ca_system_score_codex":0.00041703484,"about_ca_system_score_gemma":0.00092193997,"threshold_uncertainty_score":0.9997479},"labels":[],"label_agreement":null},{"id":"W1965307661","doi":"10.1093/eurjhf/hfs181","title":"Effect of Bucindolol on Heart Failure Outcomes and Heart Rate Response in Patients with Reduced Ejection Fraction Heart Failure and Atrial Fibrillation","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; ARCA Biopharma","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Cardiology; Atrial fibrillation; Hazard ratio; Heart rate; Ivabradine; Sinus rhythm; Bradycardia; Post-hoc analysis; Blood pressure; Confidence interval","score_opus":0.009598194673875553,"score_gpt":0.2613683948907203,"score_spread":0.2517702002168447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965307661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658676,0.00015534325,0.000018488985,0.03256095,0.00024947003,0.0010918024,0.0000057973325,0.000034441488,0.000016119768],"genre_scores_gemma":[0.9931886,0.000010587777,0.005767871,0.0002591404,0.0006189588,0.000002638158,0.000015457576,0.0000677298,0.00006897393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953468,0.002450674,0.00080096436,0.0003461758,0.00060259673,0.00045277967],"domain_scores_gemma":[0.99818695,0.0005602737,0.00036815708,0.00032262353,0.00019853357,0.00036346048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036789714,0.0004172742,0.0010018322,0.0006632067,0.0001491048,0.000058420712,0.00005140827,0.00011716408,0.00004840861],"category_scores_gemma":[0.00049963756,0.00029150964,0.00025131085,0.00034194207,0.000096753865,0.0006134942,0.000051460986,0.00057373114,0.000036209964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019086726,0.00013544549,0.9456278,0.00013989958,0.00021260364,0.000021379392,0.00022765396,0.000068892376,0.010571995,0.0000042272727,0.023298092,0.00060529524],"study_design_scores_gemma":[0.011506585,0.012391724,0.82874614,0.00054936146,0.00026188995,0.000182268,0.00014850078,0.000008351023,0.0028472983,0.000001352114,0.14313646,0.00022008482],"about_ca_topic_score_codex":0.000014314371,"about_ca_topic_score_gemma":0.000007866815,"teacher_disagreement_score":0.119838364,"about_ca_system_score_codex":0.00013760544,"about_ca_system_score_gemma":0.00006297459,"threshold_uncertainty_score":0.9999537},"labels":[],"label_agreement":null},{"id":"W1966058553","doi":"10.1093/eurjhf/hfq040","title":"Baseline Characteristics and Outcomes of Patients with Heart Failure Receiving Bronchodilators in the CHARM Programme","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Candesartan; Bronchodilator; Heart failure; Internal medicine; Adverse effect; Cardiology; Placebo; Randomized controlled trial; Blood pressure; Asthma; Angiotensin II","score_opus":0.009842047846101223,"score_gpt":0.23465248829029342,"score_spread":0.22481044044419218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966058553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9446081,0.000028368659,0.00003204669,0.0546206,0.000120537734,0.0005186726,0.000007668811,0.000013967438,0.00005002226],"genre_scores_gemma":[0.96797687,0.000007706508,0.03096134,0.0007374648,0.00018819433,0.000002738319,0.0000153277,0.000037393445,0.00007295544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980494,0.00031175936,0.0006476117,0.00018312885,0.00049899524,0.00030910663],"domain_scores_gemma":[0.9988165,0.00013012458,0.00028951364,0.0003117294,0.00025801902,0.0001941308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018258978,0.00023210798,0.00055266183,0.00021553064,0.000070490234,0.00005315354,0.00013752382,0.000040932682,0.000084091516],"category_scores_gemma":[0.0002702523,0.00012734647,0.000118971606,0.00021680538,0.000113662914,0.00017249548,0.00004784849,0.00068045437,0.0000124741155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015797804,0.00044451703,0.9758653,0.00006646531,0.00008117461,0.000079142155,0.0005458337,3.524515e-7,0.0005402165,0.000019863019,0.019462224,0.0027369277],"study_design_scores_gemma":[0.0022481761,0.00080186024,0.67458475,0.00014011146,0.000100045145,0.000083840925,0.0002502117,0.000003034776,0.00005256018,0.0000015327244,0.32164553,0.00008833671],"about_ca_topic_score_codex":0.0000062067606,"about_ca_topic_score_gemma":0.000047970025,"teacher_disagreement_score":0.3021833,"about_ca_system_score_codex":0.000018738507,"about_ca_system_score_gemma":0.00005959276,"threshold_uncertainty_score":0.51930386},"labels":[],"label_agreement":null},{"id":"W1966096666","doi":"10.1093/eurjhf/hfp088","title":"Ghrelin Resistance Occurs in Severe Heart Failure and Resolves After Heart Transplantation","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Ghrelin; Heart failure; Heart transplantation; Appetite; Internal medicine; Cachexia; Endocrinology; Transplantation; Cardiology; Body mass index; Hormone","score_opus":0.01037809180780965,"score_gpt":0.23184305995517268,"score_spread":0.22146496814736302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966096666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442475,0.00043677248,0.000084024876,0.054583617,0.00009535186,0.00013995449,0.000010923202,0.000025640682,0.00037623447],"genre_scores_gemma":[0.9867446,0.000101433536,0.009559937,0.0031057154,0.00019971853,4.934078e-7,0.0000013556445,0.000021129485,0.00026560778],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99769783,0.0006834154,0.0005841267,0.00031296056,0.00042871837,0.00029295456],"domain_scores_gemma":[0.9992578,0.000114485236,0.00016339586,0.00020778278,0.00007589072,0.0001806279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007936139,0.00019672062,0.00030341023,0.00023389091,0.00012963294,0.00012527443,0.00017364806,0.000051306884,0.00007235002],"category_scores_gemma":[0.00011463764,0.00017471905,0.0001212674,0.0002968982,0.00009570838,0.0005947826,0.000017253067,0.0004646871,0.00006119594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003426325,0.0004513042,0.06705467,0.00021447046,0.000015916183,0.0027714758,0.0036287473,0.0007993798,0.5649343,0.0006744011,0.35483688,0.0011921115],"study_design_scores_gemma":[0.001573036,0.00043007924,0.5101377,0.0005315528,0.000015521295,0.0012666424,0.00012508163,0.0000129898835,0.02483541,0.00028443916,0.46049824,0.0002893433],"about_ca_topic_score_codex":0.000001319322,"about_ca_topic_score_gemma":0.00004336533,"teacher_disagreement_score":0.5400989,"about_ca_system_score_codex":0.00002577228,"about_ca_system_score_gemma":0.00004481731,"threshold_uncertainty_score":0.71248364},"labels":[],"label_agreement":null},{"id":"W1967260367","doi":"10.1093/eurjhf/hfs072","title":"Heart Failure: Can We Define, Assess, and Treat Diastolic Heart Failure?","year":2012,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Life expectancy; Heart failure; Public health; Epidemiology; Stroke (engine); Population; Worry; Blood pressure; Intensive care medicine; Gerontology; Cardiology; Internal medicine; Environmental health; Anxiety; Nursing; Psychiatry","score_opus":0.0241661745368328,"score_gpt":0.2506657902179436,"score_spread":0.22649961568111082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967260367","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058645234,0.0048278887,0.00007546329,0.9863655,0.0008369898,0.001164882,0.00007882396,0.00018011894,0.00060582504],"genre_scores_gemma":[0.08102224,0.0012143072,0.17203961,0.6804467,0.040654343,0.000069270754,0.000799371,0.0016961121,0.02205805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918979,0.0016231622,0.0019175337,0.0010096648,0.0017236012,0.0018281625],"domain_scores_gemma":[0.99573505,0.00033969228,0.00082069554,0.0013308055,0.0005122001,0.0012615698],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0017384765,0.0015590325,0.0028255743,0.0012281172,0.00039912196,0.00038133102,0.00048367665,0.0006431797,0.0010946826],"category_scores_gemma":[0.00018746042,0.0012291471,0.0012159344,0.0005900403,0.00044467358,0.0005661242,0.0003399964,0.0048217615,0.0010446282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010620606,0.00024888004,0.008312271,0.0006483502,0.00068979606,0.002944104,0.00028881553,0.0000018765932,0.00082609267,0.000027853286,0.9852107,0.00069502176],"study_design_scores_gemma":[0.0039487705,0.0015411263,0.004011355,0.0015871646,0.0017510022,0.010696077,0.00024262995,0.0000016981663,0.00021730804,0.00002128708,0.9750163,0.0009652808],"about_ca_topic_score_codex":0.000056434503,"about_ca_topic_score_gemma":0.00009450097,"teacher_disagreement_score":0.30591878,"about_ca_system_score_codex":0.0003494699,"about_ca_system_score_gemma":0.00047900708,"threshold_uncertainty_score":0.99981844},"labels":[],"label_agreement":null},{"id":"W1967329774","doi":"10.1016/j.ejheart.2007.03.004","title":"Angiotensin-Converting Enzyme Inhibitors and Survival in Women and Men with Heart Failure","year":2007,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hazard ratio; Heart failure; Angiotensin-converting enzyme; Internal medicine; ACE inhibitor; Confidence interval; Medical prescription; Cohort; Retrospective cohort study; Cohort study; Proportional hazards model; Cardiology; Pharmacology; Blood pressure","score_opus":0.008786088826480444,"score_gpt":0.2269551854537624,"score_spread":0.21816909662728196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967329774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94032246,0.0004935785,0.00009980257,0.05822198,0.000069681904,0.00029236468,8.8234384e-7,0.00002850816,0.00047076913],"genre_scores_gemma":[0.97862405,0.00002852573,0.019715907,0.00084776216,0.00038878474,8.3024895e-7,0.000001600621,0.000051990748,0.0003405579],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799156,0.00021978944,0.00060612004,0.00026558858,0.00040028826,0.000516668],"domain_scores_gemma":[0.9989777,0.000089420384,0.00016215068,0.00018215628,0.00013046215,0.0004580627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025220048,0.00026082105,0.0005653595,0.00038913323,0.00009225358,0.000056442073,0.000056325123,0.000048726302,0.00004201593],"category_scores_gemma":[0.000064803884,0.00018813557,0.000072440685,0.00026926683,0.00014261072,0.0002372266,0.00007561976,0.00045711405,0.000015892816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002505894,0.00042322167,0.6610144,0.0002310874,0.00047731848,0.006036711,0.0067463513,0.00001175717,0.028627874,0.000113961745,0.28702906,0.0067824125],"study_design_scores_gemma":[0.0067591113,0.0022286056,0.26529133,0.00061199,0.000091744165,0.0021643771,0.004447515,0.000011043237,0.001595991,0.000012848701,0.7164971,0.00028830944],"about_ca_topic_score_codex":0.000012395739,"about_ca_topic_score_gemma":0.00004631165,"teacher_disagreement_score":0.4294681,"about_ca_system_score_codex":0.00009436677,"about_ca_system_score_gemma":0.000060814007,"threshold_uncertainty_score":0.76719457},"labels":[],"label_agreement":null},{"id":"W1967348896","doi":"10.1093/eurjhf/hfs110","title":"Troponin I in Acute Decompensated Heart Failure: Insights from the ASCEND-HF Study","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Troponin I; Cardiology; Internal medicine; Heart failure; Acute decompensated heart failure; Troponin; Acute coronary syndrome; Percentile; Etiology; Cohort; Myocardial infarction","score_opus":0.02414318953463105,"score_gpt":0.3058864716681919,"score_spread":0.2817432821335608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967348896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8997285,0.0008027689,0.000052178922,0.09795522,0.00047973497,0.000600566,0.000008696231,0.000035020512,0.0003373535],"genre_scores_gemma":[0.98832375,0.000028137925,0.0051138154,0.0046760803,0.0016151912,0.0000031371974,0.000010467433,0.00007907585,0.00015032389],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99459743,0.002639615,0.0009264401,0.0002527785,0.001006378,0.0005773292],"domain_scores_gemma":[0.9979778,0.0003102214,0.0002360433,0.0005923144,0.00035370144,0.00052993256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021369103,0.00028788787,0.0007047079,0.00032521648,0.00018983336,0.00009641132,0.00038568678,0.000063633175,0.0004912859],"category_scores_gemma":[0.00029521176,0.0001802713,0.0003103958,0.00064070715,0.00013684144,0.0004065816,0.00018361156,0.0017720422,0.0008640327],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000766224,0.0008393992,0.25965956,0.0000060071648,0.0008068716,0.0009330503,0.00317186,0.000014809406,0.02571133,0.000020757127,0.7077484,0.00032173545],"study_design_scores_gemma":[0.003197947,0.00085480505,0.43199697,0.00008702153,0.00014736659,0.00088815344,0.00238671,0.000008840405,0.00066875125,0.0000049910336,0.55962443,0.00013399648],"about_ca_topic_score_codex":0.00007498913,"about_ca_topic_score_gemma":0.0000371625,"teacher_disagreement_score":0.1723374,"about_ca_system_score_codex":0.00015001431,"about_ca_system_score_gemma":0.00016537192,"threshold_uncertainty_score":0.99991393},"labels":[],"label_agreement":null},{"id":"W1967692565","doi":"10.1016/j.ejheart.2008.08.010","title":"Is Ventilatory Efficiency (VE/VCO2 slope) Associated with Right Ventricular Oxidative Metabolism in Patients with Congestive Heart Failure","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Ottawa","funders":"Academy of Finland; Suomen Lääketieteen Säätiö; Canadian Institutes of Health Research; University of Ottawa","keywords":"Medicine; Cardiology; Heart failure; Internal medicine; Ventricle; Oxidative metabolism; Perfusion; Metabolism","score_opus":0.006466033901133166,"score_gpt":0.19974247479646765,"score_spread":0.19327644089533447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967692565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969379,0.0009053022,0.00010509381,0.0013471146,0.00011502104,0.000399405,0.000014469178,0.000023164308,0.0001525583],"genre_scores_gemma":[0.9978752,0.00001842782,0.0012953024,0.00045691011,0.00017759688,0.0000021600033,0.000027225973,0.00006346805,0.0000837147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997255,0.0005832289,0.00055394106,0.00035275682,0.0008120108,0.00044300582],"domain_scores_gemma":[0.99822783,0.000051206756,0.00032734734,0.00035203694,0.0007552086,0.00028637686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071700785,0.00032602032,0.0011127802,0.00032442212,0.00015534465,0.000018627472,0.00016081195,0.000072784875,0.0001460741],"category_scores_gemma":[0.00011347791,0.00021598584,0.00041400787,0.0006278316,0.00029116147,0.00022935285,0.000051358376,0.00083714724,0.0000793567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013830967,0.0054983958,0.6430122,0.00016739851,0.0053695356,0.029746057,0.0074129724,0.0019796875,0.003226098,0.000050863004,0.28937122,0.00033457275],"study_design_scores_gemma":[0.00992486,0.0017016011,0.9406283,0.0006307539,0.00046461012,0.0015513061,0.00019032626,0.000005988491,0.0022840647,0.000003501507,0.042312946,0.00030173184],"about_ca_topic_score_codex":0.0000045084703,"about_ca_topic_score_gemma":0.000003572247,"teacher_disagreement_score":0.29761606,"about_ca_system_score_codex":0.0001103662,"about_ca_system_score_gemma":0.00022207784,"threshold_uncertainty_score":0.8807647},"labels":[],"label_agreement":null},{"id":"W1968035999","doi":"10.1093/eurjhf/hfr176","title":"Right Ventricular Dysfunction is Associated with Chronic Kidney Disease and Predicts Survival in Patients with Chronic Systolic Heart Failure","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute of Dental and Craniofacial Research; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Cardiology; Internal medicine; Kidney disease; Heart failure; Hazard ratio; Ejection fraction; Renal function; Confidence interval; Odds ratio; Proportional hazards model","score_opus":0.007640537085706155,"score_gpt":0.21414956966521514,"score_spread":0.20650903257950898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968035999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901616,0.0023092995,0.000015845188,0.0067954813,0.00011521607,0.0005102123,0.000036960675,0.000022834362,0.000032569467],"genre_scores_gemma":[0.99874926,0.000035207624,0.00020273884,0.00034462713,0.0003495466,0.0000036386175,0.00009247836,0.000056078465,0.00016641177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973416,0.00052874564,0.0003747554,0.00024206447,0.0009185165,0.0005943588],"domain_scores_gemma":[0.99780494,0.000041777697,0.00019641053,0.00025493593,0.00032426778,0.0013776982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055933185,0.00026918662,0.0005027691,0.00027638298,0.0001381807,0.00003713912,0.000082824816,0.000047380097,0.0001831356],"category_scores_gemma":[0.00015691454,0.00016465316,0.00009981855,0.00036957674,0.00011955103,0.00041744858,0.0000461206,0.00054848957,0.000052312633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011232045,0.0009229828,0.95918703,0.00010310537,0.0003921794,0.0036512753,0.000027309805,0.000009381195,0.000111753216,0.0000023666992,0.034411408,0.000057982787],"study_design_scores_gemma":[0.012363116,0.0038248498,0.9150375,0.0015791715,0.00030317382,0.0007322744,0.00001767566,0.000029894481,0.000056520013,0.0000010544217,0.06589014,0.00016461444],"about_ca_topic_score_codex":0.000008180112,"about_ca_topic_score_gemma":0.000011452958,"teacher_disagreement_score":0.044149537,"about_ca_system_score_codex":0.0003896277,"about_ca_system_score_gemma":0.0004934261,"threshold_uncertainty_score":0.6714361},"labels":[],"label_agreement":null},{"id":"W1968736423","doi":"10.1016/j.ejheart.2004.10.012","title":"Vagal Heart Rate Responses to Chronic Beta-Blockade in Human Heart Failure Relate to Cardiac Norepinephrine Spillover","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Centre National d’Etudes Spatiales; Heart and Stroke Foundation of Canada","keywords":"Baroreflex; Medicine; Heart failure; Metoprolol; Blockade; Internal medicine; Heart rate; Cardiology; Carvedilol; Ejection fraction; Anesthesia; Blood pressure; Receptor","score_opus":0.012253532909240175,"score_gpt":0.26302013133587504,"score_spread":0.25076659842663485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968736423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7280655,0.0003136144,0.00004826601,0.2703685,0.00023772565,0.0006631773,0.000021074962,0.000049607654,0.00023257117],"genre_scores_gemma":[0.97498727,0.000009543842,0.013156074,0.007015614,0.002829774,0.0000072394146,0.0000073762553,0.00011331628,0.0018737733],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943702,0.0019279674,0.0016562751,0.000598405,0.00056723994,0.0008798697],"domain_scores_gemma":[0.9974037,0.00025501123,0.00020231742,0.00079703203,0.00031627354,0.0010256759],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005879787,0.00047095423,0.0013579202,0.00073515036,0.00021628012,0.00011919294,0.00030428567,0.00012146391,0.00072693353],"category_scores_gemma":[0.00062417536,0.00041498442,0.0005889247,0.00063891703,0.000093178256,0.0003414194,0.0001897148,0.0016200012,0.0015351303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006936123,0.00026525607,0.013265285,0.000064600536,0.00016237969,0.00033001773,0.00079572026,0.0020936853,0.7707202,0.00004142989,0.21057068,0.0009971434],"study_design_scores_gemma":[0.0025004346,0.0017829129,0.20365286,0.00045659152,0.00008036698,0.00039704845,0.00008986251,0.00003089256,0.008450773,0.000005152239,0.7822377,0.00031540394],"about_ca_topic_score_codex":0.000032318054,"about_ca_topic_score_gemma":0.00011435361,"teacher_disagreement_score":0.76226944,"about_ca_system_score_codex":0.0005326644,"about_ca_system_score_gemma":0.00058313826,"threshold_uncertainty_score":0.9998302},"labels":[],"label_agreement":null},{"id":"W1969129654","doi":"10.1016/s1388-9842(00)80082-3","title":"Current Treatment in Hospital Based Outpatient Heart Failure Clinics: The Canadian CHF Clinics Network Initial Experience","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Medicine; University hospital; Library science; Family medicine","score_opus":0.02257448960884421,"score_gpt":0.29987118225740017,"score_spread":0.27729669264855594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969129654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8358741,0.0014730353,0.000031600674,0.15861051,0.0014231533,0.0017191821,0.000019962685,0.00005461289,0.0007938839],"genre_scores_gemma":[0.98623586,0.00015480738,0.008953573,0.0026021108,0.0016795993,0.000022778484,0.00002957479,0.00007208935,0.0002496033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959331,0.0008551132,0.0013149696,0.0004112437,0.00064807665,0.00083748606],"domain_scores_gemma":[0.9980024,0.00015587831,0.0002555148,0.0006118937,0.0001945221,0.0007797797],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013895474,0.0004400502,0.00073187763,0.00026120982,0.00035290167,0.00012885308,0.00028654217,0.00008981003,0.0010945165],"category_scores_gemma":[0.00009805658,0.00028908817,0.000517223,0.00043660347,0.00017967614,0.00020152352,0.000038523187,0.0008829942,0.0004813769],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090897945,0.0028470014,0.26874658,0.000060938266,0.00031850842,0.002712139,0.0059302514,0.0023674916,0.000008681901,0.000060071663,0.6473499,0.068689466],"study_design_scores_gemma":[0.004098361,0.0046135127,0.04225492,0.0004078458,0.00013795386,0.00011779314,0.00049509894,0.00014808598,0.0000159435,0.000008265602,0.9474449,0.00025733132],"about_ca_topic_score_codex":0.00084724306,"about_ca_topic_score_gemma":0.013201326,"teacher_disagreement_score":0.300095,"about_ca_system_score_codex":0.0005123395,"about_ca_system_score_gemma":0.0009037911,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W1969573398","doi":"10.1093/eurjhf/hfq230","title":"The Heart Failure Revascularisation Trial (HEART)","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Revascularization; Cardiology; Heart failure; Ejection fraction; Canadian Cardiovascular Society; Internal medicine; Coronary artery disease; Angina; Randomized controlled trial; Surgery; Myocardial infarction","score_opus":0.010091928186783058,"score_gpt":0.2563066971063803,"score_spread":0.24621476891959726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969573398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7379353,0.0011461943,0.0002727581,0.25465664,0.003971269,0.00059370324,0.0000061837127,0.00007615339,0.0013418066],"genre_scores_gemma":[0.9736731,0.000025821724,0.018239934,0.0019070485,0.0057257675,0.0000017843328,0.000006236172,0.00006659471,0.00035373043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976929,0.0005401774,0.0006377933,0.00017751152,0.0006382835,0.00031333513],"domain_scores_gemma":[0.99807787,0.00042317927,0.00021327133,0.00052341324,0.00045304984,0.00030921734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032408957,0.00018545285,0.00041877173,0.00011802779,0.00029631713,0.00017123773,0.00015699022,0.00006054945,0.00009797793],"category_scores_gemma":[0.0024466862,0.0001215055,0.0005968576,0.00018036917,0.00015081298,0.00014449925,0.000048970225,0.0014362772,0.00034358492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015268931,0.00009761864,0.009596992,0.000017019003,0.0000909506,0.00011367427,0.00015279067,0.000009534769,0.015016445,0.00007536867,0.9724165,0.0008861635],"study_design_scores_gemma":[0.013150673,0.0006473998,0.03590715,0.00011471287,0.00017319788,0.002612569,0.00018342954,0.0000073665383,0.0009816841,0.000029872625,0.9460685,0.00012341257],"about_ca_topic_score_codex":0.0000045571683,"about_ca_topic_score_gemma":0.000008315172,"teacher_disagreement_score":0.2527496,"about_ca_system_score_codex":0.000027081727,"about_ca_system_score_gemma":0.00022031974,"threshold_uncertainty_score":0.62399894},"labels":[],"label_agreement":null},{"id":"W1970498375","doi":"10.1093/eurjhf/hft072","title":"Impact of Left Bundle Branch Block on Heart Rate and its Relationship to Treatment with Ivabradine in Chronic Heart Failure","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Servier; Deutsche Forschungsgemeinschaft","keywords":"Ivabradine; Medicine; Cardiology; Left bundle branch block; Heart failure; Internal medicine; Heart rate; Clinical endpoint; Bradycardia; Bundle branch block; Sinus rhythm; Electrocardiography; Randomized controlled trial; Atrial fibrillation; Blood pressure","score_opus":0.01843994186532686,"score_gpt":0.27700890715555315,"score_spread":0.25856896529022627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970498375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716043,0.0012442656,0.000019633428,0.026247531,0.00004111348,0.00071488257,0.0000061804553,0.00001551122,0.00010659559],"genre_scores_gemma":[0.9972167,0.00007092352,0.0014742276,0.0005169953,0.00037188435,0.000003337823,0.000004460822,0.00006300928,0.00027848384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973666,0.0008135266,0.0006862832,0.00028170098,0.0004060861,0.000445816],"domain_scores_gemma":[0.9984343,0.00012373278,0.00014178979,0.00037911892,0.00028381063,0.00063723756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011990048,0.00029405483,0.0008683382,0.0003992385,0.00009450714,0.000041326817,0.00007352333,0.00006284905,0.00018674154],"category_scores_gemma":[0.000096031894,0.00019473194,0.00034132611,0.0003597919,0.000054044864,0.00021946714,0.00002273416,0.0005493737,0.0002540825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017337349,0.0016037321,0.6099295,0.00057631306,0.0012919483,0.00036884483,0.0028858786,0.005469526,0.23893791,0.000054974582,0.1348773,0.0022703193],"study_design_scores_gemma":[0.0049369014,0.02014664,0.8616693,0.00096547237,0.00010155026,0.0036226152,0.00010668737,0.000037686084,0.0025251277,0.0000053926346,0.1056688,0.00021384115],"about_ca_topic_score_codex":0.00008080452,"about_ca_topic_score_gemma":0.00007227359,"teacher_disagreement_score":0.25173977,"about_ca_system_score_codex":0.00036889614,"about_ca_system_score_gemma":0.00063890236,"threshold_uncertainty_score":0.7940938},"labels":[],"label_agreement":null},{"id":"W1971240641","doi":"10.1016/s1388-9842(03)00163-6","title":"Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON)","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Moxonidine; Medicine; Placebo; Heart failure; Adverse effect; Anesthesia; Internal medicine; Randomized controlled trial; Cardiology; Agonist; Receptor","score_opus":0.003769685408574886,"score_gpt":0.20003822967410745,"score_spread":0.19626854426553256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971240641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605215,0.000035313325,0.00010120482,0.0029096995,0.000066469845,0.000703283,0.000012468159,0.000017141338,0.00010225823],"genre_scores_gemma":[0.9980023,0.0000017420396,0.0016311771,0.000193054,0.0000803933,0.0000021842168,0.000012168845,0.00004559909,0.000031381427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966755,0.0012786482,0.00084092736,0.0002742797,0.00047216614,0.00045848443],"domain_scores_gemma":[0.99849373,0.00011346806,0.00032034743,0.00035783078,0.0003438623,0.00037076717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017756206,0.0002989378,0.00082167774,0.00023076117,0.00006153017,0.000018628032,0.00007116828,0.00005938169,0.00016933208],"category_scores_gemma":[0.00027328724,0.000197679,0.0002051924,0.00033532115,0.0001511171,0.00026982452,0.000018236693,0.00064925,0.000016175687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013957131,0.000783703,0.98965937,0.0003144706,0.0001304386,0.0003621759,0.00032912387,0.00077728776,0.0047391895,0.000044391196,0.0012738623,0.00019025728],"study_design_scores_gemma":[0.028729968,0.012697185,0.9126915,0.0016151045,0.00042111697,0.00037190135,0.000523996,0.00005949613,0.00821191,0.000008155357,0.034282785,0.00038690583],"about_ca_topic_score_codex":0.00001328436,"about_ca_topic_score_gemma":0.000021944787,"teacher_disagreement_score":0.07696791,"about_ca_system_score_codex":0.00015606562,"about_ca_system_score_gemma":0.00037603712,"threshold_uncertainty_score":0.8061116},"labels":[],"label_agreement":null},{"id":"W1971692135","doi":"10.1016/j.ejheart.2005.11.007","title":"Previously Known and Newly Diagnosed Atrial Fibrillation: A Major Risk Indicator After a Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction","year":2006,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Western Hospital","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Atrial fibrillation; Myocardial infarction; Angina; Randomization; Randomized controlled trial","score_opus":0.010537267122904218,"score_gpt":0.24304076774016461,"score_spread":0.23250350061726038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971692135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689596,0.002095001,0.0009506839,0.026474508,0.00047171477,0.0008826758,0.000017086184,0.00008690646,0.00006176882],"genre_scores_gemma":[0.98687965,0.000117747644,0.0050005703,0.00031346898,0.0071338336,7.5966693e-7,0.00006300941,0.00006247243,0.00042847384],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733275,0.0006130687,0.0008984437,0.00030551763,0.00054685975,0.00030336776],"domain_scores_gemma":[0.9986065,0.00015558868,0.0005642064,0.00023538196,0.00019221549,0.0002460949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008848192,0.00028149484,0.0005999752,0.00032094592,0.00020886287,0.00014057315,0.00007326719,0.000094425726,0.00037847343],"category_scores_gemma":[0.00022550108,0.00021351356,0.00048087072,0.0003200409,0.00007880212,0.00033041448,0.00006347087,0.00037970813,0.00011779114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002100684,0.00001426919,0.71224916,0.000050187704,0.0002852731,0.00014977272,0.00008438384,0.0001993199,0.00095410185,0.000005489701,0.2828125,0.0010948726],"study_design_scores_gemma":[0.0049736574,0.00061322155,0.40213916,0.00008593643,0.0004416699,0.00057865964,0.000044449735,0.000031857624,0.000055456392,0.000008241707,0.590879,0.00014865457],"about_ca_topic_score_codex":0.00002664727,"about_ca_topic_score_gemma":0.000013089849,"teacher_disagreement_score":0.31010997,"about_ca_system_score_codex":0.00008868085,"about_ca_system_score_gemma":0.00008250821,"threshold_uncertainty_score":0.870683},"labels":[],"label_agreement":null},{"id":"W1973113315","doi":"10.1093/eurjhf/hfq065","title":"Efficacy and Safety of Angiotensin Receptor Blockade are Not Modified by Aspirin in Patients with Chronic Heart Failure: A Cohort Study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) Programme","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Candesartan; Medicine; Aspirin; Heart failure; Internal medicine; Discontinuation; Placebo; Cardiology; Ejection fraction; Adverse effect; Angiotensin II; Blood pressure","score_opus":0.018997002894665365,"score_gpt":0.2726135928770653,"score_spread":0.25361658998239994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973113315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971521,0.0000997062,0.0000070373053,0.025582328,0.00009670798,0.0026374732,0.000037607806,0.000013376863,0.000004770017],"genre_scores_gemma":[0.99314654,0.000016684191,0.006510925,0.000077071454,0.00013514054,0.000015031763,0.00004167121,0.000045078654,0.000011848037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996292,0.00086156203,0.0011758774,0.0004903612,0.00075741904,0.00042279417],"domain_scores_gemma":[0.998435,0.00011144806,0.0004819322,0.00050267123,0.00023040987,0.00023850503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023263465,0.0003644101,0.0010620005,0.0002774825,0.00007419343,0.0000428524,0.00013648317,0.00009365499,0.000038217335],"category_scores_gemma":[0.00010659322,0.00025259558,0.000103935716,0.00046001148,0.00023039163,0.00021050581,0.00010476924,0.0010804826,0.0000013607302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008668309,0.0019855115,0.97629344,0.000057024325,0.00022523334,0.000038053342,0.00047982045,0.000048236332,0.011217207,0.000002867862,0.008479328,0.00030644058],"study_design_scores_gemma":[0.0139163295,0.0025000107,0.9674526,0.00059684535,0.0001936277,0.000030771887,0.00066719245,0.000036759273,0.00060653914,0.0000016253063,0.0137961805,0.0002015519],"about_ca_topic_score_codex":0.0015375019,"about_ca_topic_score_gemma":0.008051682,"teacher_disagreement_score":0.025505256,"about_ca_system_score_codex":0.00018698949,"about_ca_system_score_gemma":0.00020045479,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W1976132370","doi":"10.1016/j.ejheart.2005.11.005","title":"Programme to Improve the Use of Beta-Blockers for Heart Failure in the Elderly and in those with Severe Symptoms: Results of the BRING-UP 2 Study","year":2006,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Impact Fund","keywords":"Carvedilol; Medicine; Discontinuation; Heart failure; Beta blocker; Adverse effect; Internal medicine; Incidence (geometry); Metoprolol; Cardiology","score_opus":0.024084518104770743,"score_gpt":0.25695047595557174,"score_spread":0.232865957850801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976132370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88290524,0.000083532854,0.000016408294,0.11412166,0.000055062475,0.0027694043,0.000015116143,0.0000070281726,0.000026551279],"genre_scores_gemma":[0.98941666,0.000003038196,0.009674459,0.00039876325,0.00012202987,0.00001797391,0.000002947149,0.000033760738,0.0003303921],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974078,0.0006389094,0.0008398219,0.0002430852,0.0005244601,0.00034595185],"domain_scores_gemma":[0.998613,0.00026658535,0.00031018257,0.0005172641,0.00020621932,0.00008674495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021086668,0.00023363734,0.0005016645,0.00018173037,0.000083211315,0.00006409546,0.00024044783,0.00003155756,0.0000031161721],"category_scores_gemma":[0.00014245731,0.000103054466,0.00016451045,0.00046455307,0.00012219597,0.00014226737,0.000084721825,0.00039534288,0.0000017234534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073330784,0.0032106284,0.44084525,0.0003413664,0.0006937862,0.00035856673,0.015050435,0.00065263856,0.0031968127,0.00009611143,0.5181074,0.010113884],"study_design_scores_gemma":[0.013306008,0.010944005,0.267802,0.0008639431,0.0003887642,0.0003476553,0.008241897,0.000017538714,0.00046606924,0.000009189215,0.6974263,0.00018659625],"about_ca_topic_score_codex":0.00021127146,"about_ca_topic_score_gemma":0.0021404978,"teacher_disagreement_score":0.1793189,"about_ca_system_score_codex":0.000039619208,"about_ca_system_score_gemma":0.00009595893,"threshold_uncertainty_score":0.42024392},"labels":[],"label_agreement":null},{"id":"W1977566196","doi":"10.1016/s1388-9842(00)00057-x","title":"Does in-Patient ECG Monitoring have an Impact on Medical Care in Chronic Heart Failure Patients?","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Healthcare Technology and Patient Monitoring","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Telemetry; Medicine; Heart failure; Intensive care unit; Atrial fibrillation; Emergency medicine; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.014941442379231224,"score_gpt":0.31045263479423635,"score_spread":0.2955111924150051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977566196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923316,0.00042926826,0.0000015132737,0.006240093,0.0005091365,0.00031943212,0.000006369025,0.00004601184,0.000116563504],"genre_scores_gemma":[0.9972705,0.000067398905,0.0014076357,0.00023657506,0.0009270453,0.000002984267,0.000010399115,0.000058890433,0.000018538572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650514,0.0007301423,0.0009934376,0.00032999407,0.00084084645,0.0006004475],"domain_scores_gemma":[0.9985754,0.00008189048,0.00017639976,0.00040449735,0.00020091947,0.0005609002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007935389,0.00030836277,0.00060516235,0.00055775634,0.00010333731,0.000024463334,0.0002386655,0.00020204761,0.0004286214],"category_scores_gemma":[0.00018090854,0.00019385602,0.0001957673,0.00030469632,0.00008114809,0.0002578558,0.000041386444,0.0021548767,0.00008697284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005802147,0.00031416153,0.9326058,0.00008445389,0.00002517185,0.0013046155,0.0021654046,0.00035862558,0.00018288444,8.8749965e-7,0.0014016661,0.060976133],"study_design_scores_gemma":[0.005763857,0.016508266,0.8815861,0.0051398156,0.000029259332,0.00047369295,0.002781079,0.00006718008,0.002624189,0.0000067462174,0.08462935,0.00039047885],"about_ca_topic_score_codex":0.000063894455,"about_ca_topic_score_gemma":0.00015584806,"teacher_disagreement_score":0.08322769,"about_ca_system_score_codex":0.00078632287,"about_ca_system_score_gemma":0.000448279,"threshold_uncertainty_score":0.9361987},"labels":[],"label_agreement":null},{"id":"W1978364141","doi":"10.1016/j.ejheart.2007.11.007","title":"Preservation of Heart Function in Diabetic Rats by the Combined Effects of Muscle Cell Implantation and Insulin Therapy","year":2007,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Insulin; Internal medicine; Diabetic cardiomyopathy; Transplantation; Cardiac function curve; Diabetes mellitus; Cardiomyopathy; Heart failure; Streptozotocin; Cardiac muscle; Endocrinology; Myocyte; Cardiology; Heart transplantation","score_opus":0.007392250799121687,"score_gpt":0.21681208164470225,"score_spread":0.20941983084558058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978364141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603194,0.0018533529,0.0005241236,0.0010892139,0.00020007834,0.00024540414,0.000001205329,0.000005029668,0.00004963801],"genre_scores_gemma":[0.99915826,0.00029287054,0.00022953717,0.0001872572,0.00007866245,3.6927477e-7,0.0000057152643,0.000014757418,0.000032550575],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875903,0.0003721245,0.0004200795,0.00007915093,0.00027020706,0.00009942583],"domain_scores_gemma":[0.9993004,0.00016189596,0.00020119529,0.00012750874,0.00014648502,0.000062511266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014419568,0.000083664214,0.00026213913,0.00013850213,0.000031645417,0.000007651329,0.00003696007,0.0000298564,0.00001328037],"category_scores_gemma":[0.000074053445,0.000053520504,0.00013157616,0.0001956278,0.000045191988,0.00010239447,0.000010448325,0.00022507351,0.0000022342356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016198296,0.00031433333,0.14207779,0.00021844717,0.00011969735,0.00002715087,0.001091863,0.000051855106,0.8252382,0.0000048678253,0.016752502,0.012483425],"study_design_scores_gemma":[0.0042808717,0.0014415474,0.88520896,0.00013735435,0.00005808286,0.000065860746,0.00024277372,0.000010572634,0.080234826,0.000005272952,0.02826655,0.00004731828],"about_ca_topic_score_codex":0.000015244617,"about_ca_topic_score_gemma":0.000004446883,"teacher_disagreement_score":0.7450034,"about_ca_system_score_codex":0.000014740127,"about_ca_system_score_gemma":0.000025719031,"threshold_uncertainty_score":0.21825027},"labels":[],"label_agreement":null},{"id":"W1979077415","doi":"10.1093/eurjhf/hfr111","title":"Design and Preliminary Results of the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS) in Patients with Acute and Chronic Heart Failure","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"Saudi Heart Association","keywords":"Medicine; Heart failure; Internal medicine; Diabetes mellitus; Cardiology; Coronary artery disease; Population; ACE inhibitor; Angiotensin-converting enzyme; Blood pressure","score_opus":0.018007665159081716,"score_gpt":0.23817117830172027,"score_spread":0.22016351314263854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979077415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98137665,0.00021238453,0.00019262308,0.016334053,0.00015963253,0.0015900127,0.0000045612305,0.000013316597,0.00011674488],"genre_scores_gemma":[0.97243077,0.000031992135,0.026997179,0.00021005482,0.00011293584,0.000007385538,0.000005633643,0.000037161357,0.00016687396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972281,0.0008254694,0.00082422077,0.00031906826,0.00048597527,0.00031718795],"domain_scores_gemma":[0.99888456,0.00007719462,0.00033550302,0.00039433097,0.00013542939,0.00017296584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015867844,0.000262561,0.00058244006,0.00026245383,0.00007999182,0.000028958282,0.00009825887,0.00006665914,0.00003135586],"category_scores_gemma":[0.00005523936,0.00016675048,0.000103056824,0.000280708,0.0001818923,0.0002541643,0.000096482036,0.0005889032,0.0000047058297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19522554,0.0030917414,0.55557764,0.0003875449,0.0007415571,0.0006761204,0.0021720368,0.00012597135,0.0021359876,0.00005110147,0.23785827,0.0019565143],"study_design_scores_gemma":[0.06718688,0.021443343,0.86010927,0.0011087292,0.00029657688,0.00029318695,0.00020528105,0.000022496206,0.00029925446,0.000015270602,0.048834655,0.00018506644],"about_ca_topic_score_codex":0.000016667422,"about_ca_topic_score_gemma":0.000033317014,"teacher_disagreement_score":0.30453163,"about_ca_system_score_codex":0.00011777268,"about_ca_system_score_gemma":0.00022116354,"threshold_uncertainty_score":0.67998874},"labels":[],"label_agreement":null},{"id":"W1980828265","doi":"10.1093/eurjhf/hfp188","title":"Haemodialysis, not Ultrafiltration, can Correct Hyponatraemia in Heart Failure","year":2009,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ultrafiltration (renal); Heart failure; Intravascular volume status; Hyponatremia; Internal medicine; Extracorporeal; Intensive care medicine; Population; Cardiology; Tolvaptan; Blood pressure; Chromatography","score_opus":0.011515036182403007,"score_gpt":0.23341525296186022,"score_spread":0.2219002167794572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980828265","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011658789,0.0012074591,0.000044722536,0.98503333,0.00021263005,0.00038042435,0.000027544766,0.000046621004,0.0013884836],"genre_scores_gemma":[0.17984796,0.00028115965,0.005198366,0.80312425,0.008651401,0.000003084874,0.0003687778,0.00024303173,0.0022819908],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950416,0.00096018094,0.0014977339,0.00051013805,0.001187873,0.00080244604],"domain_scores_gemma":[0.99792683,0.00017039066,0.0005916201,0.00052418653,0.00048532122,0.0003016465],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011973123,0.0006485253,0.0015318582,0.000973682,0.00012484542,0.000121183235,0.00041839015,0.0004249276,0.0002798061],"category_scores_gemma":[0.00024802776,0.00056172576,0.0008875909,0.0005825826,0.000145333,0.00019793899,0.000025175399,0.0063827224,0.00016112888],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023094265,0.00009500441,0.0007441061,0.00008138338,0.00017247979,0.003899351,0.00018754472,0.00003462326,0.016568666,0.0000041251906,0.97689325,0.0010885029],"study_design_scores_gemma":[0.002259674,0.0015365247,0.01644577,0.0006608774,0.00036746933,0.005418952,0.00008421732,0.0000037814254,0.0011950226,0.00003000074,0.971515,0.0004827157],"about_ca_topic_score_codex":0.000026411351,"about_ca_topic_score_gemma":0.00015229659,"teacher_disagreement_score":0.1819091,"about_ca_system_score_codex":0.00021299339,"about_ca_system_score_gemma":0.0007903044,"threshold_uncertainty_score":0.99968344},"labels":[],"label_agreement":null},{"id":"W1981823969","doi":"10.1016/s1388-9842(00)80256-1","title":"Heart Failure Patient Selection for Cardiac Resynchronization Therapy: Is QRS Dispersion Better than Maximum QRS Duration?","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"Medicine; Heart failure; Cardiac resynchronization therapy; Internal medicine; Cardiology; German; QRS complex; Ejection fraction; History","score_opus":0.010839779442719072,"score_gpt":0.2445982815431765,"score_spread":0.23375850210045743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981823969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521726,0.001074903,0.00080916897,0.04374003,0.00040928513,0.000510093,0.000027058273,0.00006207073,0.0011948192],"genre_scores_gemma":[0.98857784,0.00014786427,0.007828637,0.0015734773,0.0013365593,0.0000033156252,0.000029010454,0.000063457024,0.0004398085],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980922,0.0003214504,0.00060755404,0.00024415608,0.00047760166,0.00025705728],"domain_scores_gemma":[0.99885553,0.000064174754,0.00021180062,0.00019710242,0.00051398535,0.00015743509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005240792,0.00021687297,0.00050759484,0.00018253851,0.00032356236,0.00007523326,0.000027427646,0.0000565357,0.00016381852],"category_scores_gemma":[0.00006063542,0.00017174725,0.0005020158,0.00028076323,0.00004906715,0.00023392093,0.000014518726,0.00024846525,0.00009120715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006843379,0.00006506204,0.062495798,0.00003853022,0.00030725423,0.0000066003327,0.0016457143,0.00032410544,0.010812941,0.000004365413,0.91266006,0.010955246],"study_design_scores_gemma":[0.0015201807,0.0011767473,0.035101358,0.00015390165,0.00010635358,0.00051913067,0.0004302556,0.000045508714,0.0033051553,0.000011868894,0.9574536,0.00017590956],"about_ca_topic_score_codex":0.0000049075798,"about_ca_topic_score_gemma":0.0000021019391,"teacher_disagreement_score":0.044793587,"about_ca_system_score_codex":0.000093345094,"about_ca_system_score_gemma":0.00007296502,"threshold_uncertainty_score":0.70036495},"labels":[],"label_agreement":null},{"id":"W1984747321","doi":"10.1093/eurjhf/hfr005","title":"Reflex Systemic Sympatho-Neural Response to Brachial Adenosine Infusion in Treated Heart Failure","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Candesartan; Anesthesia; Brachial artery; Reflex; Heart failure; Vasodilation; Adenosine; Ejection fraction; Angiotensin II; Cardiology; Endocrinology; Blood pressure","score_opus":0.021458350121476632,"score_gpt":0.2537006472339615,"score_spread":0.2322422971124849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984747321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96762365,0.00019419979,0.0000550887,0.031098042,0.0002545701,0.0005535226,0.000011176959,0.00005659454,0.00015317301],"genre_scores_gemma":[0.99080545,0.0000045146935,0.0067414553,0.0015049258,0.0005047882,0.0000030164472,0.000004001096,0.00006713092,0.00036470394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9949861,0.0023994527,0.0013571973,0.00036762215,0.00038560617,0.0005040148],"domain_scores_gemma":[0.99818045,0.00018209893,0.00024767348,0.0005103249,0.00028502007,0.00059444684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042053964,0.0003236243,0.0008871197,0.0006316843,0.00010588272,0.000049015798,0.00022887667,0.00011144283,0.0003544149],"category_scores_gemma":[0.0007112999,0.00026004593,0.00029871985,0.0005010473,0.00008535606,0.00026610488,0.00009730325,0.0009766365,0.00037732042],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062833093,0.00044075868,0.03476321,0.00009401451,0.000061009443,0.0018691656,0.0034246258,0.00006332461,0.9291375,0.000020461606,0.022474654,0.001367949],"study_design_scores_gemma":[0.009133493,0.0067355153,0.5017625,0.0021824464,0.00015746923,0.00918486,0.0010539953,0.00013016057,0.009015724,0.0000095739915,0.46011734,0.0005169177],"about_ca_topic_score_codex":0.00003172805,"about_ca_topic_score_gemma":0.000022101554,"teacher_disagreement_score":0.9201218,"about_ca_system_score_codex":0.00021083864,"about_ca_system_score_gemma":0.00032225405,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W1985149927","doi":"10.1093/eurjhf/hfq029","title":"Effectiveness of Cardiac Resynchronization Therapy in Mild Congestive Heart Failure: Systematic Review and Meta-Analysis of Randomized Trials","year":2010,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Heart failure; Cardiac resynchronization therapy; Meta-analysis; Cardiology; Internal medicine; Randomized controlled trial; Ejection fraction","score_opus":0.08959045142733416,"score_gpt":0.3772482971208781,"score_spread":0.2876578456935439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985149927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067235196,0.99487996,0.000053598582,0.00042042442,0.00010068021,0.004297631,0.00009384585,0.000007574624,0.00007902359],"genre_scores_gemma":[0.0020926937,0.99677634,0.00085665646,0.000046036817,0.00008171852,0.000037375088,0.000028588425,0.000054901964,0.000025666995],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96415544,0.030211214,0.0045609917,0.00030529365,0.00060398085,0.00016307579],"domain_scores_gemma":[0.98512465,0.008778298,0.0042715413,0.0005141891,0.0011899103,0.000121391706],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.040436413,0.0004912234,0.045341637,0.0010784133,0.0000401217,0.000023859135,0.000063758926,0.00013601023,0.00002309828],"category_scores_gemma":[0.00990033,0.00027005118,0.010688862,0.001259168,0.00021133662,0.00007626929,0.00004345685,0.000604419,0.0000039171464],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017905666,0.000053903015,0.000033332628,0.6338043,0.3608754,0.000011321226,0.00015933938,0.000013167227,0.000034257875,0.000016817221,0.0027259167,0.000481653],"study_design_scores_gemma":[0.008456289,0.00019963445,0.000055566074,0.11583897,0.7842123,0.0002363637,0.000029680654,3.8637347e-7,0.000013913422,0.0000015846673,0.0907702,0.0001851368],"about_ca_topic_score_codex":0.00000638384,"about_ca_topic_score_gemma":0.0000011773561,"teacher_disagreement_score":0.5179654,"about_ca_system_score_codex":0.00004703333,"about_ca_system_score_gemma":0.00021268737,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W1985862112","doi":"10.1093/eurjhf/hfr115","title":"The Effect of Cardiac Resynchronization Therapy on Left Ventricular Diastolic Function Assessed with Speckle-Tracking Echocardiography","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Canadian VIGOUR Centre; University of Alberta","funders":"St. Jude Medical; Boston Scientific Corporation","keywords":"Medicine; Cardiology; Cardiac resynchronization therapy; Internal medicine; Heart failure; Speckle tracking echocardiography; Diastole; Isovolumic relaxation time; Cardiomyopathy; Ejection fraction; Diastolic function; Blood pressure","score_opus":0.013606689423112502,"score_gpt":0.23417920157737568,"score_spread":0.22057251215426318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985862112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906998,0.0034510926,0.00075541437,0.00027395837,0.00038717227,0.00024097334,0.000002060224,0.000026407086,0.0041631134],"genre_scores_gemma":[0.99877524,0.00035107182,0.00031047917,0.00003849371,0.00047236774,5.3826983e-7,0.000001926673,0.00003184505,0.000018043922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982256,0.0007044065,0.00033836797,0.000121792655,0.0004573943,0.00015238613],"domain_scores_gemma":[0.99886805,0.00019193799,0.0003009284,0.00024167121,0.00032066499,0.00007677133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012792456,0.00015107512,0.0004777457,0.00019729779,0.00017059398,0.000026779962,0.000030497678,0.00002375737,0.0000053807908],"category_scores_gemma":[0.00010230807,0.00008048336,0.00043531682,0.00030324011,0.00008117871,0.00008387482,0.0000117314785,0.0002343046,0.0000113316155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047973655,0.00006669404,0.9456652,0.00007321164,0.0023714493,0.00014759912,0.0010215541,0.00042804866,0.0049363445,0.000029857487,0.027732642,0.0127300415],"study_design_scores_gemma":[0.00164108,0.005613845,0.8337038,0.00035661506,0.00032652065,0.00052396517,0.00019070064,0.0000018027444,0.010776865,0.0000030065844,0.1467561,0.00010569598],"about_ca_topic_score_codex":0.0000023596572,"about_ca_topic_score_gemma":2.971927e-7,"teacher_disagreement_score":0.11902345,"about_ca_system_score_codex":0.000023947814,"about_ca_system_score_gemma":0.00002996123,"threshold_uncertainty_score":0.32820162},"labels":[],"label_agreement":null},{"id":"W1986770588","doi":"10.1093/eurjhf/hfn016","title":"Heart Rate <i>per se</i> Impacts Cardiac Function in Patients with Systolic Heart Failure and Pacing: A Pilot Study","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Heart failure; Radionuclide ventriculography; QRS complex; Heart rate; Natriuretic peptide; Cardiac function curve; Pulmonary artery; Blood pressure","score_opus":0.01199574387540484,"score_gpt":0.23647995521406465,"score_spread":0.2244842113386598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986770588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885487,0.0007923366,0.000029624935,0.009379575,0.00017296968,0.0009018532,0.0000046590867,0.00003695041,0.00013334794],"genre_scores_gemma":[0.9957051,0.000020806237,0.00094585126,0.0026918128,0.00050850015,0.0000018688859,0.0000073086985,0.0000657757,0.0000529445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957705,0.0017263999,0.0007834206,0.0003774203,0.0007712602,0.0005709756],"domain_scores_gemma":[0.9982341,0.00004490717,0.00018114458,0.00046105706,0.00040290045,0.00067587424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030879544,0.00035581377,0.0011117228,0.00035385127,0.00016653669,0.000093661336,0.00007400486,0.000047601996,0.00003806532],"category_scores_gemma":[0.00008301519,0.00025803983,0.00023004838,0.00044334817,0.00004979969,0.0003760314,0.000029819284,0.0009475079,0.00007174347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00318298,0.0018683961,0.87524056,0.00018137481,0.00047116674,0.00045605225,0.0011722879,0.00008025068,0.009051094,0.0000034085388,0.107577264,0.0007151505],"study_design_scores_gemma":[0.0068302285,0.02348128,0.86973864,0.00048777976,0.00024160469,0.0006514097,0.00072686234,0.0000017698648,0.00007461464,0.0000015344151,0.09753869,0.00022557215],"about_ca_topic_score_codex":0.000030112391,"about_ca_topic_score_gemma":0.00002238882,"teacher_disagreement_score":0.021612883,"about_ca_system_score_codex":0.00011271472,"about_ca_system_score_gemma":0.00026690494,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W1987141738","doi":"10.1016/j.ejheart.2008.01.017","title":"BNP and NT-proBNP Predict Echocardiographic Severity of Diastolic Dysfunction","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Heart failure; Ejection fraction; Diastole; Atrial fibrillation; Diabetes mellitus; Natriuretic peptide; Diastolic heart failure; Coronary artery disease; Doppler echocardiography; Endocrinology; Blood pressure","score_opus":0.012152896491569897,"score_gpt":0.2059362590705366,"score_spread":0.1937833625789667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987141738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995154,0.001403531,0.0010256659,0.0012661312,0.0004576777,0.0001348733,0.000004783743,0.00002919251,0.0005241152],"genre_scores_gemma":[0.9967471,0.00092126353,0.0015676356,0.00014573999,0.0004761849,3.050149e-7,0.000003046531,0.000028246684,0.00011052943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984722,0.00033455677,0.00044902778,0.00014431305,0.00044905575,0.00015082276],"domain_scores_gemma":[0.9990497,0.000026945647,0.00018746586,0.0002362145,0.0002609181,0.00023873015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007798405,0.00014124911,0.00048707626,0.0003037029,0.00009788618,0.000008500889,0.00005345366,0.000044147437,0.00006357089],"category_scores_gemma":[0.00010509291,0.00010548291,0.0006005777,0.000284213,0.00016335268,0.00012551843,0.000029996225,0.0004294771,0.000016079572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005667393,0.00015261905,0.8905202,0.0001290228,0.0009330114,0.0007533374,0.00060896494,0.00007376724,0.0052641286,0.000006836604,0.0959984,0.0049929777],"study_design_scores_gemma":[0.0019616673,0.00068472495,0.7826763,0.00012889299,0.0002288794,0.011116823,0.00016105494,0.000010583173,0.00045295787,0.0000029530433,0.20249091,0.0000842849],"about_ca_topic_score_codex":0.000007001858,"about_ca_topic_score_gemma":0.0000010915546,"teacher_disagreement_score":0.10784392,"about_ca_system_score_codex":0.00001929804,"about_ca_system_score_gemma":0.000070717506,"threshold_uncertainty_score":0.4301468},"labels":[],"label_agreement":null},{"id":"W1988510963","doi":"10.1016/j.ejheart.2004.04.015","title":"Selective Versus Nonselective β-Adrenergic Receptor Blockade in Chronic Heart Failure: Differential Effects on Myocardial Energy Substrate Utilization","year":2004,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Heart failure; Adrenergic; Blockade; Cardiology; Internal medicine; Differential (mechanical device); Differential effects; Substrate (aquarium); Adrenergic receptor; β2 adrenergic receptor; Receptor; Agonist","score_opus":0.012175968360948782,"score_gpt":0.23656180717850037,"score_spread":0.22438583881755159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988510963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306536,0.00049503177,0.0010855775,0.0031343983,0.0016419706,0.00028045097,0.000004774043,0.00005810035,0.00023436184],"genre_scores_gemma":[0.9966567,0.0001346395,0.00061990105,0.000194287,0.0022258533,0.0000036517642,0.000025353993,0.0000793816,0.000060239843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970916,0.00088433665,0.00055947644,0.0003697313,0.00066274166,0.0004321175],"domain_scores_gemma":[0.9988361,0.00011060055,0.0002052164,0.00026514963,0.00026569172,0.00031724162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042955144,0.0003502933,0.0007128495,0.00051506824,0.00013553283,0.000051275354,0.00010848409,0.00012055804,0.00009743661],"category_scores_gemma":[0.00016391257,0.00028823692,0.00072208955,0.0006686339,0.00007686263,0.00014820725,0.000027837848,0.00089722255,0.00009062049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03038702,0.0020524513,0.020507006,0.00035736314,0.006000725,0.0024428188,0.0027315186,0.027716776,0.795743,0.00088444975,0.099166535,0.012010357],"study_design_scores_gemma":[0.047348928,0.014648204,0.2582005,0.0013879864,0.0007432969,0.0014601869,0.00038675082,0.00005970698,0.42043337,0.000037010006,0.2544185,0.0008755514],"about_ca_topic_score_codex":0.000035245164,"about_ca_topic_score_gemma":0.00010932295,"teacher_disagreement_score":0.3753096,"about_ca_system_score_codex":0.0008494933,"about_ca_system_score_gemma":0.00057006034,"threshold_uncertainty_score":0.99995697},"labels":[],"label_agreement":null},{"id":"W1988620868","doi":"10.1093/eurjhf/hfs114","title":"Prognostic Importance of Exercise Brain Natriuretic Peptide in Asymptomatic Degenerative Mitral Regurgitation","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Asymptomatic; Mitral regurgitation; Cardiology; Internal medicine; Heart failure; Brain natriuretic peptide; Natriuretic peptide","score_opus":0.010969145838036824,"score_gpt":0.2930456323783231,"score_spread":0.2820764865402863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988620868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933019,0.003952216,0.000026258014,0.002084314,0.000110719026,0.0002826429,0.0000069848393,0.0000071057757,0.00022785361],"genre_scores_gemma":[0.9950286,0.000020189149,0.004523738,0.00012508908,0.00016751692,0.0000022776956,0.000011328517,0.000027756709,0.00009347735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985639,0.00025440534,0.00055802375,0.000094326,0.00030908338,0.00022030373],"domain_scores_gemma":[0.9990729,0.000078097735,0.00029565542,0.00014519799,0.00018185664,0.00022631249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005894515,0.00013427828,0.00038934572,0.00017362626,0.00002488153,0.00001094603,0.000050979954,0.000021076126,0.000050288618],"category_scores_gemma":[0.00032287042,0.00010540837,0.00060748856,0.00019855826,0.00004277037,0.00019672717,0.000014904282,0.00017006273,0.00002663146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020058245,0.00032425468,0.9818444,0.00012642989,0.00018841674,0.00013870571,0.0007475243,0.000020620351,0.0009735922,0.000024580142,0.015077205,0.0003336455],"study_design_scores_gemma":[0.0024458203,0.00042367945,0.9938438,0.00096340483,0.00045452785,0.00026470824,0.00043770976,0.000009272023,0.00036935057,0.000017105027,0.00068286544,0.00008778295],"about_ca_topic_score_codex":0.0000015400956,"about_ca_topic_score_gemma":9.999012e-7,"teacher_disagreement_score":0.01439434,"about_ca_system_score_codex":0.000056064022,"about_ca_system_score_gemma":0.000084785905,"threshold_uncertainty_score":0.42984286},"labels":[],"label_agreement":null},{"id":"W1993848345","doi":"10.1016/j.ejheart.2006.11.006","title":"Prevalence and Prognostic Impact of Bundle Branch Block in Patients with Heart Failure: Evidence from the CHARM Programme","year":2007,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Bristol-Myers Squibb","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Hazard ratio; Cardiology; Confidence interval; Candesartan; Left bundle branch block; Relative risk; Placebo; Bundle branch block; Propensity score matching; Electrocardiography; Blood pressure; Angiotensin II; Pathology","score_opus":0.018190639845722223,"score_gpt":0.27063283973250046,"score_spread":0.25244219988677824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993848345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951074,0.002266072,0.000036328005,0.0020982234,0.000047235848,0.00036259074,0.000008426079,0.000010870632,0.00006286551],"genre_scores_gemma":[0.99751574,0.00003939476,0.0021263603,0.00007655006,0.00020502982,5.3909696e-7,0.0000011604461,0.000021022992,0.000014178111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838686,0.00022438933,0.000494845,0.0001633468,0.00047726717,0.00025328714],"domain_scores_gemma":[0.99854934,0.00044985214,0.00025707527,0.00020215363,0.0003862098,0.0001553835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012979934,0.00015708747,0.00044456008,0.00009936548,0.0000656775,0.000030994852,0.000041775344,0.000022779575,0.000008312664],"category_scores_gemma":[0.0005850162,0.000087384906,0.00015108022,0.00026697796,0.00013911721,0.00013982288,0.000043519856,0.00030843331,0.0000069971134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005223919,0.00008731045,0.99101543,0.00005112351,0.00009425961,0.0000074619047,0.00077116746,0.000020582549,0.0006464826,2.9870014e-7,0.0064937393,0.0002897554],"study_design_scores_gemma":[0.0016640123,0.0021769276,0.98917735,0.0018481681,0.00010670235,0.00031917717,0.00014944609,0.0000012053135,0.00014159082,0.0000016695788,0.004325868,0.00008786942],"about_ca_topic_score_codex":0.000030481748,"about_ca_topic_score_gemma":0.000014124049,"teacher_disagreement_score":0.0024083767,"about_ca_system_score_codex":0.00003734457,"about_ca_system_score_gemma":0.00008246373,"threshold_uncertainty_score":0.35634533},"labels":[],"label_agreement":null},{"id":"W1994866568","doi":"10.1016/s1388-9842(01)00206-9","title":"An Evaluation of Symptom Classification Systems used for the Assessment of Patients with Heart Failure in France","year":2001,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exertion; Medicine; Test (biology); Heart failure; Scale (ratio); Variety (cybernetics); Physical therapy; Artificial intelligence; Computer science; Internal medicine","score_opus":0.1901788796397022,"score_gpt":0.3995347626768562,"score_spread":0.20935588303715402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994866568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96721494,0.0005169949,0.010062439,0.020408597,0.00030376387,0.001310654,0.00010023398,0.0000066329153,0.000075721895],"genre_scores_gemma":[0.990715,0.000013259636,0.008655384,0.00031120074,0.00020964345,0.000024198207,0.000020762722,0.0000348216,0.000015697202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939272,0.0015560072,0.003652118,0.0002604694,0.00037862855,0.00022561692],"domain_scores_gemma":[0.99432284,0.0006040206,0.0037139542,0.00047987443,0.0007795222,0.00009979077],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031132936,0.00015334589,0.000787559,0.0003362766,0.00009926386,0.00005382079,0.00031804317,0.00005383882,0.00006322623],"category_scores_gemma":[0.0006613671,0.00013173539,0.00012109147,0.00026588998,0.000068286114,0.0005679326,0.000013355109,0.00021960441,0.000017293592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031499043,0.0002518499,0.9747121,0.00015973026,0.000062167484,2.1154094e-7,0.0006538331,0.013630892,0.00008115784,0.0015309874,0.008815427,0.000070191236],"study_design_scores_gemma":[0.0028573987,0.00058049924,0.912203,0.00027403492,0.00002885654,0.000006141636,0.0013631524,0.024516677,0.000006935774,0.00008114211,0.057943374,0.00013875101],"about_ca_topic_score_codex":0.000042476113,"about_ca_topic_score_gemma":0.000054269898,"teacher_disagreement_score":0.062509015,"about_ca_system_score_codex":0.0002423062,"about_ca_system_score_gemma":0.0002515907,"threshold_uncertainty_score":0.99765253},"labels":[],"label_agreement":null},{"id":"W1995588280","doi":"10.1016/j.ejheart.2006.10.012","title":"Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM","year":2006,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; McMaster University Medical Centre; Hamilton General Hospital; Montreal Heart Institute","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Candesartan; Quality of life (healthcare); Heart failure with preserved ejection fraction; Population; Body mass index; Blood pressure","score_opus":0.021169474314348187,"score_gpt":0.2580538181149971,"score_spread":0.23688434380064893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995588280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476243,0.00007200572,0.000091770926,0.01422965,0.00014890166,0.00061470113,0.000007355231,0.000015706331,0.000057457717],"genre_scores_gemma":[0.99684393,0.000012815722,0.0027871714,0.000079633486,0.00008760242,0.0000025900817,0.00010441537,0.000032837237,0.000048987702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642485,0.0009301232,0.0016639449,0.00019864517,0.0005365019,0.0002459466],"domain_scores_gemma":[0.9982892,0.000055223696,0.00102008,0.00021896503,0.00030504892,0.00011144358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015772249,0.00019024892,0.0007850831,0.0005025663,0.000038612954,0.000012457587,0.00006901769,0.000058176767,0.00008265228],"category_scores_gemma":[0.00011791286,0.00015521992,0.00012875423,0.00053251616,0.000045876874,0.00035291055,0.00002498393,0.0003678868,0.00001069532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036154508,0.001628764,0.9705711,0.00035960847,0.0001065265,0.000019345975,0.00020209447,0.00015880248,0.017099358,0.000017545346,0.0058374275,0.00038399614],"study_design_scores_gemma":[0.01223606,0.0018061223,0.9720466,0.000712532,0.000033569446,0.0000053319895,0.00019204424,0.000019100855,0.0008537681,0.0000025488318,0.011981356,0.00011094341],"about_ca_topic_score_codex":0.00034001027,"about_ca_topic_score_gemma":0.00026860106,"teacher_disagreement_score":0.01624559,"about_ca_system_score_codex":0.00016215336,"about_ca_system_score_gemma":0.00013639564,"threshold_uncertainty_score":0.6329685},"labels":[],"label_agreement":null},{"id":"W1997978342","doi":"10.1093/eurjhf/hfr050","title":"The Effect of Ventricular Assist Devices on Long-Term Post-Transplant Outcomes: A Systematic Review of Observational Studies","year":2011,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; CINAHL; Observational study; Ventricular assist device; MEDLINE; Meta-analysis; Destination therapy; Heart transplantation; Internal medicine; Intensive care medicine; Transplantation; Heart failure; Psychological intervention","score_opus":0.05657946438276845,"score_gpt":0.307336857733143,"score_spread":0.25075739335037456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997978342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033919254,0.9980681,0.000019170995,0.00007356616,0.0003980892,0.0010147422,0.000041010706,0.000019597508,0.000026566033],"genre_scores_gemma":[0.0028174608,0.99674904,0.00011451654,0.00007149198,0.00009771664,0.00001663627,0.000021049,0.00010051681,0.00001157994],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99375516,0.0022003024,0.002954749,0.0001713582,0.0006869575,0.00023149532],"domain_scores_gemma":[0.995551,0.0015680916,0.0018650703,0.0005499979,0.00034611826,0.000119706696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00434696,0.00051405845,0.0042795422,0.00016568515,0.00006484733,0.00002268824,0.0007828367,0.000071198374,0.0000371534],"category_scores_gemma":[0.00071801024,0.00025134932,0.0015762412,0.0002536375,0.000056351313,0.00010093247,0.000045322453,0.00061077223,0.00006474654],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005553369,0.000017189694,0.0018051377,0.9935694,0.0024260157,0.00027100346,0.000022343585,0.0000037512157,3.110135e-7,0.000029384968,0.0006372401,0.0012127144],"study_design_scores_gemma":[0.00018048221,0.00042247883,0.0013567901,0.91802275,0.0057278136,0.00065718836,0.0000083121995,6.0534137e-7,0.0000068068475,7.040213e-7,0.07337913,0.00023694994],"about_ca_topic_score_codex":1.6879987e-7,"about_ca_topic_score_gemma":0.0000014094431,"teacher_disagreement_score":0.075546615,"about_ca_system_score_codex":0.00006594382,"about_ca_system_score_gemma":0.00006331061,"threshold_uncertainty_score":0.99999386},"labels":[],"label_agreement":null},{"id":"W1998603758","doi":"10.1093/eurjhf/hfq124","title":"Exercise Training in Chagas' Cardiomyopathy: Trials are Welcome for this Neglected Heart Disease","year":2010,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Trypanosoma species research and implications","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chagas disease; Heart failure; Cardiomyopathy; Dilated cardiomyopathy; Cardiology; Population; Heart disease; Internal medicine; Pathology; Environmental health","score_opus":0.06558641653807777,"score_gpt":0.3217204322188085,"score_spread":0.25613401568073074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998603758","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038776228,0.002013639,0.00011904329,0.9906154,0.0008402119,0.0017369697,0.00040089336,0.000050947765,0.0003452509],"genre_scores_gemma":[0.122905724,0.0010830921,0.042372286,0.7123616,0.102600455,0.00031845094,0.0016192694,0.0014435836,0.015295578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99484295,0.0012728575,0.0016740477,0.00045948333,0.00092643313,0.0008242157],"domain_scores_gemma":[0.9962776,0.00060701993,0.00081674824,0.0007925574,0.00078273675,0.0007233563],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00094849715,0.00046021483,0.002136595,0.0010384669,0.00017639226,0.00016211614,0.00046013633,0.00037517527,0.0005550375],"category_scores_gemma":[0.0041737203,0.0003671488,0.0012002409,0.0004501082,0.0001508782,0.00019404257,0.00007969312,0.0063895215,0.0001367913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053711387,0.000060462145,0.00023473248,0.00029840122,0.00010098597,0.0021043378,0.00022467546,0.0000012874449,0.009114302,0.0000029670664,0.9858393,0.001481445],"study_design_scores_gemma":[0.003285724,0.0004948487,0.032906786,0.0020376462,0.00029541543,0.0008929655,0.00012864433,0.0000045233824,0.00009357059,0.000035905236,0.9595313,0.00029268346],"about_ca_topic_score_codex":0.000004373562,"about_ca_topic_score_gemma":0.0000046945825,"teacher_disagreement_score":0.27825385,"about_ca_system_score_codex":0.00012456514,"about_ca_system_score_gemma":0.0010651199,"threshold_uncertainty_score":0.99987805},"labels":[],"label_agreement":null},{"id":"W1999087624","doi":"10.1016/s1388-9842(00)80095-1","title":"How Right Ventricular Function Relates to Pulmonary Artery Pressure in Advanced Congestive Heart Failure: Prognostic Implications","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine","score_opus":0.010562555290406742,"score_gpt":0.23939777962079697,"score_spread":0.22883522433039022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999087624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86514914,0.002880697,0.00005369939,0.13052934,0.00009059822,0.0008948946,0.000021233249,0.00004086686,0.00033951458],"genre_scores_gemma":[0.99340314,0.000055382287,0.0038786246,0.00071364327,0.00020127067,0.00001531211,0.000029733406,0.000043254677,0.0016596642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799377,0.00042001455,0.00043516056,0.00032162596,0.00041306647,0.00041638105],"domain_scores_gemma":[0.99858385,0.00010519491,0.00010578826,0.00032669405,0.00033539694,0.00054307503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003924943,0.00022683259,0.0004303265,0.00031731182,0.00013579064,0.00006056523,0.00013173973,0.000055224755,0.0002966867],"category_scores_gemma":[0.00021292343,0.00016972666,0.00018450757,0.0005132874,0.000057606216,0.00036795868,0.000033461074,0.0006093558,0.00031143124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046318346,0.003965144,0.5718645,0.00019001095,0.0010519959,0.06234862,0.00016277927,0.0010792316,0.05011416,0.000053051626,0.2877702,0.016768496],"study_design_scores_gemma":[0.0015337545,0.0016079581,0.49832767,0.0004130742,0.00014467945,0.008578078,0.000085477885,0.000030039539,0.0002886695,0.00004416925,0.48881444,0.00013197944],"about_ca_topic_score_codex":0.0000019880247,"about_ca_topic_score_gemma":0.0000025703473,"teacher_disagreement_score":0.20104422,"about_ca_system_score_codex":0.00005610146,"about_ca_system_score_gemma":0.00010591301,"threshold_uncertainty_score":0.6921252},"labels":[],"label_agreement":null},{"id":"W2003478281","doi":"10.1093/eurjhf/hfq099","title":"Hepcidin-25 is a Marker of the Response Rather than Resistance to Exogenous Erythropoietin in Chronic Kidney Disease/Chronic Heart Failure Patients","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hepcidin; Medicine; Erythropoietin; Internal medicine; Soluble transferrin receptor; Ferritin; Endocrinology; Renal function; Heart failure; Kidney disease; Erythropoiesis; Iron deficiency; Anemia; Iron status","score_opus":0.006712813713098154,"score_gpt":0.23670771051648595,"score_spread":0.2299948968033878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003478281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84668803,0.0006877218,0.0000048445368,0.15126526,0.00045264533,0.0006087385,0.000051120274,0.000017998473,0.00022361705],"genre_scores_gemma":[0.9892856,0.00003803382,0.0045078914,0.002445022,0.0005112448,0.0000053613253,0.0000058282985,0.000104978026,0.0030960664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629796,0.0010408156,0.00092420075,0.0003907498,0.00080140523,0.00054487266],"domain_scores_gemma":[0.9973667,0.00011538937,0.00037966578,0.0009108228,0.0003504268,0.00087695074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014859741,0.0003722588,0.0006196291,0.00023242456,0.00017079302,0.00003950192,0.0003904151,0.000081539314,0.0012148516],"category_scores_gemma":[0.00074512133,0.00024796717,0.00048627742,0.00047765783,0.00025832103,0.000116201896,0.00015537062,0.0010268273,0.00016098889],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003925096,0.0007173405,0.15180913,0.00024775753,0.00011956788,0.00037237327,0.001152376,0.000009385223,0.12142841,0.000014740145,0.719985,0.00021880685],"study_design_scores_gemma":[0.0041455408,0.001289108,0.3088368,0.0016094373,0.000090937625,0.00014312343,0.00016549096,0.0000021666451,0.005982016,0.000008214728,0.6775245,0.00020267848],"about_ca_topic_score_codex":0.000011092891,"about_ca_topic_score_gemma":0.00019435729,"teacher_disagreement_score":0.15702765,"about_ca_system_score_codex":0.0004620632,"about_ca_system_score_gemma":0.0016372029,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W2005177820","doi":"10.1016/j.ejheart.2005.07.002","title":"Practical Recommendations for the Use of ACE Inhibitors, Beta-Blockers, Aldosterone Antagonists and Angiotensin Receptor Blockers in Heart Failure: Putting Guidelines into Practice","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AstraZeneca","keywords":"Medicine; Heart failure; Angiotensin Receptor Blockers; Aldosterone; BETA (programming language); Pharmacology; Adrenergic beta-Antagonists; Internal medicine; Cardiology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.07275180360236125,"score_gpt":0.348384881495214,"score_spread":0.27563307789285274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005177820","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00710529,0.0006148714,0.0007689792,0.9904617,0.00021840826,0.0007975384,0.000008978266,0.000022935368,0.0000013155583],"genre_scores_gemma":[0.011460137,0.00022135786,0.9829972,0.0041370443,0.0008874146,0.0000058770906,0.000019644065,0.000058634585,0.00021271796],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700433,0.000607033,0.0012910587,0.0002995335,0.00043334038,0.00036471224],"domain_scores_gemma":[0.9970803,0.000997414,0.00057286845,0.00034800736,0.00076083466,0.00024055163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026435638,0.00028118226,0.0005667365,0.00027144584,0.00020601203,0.00011569232,0.00010174113,0.00006937697,0.000048426078],"category_scores_gemma":[0.002008583,0.00019909888,0.00022166607,0.00030691223,0.00013863869,0.000786913,0.00012103747,0.0005301792,0.000021777154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037585467,0.00027838044,0.0017148355,0.000041394243,0.00025585212,0.000052424788,0.00065641303,0.000029195973,0.004468714,0.00003195386,0.9862395,0.005855518],"study_design_scores_gemma":[0.0027921402,0.00085811265,0.00022270509,0.00048638185,0.0004185889,0.0009234247,0.0012972382,0.00020522026,0.0020638625,0.0000024658764,0.9905782,0.0001517148],"about_ca_topic_score_codex":0.000043514494,"about_ca_topic_score_gemma":0.00009042227,"teacher_disagreement_score":0.98632467,"about_ca_system_score_codex":0.000117900345,"about_ca_system_score_gemma":0.0001765246,"threshold_uncertainty_score":0.8119016},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2007272937","doi":"10.1093/eurjhf/hft111","title":"Dabigatran Compared with Warfarin in Patients with Atrial Fibrillation and Symptomatic Heart Failure: A Subgroup Analysis of the RE-LY Trial","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Dabigatran; Medicine; Warfarin; Atrial fibrillation; Hazard ratio; Stroke (engine); Internal medicine; Confidence interval; Heart failure; Cardiology; Anesthesia; Subgroup analysis","score_opus":0.01806782983721995,"score_gpt":0.24693392131052688,"score_spread":0.22886609147330694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007272937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873097,0.000043371838,0.000058629026,0.010133626,0.00008792225,0.00089147885,0.0000026484151,0.000010884637,0.000040480558],"genre_scores_gemma":[0.99509054,0.0000023841894,0.004360567,0.000077216675,0.00038756503,1.9122608e-7,0.000010831562,0.000024486446,0.000046237423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772525,0.00048085846,0.00081578695,0.00017003866,0.0006277441,0.00018033735],"domain_scores_gemma":[0.99870116,0.00013119726,0.000542513,0.0002700075,0.0002378511,0.000117257456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066253665,0.00018173952,0.00075034075,0.0004125656,0.00007224786,0.00006037165,0.00009928359,0.000032540687,0.00010279394],"category_scores_gemma":[0.000106021864,0.00010023075,0.000310425,0.0008983948,0.00009511147,0.00026734918,0.0000425334,0.00020750244,0.000006157444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006809578,0.000013698797,0.9888723,0.000038225917,0.0006779856,0.0000038502135,0.00031382174,0.0014029028,0.00015341079,0.000009086537,0.0014991041,0.00020607321],"study_design_scores_gemma":[0.033678427,0.0014271095,0.95817256,0.00021622016,0.001205092,0.00001150169,0.00021819105,0.00029649757,0.000024337958,0.0000052122873,0.004628791,0.00011607092],"about_ca_topic_score_codex":0.000024078245,"about_ca_topic_score_gemma":0.00006215863,"teacher_disagreement_score":0.030699713,"about_ca_system_score_codex":0.00003503763,"about_ca_system_score_gemma":0.00005121199,"threshold_uncertainty_score":0.4087291},"labels":[],"label_agreement":null},{"id":"W2007274583","doi":"10.1016/s1388-9842(00)00091-x","title":"Comparison of Different Methods of Functional Evaluation in Patients with Chronic Heart Failure","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Cardiopulmonary exercise test; Concordance; Internal medicine; Cardiology; Anaerobic exercise; Canadian Cardiovascular Society; Physical therapy; VO2 max; Heart rate; Myocardial infarction; Blood pressure","score_opus":0.022286130305889527,"score_gpt":0.31305015936012853,"score_spread":0.290764029054239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007274583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975949,0.0006599427,0.00046213245,0.0008236427,0.00008939295,0.000241609,0.000002816803,0.0000041637268,0.00012142411],"genre_scores_gemma":[0.992583,0.000009513855,0.0071374476,0.000036231842,0.00016883525,0.0000010891476,0.00002168813,0.000021824195,0.000020375128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973602,0.0010517992,0.00066667167,0.00014214504,0.0006211753,0.00015797208],"domain_scores_gemma":[0.998987,0.000052228803,0.00021446799,0.00023483585,0.00041777358,0.00009369012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001210412,0.00013921064,0.00084077485,0.00018192703,0.000025415815,0.000004522438,0.000067223744,0.00003575824,0.0008155678],"category_scores_gemma":[0.000049263155,0.000096647906,0.00031566637,0.00018346311,0.00009319,0.00007663678,0.000017912871,0.00035683444,0.000013431702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017798485,0.0038038623,0.68986475,0.00062748214,0.0017011282,0.000028850842,0.0015563373,0.028418785,0.08527802,0.000031608874,0.070082806,0.10080791],"study_design_scores_gemma":[0.0062467675,0.0025159207,0.9724703,0.00041303856,0.00029840818,0.00006806148,0.00007776602,0.00017099179,0.004755897,0.000010717193,0.012880626,0.00009154776],"about_ca_topic_score_codex":0.0000036125823,"about_ca_topic_score_gemma":0.00000619787,"teacher_disagreement_score":0.28260553,"about_ca_system_score_codex":0.000082671984,"about_ca_system_score_gemma":0.0001247102,"threshold_uncertainty_score":0.8929896},"labels":[],"label_agreement":null},{"id":"W2008726750","doi":"10.1016/s1388-9842(00)80254-8","title":"Sub-Maximal Exercise Capacity of Heart Failure Patients with Poor Prognosis can be Improved by Ventricular Resynchronization Therapy","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Adidas (Canada); Saint Paul University","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology","score_opus":0.00888867879256573,"score_gpt":0.21064715442879947,"score_spread":0.20175847563623375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008726750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276334,0.0009803128,0.00003421628,0.0054930723,0.0000623796,0.00040134692,0.000058040794,0.000028317007,0.00017895695],"genre_scores_gemma":[0.9959745,0.00011640851,0.0032886812,0.00028435604,0.00018396044,0.0000018196752,0.00003311111,0.000049399998,0.00006780431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981292,0.00025397076,0.00056425773,0.00021011778,0.000585915,0.00025654986],"domain_scores_gemma":[0.9985559,0.00003326904,0.00029428903,0.00019781949,0.0007177262,0.00020098462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040879927,0.00022375197,0.00066313404,0.00014163656,0.00013706746,0.00003374272,0.00004141933,0.00004544535,0.00006728554],"category_scores_gemma":[0.00005885467,0.0001599857,0.00024820806,0.00035167075,0.000111720896,0.00013882105,0.000015969019,0.00026980706,0.000010428574],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024398768,0.00062443526,0.44683412,0.00013440498,0.0006018147,0.000063241765,0.0012265064,0.00015392178,0.034193616,0.0000014512757,0.508602,0.005124598],"study_design_scores_gemma":[0.010220561,0.0037858302,0.25050506,0.00094169565,0.00037379586,0.0007513936,0.00034033883,0.000013690031,0.038165268,0.0000018651411,0.69448316,0.0004173523],"about_ca_topic_score_codex":0.000020630794,"about_ca_topic_score_gemma":0.000004167129,"teacher_disagreement_score":0.19632906,"about_ca_system_score_codex":0.00005587963,"about_ca_system_score_gemma":0.00008459791,"threshold_uncertainty_score":0.65240276},"labels":[],"label_agreement":null},{"id":"W2010312935","doi":"10.1016/j.ejheart.2005.04.013","title":"The Modification of Diet in Renal Disease (MDRD) Equations Provide Valid Estimations of Glomerular Filtration Rates in Patients with Advanced Heart Failure","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut de Cardiologie de Montréal","keywords":"Renal function; Medicine; Heart failure; Urology; Heart transplantation; Cardiology; Body surface area; Internal medicine; Area under the curve","score_opus":0.011720213042201269,"score_gpt":0.2622196230280848,"score_spread":0.25049940998588355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010312935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795388,0.0005813666,0.0005846402,0.018713532,0.000023747276,0.0004834308,0.000034097207,0.0000075786074,0.000032805197],"genre_scores_gemma":[0.9905196,0.000014158481,0.009181775,0.00010382092,0.000065591965,0.0000060352086,0.00007047979,0.000019278334,0.000019254318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998277,0.00027110073,0.0007511149,0.00013036642,0.0003988381,0.00017159017],"domain_scores_gemma":[0.9986658,0.00015078388,0.0003752562,0.00025634174,0.00037243377,0.0001793927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052077096,0.00012462512,0.00026824072,0.00019289793,0.00006598629,0.000019374304,0.00009864412,0.00001925232,0.000029746592],"category_scores_gemma":[0.00071494095,0.00008541306,0.00009828876,0.0003317192,0.00011430286,0.00035795287,0.000015616655,0.00020879997,0.000006782323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053999894,0.0033275003,0.88077366,0.0005177707,0.00019545869,0.000026265496,0.0014453303,0.05843232,0.023069661,0.0007507816,0.020720024,0.0053412137],"study_design_scores_gemma":[0.007225899,0.001484365,0.96753156,0.0014758403,0.0001677871,0.0000044360763,0.00032085052,0.0025245748,0.003033125,0.000090416645,0.015973667,0.00016750222],"about_ca_topic_score_codex":0.0000030386161,"about_ca_topic_score_gemma":0.000023869528,"teacher_disagreement_score":0.086757846,"about_ca_system_score_codex":0.00007305146,"about_ca_system_score_gemma":0.0003894362,"threshold_uncertainty_score":0.34830436},"labels":[],"label_agreement":null},{"id":"W2012246049","doi":"10.1016/s1388-9842(00)00122-7","title":"Low Doses vs. High Doses of the Angiotensin Converting-Enzyme Inhibitor Lisinopril in Chronic Heart Failure: A Cost-Effectiveness Analysis Based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) Study","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"AstraZeneca","keywords":"Lisinopril; Medicine; Heart failure; ACE inhibitor; Angiotensin-converting enzyme; Effective dose (radiation); Randomized controlled trial; Urology; Internal medicine; Cardiology; Nuclear medicine; Blood pressure","score_opus":0.014249917677053225,"score_gpt":0.26705715674453906,"score_spread":0.2528072390674858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012246049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749976,0.000121196106,0.000046048634,0.022839654,0.000075666445,0.0018336577,0.000013917298,0.000016170745,0.00005610037],"genre_scores_gemma":[0.9980378,0.00003053409,0.001367894,0.00023929657,0.00015915972,0.00001690264,0.0000069099237,0.000049302613,0.00009216994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511117,0.0023325314,0.00091468124,0.00040224078,0.00086069864,0.00037868373],"domain_scores_gemma":[0.99783427,0.0005580576,0.0004294495,0.0007104681,0.00029046353,0.00017729703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001998952,0.00043835992,0.0012833322,0.00043387702,0.00015495207,0.00005959975,0.00019204023,0.000052758976,0.0002292686],"category_scores_gemma":[0.000059277732,0.00021898921,0.0004315852,0.0011124939,0.00024982673,0.00013333985,0.00006083918,0.000419172,0.0000059779873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041003763,0.0055794055,0.949069,0.0002570034,0.0043958803,0.0006173497,0.0012460062,0.0126453955,0.012518181,0.0000363851,0.0067475284,0.0027874643],"study_design_scores_gemma":[0.013985027,0.018572936,0.9239852,0.0013359141,0.0024246261,0.00006935218,0.00081642583,0.00074195804,0.010449056,0.0000017077699,0.027340842,0.00027696235],"about_ca_topic_score_codex":0.00022655161,"about_ca_topic_score_gemma":0.000553125,"teacher_disagreement_score":0.02508383,"about_ca_system_score_codex":0.0004527446,"about_ca_system_score_gemma":0.0004798718,"threshold_uncertainty_score":0.89301205},"labels":[],"label_agreement":null},{"id":"W2012644191","doi":"10.1093/eurjhf/hfq023","title":"Central Sleep Apnoea: Another Important Comorbidity in Heart Failure?","year":2010,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Comorbidity; Central sleep apnea; Cardiology; Internal medicine; Sleep apnea; Sleep disordered breathing; Breathing; Polysomnography; Intensive care medicine; Apnea; Obstructive sleep apnea; Anesthesia","score_opus":0.017664323195079375,"score_gpt":0.2661055773357315,"score_spread":0.2484412541406521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012644191","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04425214,0.00057716336,0.00011535024,0.9521614,0.0015152048,0.00073187705,0.00006486271,0.00004920406,0.00053284963],"genre_scores_gemma":[0.2959001,0.000117649884,0.05918476,0.5962872,0.044569932,0.000011714412,0.00026802352,0.0013757185,0.0022848889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925461,0.0015656039,0.0018479669,0.0006636366,0.0019293758,0.0014473444],"domain_scores_gemma":[0.996843,0.00019599855,0.00079411664,0.0010098732,0.00063984527,0.00051718624],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002432772,0.0007303728,0.0016308739,0.001006711,0.00012227758,0.00014953128,0.00071434653,0.00081106165,0.0024680723],"category_scores_gemma":[0.00050702767,0.00059546554,0.0008394155,0.000500884,0.0005246724,0.00027654055,0.0002191238,0.019511918,0.00037843696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019124626,0.00015975935,0.04899975,0.00018858847,0.00022502252,0.016069867,0.00014241064,0.000002622258,0.009816083,0.0000048729576,0.9238536,0.00034619577],"study_design_scores_gemma":[0.0031320383,0.00072216324,0.032124016,0.0004335996,0.0001426176,0.0076210015,0.00007818747,0.000014193857,0.0012194047,0.000015647487,0.95403254,0.00046457569],"about_ca_topic_score_codex":0.000025997333,"about_ca_topic_score_gemma":0.00006623433,"teacher_disagreement_score":0.35587415,"about_ca_system_score_codex":0.00033036954,"about_ca_system_score_gemma":0.00031182737,"threshold_uncertainty_score":0.9996497},"labels":[],"label_agreement":null},{"id":"W2014375805","doi":"10.1093/eurjhf/hfp142","title":"Adherence to Medication According to Sex and Age in the CHARM Programme","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"AstraZeneca","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Proportional hazards model; Medication adherence; Placebo; Confidence interval; Alternative medicine","score_opus":0.05546288048559771,"score_gpt":0.3236153984811215,"score_spread":0.26815251799552375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014375805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7691093,0.00020548637,0.0012437749,0.22684035,0.00007675098,0.00043405066,3.4243618e-7,0.000013944998,0.0020760158],"genre_scores_gemma":[0.9770491,0.000017499797,0.009337343,0.012996853,0.00026657598,0.0000025567404,9.243169e-7,0.0000062097797,0.00032295345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891776,0.0001672272,0.00031873232,0.000113925824,0.0003209055,0.00016145052],"domain_scores_gemma":[0.99938005,0.000033190652,0.00009449046,0.00016985358,0.000072022034,0.00025041716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014264196,0.00007615459,0.00017172223,0.000106594205,0.00004050089,0.000035514557,0.00017879618,0.000013110447,0.000054003478],"category_scores_gemma":[0.00026576937,0.000048899776,0.000031434443,0.00026297118,0.000020650965,0.00006543975,0.000015859196,0.00027637804,0.00021070096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024745928,0.00034794133,0.03627047,0.0000608507,0.00002569333,0.0010852354,0.011140254,0.00000669299,0.037621066,0.0002758601,0.36706975,0.5458487],"study_design_scores_gemma":[0.0012799094,0.0033543098,0.36456442,0.0009415543,0.00002446054,0.0012519821,0.0055762134,0.00001265534,0.0003948303,0.0000783559,0.6223907,0.00013061201],"about_ca_topic_score_codex":0.000001500986,"about_ca_topic_score_gemma":0.0000017262432,"teacher_disagreement_score":0.54571813,"about_ca_system_score_codex":0.00001588764,"about_ca_system_score_gemma":0.000049510047,"threshold_uncertainty_score":0.27082047},"labels":[],"label_agreement":null},{"id":"W2014916573","doi":"10.1093/eurjhf/hfq159","title":"Absence of Obesity Paradox in Patients with Chronic Heart Failure and Diabetes Mellitus: A Propensity-Matched Study","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Obesity; Hazard ratio; Internal medicine; Heart failure; Diabetes mellitus; Body mass index; Obesity paradox; Confidence interval; Propensity score matching; Endocrinology; Overweight","score_opus":0.0066253167721651825,"score_gpt":0.2069033865639634,"score_spread":0.2002780697917982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014916573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783784,0.00020765999,0.000009898599,0.0012522328,0.00015005103,0.0005141816,0.0000025537788,0.000012357172,0.000013233048],"genre_scores_gemma":[0.99820155,0.000012648817,0.0015178192,0.00007581657,0.00013981533,7.94435e-7,0.0000023673956,0.000030129417,0.000019064644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981535,0.00037695686,0.00049349765,0.00021736688,0.00053450745,0.00022413839],"domain_scores_gemma":[0.9988724,0.000038190232,0.00020855489,0.00034001385,0.00032462605,0.0002161925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011706103,0.00018930165,0.0007201878,0.00019313995,0.00006247158,0.000028478944,0.000092235656,0.00004157087,0.00006246944],"category_scores_gemma":[0.000103460334,0.00012234524,0.00017079337,0.00023938261,0.00013035416,0.00016777268,0.000053356318,0.00081552257,0.000015439015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019296256,0.0005326625,0.9935046,0.00006495458,0.00016003543,0.00006895483,0.00034463542,0.000010466856,0.0031110237,9.402414e-7,0.0017002118,0.0003085569],"study_design_scores_gemma":[0.0049442234,0.002494172,0.9694394,0.00025429274,0.00011389095,0.00011820059,0.00032244937,0.000003333831,0.0006856595,0.000001026906,0.021496328,0.00012702338],"about_ca_topic_score_codex":0.000012283449,"about_ca_topic_score_gemma":0.000115917595,"teacher_disagreement_score":0.024065195,"about_ca_system_score_codex":0.000030791565,"about_ca_system_score_gemma":0.00011712895,"threshold_uncertainty_score":0.4989094},"labels":[],"label_agreement":null},{"id":"W2015718619","doi":"10.1016/j.ejheart.2008.01.014","title":"Acute Heart Failure in the Emergency Department: Short and Long-Term Outcomes of Elderly Patients with Heart Failure","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Emergency department; Heart failure; Cohort; Population; Emergency medicine; Retrospective cohort study; Cohort study; Internal medicine; Pediatrics","score_opus":0.01640603965767008,"score_gpt":0.25739495728897516,"score_spread":0.2409889176313051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015718619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455207,0.0003647673,0.00005973626,0.05284763,0.00014971546,0.00094369776,0.000017991628,0.000028637207,0.00006712415],"genre_scores_gemma":[0.9869323,0.000103643324,0.011604823,0.00082085805,0.00017469241,0.000009536846,0.000040303737,0.00007640762,0.00023745035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996312,0.0005303188,0.0011301187,0.0004000246,0.0010539711,0.0005735728],"domain_scores_gemma":[0.9983774,0.00008743811,0.00027309536,0.0005923135,0.0003293255,0.00034045064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078460353,0.00049766194,0.0010306801,0.00040031518,0.00021395159,0.000039398015,0.00026966663,0.00007832277,0.0002563358],"category_scores_gemma":[0.000057110356,0.000295959,0.00035718366,0.0004535722,0.000228044,0.0004075322,0.00009913585,0.0006606015,0.00004705762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002706529,0.0006462316,0.8343993,0.000069461654,0.0004106191,0.0005970192,0.0005245204,0.0000036129443,0.0002755174,0.000013810448,0.16261408,0.00017521282],"study_design_scores_gemma":[0.0038857665,0.0031970486,0.7988316,0.00023578184,0.0003891351,0.0010584646,0.00021265745,7.1409096e-7,0.00012741484,0.0000029825057,0.19182108,0.00023736418],"about_ca_topic_score_codex":0.0000051473476,"about_ca_topic_score_gemma":0.00010120181,"teacher_disagreement_score":0.052026775,"about_ca_system_score_codex":0.000056334786,"about_ca_system_score_gemma":0.00010174917,"threshold_uncertainty_score":0.9999493},"labels":[],"label_agreement":null},{"id":"W2016426161","doi":"10.1093/eurjhf/hfs192","title":"Hyperpolarized 13C Magnetic Resonance Reveals Early- and Late-Onset Changes to <i>in vivo</i> Pyruvate Metabolism in the Failing Heart","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Advanced NMR Techniques and Applications","field":"Chemistry","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Alberta; General Electric (Canada); University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; British Heart Foundation","keywords":"Heart failure; Medicine; In vivo; Nuclear magnetic resonance; Magnetic resonance imaging; Internal medicine; Biology; Physics; Radiology; Genetics","score_opus":0.013288306492183885,"score_gpt":0.2515200589361624,"score_spread":0.23823175244397854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016426161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795792,0.0055168336,0.000059332233,0.014232509,0.000021225751,0.00014723116,0.00001967733,0.00002227711,0.00040172576],"genre_scores_gemma":[0.9719283,0.00021127024,0.025541048,0.0016656423,0.00028404559,0.000010367075,9.0765076e-7,0.00003754242,0.0003208926],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986297,0.00021351302,0.00042064872,0.00016395027,0.00020659853,0.00036559912],"domain_scores_gemma":[0.99928,0.00011174086,0.00012305737,0.0002912871,0.00004936588,0.00014457502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012699604,0.00016535245,0.0002979144,0.000103956205,0.00008702487,0.00005180945,0.0002656122,0.00003985382,0.000078862395],"category_scores_gemma":[0.00008325403,0.00012451595,0.000060829596,0.000260336,0.000047741614,0.00017631889,0.00007522085,0.00053584215,0.000015654487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121537756,0.0001460613,0.03931919,0.000048537975,0.000007484467,0.0000643349,0.0029191016,0.000018976898,0.93485874,0.00016342154,0.018707104,0.0036254856],"study_design_scores_gemma":[0.0005475981,0.00006011929,0.04556412,0.00022258962,0.000014914153,0.00021988318,0.00029186127,0.0000059754607,0.012170805,0.0001144944,0.9406111,0.00017652391],"about_ca_topic_score_codex":0.000014709236,"about_ca_topic_score_gemma":0.000020219226,"teacher_disagreement_score":0.92268795,"about_ca_system_score_codex":0.000018534796,"about_ca_system_score_gemma":0.000010341894,"threshold_uncertainty_score":0.5077613},"labels":[],"label_agreement":null},{"id":"W2016699271","doi":"10.1016/s1388-9842(03)00158-2","title":"Instruments to Measure Acceptability of Information and Acquisition of Knowledge in Patients with Heart Failure","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; London Health Sciences Centre","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Cronbach's alpha; Heart failure; Intervention (counseling); Psychological intervention; Internal consistency; Consistency (knowledge bases); Knowledge acquisition; Compliance (psychology); Physical therapy; Psychometrics; Nursing; Cardiology; Knowledge management; Clinical psychology; Psychology; Computer science","score_opus":0.008518528915957732,"score_gpt":0.22535441520675162,"score_spread":0.2168358862907939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016699271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494493,0.00004755924,0.00015992502,0.0037567515,0.000054109256,0.0005405741,0.00000590995,0.0000069597954,0.00048325604],"genre_scores_gemma":[0.96991074,0.0000030595818,0.029882086,0.00014322215,0.000021183057,0.0000015251317,0.000007590478,0.000014117915,0.000016470298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998232,0.00033412475,0.0007257718,0.00011845009,0.00040827916,0.00018138373],"domain_scores_gemma":[0.99887156,0.000022244061,0.0002493271,0.00020665284,0.0004644459,0.00018578491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010234205,0.0001620887,0.00044905645,0.00037945763,0.000032725446,0.000015590742,0.00006254551,0.00003492826,0.00013719892],"category_scores_gemma":[0.00010410248,0.00011920338,0.000080907645,0.0003470067,0.00006447675,0.0004603522,0.000036352187,0.0001863936,0.000018485747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070985843,0.00060905894,0.9778124,0.00024485245,0.00009240301,0.000004273564,0.0010854108,0.000014975961,0.00048349402,0.00008539094,0.01421294,0.0046449127],"study_design_scores_gemma":[0.0055118203,0.0024239458,0.8589489,0.0003623596,0.000074171134,0.000024685998,0.000549834,0.0000011629894,0.0015587525,0.000005780162,0.1304404,0.000098196826],"about_ca_topic_score_codex":0.0000042748625,"about_ca_topic_score_gemma":0.000013769356,"teacher_disagreement_score":0.11886354,"about_ca_system_score_codex":0.00006732083,"about_ca_system_score_gemma":0.000094460076,"threshold_uncertainty_score":0.48609728},"labels":[],"label_agreement":null},{"id":"W2018670126","doi":"10.1016/j.ejheart.2007.12.002","title":"Relationships Between Plasma Levels of Matrix Metalloproteinases and Neurohormonal Profile in Patients with Heart Failure","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Hamilton Health Sciences; Toronto General Hospital; University of Toronto; University Health Network; Canadian Institutes of Health Research; Heart and Stroke Foundation; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Matrix metalloproteinase; Medicine; Heart failure; Cardiology; Internal medicine","score_opus":0.027962593672245368,"score_gpt":0.23739240625591018,"score_spread":0.2094298125836648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018670126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996745,0.00024004615,0.0000632593,0.0025325222,0.000030840125,0.00028511733,0.000029019695,0.0000094059305,0.000064777465],"genre_scores_gemma":[0.96352273,0.000007442686,0.036164038,0.000027982942,0.00015833962,5.502329e-7,0.000008194033,0.000038841063,0.00007185137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809736,0.0003730365,0.00065936026,0.00017282362,0.0005012555,0.00019617552],"domain_scores_gemma":[0.99900913,0.000084302825,0.00025921979,0.00016535468,0.0002876693,0.00019433105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006906328,0.00017000698,0.00057679455,0.00026023117,0.00010782354,0.000014633369,0.00006459212,0.00004886587,0.000027992755],"category_scores_gemma":[0.00014021498,0.00011930319,0.00015793942,0.00023107072,0.00013243225,0.00020750218,0.00004277846,0.0006838685,0.000008551746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032994786,0.00009784839,0.9893382,0.00006987303,0.000072741146,0.000048209135,0.0002249498,0.00013355275,0.005204613,0.000008341349,0.0043446454,0.00012703039],"study_design_scores_gemma":[0.0029136012,0.0011684463,0.98402905,0.00043559488,0.00009581049,0.0005198532,0.00010284611,0.000016575597,0.0009154231,0.000003036308,0.0096812155,0.00011854506],"about_ca_topic_score_codex":0.0000025729573,"about_ca_topic_score_gemma":0.0000014283257,"teacher_disagreement_score":0.03610078,"about_ca_system_score_codex":0.000021705244,"about_ca_system_score_gemma":0.000104833816,"threshold_uncertainty_score":0.48650432},"labels":[],"label_agreement":null},{"id":"W2021056228","doi":"10.1093/eurjhf/hfq194","title":"Predictors and Prognostic Impact of Recurrent Myocardial Infarction in Patients with Left Ventricular Dysfunction, Heart Failure, or Both Following a First Myocardial Infarction","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cardiology; Myocardial infarction; Heart failure; Internal medicine; Electrocardiography in myocardial infarction; Infarction","score_opus":0.007715477934038093,"score_gpt":0.25006983556649737,"score_spread":0.24235435763245927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021056228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296546,0.00009657874,0.00010877124,0.004904981,0.00087622914,0.0009477244,0.000018295508,0.000034685487,0.000047291975],"genre_scores_gemma":[0.9966449,0.000031610612,0.0021783118,0.00021744537,0.00078989164,0.0000059617687,0.00003549643,0.000078342775,0.000018026027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635714,0.00057180604,0.0009860892,0.0003683225,0.0012230948,0.0004935582],"domain_scores_gemma":[0.99785954,0.00015955603,0.00041975768,0.00035629186,0.0007100627,0.0004947942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001665497,0.00035779158,0.00081268855,0.0008647961,0.00018013579,0.00008698269,0.00013629823,0.0001333709,0.00013179844],"category_scores_gemma":[0.00083269435,0.00024878216,0.000621206,0.00069719076,0.00018084512,0.00056945725,0.00007781513,0.001527782,0.00001669466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026628335,0.00030482674,0.9456653,0.000059358706,0.0009702377,0.000106220825,0.00025054353,0.00018115579,0.0011037362,0.0000010549304,0.04831286,0.00038184025],"study_design_scores_gemma":[0.0065041957,0.006534337,0.89457864,0.00041093354,0.0003510613,0.0009028701,0.000095423435,0.000032539523,0.00005697098,0.0000023233247,0.090321645,0.0002090842],"about_ca_topic_score_codex":0.000043559103,"about_ca_topic_score_gemma":0.000026826714,"teacher_disagreement_score":0.051086716,"about_ca_system_score_codex":0.00021093762,"about_ca_system_score_gemma":0.00041680306,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W2022393996","doi":"10.1093/eurjhf/hft025","title":"Association of Physical Activity and Heart Failure with Preserved vs. Reduced Ejection Fraction in the Elderly: The Framingham Heart Study","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Physical Activity and Health","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Toronto General Hospital; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Heart failure; Framingham Heart Study; Ejection fraction; Cardiology; Framingham Risk Score; Myocardial infarction; Proportional hazards model; Disease","score_opus":0.020204978364798582,"score_gpt":0.2824847967357408,"score_spread":0.2622798183709422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022393996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204394,0.000013384886,0.000028379527,0.07870494,0.000040486124,0.0006803955,0.0000012677924,0.000010986408,0.00008076805],"genre_scores_gemma":[0.9987941,0.0000035553094,0.00032271768,0.00029275825,0.00051407446,0.0000066980942,8.703e-7,0.000020931639,0.000044301032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969265,0.0017058455,0.00030439568,0.00018076676,0.0006526627,0.00022984944],"domain_scores_gemma":[0.99853456,0.00046983373,0.0003802262,0.00025373467,0.00025820918,0.00010343014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016475163,0.00015766463,0.0005054422,0.00009390478,0.00018117644,0.00007082566,0.00010713728,0.000043976335,0.000020485935],"category_scores_gemma":[0.00024596535,0.00008419402,0.00011838716,0.00031138866,0.00006368253,0.0005527798,0.000031771473,0.0012947033,0.000016308346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002222207,0.012733624,0.5089595,0.00028859,0.00053516537,0.000043857635,0.009217299,0.00011715155,0.32473904,0.000025659976,0.13764377,0.0034741908],"study_design_scores_gemma":[0.0017632572,0.00794431,0.97342163,0.0001701705,0.00011143003,0.00010613341,0.0026408138,0.00012966599,0.0018642349,0.000034393142,0.011725538,0.000088391156],"about_ca_topic_score_codex":0.00019049729,"about_ca_topic_score_gemma":0.000096914526,"teacher_disagreement_score":0.46446222,"about_ca_system_score_codex":0.000088184555,"about_ca_system_score_gemma":0.000089679066,"threshold_uncertainty_score":0.56249136},"labels":[],"label_agreement":null},{"id":"W2022579828","doi":"10.1093/eurjhf/hfr169","title":"Atrial Dyssynchrony Syndrome: An Overlooked Phenomenon and a Potential Cause of ‘Diastolic’ Heart Failure","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure with preserved ejection fraction; Heart failure; Diastole; Doppler echocardiography; Coronary sinus; Doppler imaging; Atrial fibrillation; Ejection fraction; Blood pressure","score_opus":0.016845056252418944,"score_gpt":0.2659933230268507,"score_spread":0.24914826677443175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022579828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930398,0.0029275138,0.00014012502,0.0025802902,0.00047531925,0.0001649999,0.00001655328,0.000027184808,0.00062825065],"genre_scores_gemma":[0.99221075,0.000062554616,0.005433667,0.00016340836,0.0019517374,2.592974e-7,0.00000418662,0.000046743808,0.00012672189],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979063,0.0004320726,0.00065369694,0.00016940237,0.00049720233,0.0003412931],"domain_scores_gemma":[0.9986458,0.00006492047,0.00031789034,0.00026359624,0.00025616298,0.00045162867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010805032,0.00021823197,0.0008390143,0.00025238263,0.00012359819,0.000034578017,0.000034784916,0.000051068375,0.00006206761],"category_scores_gemma":[0.0001351555,0.00017822668,0.00037695598,0.00018091303,0.00016493486,0.00033903352,0.00007118052,0.00033131876,0.000039751914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037774055,0.0007149879,0.38289714,0.0006749195,0.0037113463,0.0010927035,0.012690179,0.00044555624,0.10828038,0.00025261403,0.4827746,0.0026881674],"study_design_scores_gemma":[0.0073340596,0.003022033,0.37010562,0.00045761713,0.0010139212,0.051132597,0.0022788432,0.000007796511,0.00054886786,0.000008479718,0.56369483,0.00039530164],"about_ca_topic_score_codex":0.0000059974277,"about_ca_topic_score_gemma":0.0000012723077,"teacher_disagreement_score":0.10773151,"about_ca_system_score_codex":0.000039153972,"about_ca_system_score_gemma":0.00007685887,"threshold_uncertainty_score":0.72678727},"labels":[],"label_agreement":null},{"id":"W2024283034","doi":"10.1016/s1388-9842(03)00046-1","title":"The Diagnosis of Heart Failure in General Practice: Implications for the UK National Service Framework","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Science Foundation","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Medical diagnosis; Ejection fraction; Population; Clinical Practice; Intensive care medicine; Physical therapy; Radiology","score_opus":0.029664413689954264,"score_gpt":0.32207139758528697,"score_spread":0.2924069838953327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024283034","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02121414,0.0011934929,0.0013363389,0.97448915,0.00023774379,0.0010176697,0.00001248936,0.000018473924,0.00048048247],"genre_scores_gemma":[0.7758911,0.00028101227,0.21263841,0.010070498,0.0006668296,0.00007286408,0.000006369,0.00006959523,0.00030326602],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979097,0.0005045924,0.00068717106,0.00016955887,0.00043848786,0.00029046726],"domain_scores_gemma":[0.99670047,0.00162836,0.00031517658,0.00035794344,0.0008685435,0.00012948937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026757545,0.00017467228,0.00030348016,0.00012666384,0.00028704476,0.00006418385,0.00021093503,0.000047561927,0.00008820031],"category_scores_gemma":[0.0017251401,0.000100059886,0.00023713853,0.00045218022,0.00007130626,0.0001565669,0.000039724353,0.0004620314,0.000039663362],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018883124,0.0003575016,0.045720834,0.00004601166,0.00034723594,0.000016532249,0.00043638804,0.00026294042,0.0005017042,0.013936854,0.9375576,0.000627602],"study_design_scores_gemma":[0.0013248023,0.00034840556,0.043857105,0.00015104457,0.00017553751,0.00028856986,0.00064902066,0.000013563537,0.00020534096,0.00041797635,0.95248103,0.0000875935],"about_ca_topic_score_codex":0.0000089937685,"about_ca_topic_score_gemma":0.00007973216,"teacher_disagreement_score":0.96441865,"about_ca_system_score_codex":0.000081905826,"about_ca_system_score_gemma":0.0002391689,"threshold_uncertainty_score":0.4080324},"labels":[],"label_agreement":null},{"id":"W2024399622","doi":"10.1002/ejhf.96","title":"What is the Best Therapeutic Strategy in Patients with Low Flow, Low-Gradient Aortic Stenosis, and Wide QRS?","year":2014,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Stenosis; Ejection fraction; Aortic valve replacement; Heart failure; QRS complex; Population; Aortic valve stenosis; Cardiac resynchronization therapy","score_opus":0.00923235863994656,"score_gpt":0.2498322727419328,"score_spread":0.24059991410198622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024399622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68216723,0.0035754717,0.000006728861,0.3131373,0.00036259965,0.0006343363,0.000027960743,0.000008853164,0.00007954134],"genre_scores_gemma":[0.78250206,0.0004939463,0.00007385411,0.2156457,0.0008873813,0.0000034299383,0.00006810776,0.00012374192,0.0002018172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753237,0.0005228821,0.00056358555,0.0003101758,0.0006861672,0.00038481853],"domain_scores_gemma":[0.998636,0.00010217232,0.00036020944,0.00045088705,0.00024922352,0.00020151415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029994154,0.00040607565,0.0007165821,0.00017568837,0.000088432054,0.00022285391,0.000151412,0.000092898386,0.00006237371],"category_scores_gemma":[0.000015479043,0.00022149022,0.0006169536,0.00012805719,0.00011998651,0.00019288925,0.000039618477,0.0012758423,0.00006560447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044972604,0.00041431157,0.51956755,0.0003143867,0.0017613976,0.0012138644,0.00029522678,0.000027513133,0.0000022838615,3.8587527e-7,0.4717148,0.004238546],"study_design_scores_gemma":[0.0055514355,0.0027701566,0.8115142,0.003868895,0.0018501432,0.0001303259,0.00028477504,0.000008658096,0.0000037114921,0.0000065276176,0.17371789,0.00029330153],"about_ca_topic_score_codex":0.000006167578,"about_ca_topic_score_gemma":0.0000011383105,"teacher_disagreement_score":0.2979969,"about_ca_system_score_codex":0.00008020586,"about_ca_system_score_gemma":0.00010263617,"threshold_uncertainty_score":0.9032109},"labels":[],"label_agreement":null},{"id":"W2031217035","doi":"10.1016/j.ejheart.2005.07.006","title":"Pulsatile Hemodynamic Effects of Candesartan in Patients with Chronic Heart Failure: The CHARM Program","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Candesartan; Medicine; Cardiology; Internal medicine; Heart failure; Pulsatile flow; Hemodynamics; Ejection fraction; Blood pressure; Angiotensin II","score_opus":0.003152896485815477,"score_gpt":0.20670351878503176,"score_spread":0.20355062229921628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031217035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920877,0.00052414526,0.000028479719,0.0063860724,0.00018140725,0.00069559226,0.0000028633842,0.000020008547,0.00007370831],"genre_scores_gemma":[0.99767333,0.000017929906,0.0016008376,0.00025171653,0.00031210933,0.0000042824468,0.000008902257,0.000045178724,0.00008573099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805397,0.0004432231,0.00045314652,0.00015571687,0.0006313642,0.00026257802],"domain_scores_gemma":[0.99911267,0.000049251594,0.00020757323,0.0003190803,0.00015935354,0.00015208549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068940624,0.00017755294,0.00045891805,0.00018337708,0.00008612897,0.000020030237,0.00012291895,0.000028201672,0.00020229616],"category_scores_gemma":[0.000054468186,0.00010243154,0.00032494386,0.00031628515,0.00009172078,0.00011220141,0.000035822348,0.0006570961,0.000021495538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011352495,0.0015813048,0.88950086,0.00033283557,0.0007534713,0.0002137909,0.0010352078,0.0012418488,0.0028510937,0.00001140646,0.06837802,0.03296489],"study_design_scores_gemma":[0.004888897,0.0024380924,0.56654483,0.00021924755,0.0001107167,0.0002861887,0.000087636174,0.000034830537,0.00045664236,3.2822265e-7,0.42483586,0.00009672192],"about_ca_topic_score_codex":0.000013001025,"about_ca_topic_score_gemma":0.00008814695,"teacher_disagreement_score":0.35645786,"about_ca_system_score_codex":0.00018586816,"about_ca_system_score_gemma":0.00016269341,"threshold_uncertainty_score":0.41770372},"labels":[],"label_agreement":null},{"id":"W2032672841","doi":"10.1016/s1388-9842(03)00047-3","title":"Difficulties of Introducing the National Service Framework for Heart Failure Into General Practice in the UK","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"European Society of Cardiology; National Science Foundation","keywords":"Medicine; Medical prescription; Heart failure; Diuretic; Loop diuretic; Population; Intensive care medicine; Management of heart failure; Internal medicine; Pharmacology","score_opus":0.018418635541105052,"score_gpt":0.2944693328923911,"score_spread":0.276050697351286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032672841","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15553646,0.0007117819,0.002061441,0.8397902,0.0003120108,0.0010196958,0.000004918329,0.000016482694,0.0005469716],"genre_scores_gemma":[0.63396394,0.000022206705,0.35338143,0.011567369,0.00088628964,0.000009928932,0.0000057387183,0.00003212009,0.00013097329],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715686,0.0010016161,0.0006722379,0.00019415315,0.0007038383,0.0002712802],"domain_scores_gemma":[0.9977672,0.00084357825,0.00030996595,0.00028549694,0.0007075561,0.00008618649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039305543,0.00020181965,0.00037139753,0.0001603282,0.0001783511,0.00006736444,0.0002248134,0.000047221973,0.000084789535],"category_scores_gemma":[0.0021382312,0.000108764965,0.00021713608,0.00041908427,0.00006916371,0.00019385027,0.000038763792,0.0006015306,0.000026965046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043124682,0.0005821832,0.004262984,0.0001788509,0.00038499729,0.00007831091,0.0099933725,0.0008506558,0.004416091,0.00946836,0.9690116,0.0003413306],"study_design_scores_gemma":[0.0017432381,0.0006135364,0.006239486,0.00026276425,0.00017883339,0.0006879664,0.005987328,0.000019965337,0.000573756,0.00035200582,0.9832271,0.00011402322],"about_ca_topic_score_codex":0.000014403291,"about_ca_topic_score_gemma":0.00004502181,"teacher_disagreement_score":0.8282229,"about_ca_system_score_codex":0.00006656978,"about_ca_system_score_gemma":0.00014930037,"threshold_uncertainty_score":0.44353065},"labels":[],"label_agreement":null},{"id":"W2033533885","doi":"10.1002/ejhf.279","title":"May 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiogenic shock; Heart failure; Myocardial infarction; Observational study; Decompensation; Acute coronary syndrome; Internal medicine; Ejection fraction; Cardiology; Emergency medicine; Intensive care medicine","score_opus":0.03090929627929691,"score_gpt":0.2834212196352248,"score_spread":0.2525119233559279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033533885","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44353083,0.0027654332,0.0004837153,0.5274111,0.0010647342,0.0005738696,0.000005355053,0.00012545999,0.024039492],"genre_scores_gemma":[0.9190652,0.000032689706,0.06139139,0.001968654,0.0010913119,0.0000010394926,0.000006901529,0.00005526358,0.016387561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985143,0.00023331908,0.00040330467,0.0001376653,0.00046195957,0.00024947646],"domain_scores_gemma":[0.9988059,0.0000204925,0.0001509327,0.000260948,0.00024285284,0.0005189034],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010900077,0.00015500277,0.00034220025,0.00013671276,0.00004989954,0.000025288067,0.00010452687,0.000022346943,0.0002592854],"category_scores_gemma":[0.00009924793,0.000110035646,0.00016704781,0.00013544068,0.000047574504,0.00012909756,0.00008146863,0.00022873453,0.0015444296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025589377,0.00010567422,0.013864288,0.000017827713,0.00009057543,0.0016613714,0.00025339876,0.0000070995334,0.00082949514,0.000034054683,0.98208094,0.00079937803],"study_design_scores_gemma":[0.0032836248,0.0011857399,0.0075940765,0.00012677966,0.00010133928,0.002052314,0.00018343084,0.000005491731,0.0003893062,0.0000095803625,0.9849701,0.00009821911],"about_ca_topic_score_codex":0.0000022160925,"about_ca_topic_score_gemma":0.0000047791445,"teacher_disagreement_score":0.5254425,"about_ca_system_score_codex":0.00013099516,"about_ca_system_score_gemma":0.00010313981,"threshold_uncertainty_score":0.999233},"labels":[],"label_agreement":null},{"id":"W2035007848","doi":"10.1016/s1388-9842(00)80257-3","title":"Sensitivity and Specificity of QRS Duration to Predict Acute Benefit in Heart Failure Patients with Ventricular Resynchronization","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Adidas (Canada); Saint Paul University","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Cardiac resynchronization therapy; QRS complex; Ejection fraction","score_opus":0.005784097684448778,"score_gpt":0.21467047342038648,"score_spread":0.20888637573593768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035007848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542636,0.00011405127,0.0002323608,0.0036650624,0.000038494556,0.00020619643,0.000017398088,0.000010820383,0.00028925994],"genre_scores_gemma":[0.9947806,0.000020780975,0.004874881,0.000109165114,0.00014864575,2.5455174e-7,0.000010160212,0.000017550648,0.000037963488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869865,0.0002027429,0.00043171566,0.00014824688,0.00038408546,0.00013453467],"domain_scores_gemma":[0.9992155,0.000041643565,0.00014157659,0.00013069292,0.00034765847,0.00012294289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050065375,0.00012026681,0.0004168858,0.0001850628,0.000060077706,0.00001974393,0.0000113915075,0.000025265588,0.000019683],"category_scores_gemma":[0.00007250589,0.000093132105,0.00007593919,0.00031618282,0.000040131155,0.00013750076,0.000017534663,0.00015956072,0.000010130076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091566105,0.000102031765,0.97076964,0.000041995314,0.00014463173,0.00016721892,0.000582439,0.002402449,0.0020895437,0.000006462021,0.02146838,0.0013095211],"study_design_scores_gemma":[0.0018170921,0.0007790446,0.92772716,0.000338497,0.000086215616,0.0007786153,0.00010338503,0.000019022424,0.000699308,0.0000012960031,0.06756106,0.00008932078],"about_ca_topic_score_codex":0.0000055738774,"about_ca_topic_score_gemma":0.000016073096,"teacher_disagreement_score":0.04609268,"about_ca_system_score_codex":0.000045169076,"about_ca_system_score_gemma":0.00002971774,"threshold_uncertainty_score":0.3797817},"labels":[],"label_agreement":null},{"id":"W2038811749","doi":"10.1016/j.ejheart.2004.11.005","title":"Cardiac Resynchronisation Therapy: An Option for Inotrope-Supported Patients with End-Stage Heart Failure?","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Inotrope; Heart failure; Furosemide; Creatinine; Refractory (planetary science); Internal medicine; Cardiology; Retrospective cohort study; Cardiac index; Anesthesia; Cardiac output; Hemodynamics","score_opus":0.018580506806313086,"score_gpt":0.26847743768733295,"score_spread":0.24989693088101986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038811749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896704,0.00049245387,0.0018652166,0.006492277,0.00019883152,0.00051171647,0.00004574441,0.000057570054,0.00066580094],"genre_scores_gemma":[0.95701164,0.00003333865,0.040955957,0.00048621855,0.0011331353,0.0000027567169,0.000070818896,0.00006285985,0.00024325408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981212,0.00032554197,0.00054074073,0.00022374127,0.0005266728,0.00026209027],"domain_scores_gemma":[0.9984159,0.000063494655,0.00029914157,0.0002759254,0.0007290336,0.00021652006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008365209,0.00021180933,0.0005654538,0.00019132129,0.00019961775,0.000065186716,0.000033295262,0.000039981333,0.000046169258],"category_scores_gemma":[0.00007814713,0.00015430343,0.00028933462,0.00015583518,0.0000836869,0.0003842432,0.000017701093,0.00023750552,0.000040078463],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006251826,0.0006585633,0.4333757,0.00013811469,0.0013739095,0.00003332214,0.0033698909,0.0028570904,0.03505462,0.00023525413,0.49646494,0.020186786],"study_design_scores_gemma":[0.0035172,0.0021742475,0.1950427,0.000090266156,0.00008995395,0.00010651747,0.00027667423,0.000017072114,0.000891711,0.0000015064752,0.79764503,0.00014709304],"about_ca_topic_score_codex":0.0000025380027,"about_ca_topic_score_gemma":0.0000034435348,"teacher_disagreement_score":0.3011801,"about_ca_system_score_codex":0.00009373272,"about_ca_system_score_gemma":0.00011265332,"threshold_uncertainty_score":0.6292311},"labels":[],"label_agreement":null},{"id":"W2038895717","doi":"10.1016/j.ejheart.2004.10.003","title":"Clinical Trials Update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic Sub-Study and RHYTHM-ICD","year":2004,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enoximone; Medicine; Heart failure; Inotrope; Cardiology; Internal medicine; Randomized controlled trial; Heart Rhythm; Intensive care medicine","score_opus":0.09881553531229162,"score_gpt":0.3957883459646972,"score_spread":0.29697281065240555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038895717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051270234,0.9880485,0.00011375816,0.0048067276,0.0006164883,0.0010240965,0.000116959316,0.000025756868,0.00012072476],"genre_scores_gemma":[0.0032901918,0.9791224,0.012995607,0.0005761202,0.0038033044,0.0000023727655,0.000019190016,0.00012777591,0.00006301306],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889927,0.0055414387,0.0038108977,0.00051816175,0.0007953724,0.0003414344],"domain_scores_gemma":[0.9939761,0.002180786,0.0023433932,0.0007214344,0.00044004625,0.00033820473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006277134,0.0006060864,0.0066715805,0.00012198507,0.00022172055,0.00009205201,0.00011735665,0.00017171887,0.000030246913],"category_scores_gemma":[0.001287906,0.0003513511,0.003577596,0.00040959145,0.00041799422,0.00007233439,0.00021677434,0.0015586885,0.00012891188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001843888,0.00037092293,0.006405558,0.0026322526,0.0065448303,0.00025711383,0.00096096285,0.000016108284,0.000015499889,8.743368e-7,0.702422,0.28018948],"study_design_scores_gemma":[0.0022630135,0.0010481959,0.004238253,0.01195332,0.0047409595,0.003560616,0.0010826039,5.7918726e-7,8.725749e-7,0.0000033175982,0.97083414,0.0002741306],"about_ca_topic_score_codex":0.00002905504,"about_ca_topic_score_gemma":0.000004407644,"teacher_disagreement_score":0.27991536,"about_ca_system_score_codex":0.000059798625,"about_ca_system_score_gemma":0.00050072925,"threshold_uncertainty_score":0.99989384},"labels":[],"label_agreement":null},{"id":"W2039086932","doi":"10.1016/s1388-9842(00)00098-2","title":"Design and Methodology of the CAPRICORN Trial — A Randomised Double Blind Placebo Controlled Study of the Impact of Carvedilol on Morbidity and Mortality in Patients with Left Ventricular Dysfunction After Myocardial Infarction","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Carvedilol; Myocardial infarction; Placebo; Heart failure; Internal medicine; Cardiology; Randomized controlled trial; Alternative medicine","score_opus":0.04219302976067786,"score_gpt":0.2938185025517166,"score_spread":0.25162547279103875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039086932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958208,0.00003474302,0.000049995004,0.000327086,0.00008905144,0.0036525917,0.0000016811556,0.0000020770703,0.000021938024],"genre_scores_gemma":[0.9995412,0.0000070807323,0.00033023543,0.000020529418,0.000060726157,0.000008338519,7.1431526e-7,0.000011342551,0.000019799663],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99610275,0.0026637132,0.00060882774,0.0001305145,0.00037682947,0.00011733536],"domain_scores_gemma":[0.9990123,0.0001824059,0.00038834492,0.00021728282,0.00013937773,0.000060308717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024163271,0.00014680847,0.0007199963,0.00012423198,0.000038667873,0.000007864084,0.000053562697,0.00003232234,0.000048118596],"category_scores_gemma":[0.00010154716,0.000066468245,0.00020315486,0.0001444395,0.00008130238,0.00006403136,0.00002445724,0.00022304802,3.4378073e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6382995,0.0009960145,0.35728005,0.000017597233,0.0008162527,0.0000173166,0.0006122873,0.0012311441,0.00017605355,2.051997e-7,0.0003593906,0.00019420532],"study_design_scores_gemma":[0.4142386,0.0063758153,0.57842815,0.00006594193,0.00057657977,0.000013329011,0.00007552133,0.00001825085,0.00011938699,0.0000015115208,0.000051486688,0.000035444024],"about_ca_topic_score_codex":0.00008490934,"about_ca_topic_score_gemma":0.00001592645,"teacher_disagreement_score":0.2240609,"about_ca_system_score_codex":0.000040784045,"about_ca_system_score_gemma":0.00006976674,"threshold_uncertainty_score":0.27104962},"labels":[],"label_agreement":null},{"id":"W2040541893","doi":"10.1093/eurjhf/hfs071","title":"Left Ventricular Systolic Dysfunction Associated with Pulmonary Hypertension Riociguat Trial (LEPHT): Rationale and Design","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Riociguat; Medicine; Tolerability; Ejection fraction; Heart failure; Pulmonary hypertension; Internal medicine; Cardiology; Hemodynamics; Placebo; Blood pressure; Clinical endpoint; Randomized controlled trial; Adverse effect; Chronic thromboembolic pulmonary hypertension","score_opus":0.03430888578419047,"score_gpt":0.24306661948514055,"score_spread":0.20875773370095008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040541893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069816,0.003059399,0.00046650955,0.004694946,0.0002123257,0.00067651697,0.000004187642,0.000025419076,0.00016254104],"genre_scores_gemma":[0.99532163,0.00006459532,0.003342133,0.00032125198,0.0004758533,0.0000019745821,0.0000268644,0.00003564083,0.00041002806],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99779075,0.0007718909,0.00034767736,0.00014486117,0.00062487606,0.000319964],"domain_scores_gemma":[0.998694,0.00014871567,0.0001919528,0.0001439582,0.0003592036,0.00046215818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011988892,0.00016952564,0.0003768868,0.00019501374,0.0001744195,0.000028219198,0.00005124398,0.000044858036,0.00008340574],"category_scores_gemma":[0.00035300467,0.00010731792,0.00011186871,0.00015655595,0.000059957612,0.00031345023,0.000028071354,0.00033819256,0.00005805873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16614535,0.015621996,0.17354764,0.00026593372,0.004917467,0.14305396,0.0005051282,0.0002179691,0.16628501,0.000039132912,0.3229794,0.0064210217],"study_design_scores_gemma":[0.11390116,0.016164556,0.5922676,0.0016405764,0.0017665392,0.14926198,0.00050275505,0.00055873033,0.0026380443,0.00002360925,0.12067838,0.00059610413],"about_ca_topic_score_codex":0.000001497992,"about_ca_topic_score_gemma":2.8646375e-7,"teacher_disagreement_score":0.41871992,"about_ca_system_score_codex":0.000065501634,"about_ca_system_score_gemma":0.00011649316,"threshold_uncertainty_score":0.4376298},"labels":[],"label_agreement":null},{"id":"W2040751336","doi":"10.1093/eurjhf/hfs146","title":"TAVI In Heart Failure, How Much Risk is Acceptable?","year":2012,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; MEDLINE; Intensive care medicine","score_opus":0.014681607049596056,"score_gpt":0.28195394992222306,"score_spread":0.267272342872627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040751336","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064703435,0.0059042578,0.000012925589,0.926517,0.0012682629,0.00057242246,0.0003256038,0.000039549413,0.00065652735],"genre_scores_gemma":[0.54626316,0.0004894776,0.008125942,0.40873063,0.03074299,0.00000930279,0.00040232218,0.00057762355,0.0046585747],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558276,0.0010999293,0.0008626713,0.0004742778,0.0010843966,0.00089594483],"domain_scores_gemma":[0.9974781,0.000099751676,0.00070358015,0.0007949119,0.00037492384,0.00054869],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009413962,0.00067067286,0.0015141314,0.00062065065,0.0001194211,0.00017105868,0.00028697372,0.00031678088,0.0015533],"category_scores_gemma":[0.0001643894,0.00053032115,0.0030233092,0.00034377488,0.00009432401,0.00034788746,0.000128145,0.0040678065,0.00086830603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007212033,0.00015904645,0.14603604,0.00011833471,0.000877663,0.0021197828,0.00011026326,5.766776e-7,0.00006890267,3.3042363e-7,0.8499851,0.00045181674],"study_design_scores_gemma":[0.0029954535,0.00044932234,0.11711982,0.0005840395,0.0016111465,0.0014153393,0.00013907292,7.4463424e-7,0.000052742962,0.000004686746,0.875264,0.00036365236],"about_ca_topic_score_codex":0.000028271683,"about_ca_topic_score_gemma":0.0000035304195,"teacher_disagreement_score":0.5177864,"about_ca_system_score_codex":0.00021570215,"about_ca_system_score_gemma":0.00024732485,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W2041276037","doi":"10.1016/j.ejheart.2005.03.006","title":"Effect of Angiotensin-Converting Enzyme Inhibition on Functional Class in Patients with Left Ventricular Systolic Dysfunction—A Meta-Analysis","year":2005,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Hjerteforeningen","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Odds ratio; Myocardial infarction; Placebo; Meta-analysis; ACE inhibitor; Angiotensin-converting enzyme; Blood pressure; Pathology","score_opus":0.026862710595727365,"score_gpt":0.26737896525966964,"score_spread":0.24051625466394227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041276037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050475006,0.9885579,0.00018221665,0.003322298,0.0002523989,0.0023891511,0.000031059604,0.00004175138,0.00017575217],"genre_scores_gemma":[0.43909693,0.5312905,0.013743139,0.0023979868,0.0054345317,0.00009857206,0.003136462,0.00131762,0.0034842712],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949526,0.0018034079,0.0015393039,0.00038874248,0.0009971849,0.0003187314],"domain_scores_gemma":[0.9976465,0.00021633242,0.0012035787,0.00040753259,0.0003263705,0.00019965987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019937393,0.00057523156,0.0041468237,0.0017664,0.00006515669,0.000028392213,0.00008634544,0.0001123564,0.00040445875],"category_scores_gemma":[0.00009787858,0.00032817182,0.0032698314,0.00093104754,0.000047042176,0.0001426028,0.00004177645,0.00074775505,0.000120546574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040818104,0.0039830604,0.007927643,0.019779455,0.6096836,0.007651082,0.00022236997,0.0023958758,0.000008968876,0.00004100579,0.1592593,0.18496583],"study_design_scores_gemma":[0.0026159352,0.0032974207,0.0012860978,0.0025070796,0.25059953,0.00024302675,0.000005364168,0.0000036005622,0.00001041476,9.675653e-8,0.7392305,0.00020092259],"about_ca_topic_score_codex":0.0000027075685,"about_ca_topic_score_gemma":0.0000050066533,"teacher_disagreement_score":0.5799712,"about_ca_system_score_codex":0.00026333498,"about_ca_system_score_gemma":0.000117194526,"threshold_uncertainty_score":0.99991703},"labels":[],"label_agreement":null},{"id":"W2044002436","doi":"10.1093/eurjhf/hfq042","title":"Does Cognitive Impairment Predict Poor Self-Care in Patients with Heart Failure?","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council","keywords":"Medicine; Heart failure; Confidence interval; Cognition; Depression (economics); Multivariate analysis; Multivariate statistics; Internal medicine; Gerontology; Physical therapy; Psychiatry","score_opus":0.0036028020063323756,"score_gpt":0.21218269160449368,"score_spread":0.20857988959816132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044002436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96801656,0.000047510755,0.000024700876,0.030085623,0.00036122382,0.0010825228,0.00001822809,0.00007429783,0.00028934338],"genre_scores_gemma":[0.96419877,0.0000058279943,0.034191933,0.0008533614,0.00046449676,0.00000700425,0.00003449147,0.000076334385,0.00016776001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974093,0.00031211376,0.00067446876,0.00034061345,0.00076737534,0.00049613416],"domain_scores_gemma":[0.9983962,0.000061374514,0.0002335753,0.00030528544,0.00055346324,0.00045007578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006801209,0.00036378883,0.0005970165,0.00039729418,0.000112121525,0.0000699771,0.00014673082,0.0000653322,0.00036423412],"category_scores_gemma":[0.0000693376,0.00019827885,0.00022133306,0.000281045,0.0001117187,0.00030654616,0.00008243977,0.0009305622,0.00018238439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012819166,0.0012695391,0.90489477,0.00012700213,0.00028882973,0.00047367034,0.0011322115,0.0000025281502,0.00030630225,0.000011971111,0.08960763,0.00060360477],"study_design_scores_gemma":[0.010763452,0.0048079053,0.53974944,0.0005641862,0.0002572262,0.00010563679,0.001148123,0.0000017794372,0.00038498535,0.000002295762,0.44200605,0.00020890126],"about_ca_topic_score_codex":0.000004784745,"about_ca_topic_score_gemma":0.0000888107,"teacher_disagreement_score":0.36514533,"about_ca_system_score_codex":0.00010154641,"about_ca_system_score_gemma":0.0001775832,"threshold_uncertainty_score":0.8085577},"labels":[],"label_agreement":null},{"id":"W2044122259","doi":"10.1002/ejhf.112","title":"Geographic Variation in Heart Failure Trials: Time for Scepticism?","year":2014,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Geographic variation; Variation (astronomy); Internal medicine; Skepticism; MEDLINE; Cardiology; Environmental health","score_opus":0.029361298184607944,"score_gpt":0.2779237782263365,"score_spread":0.24856248004172857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044122259","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011051157,0.00033691523,0.0011578419,0.9945809,0.00057652744,0.001904592,0.000025571804,0.00006843006,0.00024408934],"genre_scores_gemma":[0.011049308,0.000086312895,0.2558481,0.6921688,0.031677615,0.000072274146,0.00064532284,0.00066288305,0.007789419],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99277824,0.0025954254,0.0023387587,0.00057107914,0.0009422817,0.00077418797],"domain_scores_gemma":[0.99671626,0.00076710986,0.00109458,0.00066778867,0.0004846503,0.0002696195],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008338795,0.000683221,0.0025394901,0.0015049676,0.00012644393,0.00015713267,0.00031824195,0.00043246677,0.0007196954],"category_scores_gemma":[0.0009271297,0.0005289112,0.0014806231,0.00039237365,0.000088611894,0.00021791448,0.00007043232,0.00230615,0.00070856925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025719285,0.00014315199,0.0004020541,0.0003562685,0.00050133216,0.00077865727,0.00012209218,0.00001266599,0.0010380077,0.000009371481,0.99602324,0.0003559828],"study_design_scores_gemma":[0.006418753,0.0022005138,0.0016771572,0.0014208815,0.0011240314,0.0007440725,0.000029203771,0.00003931221,0.000034486384,0.00005540215,0.9858411,0.0004150928],"about_ca_topic_score_codex":0.000009173098,"about_ca_topic_score_gemma":0.000007332026,"teacher_disagreement_score":0.30241218,"about_ca_system_score_codex":0.00016295479,"about_ca_system_score_gemma":0.00022310337,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W2044348391","doi":"10.1093/eurjhf/hft028","title":"Heart Failure in Elderly Patients: Distinctive Features and Unresolved Issues","year":2013,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Heart failure; Clinical trial; Epidemiology; Intensive care medicine; Ageing; Gerontology; Internal medicine","score_opus":0.02264473105485326,"score_gpt":0.2960552315284893,"score_spread":0.273410500473636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044348391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005759225,0.9778272,0.0000094899715,0.01901923,0.0002814239,0.0018704203,0.000021352105,0.00004530232,0.0003496468],"genre_scores_gemma":[0.0006163223,0.96140957,0.032998182,0.0004621093,0.0012294115,0.000030613068,0.00014126665,0.00026602813,0.0028465157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571085,0.0011560529,0.0014171071,0.0005262209,0.0006300142,0.00055973517],"domain_scores_gemma":[0.99792254,0.00017079849,0.00061534625,0.00048306645,0.00032770724,0.0004805482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008851266,0.0007833106,0.0027913332,0.00073754357,0.000111123256,0.00016556347,0.00023779442,0.00019132263,0.00027954968],"category_scores_gemma":[0.00023520786,0.0005236136,0.0007017299,0.00040045957,0.0001379166,0.0003071174,0.0001828241,0.0014561608,0.00032330892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006173449,0.00038001226,0.0016288551,0.0037069854,0.0004875294,0.00055569067,0.00023781958,3.026253e-7,0.0000023963278,0.000023331986,0.8045116,0.18840374],"study_design_scores_gemma":[0.0022056527,0.0019414994,0.0032663008,0.015638236,0.0009865708,0.00073508994,0.00020025516,2.504303e-7,0.0000013078326,0.0000069039497,0.9746238,0.00039413632],"about_ca_topic_score_codex":0.000023802779,"about_ca_topic_score_gemma":0.000043396954,"teacher_disagreement_score":0.1880096,"about_ca_system_score_codex":0.0001768512,"about_ca_system_score_gemma":0.00017801317,"threshold_uncertainty_score":0.9997215},"labels":[],"label_agreement":null},{"id":"W2044638262","doi":"10.1016/j.ejheart.2006.01.014","title":"Corrigendum to “Effectiveness of Comprehensive Disease Management Programmes in Improving Clinical Outcomes in Heart Failure Patients. A Meta-Analysis” [Eur J Heart Fail 7 (2005) 1133—1144]","year":2006,"lang":"en","type":"erratum","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Regret; Medicine; Confidence interval; Meta-analysis; Intervention (counseling); Heart failure; Odds ratio; Raw data; Internal medicine; Statistics; Psychiatry; Mathematics","score_opus":0.042119708860777184,"score_gpt":0.31637755024200037,"score_spread":0.27425784138122317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044638262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47202104,0.03250935,0.0033662298,0.34542513,0.06297281,0.074478425,0.0023284953,0.0011219447,0.0057765874],"genre_scores_gemma":[0.7887804,0.00030832377,0.116241045,0.0073076477,0.0028566634,0.0005342148,0.0028564155,0.0012472523,0.07986804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98659045,0.00437,0.0042409273,0.0013997359,0.0020169464,0.001381923],"domain_scores_gemma":[0.9948063,0.00032499144,0.0013678244,0.0014469981,0.0008837059,0.0011701885],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0048333304,0.00135179,0.00694752,0.0033515727,0.00011989239,0.00015660498,0.00062697433,0.00031075728,0.00021839788],"category_scores_gemma":[0.0003020285,0.0010374845,0.0051976717,0.001778239,0.00021097584,0.0003219925,0.00055710244,0.0024486184,0.00013142757],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000995721,0.0025862295,0.23947783,0.0013474756,0.024175348,0.0018331383,0.00008643741,0.00015225161,0.000010591407,0.000020805133,0.72909474,0.00021942897],"study_design_scores_gemma":[0.0039698053,0.0013604782,0.39830434,0.00057851826,0.03306637,0.000017747127,0.00023535984,0.000011572965,0.0000042544193,0.0000069377597,0.5619518,0.0004928025],"about_ca_topic_score_codex":0.00024628107,"about_ca_topic_score_gemma":0.0009080119,"teacher_disagreement_score":0.33811748,"about_ca_system_score_codex":0.00047293454,"about_ca_system_score_gemma":0.00048727117,"threshold_uncertainty_score":0.9999233},"labels":[],"label_agreement":null},{"id":"W2045102681","doi":"10.1016/j.ejheart.2004.10.023","title":"Contrast Nephropathy Post Cardiac Resynchronization Therapy: An Under-Recognized Complication with Important Morbidity","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Nephropathy; Contrast-induced nephropathy; Complication; Heart failure; Creatinine; Renal function; Surgery; Internal medicine; Cardiology; Diabetes mellitus","score_opus":0.021424094427548217,"score_gpt":0.2692666994924175,"score_spread":0.24784260506486927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045102681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834307,0.0016970168,0.0024886583,0.010063657,0.00012867083,0.00023434842,0.000017740751,0.000057146786,0.0018820849],"genre_scores_gemma":[0.9888558,0.0001862468,0.008837738,0.0007853917,0.0012112111,6.970188e-7,0.000030915333,0.000041430638,0.00005060722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984015,0.00036972278,0.000511308,0.000172871,0.0003725288,0.0001720501],"domain_scores_gemma":[0.9983682,0.000050804392,0.00033698027,0.00024727712,0.0008078583,0.00018888846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008109725,0.0001610406,0.00049131655,0.000121763864,0.00015408474,0.00005104256,0.000028963183,0.000025885487,0.000024807401],"category_scores_gemma":[0.000059205886,0.00011410724,0.00016941174,0.0001779826,0.00007637343,0.00022170207,0.000013683562,0.00021746181,0.00003997983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008667444,0.0013506047,0.30719778,0.00011400039,0.0026082334,0.00024665194,0.006004496,0.0038022846,0.357613,0.0003733004,0.2642653,0.04775689],"study_design_scores_gemma":[0.0043249107,0.0020968353,0.55953556,0.00017086437,0.0001882982,0.0025706342,0.0009415614,0.00005083209,0.002283165,0.000007425829,0.42759866,0.0002312851],"about_ca_topic_score_codex":0.00000834346,"about_ca_topic_score_gemma":0.000008411171,"teacher_disagreement_score":0.35532984,"about_ca_system_score_codex":0.000064622815,"about_ca_system_score_gemma":0.00012117819,"threshold_uncertainty_score":0.46531582},"labels":[],"label_agreement":null},{"id":"W2046804479","doi":"10.1093/eurjhf/hfs034","title":"Impairment of Activities of Daily Living and Incident Heart Failure in Community-Dwelling Older Adults","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; Geriatric Research Education and Clinical Center; NIH Clinical Center; National Institutes of Health; Hartford Foundation for Public Giving; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; John A. Hartford Foundation","keywords":"Activities of daily living; Medicine; Hazard ratio; Confidence interval; Gerontology; Heart failure; Propensity score matching; Cohort study; Physical therapy; Internal medicine","score_opus":0.012731965060927827,"score_gpt":0.2503961490455361,"score_spread":0.23766418398460826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046804479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208516,0.000982403,0.00007365292,0.0062413104,0.000107599946,0.00035123707,0.0000030162405,0.000013228079,0.00014237025],"genre_scores_gemma":[0.98172,0.00007181259,0.01770996,0.00018825216,0.00018084497,0.0000018378269,0.0000027737522,0.000039645103,0.00008487516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972218,0.00095510215,0.00087942346,0.00012002194,0.00045053737,0.0003731053],"domain_scores_gemma":[0.9986379,0.0002566357,0.00038742914,0.0003203197,0.00013625529,0.0002614333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027718295,0.00023648202,0.0007057838,0.0004314907,0.000088652705,0.000019220875,0.00012324237,0.000047235673,0.00010898516],"category_scores_gemma":[0.0001127713,0.0001904919,0.00019450582,0.0001993374,0.000114667615,0.00038566475,0.00016726358,0.0006612911,0.000009121958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000512905,0.0024572355,0.9031552,0.0012997601,0.000329305,0.00010715217,0.035583653,0.00003790918,0.01156431,0.000041485822,0.04307819,0.0018328548],"study_design_scores_gemma":[0.0044614677,0.0026336955,0.89228845,0.006356643,0.00024442753,0.0007029267,0.030339682,0.000018853887,0.0051337965,0.000004533891,0.057549514,0.0002660044],"about_ca_topic_score_codex":0.00007364615,"about_ca_topic_score_gemma":0.000061724335,"teacher_disagreement_score":0.017636307,"about_ca_system_score_codex":0.00007227638,"about_ca_system_score_gemma":0.00005996015,"threshold_uncertainty_score":0.77680343},"labels":[],"label_agreement":null},{"id":"W2047875318","doi":"10.1016/s1388-9842(01)00229-x","title":"Reply to Comment","year":2002,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Heart failure; Bisoprolol; Randomized controlled trial; Ejection fraction; Metoprolol; Population; Intensive care medicine; Hospital readmission; Clinical endpoint; Emergency medicine; Internal medicine","score_opus":0.026087818254053013,"score_gpt":0.2534610859527499,"score_spread":0.2273732676986969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047875318","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020077277,0.00026764083,0.00050582597,0.971208,0.0002347171,0.0003058945,0.0000012086642,0.000041962612,0.0073574693],"genre_scores_gemma":[0.67358935,0.000044284734,0.2036667,0.111006714,0.0011012382,0.0000023593414,0.000002725489,0.00007641848,0.010510188],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864155,0.00017890704,0.00044889326,0.00013834515,0.00035628525,0.00023601769],"domain_scores_gemma":[0.9990462,0.000025535608,0.00009934727,0.0002974635,0.0001306687,0.00040079767],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006266204,0.00014173552,0.0003027097,0.0001957057,0.000065784785,0.000033253542,0.00010381206,0.000012411903,0.0016701459],"category_scores_gemma":[0.00007140765,0.000104670034,0.00018401543,0.00013731381,0.000020757298,0.000084551044,0.000055702814,0.00022396997,0.0019086429],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052313364,0.00020320943,0.0014329694,0.000014959526,0.00008708578,0.0009674232,0.0004703213,0.000004443121,0.00060810737,0.000042260952,0.99148023,0.0046366556],"study_design_scores_gemma":[0.0015293595,0.0016836029,0.002650211,0.00016211632,0.00008610349,0.0007345244,0.00014186207,0.00000727131,0.0003345562,0.000005134499,0.99257374,0.00009150904],"about_ca_topic_score_codex":0.0000026872908,"about_ca_topic_score_gemma":6.980881e-7,"teacher_disagreement_score":0.8602013,"about_ca_system_score_codex":0.000058758145,"about_ca_system_score_gemma":0.000011878745,"threshold_uncertainty_score":0.9992425},"labels":[],"label_agreement":null},{"id":"W2048068126","doi":"10.1016/j.ejheart.2007.02.001","title":"Sex Differences in the Effectiveness of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Congestive Heart Failure — A Population Study","year":2007,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Angiotensin-converting enzyme; Confidence interval; Cardiology; ACE inhibitor; Angiotensin Receptor Blockers; Population; Blood pressure","score_opus":0.009173227034220634,"score_gpt":0.22967980957397496,"score_spread":0.22050658253975433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048068126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910689,0.000082965125,0.00001617846,0.0075940765,0.00006456919,0.001153808,0.0000016789174,0.000009698413,0.000008131519],"genre_scores_gemma":[0.99518526,0.0000015188542,0.0045612995,0.00012388664,0.00008582801,0.000001567962,0.0000071215786,0.000026029571,0.000007478892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689597,0.0014011445,0.0006646612,0.00023982205,0.0005146368,0.0002837775],"domain_scores_gemma":[0.99887514,0.0003650822,0.00025208786,0.00018164367,0.00021364511,0.00011239709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039091134,0.00023380328,0.000632112,0.0004023363,0.00006144054,0.00002673759,0.0000739312,0.00004366446,0.0000068565987],"category_scores_gemma":[0.00017188789,0.00014237854,0.00008517052,0.00043817982,0.000092849674,0.0001577033,0.000038541435,0.00038648988,0.0000026942328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013934005,0.00066631276,0.9914937,0.00004010201,0.00011255226,0.00018737813,0.0020644316,0.000007528933,0.0006798608,0.0000043131513,0.0029302381,0.0004201992],"study_design_scores_gemma":[0.006939008,0.0038449874,0.98232615,0.0009221251,0.0001112069,0.000052531428,0.0033625562,0.000006040983,0.00049230974,0.0000025009613,0.0018080217,0.0001325425],"about_ca_topic_score_codex":0.00009733222,"about_ca_topic_score_gemma":0.00015715433,"teacher_disagreement_score":0.009167514,"about_ca_system_score_codex":0.00007997471,"about_ca_system_score_gemma":0.00003541114,"threshold_uncertainty_score":0.5806029},"labels":[],"label_agreement":null},{"id":"W2048281664","doi":"10.1016/s1388-9842(00)80255-x","title":"Long Term Improvement with Ventricular Resynchronization Therapy in Heart Failure Patients: Does Etiology of Heart Failure Matter?","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Adidas (Canada); Saint Paul University","funders":"","keywords":"Heart failure; Medicine; Internal medicine; Cardiology; Etiology","score_opus":0.005818077412704111,"score_gpt":0.2296318797060736,"score_spread":0.2238138022933695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048281664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844234,0.00058907457,0.000088528126,0.014085208,0.00012160762,0.0003951433,0.000011977931,0.00002242511,0.0002626473],"genre_scores_gemma":[0.9948521,0.000089885914,0.0036639576,0.00082852686,0.00035987748,0.000002512321,0.000023001694,0.000052430543,0.00012768328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975576,0.0004461433,0.00085896393,0.00028408604,0.0005210059,0.00033220657],"domain_scores_gemma":[0.99869066,0.000060817514,0.00031352064,0.0003213439,0.0004631264,0.00015053476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005907838,0.00026960648,0.00082779897,0.00031478,0.00010240445,0.000035692945,0.0000553176,0.00006682398,0.00034356973],"category_scores_gemma":[0.000043234188,0.00017410573,0.0002571025,0.00038208748,0.00012426346,0.0001856301,0.00003215564,0.00038474976,0.00007413263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005917024,0.00019002042,0.9069485,0.0000802554,0.00019038969,0.0000800604,0.00044366173,0.0002708957,0.003860395,0.000001619095,0.08616005,0.0011824747],"study_design_scores_gemma":[0.004917069,0.0023586452,0.74741316,0.000678765,0.000069983056,0.0009211345,0.00029512818,0.0000019340723,0.0019414123,0.0000030881677,0.24119948,0.00020017721],"about_ca_topic_score_codex":0.000011835444,"about_ca_topic_score_gemma":0.000017581699,"teacher_disagreement_score":0.1595353,"about_ca_system_score_codex":0.00008764076,"about_ca_system_score_gemma":0.00008313838,"threshold_uncertainty_score":0.7099826},"labels":[],"label_agreement":null},{"id":"W2048387252","doi":"10.1093/eurjhf/hfr085","title":"The European Cardiac Resynchronization Therapy Survey: Comparison of Outcomes between De Novo Cardiac Resynchronization Therapy Implantations and Upgrades","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Boston Scientific Corporation","keywords":"Cardiac resynchronization therapy; Medicine; Heart failure; Cardiology; Internal medicine; Implantable cardioverter-defibrillator; Implant; QRS complex; Heart Rhythm; Clinical trial; Randomized controlled trial; Canadian Cardiovascular Society; Ejection fraction; Surgery","score_opus":0.07019692396956932,"score_gpt":0.3221816885089796,"score_spread":0.25198476453941027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048387252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858123,0.008229347,0.0010119552,0.0009830266,0.00029674664,0.0002609526,0.000058066864,0.000034985012,0.0033126057],"genre_scores_gemma":[0.99488246,0.0025827968,0.0018954187,0.000050795476,0.00043602614,6.466452e-7,0.000028573431,0.000052532443,0.000070758106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959454,0.0025491088,0.0007482817,0.00016197642,0.0003708477,0.0002243864],"domain_scores_gemma":[0.99803185,0.00051804207,0.00046655882,0.00027695094,0.00057034055,0.00013622527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003288238,0.00019414774,0.000717951,0.0001568368,0.0003490281,0.000056490826,0.00006350499,0.00003386517,0.0000037165012],"category_scores_gemma":[0.00031413583,0.00012760345,0.00025729623,0.0002780126,0.00018465212,0.00011996188,0.000039790026,0.00025257628,0.000008599866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014299396,0.000028605124,0.97253186,0.000012173509,0.0005512758,0.000005742014,0.0034213413,0.000016313012,0.0013491714,0.000019495359,0.015619725,0.006301337],"study_design_scores_gemma":[0.0009314037,0.000444284,0.9418555,0.000075765834,0.000104094775,0.000077399265,0.0008787151,0.0000020192533,0.001400388,0.000009775981,0.054106534,0.00011415921],"about_ca_topic_score_codex":0.00003393351,"about_ca_topic_score_gemma":0.000006552104,"teacher_disagreement_score":0.03848681,"about_ca_system_score_codex":0.000039695842,"about_ca_system_score_gemma":0.000096531156,"threshold_uncertainty_score":0.52035177},"labels":[],"label_agreement":null},{"id":"W2049182490","doi":"10.1016/j.ejheart.2008.05.013","title":"The Risk of Heart Failure in Patients with Type 2 Diabetes Treated with Oral Agent Monotherapy","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; Kidney Foundation of Canada; University of Alberta; Canadian Diabetes Association; Institute of Nutrition, Metabolism and Diabetes; Heart and Stroke Foundation of Canada","keywords":"Medicine; Sulfonylurea; Metformin; Diabetes mellitus; Type 2 diabetes; Internal medicine; Heart failure; Incidence (geometry); Retrospective cohort study; Cohort; Insulin; Endocrinology","score_opus":0.008414176568481571,"score_gpt":0.2029828851529236,"score_spread":0.19456870858444203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049182490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957623,0.00038202145,0.0000042882593,0.0033048536,0.000040140243,0.00034219347,0.000003129154,0.000013620824,0.0001474688],"genre_scores_gemma":[0.99399215,0.00009951179,0.005282778,0.00018455436,0.000057106645,0.000001580324,0.0000072191046,0.000046690995,0.0003284245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984933,0.00027103888,0.00039661865,0.00014614682,0.00041766674,0.0002752219],"domain_scores_gemma":[0.9989908,0.000042442698,0.00027836338,0.00026992374,0.0002901535,0.00012832475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038301374,0.0002016436,0.00042376708,0.00019257134,0.000109250694,0.000020518359,0.00011469916,0.000020487654,0.000042074676],"category_scores_gemma":[0.000025961219,0.00009957807,0.00009801303,0.00040819062,0.00012888027,0.00011623489,0.000021940283,0.00025711305,0.000023612545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009081283,0.00038360263,0.96442,0.000013658357,0.00045893952,0.00008574211,0.00016815399,0.0000664021,0.00012276991,0.000002512652,0.032377943,0.0009921276],"study_design_scores_gemma":[0.007116842,0.006796913,0.83364284,0.0002840266,0.00018454825,0.000015025919,0.00011726607,0.0000058950895,0.0005250476,0.0000019498455,0.15119979,0.0001098328],"about_ca_topic_score_codex":0.0000049935475,"about_ca_topic_score_gemma":0.000017420332,"teacher_disagreement_score":0.13077715,"about_ca_system_score_codex":0.00004464107,"about_ca_system_score_gemma":0.000054332653,"threshold_uncertainty_score":0.40606758},"labels":[],"label_agreement":null},{"id":"W2051241633","doi":"10.1016/j.ejheart.2004.10.016","title":"QT Dynamicity: A Prognostic Factor for Sudden Cardiac Death in Chronic Heart Failure","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Iron Ore Company (Canada)","funders":"","keywords":"Medicine; Cardiology; Heart failure; Internal medicine; Sudden death; Confidence interval; Sinus rhythm; QT interval; Sudden cardiac death; Relative risk; Electrocardiography; Atrial fibrillation","score_opus":0.010973657643092116,"score_gpt":0.2572966391903385,"score_spread":0.2463229815472464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051241633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697167,0.0020830228,0.00025461672,0.026898457,0.00022979645,0.000638994,0.000033896977,0.000037399124,0.000107095824],"genre_scores_gemma":[0.98552567,0.00004866218,0.0104236165,0.00067752623,0.0029509861,0.0000063171105,0.000014195322,0.000072921706,0.0002800988],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978101,0.00042831383,0.0006374003,0.0002832002,0.00027885474,0.0005621206],"domain_scores_gemma":[0.99887305,0.0001815269,0.0001907897,0.00027718817,0.00022080446,0.00025662748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006809884,0.0002737341,0.00082591793,0.00026670616,0.00010443621,0.000031855012,0.00012579677,0.00009012154,0.00010444105],"category_scores_gemma":[0.00023777221,0.00022459457,0.0006419738,0.00020715843,0.00008709293,0.00019372377,0.000044558892,0.0008872397,0.00012433139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031217702,0.00077323307,0.114310004,0.0008247295,0.0016635987,0.004063653,0.0019721645,0.0027026844,0.5026364,0.00056426856,0.35263488,0.014732651],"study_design_scores_gemma":[0.004268098,0.0034611507,0.18854082,0.00067140505,0.00025187395,0.003700053,0.00012600073,0.00016611388,0.002927814,0.000032497985,0.7954611,0.00039305317],"about_ca_topic_score_codex":0.000002482964,"about_ca_topic_score_gemma":0.00001906803,"teacher_disagreement_score":0.49970856,"about_ca_system_score_codex":0.00028624185,"about_ca_system_score_gemma":0.0004240672,"threshold_uncertainty_score":0.91587},"labels":[],"label_agreement":null},{"id":"W2051460167","doi":"10.1093/eurjhf/hfq185","title":"Trends in Heart Failure Care: Has the Incident Diagnosis of Heart Failure Shifted from the Hospital to the Emergency Department and Outpatient Clinics?","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; University of Alberta; Government of Alberta","keywords":"Medicine; Heart failure; Emergency department; Medical emergency; Emergency medicine; Outpatient clinic; Cardiology; Internal medicine; Nursing","score_opus":0.014867298483041873,"score_gpt":0.26501799119477626,"score_spread":0.2501506927117344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051460167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6173328,0.00078477245,0.000011615695,0.38036555,0.00063583045,0.000789477,0.000037371727,0.000017977234,0.000024627127],"genre_scores_gemma":[0.98702544,0.00009544951,0.009438065,0.0022310156,0.0009434802,0.00004933096,0.00003779361,0.000075385695,0.00010401641],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955579,0.0009431782,0.0014482324,0.00048054737,0.0009959441,0.0005741799],"domain_scores_gemma":[0.99739504,0.00035202765,0.00044617953,0.0010390577,0.0003526096,0.00041507973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019493949,0.00048593903,0.0008010318,0.0002763974,0.0003958971,0.00013762355,0.00053206465,0.00010908846,0.00056997576],"category_scores_gemma":[0.00036120787,0.00024519986,0.00055040955,0.0006552567,0.000239027,0.0002026246,0.00036729826,0.0014064503,0.000105079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000153625,0.00038943227,0.3809132,0.000019488212,0.0002199654,0.00008194638,0.00625086,0.000020956246,0.00022594981,0.000029489196,0.60934085,0.002354225],"study_design_scores_gemma":[0.0014521608,0.0015913546,0.37402177,0.00015491071,0.00024174136,0.000060871287,0.0032322116,0.0000043339537,0.000219287,0.000010613838,0.61884487,0.00016584025],"about_ca_topic_score_codex":0.00021188901,"about_ca_topic_score_gemma":0.0037020894,"teacher_disagreement_score":0.37813452,"about_ca_system_score_codex":0.00008714371,"about_ca_system_score_gemma":0.0001284579,"threshold_uncertainty_score":0.99989593},"labels":[],"label_agreement":null},{"id":"W2052258076","doi":"10.1016/s1388-9842(00)80370-0","title":"Infarct-Related Artery Patency After Transmural Anterior Myocardial Infarction and Q Wave Regression + R Wave Development: Is there a Relationship?","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Internal medicine; Citation; Library science","score_opus":0.010532156035049589,"score_gpt":0.21353367718904626,"score_spread":0.20300152115399667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052258076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895654,0.0019185266,0.000004930648,0.007315346,0.00022430018,0.00015607069,0.0000053129747,0.000027116135,0.0007830012],"genre_scores_gemma":[0.99531347,0.00024646308,0.002476948,0.00052822765,0.0003364461,0.0000011098444,0.0000064065916,0.000033308464,0.0010576056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839634,0.00024286148,0.0006579745,0.00018555103,0.0002977244,0.00021954653],"domain_scores_gemma":[0.9993565,0.000026084106,0.00014658606,0.00014598436,0.00011791937,0.0002069363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035138245,0.00020887774,0.00038685728,0.00013598874,0.00016309282,0.000045514855,0.000034794488,0.00007582667,0.001278029],"category_scores_gemma":[0.000016949147,0.00013237861,0.0003076917,0.00014098047,0.00009003731,0.00022898815,0.00002023598,0.0005127854,0.000054242813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060660904,0.00017293303,0.4912249,0.00033919243,0.0015135986,0.005892265,0.029944137,0.00001192282,0.016355574,0.000009962823,0.032187276,0.41628215],"study_design_scores_gemma":[0.0016370729,0.00034656873,0.8347291,0.0007126597,0.000093059534,0.008689812,0.00021838248,0.000012430929,0.00016109105,0.000018741632,0.15323086,0.00015023419],"about_ca_topic_score_codex":0.0000020146463,"about_ca_topic_score_gemma":9.831244e-7,"teacher_disagreement_score":0.4161319,"about_ca_system_score_codex":0.000036511014,"about_ca_system_score_gemma":0.000059805272,"threshold_uncertainty_score":0.9996349},"labels":[],"label_agreement":null},{"id":"W2052722120","doi":"10.1093/eurjhf/hfp044","title":"Growth Hormone Resistance in Severe Heart Failure Resolves After Cardiac Transplantation","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Heart failure; Heart transplantation; Internal medicine; Cachexia; Cardiology; Insulin resistance; Hormone; Transplantation; Endocrinology; Obesity; Cancer","score_opus":0.009512932611283336,"score_gpt":0.2536527619152473,"score_spread":0.244139829303964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052722120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8913896,0.005839969,0.0015161267,0.09902348,0.00027847054,0.00039256955,0.00005497789,0.000057536912,0.0014472617],"genre_scores_gemma":[0.83117026,0.00039017762,0.16629861,0.0014416197,0.0004161836,0.0000010621911,0.000013290191,0.000032557673,0.00023623933],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975964,0.0006905196,0.0007219613,0.00022369955,0.00046309014,0.00030435092],"domain_scores_gemma":[0.99913555,0.00010659157,0.00015337468,0.0002025121,0.00018597564,0.00021599531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197466,0.00022580876,0.00056907727,0.00028323263,0.00006453705,0.000044442233,0.00011099894,0.00006245783,0.00004877429],"category_scores_gemma":[0.000058248836,0.00018270628,0.00029951954,0.00031132848,0.000046093464,0.00032049115,0.0000050583812,0.00061643316,0.000031560052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018530617,0.00068059866,0.38111126,0.0011519578,0.0003947883,0.0132701155,0.0147465775,0.000055433884,0.18266362,0.0008146467,0.38398188,0.0025985183],"study_design_scores_gemma":[0.0029454392,0.0006276844,0.8945504,0.00073047384,0.00015147698,0.0009381127,0.00025430974,6.3875757e-7,0.0015689754,0.00012990554,0.09789586,0.00020673654],"about_ca_topic_score_codex":0.0000031122208,"about_ca_topic_score_gemma":0.000028530198,"teacher_disagreement_score":0.5134391,"about_ca_system_score_codex":0.000045331257,"about_ca_system_score_gemma":0.000079043224,"threshold_uncertainty_score":0.74505454},"labels":[],"label_agreement":null},{"id":"W2053229561","doi":"10.1016/j.ejheart.2004.06.004","title":"A Direct Comparison of the Natriuretic Peptides and Their Relationship to Survival in Chronic Heart Failure of a Presumed Non-Ischaemic Origin","year":2004,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of Toronto; University Health Network; Toronto General Hospital; St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Natriuretic peptide; Cardiology; Proportional hazards model; Brain natriuretic peptide; Prospective cohort study; Univariate analysis; Multivariate analysis","score_opus":0.02493226640271101,"score_gpt":0.28452062273390183,"score_spread":0.2595883563311908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053229561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957796,0.0007556977,0.00011800034,0.040212836,0.00011794924,0.00068739546,0.000005830594,0.000012578149,0.00029371653],"genre_scores_gemma":[0.9914578,0.00001479271,0.008120064,0.00009988975,0.00014713284,0.000003141754,0.000002117469,0.00003479373,0.000120237426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978228,0.00043329073,0.0008648273,0.00020631992,0.00039606975,0.00027664623],"domain_scores_gemma":[0.9988345,0.00016730632,0.0002958141,0.00035665245,0.00015945108,0.00018628659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012183953,0.000231467,0.00075092743,0.00032933484,0.00007347641,0.000018504283,0.0001744709,0.00004957952,0.000022005532],"category_scores_gemma":[0.00022658633,0.00014453825,0.00023299363,0.00050504936,0.00012725648,0.00011651359,0.00010189947,0.00049213617,0.000014938417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008151989,0.00079840043,0.81445926,0.0007390572,0.00043589153,0.00011020486,0.009624906,0.0033659788,0.106467016,0.00040971616,0.062152494,0.0006218999],"study_design_scores_gemma":[0.009783636,0.0037423687,0.72496545,0.004317076,0.00032669175,0.0003282259,0.0027186333,0.000057991238,0.022532718,0.000102545295,0.23077771,0.0003469324],"about_ca_topic_score_codex":0.00004575203,"about_ca_topic_score_gemma":0.00029846482,"teacher_disagreement_score":0.16862522,"about_ca_system_score_codex":0.00016608267,"about_ca_system_score_gemma":0.00029095853,"threshold_uncertainty_score":0.5894098},"labels":[],"label_agreement":null},{"id":"W2054313623","doi":"10.1016/s1388-9842(00)80258-5","title":"Can Cardiac Resynchronization Obviate the Need for a Heart Transplant? A Peak Oxygen Uptake Perspective","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Adidas (Canada); Saint Paul University","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Heart failure; University hospital","score_opus":0.015819867961611254,"score_gpt":0.2774661068628071,"score_spread":0.2616462389011958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054313623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6283209,0.0033705207,0.006861245,0.35544664,0.00082965347,0.0016176184,0.00025850415,0.00010502255,0.0031898909],"genre_scores_gemma":[0.95428866,0.00027974905,0.04090002,0.002023474,0.0012651981,0.000003770639,0.000022780203,0.000070165595,0.0011461724],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820876,0.00057513046,0.00047768588,0.00017065373,0.00031063656,0.000257121],"domain_scores_gemma":[0.9990582,0.00015445793,0.00011301058,0.0002035442,0.0003006181,0.0001701679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012715058,0.00017516864,0.00041330315,0.00010147119,0.00021118479,0.000048135433,0.00012400359,0.000034968918,0.00018209044],"category_scores_gemma":[0.000063616084,0.000112213,0.00040644873,0.00019464496,0.00006590344,0.00010254452,0.000003944052,0.00034965124,0.000026908121],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022327283,0.0011805522,0.08293339,0.001402338,0.0055727647,0.0023282403,0.15418126,0.0026534821,0.14252634,0.005384724,0.52383536,0.05567424],"study_design_scores_gemma":[0.004495286,0.0012744293,0.36839032,0.00043712524,0.000749076,0.0017604518,0.0030653772,0.00006403239,0.0007473601,0.00014115489,0.61863744,0.00023794266],"about_ca_topic_score_codex":0.00002225517,"about_ca_topic_score_gemma":0.00001861627,"teacher_disagreement_score":0.35342318,"about_ca_system_score_codex":0.00006499056,"about_ca_system_score_gemma":0.00015748304,"threshold_uncertainty_score":0.45759133},"labels":[],"label_agreement":null},{"id":"W2058490784","doi":"10.1016/j.ejheart.2005.08.005","title":"Effectiveness of Comprehensive Disease Management Programmes in Improving Clinical Outcomes in Heart Failure Patients. A Meta-Analysis","year":2005,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Meta-analysis; Psychological intervention; Disease management; Internal medicine; Population; Randomized controlled trial; Clinical trial; MEDLINE; Intensive care medicine; Disease; Emergency medicine; Physical therapy; Environmental health; Psychiatry","score_opus":0.0718032093779349,"score_gpt":0.37511980808271134,"score_spread":0.30331659870477645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058490784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028290746,0.98640263,0.00006317931,0.004686405,0.00021497646,0.005650024,0.00006096147,0.00004106583,0.00005165614],"genre_scores_gemma":[0.037355784,0.8602045,0.09942448,0.00063535606,0.0004935458,0.00029609376,0.00049690896,0.0005076345,0.0005856617],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887002,0.0051438916,0.0037771286,0.0007755928,0.0009849138,0.0006182867],"domain_scores_gemma":[0.9961069,0.000715961,0.0013963026,0.00089203793,0.0003616631,0.0005271195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040353937,0.00089998933,0.009171648,0.002324965,0.000048230373,0.000061740866,0.00039333547,0.00014888645,0.00012560506],"category_scores_gemma":[0.00017694476,0.00059132033,0.0078558475,0.0014811798,0.0001404583,0.00021071307,0.00030983874,0.0012373496,0.00006167485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013332366,0.012363787,0.19457039,0.06813382,0.35043523,0.0066330438,0.00018399578,0.00016393616,8.17225e-7,0.00009158152,0.018812401,0.34727776],"study_design_scores_gemma":[0.003140812,0.0007279348,0.062109888,0.0034354518,0.16950563,0.000021211743,0.00006497477,0.0000020512314,1.7839398e-7,0.0000016508759,0.7606561,0.00033412335],"about_ca_topic_score_codex":0.000018665396,"about_ca_topic_score_gemma":0.000051565894,"teacher_disagreement_score":0.7418437,"about_ca_system_score_codex":0.00026257796,"about_ca_system_score_gemma":0.00022500206,"threshold_uncertainty_score":0.9996538},"labels":[],"label_agreement":null},{"id":"W2060682446","doi":"10.1002/ejhf.12","title":"Cognitive Impairment in Heart Failure: Towards a Consensus on Screening","year":2013,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cognition; Neuropsychology; Dementia; Clinical psychology; Heart failure; Operationalization; Gold standard (test); Cognitive impairment; Cognitive test; Psychiatry; Gerontology; Disease; Cardiology; Internal medicine","score_opus":0.018303946174689723,"score_gpt":0.3082531412117474,"score_spread":0.2899491950370577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060682446","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2830273,0.0030625935,0.0004966581,0.15816972,0.53470623,0.008282806,0.00064522226,0.00026870272,0.01134075],"genre_scores_gemma":[0.25922877,0.00019549053,0.016687945,0.0023545756,0.71585184,0.000044639866,0.00033851474,0.0005188789,0.0047793346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919323,0.0019602452,0.0014992545,0.0006359671,0.0029764764,0.0009957898],"domain_scores_gemma":[0.99527407,0.0008673154,0.0006282332,0.00037207038,0.0020815842,0.0007767331],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0039103115,0.0007012433,0.0014681175,0.0011788248,0.0001448022,0.00022287981,0.00033874722,0.00031762515,0.0013534726],"category_scores_gemma":[0.0022608594,0.00056478486,0.0006867379,0.00046723723,0.00025643886,0.00015323742,0.00021670968,0.0045843665,0.00090235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001949824,0.0006273632,0.0028150696,0.00021758107,0.0004051355,0.003351917,0.00017721787,0.0000030538317,0.00031016665,0.0000014025297,0.9879824,0.0021588705],"study_design_scores_gemma":[0.010874651,0.009549399,0.018805683,0.006882697,0.00029473798,0.00072474126,0.001089749,0.000008315326,0.00044612674,0.0000064669152,0.95085275,0.00046470042],"about_ca_topic_score_codex":0.00003986612,"about_ca_topic_score_gemma":0.000013294543,"teacher_disagreement_score":0.1811456,"about_ca_system_score_codex":0.00026677703,"about_ca_system_score_gemma":0.001274076,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2061738714","doi":"10.1016/j.ejheart.2006.03.007","title":"The Effects of Intravenous Sildenafil on Hemodynamics and Cardiac Sympathetic Activity in Chronic Human Heart Failure","year":2006,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Bayer Canada","keywords":"Medicine; Sildenafil; Heart failure; Internal medicine; Cardiology; Hemodynamics; Population; Erectile dysfunction; Cardiac output; Ejection fraction; Norepinephrine; Anesthesia","score_opus":0.006263127162488698,"score_gpt":0.23234279653960924,"score_spread":0.22607966937712054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061738714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910626,0.0018525625,0.000061444414,0.0060592,0.00038895823,0.0002235132,0.000002025202,0.000016792108,0.00033294893],"genre_scores_gemma":[0.9986235,0.00008482843,0.00016255595,0.0001339499,0.00048034702,0.0000011929591,0.0000013474973,0.000029999062,0.0004823011],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984091,0.000446787,0.00041236487,0.00016212802,0.0003419805,0.00022766803],"domain_scores_gemma":[0.9990704,0.00028080295,0.00019229442,0.00021782589,0.00014138636,0.0000972771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000735073,0.0001781984,0.00047188596,0.00016161193,0.00019762291,0.00002922579,0.00006274059,0.00004015664,0.000008912686],"category_scores_gemma":[0.00011742568,0.000117552154,0.00015853284,0.00018097062,0.00018733134,0.00006506988,0.000038064474,0.00055100134,0.000015366562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012095325,0.0011008732,0.08360379,0.0009411189,0.00053225737,0.0005525423,0.001272428,0.00054454023,0.6886645,0.001977222,0.21017292,0.009428253],"study_design_scores_gemma":[0.004792425,0.008357164,0.6183038,0.00091745146,0.00018969917,0.000533061,0.0007336471,0.000039390234,0.0077838455,0.00007456331,0.35800728,0.00026769747],"about_ca_topic_score_codex":0.000020640447,"about_ca_topic_score_gemma":0.000030771476,"teacher_disagreement_score":0.68088067,"about_ca_system_score_codex":0.00012988062,"about_ca_system_score_gemma":0.00007486329,"threshold_uncertainty_score":0.47936377},"labels":[],"label_agreement":null},{"id":"W2062073531","doi":"10.1016/s1388-9842(00)80416-x","title":"Fifteen Year Experience with the Carpentier Edwards Perimount Pericardial Bioprosthesis at the Mtral Position","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Cardiothoracic surgery; Citation; General surgery; Library science; Surgery","score_opus":0.0043878389747747226,"score_gpt":0.20921021781111082,"score_spread":0.2048223788363361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062073531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609558,0.0005123191,0.000003428851,0.03601644,0.00013234932,0.00015190207,0.000006776794,0.000013351021,0.0022076278],"genre_scores_gemma":[0.99425584,0.000046579797,0.0005684384,0.0009767581,0.0010236033,0.0000015113397,0.0000026192304,0.000024846537,0.0030997999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987855,0.00023051372,0.00022910058,0.00013374965,0.00041809154,0.00020302719],"domain_scores_gemma":[0.99941057,0.000022774759,0.00008890452,0.00025654532,0.00011035018,0.00011087707],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003164725,0.00014029098,0.00024161702,0.000026569489,0.00031434075,0.000059439237,0.00013059587,0.000020497873,0.00137395],"category_scores_gemma":[0.000009262947,0.000056304576,0.00035718133,0.00012839364,0.0002708383,0.00008405602,0.000035057386,0.00027378168,0.00008741549],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007040647,0.00015330303,0.0873001,0.000075613374,0.0011149872,0.002438752,0.026696471,0.00035161478,0.046157926,0.000054124343,0.7924139,0.036202565],"study_design_scores_gemma":[0.0005606146,0.00060921314,0.27085543,0.00005103798,0.00011573511,0.005535672,0.0017904979,0.0000027104902,0.000873973,6.999803e-7,0.7195151,0.00008933482],"about_ca_topic_score_codex":0.0000113147635,"about_ca_topic_score_gemma":0.0000024088645,"teacher_disagreement_score":0.18355533,"about_ca_system_score_codex":0.000057504578,"about_ca_system_score_gemma":0.000043720556,"threshold_uncertainty_score":0.99953896},"labels":[],"label_agreement":null},{"id":"W2063921489","doi":"10.1016/s1388-9842(00)80383-9","title":"Is Resynchronization Between Left and Right Ventricles Responsible for Improving Hemodynamic Function of Heart Failure Patients with LBBB?","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"Corporation; Medicine; Internal medicine; Cardiology; Heart failure; Law; Political science","score_opus":0.007216913334033394,"score_gpt":0.22703372299024524,"score_spread":0.21981680965621184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063921489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994584,0.00041041046,0.001416395,0.002976904,0.00005482982,0.00023960574,0.000029790584,0.000018463332,0.0002695545],"genre_scores_gemma":[0.9902011,0.0000118578455,0.0091262795,0.000120156496,0.00028496512,3.4964114e-7,0.000015593765,0.00003264885,0.00020700647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987626,0.00015331613,0.0004370697,0.00016485009,0.00031895476,0.00016318454],"domain_scores_gemma":[0.99896914,0.00010224352,0.00022205125,0.00014890966,0.00045122838,0.00010641127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048322193,0.00013670411,0.00043959598,0.0001967319,0.00015405785,0.00002784291,0.000018888011,0.000034019693,0.00008020588],"category_scores_gemma":[0.00008269936,0.00010255945,0.00013135148,0.0001707309,0.00006275007,0.00017269098,0.000016261309,0.00014853307,0.000008549717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003165768,0.00009467823,0.8832454,0.00035331026,0.00042371327,0.000011183799,0.0008505852,0.00023322436,0.00654822,0.000009062672,0.0956394,0.009425443],"study_design_scores_gemma":[0.0042061335,0.002272894,0.71324545,0.00041257968,0.0003570794,0.0002449312,0.0001566411,0.000030766372,0.001985632,0.00001836528,0.2769179,0.00015163],"about_ca_topic_score_codex":0.0000023066177,"about_ca_topic_score_gemma":0.0000018075162,"teacher_disagreement_score":0.18127851,"about_ca_system_score_codex":0.00003673347,"about_ca_system_score_gemma":0.000075359305,"threshold_uncertainty_score":0.4182253},"labels":[],"label_agreement":null},{"id":"W2064278677","doi":"10.1016/j.ejheart.2007.06.010","title":"RAS blockers: Does Sex Matter/ Re: Sex Differences in the Effectiveness of ARB and ACEI in Patients with Congestive Heart Failure — A Population Study: <i>Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602–609</i>","year":2007,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Population; Environmental health","score_opus":0.010154950708441161,"score_gpt":0.2428831955244581,"score_spread":0.23272824481601695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064278677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6232833,0.0002190172,0.00003527642,0.37422425,0.00023976708,0.0019025035,0.000024960758,0.000016692162,0.000054220818],"genre_scores_gemma":[0.9409547,0.000034090383,0.0057807663,0.05198416,0.00083100394,0.000008623556,0.000092539456,0.00019686711,0.00011729239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.983959,0.010371587,0.0021862655,0.0007133309,0.0019888624,0.0007809212],"domain_scores_gemma":[0.9957725,0.001107437,0.0015186049,0.0007188656,0.00061513844,0.00026749866],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010152151,0.0009636523,0.0023622988,0.001051876,0.00014776505,0.00021156546,0.00050440815,0.00020750397,0.000101363374],"category_scores_gemma":[0.00027190428,0.0005605374,0.00038607264,0.0006728086,0.00033388496,0.0005025893,0.00019345086,0.0039041915,0.000018447245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011089137,0.0007323976,0.54748,0.00030516734,0.00042869503,0.00178992,0.0010160947,0.000012500178,0.000048484653,7.11894e-7,0.446944,0.00013312456],"study_design_scores_gemma":[0.008879181,0.0055727963,0.61132914,0.0035074411,0.0004984762,0.0003817064,0.0018873233,0.0000013443077,0.000033997614,0.0000050757744,0.3675161,0.0003874409],"about_ca_topic_score_codex":0.00010709786,"about_ca_topic_score_gemma":0.00020410959,"teacher_disagreement_score":0.32224008,"about_ca_system_score_codex":0.00022124668,"about_ca_system_score_gemma":0.00016487566,"threshold_uncertainty_score":0.99968463},"labels":[],"label_agreement":null},{"id":"W2064888474","doi":"10.1093/eurjhf/hfq122","title":"Length of Delay in Seeking Medical Care by Patients with Heart Failure Symptoms and the Role of Symptom-Related Factors: A Narrative Review","year":2010,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; York University","funders":"York University","keywords":"Medicine; Heart failure; Distress; Health care; Stroke (engine); Cognition; Intensive care medicine; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.00579462093231379,"score_gpt":0.25237760282205446,"score_spread":0.24658298188974068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064888474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007719829,0.9852147,0.0000031620968,0.0047759227,0.00008591662,0.0020224773,0.00003351914,0.000014754824,0.00012969626],"genre_scores_gemma":[0.028382046,0.96953624,0.0013246429,0.00024015014,0.0001242561,0.000016016334,0.00016836461,0.00015053755,0.000057751895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994174,0.0017531306,0.002096115,0.00037978208,0.001221805,0.00037515836],"domain_scores_gemma":[0.99681115,0.00035506368,0.0014200825,0.0005071561,0.00055408967,0.00035246453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017799616,0.00064447074,0.0036677264,0.0003580314,0.00008586106,0.000023513356,0.0003369189,0.00023623274,0.00016638174],"category_scores_gemma":[0.00038639797,0.00032219876,0.0006864339,0.00051553495,0.00041106253,0.0001545751,0.00015066793,0.0019470291,0.000008654468],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001243727,0.0029198797,0.08875314,0.12292303,0.010309345,0.0008349694,0.025185395,0.0000020552172,0.000037072146,0.00021402023,0.24131148,0.5062659],"study_design_scores_gemma":[0.004127482,0.0011155499,0.00030703787,0.10090323,0.0019737226,0.0002860772,0.0010018222,8.2318405e-7,0.000003242575,0.0000012850101,0.8900465,0.00023323648],"about_ca_topic_score_codex":0.000018827957,"about_ca_topic_score_gemma":0.000035375062,"teacher_disagreement_score":0.64873505,"about_ca_system_score_codex":0.00008841894,"about_ca_system_score_gemma":0.00042829834,"threshold_uncertainty_score":0.999923},"labels":[],"label_agreement":null},{"id":"W2067180742","doi":"10.1016/j.ejheart.2005.09.006","title":"Clinical Trials Update from the European Society of Cardiology meeting 2005: CARE-HF Extension Study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE","year":2005,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Bisoprolol; Atrial fibrillation; Quinapril; Enoximone; Perindopril; Clopidogrel; Implantable loop recorder; Warfarin; Aspirin; Intensive care medicine; Angiotensin-converting enzyme; ACE inhibitor; Blood pressure","score_opus":0.08509941357379086,"score_gpt":0.4127503458040564,"score_spread":0.32765093223026553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067180742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003547923,0.98926264,0.00010995729,0.0018508463,0.0010519754,0.0012509924,0.00019602603,0.000043906508,0.0026857308],"genre_scores_gemma":[0.012557935,0.97198814,0.0023066376,0.00025237846,0.012494691,0.0000021346839,0.000072794486,0.00016290027,0.00016240338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97787887,0.015841287,0.004276304,0.0007663422,0.000781105,0.0004560734],"domain_scores_gemma":[0.9914542,0.002929343,0.003441573,0.00085412286,0.0009944257,0.00032635772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01772861,0.00072899397,0.007235768,0.0001827906,0.0004150675,0.000079725985,0.00019579385,0.0001631816,0.000027773307],"category_scores_gemma":[0.0023944415,0.0004375775,0.0034671137,0.0002713245,0.0004375037,0.00013898537,0.0006308236,0.0017627801,0.000046815927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027672693,0.000094710835,0.0010860047,0.0005573477,0.0050188457,0.00019220352,0.0015312415,0.000028881092,0.00002779921,3.3950099e-7,0.6027276,0.38845828],"study_design_scores_gemma":[0.0033963248,0.00060202257,0.002999584,0.0068987473,0.007758137,0.0013718151,0.0036330512,0.000001230435,0.000003418842,7.5568204e-7,0.97300225,0.00033268708],"about_ca_topic_score_codex":0.00002077357,"about_ca_topic_score_gemma":0.000004993427,"teacher_disagreement_score":0.3881256,"about_ca_system_score_codex":0.000079561716,"about_ca_system_score_gemma":0.00035821463,"threshold_uncertainty_score":0.9998076},"labels":[],"label_agreement":null},{"id":"W2070230733","doi":"10.1093/eurjhf/hfp036","title":"A Systematic Review of Telemonitoring Technologies in Heart Failure","year":2009,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.026406014748356847,"score_gpt":0.3094855572054442,"score_spread":0.28307954245708733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070230733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004195744,0.9806269,0.000013373621,0.016379993,0.00016019851,0.0025875408,0.0000050569597,0.000082633174,0.00014010872],"genre_scores_gemma":[0.000033855806,0.97585845,0.023275187,0.00017754966,0.0002527433,0.000020021547,0.00001204718,0.000099572186,0.00027057654],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935366,0.0012702483,0.003507305,0.00037836275,0.00081715477,0.0004903189],"domain_scores_gemma":[0.9967507,0.0001912668,0.0016503505,0.00092593,0.0003020478,0.0001796851],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032139209,0.00069726043,0.0066770203,0.0011824836,0.00004915493,0.000038913116,0.0004854335,0.0001805974,0.00004627659],"category_scores_gemma":[0.00088722375,0.00045447247,0.0016178502,0.0010206011,0.000100507714,0.00016425911,0.00014468198,0.0013930612,0.00016840303],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008916338,0.00018307743,0.000023171762,0.8529784,0.0004589138,0.001028265,0.0000272022,1.5976659e-7,0.000004043307,0.000020320624,0.12329511,0.021972416],"study_design_scores_gemma":[0.00034170237,0.00043915154,0.0000032888297,0.48472607,0.0020288718,0.0015675123,0.00009679822,5.3084577e-8,0.0000034006212,0.0000017437849,0.5106365,0.00015489696],"about_ca_topic_score_codex":0.000001266204,"about_ca_topic_score_gemma":0.0000016558395,"teacher_disagreement_score":0.3873414,"about_ca_system_score_codex":0.00025119545,"about_ca_system_score_gemma":0.00032821004,"threshold_uncertainty_score":0.9997907},"labels":[],"label_agreement":null},{"id":"W2070323912","doi":"10.1093/eurjhf/hfq026","title":"Leptin Resistance After Heart Transplantation","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Hjärt-Lungfonden","keywords":"Medicine; Heart failure; Heart transplantation; Leptin; Transplantation; Internal medicine; Cardiology; Intensive care medicine; Obesity","score_opus":0.009859755978415832,"score_gpt":0.22857519223410844,"score_spread":0.21871543625569262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070323912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98275876,0.000027453143,0.00028875467,0.014209585,0.00038278828,0.000059166527,0.0000051951633,0.00002193087,0.0022463696],"genre_scores_gemma":[0.98712003,0.000013913132,0.010463228,0.0010762941,0.00042083507,3.2309623e-7,4.893194e-7,0.000020484606,0.0008843864],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986514,0.00033476544,0.00035397994,0.0001586727,0.00033404055,0.00016713598],"domain_scores_gemma":[0.99938405,0.00007739052,0.0001480392,0.00018015289,0.00008154253,0.00012881665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063318334,0.00010490067,0.00014305284,0.00009772785,0.0001118407,0.000078318626,0.00018475814,0.000025501073,0.00038586734],"category_scores_gemma":[0.00011321335,0.00008786358,0.0001240251,0.00013695791,0.00008562138,0.00034248448,0.000013444935,0.00044263265,0.0003276569],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020888542,0.000041081435,0.0025880956,0.00001844016,0.0000020646432,0.0002752439,0.0002698256,0.00001425046,0.96234214,0.00022813864,0.033830825,0.00018097664],"study_design_scores_gemma":[0.00043716404,0.00008145946,0.102977134,0.00005696484,0.000008126649,0.0005181699,0.00001426371,0.000003041529,0.2024443,0.00006296826,0.6932946,0.00010180744],"about_ca_topic_score_codex":3.45e-7,"about_ca_topic_score_gemma":0.000017414352,"teacher_disagreement_score":0.7598979,"about_ca_system_score_codex":0.0000065878994,"about_ca_system_score_gemma":0.000030778163,"threshold_uncertainty_score":0.4224977},"labels":[],"label_agreement":null},{"id":"W2070788396","doi":"10.1093/eurjhf/hfr104","title":"Use of Oral Proton Pump Inhibitors is not Associated with Harm in Patients with Chronic Heart Failure in an Ambulatory Setting","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Government of Alberta; Heart and Stroke Foundation of Canada","keywords":"Medicine; Internal medicine; Heart failure; Odds ratio; Confidence interval; Ambulatory; Cohort; Ramipril; Population; Logistic regression; Cohort study; Cardiology","score_opus":0.02503073377642057,"score_gpt":0.2412102677964094,"score_spread":0.21617953401998882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070788396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873877,0.000013200007,0.000002030827,0.00047456584,0.000035194826,0.0006938976,0.000012361918,0.000014356738,0.000015634416],"genre_scores_gemma":[0.9941307,6.8660023e-7,0.005475667,0.00022385227,0.00004900602,0.0000035735854,0.000015511196,0.000070164926,0.000030838175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763465,0.00043973082,0.0006907892,0.00025370112,0.00058622984,0.00039491043],"domain_scores_gemma":[0.9986841,0.00002335164,0.00045633715,0.00025211673,0.00033269383,0.00025138972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005956541,0.00026977411,0.00057711423,0.0003498263,0.00004462147,0.000025828665,0.0001022938,0.000057768328,0.00007415172],"category_scores_gemma":[0.000073715775,0.00018218745,0.000089440444,0.00032828044,0.000090548194,0.0005577086,0.000034888213,0.00065721455,0.000012226674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008265009,0.0009163916,0.9949196,0.000049145867,0.00011137152,0.0008428702,0.0009641786,0.000018965397,0.00046282803,3.977604e-7,0.0006863551,0.0002014109],"study_design_scores_gemma":[0.0086207455,0.0085852295,0.9751962,0.0012438732,0.00008264547,0.00006499545,0.00007501469,0.000007988658,0.005294288,6.2593364e-7,0.00072055083,0.00010783444],"about_ca_topic_score_codex":0.000022060645,"about_ca_topic_score_gemma":0.00008832086,"teacher_disagreement_score":0.019723376,"about_ca_system_score_codex":0.00020797597,"about_ca_system_score_gemma":0.00021085289,"threshold_uncertainty_score":0.7429388},"labels":[],"label_agreement":null},{"id":"W2071602330","doi":"10.1093/eurjhf/hfs188","title":"Predictors of Early Dyspnoea Relief in Acute Heart Failure and the Association with 30-Day Outcomes: Findings from ASCEND-HF","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Hazard ratio; Cardiology; Nesiritide; Blood pressure; Confidence interval; Natriuretic peptide","score_opus":0.007951888755257661,"score_gpt":0.22904232772340063,"score_spread":0.22109043896814298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071602330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92655057,0.0003299972,0.000051789055,0.07210464,0.00024414327,0.00044660113,0.000012403485,0.00002343318,0.00023642773],"genre_scores_gemma":[0.99235517,0.000054402448,0.0060839127,0.0006153614,0.0003256539,0.000003432467,0.000008918478,0.000049857084,0.0005032714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971878,0.00071195664,0.0007434938,0.00019245957,0.0007376224,0.00042667694],"domain_scores_gemma":[0.9985045,0.00038326427,0.00039046965,0.0002943215,0.00016368952,0.00026372683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027430546,0.00027304026,0.0007916657,0.00023791644,0.00008713262,0.000051383195,0.00013443519,0.000074462674,0.0001273354],"category_scores_gemma":[0.00024458353,0.00015355281,0.00020504609,0.00025256618,0.00010925559,0.00038401454,0.00007480278,0.0006277942,0.00006918765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029530437,0.00017367714,0.901586,0.00002027897,0.00075945596,0.000080677346,0.0023529213,0.0000023556584,0.0005549095,0.000057742214,0.09404688,0.00006982144],"study_design_scores_gemma":[0.007420932,0.0007928206,0.7779633,0.00031422602,0.000602691,0.0000613341,0.0004935146,0.0000023428406,0.00028127228,0.0000061586943,0.21193561,0.00012579237],"about_ca_topic_score_codex":0.000041467825,"about_ca_topic_score_gemma":0.000021737933,"teacher_disagreement_score":0.12362267,"about_ca_system_score_codex":0.0001316199,"about_ca_system_score_gemma":0.000064166044,"threshold_uncertainty_score":0.6261702},"labels":[],"label_agreement":null},{"id":"W2072345235","doi":"10.1093/eurjhf/hft095","title":"Clinical Outcome Endpoints in Heart Failure Trials: A European Society of Cardiology Heart Failure Association Consensus Document","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Clinical trial; Clinical endpoint; Intensive care medicine; Endpoint Determination; MEDLINE; Consistency (knowledge bases); Internal medicine","score_opus":0.05619077229551909,"score_gpt":0.344218265449564,"score_spread":0.2880274931540449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072345235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5562244,0.0004702043,0.00024690892,0.43872783,0.0010018345,0.0021868646,0.000026439777,0.000110828514,0.0010046636],"genre_scores_gemma":[0.88482434,0.00008396746,0.10877689,0.0030779194,0.0018372874,0.000011061897,0.000027425489,0.00013129921,0.0012298457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98484313,0.00815097,0.004444483,0.00061830727,0.0010659155,0.00087718444],"domain_scores_gemma":[0.99521124,0.0011386877,0.0015620256,0.00072113256,0.0007461325,0.000620807],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.018921139,0.0005878764,0.0030494793,0.00041722378,0.0001339119,0.00010703468,0.00031793464,0.00023180255,0.0006120802],"category_scores_gemma":[0.0020425187,0.00045368166,0.0021291464,0.00045265196,0.00020518037,0.00028891818,0.00023334034,0.0016044934,0.0009913044],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016041352,0.00022521989,0.29034632,0.00009838509,0.000716968,0.00018334317,0.00022542119,0.000034256136,0.003144754,0.000016691827,0.70430326,0.0005449744],"study_design_scores_gemma":[0.008584773,0.0016482288,0.18445481,0.0004284303,0.0004526337,0.0004973169,0.0011705585,0.000013009287,0.00023189702,0.00002815378,0.80217046,0.000319718],"about_ca_topic_score_codex":0.00003852233,"about_ca_topic_score_gemma":0.00002959579,"teacher_disagreement_score":0.4356499,"about_ca_system_score_codex":0.00038557377,"about_ca_system_score_gemma":0.00024477197,"threshold_uncertainty_score":0.9997915},"labels":[],"label_agreement":null},{"id":"W2072899183","doi":"10.1016/j.ejheart.2008.02.014","title":"Heart Failure in the Elderly: How Risky is it to be Discharged?","year":2008,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Intensive care medicine; Medical emergency","score_opus":0.03281941395016174,"score_gpt":0.26659896057262095,"score_spread":0.2337795466224592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072899183","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053230957,0.00039475886,0.000058758353,0.991595,0.0004461145,0.0012212793,0.000040125848,0.000040330735,0.000880548],"genre_scores_gemma":[0.0124458745,0.00015652784,0.020862455,0.9438454,0.008032063,0.000019528523,0.00010023932,0.00024407644,0.014293843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939482,0.0014931584,0.0011158194,0.0006476411,0.001787983,0.001007191],"domain_scores_gemma":[0.99750805,0.00020129055,0.00043607233,0.0011496975,0.00031050033,0.00039437853],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017801443,0.00083271594,0.0014531875,0.00089199416,0.0002531476,0.00024672935,0.0007243421,0.00031037512,0.0009172643],"category_scores_gemma":[0.00017648758,0.00052912947,0.000959235,0.0006620919,0.00013203763,0.00028380495,0.0001681578,0.004681087,0.0010108808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008221359,0.00016159957,0.00088717695,0.00015040077,0.000282559,0.011426286,0.0022423863,0.0000024634835,0.0001453735,0.0000027471249,0.98432624,0.0002905701],"study_design_scores_gemma":[0.0021854732,0.002572125,0.0010298475,0.0008886175,0.00036117603,0.004162879,0.0011568869,0.0000011253409,0.00007112696,0.000003728673,0.9870988,0.00046820473],"about_ca_topic_score_codex":0.000018855528,"about_ca_topic_score_gemma":0.000051917166,"teacher_disagreement_score":0.047749598,"about_ca_system_score_codex":0.00017377608,"about_ca_system_score_gemma":0.00025123238,"threshold_uncertainty_score":0.999996},"labels":[],"label_agreement":null},{"id":"W2072959138","doi":"10.1093/eurjhf/hfq206","title":"Relationship between Left and Right Ventricular Ejection Fractions in Chronic Advanced Systolic Heart Failure: Insights from the BEST Trial","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Ejection fraction; Medicine; Internal medicine; Cardiology; Heart failure; Quartile; Odds ratio; Ambulatory; Confidence interval; Logistic regression","score_opus":0.017324622882345285,"score_gpt":0.26718232058904307,"score_spread":0.24985769770669777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072959138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942228,0.0007164979,0.00014403243,0.05552815,0.00049922714,0.00073702604,0.0000046166037,0.00002960026,0.00011283362],"genre_scores_gemma":[0.99176794,0.000018613382,0.0057564527,0.00018011122,0.002043823,0.0000049723976,0.000023285496,0.000037164857,0.00016761622],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788004,0.00055048545,0.0006726712,0.0002523134,0.00038960957,0.0002549029],"domain_scores_gemma":[0.99865174,0.00041415473,0.00023971856,0.00035596866,0.00011460341,0.00022383613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006796102,0.00022407147,0.00044377605,0.00028320518,0.00030084094,0.00008153508,0.000115938295,0.00008585718,0.00015565105],"category_scores_gemma":[0.0002917368,0.00014827616,0.00018937519,0.00030111682,0.000089816655,0.00035550524,0.000047667152,0.0012717829,0.00016740455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032662635,0.00094005815,0.80342406,0.00013107329,0.00062627764,0.0018416276,0.0012748506,0.00014394759,0.015784897,0.0007301187,0.17023042,0.0016064219],"study_design_scores_gemma":[0.015012437,0.0009396025,0.27544087,0.0002206437,0.00027877692,0.00035834403,0.00024968534,0.000008649155,0.00028585477,0.00007818373,0.70699483,0.00013212256],"about_ca_topic_score_codex":0.00004571489,"about_ca_topic_score_gemma":0.000444028,"teacher_disagreement_score":0.5367644,"about_ca_system_score_codex":0.00014801847,"about_ca_system_score_gemma":0.00016178143,"threshold_uncertainty_score":0.6046526},"labels":[],"label_agreement":null},{"id":"W2073930646","doi":"10.1093/eurjhf/hfp141","title":"Normal Systolic Blood Pressure and Risk of Heart Failure in US Male Physicians","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Hazard ratio; Heart failure; Blood pressure; Cardiology; Internal medicine; Confidence interval; Proportional hazards model; Observational study","score_opus":0.009450320519744874,"score_gpt":0.22341967641287847,"score_spread":0.2139693558931336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073930646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549386,0.022839505,0.000008243699,0.021178372,0.0000931246,0.00020475991,0.000016905811,0.000018504854,0.0007019953],"genre_scores_gemma":[0.99171364,0.00035311907,0.0055742604,0.0015691919,0.00046972025,3.9556883e-7,0.0000013044322,0.000026871883,0.000291483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810195,0.0004029416,0.0006349087,0.00019875709,0.00037502122,0.0002864156],"domain_scores_gemma":[0.9989143,0.00006742701,0.00031668297,0.00026143086,0.00028637337,0.00015380152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068829017,0.0002133622,0.0009133429,0.00021559343,0.00009038591,0.000022109212,0.00011187799,0.000056217603,0.00004973579],"category_scores_gemma":[0.000089811576,0.00016514861,0.00020384786,0.0002079799,0.00009616584,0.00017041514,0.0000524066,0.0007082415,0.000014254002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068098994,0.0010976625,0.38243687,0.0003858952,0.002181074,0.0019131633,0.0022310507,0.00013897794,0.06185573,0.000035377503,0.54511684,0.0019263698],"study_design_scores_gemma":[0.0039423276,0.001914529,0.47861165,0.0010039968,0.003544058,0.0055235475,0.0005312956,0.000013382183,0.0026631928,0.00000895319,0.50204676,0.00019629084],"about_ca_topic_score_codex":0.000018569439,"about_ca_topic_score_gemma":0.000027763981,"teacher_disagreement_score":0.09617478,"about_ca_system_score_codex":0.0000024436151,"about_ca_system_score_gemma":0.000044071774,"threshold_uncertainty_score":0.6734565},"labels":[],"label_agreement":null},{"id":"W2074603640","doi":"10.1016/j.ejheart.2005.01.021","title":"Patient Perception of the Effect of Treatment with Candesartan in Heart Failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Medical Research Group; McMaster Children's Hospital; McMaster University Medical Centre; Hamilton General Hospital","funders":"","keywords":"Candesartan; Medicine; Placebo; Heart failure; Internal medicine; Cardiology; Angiotensin II; Blood pressure; Alternative medicine","score_opus":0.019787091223492856,"score_gpt":0.2867479435024095,"score_spread":0.26696085227891664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074603640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603184,0.0001082114,0.000003924951,0.021988694,0.00007862535,0.0017138092,0.00001991285,0.000006575703,0.000048437163],"genre_scores_gemma":[0.9946831,0.000033890712,0.0050827432,0.000036877438,0.00007839471,0.000016028627,0.00000775357,0.000030187979,0.00003106144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562216,0.0014859316,0.0014945011,0.00032468888,0.00071384717,0.00035884444],"domain_scores_gemma":[0.99831843,0.00008960205,0.0007203769,0.00054847024,0.00018231432,0.00014079481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021616914,0.00033134903,0.0010188572,0.00033752344,0.00005190465,0.00001372133,0.00012895581,0.00007198464,0.00002874152],"category_scores_gemma":[0.00008089565,0.00018231886,0.0002726298,0.0006161983,0.0002649969,0.00017855129,0.00007528585,0.00045805887,8.534789e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011632701,0.0011388755,0.94507045,0.00028885892,0.0001840448,0.000024732504,0.0020965368,0.00086007884,0.04238398,0.000009101897,0.0047220928,0.0020579896],"study_design_scores_gemma":[0.011126724,0.009780806,0.936692,0.0017496714,0.00027355994,0.00020775307,0.0018455915,0.0001148229,0.017327309,0.0000031838122,0.020708513,0.00017007304],"about_ca_topic_score_codex":0.002001575,"about_ca_topic_score_gemma":0.009829893,"teacher_disagreement_score":0.02505667,"about_ca_system_score_codex":0.0005200587,"about_ca_system_score_gemma":0.00029496726,"threshold_uncertainty_score":0.7434748},"labels":[],"label_agreement":null},{"id":"W2075045993","doi":"10.1002/ejhf.141","title":"The Global Relevance of Disease Management Programmes for Heart Failure","year":2014,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Disease management; Disease; Intensive care medicine; Grading (engineering); Health care; Heart disease; Etiology; Family medicine; Medical emergency; Cardiology; Internal medicine; Economic growth","score_opus":0.008064681036329466,"score_gpt":0.26941051192477183,"score_spread":0.2613458308884424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075045993","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062078907,0.010112941,0.0042505227,0.3575988,0.61684525,0.008339604,0.0004647449,0.00025091562,0.001516434],"genre_scores_gemma":[0.006855833,0.0013628473,0.19182834,0.00080980384,0.787195,0.0001157018,0.00038902555,0.00041489073,0.011028546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952035,0.000551489,0.001428784,0.0004964941,0.0016101024,0.0007096235],"domain_scores_gemma":[0.9959842,0.0005642571,0.0009211913,0.000942433,0.000983511,0.000604385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025744664,0.00060555915,0.0011896242,0.00017487905,0.00028078406,0.00015269285,0.00055942923,0.00015760209,0.000028805836],"category_scores_gemma":[0.0009409201,0.0003895585,0.00111615,0.00027706847,0.00029054447,0.00012821471,0.00020350277,0.0007934747,0.00007890134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015163269,0.00026909428,0.00030982986,0.0011893775,0.0008702497,0.00019184354,0.000027171298,0.0000082239,0.000008018336,0.0005070203,0.9908018,0.00430101],"study_design_scores_gemma":[0.004162418,0.0023370264,0.0003626301,0.0018335156,0.001500761,0.00003829106,0.00012397184,0.000004389056,0.00001326796,0.00014620298,0.9891771,0.00030042772],"about_ca_topic_score_codex":0.0000024670876,"about_ca_topic_score_gemma":0.000017185233,"teacher_disagreement_score":0.35678902,"about_ca_system_score_codex":0.00022796569,"about_ca_system_score_gemma":0.00036283865,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W2079072754","doi":"10.1016/j.ejheart.2004.01.014","title":"Regulation of Caspase 3 and Fas in Pressure Overload-Induced Left Ventricular Dysfunction","year":2004,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pressure overload; Apoptosis; Medicine; Internal medicine; Ventricular pressure; Heart failure; Endocrinology; Muscle hypertrophy; Left ventricular hypertrophy; Caspase 3; Western blot; Ventricular remodeling; Contractility; Cardiology; Blood pressure; Programmed cell death; Chemistry; Cardiac hypertrophy; Gene; Biochemistry","score_opus":0.005733809863103826,"score_gpt":0.2007859605408838,"score_spread":0.19505215067777998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079072754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967525,0.0008716187,0.0016120962,0.0005231928,0.00011113204,0.00008083353,0.0000013772637,0.000001970708,0.000045301687],"genre_scores_gemma":[0.99781334,0.00004153109,0.0018667302,0.00002798041,0.00016057244,1.3690148e-7,0.000008530435,0.000012591589,0.00006858621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928325,0.000116589996,0.0002746673,0.00011121639,0.00012721952,0.000087044966],"domain_scores_gemma":[0.99956703,0.0000032885173,0.00017704324,0.00010914003,0.000093651666,0.000049860602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003650074,0.00008005831,0.00012104587,0.00007895298,0.000031244545,0.000011021665,0.000045677138,0.000049629154,0.000013852649],"category_scores_gemma":[0.000032694785,0.000068512425,0.000062767205,0.000054889348,0.000016895778,0.000011172201,0.000025907588,0.00009319552,0.0000013231571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007766729,0.000041292635,0.0009849647,0.000021027743,0.000021967928,0.000031140637,0.00007051648,0.0034882892,0.99394125,0.00005675686,0.0004724046,0.00079272245],"study_design_scores_gemma":[0.004101661,0.0017106395,0.19793022,0.0002375468,0.000082181534,0.0012566276,0.00017797141,0.000105834566,0.7056496,0.00021007269,0.0883001,0.00023755679],"about_ca_topic_score_codex":0.0000060651773,"about_ca_topic_score_gemma":0.000012599474,"teacher_disagreement_score":0.28829166,"about_ca_system_score_codex":0.000008690445,"about_ca_system_score_gemma":0.00003289177,"threshold_uncertainty_score":0.27938557},"labels":[],"label_agreement":null},{"id":"W2081404783","doi":"10.1016/s1388-9842(00)80265-2","title":"Interobserver Reliability and Validity of the New York Heart Association Functional Classification (NYHA-FC) in Heart Failure Patients","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Heart failure; General hospital; Medicine; Citation; Internal medicine; Library science; Pediatrics; Computer science","score_opus":0.030397510277725973,"score_gpt":0.24015302859300997,"score_spread":0.209755518315284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081404783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8841696,0.00006279251,0.000022813632,0.11487087,0.00022746314,0.0004149969,0.00000633825,0.000016005906,0.00020913185],"genre_scores_gemma":[0.99030435,0.000013958711,0.0066549922,0.00085795176,0.0002770139,0.0000017986962,0.000015153598,0.000026549138,0.0018482502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715847,0.0008779137,0.0008144052,0.0002541391,0.0006471733,0.00024792235],"domain_scores_gemma":[0.99881274,0.0001175013,0.0002871644,0.00034093217,0.0002505973,0.00019106764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017299324,0.00019781846,0.00045207606,0.00012701016,0.00009403467,0.00003777138,0.000107544074,0.00007431757,0.0005465252],"category_scores_gemma":[0.00029112012,0.00013874579,0.00026135758,0.0003022091,0.000059913404,0.00024303826,0.0000497393,0.0005002287,0.00009270867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018818665,0.00025947505,0.52943856,0.000029262486,0.000038755097,0.000002471141,0.00017169908,0.000030134472,0.00055794686,0.0000071626855,0.46872965,0.0005467228],"study_design_scores_gemma":[0.0017280662,0.00042510103,0.56335074,0.00016527344,0.00006365054,0.000020007932,0.00006672283,0.000012289347,0.00014085899,0.000016497439,0.43394792,0.00006288203],"about_ca_topic_score_codex":0.00002807633,"about_ca_topic_score_gemma":0.00005999282,"teacher_disagreement_score":0.11401292,"about_ca_system_score_codex":0.0002514782,"about_ca_system_score_gemma":0.00012994521,"threshold_uncertainty_score":0.59840673},"labels":[],"label_agreement":null},{"id":"W2081438731","doi":"10.1093/eurjhf/hfn031","title":"Liver Function Abnormalities and Outcome in Patients with Chronic Heart Failure: Data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Candesartan; Bilirubin; Cardiology; Liver function; Liver function tests; Blood pressure","score_opus":0.0427266887938246,"score_gpt":0.30885561459850375,"score_spread":0.2661289258046792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081438731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713765,0.00043502453,0.000021540738,0.02695146,0.00008905388,0.001064886,0.000023845203,0.000018602663,0.000019115192],"genre_scores_gemma":[0.9901019,0.00005611489,0.009258739,0.00025704395,0.0001928797,0.0000059718914,0.00008375626,0.00002462367,0.00001896775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710876,0.0006551361,0.0009147412,0.00040259332,0.0005660463,0.0003527485],"domain_scores_gemma":[0.9988561,0.000062487605,0.0002620565,0.0005391421,0.000119736076,0.00016042234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017846938,0.00028742157,0.000664535,0.00026225176,0.000073667725,0.00007129632,0.0001468507,0.000059934948,0.000056338416],"category_scores_gemma":[0.00005054853,0.00019465694,0.00006641774,0.00034337956,0.00014370172,0.00062786625,0.00010874424,0.00067207013,0.0000029691605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002940834,0.00063002063,0.9792706,0.00006968096,0.000081942446,0.00006043416,0.00026918677,0.000032583004,0.00024025686,0.000016767628,0.017990861,0.0010435882],"study_design_scores_gemma":[0.0052781664,0.0024380032,0.9447042,0.00047028364,0.00014306406,0.000061642015,0.00051295536,0.00010696887,0.000027324104,0.000011773056,0.046084624,0.00016099196],"about_ca_topic_score_codex":0.00090013223,"about_ca_topic_score_gemma":0.0045002704,"teacher_disagreement_score":0.03456639,"about_ca_system_score_codex":0.00020279828,"about_ca_system_score_gemma":0.00015385047,"threshold_uncertainty_score":0.79378796},"labels":[],"label_agreement":null},{"id":"W2082704367","doi":"10.1016/s1388-9842(00)80384-0","title":"Identification of Patients Suitable for Ventricular Resynchronization Therapy Based on Normalized LV-RV Pressure Loop Area","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"Corporation; Medicine; Internal medicine; Cardiology; Law; Political science","score_opus":0.013155522526793549,"score_gpt":0.25007173011075057,"score_spread":0.236916207583957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082704367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193984,0.0014070964,0.0027205755,0.0013317962,0.00020734896,0.0005371784,0.00005056843,0.000024644953,0.0017809396],"genre_scores_gemma":[0.99818814,0.000065058586,0.0007655792,0.00015838956,0.00018019893,0.0000013772317,0.000031961437,0.000023886649,0.0005854217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986553,0.00020582652,0.00052493095,0.00011539592,0.0003748131,0.0001236906],"domain_scores_gemma":[0.99872524,0.000079382975,0.0003038963,0.0001849512,0.00064042263,0.00006612784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006765573,0.000104019964,0.0003352159,0.00013833908,0.00009062296,0.000021314248,0.000027604165,0.000026633776,0.00008909113],"category_scores_gemma":[0.00018596479,0.00008075466,0.0002226677,0.00018202023,0.00002627427,0.00008899097,0.0000050466906,0.00009729609,0.000016052663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011371769,0.0014551259,0.25589895,0.0005604553,0.0012200586,0.00006465025,0.0013504351,0.0677267,0.019453097,0.000030497795,0.62003,0.020838274],"study_design_scores_gemma":[0.008342201,0.0014802192,0.16652995,0.0003301881,0.00022379104,0.00006308326,0.00006050065,0.00091541925,0.008352692,0.0000045805523,0.8135573,0.00014004913],"about_ca_topic_score_codex":7.9966276e-7,"about_ca_topic_score_gemma":1.0198494e-7,"teacher_disagreement_score":0.19352736,"about_ca_system_score_codex":0.000021256606,"about_ca_system_score_gemma":0.00004325675,"threshold_uncertainty_score":0.32930794},"labels":[],"label_agreement":null},{"id":"W2083221422","doi":"10.1093/eurjhf/hfq170","title":"Assessment of a Novel Device-Based Diagnostic Algorithm to Monitor Patient Status in Moderate-To-Severe Heart Failure: Rationale and Design of the CLEPSYDRA Study","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Clinical endpoint; QRS complex; Adverse effect; Population; Algorithm; Prospective cohort study; Intensive care medicine; Internal medicine; Emergency medicine; Cardiology; Clinical trial","score_opus":0.023057967658844495,"score_gpt":0.2893195767344545,"score_spread":0.26626160907561003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083221422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841536,0.00008540541,0.0063698203,0.00388276,0.0002078568,0.0009310545,0.00003334315,0.0000061935098,0.000068218804],"genre_scores_gemma":[0.8967692,0.00000218632,0.102756776,0.00033852144,0.000098298355,0.000005276353,9.607529e-7,0.000020611486,0.00000817019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804145,0.000382051,0.0006543103,0.00016998609,0.00057368015,0.00017851802],"domain_scores_gemma":[0.9982851,0.0005243036,0.00022683507,0.00023406386,0.00053804147,0.00019163323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089049764,0.00015249103,0.00052394276,0.00021297357,0.00008005746,0.000026052903,0.000038318027,0.00002331613,0.000006124014],"category_scores_gemma":[0.0006282605,0.00010641163,0.00011355657,0.00030384064,0.000047193465,0.00006497967,0.00006824501,0.00031991623,0.0000026833532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007107191,0.0017380032,0.7964839,0.00011173933,0.000355405,0.00006334799,0.005599248,0.0786993,0.0817614,0.000012189533,0.031423047,0.0030417158],"study_design_scores_gemma":[0.004008395,0.0020847754,0.97497857,0.0004006558,0.00009451584,0.00022065228,0.001996865,0.0006708506,0.0013593592,0.0000019713632,0.01404225,0.0001411262],"about_ca_topic_score_codex":0.000018188124,"about_ca_topic_score_gemma":0.000022435126,"teacher_disagreement_score":0.17849469,"about_ca_system_score_codex":0.000037589914,"about_ca_system_score_gemma":0.00021125417,"threshold_uncertainty_score":0.43393403},"labels":[],"label_agreement":null},{"id":"W2084381491","doi":"10.1002/ejhf.233","title":"THe European Journal of Heart Failure Now and in the Years to Come: A Salutation from the Incoming Editor-in-Chief.","year":2015,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Impact factor; Medicine; Value (mathematics); Heart failure; Cardiology; Law; Political science; Computer science","score_opus":0.010425705342347585,"score_gpt":0.2585709005663643,"score_spread":0.2481451952240167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084381491","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.081437826,0.0046930253,0.00012484458,0.4874904,0.42334104,0.0021906474,0.00008515194,0.000036179234,0.00060092716],"genre_scores_gemma":[0.08304725,0.0004318233,0.010689323,0.0015281609,0.9036037,0.000005641866,0.000047747217,0.00021907351,0.00042729883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909433,0.0046902313,0.0016054317,0.00031005545,0.001967385,0.00048360415],"domain_scores_gemma":[0.9959049,0.0017159962,0.0008481894,0.0005868048,0.00062517327,0.00031889268],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014040128,0.00044697523,0.0009150058,0.00040323514,0.00021134563,0.00037786234,0.0007841016,0.00012421074,0.000019575582],"category_scores_gemma":[0.0017550178,0.00023011584,0.00031944874,0.00045868193,0.00016694472,0.00023460468,0.00023660436,0.0028584125,0.00009633829],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004720153,0.00010780345,0.0018156263,0.000027241926,0.0001753018,0.0011235657,0.0026030235,0.00003122754,0.00010064098,0.0000016639445,0.9922021,0.0013397974],"study_design_scores_gemma":[0.0038803886,0.0012092809,0.022575036,0.0013648939,0.00027743884,0.0002620496,0.0030926785,0.0000036781007,0.000003374676,0.000020900938,0.96711403,0.00019622821],"about_ca_topic_score_codex":0.000039356797,"about_ca_topic_score_gemma":0.00064643397,"teacher_disagreement_score":0.4859622,"about_ca_system_score_codex":0.00021749591,"about_ca_system_score_gemma":0.0004677562,"threshold_uncertainty_score":0.99944204},"labels":[],"label_agreement":null},{"id":"W2084695070","doi":"10.1016/j.ejheart.2005.03.005","title":"Utilization of Evidence-Based Therapies for Heart Failure in the Institutionalized Elderly","year":2005,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Pharmacy; Spironolactone; Long-term care; Intensive care medicine; Emergency medicine; Internal medicine; Family medicine","score_opus":0.09865105996698253,"score_gpt":0.32828095936622825,"score_spread":0.22962989939924572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084695070","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2364765,0.002727144,0.006505905,0.75235337,0.00016080815,0.0015300503,0.000008078629,0.00003337286,0.0002047995],"genre_scores_gemma":[0.91285473,0.000055337805,0.08419877,0.0023321484,0.00038158943,0.000008637791,0.000009611575,0.000022244987,0.0001369464],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997992,0.00048567835,0.0006689197,0.00015014142,0.00048747865,0.00021581867],"domain_scores_gemma":[0.998892,0.00024305936,0.00022104039,0.00025316502,0.00030745362,0.000083245264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020463902,0.000172572,0.00038777106,0.000273135,0.000089395246,0.000035859382,0.00016352496,0.00003635145,0.00014605018],"category_scores_gemma":[0.00024771751,0.00009720738,0.0002826411,0.00028890144,0.00009597005,0.00031358039,0.00001515766,0.00022124816,0.00002482725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022302717,0.0014984544,0.027885696,0.00045486653,0.0003772806,0.00013747372,0.0030799813,0.0011726362,0.014885624,0.0024668698,0.9209803,0.02483055],"study_design_scores_gemma":[0.0040023946,0.0015906355,0.013554217,0.0008308753,0.00012473098,0.000119523684,0.0005559188,0.00008542208,0.0013950624,0.000028104814,0.9776177,0.00009541428],"about_ca_topic_score_codex":0.000004357283,"about_ca_topic_score_gemma":0.000039473874,"teacher_disagreement_score":0.7500212,"about_ca_system_score_codex":0.00005795892,"about_ca_system_score_gemma":0.00020063664,"threshold_uncertainty_score":0.39640018},"labels":[],"label_agreement":null},{"id":"W2086962440","doi":"10.1093/eurjhf/hft098","title":"Evaluation of Different Strategies for Identifying Asymptomatic Left Ventricular Dysfunction and Pre-Clinical (stage B) Heart Failure in the Elderly. Results from ‘PREDICTOR’, a Population Based-Study in Central Italy","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bell (Canada)","funders":"","keywords":"Medicine; Asymptomatic; Heart failure; Diastole; Internal medicine; Cardiology; Cohort; Population; Stage (stratigraphy); Physical therapy; Blood pressure","score_opus":0.038460897071751016,"score_gpt":0.3076142497225002,"score_spread":0.26915335265074913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086962440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955062,0.00017266892,0.00081403676,0.0017352799,0.00031851404,0.0014235603,0.00001024095,0.00001059731,0.000008875437],"genre_scores_gemma":[0.9989559,0.0000059597373,0.00064872304,0.00005404008,0.00024774708,0.0000066197967,0.00005416199,0.000020553352,0.000006282691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99507767,0.0022912298,0.0011928058,0.00023529828,0.0010109168,0.00019210014],"domain_scores_gemma":[0.9986438,0.00028311394,0.0003694007,0.00027114621,0.0003276452,0.00010487799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050887424,0.00016976742,0.00050197064,0.0002596091,0.0000626619,0.000103600825,0.00008095771,0.00006167944,0.0000666856],"category_scores_gemma":[0.0006526036,0.00010927675,0.0003292636,0.00015746674,0.000028795457,0.0003158603,0.000018637915,0.0004178714,0.0000032075577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040467308,0.00055589393,0.99040216,0.000066625595,0.00021972205,0.000028573919,0.001610337,0.001881886,0.0005933999,0.0000023108787,0.00294222,0.0012921668],"study_design_scores_gemma":[0.009309062,0.001383118,0.97819567,0.0003776275,0.00048364056,0.00005242318,0.0058360333,0.0035515577,0.000030366251,0.00004010281,0.0006490011,0.00009140247],"about_ca_topic_score_codex":0.0001926692,"about_ca_topic_score_gemma":0.00045062706,"teacher_disagreement_score":0.012206526,"about_ca_system_score_codex":0.00009481432,"about_ca_system_score_gemma":0.00011886828,"threshold_uncertainty_score":0.44561765},"labels":[],"label_agreement":null},{"id":"W2087203732","doi":"10.1016/s1388-9842(00)80308-6","title":"Validation of a Novel Closed Chest Experimental Model of Post-Infarction Left Ventricular Remodelling","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Wright; Interventional cardiology; Internal medicine; Cardiology; Myocardial infarction; Art history; History","score_opus":0.015615480965822092,"score_gpt":0.24035744511042909,"score_spread":0.22474196414460698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087203732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753946,0.00030363214,0.0004082631,0.0012166321,0.00008332953,0.00010455732,0.000007911737,0.000008407068,0.00032780593],"genre_scores_gemma":[0.98320866,0.000025494755,0.016294342,0.000074903815,0.00022319955,8.937076e-8,0.0000083968025,0.000019297506,0.00014562145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988705,0.00007016733,0.00053569814,0.000097559736,0.00031459998,0.00011148974],"domain_scores_gemma":[0.9992883,0.000011567194,0.00024227268,0.00013101954,0.00023940158,0.000087418055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003036794,0.00010498342,0.00032182617,0.000097419,0.00003841838,0.0000072976877,0.00005589355,0.000028662143,0.00017367922],"category_scores_gemma":[0.000015940512,0.000078163226,0.00035850288,0.00007843339,0.000045586006,0.00011041618,0.000014202964,0.00016652892,0.000004251502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065200555,0.00017303145,0.0007431454,0.000068570625,0.000111109715,0.00004157833,0.0006760065,0.03121615,0.96449566,0.000012736603,0.000725728,0.0010842497],"study_design_scores_gemma":[0.008520792,0.003720591,0.02711663,0.0010853948,0.00048501656,0.007852189,0.0012785331,0.027160969,0.9020911,0.000016677152,0.020281702,0.00039041002],"about_ca_topic_score_codex":0.0000059509484,"about_ca_topic_score_gemma":9.616177e-8,"teacher_disagreement_score":0.06240459,"about_ca_system_score_codex":0.00003114531,"about_ca_system_score_gemma":0.00004682889,"threshold_uncertainty_score":0.31874037},"labels":[],"label_agreement":null},{"id":"W2087323626","doi":"10.1093/eurjhf/hfp048","title":"Defective Peroxisomal Proliferators Activated Receptor Gamma Activity Due to Dominant-Negative Mutation Synergizes with Hypertension to Accelerate Cardiac Fibrosis in Mice","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"Medical Research Council; Diabetes UK; British Heart Foundation; Wellcome Trust","keywords":"Internal medicine; Endocrinology; Medicine; Cardiac fibrosis; Fibrosis; Angiotensin II; Cardiac function curve; Peroxisome proliferator-activated receptor; Heart failure; Blood pressure; Insulin resistance; Receptor; Diabetes mellitus","score_opus":0.007115531023821503,"score_gpt":0.21971160108648602,"score_spread":0.2125960700626645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087323626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527246,0.00005873583,0.000353288,0.0034604499,0.00017969953,0.0005860049,0.000022279344,0.000017122004,0.000049959202],"genre_scores_gemma":[0.9896671,0.000015967327,0.009252971,0.0005447804,0.00039146052,0.000010820262,0.000011717844,0.00006926599,0.000035917383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706,0.0010843484,0.00049832446,0.0005307601,0.00035760377,0.0004689352],"domain_scores_gemma":[0.9984101,0.000050760984,0.00030353342,0.00025151283,0.00058444194,0.000399669],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067125814,0.000403509,0.00057698524,0.0003353288,0.00015194544,0.000093611394,0.00025178774,0.00012381346,0.00001471192],"category_scores_gemma":[0.00042972167,0.00032240496,0.00017054458,0.0006350121,0.000050731895,0.00007670706,0.000079138714,0.00048539104,0.00003601459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004233592,0.00018315625,0.0013351355,0.00000980963,0.000103966755,0.00009935685,0.00055582507,0.0006870205,0.9857625,6.788432e-7,0.0051324284,0.0018965596],"study_design_scores_gemma":[0.001412318,0.004513358,0.017746318,0.00022742205,0.000028974695,0.0002869601,0.00039541966,0.0000045684947,0.96789515,0.0000017178753,0.0070886,0.00039921267],"about_ca_topic_score_codex":0.000010368234,"about_ca_topic_score_gemma":0.000014200295,"teacher_disagreement_score":0.017867342,"about_ca_system_score_codex":0.00013065747,"about_ca_system_score_gemma":0.00019470477,"threshold_uncertainty_score":0.9999228},"labels":[],"label_agreement":null},{"id":"W2088639601","doi":"10.1093/eurjhf/hfr125","title":"Left Ventricular Systolic and Diastolic Function, Remodelling, and Clinical Outcomes Among Patients with Diabetes Following Myocardial Infarction and the Influence of Direct Renin Inhibition with Aliskiren","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Ejection fraction; Aliskiren; Hazard ratio; Myocardial infarction; Diabetes mellitus; Heart failure; Stroke volume; Confidence interval; Blood pressure; Renin–angiotensin system; Endocrinology","score_opus":0.007364766054770237,"score_gpt":0.2007622174338697,"score_spread":0.19339745137909947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088639601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990074,0.00030604063,0.00013868713,0.00017906107,0.00009925004,0.00022565601,0.000001478641,0.0000118815005,0.000030545983],"genre_scores_gemma":[0.9992994,0.00009774069,0.00038518704,0.00011106077,0.00007309025,6.0617947e-7,0.000002716941,0.000021926096,0.000008279771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841046,0.0005195696,0.0004496137,0.00016353768,0.00033466032,0.0001221613],"domain_scores_gemma":[0.9991145,0.00008802629,0.00029212586,0.00015225598,0.00020930533,0.0001437613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011886664,0.0001454486,0.00052038353,0.00012991618,0.00010790073,0.000024023191,0.000026564825,0.000038406328,0.0000029060316],"category_scores_gemma":[0.00014788804,0.0000747031,0.00021292584,0.00010575848,0.00028592758,0.00022182059,0.000027308784,0.00029135865,5.9884263e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000543691,0.000036957113,0.99767315,0.000020212576,0.0007498452,0.000026159621,0.00040065893,0.000057302113,0.000012048029,0.00000260958,0.00010754979,0.00036981903],"study_design_scores_gemma":[0.005771648,0.00091701926,0.99042183,0.00036029887,0.001043302,0.00014590095,0.00010588856,0.000014316315,0.000019963645,0.0000031007762,0.0011075,0.00008921875],"about_ca_topic_score_codex":0.000034751738,"about_ca_topic_score_gemma":0.000009297514,"teacher_disagreement_score":0.007251304,"about_ca_system_score_codex":0.000011110037,"about_ca_system_score_gemma":0.000024056988,"threshold_uncertainty_score":0.3046304},"labels":[],"label_agreement":null},{"id":"W2091696488","doi":"10.1093/eurjhf/hfr173","title":"Targeting Myocardial Substrate Metabolism in Heart Failure: Potential for New Therapies","year":2012,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute for Health and Care Research","keywords":"Heart failure; Medicine; Cardiology; Beta oxidation; Internal medicine; Bioinformatics; Metabolism; Biology","score_opus":0.02851899797544453,"score_gpt":0.27585230182664233,"score_spread":0.2473333038511978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091696488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012626592,0.9927934,0.00077016937,0.002851366,0.0025264327,0.00082418753,0.000018787525,0.000035304074,0.000054096017],"genre_scores_gemma":[0.0009851232,0.9659179,0.018702785,0.00020845862,0.013484647,0.000005477765,0.00007949276,0.00026403053,0.00035208356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955543,0.0013060312,0.001546439,0.00034720075,0.00064795197,0.00059805234],"domain_scores_gemma":[0.99805737,0.000100580684,0.0006471631,0.00039445242,0.00025435945,0.0005460544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030401093,0.0005989975,0.0031713608,0.000599862,0.0001160089,0.00010585312,0.00021730976,0.00021768095,0.00023440033],"category_scores_gemma":[0.00015941678,0.00041384468,0.004189309,0.00037238572,0.00006646883,0.00023083601,0.00005461262,0.001543485,0.00016001078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043311686,0.00024629003,0.00058987056,0.005244755,0.005414159,0.00057541113,0.00055907544,0.00008136228,0.00018144165,0.000035251636,0.57615805,0.4104812],"study_design_scores_gemma":[0.0022463172,0.00018013209,0.00078138936,0.002787172,0.00332059,0.0032532504,0.00016409386,7.1056763e-7,0.0000043710484,0.000002558768,0.986898,0.00036140686],"about_ca_topic_score_codex":0.000008351773,"about_ca_topic_score_gemma":0.0000030629058,"teacher_disagreement_score":0.41073996,"about_ca_system_score_codex":0.00009173618,"about_ca_system_score_gemma":0.00061983796,"threshold_uncertainty_score":0.9998313},"labels":[],"label_agreement":null},{"id":"W2094689946","doi":"10.1093/eurjhf/hfq164","title":"What Heart Failure Programme Works Best? Wrong Question, Wrong Assumptions","year":2010,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"Medicine; Heart failure; Disease management; MEDLINE; Quality of life (healthcare); Clinical trial; Heart disease; Intensive care medicine; Disease; Family medicine; Medical emergency; Nursing; Internal medicine","score_opus":0.014798875109846052,"score_gpt":0.2837080521372455,"score_spread":0.2689091770273994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094689946","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021241254,0.007181884,0.00048624811,0.22018999,0.7668741,0.0023217818,0.000042907057,0.00036048074,0.0004185087],"genre_scores_gemma":[0.0022204085,0.0021008297,0.13114002,0.00065783656,0.852642,0.00003886349,0.00064456166,0.00054961315,0.010005882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99247676,0.0011571338,0.0019289119,0.00085425936,0.0023445392,0.0012383843],"domain_scores_gemma":[0.99441445,0.00041143375,0.0009909262,0.0012098562,0.0017197703,0.0012535613],"candidate_categories":["metaepi_narrow","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003772549,0.0010834866,0.001853981,0.00089067087,0.00044002623,0.0012156559,0.0005870219,0.0009267003,0.00082913326],"category_scores_gemma":[0.001061122,0.00088727515,0.0012021306,0.0005163667,0.0002917584,0.0014552635,0.00026236434,0.006559467,0.0016043035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002019113,0.0006583193,0.00043678336,0.00027725173,0.0006409866,0.00117171,0.00021238679,0.000009185062,0.0003168761,0.000018445586,0.9895686,0.0064875428],"study_design_scores_gemma":[0.0037017777,0.0021821668,0.00027516522,0.0083822645,0.001491815,0.00075910735,0.0007691353,0.00000363747,0.000048430218,0.000019363133,0.98169225,0.000674888],"about_ca_topic_score_codex":0.000024599734,"about_ca_topic_score_gemma":0.00024704597,"teacher_disagreement_score":0.21953216,"about_ca_system_score_codex":0.00037234227,"about_ca_system_score_gemma":0.00095856405,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W2094831652","doi":"10.1016/j.ejheart.2008.07.002","title":"Non-Sustained Ventricular Tachycardia as a Predictor of Sudden Cardiac Death in Patients with Left Ventricular Dysfunction: A Meta-Analysis","year":2008,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Ventricular tachycardia; Ejection fraction; Heart failure; Receiver operating characteristic; Funnel plot; Sudden cardiac death; Ambulatory; Dilated cardiomyopathy; Area under the curve; Meta-analysis; Publication bias","score_opus":0.017864681301697223,"score_gpt":0.258809412025397,"score_spread":0.24094473072369976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094831652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009068129,0.9887311,0.000035943016,0.00013152939,0.00021180688,0.0014471475,0.00015498942,0.000014473899,0.00020489875],"genre_scores_gemma":[0.055029586,0.94037694,0.0020256902,0.0000683053,0.0010428741,0.000027948648,0.00073022436,0.00030317612,0.0003952577],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946897,0.0011410734,0.0017790097,0.00050435297,0.0014414253,0.00044445027],"domain_scores_gemma":[0.99639976,0.00010470633,0.001498433,0.00077263784,0.0007999263,0.00042455344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008202302,0.00072923774,0.0076857577,0.0013882268,0.00007930816,0.000032729386,0.0001910248,0.00015507748,0.00017524206],"category_scores_gemma":[0.00011108961,0.00044207013,0.009657861,0.0014317608,0.00006622505,0.00014526871,0.00009331643,0.0008341906,0.000048615326],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006998775,0.0013342238,0.1365558,0.003968815,0.74165004,0.09139809,0.00025449053,0.00020619668,7.5254526e-8,0.000004827218,0.017657606,0.006269946],"study_design_scores_gemma":[0.0026132555,0.0012062889,0.018823713,0.0011642003,0.3406838,0.0028187933,0.000030289102,4.5777733e-7,7.525592e-7,3.7785847e-7,0.6323838,0.00027425974],"about_ca_topic_score_codex":0.000016230179,"about_ca_topic_score_gemma":9.0113974e-7,"teacher_disagreement_score":0.6147262,"about_ca_system_score_codex":0.00029871464,"about_ca_system_score_gemma":0.00062658574,"threshold_uncertainty_score":0.9998031},"labels":[],"label_agreement":null},{"id":"W2097316779","doi":"10.1002/ejhf.420","title":"The Clinical Course of Health Status and Association with Outcomes in Patients Hospitalized for Heart Failure: Insights from ASCEND-HF","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Duke Clinical Research Institute; National Institute of General Medical Sciences","keywords":"Medicine; Confidence interval; Logistic regression; Heart failure; Odds ratio; Visual analogue scale; Quality of life (healthcare); Proportional hazards model; Internal medicine; EQ-5D; Odds; Physical therapy; Health related quality of life","score_opus":0.02434114122464287,"score_gpt":0.3113127235025824,"score_spread":0.2869715822779395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097316779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91301334,0.0005218031,0.00006247065,0.08533574,0.00025112028,0.0007649105,0.00001565229,0.000012361837,0.00002258289],"genre_scores_gemma":[0.98037684,0.000069689144,0.018547527,0.000688081,0.00013615406,0.000003443104,0.000024505794,0.000035466546,0.00011827774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699193,0.0008560032,0.001076456,0.0001935022,0.0005584154,0.00032369915],"domain_scores_gemma":[0.997949,0.00032255254,0.0006935008,0.00023064433,0.00045744912,0.00034684286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023494365,0.00019269371,0.00081301417,0.00009990918,0.00009031197,0.000042369655,0.00008257584,0.00004762923,0.0000047939475],"category_scores_gemma":[0.00044167784,0.000106990134,0.0001646001,0.0001271408,0.00007169865,0.00016033059,0.000041377923,0.0003108555,0.0000073120514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005579813,0.00045190434,0.84778094,0.000015663325,0.00028247194,0.0000073670717,0.0005057797,0.000001950143,0.0000043613127,0.000018638802,0.14920942,0.0011635355],"study_design_scores_gemma":[0.011205506,0.0037802695,0.6487447,0.00014220657,0.0000912706,0.0000023205675,0.0004985218,0.0000040354003,0.00001122277,0.000028661518,0.33541912,0.00007215586],"about_ca_topic_score_codex":0.000039114526,"about_ca_topic_score_gemma":0.000114115304,"teacher_disagreement_score":0.1990362,"about_ca_system_score_codex":0.000155924,"about_ca_system_score_gemma":0.0003141057,"threshold_uncertainty_score":0.4362931},"labels":[],"label_agreement":null},{"id":"W2098199229","doi":"10.1002/ejhf.288","title":"Clinical Characteristics and Outcomes of Patients with and without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) Trial","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Ejection fraction; Hazard ratio; Internal medicine; Heart failure; Diabetes mellitus; Cardiology; Randomized controlled trial; Coronary artery disease; Confidence interval; Artery; Clinical trial","score_opus":0.027694242269836408,"score_gpt":0.30175913087684064,"score_spread":0.27406488860700423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098199229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944648,0.00016823674,0.000010111236,0.004719306,0.000083997715,0.0004894728,0.000022028924,0.000007895796,0.000034134944],"genre_scores_gemma":[0.9953145,0.000025130594,0.004145664,0.00019944875,0.00025479536,0.00000402515,0.000012145301,0.00002150092,0.000022816608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842906,0.0003977442,0.00063236867,0.00013621258,0.00025111897,0.00015349094],"domain_scores_gemma":[0.9989502,0.00031646015,0.00022439577,0.00015606834,0.00018623963,0.00016667477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016122556,0.00015308718,0.0007543438,0.00007080981,0.00002700328,0.000020414442,0.00005050356,0.000040116123,0.0000040747786],"category_scores_gemma":[0.00021340369,0.000079293546,0.00017168783,0.000055846795,0.0001283251,0.00007675703,0.000023303,0.00021279402,6.6256484e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007801268,0.00030170038,0.97873926,0.000017587072,0.000090244794,0.000026088162,0.00012429102,6.4845146e-8,0.000019559495,0.0000034659197,0.010369319,0.0025071213],"study_design_scores_gemma":[0.024620462,0.006569869,0.7381388,0.000114080605,0.0001707675,0.000101320686,0.00014030644,0.0000025264803,0.00003130958,0.0000034373948,0.23002964,0.00007747875],"about_ca_topic_score_codex":0.0000014466019,"about_ca_topic_score_gemma":0.0000015412741,"teacher_disagreement_score":0.2406005,"about_ca_system_score_codex":0.000016369295,"about_ca_system_score_gemma":0.000079301055,"threshold_uncertainty_score":0.32334968},"labels":[],"label_agreement":null},{"id":"W2098418963","doi":"10.1093/eurjhf/hft052","title":"Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)","year":2013,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Novartis Pharma","keywords":"Enalapril; Medicine; Heart failure; Neprilysin; Sacubitril; Internal medicine; Cardiology; Valsartan; Renin–angiotensin system; Natriuretic peptide; ACE inhibitor; Natriuresis; Ejection fraction; Pharmacology; Angiotensin-converting enzyme; Endocrinology; Blood pressure; Chemistry; Enzyme","score_opus":0.028670951272544626,"score_gpt":0.2881548921477827,"score_spread":0.2594839408752381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098418963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780522,0.000043441418,0.00039647604,0.017057696,0.000038951293,0.0043743225,0.000026405125,0.000009025196,0.0000014856083],"genre_scores_gemma":[0.98148966,0.0000015171883,0.018045064,0.00023454466,0.0001543518,0.00002442987,0.000016711927,0.000029415785,0.000004320471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753416,0.00057149335,0.0007237372,0.00038607852,0.00048265824,0.0003018968],"domain_scores_gemma":[0.99865174,0.00010553005,0.00038031573,0.00022573366,0.00037075183,0.00026594434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078735355,0.00031137138,0.0007928228,0.00026134323,0.00008792934,0.00005555727,0.000041351002,0.000058926344,0.000010597543],"category_scores_gemma":[0.00014453553,0.00019980043,0.000089693516,0.0003823679,0.00013314726,0.00039542414,0.000056241766,0.0002528369,0.0000026451478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03832094,0.0018408013,0.8997386,0.00020762645,0.00047602216,0.00005940672,0.003911387,0.003159037,0.025317522,0.000078847836,0.02636309,0.00052668457],"study_design_scores_gemma":[0.030456433,0.023612507,0.9323764,0.0015233493,0.00016032658,0.00015436466,0.00036404518,0.000422655,0.010031326,0.00003911101,0.00060109963,0.00025840272],"about_ca_topic_score_codex":0.00026832827,"about_ca_topic_score_gemma":0.00059954426,"teacher_disagreement_score":0.03263774,"about_ca_system_score_codex":0.00029615016,"about_ca_system_score_gemma":0.00016502287,"threshold_uncertainty_score":0.81476253},"labels":[],"label_agreement":null},{"id":"W2098841316","doi":"10.1002/ejhf.447","title":"November 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiogenic shock; Heart failure; Internal medicine; Cardiology; Pulmonary artery; Myocardial infarction; Intensive care medicine","score_opus":0.02865552931367892,"score_gpt":0.2769141486940801,"score_spread":0.24825861938040117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098841316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49486998,0.0026815606,0.00083471515,0.46519148,0.0012207646,0.0006465231,0.000006351852,0.00013459248,0.034414046],"genre_scores_gemma":[0.9114176,0.000025873374,0.06713559,0.002776009,0.0012554657,0.0000011690696,0.000007671065,0.0000649002,0.017315721],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985416,0.00019029043,0.00040856618,0.00013997816,0.00046981734,0.0002497798],"domain_scores_gemma":[0.99878466,0.000020815462,0.00015316786,0.00026277817,0.00027127325,0.00050731597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009914557,0.00015815627,0.00034474995,0.0001270944,0.00004704016,0.000025060805,0.00009846499,0.000023243549,0.00033808104],"category_scores_gemma":[0.000097732845,0.00011240048,0.00017029038,0.00013983095,0.00004461822,0.00013875759,0.000084454674,0.00023222332,0.0016251451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002552265,0.00012365497,0.01013674,0.000016603532,0.00009717443,0.0014137188,0.00024564235,0.000011148863,0.0009567658,0.000027527069,0.9862041,0.00051172846],"study_design_scores_gemma":[0.003585307,0.0010347231,0.008183369,0.00012118769,0.00010224729,0.0020087606,0.00014373288,0.000009126865,0.00033427397,0.0000090298845,0.98436666,0.0001016013],"about_ca_topic_score_codex":0.0000023494379,"about_ca_topic_score_gemma":0.0000073174756,"teacher_disagreement_score":0.46241546,"about_ca_system_score_codex":0.00013086891,"about_ca_system_score_gemma":0.000099526376,"threshold_uncertainty_score":0.9991522},"labels":[],"label_agreement":null},{"id":"W2099769151","doi":"10.1016/j.ejheart.2008.07.014","title":"State of the Art: Using Natriuretic Peptide Levels in Clinical Practice","year":2008,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":837,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Natriuretic peptide; Heart failure; Clinical Practice; Internal medicine; Cardiology; Intensive care medicine; Family medicine","score_opus":0.09969635210221914,"score_gpt":0.3914923341093954,"score_spread":0.29179598200717627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099769151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004009448,0.98825145,0.000058211594,0.00871317,0.0005688401,0.0010394761,0.000010737231,0.000011464852,0.00094570994],"genre_scores_gemma":[0.0002530297,0.9568594,0.0408117,0.00036906605,0.00055676897,0.000001075867,0.0000033597432,0.00009893394,0.001046648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928673,0.0029983006,0.0027782004,0.00027543682,0.0007485961,0.00033217264],"domain_scores_gemma":[0.9965262,0.00053892814,0.0018283356,0.0005730232,0.0003183838,0.00021512427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031730481,0.00040989282,0.0023202803,0.00037954815,0.00006457651,0.000023505077,0.00031046182,0.0000880282,0.000059997863],"category_scores_gemma":[0.0012766726,0.00023086746,0.0014895174,0.0005393281,0.00016811636,0.00016688772,0.00016673173,0.0017139168,0.0001582545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017218347,0.0011161469,0.0008794133,0.006109595,0.0017548213,0.010080472,0.00037795134,0.000027350055,0.0000065432387,0.000017848952,0.5311849,0.44827273],"study_design_scores_gemma":[0.0012491603,0.0005006544,0.0007233766,0.017821174,0.0014535128,0.0077706017,0.000033894,0.0000020651742,0.0000011692965,0.0000019010954,0.9702792,0.0001632712],"about_ca_topic_score_codex":0.0000031448512,"about_ca_topic_score_gemma":0.000004652298,"teacher_disagreement_score":0.44810948,"about_ca_system_score_codex":0.00015721194,"about_ca_system_score_gemma":0.0009038114,"threshold_uncertainty_score":0.9414502},"labels":[],"label_agreement":null},{"id":"W2100631892","doi":"10.1002/ejhf.211","title":"Comparison of Outcomes After Hospitalization for Worsening Heart Failure, Myocardial Infarction, and Stroke in Patients with Heart Failure and Reduced and Preserved Ejection Fraction","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Ejection fraction; Cardiology; Internal medicine; Myocardial infarction; Stroke (engine); Stroke volume","score_opus":0.009672213910996468,"score_gpt":0.25541929203916963,"score_spread":0.24574707812817317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100631892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98346233,0.00009661058,0.0009065043,0.014615772,0.00011017424,0.0007687551,0.0000054409675,0.000020172434,0.0000142071785],"genre_scores_gemma":[0.97013336,0.0000073104698,0.029414555,0.00017469561,0.0001537003,0.0000099299905,0.000019572948,0.000041135678,0.000045727196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981718,0.00031371118,0.00063955324,0.00027637547,0.0003620138,0.00023654403],"domain_scores_gemma":[0.99896264,0.00009095607,0.00028938372,0.00017287959,0.00030519027,0.00017897006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071365375,0.00024356144,0.0006779866,0.00037085827,0.00010899157,0.00006989102,0.00003436686,0.000068540314,0.0000122813035],"category_scores_gemma":[0.0001507901,0.00018925725,0.00009624702,0.00015855413,0.00008091382,0.0004679445,0.000044148954,0.00027177716,0.0000014989731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082068145,0.00017424874,0.9847418,0.00011665614,0.00013540011,0.000001741835,0.0002001595,0.000033350687,0.0008582472,0.0000083772975,0.01265643,0.0002528887],"study_design_scores_gemma":[0.005945915,0.0025447677,0.898867,0.00031577257,0.00020746503,0.000020352705,0.00046087624,0.000095624375,0.00027747903,0.000007195575,0.09110412,0.00015340812],"about_ca_topic_score_codex":0.0000148135905,"about_ca_topic_score_gemma":0.000047056492,"teacher_disagreement_score":0.08587479,"about_ca_system_score_codex":0.00004501329,"about_ca_system_score_gemma":0.000026116622,"threshold_uncertainty_score":0.7717686},"labels":[],"label_agreement":null},{"id":"W2103268767","doi":"10.1093/eurjhf/hfq140","title":"The STICH Trial: Evidence-Based Conclusions","year":2010,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Heart failure; MEDLINE; Intensive care medicine; Internal medicine; Cardiology","score_opus":0.027155337973067413,"score_gpt":0.2753149385522539,"score_spread":0.2481596005791865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103268767","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008169936,0.0027487841,0.0000131559555,0.9840886,0.0041137184,0.00043617166,0.00001177896,0.000029802728,0.0003880329],"genre_scores_gemma":[0.023260962,0.00044562004,0.0046303566,0.89364964,0.069126934,0.000003408896,0.000031268773,0.00021085731,0.008640972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968724,0.00085998944,0.0008566463,0.00021081613,0.0008381367,0.0003619873],"domain_scores_gemma":[0.9970762,0.0009663994,0.00061142154,0.0005772339,0.0005730153,0.00019570596],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015233785,0.00030695557,0.00075811584,0.00012666458,0.00040166065,0.00013140285,0.00035491746,0.0003256216,0.0003291736],"category_scores_gemma":[0.000972176,0.00014883332,0.0012194151,0.00013481776,0.0002775829,0.00007147481,0.000109229935,0.007007454,0.00009387869],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020216298,0.000008732695,0.00005111799,0.00005828437,0.00014201071,0.002698688,0.000023399805,0.0000020993957,0.0005801852,0.0000018257422,0.99357754,0.0008345118],"study_design_scores_gemma":[0.0069138748,0.0014260358,0.00076870015,0.0011445276,0.0004468817,0.0029167938,0.000036004287,0.000002850309,0.000061711944,0.000006888177,0.9861059,0.00016983137],"about_ca_topic_score_codex":0.0000036332272,"about_ca_topic_score_gemma":0.0000016959301,"teacher_disagreement_score":0.09043899,"about_ca_system_score_codex":0.00005083653,"about_ca_system_score_gemma":0.0005067506,"threshold_uncertainty_score":0.9952834},"labels":[],"label_agreement":null},{"id":"W2108600107","doi":"10.1016/s1388-9842(03)00053-9","title":"A Prognostic Index to Predict Long-Term Mortality in Patients with Mild to Moderate Chronic Heart Failure Stabilised on Angiotensin Converting Enzyme Inhibitors","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Heart Foundation; Heart and Stroke Foundation of Canada","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Left ventricular hypertrophy; Creatinine; Population; Risk factor; Renal function; QRS complex; Ventricular tachycardia; Blood pressure","score_opus":0.013433752061484457,"score_gpt":0.24142649362609814,"score_spread":0.2279927415646137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108600107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784477,0.000063808606,0.00029843574,0.018913945,0.00016675027,0.0019975072,0.000007275783,0.00004933095,0.000055289198],"genre_scores_gemma":[0.9912508,0.0000014762893,0.006583742,0.0017052119,0.00024913112,0.000011623299,0.000014916275,0.00009576158,0.000087331064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962923,0.0006406129,0.00094274076,0.0005072899,0.0009179104,0.00069917075],"domain_scores_gemma":[0.9980939,0.00006724221,0.00021393156,0.00048534517,0.00038553294,0.00075407047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011235172,0.00045146843,0.00077315763,0.0005603034,0.000116705225,0.00008471204,0.00013445788,0.00006656834,0.00011733205],"category_scores_gemma":[0.0002821536,0.0003373198,0.00019718014,0.0006192927,0.000056103523,0.00023016293,0.00006497511,0.00062465225,0.00013103077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009978948,0.0007103434,0.9565789,0.000091385984,0.0001911399,0.0005190507,0.00043692777,0.0010088531,0.00049800077,0.000005435726,0.038735956,0.00022607847],"study_design_scores_gemma":[0.008092982,0.0073342924,0.9422864,0.0020426395,0.00017243273,0.00006787468,0.00009646187,0.00003305889,0.0015018979,0.0000015143168,0.038011443,0.0003590221],"about_ca_topic_score_codex":0.000011107062,"about_ca_topic_score_gemma":0.0001684294,"teacher_disagreement_score":0.017208733,"about_ca_system_score_codex":0.00038267975,"about_ca_system_score_gemma":0.0002794502,"threshold_uncertainty_score":0.9999079},"labels":[],"label_agreement":null},{"id":"W2112835310","doi":"10.1093/eurjhf/hfs011","title":"FT011, a New Anti-Fibrotic Drug, Attenuates Fibrosis and Chronic Heart Failure in Experimental Diabetic Cardiomyopathy","year":2012,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Fibrosis; Heart failure; Diabetic cardiomyopathy; Internal medicine; Ejection fraction; Cardiology; Cardiac fibrosis; Muscle hypertrophy; Cardiomyopathy; Preload; Masson's trichrome stain; Left ventricular hypertrophy; Hypertensive heart disease; Endocrinology; Blood pressure; Hemodynamics","score_opus":0.009388455953061255,"score_gpt":0.23938391358171585,"score_spread":0.2299954576286546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112835310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569456,0.030235251,0.0000075000517,0.012162632,0.00022632473,0.00026932516,0.0000069474117,0.000029930252,0.000116495314],"genre_scores_gemma":[0.99373794,0.00005857646,0.0036290952,0.00064829324,0.0016962624,0.0000022092538,0.000009047689,0.00007669283,0.00014185857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758816,0.00039629667,0.0006374477,0.00026576646,0.00042428036,0.0006880808],"domain_scores_gemma":[0.9982432,0.00008355147,0.00016878197,0.00032377016,0.00007322285,0.0011074836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007425427,0.00032404505,0.0007554647,0.00029130664,0.0000904225,0.00007253752,0.00013142909,0.000051425806,0.0003648109],"category_scores_gemma":[0.000120253746,0.0002718431,0.000319806,0.00026765434,0.00012677361,0.0004586853,0.000116120566,0.00048199744,0.0001740945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010941552,0.00034095818,0.48251218,0.00026980237,0.00014124061,0.00015857327,0.0012244697,0.000016561118,0.17824765,0.000010437847,0.3365204,0.00044830644],"study_design_scores_gemma":[0.012250733,0.0018634312,0.47780663,0.003019461,0.00047506418,0.0019572508,0.002302323,0.000032240216,0.08006534,0.000014425507,0.4194667,0.000746399],"about_ca_topic_score_codex":0.000012337037,"about_ca_topic_score_gemma":0.0000033852702,"teacher_disagreement_score":0.09818231,"about_ca_system_score_codex":0.0001854627,"about_ca_system_score_gemma":0.00037982565,"threshold_uncertainty_score":0.99997336},"labels":[],"label_agreement":null},{"id":"W2115305066","doi":"10.1016/j.ejheart.2007.12.010","title":"Heart Failure with Preserved Ejection Fraction: Clinical Characteristics of 4133 Patients Enrolled in the I-PRESERVE Trial","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"University of Hull","keywords":"Heart failure; Medicine; Ejection fraction; Cardiology; Internal medicine; Clinical trial; Stroke volume","score_opus":0.03835795492669395,"score_gpt":0.2901750026843425,"score_spread":0.2518170477576485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115305066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97477764,0.00004062761,0.000084616375,0.023308758,0.00032287592,0.0010536531,0.000004672641,0.000018319613,0.0003888497],"genre_scores_gemma":[0.9899974,0.000036293284,0.008154218,0.0005155219,0.0009789695,0.000006968202,0.000020243868,0.000038915714,0.00025145285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957096,0.001519039,0.0013784667,0.00024567355,0.0008576693,0.00028954635],"domain_scores_gemma":[0.99805254,0.00024501266,0.00059811765,0.00047567568,0.00044448796,0.00018416035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002278549,0.00024455646,0.0008293503,0.00024261643,0.0001357654,0.000031544412,0.00022105352,0.00007543327,0.00018534728],"category_scores_gemma":[0.0004323516,0.00014493875,0.00038173737,0.00037257935,0.00013878423,0.0002910024,0.00005918109,0.000824975,0.000055868357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022211485,0.0022301313,0.6849707,0.00006310964,0.00026885598,0.0005319882,0.00031933034,0.000008395681,0.00010802413,0.000006560616,0.28904992,0.00023152483],"study_design_scores_gemma":[0.04355309,0.007279665,0.5557877,0.00021704474,0.00017248695,0.00023160776,0.00032430686,0.000009946435,0.000046933055,0.0000022349893,0.39225766,0.00011734167],"about_ca_topic_score_codex":0.000011438931,"about_ca_topic_score_gemma":0.000016400114,"teacher_disagreement_score":0.129183,"about_ca_system_score_codex":0.000052919382,"about_ca_system_score_gemma":0.00015254061,"threshold_uncertainty_score":0.59104306},"labels":[],"label_agreement":null},{"id":"W2116480815","doi":"10.1002/ejhf.151","title":"Effects of Person-Centred and Integrated Chronic Heart Failure and Palliative Home Care. PREFER: A Randomized Controlled Study","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sveriges Kommuner och Landsting; Riksförbundet HjärtLung","keywords":"Medicine; Quality of life (healthcare); Heart failure; Nausea; Randomized controlled trial; Palliative care; Internal medicine; Physical therapy; Pediatrics; Nursing","score_opus":0.008603776320727785,"score_gpt":0.2287235967737326,"score_spread":0.22011982045300482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116480815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756563,0.006478883,0.00019804518,0.01336014,0.00015615181,0.0039869454,0.0000029446492,0.00004056564,0.00012007882],"genre_scores_gemma":[0.9937565,0.00014115816,0.005386039,0.00018219842,0.0002385217,0.00001995005,0.000005136527,0.000051146282,0.0002193915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955439,0.0024588916,0.00086127303,0.00032158176,0.0004803152,0.0003340228],"domain_scores_gemma":[0.99791545,0.00066972437,0.0004440171,0.00023986482,0.00038895567,0.00034200004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001580954,0.00039535304,0.0025103518,0.0003332115,0.00010743697,0.00006502582,0.0000954241,0.000053761534,0.000056200337],"category_scores_gemma":[0.0005603001,0.0002446916,0.0004244797,0.00017683735,0.00019793728,0.00013768692,0.00006564691,0.00044204493,0.000013743799],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46633187,0.0062153745,0.13056742,0.0064983983,0.02405738,0.002758791,0.073779546,0.000054622393,0.05486895,0.00042214873,0.22343343,0.011012073],"study_design_scores_gemma":[0.8593601,0.010541469,0.028137116,0.0017290532,0.00378794,0.00021254379,0.008762335,0.00015761358,0.00090640056,0.00000910611,0.086012736,0.0003835894],"about_ca_topic_score_codex":0.000016992004,"about_ca_topic_score_gemma":0.000026593596,"teacher_disagreement_score":0.39302823,"about_ca_system_score_codex":0.000083748055,"about_ca_system_score_gemma":0.000113938884,"threshold_uncertainty_score":0.99782336},"labels":[],"label_agreement":null},{"id":"W2118046716","doi":"10.1016/s1388-9842(03)00052-7","title":"Clinical Features and Contemporary Management of Patients with Low and Preserved Ejection Fraction Heart Failure: Baseline Characteristics of Patients in the Candesartan in Heart failure—Assessment of Reduction in Mortality and Morbidity (CHARM) Programme","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; McMaster University Medical Centre","funders":"AstraZeneca","keywords":"Candesartan; Heart failure; Ejection fraction; Medicine; Spironolactone; Charm (quantum number); Internal medicine; Cardiology; ACE inhibitor; Placebo; Digoxin; Angiotensin-converting enzyme; Angiotensin II; Blood pressure; Pathology","score_opus":0.034271071534385376,"score_gpt":0.3100883476668761,"score_spread":0.27581727613249074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118046716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511105,0.000114801296,0.000035314148,0.0032876371,0.00007951219,0.0013227483,0.000016548649,0.00000535933,0.000027052418],"genre_scores_gemma":[0.9900921,0.00010581013,0.009614558,0.00006233416,0.000042137566,0.000009065873,0.000043232125,0.000021716316,0.000009061745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963312,0.001324017,0.0012792672,0.0003005367,0.0005387221,0.00022625955],"domain_scores_gemma":[0.99867374,0.00009158201,0.00058283313,0.00025780615,0.0002637229,0.00013032419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003179853,0.00023295854,0.0007505968,0.00030265158,0.000040947023,0.000025842917,0.00006124799,0.00006847167,0.000010073473],"category_scores_gemma":[0.00011462487,0.00016399265,0.0000824485,0.00032142317,0.00016473855,0.00028999444,0.00004661729,0.0004957811,1.9543958e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006230704,0.0017727723,0.99283487,0.00050905364,0.00012029356,0.00003108618,0.00015215199,0.0000057099996,0.000133891,0.000017930055,0.003402178,0.00039699138],"study_design_scores_gemma":[0.007035054,0.0021293631,0.9804042,0.00084062555,0.00012518752,0.000020745283,0.0010079473,0.000021942078,0.00010897247,0.000007805026,0.008180572,0.00011758349],"about_ca_topic_score_codex":0.00018546885,"about_ca_topic_score_gemma":0.0002972924,"teacher_disagreement_score":0.012430669,"about_ca_system_score_codex":0.00006597235,"about_ca_system_score_gemma":0.000076511446,"threshold_uncertainty_score":0.6687426},"labels":[],"label_agreement":null},{"id":"W2121203580","doi":"10.1016/j.ejheart.2008.04.004","title":"Human Angiogenic Cell Precursors Restore Function in the Infarcted Rat Heart: A Comparison of Cell Delivery Routes","year":2008,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Angiogenesis; Cardiac function curve; Cardiology; Internal medicine; Artery; Neovascularization; Myocardial infarction; Aorta; Ligation; Cardiomyopathy; Heart failure","score_opus":0.01854646662836058,"score_gpt":0.24807430194832616,"score_spread":0.2295278353199656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121203580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936983,0.0052780416,0.000060887105,0.00044474928,0.00012061759,0.00009675456,0.000004523234,0.0000030436265,0.0002930713],"genre_scores_gemma":[0.998158,0.00010096129,0.00091438426,0.00027454668,0.0003436338,0.0000010884261,0.000013306871,0.000025214724,0.00016886764],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984275,0.00052601134,0.0004895583,0.00015633959,0.0002205962,0.0001799887],"domain_scores_gemma":[0.99923766,0.000016726382,0.00028091864,0.00024541444,0.00015920188,0.00006009062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050830044,0.0001421099,0.00023155054,0.00008884082,0.00011538887,0.000013202515,0.00024202823,0.000057037145,0.000035381476],"category_scores_gemma":[0.0000154727,0.000104844534,0.00027577314,0.00014915016,0.00008926699,0.000010793281,0.000048538022,0.00019447315,0.000009584727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013750342,0.00017339044,0.06324922,0.000018488547,0.000024875837,0.000017609895,0.00046952598,0.00032422965,0.7837904,0.0000015838013,0.1517338,0.00005933169],"study_design_scores_gemma":[0.0016518334,0.0027525797,0.1703017,0.0000799069,0.00007537228,0.00022393891,0.0010420695,0.000012759992,0.32697836,0.0000034068503,0.496617,0.00026107367],"about_ca_topic_score_codex":0.00000934853,"about_ca_topic_score_gemma":0.00002060802,"teacher_disagreement_score":0.45681208,"about_ca_system_score_codex":0.000012618658,"about_ca_system_score_gemma":0.00007164111,"threshold_uncertainty_score":0.42754358},"labels":[],"label_agreement":null},{"id":"W2123768025","doi":"10.1002/ejhf.221","title":"Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Ejection fraction; Angina; Myocardial infarction; Unstable angina; Hazard ratio; Revascularization; Canadian Cardiovascular Society; Confidence interval","score_opus":0.05327742388971013,"score_gpt":0.337200267779279,"score_spread":0.28392284388956884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123768025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735317,0.00008728345,0.000009269806,0.02546853,0.000068279005,0.000797516,0.000009579006,0.0000066325574,0.000021167638],"genre_scores_gemma":[0.98686165,0.00003789629,0.012798351,0.00016050827,0.000084513646,0.000005391133,0.000014642618,0.000024522104,0.000012502455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970489,0.0007710908,0.0010825137,0.00027854834,0.0005224586,0.00029646893],"domain_scores_gemma":[0.9988505,0.00009117304,0.00035290816,0.00026682223,0.0002062001,0.00023235111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031514294,0.00024690243,0.0009224763,0.00035257687,0.000031021842,0.000038398037,0.00008177979,0.00006735629,0.000007145511],"category_scores_gemma":[0.00015296238,0.00015749899,0.000083306484,0.00032274876,0.00023221002,0.00023585529,0.00007012957,0.0005726709,6.5127966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019273594,0.00077874766,0.99392664,0.00012613756,0.0000800411,0.00008180538,0.0006230436,0.0000022537754,0.000099484365,0.00003144407,0.003479177,0.00057846005],"study_design_scores_gemma":[0.005911518,0.0023044099,0.9622263,0.00037680814,0.0001160712,0.00010730043,0.001488009,0.000018367982,0.000013752235,0.000010596644,0.0273005,0.00012640687],"about_ca_topic_score_codex":0.00007835955,"about_ca_topic_score_gemma":0.0003946575,"teacher_disagreement_score":0.03170041,"about_ca_system_score_codex":0.000058281734,"about_ca_system_score_gemma":0.00013164364,"threshold_uncertainty_score":0.6422622},"labels":[],"label_agreement":null},{"id":"W2123882027","doi":"10.1002/ejhf.240","title":"Loss in Body Weight is an Independent Prognostic Factor for Mortality in Chronic Heart Failure: Insights from the GISSI-HF and Val-HeFT Trials","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Seventh Framework Programme; European Commission; AstraZeneca; Pfizer","keywords":"Medicine; Heart failure; Internal medicine; Cardiology","score_opus":0.05513646312186674,"score_gpt":0.3044755468545813,"score_spread":0.24933908373271454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123882027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855753,0.0026728294,0.00024036273,0.010031764,0.0005279364,0.00087222323,0.00004268348,0.000018493853,0.000018393945],"genre_scores_gemma":[0.99686706,0.0000966637,0.0009924212,0.00053480384,0.0013897988,0.0000047541207,0.000018221584,0.000050556893,0.00004570066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955645,0.0019958112,0.0010916694,0.00034524046,0.0006992698,0.0003034967],"domain_scores_gemma":[0.99823445,0.0003148197,0.00030897703,0.00043134275,0.00024989253,0.0004605266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003544459,0.0002750396,0.0010222847,0.00022550498,0.00008006729,0.000094349234,0.00016427552,0.00010248417,0.00012409454],"category_scores_gemma":[0.0009198172,0.00016159662,0.00046681246,0.00023025453,0.00009955752,0.00029368032,0.00005952175,0.00078983884,0.000024594538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007981742,0.0002969188,0.9469785,0.000060043607,0.00056621863,0.0004884076,0.0040603373,0.00004635914,0.0055699507,0.000013497458,0.04013871,0.0009828507],"study_design_scores_gemma":[0.006907756,0.0008259879,0.6646406,0.00025526987,0.00020219978,0.00030902747,0.00059819827,0.000056176752,0.00068941317,0.000045265882,0.32531428,0.00015578176],"about_ca_topic_score_codex":0.0000904991,"about_ca_topic_score_gemma":0.00046972235,"teacher_disagreement_score":0.2851756,"about_ca_system_score_codex":0.00020957664,"about_ca_system_score_gemma":0.00049730507,"threshold_uncertainty_score":0.6589719},"labels":[],"label_agreement":null},{"id":"W2125452996","doi":"10.1002/ejhf.256","title":"Impact of Surgical Ventricular Reconstruction on Sphericity Index in Patients with Ischaemic Cardiomyopathy: Follow-Up from the STICH Trial","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Cardiology; Hazard ratio; Internal medicine; Ischemic cardiomyopathy; Confidence interval; Ejection fraction; Heart failure; Sphericity; Artery; Randomized controlled trial","score_opus":0.013218428898313128,"score_gpt":0.23243854718599682,"score_spread":0.2192201182876837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125452996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979734,0.00011682648,0.00012655985,0.00026927562,0.0011499322,0.0002719402,0.00000894764,0.0000068759696,0.0000762671],"genre_scores_gemma":[0.9988563,0.000011606925,0.00015554744,0.000021844657,0.00091023534,3.6895935e-7,0.000008541666,0.000021099346,0.00001445575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790716,0.0007242959,0.0004440377,0.00013221292,0.00065210945,0.0001401594],"domain_scores_gemma":[0.99896026,0.00006295071,0.00024850474,0.0002415292,0.00030293872,0.0001838297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009971505,0.00014012158,0.0004963653,0.00009840594,0.000030346258,0.000015847452,0.00007748703,0.00004141211,0.000057434092],"category_scores_gemma":[0.00017858797,0.00007166608,0.00054139737,0.00027271477,0.00005658253,0.00008450057,0.00001967364,0.0004905132,0.00001182974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03691331,0.00015091899,0.94981694,0.000002913435,0.00041198096,0.00025126198,0.00015988837,0.0009055749,0.0000092269165,4.5808915e-7,0.009427714,0.0019498349],"study_design_scores_gemma":[0.081098296,0.00372844,0.8935518,0.0001896222,0.00020415647,0.0004626657,0.00021960611,0.000013110541,0.00002162773,0.0000019202716,0.020416657,0.00009209542],"about_ca_topic_score_codex":0.000078426296,"about_ca_topic_score_gemma":0.0000048784036,"teacher_disagreement_score":0.056265116,"about_ca_system_score_codex":0.00012866572,"about_ca_system_score_gemma":0.00019963532,"threshold_uncertainty_score":0.29224578},"labels":[],"label_agreement":null},{"id":"W2127749568","doi":"10.1002/ejhf.327","title":"Characterization of Subgroups of Heart Failure Patients with Preserved Ejection Fraction with Possible Implications for Prognosis and Treatment Response","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Heart, Lung, and Blood Institute; Sanofi; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Irbesartan; Heart failure; Internal medicine; Cardiology; Heart failure with preserved ejection fraction; Candesartan; Ejection fraction; Atrial fibrillation; Subgroup analysis; Placebo; Diabetes mellitus; Blood pressure; Angiotensin II; Meta-analysis; Endocrinology","score_opus":0.02019735581278551,"score_gpt":0.2414163846807837,"score_spread":0.22121902886799819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127749568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931408,0.00003710036,0.0019874386,0.0040902123,0.000052401752,0.00064180646,0.00002910812,0.000013078528,0.000008042359],"genre_scores_gemma":[0.99335045,0.0000134320635,0.0063615935,0.000027503824,0.00009537901,0.000007709633,0.00005623862,0.0000310125,0.00005669774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988356,0.0002912027,0.00036793723,0.00013994318,0.0002589159,0.00010635856],"domain_scores_gemma":[0.9982303,0.00004301379,0.00036589577,0.00018652584,0.0010124234,0.00016188988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055121025,0.00012801953,0.00036152816,0.00020563784,0.00006131097,0.000017957025,0.000030894138,0.00003468239,0.000006909023],"category_scores_gemma":[0.000085571635,0.000080504346,0.00014318129,0.0002141275,0.000052537474,0.00023744587,0.000008912462,0.00010304932,0.000001009021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008379826,0.00038800167,0.9409442,0.000046600326,0.00030313554,0.0000017635151,0.00021678151,0.000025041169,0.047711805,0.0000021079766,0.0015224988,0.0004582684],"study_design_scores_gemma":[0.005529428,0.00812639,0.92352515,0.00017876376,0.00031849655,0.00012946804,0.00028215733,0.0000065765244,0.010254853,9.0206254e-7,0.051572666,0.000075151926],"about_ca_topic_score_codex":0.000008323875,"about_ca_topic_score_gemma":0.000009284129,"teacher_disagreement_score":0.050050166,"about_ca_system_score_codex":0.000071953495,"about_ca_system_score_gemma":0.00013640578,"threshold_uncertainty_score":0.32828718},"labels":[],"label_agreement":null},{"id":"W2129388952","doi":"10.1002/ejhf.230","title":"Gender-Specific Plasma Proteomic Biomarkers in Patients with Anderson–Fabry disease","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BGC Engineering (Canada); University of British Columbia; University of British Columbia Hospital; Prevention of Organ Failure; Dalhousie University; University of Alberta; Canadian VIGOUR Centre; University of Calgary","funders":"Genome British Columbia; University of Alberta","keywords":"Biomarker; Medicine; Apolipoprotein B; Disease; Internal medicine; Biomarker discovery; Proteomics; Blood proteins; Oncology; Bioinformatics; Endocrinology; Biology; Genetics; Gene","score_opus":0.030771519597618046,"score_gpt":0.25234940106095666,"score_spread":0.22157788146333862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129388952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432355,0.00040934017,0.00010732057,0.003865225,0.00008962716,0.0005046066,0.000004710616,0.000015892205,0.00067971356],"genre_scores_gemma":[0.99554837,0.000008700104,0.0040189805,0.00013588252,0.0001491602,0.0000017208072,0.000009222981,0.00005832163,0.00006963308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765813,0.00043835194,0.00041181175,0.00021752727,0.0009222156,0.0003519366],"domain_scores_gemma":[0.9983694,0.000020783751,0.00015266541,0.00025768875,0.0003957739,0.00080367125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008424306,0.00018220108,0.0003131465,0.0003496899,0.000048529117,0.000048067257,0.00017774779,0.00002738895,0.00009766292],"category_scores_gemma":[0.00017732184,0.00012967175,0.000100381236,0.00034658515,0.00011389837,0.00022705371,0.000054593984,0.00051164697,0.00012793874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074056988,0.0005546081,0.8965949,0.00006852378,0.00013221901,0.002296953,0.0005369288,0.00003059654,0.00023211431,0.000004058678,0.09047069,0.0016727082],"study_design_scores_gemma":[0.017082723,0.002025914,0.9341768,0.00032549768,0.000039513863,0.00020030022,0.0007505691,0.00003610605,0.000062016945,0.000011333303,0.045076706,0.0002125456],"about_ca_topic_score_codex":0.000002502996,"about_ca_topic_score_gemma":0.0000017049653,"teacher_disagreement_score":0.045393985,"about_ca_system_score_codex":0.00017598188,"about_ca_system_score_gemma":0.00032531458,"threshold_uncertainty_score":0.52878606},"labels":[],"label_agreement":null},{"id":"W2149523545","doi":"10.1016/s1388-9842(03)00112-0","title":"VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context","year":2003,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Valsartan; Myocardial infarction; Killip class; Heart failure; Internal medicine; Cardiology; Placebo; Captopril; Context (archaeology); Population; Clinical trial; Blockade; Randomized controlled trial; Ejection fraction; Blood pressure; Pathology","score_opus":0.013737850348693785,"score_gpt":0.26687342039563144,"score_spread":0.25313557004693765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149523545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854941,0.0005381244,0.00027242885,0.010576888,0.001582161,0.00032852637,0.000014265578,0.000018918918,0.0011746334],"genre_scores_gemma":[0.9956607,0.00010437328,0.0019301778,0.001438274,0.00069595495,7.9109077e-7,0.000009625782,0.000040494288,0.000119587436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736685,0.0010196561,0.0008902221,0.0001511206,0.00031556672,0.0002565637],"domain_scores_gemma":[0.9989575,0.00020833782,0.00023369314,0.0002016192,0.00021724375,0.00018156336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030005798,0.0001637725,0.000652276,0.00034528953,0.000030156121,0.00004281699,0.00006226389,0.0000415648,0.00006400602],"category_scores_gemma":[0.00239406,0.00014551339,0.00023736135,0.00027421082,0.000046147812,0.00012972348,0.000015808291,0.00067339983,0.000074261785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020609044,0.0013702859,0.6837391,0.0001056428,0.00046864923,0.012343522,0.002247218,0.00009117539,0.008942378,0.00020302575,0.25864297,0.011236953],"study_design_scores_gemma":[0.053966135,0.0011846873,0.31106934,0.00065390434,0.00025120296,0.0026354878,0.0005548406,0.00002678038,0.00047132486,0.0000169048,0.62892485,0.0002445487],"about_ca_topic_score_codex":0.0000065029394,"about_ca_topic_score_gemma":0.0000059611393,"teacher_disagreement_score":0.3726698,"about_ca_system_score_codex":0.00008650292,"about_ca_system_score_gemma":0.00019360414,"threshold_uncertainty_score":0.59338635},"labels":[],"label_agreement":null},{"id":"W2150965690","doi":"10.1093/eurjhf/hfp058","title":"Patient and Informal Caregivers’ Knowledge of Heart Failure: Necessary but Insufficient for Effective Self-Care","year":2009,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; Medical emergency; Cardiology","score_opus":0.0065413094917652495,"score_gpt":0.23526937678433824,"score_spread":0.22872806729257297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150965690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783846,0.0018361228,0.00017658531,0.017097391,0.00023174993,0.0014502455,0.000018696499,0.000053861353,0.00075071503],"genre_scores_gemma":[0.9734755,0.000031437645,0.025700824,0.00043998123,0.00024693637,0.000005205307,0.000013791223,0.000031942953,0.000054387372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981595,0.00023071468,0.0006699574,0.00023570399,0.00033754267,0.00036655134],"domain_scores_gemma":[0.99840635,0.000101622056,0.0002869806,0.00025776325,0.00061350415,0.00033377946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005091295,0.00029734927,0.0006458067,0.00034435274,0.00015670445,0.000038467937,0.00010278786,0.000059079506,0.000027751556],"category_scores_gemma":[0.00008075306,0.00022923516,0.00033062435,0.00022220783,0.000073433344,0.0002525047,0.00007674308,0.0003235321,0.000021556294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030853602,0.0031682942,0.026270963,0.0018923491,0.0013141708,0.00055504456,0.062418927,0.00011496864,0.012164455,0.00035286637,0.7948373,0.09382532],"study_design_scores_gemma":[0.006103849,0.015690401,0.046874806,0.0006079711,0.0004008808,0.00043989884,0.008705129,0.000029624252,0.003626767,0.0000036621907,0.91727716,0.000239849],"about_ca_topic_score_codex":0.0000032563585,"about_ca_topic_score_gemma":0.0000051028214,"teacher_disagreement_score":0.122439876,"about_ca_system_score_codex":0.000098867196,"about_ca_system_score_gemma":0.00013456581,"threshold_uncertainty_score":0.93479383},"labels":[],"label_agreement":null},{"id":"W2150981376","doi":"10.1002/ejhf.329","title":"August 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Ambulatory; Sinus rhythm; Atrial fibrillation","score_opus":0.028645276839296088,"score_gpt":0.2745122905797047,"score_spread":0.24586701374040865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150981376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88572395,0.013075194,0.00026636105,0.059557807,0.0014648059,0.00020277686,0.000009300921,0.00006611848,0.039633706],"genre_scores_gemma":[0.98609984,0.00006276564,0.006849375,0.0010286784,0.0016881983,3.320322e-7,0.0000016652854,0.00003135313,0.004237776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988644,0.00018703629,0.00031602933,0.00009996272,0.00035413526,0.00017841606],"domain_scores_gemma":[0.99898577,0.000023706873,0.00013546599,0.00018256194,0.00035579273,0.00031672796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010463705,0.00011268348,0.00036020635,0.000078110075,0.000057072786,0.000015402453,0.00007797198,0.000017311653,0.00006441099],"category_scores_gemma":[0.00020759988,0.00008223103,0.00018811521,0.000110730165,0.00006688711,0.0000861083,0.000086701875,0.00025898716,0.0003700725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003229138,0.000034345274,0.011648987,0.000015576761,0.00007182913,0.0014212489,0.0004609225,0.0000057152597,0.0019364632,0.000009436943,0.9836323,0.00044024672],"study_design_scores_gemma":[0.002153176,0.00067668135,0.024814917,0.00014667123,0.000085358035,0.008168639,0.00047012468,0.0000010648553,0.000422818,0.000006820216,0.9629728,0.000080903046],"about_ca_topic_score_codex":0.0000013190411,"about_ca_topic_score_gemma":0.0000018397445,"teacher_disagreement_score":0.10037593,"about_ca_system_score_codex":0.00007244682,"about_ca_system_score_gemma":0.0000841611,"threshold_uncertainty_score":0.47566566},"labels":[],"label_agreement":null},{"id":"W2152288815","doi":"10.1093/eurjhf/hfs156","title":"Association Between Glycated Haemoglobin and the Risk of Congestive Heart Failure in Diabetes Mellitus: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nutrition Society; University of Toronto","funders":"","keywords":"Medicine; Diabetes mellitus; Internal medicine; Meta-analysis; Heart failure; Relative risk; Confidence interval; Type 2 diabetes; Observational study; Epidemiology; Incidence (geometry); Prospective cohort study; Cardiology; Endocrinology","score_opus":0.033796041340464614,"score_gpt":0.2959325925593776,"score_spread":0.262136551218913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152288815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003470728,0.9905821,0.000008128447,0.007202796,0.000034277895,0.0016459948,0.00015032134,0.0000068357635,0.000022466958],"genre_scores_gemma":[0.008711974,0.98993444,0.00064672786,0.00039080888,0.0001113581,0.000023843144,0.00003870664,0.000045237026,0.0000968947],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9914589,0.004787539,0.002577832,0.00027928347,0.00055127114,0.0003451651],"domain_scores_gemma":[0.9945691,0.0020833267,0.0021511628,0.00039802474,0.0005330263,0.00026535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069598695,0.0004737266,0.010759332,0.0003444256,0.00007734442,0.00004650793,0.00019449902,0.00017476192,0.000085527565],"category_scores_gemma":[0.0020637407,0.00023649834,0.0023873074,0.0006239105,0.00018751629,0.00012471752,0.00008225183,0.0011544995,0.00001359462],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008972571,0.0001686171,0.010261959,0.6161124,0.36701092,0.00004519533,0.00046756404,8.661746e-7,9.116515e-7,0.000037176316,0.003972502,0.0018321727],"study_design_scores_gemma":[0.0014986119,0.00024237012,0.00029044627,0.03430079,0.829453,0.000081689606,0.000048249967,0.0000014918937,3.435503e-7,0.000007705389,0.13388367,0.00019163293],"about_ca_topic_score_codex":0.000011574627,"about_ca_topic_score_gemma":0.00000761675,"teacher_disagreement_score":0.5818116,"about_ca_system_score_codex":0.00007694573,"about_ca_system_score_gemma":0.00008765624,"threshold_uncertainty_score":0.9644122},"labels":[],"label_agreement":null},{"id":"W2154633592","doi":"10.1016/s1388-9842(00)80279-2","title":"Percutaneous Myocardial Revascularisation (PMR). One year Follow Up","year":2000,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Emergency department; Citation; Internal medicine; Library science; Cardiology; Psychiatry; Computer science","score_opus":0.00944038156183929,"score_gpt":0.2153946972152782,"score_spread":0.2059543156534389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154633592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835177,0.0005874227,0.000013469019,0.009555108,0.00050461636,0.0001297765,0.0000041648964,0.000033807908,0.005653946],"genre_scores_gemma":[0.9866978,0.00018004653,0.0071980697,0.00061682943,0.0021932425,1.3113882e-7,0.0000067484893,0.00003819537,0.003068971],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985894,0.00024041046,0.00040390057,0.00014064212,0.00043119438,0.00019444957],"domain_scores_gemma":[0.9993105,0.000020712092,0.0000959273,0.00021654612,0.00015599257,0.00020035192],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045763174,0.00013568449,0.00040001736,0.000074704476,0.00009814808,0.000035567955,0.000075165844,0.000040572053,0.0017594527],"category_scores_gemma":[0.00005216041,0.00009999631,0.00067689846,0.00011214922,0.00005614355,0.000085357606,0.000017868255,0.00036820714,0.0003809687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004239338,0.00023650739,0.022359021,0.00023879521,0.0024528052,0.0074772486,0.0032882607,0.00039059427,0.077025406,0.00011065566,0.7546301,0.12755129],"study_design_scores_gemma":[0.0019445118,0.0008874435,0.07892738,0.00018573522,0.00031723417,0.017699642,0.00023720103,0.0000080528835,0.0002383756,0.000018740444,0.89937425,0.00016145919],"about_ca_topic_score_codex":0.0000055082837,"about_ca_topic_score_gemma":0.0000010135651,"teacher_disagreement_score":0.14474414,"about_ca_system_score_codex":0.000044675624,"about_ca_system_score_gemma":0.00005654781,"threshold_uncertainty_score":0.9991531},"labels":[],"label_agreement":null},{"id":"W2159004384","doi":"10.1093/eurjhf/hfq017","title":"Interleukin-1β Modulation Using a Genetically Engineered Antibody Prevents Adverse Cardiac Remodelling Following Acute Myocardial Infarction in the Mouse","year":2010,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Heart Association","keywords":"Medicine; Myocardial infarction; Genetically engineered; Heart failure; Cardiology; Adverse effect; Internal medicine; Gene","score_opus":0.012456985015622176,"score_gpt":0.26921275723935967,"score_spread":0.25675577222373747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159004384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915716,0.0001129002,0.006177074,0.00091408816,0.00087174284,0.00026119594,0.0000029901892,0.000015550524,0.00007284168],"genre_scores_gemma":[0.9653769,0.000035170797,0.033319898,0.00013006422,0.0010632254,4.1890365e-7,0.000011316699,0.00004872005,0.000014254066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980048,0.00039040289,0.0006587959,0.00018565259,0.0005038617,0.00025647733],"domain_scores_gemma":[0.99922925,0.000040272585,0.00017161884,0.00028520607,0.0001455348,0.00012813495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019252668,0.00018354821,0.00042827846,0.00024533528,0.000098865625,0.000055496337,0.0001304045,0.00007053726,0.000005680773],"category_scores_gemma":[0.000083745945,0.00013241761,0.0008189812,0.0002146818,0.000027975962,0.0002318386,0.000042177082,0.000932923,0.0000066092816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013634539,0.000047724458,0.007401615,0.000016392449,0.00027254337,0.0000820146,0.0008116873,0.027609866,0.9627352,0.0000062100576,0.00023726419,0.000643191],"study_design_scores_gemma":[0.017095538,0.002435813,0.56140023,0.0033916144,0.0052884123,0.008141158,0.0030946587,0.3146737,0.018995017,0.00010511511,0.063451715,0.0019270652],"about_ca_topic_score_codex":0.0000069667626,"about_ca_topic_score_gemma":9.626743e-7,"teacher_disagreement_score":0.9437401,"about_ca_system_score_codex":0.000053276024,"about_ca_system_score_gemma":0.00008172957,"threshold_uncertainty_score":0.53998333},"labels":[],"label_agreement":null},{"id":"W2160949390","doi":"10.1093/eurjhf/hft101","title":"Known and Missing Left Ventricular Ejection Fraction and Survival in Patients with Heart Failure: A MAGGIC Meta-Analysis Report","year":2013,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates; National Heart Foundation of New Zealand; University of Glasgow","keywords":"Medicine; Heart failure; Hazard ratio; Ejection fraction; Internal medicine; Cardiology; Confidence interval; Observational study; COPD; Stroke volume; Stroke (engine)","score_opus":0.03825412464651494,"score_gpt":0.2902163983770944,"score_spread":0.25196227373057944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160949390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032193544,0.98535424,0.00036180922,0.008879814,0.00016394354,0.0018623183,0.0000082093975,0.000039778755,0.00011049878],"genre_scores_gemma":[0.017261514,0.8535146,0.1227668,0.00058592146,0.0015652039,0.000053017982,0.0006267449,0.00064514944,0.0029810467],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958147,0.0011794317,0.00139486,0.00054059754,0.00072414184,0.00034628104],"domain_scores_gemma":[0.9978328,0.00010293633,0.0009831749,0.00043090282,0.00029955787,0.00035067077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017969375,0.0005763915,0.0037218402,0.0012144123,0.00012259695,0.0001722499,0.00007668342,0.00012240077,0.00028208055],"category_scores_gemma":[0.00010133926,0.00035354935,0.0011754745,0.0006921401,0.00006674927,0.00034987598,0.00007366829,0.0008265422,0.00003597262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006255229,0.003331873,0.26720896,0.01922752,0.3513952,0.019938566,0.0003362847,0.000036383582,0.000011142032,0.000022147702,0.1716684,0.16619799],"study_design_scores_gemma":[0.0010944421,0.00062178506,0.0075276108,0.001004724,0.1274071,0.0017433496,0.00004185984,0.0000019019946,4.897094e-7,0.0000015427414,0.8602992,0.00025596863],"about_ca_topic_score_codex":0.000021716533,"about_ca_topic_score_gemma":0.00002044676,"teacher_disagreement_score":0.6886308,"about_ca_system_score_codex":0.00015136693,"about_ca_system_score_gemma":0.00011687321,"threshold_uncertainty_score":0.99989164},"labels":[],"label_agreement":null},{"id":"W2165965342","doi":"10.1002/ejhf.168","title":"Systolic Blood Pressure and Mortality in Patients with Atrial Fibrillation and Heart Failure: Insights from the AFFIRM and AF-CHF Studies","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Libin Cardiovascular Institute of Alberta; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal","keywords":"Medicine; Hazard ratio; Cardiology; Internal medicine; Heart failure; Blood pressure; Ejection fraction; Atrial fibrillation; Confidence interval; Proportional hazards model; Post-hoc analysis; Prospective cohort study","score_opus":0.023230900804371565,"score_gpt":0.26560979692648196,"score_spread":0.2423788961221104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165965342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98555654,0.0050700167,0.000010543688,0.008901894,0.00010332138,0.00032278095,0.0000033438575,0.000011096952,0.000020447565],"genre_scores_gemma":[0.99712235,0.00010100774,0.0013394974,0.00014341818,0.0012486521,6.8128585e-8,0.0000046611135,0.000018558352,0.000021806301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985221,0.000459333,0.00040457436,0.00018232525,0.00031086485,0.000120796205],"domain_scores_gemma":[0.999145,0.00024895495,0.00022240393,0.00015552866,0.000128544,0.000099595105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053647306,0.00015956082,0.00044889297,0.000087138775,0.00012034983,0.00006555542,0.000040189567,0.000030472625,0.0000058679357],"category_scores_gemma":[0.0002419959,0.00009128797,0.000064240245,0.00010892897,0.00011054109,0.00020805864,0.00007378755,0.0001815349,0.0000019321164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028472752,0.0000040336913,0.996511,0.000053188567,0.0004198165,0.0000072824682,0.00065401796,0.00004543619,0.00006668059,0.000054843138,0.001638008,0.00026097492],"study_design_scores_gemma":[0.004829559,0.00054484105,0.90537816,0.00024339619,0.000745452,0.000024056597,0.00024245256,0.000027988557,0.000010671511,0.000044150038,0.087815225,0.0000940454],"about_ca_topic_score_codex":0.0000103073935,"about_ca_topic_score_gemma":0.000043785036,"teacher_disagreement_score":0.09113283,"about_ca_system_score_codex":0.0000056574127,"about_ca_system_score_gemma":0.000014605535,"threshold_uncertainty_score":0.37226155},"labels":[],"label_agreement":null},{"id":"W2171278381","doi":"10.1002/ejhf.186","title":"Worsening Heart Failure, a Critical Event During Hospital Admission for Acute Heart Failure: Results from the VERITAS Study","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Actelion Pharmaceuticals; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Hazard ratio; Confidence interval; Internal medicine; Clinical endpoint; Randomization; Proportional hazards model; Cardiology; Randomized controlled trial; Odds ratio","score_opus":0.01355176577315233,"score_gpt":0.2868927392104628,"score_spread":0.2733409734373105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171278381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.620569,0.00019990483,0.000824985,0.37585235,0.00081645476,0.00151874,0.000048483522,0.0001129249,0.000057171103],"genre_scores_gemma":[0.923648,0.000007799603,0.07223912,0.0011352429,0.002459591,0.000020225909,0.000039807852,0.00013360038,0.00031663434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946787,0.0011775413,0.001493606,0.00070558133,0.0010889614,0.00085563096],"domain_scores_gemma":[0.996563,0.0009413296,0.00033298272,0.0009168017,0.00046263324,0.000783227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002846834,0.0005793859,0.0010628435,0.00023753775,0.0006586115,0.00025291563,0.0003881479,0.000097159376,0.00015968458],"category_scores_gemma":[0.0019036741,0.00038907304,0.0007420714,0.0003281662,0.00014005818,0.0004145287,0.0002607006,0.0009861552,0.00022931103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002249328,0.0014778461,0.013003736,0.00006541389,0.0010617106,0.0006149675,0.0022142266,0.000036085432,0.007884151,0.00005559692,0.97086984,0.00046711066],"study_design_scores_gemma":[0.012559994,0.006789973,0.05068726,0.0009454861,0.0012409457,0.00054888905,0.0031649193,0.00006348607,0.001319887,0.000035341753,0.922189,0.00045483757],"about_ca_topic_score_codex":0.000023379058,"about_ca_topic_score_gemma":0.000035747507,"teacher_disagreement_score":0.37471712,"about_ca_system_score_codex":0.00013727644,"about_ca_system_score_gemma":0.00014213161,"threshold_uncertainty_score":0.9998561},"labels":[],"label_agreement":null},{"id":"W2171604827","doi":"10.1093/eurjhf/hfr030","title":"Predictors of Clinical Outcomes in Elderly Patients with Heart Failure","year":2011,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Covenant Health; University of Alberta","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Myocardial infarction; Cardiology; Ejection fraction; Cohort; Diabetes mellitus; Framingham Risk Score; Population; Heart failure with preserved ejection fraction; Coronary artery disease; Body mass index; Disease","score_opus":0.028648483711176464,"score_gpt":0.2773559030327709,"score_spread":0.24870741932159446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171604827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955625,0.000043190892,0.0000568014,0.008878644,0.0002674755,0.000466248,0.0000056386752,0.000025370577,0.00070038403],"genre_scores_gemma":[0.9517197,0.00000871468,0.047342215,0.0003626947,0.00017253819,0.0000015602906,0.000006252741,0.000051113646,0.00033518864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968617,0.00050403713,0.0014298941,0.0002484901,0.00061923283,0.00033664572],"domain_scores_gemma":[0.9984052,0.00008897365,0.00044782634,0.00038716287,0.000323934,0.00034689688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013499005,0.00026717613,0.0010084145,0.00034531814,0.000037745056,0.000013409094,0.00017091319,0.00006483719,0.0003050602],"category_scores_gemma":[0.00018252597,0.00016978737,0.00037548383,0.00024535108,0.00016616489,0.00023604404,0.00006197093,0.0005716994,0.000078710764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000574421,0.0011574675,0.9204949,0.000040965693,0.00029246847,0.00020122906,0.0003469621,0.0000013933535,0.000022628252,0.000020159217,0.0763779,0.00046949572],"study_design_scores_gemma":[0.006062582,0.0054910574,0.76007175,0.0002886644,0.00017453695,0.000042250125,0.00020784214,4.92062e-7,0.000066123604,0.0000038761395,0.22747478,0.000116033894],"about_ca_topic_score_codex":0.000013510337,"about_ca_topic_score_gemma":0.000038640734,"teacher_disagreement_score":0.16042316,"about_ca_system_score_codex":0.000031395608,"about_ca_system_score_gemma":0.00012588273,"threshold_uncertainty_score":0.6923728},"labels":[],"label_agreement":null},{"id":"W2195523276","doi":"10.1002/ejhf.448","title":"December 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Ejection fraction; Internal medicine; Obstructive sleep apnea; Sleep apnea; Heart failure with preserved ejection fraction","score_opus":0.04986708162951074,"score_gpt":0.33756445436855903,"score_spread":0.2876973727390483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195523276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86966866,0.000953277,0.000963611,0.10963919,0.00037258587,0.00019279338,0.0000072292582,0.000048103793,0.018154524],"genre_scores_gemma":[0.91683143,0.000022419403,0.07563061,0.002582139,0.0011328232,8.43507e-7,0.0000050844787,0.00004021779,0.003754404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986725,0.00017318926,0.0005127503,0.00011953045,0.0003593346,0.00016270409],"domain_scores_gemma":[0.99845016,0.0001418024,0.00020193859,0.00028714392,0.00041559275,0.0005033802],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011238919,0.00009728326,0.00026456773,0.000051157,0.000042763808,0.000016800761,0.00013990377,0.000027056545,0.00034749001],"category_scores_gemma":[0.00071203406,0.00007138848,0.00013870173,0.00013894145,0.000082009276,0.00008441719,0.000052450672,0.0003856585,0.001965017],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014707433,0.000104455576,0.029488528,0.0000064774267,0.000032084503,0.000095583804,0.00012012384,0.000007744068,0.0035287912,0.00003430366,0.96620804,0.00022677396],"study_design_scores_gemma":[0.0016530193,0.00054842455,0.029457506,0.000070951886,0.00004846306,0.0027560967,0.00006925954,0.000005285284,0.00031481,0.00009010323,0.96491474,0.000071367525],"about_ca_topic_score_codex":8.1139495e-7,"about_ca_topic_score_gemma":0.000003950584,"teacher_disagreement_score":0.10705705,"about_ca_system_score_codex":0.00007175467,"about_ca_system_score_gemma":0.00012085598,"threshold_uncertainty_score":0.9988121},"labels":[],"label_agreement":null},{"id":"W2199198784","doi":"10.1002/ejhf.429","title":"October 2015 at a glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Ejection fraction; Heart failure with preserved ejection fraction; Insulin resistance; Insulin","score_opus":0.018310593119618926,"score_gpt":0.26155478076720556,"score_spread":0.24324418764758665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199198784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8423665,0.008867827,0.00016703455,0.10849792,0.0010317896,0.00016428826,0.000003804408,0.00005687007,0.03884397],"genre_scores_gemma":[0.98542696,0.000061891034,0.005836973,0.0017475438,0.00060336513,1.7359888e-7,0.000003159221,0.000041229312,0.00627873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998856,0.00018553965,0.0003295022,0.00009533785,0.00033853555,0.00019504981],"domain_scores_gemma":[0.998991,0.000015233222,0.0001483564,0.0001706064,0.0002251585,0.00044962336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006877889,0.000109267305,0.00024728253,0.00009362347,0.000041174466,0.000013539875,0.00009249581,0.00003474768,0.00017774306],"category_scores_gemma":[0.00013899709,0.0000741467,0.00013686829,0.00012105563,0.00005972339,0.00008911532,0.000041843294,0.00039011714,0.0009376655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026603363,0.000072675146,0.010551074,0.000011430314,0.000057762787,0.0009002608,0.00033892182,0.000025648564,0.0028759935,0.000007746577,0.98453754,0.0003548832],"study_design_scores_gemma":[0.003407869,0.0006166255,0.012994768,0.0001399105,0.000067824025,0.0046748556,0.00021741424,0.000011438053,0.00022188961,0.0000150795295,0.9775445,0.000087824046],"about_ca_topic_score_codex":0.0000013829684,"about_ca_topic_score_gemma":0.0000017662737,"teacher_disagreement_score":0.14306045,"about_ca_system_score_codex":0.000055638295,"about_ca_system_score_gemma":0.00012667743,"threshold_uncertainty_score":0.9998402},"labels":[],"label_agreement":null},{"id":"W2201672233","doi":"10.1002/ejhf.434","title":"Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Trial Design","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Heart failure; Ejection fraction; Clinical endpoint; Internal medicine; Stem cell; Cardiology; Clinical trial; Adverse effect; Ischemic cardiomyopathy","score_opus":0.11510254187912099,"score_gpt":0.3264331297225425,"score_spread":0.2113305878434215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201672233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8406676,0.007509515,0.0077768215,0.13251327,0.0020352998,0.004068216,0.000018570154,0.00014426575,0.005266409],"genre_scores_gemma":[0.94306976,0.000076093995,0.050465804,0.00086127897,0.0033898712,0.000007991322,0.0000060602174,0.00012742309,0.0019956941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929176,0.0037472472,0.0008900338,0.00039189836,0.001466712,0.00058652903],"domain_scores_gemma":[0.9961665,0.00029928843,0.00031640808,0.00051958143,0.0015453876,0.0011528262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006014311,0.00036190334,0.00097505655,0.0003016192,0.00014849902,0.00012157518,0.00031159975,0.00009877048,0.0003670119],"category_scores_gemma":[0.0011077741,0.00026049826,0.00043907625,0.00041880007,0.00023524572,0.00024768992,0.0000861139,0.0012521567,0.00063167006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031895414,0.00027489982,0.00097277004,0.000026067462,0.00037975376,0.0017715087,0.0015617405,0.00024043817,0.035415914,0.000036722304,0.9267866,0.00063818577],"study_design_scores_gemma":[0.081992336,0.025278073,0.0011925069,0.0004475302,0.00014185844,0.0051460075,0.0026594026,0.00007925193,0.032206494,0.000056318197,0.85033506,0.00046518169],"about_ca_topic_score_codex":0.000008544958,"about_ca_topic_score_gemma":0.0000030809724,"teacher_disagreement_score":0.131652,"about_ca_system_score_codex":0.00018067085,"about_ca_system_score_gemma":0.0009561644,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W2203386709","doi":"10.1002/ejhf.458","title":"Predicting Heart Failure Decompensation Using Cardiac Implantable Electronic Devices: A Review of Practices and Challenges","year":2015,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Generalizability theory; Medicine; Decompensation; Heart failure; Cardiac resynchronization therapy; Psychological intervention; Intensive care medicine; Reliability engineering; Cardiology; Ejection fraction","score_opus":0.11677045718536196,"score_gpt":0.3760613961238707,"score_spread":0.25929093893850874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203386709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000333495,0.9961887,0.0000062526965,0.0013603161,0.00020482554,0.000520575,0.000023874247,0.00002298334,0.0013389584],"genre_scores_gemma":[0.0003543317,0.99500895,0.0034268838,0.00009885507,0.0009960079,0.0000016056348,0.00001703015,0.00007625101,0.000020086822],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956178,0.001655009,0.0014356768,0.00031195834,0.0006417341,0.00033783374],"domain_scores_gemma":[0.99516374,0.0004036254,0.0030546424,0.0003252068,0.0008291208,0.00022368309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049619093,0.00040077072,0.0038501434,0.00030598015,0.000112417016,0.0000423572,0.000056122644,0.000096058655,0.000006571141],"category_scores_gemma":[0.00084231386,0.00029664396,0.0007833109,0.0002941733,0.000060948936,0.00026071412,0.00009846755,0.0007695624,0.0000143256175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016227823,0.00011837265,0.0031279032,0.58543795,0.006438357,0.00011568365,0.001049293,0.000010339844,0.00007095284,0.00004280261,0.23553632,0.16788976],"study_design_scores_gemma":[0.0002960339,0.00032617134,0.00006926852,0.12833185,0.0036518292,0.0132173,0.00036146963,8.734846e-7,0.0000013541859,9.724383e-7,0.85356164,0.00018122612],"about_ca_topic_score_codex":0.0000071473355,"about_ca_topic_score_gemma":0.000004158768,"teacher_disagreement_score":0.6180253,"about_ca_system_score_codex":0.00014018969,"about_ca_system_score_gemma":0.00081473397,"threshold_uncertainty_score":0.99994856},"labels":[],"label_agreement":null},{"id":"W2217502460","doi":"10.1002/ejhf.440","title":"Liver Function Tests in Patients with Acute Heart Failure and Associated Outcomes: Insights from ASCEND-HF","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Relypsa; Novartis Pharma; Johnson and Johnson; National Institutes of Health; American Heart Association; Thoratec Corporation; Amgen; Celladon Corporation; AstraZeneca","keywords":"Medicine; Heart failure; Internal medicine; Hazard ratio; Ejection fraction; Bilirubin; Proportional hazards model; Confidence interval; Cardiology; Liver function tests; Liver function; Gastroenterology; Acute decompensated heart failure","score_opus":0.013957701702791859,"score_gpt":0.22883961721823948,"score_spread":0.2148819155154476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217502460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818437,0.00021427727,0.000048477068,0.017072793,0.00021317821,0.0004045852,0.0000089416735,0.00004320484,0.0001508606],"genre_scores_gemma":[0.9871887,0.000009331487,0.01127942,0.0009987854,0.0001553382,0.0000018033003,0.000052956988,0.000055936838,0.00025771873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977867,0.00041538468,0.00054636324,0.00028076637,0.0006703835,0.00030038826],"domain_scores_gemma":[0.99861795,0.0000790021,0.0002358273,0.00025523992,0.00036300108,0.00044899603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043748584,0.00030253473,0.0006407406,0.00031586376,0.00006859363,0.00006670388,0.00008549158,0.000067563466,0.00006319693],"category_scores_gemma":[0.00014424906,0.00019991069,0.00011596129,0.0002759461,0.000057615875,0.0004071963,0.000068565314,0.00048739038,0.00013820648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068150106,0.0005825388,0.8074503,0.000011954158,0.00056988955,0.0008482042,0.0005335676,0.0000063160232,0.00011994061,0.0000075188354,0.18887338,0.00031487006],"study_design_scores_gemma":[0.010488167,0.0027501334,0.7746362,0.0002887009,0.00036867734,0.000050326642,0.00023087239,0.000006794883,0.000020074891,0.000011621377,0.21097903,0.00016940002],"about_ca_topic_score_codex":0.000034324305,"about_ca_topic_score_gemma":0.0001677125,"teacher_disagreement_score":0.032814115,"about_ca_system_score_codex":0.000154959,"about_ca_system_score_gemma":0.0001069294,"threshold_uncertainty_score":0.81521213},"labels":[],"label_agreement":null},{"id":"W2236723195","doi":"10.1002/ejhf.480","title":"A New Format for the Journal and a Farewell","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Viewpoints; Sister; Point (geometry); Medicine; Heart failure; Order (exchange); Library science; Cardiology; Computer science; Law; Visual arts; Political science; Art","score_opus":0.01546132615529179,"score_gpt":0.2453253438417578,"score_spread":0.22986401768646603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236723195","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03644116,0.0042718705,0.13457902,0.82236814,0.0006619571,0.0008788187,0.0000050513363,0.000036472684,0.0007575322],"genre_scores_gemma":[0.7738731,0.0017364883,0.20506594,0.0038489387,0.00345786,0.0000021514652,9.978913e-7,0.00009982153,0.011914695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989553,0.00012546098,0.0003786507,0.000072238356,0.00024038753,0.00022794423],"domain_scores_gemma":[0.999038,0.0001809311,0.00016803366,0.0001517655,0.00015724287,0.0003040256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012463442,0.00012898326,0.00022826662,0.00010817898,0.00015860959,0.000051821837,0.00010446908,0.00001731818,0.00018063175],"category_scores_gemma":[0.000114655624,0.000053559725,0.00017083916,0.00006065372,0.00003954135,0.00019954718,0.000040183473,0.00017450214,0.00005713154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038805453,0.000028414008,0.0011183522,0.000021467056,0.00017985258,0.00011239127,0.00030651654,5.156701e-7,0.0033279562,0.00006462167,0.94441354,0.05003833],"study_design_scores_gemma":[0.004596765,0.0014299796,0.0036780327,0.00029264728,0.000274724,0.0047571654,0.0002823161,0.0000041938415,0.0003270832,0.000055933167,0.98423225,0.0000689358],"about_ca_topic_score_codex":0.0000010904927,"about_ca_topic_score_gemma":0.0000026918565,"teacher_disagreement_score":0.8185192,"about_ca_system_score_codex":0.0000329154,"about_ca_system_score_gemma":0.00009012614,"threshold_uncertainty_score":0.21841022},"labels":[],"label_agreement":null},{"id":"W2267320830","doi":"10.1002/ejhf.487","title":"Nesiritide in Patients Hospitalized for Acute Heart Failure: Does Timing Matter? Implication for Future Acute Heart Failure Trials","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of Alberta","funders":"Johnson and Johnson","keywords":"Medicine; Nesiritide; Heart failure; Odds ratio; Confidence interval; Internal medicine; Clinical endpoint; Placebo; Randomization; Clinical trial; Cardiology","score_opus":0.017897590320064462,"score_gpt":0.2993527273028072,"score_spread":0.28145513698274277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267320830","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4413299,0.00012252084,0.002894467,0.5499317,0.0011943036,0.0041526924,0.00025136358,0.00009815538,0.000024887458],"genre_scores_gemma":[0.6994616,0.000080527054,0.29074687,0.003543005,0.0038894378,0.0002301223,0.00023459243,0.00034131712,0.0014725322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951179,0.000688435,0.0020153266,0.0006583947,0.0006318029,0.00088814204],"domain_scores_gemma":[0.9968852,0.00050811935,0.0007555992,0.0006655818,0.0006935707,0.00049193215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028420908,0.000617295,0.0017909808,0.0005753285,0.00023943046,0.00015192272,0.0003103997,0.000166922,0.0002607112],"category_scores_gemma":[0.00045073562,0.0003653762,0.0010926923,0.00027317283,0.00008828819,0.00070688216,0.00010320005,0.00035388608,0.00019197009],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020456994,0.00043878224,0.05478976,0.0001592773,0.00091198675,0.00004861106,0.00026412538,0.0000013410071,0.021952875,0.000058798454,0.9176363,0.001692447],"study_design_scores_gemma":[0.020780347,0.0027425196,0.08937099,0.00081312313,0.0011566991,0.00017636716,0.0002348232,0.000002923084,0.0045958245,0.00008866365,0.87957996,0.00045777424],"about_ca_topic_score_codex":0.0000042258107,"about_ca_topic_score_gemma":0.00001365085,"teacher_disagreement_score":0.5463887,"about_ca_system_score_codex":0.00024008616,"about_ca_system_score_gemma":0.00014785839,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W2275551497","doi":"10.1002/ejhf.500","title":"February 2016 at a Glance. Focus Issue on Cardiac Regeneration, Medical Treatment and Cardiac Devices","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Myocardial infarction; Cardiac function curve; Reprogramming; Cardiology; Regenerative medicine; Clinical endpoint; Internal medicine; Stem cell; Randomized controlled trial; Cell","score_opus":0.009525846537729348,"score_gpt":0.2412873242791003,"score_spread":0.23176147774137096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275551497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7484645,0.066222414,0.0004816694,0.18237936,0.0016339468,0.00026923,0.000021623688,0.000054410066,0.00047282065],"genre_scores_gemma":[0.9606822,0.0034508226,0.0029537447,0.0002624395,0.010846864,0.0000035806277,0.000007380879,0.00007684465,0.021716088],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839723,0.00035137148,0.0003966137,0.00020243305,0.00043434935,0.00021802449],"domain_scores_gemma":[0.9989371,0.00011515381,0.000116941665,0.00021770259,0.00013239305,0.0004807228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006935309,0.00021461156,0.0005546617,0.00012520721,0.000098326636,0.00001254177,0.00006376651,0.00005065673,0.00021952028],"category_scores_gemma":[0.00016200267,0.00010442591,0.0001605985,0.00007751918,0.00010373113,0.000062446605,0.000026823858,0.00017724594,0.00015354813],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036945508,0.00014089707,0.034943726,0.000058362988,0.00063115056,0.0011126383,0.00055920845,0.000013011259,0.09673918,0.00011519885,0.7686316,0.09668562],"study_design_scores_gemma":[0.0023885856,0.0025629215,0.038076766,0.0010041128,0.00012828762,0.00054342346,0.000052505075,0.0000033673832,0.012322017,0.0000013460369,0.94278485,0.00013179205],"about_ca_topic_score_codex":0.000008036089,"about_ca_topic_score_gemma":0.000004107461,"teacher_disagreement_score":0.2122177,"about_ca_system_score_codex":0.00011829122,"about_ca_system_score_gemma":0.00011024182,"threshold_uncertainty_score":0.42583653},"labels":[],"label_agreement":null},{"id":"W2286974438","doi":"10.1002/ejhf.498","title":"Henry Krum, Pioneering Heart Failure Researcher","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Wishful thinking; Trial by ordeal; Law; Political science; Psychology","score_opus":0.02074592933019662,"score_gpt":0.2774911162985104,"score_spread":0.2567451869683138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286974438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81544983,0.0030481557,0.0014439769,0.17821048,0.00069730607,0.00036180837,0.000011872279,0.00008897449,0.0006875887],"genre_scores_gemma":[0.98431146,0.00020441556,0.011588445,0.0009337097,0.001922368,9.0791656e-7,0.0000021068113,0.00009347839,0.0009431279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997,0.00066315,0.00065854675,0.00023805838,0.0008760986,0.00056419236],"domain_scores_gemma":[0.9980144,0.00011772625,0.00014313577,0.00048455095,0.00039263908,0.00084756705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002637345,0.00021434147,0.0005809919,0.00031329948,0.00013877357,0.000037659833,0.00017524995,0.000070192684,0.00044935945],"category_scores_gemma":[0.0004965529,0.0001249872,0.0006609005,0.000249778,0.00011077712,0.000225246,0.00008026683,0.0007813538,0.0006021377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047441933,0.0001186988,0.040741637,0.00018585351,0.00032314402,0.0013280619,0.00028803636,0.000011530884,0.0722267,0.000030746403,0.87571687,0.008554289],"study_design_scores_gemma":[0.002474311,0.0005794161,0.086608976,0.0007221681,0.00005954476,0.0038409503,0.00019016078,0.0000012115217,0.0019694672,0.000007774334,0.90339965,0.00014636712],"about_ca_topic_score_codex":0.00000805602,"about_ca_topic_score_gemma":0.0000057928014,"teacher_disagreement_score":0.17727678,"about_ca_system_score_codex":0.000119992685,"about_ca_system_score_gemma":0.00028948698,"threshold_uncertainty_score":0.7739463},"labels":[],"label_agreement":null},{"id":"W2297321749","doi":"10.1002/ejhf.512","title":"March 2016 at a Glance. Focus on Right Ventricular Failure and Acute Heart Failure","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Blood urea nitrogen; Incidence (geometry); Comorbidity; Troponin; Epidemiology; Troponin I; Intensive care medicine; Creatinine; Myocardial infarction","score_opus":0.010920272357195343,"score_gpt":0.25211050960392595,"score_spread":0.2411902372467306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297321749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68487155,0.0022696045,0.00006811904,0.31164312,0.00019247117,0.000451586,0.00007183145,0.00004598457,0.00038576772],"genre_scores_gemma":[0.9874738,0.0003652681,0.006316372,0.001003825,0.00067996874,0.000003846601,0.000010724337,0.000085975196,0.0040602474],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969985,0.00053234975,0.00053196365,0.00040454112,0.00089893537,0.0006337347],"domain_scores_gemma":[0.9979055,0.0001951689,0.00018751928,0.00047089186,0.0003305782,0.0009103657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065385335,0.00034141776,0.00066326984,0.00034535167,0.00023588302,0.000047303074,0.00019691349,0.000079987854,0.00083144143],"category_scores_gemma":[0.0001657171,0.00018017711,0.00032830916,0.00022783909,0.00020509172,0.00023374872,0.00016445495,0.0005253906,0.001132855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012831892,0.00036957016,0.02186114,0.0000347955,0.0005301384,0.06891825,0.000017583627,3.5935415e-7,0.042201348,0.000036234076,0.8634727,0.0012746992],"study_design_scores_gemma":[0.006824194,0.0032382961,0.031222166,0.0010258517,0.0001763966,0.03914089,0.00003064925,0.0000021270948,0.005568466,0.00006234159,0.9124873,0.00022131705],"about_ca_topic_score_codex":0.0000025839172,"about_ca_topic_score_gemma":0.000004777456,"teacher_disagreement_score":0.3106393,"about_ca_system_score_codex":0.00014031047,"about_ca_system_score_gemma":0.00014342036,"threshold_uncertainty_score":0.9996449},"labels":[],"label_agreement":null},{"id":"W2297865244","doi":"10.1002/ejhf.456","title":"Increased Mortality with Elevated Plasma Endothelin-1 in Acute Heart Failure: An ASCEND-HF Biomarker Substudy","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Singulex","keywords":"Medicine; Interquartile range; Heart failure; Hazard ratio; Internal medicine; Nesiritide; Cardiology; Confidence interval; Odds ratio; Endothelin 1; Natriuretic peptide","score_opus":0.030309757729694724,"score_gpt":0.2837267494255396,"score_spread":0.25341699169584486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297865244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403775,0.00017604037,0.000065632514,0.0047707483,0.00020222728,0.00042503842,0.000020151681,0.00007175234,0.00023064858],"genre_scores_gemma":[0.98568296,0.00001032939,0.012907974,0.00076052727,0.0003975939,0.000002921682,0.000020846985,0.00011267467,0.0001041877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567467,0.0015176559,0.00093547103,0.00038581513,0.0009123153,0.00057409634],"domain_scores_gemma":[0.9974426,0.00016479884,0.00033868692,0.0005950085,0.0004958815,0.0009630379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034389996,0.00040356192,0.0008961936,0.000486081,0.000075518,0.000072746276,0.00026997484,0.000082591134,0.00010973901],"category_scores_gemma":[0.00038126277,0.00028682785,0.00020175979,0.0006576845,0.00012672001,0.00042121962,0.000056577603,0.0009046823,0.00020983437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053698355,0.0013807158,0.7304439,0.00008140878,0.0008696774,0.009694002,0.00085571577,0.000048777816,0.19088814,0.000010638021,0.05998849,0.00036872516],"study_design_scores_gemma":[0.045975506,0.010212594,0.7444525,0.0010172195,0.0011453714,0.017996343,0.0020774344,0.00034484616,0.035769485,0.00002667162,0.13999793,0.0009841202],"about_ca_topic_score_codex":0.000103513914,"about_ca_topic_score_gemma":0.00015583496,"teacher_disagreement_score":0.15511866,"about_ca_system_score_codex":0.00012201122,"about_ca_system_score_gemma":0.00042715517,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W2310229236","doi":"10.1002/ejhf.502","title":"Renal Denervation in Heart Failure with Preserved Ejection Fraction (RDT-PEF): A Randomized Controlled Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"British Heart Foundation; National Institute for Health and Care Research; Imperial College London; Queen Mary University of London","keywords":"Medicine; Heart failure; Ejection fraction; Randomized controlled trial; Denervation; Cardiology; Heart failure with preserved ejection fraction; Internal medicine","score_opus":0.01410349049652294,"score_gpt":0.24922582579876057,"score_spread":0.23512233530223764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310229236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7916191,0.00018361423,0.0077885017,0.19380999,0.0004781738,0.005444384,0.0000019923511,0.00009224224,0.00058200536],"genre_scores_gemma":[0.9749611,0.00003227758,0.0214831,0.00044436546,0.0011742293,0.0000714827,0.000007813706,0.000064177904,0.0017614573],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99528533,0.0020159094,0.0013065619,0.00030117706,0.0007348997,0.00035609226],"domain_scores_gemma":[0.99803007,0.0004248285,0.00062120624,0.00030959246,0.0003831154,0.00023118398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042052213,0.00031651586,0.0016358385,0.00056890765,0.00009762632,0.00006742472,0.00010089215,0.00007838478,0.00041927779],"category_scores_gemma":[0.0007426009,0.00016293414,0.0005757838,0.00031539926,0.00009151598,0.0005670436,0.00003068853,0.00041316572,0.00011528674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87439764,0.00045809333,0.0031474251,0.000024466022,0.0005489999,0.00022402717,0.00006742383,0.00005007744,0.007993847,0.000042234376,0.11270538,0.00034037782],"study_design_scores_gemma":[0.81371653,0.002185261,0.0021733234,0.0007359003,0.00046134734,0.0001961562,0.000105439394,0.000037580463,0.00045889843,0.000025467774,0.1797371,0.00016698988],"about_ca_topic_score_codex":0.000015328615,"about_ca_topic_score_gemma":0.000069704074,"teacher_disagreement_score":0.19336563,"about_ca_system_score_codex":0.00019111732,"about_ca_system_score_gemma":0.00017109633,"threshold_uncertainty_score":0.66442615},"labels":[],"label_agreement":null},{"id":"W2311385626","doi":"10.1002/ejhf.507","title":"Moving Away from Symptoms-Based Heart Failure Treatment: Misperceptions and Real Risks for Patients with Heart Failure","year":2016,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Medical prescription; Ejection fraction; Intensive care medicine; Palliative care; Internal medicine","score_opus":0.012112417484450235,"score_gpt":0.26932162496720385,"score_spread":0.2572092074827536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311385626","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32937026,0.002709356,0.0032203337,0.31724107,0.3181319,0.017841747,0.009561228,0.0012086894,0.0007154037],"genre_scores_gemma":[0.09444438,0.00041368266,0.23653485,0.0011538565,0.6574032,0.00018357558,0.0041366066,0.0013529942,0.0043769036],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402684,0.0007383416,0.0014694763,0.0011334918,0.0015794726,0.0010523774],"domain_scores_gemma":[0.99488175,0.0009968124,0.00082667713,0.0010270948,0.0012195274,0.001048153],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008352683,0.0013136617,0.0022295308,0.00071905646,0.00053909747,0.00030033966,0.0003242636,0.0005481486,0.00044588948],"category_scores_gemma":[0.0003277949,0.00085809716,0.0009493708,0.00026657322,0.0003420792,0.00045077523,0.00011615938,0.0011456881,0.00019933231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014242629,0.00073595997,0.02468964,0.00019655,0.0010664783,0.00012369608,0.0001833071,0.0000061891,0.00041427524,0.0000054531524,0.97044337,0.00071083236],"study_design_scores_gemma":[0.020219976,0.009505881,0.010196744,0.0027773906,0.0021894805,0.000042995343,0.00016682794,0.000005402216,0.00006950245,0.0000090707645,0.9540412,0.0007755698],"about_ca_topic_score_codex":0.00014046786,"about_ca_topic_score_gemma":0.00026187435,"teacher_disagreement_score":0.33927125,"about_ca_system_score_codex":0.0006180373,"about_ca_system_score_gemma":0.00088505197,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W2327147511","doi":"10.1002/ejhf.547","title":"Clinical Outcomes According to Qrs Duration and Morphology in the Irbesartan in Patients with Heart Failure and Preserved Systolic Function (I-PRESERVE) Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Bristol-Myers Squibb","keywords":"Medicine; Cardiology; QRS complex; Internal medicine; Ejection fraction; Heart failure; Hazard ratio; Irbesartan; Bundle branch block; Left bundle branch block; Confidence interval; Electrocardiography; Blood pressure","score_opus":0.01546625577083967,"score_gpt":0.27263148524013825,"score_spread":0.2571652294692986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327147511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628225,0.00004689821,0.00004294146,0.036426634,0.00015168541,0.0004895533,0.0000022497002,0.0000062488125,0.000011320685],"genre_scores_gemma":[0.9980503,0.000008539742,0.00064333493,0.00090603845,0.00034165333,0.000003662186,0.0000022194515,0.00001802983,0.000026232294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973216,0.0013573277,0.000678992,0.00021591748,0.00020489877,0.00022124972],"domain_scores_gemma":[0.99907154,0.00032334574,0.00018026773,0.00020571674,0.000100494966,0.00011860755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017374868,0.00014271482,0.0005123385,0.00018594727,0.00006297629,0.000023611756,0.00007346392,0.000062326464,0.000011381218],"category_scores_gemma":[0.0005965241,0.00007116306,0.00010096631,0.00015701458,0.00008491898,0.00021061327,0.00005012489,0.00045631218,0.00000774628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016468775,0.0000991969,0.9756093,0.00001300302,0.00004671438,0.00013320037,0.00008777292,0.0000060763737,0.0013886974,0.000014032245,0.005838349,0.00029485775],"study_design_scores_gemma":[0.025755905,0.004849667,0.96365124,0.00017368843,0.000050602357,0.00027390863,0.00017430128,0.0000012617493,0.000015445417,0.000015286942,0.004955042,0.00008366685],"about_ca_topic_score_codex":0.0000058578853,"about_ca_topic_score_gemma":0.000046315614,"teacher_disagreement_score":0.035520595,"about_ca_system_score_codex":0.000023680133,"about_ca_system_score_gemma":0.000042679498,"threshold_uncertainty_score":0.29019454},"labels":[],"label_agreement":null},{"id":"W2337524670","doi":"10.1002/ejhf.520","title":"Mitraclip Therapy in Patients with Functional Mitral Regurgitation and Missing Leaflet Coaptation: Is it Still an Exclusion Criterion?","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"MitraClip; Medicine; Functional mitral regurgitation; Mitral regurgitation; Cardiology; Internal medicine; Heart failure; Mitral valve; Population; Surgery; Ejection fraction","score_opus":0.019942762373229856,"score_gpt":0.2922298958875311,"score_spread":0.2722871335143013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337524670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758334,0.00024336274,0.0001652828,0.011718603,0.0000861292,0.0001314863,0.00001284414,0.000005911646,0.00005302142],"genre_scores_gemma":[0.9968196,0.000037262504,0.0018324782,0.0010238669,0.00016495788,5.2072664e-7,0.000017844617,0.00002259746,0.00008084897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989696,0.00017442448,0.00027283118,0.00014662057,0.0003166544,0.000119847566],"domain_scores_gemma":[0.99927545,0.00003491733,0.00013070507,0.00010559159,0.00027489633,0.0001784449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021335424,0.000115902134,0.00018730393,0.00012084849,0.000058940182,0.00003493464,0.000024934143,0.000018321482,0.0001479103],"category_scores_gemma":[0.000028152197,0.000067719986,0.00018217145,0.00007266508,0.000042338004,0.00034734997,0.000008852705,0.00008957204,0.000010724983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003150029,0.00037249547,0.9601824,0.000014089326,0.00016084424,0.00007754326,0.0006382281,0.0000032128823,0.0010141946,0.0000033070964,0.0071102343,0.02727341],"study_design_scores_gemma":[0.009725359,0.0020185942,0.9783773,0.0003972885,0.0000817885,0.00007206109,0.0001621699,0.000002873071,0.00004749331,0.00001553899,0.009018692,0.00008083918],"about_ca_topic_score_codex":0.000001929564,"about_ca_topic_score_gemma":8.512648e-7,"teacher_disagreement_score":0.02719257,"about_ca_system_score_codex":0.000040277486,"about_ca_system_score_gemma":0.000051229574,"threshold_uncertainty_score":0.27615407},"labels":[],"label_agreement":null},{"id":"W2342046157","doi":"10.1002/ejhf.542","title":"April 2016 at a Glance. Focus on Cardiac Remodeling, Biomarkers and Treatment","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Cardiology; Valsartan; Heart failure; Diabetic cardiomyopathy; Ventricular remodeling; Dilated cardiomyopathy; Cardiomyopathy; Endocrinology","score_opus":0.01371528126381,"score_gpt":0.22771217583361417,"score_spread":0.21399689456980417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342046157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648974,0.0031855314,0.0003574823,0.02768975,0.0008178572,0.00022055452,0.000015479909,0.00003977572,0.00277618],"genre_scores_gemma":[0.9916899,0.0023160963,0.0014955972,0.00021820897,0.0008988168,5.7183127e-7,0.0000014855323,0.000047043482,0.0033322545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988033,0.0002714221,0.0002920234,0.00017228603,0.00028628652,0.00017466853],"domain_scores_gemma":[0.99920785,0.000050524017,0.00010973595,0.00025378808,0.000098742836,0.00027936022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005441674,0.00015763432,0.0003903929,0.00013551161,0.00007788227,0.000013930293,0.00003719549,0.00003067214,0.00011187132],"category_scores_gemma":[0.000059026082,0.00007747758,0.00049591204,0.000060923958,0.000059024143,0.000055628196,0.00002341681,0.000100706966,0.00019151687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027927402,0.0001628316,0.089308895,0.000021632844,0.0020667454,0.0008511497,0.00034344522,0.000008250001,0.059061892,0.00001644797,0.5854265,0.2599395],"study_design_scores_gemma":[0.0037991954,0.001358027,0.0456425,0.00032161037,0.00019696869,0.0010734377,0.000058124213,0.0000021952242,0.0023431603,0.000003746592,0.94509387,0.00010718163],"about_ca_topic_score_codex":0.000006027229,"about_ca_topic_score_gemma":0.0000024717124,"teacher_disagreement_score":0.35966736,"about_ca_system_score_codex":0.00016572807,"about_ca_system_score_gemma":0.000059772356,"threshold_uncertainty_score":0.31594443},"labels":[],"label_agreement":null},{"id":"W2342809951","doi":"10.1002/ejhf.531","title":"A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: Rationale, Design, and Baseline Characteristics of BIOSTAT-CHF","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Commission; National Institute for Health and Care Research","keywords":"Heart failure; Medicine; Cohort; Ejection fraction; Intensive care medicine; Heart failure with preserved ejection fraction; Internal medicine; Cohort study; Cardiology","score_opus":0.024968825184286975,"score_gpt":0.27431834361283863,"score_spread":0.24934951842855166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342809951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9179216,0.00064868666,0.00691367,0.07131245,0.00022767115,0.00290384,0.000027381082,0.000028209908,0.000016494258],"genre_scores_gemma":[0.9814371,0.000075132695,0.017535372,0.00017971058,0.00035650242,0.000017782808,0.000008999907,0.00004079095,0.00034863796],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698824,0.0011062855,0.0010133537,0.00029752287,0.00027048253,0.00032410497],"domain_scores_gemma":[0.99862474,0.00023592029,0.00026422742,0.0003071436,0.00026965945,0.00029828088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017052309,0.00028096288,0.0008197794,0.00049921835,0.000051505085,0.000028602813,0.000092266106,0.000034817996,0.000079981524],"category_scores_gemma":[0.00018568238,0.00016782625,0.00011690144,0.00024771766,0.00007091928,0.0001231787,0.00005908239,0.00012684477,0.000072392184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004630924,0.006100233,0.37803507,0.00042261512,0.0019251979,0.0026290615,0.003860462,0.00017845126,0.36285082,0.00026695098,0.21942843,0.019671775],"study_design_scores_gemma":[0.016813487,0.031595565,0.11071212,0.001210161,0.00040764993,0.00063570944,0.0011811513,0.000077509474,0.0023023454,0.000007325048,0.8346754,0.00038161065],"about_ca_topic_score_codex":0.00002528842,"about_ca_topic_score_gemma":0.00004047343,"teacher_disagreement_score":0.61524695,"about_ca_system_score_codex":0.00028531803,"about_ca_system_score_gemma":0.00024855675,"threshold_uncertainty_score":0.6843756},"labels":[],"label_agreement":null},{"id":"W2345644761","doi":"10.1002/ejhf.1536","title":"Evaluation of the Effect of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality of Patients with Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR-Reduced Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"National Institute for Health and Care Research","keywords":"Heart failure; Excellence; Medicine; Publication; Medical education; Cardiology; Political science; Law","score_opus":0.028377900700966196,"score_gpt":0.2721292192022049,"score_spread":0.2437513185012387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345644761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971007,0.00021822356,0.0001256147,0.000764143,0.00008345536,0.0016674474,0.000034120138,0.0000025797638,0.0000037067155],"genre_scores_gemma":[0.99967337,0.000019684658,0.00015127349,0.000012670764,0.000111816444,0.000008508582,0.000004279692,0.000014821066,0.0000035808716],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975518,0.0010446518,0.00051518274,0.00014049883,0.0006701138,0.00007776905],"domain_scores_gemma":[0.99831635,0.00017489302,0.0006946382,0.0001703905,0.00058520125,0.000058559213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019235295,0.00012443773,0.00036885816,0.00006961571,0.000071309194,0.0000063210355,0.000032939195,0.000046453468,0.0000139961885],"category_scores_gemma":[0.00019538373,0.00005255908,0.000099887984,0.00010125159,0.00019123255,0.00012251038,0.0000072548123,0.000117052696,1.012345e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037613846,0.00040152308,0.2944908,0.0005002042,0.00053777226,8.8177626e-7,0.00036703047,0.00013097211,0.6630301,0.000002765398,0.0021163947,0.0008077312],"study_design_scores_gemma":[0.038038455,0.007956214,0.7538162,0.0030200116,0.0010417078,0.000031289204,0.00009128656,0.000029986624,0.19587024,0.000004920163,0.000039062943,0.00006064249],"about_ca_topic_score_codex":0.000004889506,"about_ca_topic_score_gemma":0.0000050929207,"teacher_disagreement_score":0.46715984,"about_ca_system_score_codex":0.00004466683,"about_ca_system_score_gemma":0.00019507491,"threshold_uncertainty_score":0.2143297},"labels":[],"label_agreement":null},{"id":"W2346194408","doi":"10.1002/ejhf.3536","title":"Frank Ruschitzka MD FESC FRCP Shares Some Thoughts on the Future Direction of the Heart Failure Association of the European Society of Cardiology","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Biosense Webster; Canadian Institutes of Health Research; CytoSorbents Europe; Servier; Fondazione Internazionale Menarini; Boston Scientific Corporation; Svenska Sällskapet för Medicinsk Forskning; Pfizer; Heart and Stroke Foundation of Canada; Vetenskapsrådet; Eli Lilly and Company; AstraZeneca; AtriCure; Foundation for Cardiovascular Research; McMaster University; Schweizerische Herzstiftung","keywords":"Medicine; Heart failure; Association (psychology); Cardiology; Internal medicine; Psychology; Psychotherapist","score_opus":0.020038664629641982,"score_gpt":0.2515127976193137,"score_spread":0.23147413298967173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346194408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6540434,0.00077762455,0.000102420854,0.3408036,0.0021027827,0.0005952714,0.000045796525,0.000024180768,0.00150498],"genre_scores_gemma":[0.99009395,0.0001887432,0.00045066336,0.00064610894,0.0073202956,2.3125996e-7,0.0000016336548,0.000035956033,0.0012624481],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961413,0.0021599268,0.0007250864,0.00014737002,0.00063951715,0.00018681258],"domain_scores_gemma":[0.9978066,0.00034630322,0.0010451978,0.0004311233,0.00031799625,0.000052755935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002569255,0.00017520382,0.00049997785,0.00006421722,0.00018381735,0.000013857962,0.00030431675,0.000058499158,0.000049738417],"category_scores_gemma":[0.00037859008,0.00006958939,0.0009788825,0.00026074273,0.0001225744,0.00013023135,0.00012652235,0.00040537334,0.00001886295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015820275,0.000017301383,0.23173015,0.00006846643,0.0004724777,0.0000027007175,0.0004516647,0.00009362465,0.04771446,0.00021722924,0.71803457,0.001039174],"study_design_scores_gemma":[0.0009402306,0.00018515495,0.44543228,0.0003102305,0.00014638726,0.00002096625,0.000292242,0.000001686509,0.004324055,0.000035382513,0.54825133,0.000060067367],"about_ca_topic_score_codex":0.0000016170741,"about_ca_topic_score_gemma":0.0000034498767,"teacher_disagreement_score":0.34015748,"about_ca_system_score_codex":0.000055749082,"about_ca_system_score_gemma":0.00005343085,"threshold_uncertainty_score":0.2837773},"labels":[],"label_agreement":null},{"id":"W2346227142","doi":"10.1002/ejhf.564","title":"May 2016 at a Glance","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Cohort; Guideline; Cardiology; Emergency medicine","score_opus":0.011158806319003458,"score_gpt":0.24529208477802472,"score_spread":0.23413327845902127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346227142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7727734,0.03292174,0.0048765307,0.14950988,0.0026008291,0.00055676926,0.000019615305,0.00016504852,0.036576193],"genre_scores_gemma":[0.96921355,0.00035756055,0.015218614,0.0005500377,0.0014873503,4.6895693e-7,6.417987e-7,0.00006539276,0.013106373],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984552,0.00031394255,0.00040858774,0.00015331677,0.00043733825,0.00023158887],"domain_scores_gemma":[0.99890524,0.000053814736,0.00015161077,0.0004600977,0.00020209864,0.00022715241],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009422963,0.0001342859,0.00038086536,0.000099165416,0.00004725795,0.000012150145,0.00015526735,0.000026208376,0.00067543244],"category_scores_gemma":[0.00023910216,0.00007611289,0.00045684923,0.0000893403,0.000089561545,0.00012142625,0.00009804873,0.00020212287,0.0015582928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031212,0.000060572605,0.015337061,0.000049997238,0.00032386248,0.006614588,0.00017929543,0.0000014508987,0.054575942,0.000037625097,0.8981124,0.024395091],"study_design_scores_gemma":[0.002681226,0.000335507,0.017061738,0.0016381487,0.000093002585,0.020074839,0.000015767064,2.1394096e-7,0.0046711597,0.000011181663,0.95331544,0.00010176658],"about_ca_topic_score_codex":2.461513e-7,"about_ca_topic_score_gemma":5.7756745e-7,"teacher_disagreement_score":0.19644016,"about_ca_system_score_codex":0.00009114028,"about_ca_system_score_gemma":0.00006289917,"threshold_uncertainty_score":0.9992191},"labels":[],"label_agreement":null},{"id":"W2346582463","doi":"10.1002/ejhf.561","title":"Insights into the Importance of the Electrocardiogram in Patients with Acute Heart Failure","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; Provincial Laboratory of Public Health; Canadian VIGOUR Centre; University of Alberta Hospital; University of Alberta","funders":"University of Alberta; Canadian Institutes of Health Research; Alberta Innovates; Alberta Innovates - Health Solutions; Government of Canada","keywords":"Medicine; Interquartile range; Hazard ratio; Heart failure; Internal medicine; Emergency department; Sinus rhythm; Cardiology; Population; Ejection fraction; Confidence interval; QRS complex; Emergency medicine; Atrial fibrillation","score_opus":0.006813774747958986,"score_gpt":0.24229225911325825,"score_spread":0.23547848436529925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346582463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8679747,0.00020461231,0.00015089395,0.13092434,0.0001220391,0.0003933466,0.0000027223418,0.000010600365,0.000216736],"genre_scores_gemma":[0.9949514,0.000037653586,0.0022953337,0.0022787487,0.00024971692,0.0000023623784,0.0000011998031,0.000044427085,0.00013912043],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721307,0.0007484974,0.00059871346,0.00018712932,0.00094792043,0.00030466524],"domain_scores_gemma":[0.9982506,0.00012048508,0.0002988831,0.0005731835,0.00059310644,0.00016371896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078746653,0.00018282048,0.00044415396,0.00019684772,0.000110463974,0.000024024284,0.000362348,0.00004202892,0.00004454921],"category_scores_gemma":[0.00020382178,0.00006986431,0.00029698407,0.0006426319,0.00034189413,0.0001959926,0.00011388409,0.0007311761,0.000034531466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084632885,0.0001340308,0.7425994,0.000015810925,0.0005077449,0.00010299014,0.00045019615,0.0000071701174,0.013271424,0.00006677152,0.24115135,0.0008467621],"study_design_scores_gemma":[0.0025170115,0.0011736172,0.47525573,0.0002642961,0.0000781103,0.00019416003,0.0000967975,6.076604e-7,0.0017930252,0.000023673481,0.51851815,0.000084809406],"about_ca_topic_score_codex":0.0000053643885,"about_ca_topic_score_gemma":0.00001595343,"teacher_disagreement_score":0.27736682,"about_ca_system_score_codex":0.00009606522,"about_ca_system_score_gemma":0.00021719998,"threshold_uncertainty_score":0.3176637},"labels":[],"label_agreement":null},{"id":"W2346841827","doi":"10.1002/ejhf.534","title":"Exercise Tolerance can Explain the Obesity Paradox in Patients with Systolic Heart Failure: Data from the MECKI Score Research Group","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Obesity paradox; Ejection fraction; Cardiorespiratory fitness; Internal medicine; Body mass index; Cardiology; Obesity; Population; VO2 max; Heart rate; Overweight; Blood pressure","score_opus":0.038113218655026156,"score_gpt":0.2632738305144408,"score_spread":0.22516061185941466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346841827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594465,0.0009585615,0.00014137996,0.038481794,0.00028968396,0.0005698002,0.00006596727,0.000018240853,0.000028101575],"genre_scores_gemma":[0.9979503,0.00013809343,0.00063436106,0.0005032605,0.0006091314,0.0000027262286,0.000027145645,0.00005181434,0.00008318132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953976,0.0019258694,0.0005309741,0.00037381152,0.0013498957,0.00042182553],"domain_scores_gemma":[0.997351,0.00033549604,0.00016129248,0.0015300607,0.00036319863,0.00025899056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041039377,0.00022105014,0.00052682916,0.0001447576,0.00030734224,0.00008341788,0.00068139064,0.000047595604,0.00018775657],"category_scores_gemma":[0.00033741415,0.00008764853,0.00020983981,0.00046108983,0.00027060026,0.0002644139,0.00022853939,0.0010398627,0.00013042838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083098334,0.00017396445,0.6914924,0.00001671662,0.00013251996,0.00015596281,0.00047942248,0.000008483795,0.00028024393,0.000009181247,0.3048472,0.0015729476],"study_design_scores_gemma":[0.003399234,0.00033009957,0.75669366,0.0014941982,0.00008076603,0.00014811974,0.0007170659,0.000003851597,0.00007684778,0.000004585126,0.23693888,0.000112655944],"about_ca_topic_score_codex":0.000172745,"about_ca_topic_score_gemma":0.00048601857,"teacher_disagreement_score":0.06790832,"about_ca_system_score_codex":0.000106412845,"about_ca_system_score_gemma":0.00016083244,"threshold_uncertainty_score":0.4517744},"labels":[],"label_agreement":null},{"id":"W2387832857","doi":"10.1002/ejhf.532","title":"Abnormal Liver Function Tests in Acute Heart Failure: Relationship with Clinical Characteristics and Outcome in the PROTECT Study","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Albumin; Hazard ratio; Heart failure; Confidence interval; Odds ratio; Gastroenterology; Liver function tests; Liver function; Serum albumin","score_opus":0.037276584138071396,"score_gpt":0.29834514924036104,"score_spread":0.26106856510228965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2387832857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890701,0.000038082802,0.00015823606,0.0101841865,0.00006169769,0.00045771885,0.000004944107,0.000008213488,0.000016810394],"genre_scores_gemma":[0.99855334,0.000014286687,0.0008193415,0.0003501483,0.0002136818,0.000003016605,0.000002775554,0.000016749735,0.000026690232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788797,0.0009349596,0.00060611963,0.00014274284,0.00028620384,0.00014200168],"domain_scores_gemma":[0.9992017,0.0002979748,0.00015872529,0.00014828033,0.000091746166,0.000101535465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019042676,0.00011643384,0.00026268177,0.00014785177,0.00005427443,0.000029778663,0.0000645842,0.000029302173,0.000020166193],"category_scores_gemma":[0.00008645141,0.00005731302,0.000059623082,0.00015762755,0.000057084926,0.00027278208,0.000011355083,0.0004930851,0.000034853838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00119068,0.00025134033,0.995747,0.000024351839,0.000070430135,0.0011066487,0.0006213874,4.3135861e-7,0.00014259612,0.0000069030284,0.00055118225,0.0002870204],"study_design_scores_gemma":[0.004682342,0.002509434,0.98902047,0.0003122861,0.00033412868,0.0010103183,0.00034685238,0.0000021350713,0.000005151805,0.0000044158933,0.0016973154,0.000075162134],"about_ca_topic_score_codex":0.0000034211434,"about_ca_topic_score_gemma":0.000037694193,"teacher_disagreement_score":0.009834038,"about_ca_system_score_codex":0.000019081403,"about_ca_system_score_gemma":0.000060024664,"threshold_uncertainty_score":0.23371571},"labels":[],"label_agreement":null},{"id":"W2395918862","doi":"10.1002/ejhf.590","title":"Updated Clinical Practice Guidelines on Heart Failure: An International Alignment","year":2016,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Society of Cardiology; Heart Failure Society of America; American Heart Association","keywords":"Heart failure; Medicine; Ivabradine; Guideline; Management of heart failure; Intensive care medicine; Clinical Practice; Cardiology; Internal medicine; Canadian Cardiovascular Society; Family medicine; Blood pressure; Heart rate; Myocardial infarction; Pathology","score_opus":0.03960644740399526,"score_gpt":0.3922702180903849,"score_spread":0.35266377068638965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395918862","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045934576,0.00021933552,0.00016858196,0.47142267,0.52456874,0.0006898949,0.00010683128,0.00012150312,0.0022431214],"genre_scores_gemma":[0.0003979794,0.0005117712,0.16543071,0.007512561,0.81992745,0.0000056883646,0.00044170985,0.0002423427,0.005529774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908272,0.0017064243,0.0030443876,0.00082205184,0.0030000524,0.00059989817],"domain_scores_gemma":[0.99198735,0.00070384576,0.001413153,0.0010698605,0.0039392905,0.0008864961],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.007107151,0.00075294747,0.0014558164,0.00054420804,0.00014888475,0.00022207692,0.0006828818,0.00042124878,0.0010780478],"category_scores_gemma":[0.0065340395,0.0005062618,0.00089374493,0.00018224097,0.00013985558,0.00074562273,0.00023326499,0.0020722393,0.0018231644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001488735,0.0009774368,0.00016061985,0.000033507047,0.0012744642,0.0019895618,0.0000448871,0.0000047739145,0.00013734396,0.000039689883,0.99055713,0.0032918502],"study_design_scores_gemma":[0.0062925606,0.0057490547,0.00019049866,0.0014214192,0.0008481288,0.0005535986,0.00016049418,0.000003301806,0.0000491504,0.0000079855445,0.9842823,0.00044152047],"about_ca_topic_score_codex":0.000007258984,"about_ca_topic_score_gemma":0.000006611709,"teacher_disagreement_score":0.4639101,"about_ca_system_score_codex":0.00034280503,"about_ca_system_score_gemma":0.00075149926,"threshold_uncertainty_score":0.9998351},"labels":[],"label_agreement":null},{"id":"W2399132479","doi":"10.1002/ejhf.574","title":"Tako-Tsubo Syndrome: Issue of Incomplete Recovery and Recurrence","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Takotsubo Cardiomyopathy and Associated Phenomena","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.009763009784091756,"score_gpt":0.2199130308102977,"score_spread":0.21015002102620595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399132479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97740537,0.001549078,0.00024375744,0.018383767,0.0003663985,0.0001200195,0.00003261111,0.000016842352,0.0018821718],"genre_scores_gemma":[0.99478394,0.00020882318,0.003937903,0.00025671802,0.00031426578,2.7052195e-7,0.0000011148999,0.000026823296,0.00047011775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984342,0.00036606964,0.0005505095,0.00014691924,0.000300129,0.00020220254],"domain_scores_gemma":[0.99885386,0.00012390001,0.00039136605,0.00020187265,0.00021760384,0.00021137828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011171891,0.00014138763,0.0005060956,0.00016145082,0.000046703706,0.000014137904,0.00011445913,0.000031540243,0.00016969653],"category_scores_gemma":[0.00027361864,0.000090446796,0.00017924448,0.00016335527,0.000107079744,0.00018618135,0.000056656867,0.00026364674,0.00007274509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018899956,0.0005495019,0.14576618,0.00063344924,0.0012945851,0.0057457746,0.0018204452,0.0000081257185,0.24087274,0.00031004142,0.45281357,0.14829558],"study_design_scores_gemma":[0.0044107307,0.0038708148,0.273448,0.0027996805,0.00021660601,0.0099073155,0.00031102062,0.0000011376943,0.0027022124,0.00022678806,0.7018206,0.0002850674],"about_ca_topic_score_codex":9.698914e-7,"about_ca_topic_score_gemma":2.7353107e-7,"teacher_disagreement_score":0.24900706,"about_ca_system_score_codex":0.000034501416,"about_ca_system_score_gemma":0.0000728297,"threshold_uncertainty_score":0.36883134},"labels":[],"label_agreement":null},{"id":"W2413467082","doi":"10.1002/ejhf.580","title":"Efficacy of Sacubitril/Valsartan vs. Enalapril at Lower than Target Doses in Heart Failure with Reduced Ejection Fraction: The PARADIGM-HF Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Enalapril; Sacubitril, Valsartan; Valsartan; Sacubitril; Medicine; Hazard ratio; Heart failure; Internal medicine; Ejection fraction; Confidence interval; Randomized controlled trial; Cardiology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.015059505277211086,"score_gpt":0.2544469955928558,"score_spread":0.23938749031564469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413467082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8649487,0.00023649955,0.00015976475,0.13276617,0.0004658919,0.0010148019,0.000005353465,0.000039772345,0.00036301953],"genre_scores_gemma":[0.9911367,0.000052391457,0.0060822214,0.00041240227,0.0011763257,0.000007992641,0.000005696956,0.00006977322,0.0010564639],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965454,0.00086860853,0.0009957633,0.00035300362,0.00079421495,0.0004430472],"domain_scores_gemma":[0.99813324,0.00031833007,0.0005192432,0.0005618782,0.00020192325,0.0002654025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016208744,0.00035830276,0.0009826696,0.0003478234,0.00017054359,0.000044624718,0.00019174845,0.000077217745,0.0006353187],"category_scores_gemma":[0.0002165341,0.00017804881,0.00040025378,0.00044635579,0.00018077357,0.0003311744,0.00006939418,0.0004882053,0.00018168201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1424039,0.002258735,0.04440287,0.00012182446,0.0009821062,0.0011766969,0.0007765844,0.00007162117,0.058250923,0.00010636297,0.74801624,0.0014321359],"study_design_scores_gemma":[0.0474048,0.005841341,0.053901244,0.0008912326,0.00029498216,0.0007913322,0.00026662895,0.0000025999136,0.008573314,0.000012072079,0.88178164,0.00023880033],"about_ca_topic_score_codex":0.000011268878,"about_ca_topic_score_gemma":0.000036840087,"teacher_disagreement_score":0.13376541,"about_ca_system_score_codex":0.00022489163,"about_ca_system_score_gemma":0.00018422994,"threshold_uncertainty_score":0.72606194},"labels":[],"label_agreement":null},{"id":"W2464585615","doi":"10.1002/ejhf.633","title":"Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes","year":2016,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Saxagliptin; Empagliflozin; Heart failure; Liraglutide; Metformin; Diabetes mellitus; Internal medicine; Population; Incretin; Type 2 diabetes; Cardiology; Sitagliptin; Intensive care medicine; Endocrinology","score_opus":0.07656538118847907,"score_gpt":0.3724456152186598,"score_spread":0.29588023403018077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464585615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14546809,0.8467256,0.0000059769404,0.0031623142,0.00092679,0.0033326994,0.00007605431,0.00003165501,0.00027083058],"genre_scores_gemma":[0.03710876,0.9497147,0.009642233,0.0007168227,0.0012019275,0.00003445385,0.00014300586,0.0005499648,0.0008881243],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99143016,0.0025751418,0.0044268076,0.0003931204,0.00068625994,0.0004884775],"domain_scores_gemma":[0.9961681,0.00075280585,0.0021110654,0.00051553943,0.00017251118,0.0002799963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0075377044,0.0005687752,0.0060716486,0.000911746,0.000023831846,0.00003573524,0.00031360835,0.00013646527,0.00017006566],"category_scores_gemma":[0.001147349,0.00030562925,0.0014650348,0.00034882245,0.00009474611,0.00019401168,0.00015185591,0.00081425044,0.00010049752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019696294,0.0014829221,0.66559255,0.0045504645,0.0017529381,0.00026507897,0.00003578657,9.5210146e-7,0.0000015447919,0.0000034610632,0.027376167,0.2987412],"study_design_scores_gemma":[0.0076168436,0.0019385722,0.10655772,0.04518404,0.0009969764,0.0000050092135,0.0000127127205,1.03444236e-7,0.000003197266,0.0000015901612,0.8374436,0.00023966562],"about_ca_topic_score_codex":8.5037664e-7,"about_ca_topic_score_gemma":0.0000047302665,"teacher_disagreement_score":0.8100674,"about_ca_system_score_codex":0.00014547797,"about_ca_system_score_gemma":0.00018413129,"threshold_uncertainty_score":0.99993956},"labels":[],"label_agreement":null},{"id":"W2465883722","doi":"10.1002/ejhf.566","title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":778,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Boston Scientific Corporation; Boehringer Ingelheim; Sanofi; Bayer; AstraZeneca; ResMed; Eli Lilly and Company; Servier; Amgen","keywords":"Medicine; Heart failure; Observational study; Internal medicine; Epidemiology; Cardiology; Mortality rate; Clinical endpoint; Intensive care medicine; Clinical trial","score_opus":0.026350338999283726,"score_gpt":0.2768683231665758,"score_spread":0.25051798416729204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465883722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87550795,0.0004256488,0.00093930925,0.121777005,0.00037388655,0.00037332394,0.000032138978,0.00006748598,0.00050326873],"genre_scores_gemma":[0.9840001,0.00030206903,0.010825843,0.00057911855,0.00065472827,0.000002034482,0.000007807987,0.0000825847,0.0035457239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671906,0.00079032726,0.0009415208,0.00043497208,0.000524101,0.0005899903],"domain_scores_gemma":[0.99796355,0.0001802292,0.0004470506,0.00066010846,0.0002996759,0.0004494111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014389307,0.000421814,0.0011555126,0.00012848999,0.00021403139,0.0000615942,0.0002860913,0.000090389214,0.000090392525],"category_scores_gemma":[0.00016510078,0.00025170654,0.00080574997,0.00017529962,0.00048219497,0.00024446973,0.0002569508,0.00044455682,0.00011046571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017294963,0.00007937102,0.6227191,0.00013866596,0.00065447704,0.00039368618,0.0004650372,3.9702877e-7,0.0067139,0.000051680912,0.36750153,0.0011092158],"study_design_scores_gemma":[0.0061049806,0.0011032934,0.65207225,0.0008045796,0.0002940724,0.0011269613,0.0007094292,3.5680122e-7,0.0002926175,0.000012939442,0.33722743,0.0002510493],"about_ca_topic_score_codex":0.000004120229,"about_ca_topic_score_gemma":0.00001812321,"teacher_disagreement_score":0.12119789,"about_ca_system_score_codex":0.000060361297,"about_ca_system_score_gemma":0.00008751327,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W2471068922","doi":"10.1002/ejhf.602","title":"June 2016 at a Glance: Epidemiology, Renal Impairment, Heart Failure with Preserved Ejection Fraction","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure with preserved ejection fraction; Heart failure; Cardiology; Internal medicine; Ejection fraction; Cardiorenal syndrome; Renal function; Diastole; Left ventricular hypertrophy; Endothelial dysfunction; Blood pressure","score_opus":0.02173910680434283,"score_gpt":0.2737608855791606,"score_spread":0.2520217787748178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471068922","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44753245,0.00071260775,0.005707906,0.5429435,0.0006796119,0.0011752816,0.000016346346,0.00020146888,0.0010308834],"genre_scores_gemma":[0.8724037,0.00024826216,0.10096056,0.002581072,0.0026142509,0.000019474295,0.000028313034,0.00016571279,0.020978676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965402,0.0010859167,0.0008988384,0.0004161321,0.000467923,0.0005909739],"domain_scores_gemma":[0.99791086,0.00024606523,0.0005334964,0.00051025604,0.0003166145,0.00048273543],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023751224,0.00036247223,0.0008056991,0.00030867246,0.00021656051,0.000026057683,0.0001445272,0.000089722904,0.0010250276],"category_scores_gemma":[0.00027904465,0.00019527554,0.00035257428,0.0002410859,0.00015208362,0.0004838953,0.00009878692,0.00044519565,0.0008520247],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014728988,0.00023210097,0.12840281,0.00004612766,0.00032563185,0.00027906467,0.000033589706,0.000008527087,0.022599949,0.00001612462,0.84608155,0.00050160673],"study_design_scores_gemma":[0.006042661,0.0032570767,0.077626504,0.0009767306,0.00024166984,0.0018199421,0.00009925368,0.0000055456085,0.0018381081,0.00002266672,0.9078565,0.00021332756],"about_ca_topic_score_codex":0.000011380608,"about_ca_topic_score_gemma":0.00005416674,"teacher_disagreement_score":0.54036236,"about_ca_system_score_codex":0.0003499348,"about_ca_system_score_gemma":0.00013162378,"threshold_uncertainty_score":0.9999259},"labels":[],"label_agreement":null},{"id":"W2491534867","doi":"10.1002/ejhf.609","title":"Worsening Renal Function and Outcome in Heart Failure Patients with Reduced and Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment: Data from the CHARM-Study Programme","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University; Population Health Research Institute","funders":"Netherlands Heart Institute; ICIN Netherlands Heart Institute","keywords":"Medicine; Ejection fraction; Heart failure; Charm (quantum number); Angiotensin receptor; Cardiology; Internal medicine; Angiotensin II; Renal function; Receptor","score_opus":0.035708608849143786,"score_gpt":0.27636692965022525,"score_spread":0.24065832080108146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491534867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96483445,0.00022197187,0.00003759364,0.033764057,0.000050003346,0.0010591218,0.000015257807,0.00001286985,0.0000046999617],"genre_scores_gemma":[0.9966487,0.000034682387,0.0029464036,0.00005076104,0.0002028051,0.0000047748335,0.00002308364,0.00002795213,0.00006081877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980433,0.0006952926,0.00048024126,0.0002869733,0.000285172,0.00020901332],"domain_scores_gemma":[0.99887186,0.00018862826,0.00028514955,0.00039292267,0.00013449788,0.00012696104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00106267,0.00022236818,0.0004536873,0.00012412488,0.00012857992,0.00006300417,0.00007144778,0.000033277516,0.00003661154],"category_scores_gemma":[0.00013835951,0.00008636113,0.000078033845,0.00016473331,0.0001336444,0.0003617696,0.00008988142,0.00021302635,0.0000035894627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035859987,0.0003933288,0.9776984,0.0000062180343,0.00052758463,0.000014215091,0.00036872734,0.0000012785088,0.0019412879,8.532357e-7,0.012197544,0.00326459],"study_design_scores_gemma":[0.017134279,0.004220103,0.9540929,0.00028006182,0.00044921474,0.000040608265,0.0007645511,0.000025612773,0.00005526332,0.000004548437,0.022837635,0.00009522235],"about_ca_topic_score_codex":0.0002733799,"about_ca_topic_score_gemma":0.00014164657,"teacher_disagreement_score":0.033713296,"about_ca_system_score_codex":0.00006848067,"about_ca_system_score_gemma":0.000035718313,"threshold_uncertainty_score":0.35217047},"labels":[],"label_agreement":null},{"id":"W2506970510","doi":"10.1002/ejhf.620","title":"July 2016 at a Glance: The Critical Role of Co-Morbidities","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Kidney disease; Diabetes mellitus; Intensive care medicine; Quality of life (healthcare); Clinical trial; Disease; Obesity; Cardiology; Physical therapy; Nursing","score_opus":0.01234341980040214,"score_gpt":0.27295331129142764,"score_spread":0.2606098914910255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506970510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7226342,0.005418161,0.000077405835,0.2514265,0.0003903156,0.00019711003,0.000042906187,0.00003211857,0.019781288],"genre_scores_gemma":[0.9931186,0.00021952386,0.0023034068,0.0004857695,0.0006649492,4.709653e-7,8.0979464e-7,0.000024459738,0.0031820496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878895,0.00023804836,0.00037725287,0.00009195891,0.00031851602,0.00018524243],"domain_scores_gemma":[0.99910843,0.00022451505,0.00012995029,0.0002140756,0.00017799794,0.00014501413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049318734,0.000112787486,0.00027309233,0.000045601853,0.00008293755,0.000009589574,0.00010873181,0.00002139021,0.0006745714],"category_scores_gemma":[0.00019576003,0.000048128168,0.00018984664,0.00004228736,0.00031540287,0.00006230478,0.00003618702,0.00017143732,0.00040776454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032608825,0.00016506012,0.008197251,0.000047635607,0.000094075156,0.00044575543,0.0005533485,2.3785338e-7,0.101777025,0.00019361786,0.8857199,0.002479988],"study_design_scores_gemma":[0.0018623704,0.0011473366,0.011848499,0.0008280595,0.000083549836,0.0025786727,0.0005234851,3.8381611e-7,0.02634776,0.0000585587,0.9546505,0.00007077662],"about_ca_topic_score_codex":0.000001145925,"about_ca_topic_score_gemma":6.5696014e-7,"teacher_disagreement_score":0.27048436,"about_ca_system_score_codex":0.000044271696,"about_ca_system_score_gemma":0.00007952422,"threshold_uncertainty_score":0.73860836},"labels":[],"label_agreement":null},{"id":"W2508365394","doi":"10.1002/ejhf.625","title":"August 2016 at a Glance: The New Esc Guidelines, and Pathophysiology, Epidemiology and Prognosis of Heart Failure","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiac resynchronization therapy; Decompensation; Internal medicine; Cardiology; Ejection fraction; Intensive care medicine","score_opus":0.035241050962261586,"score_gpt":0.29383484818034944,"score_spread":0.25859379721808784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508365394","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24019797,0.0072502396,0.00040083448,0.7512794,0.00017853307,0.00054569263,0.000012012801,0.00003114733,0.0001041533],"genre_scores_gemma":[0.77440256,0.0039887186,0.19712034,0.011703312,0.0025831538,0.000010998237,0.000010810043,0.0001407788,0.010039335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728715,0.0007969016,0.0009945413,0.0003076812,0.00021638942,0.00039730515],"domain_scores_gemma":[0.9981842,0.00041045563,0.00040786754,0.00035526007,0.0002651677,0.00037701876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020752938,0.00027374222,0.00083472836,0.00013889249,0.0001241651,0.000011829757,0.00013614293,0.00007368309,0.00019512151],"category_scores_gemma":[0.0007303372,0.00012785725,0.00021132927,0.00012492566,0.0004126166,0.00013478764,0.00020907489,0.00025423217,0.00006354104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002329803,0.00005361677,0.060080875,0.00005389828,0.00016624716,0.000071932795,0.00008710932,6.9862745e-7,0.019329797,0.00011970679,0.91318476,0.0066183605],"study_design_scores_gemma":[0.0030041889,0.0014884877,0.06695038,0.00066848035,0.00020944104,0.0009182006,0.0001092496,0.000002318806,0.00049469806,0.00016665898,0.9258558,0.00013209149],"about_ca_topic_score_codex":0.000016048662,"about_ca_topic_score_gemma":0.000013687889,"teacher_disagreement_score":0.7395761,"about_ca_system_score_codex":0.000040200703,"about_ca_system_score_gemma":0.000118578515,"threshold_uncertainty_score":0.52138674},"labels":[],"label_agreement":null},{"id":"W2508404809","doi":"10.1002/ejhf.621","title":"A Tentative Interpretation of the TOPCAT Trial Based on Randomized Evidence from the Brain Natriuretic Peptide Stratum Analysis","year":2016,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Spironolactone; Internal medicine; Ejection fraction; Placebo; Natriuretic peptide; Cardiology; Randomized controlled trial; Brain natriuretic peptide; Randomization; Aldosterone; Heart failure with preserved ejection fraction; Clinical trial","score_opus":0.018466946405739586,"score_gpt":0.274609663621698,"score_spread":0.2561427172159584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508404809","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004008344,0.00029784598,0.002367495,0.9906396,0.00058531965,0.0017222984,0.000035663033,0.0000131947745,0.00033021616],"genre_scores_gemma":[0.5247003,0.00007372235,0.0071897334,0.45390645,0.008399389,0.000033625955,0.00009256897,0.0001405378,0.0054636938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.990823,0.0060724295,0.0012759634,0.00033422446,0.0012191824,0.00027521927],"domain_scores_gemma":[0.9927532,0.004693712,0.0013375608,0.00076387555,0.00036295145,0.00008871439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035454377,0.0003965128,0.0015275461,0.00037914418,0.000102092585,0.00007495937,0.00048541912,0.0001223779,0.00046019326],"category_scores_gemma":[0.0020781145,0.00016241806,0.002274129,0.00045745197,0.000288058,0.00011418025,0.00006903646,0.0015160113,0.000049070728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08740148,0.000052661744,0.00014228586,0.000041276773,0.0027105017,0.000300686,0.00061821844,0.00004212046,0.00013507008,0.0000034106718,0.908165,0.00038733438],"study_design_scores_gemma":[0.29572728,0.0024034998,0.0012398324,0.006335679,0.015158262,0.000035593373,0.00023146748,0.00036645128,0.0001752991,0.000059233094,0.677964,0.00030341666],"about_ca_topic_score_codex":0.000028293249,"about_ca_topic_score_gemma":0.000015566424,"teacher_disagreement_score":0.53673315,"about_ca_system_score_codex":0.00012482321,"about_ca_system_score_gemma":0.0002745303,"threshold_uncertainty_score":0.6623216},"labels":[],"label_agreement":null},{"id":"W2508788883","doi":"10.1002/ejhf.614","title":"Severity of Renal Impairment in Patients with Heart Failure and Atrial Fibrillation: Implications for Non-Vitamin K Antagonist Oral Anticoagulant Dose Adjustment","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Montreal Heart Institute; University of British Columbia","funders":"","keywords":"Medicine; Renal function; Atrial fibrillation; Kidney disease; Heart failure; Internal medicine; Cardiology; Vitamin K antagonist; Urology; Warfarin","score_opus":0.021407781524551507,"score_gpt":0.281220157655224,"score_spread":0.2598123761306725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508788883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95657915,0.00005940861,0.0007500156,0.041597065,0.000116091855,0.00083475973,0.00003954054,0.000009852814,0.000014140674],"genre_scores_gemma":[0.9805797,0.000023424658,0.018312326,0.00007413057,0.00089937804,4.2871991e-7,0.00001717531,0.000025414249,0.000068030604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852026,0.00013947737,0.0006783713,0.00018520809,0.0002716436,0.00020502547],"domain_scores_gemma":[0.99893427,0.00010492551,0.00035398334,0.00019708324,0.00026267124,0.0001470766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006038552,0.0001670517,0.00048508157,0.00019307883,0.000072918374,0.000022275468,0.00006385942,0.000032453623,0.000027941584],"category_scores_gemma":[0.00007326588,0.00010177001,0.00020404112,0.00015779385,0.00007636949,0.0002019747,0.000049704835,0.00008705944,0.0000044202925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018286925,0.000022884291,0.9815359,0.000056774294,0.00010535168,0.0000041679496,0.00006280797,0.000035218327,0.0020469094,0.00003739475,0.011901266,0.0023626136],"study_design_scores_gemma":[0.011780693,0.0020307016,0.9057137,0.0002879761,0.00011562812,0.000043095853,0.000043001914,0.000011244718,0.000174864,0.000014250376,0.079668276,0.00011658258],"about_ca_topic_score_codex":0.000002570145,"about_ca_topic_score_gemma":0.000006851761,"teacher_disagreement_score":0.07582223,"about_ca_system_score_codex":0.00006273697,"about_ca_system_score_gemma":0.000082967854,"threshold_uncertainty_score":0.41500604},"labels":[],"label_agreement":null},{"id":"W2520469335","doi":"10.1002/ejhf.627","title":"September 2016 at a Glance: Pregnancy, Hypertrophic Cardiomyopathy, Epidemiology, Medical Treatment","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Peripartum cardiomyopathy; Heart failure; Atrial fibrillation; Pulmonary hypertension; Pregnancy; Internal medicine; Cardiology; Hypertrophic cardiomyopathy; Cardiomyopathy; Clinical trial; Epidemiology; Heart disease; Intensive care medicine","score_opus":0.02513248292650871,"score_gpt":0.28643533455587455,"score_spread":0.26130285162936584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520469335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72104716,0.17224377,0.003485206,0.08132139,0.003279438,0.0011075686,0.000044888704,0.00022469116,0.017245887],"genre_scores_gemma":[0.96235573,0.0063144634,0.013351792,0.0010283622,0.0037089996,0.000010733268,0.000006657876,0.0001810989,0.013042173],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957252,0.0014512859,0.0010829197,0.00040690126,0.0007705255,0.00056317],"domain_scores_gemma":[0.99736667,0.0003913532,0.00033464588,0.00088356837,0.0002785203,0.0007452647],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002403268,0.00035376768,0.0013666413,0.00017092112,0.0000992468,0.000008058736,0.00027280557,0.00013033314,0.0012859049],"category_scores_gemma":[0.0013166671,0.00018760446,0.0013795446,0.00013776038,0.00030983365,0.00012875015,0.00018412077,0.0003716437,0.0014717525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085432327,0.0004188237,0.17328465,0.00017263126,0.0027580722,0.038916226,0.00033776334,0.000010635607,0.0076896097,0.00006549464,0.644487,0.13100475],"study_design_scores_gemma":[0.0070033846,0.0015472207,0.01789875,0.0060324,0.00043390036,0.06075323,0.000018428547,0.0000027385938,0.00067107606,0.000036917136,0.9053699,0.00023209972],"about_ca_topic_score_codex":0.000002341105,"about_ca_topic_score_gemma":0.0000036611805,"teacher_disagreement_score":0.26088285,"about_ca_system_score_codex":0.00039278364,"about_ca_system_score_gemma":0.0002920035,"threshold_uncertainty_score":0.99962705},"labels":[],"label_agreement":null},{"id":"W2522132836","doi":"10.1002/ejhf.629","title":"Insufficient Reduction in Heart Rate During Hospitalization Despite Beta-Blocker Treatment in Acute Decompensated Heart Failure: Insights from the ASCEND-HF Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Cardiology; Acute decompensated heart failure; Ejection fraction; Beta blocker; Confidence interval; Adverse effect; Heart failure with preserved ejection fraction","score_opus":0.013915317144057271,"score_gpt":0.25478555639352035,"score_spread":0.24087023924946308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522132836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95074916,0.0008311195,0.00007923081,0.046779327,0.0005676531,0.0009365093,0.000008049796,0.000032168697,0.000016775073],"genre_scores_gemma":[0.99644774,0.00027536546,0.0015853797,0.00045514872,0.0010590806,0.000009304452,0.000016779491,0.00006993889,0.000081247286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99484634,0.0024211332,0.0012418055,0.00042707362,0.00058042485,0.00048320563],"domain_scores_gemma":[0.9985317,0.00011004355,0.0002649392,0.00054085965,0.00023689891,0.00031555662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016817583,0.00033860694,0.0008785647,0.00037699926,0.00017527364,0.000070415226,0.00013846358,0.00010068328,0.00007577495],"category_scores_gemma":[0.00011954226,0.0001915893,0.00048709704,0.0006164359,0.00008528596,0.00032102977,0.000047194382,0.00049191207,0.00015289389],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039076436,0.0041420143,0.14148812,0.00012989972,0.002330787,0.0047320332,0.011955814,0.00086419506,0.7259778,0.00006487506,0.06359282,0.005645211],"study_design_scores_gemma":[0.06582693,0.0032637129,0.6230392,0.001191068,0.00029714606,0.0015326069,0.00065925333,0.000023776798,0.01996903,0.000015175972,0.28380966,0.00037241526],"about_ca_topic_score_codex":0.000098863435,"about_ca_topic_score_gemma":0.00014812873,"teacher_disagreement_score":0.70600873,"about_ca_system_score_codex":0.0004975167,"about_ca_system_score_gemma":0.00038929153,"threshold_uncertainty_score":0.78127843},"labels":[],"label_agreement":null},{"id":"W2530342585","doi":"10.1002/ejhf.672","title":"October 2016 at a Glance: Treatment of Heart Failure","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Sacubitril; Enalapril; Heart failure; Valsartan; Ejection fraction; Internal medicine; Placebo; Cardiology; Clinical trial; Randomized controlled trial; ACE inhibitor; Angiotensin-converting enzyme; Blood pressure","score_opus":0.016002497365910827,"score_gpt":0.2549859059333773,"score_spread":0.23898340856746644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530342585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6451807,0.0023768393,0.0004262656,0.34830737,0.0005825971,0.0010015763,0.00003890507,0.00010264301,0.0019830645],"genre_scores_gemma":[0.9291575,0.0004458768,0.044270065,0.000763942,0.0012288447,0.0000067913497,0.000009548706,0.00011899218,0.023998415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735135,0.00036493017,0.0008980225,0.00031387858,0.00058823853,0.00048359728],"domain_scores_gemma":[0.99820834,0.000113030794,0.0003599602,0.0005679533,0.00029516072,0.00045554363],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000582609,0.00037149253,0.0008896339,0.00029300465,0.000102923994,0.00002116121,0.00014564682,0.00006281573,0.0015069745],"category_scores_gemma":[0.0000681609,0.00020063481,0.0005895171,0.00019989371,0.00017948415,0.00020982884,0.00007798507,0.00014051772,0.0010302498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006640547,0.0006382805,0.03660496,0.000060320057,0.00048146688,0.00068077544,0.00029258686,0.0000015834074,0.06581219,0.00007349134,0.8896283,0.0050620143],"study_design_scores_gemma":[0.00764539,0.0042300997,0.018721845,0.0006877379,0.00029050276,0.0011503334,0.00010478584,6.665951e-7,0.009899885,0.000011771085,0.95706403,0.00019297132],"about_ca_topic_score_codex":0.0000065175323,"about_ca_topic_score_gemma":0.000016355745,"teacher_disagreement_score":0.34754345,"about_ca_system_score_codex":0.00029675354,"about_ca_system_score_gemma":0.00015491665,"threshold_uncertainty_score":0.9997476},"labels":[],"label_agreement":null},{"id":"W2533505636","doi":"10.1002/ejhf.651","title":"Heterogeneity Across One Disease, Two Drugs, Three Trials, and Four Guidelines: Are we Further Ahead?","year":2016,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; MEDLINE; Disease; Clinical trial; Internal medicine","score_opus":0.12251483180100713,"score_gpt":0.3506314400125057,"score_spread":0.22811660821149854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533505636","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004568266,0.0070465365,0.0005984348,0.9857878,0.00071750174,0.00092777086,0.00018087508,0.00007535587,0.000097462034],"genre_scores_gemma":[0.015676025,0.005323253,0.06567676,0.80612487,0.09107865,0.00003544784,0.00021420486,0.0010237179,0.014847067],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99359906,0.0015399273,0.0021172904,0.0006527845,0.0012349623,0.00085596426],"domain_scores_gemma":[0.996047,0.00028209807,0.0013593332,0.0009147985,0.0007166006,0.0006801643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004243061,0.0007899342,0.0022669171,0.0003151805,0.0001930158,0.00018740482,0.00034137693,0.00020174275,0.00040621436],"category_scores_gemma":[0.000497083,0.00049834553,0.0010607028,0.0001510581,0.0001871743,0.00022770301,0.00026086372,0.0015973599,0.00036432242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004552978,0.000096405005,0.0022458606,0.00037406746,0.0011701953,0.006888318,0.00012548933,0.0000011797704,0.000110042674,0.0000024457606,0.97914684,0.009383834],"study_design_scores_gemma":[0.0067839064,0.0006062242,0.002203588,0.004126167,0.0013240463,0.00060556293,0.00010031148,0.000002680839,0.00002827799,0.000055654087,0.9837068,0.00045681873],"about_ca_topic_score_codex":0.000006833148,"about_ca_topic_score_gemma":0.00002775673,"teacher_disagreement_score":0.17966293,"about_ca_system_score_codex":0.00013739907,"about_ca_system_score_gemma":0.0002013338,"threshold_uncertainty_score":0.9997468},"labels":[],"label_agreement":null},{"id":"W2542456927","doi":"10.1002/ejhf.657","title":"Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"Sanofi France; Pfizer; Daiichi-Sankyo; Novo Nordisk; Steno Diabetes Center Copenhagen; Bayer; Novartis","keywords":"Medicine; Liraglutide; Heart failure; Placebo; Diabetes mellitus; Internal medicine; Glucagon-like peptide-1; Cardiology; Glucagon; Double blind; Endocrinology; Insulin; Type 2 diabetes","score_opus":0.006214557916760957,"score_gpt":0.22044858257250555,"score_spread":0.2142340246557446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542456927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328285,0.0005532868,0.000028165614,0.0011403546,0.0002534183,0.0046151415,0.0000052369373,0.000022273165,0.00009928592],"genre_scores_gemma":[0.9987835,0.000032965236,0.0003576156,0.000099583835,0.00025724326,0.000033515986,0.000017514963,0.00006172897,0.00035631182],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99669665,0.0009281502,0.00087840785,0.00035849796,0.00064142403,0.0004968708],"domain_scores_gemma":[0.9982464,0.0003703391,0.00058175006,0.00031204245,0.00022261296,0.00026690622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018507296,0.0004115015,0.0013495634,0.00051685906,0.000080237936,0.000048269412,0.00011199688,0.00006243124,0.00011496123],"category_scores_gemma":[0.00016669605,0.00021943892,0.00033309005,0.00020308238,0.00009422629,0.00030582907,0.0000538176,0.0003072923,0.000045528228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7737974,0.0007166746,0.2174011,0.00018060746,0.0009958685,0.00006208983,0.000053804608,0.00007110687,0.00073584856,0.0000023080229,0.0050752326,0.00090796605],"study_design_scores_gemma":[0.93618625,0.023980951,0.020288019,0.0017232988,0.0013476094,0.000011098774,0.000034309902,0.000027736929,0.0014068143,9.984984e-7,0.014771049,0.00022183763],"about_ca_topic_score_codex":0.0000045851884,"about_ca_topic_score_gemma":0.000025758041,"teacher_disagreement_score":0.1971131,"about_ca_system_score_codex":0.00016951669,"about_ca_system_score_gemma":0.00008962599,"threshold_uncertainty_score":0.89484596},"labels":[],"label_agreement":null},{"id":"W2551090271","doi":"10.1002/ejhf.687","title":"Dementia-Related Adverse Events in PARADIGM-HF and Other Trials in Heart Failure with Reduced Ejection Fraction","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Heart failure; Ejection fraction; Medicine; Dementia; Internal medicine; Adverse effect; Cardiology; Disease","score_opus":0.0216586282851198,"score_gpt":0.27372663547718634,"score_spread":0.25206800719206657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551090271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9325988,0.00016756234,0.00028262482,0.06583562,0.00016820237,0.00070605456,0.0000021530066,0.000028861163,0.00021009099],"genre_scores_gemma":[0.9922534,0.0000426917,0.0068037054,0.00034812625,0.00017392993,0.000005526344,0.0000023026134,0.00004823601,0.000322041],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665636,0.0013344042,0.0010647686,0.00027378785,0.00036284502,0.00030783575],"domain_scores_gemma":[0.9989995,0.00014361447,0.00039596795,0.0002017012,0.00006576777,0.00019348323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003534424,0.00023951624,0.0007422243,0.00057019305,0.000053814805,0.000012021562,0.000058634945,0.000065894936,0.0003270152],"category_scores_gemma":[0.0002177614,0.00014253953,0.0001638563,0.00031234632,0.00004729545,0.00036288038,0.00002606121,0.00033820636,0.0001130272],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002337054,0.00081586704,0.8708823,0.000089043846,0.00079303107,0.0007723571,0.00049953,0.000043276665,0.0486183,0.0000878309,0.07159979,0.0034616706],"study_design_scores_gemma":[0.019348778,0.001990173,0.35550833,0.002171963,0.00035974095,0.00087763247,0.0005621538,0.000009761926,0.0015385817,0.000053937143,0.6173079,0.00027106825],"about_ca_topic_score_codex":0.00002068514,"about_ca_topic_score_gemma":0.00009156005,"teacher_disagreement_score":0.5457081,"about_ca_system_score_codex":0.00014631436,"about_ca_system_score_gemma":0.000075916585,"threshold_uncertainty_score":0.58125937},"labels":[],"label_agreement":null},{"id":"W2551804720","doi":"10.1002/ejhf.693","title":"November 2016 at a Glance: The Left Atrium, Screening for Heart Failure, Multimodality Imaging for Cardiac Resynchronization Therapy","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Cardiac resynchronization therapy; Ejection fraction; Atrial fibrillation; Mace; Asymptomatic; Population; Ventricular dyssynchrony; Cardiac imaging; Myocardial infarction","score_opus":0.02334475447714199,"score_gpt":0.28991368554305086,"score_spread":0.26656893106590884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551804720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3791737,0.018312858,0.2919056,0.3011384,0.0025153644,0.003731535,0.00045683404,0.00025292812,0.0025127705],"genre_scores_gemma":[0.9653938,0.00015350178,0.029716725,0.0009994272,0.002693514,0.000005613991,0.000010221362,0.00007966825,0.0009475698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981552,0.00032536723,0.000568188,0.00024632816,0.00036806878,0.00033689963],"domain_scores_gemma":[0.9977672,0.00063185405,0.00030967782,0.00032459866,0.0008291227,0.00013754798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020342718,0.00021192589,0.0005888927,0.00010329287,0.0004186201,0.000053112282,0.000053033516,0.000032727487,0.000020550573],"category_scores_gemma":[0.0005040391,0.00011309801,0.00068882183,0.00010663745,0.000117612166,0.0001890392,0.00005357068,0.00014312293,0.000025753889],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010135153,0.000020186855,0.08887042,0.00004064072,0.0003127375,0.0000040718896,0.0003557656,0.00006621966,0.03772636,0.000015365316,0.86692643,0.0046482636],"study_design_scores_gemma":[0.004301658,0.00023837315,0.06187903,0.00035175547,0.00010201071,0.0004609935,0.00018244008,0.000037455695,0.0022327662,0.000012861817,0.9300484,0.0001522253],"about_ca_topic_score_codex":0.0000039653805,"about_ca_topic_score_gemma":0.000002824958,"teacher_disagreement_score":0.5862201,"about_ca_system_score_codex":0.000091644855,"about_ca_system_score_gemma":0.000092015405,"threshold_uncertainty_score":0.4612003},"labels":[],"label_agreement":null},{"id":"W2560671033","doi":"10.1002/ejhf.710","title":"December 2016 at a Glance: Cardiac Metabolism, Myocarditis, Right Ventricular Function and Prognostic Markers","year":2016,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Dilated cardiomyopathy; Heart failure; Myocarditis; Contractility; Internal medicine; Cardiology; Beta oxidation; Cardiomyopathy; Viral Myocarditis; Glycolysis; Fibrosis; Fatty acid metabolism; Metabolism","score_opus":0.00732202275288144,"score_gpt":0.23236698949043283,"score_spread":0.2250449667375514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560671033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716896,0.014804731,0.00039525735,0.010958023,0.0006750492,0.0002582648,0.00001079802,0.000025423142,0.0011828571],"genre_scores_gemma":[0.99533427,0.0011747782,0.0007200495,0.00017155228,0.0006647334,0.000002783484,0.0000032669013,0.00003405635,0.0018944952],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984794,0.0005334262,0.00031310084,0.0001581553,0.00025575425,0.00026015277],"domain_scores_gemma":[0.9991757,0.00007741273,0.0001177284,0.00018261441,0.00025870284,0.00018779935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008627934,0.00013027016,0.00034488316,0.00017825639,0.00014832184,0.000025003477,0.000054105345,0.00004315806,0.000414922],"category_scores_gemma":[0.0001955911,0.00007257182,0.00020787166,0.00015329526,0.00014382554,0.00019144305,0.00006647174,0.0002847243,0.00029511843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010059378,0.00011803527,0.2262792,0.00004324945,0.0009780247,0.0011657461,0.000024548179,9.028082e-7,0.057001207,0.000048146932,0.70307577,0.0102592595],"study_design_scores_gemma":[0.0015002381,0.0006179895,0.38328335,0.00019597754,0.00017255236,0.0017154614,0.000017515187,6.354643e-7,0.000543099,0.000012229825,0.61187506,0.00006592104],"about_ca_topic_score_codex":0.0000016473182,"about_ca_topic_score_gemma":5.799845e-7,"teacher_disagreement_score":0.15700413,"about_ca_system_score_codex":0.000057804817,"about_ca_system_score_gemma":0.00007146552,"threshold_uncertainty_score":0.45431048},"labels":[],"label_agreement":null},{"id":"W2573366583","doi":"10.1002/ejhf.703","title":"Diabetes and Heart Failure in the Crosshairs: Where is the Target?","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Heart failure; Diabetes mellitus; Cardiology; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.013410769019944894,"score_gpt":0.2573411914697717,"score_spread":0.2439304224498268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573366583","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04172953,0.0040997816,0.0000038920466,0.95250076,0.00042626422,0.00038345298,0.000041355088,0.00001134337,0.0008035957],"genre_scores_gemma":[0.20627566,0.00019726793,0.002281901,0.7804099,0.0090286825,0.000009055063,0.000033891676,0.00013766848,0.0016260014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665284,0.0007916088,0.00082203443,0.00034168948,0.0007965981,0.00059524574],"domain_scores_gemma":[0.99796015,0.0003865999,0.00036303952,0.0008190447,0.0003167412,0.00015439827],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014402578,0.00043253833,0.000914048,0.00014473312,0.00042129506,0.0004014364,0.0006955419,0.0002793278,0.0002913545],"category_scores_gemma":[0.00037093373,0.00021885247,0.00049477734,0.00009482754,0.00047012212,0.00018654838,0.00011937582,0.004354703,0.00008542448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007163677,0.00004531234,0.013829884,0.00019818448,0.00012623085,0.0016093217,0.000980596,3.5769693e-7,0.00014339731,0.000003840842,0.9827737,0.00021748728],"study_design_scores_gemma":[0.0024127157,0.0009061763,0.006598791,0.0014933131,0.00023204566,0.001472105,0.00037862884,0.0000061070464,0.000014425808,0.000079386424,0.9861657,0.00024060557],"about_ca_topic_score_codex":0.000008727428,"about_ca_topic_score_gemma":0.000006560461,"teacher_disagreement_score":0.1720909,"about_ca_system_score_codex":0.000030340807,"about_ca_system_score_gemma":0.00014816776,"threshold_uncertainty_score":0.99794227},"labels":[],"label_agreement":null},{"id":"W2578217499","doi":"10.1002/ejhf.741","title":"January 2017 at a Glance: Oncology, Diabetes and Antidiabetic Treatment, Pulmonary Hypertension","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Empagliflozin; Heart failure; Diabetes mellitus; Internal medicine; Cancer; Disease; Intensive care medicine; Coronary artery disease; Stroke (engine); Cause of death; Cardiology; Type 2 diabetes","score_opus":0.02975554483633921,"score_gpt":0.27876482327322966,"score_spread":0.24900927843689044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578217499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97995126,0.0017099277,0.000002891241,0.015219011,0.00019477932,0.00015392779,0.000004503332,0.000013194687,0.0027505073],"genre_scores_gemma":[0.99580145,0.00084878004,0.0015013705,0.00066869956,0.0006929418,7.09776e-7,0.000005472936,0.0000254164,0.00045515032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990123,0.0001845996,0.0002729141,0.00016441973,0.00016666319,0.0001990986],"domain_scores_gemma":[0.99898,0.000051037383,0.0003039677,0.00034153645,0.00011267972,0.00021077516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048208388,0.00015229108,0.00045525585,0.00007824548,0.00035511787,0.0000448489,0.00009539897,0.000057388064,0.000020725207],"category_scores_gemma":[0.00009396564,0.00011208876,0.00017356795,0.000024891206,0.0001707097,0.0001908493,0.000053017095,0.0002312355,0.00003602454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001934486,0.0001530317,0.059603427,0.000039331862,0.00013941013,0.0015957755,0.00018516864,6.9654413e-7,0.88593304,0.0000012925669,0.029488211,0.022667164],"study_design_scores_gemma":[0.004528692,0.002539582,0.46883696,0.00054062053,0.00023897552,0.007377303,0.00013170639,0.00003543218,0.1588474,0.000020511327,0.35672542,0.00017737901],"about_ca_topic_score_codex":0.0000021805554,"about_ca_topic_score_gemma":0.0000018496462,"teacher_disagreement_score":0.72708565,"about_ca_system_score_codex":0.00009774884,"about_ca_system_score_gemma":0.00006756464,"threshold_uncertainty_score":0.4570847},"labels":[],"label_agreement":null},{"id":"W2579727871","doi":"10.1002/ejhf.743","title":"Patient Outcome after Implant of a Cardioverter Defibrillator in the ‘Real World’: The Key Role of Co-Morbidities","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Implantable cardioverter-defibrillator; Heart failure; Clinical trial; Cardiac resynchronization therapy; Myocardial infarction; Sudden cardiac death; Internal medicine; Randomized controlled trial; Canadian Cardiovascular Society; Intensive care medicine; Cardiology; Ejection fraction; Angina","score_opus":0.021896139365766117,"score_gpt":0.275518861130573,"score_spread":0.2536227217648069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579727871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62247366,0.008285628,0.000006043367,0.1971466,0.0014774406,0.0008404067,0.00056206743,0.000020603822,0.16918756],"genre_scores_gemma":[0.9772747,0.00008201897,0.00014626104,0.019543068,0.0025975336,0.0000020006605,0.000009858085,0.00005019902,0.00029436703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967512,0.00079895346,0.0010880412,0.0001675071,0.00092759513,0.0002666872],"domain_scores_gemma":[0.9976565,0.00032127468,0.0009842246,0.00069725676,0.0002915064,0.00004921146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010349228,0.0002881076,0.0015303851,0.00029288876,0.00009458021,0.000048089893,0.00012033811,0.00008028109,0.000009970774],"category_scores_gemma":[0.00011261874,0.00014587323,0.00097471004,0.00009672695,0.0002482917,0.00006481714,0.00008546676,0.0010864958,0.000021282429],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019167417,0.000010039095,0.052739806,0.00013531807,0.00037522023,0.0003334365,0.0031817774,0.000008430944,0.000064553235,0.0000023442253,0.94279087,0.00016652801],"study_design_scores_gemma":[0.0005700993,0.00028294066,0.09202435,0.000541095,0.00030155116,0.003865319,0.00085211336,2.0276542e-7,0.00005827699,0.00000529682,0.9013752,0.00012356655],"about_ca_topic_score_codex":0.000057182726,"about_ca_topic_score_gemma":0.000014478972,"teacher_disagreement_score":0.35480106,"about_ca_system_score_codex":0.000041338953,"about_ca_system_score_gemma":0.00009831993,"threshold_uncertainty_score":0.59485376},"labels":[],"label_agreement":null},{"id":"W2583775195","doi":"10.1002/ejhf.760","title":"February 2017 at a Glance: Fibrosis, Acute Heart Failure and Neurologic Abnormalities","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiogenic shock; Heart failure; Acute coronary syndrome; Internal medicine; Cardiology; Atrial fibrillation; Intensive care medicine; Intensive care unit; Incidence (geometry); Myocardial infarction; Revascularization","score_opus":0.018105158361250304,"score_gpt":0.26486344489020264,"score_spread":0.24675828652895232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583775195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7593678,0.0011834094,0.000025840716,0.23737848,0.00044237782,0.00036865508,0.000017831977,0.00006426565,0.0011512925],"genre_scores_gemma":[0.969128,0.00027582736,0.024347126,0.0022305017,0.00091060606,0.000003426657,0.000012786701,0.0000634181,0.0030283125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977478,0.00032358125,0.0005925775,0.0003446003,0.00048082008,0.00051062106],"domain_scores_gemma":[0.99806505,0.000071306626,0.00043369728,0.00079185807,0.00016982618,0.00046828133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092091487,0.00036088147,0.0007182251,0.00018831337,0.00077025365,0.00026381097,0.0003075813,0.000073226314,0.00024503024],"category_scores_gemma":[0.00013940588,0.0002659728,0.0003080838,0.000058048525,0.00028703024,0.00054113765,0.00038005976,0.00054582505,0.00027991907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048332603,0.00010337487,0.10846497,0.00010618292,0.0002746993,0.0031131902,0.00023040954,0.0000021565916,0.005075247,0.000047997033,0.881744,0.0003543898],"study_design_scores_gemma":[0.0025961446,0.0016232287,0.31832275,0.00018737819,0.00029678596,0.0054900125,0.00011565413,0.0000052610344,0.00045958473,0.000015671441,0.67070115,0.0001863638],"about_ca_topic_score_codex":0.000019957146,"about_ca_topic_score_gemma":0.000030378002,"teacher_disagreement_score":0.23514798,"about_ca_system_score_codex":0.000054944052,"about_ca_system_score_gemma":0.000069352966,"threshold_uncertainty_score":0.99997926},"labels":[],"label_agreement":null},{"id":"W2589800099","doi":"10.1002/ejhf.778","title":"The Association of Chronic Kidney Disease and Microalbuminuria with Heart Failure with Preserved vs. Reduced Ejection Fraction","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Microalbuminuria; Heart failure; Ejection fraction; Cardiology; Internal medicine; Kidney disease; Heart failure with preserved ejection fraction; Disease","score_opus":0.0073830573210621146,"score_gpt":0.23426314668811976,"score_spread":0.22688008936705764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589800099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93225616,0.00078980863,0.000029660914,0.06619004,0.0001401235,0.0003252123,0.000016401918,0.000017869328,0.00023472626],"genre_scores_gemma":[0.9975613,0.000079856894,0.00079258846,0.0002730278,0.00072530797,0.0000023601403,0.000011319966,0.000040311075,0.0005139253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984526,0.000286047,0.00036269843,0.00018762192,0.00046197488,0.00024904378],"domain_scores_gemma":[0.997714,0.00008311342,0.0007769307,0.00046443148,0.0004225427,0.00053898303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008276552,0.00017335248,0.000338968,0.00007389131,0.00046314244,0.00017001135,0.00014261036,0.00003876088,0.000050781902],"category_scores_gemma":[0.00074336905,0.00010311466,0.00012422193,0.00007210452,0.00014805587,0.00042158618,0.0000418547,0.00039570793,0.000011874803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033259809,0.00024077167,0.5071812,0.0002945088,0.00050428964,0.00006959385,0.00007647166,0.00001572828,0.050998762,0.000009269954,0.43697473,0.00030865733],"study_design_scores_gemma":[0.0056974776,0.0018199967,0.64921314,0.0013299733,0.00063732965,0.000119120356,0.00016043485,0.000046012603,0.005840175,0.000010920221,0.33497322,0.00015219112],"about_ca_topic_score_codex":0.000010195979,"about_ca_topic_score_gemma":0.00002403568,"teacher_disagreement_score":0.14203194,"about_ca_system_score_codex":0.00018498073,"about_ca_system_score_gemma":0.0007623265,"threshold_uncertainty_score":0.42048937},"labels":[],"label_agreement":null},{"id":"W2590357760","doi":"10.1002/ejhf.765","title":"Comparative Effectiveness of Transitional Care Services in Patients Discharged from the Hospital with Heart Failure: A Systematic Review and Network Meta-Analysis","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Public Health Ontario; University of Toronto; McMaster University; Population Health Research Institute","funders":"National Institute for Health and Care Research; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Medicine; Meta-analysis; Confidence interval; Relative risk; Randomized controlled trial; CINAHL; Transitional care; Heart failure; Emergency medicine; MEDLINE; Internal medicine; Physical therapy; Health care; Psychological intervention; Nursing","score_opus":0.04343051874592506,"score_gpt":0.31174802258152734,"score_spread":0.26831750383560227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590357760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002820607,0.99254245,0.00001788255,0.0028940372,0.00004100557,0.004054438,0.00014593906,0.0000073082724,0.000014880365],"genre_scores_gemma":[0.04986797,0.94098204,0.0070739514,0.00044950173,0.0002968911,0.0001938381,0.0009428152,0.00014938146,0.00004362686],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99267006,0.0044821566,0.0014978418,0.0003930175,0.0006900736,0.00026683084],"domain_scores_gemma":[0.9966191,0.0005133431,0.0015307689,0.0007093514,0.00045437986,0.00017307153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020952509,0.0006058801,0.010020006,0.00021396292,0.0001546954,0.00008016653,0.00032736783,0.000067139306,0.00006291365],"category_scores_gemma":[0.00003891237,0.00028071413,0.0022504975,0.00045479587,0.00011847835,0.00019224416,0.00007708236,0.00061346666,0.000016670592],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016329112,0.00042008387,0.003479565,0.7864938,0.20201103,0.00016538064,0.0010370584,0.000016079297,1.3026511e-7,0.000009488637,0.006057279,0.00014686203],"study_design_scores_gemma":[0.0014037195,0.00089389266,0.0050708656,0.24769586,0.5714298,0.000045502853,0.00021410806,4.2576164e-7,1.9197977e-7,0.0000011875637,0.17297933,0.00026512507],"about_ca_topic_score_codex":0.00002058805,"about_ca_topic_score_gemma":0.00008792654,"teacher_disagreement_score":0.53879786,"about_ca_system_score_codex":0.00007110744,"about_ca_system_score_gemma":0.00013142503,"threshold_uncertainty_score":0.9999645},"labels":[],"label_agreement":null},{"id":"W2590795008","doi":"10.1002/ejhf.775","title":"Prognostic Role of β-Blocker Selectivity and Dosage Regimens in Heart Failure Patients. Insights from the MECKI Score Database","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Carvedilol; Heart failure; Hazard ratio; Ejection fraction; Internal medicine; Beta blocker; Confounding; Cardiology; Heart transplantation; Confidence interval","score_opus":0.013933193594953376,"score_gpt":0.23803762542356124,"score_spread":0.22410443182860787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590795008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626295,0.0006895193,0.000015609245,0.035751853,0.00009615403,0.00060742814,0.000021557915,0.000014094763,0.00017425654],"genre_scores_gemma":[0.98992777,0.000037052316,0.00932422,0.00032527524,0.00024662333,0.0000031721727,0.00002264953,0.000039757637,0.00007350816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978727,0.00047996896,0.00057007687,0.0002982182,0.0004905697,0.000288454],"domain_scores_gemma":[0.99824107,0.00015827629,0.00041985494,0.00073102117,0.0002240084,0.00022579473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068941276,0.0002609594,0.0005696018,0.00015150837,0.00026547106,0.000095438816,0.00025332466,0.000046505305,0.000056663717],"category_scores_gemma":[0.0004428747,0.00016410217,0.00014790095,0.00012482582,0.00018617563,0.00040561188,0.00023217105,0.00056074926,0.00002930986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023771792,0.0004609135,0.8945984,0.000044325883,0.00017302913,0.0002489193,0.00080515555,0.000001478807,0.0058961664,0.000051078892,0.09673654,0.00074624555],"study_design_scores_gemma":[0.003246825,0.00072485954,0.74979717,0.0007388966,0.0001986671,0.000064968124,0.0003039513,0.00001397545,0.001186769,0.000040186733,0.24355304,0.00013066907],"about_ca_topic_score_codex":0.000116474024,"about_ca_topic_score_gemma":0.0003621567,"teacher_disagreement_score":0.14681649,"about_ca_system_score_codex":0.000042744246,"about_ca_system_score_gemma":0.00009586537,"threshold_uncertainty_score":0.6691892},"labels":[],"label_agreement":null},{"id":"W2594341951","doi":"10.1002/ejhf.785","title":"Development and Validation of Multivariable Models to Predict Mortality and Hospitalization in Patients with Heart Failure","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Sphingotec GmbH; Servier; British Heart Foundation; Pfizer; Vifor Pharma; National Institute for Health and Care Research; Amgen; Singulex; European Commission; Sanofi; Alere; Boston Scientific Corporation; Celladon Corporation","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Prospective cohort study; Cohort; Cardiology; Renal function; Cohort study","score_opus":0.024737278148403652,"score_gpt":0.2539223482945352,"score_spread":0.22918507014613154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594341951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323434,0.00002280763,0.001070819,0.0050318283,0.00003772693,0.00049041974,0.0000031841903,0.000008074051,0.000100800025],"genre_scores_gemma":[0.90310645,0.000004126017,0.09669361,0.000075301396,0.0000372332,0.000002044327,0.000009650108,0.000019449211,0.000052118838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987607,0.000098197845,0.00044696973,0.00018184824,0.000351406,0.00016086944],"domain_scores_gemma":[0.99910265,0.00001300151,0.00024113926,0.00024445198,0.00021469679,0.00018404833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006794,0.00014886395,0.00034113156,0.00016526443,0.00011373976,0.0000592336,0.00006829117,0.000027447553,0.000011136574],"category_scores_gemma":[0.00006387776,0.00010990782,0.000029376553,0.00006911261,0.000058826998,0.0004234263,0.00007988129,0.00012040395,0.0000027538922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021423366,0.00023428441,0.99157447,0.00009510738,0.0000975334,0.00002174647,0.00095258566,0.00016995684,0.00032018026,0.00006119764,0.0057502477,0.00050845195],"study_design_scores_gemma":[0.0041242023,0.00091323035,0.95486915,0.00060337293,0.00008599976,0.000013746989,0.00017657474,0.00005573435,0.0011646214,0.000010966075,0.037864596,0.000117791424],"about_ca_topic_score_codex":0.000017382545,"about_ca_topic_score_gemma":0.00002141382,"teacher_disagreement_score":0.09562279,"about_ca_system_score_codex":0.000041066694,"about_ca_system_score_gemma":0.00005994918,"threshold_uncertainty_score":0.4481911},"labels":[],"label_agreement":null},{"id":"W2594638462","doi":"10.1002/ejhf.786","title":"Measurement of Troponin and Natriuretic Peptides Shortly After Admission in Patients with Heart Failure—Does it Add Useful Prognostic Information? an Analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies (VERITAS)","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Actelion Pharmaceuticals; National Institute for Health and Care Research","keywords":"Medicine; Interquartile range; Heart failure; Natriuretic peptide; Internal medicine; Cardiology; Troponin; Troponin I; Troponin T; Myocardial infarction","score_opus":0.010491191269336238,"score_gpt":0.24618433201602713,"score_spread":0.2356931407466909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594638462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824412,0.00013493915,0.000018885165,0.016315473,0.000047697682,0.0009772086,0.0000468238,0.000007937378,0.000009867436],"genre_scores_gemma":[0.9878329,0.00003205282,0.011866631,0.00016101408,0.00003588613,0.000011858488,0.000016204514,0.00003077898,0.0000126765735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636346,0.0005826896,0.001254683,0.00026490798,0.0012368397,0.00029744479],"domain_scores_gemma":[0.99741143,0.000059764734,0.0008742816,0.00057999557,0.00088648964,0.00018806742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014849675,0.00034048362,0.001073332,0.00079814985,0.00012174397,0.000055030367,0.00017664631,0.000058391524,0.00004752652],"category_scores_gemma":[0.00033372553,0.00018484927,0.00021948403,0.00045897995,0.00030453844,0.0008374273,0.00011816759,0.00036862842,0.0000022539207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019172891,0.0005780786,0.98768073,0.00027220152,0.0011090514,0.00002420218,0.0017852508,0.0000983898,0.003047944,0.0000066937723,0.0033825522,0.00009764003],"study_design_scores_gemma":[0.0062445863,0.0039063226,0.97055334,0.0035305715,0.0018338768,0.000026032607,0.0030434215,0.000027201118,0.0042488864,0.000003967718,0.006372189,0.00020958151],"about_ca_topic_score_codex":0.00003597217,"about_ca_topic_score_gemma":0.0009923822,"teacher_disagreement_score":0.017127344,"about_ca_system_score_codex":0.00013268681,"about_ca_system_score_gemma":0.00016967143,"threshold_uncertainty_score":0.7537935},"labels":[],"label_agreement":null},{"id":"W2598563835","doi":"10.1002/ejhf.794","title":"March 2017 at a Glance: Pathophysiology, Imaging, Biomarkers and Devices","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Internal medicine; Heart failure; Cardiology; Pathophysiology; Ambulatory","score_opus":0.055086118328781894,"score_gpt":0.3511080670855003,"score_spread":0.2960219487567184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598563835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006616837,0.9846932,0.000004570227,0.0131109925,0.00034214352,0.00061099924,0.000019299574,0.000024668338,0.0011279414],"genre_scores_gemma":[0.000072129216,0.9887638,0.007991955,0.00029765107,0.0008487605,0.0000049183354,0.00004335973,0.000094170886,0.0018832374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724275,0.00071273866,0.0008843293,0.0004054495,0.00033968603,0.00041502522],"domain_scores_gemma":[0.9976759,0.000093911716,0.001007254,0.00069210364,0.00014165156,0.00038921312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013295775,0.00051490974,0.0021113518,0.00039113598,0.00028407833,0.000109557775,0.00032760843,0.00008432468,0.00013596198],"category_scores_gemma":[0.00010874437,0.00033738517,0.00073295215,0.00008470383,0.00024648043,0.00015784419,0.0003572711,0.0006181964,0.00036867487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059656883,0.000054433553,0.00040522043,0.004636494,0.0006610417,0.003749028,0.000029281817,1.2586484e-8,0.000009539935,0.0000029055,0.54192364,0.44846877],"study_design_scores_gemma":[0.0011434654,0.00041107502,0.0011329711,0.014424631,0.0017604585,0.0046433504,0.000023338298,6.088737e-7,3.7459554e-7,0.0000037718453,0.9761994,0.00025655184],"about_ca_topic_score_codex":0.000003934155,"about_ca_topic_score_gemma":0.0000055991813,"teacher_disagreement_score":0.4482122,"about_ca_system_score_codex":0.000119046796,"about_ca_system_score_gemma":0.00020775471,"threshold_uncertainty_score":0.9999078},"labels":[],"label_agreement":null},{"id":"W2601460002","doi":"10.1002/ejhf.209","title":"Steps Forward in Regulatory Pathways for Acute and Chronic Heart failure","year":2015,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Agenzia Italiana del Farmaco, Ministero della Salute","keywords":"Medicine; Context (archaeology); Multidisciplinary approach; Heart failure; Authorization; Health care; Intensive care medicine; Computer science","score_opus":0.04096382842213057,"score_gpt":0.3159866944096972,"score_spread":0.2750228659875666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601460002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016219489,0.9849713,0.000086356886,0.011843512,0.0003456945,0.0023358667,0.000050909883,0.000047748817,0.00015645762],"genre_scores_gemma":[0.00019169088,0.9514302,0.04360561,0.00037611174,0.0021661764,0.000048231428,0.00012654414,0.00033063235,0.0017247746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591357,0.00068124826,0.0015962321,0.00053112017,0.0006190588,0.0006587635],"domain_scores_gemma":[0.99767905,0.0001218429,0.0006327747,0.0006123391,0.00030163242,0.00065237255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002659457,0.0007282619,0.003277478,0.0007806364,0.0000979215,0.000091348236,0.00025405124,0.00021510225,0.00006233909],"category_scores_gemma":[0.00009083341,0.00052654574,0.00101997,0.00034464186,0.00013803896,0.0002426529,0.00017145458,0.0010372117,0.00012788584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112054455,0.00017234783,0.000057602865,0.007596603,0.0011457215,0.0010885128,0.00014715859,0.0000012144659,0.000025056368,0.00013717749,0.812423,0.17709358],"study_design_scores_gemma":[0.00371047,0.0024488615,0.000042507014,0.014285802,0.0029467556,0.002852348,0.000097867654,0.0000020637865,0.000004720493,0.000020404092,0.97319174,0.00039648128],"about_ca_topic_score_codex":0.0000010456819,"about_ca_topic_score_gemma":0.000014914502,"teacher_disagreement_score":0.17669709,"about_ca_system_score_codex":0.00053944776,"about_ca_system_score_gemma":0.001056339,"threshold_uncertainty_score":0.9997186},"labels":[],"label_agreement":null},{"id":"W2604340973","doi":"10.1002/ejhf.790","title":"Design of the Effect of Adaptive Servo-Ventilation on Survival and Cardiovascular Hospital Admissions in Patients with Heart Failure and Sleep Apnoea: The ADVENT-HF Trial","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université de Montréal; St. Michael's Hospital; University of Ottawa; McGill University Health Centre; University of British Columbia; Women's College Hospital; Queen's University; Capital District Health Authority; University Health Network; Hôtel-Dieu de Montréal; Vancouver General Hospital; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Heart failure; Ejection fraction; Polysomnography; Atrial fibrillation; Cardiology; Internal medicine; Randomized controlled trial; Clinical endpoint; Central sleep apnea; Implantable cardioverter-defibrillator; Apnea","score_opus":0.012881963824405249,"score_gpt":0.24400402197853518,"score_spread":0.23112205815412995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604340973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566066,0.0002151433,0.00015717339,0.0025163416,0.00016447825,0.0012460209,0.000006633927,0.0000026329071,0.00003089934],"genre_scores_gemma":[0.9989333,0.0000045695483,0.00088506175,0.000009118922,0.00012857481,0.000002295788,9.4924394e-7,0.000029172405,0.000006967835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965058,0.0018439998,0.00039614658,0.00019363432,0.00086913665,0.00019131164],"domain_scores_gemma":[0.9984173,0.00023084162,0.0003637711,0.0005349266,0.0002918988,0.00016122728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023584687,0.00017659785,0.00055785547,0.000112669055,0.00021537775,0.000036128553,0.00021610598,0.00004200286,0.000013867225],"category_scores_gemma":[0.000809205,0.00008691116,0.0002255645,0.000115602765,0.0002731477,0.00017328108,0.00013098653,0.0005865768,0.0000013543638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05040491,0.00039297584,0.9402242,0.00014347973,0.0012820758,0.000076571596,0.0006478506,0.0007118485,0.0014855746,0.000016745716,0.00086737593,0.0037463931],"study_design_scores_gemma":[0.036286894,0.013248955,0.94587666,0.0005459215,0.00031446473,0.000037766767,0.00024221557,0.00007464689,0.002480258,0.0000036752244,0.00079051283,0.000098039214],"about_ca_topic_score_codex":0.000008334717,"about_ca_topic_score_gemma":0.0000038014673,"teacher_disagreement_score":0.014118015,"about_ca_system_score_codex":0.000028753599,"about_ca_system_score_gemma":0.000051277017,"threshold_uncertainty_score":0.35441342},"labels":[],"label_agreement":null},{"id":"W2604569584","doi":"10.1002/ejhf.831","title":"April 2017 at a Glance: Cardiomyopathies and Clinical Trials","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Cardiology; Cardiomyopathy; Dilated cardiomyopathy; Spironolactone; Clinical trial","score_opus":0.10662557612989369,"score_gpt":0.3949910772168586,"score_spread":0.2883655010869649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604569584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8053812,0.0027260322,0.0001811419,0.18210782,0.0013870175,0.00068067084,0.000009935722,0.000047697347,0.007478475],"genre_scores_gemma":[0.9738464,0.00090382673,0.018384427,0.00062297814,0.002369356,0.0000011728887,0.0000029048558,0.000039346927,0.0038296394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969642,0.0011823028,0.0010381278,0.00021827075,0.000355618,0.00024143915],"domain_scores_gemma":[0.99788034,0.00020033243,0.0007542386,0.00061659643,0.00016269113,0.00038578338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009853385,0.0001905931,0.0010678485,0.000110562716,0.000388754,0.00014732056,0.00018119618,0.000049140624,0.00010524004],"category_scores_gemma":[0.0019856652,0.00012684577,0.00052271486,0.000027464208,0.00021778604,0.00020265867,0.00021693375,0.00037492503,0.00019684198],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006268294,0.000111738445,0.16529967,0.000058167425,0.00055564055,0.0027083724,0.000133462,4.1813541e-7,0.00067788165,0.00003690382,0.81587315,0.013917752],"study_design_scores_gemma":[0.004222395,0.0008704616,0.23638259,0.00023620448,0.00042802957,0.0012428049,0.00006798859,0.0000038523535,0.000070706476,0.000010687254,0.7563692,0.000095085976],"about_ca_topic_score_codex":0.0000044666845,"about_ca_topic_score_gemma":0.000008765464,"teacher_disagreement_score":0.18148485,"about_ca_system_score_codex":0.000037050333,"about_ca_system_score_gemma":0.000066619745,"threshold_uncertainty_score":0.51726204},"labels":[],"label_agreement":null},{"id":"W2605331242","doi":"10.1002/ejhf.825","title":"Non-Invasive Measurement of Right Atrial Pressure by Near-Infrared Spectroscopy: Preliminary Experience. A Report from the SICA-HF Study","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Seventh Framework Programme; European Commission; National Institute for Health and Care Research","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Interquartile range; Atrial fibrillation; Ejection fraction; Hazard ratio; Ambulatory; Confidence interval; Ambulatory blood pressure","score_opus":0.018101547863562297,"score_gpt":0.26189024240720216,"score_spread":0.24378869454363986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605331242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904194,0.0016341201,0.00022578005,0.0046687936,0.0013968919,0.0007677511,0.00001776122,0.000017586908,0.00085192727],"genre_scores_gemma":[0.99693406,0.00004704628,0.00090719026,0.00008077121,0.001483921,0.000001742581,0.000005103391,0.000038548013,0.0005016493],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9968199,0.0004788534,0.0008060449,0.00028197042,0.0013985647,0.00021462455],"domain_scores_gemma":[0.9970205,0.00006402936,0.0009034121,0.001227754,0.00056301244,0.00022130564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019642909,0.00022376154,0.0006623622,0.000045110824,0.00045437322,0.00013344214,0.000401563,0.000043974218,0.00029890842],"category_scores_gemma":[0.0008784686,0.00013066996,0.0008450127,0.00006651627,0.00021941948,0.00018520813,0.00012851493,0.00056016527,0.000023327071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025456897,0.00051185064,0.27626202,0.000027480048,0.0027347994,0.003863072,0.0061998363,0.000033654094,0.029285237,3.8979775e-7,0.6781991,0.00033684302],"study_design_scores_gemma":[0.0047034496,0.002201502,0.52765214,0.00028167822,0.0011331718,0.0010161706,0.0023792502,0.0000061440887,0.01013965,0.000002252649,0.45034063,0.00014397457],"about_ca_topic_score_codex":0.000086374486,"about_ca_topic_score_gemma":0.000012219308,"teacher_disagreement_score":0.2513901,"about_ca_system_score_codex":0.000046384797,"about_ca_system_score_gemma":0.0003070377,"threshold_uncertainty_score":0.5328566},"labels":[],"label_agreement":null},{"id":"W2605642451","doi":"10.1002/ejhf.795","title":"Predictors of Short-Term Clinical Response to Cardiac Resynchronization Therapy","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; University of British Columbia","funders":"National Institute for Health and Care Research","keywords":"Medicine; Ejection fraction; QRS complex; Cardiology; Heart failure; Internal medicine; Cardiac resynchronization therapy; Odds ratio; Randomized controlled trial; Clinical trial","score_opus":0.13361471982133574,"score_gpt":0.4269917112206838,"score_spread":0.29337699139934803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605642451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026439023,0.9931378,0.00004346098,0.0005807948,0.0014828152,0.0004927225,0.000047120193,0.000021412543,0.0015500158],"genre_scores_gemma":[0.003892118,0.99159956,0.00091029657,0.0000431195,0.0030469352,0.0000012349276,0.000012767479,0.00009136965,0.0004025817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99447036,0.0026561157,0.0018355848,0.00026391924,0.0005745887,0.00019941806],"domain_scores_gemma":[0.99684286,0.0004981759,0.001000789,0.00072499714,0.0006228439,0.00031034352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005302318,0.0003165213,0.003453626,0.00040742577,0.00011872137,0.00004444657,0.00010693792,0.00012187592,0.000009709785],"category_scores_gemma":[0.0017302536,0.00021926673,0.0020104123,0.00018590974,0.00013361567,0.00007087924,0.00009733697,0.0006015496,0.00006433745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015341386,0.000081944585,0.014400834,0.0018899458,0.0028337657,0.00024378738,0.0003675228,0.0000037886105,0.000039519826,0.0000013105774,0.4064035,0.57219994],"study_design_scores_gemma":[0.00049704756,0.0012352789,0.017374612,0.012157963,0.0008706753,0.00081067625,0.000023291259,3.7009055e-8,0.0000024725546,1.2013167e-7,0.96687263,0.00015520828],"about_ca_topic_score_codex":4.1586745e-7,"about_ca_topic_score_gemma":1.2479927e-7,"teacher_disagreement_score":0.57204473,"about_ca_system_score_codex":0.0000674106,"about_ca_system_score_gemma":0.00054657966,"threshold_uncertainty_score":0.8941438},"labels":[],"label_agreement":null},{"id":"W2609879055","doi":"10.1002/ejhf.823","title":"Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Abbott Vascular; Servier; Janssen Canada; Relypsa; Vifor Pharma; Novartis; Bayer","keywords":"Medicine; Heart failure; Internal medicine; Confidence interval; Placebo; Meta-analysis; Mortality rate; Iron deficiency; Randomized controlled trial; Quality of life (healthcare); Pediatrics; Anemia","score_opus":0.13822242706076554,"score_gpt":0.3801596701196882,"score_spread":0.24193724305892267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609879055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07535561,0.9211504,0.000002307814,0.0012955415,0.00017385157,0.0013654071,0.0005886125,0.000014054866,0.00005424854],"genre_scores_gemma":[0.2734585,0.71358764,0.008777719,0.00042165697,0.0004738807,0.00003846326,0.0028652553,0.0002851473,0.00009171737],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941759,0.0019928985,0.0017890676,0.0006935,0.0009933296,0.00035527372],"domain_scores_gemma":[0.99560887,0.00027635656,0.0017759389,0.001662601,0.00027261433,0.00040364318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016189949,0.0006569725,0.0044582924,0.00083079044,0.0001594058,0.0001138558,0.0005629501,0.00014052563,0.00006791604],"category_scores_gemma":[0.00043374565,0.00041974866,0.0015375522,0.00044505124,0.00020369006,0.00026101884,0.00031558436,0.000925327,0.000014033287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004285297,0.032731485,0.12124661,0.06366262,0.4599795,0.0060476647,0.0070854034,0.0002280139,0.00003008562,0.000112229514,0.13119923,0.17724861],"study_design_scores_gemma":[0.0020154987,0.004556793,0.035852566,0.0039748615,0.30868545,0.00015322748,0.00021442887,0.0000036475187,0.000010944213,0.0000021774065,0.6440098,0.00052056956],"about_ca_topic_score_codex":0.00005037606,"about_ca_topic_score_gemma":0.00005040448,"teacher_disagreement_score":0.5128106,"about_ca_system_score_codex":0.00008938049,"about_ca_system_score_gemma":0.00026579632,"threshold_uncertainty_score":0.9998254},"labels":[],"label_agreement":null},{"id":"W2609921509","doi":"10.1002/ejhf.830","title":"Serelaxin in Addition to Standard Therapy in Acute Heart Failure: Rationale and Design of the RELAX-AHF-2 Study","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Clinical endpoint; Placebo; Internal medicine; Blood pressure; Nesiritide; Cardiology; Randomized controlled trial; Clinical trial; Natriuretic peptide; Intensive care medicine","score_opus":0.03768364551358464,"score_gpt":0.3207005643740084,"score_spread":0.28301691886042374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609921509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.930651,0.0008204862,0.00031338178,0.06655163,0.0001440244,0.0014044658,0.0000146391385,0.0000074090035,0.000092924754],"genre_scores_gemma":[0.99278086,0.00022914316,0.0063362825,0.00033555948,0.000107297834,0.000006451375,0.0000013247497,0.000032275293,0.00017081446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968191,0.0011567519,0.00064798794,0.00020348537,0.0009057943,0.0002669138],"domain_scores_gemma":[0.99851274,0.00023638521,0.0002432185,0.0004837243,0.0002721843,0.0002517363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036010146,0.0001482262,0.00044228364,0.0002541759,0.00014189821,0.000053396958,0.000327335,0.000055847882,0.00014438895],"category_scores_gemma":[0.0019828724,0.00009679916,0.00008690948,0.00023256885,0.00014848786,0.0002415797,0.0001343897,0.0010875515,0.000019739002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01105295,0.0021656877,0.4422706,0.00013113642,0.0006284817,0.0032566625,0.008761239,0.00044051078,0.10684673,0.00008802816,0.40069935,0.023658616],"study_design_scores_gemma":[0.014637187,0.007500427,0.9077739,0.005519086,0.000055149256,0.00052010076,0.0008522033,0.000048552312,0.0033068615,0.00009801965,0.059496745,0.00019176697],"about_ca_topic_score_codex":0.000011180672,"about_ca_topic_score_gemma":0.00005932284,"teacher_disagreement_score":0.4655033,"about_ca_system_score_codex":0.000092792245,"about_ca_system_score_gemma":0.00036253931,"threshold_uncertainty_score":0.47249302},"labels":[],"label_agreement":null},{"id":"W2613695111","doi":"10.1002/ejhf.901","title":"Prevalence and Prognostic Importance of Precipitating Factors Leading to Heart Failure Hospitalization: Recurrent Hospitalizations and Mortality","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Biotech; National Heart, Lung, and Blood Institute; Relypsa; Janssen Research and Development; National Institutes of Health; Parexel; Boston Scientific Corporation; Alnylam Pharmaceuticals; Medicines Company; Teva Pharmaceutical Industries; Novartis; Sanofi; Merck; GlaxoSmithKline; Genzyme; Bristol-Myers Squibb; AstraZeneca; Bayer; Boehringer Ingelheim; Amgen; Gilead Sciences","keywords":"Medicine; Heart failure; Decompensation; Internal medicine; Ejection fraction; Candesartan; Cardiology; Mortality rate; Emergency medicine; Blood pressure; Angiotensin II","score_opus":0.025045478575223164,"score_gpt":0.299734237591845,"score_spread":0.2746887590166218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613695111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98093355,0.0005832786,0.000427559,0.017079417,0.00015658949,0.0006617245,0.000011128723,0.000022120208,0.00012462973],"genre_scores_gemma":[0.9744249,0.000066745095,0.025076164,0.00010323457,0.00014579819,0.0000037068542,0.0000060040184,0.0000343934,0.00013907338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982378,0.00016055105,0.0006660286,0.00029099447,0.00039308728,0.0002515621],"domain_scores_gemma":[0.9983431,0.00006712684,0.0005051402,0.00041591772,0.00032421385,0.00034446685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076182885,0.00023214804,0.0004832181,0.0001554927,0.00031545418,0.00013760335,0.00014587044,0.000034688757,0.000042704964],"category_scores_gemma":[0.0009167152,0.00018688878,0.000108723994,0.00011318433,0.00014922676,0.0004382359,0.00014409047,0.00019517024,0.0000060689736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021326021,0.000095462514,0.98100895,0.00034790227,0.0001082641,0.000042365282,0.001064803,0.0000072863954,0.0005421305,0.000118175085,0.0163907,0.00025263306],"study_design_scores_gemma":[0.00081262103,0.001442322,0.974141,0.0013288063,0.0002814914,0.000096119235,0.00042669874,0.000017146967,0.00029023679,0.000021967748,0.020969396,0.00017219747],"about_ca_topic_score_codex":0.000004507165,"about_ca_topic_score_gemma":0.000019631841,"teacher_disagreement_score":0.024648605,"about_ca_system_score_codex":0.000034475386,"about_ca_system_score_gemma":0.000058236412,"threshold_uncertainty_score":0.76211035},"labels":[],"label_agreement":null},{"id":"W2619549767","doi":"10.1002/ejhf.884","title":"Emphasis on Abdominal Obesity as a Modifier of Eplerenone Effect in Heart Failure: Hypothesis-Generating Signals from EMPHASIS-HF","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Heart failure; Eplerenone; Emphasis (telecommunications); Cardiology; Internal medicine; Obesity; Abdominal obesity; Spironolactone; Metabolic syndrome","score_opus":0.03190562134726764,"score_gpt":0.27083960322166234,"score_spread":0.23893398187439469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619549767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6023993,0.0007568154,0.0000376423,0.39574918,0.0002629589,0.00042353317,0.000042282623,0.000019510348,0.00030876565],"genre_scores_gemma":[0.867329,0.000054989094,0.018144025,0.10543875,0.0075740125,0.0000046299297,0.00008296307,0.0002703688,0.0011012488],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936781,0.0020279088,0.001595876,0.000587029,0.0015633982,0.00054768345],"domain_scores_gemma":[0.9962039,0.00083674706,0.0012980629,0.000890212,0.0004361333,0.00033495502],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023468395,0.0006882395,0.002334707,0.0007524787,0.0002262602,0.00013311044,0.0004524636,0.0004592673,0.0006429509],"category_scores_gemma":[0.001201224,0.0005291467,0.0009501313,0.00017881357,0.00017653662,0.00021354565,0.00009697158,0.0028634956,0.00034015687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011432801,0.00022759836,0.0021177484,0.00014713337,0.000348825,0.007844136,0.00018127546,0.00006468587,0.075303555,0.0000012876002,0.9068818,0.0057386733],"study_design_scores_gemma":[0.0066001927,0.0036434024,0.03187842,0.00478493,0.00062719145,0.002579133,0.000054897126,0.00011867791,0.014309104,0.00003842733,0.9347645,0.00060113135],"about_ca_topic_score_codex":0.00007093219,"about_ca_topic_score_gemma":0.000015698626,"teacher_disagreement_score":0.29031044,"about_ca_system_score_codex":0.00015701054,"about_ca_system_score_gemma":0.0003739553,"threshold_uncertainty_score":0.999716},"labels":[],"label_agreement":null},{"id":"W2620562790","doi":"10.1002/ejhf.866","title":"Understanding Worsening Heart Failure as a Therapeutic Target: Another Step Forward?","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Clinical endpoint; Decompensation; Clinical trial; Myocardial infarction; Intensive care medicine; Internal medicine; Cardiology; Emergency medicine","score_opus":0.05915406340326228,"score_gpt":0.27989178422114197,"score_spread":0.22073772081787968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620562790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023796785,0.0010594629,0.0037030047,0.9883751,0.0009210798,0.00088686694,0.00001351343,0.000114377624,0.004688619],"genre_scores_gemma":[0.061309252,0.00012588731,0.13650022,0.7309428,0.0229421,0.000016650609,0.00016181108,0.0011472397,0.04685408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994702,0.00092125084,0.0012016719,0.0006627916,0.0014414826,0.0010707945],"domain_scores_gemma":[0.99693197,0.0001632555,0.0010365013,0.0012104762,0.0002957572,0.0003620489],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017063774,0.0009261436,0.0017136575,0.000817587,0.0005521045,0.00045524194,0.0005782015,0.0004166223,0.0017780645],"category_scores_gemma":[0.00012647196,0.000711903,0.0012336016,0.00020679456,0.0002330197,0.0004090181,0.00017718773,0.0037971952,0.0011785795],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016728038,0.00008766675,0.0009605261,0.00025172034,0.0012976847,0.00990379,0.00028003138,0.0000053780072,0.00037904977,0.00003492697,0.9863861,0.00024579582],"study_design_scores_gemma":[0.003290289,0.0015192201,0.00022030403,0.0021218488,0.00096689403,0.004272992,0.0004276225,0.000009575392,0.0000961943,0.00010933209,0.98636806,0.0005976708],"about_ca_topic_score_codex":0.000011862167,"about_ca_topic_score_gemma":0.000009346869,"teacher_disagreement_score":0.25743234,"about_ca_system_score_codex":0.00048186426,"about_ca_system_score_gemma":0.0004058108,"threshold_uncertainty_score":0.9995991},"labels":[],"label_agreement":null},{"id":"W2620991452","doi":"10.1002/ejhf.898","title":"Benefit of Cardiopoietic Mesenchymal Stem Cell Therapy on Left Ventricular Remodelling: Results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Study","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Waalse Gewest","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Ventricular remodeling; Myocardial infarction; Stem-cell therapy; Transplantation","score_opus":0.053319921740852594,"score_gpt":0.29233432378964497,"score_spread":0.23901440204879237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620991452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723147,0.0040902053,0.000062615196,0.02024755,0.00041705626,0.0017061877,0.000086321306,0.000025028006,0.0010503333],"genre_scores_gemma":[0.99578977,0.0005070291,0.0010843457,0.00026141855,0.0013533463,0.000004562227,0.000012694128,0.00012932793,0.000857486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99204975,0.0027428942,0.0014760757,0.00078436563,0.002264174,0.00068272534],"domain_scores_gemma":[0.9937761,0.00074868294,0.0011769347,0.002320823,0.0014471845,0.0005302635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005149534,0.0005975365,0.0015213768,0.00022076021,0.0007873903,0.00026078295,0.0011491021,0.00013448417,0.00010976349],"category_scores_gemma":[0.00032072383,0.0003674653,0.00087789097,0.00021843586,0.00040785017,0.00023478385,0.0002071897,0.0017656581,0.00011605274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051905543,0.007989112,0.23244894,0.0002914543,0.010862877,0.021305172,0.08020926,0.019011682,0.20743631,0.00015166996,0.35497692,0.0134110395],"study_design_scores_gemma":[0.05871991,0.0458452,0.2885472,0.0031584764,0.0009660829,0.0024707108,0.024661398,0.000628384,0.21540491,0.000107972235,0.35768762,0.0018021225],"about_ca_topic_score_codex":0.00016587794,"about_ca_topic_score_gemma":0.0000291972,"teacher_disagreement_score":0.05609825,"about_ca_system_score_codex":0.00013343753,"about_ca_system_score_gemma":0.00033735848,"threshold_uncertainty_score":0.99987775},"labels":[],"label_agreement":null},{"id":"W2622545583","doi":"10.1002/ejhf.877","title":"Improving Heart Failure Health: Is there a Secret Swedish Sauce?","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; MEDLINE; Environmental health; Internal medicine; Intensive care medicine","score_opus":0.023628630308956615,"score_gpt":0.2724994263665474,"score_spread":0.24887079605759077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622545583","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014243365,0.0028417942,0.00012271068,0.9922082,0.0011459852,0.0010845651,0.00007952506,0.0001259661,0.00096691796],"genre_scores_gemma":[0.010494204,0.00024916956,0.0660013,0.8706559,0.026989652,0.000014338259,0.00030431192,0.00070785044,0.024583263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993353,0.0010973302,0.0017453303,0.0008556091,0.0016212278,0.0013274879],"domain_scores_gemma":[0.99495304,0.00011969164,0.0018099168,0.0017904826,0.00056126516,0.0007656236],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002297052,0.001055682,0.0022897117,0.00066548004,0.0006161841,0.00047598028,0.0007991883,0.0003963888,0.0015067735],"category_scores_gemma":[0.0002188535,0.00082035904,0.0014242822,0.00019883514,0.0002179697,0.0004544139,0.00032293214,0.0053240247,0.0011688345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009227449,0.000111602545,0.001005881,0.00094301574,0.00065609807,0.009947993,0.00039636437,4.8573537e-7,0.00018193608,0.0000022702584,0.9848707,0.0017914269],"study_design_scores_gemma":[0.0031179604,0.0022711325,0.001207889,0.0029022472,0.0005461618,0.0054193293,0.00020266588,0.0000049820906,0.00007559881,0.000011990219,0.983637,0.00060303806],"about_ca_topic_score_codex":0.000083803934,"about_ca_topic_score_gemma":0.000030490704,"teacher_disagreement_score":0.12155229,"about_ca_system_score_codex":0.0003588157,"about_ca_system_score_gemma":0.00085751177,"threshold_uncertainty_score":0.9996089},"labels":[],"label_agreement":null},{"id":"W2623336801","doi":"10.1002/ejhf.900","title":"Mineralocorticoid Receptor Antagonist Pattern of Use in Heart Failure with Reduced Ejection Fraction: Findings from BIOSTAT-CHF","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research; European Commission; Alere; Amgen","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Mineralocorticoid receptor; Spironolactone; Discontinuation; Aldosterone","score_opus":0.02469856246490711,"score_gpt":0.2596700810697724,"score_spread":0.2349715186048653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623336801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96787524,0.000056966703,0.00012365053,0.03150412,0.00019267332,0.00015597869,0.000011842069,0.000012267285,0.00006726542],"genre_scores_gemma":[0.98816615,0.00002231984,0.010699679,0.00043211944,0.00041763257,5.17658e-7,0.000018655503,0.000041563144,0.00020137896],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833935,0.0001889289,0.00061918277,0.00021045194,0.00045211264,0.0001899699],"domain_scores_gemma":[0.99848455,0.000054821343,0.00048571848,0.00038288705,0.00038860767,0.00020339838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004362024,0.00017890836,0.0005025188,0.00022966236,0.00017224869,0.00011280288,0.00011467156,0.000059781018,0.00024819092],"category_scores_gemma":[0.0002352162,0.00013274321,0.00014470938,0.00010794879,0.00011649772,0.00051474624,0.000033123364,0.00049542147,0.00006088576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008751124,0.00015067919,0.35202757,0.000019212475,0.000065271466,0.0003036043,0.00015901978,0.00000970357,0.5769092,0.0000016832649,0.06847303,0.0010058894],"study_design_scores_gemma":[0.002767833,0.00083342055,0.75939673,0.00072956714,0.000065688015,0.00072344573,0.0003421337,0.000037474707,0.01637329,0.0000017153249,0.21859886,0.00012986953],"about_ca_topic_score_codex":0.00017417992,"about_ca_topic_score_gemma":0.00010991876,"teacher_disagreement_score":0.5605359,"about_ca_system_score_codex":0.00006776309,"about_ca_system_score_gemma":0.000105887164,"threshold_uncertainty_score":0.54131114},"labels":[],"label_agreement":null},{"id":"W2623625662","doi":"10.1002/ejhf.924","title":"June 2017 at a Glance: Biomarkers and Medical Treatment","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Adrenomedullin; Neprilysin; Medicine; Heart failure; Ejection fraction; Sacubitril; Natriuretic peptide; Valsartan; Internal medicine; Biomarker; Cardiology; Bradykinin; Brain natriuretic peptide; Bioinformatics; Receptor; Biology; Blood pressure","score_opus":0.022937113733488924,"score_gpt":0.2915944734835191,"score_spread":0.26865735975003013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623625662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5806131,0.0016934864,0.00005129229,0.40820995,0.00068409956,0.00040849275,0.000005340453,0.000039101193,0.008295137],"genre_scores_gemma":[0.96970373,0.0010251553,0.015708627,0.0007978923,0.0009467701,0.0000023666516,0.0000066300627,0.000050091036,0.011758748],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850106,0.00015775554,0.0003924583,0.00019836945,0.00048327024,0.0002670642],"domain_scores_gemma":[0.99855995,0.000036554524,0.00026635846,0.00048769478,0.000084154744,0.0005652646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083928707,0.00020220374,0.00044561276,0.00011768729,0.0003813361,0.00008486475,0.0001639948,0.000042743555,0.0004356075],"category_scores_gemma":[0.0001792923,0.00013164738,0.00018878984,0.000030852094,0.0001974431,0.00015416622,0.00014052038,0.00016793022,0.00020791579],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005462199,0.0002673422,0.056536637,0.00004814762,0.00067869516,0.008362288,0.0002571525,2.1482879e-7,0.0013456683,0.000034651068,0.9148218,0.017101197],"study_design_scores_gemma":[0.0055018594,0.001230892,0.07891601,0.0002891183,0.0002096601,0.0033343097,0.00006584905,0.000010469698,0.0002486816,0.0000049036726,0.91008216,0.0001061102],"about_ca_topic_score_codex":0.000011674561,"about_ca_topic_score_gemma":0.00004844365,"teacher_disagreement_score":0.40741205,"about_ca_system_score_codex":0.00010555898,"about_ca_system_score_gemma":0.00009432696,"threshold_uncertainty_score":0.5368424},"labels":[],"label_agreement":null},{"id":"W2624628178","doi":"10.1002/ejhf.816","title":"Should Recommendations for Clinical use be Restricted to Patients who were Enrolled in a Pivotal Clinical Trial?","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Heart failure; Intensive care medicine; MEDLINE; Internal medicine","score_opus":0.24319081647179858,"score_gpt":0.43288452873734956,"score_spread":0.18969371226555098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624628178","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035741482,0.0000422803,0.0000792532,0.9574903,0.0026272608,0.0036418182,0.00011273515,0.000034249715,0.000230574],"genre_scores_gemma":[0.0053143376,0.0007452648,0.10774226,0.82664937,0.030955303,0.00010690469,0.0014377823,0.0005438294,0.026504973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99166226,0.002453801,0.0037514141,0.00069407094,0.0007825009,0.0006559469],"domain_scores_gemma":[0.99480456,0.0014008206,0.001476888,0.0010808081,0.00068371627,0.0005532282],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035316423,0.00055896846,0.0022356263,0.00076309964,0.00020362782,0.0002482052,0.0005205199,0.00052614126,0.00017671927],"category_scores_gemma":[0.0054693287,0.00043396835,0.0015198664,0.00019130559,0.00010790775,0.00030933862,0.00022281658,0.0038470873,0.00013566304],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011483963,0.0009583998,0.016461978,0.000061112565,0.00050881156,0.0017316947,0.0000650549,3.9185136e-7,7.525824e-7,0.0000017854449,0.9654616,0.003264453],"study_design_scores_gemma":[0.07837143,0.009367388,0.035132803,0.0010529442,0.00058504625,0.00005077233,0.000018734032,0.000002778436,5.4171244e-7,0.0000032284258,0.87510157,0.00031278245],"about_ca_topic_score_codex":0.000014400243,"about_ca_topic_score_gemma":0.000030891937,"teacher_disagreement_score":0.130841,"about_ca_system_score_codex":0.00015476653,"about_ca_system_score_gemma":0.00040943746,"threshold_uncertainty_score":0.99981123},"labels":[],"label_agreement":null},{"id":"W2702989957","doi":"10.1002/ejhf.912","title":"A Network Analysis to Compare Biomarker Profiles in Patients with and without Diabetes Mellitus in Acute Heart Failure","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Trevena; Relypsa; Servier; Vifor Pharma; National Institute for Health and Care Research; Amgen; Singulex; MSD France; Roche; Sphingotec GmbH; BMS College of Engineering; Novartis; Bayer; AstraZeneca; Cytokinetics; Alere; Merck; GlaxoSmithKline","keywords":"Medicine; Diabetes mellitus; Periostin; Internal medicine; Heart failure; Biomarker; Pathophysiology; Creatinine; Cardiology; Renal function; Type 2 diabetes; Endocrinology","score_opus":0.012377792682882117,"score_gpt":0.2523209429606259,"score_spread":0.2399431502777438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2702989957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990668,0.0004868812,0.000050443952,0.008374238,0.0000777239,0.00028174833,0.000009341971,0.0000076038646,0.000044001856],"genre_scores_gemma":[0.9797969,0.000012468933,0.019673916,0.00028358097,0.00016647339,0.0000012265348,0.000009240077,0.000035789028,0.000020418793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982162,0.00025086163,0.0005422481,0.00025943,0.00037017072,0.0003610505],"domain_scores_gemma":[0.99883455,0.000029526245,0.00025400997,0.00039086674,0.00021481403,0.00027622702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009025874,0.00021250156,0.00088282075,0.00040063262,0.00014451628,0.00014443396,0.00013600544,0.000029604797,0.000014519059],"category_scores_gemma":[0.00006485873,0.00014319629,0.00019066504,0.00036088817,0.000094350136,0.00020176049,0.00010121651,0.00038093387,0.0000072847624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045093053,0.000071322414,0.98860234,0.000025925945,0.00044531195,0.000027635739,0.00018220783,0.0006560946,0.0005929686,0.0000013227366,0.008611271,0.0003326467],"study_design_scores_gemma":[0.002776646,0.00040728928,0.9818127,0.0009504969,0.0004723644,0.00002507691,0.00008294995,0.00021487071,0.00004355491,0.000001968647,0.013045053,0.000167037],"about_ca_topic_score_codex":0.000012521029,"about_ca_topic_score_gemma":0.000083013,"teacher_disagreement_score":0.019623471,"about_ca_system_score_codex":0.000037327205,"about_ca_system_score_gemma":0.00004260199,"threshold_uncertainty_score":0.5839375},"labels":[],"label_agreement":null},{"id":"W2735296799","doi":"10.1002/ejhf.895","title":"Rationale and Design of the Adaptresponse Trial: A Prospective Randomized Study of Cardiac Resynchronization Therapy with Preferential Adaptive Left Ventricular-Only Pacing","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa; Boston Scientific Corporation; Boehringer Ingelheim; Medtronic; Heart and Stroke Foundation of Canada; Biotronik; Bayer; St. Jude Medical; Servier; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Clinical endpoint; Cardiac resynchronization therapy; Heart failure; Decompensation; Left bundle branch block; Randomized controlled trial; Cardiology; Internal medicine; Atrial fibrillation; Clinical trial; Hazard ratio; Ejection fraction; Confidence interval","score_opus":0.08159151554056235,"score_gpt":0.3253401341125595,"score_spread":0.24374861857199717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735296799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070925015,0.98460585,0.0007806585,0.00007718313,0.00024347325,0.0069379895,0.00002322832,0.0000087275685,0.00023041484],"genre_scores_gemma":[0.19891916,0.7984989,0.0014838274,0.000006617766,0.00072215043,0.000021753538,0.000006324154,0.00009477845,0.00024646087],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99253255,0.0054539726,0.0010389755,0.00021372532,0.0006444627,0.000116326766],"domain_scores_gemma":[0.99574226,0.00079513824,0.0022257266,0.00036444244,0.00080907124,0.00006338274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003018249,0.00028668757,0.00331346,0.00022775165,0.00018383996,0.00003751255,0.00006121418,0.000050772927,0.000003322182],"category_scores_gemma":[0.00086189096,0.00014399747,0.00075366866,0.00016181686,0.00020261585,0.00008410079,0.000056936897,0.00034619748,7.7964404e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9115249,0.0008146188,0.0011097686,0.0020135976,0.017800333,0.00010003997,0.008684474,0.0003384396,0.000026996488,0.000025995167,0.0055575506,0.05200327],"study_design_scores_gemma":[0.47252885,0.009626413,0.0018641034,0.022107244,0.010165816,0.0025713088,0.0016228998,0.000006006515,0.000030745472,0.000006198705,0.47906613,0.0004042745],"about_ca_topic_score_codex":0.0000039855317,"about_ca_topic_score_gemma":0.000001406146,"teacher_disagreement_score":0.4735086,"about_ca_system_score_codex":0.000052323096,"about_ca_system_score_gemma":0.0006897613,"threshold_uncertainty_score":0.5872047},"labels":[],"label_agreement":null},{"id":"W2735516574","doi":"10.1002/ejhf.926","title":"July 2017 at a Glance: Clinical Assessment, Biomarkers, Cardiac Imaging and Treatment","year":2017,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Hazard ratio; Cardiology; Heart transplantation; Retrospective cohort study; Clinical significance; Confidence interval","score_opus":0.01920460589084862,"score_gpt":0.353778770305148,"score_spread":0.3345741644142994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735516574","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067799273,0.0065587847,0.000017056826,0.005727954,0.97499996,0.00039399407,0.00016959255,0.000027414086,0.0053253258],"genre_scores_gemma":[0.0066136844,0.0061908006,0.004366181,0.000050184775,0.9806182,0.0000019143913,0.00019072594,0.00011252169,0.0018558257],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675447,0.0009041452,0.0008885652,0.00037786542,0.000777643,0.00029729903],"domain_scores_gemma":[0.9969808,0.0004662307,0.0010970379,0.0005592984,0.0004701682,0.00042645336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026859008,0.00036424215,0.0012533019,0.00018122348,0.0003200382,0.00017578396,0.00016564917,0.00018205533,0.00001471908],"category_scores_gemma":[0.0006884633,0.0002593651,0.0009294343,0.000040163166,0.0002519369,0.00016164256,0.00012580586,0.0010790463,0.00007001413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004747711,0.00006184376,0.03288427,0.00007379641,0.0008541038,0.0015709931,0.000069331865,1.7386263e-7,0.00017596532,2.9611925e-7,0.95730525,0.0065291896],"study_design_scores_gemma":[0.0038502335,0.0005502008,0.0765674,0.0008986769,0.00095165364,0.00015372767,0.000047015772,0.0000022818879,0.000003973327,0.0000015109013,0.91676927,0.00020408657],"about_ca_topic_score_codex":0.0000062777904,"about_ca_topic_score_gemma":0.0000040869622,"teacher_disagreement_score":0.043683127,"about_ca_system_score_codex":0.00025140503,"about_ca_system_score_gemma":0.0007269669,"threshold_uncertainty_score":0.9999859},"labels":[],"label_agreement":null},{"id":"W2742479941","doi":"10.1002/ejhf.936","title":"August 2017 at a Glance: Tailored Treatment, Acute Heart Failure and Cardiac Resynchronization","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Spironolactone; Internal medicine; Cardiology; Asymptomatic; Randomized controlled trial; Mineralocorticoid receptor; Cardiac resynchronization therapy; Randomization; Heart failure with preserved ejection fraction; Aldosterone","score_opus":0.011999857552781849,"score_gpt":0.2502458312040723,"score_spread":0.23824597365129044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742479941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8121501,0.00234642,0.00096089905,0.1792502,0.0009548557,0.0012853325,0.000032069824,0.0001950736,0.0028250432],"genre_scores_gemma":[0.95024544,0.00040632265,0.03997928,0.00069907104,0.0016309326,0.000007020072,0.00007803393,0.00011480105,0.006839115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765986,0.00054074294,0.0005823235,0.00035401026,0.00043112313,0.00043196595],"domain_scores_gemma":[0.9985064,0.000083057625,0.0002573789,0.00047045847,0.00020986635,0.0004728011],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007564199,0.0003624756,0.0007793502,0.00024890466,0.00026013507,0.000094162984,0.00010739769,0.00006984539,0.00019673763],"category_scores_gemma":[0.00009588471,0.00026678745,0.00031257322,0.00019926709,0.00011677137,0.00027093684,0.00009727654,0.00026108854,0.00031428062],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035897404,0.0001621494,0.04563311,0.00006146761,0.00064004416,0.00039321868,0.00029453504,0.00001074203,0.010173643,0.000082174214,0.94043154,0.0017583882],"study_design_scores_gemma":[0.004392625,0.0027848775,0.030942416,0.00021399562,0.0006653365,0.00090566947,0.00012255413,0.000033084772,0.0009858332,0.000007971556,0.9587277,0.00021790617],"about_ca_topic_score_codex":0.000009259871,"about_ca_topic_score_gemma":0.000016226959,"teacher_disagreement_score":0.17855112,"about_ca_system_score_codex":0.00022510877,"about_ca_system_score_gemma":0.00008314653,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W2746903407","doi":"10.1002/ejhf.933","title":"Moderated ePoster Session 2","year":2014,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute on Aging; Medical Research Council; Sundhedsvidenskabelige Fakultet, Aarhus Universitet; National Institutes of Health; H. Lundbeck A/S; Hjartavernd; Lundbeckfonden; Institut National de la Santé et de la Recherche Médicale; Aarhus Universitet; Université de Lille; Wellcome Trust; Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease; Centre hospitalier régional universitaire de Lille; Danmarks Frie Forskningsfond; Erasmus Medisch Centrum; Novo Nordisk; Bundesministerium für Bildung und Forschung; National Heart, Lung, and Blood Institute; Villum Fonden","keywords":"Empagliflozin; Medicine; Heart failure; Canagliflozin; Diabetes mellitus; Internal medicine; Intensive care medicine; Clinical trial; Disease; Type 2 Diabetes Mellitus; Cardiology; Endocrinology","score_opus":0.03160162829318401,"score_gpt":0.30447044304439363,"score_spread":0.2728688147512096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746903407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021316688,0.99377406,0.00008816607,0.0014022257,0.00033913675,0.00036057844,0.0000024339877,0.000025481286,0.003986594],"genre_scores_gemma":[0.000097106036,0.9893108,0.0046864985,0.0004172174,0.0009058252,0.0000016110766,0.000045415592,0.00011490784,0.004420631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978329,0.00059093576,0.00084546435,0.0001857148,0.00031995558,0.00022506075],"domain_scores_gemma":[0.99870783,0.00004014899,0.0005720428,0.0003129771,0.0001438392,0.00022313655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007210885,0.00033297174,0.0016927235,0.0002971511,0.0000498019,0.000061257844,0.00014888417,0.000061690844,0.00020940001],"category_scores_gemma":[0.000042715503,0.00019780289,0.00075637473,0.00014382222,0.0000253884,0.0000812503,0.00007902056,0.00052683963,0.0007592953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001721163,0.00009478941,0.000009408622,0.004888464,0.0004767789,0.00055514876,0.000016242924,7.077471e-7,0.0000024369997,0.0000074613995,0.30839667,0.68553466],"study_design_scores_gemma":[0.00082821003,0.0007113458,0.000015134866,0.027317524,0.002154578,0.00073878496,0.0000051039874,0.0000016268037,0.0000017592131,0.0000022987024,0.968072,0.00015166444],"about_ca_topic_score_codex":1.16059674e-7,"about_ca_topic_score_gemma":1.07576994e-7,"teacher_disagreement_score":0.685383,"about_ca_system_score_codex":0.00006437869,"about_ca_system_score_gemma":0.0000985577,"threshold_uncertainty_score":0.97594583},"labels":[],"label_agreement":null},{"id":"W2751906665","doi":"10.1002/ejhf.889","title":"Systolic Blood Pressure Reduction During the First 24 H in Acute Heart Failure Admission: Friend or Foe?","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Surgical Specialties (Canada)","funders":"National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Hazard ratio; Blood pressure; Cardiology; Creatinine; Internal medicine; Confidence interval; Proportional hazards model; Randomization; Adverse effect; Renal function; Randomized controlled trial","score_opus":0.016555685875296954,"score_gpt":0.26280702209816154,"score_spread":0.24625133622286458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751906665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60433775,0.0010733505,0.000011964041,0.39221147,0.0009344032,0.0008533758,0.000007500677,0.000063777545,0.00050641043],"genre_scores_gemma":[0.985312,0.00010103401,0.0066507184,0.00026409188,0.0013673169,0.000007890381,0.0000032489188,0.00007286547,0.0062208213],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975327,0.0003063227,0.0007406607,0.00034696242,0.00059029873,0.0004830154],"domain_scores_gemma":[0.9980033,0.00004571834,0.0004462557,0.000977649,0.00017194934,0.00035514543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010163044,0.00033678775,0.0006174071,0.00025192366,0.00081339217,0.0002466232,0.00042988162,0.00007769358,0.0004408615],"category_scores_gemma":[0.00023888881,0.00019624128,0.00030516324,0.00017549339,0.0001324809,0.0005100241,0.00020633564,0.00083841995,0.00013348386],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018626368,0.0007694137,0.030900909,0.00057642296,0.0017686896,0.0071514333,0.0021092002,0.00006879609,0.012232378,0.000053601387,0.9419821,0.0005244472],"study_design_scores_gemma":[0.004609737,0.0008626718,0.069969185,0.0011799594,0.0009910668,0.008525909,0.0005599108,0.000008427879,0.0018880016,0.0000042940705,0.91120434,0.00019651897],"about_ca_topic_score_codex":0.000017125689,"about_ca_topic_score_gemma":0.00007168637,"teacher_disagreement_score":0.3919474,"about_ca_system_score_codex":0.000051187442,"about_ca_system_score_gemma":0.0001388303,"threshold_uncertainty_score":0.80024874},"labels":[],"label_agreement":null},{"id":"W2754307347","doi":"10.1002/ejhf.947","title":"September 2017 At A Glance: Epidemiology, Prognosis, Mediterranean Diet and Different Viewpoints on Aspirin","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Aspirin; Heart failure; Internal medicine; Epidemiology; Intensive care medicine; Cancer; Eplerenone; Clinical trial; Oncology; Spironolactone","score_opus":0.06984935247914908,"score_gpt":0.33508058494199766,"score_spread":0.2652312324628486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754307347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8210665,0.0010467736,0.000027429167,0.17212312,0.0005815982,0.00058919983,0.000007931356,0.000035759644,0.0045216647],"genre_scores_gemma":[0.9874803,0.00035642632,0.005979021,0.0023060467,0.001058189,0.000005852913,0.000012393948,0.00005034849,0.0027514405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792045,0.0004208564,0.00065110315,0.00030643382,0.00031149155,0.00038967122],"domain_scores_gemma":[0.99817854,0.00013238176,0.0005398074,0.00058997143,0.000097836404,0.00046147904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016454619,0.00029689545,0.000793229,0.00012753688,0.0003809277,0.00004998757,0.00021232804,0.000054622513,0.00025449973],"category_scores_gemma":[0.00036254432,0.00018780248,0.00025535256,0.000025203517,0.00021533653,0.00014603633,0.00021652598,0.00045180143,0.00037330858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008352217,0.00026015955,0.17095353,0.00013386761,0.00028658687,0.001190084,0.00016932777,8.2074405e-7,0.00048802604,0.000045020002,0.82069296,0.004944378],"study_design_scores_gemma":[0.0026080322,0.0026809443,0.35506633,0.00077055563,0.00015686674,0.00059593085,0.000024837795,0.000010082724,0.00015968776,0.000026830154,0.6377727,0.00012724959],"about_ca_topic_score_codex":0.0000025163883,"about_ca_topic_score_gemma":0.000018615388,"teacher_disagreement_score":0.1841128,"about_ca_system_score_codex":0.00007207265,"about_ca_system_score_gemma":0.000021968382,"threshold_uncertainty_score":0.7658363},"labels":[],"label_agreement":null},{"id":"W2755316197","doi":"10.1002/ejhf.952","title":"Patient Information Websites: How do we Assess their Usefulness?","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.1218446373972116,"score_gpt":0.38351413302146026,"score_spread":0.2616694956242487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755316197","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00509336,0.0005235004,0.00022870654,0.9853611,0.0052102706,0.0006413987,0.00007645065,0.000029903124,0.0028353366],"genre_scores_gemma":[0.06241012,0.0015689904,0.007861605,0.8609199,0.056816235,0.000069403664,0.00033966138,0.0002525672,0.009761552],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99183244,0.004257286,0.0012970706,0.00023259742,0.0013169307,0.0010636903],"domain_scores_gemma":[0.9939358,0.0006657908,0.0025832192,0.0007773565,0.0015500247,0.00048780048],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004922476,0.00033853558,0.00060592446,0.00064499496,0.0016728553,0.00041806055,0.0010450148,0.00034920263,0.00097088004],"category_scores_gemma":[0.0015396593,0.00023026306,0.00024309373,0.0002157549,0.0001497268,0.002133375,0.00021647138,0.007316811,0.0026979414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018862898,0.0000149250145,0.0007318105,0.00059479335,0.000022781287,0.00011191701,0.0039028826,0.0000018266695,0.000009134693,0.0000022015133,0.9888074,0.005781458],"study_design_scores_gemma":[0.0003902352,0.00039065408,0.0030015393,0.0022687456,0.000013126813,0.000104304105,0.0041388953,0.000007334571,0.000007032291,0.000037065885,0.98942494,0.00021612576],"about_ca_topic_score_codex":0.0000137131365,"about_ca_topic_score_gemma":0.000006621476,"teacher_disagreement_score":0.12444121,"about_ca_system_score_codex":0.00028994514,"about_ca_system_score_gemma":0.002720765,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W2756884169","doi":"10.1002/ejhf.986","title":"Chronic Obstructive Pulmonary Disease and Heart Failure in Europe—Further Evidence of the Need for Integrated Care","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Heart failure; Pulmonary disease; Intensive care medicine; Cardiology; Internal medicine; MEDLINE; Chronic disease","score_opus":0.0211655885695208,"score_gpt":0.28325774620824695,"score_spread":0.2620921576387262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756884169","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12442559,0.031238802,0.000017895283,0.84031194,0.0006925115,0.002632796,0.0004477443,0.000027878865,0.00020486469],"genre_scores_gemma":[0.96246475,0.00032629154,0.0024390975,0.02199547,0.009753625,0.000041670406,0.00016490249,0.0005984408,0.0022157806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947218,0.0015589134,0.0010991647,0.00071184564,0.0011573259,0.0007509905],"domain_scores_gemma":[0.99491405,0.00036786287,0.00094796787,0.0013527796,0.001968401,0.00044895988],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00085501646,0.00066130713,0.0012559426,0.0005154827,0.00024127384,0.00012143761,0.0010233056,0.00023443036,0.00011942068],"category_scores_gemma":[0.0015813517,0.00045606084,0.00068533607,0.00045303968,0.0009511721,0.00042740718,0.0004449913,0.0040354286,0.000018976578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021924365,0.00013483776,0.08238785,0.009264197,0.00048096784,0.008992536,0.0007956749,0.00004253076,0.00612339,0.000006665278,0.8857837,0.0037952422],"study_design_scores_gemma":[0.0018325511,0.000466039,0.30552095,0.009463715,0.00045824167,0.0013159864,0.000682446,0.000035956073,0.00011822569,0.00002135368,0.6797184,0.00036613274],"about_ca_topic_score_codex":0.000031017593,"about_ca_topic_score_gemma":0.000026245865,"teacher_disagreement_score":0.8380391,"about_ca_system_score_codex":0.0006848237,"about_ca_system_score_gemma":0.0029140096,"threshold_uncertainty_score":0.9997891},"labels":[],"label_agreement":null},{"id":"W2759623414","doi":"10.1002/ejhf.989","title":"Multiparametric Prognostic Scores in Chronic Heart Failure with Reduced Ejection Fraction: A Long-Term Comparison","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Heart transplantation; Cohort; Receiver operating characteristic; Area under the curve; Transplantation; Clinical endpoint; Ventricular assist device; Clinical trial","score_opus":0.038383110241349466,"score_gpt":0.34207657362237026,"score_spread":0.30369346338102077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759623414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776317,0.00055558124,0.0028001305,0.00802853,0.0002781437,0.00041634822,0.000002347149,0.000031926702,0.00012381251],"genre_scores_gemma":[0.9406083,0.000036608937,0.05838862,0.00010536658,0.0007306281,0.0000027147578,0.0000055068795,0.000046038098,0.00007617526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978352,0.00046939016,0.00066923606,0.00025850037,0.00046266106,0.0003049984],"domain_scores_gemma":[0.99844986,0.00017767014,0.00055508036,0.00035881746,0.00023761108,0.0002209503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009991099,0.00023300965,0.00063697866,0.00046385906,0.00027498524,0.00017363548,0.00019181558,0.00006126751,0.00009275081],"category_scores_gemma":[0.00034657525,0.0001703241,0.00017556056,0.00026581128,0.000121469726,0.00045279448,0.000022774935,0.0009297735,0.00006222035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006191472,0.00015777125,0.9823731,0.00018952701,0.00008658124,0.00075781374,0.00016707533,0.00013247384,0.010730767,0.0000034206782,0.002563236,0.002219055],"study_design_scores_gemma":[0.0046236347,0.0016945082,0.97858626,0.0016552141,0.00018395558,0.0033841303,0.00013665535,0.00006582927,0.0027649323,0.0000021183578,0.006724971,0.00017778689],"about_ca_topic_score_codex":0.000018220488,"about_ca_topic_score_gemma":0.000119135206,"teacher_disagreement_score":0.05558849,"about_ca_system_score_codex":0.00016402766,"about_ca_system_score_gemma":0.00023182156,"threshold_uncertainty_score":0.6945615},"labels":[],"label_agreement":null},{"id":"W2760484234","doi":"10.1002/ejhf.921","title":"The Autonomic Nervous System as a Therapeutic Target in Heart Failure: A Scientific Position Statement from the Translational Research Committee of the Heart Failure Association of The European Society of Cardiology","year":2017,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"British Heart Foundation","keywords":"Medicine; Heart failure; Position paper; Position statement; Autonomic nervous system; Translational research; Intensive care medicine; Cardiology; Disease; Internal medicine; Neuroscience; Blood pressure; Pathology; Heart rate; Family medicine; Psychology","score_opus":0.06319022631513807,"score_gpt":0.3369306030488666,"score_spread":0.27374037673372853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760484234","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025797604,0.58361363,0.0001640449,0.37879667,0.0025225126,0.0074998555,0.0010484878,0.00004049046,0.0005167131],"genre_scores_gemma":[0.96346027,0.031169092,0.0018365273,0.00047002477,0.0020676488,0.00003686853,0.00009885628,0.00022468732,0.00063601194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9748283,0.020055583,0.0027694409,0.00045884986,0.0013247436,0.00056306255],"domain_scores_gemma":[0.99280906,0.0022602605,0.0023065405,0.0015908631,0.00091122964,0.00012202888],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.031370625,0.0004181343,0.0020576506,0.00015919736,0.0010357387,0.0001904623,0.0013789813,0.00020715877,0.000031001815],"category_scores_gemma":[0.00050679396,0.00020092826,0.0021070794,0.00051973097,0.0009448296,0.00015221123,0.00028287605,0.0026281306,0.000033408665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062673073,0.0011649613,0.03120354,0.012888035,0.010684017,0.00006665149,0.013700376,0.0024063922,0.032339264,0.0013611013,0.81507665,0.07848228],"study_design_scores_gemma":[0.0011859538,0.0002274436,0.02009486,0.0069685327,0.00056080706,0.00016071074,0.0007821092,0.00007590534,0.00005931329,0.00006318517,0.96967125,0.0001499075],"about_ca_topic_score_codex":0.00009367097,"about_ca_topic_score_gemma":0.00009379948,"teacher_disagreement_score":0.93766266,"about_ca_system_score_codex":0.00065172766,"about_ca_system_score_gemma":0.0028255899,"threshold_uncertainty_score":0.99967283},"labels":[],"label_agreement":null},{"id":"W2760760150","doi":"10.1002/ejhf.943","title":"Teleconsultation for Left Ventricular Assist Device Patients: A New Standard of Care","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Heart failure; Standard of care; Cardiology; Ventricular assist device; Internal medicine; Intensive care medicine","score_opus":0.01190564213416778,"score_gpt":0.22597544600534028,"score_spread":0.2140698038711725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760760150","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17499924,0.039050575,0.070243865,0.6755518,0.02179963,0.008156341,0.0049122577,0.0008541171,0.0044322195],"genre_scores_gemma":[0.8623433,0.00003432853,0.06763922,0.04890903,0.018009035,0.000008060202,0.0013029729,0.001218228,0.0005358354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784255,0.00018505235,0.0009289021,0.00019170373,0.00055987417,0.0002919191],"domain_scores_gemma":[0.99771756,0.00010742386,0.00078023545,0.00039415105,0.0008508302,0.00014977298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041312043,0.0003059924,0.000749453,0.00020054891,0.00008699618,0.00010000351,0.0005095379,0.00018457184,0.000100132995],"category_scores_gemma":[0.00032634413,0.00027925466,0.00042389712,0.000057969846,0.00002686079,0.00022700973,0.00003074229,0.0010518917,0.000031044936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028337374,0.0000064528303,0.0015442844,0.0010404442,0.000192186,0.00034680552,0.00013906189,0.00020388377,0.000032792097,0.0000014569852,0.9950763,0.0013880068],"study_design_scores_gemma":[0.0011109468,0.00040601307,0.0012048314,0.00071704556,0.00022394724,0.00010564747,0.000041087293,0.000016650602,0.00044189987,0.000009481492,0.9954593,0.00026310704],"about_ca_topic_score_codex":9.80284e-7,"about_ca_topic_score_gemma":0.00000447435,"teacher_disagreement_score":0.6873441,"about_ca_system_score_codex":0.00011627353,"about_ca_system_score_gemma":0.00016419288,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W2761429621","doi":"10.1002/ejhf.937","title":"Rapid Fire - Basic Science 1","year":2014,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; National Institutes of Health; National Heart, Lung, and Blood Institute; University of Pittsburgh","keywords":"Enalapril; Medicine; Heart failure; Ejection fraction; Placebo; Hazard ratio; Clinical endpoint; Randomization; Internal medicine; Cardiology; Confidence interval; ACE inhibitor; Angiotensin-converting enzyme; Randomized controlled trial; Blood pressure","score_opus":0.015297629588091763,"score_gpt":0.24539527374731956,"score_spread":0.2300976441592278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761429621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70353645,0.0008095888,0.0011770283,0.25903547,0.0010159296,0.0005043317,0.0000016416162,0.00012480494,0.03379475],"genre_scores_gemma":[0.96146315,0.000026970532,0.034948874,0.0015648564,0.0006632909,4.5390195e-7,0.0000011565606,0.000027498938,0.0013037574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983895,0.00020130744,0.00038355408,0.00017703643,0.00054801,0.00030058486],"domain_scores_gemma":[0.99893266,0.00003746117,0.00013709292,0.00031256973,0.00022936243,0.0003508518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022270186,0.00014347665,0.00029779912,0.00022167152,0.00015770858,0.000058883703,0.00018331574,0.000015132802,0.0005463273],"category_scores_gemma":[0.00021401509,0.00010119855,0.00016647803,0.0003211629,0.00017728699,0.00022860231,0.00006671354,0.00025980128,0.00084314775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012459602,0.00024214458,0.0045717875,0.000056831857,0.00008846932,0.00049218984,0.0003084924,0.000011929967,0.0117166275,0.00032761449,0.9162943,0.06576502],"study_design_scores_gemma":[0.0015501477,0.0013286306,0.017134732,0.00016273095,0.0000806369,0.00066524296,0.00007578949,0.00006260528,0.0011892123,0.000010595172,0.97764695,0.00009271346],"about_ca_topic_score_codex":9.4874264e-7,"about_ca_topic_score_gemma":3.1004532e-7,"teacher_disagreement_score":0.2579267,"about_ca_system_score_codex":0.00005128214,"about_ca_system_score_gemma":0.000116358584,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W2761528328","doi":"10.1002/ejhf.1034","title":"October 2017 at a Glance: Phenotyping Heart Failure, Co-Morbidities, Use of Evidence-Based Therapy and New Treatments","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Cardiology; Blood pressure; Heart failure with preserved ejection fraction","score_opus":0.23266380128496264,"score_gpt":0.3456393759286967,"score_spread":0.11297557464373406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761528328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8846343,0.003664129,0.00017469809,0.10992076,0.00032679297,0.00089263247,0.000020052115,0.00004879641,0.00031781563],"genre_scores_gemma":[0.9233517,0.0012478543,0.065932706,0.0019212744,0.0008944975,0.0000041694075,0.000017362501,0.00010444106,0.0065259617],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976625,0.0003415316,0.00068095024,0.0003220584,0.00059374445,0.00039920586],"domain_scores_gemma":[0.9976497,0.00017082464,0.0006375781,0.00083666755,0.00022489823,0.00048027316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007692793,0.00036187077,0.0008030651,0.00022709066,0.00040604657,0.00020243642,0.00022509454,0.00006087211,0.00033860104],"category_scores_gemma":[0.0002528625,0.00024241922,0.00032080023,0.00007195408,0.00022579204,0.00080176315,0.000099096585,0.0002967681,0.00009402116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013366626,0.00026091677,0.1651017,0.00009931307,0.00052247196,0.0005737551,0.00031685477,0.000010159317,0.011380077,0.000020947755,0.81438226,0.005994867],"study_design_scores_gemma":[0.0061284737,0.0014893699,0.21160127,0.0014687658,0.00023901899,0.00036040822,0.000055465378,0.000016162949,0.0032156755,0.000007032904,0.7752268,0.00019157262],"about_ca_topic_score_codex":0.00010580791,"about_ca_topic_score_gemma":0.00003654052,"teacher_disagreement_score":0.10799949,"about_ca_system_score_codex":0.00012014113,"about_ca_system_score_gemma":0.0002483227,"threshold_uncertainty_score":0.98855686},"labels":[],"label_agreement":null},{"id":"W2765935265","doi":"10.1002/ejhf.1019","title":"Pre-Discharge and Early Post-Discharge Troponin Elevation Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Findings from the ASTRONAUT Trial","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Heart, Lung, and Blood Institute; Novartis Pharma; Feinberg School of Medicine; Northwestern University","keywords":"Medicine; Interquartile range; Troponin; Internal medicine; Hazard ratio; Cardiology; Ejection fraction; Heart failure; Troponin T; Troponin I; Confidence interval; ST elevation; Myocardial infarction","score_opus":0.014001289042798638,"score_gpt":0.27797397514468586,"score_spread":0.26397268610188723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765935265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433461,0.000029800249,0.0005233903,0.053987324,0.00045336562,0.0015225764,0.00005368856,0.000026152922,0.00005761572],"genre_scores_gemma":[0.9912275,0.000008734998,0.006061361,0.0004796251,0.0017521823,0.000021604545,0.00005205781,0.00007623004,0.00032067308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974535,0.00047061438,0.0006205245,0.00033431174,0.0007663339,0.00035468084],"domain_scores_gemma":[0.9975164,0.00014054783,0.0006415454,0.0004942022,0.00093149766,0.00027580612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013153934,0.00025641941,0.0005136926,0.00015439907,0.000929387,0.0004225955,0.00024124532,0.00008736542,0.00013108036],"category_scores_gemma":[0.0009007923,0.00016614486,0.0002712493,0.000099725046,0.00021978619,0.0009951236,0.00007876323,0.0008656792,0.00002842032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039773285,0.00027063928,0.66823834,0.000029007306,0.00063754665,0.000016235965,0.0006244515,0.0000034783432,0.018237164,0.000020220961,0.2717002,0.00044942362],"study_design_scores_gemma":[0.030324582,0.005231476,0.83259493,0.0002090329,0.00018460205,0.00005453371,0.00025390775,0.000016530976,0.0009200656,0.000007325676,0.13004667,0.00015636321],"about_ca_topic_score_codex":0.000101451216,"about_ca_topic_score_gemma":0.000006650434,"teacher_disagreement_score":0.16435656,"about_ca_system_score_codex":0.00009416532,"about_ca_system_score_gemma":0.00013275846,"threshold_uncertainty_score":0.7148187},"labels":[],"label_agreement":null},{"id":"W2766858611","doi":"10.1002/ejhf.1020","title":"Aetiology, Timing and Clinical Predictors of Early vs. Late Readmission Following Index Hospitalization for Acute Heart Failure: Insights from ASCEND-HF","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Canadian VIGOUR Centre; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Interquartile range; Heart failure; Hazard ratio; Nesiritide; Internal medicine; Confidence interval; Proportional hazards model; Population; Cardiology; Emergency medicine","score_opus":0.0237728945453359,"score_gpt":0.31934080952548377,"score_spread":0.2955679149801479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766858611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96891725,0.00021031404,0.0012713199,0.028163478,0.0007941675,0.00053040736,0.000009054497,0.00003114123,0.000072872506],"genre_scores_gemma":[0.9696966,0.00008348076,0.028959405,0.00024421985,0.0007055,0.0000021209444,0.00002860378,0.000055772834,0.00022433701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977317,0.000330928,0.0009861161,0.00032843606,0.0003532924,0.00026955784],"domain_scores_gemma":[0.9980911,0.00016859284,0.0006664016,0.0004746305,0.00022383645,0.00037543447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094071677,0.00025489324,0.0008174634,0.00019048523,0.0003096026,0.00009730936,0.00019615609,0.00012423436,0.000025876876],"category_scores_gemma":[0.00049517106,0.00019198937,0.00044057335,0.00006480154,0.00014665644,0.00043957442,0.00013909473,0.00036730408,0.000013323073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010853432,0.00027276383,0.87151325,0.00006068706,0.0016846007,0.00034318957,0.0006305011,0.0000069732273,0.004861344,0.0000355199,0.11814011,0.0013657403],"study_design_scores_gemma":[0.006701184,0.003790544,0.725059,0.00090423314,0.0012091422,0.000058688,0.00011335504,0.0001201294,0.0006254561,0.000061698534,0.26115498,0.00020162838],"about_ca_topic_score_codex":0.000021834978,"about_ca_topic_score_gemma":0.000013311762,"teacher_disagreement_score":0.14645427,"about_ca_system_score_codex":0.00003442152,"about_ca_system_score_gemma":0.00009423186,"threshold_uncertainty_score":0.78290987},"labels":[],"label_agreement":null},{"id":"W2767098467","doi":"10.1002/ejhf.1040","title":"Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure with Preserved Ejection Fraction","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Ejection fraction; Medicine; Cardiology; Heart failure; Internal medicine; Sudden cardiac death; Myocardial infarction; Spironolactone; Cause of death; Stroke volume; Heart failure with preserved ejection fraction","score_opus":0.03393254103001375,"score_gpt":0.282634629944403,"score_spread":0.24870208891438927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767098467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59959126,0.00012512282,0.00015621734,0.39792037,0.00045404758,0.0011306787,0.000013845205,0.000068696005,0.00053979876],"genre_scores_gemma":[0.9632635,0.00021274024,0.006799665,0.021510758,0.0062905475,0.000025704527,0.00018245676,0.00028238492,0.0014322535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528,0.0010054188,0.0012515663,0.00061392423,0.0013531672,0.0004959054],"domain_scores_gemma":[0.9964197,0.0001229608,0.0015452066,0.0010934738,0.0006373518,0.00018129854],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014888718,0.0006026686,0.0012563,0.0010121203,0.00021939703,0.00012962602,0.00025520197,0.00038789373,0.00016658539],"category_scores_gemma":[0.00016054479,0.00047557644,0.00040594328,0.00033242648,0.00014596399,0.00085895706,0.00005915778,0.0036551883,0.00016842385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007218119,0.00031582042,0.09639347,0.00035495393,0.00044700436,0.0020230678,0.000046343946,0.0005732957,0.002229518,0.0000021553408,0.8967952,0.00009736281],"study_design_scores_gemma":[0.0022569506,0.0023237732,0.21119894,0.0021556234,0.0003608118,0.0004605121,0.000109163055,0.0000072632306,0.0007301633,0.0000067246906,0.7801026,0.00028746822],"about_ca_topic_score_codex":0.00011375489,"about_ca_topic_score_gemma":0.00010285081,"teacher_disagreement_score":0.3764096,"about_ca_system_score_codex":0.00051806297,"about_ca_system_score_gemma":0.0001889939,"threshold_uncertainty_score":0.99976957},"labels":[],"label_agreement":null},{"id":"W2769469815","doi":"10.1002/ejhf.1074","title":"November 2017 At a Glance: Quality of Care and Disease Management","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Medical prescription; Observational study; Deferral; Heart failure; Dosing; Guideline; Intensive care medicine; Randomized controlled trial; Quality of life (healthcare); Internal medicine; Ejection fraction; Disease management; Emergency medicine; Disease","score_opus":0.027799612463253492,"score_gpt":0.31106075023837987,"score_spread":0.2832611377751264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769469815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91057473,0.0026492474,0.000111107314,0.06550237,0.00031784596,0.00061734614,0.000023549312,0.000024436693,0.020179367],"genre_scores_gemma":[0.98136765,0.00020859357,0.015303437,0.0003116926,0.00020351462,0.0000011980242,0.000005518141,0.000023328084,0.0025750808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998641,0.00015126274,0.00045724295,0.00017598568,0.00038549746,0.00018901586],"domain_scores_gemma":[0.9983786,0.000019941,0.00041314188,0.0006165997,0.0001641625,0.0004075804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062190887,0.00015729731,0.0004133593,0.0000932268,0.00021842422,0.000047192778,0.00015692173,0.000016889504,0.00011264719],"category_scores_gemma":[0.000102399485,0.00011676369,0.00019657437,0.000027762995,0.00012898602,0.00014908376,0.00023423407,0.00014055376,0.000052498308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002281924,0.0003683479,0.31354296,0.001968568,0.0007112749,0.003789418,0.0010007208,0.0000059862477,0.0014243358,0.0007646804,0.66442853,0.009713229],"study_design_scores_gemma":[0.0029065628,0.00038399588,0.49182153,0.0003987251,0.00021638302,0.00006802303,0.0002342703,0.0000014955333,0.00007355887,0.00001278121,0.5037961,0.00008657866],"about_ca_topic_score_codex":0.0000046133714,"about_ca_topic_score_gemma":0.000012722206,"teacher_disagreement_score":0.17827857,"about_ca_system_score_codex":0.00005057713,"about_ca_system_score_gemma":0.000035774967,"threshold_uncertainty_score":0.4761485},"labels":[],"label_agreement":null},{"id":"W2769520135","doi":"10.1002/ejhf.1060","title":"Systolic Blood Pressure and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: An Analysis of the TOPCAT trial","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Blood pressure","score_opus":0.019340774149574053,"score_gpt":0.2621677334922536,"score_spread":0.24282695934267953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769520135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769582,0.0006436801,0.00004959904,0.021271091,0.00015670202,0.0007536128,0.000004904978,0.000015435986,0.0001467308],"genre_scores_gemma":[0.9958609,0.00002393157,0.0034121373,0.00008422958,0.00025817237,0.000004974336,0.0000030091942,0.000027470753,0.00032518536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976185,0.0007009851,0.00054748316,0.00027465308,0.00064410956,0.00021428974],"domain_scores_gemma":[0.9980778,0.000043355027,0.00038490057,0.0011272009,0.00020140324,0.0001653125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014654618,0.00021705923,0.0010323396,0.00034561,0.00023981396,0.0001119167,0.00022950154,0.000056283257,0.00006203888],"category_scores_gemma":[0.00016585122,0.00012582814,0.00062005775,0.00025407548,0.000111474896,0.0004285222,0.000091643225,0.00039662194,0.0000029707264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029902102,0.00065410277,0.97287023,0.0001301551,0.01489257,0.00022597435,0.00027169212,0.0006380956,0.00059813214,0.00001984314,0.0065074023,0.0002015706],"study_design_scores_gemma":[0.022185398,0.001596209,0.77258694,0.00023410392,0.016018335,0.00018835897,0.00048414804,0.000062136416,0.0002869413,0.0000020917037,0.18621472,0.00014063029],"about_ca_topic_score_codex":0.00014495768,"about_ca_topic_score_gemma":0.00032344816,"teacher_disagreement_score":0.20028332,"about_ca_system_score_codex":0.000018866316,"about_ca_system_score_gemma":0.00006632998,"threshold_uncertainty_score":0.51311225},"labels":[],"label_agreement":null},{"id":"W2769561596","doi":"10.1002/ejhf.1069","title":"The Need for Evaluating Right Ventricular Adaptation and Ventriculo–Arterial Coupling","year":2017,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Ejection fraction; Afterload; Heart failure; Pulmonary hypertension; Pulmonary artery; Ventricle; Blood pressure; Hemodynamics","score_opus":0.0482681667813094,"score_gpt":0.31121181960354444,"score_spread":0.26294365282223503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769561596","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05407586,0.005313579,0.00020158596,0.9384047,0.0009414963,0.0009544911,0.000029860883,0.000014084318,0.000064350315],"genre_scores_gemma":[0.5952284,0.0021462028,0.065162346,0.22561722,0.09598307,0.00009691094,0.0014903157,0.0010378741,0.013237706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801475,0.0002669073,0.00047885155,0.00019697372,0.00069438026,0.00034812588],"domain_scores_gemma":[0.998074,0.00030832007,0.00055672805,0.0002977845,0.00060154893,0.00016161085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014485396,0.00021161062,0.00044161515,0.00013394581,0.0006756149,0.0001978797,0.00018571773,0.00009684553,0.000023839959],"category_scores_gemma":[0.00066618103,0.00011955103,0.00027599413,0.000046077825,0.00008595878,0.00010314197,0.000050157938,0.0009688814,0.000021297994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004087835,0.000036998306,0.00011810781,0.00008479948,0.0003179934,0.030630855,0.000015836342,0.000009960987,0.0003964211,7.7549913e-7,0.9668338,0.0011456858],"study_design_scores_gemma":[0.0035766896,0.0014576839,0.0010873392,0.0005987772,0.0004250717,0.008176388,0.00004890981,0.0011530885,0.00004744999,0.000023709385,0.98329073,0.00011416189],"about_ca_topic_score_codex":0.0000019966892,"about_ca_topic_score_gemma":3.3284383e-7,"teacher_disagreement_score":0.7127875,"about_ca_system_score_codex":0.000050968687,"about_ca_system_score_gemma":0.00019692042,"threshold_uncertainty_score":0.5196352},"labels":[],"label_agreement":null},{"id":"W2771310329","doi":"10.1002/ejhf.1091","title":"Predictors and Outcomes of Heart Failure with Mid-Range Ejection Fraction","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Heart and Stroke Foundation of Canada; National Heart, Lung, and Blood Institute; National Institute on Aging; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Nierstichting","keywords":"Medicine; Heart failure; Ejection fraction; Cardiology; Internal medicine; Fraction (chemistry)","score_opus":0.014624576209319402,"score_gpt":0.25849304804571943,"score_spread":0.24386847183640004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771310329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92563045,0.00014116571,0.0002501807,0.07271468,0.00023108166,0.00035360488,0.0000044111102,0.00003257093,0.00064184197],"genre_scores_gemma":[0.97533655,0.00004355172,0.023409205,0.000229648,0.0003176841,0.0000015688431,0.0000034028571,0.000041963933,0.0006164503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847335,0.00017676689,0.00046475217,0.00020155436,0.00046084533,0.00022276468],"domain_scores_gemma":[0.9985871,0.000043700773,0.0004637034,0.0004407212,0.00022963948,0.00023518574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071730115,0.00022152437,0.0005713399,0.00022295742,0.0002492808,0.0000828946,0.00011060213,0.000047300102,0.00012438203],"category_scores_gemma":[0.00010317613,0.00014716112,0.00017397596,0.000069988666,0.00014655205,0.0004669953,0.000044207798,0.00034879474,0.000037010304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030551458,0.00017420095,0.88213956,0.00009020422,0.00039517658,0.00017906714,0.00018991533,0.0000035427222,0.0029546742,0.000012644053,0.112936765,0.0006187344],"study_design_scores_gemma":[0.002562449,0.0013762483,0.5792883,0.00025933527,0.00028955293,0.00039996416,0.00031277508,0.0000031042066,0.0008382468,0.0000034332697,0.41457167,0.00009490734],"about_ca_topic_score_codex":0.00002149557,"about_ca_topic_score_gemma":0.000037202757,"teacher_disagreement_score":0.30285123,"about_ca_system_score_codex":0.00004524957,"about_ca_system_score_gemma":0.000048972546,"threshold_uncertainty_score":0.60010564},"labels":[],"label_agreement":null},{"id":"W2772496112","doi":"10.1002/ejhf.1073","title":"Contribution of Cardiac and Extra-Cardiac Disease Burden to Risk of Cardiovascular Outcomes Varies by Ejection Fraction in Heart Failure","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AstraZeneca","keywords":"Medicine; Ejection fraction; Internal medicine; Cardiology; Heart failure; Myocardial infarction; Diabetes mellitus; Heart failure with preserved ejection fraction; Stroke (engine); Stroke volume; Hazard ratio; Population; Confidence interval","score_opus":0.009246469769789732,"score_gpt":0.2480722023960597,"score_spread":0.23882573262626997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772496112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614228,0.004694526,0.00092775223,0.031559564,0.00038785682,0.00085242954,0.000073300915,0.000019586314,0.0000621603],"genre_scores_gemma":[0.99431115,0.0005108426,0.0047026165,0.000037896698,0.00026738187,0.0000048127945,0.00001460846,0.00003157664,0.000119098135],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758434,0.0006677294,0.0006609816,0.00025001934,0.00058628706,0.0002506532],"domain_scores_gemma":[0.9982214,0.00007757031,0.0004184291,0.0006015601,0.00036268515,0.0003183625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020311887,0.0002306614,0.0010877016,0.00026508074,0.00017161625,0.000059343263,0.00010570605,0.000054444725,0.000020882544],"category_scores_gemma":[0.00070672744,0.00018662783,0.00066133554,0.0001133311,0.00012918645,0.00035731055,0.00007600086,0.00032761967,0.000014118805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113216,0.00021932193,0.88342506,0.00016503983,0.0021931834,0.0000837723,0.0003333701,0.00015251347,0.009349547,0.000055921068,0.098164186,0.005146766],"study_design_scores_gemma":[0.0014659922,0.00045458906,0.4267108,0.00025524825,0.0009423721,0.000010462737,0.000399329,0.000005786146,0.0011181532,0.000012568977,0.56851107,0.00011360396],"about_ca_topic_score_codex":0.00017794923,"about_ca_topic_score_gemma":0.000008310083,"teacher_disagreement_score":0.4703469,"about_ca_system_score_codex":0.00008260683,"about_ca_system_score_gemma":0.00006282424,"threshold_uncertainty_score":0.76104623},"labels":[],"label_agreement":null},{"id":"W2773999918","doi":"10.1002/ejhf.1056","title":"Sacubitril/Valsartan Reduces Serum Uric Acid Concentration, An Independent Predictor of Adverse Outcomes in PARADIGM-HF","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Hjerteforeningen; Novartis","keywords":"Medicine; Sacubitril, Valsartan; Valsartan; Heart failure; Internal medicine; Uric acid; Sacubitril; Cardiology; Adverse effect; Blood pressure","score_opus":0.018900868752312883,"score_gpt":0.27984411536386705,"score_spread":0.26094324661155416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773999918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852324,0.00042693174,0.00003647974,0.009640909,0.00047009625,0.0003076597,0.000023357534,0.000021537113,0.00054979674],"genre_scores_gemma":[0.9962078,0.00005128027,0.0026621944,0.000292769,0.0004951294,0.0000011361274,0.0000062069485,0.000052999425,0.00023049145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968297,0.0004961132,0.001184247,0.0002861463,0.0008189609,0.00038483628],"domain_scores_gemma":[0.9973564,0.00005231676,0.0011206298,0.00078005367,0.00026463383,0.00042594265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001542639,0.00027666046,0.0009632965,0.00020931907,0.00016718074,0.000048582355,0.0005392955,0.000086295244,0.00019006498],"category_scores_gemma":[0.00061553274,0.00021676437,0.0002434707,0.00012728522,0.00020076815,0.0007573808,0.00009297221,0.0007362584,0.000045770885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038931234,0.0005197348,0.9364039,0.000072919895,0.00023187647,0.0013460276,0.0017526775,0.000047748035,0.052819964,0.000041732765,0.0059096776,0.0004644868],"study_design_scores_gemma":[0.005051768,0.0012217463,0.96319497,0.00039071805,0.00022834433,0.0010894652,0.0007967039,0.00002837702,0.015971737,0.000027461116,0.011788896,0.00020980096],"about_ca_topic_score_codex":0.000011221335,"about_ca_topic_score_gemma":0.000011543182,"teacher_disagreement_score":0.03684823,"about_ca_system_score_codex":0.00009854704,"about_ca_system_score_gemma":0.0003422403,"threshold_uncertainty_score":0.88393945},"labels":[],"label_agreement":null},{"id":"W2779437496","doi":"10.1002/ejhf.1095","title":"December 2017 at a Glance: Left Ventricular Ejection Fraction, Exercise Capacity, Peripartum Cardiomyopathy","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Cardiology; Heart failure; Internal medicine; Coronary artery disease; Cardiomyopathy; Troponin; Myocardial infarction","score_opus":0.018400078267389146,"score_gpt":0.2640361556410972,"score_spread":0.24563607737370807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779437496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97034365,0.0103907,0.0013597911,0.004331754,0.0030375654,0.00047352837,0.000008633522,0.0000710466,0.009983356],"genre_scores_gemma":[0.9911321,0.00055463467,0.0048237965,0.00010276144,0.0020223695,0.0000016816891,0.0000050687618,0.00007630523,0.0012812901],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976108,0.00035859484,0.0005578892,0.0003023323,0.0008239161,0.00034646114],"domain_scores_gemma":[0.99725825,0.00002040469,0.0005449635,0.0012813752,0.0005585488,0.00033647136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014919614,0.0002595192,0.00077029766,0.00018044528,0.00063192204,0.00016750289,0.00032529427,0.00007842227,0.00024350024],"category_scores_gemma":[0.00043785578,0.00022404302,0.0009636481,0.00006839239,0.00016462545,0.00058562687,0.0002052605,0.0006917431,0.00047231486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081306446,0.0003075936,0.30812666,0.00036562208,0.0012409042,0.030952305,0.0008451472,0.00015453216,0.008454987,0.000013812499,0.6442151,0.0045102797],"study_design_scores_gemma":[0.0027110532,0.000266824,0.13969852,0.0013649997,0.0006383759,0.049633633,0.000110740635,0.000013923174,0.0029101493,0.000016235486,0.80239975,0.00023579568],"about_ca_topic_score_codex":0.0000059913364,"about_ca_topic_score_gemma":0.0000055323503,"teacher_disagreement_score":0.16842815,"about_ca_system_score_codex":0.00022144006,"about_ca_system_score_gemma":0.00007401338,"threshold_uncertainty_score":0.9136209},"labels":[],"label_agreement":null},{"id":"W2779643952","doi":"10.1002/ejhf.1078","title":"Sudden Cardiac Death After Acute Heart Failure Hospital Admission: Insights from ASCEND-HF","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Heart failure; Hazard ratio; Ejection fraction; Sudden cardiac death; Ventricular fibrillation; Ventricular tachycardia; Proportional hazards model; Confidence interval","score_opus":0.011560703347302624,"score_gpt":0.25672770052388927,"score_spread":0.24516699717658663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779643952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8023641,0.0016325284,0.00007840717,0.19182928,0.0017518265,0.0006364031,0.000039391547,0.000092927075,0.0015751449],"genre_scores_gemma":[0.95550776,0.000101190075,0.03874837,0.0009028671,0.0027514694,0.00000627568,0.000029828763,0.0001154421,0.001836818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689865,0.0004130967,0.0007895758,0.0004886901,0.0008675201,0.00054245855],"domain_scores_gemma":[0.99696904,0.00006943117,0.000443845,0.0012471909,0.000332282,0.00093820546],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005077728,0.0005008299,0.001025799,0.00023533887,0.00047000978,0.0003520625,0.00044126224,0.00011276756,0.0008383613],"category_scores_gemma":[0.00017286435,0.00036209103,0.00080118596,0.00009403239,0.00012641413,0.00070166023,0.00030141114,0.0007951981,0.0010544356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052220636,0.00037159314,0.086354524,0.00003913883,0.0013420392,0.006502921,0.0007918772,0.0000010263269,0.0039697355,0.00004163504,0.8989558,0.0011074567],"study_design_scores_gemma":[0.0025890307,0.0012374258,0.21353677,0.00053597655,0.00071638223,0.00020980877,0.0002474066,0.0000023784112,0.0011907114,0.00002688013,0.77940565,0.0003015878],"about_ca_topic_score_codex":0.00003000867,"about_ca_topic_score_gemma":0.000013622078,"teacher_disagreement_score":0.19092642,"about_ca_system_score_codex":0.000103256105,"about_ca_system_score_gemma":0.00019078165,"threshold_uncertainty_score":0.9998831},"labels":[],"label_agreement":null},{"id":"W2781650855","doi":"10.1002/ejhf.1104","title":"Structural Brain Abnormalities and Cardiac Dysfunction in Patients with Chronic Heart Failure","year":2018,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Aging","funders":"Japan Society for the Promotion of Science","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Asymptomatic; Magnetic resonance imaging; Hippocampus; Radiology","score_opus":0.010675881658876998,"score_gpt":0.20354093766286918,"score_spread":0.19286505600399217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781650855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75340205,0.00016438737,0.000007316112,0.24503529,0.0007348456,0.0004246636,0.00014687465,0.000035283414,0.00004926561],"genre_scores_gemma":[0.844602,0.000014364095,0.00070086756,0.15074167,0.0032224108,0.000004640068,0.00005066134,0.0001522168,0.00051116385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960465,0.0015650142,0.00054859376,0.0005510628,0.00074710615,0.0005417369],"domain_scores_gemma":[0.9988266,0.00016024547,0.00039135158,0.00031217,0.00012830795,0.00018132168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002981665,0.00047564018,0.0006346195,0.00027206563,0.00019784058,0.00020010903,0.00026898502,0.00015078826,0.00015912231],"category_scores_gemma":[0.00012655699,0.0003200209,0.00020316792,0.00019463975,0.00023692627,0.00041170383,0.00012125247,0.0015965066,0.000072174924],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027257757,0.000048072423,0.022705393,0.00009935853,0.00004870964,0.0014323842,0.000064156106,0.000009511325,0.0008417975,0.00002877553,0.9742703,0.00017900439],"study_design_scores_gemma":[0.002904226,0.0047696205,0.08667965,0.00027509534,0.000086553235,0.00023073882,0.000015955133,0.0000031392706,0.0004176441,0.00008262612,0.9040959,0.00043884758],"about_ca_topic_score_codex":0.000004154571,"about_ca_topic_score_gemma":0.000003345728,"teacher_disagreement_score":0.09429362,"about_ca_system_score_codex":0.00009474263,"about_ca_system_score_gemma":0.000088273155,"threshold_uncertainty_score":0.9999252},"labels":[],"label_agreement":null},{"id":"W2781931840","doi":"10.1002/ejhf.1133","title":"The Interaction of Sex, Height, and QRS Duration on the Effects of Cardiac Resynchronization Therapy on Morbidity and Mortality: An Individual-Patient Data Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; University of British Columbia","funders":"St. Jude Medical; National Institute for Health and Care Research; LivaNova","keywords":"Medicine; Cardiac resynchronization therapy; Meta-analysis; QRS complex; Heart failure; Internal medicine; Cardiology; Duration (music); Patient data; Database","score_opus":0.1684096554376756,"score_gpt":0.3796100004124621,"score_spread":0.2112003449747865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781931840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03129768,0.9670577,0.000025156738,0.00048527584,0.00022902504,0.0005712037,0.00011415589,0.0000065307695,0.00021328821],"genre_scores_gemma":[0.12531024,0.87406415,0.000098110155,0.000059609938,0.00033005807,0.0000023888188,0.00008987072,0.000028928936,0.000016654833],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955881,0.0026263173,0.0008737816,0.00024515143,0.0005742203,0.00009239361],"domain_scores_gemma":[0.9965546,0.0010736363,0.0012866975,0.0007423422,0.00027781635,0.00006488348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026554358,0.00023376111,0.0018923896,0.00022606929,0.00017559694,0.00005905807,0.00007253483,0.000046098023,0.0000036713554],"category_scores_gemma":[0.00048501595,0.00010589395,0.0007180125,0.0003047294,0.00014667396,0.00011653638,0.000085777,0.00030497432,0.0000012777657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004925202,0.00034290185,0.002000822,0.0053157983,0.5166372,0.00003439369,0.0058319033,0.00006605245,0.00010192727,0.00012175091,0.08259313,0.3864616],"study_design_scores_gemma":[0.0002019362,0.001491776,0.0028547833,0.00090932567,0.09312001,0.00009621617,0.00022606451,0.000007688831,0.000091272035,0.0000028929055,0.9008863,0.000111738475],"about_ca_topic_score_codex":0.00000838154,"about_ca_topic_score_gemma":0.0000047043677,"teacher_disagreement_score":0.81829315,"about_ca_system_score_codex":0.00001983237,"about_ca_system_score_gemma":0.000056829587,"threshold_uncertainty_score":0.43182302},"labels":[],"label_agreement":null},{"id":"W2782064036","doi":"10.1002/ejhf.1109","title":"Sudden Cardiac Death Following Admission for Acute Heart Failure: Adding Insult to Injury","year":2018,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Insult; Heart failure; Cardiology; Sudden cardiac death; Internal medicine","score_opus":0.019578635917834368,"score_gpt":0.29710959232937395,"score_spread":0.2775309564115396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782064036","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009377322,0.00041554886,0.00043647722,0.9843588,0.0028263128,0.0019582496,0.00013321072,0.00013468896,0.0003594305],"genre_scores_gemma":[0.011597545,0.000091952636,0.4392173,0.4861311,0.046287004,0.000072353185,0.0006747817,0.0009516187,0.014976335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99472535,0.0006905438,0.0014154586,0.00077670475,0.0012796272,0.001112308],"domain_scores_gemma":[0.9968815,0.00024749144,0.00050947675,0.00088781846,0.0006300192,0.0008436906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00199016,0.00088968046,0.0019962143,0.00096567,0.00036089603,0.00023164875,0.0004626658,0.00038678845,0.00028489457],"category_scores_gemma":[0.0004705383,0.00070201093,0.0019638187,0.00042463216,0.000044531906,0.00033045415,0.00027809205,0.0020248771,0.0007151096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037970004,0.00007343643,0.00073407235,0.00017968575,0.002016159,0.0021155796,0.00024910248,7.66915e-7,0.003252127,0.0000032658083,0.9902872,0.00070894934],"study_design_scores_gemma":[0.0022083994,0.004156401,0.00035915663,0.0023556524,0.0026530526,0.00043812513,0.00012036548,0.0000016307164,0.00090564316,0.0000066901475,0.98618317,0.0006117191],"about_ca_topic_score_codex":0.000006208273,"about_ca_topic_score_gemma":0.0000017753529,"teacher_disagreement_score":0.49822766,"about_ca_system_score_codex":0.000323946,"about_ca_system_score_gemma":0.00040801187,"threshold_uncertainty_score":0.99954313},"labels":[],"label_agreement":null},{"id":"W2783929973","doi":"10.1002/ejhf.1101","title":"Proteomic Diversity of High-Density Lipoprotein Explains its Association with Clinical Outcome in Patients with Heart Failure","year":2017,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Abbott Vascular; Sphingotec GmbH; British Heart Foundation; National Institute for Health and Care Research; Amgen; Singulex; Servier; European Commission; ResMed; Celladon Corporation; Bristol-Myers Squibb; AstraZeneca; Alere","keywords":"Medicine; Proteome; Heart failure; Confidence interval; Internal medicine; Odds ratio; Lipoprotein; Filamin; Cardiology; Cholesterol; Bioinformatics; Cytoskeleton; Biology; Biochemistry","score_opus":0.023181727757836963,"score_gpt":0.2651403490611928,"score_spread":0.24195862130335585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783929973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175674,0.000013460601,0.00007791611,0.0074617895,0.00016101754,0.00046925803,0.000010795557,0.000010015349,0.000039003524],"genre_scores_gemma":[0.9879565,0.000004303158,0.0114870565,0.00012392762,0.0003091263,4.1779347e-7,0.0000039968395,0.00003162852,0.00008303926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975251,0.00042124282,0.00077709585,0.00022773503,0.0007977712,0.00025102953],"domain_scores_gemma":[0.9975526,0.000039560247,0.0010863275,0.00040582276,0.0007133236,0.00020241809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002261626,0.00018563138,0.0008557761,0.00013125836,0.00028028336,0.00005088902,0.00018806999,0.00008854095,0.000016297865],"category_scores_gemma":[0.0004369144,0.00012327946,0.000265647,0.00007916389,0.00009102072,0.00032521927,0.00019713756,0.00085527234,0.000017805858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012307742,0.0002276945,0.99423915,0.000054083044,0.000110322784,0.000036757032,0.00012235684,0.000052274023,0.0007097447,0.0000028751722,0.003048113,0.00016585916],"study_design_scores_gemma":[0.007008099,0.0017711729,0.98769104,0.0007519148,0.00013789795,0.00003758795,0.00005783406,0.000007686601,0.0007048437,0.0000018198601,0.0016906332,0.0001394832],"about_ca_topic_score_codex":0.00006801727,"about_ca_topic_score_gemma":0.000046951078,"teacher_disagreement_score":0.01140914,"about_ca_system_score_codex":0.00012630271,"about_ca_system_score_gemma":0.00010073202,"threshold_uncertainty_score":0.50271904},"labels":[],"label_agreement":null},{"id":"W2788475243","doi":"10.1002/ejhf.996","title":"February 2018 at a Glance: Heart and Brain Interaction, Prognostic Variables, and Acute Heart Failure and Post-Discharge Outcomes","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Hazard ratio; Vascular resistance; Ejection fraction; Diastolic heart failure; Heart failure with preserved ejection fraction; Pulmonary hypertension; Cohort; Diastole; Blood pressure; Confidence interval","score_opus":0.009633015967318451,"score_gpt":0.251710253466508,"score_spread":0.24207723749918955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788475243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78835756,0.00053906365,0.0000612459,0.21025261,0.00030400377,0.00036097888,0.000029979457,0.000035183864,0.00005936924],"genre_scores_gemma":[0.97975606,0.0000371807,0.011495397,0.007101322,0.00085413636,0.0000027357894,0.000010277013,0.00005730876,0.00068561255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760544,0.0005489851,0.0007531759,0.00041636042,0.000258067,0.00041796043],"domain_scores_gemma":[0.9981577,0.00047215275,0.00020678909,0.0003050461,0.00031313216,0.00054522225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017050926,0.00032157963,0.00079632946,0.0002004011,0.00032438792,0.00014735424,0.00008420125,0.000089545036,0.0003095293],"category_scores_gemma":[0.00067620334,0.0002459577,0.0001329,0.00013596001,0.00033615655,0.00045171546,0.00017270251,0.0006432724,0.00010473905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005561439,0.00021741482,0.33317682,0.00020111036,0.00050101,0.00018960325,0.0012767342,7.8455975e-7,0.2535336,0.0000689995,0.40952715,0.0007506153],"study_design_scores_gemma":[0.002713709,0.0015295454,0.4248288,0.00033996752,0.00018061916,0.0075555854,0.00023845829,0.00006413405,0.00041816014,0.000022598504,0.56190425,0.00020418385],"about_ca_topic_score_codex":0.000034233166,"about_ca_topic_score_gemma":0.000042518943,"teacher_disagreement_score":0.25311542,"about_ca_system_score_codex":0.000063297215,"about_ca_system_score_gemma":0.00017390925,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W2790275265","doi":"10.1002/ejhf.1149","title":"Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction Spectrum","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":425,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Vetenskapsrådet; Stockholms Läns Landsting; AstraZeneca","keywords":"Candesartan; Medicine; Ejection fraction; Heart failure; Internal medicine; Hazard ratio; Cardiology; Incidence (geometry); Confidence interval; Placebo; Angiotensin II; Blood pressure","score_opus":0.009659056238576194,"score_gpt":0.2672200015461359,"score_spread":0.2575609453075597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790275265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720368,0.000078952406,0.00021542297,0.026521375,0.00041968378,0.0005921077,0.0000056380354,0.0000319994,0.00009802095],"genre_scores_gemma":[0.99762464,0.00004155755,0.0010118643,0.00025016052,0.000827953,0.0000051888387,0.000009566528,0.00004715822,0.00018192736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977535,0.0005747921,0.0006097011,0.0002678948,0.0004592884,0.0003348484],"domain_scores_gemma":[0.99884385,0.00011396476,0.00042523607,0.00028396197,0.00018713344,0.00014584784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015946487,0.00029023527,0.0006569372,0.00025905145,0.00023451251,0.00007277941,0.00007486838,0.00006841686,0.00012340149],"category_scores_gemma":[0.00010764647,0.00017419874,0.00016515449,0.00031207062,0.00017116849,0.00037784394,0.00003740139,0.0005729211,0.000051557057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001320057,0.00016466838,0.97508126,0.0001265218,0.00022446093,0.000098690536,0.00040885145,0.0000016656497,0.00690714,0.0000036444685,0.014140056,0.0015229606],"study_design_scores_gemma":[0.0038632134,0.004479651,0.8031596,0.00044859375,0.00025935733,0.0005805595,0.00077489513,0.000023094753,0.0052548507,0.0000029464723,0.18099688,0.00015635056],"about_ca_topic_score_codex":0.00010841931,"about_ca_topic_score_gemma":0.00034696978,"teacher_disagreement_score":0.17192167,"about_ca_system_score_codex":0.0001572584,"about_ca_system_score_gemma":0.00004157939,"threshold_uncertainty_score":0.7103618},"labels":[],"label_agreement":null},{"id":"W2792129060","doi":"10.1002/ejhf.994","title":"January 2018 at a Glance: Biomarkers, Co-Morbidities and Mechanical Circulatory Support","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Ejection fraction; Atrial fibrillation; Heart failure with preserved ejection fraction; Intensive care medicine","score_opus":0.01421098194386408,"score_gpt":0.26678302597916453,"score_spread":0.2525720440353005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792129060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98769027,0.0006780165,0.00008048734,0.0058255396,0.0013640282,0.00012388786,0.00000952773,0.000023274037,0.0042049624],"genre_scores_gemma":[0.9941161,0.000079992955,0.0024224801,0.00068049773,0.0023227353,3.0108336e-7,0.000009318696,0.000028086668,0.00034044232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998781,0.00021818122,0.000350504,0.00013941654,0.0003292322,0.00018161736],"domain_scores_gemma":[0.99923766,0.00004248016,0.00014877896,0.00015932666,0.00016855824,0.000243185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009209076,0.00011919562,0.00028039992,0.000118295924,0.0001302326,0.000023979515,0.000056800152,0.00003894,0.00022880555],"category_scores_gemma":[0.00007765344,0.00009096643,0.00016010077,0.0000770712,0.00023614234,0.00011554913,0.00004567158,0.00021012811,0.00021556477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041588975,0.00003148076,0.024691088,0.000050417544,0.00015828758,0.0005211947,0.00039795157,1.4226262e-7,0.059221234,0.000020162024,0.91384387,0.0006482864],"study_design_scores_gemma":[0.0017998455,0.0007903473,0.2054295,0.00019574452,0.00011332556,0.002600572,0.0004073294,0.0000065189124,0.0026009837,0.000018075674,0.78591347,0.00012431797],"about_ca_topic_score_codex":0.0000010689857,"about_ca_topic_score_gemma":0.0000019085396,"teacher_disagreement_score":0.1807384,"about_ca_system_score_codex":0.000047494545,"about_ca_system_score_gemma":0.000088718916,"threshold_uncertainty_score":0.37095034},"labels":[],"label_agreement":null},{"id":"W2792329549","doi":"10.1002/ejhf.1143","title":"The promise of Patient-Reported Outcomes: One Step Closer to Routine Care","year":2018,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Psychosocial; Anxiety; Observational study; Heart failure; Depression (economics); Cohort; Health care; Adverse effect; Quality of life (healthcare); Intensive care medicine; Emergency medicine; Psychiatry; Internal medicine","score_opus":0.018091823094970677,"score_gpt":0.2581890422447382,"score_spread":0.24009721914976753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792329549","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034429394,0.0004792914,0.0000387355,0.9616213,0.00075788714,0.0014450321,0.000018149361,0.00003840162,0.0011718504],"genre_scores_gemma":[0.1584227,0.00016239333,0.09945916,0.69556284,0.018149437,0.000045144145,0.00033636266,0.00090054865,0.026961396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558264,0.0006452298,0.0016333165,0.00035235385,0.0012498406,0.0005365918],"domain_scores_gemma":[0.9964218,0.00012581208,0.0010351436,0.000982127,0.0011495312,0.00028557825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091867463,0.00048711098,0.0011514829,0.00033528314,0.00016546354,0.00006849195,0.0003495942,0.00015204483,0.00016898113],"category_scores_gemma":[0.00030648505,0.00028462225,0.00065517105,0.00025011026,0.00012810617,0.00008060818,0.00019438598,0.0013763355,0.00024792145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026701688,0.00012082424,0.004522269,0.00024006932,0.0011412193,0.0026794604,0.0008626145,7.410471e-7,0.00010232556,0.0000020180012,0.9881792,0.0018822525],"study_design_scores_gemma":[0.0024781765,0.0033737503,0.004890516,0.0011231364,0.0009464653,0.00033390266,0.0005308803,3.0676216e-7,0.00020821586,0.0000015703337,0.98587704,0.0002360137],"about_ca_topic_score_codex":0.000010439815,"about_ca_topic_score_gemma":0.000011742981,"teacher_disagreement_score":0.2660584,"about_ca_system_score_codex":0.00015022831,"about_ca_system_score_gemma":0.00022738239,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2792867832","doi":"10.1002/ejhf.1146","title":"Treatment with Insulin is Associated with Worse Outcome in Patients with Chronic Heart Failure and Diabetes","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Agence Régionale de Santé Île-de-France; Regione Puglia; National Institute for Health and Care Research","keywords":"Medicine; Diabetes mellitus; Hazard ratio; Internal medicine; Propensity score matching; Proportional hazards model; Insulin; Confidence interval; Heart failure; Odds ratio; Population; Cohort study; Cohort; Endocrinology","score_opus":0.008761361845431111,"score_gpt":0.23282532819738863,"score_spread":0.22406396635195752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792867832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907928,0.00019867258,0.000008672971,0.0084373895,0.000049094255,0.00034413344,0.000015542335,0.000017973152,0.00013569977],"genre_scores_gemma":[0.9965768,0.000008130412,0.0021611515,0.0008484472,0.00019761486,0.0000031005352,0.000013112086,0.000052879932,0.00013878985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981533,0.00018085515,0.0005156049,0.00027105547,0.00045079866,0.0004283662],"domain_scores_gemma":[0.9987257,0.00006720031,0.00018582311,0.00022513302,0.00047065548,0.0003254589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002294956,0.00030244657,0.00069928163,0.00017485798,0.00010844696,0.00004761577,0.00008014398,0.000057865404,0.00011765928],"category_scores_gemma":[0.000059619535,0.00016597076,0.00007887102,0.00024929302,0.0002556148,0.00017394444,0.000024498291,0.00038206967,0.00002372473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018691862,0.00048596505,0.99427193,0.000026391066,0.00025545293,0.00021769434,0.00038938306,0.0000017621912,0.000107011,0.0000026505616,0.0016469606,0.00072563573],"study_design_scores_gemma":[0.034778353,0.051914994,0.8539251,0.0013153438,0.0003360923,0.00015930746,0.00014048914,0.00002347855,0.00012844466,0.0000029088715,0.056970667,0.00030479996],"about_ca_topic_score_codex":0.00000770751,"about_ca_topic_score_gemma":0.00007891366,"teacher_disagreement_score":0.14034678,"about_ca_system_score_codex":0.00015269803,"about_ca_system_score_gemma":0.00015168724,"threshold_uncertainty_score":0.67680913},"labels":[],"label_agreement":null},{"id":"W2793346093","doi":"10.1002/ejhf.1148","title":"Guideline Recommendations for Cardiac Resynchronization Therapy Evolve But Does Clinical Practice Match the Pace?","year":2018,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiac resynchronization therapy; Medicine; Heart failure; Guideline; Ejection fraction; Internal medicine; Cardiology; Clinical Practice; Heart Rhythm; Canadian Cardiovascular Society; QRS complex; Physical therapy","score_opus":0.05471800028925546,"score_gpt":0.37851513659890246,"score_spread":0.323797136309647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793346093","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025780566,0.0031410735,0.0036449947,0.98557305,0.0036570916,0.0005867592,0.00014202249,0.00004089713,0.002956284],"genre_scores_gemma":[0.0012780089,0.0049839853,0.13077465,0.7391902,0.116049916,0.000009359993,0.0004428591,0.00026633908,0.007004663],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99519676,0.0019182975,0.0016598549,0.00030674238,0.00063217286,0.00028615858],"domain_scores_gemma":[0.9928496,0.0018845446,0.0012997682,0.00057455775,0.0032889524,0.00010256039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005722552,0.00030434516,0.0010125363,0.00015884556,0.00035883527,0.00012487348,0.0000910873,0.00019375514,0.000054338157],"category_scores_gemma":[0.0030590536,0.00016498676,0.0010219765,0.00017761889,0.00017974473,0.0001640238,0.00006394996,0.0014950355,0.00010129224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022511874,0.000023301369,0.00030537628,0.000030185507,0.00093941914,0.00004021891,0.00024986066,0.0000029329665,0.000027538103,0.0000021884994,0.9963797,0.0017742115],"study_design_scores_gemma":[0.0012669102,0.00078844925,0.00032123708,0.00030811614,0.00064543664,0.0011104819,0.0006714789,0.000005133155,0.000020416468,0.00001675646,0.99466395,0.00018160205],"about_ca_topic_score_codex":0.0000044226485,"about_ca_topic_score_gemma":5.584311e-7,"teacher_disagreement_score":0.24638286,"about_ca_system_score_codex":0.000076123964,"about_ca_system_score_gemma":0.0002865627,"threshold_uncertainty_score":0.6727965},"labels":[],"label_agreement":null},{"id":"W2793844490","doi":"10.1002/ejhf.1139","title":"Effect of Sacubitril/Valsartan on Recurrent Events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial (PARADIGM-HF)","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Hjerteforeningen; Novartis","keywords":"Medicine; Enalapril; Sacubitril; Heart failure; Valsartan; Hazard ratio; Internal medicine; Confidence interval; Sacubitril, Valsartan; Clinical endpoint; Cardiology; Randomized controlled trial; Angiotensin-converting enzyme; Ejection fraction; Blood pressure","score_opus":0.03627306645841549,"score_gpt":0.364413409429376,"score_spread":0.3281403429709605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793844490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902397,0.00007582895,0.000012990363,0.0074339393,0.0001224796,0.0019706662,0.000015736037,0.00000799948,0.00012067573],"genre_scores_gemma":[0.99871606,0.0000044430576,0.00082546426,0.00012584224,0.00028474457,0.000008477993,0.0000040939194,0.000022345786,0.000008557478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962037,0.0015347174,0.0008548132,0.0003101863,0.0007592719,0.00033730557],"domain_scores_gemma":[0.9986458,0.00022901573,0.00038297093,0.00041014067,0.000118265445,0.00021380908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026925001,0.00034287325,0.0012973106,0.00025949779,0.000053491247,0.000017328019,0.00016957949,0.000049144895,0.00002654655],"category_scores_gemma":[0.00022886807,0.00018407626,0.00021490177,0.0005046954,0.00013074632,0.00010402516,0.0000493092,0.00047572426,0.000015523434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07132895,0.0019008506,0.89996547,0.00014546527,0.0002646285,0.00021682016,0.0012080779,0.00008156162,0.00057605095,0.000026869795,0.023202766,0.0010824706],"study_design_scores_gemma":[0.03254012,0.091317475,0.8641884,0.0014885429,0.00026029357,0.00016393999,0.00020807647,0.000029020108,0.002943706,0.000012558929,0.006668494,0.00017941042],"about_ca_topic_score_codex":0.00007223281,"about_ca_topic_score_gemma":0.00039673812,"teacher_disagreement_score":0.08941662,"about_ca_system_score_codex":0.00020181555,"about_ca_system_score_gemma":0.00009643005,"threshold_uncertainty_score":0.75064117},"labels":[],"label_agreement":null},{"id":"W2795607274","doi":"10.1002/ejhf.1169","title":"Acute Heart Failure: Lessons Learned, Roads Ahead","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Abbott Vascular; Pfizer; Servier; Sanofi; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Heart failure; Intensive care medicine; Population; Clinical trial; Psychological intervention; Internal medicine","score_opus":0.07338254034948286,"score_gpt":0.3599108368570931,"score_spread":0.28652829650761025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795607274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025919995,0.88864386,0.00011903674,0.10751102,0.0011567476,0.0011863938,0.000042230888,0.00014209298,0.0011726692],"genre_scores_gemma":[0.000057861318,0.9354146,0.051024448,0.00089144363,0.00453053,0.000014115997,0.00011919302,0.00041183666,0.0075359414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931233,0.0016418255,0.0022527461,0.000816993,0.0011559019,0.001009245],"domain_scores_gemma":[0.99592507,0.0002012412,0.0011042817,0.0012785001,0.0005024907,0.0009884088],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002495704,0.0011588495,0.0041697724,0.0009878649,0.00029071933,0.00022116594,0.00063009566,0.00030345423,0.0010380707],"category_scores_gemma":[0.00023304072,0.0008174441,0.0027539122,0.0007748122,0.0002606631,0.00031895444,0.00033321037,0.00211022,0.006012339],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007106925,0.00025563806,0.000018653469,0.0024889528,0.0019256681,0.0020907475,0.00008164387,2.9101523e-7,0.0000151095865,0.000045527133,0.8812977,0.111708984],"study_design_scores_gemma":[0.0019117758,0.0021043885,0.00002126798,0.017010849,0.0060407855,0.008408005,0.00006991083,6.1095744e-7,0.000009996155,0.000008028527,0.9638123,0.0006020893],"about_ca_topic_score_codex":0.0000037436141,"about_ca_topic_score_gemma":0.000010026331,"teacher_disagreement_score":0.11110689,"about_ca_system_score_codex":0.0003093256,"about_ca_system_score_gemma":0.0008095792,"threshold_uncertainty_score":0.9998751},"labels":[],"label_agreement":null},{"id":"W2795772830","doi":"10.1002/ejhf.998","title":"March 2018 at a Glance: Clinical Trials, Co-Morbidities and Treatment of Mitral Regurgitation","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Natriuretic peptide; Cardiology; Cardiac function curve; Clinical trial","score_opus":0.10913991697667971,"score_gpt":0.45435331454525274,"score_spread":0.34521339756857305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795772830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417466,0.002064196,0.0000097409875,0.002537938,0.0003049607,0.00020552654,0.00005745293,0.0000068048803,0.00063873903],"genre_scores_gemma":[0.9953241,0.00062610675,0.0018175085,0.00010386511,0.0015583815,8.5454695e-7,0.000020544103,0.000021216705,0.0005274194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978171,0.0008696031,0.0007964434,0.00013316619,0.00024679428,0.0001369136],"domain_scores_gemma":[0.99877304,0.00023205012,0.00038017047,0.00016800543,0.00021452484,0.0002322035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013043312,0.00012475929,0.0006799967,0.00008593883,0.00006347896,0.000015791973,0.000032449738,0.000027656964,0.00015750622],"category_scores_gemma":[0.00024995286,0.00008280168,0.001139725,0.000052262065,0.00020980899,0.00006238947,0.000015178793,0.00007642006,0.000051091083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063567627,0.00075544015,0.7180613,0.000059078735,0.0023542321,0.0003348039,0.0005445133,4.375744e-7,0.0012500455,0.000015849475,0.25552145,0.014746074],"study_design_scores_gemma":[0.008472267,0.0075117117,0.78873944,0.00016714334,0.0009161088,0.0003889778,0.00023538555,0.0000024710514,0.00043516452,0.000008998685,0.19305384,0.0000685053],"about_ca_topic_score_codex":0.0000044416065,"about_ca_topic_score_gemma":0.0000017007038,"teacher_disagreement_score":0.07067812,"about_ca_system_score_codex":0.000059416212,"about_ca_system_score_gemma":0.0000876793,"threshold_uncertainty_score":0.33765545},"labels":[],"label_agreement":null},{"id":"W2797934830","doi":"10.1002/ejhf.1000","title":"April 2018 at a Glance: Focus on Prognostic Variables","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Ejection fraction; Cardiology; Aliskiren; Natriuretic peptide; Brain natriuretic peptide; Myocardial infarction; Diabetes mellitus; Biomarker; Renin–angiotensin system; Blood pressure; Endocrinology","score_opus":0.013476877377394853,"score_gpt":0.23407906453048793,"score_spread":0.22060218715309307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797934830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95779425,0.0010181343,0.0014687001,0.01929794,0.0026363034,0.00037632225,0.000008504356,0.000098854754,0.017300965],"genre_scores_gemma":[0.99094814,0.000047585618,0.0034712995,0.00085271866,0.002952096,4.125816e-7,0.0000024733758,0.000045461384,0.0016798315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984841,0.00028820636,0.00037171828,0.00016096726,0.00047787218,0.0002171347],"domain_scores_gemma":[0.9989533,0.000054675485,0.00015903353,0.0002929521,0.00027488597,0.00026514143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009127754,0.00014889626,0.00036570834,0.00014394482,0.00013444787,0.00002656202,0.00008666429,0.00003747461,0.0007035034],"category_scores_gemma":[0.00030346768,0.000099023884,0.00037885856,0.00016695165,0.00010701245,0.000064664266,0.000041060037,0.00034975872,0.0012598238],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009317094,0.00016575474,0.05646576,0.000034444205,0.00042074473,0.0007741389,0.0002836281,0.000010805996,0.0065764254,0.00004668996,0.9305339,0.0037560144],"study_design_scores_gemma":[0.002029001,0.0022453484,0.1137203,0.00028887458,0.0001690275,0.0033025981,0.00006588388,0.000006816667,0.0020606006,0.000011348942,0.8759931,0.000107133616],"about_ca_topic_score_codex":0.0000027069366,"about_ca_topic_score_gemma":0.000003493891,"teacher_disagreement_score":0.05725454,"about_ca_system_score_codex":0.00007681193,"about_ca_system_score_gemma":0.00008850623,"threshold_uncertainty_score":0.9995178},"labels":[],"label_agreement":null},{"id":"W2800434402","doi":"10.1002/ejhf.1079","title":"Potassium and the Use of Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure with Reduced Ejection Fraction: Data from BIOSTAT-CHF","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Commission; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Interquartile range; Hazard ratio; Internal medicine; Aldosterone; Ejection fraction; Hyperkalemia; Confidence interval; Odds ratio; Potassium; Cardiology; Hypokalemia; Renin–angiotensin system","score_opus":0.025609180556694644,"score_gpt":0.24107524039402348,"score_spread":0.21546605983732883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800434402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92367816,0.0009044417,0.00021516425,0.07411237,0.0005344396,0.00036500502,0.000034614586,0.000032412787,0.00012337111],"genre_scores_gemma":[0.9874411,0.00004121629,0.011287644,0.00037784004,0.0007037579,4.670833e-7,0.00002975785,0.000049068578,0.00006912482],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751854,0.0007611069,0.0007533141,0.0003028584,0.00042527638,0.00023891575],"domain_scores_gemma":[0.9982399,0.00014371684,0.00048867613,0.00062809396,0.00032225536,0.00017738402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979163,0.00022048893,0.00057748664,0.00026285203,0.00013195725,0.000069182766,0.00015718237,0.000096668686,0.00003303938],"category_scores_gemma":[0.00018393059,0.00012778614,0.000093762486,0.00038621025,0.0004568822,0.00047179524,0.00010539684,0.0007453414,0.00003137322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006902228,0.0002497256,0.036833476,0.00009450355,0.000592173,0.00046716133,0.0012080814,0.000048976093,0.07096815,0.000011942797,0.88186175,0.0007618156],"study_design_scores_gemma":[0.02330253,0.0033478532,0.13616472,0.005771248,0.0010557913,0.0073495246,0.006107756,0.0008479795,0.0067518526,0.000007325184,0.80878323,0.0005101836],"about_ca_topic_score_codex":0.0001681141,"about_ca_topic_score_gemma":0.00009321684,"teacher_disagreement_score":0.09933126,"about_ca_system_score_codex":0.00004964326,"about_ca_system_score_gemma":0.00012492534,"threshold_uncertainty_score":0.52109677},"labels":[],"label_agreement":null},{"id":"W2803100393","doi":"10.1002/ejhf.1002","title":"May 2018 at a Glance: The Central Role of Co-Morbidities","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Hazard ratio; Diabetes mellitus; Confidence interval; Internal medicine; Clinical trial; Intensive care medicine; Randomized controlled trial; Cardiology; Endocrinology","score_opus":0.02107774184980802,"score_gpt":0.28375887337174843,"score_spread":0.2626811315219404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803100393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9195716,0.0015852351,0.00003305667,0.020189814,0.00047243005,0.00022772151,0.000019467498,0.000028353616,0.05787233],"genre_scores_gemma":[0.9953186,0.00005798989,0.0006153278,0.00048586412,0.0015817509,3.4251192e-7,0.0000042503193,0.000026078289,0.0019098339],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986448,0.0001989197,0.0003928241,0.00010332956,0.00040417004,0.00025592052],"domain_scores_gemma":[0.9991388,0.000035868074,0.00024856752,0.00029247065,0.00014902058,0.00013532488],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005063469,0.00012387824,0.00025312894,0.000073067946,0.00010334787,0.000030364175,0.00020329612,0.000014728753,0.0015720217],"category_scores_gemma":[0.000052662082,0.0000773005,0.00017254597,0.00009585335,0.00040077895,0.00010837069,0.00007747539,0.0001851287,0.00022116477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003811519,0.00008563359,0.014599012,0.00008125557,0.0001730542,0.00016690386,0.0008552622,0.0000055814326,0.0064405324,0.0003643185,0.9763392,0.00050806056],"study_design_scores_gemma":[0.0012869524,0.00077638536,0.11496139,0.00023320716,0.0001240221,0.0003847141,0.0020948497,0.000010614803,0.0026440474,0.000042787964,0.8773661,0.000074915304],"about_ca_topic_score_codex":0.000005554548,"about_ca_topic_score_gemma":0.000007077515,"teacher_disagreement_score":0.10036238,"about_ca_system_score_codex":0.0000645155,"about_ca_system_score_gemma":0.00012106541,"threshold_uncertainty_score":0.99934065},"labels":[],"label_agreement":null},{"id":"W2804625362","doi":"10.1002/ejhf.1192","title":"Implantable Cardioverter-Defibrillators in Heart Failure Patients with Reduced Ejection Fraction and Diabetes","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; Canadian VIGOUR Centre; St. Michael's Hospital; University of Alberta","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Diabetes mellitus; Internal medicine; Heart failure; Hazard ratio; Implantable cardioverter-defibrillator; Ejection fraction; Sudden cardiac death; Cardiology; Cause of death; Ischemic cardiomyopathy; Confidence interval; Disease","score_opus":0.007530107653329531,"score_gpt":0.22860942186717373,"score_spread":0.2210793142138442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804625362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353105,0.00022696069,0.000021313659,0.00089163403,0.00024278795,0.00013248977,0.0000056592794,0.000024368706,0.004923726],"genre_scores_gemma":[0.9970196,0.000012169544,0.0019172104,0.00015907685,0.00082343916,4.0026464e-7,0.000003691491,0.000031114563,0.000033313558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986918,0.00020417338,0.00036254933,0.00018540445,0.0003344411,0.00022161748],"domain_scores_gemma":[0.9991506,0.000050098646,0.00017045846,0.00014971092,0.00034585572,0.00013332441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043796576,0.00015989464,0.0005915714,0.00025689162,0.00013173172,0.000046211328,0.000013114573,0.000036064142,0.000005237346],"category_scores_gemma":[0.00006647809,0.0001196721,0.00010859066,0.0002497959,0.00008177118,0.0002484047,0.000026774738,0.00023140386,0.000029169425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024871388,0.000019845631,0.8234574,0.000023204015,0.0001263851,0.0000032923033,0.00014631526,0.00000850716,0.004317588,8.288902e-7,0.17131795,0.0003299253],"study_design_scores_gemma":[0.0017103688,0.0010472595,0.6154662,0.00029289426,0.00007780847,0.00071236584,0.00032006766,0.0000019154268,0.0013389509,0.0000021411106,0.37891638,0.00011369574],"about_ca_topic_score_codex":0.0000073806445,"about_ca_topic_score_gemma":0.000004902905,"teacher_disagreement_score":0.20799129,"about_ca_system_score_codex":0.00006087358,"about_ca_system_score_gemma":0.00003732518,"threshold_uncertainty_score":0.48800868},"labels":[],"label_agreement":null},{"id":"W2805115770","doi":"10.1002/ejhf.1236","title":"Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":858,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; Astellas Pharma; Abiomed; HeartWare; European Society of Cardiology; Vifor Pharma; Pfizer; Thoratec Corporation; Sanofi; Respicardia; Abbott Vascular; St. Jude Medical; ZOLL Medical Corporation; AstraZeneca; Amgen","keywords":"Medicine; Heart failure; Cardiogenic shock; Intensive care medicine; Heart transplantation; Decompensation; Canadian Cardiovascular Society; Ejection fraction; Destination therapy; Quality of life (healthcare); Population; Inotrope; Internal medicine; Management of heart failure; Cardiology; Myocardial infarction; Angina","score_opus":0.017152662768555777,"score_gpt":0.25131900462869505,"score_spread":0.23416634186013927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805115770","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009871936,0.964929,0.0017010324,0.012718215,0.0047494266,0.0038726614,0.0008347315,0.00019705537,0.0011259428],"genre_scores_gemma":[0.57970375,0.34859163,0.059382167,0.0013579708,0.008052556,0.000040141793,0.00021599376,0.0020477762,0.0006080199],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99123716,0.004313783,0.0026772844,0.00032816574,0.0009910748,0.0004525398],"domain_scores_gemma":[0.9956715,0.00023366537,0.0024048947,0.00091544236,0.00062030146,0.00015417874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004909,0.00054247957,0.0022398955,0.00013003398,0.00012682356,0.000032178472,0.0009679772,0.00020789754,0.0000754386],"category_scores_gemma":[0.0002040479,0.0003458539,0.0025038493,0.00056828,0.00015294708,0.00021110145,0.00026772654,0.0013317442,0.00005021864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020477999,0.00009790586,0.0018033634,0.0141152665,0.0026721843,0.000014387405,0.00048260306,0.0021943036,0.006702085,0.000042803655,0.9662264,0.0056282254],"study_design_scores_gemma":[0.00045926488,0.00019921073,0.00099048,0.006469342,0.00069542514,0.00021696466,0.00012256662,0.000013077872,0.00046775618,0.000010928719,0.99007666,0.0002783055],"about_ca_topic_score_codex":0.0000015054065,"about_ca_topic_score_gemma":0.0000062764984,"teacher_disagreement_score":0.61633736,"about_ca_system_score_codex":0.00030596607,"about_ca_system_score_gemma":0.00023223947,"threshold_uncertainty_score":0.9998993},"labels":[],"label_agreement":null},{"id":"W2805442953","doi":"10.1002/ejhf.1004","title":"June 2018 at a Glance: Peripartum Cardiomyopathy and Pathophysiology, Prognosis, and Device Therapy of Heart Failure","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Peripartum cardiomyopathy; Heart failure; Cardiology; Internal medicine; Incidence (geometry); Prospective cohort study; Cardiomyopathy","score_opus":0.012966857050477407,"score_gpt":0.2542522507806166,"score_spread":0.24128539373013919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805442953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489671,0.039605666,0.000050507195,0.010290382,0.00046150485,0.00039508706,0.000011521925,0.00002798816,0.0001902266],"genre_scores_gemma":[0.9777802,0.0020471734,0.017740175,0.0006926887,0.0014738622,0.0000032958856,0.000004394862,0.00007553494,0.00018262629],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997561,0.0006894314,0.00061795954,0.0003521675,0.00044173314,0.00033775694],"domain_scores_gemma":[0.9984001,0.000055598273,0.00026806968,0.0004964039,0.0004948202,0.00028501634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012325803,0.00028665966,0.0009807918,0.00016018709,0.00014442403,0.000031845437,0.00014400104,0.00008209472,0.0000745618],"category_scores_gemma":[0.00013354559,0.00022080661,0.00038536676,0.00021226017,0.0007442063,0.0001618649,0.00018950755,0.0004269332,0.000033657176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018069801,0.00032540783,0.14552195,0.00060756115,0.0014848235,0.0014565822,0.0040013976,0.0000032720668,0.3313076,0.000033475968,0.50376,0.009690944],"study_design_scores_gemma":[0.00383738,0.0024301664,0.08201184,0.0010926772,0.00019229896,0.010314605,0.00032812066,0.000004563276,0.009041403,0.000019988727,0.89049584,0.00023110684],"about_ca_topic_score_codex":0.0000025047202,"about_ca_topic_score_gemma":0.0000052872474,"teacher_disagreement_score":0.38673583,"about_ca_system_score_codex":0.00003501668,"about_ca_system_score_gemma":0.00007596454,"threshold_uncertainty_score":0.9004232},"labels":[],"label_agreement":null},{"id":"W2809827709","doi":"10.1002/ejhf.1244","title":"Waist-To-Hip Ratio and Mortality in Heart Failure","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Abbott Vascular; Hartstichting; Boston Scientific Corporation; Sanofi; Servier; European Commission; Amgen; Pfizer; ARCA Biopharma","keywords":"Medicine; Heart failure; Waist; Cardiology; Waist–hip ratio; Internal medicine; Body mass index","score_opus":0.017574806417782276,"score_gpt":0.26373588195879666,"score_spread":0.24616107554101438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809827709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780563,0.00022279425,0.00065732916,0.020016138,0.00043660513,0.00018868948,0.0000027357112,0.0000224929,0.00039690416],"genre_scores_gemma":[0.9917482,0.00001737069,0.005092093,0.0016419331,0.0011781667,4.5073455e-7,0.0000022181443,0.000032691172,0.00028688143],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983013,0.0003979936,0.00047936608,0.000200949,0.00039703728,0.00022333574],"domain_scores_gemma":[0.99896353,0.00002661431,0.000089396744,0.00028904673,0.0002566925,0.0003746965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014439755,0.00016001504,0.00045077887,0.00025491018,0.000084558385,0.000047799414,0.00007007042,0.000041902935,0.00027962346],"category_scores_gemma":[0.00020199406,0.00011938279,0.0002583112,0.00027917273,0.00013407087,0.00012676397,0.000045416462,0.0004597911,0.0002162925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025513177,0.000099085155,0.6419651,0.000043510765,0.00020005912,0.0004089338,0.0008497713,0.00001574588,0.018088073,0.000040140134,0.33702227,0.0010121934],"study_design_scores_gemma":[0.0010858583,0.00047976393,0.458681,0.00010612126,0.000052499043,0.0012083527,0.0002522624,0.000004412995,0.0009875996,0.000003676061,0.5370567,0.00008179064],"about_ca_topic_score_codex":0.000012976842,"about_ca_topic_score_gemma":0.0000584042,"teacher_disagreement_score":0.20003438,"about_ca_system_score_codex":0.00004167064,"about_ca_system_score_gemma":0.00008659201,"threshold_uncertainty_score":0.4868289},"labels":[],"label_agreement":null},{"id":"W2810338709","doi":"10.1002/ejhf.1006","title":"July 2018 at a Glance: Practical Guidance in Acute Heart Failure, Pathophysiology and Clinical Trials of Medical Therapy","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Hazard ratio; Myocardial infarction; Cohort; Ejection fraction; Diastole; Confidence interval; Heart rate; Heart failure with preserved ejection fraction; Blood pressure","score_opus":0.0759801052790355,"score_gpt":0.4168800116294597,"score_spread":0.3408999063504242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810338709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6981776,0.0014783251,0.00024209046,0.2984672,0.00073221064,0.00065208744,0.000011209107,0.000028206428,0.00021109544],"genre_scores_gemma":[0.86787987,0.0027725745,0.117456906,0.0074378443,0.003850487,0.0000064799274,0.00001209791,0.00009972942,0.000483996],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99230254,0.003666045,0.0023866638,0.00037831176,0.0008490596,0.0004173587],"domain_scores_gemma":[0.9970647,0.0009944654,0.00072001334,0.00041252046,0.0002837476,0.00052453874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013768482,0.00028157097,0.0016463178,0.00023953352,0.000076963275,0.000024523602,0.00018521851,0.00017302057,0.0005993889],"category_scores_gemma":[0.00284983,0.00018750038,0.00044642514,0.00021657882,0.0005586127,0.00017139711,0.00018230705,0.00077793293,0.000198601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033135891,0.0007418429,0.03101994,0.000046752073,0.00055627106,0.001449477,0.00022315812,1.7476624e-7,0.008657249,0.00006783473,0.9489798,0.0049439236],"study_design_scores_gemma":[0.009999505,0.006569418,0.06955491,0.0005072115,0.00019989542,0.0014043963,0.00007638161,0.0000220481,0.0007603419,0.000049975974,0.91069674,0.00015914987],"about_ca_topic_score_codex":0.0000072146636,"about_ca_topic_score_gemma":0.000026155869,"teacher_disagreement_score":0.29102936,"about_ca_system_score_codex":0.00006108525,"about_ca_system_score_gemma":0.0003267244,"threshold_uncertainty_score":0.7646044},"labels":[],"label_agreement":null},{"id":"W2811303842","doi":"10.1002/ejhf.1223","title":"Multi-Ethnic Comparisons of Diabetes in Heart Failure with Reduced Ejection Fraction: Insights from the HF-ACTION trial and the ASIAN-HF Registry","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Ejection fraction; Hazard ratio; Diabetes mellitus; Coronary artery disease; Cardiology; Body mass index; Ethnic group; Atrial fibrillation; Kidney disease; Confidence interval; Endocrinology","score_opus":0.03690161289923731,"score_gpt":0.29016218366516716,"score_spread":0.25326057076592984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811303842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9128566,0.00055647694,0.00027409708,0.084946536,0.00036348813,0.00079055,0.000002660983,0.000023330242,0.00018625363],"genre_scores_gemma":[0.9838219,0.000050427647,0.014278322,0.0004129823,0.0012615744,0.000006669206,0.0000073864,0.00003172497,0.00012898998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749494,0.0010242445,0.0006368832,0.00023362058,0.00039859445,0.00021171688],"domain_scores_gemma":[0.99861705,0.00022011525,0.00043114665,0.00040166377,0.00021066255,0.000119349505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095987803,0.00021889718,0.00056592963,0.00013965412,0.00020478983,0.000056332283,0.00012253474,0.00006107466,0.000070021444],"category_scores_gemma":[0.0001525472,0.000111621346,0.00016196711,0.00033692596,0.00038959747,0.00023807885,0.000045332155,0.0006667931,0.000029942225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039059505,0.0015085327,0.08366557,0.00011444369,0.0015492709,0.00014247387,0.0041652964,0.000034487217,0.047342464,0.00008115457,0.81886065,0.0034761555],"study_design_scores_gemma":[0.065356076,0.0035733331,0.24365231,0.00080596254,0.0005555488,0.00015919577,0.0065805903,0.00018562934,0.0030737112,0.00001703205,0.6758288,0.00021177412],"about_ca_topic_score_codex":0.0000716758,"about_ca_topic_score_gemma":0.0004814256,"teacher_disagreement_score":0.15998675,"about_ca_system_score_codex":0.00006357589,"about_ca_system_score_gemma":0.00008763403,"threshold_uncertainty_score":0.45517862},"labels":[],"label_agreement":null},{"id":"W2883188598","doi":"10.1002/ejhf.1284","title":"Long-Term Evaluation of a Fully Magnetically Levitated Circulatory Support Device for Advanced Heart Failure—Two-Year Results from The Heartmate 3 CE Mark Study","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Heart failure; Cardiology; Ventricular assist device; Internal medicine; Ejection fraction; Cardiac index; Destination therapy; Inotrope; Stroke (engine); Heart transplantation; Adverse effect; Myocardial infarction; Cardiac output; Hemodynamics","score_opus":0.028706168552348286,"score_gpt":0.2783902511984987,"score_spread":0.2496840826461504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883188598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952871,0.00024751804,0.00041340338,0.0018556715,0.00056397077,0.0011903975,0.000103249804,0.00008815539,0.00025048657],"genre_scores_gemma":[0.99053407,0.0000020290788,0.008355798,0.00027365665,0.00065359887,0.000009789055,0.000031631655,0.00012451255,0.000014923162],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99480426,0.001347933,0.0016958604,0.00041936748,0.0012389072,0.00049368717],"domain_scores_gemma":[0.9965407,0.00043699832,0.000447928,0.0008175585,0.0014551614,0.00030165593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0068369973,0.0003741514,0.000666635,0.00014780724,0.00016289816,0.00010262223,0.0005805328,0.00006972167,0.00067480747],"category_scores_gemma":[0.000710337,0.00029967233,0.00030473,0.00033918823,0.00012657854,0.0003802002,0.00008823631,0.00051085936,0.0002483661],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004747632,0.0014111251,0.1385131,0.00063717953,0.002589182,0.0002989042,0.007538866,0.010331307,0.5379788,0.000102835256,0.28916606,0.0066849776],"study_design_scores_gemma":[0.022272266,0.006100109,0.86570567,0.00094899023,0.0015763852,0.0003811454,0.002998632,0.003963198,0.011419772,0.0001514314,0.08321031,0.0012720844],"about_ca_topic_score_codex":0.0000043737296,"about_ca_topic_score_gemma":0.0000709854,"teacher_disagreement_score":0.7271926,"about_ca_system_score_codex":0.00008751814,"about_ca_system_score_gemma":0.0001955577,"threshold_uncertainty_score":0.9999455},"labels":[],"label_agreement":null},{"id":"W2886666050","doi":"10.1002/ejhf.1008","title":"August 2018 at a Glance: Patients' Outcomes, Obesity and Medical Therapy","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Obesity; Body mass index; Health care; Emergency medicine; Ethnic group; Demography; Internal medicine; Intensive care medicine; Physical therapy","score_opus":0.010625980299814377,"score_gpt":0.2414892559407553,"score_spread":0.23086327564094092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886666050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235976,0.00048978534,0.00009680514,0.0055121267,0.000720825,0.00009908032,0.0000027248652,0.000020728967,0.00069819053],"genre_scores_gemma":[0.9944343,0.00034191017,0.00088751625,0.0023520538,0.0010832148,1.7632793e-7,0.000003945742,0.00003042816,0.0008664754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840474,0.0002795406,0.00034150577,0.00013795451,0.0006685475,0.00016769476],"domain_scores_gemma":[0.9989967,0.00003236568,0.00011745653,0.00021057024,0.00024574267,0.00039718614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009026436,0.0001315631,0.0003738696,0.000088881985,0.00012598866,0.000018475219,0.00007729972,0.00004740587,0.0014376284],"category_scores_gemma":[0.00019983145,0.00008077469,0.00028470138,0.00008921692,0.00017324642,0.00007163888,0.000058376507,0.0003340511,0.00020098503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019524254,0.00009429669,0.6992916,0.000006768905,0.00014942641,0.00011239647,0.000119538854,4.9759397e-8,0.000104586514,0.0000019357844,0.2968635,0.0030606838],"study_design_scores_gemma":[0.002458344,0.00056061015,0.5106506,0.000045174664,0.000026925913,0.0005804613,0.000022232798,8.255239e-7,0.0000761899,7.44298e-7,0.48553014,0.000047800157],"about_ca_topic_score_codex":0.0000047976737,"about_ca_topic_score_gemma":0.00000652415,"teacher_disagreement_score":0.18866663,"about_ca_system_score_codex":0.000044334487,"about_ca_system_score_gemma":0.00006340798,"threshold_uncertainty_score":0.9994752},"labels":[],"label_agreement":null},{"id":"W2891623183","doi":"10.1002/ejhf.1010","title":"September 2018 at a Glance: Co-Morbidities, Heart Failure with Preserved Ejection Fraction and Mineralocorticoid Receptor Antagonists","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Overweight; Obesity paradox; Diabetes mellitus; Heart failure with preserved ejection fraction; Kidney disease; Obesity; Body mass index; Coronary artery disease; Endocrinology","score_opus":0.016285870278073558,"score_gpt":0.26225068799649315,"score_spread":0.2459648177184196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891623183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603561,0.00026201818,0.00020718676,0.035944853,0.000369997,0.00062367454,0.000012078378,0.00008619501,0.0021378843],"genre_scores_gemma":[0.92910546,0.00007520795,0.056304224,0.0013222705,0.002918233,0.000008895844,0.00005999072,0.00011745402,0.010088238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978616,0.00029023923,0.00056515966,0.0003412135,0.00054544973,0.00039633166],"domain_scores_gemma":[0.9985743,0.00004598162,0.00030767825,0.00035449644,0.00034182848,0.00037568656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006701096,0.00031454224,0.00054770557,0.00021719278,0.00029794918,0.0000911391,0.00008282458,0.000067579706,0.0014270463],"category_scores_gemma":[0.00004981848,0.00022665388,0.0001461021,0.00021154912,0.0002339757,0.00041535572,0.00006186473,0.00039208788,0.0006429668],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009607629,0.00015129053,0.07924341,0.000081348684,0.00021834469,0.0001774147,0.00013066268,0.0000014858513,0.032729287,0.0000048611405,0.8861554,0.00014570772],"study_design_scores_gemma":[0.0035152968,0.0036291527,0.04305273,0.000366485,0.00019969641,0.0017955346,0.0003158301,0.00001417044,0.0060557323,0.0000028510542,0.94083595,0.00021654619],"about_ca_topic_score_codex":0.00001897024,"about_ca_topic_score_gemma":0.00010511691,"teacher_disagreement_score":0.056097038,"about_ca_system_score_codex":0.00019125103,"about_ca_system_score_gemma":0.00009416595,"threshold_uncertainty_score":0.9994858},"labels":[],"label_agreement":null},{"id":"W2891979996","doi":"10.1002/ejhf.1301","title":"Growth Differentiation Factor-15 is Not Modified by Sacubitril/Valsartan and is an Independent Marker of Risk in Patients with Heart Failure and Reduced Ejection Fraction: The PARADIGM-HF Trial","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Novartis","keywords":"Medicine; Heart failure; Ejection fraction; Sacubitril; Internal medicine; Valsartan; Hazard ratio; GDF15; Sacubitril, Valsartan; Cardiology; Enalapril; Creatinine; Natriuretic peptide; Confidence interval; Angiotensin-converting enzyme; Blood pressure","score_opus":0.01080166213265953,"score_gpt":0.2290968457627463,"score_spread":0.21829518363008676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891979996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402344,0.00010834529,0.000060570204,0.005114776,0.00020743423,0.00041609115,0.000028209322,0.000009259912,0.000031893735],"genre_scores_gemma":[0.9990216,0.000045294786,0.0003222624,0.00027551866,0.00026253657,8.8476475e-7,0.000011565746,0.000031878943,0.000028486647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773043,0.0006831598,0.0005967704,0.00025683653,0.0005355052,0.00019730808],"domain_scores_gemma":[0.99877006,0.00006639282,0.00050290354,0.00020515382,0.0002665424,0.00018894249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006852856,0.00021106833,0.00046637096,0.0002032002,0.00016481621,0.000058940746,0.00007416153,0.00011314195,0.000087788874],"category_scores_gemma":[0.00007649986,0.00012549105,0.000088605484,0.0002113219,0.00015440532,0.00029252583,0.000026260663,0.00063073897,0.000003777091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056492902,0.0008013571,0.87167716,0.00006710881,0.0005001006,0.00001719067,0.0024348786,0.0000014195492,0.01801516,0.0000040328487,0.048946664,0.0010420112],"study_design_scores_gemma":[0.027184803,0.003985022,0.9593967,0.00020680395,0.00022385,0.00009837153,0.00046300003,0.000053669144,0.0043704235,0.00001411983,0.003845765,0.0001574712],"about_ca_topic_score_codex":0.000030531563,"about_ca_topic_score_gemma":0.0000109372695,"teacher_disagreement_score":0.08771952,"about_ca_system_score_codex":0.000041636587,"about_ca_system_score_gemma":0.000047839374,"threshold_uncertainty_score":0.51173764},"labels":[],"label_agreement":null},{"id":"W2892680253","doi":"10.1002/ejhf.1347","title":"Heart Failure with Reduced Ejection Fraction: Comparison of Patient Characteristics and Clinical Outcomes Within Asia and between Asia, Europe and the Americas","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"European Society of Cardiology","keywords":"Medicine; China; Ejection fraction; Heart failure; Latin Americans; Population; Demography; Internal medicine; Geography; Environmental health; Political science","score_opus":0.02721364047914761,"score_gpt":0.3169769751094713,"score_spread":0.2897633346303237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892680253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450448,0.000104418024,0.00016421892,0.053961612,0.00014310787,0.0003943701,0.0000034405648,0.000019002899,0.00016502172],"genre_scores_gemma":[0.9797002,0.000036438032,0.019319953,0.0003658542,0.00045234288,0.0000011066752,0.0000044958188,0.000035303565,0.00008426872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746907,0.0007542713,0.0009656287,0.0002508735,0.00037180976,0.00018832239],"domain_scores_gemma":[0.99829084,0.00023093678,0.0006445604,0.00025145212,0.00033157508,0.0002506119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012062679,0.0002337632,0.0009122125,0.00012995413,0.0001853994,0.00006564416,0.00006015918,0.000045409564,0.000026133212],"category_scores_gemma":[0.00023112512,0.00013148278,0.00010318772,0.00017975713,0.0006757176,0.00015758819,0.000083231185,0.0005317541,0.000012644118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008977473,0.00016957789,0.9675628,0.0000443494,0.00048714495,0.00004989153,0.0007452872,3.947919e-7,0.00022247246,0.000047820762,0.025658244,0.004114289],"study_design_scores_gemma":[0.003473318,0.0049143843,0.71874815,0.00020577485,0.00059949694,0.00043569307,0.0014620764,0.000022079037,0.0001783163,0.000003324557,0.2698356,0.00012180246],"about_ca_topic_score_codex":0.000009266978,"about_ca_topic_score_gemma":0.00000896164,"teacher_disagreement_score":0.24881463,"about_ca_system_score_codex":0.000017866618,"about_ca_system_score_gemma":0.000049745595,"threshold_uncertainty_score":0.53617126},"labels":[],"label_agreement":null},{"id":"W2897064634","doi":"10.1002/ejhf.1323","title":"Heart Failure in the Outpatient Versus Inpatient Setting: Findings from the BIOSTAT-CHF Study","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Commission","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Renal function; Confidence interval; Ambulatory; Diabetes mellitus; Cardiology; Incidence (geometry); Angiotensin-converting enzyme; Blood pressure; Endocrinology","score_opus":0.024246903168635068,"score_gpt":0.27519819808830476,"score_spread":0.25095129491966967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897064634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8132881,0.000108251705,0.000019091083,0.18472978,0.00056031655,0.0009812571,0.000007879538,0.000024341394,0.00028098928],"genre_scores_gemma":[0.9897497,0.0000056281583,0.005721546,0.003352663,0.0009993382,0.0000072525877,0.000012845472,0.00004873602,0.00010225207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604404,0.0013463246,0.000858826,0.00032790613,0.0009576479,0.00046527595],"domain_scores_gemma":[0.9982815,0.00038138483,0.0002360441,0.00066256657,0.00025059536,0.00018793688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025271454,0.00032636337,0.00046456628,0.00020089907,0.0003086164,0.00013845014,0.00041791174,0.000043824628,0.00026040018],"category_scores_gemma":[0.0003088266,0.00017046872,0.00025325915,0.00045414548,0.00016291632,0.00017757104,0.00016562622,0.00080626615,0.0004452523],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000947089,0.0010827152,0.1592044,0.000010874286,0.00027889904,0.00046580646,0.018192915,0.0000061635315,0.00032757965,0.000021787011,0.8186216,0.0008402087],"study_design_scores_gemma":[0.006126437,0.007990824,0.19310842,0.00020275796,0.0002379949,0.000082187405,0.018234842,0.000007354471,0.00012721916,0.0000067877563,0.77371794,0.00015723071],"about_ca_topic_score_codex":0.00006631724,"about_ca_topic_score_gemma":0.0003543258,"teacher_disagreement_score":0.18137713,"about_ca_system_score_codex":0.0001145812,"about_ca_system_score_gemma":0.000100848934,"threshold_uncertainty_score":0.6951512},"labels":[],"label_agreement":null},{"id":"W2897124644","doi":"10.1002/ejhf.1012","title":"October 2018 at a Glance: From Demographic Variables to Genotype–Phenotype Interactions","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Heart failure; Quartile; Ejection fraction; Dilated cardiomyopathy; Spironolactone; Cohort; Diastole; Cardiomyopathy; Blood pressure; Confidence interval","score_opus":0.015181755242491924,"score_gpt":0.2580199557128853,"score_spread":0.24283820047039334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897124644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98312104,0.0002124832,0.002372713,0.010637515,0.0007336439,0.00015577544,0.000012831764,0.00003323918,0.0027207818],"genre_scores_gemma":[0.96113425,0.000021788295,0.03155329,0.0034096965,0.0031904303,6.72042e-7,0.000009626513,0.00004387448,0.00063639344],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987362,0.0002003263,0.00038979587,0.00018310093,0.000284712,0.00020583697],"domain_scores_gemma":[0.9988797,0.000058588535,0.0001613954,0.00027879505,0.0003432433,0.00027830398],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004483218,0.00014750092,0.00030637358,0.0001830947,0.00015058853,0.000035712885,0.00011374878,0.00004016066,0.0010282014],"category_scores_gemma":[0.000109622335,0.00012386973,0.0001982279,0.00028348353,0.00007379258,0.00013424594,0.000046215653,0.00034588485,0.0006507455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045348937,0.000059602036,0.0031911503,0.000008831229,0.00018664067,0.00006528388,0.0007345348,0.000006474586,0.7819385,0.000012859673,0.21184993,0.0014927227],"study_design_scores_gemma":[0.0014256045,0.00079469435,0.056787007,0.00034173534,0.00013348168,0.00067393656,0.00013398768,0.000009804576,0.079092465,0.00006135718,0.8603936,0.00015233994],"about_ca_topic_score_codex":0.000015339443,"about_ca_topic_score_gemma":0.000050081,"teacher_disagreement_score":0.70284605,"about_ca_system_score_codex":0.000091567534,"about_ca_system_score_gemma":0.000070217386,"threshold_uncertainty_score":0.999885},"labels":[],"label_agreement":null},{"id":"W2897683855","doi":"10.1002/ejhf.1337","title":"Treating Central Sleep Apnoea in Heart Failure: Is Pull Better Than Push?","year":2018,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Central sleep apnea; Heart failure; Cheyne–Stokes respiration; Continuous positive airway pressure; Ejection fraction; Positive airway pressure; Hyperventilation; Cardiology; Periodic breathing; Sleep apnea; Anesthesia; Sleep and breathing; Internal medicine; Apnea; Polysomnography; Obstructive sleep apnea","score_opus":0.01691494239361007,"score_gpt":0.26524084888655014,"score_spread":0.24832590649294006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897683855","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.105262935,0.00036013214,0.00006635357,0.89183486,0.00083254406,0.00062835304,0.000057422527,0.00004672835,0.0009106983],"genre_scores_gemma":[0.24231705,0.000031060306,0.061715923,0.6283625,0.06324169,0.00001192949,0.00023610357,0.001124325,0.0029594323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99160063,0.001941717,0.0017451344,0.0008360786,0.0020987561,0.0017776544],"domain_scores_gemma":[0.99664164,0.00023631011,0.00072832877,0.0009844239,0.00080219907,0.00060712354],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018518548,0.00084985455,0.0016621182,0.001284213,0.00018519348,0.00024353921,0.0007582089,0.000497333,0.0023620448],"category_scores_gemma":[0.00042893965,0.0007041863,0.0009501963,0.0006767719,0.00042545542,0.00040809013,0.0002806122,0.008185848,0.0011810763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019591884,0.000102792495,0.061945394,0.00024891348,0.00034913153,0.0076520448,0.0006322769,0.0000013557709,0.0027641503,6.9777275e-7,0.9249498,0.001157517],"study_design_scores_gemma":[0.0033112923,0.0013831287,0.033032645,0.0011145696,0.00021549994,0.005365259,0.00022784447,0.000028105147,0.0014157669,0.000013909839,0.9533497,0.00054227456],"about_ca_topic_score_codex":0.000029002935,"about_ca_topic_score_gemma":0.000023840495,"teacher_disagreement_score":0.26347235,"about_ca_system_score_codex":0.0004956184,"about_ca_system_score_gemma":0.00020038504,"threshold_uncertainty_score":0.9995966},"labels":[],"label_agreement":null},{"id":"W2899189284","doi":"10.1002/ejhf.1338","title":"Association with Outcomes and Response to Treatment of Trimethylamine N-Oxide in Heart Failure: Results from BIOSTAT-CHF","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Medical Research Council; John and Lucille Van Geest Foundation; National Institute for Health and Care Research; Novo Nordisk; British Heart Foundation; NIHR Leicester Biomedical Research Centre; ResMed; Boston Scientific Corporation; Japan Heart Foundation; AstraZeneca; Servier; Amgen; University of Tokyo; European Commission; Japan Agency for Medical Research and Development","keywords":"Trimethylamine N-oxide; Medicine; Hazard ratio; Heart failure; Guideline; Internal medicine; Confidence interval; Adverse effect; Natriuretic peptide; Cardiology; Intensive care medicine; Gastroenterology; Trimethylamine; Pathology","score_opus":0.009382447883941696,"score_gpt":0.2556875839963635,"score_spread":0.2463051361124218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899189284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97255945,0.00020394905,0.000034184344,0.026912997,0.00005409242,0.00013524201,0.00007893308,0.0000028824861,0.000018286219],"genre_scores_gemma":[0.9775609,0.000035959984,0.02145348,0.00041606452,0.00016534042,4.4948789e-7,0.000017114626,0.000021977216,0.0003287072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983305,0.00060921995,0.00050181465,0.00021187466,0.00014070756,0.00020590863],"domain_scores_gemma":[0.9990987,0.000086624575,0.00027522407,0.00021027634,0.00019136324,0.00013780787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010317479,0.00014866954,0.00032149293,0.00013279417,0.000044978256,0.000020121548,0.000081918915,0.00005638071,0.0000070789592],"category_scores_gemma":[0.00028213204,0.00010823175,0.00007131176,0.000120444296,0.000045345485,0.000008026358,0.00003228386,0.00009524671,0.000012245698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003759476,0.00010407069,0.06921593,0.000003561326,0.00007490164,0.000018824081,0.00049967854,0.000004140635,0.89961845,3.8104275e-7,0.026484357,0.0002162078],"study_design_scores_gemma":[0.0039833225,0.0055956566,0.4769984,0.000058746664,0.000024038465,0.0000406571,0.00020494756,3.6724762e-7,0.16528815,0.0000013117597,0.34769595,0.0001084613],"about_ca_topic_score_codex":0.0000730185,"about_ca_topic_score_gemma":0.00032344155,"teacher_disagreement_score":0.7343303,"about_ca_system_score_codex":0.00006148095,"about_ca_system_score_gemma":0.00013470615,"threshold_uncertainty_score":0.44135624},"labels":[],"label_agreement":null},{"id":"W2899339705","doi":"10.1002/ejhf.1319","title":"Management and Outcomes of Cardiac Sarcoidosis: A 20-Year Experience in Two Tertiary Care Centres","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Cardiology; Heart transplantation; Heart failure; Prednisone; Immunosuppression; Cardiomyopathy; Exacerbation","score_opus":0.016857554804742082,"score_gpt":0.3125284774765968,"score_spread":0.2956709226718547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899339705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292403,0.002025523,0.000004911969,0.0035708875,0.00010260772,0.00017850484,0.000005648806,0.000006485887,0.0011813998],"genre_scores_gemma":[0.99430764,0.00019050569,0.004874821,0.00020217834,0.00021592467,0.000001167242,0.0000011570768,0.000022153632,0.00018446986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831915,0.00029974306,0.00047124992,0.0001715758,0.00047799514,0.00026031223],"domain_scores_gemma":[0.99922436,0.000038696257,0.00011491327,0.00023422834,0.00020902109,0.00017875865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053588994,0.00013303573,0.00041171792,0.00027582535,0.000049837156,0.000026434103,0.00014632224,0.000016886295,0.00009409891],"category_scores_gemma":[0.00005540823,0.000096188414,0.00014981416,0.00018494342,0.00019828428,0.000110581175,0.00013090865,0.00025016326,0.000022822795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013398535,0.000100282356,0.97435045,0.00010217138,0.00009679175,0.00021285687,0.0031890457,7.8405486e-7,0.011644119,0.000013117173,0.00548719,0.004669187],"study_design_scores_gemma":[0.0016618418,0.0004241039,0.9389487,0.0005098007,0.00005318087,0.00008186085,0.007721134,0.000003537425,0.008146934,0.000002955123,0.04234904,0.00009690854],"about_ca_topic_score_codex":0.000017499677,"about_ca_topic_score_gemma":0.000014786387,"teacher_disagreement_score":0.03686185,"about_ca_system_score_codex":0.000035018118,"about_ca_system_score_gemma":0.000032797496,"threshold_uncertainty_score":0.39224496},"labels":[],"label_agreement":null},{"id":"W2900196560","doi":"10.1002/ejhf.1311","title":"Impact of Exercise-Based Cardiac Rehabilitation in Patients with Heart Failure (ExTraMATCH II) on Mortality and Hospitalisation: An Individual Patient Data Meta-Analysis of Randomised Trials","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"Keele University; Department of Health and Social Care; National Center for Complementary and Integrative Health; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Rehabilitation; Meta-analysis; Physical therapy; Patient data; Emergency medicine; Internal medicine","score_opus":0.14968757015433634,"score_gpt":0.41555595279839874,"score_spread":0.26586838264406243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900196560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6249425,0.36426917,0.0000071402437,0.0005848152,0.00019368448,0.0058168,0.004162733,0.000011550401,0.000011620446],"genre_scores_gemma":[0.81437105,0.1517392,0.021831723,0.00030899481,0.00070529745,0.00009186785,0.0105983745,0.00034560479,0.000007904055],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9866015,0.006887129,0.004128974,0.00059112225,0.0014340227,0.0003572566],"domain_scores_gemma":[0.992783,0.0010266664,0.0034876599,0.0013428866,0.0007228042,0.00063698663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014326809,0.00056010537,0.009980502,0.0012206591,0.000085205524,0.000030369367,0.00025920503,0.00016134848,0.0001022961],"category_scores_gemma":[0.0010699918,0.00033366613,0.0035245095,0.0010385221,0.00017977196,0.00027984317,0.00008360391,0.0006486798,0.0000018312204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048030745,0.011933595,0.41598618,0.06648939,0.2766857,0.00008233028,0.006260886,0.0003187009,0.000007010246,0.0000048576685,0.09090102,0.08329958],"study_design_scores_gemma":[0.027895803,0.03782739,0.35274923,0.011119496,0.47352877,0.00002002043,0.0003346514,0.0000062485356,0.0000041799562,0.000001553776,0.09586235,0.00065027794],"about_ca_topic_score_codex":0.00011375091,"about_ca_topic_score_gemma":0.000020075835,"teacher_disagreement_score":0.21252996,"about_ca_system_score_codex":0.00019215098,"about_ca_system_score_gemma":0.0013630334,"threshold_uncertainty_score":0.99991155},"labels":[],"label_agreement":null},{"id":"W2901197232","doi":"10.1002/ejhf.1014","title":"November 2018 at a Glance: From Prediction of Heart Failure in Asymptomatic Subjects to Advanced Chronic Heart Failure","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Decompensation; Ejection fraction; Internal medicine; Asymptomatic; Cardiology; Inotrope; Heart failure with preserved ejection fraction; Intensive care medicine","score_opus":0.009057426890982911,"score_gpt":0.23407671415727122,"score_spread":0.2250192872662883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901197232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98151594,0.000773614,0.0006055016,0.015046766,0.0011642833,0.0005986102,0.00005545603,0.00007148415,0.0001683382],"genre_scores_gemma":[0.9815262,0.000038928378,0.014664975,0.0009543742,0.0022564477,0.0000041799817,0.000032187316,0.00010751502,0.00041517147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962428,0.00059149263,0.0011774969,0.00047029697,0.0009862984,0.000531617],"domain_scores_gemma":[0.9977767,0.00009571399,0.00035155582,0.0007395975,0.0005078389,0.0005285976],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011523319,0.00039652226,0.0011235935,0.0005156787,0.0001419354,0.0000411,0.00020029023,0.00014242248,0.0010983706],"category_scores_gemma":[0.00028097077,0.00032279294,0.00070928986,0.0007139119,0.00020864744,0.0003247721,0.0001255877,0.0007727984,0.0007077905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095911423,0.00022565864,0.1587087,0.00015280764,0.00041746654,0.00012435118,0.00096969283,0.00031467702,0.19363627,0.0000039276906,0.6439958,0.0004915053],"study_design_scores_gemma":[0.0049794815,0.0021850022,0.31101924,0.0013184727,0.0001569651,0.0011370309,0.00039894154,0.000043312357,0.010776393,0.000004001148,0.66775876,0.00022238554],"about_ca_topic_score_codex":0.00003875862,"about_ca_topic_score_gemma":0.00048643412,"teacher_disagreement_score":0.18285987,"about_ca_system_score_codex":0.00044524122,"about_ca_system_score_gemma":0.0002922598,"threshold_uncertainty_score":0.9999224},"labels":[],"label_agreement":null},{"id":"W2904389347","doi":"10.1002/ejhf.1016","title":"December 2018 at a Glance: New Imaging Methods, Translational Cardiology and Non-Medical Treatment","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Ejection fraction; Magnetic resonance imaging; Cardiac magnetic resonance imaging; Cardiac catheterization; Radiology","score_opus":0.016191785420232373,"score_gpt":0.30273769334635214,"score_spread":0.2865459079261198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904389347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7998095,0.008548939,0.110675864,0.06990314,0.0030473638,0.00043491978,0.00001007325,0.00006920726,0.0075009638],"genre_scores_gemma":[0.8836743,0.00060982263,0.10391532,0.0017085442,0.007884514,6.764672e-7,0.000011543211,0.00006748159,0.0021277873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985497,0.00043908364,0.00033967427,0.0001655756,0.00032724394,0.00017871127],"domain_scores_gemma":[0.9991084,0.000070392394,0.00008194431,0.00016160948,0.00012458743,0.0004530682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009670143,0.00013992857,0.00044141666,0.0001080536,0.000101447935,0.000014278251,0.000046919773,0.00003976947,0.00069571915],"category_scores_gemma":[0.00009331983,0.00009232627,0.00036417515,0.00008268816,0.0001593594,0.00005976402,0.000024196917,0.00021605896,0.00010634971],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006911865,0.000052261123,0.2729232,0.000017103186,0.0009021317,0.0012251403,0.0007967326,0.000008702424,0.0050873323,0.000005550716,0.60856205,0.10972859],"study_design_scores_gemma":[0.003092027,0.0004808488,0.18802284,0.00006425714,0.00018706666,0.014775861,0.000053499578,0.000044806693,0.0003031978,0.000004505712,0.7928968,0.000074268835],"about_ca_topic_score_codex":0.0000104901055,"about_ca_topic_score_gemma":0.000012630058,"teacher_disagreement_score":0.18433475,"about_ca_system_score_codex":0.00005625464,"about_ca_system_score_gemma":0.00021118017,"threshold_uncertainty_score":0.76176363},"labels":[],"label_agreement":null},{"id":"W2904656617","doi":"10.1002/ejhf.1359","title":"The Prognostic Value of Troponin T and N-terminal pro B-type Natriuretic Peptide, Alone and in Combination, in Heart Failure Patients with and without Diabetes","year":2018,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Heart failure; Natriuretic peptide; Internal medicine; Cardiology; Troponin T; Diabetes mellitus; Value (mathematics); Troponin I; Troponin; Endocrinology; Myocardial infarction","score_opus":0.006859268349622318,"score_gpt":0.23001338166776897,"score_spread":0.22315411331814666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904656617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98173004,0.0004885276,0.0000047559506,0.01706236,0.000039522783,0.00064093637,0.0000012090517,0.0000068020613,0.000025828971],"genre_scores_gemma":[0.9910443,0.000031799445,0.008628067,0.00013105782,0.00006284437,0.0000027356414,0.0000029754558,0.000027133521,0.00006913157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983972,0.00035070258,0.000479762,0.00019531335,0.00032155906,0.00025550651],"domain_scores_gemma":[0.9991453,0.0001056229,0.00017723317,0.00014422507,0.00028515083,0.00014241124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008987763,0.00018604318,0.00041488814,0.00023910624,0.00009683482,0.000049584316,0.000059769543,0.000031386728,0.0000071945337],"category_scores_gemma":[0.00020082264,0.00011306106,0.000028950342,0.00024790684,0.00035238639,0.00016609683,0.000060156923,0.00027654748,0.000003019224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004442368,0.00021176106,0.99296063,0.00010098107,0.000055249366,0.00004581379,0.0004652268,7.730168e-7,0.00033182322,0.000033127464,0.00486093,0.0004894426],"study_design_scores_gemma":[0.006642452,0.0052271914,0.9621921,0.0008662665,0.00011600898,0.00016384656,0.00024359084,0.000049059676,0.00016769768,0.00003083918,0.024184648,0.00011626005],"about_ca_topic_score_codex":0.000005835988,"about_ca_topic_score_gemma":0.0000743206,"teacher_disagreement_score":0.030768495,"about_ca_system_score_codex":0.00002678245,"about_ca_system_score_gemma":0.000060030114,"threshold_uncertainty_score":0.46104965},"labels":[],"label_agreement":null},{"id":"W2907436115","doi":"10.1002/ejhf.1366","title":"Adrenomedullin in Heart Failure: Pathophysiology and Therapeutic Application","year":2018,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Adrenomedullin; Medicine; Heart failure; Aldosterone; Internal medicine; Endocrinology; Volume overload; Pathophysiology; Pharmacology; Receptor","score_opus":0.038389392953687464,"score_gpt":0.2959196422182178,"score_spread":0.25753024926453033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907436115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00358349,0.99367994,0.000017752527,0.0016205566,0.00034027817,0.0006192143,0.000023391427,0.000034880362,0.00008050295],"genre_scores_gemma":[0.01200208,0.98342323,0.0013346687,0.0016624222,0.0013493374,0.000008171054,0.0000047558956,0.00015922062,0.000056108867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504966,0.0025161323,0.0011439379,0.000638873,0.00021597973,0.0004353939],"domain_scores_gemma":[0.9982321,0.00033591574,0.0007775082,0.00039753004,0.00007344277,0.00018348481],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006596518,0.00045889182,0.001523854,0.00034675872,0.000114069044,0.00006536538,0.000570032,0.0001166189,0.000048422844],"category_scores_gemma":[0.00014937959,0.0003364183,0.00040241063,0.0004291808,0.0003254958,0.000118983895,0.0002029509,0.0011486228,0.0004907162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017547238,0.00045213613,0.000035022425,0.0043565854,0.000073935174,0.0006701741,0.00021040719,0.000009808607,0.25210738,0.0006903769,0.06125388,0.67996484],"study_design_scores_gemma":[0.0002888282,0.00090431486,0.00008559823,0.0015733676,0.00006279388,0.0010885117,0.000011103412,0.000002504256,0.000118006144,0.00019275233,0.99538803,0.00028416896],"about_ca_topic_score_codex":0.0000013058258,"about_ca_topic_score_gemma":0.0000023740781,"teacher_disagreement_score":0.9341342,"about_ca_system_score_codex":0.000040137424,"about_ca_system_score_gemma":0.00013199002,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W2907717983","doi":"10.1002/ejhf.1401","title":"Cardiac Resynchronization Therapy Improves Survival in Selected Patients with Moderately Impaired Ejection Fraction — the Importance of Left Ventricular Remodelling","year":2018,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cardiac resynchronization therapy; Ejection fraction; Medicine; Cardiology; Internal medicine; Left bundle branch block; Heart failure; Hazard ratio; QRS complex; Implantable cardioverter-defibrillator; Clinical endpoint; Population; Randomized controlled trial; Confidence interval","score_opus":0.014122820666162184,"score_gpt":0.2320992722461851,"score_spread":0.2179764515800229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907717983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96071064,0.0018892178,0.0016152618,0.03393305,0.00073131674,0.0006341771,0.000017914312,0.000034516706,0.00043392423],"genre_scores_gemma":[0.9904732,0.00028539306,0.0009242781,0.0044131493,0.0036221563,0.0000010125545,0.00011085591,0.000098450866,0.00007150185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728143,0.0007943246,0.00073974265,0.00023258332,0.0007299869,0.0002219531],"domain_scores_gemma":[0.9970249,0.00010880231,0.0008987154,0.00027395884,0.001652109,0.000041504794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088727585,0.00025374428,0.0007983727,0.00027430954,0.0001269492,0.000040287658,0.000041719537,0.0001261195,0.000005017717],"category_scores_gemma":[0.00013862138,0.0001586245,0.00024725092,0.0004216742,0.00007612804,0.00015024492,0.00001757087,0.0009662271,0.0000038113644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023186463,0.00008445662,0.37665677,0.0001631903,0.0010348207,0.00016127854,0.0006298322,0.0014011349,0.0008658849,2.9419115e-7,0.6162135,0.00047018167],"study_design_scores_gemma":[0.0032810457,0.002160686,0.46558127,0.000988263,0.00034006164,0.00037491345,0.00019782907,0.00019113021,0.0006789232,0.0000062853364,0.52584946,0.00035012176],"about_ca_topic_score_codex":0.000010206211,"about_ca_topic_score_gemma":0.0000029058176,"teacher_disagreement_score":0.09036405,"about_ca_system_score_codex":0.00014154286,"about_ca_system_score_gemma":0.00015950623,"threshold_uncertainty_score":0.64685196},"labels":[],"label_agreement":null},{"id":"W2908676513","doi":"10.1002/ejhf.1419","title":"Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at Baseline","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Relypsa; Astellas Pharma; University of Toronto; Universität des Saarlandes; Universität Heidelberg; Servier; Institut National de la Santé et de la Recherche Médicale; University of Glasgow; Pfizer; Université de Lorraine; Boston Scientific Corporation; Massachusetts General Hospital; Daiichi Sankyo Europe; Sanofi; Cedars-Sinai Medical Center; Amgen; Eli Lilly and Company; AstraZeneca; ResMed","keywords":"Empagliflozin; Medicine; Heart failure; Canagliflozin; Hazard ratio; Internal medicine; Cardiology; Myocardial infarction; Population; Confidence interval; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.011497445123190276,"score_gpt":0.23836473681677234,"score_spread":0.22686729169358205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908676513","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27264977,0.002508376,0.000017328128,0.72187895,0.0007733,0.0012816524,0.00041249717,0.000039090242,0.00043904939],"genre_scores_gemma":[0.7576388,0.0014418557,0.050157737,0.14396882,0.009713523,0.000025831248,0.0009172802,0.0012169218,0.03491921],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99154323,0.0021259144,0.0026392047,0.00068314804,0.0019869732,0.0010215242],"domain_scores_gemma":[0.99371696,0.00071052945,0.0028671992,0.0016946944,0.0007190578,0.00029154183],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027998944,0.0009936657,0.0032989273,0.0008727099,0.00014622281,0.00006564883,0.00076485134,0.00033475662,0.00086564827],"category_scores_gemma":[0.0004708097,0.00062622014,0.0019781152,0.00052909605,0.00047915717,0.00023969145,0.00043086382,0.0027752484,0.00018750838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003869628,0.00032663558,0.058521263,0.0009726889,0.0025793102,0.00028883287,0.00039393007,0.000052522988,0.0025540143,0.000005493833,0.93375355,0.00016479407],"study_design_scores_gemma":[0.0044153356,0.0026341623,0.02027112,0.0024426202,0.0025895194,0.00026708966,0.0006279257,0.000006569224,0.0063870735,0.000013314139,0.95988154,0.0004637187],"about_ca_topic_score_codex":0.00007772652,"about_ca_topic_score_gemma":0.000055478005,"teacher_disagreement_score":0.5779101,"about_ca_system_score_codex":0.00019753611,"about_ca_system_score_gemma":0.00036997945,"threshold_uncertainty_score":0.9996189},"labels":[],"label_agreement":null},{"id":"W2908991147","doi":"10.1002/ejhf.1364","title":"Heart Failure Prognosis Over Time: How the Prognostic Role of Oxygen Consumption and Ventilatory Efficiency During Exercise has Changed in the Last 20 Years","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Confidence interval; Respiratory minute volume; Heart transplantation; VO2 max; Respiratory exchange ratio; Ventilation (architecture); Respiratory system; Heart rate; Blood pressure","score_opus":0.012366800535266167,"score_gpt":0.2171245093712687,"score_spread":0.20475770883600253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908991147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696845,0.0012190072,0.0000012794519,0.027875334,0.000060692222,0.0011085065,0.0000031098575,0.000014824354,0.00003275154],"genre_scores_gemma":[0.99862415,0.000041374522,0.00082278467,0.0001499704,0.00012878375,0.000008600794,0.0000041361955,0.0000322336,0.00018799142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833435,0.00032214465,0.00037405686,0.00019921416,0.0004896204,0.0002806405],"domain_scores_gemma":[0.99926144,0.00007173235,0.00019897209,0.0002830823,0.00008407259,0.00010067866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001190438,0.00018663766,0.0003840403,0.00017738575,0.00009596497,0.00008508936,0.00016205115,0.000039380393,0.0001395108],"category_scores_gemma":[0.000041595882,0.000112193375,0.0001590406,0.0002274663,0.00012662185,0.000165145,0.000078412035,0.0003792779,0.00012760672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038227532,0.0006489287,0.8619025,0.00040083917,0.0002147618,0.0002728983,0.0051508374,0.00002577793,0.05100124,0.000014364865,0.079123266,0.0008623166],"study_design_scores_gemma":[0.0020813316,0.0005250339,0.85630023,0.00077933684,0.00020336425,0.00026201282,0.00091666984,0.000031316376,0.0007683491,0.000002286812,0.13802075,0.00010928556],"about_ca_topic_score_codex":0.0000023477387,"about_ca_topic_score_gemma":0.000012132151,"teacher_disagreement_score":0.058897484,"about_ca_system_score_codex":0.000030511943,"about_ca_system_score_gemma":0.00004936045,"threshold_uncertainty_score":0.4575113},"labels":[],"label_agreement":null},{"id":"W2910990228","doi":"10.1002/ejhf.1254","title":"January 2019 at a Glance: Prognostic Assessment, Left Ventricular Assist Devices, Disease Management and Quality of Care","year":2019,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Heart failure; Cardiology; Diabetes mellitus; Coronary artery disease; Atrial fibrillation; Kidney disease; Prospective cohort study; Endocrinology","score_opus":0.009101974764982942,"score_gpt":0.27765636113438824,"score_spread":0.2685543863694053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910990228","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28691787,0.06220952,0.0005061879,0.014666395,0.62120485,0.0071847173,0.0026904142,0.0001314461,0.004488604],"genre_scores_gemma":[0.56334305,0.00068952277,0.008375083,0.0004337524,0.41981262,0.000010120639,0.0013724546,0.0002802082,0.005683178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955074,0.0012505405,0.0013849726,0.0004586934,0.0010524966,0.0003458872],"domain_scores_gemma":[0.9967174,0.000597374,0.0009896996,0.0006084764,0.000626967,0.00046010467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023393305,0.00038966507,0.0013470057,0.00022037303,0.0001027746,0.00006616689,0.00024463586,0.00015986092,0.0000968153],"category_scores_gemma":[0.0005403701,0.00031721813,0.00047849404,0.00010718266,0.00011049423,0.0001304112,0.00024190244,0.0011749226,0.000045917972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047056683,0.00024013869,0.11869606,0.0059806406,0.00057177426,0.0014239437,0.00011981533,0.000016082768,0.00011650992,0.000012130239,0.87181515,0.000537211],"study_design_scores_gemma":[0.0028742536,0.0005029265,0.25203294,0.001988199,0.00073217135,0.00006186617,0.00010447374,0.0000067528244,0.000005215338,0.0000016048905,0.74148625,0.00020335484],"about_ca_topic_score_codex":0.000007805192,"about_ca_topic_score_gemma":0.000006537397,"teacher_disagreement_score":0.27642518,"about_ca_system_score_codex":0.00034464785,"about_ca_system_score_gemma":0.000937848,"threshold_uncertainty_score":0.999928},"labels":[],"label_agreement":null},{"id":"W2911348796","doi":"10.1002/ejhf.1404","title":"Burden of Medical Co-Morbidities and Benefit from Surgical Revascularization in Patients with Ischaemic Cardiomyopathy","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Revascularization; Heart failure; Cardiology; Internal medicine; Ischaemic heart disease; Cardiomyopathy; Medical therapy; Myocardial revascularization; Intensive care medicine; Myocardial infarction","score_opus":0.006421142486205897,"score_gpt":0.24956608628569354,"score_spread":0.24314494379948765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911348796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559677,0.00069987914,0.000009628946,0.0028965177,0.00014040417,0.00025483256,0.000017101698,0.000004536765,0.0003803266],"genre_scores_gemma":[0.99862945,0.00020319261,0.00055582187,0.0002076794,0.00031790163,3.4288735e-7,0.000034122568,0.000020855645,0.00003064469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981414,0.00020402974,0.0005236935,0.00012994527,0.0008262406,0.00017467437],"domain_scores_gemma":[0.9991439,0.00005870896,0.0001736278,0.00014520879,0.00012916554,0.00034936442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010670521,0.000102554535,0.0005185398,0.00013607887,0.000021401294,0.000007167357,0.000059330134,0.000049558697,0.00013126583],"category_scores_gemma":[0.000037410577,0.00007419894,0.00009133983,0.000102500155,0.000050414175,0.00008508674,0.000028574792,0.0003825724,0.0000148309455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011136401,0.00008279692,0.9937971,0.00028937362,0.000043462434,0.00028174103,0.0007695193,0.000015963053,0.000073560004,0.000019923555,0.0012993776,0.0022135144],"study_design_scores_gemma":[0.0116501255,0.001841838,0.92998034,0.0017674932,0.000058525442,0.00053570187,0.00056827604,0.0000148375175,0.00007290448,0.0000057796055,0.053403564,0.00010059564],"about_ca_topic_score_codex":0.00010822799,"about_ca_topic_score_gemma":0.0000048337265,"teacher_disagreement_score":0.06381677,"about_ca_system_score_codex":0.000048231905,"about_ca_system_score_gemma":0.00016851988,"threshold_uncertainty_score":0.30257452},"labels":[],"label_agreement":null},{"id":"W2912800297","doi":"10.1002/ejhf.1437","title":"Bio-Adrenomedullin as a Marker of Congestion in Patients with New-Onset and Worsening Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Commission; National Institute for Health and Care Research","keywords":"Medicine; Adrenomedullin; Internal medicine; Heart failure; Hazard ratio; Cardiology; Confidence interval; Cohort; Body mass index; Endocrinology; Receptor","score_opus":0.008575220302828462,"score_gpt":0.2096775200501163,"score_spread":0.20110229974728785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912800297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978083,0.00002912714,0.0000033391486,0.0017832022,0.00009709966,0.00016047683,0.0000055436863,0.000008818987,0.000104094084],"genre_scores_gemma":[0.99774754,0.000007629492,0.0014302332,0.00056956685,0.0000669203,1.823999e-7,0.0000010990473,0.000034644145,0.00014215615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982973,0.0004655039,0.0004497186,0.00026964286,0.00026794252,0.00024994696],"domain_scores_gemma":[0.9991684,0.0001238138,0.0002982523,0.00016649443,0.00008447507,0.00015857819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002997353,0.00017334726,0.00035368124,0.00019701915,0.000042910244,0.000040399173,0.00016583588,0.00002806178,0.00013841108],"category_scores_gemma":[0.0001525052,0.00012985732,0.00006692108,0.00025041934,0.00014057512,0.00026923866,0.00008117438,0.0004332633,0.00010041449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012596421,0.00014717113,0.60843486,0.00003595399,0.000011324997,0.00006329842,0.00020538313,0.00016959639,0.37973723,0.0000849987,0.009386224,0.00046431567],"study_design_scores_gemma":[0.002948092,0.0034899276,0.9234723,0.0004182773,0.000013310938,0.00035010435,0.00010532469,0.000007684669,0.00789454,0.00003969059,0.06104533,0.00021543505],"about_ca_topic_score_codex":0.000005690929,"about_ca_topic_score_gemma":0.000004195685,"teacher_disagreement_score":0.3718427,"about_ca_system_score_codex":0.000011731861,"about_ca_system_score_gemma":0.000062015526,"threshold_uncertainty_score":0.5295428},"labels":[],"label_agreement":null},{"id":"W2913730011","doi":"10.1002/ejhf.1379","title":"Lung Ultrasound Integrated with Clinical Assessment for the Diagnosis of Acute Decompensated Heart Failure in the Emergency Department: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Emergency department; Acute decompensated heart failure; Heart failure; Randomized controlled trial; Intensive care medicine; Lung ultrasound; Emergency medicine; Ultrasound; Cardiology; Lung; Internal medicine; Radiology","score_opus":0.02469754539882701,"score_gpt":0.3634751226027916,"score_spread":0.33877757720396456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913730011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93960667,0.0002470436,0.0022165277,0.046114095,0.00050993456,0.011072475,0.000041272204,0.000017556915,0.00017442658],"genre_scores_gemma":[0.975273,0.0002895867,0.022488406,0.0009372637,0.00045731157,0.00035751157,0.000038571634,0.000050898492,0.00010742318],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922797,0.0033146576,0.0031132714,0.00030458468,0.00066626124,0.00032150774],"domain_scores_gemma":[0.980884,0.016361132,0.0012824946,0.00061222765,0.0007002977,0.00015983253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012772887,0.00029941107,0.002276536,0.00012757612,0.00012197506,0.00005345198,0.00048056818,0.00008734975,0.00065717654],"category_scores_gemma":[0.0025411334,0.0001269542,0.0014084028,0.00044957112,0.00026624306,0.00011461505,0.000030052364,0.0011619146,0.000024510062],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7976303,0.0018327879,0.10091521,0.000041972522,0.003497423,0.000019686537,0.0002629849,0.00005000231,0.0007359008,0.00027806617,0.094652794,0.00008288308],"study_design_scores_gemma":[0.8838566,0.0039644665,0.029673038,0.00026356903,0.0028245877,0.0002704381,0.0005239826,0.00018616153,0.000045718847,0.00007068506,0.07815132,0.00016945851],"about_ca_topic_score_codex":0.000006258887,"about_ca_topic_score_gemma":0.000029091669,"teacher_disagreement_score":0.086226285,"about_ca_system_score_codex":0.000047883477,"about_ca_system_score_gemma":0.0003412319,"threshold_uncertainty_score":0.71956223},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2914390948","doi":"10.1002/ejhf.1256","title":"February 2019 At a Glance: Pathophysiology, Exercise Capacity, Diuretics and Valve Disease","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Pulmonary hypertension; Pulmonary wedge pressure; Adrenomedullin; Heart failure with preserved ejection fraction; Natriuretic peptide; Pulmonary artery; Brain natriuretic peptide; Vasodilation; Ejection fraction","score_opus":0.009215252633688935,"score_gpt":0.22374465503479493,"score_spread":0.214529402401106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914390948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97043496,0.0020920131,0.000019417539,0.026342086,0.00030167523,0.0004430955,0.000012110377,0.000029891202,0.00032472718],"genre_scores_gemma":[0.98484147,0.00056715944,0.01053206,0.0012863227,0.000367494,0.0000014971763,0.000016430964,0.000051938758,0.0023356301],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99853325,0.00021592314,0.00039651783,0.00023847425,0.00032185332,0.00029395547],"domain_scores_gemma":[0.9988297,0.000042238586,0.00016713973,0.00034719816,0.00012277685,0.00049094035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004658433,0.0002246095,0.0004920691,0.0001409524,0.000079653626,0.000028250757,0.00009875371,0.000035309702,0.00027650144],"category_scores_gemma":[0.000038814094,0.00016418356,0.00028164874,0.00010088804,0.000099005,0.00013162913,0.00015724308,0.00031683786,0.0006468654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011206745,0.00036278553,0.19853424,0.0003570553,0.0002755545,0.001465344,0.0005047843,0.000015824897,0.012927804,0.00009032882,0.78216153,0.002184063],"study_design_scores_gemma":[0.0044907993,0.0014691771,0.6169287,0.0008327855,0.0005436213,0.00041024917,0.00013308828,0.0000245844,0.00020942767,0.000114190734,0.3745843,0.00025909604],"about_ca_topic_score_codex":0.0000044627595,"about_ca_topic_score_gemma":0.0000014794549,"teacher_disagreement_score":0.41839445,"about_ca_system_score_codex":0.000056718975,"about_ca_system_score_gemma":0.00005369792,"threshold_uncertainty_score":0.83143616},"labels":[],"label_agreement":null},{"id":"W2914497003","doi":"10.1002/ejhf.1402","title":"Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared with Enalapril: The PARADIGM-HF Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"U.S. Department of Veterans Affairs","keywords":"Enalapril; Diuretic; Medicine; Loop diuretic; Sacubitril; Furosemide; Valsartan; Heart failure; Sacubitril, Valsartan; Bumetanide; Randomization; Internal medicine; Randomized controlled trial; Cardiology; Ejection fraction; Angiotensin-converting enzyme; Blood pressure; Sodium; Chemistry","score_opus":0.023786101493198295,"score_gpt":0.24962995382967273,"score_spread":0.22584385233647444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914497003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834656,0.000090201385,0.000024550754,0.014386717,0.00033585497,0.0012892331,0.000002133661,0.000023508745,0.0003821956],"genre_scores_gemma":[0.9954812,0.000008734153,0.0028175476,0.0006376014,0.00029983828,0.00000273617,0.00001074374,0.00005911448,0.00068251847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971844,0.00068581867,0.0007722715,0.00026098397,0.0006946645,0.00040184084],"domain_scores_gemma":[0.9985312,0.00014691081,0.00047210214,0.00047778993,0.00016018242,0.00021177462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009641648,0.00028004026,0.0007699041,0.00025102717,0.00008713969,0.00011210205,0.00020009551,0.000035654382,0.00020439916],"category_scores_gemma":[0.00012827825,0.00015804775,0.00020672819,0.00034081665,0.00007295895,0.00027566834,0.000058137484,0.0005748969,0.00019444484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06469906,0.0022434755,0.7741651,0.00014610909,0.0008264444,0.0015947561,0.001961387,0.0003521362,0.002165927,0.00024094344,0.15018064,0.0014240552],"study_design_scores_gemma":[0.12100531,0.007643012,0.5046196,0.0012504783,0.00046489818,0.00027250868,0.00043904094,0.000056521687,0.00035245004,0.000008257182,0.36350685,0.00038108762],"about_ca_topic_score_codex":0.00001087304,"about_ca_topic_score_gemma":0.00001663134,"teacher_disagreement_score":0.26954547,"about_ca_system_score_codex":0.00008711031,"about_ca_system_score_gemma":0.00012211781,"threshold_uncertainty_score":0.6445},"labels":[],"label_agreement":null},{"id":"W2915301701","doi":"10.1002/ejhf.1426","title":"Individualizing Surgical Revascularization in Patients with Ischaemic Heart Failure — A Further Dive into Stiches","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Glasgow; British Heart Foundation","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Revascularization; Canadian Cardiovascular Society; Coronary artery disease; Angina; Ischemic cardiomyopathy; Clinical endpoint; Randomized controlled trial; Medical therapy; Unstable angina; Myocardial infarction","score_opus":0.008057253171054695,"score_gpt":0.2122691577409903,"score_spread":0.20421190456993563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915301701","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38868663,0.0013586739,0.0003633961,0.606623,0.0012723417,0.0014113641,0.000032677875,0.00007426693,0.00017767011],"genre_scores_gemma":[0.6616669,0.00022326021,0.022226917,0.2925049,0.018177355,0.000011280553,0.0018062482,0.0012385746,0.0021445192],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952997,0.0013534881,0.00091356295,0.00045853935,0.0015440288,0.00043068375],"domain_scores_gemma":[0.9981145,0.00011379688,0.0004892634,0.0005715127,0.0005398233,0.00017108026],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012865266,0.0004983291,0.0013019912,0.0007281115,0.000081188686,0.000094867355,0.00020497218,0.00036347902,0.00025459216],"category_scores_gemma":[0.0001679143,0.00034162804,0.0008527977,0.00042351885,0.00010526814,0.00023462549,0.00010000612,0.0036351508,0.00023206818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027100003,0.00008175222,0.3084559,0.00020785075,0.0007228295,0.0013108016,0.0007082819,0.00006172756,0.000020536467,4.6685403e-7,0.6878892,0.0002696138],"study_design_scores_gemma":[0.0059334305,0.0008434137,0.107795715,0.001712424,0.0005229645,0.00097446126,0.00018001065,0.000001694639,0.000014460265,0.0000012779207,0.88167214,0.00034799767],"about_ca_topic_score_codex":0.000014042714,"about_ca_topic_score_gemma":0.0000068730533,"teacher_disagreement_score":0.31411806,"about_ca_system_score_codex":0.00018168495,"about_ca_system_score_gemma":0.00023842687,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W2916210177","doi":"10.1002/ejhf.1428","title":"Serial Assessment of Spot Urine Sodium Predicts Effectiveness of Decongestion and Outcome in Patients with Acute Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Furosemide; Diuretic; Heart failure; Loop diuretic; Internal medicine; Renal function; Acute kidney injury; Urine; Gastroenterology; Urinary system","score_opus":0.007085689498934838,"score_gpt":0.2520104402512466,"score_spread":0.24492475075231174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916210177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590224,0.00003303164,0.000084407,0.002822919,0.00020135644,0.00083029974,0.000010583858,0.000011038866,0.000104093866],"genre_scores_gemma":[0.9821104,0.000006653618,0.017643154,0.000044051507,0.00007571625,0.0000021725646,0.00001812204,0.00003638925,0.00006333473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978101,0.0004931805,0.00072452566,0.00022672211,0.00051147665,0.00023396454],"domain_scores_gemma":[0.99882734,0.000110471956,0.0003408022,0.00026637383,0.00028661563,0.00016839788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012764931,0.00023016358,0.0008265653,0.00032013797,0.00002390867,0.000016047317,0.000084848594,0.000046864985,0.00007319451],"category_scores_gemma":[0.00004472863,0.00016256656,0.00012235182,0.00019363956,0.00008125521,0.00023599427,0.00007314117,0.00031180726,0.000009616584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019205946,0.00051146455,0.9900202,0.0004633759,0.00028486634,0.0000958734,0.00006803618,0.000059747883,0.0049549276,0.000042442975,0.0014287725,0.00014969721],"study_design_scores_gemma":[0.014179798,0.006220366,0.96628666,0.0010882128,0.0002725014,0.00008756259,0.000058406928,0.000010856574,0.0011244188,0.0000032752919,0.010543905,0.00012404648],"about_ca_topic_score_codex":0.0000088539455,"about_ca_topic_score_gemma":0.000010236257,"teacher_disagreement_score":0.02373355,"about_ca_system_score_codex":0.00007604929,"about_ca_system_score_gemma":0.000104347644,"threshold_uncertainty_score":0.6629272},"labels":[],"label_agreement":null},{"id":"W2917518980","doi":"10.1002/ejhf.1424","title":"Klotho, Fibroblast Growth Factor-23, and the Renin–Angiotensin System — an Analysis from the PEACE Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University Health Network","funders":"Peter Munk Cardiac Centre, University Health Network; National Heart, Lung, and Blood Institute; Abbott Laboratories","keywords":"Medicine; Internal medicine; Hazard ratio; Heart failure; Klotho; Natriuretic peptide; Endocrinology; Trandolapril; Renal function; Cardiology; Fibroblast growth factor 23; Ejection fraction; Creatinine; ACE inhibitor; Confidence interval; Urology; Angiotensin-converting enzyme; Blood pressure; Kidney","score_opus":0.011072665397318843,"score_gpt":0.23376559946249462,"score_spread":0.22269293406517576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917518980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865151,0.00276557,0.00011044868,0.009766179,0.00014308722,0.00036111343,0.000020845422,0.000016264328,0.0003014144],"genre_scores_gemma":[0.99790704,0.000038616894,0.00096039154,0.00028976615,0.00045693055,5.3332633e-7,0.000014390856,0.000027511725,0.00030482298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977719,0.0010457335,0.00044139393,0.00019719396,0.0003638522,0.00017990859],"domain_scores_gemma":[0.9988169,0.00017630079,0.00029603238,0.000397238,0.00014959552,0.00016392593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007169385,0.00018345976,0.0005684658,0.000090173955,0.00014057975,0.000104437764,0.00016825447,0.000031872405,0.00003518808],"category_scores_gemma":[0.000077636774,0.00008369813,0.00038197287,0.0002408733,0.0000938649,0.000128994,0.000043335633,0.00031204874,0.00011843473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101702325,0.0011004597,0.44634974,0.00003949016,0.015030482,0.0017136959,0.0125997495,0.0002600914,0.01120097,0.0007622896,0.40856504,0.0006756727],"study_design_scores_gemma":[0.14986408,0.0034891344,0.7973759,0.00024860725,0.003963316,0.00078117993,0.00328094,0.000662832,0.00022770213,0.000018270384,0.039769147,0.00031887076],"about_ca_topic_score_codex":0.000079354315,"about_ca_topic_score_gemma":0.00002600391,"teacher_disagreement_score":0.3687959,"about_ca_system_score_codex":0.00002826806,"about_ca_system_score_gemma":0.00004826696,"threshold_uncertainty_score":0.34131107},"labels":[],"label_agreement":null},{"id":"W2921909893","doi":"10.1002/ejhf.1436","title":"The Role of Ventricular–Arterial Coupling in Cardiac Disease and Heart Failure: Assessment, Clinical Implications and Therapeutic Interventions. A Consensus Document of the European Society of Cardiology Working Group on Aorta &amp; Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; valvular heart disease; Pathophysiology; Compliance (psychology); Cardiac function curve","score_opus":0.01210325077283122,"score_gpt":0.2710647052507983,"score_spread":0.2589614544779671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921909893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833317,0.011162458,0.00018997457,0.004165019,0.00038121367,0.000677451,0.000044561428,0.000011439273,0.00003620659],"genre_scores_gemma":[0.99818105,0.00080485694,0.0005617913,0.00006069365,0.0003110768,0.0000025896961,0.000017546476,0.000045689143,0.000014713032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932852,0.0041598077,0.0012725521,0.0003343101,0.00069226814,0.0002558885],"domain_scores_gemma":[0.99748355,0.00037704158,0.0009863949,0.000579063,0.0003970261,0.00017694363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00748284,0.00023630862,0.0010710168,0.000112102345,0.00015242527,0.000052267635,0.00014210769,0.00006148668,0.0000058879377],"category_scores_gemma":[0.00031146494,0.00016520084,0.0022312242,0.00024496642,0.00021399699,0.000069611786,0.00015134962,0.0005816435,0.0000012415383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010258651,0.00010618457,0.99024415,0.00013285922,0.002831012,0.000004029495,0.0001236053,0.0007108974,0.0026914696,0.00004277634,0.0021417988,0.0008686515],"study_design_scores_gemma":[0.0026257928,0.00018920407,0.87098116,0.0004997373,0.0015459001,0.000039295828,0.0005288829,0.000062324674,0.000023911098,0.000019250763,0.123364225,0.00012033961],"about_ca_topic_score_codex":0.00001937631,"about_ca_topic_score_gemma":0.0000068332893,"teacher_disagreement_score":0.12122243,"about_ca_system_score_codex":0.00015379163,"about_ca_system_score_gemma":0.000109552035,"threshold_uncertainty_score":0.67366946},"labels":[],"label_agreement":null},{"id":"W2923034994","doi":"10.1002/ejhf.1444","title":"Figures of the Heart Failure Association: Andrew J. Stewart Coats, President-Elect, 2018–2020","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Charisma; Gerontology; Classics; History; Law; Political science","score_opus":0.007379294724844561,"score_gpt":0.21631392533826788,"score_spread":0.20893463061342332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923034994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384973,0.0022387148,0.00004147217,0.054977186,0.0019765282,0.0005585607,0.000018627597,0.000040182127,0.0016514491],"genre_scores_gemma":[0.9871088,0.00011079717,0.0008112098,0.0011617208,0.0010257241,5.33291e-7,0.000004966192,0.000053263524,0.009722984],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711406,0.0007625282,0.0006579607,0.0001924952,0.0010078792,0.00026507836],"domain_scores_gemma":[0.9982962,0.000105461324,0.00047344665,0.0004816531,0.00044522472,0.00019802699],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001403796,0.00019522719,0.0006204127,0.00011118416,0.00009753541,0.000045616576,0.0001991638,0.00008071523,0.0009562443],"category_scores_gemma":[0.00032591185,0.0001233514,0.00096647267,0.00030686398,0.000047085803,0.00015942758,0.00007089473,0.0007776866,0.00034713486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093738825,0.000050264167,0.27286324,0.0000610799,0.0003319639,0.000025822248,0.00015124804,0.000057044694,0.010650858,0.0000048979423,0.71564,0.000069867965],"study_design_scores_gemma":[0.0016242531,0.00037610836,0.2820794,0.00028056922,0.000198903,0.00082379754,0.00023136538,0.0000027460092,0.004419607,0.0000024588073,0.709865,0.000095813244],"about_ca_topic_score_codex":0.000008944506,"about_ca_topic_score_gemma":0.0000129672135,"teacher_disagreement_score":0.053815465,"about_ca_system_score_codex":0.000104384686,"about_ca_system_score_gemma":0.00021329224,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W2924140199","doi":"10.1002/ejhf.1258","title":"March 2019 at a Glance: Epidemiology and Clinical Trials","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Diabetes mellitus; Internal medicine; Epidemiology; Heart failure with preserved ejection fraction; Cardiology; Cluster (spacecraft); Intensive care medicine","score_opus":0.09687069207669669,"score_gpt":0.4071709911202982,"score_spread":0.3103002990436015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924140199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77206105,0.0022881802,0.0001364711,0.22219554,0.00078802824,0.000733307,0.0000056280937,0.000028452065,0.0017633461],"genre_scores_gemma":[0.8819261,0.0016169143,0.08541942,0.00759564,0.0026730904,0.0000019284373,0.000022067523,0.00009341872,0.020651422],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99364865,0.0039823423,0.0015809045,0.00025089507,0.0002189357,0.00031824474],"domain_scores_gemma":[0.9973275,0.0013735374,0.0004928803,0.00030810872,0.0001145267,0.00038341962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019288784,0.00017446173,0.0013383309,0.00014737467,0.00005153729,0.000012657754,0.00009357528,0.000061874525,0.0008602189],"category_scores_gemma":[0.0017601886,0.00011290766,0.0004441502,0.000083297,0.000092100454,0.000082811755,0.00012463628,0.00047520874,0.0012592471],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068800244,0.000100784266,0.29937342,0.000043404416,0.00029344056,0.00029328262,0.00003788841,0.000001306405,0.00059145386,0.000072340954,0.693433,0.0050716917],"study_design_scores_gemma":[0.004539111,0.0020020972,0.19204952,0.00015961716,0.00020334918,0.0009198916,0.00004476426,0.000012812091,0.000018695466,0.000019831761,0.79994696,0.000083320636],"about_ca_topic_score_codex":0.0000023743676,"about_ca_topic_score_gemma":0.0000023811576,"teacher_disagreement_score":0.21459989,"about_ca_system_score_codex":0.00004676405,"about_ca_system_score_gemma":0.00006485719,"threshold_uncertainty_score":0.9995184},"labels":[],"label_agreement":null},{"id":"W2927013814","doi":"10.1002/ejhf.1450","title":"Clinical Factors Related to Morbidity and Mortality in High-Risk Heart Failure Patients: The GUIDE-IT Predictive Model and Risk Score","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Roche Diagnostics; National Institutes of Health","keywords":"Medicine; Clinical endpoint; Heart failure; Proportional hazards model; Internal medicine; Ejection fraction; Biomarker; Clinical trial; Framingham Risk Score; Randomized controlled trial; Cardiology; Disease","score_opus":0.024240770429945595,"score_gpt":0.2952880434522972,"score_spread":0.2710472730223516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927013814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804804,0.00010532806,0.000085270425,0.01783978,0.0002313351,0.0010279833,0.000044587006,0.000028147151,0.00015721047],"genre_scores_gemma":[0.9917131,0.00023450273,0.0068216072,0.0007216388,0.000117267846,0.0000025917232,0.000013132578,0.000048029695,0.00032814563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962059,0.0011773731,0.0012448132,0.0004508372,0.00055282656,0.00036822748],"domain_scores_gemma":[0.99815476,0.00023779369,0.00039467055,0.00049851916,0.00025072537,0.00046352984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031328877,0.0003267357,0.0007727344,0.00020561213,0.00014538097,0.00006199803,0.00015137027,0.00009758315,0.000074264695],"category_scores_gemma":[0.0005401601,0.00020179946,0.00021371285,0.00024984297,0.00014548433,0.00028122868,0.00020808323,0.0011633043,0.000067738656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018467625,0.00021018166,0.89099735,0.000024251585,0.00026527062,0.00004097694,0.00069819024,0.00040974305,0.000021383607,0.00001545531,0.10677921,0.00035331468],"study_design_scores_gemma":[0.004067267,0.0021038002,0.91606176,0.00027076036,0.00038396186,0.000033495515,0.0006330244,0.00042861947,0.000011294404,0.00005438567,0.07577986,0.0001717948],"about_ca_topic_score_codex":0.00015779787,"about_ca_topic_score_gemma":0.00019754606,"teacher_disagreement_score":0.030999342,"about_ca_system_score_codex":0.00007705376,"about_ca_system_score_gemma":0.00009437889,"threshold_uncertainty_score":0.8229143},"labels":[],"label_agreement":null},{"id":"W2930874916","doi":"10.1002/ejhf.1442","title":"Cognitive Impairment in Asian Patients with Heart Failure: Prevalence, Biomarkers, Clinical Correlates, and Outcomes","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council","keywords":"Medicine; Heart failure; Cognitive impairment; Internal medicine; Cognition; Cardiology; Intensive care medicine; Disease; Psychiatry","score_opus":0.01321697367116393,"score_gpt":0.26740928823910937,"score_spread":0.25419231456794544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930874916","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11244356,0.00043576225,0.000025015535,0.8836049,0.0006651577,0.002386691,0.00006438496,0.000044158787,0.00033037472],"genre_scores_gemma":[0.40686804,0.00041861006,0.037454214,0.540166,0.0043404507,0.00003293437,0.00076423987,0.00075581507,0.009199657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99456483,0.0013678771,0.0016152557,0.00068698905,0.0010684626,0.0006966117],"domain_scores_gemma":[0.99766886,0.00039477705,0.0007350972,0.00048719873,0.0003867674,0.00032730502],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001677229,0.0007288063,0.0017256667,0.0007069837,0.00008297885,0.000104228355,0.00020764765,0.00033248082,0.00026409756],"category_scores_gemma":[0.00017752548,0.0004868698,0.00050108717,0.00028137528,0.00024690578,0.00026612947,0.00016563252,0.0029832504,0.0003207993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003994495,0.00028998358,0.46851778,0.0002719147,0.00055685156,0.0016382618,0.00006526365,1.6895318e-7,3.6683616e-7,3.5058395e-7,0.5279175,0.00034209754],"study_design_scores_gemma":[0.008320739,0.0042620837,0.42397356,0.0024686083,0.000655747,0.00034420198,0.00009683269,0.0000011705381,5.7393197e-7,0.0000012426506,0.55958635,0.0002889192],"about_ca_topic_score_codex":0.0000053449603,"about_ca_topic_score_gemma":0.000010927694,"teacher_disagreement_score":0.34343886,"about_ca_system_score_codex":0.0001437448,"about_ca_system_score_gemma":0.00025337545,"threshold_uncertainty_score":0.9997583},"labels":[],"label_agreement":null},{"id":"W2936316583","doi":"10.1002/ejhf.1461","title":"Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University Hospital Foundation","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Ejection fraction; Etiology; Intensive care medicine; Cardiomyopathy","score_opus":0.007926918952933378,"score_gpt":0.2180890254392268,"score_spread":0.21016210648629344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936316583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88884246,0.0016362568,0.000073874966,0.10651903,0.0007286801,0.0006302654,0.00009609761,0.00002469928,0.0014486513],"genre_scores_gemma":[0.9939348,0.00008731724,0.0023939263,0.0019438167,0.0014050809,0.0000020102839,0.0000122155425,0.00006374348,0.00015706863],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9939137,0.003424669,0.0011105357,0.00031901707,0.00083519786,0.00039689156],"domain_scores_gemma":[0.99743074,0.0004349476,0.0007133365,0.00068708806,0.0006289581,0.00010489969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00469205,0.00031711662,0.0012786218,0.000102393526,0.00015619968,0.000032737684,0.0003309625,0.00012065562,0.00004809567],"category_scores_gemma":[0.00033296229,0.00019617508,0.0014965597,0.0004740777,0.00020034343,0.00021494241,0.00024669775,0.0011798225,0.0000579314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015757034,0.00005490108,0.41382807,0.00009280314,0.0006245117,0.00003120794,0.0023195092,0.00028423622,0.093779445,0.000015991069,0.4886921,0.00011962934],"study_design_scores_gemma":[0.0021483046,0.0003805689,0.5303237,0.00073742395,0.00031160456,0.00046989456,0.0039527207,0.0000035282558,0.0011052657,0.000018154207,0.46039852,0.0001502854],"about_ca_topic_score_codex":0.000045665634,"about_ca_topic_score_gemma":0.000034906945,"teacher_disagreement_score":0.116495624,"about_ca_system_score_codex":0.00016812349,"about_ca_system_score_gemma":0.00016256116,"threshold_uncertainty_score":0.7999788},"labels":[],"label_agreement":null},{"id":"W2939174996","doi":"10.1002/ejhf.1260","title":"April 2019 at a Glance: Prediction of Heart Failure, Left Atrial Function, Cardio-Oncology","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiorespiratory fitness; Hazard ratio; Body mass index; Internal medicine; Overweight; Natriuretic peptide; Cardiology; Confidence interval; Obesity; Risk factor","score_opus":0.009515942888074686,"score_gpt":0.22753792426592545,"score_spread":0.21802198137785075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939174996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97860307,0.002239407,0.0007964476,0.00924265,0.00683371,0.00061928993,0.00004830444,0.00008183944,0.0015353082],"genre_scores_gemma":[0.9907085,0.00019555567,0.0022393914,0.0004583916,0.0038487932,3.8535345e-7,0.000040466766,0.00007909239,0.0024294262],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677247,0.0008352376,0.00095342036,0.00029901968,0.000825247,0.0003146325],"domain_scores_gemma":[0.9980477,0.00008609001,0.0004274151,0.00051661395,0.0006053904,0.0003167636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020022986,0.00025149257,0.0010338151,0.00032704536,0.000105040366,0.000020716776,0.000120795135,0.00014189567,0.0011496805],"category_scores_gemma":[0.00015691621,0.00019474966,0.001582936,0.00023806562,0.00010246445,0.00019694853,0.0000787272,0.0007457266,0.0007490359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001940641,0.0000743528,0.28580582,0.00007712822,0.0009330297,0.00007267938,0.0002130624,0.00042724176,0.029490605,0.0000069428825,0.6804156,0.0005429139],"study_design_scores_gemma":[0.0056137717,0.0022745875,0.18964207,0.0001335892,0.000479325,0.0043298267,0.00027657193,0.000009724463,0.0007908757,0.0000022540844,0.79632956,0.00011786633],"about_ca_topic_score_codex":0.000009747238,"about_ca_topic_score_gemma":0.0000067914925,"teacher_disagreement_score":0.11591396,"about_ca_system_score_codex":0.00022054046,"about_ca_system_score_gemma":0.00029428414,"threshold_uncertainty_score":0.9997634},"labels":[],"label_agreement":null},{"id":"W2943946268","doi":"10.1002/ejhf.1499","title":"Expert Consensus Document: Reporting Checklist for Quantification of Pulmonary Congestion by Lung Ultrasound in Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo; HeartWare; National Heart, Lung, and Blood Institute; Servier; Sanofi","keywords":"Medicine; Checklist; Standardization; Heart failure; Lung ultrasound; Ultrasound; Medical physics; Intensive care medicine; Radiology; Cardiology; Computer science","score_opus":0.027718884284002522,"score_gpt":0.3308752378850148,"score_spread":0.30315635360101223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943946268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95789033,0.0007861476,0.0011389935,0.038587082,0.00023593869,0.00095597154,0.000033206215,0.000028232016,0.00034407288],"genre_scores_gemma":[0.9644885,0.000040136554,0.034163676,0.00040300336,0.00024128337,0.000008753463,0.00008991724,0.000051549443,0.0005131831],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618995,0.00028556047,0.0025532504,0.00032012316,0.00038959616,0.00026154757],"domain_scores_gemma":[0.9956558,0.0012146924,0.0019539525,0.00044870315,0.00054993766,0.00017693028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032287226,0.00018924555,0.0006411838,0.00015146128,0.000066814006,0.000036348334,0.00015308881,0.00008749017,0.00019645038],"category_scores_gemma":[0.0032095192,0.00016665277,0.00027359638,0.0002587006,0.00016103924,0.00014663966,0.000021904501,0.0005343256,0.00004094919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031047614,0.00030709626,0.107495256,0.00014932208,0.00005920301,0.000016118207,0.00018205389,0.000049774422,0.7222304,0.000162769,0.1687804,0.00025715138],"study_design_scores_gemma":[0.0035875044,0.0008954291,0.11672075,0.001178408,0.0001360052,0.0029607096,0.0013972381,0.00014977527,0.027395718,0.00016047109,0.8450701,0.00034785154],"about_ca_topic_score_codex":0.000011614036,"about_ca_topic_score_gemma":0.0000033373933,"teacher_disagreement_score":0.69483465,"about_ca_system_score_codex":0.00008887022,"about_ca_system_score_gemma":0.00012967216,"threshold_uncertainty_score":0.6795902},"labels":[],"label_agreement":null},{"id":"W2944333322","doi":"10.1002/ejhf.1482","title":"The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Institute of Infection and Immunity","funders":"European Commission; National Institute for Health and Care Research; Singulex","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Natriuretic peptide; Cohort; Confidence interval; Cardiology","score_opus":0.023249561780189665,"score_gpt":0.26927986724426817,"score_spread":0.2460303054640785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944333322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98224676,0.0008056982,0.000010276554,0.014188066,0.0016479603,0.0004393289,0.00033820167,0.000013334928,0.00031038906],"genre_scores_gemma":[0.99835324,0.00006471322,0.00035509354,0.000489577,0.00023113178,0.0000010672062,0.00001241111,0.000030019946,0.00046272203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321854,0.004294177,0.0016511112,0.000315339,0.0001379949,0.00038281697],"domain_scores_gemma":[0.99658054,0.0017751275,0.0006686001,0.00069286494,0.000236556,0.000046293895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053084143,0.0002255604,0.00058762863,0.000077588484,0.00018326164,0.000044499866,0.00081648945,0.000092995695,0.000078486366],"category_scores_gemma":[0.00086265884,0.00012333393,0.00027420925,0.00023087933,0.0003666728,0.00012883887,0.00017525065,0.0014548881,0.0008120476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035172151,0.000830363,0.13836108,0.000011170633,0.0004998473,0.00010850844,0.007159378,0.000028047372,0.10625509,0.000070214286,0.7411563,0.002002789],"study_design_scores_gemma":[0.004338315,0.002083609,0.1274333,0.00014704456,0.000032595264,0.000086955486,0.0071530603,6.546508e-7,0.002636351,0.000023753591,0.8559272,0.0001371285],"about_ca_topic_score_codex":0.00008563226,"about_ca_topic_score_gemma":0.00035236301,"teacher_disagreement_score":0.114770934,"about_ca_system_score_codex":0.000024992843,"about_ca_system_score_gemma":0.00019453677,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W2944456884","doi":"10.1002/ejhf.1262","title":"May 2019 at a Glance: Epidemiology, Drug Effects On Biomarkers, Adverse Events With LVAD","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Valsartan; Sacubitril; Heart failure; Ejection fraction; Sacubitril, Valsartan; Medical prescription; Internal medicine; Clinical trial; Epidemiology; Adverse effect; China; Blood pressure","score_opus":0.01014996229056609,"score_gpt":0.25651364976607793,"score_spread":0.24636368747551185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944456884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90450484,0.000485447,0.000043809192,0.09115554,0.0005324756,0.00087117375,0.0000040175464,0.00005060933,0.002352069],"genre_scores_gemma":[0.9509325,0.00007678735,0.027571473,0.0038994094,0.0005261156,0.0000031672105,0.000023476354,0.000086298176,0.016880762],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973658,0.00094189035,0.00054278853,0.00031405754,0.00039030038,0.0004452152],"domain_scores_gemma":[0.99842954,0.00031177525,0.000332493,0.00045932794,0.0001057308,0.0003611443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018345339,0.00030328866,0.0007227171,0.00023618144,0.00008169473,0.000005152466,0.00014867989,0.000041952087,0.00031968416],"category_scores_gemma":[0.00012114723,0.00018918773,0.00028609816,0.0001728049,0.00005467568,0.00012540718,0.00008149334,0.00040121024,0.0027078448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018743941,0.00019150987,0.29375616,0.0001497203,0.000585252,0.001244103,0.0001193297,0.000027257793,0.0011362389,0.000041448086,0.6997139,0.0011606786],"study_design_scores_gemma":[0.0070860316,0.0034093207,0.19417916,0.0011860302,0.00022263362,0.0008048007,0.00008129971,0.0000070998312,0.0005075396,0.000006428555,0.7923219,0.00018773034],"about_ca_topic_score_codex":0.000004991319,"about_ca_topic_score_gemma":0.000005159916,"teacher_disagreement_score":0.099576995,"about_ca_system_score_codex":0.00015769652,"about_ca_system_score_gemma":0.000066462,"threshold_uncertainty_score":0.9980687},"labels":[],"label_agreement":null},{"id":"W2944687799","doi":"10.1002/ejhf.1494","title":"Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":785,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Intracardiac injection; Natriuretic peptide; Atrial fibrillation; Myocardial infarction; Pulmonary embolism","score_opus":0.08759918885117787,"score_gpt":0.3238729917196438,"score_spread":0.23627380286846592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944687799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020197355,0.6315118,0.0007973771,0.3488533,0.0023590126,0.008929948,0.00046483337,0.00008134274,0.004982649],"genre_scores_gemma":[0.033890773,0.887582,0.06273684,0.002677982,0.0036805489,0.000019038569,0.00010773623,0.0005163255,0.008788762],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99116725,0.0054530553,0.0018302293,0.00028608833,0.00092452945,0.00033885325],"domain_scores_gemma":[0.99441063,0.0013806651,0.0025115008,0.00085494836,0.0007192997,0.00012294602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037993612,0.0004107473,0.002137183,0.0001236136,0.00010655563,0.000031343818,0.0003408669,0.00014463492,0.00006836278],"category_scores_gemma":[0.0013121128,0.00021740599,0.0022081872,0.00041536926,0.0002289488,0.00013225572,0.0001607877,0.0012991243,0.00007948033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034499455,0.00014519751,0.0019583001,0.0027277083,0.0016124136,0.000031014974,0.00014680396,0.000056440156,0.00012530896,0.0002327226,0.99093884,0.0019907262],"study_design_scores_gemma":[0.00078593806,0.0006678085,0.0015988359,0.0077361222,0.0025057925,0.00028164114,0.00011497727,0.000003876205,0.00002413892,0.0000017611742,0.98613536,0.00014373417],"about_ca_topic_score_codex":0.0000033391764,"about_ca_topic_score_gemma":0.0000026835892,"teacher_disagreement_score":0.3461753,"about_ca_system_score_codex":0.00022054774,"about_ca_system_score_gemma":0.00057346997,"threshold_uncertainty_score":0.8865559},"labels":[],"label_agreement":null},{"id":"W2945685138","doi":"10.1002/ejhf.1491","title":"Treatment of Functional Mitral Regurgitation in Chronic Heart Failure: Can We Get A ‘Proof of Concept’ from the MITRA-FR and COAPT TRIALS?","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"MitraClip; Medicine; Functional mitral regurgitation; Heart failure; Cardiology; Clinical endpoint; Internal medicine; Mitral regurgitation; Randomized controlled trial; Observational study; Ejection fraction","score_opus":0.06553525512188248,"score_gpt":0.3534962861594195,"score_spread":0.28796103103753706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945685138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053604003,0.98925114,0.000009308407,0.0031561772,0.00030313773,0.0012242013,0.00066232757,0.0000046373502,0.000028698592],"genre_scores_gemma":[0.082814895,0.91418576,0.00074752956,0.000065736596,0.0014231823,0.000016065113,0.00046787667,0.00011282922,0.00016610879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558353,0.0017219681,0.0016581097,0.0003031465,0.00049912225,0.00023412562],"domain_scores_gemma":[0.9971594,0.00076146814,0.0012778094,0.00039325887,0.00021549806,0.0001925436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070443004,0.00042988817,0.0032543058,0.00021410333,0.000042592805,0.000028316312,0.00010050025,0.00010245056,0.00014604327],"category_scores_gemma":[0.00016607375,0.0002471525,0.0038047752,0.00020914755,0.0001498912,0.00007757155,0.000028803835,0.00035057528,0.000010057748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024467434,0.0019112625,0.012900833,0.008124406,0.022599526,0.0006089352,0.0017334869,0.00011966989,0.00014244826,0.00006425178,0.07662492,0.8727235],"study_design_scores_gemma":[0.00794156,0.0026545047,0.006674018,0.010761152,0.008298256,0.00047596922,0.00024640956,0.0000019748093,0.00002439529,0.000008975638,0.9627318,0.00018101426],"about_ca_topic_score_codex":0.00006775984,"about_ca_topic_score_gemma":0.000025917077,"teacher_disagreement_score":0.88610685,"about_ca_system_score_codex":0.0003655195,"about_ca_system_score_gemma":0.0011968162,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2945994263","doi":"10.1002/ejhf.1531","title":"Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":608,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; Guideline; MitraClip; Clinical trial; Rivaroxaban; Atrial fibrillation; Evidence-based practice; Canadian Cardiovascular Society; MEDLINE; Consensus conference; Cardiac resynchronization therapy; Management of heart failure; Position paper; Evidence-based medicine; Systematic review; Cardiology; Internal medicine; Alternative medicine; Warfarin; Ejection fraction; Pathology","score_opus":0.016048345079690718,"score_gpt":0.30683799199833944,"score_spread":0.2907896469186487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945994263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7723954,0.00078875583,0.000018522695,0.22266968,0.00064379943,0.0015672459,0.000020132738,0.000031952914,0.0018645274],"genre_scores_gemma":[0.95998466,0.00023250999,0.034099363,0.004762828,0.00043896819,0.0000027258018,0.000008199761,0.00007975975,0.0003909857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928007,0.0036006412,0.0017832126,0.00043601033,0.001010252,0.0003691443],"domain_scores_gemma":[0.99588966,0.000354822,0.0021256101,0.00075396814,0.00069128437,0.00018463598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00561966,0.00034016202,0.0009624435,0.00010974451,0.00015243996,0.000032550222,0.00029942708,0.00009567825,0.00003974546],"category_scores_gemma":[0.0003984292,0.000205405,0.000711505,0.00029212807,0.00020238801,0.00019559373,0.00024091917,0.0007262892,0.000017265611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041622788,0.00042708506,0.15039738,0.0002804367,0.0014622449,0.00010204337,0.0008329114,0.0001265792,0.013588204,0.000026887794,0.8314457,0.00089431705],"study_design_scores_gemma":[0.0031472628,0.001284764,0.06609205,0.0009061064,0.00050837896,0.0008872057,0.0026033933,0.000011829575,0.001896359,0.0000036345068,0.9224854,0.0001735881],"about_ca_topic_score_codex":0.000016446449,"about_ca_topic_score_gemma":0.000012226694,"teacher_disagreement_score":0.21790685,"about_ca_system_score_codex":0.00007955378,"about_ca_system_score_gemma":0.00015336522,"threshold_uncertainty_score":0.8376173},"labels":[],"label_agreement":null},{"id":"W2946666273","doi":"10.1002/ejhf.1476","title":"Appropriate Prescriptions Mean Better Outcomes: How Can We Improve Ourselves?","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Medical prescription; Heart failure; MEDLINE; Intensive care medicine; Internal medicine; Nursing","score_opus":0.02082776522862451,"score_gpt":0.2425383206278975,"score_spread":0.221710555399273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946666273","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016668837,0.0003406551,0.00016709564,0.9935146,0.0020882403,0.0011455517,0.00006750468,0.00008861652,0.0009208545],"genre_scores_gemma":[0.007618765,0.00016070453,0.0460982,0.80694467,0.016517509,0.000016638418,0.0002941246,0.0005707314,0.12177866],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955275,0.0008114298,0.0009901619,0.00059870596,0.0012182415,0.0008539401],"domain_scores_gemma":[0.99720263,0.00010720793,0.0008284608,0.0011238874,0.00041741822,0.0003203771],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009312078,0.00082367146,0.0015992979,0.0007002865,0.0001408046,0.00025787303,0.00047021412,0.0003187255,0.000367479],"category_scores_gemma":[0.000099125245,0.0005744725,0.0012085662,0.00020072034,0.00011135874,0.00026268887,0.00017880686,0.0038180908,0.00088050344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046033365,0.00012071239,0.0014151821,0.00041230372,0.0013177976,0.00462181,0.00040375185,0.0000013735811,0.0005284787,0.0000039006936,0.9897006,0.0014280367],"study_design_scores_gemma":[0.0032088258,0.0012598209,0.0010424445,0.0008519018,0.0014285257,0.00075012795,0.00022512047,0.000003509991,0.00006163272,0.000018892892,0.99066365,0.0004855546],"about_ca_topic_score_codex":0.000009122649,"about_ca_topic_score_gemma":0.000009771096,"teacher_disagreement_score":0.18656993,"about_ca_system_score_codex":0.0002293412,"about_ca_system_score_gemma":0.00027437994,"threshold_uncertainty_score":0.9998974},"labels":[],"label_agreement":null},{"id":"W2947681783","doi":"10.1002/ejhf.1532","title":"Sacubitril/Valsartan Eligibility and Outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: Bridging Between European Medicines Agency/Food and Drug Administration Label, the PARADIGM-HF Trial, ESC Guidelines, and Real World","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Servier; Boston Scientific Corporation; Daiichi Sankyo Europe; ResMed; Edwards Lifesciences; European Society of Cardiology; Sanofi; AstraZeneca; Bayer; Boehringer Ingelheim","keywords":"Medicine; Sacubitril; Heart failure; Sacubitril, Valsartan; Valsartan; Ejection fraction; Enalapril; Guideline; Internal medicine; Cardiology; Intensive care medicine; Blood pressure; Angiotensin-converting enzyme","score_opus":0.04177887841795871,"score_gpt":0.3317047626631524,"score_spread":0.2899258842451937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947681783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7827952,0.0012166457,0.000023569202,0.21431771,0.00014664182,0.0012000711,0.000011226913,0.000030623356,0.00025832374],"genre_scores_gemma":[0.99417794,0.0003513953,0.0019409076,0.0019338211,0.00094760634,0.0000045317934,0.00002575373,0.000059596427,0.0005584738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995172,0.0017859978,0.0013871371,0.0005167461,0.00069794647,0.00044013775],"domain_scores_gemma":[0.9979017,0.0004444667,0.00048612314,0.00070827967,0.00015361595,0.00030584703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063244626,0.0004507091,0.0010750432,0.00025765077,0.00027003323,0.00025826824,0.00026348283,0.00004806228,0.000029661338],"category_scores_gemma":[0.00033561286,0.00025232072,0.0001566584,0.0003327427,0.00025219814,0.00031080234,0.00014239158,0.0007288332,0.000020328895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011115419,0.00018677353,0.8729631,0.00018517376,0.00024291193,0.00043086446,0.0011338227,0.0000012100927,0.00031133246,0.00007603467,0.12052154,0.0028357196],"study_design_scores_gemma":[0.017281184,0.0023384467,0.8117133,0.00074838795,0.0005501917,0.00068634667,0.0007193673,0.0000103818875,0.00006175491,0.00004292188,0.16554247,0.00030526228],"about_ca_topic_score_codex":0.000041081144,"about_ca_topic_score_gemma":0.00033998842,"teacher_disagreement_score":0.21238388,"about_ca_system_score_codex":0.000048316135,"about_ca_system_score_gemma":0.00012569923,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W2947972779","doi":"10.1002/ejhf.1498","title":"Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"National Institute for Health and Care Research; Novartis","keywords":"Medicine; Sacubitril, Valsartan; Heart failure; Valsartan; Sacubitril; Cardiology; Internal medicine; Ejection fraction","score_opus":0.006039076943491355,"score_gpt":0.22056661991853835,"score_spread":0.214527542975047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947972779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852317,0.00002888808,0.000015003644,0.011749836,0.00014628092,0.002713121,0.000029370822,0.00000821132,0.00007757845],"genre_scores_gemma":[0.99778426,0.000005336767,0.0018712148,0.00015157575,0.00005706004,0.0000074495506,0.00002070379,0.000038753406,0.00006363639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606323,0.0011121059,0.0015368672,0.00026584152,0.00075504323,0.00026692136],"domain_scores_gemma":[0.99858046,0.00014189238,0.00047612915,0.00039322773,0.00029848434,0.00010979577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015552667,0.00024487762,0.0010024337,0.0003602997,0.00002588537,0.000020018864,0.0001558923,0.000056441037,0.00008761744],"category_scores_gemma":[0.00019442274,0.00015127254,0.00028863928,0.00047051712,0.00006417424,0.0003482126,0.00005604174,0.0004495686,0.000014151983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04361087,0.007262093,0.91945076,0.0003884131,0.00022619472,0.00019237993,0.012660765,0.00014614609,0.009481746,0.0000033098686,0.0063148867,0.00026241445],"study_design_scores_gemma":[0.06910665,0.005265511,0.9211046,0.0008738456,0.00014666973,0.000010309233,0.0010786087,0.000022022788,0.00042457596,0.0000039374677,0.0018171569,0.00014612995],"about_ca_topic_score_codex":0.000026404043,"about_ca_topic_score_gemma":0.00012956574,"teacher_disagreement_score":0.025495782,"about_ca_system_score_codex":0.00012110137,"about_ca_system_score_gemma":0.00015229797,"threshold_uncertainty_score":0.61687154},"labels":[],"label_agreement":null},{"id":"W2951059146","doi":"10.1002/ejhf.1486","title":"Rationale and Design of The Emperial-Preserved and Emperial-Reduced Trials of Empagliflozin in Patients with Chronic Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Heart failure; Internal medicine; Cardiology; Clinical trial; Intensive care medicine; Diabetes mellitus","score_opus":0.018822421577959415,"score_gpt":0.234219809688949,"score_spread":0.2153973881109896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951059146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940285,0.0003687954,0.000011420505,0.004220254,0.00013191887,0.0011954866,0.0000093938,0.0000036720019,0.000030531304],"genre_scores_gemma":[0.99549294,0.000019520805,0.0040776986,0.00008386234,0.00011271027,0.0000025992103,0.000005953803,0.000024738407,0.00017997334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775875,0.0008368122,0.00074238883,0.00015215679,0.0003550419,0.00015484422],"domain_scores_gemma":[0.99891543,0.0001366918,0.0004517987,0.00023918111,0.00017341951,0.00008349409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016514874,0.00015691307,0.0007145635,0.0001481582,0.000031968622,0.000025560279,0.000098597426,0.000028753666,0.00014741116],"category_scores_gemma":[0.00021309752,0.000090176945,0.00010694236,0.00014847997,0.00010284611,0.00015874258,0.0000721605,0.00014607118,0.000003971229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004109224,0.00073508086,0.7450037,0.0004884374,0.0008449593,0.000016959719,0.0011088998,0.00039043382,0.20047912,0.00007638278,0.046186093,0.0005607037],"study_design_scores_gemma":[0.02598954,0.0060513197,0.9218074,0.0014016113,0.0003862924,0.000018469811,0.00029852812,0.000020889218,0.013749148,0.000017475719,0.030080777,0.0001785365],"about_ca_topic_score_codex":0.0000036407523,"about_ca_topic_score_gemma":0.000005750403,"teacher_disagreement_score":0.18672997,"about_ca_system_score_codex":0.000033390603,"about_ca_system_score_gemma":0.00013308681,"threshold_uncertainty_score":0.36773092},"labels":[],"label_agreement":null},{"id":"W2952558406","doi":"10.1002/ejhf.1264","title":"June 2019 at a Glance: From Genetics to Haemodynamics, Biomarkers and Imaging for the Prediction of Outcomes","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Effects of Exercise","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Hemodynamics","score_opus":0.005949065000441811,"score_gpt":0.22834335106906195,"score_spread":0.22239428606862013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952558406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97926646,0.0037215552,0.0022576917,0.0132898735,0.0006990948,0.0006369065,0.00007355183,0.0000098019555,0.000045069977],"genre_scores_gemma":[0.9803902,0.0001424452,0.018490337,0.00036901864,0.0002845132,0.0000010550145,0.000010872188,0.00004761768,0.00026397916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989527,0.00011944916,0.0003488033,0.00014350371,0.00029275936,0.00014281669],"domain_scores_gemma":[0.9989991,0.00019758832,0.00015352987,0.0003413748,0.00018710612,0.00012128114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087557605,0.00011956207,0.0004165208,0.00010270801,0.00004385744,0.000019263103,0.000105964886,0.000018499262,0.000018107581],"category_scores_gemma":[0.00014579711,0.00007855883,0.0003188311,0.00007389323,0.000049561117,0.000060022277,0.00008228544,0.0001385509,0.000018960305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016576962,0.000068499976,0.6419815,0.00017819583,0.001460353,0.00010521,0.0005960967,0.0005271215,0.124409474,0.000003483548,0.21601567,0.012996702],"study_design_scores_gemma":[0.0047651487,0.00044984787,0.8516023,0.00044465932,0.00059101486,0.00046625218,0.00021898773,0.001643384,0.001459827,0.000007604899,0.13824446,0.00010651611],"about_ca_topic_score_codex":0.000008390054,"about_ca_topic_score_gemma":0.0000042491233,"teacher_disagreement_score":0.20962079,"about_ca_system_score_codex":0.000041531745,"about_ca_system_score_gemma":0.00002932117,"threshold_uncertainty_score":0.3203536},"labels":[],"label_agreement":null},{"id":"W2953451576","doi":"10.1002/ejhf.1535","title":"Insulin Treatment and Clinical Outcomes in Patients with Diabetes and Heart Failure with Preserved Ejection Fraction","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Western University","funders":"British Heart Foundation","keywords":"Medicine; Heart failure; Ejection fraction; Diabetes mellitus; Internal medicine; Cardiology; Insulin; Endocrinology","score_opus":0.01026246056422389,"score_gpt":0.23980763714755482,"score_spread":0.22954517658333093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953451576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974997,0.00010522645,0.00001450569,0.0018746818,0.00012360247,0.00033326232,0.000002097194,0.0000131541265,0.00003374428],"genre_scores_gemma":[0.9978423,0.000041793257,0.0017391618,0.00014808864,0.00010570609,7.027542e-7,0.0000059220383,0.000027939794,0.0000883529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986733,0.0003621186,0.00036645806,0.00019708398,0.00025891574,0.00014208148],"domain_scores_gemma":[0.9992917,0.00007324062,0.00014774132,0.00017682923,0.00013975022,0.00017074576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005037978,0.0001591006,0.00052729726,0.00015924705,0.000042913027,0.00003517942,0.000023337143,0.00004489121,0.000043965338],"category_scores_gemma":[0.000053415293,0.00008819595,0.00014571806,0.00010907531,0.000050851133,0.00020963654,0.000016037278,0.000355339,0.000018320075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000638428,0.0002431814,0.99705845,0.000018812229,0.00032955312,0.000013134687,0.000043241762,0.000013878834,0.00006262588,2.7811404e-7,0.00089977134,0.00067863683],"study_design_scores_gemma":[0.009943116,0.0054725553,0.9293408,0.00016342493,0.00016286185,0.00005139898,0.00022054906,0.0000071046006,0.000039305916,3.6889446e-7,0.05450377,0.000094773364],"about_ca_topic_score_codex":0.000008637601,"about_ca_topic_score_gemma":0.000027165093,"teacher_disagreement_score":0.06771769,"about_ca_system_score_codex":0.000049802456,"about_ca_system_score_gemma":0.00004075897,"threshold_uncertainty_score":0.35965264},"labels":[],"label_agreement":null},{"id":"W2962811812","doi":"10.1002/ejhf.1551","title":"Heart Failure Patients Unresponsive to Implantable Cardioverter-Defibrillator Therapy: A Neglected Problem","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Implantable cardioverter-defibrillator; Heart failure; Ejection fraction; Internal medicine; Sudden cardiac death; Cardiology; Cardiac resynchronization therapy; Clinical trial; Guideline; Randomized controlled trial; Canadian Cardiovascular Society; Intensive care medicine; Myocardial infarction","score_opus":0.03663039414560009,"score_gpt":0.30917555831394045,"score_spread":0.27254516416834035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962811812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089656835,0.98060876,0.000023711165,0.0005690779,0.0008579218,0.0018154761,0.00019845375,0.00008535237,0.014944648],"genre_scores_gemma":[0.0024929575,0.98289126,0.008254595,0.0012780846,0.0028806513,0.000011925058,0.00011227642,0.0005055178,0.0015727358],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947375,0.0014806001,0.0015842918,0.00056962273,0.001000967,0.0006270121],"domain_scores_gemma":[0.9963925,0.00034007308,0.00083744124,0.0007242152,0.0011527654,0.0005530382],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006831808,0.00078824826,0.0057525206,0.0008128106,0.00018320761,0.00014458284,0.000115347946,0.00018055964,0.000017026214],"category_scores_gemma":[0.00029315124,0.00055977795,0.0023497161,0.00084891025,0.000052543764,0.00015806031,0.00017929295,0.0009258465,0.0012630661],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003101056,0.000041707783,0.00043970963,0.001970259,0.0016528842,0.00002025385,0.0002374179,0.000012903451,0.000039543043,0.0000014741647,0.963913,0.031360716],"study_design_scores_gemma":[0.0017161054,0.0016591998,0.00057724566,0.014096149,0.0011267519,0.008921828,0.00007681361,5.6937477e-8,0.0000052895175,6.946485e-7,0.9713283,0.0004915754],"about_ca_topic_score_codex":0.0000055848195,"about_ca_topic_score_gemma":0.0000013136773,"teacher_disagreement_score":0.03086914,"about_ca_system_score_codex":0.00023177934,"about_ca_system_score_gemma":0.00069022714,"threshold_uncertainty_score":0.99968535},"labels":[],"label_agreement":null},{"id":"W2963678375","doi":"10.1002/ejhf.1542","title":"Application of the H2FPEF Score to a Global Clinical Trial of Patients with Heart Failure with Preserved Ejection Fraction: The TOPCAT Trial","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; Brigham and Women's Hospital","keywords":"Medicine; Heart failure; Ejection fraction; Heart failure with preserved ejection fraction; Internal medicine; Spironolactone; Cardiology; Population; Clinical trial; Randomization; Randomized controlled trial; Placebo; Blood pressure","score_opus":0.029092566197429077,"score_gpt":0.2917656763715128,"score_spread":0.26267311017408373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963678375","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2268994,0.00003513816,0.0006310501,0.7639387,0.0011611355,0.00701463,0.0000411057,0.000024707644,0.00025408887],"genre_scores_gemma":[0.8030491,0.000025876496,0.023576658,0.1431479,0.02666812,0.00014364994,0.00030929936,0.0003811847,0.0026982126],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455106,0.0015006339,0.0015487671,0.0004532137,0.0016029688,0.0003433714],"domain_scores_gemma":[0.995995,0.000239086,0.0015652868,0.0012066877,0.00085520645,0.00013877217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001675736,0.00043624625,0.0012196462,0.00015209877,0.00012697822,0.000054412478,0.00047095693,0.00023927548,0.00007929264],"category_scores_gemma":[0.00022523293,0.00020632733,0.0006847954,0.0005316477,0.00018779005,0.0001704774,0.00014208032,0.0017413935,0.000058855534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101958826,0.0005654858,0.05029618,0.00013868892,0.0005413408,0.000020083397,0.000030589214,0.000022286165,0.000009562873,0.000003298113,0.8461347,0.00027896228],"study_design_scores_gemma":[0.10394969,0.013660278,0.037372153,0.0006088125,0.0009359372,0.00004479807,0.000063967185,0.00000227596,0.00001950083,0.0000028138606,0.84317124,0.00016856028],"about_ca_topic_score_codex":0.000025166572,"about_ca_topic_score_gemma":0.000033413595,"teacher_disagreement_score":0.62079084,"about_ca_system_score_codex":0.00015013035,"about_ca_system_score_gemma":0.00038888768,"threshold_uncertainty_score":0.8413784},"labels":[],"label_agreement":null},{"id":"W2964622293","doi":"10.1002/ejhf.1266","title":"July 2019 at a Glance: Imaging of Congestion, Sodium–Glucose Co-Transporter 2 Inhibitors, Myocardial Function and Mitraclip Trials","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Empagliflozin; Heart failure; Ejection fraction; Internal medicine; Cardiology; Ketone bodies; Myocardial infarction; Cardiac function curve; Diabetes mellitus; Endocrinology; Type 2 diabetes; Metabolism","score_opus":0.012447020662789562,"score_gpt":0.25413726852404495,"score_spread":0.24169024786125537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964622293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727328,0.0022714227,0.00016516651,0.022235692,0.00090101827,0.0007366743,0.00002036782,0.000034408386,0.00090245064],"genre_scores_gemma":[0.9945356,0.00017319428,0.0027090246,0.0005714205,0.0008835478,0.0000012075354,0.000031657695,0.00004192748,0.0010523874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997583,0.00051088614,0.0010019757,0.00022171586,0.00044300486,0.00023946453],"domain_scores_gemma":[0.99873835,0.00011550599,0.00047539908,0.00023582525,0.0002191037,0.00021580495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026104255,0.000219026,0.000838428,0.00022784754,0.00006181112,0.000030237337,0.00005938373,0.00004105336,0.00027288514],"category_scores_gemma":[0.00008460812,0.00016317,0.000354517,0.00010642263,0.00007734729,0.00023244691,0.000026871594,0.00028941064,0.00024271099],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024940772,0.00020296109,0.26584804,0.00019557838,0.0005339955,0.00027863946,0.0003577518,0.0000093148565,0.064476654,0.000025243973,0.6621645,0.0034132388],"study_design_scores_gemma":[0.00846266,0.0011837096,0.22801419,0.00045456784,0.00064253516,0.00048058276,0.0001306985,0.0000043041114,0.0029065965,0.000011959682,0.757553,0.00015524743],"about_ca_topic_score_codex":0.0000038837466,"about_ca_topic_score_gemma":0.0000015986055,"teacher_disagreement_score":0.09538846,"about_ca_system_score_codex":0.000052388594,"about_ca_system_score_gemma":0.00007020499,"threshold_uncertainty_score":0.6653879},"labels":[],"label_agreement":null},{"id":"W2965058723","doi":"10.1002/ejhf.1268","title":"August 2019 at a Glance: Arrhythmogenic Cardiomyopathy, Biomarkers of Inflammation, Insulin Treatment, Initiation of Sacubitril/Valsartan, and Pharmacy-Based Intervention to Increase Medication Adherence","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Effects of Exercise","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Cardiology; Cardiomyopathy; Sacubitril; Diabetes mellitus; Sacubitril, Valsartan; Disease; Endocrinology","score_opus":0.009524890404708641,"score_gpt":0.26266604700064977,"score_spread":0.2531411565959411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965058723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482363,0.002671899,0.0005501461,0.000890095,0.00018866615,0.0007058037,0.000031572923,0.000013147455,0.00012503567],"genre_scores_gemma":[0.99669635,0.00019207798,0.002726854,0.000047163023,0.00020232925,0.000004136151,0.000053046348,0.00003187807,0.000046159876],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976262,0.0006785937,0.00085335656,0.00020211456,0.00049369864,0.00014603451],"domain_scores_gemma":[0.99810874,0.00011543005,0.0006904621,0.000350037,0.0005153296,0.0002200105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018188466,0.00018137593,0.0007814551,0.00040874167,0.000029953655,0.000012672347,0.00009138015,0.00003621238,0.00012444603],"category_scores_gemma":[0.0003566515,0.00015506893,0.0004463535,0.00029572344,0.0000629705,0.00020220499,0.00004808864,0.00013043429,0.000052239448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076042623,0.00030947517,0.12614618,0.0011242875,0.0011700244,0.00022629755,0.00062428205,0.00043735042,0.8133003,0.0000052294004,0.013194713,0.0358576],"study_design_scores_gemma":[0.042614125,0.00747743,0.5291647,0.0052960473,0.0023577104,0.0021554956,0.0003131246,0.0006657784,0.3612352,0.000008656816,0.048211273,0.00050051237],"about_ca_topic_score_codex":0.00006325668,"about_ca_topic_score_gemma":0.000008514446,"teacher_disagreement_score":0.4520651,"about_ca_system_score_codex":0.00014468125,"about_ca_system_score_gemma":0.00017201234,"threshold_uncertainty_score":0.63235277},"labels":[],"label_agreement":null},{"id":"W2965446700","doi":"10.1002/ejhf.1565","title":"Salvage MitraClip in Severe Secondary Mitral Regurgitation Complicating Acute Myocardial Infarction: Data from a Multicentre International Study","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; MitraClip; Mitral regurgitation; Heart failure; Myocardial infarction; Mitral valve repair; Randomized controlled trial; Cardiology; Internal medicine; Surgery","score_opus":0.027351638080539573,"score_gpt":0.3281693706836055,"score_spread":0.30081773260306593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965446700","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4828414,0.0010744786,0.000020512769,0.50646657,0.0033479873,0.0015922615,0.0029085623,0.000047835,0.0017004092],"genre_scores_gemma":[0.7995386,0.000087401124,0.0062601175,0.1619213,0.017505217,0.0000073471792,0.013503373,0.00026662915,0.00090998044],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965386,0.00074752455,0.0009822892,0.0005652445,0.0008644276,0.00030190666],"domain_scores_gemma":[0.9977451,0.00022241237,0.00067089923,0.00091258873,0.00031506745,0.00013394459],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048890413,0.00038145564,0.00085467077,0.00032339818,0.00006271967,0.00014138693,0.00051376125,0.0001344017,0.00039155994],"category_scores_gemma":[0.00012830988,0.0003398666,0.0011275024,0.00014009871,0.00003819918,0.00042442782,0.0002646981,0.0023469757,0.00031274316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004569432,0.00031032827,0.21264474,0.00003847325,0.00565859,0.0037676115,0.0003347121,0.000010807436,0.00004326891,7.027952e-8,0.775912,0.00082246336],"study_design_scores_gemma":[0.0077639,0.0003335118,0.56617266,0.00047681737,0.0020297961,0.0005060699,0.00053606456,0.00002455882,7.606765e-7,0.00000246808,0.42194057,0.00021278748],"about_ca_topic_score_codex":0.000047262412,"about_ca_topic_score_gemma":0.0000067959286,"teacher_disagreement_score":0.35397142,"about_ca_system_score_codex":0.00019773768,"about_ca_system_score_gemma":0.0002558703,"threshold_uncertainty_score":0.99995464},"labels":[],"label_agreement":null},{"id":"W2966162351","doi":"10.1002/ejhf.1550","title":"Geographical Location Affects the Levels and Association of Trimethylamine N-Oxide with Heart Failure Mortality in BIOSTAT-CHF: A Post-Hoc Analysis","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"NIHR Leicester Biomedical Research Centre; John and Lucille Van Geest Foundation; University of Tokyo; Japan Agency for Medical Research and Development; European Commission; British Heart Foundation; Japan Heart Foundation; National Institute for Health and Care Research; Compagnia di San Paolo","keywords":"Medicine; Trimethylamine N-oxide; Heart failure; Renal function; Confounding; Internal medicine; Demography; Population; Cohort; Environmental health; Biology","score_opus":0.012024099507924465,"score_gpt":0.24833716988705717,"score_spread":0.2363130703791327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966162351","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39359185,0.0004001866,0.00009339016,0.6050515,0.00006607429,0.0007242621,0.000028982091,0.000015010311,0.000028705128],"genre_scores_gemma":[0.92455983,0.000070670925,0.0090684835,0.06421518,0.0008744617,0.0000074079403,0.00020915449,0.0001105843,0.00088421494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951897,0.0016820172,0.0009953448,0.00044163066,0.001224039,0.00046721793],"domain_scores_gemma":[0.99705625,0.0005065131,0.0010068602,0.0006118965,0.00069007324,0.00012839265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032397697,0.00047053056,0.0014964332,0.0012650121,0.00007564114,0.00008073,0.00019446664,0.00027856472,0.00005937763],"category_scores_gemma":[0.00025294375,0.00029009854,0.00053957326,0.0014741432,0.00013251696,0.00019591994,0.000078077006,0.0019759547,0.000020665424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034041228,0.00017631335,0.25637972,0.0004317868,0.0034715717,0.00051186146,0.00025380767,0.000053390693,0.0009777881,0.0000039618712,0.7372668,0.00013259868],"study_design_scores_gemma":[0.0031410886,0.0024107082,0.45339718,0.00061693636,0.0040610405,0.00016256396,0.0001989887,0.000016264321,0.00015299243,0.0000030646509,0.53558004,0.00025910468],"about_ca_topic_score_codex":0.00009520894,"about_ca_topic_score_gemma":0.0003003128,"teacher_disagreement_score":0.54083633,"about_ca_system_score_codex":0.0001788557,"about_ca_system_score_gemma":0.00024436004,"threshold_uncertainty_score":0.9999551},"labels":[],"label_agreement":null},{"id":"W2968004994","doi":"10.1002/ejhf.1568","title":"Cardiac Implantable Electronic Devices with a Defibrillator Component and All-Cause Mortality in Left Ventricular Assist Device Carriers: Results from the PCHF-VAD Registry","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Tufts University School of Medicine; Servier; Universität Zürich; HeartWare; Sveučilište u Zagrebu; Alnylam Pharmaceuticals; Università degli Studi di Brescia; Pfizer; Vifor Pharma; Teva Pharmaceutical Industries; Sanofi; Bristol-Myers Squibb; AstraZeneca; Amgen","keywords":"Medicine; Interquartile range; Implantable cardioverter-defibrillator; Hazard ratio; Cardiology; Cardiac resynchronization therapy; Internal medicine; Ventricular assist device; Defibrillation; Confidence interval; Heart failure; Implant; Ejection fraction; Surgery","score_opus":0.013306541895327704,"score_gpt":0.21687777048453266,"score_spread":0.20357122858920496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968004994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948464,0.0038249313,0.000026278525,0.00044878203,0.00017519855,0.00021144278,0.00006693838,0.00003723566,0.00036280492],"genre_scores_gemma":[0.9992113,0.000046075573,0.00036195898,0.00015029318,0.00015075831,5.934684e-7,0.000020881867,0.000051333747,0.000006803864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776775,0.00044423775,0.0006590577,0.00027012677,0.0004286307,0.0004302229],"domain_scores_gemma":[0.9988189,0.0001865194,0.000237877,0.00047735724,0.000068933754,0.00021044754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012774479,0.00025336776,0.0005202554,0.000060540475,0.000059561396,0.00012666034,0.0002831958,0.000053650987,0.000028573271],"category_scores_gemma":[0.000039205264,0.00017471622,0.00011537436,0.00015119693,0.000034590226,0.000267948,0.000057526213,0.0006324975,0.000045562883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018550652,0.000026643347,0.97648805,0.00012215192,0.0018677873,0.000529645,0.00048868597,0.0037260596,0.0042720917,0.000047339865,0.012172071,0.00007397902],"study_design_scores_gemma":[0.0018907369,0.00020979282,0.5020819,0.0005441691,0.00049836235,0.0011113218,0.0010280597,0.00040821824,0.0012093921,0.000016705433,0.490519,0.00048235303],"about_ca_topic_score_codex":0.000083272935,"about_ca_topic_score_gemma":0.00028560098,"teacher_disagreement_score":0.47834694,"about_ca_system_score_codex":0.000106217914,"about_ca_system_score_gemma":0.000079670965,"threshold_uncertainty_score":0.712472},"labels":[],"label_agreement":null},{"id":"W2968085831","doi":"10.1002/ejhf.1582","title":"When is an implantable Cardioverter-Defibrillator Controversial?","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Implantable cardioverter-defibrillator; Intensive care medicine; Randomized controlled trial; Heart failure; Sudden cardiac death; Evidence-based medicine; Expert opinion; Secondary prevention; Medical emergency; Alternative medicine; Cardiology; Internal medicine; Pathology","score_opus":0.0639268207483354,"score_gpt":0.3266569498808546,"score_spread":0.2627301291325192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968085831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002375176,0.87662005,0.000028207065,0.00013767122,0.00088587706,0.00034623168,0.00012135544,0.00003250774,0.12180433],"genre_scores_gemma":[0.00042963744,0.99281704,0.0013714653,0.00048045645,0.003133223,5.917065e-7,0.000025966932,0.00014836268,0.001593267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690366,0.0006833456,0.0010909294,0.00034328102,0.0006270555,0.00035175955],"domain_scores_gemma":[0.9977398,0.00015951115,0.00078350795,0.00061401224,0.0003536766,0.00034951008],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087731966,0.00047138712,0.0051240185,0.00034065868,0.00010523935,0.000100113335,0.00007630173,0.00011967044,0.000025432948],"category_scores_gemma":[0.00009226562,0.00033710335,0.0022923206,0.00016202668,0.000052905612,0.00019499766,0.000091521346,0.0006190322,0.00091096683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056953453,0.000011735558,0.00004650485,0.002383801,0.001430415,0.000026045016,0.00021854827,9.745418e-7,0.0000041166413,0.0000028207116,0.9501155,0.045702573],"study_design_scores_gemma":[0.0010560366,0.0005715297,0.000016141155,0.0074187694,0.0032710638,0.030267715,0.0001090675,1.5808648e-7,0.0000012708981,0.0000020953196,0.9569948,0.00029137914],"about_ca_topic_score_codex":0.0000048705797,"about_ca_topic_score_gemma":3.6109753e-7,"teacher_disagreement_score":0.12021106,"about_ca_system_score_codex":0.00012410623,"about_ca_system_score_gemma":0.00038426789,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W2969953468","doi":"10.1002/ejhf.1575","title":"Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP and GDF-15, of Heart Failure Therapies (STRONG-HF): Rationale and Design for a Multicentre, Randomized, Parallel-Group Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Tolerability; Adverse effect; Internal medicine; Clinical endpoint; Randomized controlled trial; Natriuretic peptide; Renal function; Cardiology","score_opus":0.011374771366225325,"score_gpt":0.23644440156510846,"score_spread":0.22506963019888312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969953468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636238,0.007873176,0.01011479,0.013164612,0.000115341674,0.005037152,0.000027575212,0.000016747905,0.000026778847],"genre_scores_gemma":[0.91191924,0.00027748183,0.08748746,0.00009997168,0.000059261474,0.0000048543666,0.000017929771,0.00003456408,0.00009925728],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99706197,0.0011457113,0.0010190657,0.00026985537,0.00030690516,0.00019648123],"domain_scores_gemma":[0.99799407,0.00077049294,0.0004851326,0.00019906272,0.0003705106,0.00018076118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026364103,0.00023234416,0.0010269801,0.00013149586,0.00009709,0.000032138418,0.000076608405,0.000072152914,0.00009847411],"category_scores_gemma":[0.00032206535,0.00015916157,0.00017822343,0.000116565796,0.00026953654,0.00016005222,0.000043038002,0.00025427112,0.000001275824],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56070817,0.0072468678,0.1909832,0.0023529867,0.008546514,0.00005783191,0.01999086,0.016586423,0.08226322,0.00011192821,0.1067694,0.0043826196],"study_design_scores_gemma":[0.8583506,0.015945982,0.063456975,0.0016073047,0.0021371434,0.0008025923,0.011151372,0.009043233,0.0014595741,0.000045185297,0.0351964,0.00080363726],"about_ca_topic_score_codex":0.000004664019,"about_ca_topic_score_gemma":0.0000021621097,"teacher_disagreement_score":0.29764244,"about_ca_system_score_codex":0.000014536584,"about_ca_system_score_gemma":0.00006455672,"threshold_uncertainty_score":0.64904207},"labels":[],"label_agreement":null},{"id":"W2971207508","doi":"10.1002/ejhf.1592","title":"Haemoconcentration During Treatment of Acute Heart Failure with Cardiorenal Syndrome: From the CARRESS-HF Trial","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Heart failure; Library science; Medical school; Gerontology; Family medicine; Internal medicine; Medical education","score_opus":0.014791198723729033,"score_gpt":0.23767801615042053,"score_spread":0.2228868174266915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971207508","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23014644,0.00080199324,0.000047821424,0.7652839,0.0010554382,0.0023312366,0.0001729396,0.000043350723,0.000116874035],"genre_scores_gemma":[0.65973777,0.0012188675,0.08993764,0.15885308,0.06923742,0.0001651826,0.0037448544,0.0017200003,0.01538516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99524564,0.0010235353,0.001228496,0.00054916024,0.0013439694,0.0006092028],"domain_scores_gemma":[0.99729955,0.00025273373,0.0008743035,0.0010390262,0.0003425094,0.00019190014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005065293,0.0007468248,0.0019473453,0.0002694148,0.00017455113,0.0001292724,0.0003249654,0.00024595068,0.00029717016],"category_scores_gemma":[0.000032454103,0.00041532287,0.0010836496,0.00025730964,0.00017837905,0.00023067945,0.000069536574,0.0014049112,0.00018497967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005636509,0.0002024075,0.0027791925,0.00012715228,0.005409457,0.009752264,0.00043339469,0.000020903532,0.0007758116,9.832386e-7,0.9747025,0.00015944372],"study_design_scores_gemma":[0.040528204,0.006926997,0.0044269226,0.0013017706,0.004423456,0.0036377918,0.0001486108,0.0000013514691,0.00072299456,0.0000011558848,0.9375422,0.0003385581],"about_ca_topic_score_codex":0.000049551156,"about_ca_topic_score_gemma":0.000017079536,"teacher_disagreement_score":0.6064308,"about_ca_system_score_codex":0.00031739802,"about_ca_system_score_gemma":0.00041775688,"threshold_uncertainty_score":0.9998299},"labels":[],"label_agreement":null},{"id":"W2971720436","doi":"10.1002/ejhf.1616","title":"Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Abbott Vascular; Hospices Civils de Lyon","keywords":"Medicine; Percutaneous; Mitral regurgitation; Heart failure; Cardiology; Internal medicine; Functional mitral regurgitation; MitraClip; Ejection fraction","score_opus":0.01462467603724673,"score_gpt":0.31678052105095,"score_spread":0.3021558450137033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971720436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111813,0.000659227,0.0000035605942,0.006528082,0.00041646173,0.00037199009,0.00004046212,0.000032422246,0.00082968315],"genre_scores_gemma":[0.9841434,0.00005067599,0.004752286,0.0009849428,0.00038765572,0.0000017712626,0.00003545445,0.000051048155,0.0095928],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986711,0.00012392017,0.00040410936,0.00017488454,0.00042037008,0.00020562632],"domain_scores_gemma":[0.99897695,0.00014432266,0.00012807404,0.00023309483,0.00013047783,0.00038708065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025617515,0.00016104725,0.00047302243,0.00006527249,0.00005218036,0.00001750596,0.000061308885,0.00003645862,0.0022021008],"category_scores_gemma":[0.000117530486,0.00010135936,0.002136547,0.00005426604,0.000033288623,0.000066876964,0.000024325464,0.00012807647,0.00034345608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005578136,0.0007841381,0.69834524,0.00016963738,0.0050637336,0.012888178,0.00070264505,0.000012187812,0.0003445796,0.000024484503,0.26589245,0.010194614],"study_design_scores_gemma":[0.008066812,0.0043651164,0.48256668,0.00017518848,0.0007798844,0.0084222285,0.00029374333,0.000008334374,0.000022891181,0.0000039561132,0.49516696,0.00012819881],"about_ca_topic_score_codex":0.0000020522145,"about_ca_topic_score_gemma":0.0000026304792,"teacher_disagreement_score":0.22927453,"about_ca_system_score_codex":0.00017039699,"about_ca_system_score_gemma":0.00028900604,"threshold_uncertainty_score":0.99871004},"labels":[],"label_agreement":null},{"id":"W2972165764","doi":"10.1002/ejhf.1541","title":"Association of Diabetes and Kidney Function According to Age and Systolic Function with the Incidence of Sudden Cardiac Death and Non-Sudden Cardiac Death in Myocardial Infarction Survivors with Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Ejection fraction; Internal medicine; Cardiology; Hazard ratio; Sudden cardiac death; Heart failure; Myocardial infarction; Diabetes mellitus; Renal function; Cardiac function curve; Confidence interval; Endocrinology","score_opus":0.005083186953493359,"score_gpt":0.197902949527944,"score_spread":0.19281976257445063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972165764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961592,0.00043650146,0.00022583808,0.0021886986,0.00035062424,0.0005471459,0.000010419488,0.000012958223,0.000068645284],"genre_scores_gemma":[0.9988056,0.00011984805,0.0004399939,0.00022596707,0.00028380347,0.0000035314013,0.000008676033,0.00004086027,0.000071721566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771845,0.00066249876,0.0004504393,0.000274061,0.0006522811,0.00024223737],"domain_scores_gemma":[0.9986241,0.00015861158,0.00035670822,0.00024796207,0.000373915,0.0002387038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002326696,0.00023352786,0.0008485042,0.00035685897,0.0000959428,0.000058967566,0.00005140397,0.00008401445,0.0000075309845],"category_scores_gemma":[0.0001491871,0.00015068072,0.00020301239,0.00039027532,0.00006921882,0.00032744152,0.00005684927,0.0004653435,0.0000031829459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000504907,0.000017974895,0.9813719,0.00013755095,0.0006694506,0.000006136064,0.00062983664,0.00012351127,0.013363016,0.000005633861,0.0028905317,0.00027957855],"study_design_scores_gemma":[0.001633283,0.0016629379,0.96827465,0.0006230927,0.0007543037,0.00007378396,0.002654762,0.000011446729,0.00034806246,0.0000014913495,0.023802882,0.00015929934],"about_ca_topic_score_codex":0.00017925451,"about_ca_topic_score_gemma":0.000056812638,"teacher_disagreement_score":0.02091235,"about_ca_system_score_codex":0.00009090449,"about_ca_system_score_gemma":0.000116118055,"threshold_uncertainty_score":0.6144581},"labels":[],"label_agreement":null},{"id":"W2973033728","doi":"10.1002/ejhf.1270","title":"September 2019 at a Glance: Focus on Devices","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Cardiology; Inotrope; Clinical endpoint; Population; Cardiac resynchronization therapy; Regimen; Intravascular volume status; Diuretic; Underweight; Body mass index; Blood pressure; Randomized controlled trial; Overweight","score_opus":0.01032951341855695,"score_gpt":0.24677975895000964,"score_spread":0.2364502455314527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973033728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89342207,0.00059436116,0.000021671387,0.06700078,0.00048789414,0.0004686325,0.0000038045787,0.000049492257,0.037951298],"genre_scores_gemma":[0.96096253,0.000025146266,0.007912473,0.002079689,0.00055191614,8.238204e-7,0.000005962086,0.00005421379,0.028407263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847186,0.00015925338,0.00042282257,0.00019792667,0.00046450156,0.0002836162],"domain_scores_gemma":[0.9990675,0.000053450418,0.00018964849,0.00033393447,0.00011783324,0.00023767588],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00061022997,0.0002013308,0.0004224191,0.00017128604,0.000059696937,0.000028071407,0.00011321317,0.000031075513,0.002014157],"category_scores_gemma":[0.00002028487,0.00013791799,0.0002597435,0.00012986925,0.000025727424,0.00012095646,0.00006685613,0.00030573618,0.010914848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003924181,0.0001567846,0.042929843,0.00005244028,0.0001877484,0.00073318643,0.00011956671,0.000014574246,0.0025673348,0.00007624102,0.95147043,0.0012994285],"study_design_scores_gemma":[0.003030696,0.0018830823,0.041805543,0.00037016903,0.000105325795,0.00061924144,0.00007098,0.0000049763657,0.0008399718,0.000009057203,0.95113355,0.00012741891],"about_ca_topic_score_codex":0.0000018366592,"about_ca_topic_score_gemma":0.000006485077,"teacher_disagreement_score":0.067540444,"about_ca_system_score_codex":0.000097030796,"about_ca_system_score_gemma":0.00004587115,"threshold_uncertainty_score":0.99889815},"labels":[],"label_agreement":null},{"id":"W2974103247","doi":"10.1002/ejhf.1613","title":"Letter on ‘Pharmacy-Based Interdisciplinary Intervention for Patients with Chronic Heart Failure: Results of the PHARM-CHF Randomized Controlled Trial’: Reply","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Pharmacy; Pharmacist; Heart failure; Guideline; Intensive care medicine; Alternative medicine; MEDLINE; Quality of life (healthcare); Intervention (counseling); Family medicine; Nursing; Internal medicine","score_opus":0.013048931722780087,"score_gpt":0.2759022868076887,"score_spread":0.2628533550849086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974103247","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008339717,0.00017659787,0.00023716122,0.9740471,0.0020323053,0.014844493,0.00008424058,0.000038042966,0.00020033076],"genre_scores_gemma":[0.23990549,0.000025959449,0.013789788,0.7113714,0.018383315,0.00055820955,0.001057997,0.00074094266,0.014166852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99148744,0.0031466465,0.0028503172,0.00060926547,0.0013385371,0.00056781946],"domain_scores_gemma":[0.9940787,0.0012440507,0.0027503048,0.0010246746,0.00076705246,0.00013520037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004235156,0.00077877974,0.0035565128,0.000601138,0.00015794959,0.00008543608,0.0004644141,0.00014901938,0.00015752554],"category_scores_gemma":[0.00054424687,0.00040109226,0.003624418,0.00022030051,0.00023479253,0.00016476699,0.00017924736,0.0020180552,0.0000867148],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44855657,0.00044906928,0.000039359908,0.0003616815,0.0012755789,0.00008367639,0.000046150144,0.000022774562,0.00003518805,6.462327e-7,0.5490358,0.00009349382],"study_design_scores_gemma":[0.48501274,0.0058443104,0.000031358202,0.002604159,0.0016540956,0.000021323895,0.0000068284726,0.000023840486,0.0001224003,0.000001989791,0.5044942,0.00018278194],"about_ca_topic_score_codex":0.0000045643246,"about_ca_topic_score_gemma":0.000004088347,"teacher_disagreement_score":0.26267567,"about_ca_system_score_codex":0.000300208,"about_ca_system_score_gemma":0.00036019168,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W2982132861","doi":"10.1002/ejhf.1607","title":"Is Plasma Renin Activity Associated with Worse Outcomes in Acute Heart Failure? A Secondary Analysis from the BLAST-AHF Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of Alberta","funders":"Trevena","keywords":"Medicine; Heart failure; Hazard ratio; Plasma renin activity; Internal medicine; Cardiology; Confidence interval; Proportional hazards model; Renal function; Heart failure with preserved ejection fraction; Blood pressure; Ejection fraction; Renin–angiotensin system","score_opus":0.014693584261128288,"score_gpt":0.253814607700516,"score_spread":0.2391210234393877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982132861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448821,0.00012673222,0.000019084067,0.053785603,0.00035044312,0.0005745236,0.000061147526,0.000031637526,0.00016873286],"genre_scores_gemma":[0.9953589,0.000005986774,0.002324807,0.0008365222,0.00034008798,0.0000024238973,0.000011696552,0.000070984235,0.0010486266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99541336,0.0017017565,0.0010013663,0.00042958793,0.0009837438,0.00047020076],"domain_scores_gemma":[0.99697983,0.0009488916,0.0008010733,0.0006780018,0.00037485035,0.00021735855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020638227,0.00042081779,0.0019083881,0.00044592808,0.0001344949,0.000107227395,0.00029173223,0.00009959596,0.00038806847],"category_scores_gemma":[0.000493513,0.00024064253,0.00089930586,0.0010985009,0.00012482703,0.00027483542,0.00012904411,0.0013302371,0.000200239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009295527,0.0002222183,0.8571064,0.0000045998977,0.008535897,0.0005386688,0.0015842954,0.00004681431,0.0026604552,5.25686e-7,0.1198753,0.0001293334],"study_design_scores_gemma":[0.032774,0.0017043331,0.92860353,0.00044117056,0.0021558637,0.00021396358,0.00041020915,0.000047865735,0.0004768274,0.0000014068139,0.032909576,0.0002612498],"about_ca_topic_score_codex":0.00008080674,"about_ca_topic_score_gemma":0.0006831444,"teacher_disagreement_score":0.08696572,"about_ca_system_score_codex":0.00014874939,"about_ca_system_score_gemma":0.00022788218,"threshold_uncertainty_score":0.9813118},"labels":[],"label_agreement":null},{"id":"W2982380964","doi":"10.1002/ejhf.1272","title":"October 2019 at a Glance: Epidemiology, Prevention, and Modes of Death","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Internal medicine; Atrial fibrillation; Heart failure; Cardiology; Diabetes mellitus; MitraClip; Body mass index; Cardiac resynchronization therapy; Ejection fraction; Endocrinology","score_opus":0.03542085375283156,"score_gpt":0.29526303832282286,"score_spread":0.2598421845699913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982380964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95790696,0.025975717,0.000041571253,0.014234732,0.00011482176,0.0001323315,0.0000038469616,0.000008150846,0.0015818633],"genre_scores_gemma":[0.984946,0.0004586882,0.009510135,0.0015036284,0.00019008221,1.811899e-7,0.000001524714,0.000016214828,0.0033735335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881446,0.0003347678,0.00046533,0.000116797215,0.0001326771,0.00013594772],"domain_scores_gemma":[0.9991035,0.0001431445,0.00025253353,0.00016410963,0.00023853155,0.00009818442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011142836,0.000098372686,0.00064345193,0.00007183492,0.000038689956,0.0000029621017,0.00005241152,0.000029132783,0.00013260015],"category_scores_gemma":[0.00013311296,0.00006514747,0.00013656156,0.00003700415,0.000060292543,0.000065752734,0.00007812721,0.00021020598,0.000062523075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032859796,0.000081068305,0.43947664,0.00011934918,0.00041360818,0.000067424466,0.00023581945,0.000010461355,0.021764439,0.00010035212,0.5368125,0.0005897742],"study_design_scores_gemma":[0.0022464595,0.0010707754,0.40813679,0.0005201682,0.00040752196,0.0020578601,0.00013780978,0.00001270602,0.00079317065,0.000091483336,0.58443743,0.000087857356],"about_ca_topic_score_codex":0.0000025891027,"about_ca_topic_score_gemma":0.0000016000483,"teacher_disagreement_score":0.04762494,"about_ca_system_score_codex":0.000004454056,"about_ca_system_score_gemma":0.000027201917,"threshold_uncertainty_score":0.26566368},"labels":[],"label_agreement":null},{"id":"W2983837781","doi":"10.1002/ejhf.1632","title":"Concentric vs. Eccentric Remodelling in Heart Failure with Reduced Ejection Fraction: Clinical Characteristics, Pathophysiology and Response to Treatment","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Institute of Infection and Immunity","funders":"GE Healthcare; Biotronik; National Institute for Health and Care Research; Boston Scientific Corporation; Edwards Lifesciences; European Commission; Medtronic","keywords":"Ejection fraction; Heart failure; Cardiology; Medicine; Internal medicine; Concentric hypertrophy; Valsartan; Muscle hypertrophy; Left ventricular hypertrophy; Natriuretic peptide; Eccentric; Blood pressure","score_opus":0.0183710549470378,"score_gpt":0.28050265608728003,"score_spread":0.26213160114024225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983837781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511179,0.00012469298,0.00019936773,0.047413953,0.00030242166,0.00076225837,0.00000304594,0.000027531372,0.000048850183],"genre_scores_gemma":[0.97362524,0.00017884128,0.02399189,0.0011277298,0.0005167926,0.000003547695,0.000009035278,0.000048962247,0.0004979858],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969094,0.0011286187,0.0008749218,0.00041865237,0.0002954422,0.00037301186],"domain_scores_gemma":[0.9985862,0.00021071658,0.00027801908,0.00033487612,0.00019933643,0.0003908647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001426249,0.00028340163,0.000860839,0.00038620838,0.000074719865,0.000047108635,0.00006969839,0.00007591369,0.00012811352],"category_scores_gemma":[0.00013421175,0.00020320843,0.00016920807,0.0003870977,0.000051290233,0.00017557172,0.000041269966,0.0004690125,0.0002946227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037894186,0.0017867007,0.8313546,0.00013825699,0.000567705,0.0033638543,0.0011233415,0.00030147668,0.037228294,0.000020432248,0.07319663,0.013024512],"study_design_scores_gemma":[0.007061139,0.010722995,0.31962657,0.0004326891,0.00016823153,0.00066865573,0.00039752026,0.00010376187,0.00028166996,0.000003183773,0.66031885,0.00021472125],"about_ca_topic_score_codex":0.000008400133,"about_ca_topic_score_gemma":0.000004894782,"teacher_disagreement_score":0.5871222,"about_ca_system_score_codex":0.00027362953,"about_ca_system_score_gemma":0.00018033669,"threshold_uncertainty_score":0.82865995},"labels":[],"label_agreement":null},{"id":"W2987390185","doi":"10.1002/ejhf.1608","title":"Plasma Proteomic Approach in Patients with Heart Failure: Insights into Pathogenesis of Disease Progression and Potential Novel Treatment Targets","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"John and Lucille Van Geest Foundation; NIHR Leicester Biomedical Research Centre; European Commission; British Heart Foundation; National Institute for Health and Care Research","keywords":"Heart failure; Pathogenesis; Medicine; Proteome; Heart disease; Disease; Arginine; Bioinformatics; Internal medicine; Biochemistry; Amino acid; Biology","score_opus":0.006036534596005182,"score_gpt":0.20897404463257407,"score_spread":0.2029375100365689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987390185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765843,0.00042733553,0.00013878365,0.0008630384,0.00007539704,0.00080509443,0.0000063916127,0.000007673708,0.00001783175],"genre_scores_gemma":[0.95250493,0.000015387888,0.047253113,0.000029924058,0.000119386146,0.0000025592487,0.000016484322,0.000043897402,0.000014325939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984099,0.00017881882,0.0005071308,0.00025533585,0.00045394315,0.00019485572],"domain_scores_gemma":[0.9990563,0.00001085372,0.00024331534,0.00021604072,0.00019854802,0.00027498964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619959,0.00021728393,0.0005562823,0.00021931375,0.000052140815,0.000024757623,0.00005755468,0.000039894723,0.000007451576],"category_scores_gemma":[0.000014405758,0.00012901115,0.00018423122,0.00013620287,0.000055537243,0.00015193044,0.000047879083,0.00020462462,0.0000050135263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049922466,0.0017687368,0.76692504,0.00040907346,0.0001557751,0.00005100984,0.0008269474,0.0016042588,0.22125119,0.0000043279947,0.00054541026,0.001465971],"study_design_scores_gemma":[0.011953512,0.004298671,0.9761007,0.0011494837,0.00016828015,0.000103736704,0.0001451982,0.00052622944,0.0019807862,0.0000016511808,0.0033743868,0.00019739597],"about_ca_topic_score_codex":0.000002714488,"about_ca_topic_score_gemma":6.401396e-7,"teacher_disagreement_score":0.21927041,"about_ca_system_score_codex":0.00006242077,"about_ca_system_score_gemma":0.0001252819,"threshold_uncertainty_score":0.52609223},"labels":[],"label_agreement":null},{"id":"W2990208812","doi":"10.1002/ejhf.1655","title":"Heart Failure Treatment and the Art of Medical Decision Making","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Institutes of Health; Heart and Stroke Foundation of Canada; Sanofi; AstraZeneca; CSL Limited; Servier; Alberta Health Services; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Heart failure; Intensive care medicine; Clinical decision making; Medical decision making; MEDLINE; Cardiology; Medical emergency","score_opus":0.04141410526786353,"score_gpt":0.3429146165448744,"score_spread":0.30150051127701083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990208812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007824863,0.9522148,0.00018415246,0.04515978,0.00040125972,0.0014790738,0.000009962554,0.00002295154,0.0004497784],"genre_scores_gemma":[0.0005021733,0.97419006,0.022732435,0.0005044894,0.0009177889,0.00000881109,0.000018579918,0.00013567261,0.0009899663],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99468267,0.0013570498,0.001817466,0.00040116854,0.001338782,0.00040286232],"domain_scores_gemma":[0.99699646,0.0008533145,0.00085969723,0.0007383687,0.0001838619,0.00036830254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003479344,0.00063260505,0.0035559372,0.00045997722,0.00010972118,0.000081693484,0.00036833284,0.00020432488,0.00061603385],"category_scores_gemma":[0.00033670574,0.00030754425,0.0015437441,0.00031051988,0.00027300388,0.00010993057,0.00024228486,0.00092857087,0.00048625018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027610915,0.00024224633,0.00007509811,0.0036045015,0.0012737397,0.00059947686,0.00016098589,0.0000010426985,0.0000011745954,0.0001589329,0.536354,0.45725265],"study_design_scores_gemma":[0.004860977,0.0013397408,0.00003310693,0.033382945,0.0033069833,0.004953898,0.000099774625,0.0000042170077,0.0000010627673,0.00000850109,0.9518013,0.00020750781],"about_ca_topic_score_codex":0.0000029891335,"about_ca_topic_score_gemma":0.000008740108,"teacher_disagreement_score":0.45704517,"about_ca_system_score_codex":0.00014599384,"about_ca_system_score_gemma":0.00054940605,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2990536224","doi":"10.1002/ejhf.1654","title":"Cardiovascular and Non-Cardiovascular Death Distinction: The Utility of Troponin Beyond N-Terminal Pro-B-Type Natriuretic Peptide. Findings from the BIOSTAT-CHF Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Institute of Infection and Immunity","funders":"Agence Nationale de la Recherche; European Commission","keywords":"Medicine; Natriuretic peptide; Heart failure; Internal medicine; Cardiology; Population; Troponin; Sudden cardiac death; Myocardial infarction","score_opus":0.01516172152901533,"score_gpt":0.23499082733171356,"score_spread":0.21982910580269824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990536224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986986,0.0038881088,0.00014310364,0.0068555027,0.00032770704,0.0013648958,0.0000073734423,0.000015106074,0.00041222575],"genre_scores_gemma":[0.9973563,0.00009192936,0.0017286615,0.00013945678,0.00038945136,0.0000029498212,0.0000063254756,0.00003997742,0.00024498074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968456,0.0009357729,0.00063911657,0.00034209958,0.00095994875,0.00027744615],"domain_scores_gemma":[0.9982967,0.00015518152,0.00017353968,0.0009272543,0.00029441685,0.00015295263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031765369,0.0002826692,0.0008349442,0.000094724084,0.00019596561,0.00006749824,0.00024450684,0.00003805758,0.00019867445],"category_scores_gemma":[0.00013066188,0.00014851555,0.0008557996,0.00026535685,0.00014900783,0.0001334554,0.0001571367,0.00054092973,0.0000728295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014219484,0.0008860555,0.8814822,0.00023322778,0.0133917425,0.0027112954,0.005153199,0.000053422304,0.0008337634,0.000020399048,0.086949274,0.006863519],"study_design_scores_gemma":[0.0040960293,0.0022017702,0.65325326,0.00020113742,0.0028643706,0.0007829815,0.0028157334,0.00003680082,0.00013750022,0.00001073567,0.33344877,0.00015093038],"about_ca_topic_score_codex":0.00006854527,"about_ca_topic_score_gemma":0.000007997108,"teacher_disagreement_score":0.24649948,"about_ca_system_score_codex":0.000038290837,"about_ca_system_score_gemma":0.00009330458,"threshold_uncertainty_score":0.60562885},"labels":[],"label_agreement":null},{"id":"W2990609349","doi":"10.1002/ejhf.1691","title":"Cardiac Remodelling Patterns and Proteomics: The Keys to Move Beyond Ejection Fraction in Heart Failure?","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Ejection fraction; Heart failure; Cardiology; Medicine; Internal medicine; Heart failure with preserved ejection fraction; Valsartan; Stroke volume; Ventricular remodeling; Hypertensive heart disease; Disease; Blood pressure","score_opus":0.010578933648513918,"score_gpt":0.22327864350268475,"score_spread":0.21269970985417083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990609349","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13322252,0.00060264545,0.0048854654,0.8571592,0.0024717683,0.0014013208,0.000026004696,0.000037044563,0.00019400596],"genre_scores_gemma":[0.21901841,0.0013289027,0.023844209,0.7005026,0.048834387,0.000025627385,0.00022248174,0.00086737116,0.005356003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966296,0.0011031524,0.0007436404,0.00040441562,0.0007615315,0.00035766742],"domain_scores_gemma":[0.9986048,0.00011347272,0.00032575603,0.00053239637,0.00027856426,0.00014506424],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018739058,0.00037443297,0.0009505112,0.0005535818,0.00011922387,0.00013025622,0.00012835061,0.00026839986,0.00006518981],"category_scores_gemma":[0.000115749666,0.000256184,0.0007885091,0.00023776703,0.00005007622,0.00018575603,0.00006517716,0.004014543,0.0001740135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001278514,0.000018422845,0.030964399,0.00014033781,0.00028908873,0.00025177485,0.00023478213,0.00033261065,0.0014345322,5.2037007e-7,0.9657541,0.00045161665],"study_design_scores_gemma":[0.0009003855,0.00033796128,0.026454411,0.0007142327,0.00026049252,0.0013430177,0.00041599054,0.000027221122,0.00027912005,0.000003859145,0.9690127,0.0002506272],"about_ca_topic_score_codex":0.000055556848,"about_ca_topic_score_gemma":0.000007660329,"teacher_disagreement_score":0.15665662,"about_ca_system_score_codex":0.00021175494,"about_ca_system_score_gemma":0.00012096657,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W2991338253","doi":"10.1002/ejhf.1595","title":"Exercise Oscillatory Ventilation and Prognosis in Heart Failure Patients with Reduced and Mid-Range Ejection Fraction","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Heart failure; Internal medicine; Cardiology; Mechanical ventilation","score_opus":0.005696800638557064,"score_gpt":0.20808530062147204,"score_spread":0.20238849998291497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991338253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979143,0.00053769397,0.00000918108,0.0009951323,0.00013686901,0.0003550086,0.000001347315,0.0000114771165,0.0000389969],"genre_scores_gemma":[0.99811476,0.00006427075,0.0015740568,0.00005765436,0.00013575671,0.0000014955857,0.0000071934555,0.000027479886,0.000017312637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896145,0.00017619229,0.00027743969,0.00019209202,0.00024823323,0.00014459243],"domain_scores_gemma":[0.9994533,0.000016259262,0.00012594863,0.00012667164,0.00016474439,0.00011306164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004336821,0.0001281083,0.00042213328,0.00021629847,0.000046584457,0.000024145678,0.00002482274,0.000045617617,0.000024328101],"category_scores_gemma":[0.000022211705,0.00010055401,0.00010664672,0.00014822376,0.000037948845,0.00025816998,0.000021062764,0.00031454675,0.000019714433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003589391,0.00018895675,0.95706207,0.00020677446,0.000107189524,0.000041652613,0.00034859238,0.000048551527,0.028222656,0.0000010649679,0.007009398,0.0031737278],"study_design_scores_gemma":[0.003291547,0.0008749115,0.97849375,0.00069045136,0.00012641697,0.00027574992,0.000212664,0.0000089824525,0.0019751573,0.0000033434467,0.013938666,0.00010836693],"about_ca_topic_score_codex":0.0000057027505,"about_ca_topic_score_gemma":0.0000033289405,"teacher_disagreement_score":0.0262475,"about_ca_system_score_codex":0.000039882612,"about_ca_system_score_gemma":0.000028204639,"threshold_uncertainty_score":0.41004735},"labels":[],"label_agreement":null},{"id":"W2991390341","doi":"10.1002/ejhf.1274","title":"November 2019 at a Glance. Chronic and Acute Heart Failure: From Epidemiology to Treatment","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Valsartan; Ejection fraction; Internal medicine; Population; Epidemiology; Hazard ratio; Cardiology; Sacubitril, Valsartan; Intensive care medicine; Blood pressure; Confidence interval; Environmental health","score_opus":0.0170562032140364,"score_gpt":0.27609529708260916,"score_spread":0.25903909386857277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991390341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76827323,0.0019854277,0.00014056318,0.22782284,0.0004946838,0.00079118315,0.000031629617,0.000047523004,0.00041293446],"genre_scores_gemma":[0.8585664,0.00044366537,0.11583362,0.008016995,0.0020940518,0.000011802764,0.00008675787,0.00016221791,0.014784462],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732393,0.00051199907,0.00079813285,0.00048473885,0.0002953397,0.0005858672],"domain_scores_gemma":[0.9981488,0.0002853634,0.00023741022,0.0005650143,0.000117016956,0.00064638193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008218245,0.00040109816,0.001153984,0.0002289071,0.000099027624,0.00003043703,0.0001321564,0.000075721,0.001466123],"category_scores_gemma":[0.00007970438,0.00028095758,0.00034418798,0.00016987036,0.00006669905,0.00016124468,0.00016736056,0.00031601594,0.0036752536],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062282686,0.00020058877,0.09695151,0.000032578497,0.0009309502,0.0005090264,0.00030001064,0.000037711758,0.020727685,0.000040458606,0.87772685,0.0019198151],"study_design_scores_gemma":[0.005195327,0.005027449,0.071384765,0.00025146268,0.0003717634,0.000978495,0.00006290023,0.00001777122,0.0007220384,0.000011001434,0.9157542,0.00022279932],"about_ca_topic_score_codex":0.00005114271,"about_ca_topic_score_gemma":0.0001016725,"teacher_disagreement_score":0.21980584,"about_ca_system_score_codex":0.0004449548,"about_ca_system_score_gemma":0.0001238866,"threshold_uncertainty_score":0.99996424},"labels":[],"label_agreement":null},{"id":"W2994130923","doi":"10.1002/ejhf.1674","title":"The Role of Cathepsin D in the Pathophysiology of Heart Failure and its Potentially Beneficial Properties: A Translational Approach","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Commission; National Institute for Health and Care Research","keywords":"Medicine; Heart failure; Cathepsin; Cathepsin D; Cathepsin S; Cathepsin B; Internal medicine; Hazard ratio; Endocrinology; Cathepsin K; Cathepsin L; Autophagy; Confidence interval; Apoptosis; Biology; Biochemistry; Enzyme; Osteoclast","score_opus":0.00586983924847337,"score_gpt":0.18780234334993784,"score_spread":0.18193250410146447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994130923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383837,0.0035839695,0.00006836517,0.0021157905,0.000053702282,0.00023036954,0.00001062578,0.0000011732928,0.00009763308],"genre_scores_gemma":[0.9978451,0.000048602833,0.0017401446,0.0001251197,0.00020231654,0.0000016289235,0.000005415576,0.000014827144,0.000016842852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862957,0.00050167256,0.00039116264,0.00013605467,0.00019407526,0.00014749254],"domain_scores_gemma":[0.99945635,0.000015907926,0.00018683326,0.0001716486,0.00013510452,0.00003414955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008497524,0.000110203415,0.0001938708,0.000040056264,0.00005906705,0.000014381879,0.0002339152,0.000053635024,0.000006108147],"category_scores_gemma":[0.000036389418,0.00006229519,0.00012843503,0.00006600388,0.0000600471,0.000011080554,0.00004491308,0.00019900991,0.000002511611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019655174,0.00006855852,0.00025246377,0.00002352082,0.000024418427,0.0000017399841,0.0002972314,0.000117250864,0.9979271,0.00019546109,0.00058616034,0.0003095326],"study_design_scores_gemma":[0.0017658304,0.0025653248,0.002728949,0.00015719385,0.00004310061,0.00033921844,0.0021414713,0.00021358478,0.86526126,0.00054260687,0.12400216,0.00023930347],"about_ca_topic_score_codex":0.0000027570234,"about_ca_topic_score_gemma":0.0000044448984,"teacher_disagreement_score":0.13266586,"about_ca_system_score_codex":0.0000023679966,"about_ca_system_score_gemma":0.00008630155,"threshold_uncertainty_score":0.25403243},"labels":[],"label_agreement":null},{"id":"W2995061256","doi":"10.1002/ejhf.1663","title":"Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients with Atrial Fibrillation: Data from the EMPA-REG OUTCOME Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"Boehringer Ingelheim; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Internal medicine; Hazard ratio; Atrial fibrillation; Heart failure; Cardiology; Confidence interval; Diabetes mellitus; Clinical endpoint; Adverse effect; Randomized controlled trial; Type 2 diabetes; Endocrinology","score_opus":0.025114661905414865,"score_gpt":0.2705442719564672,"score_spread":0.24542961005105232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995061256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494214,0.00008117702,0.0000027615247,0.013755177,0.00024280434,0.00084451045,0.000039651542,0.000009205468,0.00008256908],"genre_scores_gemma":[0.99657595,0.000004121333,0.002209394,0.0003158741,0.00059857045,2.0850382e-7,0.0000800319,0.00003177713,0.000184058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979191,0.00035814382,0.00069211243,0.00025511472,0.00058187573,0.00019365312],"domain_scores_gemma":[0.9984655,0.00034532676,0.00034255564,0.0006514191,0.00008525221,0.00010998661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007798239,0.00020983636,0.0006636454,0.0001364313,0.000041723233,0.000044011438,0.00022429334,0.000031645563,0.00012540935],"category_scores_gemma":[0.000190396,0.00011251125,0.00017028609,0.00013912702,0.000054247692,0.00020752894,0.00014468785,0.00028686065,0.000063670064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016137363,0.00015264974,0.9613866,0.000013838714,0.00034487853,0.000022693564,0.00011425148,0.000061369596,0.000022485408,0.0000070578685,0.02126857,0.00046823145],"study_design_scores_gemma":[0.07994057,0.0044218944,0.8228875,0.000290295,0.00026825062,0.0000038255116,0.00007941633,0.000009178669,0.000012360247,0.0000023058328,0.09198154,0.00010286803],"about_ca_topic_score_codex":0.000008003161,"about_ca_topic_score_gemma":0.000014600424,"teacher_disagreement_score":0.13849911,"about_ca_system_score_codex":0.000029997118,"about_ca_system_score_gemma":0.000046636804,"threshold_uncertainty_score":0.45880753},"labels":[],"label_agreement":null},{"id":"W2995323635","doi":"10.1002/ejhf.1664","title":"Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Relypsa; Respicardia; Abbott Vascular; Servier; National Institute of General Medical Sciences; Novo Nordisk; Amgen; Singulex; Boston Scientific Corporation; Cytokinetics; Alere; MyoKardia; Bayer; Abbott Diagnostics; Bristol-Myers Squibb; AstraZeneca; Celladon Corporation; National Heart, Lung, and Blood Institute; Vifor Pharma; Pfizer","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Baseline (sea); Fraction (chemistry)","score_opus":0.009589552389736217,"score_gpt":0.2531789376323499,"score_spread":0.24358938524261367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995323635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97521675,0.000051501247,0.00004347252,0.021828415,0.0005235277,0.001784905,0.0000028806703,0.000025543077,0.000523012],"genre_scores_gemma":[0.99297523,0.0000034131544,0.005699782,0.00026207266,0.0005526375,0.000004886016,0.000003923011,0.000041509815,0.00045653252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696505,0.00092041685,0.00063593354,0.00030147732,0.00087868,0.00029841895],"domain_scores_gemma":[0.99857455,0.00007190788,0.00039458656,0.0004928556,0.0003130171,0.00015308437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013174857,0.00029549966,0.00068486517,0.00019551694,0.000084475745,0.000045498888,0.0001577582,0.00004849843,0.00015661806],"category_scores_gemma":[0.000092055656,0.00015966961,0.00019097773,0.000774732,0.000057068297,0.00026019357,0.00005278131,0.00060215744,0.0000479676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063579746,0.0032239899,0.75978744,0.00013616668,0.00080074766,0.0005029192,0.00069225853,0.0003358495,0.007131528,0.000033294506,0.16341239,0.00036365437],"study_design_scores_gemma":[0.083822876,0.017151982,0.6324825,0.00089547166,0.0005892547,0.0009675879,0.00413283,0.0000071711984,0.0013405754,0.0000039008755,0.2583017,0.00030410307],"about_ca_topic_score_codex":0.000046783945,"about_ca_topic_score_gemma":0.00036108232,"teacher_disagreement_score":0.12730491,"about_ca_system_score_codex":0.00019459269,"about_ca_system_score_gemma":0.00025966557,"threshold_uncertainty_score":0.65111375},"labels":[],"label_agreement":null},{"id":"W2995624755","doi":"10.1002/ejhf.1682","title":"Relationship Between Heart Rate and Outcomes in Patients in Sinus Rhythm or Atrial Fibrillation with Heart Failure and Reduced Ejection Fraction","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Heart failure; Sinus rhythm; Cardiology; Atrial fibrillation; Internal medicine; Ejection fraction; Heart rate; Blood pressure","score_opus":0.018543675863018593,"score_gpt":0.26937961448331377,"score_spread":0.2508359386202952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995624755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053216,0.00012919068,0.000024539415,0.008601814,0.00013312901,0.0005287859,0.0000029648397,0.000014342245,0.000033087275],"genre_scores_gemma":[0.996797,0.000016411333,0.0023939987,0.000182538,0.00048890867,4.4076543e-7,0.0000127589965,0.0000371706,0.00007076977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747705,0.0009995213,0.00065572,0.0002519641,0.00037126068,0.0002444881],"domain_scores_gemma":[0.9990447,0.00022440031,0.00018794923,0.00019014544,0.00015615305,0.00019662458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018824197,0.00018272625,0.0006628865,0.00038809588,0.00008171342,0.000049209233,0.000023530125,0.000089243396,0.000018399889],"category_scores_gemma":[0.00028504574,0.00013395812,0.00013388452,0.00034323882,0.00003305779,0.0004432603,0.000016556343,0.0006447044,0.000031188163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000706319,0.000017200477,0.99758786,0.00006948198,0.000034838577,0.000037279817,0.00012402028,0.000085872045,0.00019844515,0.000001377717,0.0008144317,0.00032289088],"study_design_scores_gemma":[0.006108681,0.0016634198,0.96596104,0.0003505682,0.00006493278,0.00066797435,0.0002461012,0.000013948972,0.00004145299,0.0000054300526,0.024743253,0.00013317438],"about_ca_topic_score_codex":0.00003539945,"about_ca_topic_score_gemma":0.00004757369,"teacher_disagreement_score":0.03162678,"about_ca_system_score_codex":0.000110951965,"about_ca_system_score_gemma":0.00016398203,"threshold_uncertainty_score":0.54626536},"labels":[],"label_agreement":null},{"id":"W2996113382","doi":"10.1002/ejhf.1648","title":"Association between Body Surface Area and Prescribed Doses of Guideline-Directed Medications Among International Patients with Heart Failure and Reduced Ejection Fraction","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute; National Medical Research Council; Bayer","keywords":"Medicine; Carvedilol; Ejection fraction; Body surface area; Heart failure; Lisinopril; Guideline; Internal medicine; Dose; Cardiology; ACE inhibitor; Angiotensin-converting enzyme; Blood pressure","score_opus":0.010455513644123775,"score_gpt":0.24181353252124263,"score_spread":0.23135801887711885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996113382","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41122878,0.00008564934,0.00015093607,0.5871327,0.00034871642,0.00077411503,0.00006447154,0.00005633977,0.0001583296],"genre_scores_gemma":[0.88012266,0.00021637001,0.076292,0.02879981,0.0058697676,0.000011368254,0.003150639,0.0003149522,0.0052224374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966971,0.0005143075,0.0010528568,0.00036396924,0.0011051752,0.00026653803],"domain_scores_gemma":[0.9968887,0.0002378846,0.0012555043,0.0002849093,0.0011919704,0.00014106334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093777414,0.00035271965,0.0008009889,0.00042093848,0.000100131074,0.00008010486,0.000114613336,0.00024845309,0.00012461109],"category_scores_gemma":[0.0003072214,0.00027441062,0.00014994103,0.0002007553,0.00007809494,0.00039643853,0.000068680645,0.0012282799,0.000013477009],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007109574,0.000060093564,0.35169947,0.00007297517,0.000834654,0.00001917695,0.000046969908,0.000003912862,0.00034527908,1.7939135e-7,0.6467832,0.000063005464],"study_design_scores_gemma":[0.0024640025,0.00071106193,0.29630566,0.0006953543,0.0010715994,0.00003565657,0.000079547215,0.000025918916,0.00011798352,0.0000017654389,0.6983182,0.00017329253],"about_ca_topic_score_codex":0.000033177057,"about_ca_topic_score_gemma":0.000009972654,"teacher_disagreement_score":0.55833286,"about_ca_system_score_codex":0.00022835954,"about_ca_system_score_gemma":0.000121998644,"threshold_uncertainty_score":0.9999708},"labels":[],"label_agreement":null},{"id":"W2996188219","doi":"10.1002/ejhf.1678","title":"Imaging in Patients with Suspected Acute Heart Failure: Timeline Approach Position Statement on Behalf of the Heart Failure Association of the European Society of Cardiology","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Management of heart failure; Intensive care medicine; Internal medicine; Cardiac imaging","score_opus":0.008224623096857961,"score_gpt":0.24747043423739176,"score_spread":0.2392458111405338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996188219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957921,0.00002227221,0.00019155486,0.040502068,0.000120597804,0.00078361755,0.00007663411,0.000011550644,0.00037070268],"genre_scores_gemma":[0.98551774,0.000005175933,0.01358748,0.00053892855,0.00016552543,0.0000018962827,0.0000436839,0.00005113962,0.00008844075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99577737,0.0015597583,0.0012946281,0.0002641279,0.0008381604,0.00026593247],"domain_scores_gemma":[0.9969754,0.0002981063,0.001216568,0.00060252525,0.000818521,0.000088841065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024408936,0.00021441307,0.0006776364,0.000091015085,0.00007652132,0.000014255779,0.00031703498,0.00005730706,0.000039606788],"category_scores_gemma":[0.00020316169,0.00012572219,0.00046166306,0.00047781604,0.00016653394,0.00012128229,0.00011401564,0.00088353414,0.00001814639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002276332,0.00046211388,0.8678846,0.000060234197,0.00026859954,0.0000010033273,0.00029604838,0.00054142054,0.037454613,0.00001986767,0.09274575,0.000038109967],"study_design_scores_gemma":[0.004019002,0.0010217323,0.9650994,0.0004382173,0.00025213842,0.000049514336,0.00032472255,0.000030621894,0.0022240176,0.000012642689,0.0264055,0.00012248711],"about_ca_topic_score_codex":0.0000075469407,"about_ca_topic_score_gemma":0.000004263904,"teacher_disagreement_score":0.0972148,"about_ca_system_score_codex":0.00019336453,"about_ca_system_score_gemma":0.00014433607,"threshold_uncertainty_score":0.5126802},"labels":[],"label_agreement":null},{"id":"W2996236701","doi":"10.1002/ejhf.1670","title":"Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( <i>de novo</i> ) Heart Failure: A Subgroup Analysis of the TRANSITION Study","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"National Institute for Health and Care Research; Novartis","keywords":"Sacubitril, Valsartan; Sacubitril; Medicine; Valsartan; Tolerability; Heart failure; Internal medicine; Ejection fraction; Acute decompensated heart failure; Cardiology; Adverse effect; Blood pressure","score_opus":0.007615374951186558,"score_gpt":0.23189766146165264,"score_spread":0.22428228651046608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996236701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414177,0.000041192074,0.00042723297,0.012630182,0.000100307996,0.0025770008,0.00005303456,0.000018539053,0.000010747726],"genre_scores_gemma":[0.9873789,0.000002782548,0.011736698,0.00059777003,0.00008191626,0.000023776971,0.00009670376,0.00006213997,0.000019321913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963765,0.00076173845,0.0012591071,0.00036413068,0.0008543459,0.00038414611],"domain_scores_gemma":[0.9979088,0.00016348905,0.00056071894,0.000513048,0.000685758,0.00016821089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014422447,0.0003515391,0.00131534,0.00075104384,0.000071117895,0.000046267123,0.00017715208,0.00007968244,0.00012379368],"category_scores_gemma":[0.00008489499,0.00024281717,0.00056388264,0.0013636727,0.000071648006,0.00043057385,0.00003865918,0.00035121577,0.000009043589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021583794,0.0018020304,0.980455,0.00012491428,0.001225871,0.000033989792,0.0027176568,0.00084246,0.0031659515,0.000007819378,0.0073848963,0.00008107541],"study_design_scores_gemma":[0.012414756,0.0052275565,0.9690255,0.00044980666,0.002705077,0.000018677903,0.0015616656,0.00010966083,0.0008999326,0.000003955475,0.0073507894,0.00023262955],"about_ca_topic_score_codex":0.000034351866,"about_ca_topic_score_gemma":0.00047700555,"teacher_disagreement_score":0.012032412,"about_ca_system_score_codex":0.00015014429,"about_ca_system_score_gemma":0.00015146837,"threshold_uncertainty_score":0.99017966},"labels":[],"label_agreement":null},{"id":"W2996500186","doi":"10.1002/ejhf.1673","title":"European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-Lowering Drugs in Patients with Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Pfizer; Servier; Boston Scientific Corporation; Sanofi; AstraZeneca","keywords":"Dapagliflozin; Empagliflozin; Medicine; Heart failure; Saxagliptin; Canagliflozin; Ejection fraction; Internal medicine; Cardiology; Liraglutide; Type 2 diabetes; Benzhydryl compounds; Diabetes mellitus; Intensive care medicine; Sitagliptin; Endocrinology","score_opus":0.0038454431696052565,"score_gpt":0.186350849677464,"score_spread":0.18250540650785874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996500186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758358,0.0001406578,0.000015664897,0.022238996,0.00007638377,0.00049896195,0.000008877704,0.000013201588,0.0011714764],"genre_scores_gemma":[0.9959434,0.00002493872,0.0027239507,0.0007919426,0.00016605564,6.954544e-7,0.000018906756,0.000046585807,0.00028349928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796206,0.00046917357,0.0005635548,0.000217707,0.0005194985,0.00026798926],"domain_scores_gemma":[0.9988858,0.00009877402,0.00040826696,0.0002803491,0.0002089279,0.00011784908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012929422,0.00022145969,0.00057519536,0.00011476381,0.00006072563,0.000026297394,0.00011216259,0.00004938205,0.00006273672],"category_scores_gemma":[0.000039657083,0.00014452304,0.00024398141,0.00019041295,0.000054344055,0.0002177363,0.0000747176,0.00042280758,0.000037597725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053975574,0.00016945552,0.90164906,0.00008101103,0.00047535868,0.000005736559,0.0008372921,0.00015116489,0.00965548,0.000042464115,0.08571533,0.0006779133],"study_design_scores_gemma":[0.0049472116,0.0020553072,0.78220564,0.0007477004,0.00017647212,0.000010580305,0.00090936804,0.000004517989,0.0010652151,0.000009375139,0.20773645,0.00013218843],"about_ca_topic_score_codex":0.0000051194843,"about_ca_topic_score_gemma":0.0000030807062,"teacher_disagreement_score":0.12202111,"about_ca_system_score_codex":0.000121805155,"about_ca_system_score_gemma":0.00004826279,"threshold_uncertainty_score":0.58934784},"labels":[],"label_agreement":null},{"id":"W2998046891","doi":"10.1002/ejhf.1276","title":"December 2019 at a Glance: Economic Burden, Co-Morbidities, and Prognosis","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Natriuretic peptide; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.009114739437588577,"score_gpt":0.2472773558951057,"score_spread":0.2381626164575171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998046891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97659075,0.010739408,0.000012130589,0.0040554893,0.000540326,0.0003024569,0.000010941143,0.000025050058,0.007723426],"genre_scores_gemma":[0.98803985,0.0006520011,0.004729451,0.00029079345,0.001207545,0.0000010804921,0.000009156695,0.0000768788,0.0049932613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985669,0.00023293986,0.00044917714,0.00021643925,0.0002939576,0.0002405408],"domain_scores_gemma":[0.99908954,0.000048624912,0.0001796768,0.00037137722,0.00009608937,0.000214667],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00077789335,0.00017631335,0.00053983094,0.000118814154,0.000050702456,0.000042645563,0.000121487574,0.000040707015,0.0009757916],"category_scores_gemma":[0.00004124263,0.00014765222,0.0003181792,0.000048647395,0.00007994568,0.00015782434,0.00010202647,0.00035503283,0.001508861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031791104,0.000042140004,0.12782744,0.00020449185,0.00061050453,0.0015979471,0.0007383925,0.000064054315,0.004620903,0.000029454763,0.86101925,0.0029275124],"study_design_scores_gemma":[0.0029031532,0.00049584365,0.030970875,0.00068626826,0.00016131031,0.017755827,0.00013733885,0.000012971156,0.001200728,0.0000052375103,0.94550574,0.00016473673],"about_ca_topic_score_codex":0.0000032243906,"about_ca_topic_score_gemma":0.0000028215447,"teacher_disagreement_score":0.09685656,"about_ca_system_score_codex":0.00011905301,"about_ca_system_score_gemma":0.00008664098,"threshold_uncertainty_score":0.9999375},"labels":[],"label_agreement":null},{"id":"W2998077612","doi":"10.1002/ejhf.1692","title":"Effects of Serelaxin in Patients Admitted for Acute Heart Failure: A Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Nesiritide; Hazard ratio; Randomized controlled trial; Acute decompensated heart failure; Confidence interval; Clinical endpoint; Tolvaptan; Adverse effect; Internal medicine; Cardiology; Natriuretic peptide","score_opus":0.045385092011359277,"score_gpt":0.3268216714816127,"score_spread":0.2814365794702534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998077612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044189137,0.9873972,0.00018081955,0.0064529413,0.00035814333,0.004996699,0.00009837406,0.000032281478,0.00004162985],"genre_scores_gemma":[0.0032005385,0.85665584,0.13139245,0.0012170533,0.00092773593,0.00021342373,0.00078690035,0.00081440347,0.004791637],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.994011,0.0015011288,0.0024738116,0.0005780092,0.000858798,0.0005772753],"domain_scores_gemma":[0.996256,0.00062876364,0.0014772702,0.0007756856,0.0004919343,0.00037036193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017355976,0.0008376034,0.008996715,0.0018999325,0.000052084135,0.00004758304,0.00037269006,0.00020284312,0.00022410692],"category_scores_gemma":[0.00027019306,0.0005496241,0.008385163,0.0014102935,0.00005578134,0.0001852896,0.00014219967,0.00088843465,0.0001902315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050876674,0.0021049995,0.0012556005,0.0335569,0.5550175,0.00068560225,0.0002058825,0.000011951184,0.000019489076,0.000026569563,0.387877,0.018729787],"study_design_scores_gemma":[0.0026205464,0.001686949,0.00053878006,0.0017583126,0.35691604,0.00005029573,0.000008523161,0.00000104704,0.000008412699,9.244867e-7,0.6361703,0.00023983677],"about_ca_topic_score_codex":0.0000049578694,"about_ca_topic_score_gemma":0.0000075570797,"teacher_disagreement_score":0.24829336,"about_ca_system_score_codex":0.00016982648,"about_ca_system_score_gemma":0.00030884836,"threshold_uncertainty_score":0.99969554},"labels":[],"label_agreement":null},{"id":"W2998998206","doi":"10.1002/ejhf.1708","title":"Use of Sodium–Glucose Co-Transporter-2 Inhibitors in Patients with and without Type 2 Diabetes: Implications for Incident and Prevalent Heart Failure","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of General Medical Sciences; AstraZeneca","keywords":"Medicine; Heart failure; Ejection fraction; Type 2 diabetes; Internal medicine; Cardiology; Diabetes mellitus; Heart failure with preserved ejection fraction; Endocrinology","score_opus":0.028997952413673055,"score_gpt":0.2814480441105888,"score_spread":0.2524500916969158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998998206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13451722,0.8571138,0.00002250795,0.0039429665,0.00011773559,0.004076418,0.00016718394,0.000025976875,0.000016219034],"genre_scores_gemma":[0.05377991,0.9241991,0.020188892,0.00050310005,0.00039108467,0.00005284313,0.0004348205,0.00030808145,0.00014218429],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997991,0.00020593066,0.00096313126,0.0003197537,0.00026468295,0.00025549697],"domain_scores_gemma":[0.99852633,0.00007909091,0.0006188855,0.00026569323,0.00023376392,0.00027621118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037693357,0.00038268554,0.0016001686,0.00032187413,0.000045503555,0.000051182447,0.000097639095,0.00006382454,0.000008567423],"category_scores_gemma":[0.00005892641,0.0002621405,0.00023447962,0.0002249523,0.000112961876,0.00019427235,0.000051585714,0.00034519949,0.000004165801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038266738,0.00083307544,0.75517225,0.02011901,0.0015261013,0.00003203753,0.00032183097,0.0000011472825,0.000027894994,0.000020753381,0.041757286,0.17980593],"study_design_scores_gemma":[0.0024023275,0.0028749409,0.07232366,0.011818355,0.0019226781,0.000019720686,0.000019238236,3.9198835e-7,0.000009065639,0.0000015886844,0.9084106,0.00019745356],"about_ca_topic_score_codex":8.57708e-7,"about_ca_topic_score_gemma":0.000004368729,"teacher_disagreement_score":0.8666533,"about_ca_system_score_codex":0.00006717757,"about_ca_system_score_gemma":0.00013046566,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W2999063445","doi":"10.1002/ejhf.1735","title":"Genetic Risk and Atrial Fibrillation in Patients with Heart Failure","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Hartstichting; European Commission; British Heart Foundation; National Institute for Health and Care Research","keywords":"Medicine; Atrial fibrillation; Heart failure; Cardiology; Internal medicine","score_opus":0.007088513921748689,"score_gpt":0.19682524994912945,"score_spread":0.18973673602738075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999063445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991158,0.00038189156,0.00032395226,0.007809322,0.00011133094,0.00018085264,0.0000041914745,0.000013838918,0.00001660765],"genre_scores_gemma":[0.99186134,0.000050708757,0.0066391598,0.00026216372,0.0011422043,5.2638313e-8,0.0000037778045,0.00003003726,0.000010567883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986418,0.0003480985,0.0003570082,0.00015391386,0.00036616594,0.0001330055],"domain_scores_gemma":[0.99932426,0.000025168703,0.0001401646,0.00011652564,0.00013931212,0.00025455604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031427963,0.0001259965,0.00034587638,0.000111426765,0.000050064373,0.000029021901,0.0000330438,0.00003075331,0.00006742806],"category_scores_gemma":[0.00014128191,0.00008723714,0.00023832316,0.00019213058,0.000045764067,0.000094937306,0.000021987917,0.00038000807,0.000034824232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006932599,0.000007590723,0.98450464,0.000017584993,0.00008529174,0.000041704894,0.00020222836,0.00070479774,0.00007631168,4.830838e-7,0.011945679,0.0017204286],"study_design_scores_gemma":[0.004228854,0.0009970226,0.6766632,0.00006130598,0.000103948114,0.00013391998,0.000077629644,0.000019779452,0.000013669485,4.6450342e-7,0.31763244,0.00006776973],"about_ca_topic_score_codex":0.0000036278414,"about_ca_topic_score_gemma":0.0000036846454,"teacher_disagreement_score":0.30784145,"about_ca_system_score_codex":0.000021176264,"about_ca_system_score_gemma":0.000050230203,"threshold_uncertainty_score":0.35574272},"labels":[],"label_agreement":null},{"id":"W2999574853","doi":"10.1002/ejhf.1694","title":"Predictors of Sudden Cardiac Death in High-Risk Patients Following a Myocardial Infarction","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"British Heart Foundation","keywords":"Medicine; Cardiology; Myocardial infarction; Internal medicine; Ejection fraction; Killip class; Heart failure; Sudden cardiac death; Framingham Risk Score; Atrial fibrillation; Ventricular fibrillation; Disease","score_opus":0.0064935393041428615,"score_gpt":0.2108028859182399,"score_spread":0.20430934661409703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999574853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963813,0.00024915408,0.000021786691,0.0024447348,0.0005650586,0.00015398435,0.000011220975,0.0000129154005,0.00015988981],"genre_scores_gemma":[0.9975587,0.00006256408,0.00077373185,0.00035706634,0.0012000223,5.534886e-7,0.000010168456,0.000028634784,0.000008546053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998144,0.00065696315,0.00053854566,0.00014962269,0.00031113884,0.00019974186],"domain_scores_gemma":[0.99924827,0.000058256053,0.00025587704,0.00012608734,0.00012937574,0.000182108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050650554,0.00013669119,0.00060322176,0.00013535596,0.000042204545,0.000006987966,0.00006678687,0.00004631391,0.000014893784],"category_scores_gemma":[0.00034227697,0.000114279086,0.00054289255,0.00022728722,0.000032863416,0.00012243677,0.00004050491,0.0006218293,0.000021040012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007230613,0.000058796868,0.96884555,0.00002678875,0.0004892468,0.00035360293,0.0006121715,0.0002447774,0.00735693,0.0000054231564,0.020635447,0.00064818765],"study_design_scores_gemma":[0.0029556388,0.0022084417,0.9785331,0.00013677284,0.0002979377,0.000050417995,0.000087537504,0.0000062899894,0.0007272567,0.000008153132,0.014889967,0.00009851327],"about_ca_topic_score_codex":0.0000075355374,"about_ca_topic_score_gemma":3.3875568e-7,"teacher_disagreement_score":0.0096875075,"about_ca_system_score_codex":0.00003557851,"about_ca_system_score_gemma":0.000087272565,"threshold_uncertainty_score":0.4660166},"labels":[],"label_agreement":null},{"id":"W3001727981","doi":"10.1002/ejhf.1743","title":"Treatment with 24 Hour Istaroxime Infusion in Patients Hospitalised for Acute Heart Failure: A Randomised, Placebo-Controlled Trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Placebo; Ejection fraction; Heart failure; Cohort; Stroke volume; Clinical endpoint; Adverse effect; Internal medicine; Cardiology; Blood pressure; Heart rate; Anesthesia; Cardiac index; Randomized controlled trial","score_opus":0.011399489360009564,"score_gpt":0.2400662368829427,"score_spread":0.22866674752293314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001727981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8545508,0.000119108015,0.00031608436,0.13475792,0.00035169476,0.009673559,0.000019610252,0.000064393345,0.00014687324],"genre_scores_gemma":[0.95854354,0.000032534517,0.037890542,0.0016418486,0.0010127571,0.00015333573,0.00006164319,0.00013345893,0.00053035974],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967373,0.00052713865,0.0011764952,0.00041290052,0.00063309964,0.0005130715],"domain_scores_gemma":[0.99821097,0.00019394943,0.00043812353,0.0002980324,0.0002807302,0.0005782091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068520475,0.00049349584,0.0016281649,0.0002904969,0.0001197703,0.00008663984,0.00015001786,0.000068767724,0.00012866291],"category_scores_gemma":[0.00020166003,0.00031068947,0.0007184707,0.00024660886,0.000054502114,0.0002533699,0.000046858982,0.00033699253,0.000073176765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82499295,0.0012762203,0.005083068,0.000045338435,0.0012469756,0.00049817923,0.0009234209,0.000021956988,0.0006986691,0.0000053969193,0.16466948,0.0005383493],"study_design_scores_gemma":[0.6728777,0.03524195,0.0009012726,0.000154493,0.0010058909,0.000047969654,0.00016043056,0.00004794962,0.00019131074,0.0000015573237,0.28915313,0.00021632707],"about_ca_topic_score_codex":0.0000051652523,"about_ca_topic_score_gemma":0.000011140374,"teacher_disagreement_score":0.15211524,"about_ca_system_score_codex":0.00019693324,"about_ca_system_score_gemma":0.00022447255,"threshold_uncertainty_score":0.9999345},"labels":[],"label_agreement":null},{"id":"W3001893346","doi":"10.1002/ejhf.1811","title":"A Network Analysis to Identify Pathophysiological Pathways Distinguishing Ischaemic from Non-Ischaemic Heart Failure","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Medical Research Council; Vifor Pharma; National Institute for Health and Care Research; AstraZeneca; MyoKardia; Medical Research Council; Cytokinetics; Boston Scientific Corporation; Servier; European Commission; Amgen","keywords":"Medicine; Heart failure; Internal medicine; Pathophysiology; Myocardial infarction; Cardiology; Inflammation; Bioinformatics; Biology","score_opus":0.014211178751306197,"score_gpt":0.23464409384314022,"score_spread":0.22043291509183402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001893346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9397075,0.0006952768,0.048195858,0.010714808,0.0003010678,0.00019004037,0.0000700009,0.000020936692,0.000104518345],"genre_scores_gemma":[0.9368713,0.00002304629,0.052996885,0.0062037264,0.003730435,0.0000015039299,0.000111358415,0.0000456398,0.000016112985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997604,0.00034698585,0.0008820687,0.0004047247,0.00028497554,0.00047721638],"domain_scores_gemma":[0.9984312,0.00003885116,0.00040206648,0.00039681167,0.0001915689,0.0005395162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076718436,0.0003186344,0.00062164344,0.00007534315,0.00018461788,0.00015054987,0.0005811006,0.00012996432,0.00006525078],"category_scores_gemma":[0.00020395154,0.0002670389,0.00056943117,0.00046847234,0.00007219608,0.000019382329,0.0004377523,0.00062784407,0.0001214667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023794745,0.0000372889,0.0033978412,0.000015608823,0.0006112483,0.00010844399,0.0007074355,0.017107282,0.53411037,0.000014556483,0.44297168,0.0006802988],"study_design_scores_gemma":[0.0021567226,0.002718807,0.030111358,0.00028947747,0.00088120095,0.00018912744,0.0013381676,0.0028244208,0.0059606154,0.00028487245,0.9518844,0.0013608391],"about_ca_topic_score_codex":0.0000047042945,"about_ca_topic_score_gemma":0.000009648533,"teacher_disagreement_score":0.5281498,"about_ca_system_score_codex":0.000016086982,"about_ca_system_score_gemma":0.00006669523,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W3004320786","doi":"10.1002/ejhf.1505","title":"January 2020 at a Glance: Translational Medicine, Predictors of Outcome and Treatments","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; RNA methylation; Biomarker; Transthyretin; Internal medicine; Cardiac amyloidosis; Demethylase; Cardiology; Bioinformatics; Endocrinology; Methylation; Epigenetics; Biology; Methyltransferase; Biochemistry","score_opus":0.015663487438297305,"score_gpt":0.2502887246067994,"score_spread":0.2346252371685021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004320786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98105603,0.0031149879,0.00039144015,0.014768995,0.000075133496,0.0000633284,0.000027220853,0.0000023143314,0.0005005223],"genre_scores_gemma":[0.9972102,0.00023788297,0.001471203,0.0004040071,0.00049133215,4.2638118e-7,0.000017866243,0.000011176384,0.00015590858],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992847,0.00009209976,0.00031578794,0.00010641646,0.00013191113,0.00006912909],"domain_scores_gemma":[0.99958473,0.0000067224073,0.00014554198,0.00008167495,0.00007037459,0.000110942594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014398467,0.00007805047,0.0001476692,0.000017828752,0.000034974375,0.0000038163616,0.00008243179,0.000020548106,0.000052178246],"category_scores_gemma":[0.00002964727,0.00005812717,0.000064967535,0.00004872745,0.0000716213,0.000005119995,0.00002046922,0.00006800455,0.000003426481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003253262,0.000044944194,0.32193074,0.000044565197,0.00020417619,0.000027422408,0.0004989381,0.00009588492,0.46837717,0.000014279058,0.20727316,0.0011633995],"study_design_scores_gemma":[0.0023315556,0.001461683,0.2901708,0.000043908196,0.000085837855,0.00017379149,0.00013580301,0.000021274069,0.0065997634,0.000004878917,0.69885415,0.000116583076],"about_ca_topic_score_codex":6.016276e-7,"about_ca_topic_score_gemma":0.0000011148659,"teacher_disagreement_score":0.491581,"about_ca_system_score_codex":0.000004251147,"about_ca_system_score_gemma":0.000022845345,"threshold_uncertainty_score":0.23703572},"labels":[],"label_agreement":null},{"id":"W3007515386","doi":"10.1002/ejhf.1765","title":"Effects of Vericiguat in Heart Failure with Reduced Ejection Fraction: Do Not Forget sST2. Reply","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Biomarker; Internal medicine; Cardiology; Natriuretic peptide; Baseline (sea); Measure (data warehouse); Data mining","score_opus":0.008982719457930135,"score_gpt":0.20608424232626826,"score_spread":0.19710152286833812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007515386","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13828027,0.002131929,0.00037683485,0.85144764,0.0049554426,0.0012088382,0.0004480122,0.00015133349,0.0009997089],"genre_scores_gemma":[0.67429847,0.00021790835,0.0071966844,0.30769196,0.007727965,0.00001542805,0.00042723713,0.0004915667,0.0019328138],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954042,0.0021183377,0.0011273031,0.0005391974,0.0002398413,0.0005711112],"domain_scores_gemma":[0.9977294,0.0003047613,0.0010669493,0.00045606834,0.000375779,0.00006703752],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006784928,0.0005553801,0.0012968071,0.00049535616,0.00018520618,0.0000489993,0.00041318714,0.0004462245,0.000100043915],"category_scores_gemma":[0.00032075073,0.00045029834,0.00040495064,0.00046991697,0.0002165101,0.0003143298,0.00009265773,0.005069047,0.00034650773],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005678082,0.00006709781,0.0002851639,0.0003380262,0.00025000208,0.0012280676,0.00030897086,0.000006460928,0.21359181,0.0000016979747,0.783241,0.000113928305],"study_design_scores_gemma":[0.0025268218,0.0023907854,0.0014542175,0.0010534867,0.0001748021,0.002667859,0.00021046697,2.849551e-7,0.05982351,0.000006540292,0.92929226,0.0003989855],"about_ca_topic_score_codex":0.000019038589,"about_ca_topic_score_gemma":0.000007405325,"teacher_disagreement_score":0.5437557,"about_ca_system_score_codex":0.00010996508,"about_ca_system_score_gemma":0.00027597457,"threshold_uncertainty_score":0.9997949},"labels":[],"label_agreement":null},{"id":"W3007728378","doi":"10.1002/ejhf.1777","title":"Heart Failure Disease Management Interventions: Time for a Reappraisal","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; Psychological intervention; Disease management; Disease; MEDLINE; Cardiology; Internal medicine; Psychiatry","score_opus":0.02815339889547507,"score_gpt":0.291845773851234,"score_spread":0.2636923749557589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007728378","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012951215,0.0014413979,0.010681835,0.9700003,0.00035701727,0.0024130177,0.000047867794,0.00021807746,0.0018892392],"genre_scores_gemma":[0.4582623,0.00007421349,0.5200315,0.012443419,0.0027179199,0.000046346548,0.0001267542,0.0002502121,0.006047324],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772054,0.00027263767,0.000825081,0.00033372696,0.00046552625,0.0003825152],"domain_scores_gemma":[0.9983308,0.000060409453,0.00022773253,0.00032279993,0.00021323883,0.000845068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007826908,0.0002923735,0.00056965253,0.00022241262,0.00012884272,0.000084253916,0.00019973134,0.000029693101,0.0006302307],"category_scores_gemma":[0.00018146404,0.00023620119,0.0009938765,0.0002516157,0.000059884944,0.00022864236,0.0001241717,0.00029523627,0.00089294405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094601215,0.00035163978,0.0006904145,0.00077189435,0.00054566876,0.0007969068,0.00014367304,0.00003141997,0.0007322403,0.0003306047,0.993042,0.0016175047],"study_design_scores_gemma":[0.004306857,0.0023216307,0.004043282,0.0009993371,0.00081895705,0.00015736546,0.00025803712,0.00007253531,0.0000808625,0.000020922313,0.9867193,0.00020091161],"about_ca_topic_score_codex":3.8458353e-7,"about_ca_topic_score_gemma":7.532672e-7,"teacher_disagreement_score":0.9575569,"about_ca_system_score_codex":0.00003678228,"about_ca_system_score_gemma":0.00006480572,"threshold_uncertainty_score":0.99988496},"labels":[],"label_agreement":null},{"id":"W3007761445","doi":"10.1002/ejhf.1767","title":"Time to End the War on Cell Therapy","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ejection fraction; Placebo; Heart failure; Cardiology; Clinical endpoint; Internal medicine; Mesenchymal stem cell; Angina; Canadian Cardiovascular Society; Clinical trial; Myocardial infarction; Pathology","score_opus":0.030481960026288047,"score_gpt":0.2657077218687614,"score_spread":0.23522576184247335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007761445","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017277142,0.0008110353,0.000007926598,0.97612834,0.00021438506,0.0005421115,0.000011286108,0.00002208805,0.02053509],"genre_scores_gemma":[0.002660446,0.00013169379,0.0011985585,0.9448102,0.014712321,0.0000017341373,0.000018217443,0.00021987183,0.036246974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99520546,0.0015762134,0.0006568288,0.00033010467,0.0017238037,0.00050757005],"domain_scores_gemma":[0.9979897,0.00036644368,0.00028146923,0.0006213942,0.0003074383,0.0004335165],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013480461,0.0003694528,0.0007073701,0.00025116833,0.00013033184,0.00006825036,0.0007129031,0.00011967815,0.006919488],"category_scores_gemma":[0.00021364658,0.00020368234,0.00047688707,0.0002906064,0.000108188535,0.00004054628,0.0001223387,0.0055384734,0.020913118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000296568,0.00003865627,0.000011128224,0.000071502196,0.000095190844,0.011931802,0.000270313,0.00000444957,0.00685114,1.4294416e-7,0.979137,0.0012921273],"study_design_scores_gemma":[0.00096859294,0.003717909,0.00013556708,0.00039024084,0.000042430467,0.0009189449,0.00003677561,0.0000033705007,0.0015418747,0.000001468744,0.9920663,0.00017647338],"about_ca_topic_score_codex":0.0000013005913,"about_ca_topic_score_gemma":9.217597e-8,"teacher_disagreement_score":0.031318177,"about_ca_system_score_codex":0.000081689264,"about_ca_system_score_gemma":0.00025565884,"threshold_uncertainty_score":0.9967558},"labels":[],"label_agreement":null},{"id":"W3007981174","doi":"10.1002/ejhf.1507","title":"February 2020 at a Glance: Acute Heart Failure and Cardio-Oncology","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Procalcitonin; Internal medicine; Acute kidney injury; Renal function; Biomarker; Creatinine; Cardiology; Cardiorenal syndrome; Acute decompensated heart failure; Intensive care medicine; Sepsis","score_opus":0.014604107474183704,"score_gpt":0.2576430329926047,"score_spread":0.24303892551842102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007981174","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3397945,0.001692821,0.00014271465,0.6565401,0.0003037033,0.0004694936,0.000013966219,0.00008535829,0.0009573502],"genre_scores_gemma":[0.9133654,0.00032674032,0.06997547,0.013118912,0.002404429,0.000004039502,0.000023048698,0.00010668178,0.00067526253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975442,0.00050714164,0.00066354114,0.0003712768,0.00047719528,0.00043660158],"domain_scores_gemma":[0.9984015,0.000082818886,0.00021297492,0.00027605207,0.00016891952,0.00085771317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067330437,0.00032713576,0.0009297188,0.00012009079,0.00016512463,0.000051377367,0.00014601623,0.00007735281,0.00039509716],"category_scores_gemma":[0.00010700621,0.00025366616,0.00035933466,0.0002627012,0.00012376363,0.00020112858,0.00023471111,0.0006472536,0.0005242168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057035417,0.0000825617,0.020820638,0.000085427346,0.0005961989,0.0056850254,0.0006659595,0.0000058271658,0.014337483,0.000013862669,0.95617086,0.0009657948],"study_design_scores_gemma":[0.004310855,0.0032951345,0.02252915,0.0001326197,0.00055132626,0.0063906442,0.00043241814,0.000014622556,0.0006698808,0.0000037155246,0.9614641,0.00020551842],"about_ca_topic_score_codex":0.000004450244,"about_ca_topic_score_gemma":0.000009209786,"teacher_disagreement_score":0.6434212,"about_ca_system_score_codex":0.0001248456,"about_ca_system_score_gemma":0.00014157999,"threshold_uncertainty_score":0.99999154},"labels":[],"label_agreement":null},{"id":"W3009508937","doi":"10.1002/ejhf.1768","title":"The Heart Failure Association Atlas: Rationale, Objectives, and Methods","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Reimbursement; Epidemiology; Heart failure; Health care; Medical emergency; Intensive care medicine; Cardiology; Political science; Internal medicine","score_opus":0.016840415210489814,"score_gpt":0.28530529638307883,"score_spread":0.26846488117258904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009508937","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029290458,0.0017021951,0.0023677691,0.96479917,0.0002320923,0.000601603,0.0000039691486,0.000057523328,0.00094523723],"genre_scores_gemma":[0.42759126,0.00033806678,0.55363303,0.011892458,0.0028387965,0.000008645119,0.000016682008,0.00011553044,0.0035655436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974615,0.0010858908,0.0005212057,0.0002001794,0.00046897543,0.00026225438],"domain_scores_gemma":[0.9985845,0.00037788574,0.0002672109,0.00015938717,0.00029122032,0.00031978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021929115,0.00018710794,0.00038228673,0.00007545916,0.00027178405,0.0001258063,0.00009991672,0.000041371604,0.00009074033],"category_scores_gemma":[0.0008124368,0.00012004003,0.00020305095,0.00022641844,0.00005312455,0.0002089022,0.00007189867,0.00048634232,0.00011837612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016868324,0.000056154902,0.012568516,0.000035536956,0.0003546791,0.000080368794,0.0007256312,0.000009000244,0.007102237,0.00021733184,0.9757969,0.0028849714],"study_design_scores_gemma":[0.0016103599,0.00081126625,0.022081995,0.0000672927,0.00017819552,0.00020527041,0.00079911324,0.00003868404,0.0007970184,0.000031246575,0.9732745,0.00010502697],"about_ca_topic_score_codex":0.0000016528649,"about_ca_topic_score_gemma":0.000006278577,"teacher_disagreement_score":0.95290667,"about_ca_system_score_codex":0.00009338163,"about_ca_system_score_gemma":0.00010326357,"threshold_uncertainty_score":0.48950905},"labels":[],"label_agreement":null},{"id":"W3009757879","doi":"10.1002/ejhf.1772","title":"Relationship Between Left Ventricular Ejection Fraction and Cardiovascular Outcomes Following Hospitalization for Heart Failure: Insights from the RELAX-AHF-2 Trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Heart failure; Internal medicine; Cardiology; Hazard ratio; Quartile; Confidence interval","score_opus":0.029859854812353166,"score_gpt":0.2590150227833444,"score_spread":0.2291551679709912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009757879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8714948,0.0015400574,0.017702302,0.1071931,0.00047609338,0.0014938189,0.0000065375557,0.00006662472,0.00002661008],"genre_scores_gemma":[0.9846687,0.000009147078,0.012966786,0.00071785157,0.0014864098,0.000005550378,0.000057313864,0.000050710816,0.000037571084],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770397,0.0006014968,0.0006404142,0.00028925383,0.0005701429,0.00019470936],"domain_scores_gemma":[0.9987629,0.00038989083,0.00021483094,0.00027319166,0.00013859922,0.00022055834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088203646,0.00022804654,0.00062835385,0.000114122704,0.00033331636,0.00010662445,0.000087496104,0.00007442896,0.000015912907],"category_scores_gemma":[0.0008453211,0.00015414564,0.00081554643,0.00022004962,0.00003088304,0.00038279948,0.000041547024,0.00039412722,0.000032332242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008243953,0.000072976465,0.91607094,0.00004020076,0.0013949525,0.00011856645,0.0005021138,0.000057702193,0.00013549432,0.00005856236,0.08043727,0.0002868402],"study_design_scores_gemma":[0.017857648,0.0012659235,0.3711634,0.00011028286,0.0017636631,0.000027843627,0.00055541325,0.000023187766,0.000091725924,0.00006282121,0.60692364,0.00015446746],"about_ca_topic_score_codex":0.000010587648,"about_ca_topic_score_gemma":0.0000038841317,"teacher_disagreement_score":0.5449075,"about_ca_system_score_codex":0.00006519284,"about_ca_system_score_gemma":0.000050015726,"threshold_uncertainty_score":0.62858766},"labels":[],"label_agreement":null},{"id":"W3011930481","doi":"10.1002/ejhf.1783","title":"The Impact of Palliative Care on Clinical and Patient-Centred Outcomes in Patients with Advanced Heart Failure: A Systematic Review of Randomized Controlled Trials","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Palliative care; Randomized controlled trial; CINAHL; Heart failure; Quality of life (healthcare); MEDLINE; Odds ratio; Psychological intervention; Confidence interval; Adverse effect; Intensive care medicine; Meta-analysis; Emergency medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.09905849485435761,"score_gpt":0.43762438524984126,"score_spread":0.3385658903954837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011930481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013817028,0.9890136,0.000002568959,0.000862836,0.00011534015,0.008493211,0.00010187978,0.0000051442426,0.000023718307],"genre_scores_gemma":[0.0062929383,0.9921389,0.0012337463,0.0001377655,0.00006774634,0.000033653498,0.000024057985,0.00006525046,0.000005935425],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97285,0.016786937,0.0088508725,0.0002948753,0.00096509967,0.00025217645],"domain_scores_gemma":[0.97692823,0.011298785,0.009706869,0.00045311663,0.001363096,0.00024986998],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0054352577,0.0006329446,0.030458968,0.00026017646,0.00003567007,0.000018358973,0.0002476206,0.000107682325,0.000017140419],"category_scores_gemma":[0.04165555,0.00024401883,0.005581777,0.0003371691,0.00026973704,0.000064828164,0.000057253223,0.00089185865,0.000004083522],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12509932,0.00081993506,0.013277277,0.811812,0.023051871,0.00014668537,0.0034157012,0.0000043210184,0.0000010253502,0.000011527311,0.0059063565,0.016453993],"study_design_scores_gemma":[0.15803261,0.0050594895,0.00033761517,0.7919976,0.0087036975,0.00000817276,0.00071447564,4.1949934e-7,0.0000010161422,8.9339875e-7,0.03496197,0.00018204465],"about_ca_topic_score_codex":0.0000025673946,"about_ca_topic_score_gemma":0.0000012060202,"teacher_disagreement_score":0.036220293,"about_ca_system_score_codex":0.000091899485,"about_ca_system_score_gemma":0.00055274816,"threshold_uncertainty_score":0.99507993},"labels":[],"label_agreement":null},{"id":"W3013168322","doi":"10.1002/ejhf.1805","title":"Evolving Towards a More Realistic Approach to the Importance of Left Ventricular Ejection Fraction and Sex in Heart Failure and its Therapy","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Heart failure; Ejection fraction; Medicine; Cardiology; Internal medicine; Fraction (chemistry)","score_opus":0.0221991794785359,"score_gpt":0.25796040410045357,"score_spread":0.23576122462191768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013168322","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024670755,0.0030650122,0.0002382982,0.9706555,0.00012429063,0.0010560948,0.000011631663,0.000024706007,0.00015372042],"genre_scores_gemma":[0.5938895,0.0010758368,0.03358798,0.36290842,0.007128885,0.000024651585,0.000170998,0.00031897932,0.0008947829],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973717,0.00055052806,0.0007411342,0.00039463027,0.00063348043,0.0003085507],"domain_scores_gemma":[0.99891746,0.00006614323,0.000372437,0.00028768962,0.00017860258,0.00017768546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088709005,0.00036367276,0.0008296098,0.00036395015,0.00010083877,0.0000728001,0.00012943902,0.00013276258,0.00003816038],"category_scores_gemma":[0.00015046768,0.00024308528,0.00019350936,0.00030520497,0.000051852752,0.00016465096,0.00008160692,0.0015533785,0.000007941212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090421054,0.00007676155,0.010358067,0.0003281806,0.00021040594,0.0014796469,0.0005760674,0.000020174346,0.00030980117,0.0000025225954,0.98620945,0.00033850322],"study_design_scores_gemma":[0.0013825347,0.00084919546,0.014535022,0.00055322045,0.00020652683,0.001837629,0.000565294,0.00012763067,0.00008825358,0.000005912755,0.9796514,0.00019738868],"about_ca_topic_score_codex":0.000017260636,"about_ca_topic_score_gemma":0.0000063892307,"teacher_disagreement_score":0.6077471,"about_ca_system_score_codex":0.00010391738,"about_ca_system_score_gemma":0.000095030824,"threshold_uncertainty_score":0.991273},"labels":[],"label_agreement":null},{"id":"W3013432607","doi":"10.1002/ejhf.1799","title":"Heart failure treatment up‐titration and outcome and age: an analysis of BIOSTAT‐CHF","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European Commission; National Institute for Health and Care Research; NHS Education for Scotland","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Confidence interval; Ejection fraction; Beta blocker; Incidence (geometry); Cardiology","score_opus":0.03627806539321102,"score_gpt":0.2921898229646721,"score_spread":0.2559117575714611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013432607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88954514,0.00043131143,0.00024291522,0.109275445,0.000056071938,0.0003234601,0.000015604992,0.000030636107,0.00007942565],"genre_scores_gemma":[0.97256124,0.0000663304,0.02569262,0.0012574479,0.0001910285,0.0000011823179,0.000033430922,0.00003193631,0.00016480357],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981147,0.00031834273,0.00072400906,0.00028511471,0.0003365828,0.0002212712],"domain_scores_gemma":[0.9988217,0.000045581477,0.00023237825,0.00023441354,0.00014236508,0.00052359246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046595896,0.00025600157,0.000879095,0.0003758167,0.00008505188,0.000066653345,0.00006481548,0.000041415526,0.00013113832],"category_scores_gemma":[0.00006110021,0.00018533823,0.00027238578,0.00043263184,0.00009571197,0.0002537722,0.000042785745,0.00019223407,0.000015252667],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011930467,0.00088647165,0.8364955,0.00034090912,0.0060081757,0.0017894795,0.007863645,0.00017438778,0.04021217,0.0002808379,0.097546645,0.0072086947],"study_design_scores_gemma":[0.005498557,0.007996559,0.34798476,0.000102322796,0.0051665935,0.00028351665,0.0023120153,0.0003729968,0.0011735656,0.000005179994,0.6288174,0.00028653527],"about_ca_topic_score_codex":0.000017119986,"about_ca_topic_score_gemma":0.000059291913,"teacher_disagreement_score":0.53127074,"about_ca_system_score_codex":0.000042358133,"about_ca_system_score_gemma":0.0000470536,"threshold_uncertainty_score":0.7557874},"labels":[],"label_agreement":null},{"id":"W3013602579","doi":"10.1002/ejhf.1509","title":"March 2020 at a Glance: Heart Failure with Preserved Ejection Fraction, Left Atrial Myopathy, Atrial Fibrillation and Cardiac Amyloidosis","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Atrial fibrillation; Ejection fraction; Heart failure with preserved ejection fraction; Diastole; Myopathy; Endothelial dysfunction; Blood pressure","score_opus":0.011949304093528929,"score_gpt":0.2285645611113336,"score_spread":0.21661525701780468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013602579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572902,0.0019715356,0.0005395525,0.03860419,0.0008873293,0.0005310485,0.000021755252,0.000076630145,0.000077786746],"genre_scores_gemma":[0.98318446,0.00045888557,0.0036371232,0.0002889792,0.012120308,2.5940344e-7,0.000036372243,0.000082956074,0.00019063863],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712527,0.0008682354,0.0005907764,0.00036276263,0.00079141697,0.0002615638],"domain_scores_gemma":[0.9984899,0.000093790724,0.00028639415,0.00025464463,0.00038261537,0.0004926124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009513489,0.00026404625,0.00075041514,0.00013597599,0.00024693547,0.00009541224,0.000069323236,0.000092449554,0.00031806252],"category_scores_gemma":[0.00030567663,0.00019966617,0.001016503,0.00031334377,0.000078524376,0.00031286365,0.000074741474,0.000677153,0.0001013373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050538243,0.00001043742,0.7638969,0.00009186204,0.0007935569,0.00010957261,0.0002622202,0.00073779066,0.009144746,9.88683e-7,0.21943015,0.00046796672],"study_design_scores_gemma":[0.0042578387,0.001424494,0.25854596,0.00011061855,0.00052368105,0.00097615377,0.0003617153,0.00007253044,0.000398629,6.908243e-7,0.73315,0.00017766283],"about_ca_topic_score_codex":0.000014383057,"about_ca_topic_score_gemma":0.000009158419,"teacher_disagreement_score":0.51371986,"about_ca_system_score_codex":0.000116165924,"about_ca_system_score_gemma":0.00013921344,"threshold_uncertainty_score":0.814215},"labels":[],"label_agreement":null},{"id":"W3013637479","doi":"10.1002/ejhf.1790","title":"Hyperglycaemia, Ejection Fraction and the Risk of Heart Failure or Cardiovascular Death in Patients with Type 2 Diabetes and a Recent Acute Coronary Syndrome","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi","keywords":"Medicine; Ejection fraction; Heart failure; Acute coronary syndrome; Cardiology; Internal medicine; Type 2 diabetes; Diabetes mellitus; Myocardial infarction; Endocrinology","score_opus":0.009133683604911538,"score_gpt":0.21368499562925658,"score_spread":0.20455131202434504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013637479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921889,0.0014181915,0.000030036868,0.005912408,0.00008326808,0.0003224203,0.000009341517,0.000008770949,0.000026712509],"genre_scores_gemma":[0.9968115,0.00059270137,0.0019056774,0.0005709168,0.000076171804,0.0000014899807,0.0000067123938,0.00002590701,0.000008935211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983638,0.00043588062,0.00044178683,0.00019338095,0.00038223044,0.0001829193],"domain_scores_gemma":[0.9990746,0.00010795684,0.00015339581,0.00015684927,0.0003131417,0.00019409352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004947993,0.00016735101,0.0006563713,0.00007883518,0.00008150368,0.000021898328,0.00005992814,0.000050488146,0.000036562084],"category_scores_gemma":[0.00027437203,0.000092175855,0.00013881948,0.0002033263,0.00012942286,0.00014947772,0.00004118681,0.00053232623,0.000003831959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008273733,0.00011703525,0.9868602,0.00008428943,0.00088626344,0.00018247138,0.00030753794,0.000023354849,0.00021231319,0.000003420852,0.0017476453,0.001301714],"study_design_scores_gemma":[0.021461165,0.008738822,0.91117275,0.00046206417,0.0013831918,0.0006888281,0.00038551603,0.00008109536,0.000057780937,0.00001006138,0.055386003,0.0001727143],"about_ca_topic_score_codex":0.0000063620378,"about_ca_topic_score_gemma":0.0000018055728,"teacher_disagreement_score":0.07568746,"about_ca_system_score_codex":0.000025147297,"about_ca_system_score_gemma":0.000055220626,"threshold_uncertainty_score":0.3758822},"labels":[],"label_agreement":null},{"id":"W3013762090","doi":"10.1002/ejhf.1780","title":"Mega-Trials in Heart Failure: Effects of Dilution in Examination of New Therapies","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Placebo; Clinical trial; Ejection fraction; Internal medicine; Heart failure with preserved ejection fraction; Randomized controlled trial; Sample size determination; Cardiology; Intensive care medicine; Alternative medicine; Pathology; Statistics","score_opus":0.04948006795477062,"score_gpt":0.3250325647449308,"score_spread":0.2755524967901602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013762090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010230163,0.98206323,0.0001105792,0.014345505,0.000285021,0.0020528624,0.0000056813806,0.000018549013,0.000095571755],"genre_scores_gemma":[0.013508987,0.96114373,0.023963269,0.0001325748,0.0008254274,0.00001124462,0.000039971015,0.00013629528,0.00023850582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99120486,0.0044671474,0.0030329998,0.0003187457,0.0006731125,0.0003031607],"domain_scores_gemma":[0.99691945,0.00076273107,0.0015963042,0.000342121,0.00015456359,0.0002247972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053357724,0.00048326506,0.004729868,0.0011975735,0.0000216436,0.000023800407,0.00021281884,0.00014901646,0.000098204764],"category_scores_gemma":[0.0013702338,0.00034545062,0.0010935301,0.0008833838,0.000065314656,0.0001922161,0.00008257342,0.0007922846,0.00003223429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002509871,0.00080482714,0.00079693826,0.031722084,0.0012463024,0.0013285698,0.0020032108,0.00000657581,0.00076671503,0.0001371908,0.17056488,0.7903717],"study_design_scores_gemma":[0.0030423198,0.0014828239,0.002560903,0.03407219,0.0010397217,0.00018158188,0.00011501774,0.0000010414718,0.00013532126,0.0000087899525,0.957164,0.0001963243],"about_ca_topic_score_codex":0.000017419388,"about_ca_topic_score_gemma":0.000021857231,"teacher_disagreement_score":0.7901754,"about_ca_system_score_codex":0.00018974727,"about_ca_system_score_gemma":0.0004440938,"threshold_uncertainty_score":0.99989974},"labels":[],"label_agreement":null},{"id":"W3013939526","doi":"10.1002/ejhf.1795","title":"The Burden of Non-Cardiac Comorbidities and Association with Clinical Outcomes in an Acute Heart Failure Trial – Insights from ASCEND-HF","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Heart, Lung, and Blood Institute; Abbott Laboratories; GE Healthcare; Merck Sharp and Dohme; Johnson and Johnson; National Institutes of Health; BG Medicine; European Commission; Boehringer Ingelheim; Amgen; Bristol-Myers Squibb; American Heart Association","keywords":"Medicine; Comorbidity; Heart failure; Internal medicine; Odds ratio; Diabetes mellitus; Confidence interval; Intensive care medicine","score_opus":0.025731832123593958,"score_gpt":0.29730568142414066,"score_spread":0.2715738493005467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013939526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8482797,0.00015859658,0.000023952347,0.15065786,0.00028167595,0.00050040474,0.000012580764,0.000016638354,0.000068554786],"genre_scores_gemma":[0.98846436,0.00010958248,0.009141528,0.00066368154,0.0014312197,0.0000027750896,0.000015843976,0.000039688104,0.00013134012],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969552,0.0010005161,0.0009513139,0.00023796923,0.0006190149,0.00023597432],"domain_scores_gemma":[0.9982935,0.00050821004,0.000440704,0.00025213385,0.00019911779,0.00030630472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011230102,0.00022659177,0.0009517706,0.00009547213,0.000103648716,0.0000845776,0.00014363082,0.00007134509,0.000026766505],"category_scores_gemma":[0.00023965238,0.00013103071,0.0002771473,0.0001618414,0.00010104833,0.000260214,0.00007192839,0.00062206207,0.000025541753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154579915,0.0004742774,0.5646009,0.000046086418,0.0026426055,0.00062298245,0.0048471843,0.000024254434,0.002303919,0.000036586818,0.4078302,0.0011130092],"study_design_scores_gemma":[0.041839086,0.009757846,0.28281045,0.00025873008,0.0008665275,0.00002400742,0.0034644508,0.000060079474,0.0002530764,0.000012627439,0.66041666,0.00023643991],"about_ca_topic_score_codex":0.00003349121,"about_ca_topic_score_gemma":0.000042721927,"teacher_disagreement_score":0.28179044,"about_ca_system_score_codex":0.000050453767,"about_ca_system_score_gemma":0.00011599709,"threshold_uncertainty_score":0.5343277},"labels":[],"label_agreement":null},{"id":"W3014265074","doi":"10.1002/ejhf.1804","title":"Factors Predicting Recovery of Left Ventricular Dysfunction in Non-Ischaemic Cardiomyopathy","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiology; Ejection fraction; Internal medicine; Heart failure; Dilated cardiomyopathy; Dobutamine; Cardiomyopathy; Coronary artery disease; Cardiac magnetic resonance imaging; Stroke volume; Mineralocorticoid receptor; Magnetic resonance imaging; Ivabradine; Blood pressure; Heart rate; Receptor; Hemodynamics; Radiology","score_opus":0.012719712230465486,"score_gpt":0.22062115639542074,"score_spread":0.20790144416495526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014265074","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.386699,0.0034947642,0.0010024767,0.6025874,0.0044408203,0.00057583745,0.00009211503,0.00006142124,0.0010461767],"genre_scores_gemma":[0.87121874,0.00015936774,0.0020617407,0.10879661,0.01700652,9.60933e-7,0.00024777005,0.00028598125,0.00022232565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972116,0.00050557515,0.0010036483,0.00026321382,0.00070711493,0.00030889854],"domain_scores_gemma":[0.9983076,0.00027126397,0.0006755447,0.00029877742,0.00029210036,0.00015469939],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00072049943,0.00032952786,0.0011715218,0.00054442475,0.000039537346,0.000032085976,0.00014749386,0.00015224997,0.00003389427],"category_scores_gemma":[0.0010776899,0.00027430378,0.00086520385,0.0002523202,0.000058094152,0.00011802077,0.0000728021,0.0031944169,0.000029314939],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006295658,0.000023400642,0.14714766,0.00036536503,0.00019262053,0.012226173,0.00022921908,0.0001400129,0.00040541936,3.283737e-8,0.8390348,0.000172369],"study_design_scores_gemma":[0.0020436603,0.0010127879,0.073445015,0.0035652989,0.0007941357,0.003363346,0.00029808833,0.0000180355,0.0006458306,0.0000035893456,0.9145221,0.00028807388],"about_ca_topic_score_codex":0.000010364793,"about_ca_topic_score_gemma":3.9342163e-7,"teacher_disagreement_score":0.4937908,"about_ca_system_score_codex":0.00013149735,"about_ca_system_score_gemma":0.00022065449,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W3014402739","doi":"10.1002/ejhf.1796","title":"Association Between Loop Diuretic Dose Changes and Outcomes in Chronic Heart Failure: Observations from the ESC-EORP Heart Failure Long-Term Registry","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Abbott Vascular; Novartis Pharma; Servier; Bayer; Gedeon Richter; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Daiichi-Sankyo; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; ResMed","keywords":"Medicine; Heart failure; Hazard ratio; Loop diuretic; Interquartile range; Ejection fraction; Internal medicine; Cardiology; Diuretic; Confidence interval; Heart failure with preserved ejection fraction; Odds ratio","score_opus":0.03579175167568047,"score_gpt":0.26858113601463773,"score_spread":0.23278938433895727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014402739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50237477,0.0006958765,0.00006194703,0.4961729,0.000099078,0.000502848,0.000030178533,0.000047947025,0.000014452171],"genre_scores_gemma":[0.9808896,0.00013137609,0.0087875165,0.007218235,0.0019987065,0.0000098365435,0.000102193764,0.000101690406,0.00076080306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963547,0.0007604315,0.0009390858,0.0004867472,0.00087366014,0.00058540335],"domain_scores_gemma":[0.9977544,0.00054317096,0.00047367718,0.00051770185,0.0002275351,0.0004834985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012142938,0.00045683671,0.0010155092,0.00017130542,0.0002585751,0.00021695394,0.0003054003,0.00015349443,0.00022223275],"category_scores_gemma":[0.0005686684,0.00032585007,0.00031811223,0.00048514333,0.00011429498,0.00035638167,0.00019825596,0.001246527,0.00016238452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049290324,0.00007561888,0.7430476,0.00007911452,0.0003922551,0.00014913561,0.0005375636,0.000010266331,0.0022941614,0.000012966385,0.2531095,0.00024248176],"study_design_scores_gemma":[0.0028399331,0.0006618667,0.6541087,0.00042969125,0.0004407906,0.00004839944,0.00032552204,0.000012640868,0.00020396034,0.000011380446,0.3407071,0.00021001924],"about_ca_topic_score_codex":0.00005331669,"about_ca_topic_score_gemma":0.0009339392,"teacher_disagreement_score":0.48895466,"about_ca_system_score_codex":0.0003247381,"about_ca_system_score_gemma":0.00023758912,"threshold_uncertainty_score":0.99991935},"labels":[],"label_agreement":null},{"id":"W3014511103","doi":"10.1002/ejhf.1815","title":"The Electrocardiogram in the Diagnosis and Management of Patients with Dilated Cardiomyopathy","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Ministero della Salute; Ente Cassa di Risparmio di Firenze; European Commission","keywords":"Medicine; Dilated cardiomyopathy; Cardiology; Internal medicine; Heart failure; Coronary artery disease; Ambulatory ECG; Disease; Hypertrophic cardiomyopathy; Electrocardiography","score_opus":0.017985468140517217,"score_gpt":0.26410916256134437,"score_spread":0.24612369442082715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014511103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004975974,0.9966101,0.000011008606,0.0014265556,0.000094714655,0.00093622913,0.000012737714,0.0000065663257,0.00040450794],"genre_scores_gemma":[0.0047542816,0.9944814,0.00039125257,0.00008075101,0.00021135186,0.000017345088,0.0000072680627,0.000046740028,0.000009605839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972489,0.0010024661,0.0007643286,0.00019322557,0.0005577692,0.00023331045],"domain_scores_gemma":[0.99876446,0.0002002125,0.00047018303,0.00031341592,0.0001647004,0.000087057124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013402766,0.0003060252,0.0016466737,0.00013582227,0.00011579935,0.000044917764,0.00023657508,0.00003532881,0.0000013353484],"category_scores_gemma":[0.000049270628,0.00013232519,0.0006664022,0.00057563116,0.00013707067,0.000040412277,0.0001151353,0.00071389455,0.000004041277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023934053,0.000114048846,0.007313289,0.0060540875,0.003239503,0.0022835638,0.0004387048,7.756773e-7,8.578116e-8,0.00002363796,0.030733896,0.9495591],"study_design_scores_gemma":[0.0009567675,0.0009560839,0.017572114,0.009469259,0.0031973454,0.000577871,0.00027662163,3.8078447e-8,1.9111089e-7,9.0718373e-7,0.96687394,0.000118851676],"about_ca_topic_score_codex":8.5292817e-7,"about_ca_topic_score_gemma":8.7568503e-7,"teacher_disagreement_score":0.94944024,"about_ca_system_score_codex":0.000036628753,"about_ca_system_score_gemma":0.00005525521,"threshold_uncertainty_score":0.5396065},"labels":[],"label_agreement":null},{"id":"W3014685152","doi":"10.1002/ejhf.1803","title":"Implantable Cardioverter-Defibrillators and Survival – The Fine Line Between Efficacy Concerns and Ageism","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Heart failure; Implantable cardioverter-defibrillator; Line (geometry); Cardiac resynchronization therapy; Intensive care medicine; Internal medicine","score_opus":0.0380091146271788,"score_gpt":0.2760162206069334,"score_spread":0.23800710597975464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014685152","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064505994,0.009620787,0.00006277691,0.9089118,0.00084546435,0.00034523977,0.00022867357,0.00006389452,0.015415343],"genre_scores_gemma":[0.8322376,0.00084254536,0.0006167113,0.11169372,0.05340953,5.1915737e-7,0.000073767784,0.0001887957,0.00093682884],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977429,0.00054535817,0.00060863304,0.00028140153,0.00054183445,0.00027985347],"domain_scores_gemma":[0.9984584,0.0005612174,0.0003492838,0.00026338774,0.00017883803,0.00018886608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005751303,0.00034000806,0.001600499,0.000115780385,0.00020346035,0.00010842393,0.000046337685,0.00010326821,0.000004664117],"category_scores_gemma":[0.00015742825,0.00021636959,0.00036426572,0.00013434095,0.00019607141,0.00006147555,0.00015810889,0.00148718,0.000027566623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000529483,0.0000017229547,0.005086251,0.000100082136,0.0007918654,0.00036814992,0.00035445692,0.0000030019767,0.000059695583,5.9864016e-7,0.99242747,0.0007537629],"study_design_scores_gemma":[0.001435714,0.00041674814,0.013352879,0.00034795524,0.00080940966,0.006947006,0.0001080816,5.830921e-7,0.000024693027,0.000002770051,0.97635573,0.00019843422],"about_ca_topic_score_codex":0.000008439804,"about_ca_topic_score_gemma":5.5448254e-7,"teacher_disagreement_score":0.79721814,"about_ca_system_score_codex":0.000023299002,"about_ca_system_score_gemma":0.0000675608,"threshold_uncertainty_score":0.8823296},"labels":[],"label_agreement":null},{"id":"W3014729277","doi":"10.1002/ejhf.1802","title":"Spironolactone Metabolite Concentrations in Decompensated Heart Failure: Insights from the ATHENA-HF Trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Spironolactone; Heart failure; Medicine; Aldosterone; Metabolite; Internal medicine; Placebo; Endocrinology; Pharmacology; Natriuresis; Blood pressure","score_opus":0.03174008471424309,"score_gpt":0.25619054099130506,"score_spread":0.22445045627706198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014729277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81018955,0.0012913246,0.00016172406,0.18771377,0.00015075585,0.0003287825,0.000006242581,0.000020917545,0.00013693125],"genre_scores_gemma":[0.9856046,0.000033734188,0.005629505,0.0073673897,0.0012800983,6.606853e-7,0.00001920676,0.000032837033,0.000031970005],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768955,0.0006998927,0.0007704858,0.00019099303,0.0004527724,0.00019628955],"domain_scores_gemma":[0.9988467,0.00016490783,0.00021432676,0.00020913087,0.00022198037,0.00034295983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040984215,0.00017859593,0.0005350559,0.000080754275,0.000109851535,0.00006210243,0.0001515648,0.000046182435,0.00027461912],"category_scores_gemma":[0.0003689002,0.00010909584,0.00024097285,0.00027399865,0.00007718662,0.00018720675,0.0000394946,0.00065962446,0.00019281199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031840146,0.0008181441,0.028336795,0.000026677691,0.000586889,0.0017583808,0.009678904,0.00028402524,0.57645315,0.0011421683,0.3460023,0.0030723885],"study_design_scores_gemma":[0.022027386,0.00059371395,0.122605436,0.000091840906,0.00010641457,0.00016391576,0.00049086293,0.00025305388,0.0015861425,0.00002229136,0.8519473,0.00011162908],"about_ca_topic_score_codex":0.000014313112,"about_ca_topic_score_gemma":0.000031517025,"teacher_disagreement_score":0.574867,"about_ca_system_score_codex":0.000033551518,"about_ca_system_score_gemma":0.00018224101,"threshold_uncertainty_score":0.44487992},"labels":[],"label_agreement":null},{"id":"W3016855429","doi":"10.1002/ejhf.1817","title":"Age and Biomarkers in Heart Failure: Challenging the Current Model to Select Patients for Clinical Trials","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Montreal Heart Institute","funders":"","keywords":"Medicine; Heart failure; Natriuretic peptide; Internal medicine; Ejection fraction; Clinical trial; Cardiology; Troponin; Biomarker; Troponin T; Intensive care medicine; Myocardial infarction","score_opus":0.1278838768010585,"score_gpt":0.37744305215949614,"score_spread":0.24955917535843763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016855429","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016471677,0.0011575405,0.0010110337,0.99271095,0.0006227697,0.0027344495,0.000036272857,0.00003241442,0.000047410773],"genre_scores_gemma":[0.047015753,0.0011736294,0.10438563,0.82980686,0.016138202,0.00010089051,0.0003188915,0.00056420104,0.00049594935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99324036,0.002560481,0.0023032143,0.0005811206,0.00070573855,0.0006090728],"domain_scores_gemma":[0.9974239,0.0008884694,0.0006128461,0.00040840937,0.0002441804,0.00042219585],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006448194,0.00054112275,0.0019306343,0.00046791203,0.00014371648,0.00012531219,0.00028323068,0.00015189842,0.000017884637],"category_scores_gemma":[0.0016505329,0.00034430635,0.0009118391,0.0002839166,0.000087877204,0.00011258974,0.00017023359,0.0025835168,0.000052483192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042172804,0.0001411113,0.0009205468,0.00028266234,0.000551927,0.00050449144,0.00025710958,0.000019919982,0.000017797372,0.0000025052707,0.9885089,0.008371322],"study_design_scores_gemma":[0.005257187,0.0018341045,0.0008679571,0.0010509846,0.0006235155,0.000055367218,0.000054166234,0.00023515575,0.00000507705,0.000021519756,0.9897024,0.00029258442],"about_ca_topic_score_codex":0.0000015804703,"about_ca_topic_score_gemma":0.0000064469127,"teacher_disagreement_score":0.16290408,"about_ca_system_score_codex":0.00011083888,"about_ca_system_score_gemma":0.00019752112,"threshold_uncertainty_score":0.9999009},"labels":[],"label_agreement":null},{"id":"W3017336514","doi":"10.1002/ejhf.1827","title":"Incident Heart Failure in Outpatients with Chronic Coronary Syndrome: Results from the International Prospective CLARIFY Registry","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Cardiology; Coronary artery disease; Incidence (geometry); Ambulatory; Atrial fibrillation; Acute coronary syndrome; Revascularization; Body mass index; Angina; Myocardial infarction","score_opus":0.015234680365831648,"score_gpt":0.23631015190939864,"score_spread":0.221075471543567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017336514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6217555,0.00020375694,0.00006381845,0.37685376,0.00018294762,0.0005975417,0.000034939967,0.000032958545,0.0002748145],"genre_scores_gemma":[0.98401636,0.00002143818,0.011270708,0.003698833,0.0006316072,0.000005131722,0.00006298605,0.000051709147,0.00024119901],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99732685,0.0003235306,0.0007900489,0.00039224635,0.00085611915,0.0003112125],"domain_scores_gemma":[0.9986453,0.0001044176,0.0003594285,0.00037892538,0.00022065276,0.00029127623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065215694,0.00028346936,0.00048293103,0.00010764483,0.00009797344,0.00008456298,0.00036023,0.00007532191,0.00019310735],"category_scores_gemma":[0.00023048132,0.00017691735,0.00017807337,0.00028428066,0.0001083759,0.00026724534,0.00017482288,0.0013769789,0.00020828279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028280343,0.00028872667,0.43091413,0.000028563023,0.00046987375,0.0053799246,0.0017745823,0.0001344138,0.0007770547,0.000020303436,0.55707014,0.0003142584],"study_design_scores_gemma":[0.008242062,0.0026543639,0.50691754,0.0006164347,0.000113541995,0.0010914773,0.0007475634,0.000029782123,0.00013788335,0.0000069207304,0.47928983,0.00015259668],"about_ca_topic_score_codex":0.000053023643,"about_ca_topic_score_gemma":0.0002095904,"teacher_disagreement_score":0.37315494,"about_ca_system_score_codex":0.0003320589,"about_ca_system_score_gemma":0.00027758995,"threshold_uncertainty_score":0.72144806},"labels":[],"label_agreement":null},{"id":"W3019853805","doi":"10.1002/ejhf.1511","title":"April 2020 at a Glance: Epidemiology, Prevention, and Biomarkers","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiogenic shock; Heart failure; Epidemiology; Myocardial infarction; Internal medicine; Incidence (geometry); Cardiology","score_opus":0.032511928868165715,"score_gpt":0.2864210113508793,"score_spread":0.25390908248271354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019853805","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27169275,0.0033586158,0.00083289883,0.72228205,0.00017327898,0.00040924145,0.0000037650839,0.00005515981,0.0011922492],"genre_scores_gemma":[0.8677451,0.0005087585,0.11762574,0.0112025775,0.0012436422,0.000002021762,0.000015508442,0.000060663882,0.0015959657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983067,0.0005307965,0.0005587951,0.00020555547,0.00016913807,0.00022899921],"domain_scores_gemma":[0.9990145,0.00008376741,0.00021332572,0.0001419782,0.000084999396,0.0004614578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011431423,0.00015869408,0.00046688586,0.00006301166,0.000082117556,0.000012109423,0.00007403179,0.000029875548,0.00032698552],"category_scores_gemma":[0.00037002645,0.00011683102,0.00018879113,0.00014358161,0.00008711469,0.00009496206,0.00010066718,0.00022623464,0.00020489734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040529788,0.00005641505,0.06479465,0.000085705426,0.0003190588,0.00065014075,0.00024046857,0.0000026026057,0.0020652674,0.000032137756,0.92840064,0.0029476157],"study_design_scores_gemma":[0.0025764648,0.0015392827,0.050825905,0.00014975593,0.00018348343,0.0009797431,0.00015144615,0.000027341888,0.000115720926,0.000021490641,0.94333196,0.00009739865],"about_ca_topic_score_codex":9.955119e-7,"about_ca_topic_score_gemma":0.0000018738269,"teacher_disagreement_score":0.7110795,"about_ca_system_score_codex":0.00003733925,"about_ca_system_score_gemma":0.000043954824,"threshold_uncertainty_score":0.47642305},"labels":[],"label_agreement":null},{"id":"W3020224222","doi":"10.1002/ejhf.1831","title":"Acute Coronary Syndromes and Acute Heart Failure: A Diagnostic Dilemma and High-Risk Combination. A Statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Deutsche Forschungsgemeinschaft; European Society of Cardiology","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Dilemma; Statement (logic); Intensive care medicine","score_opus":0.011299821114039895,"score_gpt":0.22671807881006867,"score_spread":0.21541825769602876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020224222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6274892,0.00044504786,0.00012074193,0.37025735,0.00024960522,0.0010204178,0.0003718567,0.000029388162,0.000016401958],"genre_scores_gemma":[0.98545617,0.00041791666,0.010979089,0.0025298798,0.00035118923,0.000010088586,0.000051713272,0.00010007941,0.00010388011],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9925013,0.0036556988,0.0015869802,0.00052827445,0.0011806994,0.00054700073],"domain_scores_gemma":[0.99550325,0.0014128082,0.0013590682,0.0008178245,0.0005804534,0.0003265781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024399688,0.0005716036,0.0015330693,0.0000988531,0.0004492191,0.00008773286,0.00054884976,0.00013861814,0.00006549362],"category_scores_gemma":[0.00053901307,0.00033165442,0.00086884166,0.0005429448,0.0005469405,0.00031920878,0.0007517987,0.0012202775,0.000020206815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015919785,0.00015264345,0.31862092,0.00010461195,0.003695465,0.00006263856,0.0014918386,0.00005005894,0.007923892,0.000043835775,0.66755694,0.000137926],"study_design_scores_gemma":[0.005895808,0.0019044298,0.57474256,0.00056649157,0.0034392497,0.0004929309,0.0014559496,0.000036523867,0.0012806931,0.000049242604,0.4098607,0.00027545134],"about_ca_topic_score_codex":0.00008928945,"about_ca_topic_score_gemma":0.00006239802,"teacher_disagreement_score":0.36772746,"about_ca_system_score_codex":0.00013466233,"about_ca_system_score_gemma":0.0001894271,"threshold_uncertainty_score":0.9999136},"labels":[],"label_agreement":null},{"id":"W3021974182","doi":"10.1002/ejhf.289","title":"Recommendations on Pre-Hospital &amp; Early Hospital Management of Acute Heart Failure: A Consensus Paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine","year":2015,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Respicardia; Abbott Vascular; Servier; Schweizerische Herzstiftung; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; BG Medicine; Medicines Company; Teva Pharmaceutical Industries; Universitätsspital Basel; Alere; Sanofi; Eli Lilly and Company; Amgen; Vifor Pharma; Pfizer; National Science Foundation","keywords":"Medicine; Heart failure; Intensive care medicine; Medical emergency; Acute care; Health care; Emergency medicine; Internal medicine","score_opus":0.044838519918298285,"score_gpt":0.32337143035963317,"score_spread":0.2785329104413349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021974182","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070849275,0.3801332,0.00019272217,0.60058355,0.0029876637,0.0061721834,0.0007604612,0.00006240147,0.0020228666],"genre_scores_gemma":[0.019705527,0.965209,0.008648986,0.0007121338,0.0031447615,0.000030771647,0.00027311966,0.0003240918,0.0019515847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848843,0.0073164483,0.0046230536,0.0006681852,0.001899569,0.000608393],"domain_scores_gemma":[0.99037045,0.0009876506,0.0054743607,0.0016010164,0.0013115918,0.00025490098],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014529594,0.00095048256,0.0035496731,0.000116602816,0.0003654548,0.0000108347895,0.0012187064,0.00026680273,0.0002870964],"category_scores_gemma":[0.00040265225,0.0004382478,0.003968238,0.0009897994,0.001496884,0.00015380536,0.00079848815,0.0023774633,0.000018081613],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008395852,0.00019398157,0.0033898496,0.0019010053,0.010207316,0.0000037117861,0.006620082,0.00000706674,0.00017944945,0.00006881504,0.97469467,0.002650119],"study_design_scores_gemma":[0.0041501746,0.0014368696,0.011354672,0.009155878,0.0104779145,0.00004234616,0.004981505,0.0000029112741,0.0000074762647,0.000047182577,0.9580212,0.00032184165],"about_ca_topic_score_codex":0.00010221447,"about_ca_topic_score_gemma":0.000013893393,"teacher_disagreement_score":0.5998714,"about_ca_system_score_codex":0.00018632239,"about_ca_system_score_gemma":0.00022412308,"threshold_uncertainty_score":0.99992406},"labels":[],"label_agreement":null},{"id":"W3022384237","doi":"10.1002/ejhf.1832","title":"The Prevalence and Importance of Frailty in Heart Failure with Reduced Ejection Fraction – An Analysis of PARADIGM-HF and ATMOSPHERE","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Frailty in Older Adults","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"British Heart Foundation","keywords":"Medicine; Heart failure; Hazard ratio; Ejection fraction; Decompensation; Internal medicine; Cardiology; Confidence interval","score_opus":0.016442803132322357,"score_gpt":0.26038837627656375,"score_spread":0.2439455731442414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022384237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742853,0.0008699046,0.00011224054,0.024466563,0.000025851365,0.00018607231,0.0000070439337,0.00000934342,0.00003764719],"genre_scores_gemma":[0.99338067,0.00016208005,0.0060848226,0.00021853475,0.00009942615,7.358825e-7,0.0000027508709,0.000022948707,0.000028030257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819785,0.00038079103,0.0006539595,0.00023218128,0.00037633127,0.00015890559],"domain_scores_gemma":[0.9987174,0.00011564836,0.0005007306,0.00025766276,0.00020141907,0.00020710268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007198377,0.00015440576,0.00052847236,0.00006263195,0.00006669314,0.00002647784,0.000098864024,0.00004128266,0.00004871263],"category_scores_gemma":[0.00023500429,0.00010407461,0.00009596836,0.0006226271,0.0001729506,0.00030347658,0.000026446884,0.0004672912,0.0000011134138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008447253,0.0000836875,0.97422284,0.0002417847,0.0003437127,0.00006572149,0.0010263147,0.00036627855,0.018023508,0.000010876105,0.0041879523,0.00058260997],"study_design_scores_gemma":[0.0015507112,0.0021888625,0.9772269,0.00042802174,0.0006191144,0.00038266322,0.0013465075,0.00092208484,0.0015161784,0.0000071947675,0.013699099,0.00011263035],"about_ca_topic_score_codex":0.000017291924,"about_ca_topic_score_gemma":0.00015646698,"teacher_disagreement_score":0.024248028,"about_ca_system_score_codex":0.000027860588,"about_ca_system_score_gemma":0.00007386833,"threshold_uncertainty_score":0.42440394},"labels":[],"label_agreement":null},{"id":"W3022392020","doi":"10.1002/ejhf.1852","title":"Effects of Vericiguat in Heart Failure with Reduced Ejection Fraction: Do not Forget sST2. Letter Regarding the Article ‘Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) Trial’","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Heart failure; Medicine; Internal medicine; Cardiology; Valsartan; Natriuretic peptide; Population; Blood pressure","score_opus":0.01090277638089124,"score_gpt":0.24779146440512131,"score_spread":0.23688868802423008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022392020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5031418,0.000094177725,0.00013112492,0.49227035,0.00064602884,0.003592619,0.0000081979515,0.0000524155,0.00006329966],"genre_scores_gemma":[0.964001,0.000012100178,0.005110311,0.02664988,0.0037807766,0.0000703066,0.00002687066,0.0001856335,0.00016312423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915557,0.0031918946,0.0015432301,0.00089054735,0.0020817744,0.0007368606],"domain_scores_gemma":[0.99632245,0.00046853293,0.0014042228,0.0009856885,0.0006153075,0.00020380493],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018046183,0.0009272916,0.0019505309,0.0005539227,0.0002961216,0.00016688246,0.00037967932,0.0002869993,0.000041587933],"category_scores_gemma":[0.0003595041,0.00051106984,0.00048657917,0.0022264065,0.00022807672,0.0006263642,0.00012492303,0.003844692,0.000017311713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028812556,0.001078754,0.034955,0.00057471026,0.0011169045,0.0015703932,0.00065649214,0.00032485495,0.015967175,0.0000023958776,0.91483533,0.00010542843],"study_design_scores_gemma":[0.06021382,0.015903797,0.097354844,0.004953353,0.002590742,0.0017894803,0.003804715,0.000020326725,0.01585562,0.0000063463494,0.79656976,0.00093718094],"about_ca_topic_score_codex":0.00016644086,"about_ca_topic_score_gemma":0.0005345254,"teacher_disagreement_score":0.46562046,"about_ca_system_score_codex":0.0006648682,"about_ca_system_score_gemma":0.00043283484,"threshold_uncertainty_score":0.9997341},"labels":[],"label_agreement":null},{"id":"W3023145403","doi":"10.1002/ejhf.1830","title":"Impact of Tricuspid Regurgitation on Survival in Patients with Heart Failure: A Large Electronic Health Record Patient-Level Database Analysis","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Heart failure; Confidence interval; Proportional hazards model; Internal medicine; Database; Ejection fraction; Cardiology; Survival analysis","score_opus":0.01507437708304049,"score_gpt":0.29921286522895796,"score_spread":0.28413848814591747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023145403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450696,0.00017202817,0.00014379359,0.004399201,0.00003894939,0.00036140688,0.0003455588,0.0000103929215,0.000021690821],"genre_scores_gemma":[0.9975903,0.000019803592,0.001442661,0.00051156944,0.000086568645,0.000001185769,0.00030106734,0.000041875785,0.000004985957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972441,0.0006504096,0.0007540779,0.00027477072,0.00066757336,0.00040907058],"domain_scores_gemma":[0.99829257,0.000058639216,0.00054249604,0.00028504722,0.00033808936,0.00048315167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004904392,0.0002386533,0.0008758449,0.00043768875,0.000052840544,0.00002083524,0.00007977341,0.000022474258,0.00010139961],"category_scores_gemma":[0.00015708881,0.00016650425,0.0011440668,0.0011581449,0.000021435346,0.00017906768,0.000029491051,0.0003933399,0.00002036373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038048015,0.0010927826,0.97811174,0.000041725652,0.0017228122,0.000042347114,0.00022426726,0.00015959809,0.000033417473,0.000004187974,0.013939758,0.0008225857],"study_design_scores_gemma":[0.008523592,0.013676369,0.972627,0.00019185498,0.00072603114,0.000007435615,0.00017175991,0.000019761208,0.000012471083,8.1170805e-7,0.0039149793,0.00012797443],"about_ca_topic_score_codex":0.000047289108,"about_ca_topic_score_gemma":0.00003170728,"teacher_disagreement_score":0.012583585,"about_ca_system_score_codex":0.00023805542,"about_ca_system_score_gemma":0.00039748044,"threshold_uncertainty_score":0.67898464},"labels":[],"label_agreement":null},{"id":"W3023253952","doi":"10.1002/ejhf.1845","title":"The Intersecting Role of Glycaemia and Cardiac Function in the Development of Heart Failure Among Patients with Type 2 Diabetes Mellitus After an Acute Coronary Syndrome","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ejection fraction; Acute coronary syndrome; Heart failure; Internal medicine; Cardiology; Diabetes mellitus; Population; Type 2 Diabetes Mellitus; Lixisenatide; Type 2 diabetes; Liraglutide; Myocardial infarction; Endocrinology","score_opus":0.005517785670720785,"score_gpt":0.18993673727151109,"score_spread":0.1844189516007903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023253952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96253675,0.0011429427,0.0000017072535,0.03558063,0.00018599615,0.0004924735,0.00000884314,0.000008229002,0.000042417098],"genre_scores_gemma":[0.99062365,0.000023297143,0.0018376572,0.0071006995,0.0002198628,0.000006580251,0.000076703844,0.000061110506,0.00005045808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977215,0.00050747814,0.0006873646,0.00022779508,0.00057564006,0.00028021558],"domain_scores_gemma":[0.99888235,0.000102131096,0.00045573703,0.00027873926,0.00019869182,0.0000823331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061806967,0.0002923529,0.000638354,0.00016224776,0.000085077314,0.000049151957,0.0001826413,0.00006932993,0.000017611388],"category_scores_gemma":[0.000022516397,0.00015738145,0.00014318952,0.00019537857,0.00012771807,0.00016536936,0.000099587574,0.00094622455,0.000005990414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008520187,0.0001615979,0.7682076,0.00037270185,0.0023352,0.0004958706,0.003203165,0.000002709994,0.00033193844,9.2674003e-7,0.22095585,0.0030803997],"study_design_scores_gemma":[0.0011584745,0.0039206645,0.68628025,0.0010641662,0.0007913535,0.000030010813,0.0012430906,0.0000017669511,0.00007570997,0.0000046647606,0.30526596,0.00016389694],"about_ca_topic_score_codex":0.0000018345747,"about_ca_topic_score_gemma":0.000007658876,"teacher_disagreement_score":0.0843101,"about_ca_system_score_codex":0.000054871853,"about_ca_system_score_gemma":0.00007382412,"threshold_uncertainty_score":0.64178294},"labels":[],"label_agreement":null},{"id":"W3025281820","doi":"10.1002/ejhf.1853","title":"Liver Function and Prognosis, and Influence of Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Valsartan; Ejection fraction; Hazard ratio; Heart failure; Enalapril; Bilirubin; Clinical endpoint; Confidence interval; Gastroenterology; Sacubitril; Cardiology; Liver function; Liver function tests; Randomized controlled trial; Angiotensin-converting enzyme; Blood pressure","score_opus":0.008859932020917357,"score_gpt":0.21055875119924308,"score_spread":0.20169881917832572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025281820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854587,0.00012406768,0.0001025207,0.013763703,0.000018830899,0.00048975897,0.0000015341645,0.00001754189,0.000023374538],"genre_scores_gemma":[0.9895562,0.000022870987,0.009860091,0.00042159995,0.000092316885,0.0000017071203,0.0000054589946,0.000027896953,0.000011880697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986817,0.00019374759,0.00038318796,0.00022287178,0.00035606092,0.00016242533],"domain_scores_gemma":[0.9991711,0.000026213827,0.0002299507,0.00010291663,0.00026847917,0.00020133602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029723052,0.00017882398,0.00045943315,0.00018292715,0.000058034788,0.000032553427,0.00003143705,0.000034782024,0.00002226697],"category_scores_gemma":[0.000049389102,0.00012256221,0.000040450504,0.00028908902,0.000072396986,0.00044305756,0.000025310816,0.00031902414,0.0000072227003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022759193,0.0002448704,0.98165506,0.00017363728,0.00011271921,0.00004867741,0.00029499317,0.000055793895,0.00555775,0.0000056236718,0.008967736,0.00060721324],"study_design_scores_gemma":[0.004893812,0.007114749,0.94749004,0.0005549848,0.00024486418,0.00008336725,0.0003905364,0.000015468815,0.0007087519,0.0000015277436,0.038379632,0.00012225281],"about_ca_topic_score_codex":0.000010034232,"about_ca_topic_score_gemma":0.000011585497,"teacher_disagreement_score":0.03416501,"about_ca_system_score_codex":0.00003450708,"about_ca_system_score_gemma":0.000046875237,"threshold_uncertainty_score":0.49979416},"labels":[],"label_agreement":null},{"id":"W3026423150","doi":"10.1002/ejhf.1841","title":"Impact of Recent Heart Failure Hospitalization on Clinical Outcomes in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis from the PARTNER 2 Trial and Registries","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Propensity score matching; Hazard ratio; Internal medicine; Heart failure; Cardiology; Stenosis; Proportional hazards model; Confidence interval; Valve replacement; Aortic valve stenosis; Aortic valve replacement; Surgery","score_opus":0.027652804696922946,"score_gpt":0.33493726700815957,"score_spread":0.30728446231123663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026423150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939288,0.000075305536,0.000038282516,0.0053525195,0.000049233553,0.00047435876,0.00006546355,0.0000083259,0.000007720215],"genre_scores_gemma":[0.99893284,0.000057374098,0.00032199334,0.00045139523,0.0001186527,0.0000016183033,0.00008125067,0.000031719515,0.000003159328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974419,0.00074045575,0.0008588134,0.00028274336,0.0004965986,0.00017949291],"domain_scores_gemma":[0.9985656,0.00020216577,0.00042373943,0.00031851206,0.0001935126,0.0002964641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041059416,0.00021782643,0.0007880725,0.000097504126,0.00006047332,0.000052053154,0.00008003226,0.000037382426,0.00009394832],"category_scores_gemma":[0.00026417398,0.000119595235,0.0016406738,0.0003314084,0.00007030719,0.00015812239,0.00002066248,0.00024913138,0.0000030748838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015981995,0.00076161907,0.97566056,0.000011505312,0.005460386,0.0000052207906,0.00043973085,0.0001830036,0.0000017881046,8.8518976e-7,0.0012141123,0.00027919264],"study_design_scores_gemma":[0.028578877,0.0125760585,0.95361364,0.00012765531,0.004397038,0.0000012598034,0.00035808884,0.000017770168,0.0000020220841,0.0000028616228,0.00021176177,0.00011296542],"about_ca_topic_score_codex":0.000025221098,"about_ca_topic_score_gemma":0.0000124104,"teacher_disagreement_score":0.022046922,"about_ca_system_score_codex":0.000058019243,"about_ca_system_score_gemma":0.00011253945,"threshold_uncertainty_score":0.48769522},"labels":[],"label_agreement":null},{"id":"W3028175580","doi":"10.1002/ejhf.1857","title":"Guideline-Directed Medical Therapy for Heart Failure does not Exist: A Non-Judgmental Framework for Describing the Level of Adherence to Evidence-Based Drug Treatments for Patients with a Reduced Ejection Fraction","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Guideline; Heart failure; Ejection fraction; Intensive care medicine; Dosing; Clinical trial; Adverse effect; Randomized controlled trial; Pharmacotherapy; Internal medicine; Pathology","score_opus":0.1637144166872602,"score_gpt":0.36776741260173756,"score_spread":0.20405299591447737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028175580","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073956065,0.40388507,0.20616236,0.29686663,0.0039279955,0.07938772,0.0019199789,0.00043153678,0.00002310052],"genre_scores_gemma":[0.0065464526,0.09252146,0.8923275,0.0032449618,0.0027925903,0.0012831052,0.0005106564,0.00046302762,0.00031025932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533534,0.0005587848,0.0018823319,0.0006382292,0.0010831385,0.00050215726],"domain_scores_gemma":[0.9954101,0.0012765635,0.0012620657,0.000485523,0.001088036,0.00047772672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017551244,0.0007215278,0.0021932826,0.00035616945,0.0003002417,0.00009228103,0.0003600353,0.00018600334,0.00006204442],"category_scores_gemma":[0.0014226617,0.00037433003,0.0013186675,0.0004693817,0.000081070684,0.00023808004,0.00005381947,0.00062680314,0.000011915073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010152503,0.0017266003,0.00051834626,0.0055813957,0.003584244,0.000052024207,0.0005070691,0.000008313174,0.00026792492,0.000018071922,0.46958542,0.5079981],"study_design_scores_gemma":[0.0064011584,0.011388202,0.000099819124,0.037590075,0.002503684,0.00004372039,0.00022870244,0.000038322953,0.00037977996,0.000008556548,0.940964,0.00035399877],"about_ca_topic_score_codex":0.000016636728,"about_ca_topic_score_gemma":0.000017938342,"teacher_disagreement_score":0.68616515,"about_ca_system_score_codex":0.0003834856,"about_ca_system_score_gemma":0.0009364268,"threshold_uncertainty_score":0.99987084},"labels":[],"label_agreement":null},{"id":"W3028855474","doi":"10.1002/ejhf.1513","title":"May 2020 at a Glance: Ischaemic Heart Failure and Sex-Related Differences","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Cardiology; Acute coronary syndrome; Diabetes mellitus; Etiology; Pathophysiology; Myocardial infarction; Endocrinology","score_opus":0.01237754044167398,"score_gpt":0.22129282957746635,"score_spread":0.20891528913579238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028855474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9120994,0.0020958653,0.00006275321,0.08500521,0.00028318397,0.00015860183,0.0000071860068,0.000054207387,0.00023359842],"genre_scores_gemma":[0.9942369,0.00025163408,0.0017072157,0.002209601,0.00078222883,3.9614608e-7,0.0000063951293,0.000046785466,0.00075884495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980704,0.0004176166,0.00052418443,0.00026431546,0.00048083143,0.00024261468],"domain_scores_gemma":[0.9988956,0.000044167755,0.00016790496,0.00019680356,0.0001152084,0.0005803118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050255354,0.00022791732,0.00065937423,0.00008682739,0.00013482444,0.000045790915,0.00009957989,0.00006619556,0.0006682549],"category_scores_gemma":[0.00012748175,0.00015968693,0.00044677424,0.00023500079,0.00011141263,0.00011875261,0.000092302915,0.0007726437,0.00024160599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002932979,0.00004581975,0.34000614,0.00008251798,0.00052502955,0.0010572628,0.0016137387,0.000015815021,0.018517729,0.0000058325763,0.63687646,0.00096038665],"study_design_scores_gemma":[0.002767371,0.0008265245,0.1484283,0.0001868674,0.00020598611,0.0069712056,0.0010676725,0.000031025924,0.00066896126,0.0000020690416,0.8386625,0.00018149223],"about_ca_topic_score_codex":0.000002277655,"about_ca_topic_score_gemma":0.0000027776557,"teacher_disagreement_score":0.20178607,"about_ca_system_score_codex":0.000034137574,"about_ca_system_score_gemma":0.000067246954,"threshold_uncertainty_score":0.73169225},"labels":[],"label_agreement":null},{"id":"W3029617361","doi":"10.1002/ejhf.1922","title":"Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":489,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Respicardia; Abbott Vascular; Servier; Pfizer; Vifor Pharma; Impulse Dynamics; HeartWare; Boston Scientific Corporation; Eisai; Sanofi; MyoKardia; Bristol-Myers Squibb; AstraZeneca; Amgen","keywords":"Medicine; Cardiogenic shock; Intensive care medicine; Heart failure; Clinical trial; Psychological intervention; Epidemiology; Harm; Translational research; Cardiology; Internal medicine; Pathology; Myocardial infarction; Nursing","score_opus":0.03431570527179768,"score_gpt":0.26015211007980377,"score_spread":0.2258364048080061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029617361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015584853,0.99321187,0.0006232727,0.0027882212,0.00046786078,0.0007402367,0.00042083883,0.000024295052,0.00016491432],"genre_scores_gemma":[0.22030385,0.77085596,0.0068919533,0.0004908595,0.0010711986,0.0000086940545,0.00013838899,0.00022342392,0.000015692607],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98938435,0.00752214,0.0022499596,0.00028022926,0.00031503392,0.00024828067],"domain_scores_gemma":[0.9967642,0.0006435712,0.0018385047,0.0004899318,0.00015817214,0.000105611514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00456319,0.0003704112,0.0025310314,0.000051147916,0.000059016093,0.000006903831,0.0005466112,0.00014390555,0.000013467896],"category_scores_gemma":[0.00009850401,0.00022864659,0.0015607756,0.0002143549,0.00012045001,0.00007394771,0.0002843899,0.00086248317,0.00001028546],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007219074,0.00008772171,0.013625564,0.027238999,0.02414173,0.00021977782,0.0009528829,0.0026666583,0.0025249405,0.00018019254,0.87949884,0.04879052],"study_design_scores_gemma":[0.00040317306,0.00016085106,0.005342764,0.0034687326,0.0012028082,0.00006971023,0.0002368523,0.000023378732,0.000017780656,0.000052270363,0.98883045,0.00019122],"about_ca_topic_score_codex":0.0000038363514,"about_ca_topic_score_gemma":8.751657e-7,"teacher_disagreement_score":0.22235593,"about_ca_system_score_codex":0.00011217102,"about_ca_system_score_gemma":0.000082413666,"threshold_uncertainty_score":0.9323937},"labels":[],"label_agreement":null},{"id":"W3029659839","doi":"10.1002/ejhf.1863","title":"Mitral Regurgitation, Edge-to-Edge Valve Repair and the Left Atrium: One Step Beyond the Left Ventricle?","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ventricle; Cardiology; Internal medicine; Mitral regurgitation; Library science","score_opus":0.011779896019024285,"score_gpt":0.25996124007620464,"score_spread":0.24818134405718034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029659839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013941191,0.008995039,0.00003232036,0.9745724,0.0007168847,0.0008569474,0.00009067619,0.000047013145,0.00074748514],"genre_scores_gemma":[0.14924875,0.00045382066,0.002973801,0.8250893,0.018699642,0.0000049520017,0.00019662225,0.00030434062,0.0030288184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632925,0.0012017146,0.0007997546,0.0003840695,0.00088491343,0.00040027473],"domain_scores_gemma":[0.99768406,0.00038366442,0.00047347753,0.0005934349,0.0004961643,0.0003691997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078768353,0.00041402795,0.0009067825,0.00016487256,0.00028944746,0.0001675572,0.00027972183,0.00009765565,0.00014626462],"category_scores_gemma":[0.0003354064,0.00023245519,0.0045160423,0.00018905096,0.00024016904,0.00010559835,0.00014351796,0.0018976124,0.00023223716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057052565,0.000053700216,0.008014981,0.00013142567,0.0033504264,0.0019434829,0.0006410278,0.0000028605898,0.0000129188,0.0000075460994,0.9849352,0.0003358569],"study_design_scores_gemma":[0.0046833637,0.000648922,0.07915494,0.0003627385,0.005164879,0.001489794,0.00021175394,0.0000030765623,0.000005208614,0.000041006428,0.9080247,0.00020957697],"about_ca_topic_score_codex":0.0000037812085,"about_ca_topic_score_gemma":9.00332e-7,"teacher_disagreement_score":0.14948319,"about_ca_system_score_codex":0.00008496431,"about_ca_system_score_gemma":0.00020509225,"threshold_uncertainty_score":0.94792473},"labels":[],"label_agreement":null},{"id":"W3030967944","doi":"10.1002/ejhf.1909","title":"Spironolactone Dose in Heart Failure with Preserved Ejection Fraction: Findings from TOPCAT","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Centro Nacional de Investigaciones Cardiovasculares; Agence Nationale de la Recherche","keywords":"Spironolactone; Medicine; Heart failure; Ejection fraction; Cardiology; Internal medicine; Heart failure with preserved ejection fraction","score_opus":0.021577686815992463,"score_gpt":0.24579103397270288,"score_spread":0.22421334715671043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030967944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7551444,0.00017958497,0.00037367924,0.24332495,0.000102769875,0.00042562644,0.0000037836737,0.00005793568,0.00038728255],"genre_scores_gemma":[0.954199,0.000019576015,0.04226148,0.002308274,0.00084817974,0.000003187298,0.00001974231,0.000063975705,0.00027656477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978439,0.0003296988,0.0006287148,0.00034363047,0.00052188727,0.00033217284],"domain_scores_gemma":[0.99890745,0.000061801045,0.00018596003,0.00028253839,0.00013936353,0.00042289033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004755098,0.00028727236,0.00060385134,0.00022226496,0.000089590365,0.0000829379,0.00013929984,0.00006276978,0.0009839013],"category_scores_gemma":[0.00009529412,0.000214653,0.0002013124,0.00035225606,0.000049569036,0.00048922066,0.00006636845,0.00080094644,0.00037969014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019658625,0.0004133231,0.43205246,0.00009250141,0.00030870002,0.0015595458,0.00074548385,0.00010006877,0.020248566,0.000009338422,0.54212314,0.0003810095],"study_design_scores_gemma":[0.0053286995,0.0020264788,0.19471924,0.00035377798,0.00015713806,0.00017356363,0.0010116353,0.000037465517,0.0021760084,0.000004566598,0.7938201,0.00019134865],"about_ca_topic_score_codex":0.000045132692,"about_ca_topic_score_gemma":0.00007348916,"teacher_disagreement_score":0.25169694,"about_ca_system_score_codex":0.00012412778,"about_ca_system_score_gemma":0.00009329118,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W3031292493","doi":"10.1002/ejhf.1920","title":"Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":770,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital; University of Toronto; University Health Network; Sinai Health System; Mount Sinai Hospital","funders":"Cilag; National Heart, Lung, and Blood Institute; Pharmacyclics; Ipsen; National Cancer Institute; Servier; Astellas Pharma; Eisai; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Sanofi; Abiomed; Pfizer; Incyte; Intas Pharmaceuticals; CTI Biopharma; Fondation Leducq; Novo Nordisk; MyoKardia; Accuray; Amicus Therapeutics; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Barts Charity; Karyopharm Therapeutics; Alere; Audentes Therapeutics; Amgen; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Cancer; Cardiotoxicity; Oncology; Trastuzumab; Risk assessment; Heart failure; Intensive care medicine; Breast cancer; Chemotherapy","score_opus":0.018106433886804444,"score_gpt":0.291954862261243,"score_spread":0.27384842837443857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031292493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9242976,0.0005975621,0.0010543271,0.071350776,0.00031036517,0.0020174948,0.00031471293,0.0000065498652,0.000050632207],"genre_scores_gemma":[0.9940104,0.0009303112,0.0027530335,0.0014769387,0.0007259018,0.000037133294,0.000020990925,0.00004102347,0.0000042915376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.988429,0.00869113,0.0010842384,0.00037690502,0.0011748007,0.00024391706],"domain_scores_gemma":[0.9965939,0.0005253809,0.0013279055,0.0004377275,0.0010082815,0.00010679381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074522663,0.0002750136,0.0011319024,0.0000549084,0.00017283938,0.00004236971,0.0003695462,0.00010924689,0.000010016519],"category_scores_gemma":[0.00028515316,0.00014949746,0.00082697516,0.00065890077,0.0001472931,0.00018654719,0.00018119375,0.0012006349,3.24418e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046238487,0.00022770127,0.8705326,0.00003947725,0.0063322815,0.000007168038,0.021187235,0.024995258,0.04815552,0.000001921261,0.024402652,0.0036558418],"study_design_scores_gemma":[0.008480371,0.001648053,0.92190075,0.00030518274,0.0012118446,0.000012394914,0.022169119,0.00014967602,0.002851124,0.000005016007,0.041112803,0.0001536661],"about_ca_topic_score_codex":0.0007760567,"about_ca_topic_score_gemma":0.0009877306,"teacher_disagreement_score":0.06987384,"about_ca_system_score_codex":0.0014477797,"about_ca_system_score_gemma":0.0011100346,"threshold_uncertainty_score":0.6096329},"labels":[],"label_agreement":null},{"id":"W3031741576","doi":"10.1002/ejhf.1915","title":"Management of Heart Failure Patients with COVID-19: A Joint Position Paper of the Chinese Heart Failure Association &amp; National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Pandemic; Concomitant; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Disease; Position paper; Disease management; Internal medicine; Infectious disease (medical specialty); Pathology","score_opus":0.015105446468675711,"score_gpt":0.2627155376474622,"score_spread":0.2476100911787865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031741576","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011354728,0.08060797,0.0003726927,0.89286894,0.0010017337,0.011719975,0.0012245384,0.00014852143,0.00070087507],"genre_scores_gemma":[0.65505147,0.124060854,0.17125696,0.031616155,0.0077812634,0.00040026568,0.0027155958,0.0022360343,0.0048814123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9838344,0.007906942,0.003335781,0.0008480746,0.0033024147,0.0007724083],"domain_scores_gemma":[0.99110764,0.00087725325,0.0044942745,0.0012438801,0.001827243,0.00044968075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0074030813,0.001170639,0.0043912134,0.00037446865,0.00054479716,0.000106379164,0.0007956933,0.00043239933,0.00013050727],"category_scores_gemma":[0.0009238046,0.0006383216,0.0032493523,0.0015520446,0.00059806224,0.00039370946,0.0007729576,0.002206701,0.00003874193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029692534,0.00046650425,0.048814535,0.0067993137,0.005294613,0.0000143076695,0.0009059475,0.00014265701,0.00025239412,0.00015308741,0.9363055,0.0005541746],"study_design_scores_gemma":[0.0069266097,0.0007317136,0.04095412,0.006171359,0.0036034475,0.00026528048,0.0005705003,0.0000041650246,0.000020547903,0.000039107126,0.9402482,0.00046493532],"about_ca_topic_score_codex":0.000038834445,"about_ca_topic_score_gemma":0.000116874195,"teacher_disagreement_score":0.8612528,"about_ca_system_score_codex":0.0010325938,"about_ca_system_score_gemma":0.00082813296,"threshold_uncertainty_score":0.9996068},"labels":[],"label_agreement":null},{"id":"W3032693035","doi":"10.1002/ejhf.1850","title":"Percutaneous Valve Repair of Functional Mitral Regurgitation: Aiming at Optimal and Durable Results","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; MitraClip; Cardiology; Mitral regurgitation; Heart failure; Internal medicine; Functional mitral regurgitation; Retrospective cohort study; Percutaneous; Mitral valve; Surgery; Ejection fraction","score_opus":0.017144003351178164,"score_gpt":0.2578802555445895,"score_spread":0.24073625219341133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032693035","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14287293,0.005516728,0.000019013989,0.8473688,0.0008232958,0.00041788124,0.00043910329,0.00006772875,0.0024745134],"genre_scores_gemma":[0.58981496,0.0006140337,0.033429105,0.33401,0.022073476,0.0000032178295,0.0019234419,0.00054508424,0.017586702],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976794,0.00029917667,0.00079979614,0.00031997863,0.0006633779,0.00023825886],"domain_scores_gemma":[0.99842966,0.00014663888,0.00052858365,0.00025033913,0.00039384255,0.00025092578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024457398,0.00028942266,0.00072035036,0.00015540818,0.00009774089,0.000030109486,0.00006608366,0.000097281336,0.00014356372],"category_scores_gemma":[0.00020295585,0.00023855054,0.0033424096,0.00010400003,0.00010504678,0.000089041365,0.00006727128,0.00096034934,0.000049306105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001538067,0.000044110675,0.0023734285,0.00027019222,0.002483322,0.015056689,0.00018780096,0.000054476757,0.00024467264,5.410695e-7,0.97765416,0.000092510345],"study_design_scores_gemma":[0.0028930386,0.0015862727,0.030056288,0.00080074783,0.003055556,0.021025412,0.00015862711,0.000012103668,0.000019798437,0.000002361852,0.94018084,0.00020893486],"about_ca_topic_score_codex":0.0000019915972,"about_ca_topic_score_gemma":1.8343822e-7,"teacher_disagreement_score":0.5133588,"about_ca_system_score_codex":0.000103427934,"about_ca_system_score_gemma":0.00016334912,"threshold_uncertainty_score":0.9727808},"labels":[],"label_agreement":null},{"id":"W3032791994","doi":"10.1002/ejhf.1913","title":"Transcatheter Aortic Valve Replacement After Heart Failure Hospitalization: Too Little, too Late?","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Valve replacement; Heart failure; Aortic valve replacement; Stenosis; Internal medicine; Cardiology; Aortic valve stenosis; Retrospective cohort study; Inotrope; valvular heart disease; Acute kidney injury","score_opus":0.009611271055730897,"score_gpt":0.2597764232874049,"score_spread":0.250165152231674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032791994","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033907015,0.0035679024,0.000114370014,0.959921,0.0009895405,0.0008299335,0.00019348768,0.00007967588,0.00039704883],"genre_scores_gemma":[0.2675542,0.00016206838,0.004265095,0.71251017,0.010775791,0.000023740497,0.0006021947,0.00046877906,0.0036379606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957272,0.00061473204,0.0012290307,0.0006313281,0.0011980352,0.0005996734],"domain_scores_gemma":[0.9977242,0.00005732914,0.00047268215,0.00074219034,0.00045348727,0.0005501177],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032270132,0.0007147262,0.0013141363,0.00026233876,0.00011694846,0.00018871033,0.00023171419,0.0002197683,0.0011774617],"category_scores_gemma":[0.000072364805,0.00057101564,0.006237764,0.00027432776,0.00010117376,0.0002211349,0.00008104209,0.0018621709,0.0007318761],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004103406,0.00016343806,0.022836793,0.00036415202,0.002990958,0.0017959771,0.00034425384,0.000004960696,0.000039635823,6.6292444e-7,0.97093,0.000118833115],"study_design_scores_gemma":[0.0027565418,0.0019682378,0.03889983,0.0009066126,0.0038669298,0.000776206,0.000061309685,0.0000022089666,0.000031468164,0.000010911836,0.95024985,0.00046987936],"about_ca_topic_score_codex":0.0000029187981,"about_ca_topic_score_gemma":3.075814e-7,"teacher_disagreement_score":0.24741085,"about_ca_system_score_codex":0.00017374397,"about_ca_system_score_gemma":0.00025207215,"threshold_uncertainty_score":0.9997356},"labels":[],"label_agreement":null},{"id":"W3034942267","doi":"10.1002/ejhf.1936","title":"The Time has Finally Come to Prioritize Drug Initiation Before Dose Titration for Patients with Heart Failure and Reduced Ejection Fraction","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Guideline; Aldosterone; Internal medicine; Cardiology; Pharmacology","score_opus":0.012885839181944782,"score_gpt":0.23441051145087347,"score_spread":0.2215246722689287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034942267","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031097142,0.0000469362,0.00030120774,0.96615946,0.00028760705,0.0019546147,0.000026878231,0.000055445264,0.00007071043],"genre_scores_gemma":[0.2681424,0.00006013864,0.13890992,0.5620855,0.021226313,0.0001356595,0.0024364218,0.0007126112,0.006291061],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974675,0.00040880532,0.0007027193,0.0003679334,0.0007074727,0.00034556192],"domain_scores_gemma":[0.9982314,0.00014906612,0.00047335046,0.00027545745,0.00065424107,0.00021644482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005939077,0.00038894822,0.00059118884,0.00025586173,0.00048961624,0.00031196562,0.00011709608,0.00011955391,0.000036991678],"category_scores_gemma":[0.00017745237,0.0002581052,0.0002145714,0.00022534095,0.000070496746,0.0003437985,0.000045140703,0.0011416158,0.00011463711],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067719794,0.00007122071,0.0015354268,0.00014666161,0.0001968337,0.00010811838,0.00019891189,0.000002477124,0.0003344111,0.000002817635,0.9961776,0.000548311],"study_design_scores_gemma":[0.0029864272,0.0044297855,0.015105944,0.0005591725,0.00046932406,0.00012794077,0.00008241939,0.000014258339,0.00005029755,0.000017182654,0.97593564,0.00022159447],"about_ca_topic_score_codex":0.0000031755812,"about_ca_topic_score_gemma":0.0000141552855,"teacher_disagreement_score":0.40407398,"about_ca_system_score_codex":0.0001823102,"about_ca_system_score_gemma":0.00018129194,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W3035255089","doi":"10.1002/ejhf.1867","title":"Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibition According to Left Ventricular Ejection Fraction in DAPA-HF","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Defense Acquisition Program Administration; British Heart Foundation; AstraZeneca","keywords":"Dapagliflozin; Ejection fraction; Medicine; Hazard ratio; Heart failure; Internal medicine; Placebo; Cardiology; Clinical endpoint; Confidence interval; Randomized controlled trial; Adverse effect; Diabetes mellitus; Endocrinology","score_opus":0.012583925948587083,"score_gpt":0.24159811401001752,"score_spread":0.22901418806143042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035255089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891346,0.00014561984,0.00087322656,0.009130984,0.000060363156,0.0002761339,0.0000017271226,0.000012653887,0.0003646803],"genre_scores_gemma":[0.9974616,0.000053652337,0.0016711366,0.00058022497,0.0001881318,3.4068282e-7,0.00001155593,0.00001761172,0.000015753178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904746,0.00010356248,0.00040328482,0.00012519461,0.00020148253,0.00011899261],"domain_scores_gemma":[0.9995585,0.000019432966,0.00014601726,0.00006933956,0.000060573777,0.00014615597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036933422,0.00010066246,0.00026726007,0.00018838239,0.00003061571,0.000015414491,0.000028066943,0.000018888772,0.000046451198],"category_scores_gemma":[0.000040205996,0.00008579218,0.00007918315,0.00015764563,0.000014584197,0.00017728258,0.000015157102,0.00018785827,0.000023146136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007663725,0.0013924092,0.61439633,0.0007190247,0.000639795,0.004095726,0.00292469,0.00054451666,0.2951031,0.000054456,0.035349138,0.037117064],"study_design_scores_gemma":[0.012904982,0.004237217,0.66755813,0.0013030224,0.00042346958,0.00022024737,0.0016536013,0.000060321836,0.039259247,0.0000061055453,0.27214617,0.00022745409],"about_ca_topic_score_codex":0.0000015646057,"about_ca_topic_score_gemma":9.596556e-7,"teacher_disagreement_score":0.25584388,"about_ca_system_score_codex":0.000045162866,"about_ca_system_score_gemma":0.000013990009,"threshold_uncertainty_score":0.34985033},"labels":[],"label_agreement":null},{"id":"W3037127994","doi":"10.1002/ejhf.1946","title":"What Should the C (‘Congestive Heart Failure’) Represent in the CHA2DS2-VASc Score?","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Internal medicine; Cardiology","score_opus":0.11681295559601695,"score_gpt":0.32694815799877947,"score_spread":0.2101352024027625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037127994","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16668837,0.0009350728,0.00009251385,0.8310527,0.00037166508,0.00045502651,9.520931e-7,0.000021412261,0.0003823011],"genre_scores_gemma":[0.9757677,0.00012544953,0.0011318107,0.01932584,0.0033264875,6.1382104e-7,0.0000029935613,0.00003625696,0.0002828666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972438,0.0009732871,0.0006499533,0.00021468477,0.00065797317,0.00026028577],"domain_scores_gemma":[0.9987847,0.00030197029,0.00024106976,0.00035572285,0.00014641689,0.00017009533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018857453,0.00019445753,0.00042063548,0.00010550377,0.00012967143,0.00020884376,0.00032379958,0.000032725882,0.00022496065],"category_scores_gemma":[0.00053854904,0.00010019597,0.00036110298,0.00043450305,0.0001058509,0.0004112967,0.000116867486,0.0007597925,0.00021659781],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005617523,0.000027971017,0.15919378,0.000059664068,0.00019381529,0.00068848743,0.00627251,0.0004753622,0.0018376535,0.00044461043,0.8289541,0.0012902716],"study_design_scores_gemma":[0.0014388363,0.00043575605,0.11742528,0.00020561718,0.000102836995,0.00029777602,0.0068254997,0.000058380923,0.00019452494,0.00003012573,0.87287825,0.00010714297],"about_ca_topic_score_codex":0.0000035996804,"about_ca_topic_score_gemma":0.000007849681,"teacher_disagreement_score":0.81172687,"about_ca_system_score_codex":0.000025357967,"about_ca_system_score_gemma":0.000057752495,"threshold_uncertainty_score":0.4085873},"labels":[],"label_agreement":null},{"id":"W3037737029","doi":"10.1002/ejhf.1869","title":"Effects of Combined Renin–Angiotensin–Aldosterone System Inhibitor and Beta-Blocker Treatment on Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from BIOSTAT-CHF and ASIAN-HF Registries","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Medical Research Council; Boston Scientific Corporation; Biomedical Research Council; Vifor Pharma; Servier; European Commission; Medical Research Council; Alere; Abbott Laboratories","keywords":"Medicine; Ejection fraction; Heart failure; Hazard ratio; Internal medicine; Cardiology; Confidence interval; Beta blocker; Guideline; Angiotensin receptor; Renin–angiotensin system; Blood pressure","score_opus":0.011255630880551903,"score_gpt":0.2202563669013363,"score_spread":0.2090007360207844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037737029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8676313,0.00044020146,0.00003751423,0.13094096,0.00011859833,0.0007369398,0.0000075677576,0.000043615935,0.000043288597],"genre_scores_gemma":[0.98733646,0.00003300117,0.011793961,0.00040964456,0.00025559345,0.000004851531,0.000015705093,0.000052281288,0.00009847649],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978609,0.00044658268,0.0006729587,0.00038186272,0.00041135706,0.00022634419],"domain_scores_gemma":[0.9987876,0.00014957035,0.00034772672,0.00023854534,0.0001401783,0.00033639855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017022794,0.000378839,0.0010556221,0.00027450046,0.000098819975,0.000059331232,0.000049376486,0.000074904085,0.000008450349],"category_scores_gemma":[0.000060362756,0.00024969183,0.0001422682,0.00024755433,0.00010826924,0.00021130145,0.000040982122,0.00032817738,0.000016233276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02108366,0.0031742775,0.30725375,0.001744132,0.005540227,0.011024871,0.010214044,0.00003287341,0.3035462,0.0002113868,0.33172354,0.004451027],"study_design_scores_gemma":[0.041198168,0.040593807,0.4787169,0.005260345,0.0020299952,0.00088309194,0.0051009427,0.000046396613,0.13214767,0.000009163401,0.29324323,0.00077027915],"about_ca_topic_score_codex":0.0000421818,"about_ca_topic_score_gemma":0.000034114408,"teacher_disagreement_score":0.17146316,"about_ca_system_score_codex":0.0001330959,"about_ca_system_score_gemma":0.000064248976,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W3038598579","doi":"10.1002/ejhf.1958","title":"Association Between Glycated Haemoglobin Levels and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Interquartile range; Heart failure; Myocardial infarction; Unstable angina; Diabetes mellitus; Type 2 diabetes; Cardiology; Stroke (engine); Randomized controlled trial; Glycated hemoglobin; Sitagliptin; Confidence interval; Endocrinology","score_opus":0.0200420869177983,"score_gpt":0.24495044799100377,"score_spread":0.22490836107320547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038598579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500793,0.0017816626,0.000019311552,0.0022743857,0.000060445378,0.00080024084,0.000021594138,0.0000067426968,0.000027703174],"genre_scores_gemma":[0.9992877,0.000051030616,0.00032967483,0.00018077585,0.00009197212,0.0000018337197,0.00001690497,0.000017296281,0.00002280303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968038,0.0015762801,0.00070129335,0.00020085975,0.0005739159,0.00014380341],"domain_scores_gemma":[0.9988683,0.00023488449,0.0002933979,0.0002542028,0.00017581307,0.00017340672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003230042,0.00014933838,0.0017700745,0.00014764711,0.000034401717,0.000026536227,0.00007943547,0.000030944262,0.000018631028],"category_scores_gemma":[0.00096903724,0.000084011444,0.0011199227,0.00042189434,0.00007453872,0.00008742754,0.000073132534,0.00024307557,0.000001224849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01372675,0.00009307539,0.9295489,0.000038365783,0.05259326,0.000018134291,0.000082004044,0.0000670032,0.0000012189255,4.4579397e-7,0.0006595945,0.0031712526],"study_design_scores_gemma":[0.21681388,0.0005323056,0.7535949,0.00005527727,0.02432864,1.423206e-7,0.000021741469,0.000024286666,0.000004621428,0.0000012114773,0.0045574973,0.00006553148],"about_ca_topic_score_codex":0.000002095584,"about_ca_topic_score_gemma":7.5842814e-7,"teacher_disagreement_score":0.20308712,"about_ca_system_score_codex":0.000025151498,"about_ca_system_score_gemma":0.000049179354,"threshold_uncertainty_score":0.34258872},"labels":[],"label_agreement":null},{"id":"W3040668198","doi":"10.1002/ejhf.1954","title":"Sodium–Glucose Co-Transporter 2 Inhibitors in Heart Failure: Beyond Glycaemic Control. A Position Paper of the Heart Failure Association of the European Society of Cardiology","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Boston Scientific Corporation; Servier; Universität Zürich; AstraZeneca; MyoKardia; Bristol-Myers Squibb","keywords":"Dapagliflozin; Empagliflozin; Medicine; Canagliflozin; Heart failure; Ejection fraction; Internal medicine; Cardiology; Benzhydryl compounds; Diabetes mellitus; Clinical trial; Type 2 diabetes; Endocrinology","score_opus":0.006179615316602618,"score_gpt":0.2049329562339143,"score_spread":0.1987533409173117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040668198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79195887,0.0003724104,0.00005932155,0.20573728,0.00024773498,0.00077623024,0.00005794737,0.000018382343,0.0007718587],"genre_scores_gemma":[0.99402505,0.000029196646,0.001229795,0.0040821177,0.00047999158,0.0000018757961,0.00001483974,0.000052566924,0.000084579],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9960818,0.0015323798,0.0011418283,0.00024180712,0.0006789818,0.00032318337],"domain_scores_gemma":[0.9982691,0.00010376816,0.0008242895,0.0003550939,0.00031224967,0.00013550215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018333662,0.00026574277,0.000891233,0.00008937396,0.0000766037,0.000016655085,0.00026949245,0.00008395778,0.000048300633],"category_scores_gemma":[0.000103508144,0.00016798041,0.0009954046,0.0003775198,0.00017258928,0.00018628454,0.00007839176,0.0006572203,0.000015586482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025306334,0.00017154656,0.29813758,0.00019416193,0.0006229541,0.000023708293,0.0010975202,0.00019205168,0.2465145,0.00002061387,0.45261922,0.00015306713],"study_design_scores_gemma":[0.009688712,0.001471177,0.49715027,0.000785503,0.0008999068,0.00008114023,0.0010605889,0.00001778577,0.02393058,0.000020690417,0.4646697,0.00022393643],"about_ca_topic_score_codex":0.000006895605,"about_ca_topic_score_gemma":0.000013131431,"teacher_disagreement_score":0.22258392,"about_ca_system_score_codex":0.00011490409,"about_ca_system_score_gemma":0.0001073881,"threshold_uncertainty_score":0.68500423},"labels":[],"label_agreement":null},{"id":"W3043428679","doi":"10.1002/ejhf.1951","title":"Implications of Serial Measurements of Natriuretic Peptides in Heart Failure: Insights from BIOSTAT-CHF","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"NIH Clinical Center; Istituto Auxologico Italiano; National Institute for Health and Care Research; Universitetet i Bergen; Linköpings Universitet; Karolinska Institutet","keywords":"Medicine; Natriuretic peptide; Heart failure; Cohort; Internal medicine; Guideline; Cohort study; Brain natriuretic peptide; Cardiology; Intensive care medicine; Pathology","score_opus":0.034237432604441835,"score_gpt":0.2574952968379777,"score_spread":0.22325786423353589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043428679","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025846347,0.0009242168,0.00004591358,0.9712266,0.00042845134,0.0009319948,0.00010007933,0.00003321105,0.0004631851],"genre_scores_gemma":[0.723659,0.00014566565,0.11610363,0.15117694,0.0074401223,0.00001691957,0.00065676763,0.00041115086,0.0003898444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948832,0.0009682096,0.0020456878,0.0004985377,0.0011668144,0.00043755263],"domain_scores_gemma":[0.9971842,0.00017190697,0.0010518589,0.00070001744,0.0006135196,0.0002784851],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005432388,0.0005631269,0.0017333098,0.000801752,0.0000653508,0.00004172122,0.0004195231,0.00023090722,0.00027805977],"category_scores_gemma":[0.000245461,0.00046338243,0.00069652655,0.0005960217,0.00018789408,0.00018877024,0.00015067463,0.0018018445,0.00011971662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023899568,0.00022313338,0.0063903257,0.000356888,0.0006233494,0.00074704585,0.0004440142,0.0000084027415,0.030590842,0.0000069537364,0.9602539,0.00011616187],"study_design_scores_gemma":[0.0041858023,0.0015012071,0.01133008,0.0017160198,0.00075487804,0.00015447376,0.00017471603,0.000001284494,0.003912079,0.00011159477,0.9758288,0.00032903888],"about_ca_topic_score_codex":0.000056399018,"about_ca_topic_score_gemma":0.00005124865,"teacher_disagreement_score":0.82004964,"about_ca_system_score_codex":0.00016436257,"about_ca_system_score_gemma":0.0004079424,"threshold_uncertainty_score":0.9997818},"labels":[],"label_agreement":null},{"id":"W3044952954","doi":"10.1002/ejhf.1973","title":"Frailty and the Failing Heart do not Travel Alone","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; St. Boniface Hospital; Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Subclinical infection; Stressor; Disease; Cohort; Intensive care medicine; Cardiovascular health; Gerontology; Internal medicine; Psychiatry","score_opus":0.027484060763974395,"score_gpt":0.25393701387195977,"score_spread":0.22645295310798538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044952954","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002136585,0.0018120521,0.00015935954,0.9938843,0.0006494674,0.00044816776,0.00003380316,0.000038508355,0.00083774625],"genre_scores_gemma":[0.049030993,0.0001663856,0.012177227,0.9201974,0.015756745,0.000001894488,0.00003384449,0.00024810192,0.0023873833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954598,0.0012515346,0.0011989564,0.0004484007,0.0011349873,0.00050631654],"domain_scores_gemma":[0.9976301,0.0005186246,0.0005612199,0.000602448,0.00034515216,0.00034245904],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014005953,0.0005356521,0.0014827946,0.00021405378,0.00019427907,0.00019982975,0.00043237986,0.00021348624,0.00028802236],"category_scores_gemma":[0.00075478817,0.0003392219,0.0006402781,0.00021009352,0.0005072848,0.00015009857,0.0001675432,0.0068608895,0.00031945616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039115272,0.000019116189,0.00010549328,0.00024571636,0.00026406598,0.005625575,0.000918185,0.000002008733,0.0011845543,0.0000039065317,0.9905761,0.0006641662],"study_design_scores_gemma":[0.0063633104,0.00064994185,0.0014079825,0.001299057,0.00044008112,0.012763164,0.00023018398,0.000016788152,0.0002760392,0.00002464293,0.97622496,0.00030386116],"about_ca_topic_score_codex":0.0000075298917,"about_ca_topic_score_gemma":0.0000015144034,"teacher_disagreement_score":0.07368688,"about_ca_system_score_codex":0.000054004962,"about_ca_system_score_gemma":0.0002018211,"threshold_uncertainty_score":0.999906},"labels":[],"label_agreement":null},{"id":"W3045492373","doi":"10.1002/ejhf.1515","title":"June 2020 at a Glance: Focus on COVID-19, Quality of Life and Comorbidities","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Coronavirus disease 2019 (COVID-19); Pandemic; Intensive care medicine; Internal medicine; Concomitant; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Angiotensin-converting enzyme 2; Angiotensin Receptor Blockers; Angiotensin receptor; Disease; Angiotensin-converting enzyme; Cardiology; Renin–angiotensin system; Blood pressure; Infectious disease (medical specialty)","score_opus":0.05353504730189552,"score_gpt":0.30569630521939734,"score_spread":0.2521612579175018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045492373","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37345642,0.0010304861,0.00020309076,0.6237191,0.00013479838,0.0002832965,0.000018661189,0.000035914265,0.0011182671],"genre_scores_gemma":[0.98335636,0.0001715201,0.0051932326,0.010148249,0.000510238,8.1713387e-7,0.0000058192268,0.000028893452,0.00058488175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806577,0.00047420338,0.0006530121,0.00018252924,0.0004399204,0.00018456423],"domain_scores_gemma":[0.9984857,0.00013915676,0.00030141778,0.0001837528,0.00009737442,0.00079262565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008249549,0.0001751077,0.0006052846,0.000076542565,0.000086024345,0.000018378529,0.00008919467,0.000026534313,0.00039632843],"category_scores_gemma":[0.0006155909,0.00013033421,0.00017570924,0.0001377175,0.00011379256,0.0000738978,0.00009234936,0.00026677139,0.00008631642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016685481,0.00014241024,0.023076631,0.00037135862,0.0002272242,0.00069749233,0.0012395113,0.000016959972,0.0030464795,0.00024022347,0.96887815,0.00039500088],"study_design_scores_gemma":[0.005262363,0.0022175254,0.02066183,0.00012260022,0.00009963869,0.00017109205,0.0006500229,0.0000097983775,0.00051585404,0.0000225065,0.9701378,0.00012901035],"about_ca_topic_score_codex":0.000009345106,"about_ca_topic_score_gemma":0.000013529006,"teacher_disagreement_score":0.6135708,"about_ca_system_score_codex":0.00005485494,"about_ca_system_score_gemma":0.00012744746,"threshold_uncertainty_score":0.5314875},"labels":[],"label_agreement":null},{"id":"W3046177958","doi":"10.1002/ejhf.1972","title":"Prevalence and Incidence of Intra-Ventricular Conduction Delays and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction: Insights from PARADIGM-HF and ATMOSPHERE","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"British Heart Foundation","keywords":"Heart failure; Ejection fraction; Medicine; Cardiology; Internal medicine; Incidence (geometry); Atmosphere (unit); Meteorology","score_opus":0.010504965854369018,"score_gpt":0.2283099081962874,"score_spread":0.21780494234191838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046177958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937623,0.0025091234,0.000069906964,0.0034018971,0.00004827045,0.00016575925,0.000004754399,0.000009403893,0.000028584134],"genre_scores_gemma":[0.9970771,0.0001947338,0.0024676044,0.00014449559,0.00009791343,4.144641e-7,0.0000016478255,0.000012359299,0.0000037273235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989479,0.00018808199,0.00034662205,0.00019783682,0.00023488876,0.000084661064],"domain_scores_gemma":[0.9993421,0.00008378671,0.00020971289,0.00007555221,0.00014300665,0.0001458491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014546681,0.00013282547,0.0004586615,0.000040509804,0.00007431105,0.0000295639,0.000010298111,0.00003331959,0.0000039478214],"category_scores_gemma":[0.00013632556,0.000097384785,0.00003573901,0.0001371926,0.00010233977,0.0002775094,0.00003185668,0.00023043415,8.2865506e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030521353,0.000020100371,0.99645066,0.00008242663,0.000079445446,0.000024041636,0.00057810126,0.000024381943,0.00119958,0.0000027544245,0.0010968011,0.00013648708],"study_design_scores_gemma":[0.0022187193,0.00088208297,0.99066114,0.00037553775,0.00012363549,0.0004531539,0.00068585586,0.000019391435,0.00026637726,0.000010304746,0.004208397,0.000095408264],"about_ca_topic_score_codex":0.000012631008,"about_ca_topic_score_gemma":0.0000035615722,"teacher_disagreement_score":0.005789531,"about_ca_system_score_codex":0.000016364833,"about_ca_system_score_gemma":0.000021596981,"threshold_uncertainty_score":0.39712363},"labels":[],"label_agreement":null},{"id":"W3078936950","doi":"10.1002/ejhf.1987","title":"Serum Potassium in the PARADIGM-HF Trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"University of Glasgow; British Heart Foundation","keywords":"Medicine; Heart failure; Potassium; Internal medicine; Cardiology; Pharmacology; Metallurgy","score_opus":0.021641937381935865,"score_gpt":0.24841627718590328,"score_spread":0.2267743398039674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3078936950","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44704,0.001019985,0.000061804756,0.5458146,0.00038498253,0.0003120109,0.0000029479334,0.000019768839,0.005343905],"genre_scores_gemma":[0.9894898,0.000047582653,0.00050268765,0.008921795,0.0009379597,4.2586825e-7,0.0000017242321,0.00002463265,0.000073373434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998197,0.00061748445,0.00050211133,0.00011575361,0.00034924835,0.00021837946],"domain_scores_gemma":[0.99938655,0.000056480738,0.0001579071,0.00015162589,0.000039052018,0.00020837404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090926036,0.00012602797,0.0002933216,0.00008206855,0.00005517517,0.000032880787,0.00020251289,0.00004043467,0.0001477682],"category_scores_gemma":[0.00017776572,0.000071180846,0.00021505711,0.00027791856,0.0000558309,0.00008517251,0.000023060826,0.0009350354,0.00018202266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017756663,0.00050284975,0.005833409,0.00007376935,0.00017301117,0.005695978,0.005392352,0.00012703892,0.0026875455,0.00016715033,0.95934993,0.002240297],"study_design_scores_gemma":[0.046812527,0.002910919,0.020253303,0.00013251355,0.00012058,0.0014300507,0.0013988992,0.000039803348,0.0000740826,0.00003139681,0.9266691,0.00012682231],"about_ca_topic_score_codex":0.0000010542827,"about_ca_topic_score_gemma":9.609055e-7,"teacher_disagreement_score":0.54244983,"about_ca_system_score_codex":0.000013777714,"about_ca_system_score_gemma":0.0001142252,"threshold_uncertainty_score":0.40623155},"labels":[],"label_agreement":null},{"id":"W3081335451","doi":"10.1002/ejhf.1984","title":"Serum Uric Acid, Influence of Sacubitril–Valsartan, and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: PARAGON-HF","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Sacubitril, Valsartan; Medicine; Heart failure; Ejection fraction; Sacubitril; Internal medicine; Cardiology; Valsartan; Uric acid; Blood pressure","score_opus":0.013574046512910921,"score_gpt":0.22983153371979026,"score_spread":0.21625748720687935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081335451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97512454,0.0022705158,0.00030336896,0.02172698,0.00006640884,0.00038398278,0.0000074747068,0.000036071757,0.00008068171],"genre_scores_gemma":[0.9891647,0.00007326954,0.0094706295,0.00087182637,0.00031018446,0.000002385884,0.0000023833913,0.00006537241,0.000039267135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682456,0.0006478948,0.00088955124,0.00038223903,0.00091496523,0.00034080815],"domain_scores_gemma":[0.99829376,0.000087862594,0.00036790455,0.00047817177,0.00038079315,0.00039149597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011277357,0.00032059936,0.0013921845,0.00025230253,0.00008416943,0.000043636068,0.00018630602,0.00009228324,0.000069095],"category_scores_gemma":[0.00048324568,0.0002417163,0.0003560999,0.0006777817,0.00012031741,0.00056641496,0.00008972653,0.0010668829,0.00003691752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005772587,0.00015191038,0.9552416,0.00031762777,0.00079942215,0.0010619432,0.0005283453,0.002521058,0.02719538,0.0000029354387,0.011444635,0.00015788556],"study_design_scores_gemma":[0.0055519086,0.002015407,0.82417303,0.0005778428,0.0006585774,0.0035129827,0.001301081,0.000054994,0.007902628,0.0000046710124,0.15392263,0.0003242176],"about_ca_topic_score_codex":0.000017908518,"about_ca_topic_score_gemma":0.000006986242,"teacher_disagreement_score":0.142478,"about_ca_system_score_codex":0.000056565044,"about_ca_system_score_gemma":0.00016017817,"threshold_uncertainty_score":0.9856905},"labels":[],"label_agreement":null},{"id":"W3084074131","doi":"10.1002/ejhf.1994","title":"Integration of a Palliative Approach into Heart Failure Care: A European Society of Cardiology Heart Failure Association Position Paper","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"European Society of Cardiology","keywords":"Medicine; Palliative care; Heart failure; Psychosocial; Guideline; Position paper; Intensive care medicine; Position (finance); Disease; Disease management; Advance care planning; Nursing; Cardiology; Internal medicine; Psychiatry; Pathology","score_opus":0.018109452083944957,"score_gpt":0.2511828807114989,"score_spread":0.23307342862755395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084074131","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31368092,0.0015684973,0.01966872,0.6588333,0.0004530969,0.002648012,0.00009319985,0.0002211287,0.002833108],"genre_scores_gemma":[0.83248633,0.00004599505,0.16390964,0.0023648876,0.0009029916,0.000004637022,0.00012212487,0.00008165259,0.00008173961],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952541,0.001687828,0.0013195783,0.00044746214,0.0008750614,0.00041595256],"domain_scores_gemma":[0.9972491,0.00011369039,0.0008392182,0.0003637205,0.0010733563,0.00036089192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015521048,0.0004284808,0.0012510713,0.00019458325,0.00014658598,0.000046889647,0.00021493886,0.00014529709,0.00008103268],"category_scores_gemma":[0.00026414785,0.00034862696,0.0010135806,0.00053831405,0.000127052,0.0003803333,0.00013248899,0.0008787367,0.00007801805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037851292,0.00021359834,0.02453411,0.00053763296,0.0010179003,0.00005515984,0.0092797745,0.0002328729,0.22245684,0.00008250817,0.7406922,0.00051889155],"study_design_scores_gemma":[0.005446624,0.0043283943,0.054974146,0.0006942146,0.0009439521,0.00016287954,0.0123591,0.00010354089,0.0069019366,0.000017614704,0.9136508,0.00041678842],"about_ca_topic_score_codex":0.000017789685,"about_ca_topic_score_gemma":0.000010943808,"teacher_disagreement_score":0.65646845,"about_ca_system_score_codex":0.00031684665,"about_ca_system_score_gemma":0.00018212257,"threshold_uncertainty_score":0.9998966},"labels":[],"label_agreement":null},{"id":"W3084273965","doi":"10.1002/ejhf.1997","title":"If it Ain’t Broken, don’t Fix it (but if it is, Make Sure you know): Aortic Valve Interventions During Left Ventricular Assist Device Implantation","year":2020,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Aortic valve; Ventricle; Internal medicine; Regurgitation (circulation); Ventricular assist device; Aortic valve replacement; Implant; Ascending aorta; Hemodynamics; Aortic valve regurgitation; Aorta; Surgery; Heart failure; Stenosis","score_opus":0.018861258017950536,"score_gpt":0.24421425517096645,"score_spread":0.22535299715301593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084273965","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032017246,0.005370411,0.005428931,0.95008045,0.0040609213,0.0009833955,0.0005657483,0.00049492967,0.0009979835],"genre_scores_gemma":[0.67166895,0.00029209018,0.0051000635,0.3013928,0.016396357,0.00001489731,0.0009972116,0.0012530743,0.0028845423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942983,0.00088139134,0.002262386,0.0006004223,0.0011469544,0.00081055507],"domain_scores_gemma":[0.997558,0.00014737193,0.00087214774,0.0006418176,0.00032864607,0.0004520267],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008959753,0.0007932937,0.0011452994,0.00046102094,0.00025095284,0.00036265107,0.000921593,0.0003525525,0.0027028895],"category_scores_gemma":[0.00016273157,0.000793242,0.0017838674,0.0003417915,0.000053041364,0.0004208585,0.00017616904,0.004253693,0.0013040861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013762234,0.00003254991,0.001494579,0.0022986978,0.0008891645,0.0075564403,0.00030631147,0.00072422053,0.00035550722,9.587473e-7,0.98615956,0.00016823669],"study_design_scores_gemma":[0.0007807448,0.0001402578,0.0034998418,0.0028294437,0.0008618131,0.0034891001,0.00030685752,0.00024774793,0.0003084468,0.000009415755,0.9867532,0.0007731201],"about_ca_topic_score_codex":0.0000062829936,"about_ca_topic_score_gemma":0.000023604018,"teacher_disagreement_score":0.6486876,"about_ca_system_score_codex":0.00028106375,"about_ca_system_score_gemma":0.000102573904,"threshold_uncertainty_score":0.9994735},"labels":[],"label_agreement":null},{"id":"W3087016021","doi":"10.1002/ejhf.1517","title":"July 2020 at a Glance: Focus on Imaging and Cardiomyopathies","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Heart failure; Hazard ratio; Myocardial infarction; Dilated cardiomyopathy; Cardiomyopathy; Sudden cardiac death; Diabetes mellitus; Confidence interval","score_opus":0.009050243566868338,"score_gpt":0.22899430264728726,"score_spread":0.21994405908041892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087016021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.513517,0.016952757,0.00054712663,0.4538253,0.0007252114,0.00025656342,0.00003122424,0.00011106645,0.014033743],"genre_scores_gemma":[0.9906704,0.00010241835,0.0027760179,0.004714954,0.0016246139,2.1498307e-7,0.0000014487094,0.000035595564,0.00007437114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989406,0.00017537778,0.00027878617,0.0001493091,0.00028567485,0.00017029309],"domain_scores_gemma":[0.999203,0.00010177685,0.000106421,0.00012727699,0.0001241095,0.0003373783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038456896,0.00013365339,0.00036161122,0.000057553356,0.00007544169,0.000044584704,0.00005441883,0.000011768421,0.00001757203],"category_scores_gemma":[0.0005227461,0.00010695085,0.00018299092,0.00010849127,0.0000663235,0.000065645094,0.000065695494,0.00040874406,0.00015842312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032800625,0.000021625256,0.08257903,0.00006124772,0.00006263388,0.004772409,0.00070894795,0.000022236982,0.004266656,0.000008406114,0.9035359,0.0036328922],"study_design_scores_gemma":[0.0024841025,0.00067464064,0.094764024,0.00040194835,0.00017642973,0.0061672973,0.00025982095,0.000031737633,0.001445142,0.000010738568,0.893433,0.00015112557],"about_ca_topic_score_codex":8.089072e-7,"about_ca_topic_score_gemma":1.1141321e-7,"teacher_disagreement_score":0.47715336,"about_ca_system_score_codex":0.00002594823,"about_ca_system_score_gemma":0.00004154361,"threshold_uncertainty_score":0.4361329},"labels":[],"label_agreement":null},{"id":"W3087758623","doi":"10.1002/ejhf.1519","title":"August 2020 at a Glance: Focus on Neurohormonal Antagonists and Electrolytes","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Discontinuation; Medicine; Heart failure; Internal medicine; Cardiology; Mineralocorticoid receptor; Aldosterone; Sudden cardiac death; Hyperkalemia; Ejection fraction; Endocrinology","score_opus":0.01454727964112916,"score_gpt":0.23102576624511822,"score_spread":0.21647848660398905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087758623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78423524,0.0011192479,0.00003172866,0.21322674,0.000046164256,0.0000880888,0.000002861479,0.000022396238,0.0012275641],"genre_scores_gemma":[0.99111706,0.00013374566,0.0015656142,0.0062084515,0.0007425009,1.376276e-7,0.0000026810237,0.000030833668,0.00019897183],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998862,0.00014023724,0.0003127961,0.00015670146,0.00036192936,0.00016633232],"domain_scores_gemma":[0.99921846,0.000042036234,0.00012393821,0.00008846908,0.000119152464,0.00040796713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021585952,0.0001322705,0.00030590937,0.000053393695,0.000089019944,0.000027852318,0.000060594673,0.000023830931,0.00016316315],"category_scores_gemma":[0.00013697126,0.0000963237,0.0001119089,0.000115475224,0.00004725282,0.000066151675,0.00003983502,0.00038116696,0.000121022975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002898164,0.00007634749,0.007982385,0.000029040322,0.000069496156,0.0038083314,0.00019568509,0.000009093471,0.4075788,0.000094540075,0.5707464,0.00651168],"study_design_scores_gemma":[0.0025245454,0.003601483,0.19511575,0.00008906625,0.00006382175,0.006311825,0.00003239334,0.00020573648,0.0049680048,0.000011783314,0.78695893,0.000116642696],"about_ca_topic_score_codex":3.7840425e-7,"about_ca_topic_score_gemma":5.0619417e-7,"teacher_disagreement_score":0.40261078,"about_ca_system_score_codex":0.000024171237,"about_ca_system_score_gemma":0.00005374103,"threshold_uncertainty_score":0.39279667},"labels":[],"label_agreement":null},{"id":"W3088907338","doi":"10.1002/ejhf.2012","title":"Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the <scp>RELAX‐AHF</scp> ‐2 study","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Heart failure; Cardiology; Quartile; Internal medicine; Hazard ratio; Renal function; Confidence interval","score_opus":0.007199008399025956,"score_gpt":0.2016799301412127,"score_spread":0.19448092174218673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088907338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506385,0.000071050235,0.00096209405,0.01290852,0.00013993797,0.000773857,0.0000033980336,0.00003249711,0.000044814587],"genre_scores_gemma":[0.99517095,0.0000046873956,0.003826449,0.00042725375,0.0004166178,0.000002923283,0.000034395303,0.000045246346,0.0000714957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710983,0.00074760924,0.0006307037,0.00027931744,0.000992241,0.00024027398],"domain_scores_gemma":[0.998438,0.00018286276,0.0006262732,0.00021144107,0.00037461423,0.00016677963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005655192,0.00024965877,0.0005079886,0.0001949701,0.00013943075,0.00005963532,0.000090973255,0.000054137083,0.000035576795],"category_scores_gemma":[0.00017465733,0.00014957268,0.0001348802,0.0005460171,0.000026209573,0.00042289475,0.000039489714,0.0006921877,0.000040324776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007387814,0.000632498,0.9333875,0.00001336674,0.001158132,0.0002633648,0.0012412377,0.00028272817,0.0007352209,0.0000015894014,0.06141433,0.00013121238],"study_design_scores_gemma":[0.007907981,0.007139406,0.8116623,0.00027803716,0.0011019198,0.0000308522,0.0022056685,0.000029261942,0.0002693195,0.0000022474649,0.16930024,0.00007277066],"about_ca_topic_score_codex":0.000025748688,"about_ca_topic_score_gemma":0.00009360039,"teacher_disagreement_score":0.12172524,"about_ca_system_score_codex":0.00019299566,"about_ca_system_score_gemma":0.000073260126,"threshold_uncertainty_score":0.6099397},"labels":[],"label_agreement":null},{"id":"W3088948579","doi":"10.1002/ejhf.2015","title":"Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical Trials","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Calgary; Montreal Heart Institute; Libin Cardiovascular Institute of Alberta; Surgical Specialties (Canada)","funders":"Servier; Cytokinetics; Amgen","keywords":"Heart failure; Medicine; Ejection fraction; Internal medicine; Cardiology; Sacubitril; Heart failure with preserved ejection fraction; Sacubitril, Valsartan; Placebo; Valsartan; Blood pressure","score_opus":0.08811326690012837,"score_gpt":0.3500910779540701,"score_spread":0.2619778110539417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088948579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68749535,0.0010142542,0.002852799,0.30617318,0.00029098318,0.001625423,0.000011994405,0.000109508226,0.00042654003],"genre_scores_gemma":[0.976865,0.0000780801,0.019560859,0.0015123254,0.0017860438,0.0000050603408,0.000028644272,0.0000733998,0.00009060008],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99411356,0.0026780616,0.0018856353,0.0004443192,0.00055967073,0.000318739],"domain_scores_gemma":[0.9974818,0.00044426162,0.00088132994,0.00028043528,0.0003184659,0.0005936945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005416104,0.00036917368,0.0017262312,0.00023915018,0.000103565035,0.000105845276,0.00009189448,0.000089331304,0.00019269652],"category_scores_gemma":[0.0007622397,0.0002451447,0.00022221588,0.00039435714,0.00013045545,0.00040652504,0.000047018508,0.001238233,0.000064795975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012483765,0.00096214144,0.44300017,0.00042486854,0.0011115817,0.0025973117,0.00055522105,0.000046097877,0.009478085,0.000016389533,0.5248566,0.004467761],"study_design_scores_gemma":[0.0137332855,0.01127047,0.09674285,0.0010158984,0.00054480275,0.0008524641,0.001138979,0.0003988313,0.0006222292,0.000001069867,0.873366,0.00031310428],"about_ca_topic_score_codex":0.000008307258,"about_ca_topic_score_gemma":0.000020247751,"teacher_disagreement_score":0.3485094,"about_ca_system_score_codex":0.00015187869,"about_ca_system_score_gemma":0.000504792,"threshold_uncertainty_score":0.9996711},"labels":[],"label_agreement":null},{"id":"W3093015048","doi":"10.1002/ejhf.2026","title":"Heart Failure Association of the European Society of Cardiology Update on Sodium–Glucose Co-Transporter 2 Inhibitors in Heart Failure","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Canagliflozin; Heart failure; Internal medicine; Benzhydryl compounds; Cardiology; Diabetes mellitus; Ejection fraction; Type 2 diabetes; Type 2 Diabetes Mellitus; Intensive care medicine; Endocrinology","score_opus":0.010712329798872868,"score_gpt":0.22326951459022093,"score_spread":0.21255718479134805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093015048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7578847,0.00026245814,0.000058601567,0.23934163,0.00029712284,0.00063058943,0.000043601718,0.000038669932,0.0014426571],"genre_scores_gemma":[0.99158365,0.00004471485,0.0031818703,0.004141887,0.0007684861,0.0000013722187,0.000027112459,0.00007504285,0.00017588832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620163,0.0012647936,0.0011022086,0.00031289388,0.0007110937,0.000407358],"domain_scores_gemma":[0.9984436,0.000078745754,0.0006414173,0.0003716171,0.00024154999,0.00022304924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019477038,0.0003199234,0.0009519971,0.00014264499,0.000076067656,0.000025299034,0.00026945813,0.00008491435,0.000074315554],"category_scores_gemma":[0.000096986136,0.00022710765,0.00089272554,0.0003978398,0.00014021175,0.00016764892,0.000088010645,0.0008309765,0.0001015272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015829856,0.00016943194,0.22673008,0.00015655078,0.00044266204,0.00006957644,0.00072541204,0.00022722398,0.023808746,0.000021731763,0.74723625,0.0002540434],"study_design_scores_gemma":[0.0039110132,0.0012474748,0.15863484,0.00048361663,0.0002904452,0.000034642533,0.0006328843,0.000008066414,0.009957309,0.0000062031354,0.8246157,0.0001778034],"about_ca_topic_score_codex":0.0000029903385,"about_ca_topic_score_gemma":0.000007180031,"teacher_disagreement_score":0.23519975,"about_ca_system_score_codex":0.00012245646,"about_ca_system_score_gemma":0.000092113056,"threshold_uncertainty_score":0.92611814},"labels":[],"label_agreement":null},{"id":"W3094748887","doi":"10.1002/ejhf.1521","title":"September 2020 at a Glance: Focus on Heart Failure with Preserved Ejection Fraction and Medical Therapy","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Spironolactone; Medicine; Heart failure; Ejection fraction; Discontinuation; Internal medicine; Hazard ratio; Heart failure with preserved ejection fraction; Cardiology; Diuretic; Loop diuretic; Thiazide; Diabetes mellitus; Confidence interval; Endocrinology","score_opus":0.017235578246274356,"score_gpt":0.25435371326795475,"score_spread":0.2371181350216804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094748887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5868665,0.0004722794,0.00027627876,0.41031626,0.000108904365,0.0005328916,0.0000027299145,0.00007945104,0.0013447125],"genre_scores_gemma":[0.9822861,0.00016608626,0.009647408,0.0058786096,0.0013610829,0.0000047022077,0.00000963619,0.00007439294,0.00057199184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977294,0.00034464532,0.0004475947,0.00032089907,0.00087880983,0.00027863833],"domain_scores_gemma":[0.99873245,0.00007369496,0.00018623394,0.00021577752,0.00014998739,0.0006418837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006130399,0.00026939972,0.0005079827,0.0000984696,0.00014701133,0.000050882605,0.00009047721,0.000071612565,0.0013321778],"category_scores_gemma":[0.000096702104,0.00017641611,0.00016334448,0.00023191534,0.0000726971,0.00021176356,0.00005919712,0.00065752456,0.00032833448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026377696,0.00021700402,0.05742684,0.00006222928,0.00032259617,0.0011283039,0.00019654652,0.000012950234,0.003615899,0.000011422546,0.9330669,0.0013015436],"study_design_scores_gemma":[0.0063401912,0.005495738,0.028982077,0.00034011417,0.00010459169,0.0010948274,0.00021456712,0.000061039085,0.0014723159,0.000005652199,0.95571893,0.00016992562],"about_ca_topic_score_codex":0.0000043900573,"about_ca_topic_score_gemma":0.000020831425,"teacher_disagreement_score":0.40443766,"about_ca_system_score_codex":0.00007673859,"about_ca_system_score_gemma":0.00008310495,"threshold_uncertainty_score":0.99958074},"labels":[],"label_agreement":null},{"id":"W3097010854","doi":"10.1002/ejhf.1523","title":"October 2020 at a Glance: Focus on Outcomes, Valve Disease and Patients’ Monitoring","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Cardiology; Ejection fraction; Heart failure; Coronary artery disease; Confidence interval; Proportional hazards model; Framingham Risk Score; Clinical endpoint; Disease; Clinical trial","score_opus":0.01315160529258294,"score_gpt":0.27885997651980937,"score_spread":0.26570837122722646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097010854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845508,0.0012410253,0.0000030589447,0.013568186,0.00018551871,0.00016039623,0.000036587116,0.000016604608,0.00023782396],"genre_scores_gemma":[0.99773026,0.000072804,0.0003862602,0.0010537913,0.00064192276,7.741749e-7,0.000007850347,0.000038335027,0.00006801616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886,0.00012434978,0.0002854428,0.00017909586,0.00037913377,0.00017196822],"domain_scores_gemma":[0.99873066,0.00003429244,0.00012631483,0.00014542276,0.00011082086,0.00085246406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087557935,0.00016878244,0.0003397416,0.000037946553,0.00007464501,0.000028304514,0.000050448773,0.000013477564,0.00009315608],"category_scores_gemma":[0.00014758615,0.000120955054,0.0007879678,0.00007661747,0.000024746818,0.00006693568,0.00006510717,0.00020240614,0.00015191738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077014166,0.00014688603,0.9657852,0.0000356244,0.0004560857,0.00057756563,0.00011484363,0.0000044751787,0.00006093306,0.0000023048299,0.031123077,0.00092286937],"study_design_scores_gemma":[0.004103284,0.00082566997,0.9687678,0.00016960235,0.00057857495,0.000023490662,0.000038252285,0.0000015831797,0.000032954733,0.000003909889,0.025357805,0.00009704582],"about_ca_topic_score_codex":8.8906313e-7,"about_ca_topic_score_gemma":5.8347887e-8,"teacher_disagreement_score":0.0131794475,"about_ca_system_score_codex":0.000053000826,"about_ca_system_score_gemma":0.000033277403,"threshold_uncertainty_score":0.49324042},"labels":[],"label_agreement":null},{"id":"W3097319709","doi":"10.1002/ejhf.2034","title":"Trial characteristics associated with under‐enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review","year":2020,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Medicine; Heart failure; Ejection fraction; Randomized controlled trial; Internal medicine; Cardiology","score_opus":0.055613191600865204,"score_gpt":0.32774214157715836,"score_spread":0.27212894997629317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097319709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020438513,0.9625765,0.00018523964,0.012535815,0.0002689238,0.024072535,0.000031712847,0.00003708255,0.00008780704],"genre_scores_gemma":[0.0031126384,0.9908291,0.0043677357,0.00026772742,0.0005797577,0.00031543203,0.00013578478,0.00017482722,0.00021700947],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97180086,0.016876817,0.009187877,0.0004284759,0.0013565813,0.00034935732],"domain_scores_gemma":[0.9833807,0.0031068914,0.0119987065,0.00053452223,0.0006980132,0.00028120642],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.021695107,0.00087694585,0.035642654,0.0008087955,0.0000600126,0.00005440341,0.00021627065,0.00017849992,0.00015836734],"category_scores_gemma":[0.007875624,0.0004409216,0.0039364966,0.00084326096,0.00014162222,0.00014999397,0.000045632612,0.0010452652,0.000020950922],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33178014,0.001581756,0.000018273104,0.618903,0.025923515,0.00089014653,0.00013463956,0.0000027433268,0.000028630322,0.000031396128,0.019228088,0.0014776723],"study_design_scores_gemma":[0.31718454,0.0031427194,0.000005902323,0.51441944,0.038355306,0.00040471554,0.00012403615,0.0000015137289,0.0000029890923,8.359667e-7,0.12611966,0.00023834608],"about_ca_topic_score_codex":0.0000038561348,"about_ca_topic_score_gemma":0.000006526818,"teacher_disagreement_score":0.106891565,"about_ca_system_score_codex":0.00034346583,"about_ca_system_score_gemma":0.0010010003,"threshold_uncertainty_score":0.99980426},"labels":[],"label_agreement":null},{"id":"W3101001025","doi":"10.1002/ejhf.2052","title":"Impact of Heart Failure on the Clinical Course and Outcomes of Patients Hospitalized for COVID-19. Results of the Cardio-COVID-Italy Multicentre Study","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Interquartile range; Heart failure; Hazard ratio; Internal medicine; Fraction of inspired oxygen; Proportional hazards model; Ejection fraction; Confidence interval; Cardiology; Troponin; Mechanical ventilation; Myocardial infarction","score_opus":0.0738970579278209,"score_gpt":0.43998684039126623,"score_spread":0.3660897824634453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101001025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83715785,0.000078805155,0.000025726009,0.16058598,0.00010640744,0.0017325076,0.00029163036,0.000009334614,0.000011777165],"genre_scores_gemma":[0.9960108,0.00004006376,0.0006606297,0.0030276072,0.00018324246,0.0000034174025,0.0000037509772,0.000041413132,0.000029107583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99353576,0.002292801,0.0021811337,0.00037341472,0.0012717036,0.00034516564],"domain_scores_gemma":[0.98705703,0.009287728,0.0012032898,0.0006691329,0.0010744643,0.00070837134],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054525733,0.0002990542,0.0015812174,0.00009162984,0.00015817431,0.00002039611,0.0004822643,0.00006437615,0.000029155819],"category_scores_gemma":[0.119851336,0.00014333523,0.001401992,0.00032575964,0.0006423099,0.00008339938,0.0003601855,0.00084399176,0.0000040793416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065085883,0.001449093,0.8853369,0.0002475701,0.0013971877,0.000029422155,0.002190413,0.00015390712,0.00012891981,0.0000034621037,0.102378614,0.00017592062],"study_design_scores_gemma":[0.019587059,0.014599748,0.9246531,0.00020266366,0.000534231,0.0000030367235,0.0014837428,0.00003824383,0.000039043687,0.0000071458376,0.038735397,0.00011659823],"about_ca_topic_score_codex":0.000038593484,"about_ca_topic_score_gemma":0.000010524687,"teacher_disagreement_score":0.15885293,"about_ca_system_score_codex":0.00008090514,"about_ca_system_score_gemma":0.00085084623,"threshold_uncertainty_score":0.8875625},"labels":[],"label_agreement":null},{"id":"W3107459439","doi":"10.1002/ejhf.2064","title":"Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital; McGill University Health Centre","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Heart failure with preserved ejection fraction; Cardiology; Atrial fibrillation; Diabetes mellitus; Valsartan; Natriuretic peptide; Placebo; Blood pressure; Endocrinology","score_opus":0.02062380960108927,"score_gpt":0.23910767594871096,"score_spread":0.21848386634762168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107459439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92312616,0.000022879989,0.00044013403,0.075129926,0.00008222861,0.0010824422,0.000011481818,0.000022372229,0.0000824025],"genre_scores_gemma":[0.9879603,0.0000071587483,0.010205874,0.0010594622,0.00060887216,0.000006263318,0.000056784666,0.00004759616,0.000047682024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696946,0.0009432061,0.0007827633,0.00023888543,0.00081027305,0.00025543335],"domain_scores_gemma":[0.9984661,0.000115299415,0.00044015326,0.0003297705,0.0004504944,0.00019820483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011981536,0.00025146475,0.00060879946,0.00016988884,0.000081097525,0.000055684304,0.00017964725,0.00004588246,0.00019612108],"category_scores_gemma":[0.00028908983,0.00014052758,0.00016071305,0.00043181903,0.00006369103,0.00035564872,0.00004445738,0.0006218919,0.000029801942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070176594,0.0017455494,0.7104479,0.00027920137,0.00038510145,0.00033524522,0.0008052505,0.000065351116,0.0014466197,0.00000814924,0.21395503,0.00035000526],"study_design_scores_gemma":[0.04872089,0.012601534,0.48371178,0.00041756008,0.00035893806,0.00003914178,0.00092991744,0.00005566306,0.0002834426,0.0000012430276,0.45268884,0.0001910483],"about_ca_topic_score_codex":0.000011793675,"about_ca_topic_score_gemma":0.000026222178,"teacher_disagreement_score":0.23873383,"about_ca_system_score_codex":0.000046277928,"about_ca_system_score_gemma":0.000101730824,"threshold_uncertainty_score":0.57305485},"labels":[],"label_agreement":null},{"id":"W3108719605","doi":"10.1002/ejhf.2073","title":"Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in <scp>DECLARE‐TIMI</scp> 58","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Deutsche Forschungsgemeinschaft; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; TIMI; Transporter; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.025278402926551865,"score_gpt":0.24562268572199855,"score_spread":0.22034428279544668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108719605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841658,0.00270839,0.0020420104,0.009797921,0.000054442484,0.0011045103,0.000034593246,0.0000352526,0.00005711405],"genre_scores_gemma":[0.9806265,0.00020460335,0.017894393,0.0005758799,0.00046240404,0.000009090492,0.00009354943,0.00007711748,0.000056420544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823165,0.00032253604,0.00048433882,0.00032780014,0.000366414,0.00026725003],"domain_scores_gemma":[0.9990059,0.00017212486,0.00014205684,0.00020005982,0.00015521255,0.00032462098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011030487,0.00027256933,0.000692983,0.0001945948,0.00009912176,0.00007475524,0.000063353385,0.000057637793,0.000007881497],"category_scores_gemma":[0.00016646023,0.0001890875,0.00023251027,0.00024300425,0.00007147846,0.0002717262,0.000018276789,0.00023851408,0.000004520949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004053576,0.00006260976,0.9661715,0.00015099252,0.00094681216,0.000085139356,0.0007439768,0.000020699523,0.00024981404,0.0000066949356,0.029941315,0.0012150765],"study_design_scores_gemma":[0.008615031,0.0029660526,0.59633756,0.0003106369,0.0008335053,0.00003563018,0.0008589084,0.000030302459,0.0008599916,0.0000051747525,0.3890149,0.00013231023],"about_ca_topic_score_codex":0.0000025802403,"about_ca_topic_score_gemma":0.0000033394927,"teacher_disagreement_score":0.36983395,"about_ca_system_score_codex":0.000030289633,"about_ca_system_score_gemma":0.00007021549,"threshold_uncertainty_score":0.77107644},"labels":[],"label_agreement":null},{"id":"W3108731130","doi":"10.1002/ejhf.1525","title":"November 2020 at a Glance: Focus on Comorbidities and Medical Treatment","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Cardiology; Hazard ratio; Valsartan; Diabetes mellitus; Enalapril; Hyperkalemia; Concomitant; Endocrinology; Angiotensin-converting enzyme; Confidence interval; Blood pressure","score_opus":0.021934717780472686,"score_gpt":0.2585057462022229,"score_spread":0.2365710284217502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108731130","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33048305,0.0008919028,0.00006548355,0.66320765,0.00015167255,0.0003043763,0.000007566542,0.00004834237,0.004839969],"genre_scores_gemma":[0.98568416,0.0003865796,0.004566583,0.006706194,0.0012366191,0.0000018792822,0.000006715195,0.000044106182,0.0013671638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984344,0.00019681992,0.0003979252,0.00019879153,0.0005486474,0.0002234036],"domain_scores_gemma":[0.998938,0.00006951518,0.000112948765,0.00014969034,0.00006102797,0.0006688096],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029947254,0.00021112498,0.000462238,0.000059962815,0.00008532605,0.00002757409,0.00007314304,0.000034680525,0.0011658682],"category_scores_gemma":[0.00009466936,0.00013813803,0.00016823945,0.000096465476,0.00007916,0.00006517813,0.00007134924,0.00024865076,0.0003789553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008621511,0.00027389888,0.00911395,0.000055103268,0.0003433142,0.007489437,0.000927224,0.0000038504863,0.0006461191,0.00011171686,0.97320664,0.006966569],"study_design_scores_gemma":[0.0052713817,0.005649075,0.007914737,0.00020935548,0.00015631523,0.0013726389,0.00019115504,0.00003404999,0.0005856201,0.000005992634,0.97849095,0.000118710675],"about_ca_topic_score_codex":0.0000041299845,"about_ca_topic_score_gemma":0.000011683669,"teacher_disagreement_score":0.6565015,"about_ca_system_score_codex":0.00008818997,"about_ca_system_score_gemma":0.00007378907,"threshold_uncertainty_score":0.9997472},"labels":[],"label_agreement":null},{"id":"W3113765054","doi":"10.1002/ejhf.2083","title":"Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of <scp>DAPA‐HF</scp>","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of British Columbia","funders":"Janssen Research and Development; National Heart, Lung, and Blood Institute; Relypsa; Respicardia; Vifor Pharma; Shionogi; Daiichi-Sankyo; University of Oxford; British Heart Foundation; Kidney Research UK; Zora Biosciences; GlaxoSmithKline; IFM Therapeutics; Mitsubishi Tanabe Pharma Corporation; Toa Eiyo; Medicines Company; Intarcia Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; AstraZeneca; Amarin Corporation; Sanofi Pasteur; Universitair Medisch Centrum Groningen; Kowa Company; Celladon Corporation; Zafgen; Defense Acquisition Program Administration; Boston Scientific Corporation; Esperion Therapeutics; Alere; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; Servier; Gilead Sciences; Astellas Pharma; Eisai; Cytokinetics; Brigham and Women's Hospital; Ironwood Pharmaceuticals, Incorporated; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Amgen; Pfizer; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Dapagliflozin; Heart failure; Ejection fraction; Pulmonary disease; Cardiology; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.006881245322832636,"score_gpt":0.22220581084947907,"score_spread":0.21532456552664644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113765054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585134,0.000910436,0.00012060026,0.0026077286,0.00004435069,0.00034064276,0.000005853133,0.000015751475,0.00010331495],"genre_scores_gemma":[0.9968637,0.00004942302,0.0026942368,0.00012249868,0.0001745926,0.0000024020228,0.000023870776,0.00003203742,0.000037214577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831355,0.00037835265,0.00046984127,0.0002581495,0.00038639823,0.00019370999],"domain_scores_gemma":[0.99887305,0.000103707425,0.0003726836,0.0001817876,0.00015939397,0.00030935748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031353228,0.00019562876,0.0006589928,0.0004991093,0.00003870843,0.000019558325,0.00007405318,0.00003123098,0.000023120456],"category_scores_gemma":[0.00013010114,0.00015379075,0.00018126552,0.00078807987,0.000087142354,0.00034132824,0.000036639063,0.00028604807,0.000003626067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013735186,0.0013951932,0.6749129,0.0016696631,0.004239076,0.0012779348,0.0014485874,0.002487188,0.298198,0.000041148654,0.007732998,0.0052237557],"study_design_scores_gemma":[0.0022776537,0.0029398226,0.9663725,0.00045979803,0.0033145256,0.00003368332,0.001099509,0.00072112447,0.009898329,0.0000052481037,0.012799308,0.0000785196],"about_ca_topic_score_codex":0.00000705082,"about_ca_topic_score_gemma":0.000011026244,"teacher_disagreement_score":0.29145956,"about_ca_system_score_codex":0.00009180269,"about_ca_system_score_gemma":0.000074074094,"threshold_uncertainty_score":0.62714046},"labels":[],"label_agreement":null},{"id":"W3118638029","doi":"10.1002/ejhf.2094","title":"Cardiac myosin‐binding protein <scp>C</scp> in the diagnosis and risk stratification of acute heart failure","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Guy's and St Thomas' NHS Foundation Trust; Medical Research Council; Medical Research Council Canada; Schweizerische Herzstiftung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute for Health and Care Research; Alere; Universitätsspital Basel; Universität Basel; Singulex; Cardiovascular Research Foundation; European Commission; Guy's and St Thomas' Charity; British Heart Foundation; Roche; Abbott Laboratories; National Science Foundation","keywords":"Interquartile range; Medicine; Natriuretic peptide; Hazard ratio; Heart failure; Internal medicine; Troponin complex; Heart-type fatty acid binding protein; Confidence interval; Cardiology; Troponin T; Emergency department; Prospective cohort study; Troponin; Receiver operating characteristic; Risk stratification; Biomarker; Gastroenterology; Myocardial infarction","score_opus":0.022686492271300526,"score_gpt":0.28814080871217007,"score_spread":0.26545431644086953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118638029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9389282,0.0009971852,0.00007464019,0.058865152,0.00011728711,0.0005087101,0.000046752808,0.0000116848,0.00045039202],"genre_scores_gemma":[0.9828925,0.0009449259,0.0144773405,0.0005536753,0.0005555868,0.000016274156,0.000022383938,0.000057260455,0.00048004359],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591905,0.002097084,0.0007006289,0.00023985663,0.00074838806,0.00029501203],"domain_scores_gemma":[0.9981269,0.00042733861,0.00032307245,0.0003999699,0.0005290477,0.00019366527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002897687,0.0001784548,0.0005203121,0.00025588056,0.00013822972,0.000104140476,0.00017075118,0.000065595676,0.000043312644],"category_scores_gemma":[0.0011396824,0.00012986385,0.0002767424,0.00060178817,0.00021431995,0.0002255669,0.00007624404,0.0011345631,0.000036538175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006930616,0.00026001706,0.1398962,0.00013178829,0.0008592168,0.00064148544,0.0024836403,0.00001772977,0.29945722,0.00017284196,0.55446225,0.001548261],"study_design_scores_gemma":[0.001472202,0.00085382385,0.10785285,0.0005153028,0.00038610317,0.0011772632,0.006405631,0.000008719792,0.056274686,0.000028378763,0.8249347,0.00009033141],"about_ca_topic_score_codex":0.000015762807,"about_ca_topic_score_gemma":0.000004772563,"teacher_disagreement_score":0.27047244,"about_ca_system_score_codex":0.00004955476,"about_ca_system_score_gemma":0.00021158789,"threshold_uncertainty_score":0.5295694},"labels":[],"label_agreement":null},{"id":"W3120456088","doi":"10.1002/ejhf.2098","title":"Renin <b>–</b> angiotensin <b>–</b> aldosterone inhibitors and <scp>COVID</scp> ‐19: nearing the end of a media‐fuelled controversy","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Renin–angiotensin system; Medicine; Aldosterone; Angiotensin-converting enzyme 2; Internal medicine; Angiotensin II; Endocrinology; Receptor; Pharmacology; Disease; Coronavirus disease 2019 (COVID-19); Blood pressure; Infectious disease (medical specialty)","score_opus":0.03252608098119342,"score_gpt":0.31051606454160224,"score_spread":0.2779899835604088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120456088","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021140093,0.005720307,0.00010098071,0.9715549,0.0006823216,0.00054961105,0.000052208572,0.00003158253,0.00016801374],"genre_scores_gemma":[0.13242814,0.0029063788,0.009465802,0.82936233,0.020193046,0.000006930421,0.000086242035,0.00044062908,0.0051105013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99247086,0.002402929,0.0018266033,0.00059525407,0.0019338588,0.0007704758],"domain_scores_gemma":[0.97949344,0.016646279,0.0011589052,0.00079658924,0.0013125308,0.00059226516],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004533973,0.0005689179,0.001998069,0.00045641258,0.0002296383,0.00013445583,0.00047599667,0.00031795932,0.00010441154],"category_scores_gemma":[0.07749245,0.0003721832,0.00088656007,0.0004497607,0.0011480273,0.0001337126,0.00077567116,0.0056369235,0.00002995315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015525302,0.00006184654,0.002487923,0.0004508565,0.0006982715,0.0084034195,0.0011876578,0.000010425211,0.005602986,0.00000194,0.9801061,0.00083332544],"study_design_scores_gemma":[0.0041985805,0.001459592,0.0059287995,0.0017720651,0.0006132707,0.0006652221,0.00033765842,0.0000150511705,0.00026436764,0.000022770828,0.98458433,0.00013830025],"about_ca_topic_score_codex":0.000045038723,"about_ca_topic_score_gemma":0.0000145280555,"teacher_disagreement_score":0.14219256,"about_ca_system_score_codex":0.00016350942,"about_ca_system_score_gemma":0.00107763,"threshold_uncertainty_score":0.999873},"labels":[],"label_agreement":null},{"id":"W3126744581","doi":"10.1002/ejhf.2120","title":"Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a <scp>PARADIGM‐HF</scp> analysis","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Hazard ratio; Internal medicine; Heart failure; Cardiology; Ejection fraction; Sudden cardiac death; Proportional hazards model; Natriuretic peptide; Confidence interval; Cart; Clinical endpoint; Clinical trial","score_opus":0.007627307548987399,"score_gpt":0.22776301642409172,"score_spread":0.2201357088751043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126744581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890369,0.004529459,0.0001805064,0.005713688,0.00014329437,0.00032713998,0.0000053724784,0.000019902114,0.00004373939],"genre_scores_gemma":[0.9936442,0.00024413354,0.0054485523,0.00028141428,0.00024653453,0.0000084244875,0.000013550137,0.000044267046,0.00006895274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700373,0.0012535327,0.0004894147,0.0004551164,0.00040191007,0.00039628905],"domain_scores_gemma":[0.99882555,0.00015012194,0.00015911147,0.00042387296,0.00018712675,0.00025420508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011833566,0.00026455984,0.0013679899,0.0008004332,0.00008816593,0.0000507648,0.00006482189,0.000092579,0.000009214696],"category_scores_gemma":[0.00019699386,0.0002248008,0.0005863862,0.0014071871,0.000049632603,0.0001486534,0.00004079864,0.0008267011,0.000017210252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016585329,0.00045551307,0.58942765,0.00078511087,0.019917563,0.030242544,0.0047613075,0.043968365,0.2910698,0.000025432337,0.014278989,0.0034091496],"study_design_scores_gemma":[0.003419135,0.0017525537,0.9235952,0.0014059067,0.0032546888,0.019384768,0.0040422296,0.00014673696,0.004458549,0.000007977323,0.03822807,0.00030418896],"about_ca_topic_score_codex":0.000030042007,"about_ca_topic_score_gemma":0.00013224942,"teacher_disagreement_score":0.3341675,"about_ca_system_score_codex":0.000206304,"about_ca_system_score_gemma":0.00018140386,"threshold_uncertainty_score":0.91671103},"labels":[],"label_agreement":null},{"id":"W3126841512","doi":"10.1002/ejhf.2113","title":"Use of biomarkers to diagnose and manage cardiac amyloidosis","year":2021,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiac amyloidosis; Heart failure; Amyloidosis; Intensive care medicine; Internal medicine; Cardiology","score_opus":0.03264408103094623,"score_gpt":0.2962326810794957,"score_spread":0.26358860004854945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126841512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030391256,0.9952068,0.000023916644,0.00082627434,0.0003039126,0.0003835318,0.00016098432,0.0000059001654,0.00004956754],"genre_scores_gemma":[0.00048779813,0.9900827,0.008329985,0.00026492804,0.00034504625,0.000010014729,0.0000785699,0.00013075468,0.00027022316],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966645,0.0012781073,0.0010033445,0.00046538498,0.00027707487,0.00031157464],"domain_scores_gemma":[0.9979512,0.00017103433,0.00070533744,0.00063090044,0.00020285223,0.00033865205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006217611,0.00050585385,0.0017638054,0.0002830639,0.000061845436,0.00009219651,0.0003320715,0.00015177163,0.00003523797],"category_scores_gemma":[0.00046003153,0.0004091047,0.0012016221,0.00028141533,0.00009752636,0.000014535911,0.0004103841,0.00027654512,0.000023159277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004176294,0.0002311537,0.0031140991,0.0025329455,0.0045989933,0.00063162594,0.000073462485,0.000004979916,0.0011048376,0.000007519159,0.5536811,0.4339775],"study_design_scores_gemma":[0.00025687323,0.00045246075,0.0004463935,0.004290826,0.0011609131,0.00022176451,0.00005008575,3.209901e-8,0.0005762924,1.9571901e-7,0.99221045,0.0003336961],"about_ca_topic_score_codex":0.000008337538,"about_ca_topic_score_gemma":0.0000054601064,"teacher_disagreement_score":0.43852937,"about_ca_system_score_codex":0.00003877196,"about_ca_system_score_gemma":0.00013093004,"threshold_uncertainty_score":0.9998361},"labels":[],"label_agreement":null},{"id":"W3127791464","doi":"10.1002/ejhf.1527","title":"December 2020 at a Glance: Focus on COVID-19, Comorbidities and Palliative Care","year":2020,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Heart failure; Confidence interval; Internal medicine; Coronavirus disease 2019 (COVID-19); Pandemic; Fraction of inspired oxygen; Mortality rate; Emergency medicine; Cardiology; Disease; Infectious disease (medical specialty)","score_opus":0.0371979378309564,"score_gpt":0.2954942729239018,"score_spread":0.25829633509294536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127791464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55497795,0.0036904756,0.00017835555,0.4366581,0.00023404426,0.00032435442,0.000062561056,0.000062223975,0.0038119354],"genre_scores_gemma":[0.98141706,0.000159912,0.0029507224,0.014294547,0.0008714144,7.4532903e-7,0.000008821768,0.000046771966,0.00024998683],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984685,0.00030347193,0.00038678793,0.0002095106,0.00042146078,0.00021023143],"domain_scores_gemma":[0.9985098,0.00015815887,0.00019460784,0.0001601384,0.00019000068,0.000787276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019341464,0.00019355175,0.0004059094,0.000054916793,0.00013279748,0.00003361344,0.00011558658,0.00003374964,0.00031944003],"category_scores_gemma":[0.0006896813,0.00015133747,0.000128706,0.0001258686,0.00012845958,0.000079237674,0.00008877646,0.0005399779,0.00017314398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000980561,0.00003609261,0.04295497,0.0002702332,0.00011387853,0.0038346671,0.012822992,0.000048541475,0.0014656669,0.000025176607,0.9366172,0.00083002774],"study_design_scores_gemma":[0.00511572,0.0030032753,0.038710512,0.0004287368,0.00009811157,0.0012181927,0.003440237,0.000021709344,0.0011867,0.000014651866,0.94656783,0.00019429291],"about_ca_topic_score_codex":0.0000043853283,"about_ca_topic_score_gemma":0.00002659715,"teacher_disagreement_score":0.42643914,"about_ca_system_score_codex":0.00012988184,"about_ca_system_score_gemma":0.00014393475,"threshold_uncertainty_score":0.6171363},"labels":[],"label_agreement":null},{"id":"W3130610755","doi":"10.1002/ejhf.2141","title":"Pharmacotherapy for heart failure with reduced ejection fraction and <scp>health‐related</scp> quality of life: a systematic review and <scp>meta‐analysis</scp>","year":2021,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Native Mental Health Association of Canada; University of British Columbia","funders":"","keywords":"Medicine; Placebo; Internal medicine; Ivabradine; Heart failure; Ejection fraction; Randomized controlled trial; Meta-analysis; Pharmacotherapy; Confidence interval; Strictly standardized mean difference; Digoxin; Blood pressure; Heart rate; Pathology","score_opus":0.06114225924491068,"score_gpt":0.3610345024374152,"score_spread":0.2998922431925045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130610755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001411777,0.9868958,0.00051906466,0.007527919,0.00010714927,0.0046760472,0.00004335869,0.0000466553,0.000042817683],"genre_scores_gemma":[0.00017943273,0.98368096,0.01348169,0.0010734326,0.00025075593,0.00010109783,0.00011467803,0.00015787606,0.00096007384],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98973745,0.0046618413,0.0035639727,0.0007082171,0.00081199734,0.00051649165],"domain_scores_gemma":[0.9928459,0.0012819391,0.0037927984,0.0006721344,0.0007060771,0.0007011763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0070124394,0.000850744,0.010625482,0.00085820135,0.0002211969,0.00011887811,0.0001672783,0.00018464895,0.000057457935],"category_scores_gemma":[0.0010220573,0.000552801,0.0025855661,0.0012743938,0.000110216126,0.00028688475,0.00006222344,0.001062951,0.00001732938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019434194,0.00036553032,0.000062558924,0.704417,0.11471757,0.000084688996,0.000247337,0.000002979976,0.000032248103,0.00002339601,0.17849082,0.0015364212],"study_design_scores_gemma":[0.0014186711,0.0009587642,0.000031239142,0.07277656,0.22237034,0.00095233205,0.00035801102,0.0000020948562,0.0000057513257,0.0000015402741,0.7010265,0.00009818876],"about_ca_topic_score_codex":0.000013149358,"about_ca_topic_score_gemma":0.00001074567,"teacher_disagreement_score":0.63164043,"about_ca_system_score_codex":0.00015261052,"about_ca_system_score_gemma":0.00056213414,"threshold_uncertainty_score":0.9996923},"labels":[],"label_agreement":null},{"id":"W3130684163","doi":"10.1002/ejhf.2134","title":"Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the <scp>PARAGON‐HF</scp> trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"University of Glasgow; British Heart Foundation","keywords":"Medicine; Heart failure; Ejection fraction; Post-hoc analysis; Internal medicine; Cardiology; Potassium; Post hoc; Fraction (chemistry); Chromatography","score_opus":0.009431648667520508,"score_gpt":0.23992580840196354,"score_spread":0.23049415973444304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130684163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637527,0.0007400237,0.000032444044,0.03451831,0.00025266074,0.00025374547,0.000013886371,0.000014093466,0.00042215805],"genre_scores_gemma":[0.9969114,0.000056325094,0.0014254461,0.00062745006,0.00015674328,0.0000014224026,0.000009279797,0.000034083492,0.0007778441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725115,0.000904835,0.0007495021,0.00025207063,0.00056992064,0.00027249395],"domain_scores_gemma":[0.9983987,0.00019478917,0.00043749195,0.00037497745,0.00040327385,0.00019077069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008609727,0.00022185934,0.0008253812,0.00044685084,0.00012000345,0.000054267613,0.00012364818,0.00010458148,0.0001229662],"category_scores_gemma":[0.00046276793,0.00013210089,0.00047082014,0.0012640496,0.0001201553,0.00022710503,0.000067254725,0.0009259921,0.000007674958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040255887,0.00095693255,0.9344076,0.0001240265,0.0036418652,0.0006928126,0.0008651847,0.001072889,0.013667094,0.000014361549,0.04033796,0.0001936815],"study_design_scores_gemma":[0.027032604,0.0018995062,0.871031,0.0003070334,0.002167747,0.00096527557,0.0041075693,0.00008885491,0.0009883749,0.00000725835,0.0913104,0.00009437061],"about_ca_topic_score_codex":0.000017829436,"about_ca_topic_score_gemma":0.00019856688,"teacher_disagreement_score":0.0633766,"about_ca_system_score_codex":0.000046403835,"about_ca_system_score_gemma":0.000276518,"threshold_uncertainty_score":0.5386918},"labels":[],"label_agreement":null},{"id":"W3131224591","doi":"10.1002/ejhf.2129","title":"The path to universality","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.018054304372769663,"score_gpt":0.24434960724517701,"score_spread":0.22629530287240734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131224591","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005178519,0.0005878604,0.00011521583,0.9955493,0.00066011073,0.00031214958,0.00000681073,0.000025241703,0.0022254444],"genre_scores_gemma":[0.0020234801,0.00020762389,0.026381273,0.9204778,0.011210252,0.0000021840099,0.00006362255,0.00016322061,0.039470553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971344,0.00087348366,0.0005980249,0.00025142625,0.0007301012,0.00041260547],"domain_scores_gemma":[0.9983366,0.00013650587,0.00025327364,0.00061741075,0.00040635682,0.00024984725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011946368,0.00029950123,0.0005832424,0.00016180261,0.00019085388,0.00012893006,0.00027472593,0.00009939008,0.0002585823],"category_scores_gemma":[0.00014771495,0.00018144675,0.0005052446,0.00022950646,0.00006210665,0.00006412823,0.00014854642,0.0018579412,0.0004597186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005147729,0.000034115346,0.00012938466,0.000076830904,0.00034092847,0.018312376,0.00011317495,8.5399967e-7,0.00006775301,0.0000112317575,0.9796557,0.0012062007],"study_design_scores_gemma":[0.0008013005,0.00066110736,0.0007537074,0.00058678363,0.00033828628,0.0010698161,0.00021829216,3.8591065e-7,0.000029967083,0.000004281363,0.995379,0.00015711047],"about_ca_topic_score_codex":0.0000038324597,"about_ca_topic_score_gemma":0.000004340386,"teacher_disagreement_score":0.07507153,"about_ca_system_score_codex":0.00014422755,"about_ca_system_score_gemma":0.00025854158,"threshold_uncertainty_score":0.8071933},"labels":[],"label_agreement":null},{"id":"W3132186621","doi":"10.1002/ejhf.2124","title":"Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the <scp>DAPA‐HF</scp> trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Defense Acquisition Program Administration; British Heart Foundation; AstraZeneca","keywords":"Heart failure; Ejection fraction; Medicine; Dapagliflozin; Internal medicine; Cardiology; Endocrinology","score_opus":0.014853880749564686,"score_gpt":0.24612530911277436,"score_spread":0.23127142836320969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132186621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185074,0.00045435468,0.00012812286,0.0161661,0.00029959087,0.00047469154,0.0000028029683,0.000014174776,0.00060942105],"genre_scores_gemma":[0.9911409,0.00004843031,0.0071491254,0.000713624,0.0007476912,0.0000028771149,0.000015666725,0.000030296991,0.000151387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980682,0.00063259515,0.00055713754,0.0002518102,0.00028995948,0.00020030419],"domain_scores_gemma":[0.9987798,0.00038910154,0.00023427252,0.00026894742,0.00017992167,0.00014800901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053437805,0.0001810162,0.00053236244,0.00017889682,0.00009668127,0.00004511951,0.00008846534,0.00004536219,0.00004697205],"category_scores_gemma":[0.0003597254,0.000116361545,0.00010857154,0.00037616747,0.00006046622,0.0001628246,0.00007556651,0.0004260469,0.000023876792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03794508,0.0032006712,0.19838041,0.00020861167,0.0036758173,0.002705421,0.006785327,0.0009555086,0.3134891,0.00043981714,0.41743997,0.014774279],"study_design_scores_gemma":[0.04557082,0.004205113,0.25292367,0.00092816405,0.00042884267,0.00025851055,0.005982672,0.000008473885,0.0057508857,0.000026020964,0.68381923,0.00009762144],"about_ca_topic_score_codex":0.000011426523,"about_ca_topic_score_gemma":0.00004401557,"teacher_disagreement_score":0.3077382,"about_ca_system_score_codex":0.00006336724,"about_ca_system_score_gemma":0.00009711368,"threshold_uncertainty_score":0.4745086},"labels":[],"label_agreement":null},{"id":"W3132267344","doi":"10.1002/ejhf.2139","title":"Current challenges for using the Kansas City Cardiomyopathy Questionnaire to obtain a standardized <scp>patient‐reported</scp> health status outcome","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; Ted Rogers Centre for Heart Research; University Health Network","funders":"","keywords":"Medicine; Cardiomyopathy; Outcome (game theory); Heart failure; Cardiovascular health; Family medicine; Environmental health; Internal medicine; Disease","score_opus":0.06866388746286915,"score_gpt":0.3392416918996764,"score_spread":0.27057780443680723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132267344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6516221,0.045460604,0.05997519,0.23655444,0.002567654,0.003254972,0.00008393387,0.00015901407,0.00032208167],"genre_scores_gemma":[0.9119607,0.0007592016,0.08384731,0.0020756794,0.0009960976,0.000016556092,0.000019550725,0.00010913508,0.00021577322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962081,0.0009508887,0.0011103069,0.0003532707,0.00075154635,0.0006258875],"domain_scores_gemma":[0.99743074,0.00013248969,0.0004588463,0.000500844,0.00083470216,0.00064235245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025247098,0.00030430805,0.0008200559,0.00021249412,0.00032412363,0.0000856216,0.00011535129,0.00003213752,0.000015240322],"category_scores_gemma":[0.0009632837,0.0002082571,0.0005327208,0.00030173545,0.00005079901,0.00013423267,0.00010997815,0.00043985812,0.000012147897],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090476335,0.0021761092,0.13678157,0.0022155517,0.0033867862,0.0052637476,0.027460808,0.0010503267,0.0014920934,0.0010058843,0.6286487,0.18961369],"study_design_scores_gemma":[0.0027478212,0.0014258875,0.023508983,0.00080411247,0.00032546482,0.0007892772,0.0036004751,0.000020420455,0.00023101919,0.000025241272,0.96642447,0.00009680577],"about_ca_topic_score_codex":0.000009506657,"about_ca_topic_score_gemma":0.000025298617,"teacher_disagreement_score":0.33777583,"about_ca_system_score_codex":0.0003759601,"about_ca_system_score_gemma":0.00075055554,"threshold_uncertainty_score":0.8492478},"labels":[],"label_agreement":null},{"id":"W3137639126","doi":"10.1002/ejhf.1874","title":"January 2021 at a glance: focus on sex differences, acute heart failure and exercise capacity","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Cohort; Internal medicine; Cohort study; Cardiology; Emergency medicine","score_opus":0.01956357850332206,"score_gpt":0.2664156060667764,"score_spread":0.24685202756345434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137639126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.864145,0.01578037,0.00011481216,0.116599,0.00042887544,0.00041576475,0.000039125902,0.000044447224,0.002432622],"genre_scores_gemma":[0.97772175,0.004487293,0.01100528,0.0015414433,0.0009212468,0.0000039945235,0.000015238011,0.00009334696,0.0042104134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621433,0.00076994335,0.0006722748,0.00044814643,0.0012755555,0.0006197331],"domain_scores_gemma":[0.997463,0.00028195616,0.00018077923,0.0005322429,0.0004063256,0.0011357141],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011122233,0.00031790996,0.00087476295,0.00020677631,0.00019971821,0.000073707444,0.00021884474,0.00013827883,0.00092136813],"category_scores_gemma":[0.00085371186,0.00023894887,0.00027761413,0.00037888577,0.00026430457,0.0001591573,0.00026421944,0.0021351217,0.00034094235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00105573,0.0005893234,0.02119817,0.00028200643,0.00052625616,0.021660963,0.0009418371,0.0000024809785,0.06426202,0.000037206057,0.86500245,0.024441568],"study_design_scores_gemma":[0.013114114,0.004580281,0.082272366,0.025331683,0.000738026,0.024525149,0.00093639985,0.00008066712,0.04384647,0.00025103657,0.8034867,0.00083712535],"about_ca_topic_score_codex":0.0000060137163,"about_ca_topic_score_gemma":0.00001347564,"teacher_disagreement_score":0.11505756,"about_ca_system_score_codex":0.00013677473,"about_ca_system_score_gemma":0.00038521862,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W3145147119","doi":"10.1002/ejhf.1876","title":"February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Transthyretin; Internal medicine; Hazard ratio; Cardiology; Heart failure; Cardiac amyloidosis; Amyloidosis; Natriuretic peptide; Cardiomyopathy; Confidence interval; Gastroenterology","score_opus":0.0066727302341916634,"score_gpt":0.22342033905021472,"score_spread":0.21674760881602306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145147119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732841,0.013464577,0.000074997224,0.011346427,0.00037563356,0.00010510126,0.000052961725,0.000008759437,0.0012874445],"genre_scores_gemma":[0.9918623,0.0025647718,0.0029189528,0.0011585568,0.0010038009,0.0000034240668,0.00003222044,0.00006134393,0.00039463758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980431,0.0005939771,0.00040032712,0.00037817474,0.00028488593,0.00029950516],"domain_scores_gemma":[0.9989035,0.00004399425,0.00020630658,0.00042354714,0.00018181386,0.00024083335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003929551,0.00026527638,0.0004145227,0.00007144905,0.00014843972,0.00006482439,0.00016167488,0.00007128809,0.000100404926],"category_scores_gemma":[0.00015528809,0.0002334634,0.0003614258,0.00011552166,0.00008346972,0.000011524368,0.00022884007,0.00023265694,0.00008754537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027809598,0.00024546307,0.22185604,0.000036882484,0.00088917854,0.0033354366,0.00016163208,0.00006904663,0.22123985,0.000033808356,0.54083794,0.011016642],"study_design_scores_gemma":[0.0025653355,0.0012588332,0.26006338,0.00016013299,0.00015875864,0.003186227,0.00023368154,8.7092064e-7,0.1641399,0.000017658595,0.5678405,0.00037468594],"about_ca_topic_score_codex":0.0000047168296,"about_ca_topic_score_gemma":0.00001540125,"teacher_disagreement_score":0.057099957,"about_ca_system_score_codex":0.000047834026,"about_ca_system_score_gemma":0.00009114659,"threshold_uncertainty_score":0.95203614},"labels":[],"label_agreement":null},{"id":"W3146068024","doi":"10.1002/ejhf.2177","title":"Cognitive impairment as a determinant of response to management plans after heart failure admission","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; National Heart Foundation of Australia; U.S. Department of Health and Human Services","keywords":"Medicine; Confidence interval; Odds ratio; Montreal Cognitive Assessment; Heart failure; Cognition; Internal medicine; Cognitive impairment; Physical therapy; Disease; Psychiatry","score_opus":0.010963536751522672,"score_gpt":0.2739066381505669,"score_spread":0.2629431013990442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146068024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982643,0.00026869052,0.00032227443,0.099566326,0.0002018069,0.00078156724,0.000022493645,0.000031894324,0.0005406665],"genre_scores_gemma":[0.9443691,0.000026471887,0.048937302,0.0027470253,0.0002177165,0.000012462928,0.000011099461,0.00006655357,0.003612266],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965985,0.00087477354,0.00089623895,0.0003801046,0.00079293293,0.00045746632],"domain_scores_gemma":[0.9980763,0.00011663352,0.00021553959,0.00043099906,0.000455868,0.0007046658],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014367262,0.00033661476,0.000694015,0.00044872717,0.00008904241,0.00004934492,0.00013091884,0.000051402243,0.0010020103],"category_scores_gemma":[0.00018797546,0.00026084832,0.0004384842,0.00039875042,0.000058343092,0.00014327446,0.00022996373,0.00034802375,0.00049690926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0325982,0.0029421123,0.023241663,0.0008176855,0.0016288989,0.06285269,0.0038757888,0.000020930876,0.07996594,0.000045205474,0.78448755,0.0075233323],"study_design_scores_gemma":[0.0057448484,0.0055533214,0.089756176,0.0032333785,0.0005810292,0.0025587713,0.0030931316,0.0000022124855,0.0246012,0.000008113384,0.8645911,0.00027670545],"about_ca_topic_score_codex":0.000002495981,"about_ca_topic_score_gemma":0.000010073197,"teacher_disagreement_score":0.0968193,"about_ca_system_score_codex":0.00011428585,"about_ca_system_score_gemma":0.0002283022,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W3155587303","doi":"10.1002/ejhf.2192","title":"Cautious optimism for machine learning techniques for prediction of heart failure outcomes","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Machine learning; Artificial intelligence; Receiver operating characteristic; Medicine; Predictive modelling; Heart failure; Predictive value; Set (abstract data type); Ejection fraction; Computer science; Internal medicine","score_opus":0.023666021887150404,"score_gpt":0.26576000018180507,"score_spread":0.24209397829465468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155587303","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039978238,0.0009232117,0.00782373,0.9876291,0.00056563865,0.0020758456,0.00030178492,0.0001462928,0.00013459628],"genre_scores_gemma":[0.0036979055,0.00018266538,0.8363811,0.13233942,0.008377339,0.00010537656,0.0022199256,0.00054086436,0.016155448],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627066,0.000501115,0.0014482321,0.000479546,0.00071836595,0.00058208767],"domain_scores_gemma":[0.99722755,0.0003162943,0.000841586,0.00049852306,0.0009144112,0.00020160625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015144061,0.0006042651,0.0017107724,0.0006052992,0.00020092512,0.00007871247,0.00022574428,0.0003467142,0.0001610835],"category_scores_gemma":[0.00040979564,0.00047716565,0.0014198405,0.00019322586,0.000093977666,0.0001730284,0.00009699232,0.0019243297,0.000012563916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015809426,0.00014460595,0.002134499,0.0010570689,0.00094108435,0.00047392043,0.000118161406,0.000016213025,0.0016721787,0.000008177374,0.99270767,0.00056835427],"study_design_scores_gemma":[0.0032682838,0.0034334953,0.0004672445,0.0013444759,0.0012823393,0.0009568774,0.00011110292,0.000037142134,0.0017635529,0.0000138365085,0.98702914,0.00029254018],"about_ca_topic_score_codex":0.000007511826,"about_ca_topic_score_gemma":0.000005588556,"teacher_disagreement_score":0.8552897,"about_ca_system_score_codex":0.00015932067,"about_ca_system_score_gemma":0.00024704056,"threshold_uncertainty_score":0.999768},"labels":[],"label_agreement":null},{"id":"W3156986328","doi":"10.1002/ejhf.2191","title":"Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Institutes of Health; Novo Nordisk; Servier; University of Glasgow; Boston Scientific Corporation; North Carolina State University; Alnylam Pharmaceuticals; Janssen Pharmaceuticals; MyoKardia; Gilead Sciences; Cytokinetics; Brigham and Women's Hospital; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Daiichi Sankyo Europe; Bayer HealthCare; Sanofi; American Heart Association","keywords":"Medicine; Heart failure; Myocardial infarction; Internal medicine; Cardiology; ACE inhibitor; Prospective cohort study; Angiotensin-converting enzyme","score_opus":0.01563593336883602,"score_gpt":0.2522057668303789,"score_spread":0.23656983346154287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156986328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367948,0.00020112211,0.0008877559,0.05998242,0.0008428354,0.0012298533,0.000011041648,0.00003123736,0.000018893326],"genre_scores_gemma":[0.9213877,0.0000495749,0.074435964,0.0010374169,0.0027527828,0.000022127928,0.000014719375,0.00006270823,0.00023702493],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.996643,0.0010847512,0.0008987212,0.00044276315,0.00051467994,0.00041609036],"domain_scores_gemma":[0.9985921,0.00010622768,0.00016969579,0.0003228109,0.0003402455,0.0004689134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018588016,0.0003314297,0.0007981228,0.00033353534,0.00010334753,0.00009847878,0.00007495156,0.00007571886,0.00015048301],"category_scores_gemma":[0.0006112944,0.0002943491,0.0002290773,0.00037816283,0.000049315728,0.00031972115,0.00012259492,0.00060177204,0.00006363261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13061462,0.0032748836,0.44155487,0.00054680696,0.0012056063,0.011387715,0.0066086897,0.00014133147,0.06014106,0.00001604306,0.33508345,0.00942489],"study_design_scores_gemma":[0.03846653,0.0051395516,0.3225282,0.0012345741,0.00041163067,0.0017668523,0.0003653961,0.000051412968,0.0028673827,0.00001093044,0.626698,0.00045952346],"about_ca_topic_score_codex":0.0000063701646,"about_ca_topic_score_gemma":0.000012097517,"teacher_disagreement_score":0.29161453,"about_ca_system_score_codex":0.00018658108,"about_ca_system_score_gemma":0.00024666233,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W3157602851","doi":"10.1002/ejhf.1878","title":"March 2021 at a glance: focus on epidemiology, prevention and <scp>COVID</scp> ‐19","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Cardiology; Natriuretic peptide; Refractory (planetary science); Guideline; Abnormality; Stage (stratigraphy); Pathology","score_opus":0.03459941536788434,"score_gpt":0.30964252857012625,"score_spread":0.2750431132022419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157602851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7054048,0.007541204,0.001210943,0.27653167,0.0005543889,0.00069516356,0.000012485276,0.00005655474,0.007992776],"genre_scores_gemma":[0.8561988,0.0017383967,0.09527259,0.007027979,0.0020856692,0.000008243616,0.000060914583,0.00011698054,0.037490442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720514,0.0012486979,0.0006000161,0.00030633467,0.00028247316,0.00035736416],"domain_scores_gemma":[0.998388,0.0004475394,0.00022899373,0.0003082481,0.00015139888,0.00047584123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020839681,0.0002068508,0.0005617562,0.00016344653,0.00014281241,0.000024347832,0.00007451456,0.00005334346,0.0003634428],"category_scores_gemma":[0.0012453332,0.0001595861,0.00025143466,0.00017981498,0.000077838195,0.000090975314,0.00013381234,0.00042805975,0.0002921325],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013844334,0.00030024356,0.07084206,0.00011927465,0.00031804986,0.0040333066,0.00029892623,0.000013184658,0.0026719766,0.00030500191,0.91299844,0.007961073],"study_design_scores_gemma":[0.0029080277,0.0015704865,0.0560939,0.0003338467,0.00017537933,0.0025313252,0.0002762681,0.0000091949905,0.00032944998,0.00023946188,0.9354742,0.000058437796],"about_ca_topic_score_codex":0.00000269713,"about_ca_topic_score_gemma":0.000014933562,"teacher_disagreement_score":0.26950368,"about_ca_system_score_codex":0.00012698544,"about_ca_system_score_gemma":0.00014833009,"threshold_uncertainty_score":0.6507732},"labels":[],"label_agreement":null},{"id":"W3157792387","doi":"10.1002/ejhf.2213","title":"Optimizing evidence‐based heart failure medication: every contact counts","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Guideline; Acute coronary syndrome; Canadian Cardiovascular Society; Clinical trial; Randomized controlled trial; Health care; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.045410763674025745,"score_gpt":0.28284010158988404,"score_spread":0.2374293379158583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157792387","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013507833,0.00447124,0.00045152457,0.9923114,0.001012107,0.00039783047,0.000010732472,0.00006576415,0.0011443229],"genre_scores_gemma":[0.0069767334,0.00040668526,0.14182639,0.82328933,0.01622145,0.0000106091475,0.0003250425,0.0003018116,0.010641924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99598527,0.00082707254,0.00095827726,0.00043598644,0.0013007681,0.00049264624],"domain_scores_gemma":[0.99768424,0.00026709636,0.0004898438,0.0006958242,0.0005579712,0.0003050419],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013049949,0.00048296645,0.0010482376,0.00041849606,0.00012955058,0.00014373791,0.00028510913,0.00026254752,0.0039454047],"category_scores_gemma":[0.00026597243,0.0003886597,0.0006796519,0.00026959216,0.00008193389,0.00027755616,0.00008222347,0.002411754,0.0011952783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046876627,0.00006133434,0.0002876853,0.0003027541,0.00034374796,0.0065819127,0.000052183685,0.0000053339854,0.00034763847,0.0000035089524,0.9916978,0.00026925278],"study_design_scores_gemma":[0.0013592707,0.00060252723,0.00039942746,0.00499437,0.0006384618,0.0013995322,0.00007297418,0.00001056545,0.00014922659,0.0000016203122,0.99007016,0.00030188283],"about_ca_topic_score_codex":0.0000033437311,"about_ca_topic_score_gemma":0.0000016495616,"teacher_disagreement_score":0.16902205,"about_ca_system_score_codex":0.000229449,"about_ca_system_score_gemma":0.000786041,"threshold_uncertainty_score":0.99988973},"labels":[],"label_agreement":null},{"id":"W3158596701","doi":"10.1002/ejhf.2204","title":"The multifaceted mechanisms of nitroxyl in heart failure: inodilator or ‘only’ vasodilator?","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Afterload; Ejection fraction; Vasodilation; Cardiology; Internal medicine; Cardiac output; Hemodynamics; Phosphodiesterase","score_opus":0.01983711105916208,"score_gpt":0.25014303945088256,"score_spread":0.23030592839172048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158596701","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007129403,0.0010355855,0.00018272403,0.9892974,0.001050403,0.0010504787,0.000029733224,0.000053322823,0.0001709362],"genre_scores_gemma":[0.10002856,0.0006485103,0.30430838,0.54095745,0.016014736,0.00005235458,0.000448784,0.0013277024,0.036213506],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99340576,0.0015579816,0.0020806417,0.0005745179,0.0014710276,0.0009100872],"domain_scores_gemma":[0.9964701,0.00044481712,0.000924099,0.0011008953,0.00073877175,0.000321346],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023061107,0.00077038683,0.0018615178,0.0006487897,0.00019906106,0.00014778125,0.0005455179,0.00038866574,0.0007415388],"category_scores_gemma":[0.00051425095,0.0004775367,0.0009358389,0.0007142325,0.00020044977,0.00019812366,0.00027123097,0.0036863533,0.00030083643],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037749452,0.00018899945,0.00097540877,0.00032133298,0.0006501959,0.0068685655,0.0001749758,0.0000049367327,0.002160831,0.000027826034,0.9878739,0.0003755335],"study_design_scores_gemma":[0.004113801,0.0013656388,0.0012979191,0.0018470329,0.0005091316,0.0020727976,0.0006381613,0.000008100721,0.0016563145,0.000027553693,0.9860633,0.00040026588],"about_ca_topic_score_codex":0.000017713179,"about_ca_topic_score_gemma":0.00005890806,"teacher_disagreement_score":0.44833997,"about_ca_system_score_codex":0.00024543554,"about_ca_system_score_gemma":0.000847891,"threshold_uncertainty_score":0.99976766},"labels":[],"label_agreement":null},{"id":"W3161140882","doi":"10.1002/ejhf.2219","title":"Association between up‐titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"FP7 Health; European Commission; National Institute for Health and Care Research","keywords":"Medicine; Ejection fraction; Heart failure; Hazard ratio; Internal medicine; Confidence interval; Cardiology","score_opus":0.014089834436356774,"score_gpt":0.2723041499933629,"score_spread":0.25821431555700614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161140882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9369287,0.0001472483,0.0002917447,0.062239874,0.00010866977,0.0002495022,0.000004016057,0.000009694646,0.00002057777],"genre_scores_gemma":[0.9978528,0.00021171612,0.0014487216,0.00016782091,0.0002239301,0.0000014390736,0.000030576175,0.000017363669,0.000045620945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809706,0.00041022524,0.00045169212,0.0001601511,0.0007111847,0.00016969757],"domain_scores_gemma":[0.99917203,0.00007064987,0.0002650001,0.00012714544,0.0002541537,0.00011099607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012680173,0.00012549887,0.0003022368,0.000075384356,0.00012436068,0.000059718623,0.000033342396,0.00005957004,0.00006754946],"category_scores_gemma":[0.00016025399,0.00008420571,0.000056248675,0.0002883289,0.00004568683,0.000247625,0.000032205968,0.00035128088,0.0000018546411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080139354,0.00013601853,0.99308157,0.000018338658,0.00021664944,0.000015917627,0.00044592182,0.000008106764,0.00009155537,0.000012419184,0.004453603,0.0014397319],"study_design_scores_gemma":[0.0029618582,0.00062007963,0.96375823,0.00018854083,0.00010704376,0.000036818827,0.00066233205,0.000014715292,0.00033894076,0.000009665583,0.03122951,0.000072292896],"about_ca_topic_score_codex":0.000020570084,"about_ca_topic_score_gemma":0.00013110826,"teacher_disagreement_score":0.062072054,"about_ca_system_score_codex":0.00009475246,"about_ca_system_score_gemma":0.00007835857,"threshold_uncertainty_score":0.34338093},"labels":[],"label_agreement":null},{"id":"W3162755126","doi":"10.1002/ejhf.2221","title":"Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> ( <scp>Vericiguat</scp> Global Study in Subjects with <scp>HFrEF</scp> ) trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Duke Clinical Research Institute; Merck; Bayer","keywords":"Ejection fraction; Heart failure; Medicine; Cardiology; Renal function; Internal medicine","score_opus":0.006716490104843227,"score_gpt":0.2133845004356755,"score_spread":0.20666801033083226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162755126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943993,0.00054201944,0.00018030462,0.0015031189,0.0006061631,0.0024335152,0.0000048508105,0.000044062246,0.00028666912],"genre_scores_gemma":[0.99642676,0.00002839997,0.002076836,0.00030004416,0.0008450441,0.000033076954,0.00003403642,0.00008129466,0.00017453168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939804,0.0023686145,0.0010028807,0.00065831933,0.0014325937,0.00055720744],"domain_scores_gemma":[0.99615186,0.0016748057,0.0007477256,0.0006222989,0.0005348001,0.00026848115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011500177,0.00059748266,0.0011815041,0.00029114806,0.0002987854,0.00018830459,0.00019383094,0.00011362974,0.000007256388],"category_scores_gemma":[0.001093169,0.0003183456,0.00018821066,0.001622963,0.0002204967,0.0005734348,0.000121092104,0.001145909,0.0000136764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01179294,0.0034975456,0.9252811,0.00016594768,0.002145111,0.0018023128,0.007428591,0.00039549603,0.0017627884,0.000041273088,0.045289498,0.00039736723],"study_design_scores_gemma":[0.117223285,0.013333814,0.79933566,0.0015243696,0.0011939268,0.00020098052,0.0133948,0.000016203143,0.00070630206,0.000020775778,0.05296304,0.00008681776],"about_ca_topic_score_codex":0.00013397365,"about_ca_topic_score_gemma":0.0008848162,"teacher_disagreement_score":0.12594545,"about_ca_system_score_codex":0.00026821138,"about_ca_system_score_gemma":0.00033595215,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W3164633248","doi":"10.1002/ejhf.2255","title":"Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the <scp>HEAAL</scp> trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Losartan; Medicine; Heart failure; Hazard ratio; Ejection fraction; Renal function; Internal medicine; Cardiology; Confidence interval; Dosing; Urology; Proportional hazards model; Angiotensin II; Endocrinology; Blood pressure","score_opus":0.017359197206377373,"score_gpt":0.2549714373050291,"score_spread":0.2376122400986517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164633248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660623,0.00016041395,0.000109619694,0.030163161,0.00027331297,0.00062688463,0.0000020532439,0.000029341769,0.002572879],"genre_scores_gemma":[0.98668367,0.00002517632,0.0115709035,0.00023786045,0.000767785,0.000008918092,0.0000073164138,0.000062432584,0.000635938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971683,0.00071591337,0.0006849404,0.0002938265,0.0007173937,0.00041959435],"domain_scores_gemma":[0.99840176,0.0002212071,0.000360314,0.0004245018,0.00035992448,0.00023229301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013045287,0.00027578717,0.00065979717,0.00025814006,0.00014963267,0.00008017631,0.00011519111,0.000054520988,0.00014045065],"category_scores_gemma":[0.00018190875,0.00016783537,0.00014914466,0.0007011158,0.00010944216,0.00030511204,0.000047039815,0.00070426066,0.000036740355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12819989,0.0035004853,0.03242407,0.0004723816,0.0034016762,0.0058453293,0.0075908313,0.00057621434,0.067455836,0.00024184308,0.74847716,0.0018142539],"study_design_scores_gemma":[0.07583588,0.015248974,0.015934665,0.0008832067,0.00043021975,0.0012750352,0.022011857,0.0000136295575,0.0075747417,0.000008044486,0.86064667,0.00013707671],"about_ca_topic_score_codex":0.00001207596,"about_ca_topic_score_gemma":0.000055891906,"teacher_disagreement_score":0.11216948,"about_ca_system_score_codex":0.00025831585,"about_ca_system_score_gemma":0.00038076338,"threshold_uncertainty_score":0.6844128},"labels":[],"label_agreement":null},{"id":"W3164716110","doi":"10.1002/ejhf.2248","title":"Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Population; Library science; Environmental health","score_opus":0.026762939193694456,"score_gpt":0.28462000780914515,"score_spread":0.2578570686154507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164716110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96157646,0.0007852341,0.0008602885,0.03553991,0.000301236,0.000558047,0.000011397563,0.00003248357,0.00033493488],"genre_scores_gemma":[0.8891102,0.0010025846,0.10776805,0.000074521355,0.00072094915,0.0000041189005,0.000011988137,0.00005809669,0.0012494687],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956423,0.0021939892,0.0011723798,0.00031229903,0.00044017148,0.00023883267],"domain_scores_gemma":[0.9980089,0.00021852023,0.0008857911,0.00029428033,0.0003917727,0.00020070118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036900432,0.00023998793,0.0009606668,0.00039206693,0.0001333614,0.000043637203,0.000047723268,0.00007209309,0.00036599042],"category_scores_gemma":[0.0009214935,0.00016233459,0.00023719225,0.00056321744,0.000087440814,0.000436922,0.00003645542,0.0007934564,0.000029517867],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014122029,0.0020953922,0.21594791,0.00052592997,0.003740859,0.0034235476,0.0031932374,0.00048067968,0.08613936,0.000111575566,0.65237963,0.017839829],"study_design_scores_gemma":[0.010718642,0.0038617437,0.15421976,0.0013810182,0.0014620117,0.004689153,0.0039757667,0.000024344485,0.00901408,0.00004987225,0.8103253,0.00027826647],"about_ca_topic_score_codex":0.000040101953,"about_ca_topic_score_gemma":0.00008181815,"teacher_disagreement_score":0.1579457,"about_ca_system_score_codex":0.000106633735,"about_ca_system_score_gemma":0.00021029661,"threshold_uncertainty_score":0.6619812},"labels":[],"label_agreement":null},{"id":"W3165787706","doi":"10.1002/ejhf.2220","title":"Use of diuretics and outcomes in patients with type 2 diabetes: findings from the <scp>EMPA‐REG OUTCOME</scp> trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"Heart Research UK; British Heart Foundation","keywords":"Medicine; Hazard ratio; Internal medicine; Heart failure; EMPA; Diabetes mellitus; Confidence interval; Empagliflozin; Placebo; Type 2 Diabetes Mellitus; Type 2 diabetes; Cardiology; Endocrinology; Pathology","score_opus":0.020590784635069016,"score_gpt":0.23393789824415942,"score_spread":0.2133471136090904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165787706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695563,0.00021026601,0.0000022680376,0.0023415587,0.00016911853,0.00023538746,0.000010402055,0.000005388141,0.000069956615],"genre_scores_gemma":[0.99587935,0.000023766146,0.0027570813,0.00072299666,0.0000752998,5.0431646e-7,0.000016074484,0.000026493348,0.0004984184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869794,0.00020427254,0.00045536403,0.00012828787,0.00033849545,0.00017564531],"domain_scores_gemma":[0.99898857,0.00033473238,0.00018543622,0.00021505072,0.00017972736,0.000096500844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032054624,0.00014439659,0.0004562556,0.00007706685,0.000032367952,0.00004631775,0.00008018235,0.00002188405,0.000025260262],"category_scores_gemma":[0.00057799876,0.00007963821,0.00009775615,0.00016639469,0.00006093576,0.00012528642,0.00007578217,0.00022927702,0.000008985099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033658036,0.00031286653,0.9865497,0.000017967752,0.00028177415,0.00008174911,0.00031715265,0.000003920861,0.00007514765,0.000007851242,0.01162012,0.0003951648],"study_design_scores_gemma":[0.019938074,0.0018015532,0.92189854,0.00022416229,0.0002924779,0.0000015173206,0.00020161149,0.0000016720087,0.00019065387,0.0000054506945,0.055409692,0.000034598943],"about_ca_topic_score_codex":0.0000021152368,"about_ca_topic_score_gemma":0.0000059494546,"teacher_disagreement_score":0.06465117,"about_ca_system_score_codex":0.000021951999,"about_ca_system_score_gemma":0.000033155862,"threshold_uncertainty_score":0.32475516},"labels":[],"label_agreement":null},{"id":"W3168936597","doi":"10.1002/ejhf.2259","title":"Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the <scp>PARADIGM‐HF</scp> trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Enalapril; Sacubitril; Valsartan; Sacubitril, Valsartan; Medicine; Heart failure; Internal medicine; Dosing; Ejection fraction; Cardiology; Pharmacology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.010780943121418548,"score_gpt":0.25843519250376523,"score_spread":0.24765424938234668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168936597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8867254,0.0017376273,0.000008024655,0.10919651,0.00040591386,0.001045014,0.000010639931,0.000038170405,0.00083265355],"genre_scores_gemma":[0.99115354,0.00017790432,0.0020861728,0.0024051175,0.0014894516,0.000012873748,0.000019712053,0.00011094481,0.0025443132],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495614,0.0023684711,0.0008554041,0.00036177316,0.0009358939,0.00052233523],"domain_scores_gemma":[0.99757546,0.0010149375,0.00037177617,0.00062348746,0.00016506673,0.00024927178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032668654,0.0004404793,0.0014232802,0.00037236937,0.0001291654,0.000086687796,0.0002435311,0.00009245493,0.0005743652],"category_scores_gemma":[0.00053021556,0.00026551803,0.00056146056,0.0005590125,0.00014817872,0.00014843704,0.00010005167,0.00081517897,0.00023780079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068013184,0.00097639475,0.008226129,0.0002811741,0.00092125626,0.0020174102,0.0019312261,0.000043818767,0.032295678,0.0001612714,0.94371694,0.0026273648],"study_design_scores_gemma":[0.030003421,0.009782129,0.010898358,0.00079265307,0.0003762743,0.0004545813,0.00028054163,0.000011100447,0.021681154,0.000013064543,0.92559576,0.000110971356],"about_ca_topic_score_codex":0.0000056044464,"about_ca_topic_score_gemma":0.000031982963,"teacher_disagreement_score":0.10679139,"about_ca_system_score_codex":0.000092333365,"about_ca_system_score_gemma":0.00016805583,"threshold_uncertainty_score":0.9999797},"labels":[],"label_agreement":null},{"id":"W3172582615","doi":"10.1002/ejhf.1880","title":"April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Heart failure; Cardiology; Internal medicine; Quality of life (healthcare); Cohort; Cardiomyopathy; Stroke volume","score_opus":0.024825584299683044,"score_gpt":0.27095821321008007,"score_spread":0.24613262891039703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172582615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87583214,0.0023186244,0.000063810265,0.12047241,0.00019857401,0.00040788774,0.000011122878,0.000018875611,0.00067652797],"genre_scores_gemma":[0.9903608,0.0002076345,0.006512472,0.00079048343,0.00043690114,0.0000048768634,0.000013341203,0.000042799118,0.0016307122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701154,0.0008588695,0.00097248104,0.00033462408,0.00049993116,0.0003225641],"domain_scores_gemma":[0.99852777,0.0001310935,0.00028860895,0.00042619763,0.0002517174,0.00037463938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009485616,0.0002892067,0.00095089595,0.00025883477,0.000088347195,0.00003119888,0.00006342779,0.00005948972,0.00045190463],"category_scores_gemma":[0.00020094101,0.00021886067,0.00029599963,0.00033274337,0.00008805109,0.00011242028,0.00007490451,0.0002930603,0.00011369367],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00398212,0.0027377065,0.41690522,0.0005617573,0.0013218301,0.00274075,0.0015540197,0.000087636094,0.031444453,0.0010050088,0.5306575,0.007001996],"study_design_scores_gemma":[0.008308888,0.002810673,0.18541257,0.00053921755,0.000171815,0.0005226106,0.0007915932,0.0000043195528,0.0017563034,0.000024861749,0.7994614,0.00019574481],"about_ca_topic_score_codex":0.000030492394,"about_ca_topic_score_gemma":0.00026023827,"teacher_disagreement_score":0.26880392,"about_ca_system_score_codex":0.00022872764,"about_ca_system_score_gemma":0.00024160763,"threshold_uncertainty_score":0.89248794},"labels":[],"label_agreement":null},{"id":"W3174049001","doi":"10.1002/ejhf.2287","title":"Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"Vetenskapsrådet; Stockholms Läns Landsting; Hjärt-Lungfonden","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Confidence interval; Cardiology; Hyperkalemia; Myocardial infarction; Hypokalemia; Stroke (engine)","score_opus":0.038360008358716266,"score_gpt":0.288490633588359,"score_spread":0.25013062522964274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174049001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147315,0.0023806414,0.00007979187,0.015404255,0.0003565915,0.00013830088,0.000023460569,0.000010940725,0.00013287099],"genre_scores_gemma":[0.98667765,0.000048208207,0.010847386,0.000618248,0.0013525183,4.0326765e-7,0.00026034046,0.000030012154,0.00016521699],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982261,0.00035608327,0.0006466397,0.0002279899,0.00038695926,0.00015622046],"domain_scores_gemma":[0.9988651,0.000049916718,0.00016697349,0.00039416083,0.00036234135,0.00016149537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039880237,0.00012770228,0.00038846466,0.00011711992,0.000042022417,0.000042882344,0.00010432132,0.000047627633,0.000357527],"category_scores_gemma":[0.00038097362,0.000105012616,0.00010506938,0.0001755315,0.000024505805,0.00021260466,0.00009334045,0.0003980066,0.00006541081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052469634,0.0010364035,0.17736256,0.00013323186,0.00028741203,0.018169748,0.0033337807,0.0002085525,0.5839697,0.000013211806,0.14174397,0.021271797],"study_design_scores_gemma":[0.037190977,0.0005437224,0.38615215,0.00071929005,0.0001483897,0.00092277955,0.00097271753,0.0004155988,0.001511455,0.000002499389,0.5712206,0.00019987575],"about_ca_topic_score_codex":0.000007780555,"about_ca_topic_score_gemma":0.000041153802,"teacher_disagreement_score":0.58245826,"about_ca_system_score_codex":0.00007305237,"about_ca_system_score_gemma":0.00021980004,"threshold_uncertainty_score":0.428229},"labels":[],"label_agreement":null},{"id":"W3174901577","doi":"10.1002/ejhf.1882","title":"May 2021 at a glance: focus on acute heart failure and heart failure with preserved ejection fraction","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Ejection fraction; Hazard ratio; Acute kidney injury; Acute decompensated heart failure; Renal function; Confidence interval; Prospective cohort study; Emergency department; Inotrope; Heart failure with preserved ejection fraction","score_opus":0.01257003349330265,"score_gpt":0.25089669294331873,"score_spread":0.23832665945001608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174901577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62673676,0.0007507903,0.00036486814,0.36974034,0.00042252778,0.00078583806,0.000019741556,0.00010310932,0.0010760092],"genre_scores_gemma":[0.92662704,0.00015636803,0.06535609,0.0018848156,0.0015189538,0.000013482354,0.0000618618,0.00015908881,0.004222275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963245,0.0007711048,0.00073520496,0.00063893804,0.00093461084,0.0005956865],"domain_scores_gemma":[0.9978124,0.0001394059,0.00031364348,0.00065188995,0.00050858274,0.0005740974],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008450829,0.0005115967,0.0009261529,0.000336569,0.0003672698,0.00018755454,0.00012031628,0.00012792648,0.0011351003],"category_scores_gemma":[0.0001258167,0.00038664395,0.00035204113,0.00051999075,0.00011287309,0.0005091929,0.00015011593,0.0009938634,0.0004493816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013449998,0.00048069452,0.062073432,0.00013056022,0.0008707281,0.0030147606,0.00014791614,0.0000373793,0.035174374,0.00004459189,0.89615756,0.0005229804],"study_design_scores_gemma":[0.005559928,0.0032145407,0.04461609,0.0008236858,0.00058226025,0.005762143,0.000703642,0.00001662052,0.011381141,0.000014469621,0.92697155,0.0003539058],"about_ca_topic_score_codex":0.000013909989,"about_ca_topic_score_gemma":0.00015938494,"teacher_disagreement_score":0.36785552,"about_ca_system_score_codex":0.00025280463,"about_ca_system_score_gemma":0.00019532109,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W3176838616","doi":"10.1002/ejhf.2285","title":"Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Duke Clinical Research Institute; Merck Sharp and Dohme; Bayer","keywords":"Medicine; Atrial fibrillation; Hazard ratio; Internal medicine; Heart failure; Ejection fraction; Cardiology; Myocardial infarction; Stroke (engine); Confidence interval; Randomized controlled trial; Population; Lower risk; Randomization","score_opus":0.016830545248055002,"score_gpt":0.2469777476832641,"score_spread":0.23014720243520911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176838616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909431,0.00026426296,0.00011115715,0.007353911,0.0006933929,0.00046454655,0.0000027003487,0.000020383632,0.00014655289],"genre_scores_gemma":[0.98939395,0.000021653954,0.003653126,0.00018147157,0.006562218,1.5741544e-7,0.00003924416,0.00003735405,0.00011084181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978758,0.0005923934,0.0005334771,0.00023989091,0.00059531926,0.00016313174],"domain_scores_gemma":[0.9986161,0.00034575275,0.00036245413,0.00022269796,0.00033622168,0.00011679022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036151276,0.00019386088,0.00044025236,0.00013576585,0.00015768423,0.00012186273,0.000053632215,0.000054476895,0.00004381661],"category_scores_gemma":[0.00037194084,0.00011622237,0.00015471406,0.00044415842,0.00004665041,0.00040676518,0.00003749955,0.00037635732,0.00001914513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010021321,0.00002377279,0.965195,0.000018200284,0.0003168658,0.00008315493,0.000556688,0.0004210041,0.00114469,0.000023568298,0.021784147,0.00041156908],"study_design_scores_gemma":[0.030798448,0.0012532119,0.600063,0.00016364375,0.00018156723,0.000037249287,0.00058750616,0.000011577125,0.00013858406,0.0000108003505,0.36669955,0.00005484202],"about_ca_topic_score_codex":0.000008273695,"about_ca_topic_score_gemma":0.000024558289,"teacher_disagreement_score":0.365132,"about_ca_system_score_codex":0.000067122506,"about_ca_system_score_gemma":0.00012034153,"threshold_uncertainty_score":0.47394106},"labels":[],"label_agreement":null},{"id":"W3177753203","doi":"10.1002/ejhf.1884","title":"June 2021 at a glance: focus on epidemiology, biomarkers and medical treatment","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Interquartile range; Epidemiology; Heart failure; Ejection fraction; Internal medicine; Cardiology; Transferrin saturation; Anemia","score_opus":0.0256519320408789,"score_gpt":0.29542912510947406,"score_spread":0.26977719306859516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177753203","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23278195,0.0058835647,0.00011902228,0.7559868,0.00054185,0.0002912476,0.0000069787693,0.00002911222,0.0043594465],"genre_scores_gemma":[0.89938927,0.005213906,0.06658367,0.008547527,0.002417248,0.000008069747,0.00005113123,0.00012857279,0.017660609],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750185,0.0008819542,0.0006163768,0.0002919258,0.00037019196,0.00033767358],"domain_scores_gemma":[0.9985121,0.00030115878,0.00016632833,0.0002984303,0.00011436079,0.00060765253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014044755,0.00023328862,0.00067663426,0.00013874237,0.00011007678,0.000014742658,0.00006553955,0.00006251762,0.0014659293],"category_scores_gemma":[0.000561899,0.0001550585,0.00026561652,0.00015455566,0.00012149473,0.000052841875,0.00008847163,0.00025887316,0.0002691526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073689874,0.0006226615,0.039427787,0.000045869332,0.0011108817,0.01813553,0.00020506946,0.0000023794887,0.0012301095,0.0002390652,0.8888001,0.049443662],"study_design_scores_gemma":[0.0051630028,0.002117918,0.018440543,0.00040828213,0.00023569337,0.0051114215,0.00015019323,0.000013307545,0.00095618336,0.000034325225,0.9672433,0.00012581694],"about_ca_topic_score_codex":0.000005704571,"about_ca_topic_score_gemma":0.00004351095,"teacher_disagreement_score":0.7474393,"about_ca_system_score_codex":0.00016753041,"about_ca_system_score_gemma":0.00016128011,"threshold_uncertainty_score":0.99944687},"labels":[],"label_agreement":null},{"id":"W3179898468","doi":"10.1002/ejhf.2299","title":"Untying the Gordian knot of sex and heart failure therapy","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Knot (papermaking); Heart failure; Sex therapy; Internal medicine","score_opus":0.02241364504474359,"score_gpt":0.25007118869557665,"score_spread":0.22765754365083307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179898468","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010716697,0.0043259216,0.000034721295,0.98337716,0.00033917546,0.0005614218,0.000013583118,0.000028709086,0.0006026268],"genre_scores_gemma":[0.07837796,0.0018359035,0.048990913,0.8427566,0.0165446,0.000013102377,0.00018443725,0.0005711981,0.010725287],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595004,0.0012495759,0.0010190881,0.000400444,0.0008662767,0.00051456626],"domain_scores_gemma":[0.99793595,0.00023759228,0.0005142938,0.00073470257,0.0003606402,0.00021684785],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014881825,0.0005343195,0.001258264,0.00034052625,0.00018586598,0.00013034586,0.00027928414,0.00021082886,0.00050675933],"category_scores_gemma":[0.00008444751,0.0003308795,0.0006594174,0.0002974057,0.00021963893,0.0001389192,0.00015136586,0.0025239766,0.000059041347],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051261628,0.00007672375,0.0015482927,0.00022001874,0.00070936896,0.0024977091,0.00052273175,0.0000019253205,0.0015229931,0.0000053597214,0.99059516,0.0022484276],"study_design_scores_gemma":[0.0021073443,0.0009668958,0.0019135785,0.0009868236,0.00036512152,0.0025300898,0.00067280023,0.0000017832074,0.0005719358,0.000007929948,0.98961586,0.0002598363],"about_ca_topic_score_codex":0.000012638257,"about_ca_topic_score_gemma":0.000008336744,"teacher_disagreement_score":0.14062054,"about_ca_system_score_codex":0.00006113219,"about_ca_system_score_gemma":0.00024848597,"threshold_uncertainty_score":0.99991435},"labels":[],"label_agreement":null},{"id":"W3179920812","doi":"10.1002/ejhf.2308","title":"Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Defense Acquisition Program Administration; British Heart Foundation; AstraZeneca","keywords":"Medicine; Ejection fraction; Heart failure; Dapagliflozin; Body mass index; Cardiology; Internal medicine; Index (typography); Endocrinology; Diabetes mellitus","score_opus":0.011380552952050087,"score_gpt":0.24945376256047208,"score_spread":0.238073209608422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179920812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725873,0.00011565968,0.0026942259,0.008967445,0.00043708752,0.00021015962,0.000001663809,0.000024854226,0.00029018783],"genre_scores_gemma":[0.99035543,0.000019254581,0.008575291,0.00028278885,0.00057033374,7.808727e-7,0.000006549197,0.000050286053,0.00013929096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977912,0.00053806556,0.00061126554,0.00025057202,0.00058254565,0.00022636965],"domain_scores_gemma":[0.9986886,0.00006231341,0.00021251189,0.0003294574,0.00045616415,0.00025098576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097524724,0.00018390783,0.0006030216,0.00047280305,0.00006590295,0.000039503422,0.00006849335,0.000062538864,0.00015139618],"category_scores_gemma":[0.00033697698,0.00014528133,0.0003800166,0.00078758236,0.000031165717,0.00020061721,0.000030651005,0.0007713123,0.000051687348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018380408,0.00029112346,0.49987411,0.00007917466,0.00042263797,0.0008227036,0.0002412574,0.0018994813,0.45766854,0.000004787802,0.03547768,0.0013804444],"study_design_scores_gemma":[0.0050046197,0.000871602,0.6215402,0.000873018,0.00018585337,0.0032080011,0.0036097958,0.000023920162,0.034012064,0.0000014090623,0.33047485,0.00019466522],"about_ca_topic_score_codex":0.0000132706755,"about_ca_topic_score_gemma":0.00001457496,"teacher_disagreement_score":0.42365646,"about_ca_system_score_codex":0.0001305272,"about_ca_system_score_gemma":0.00021762322,"threshold_uncertainty_score":0.59244007},"labels":[],"label_agreement":null},{"id":"W3181883550","doi":"10.1002/ejhf.2306","title":"Best of European Journal of Heart Failure at the <scp>ESC</scp> / <scp>HFA</scp> Heart Failure Congress 2021","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Internal medicine; Cardiology","score_opus":0.015923688004302022,"score_gpt":0.2479084205073329,"score_spread":0.23198473250303087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181883550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82314986,0.009136891,0.00034653558,0.15793875,0.0023576806,0.001191091,0.00009647783,0.00008018596,0.005702548],"genre_scores_gemma":[0.8968339,0.0008606568,0.059533413,0.004472463,0.0060205394,0.000007407512,0.00009696288,0.0005843036,0.03159034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886935,0.0038762484,0.0030671642,0.0007409823,0.0023150211,0.0013070924],"domain_scores_gemma":[0.99184674,0.0010992382,0.00182731,0.0014625734,0.0025317448,0.0012323658],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0055670193,0.0009780576,0.0022011914,0.0006951693,0.00054230244,0.0003204002,0.0008831452,0.00017790262,0.0008930027],"category_scores_gemma":[0.0022185766,0.00069366256,0.0017636173,0.0011533187,0.0005843016,0.00066408154,0.000705043,0.0022803384,0.0011374915],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007226435,0.0008398624,0.017741924,0.0002713898,0.0011938841,0.00503193,0.0013076543,0.00012439842,0.041493054,0.00005974203,0.93136007,0.0005038413],"study_design_scores_gemma":[0.005923205,0.002788697,0.012435707,0.0018546145,0.0011193032,0.011567573,0.007678802,0.000008866038,0.016625747,0.000012302056,0.93981934,0.00016587214],"about_ca_topic_score_codex":0.000012965812,"about_ca_topic_score_gemma":0.000104703984,"teacher_disagreement_score":0.15346628,"about_ca_system_score_codex":0.00024969343,"about_ca_system_score_gemma":0.00072880404,"threshold_uncertainty_score":0.9996402},"labels":[],"label_agreement":null},{"id":"W3183706825","doi":"10.1002/ejhf.2312","title":"Effect of patient‐centered transitional care services on patient‐reported outcomes in heart failure: sex‐specific analysis of the <scp>PACT‐HF</scp> randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Alberta Hospital; Population Health Research Institute; University of Alberta; McMaster University; Hamilton Health Sciences; Institute for Clinical Evaluative Sciences; Impact; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Confidence interval; Randomized controlled trial; Heart failure; Transitional care; Quality of life (healthcare); Internal medicine; Health care; Nursing","score_opus":0.00772919144338714,"score_gpt":0.24406472975068486,"score_spread":0.23633553830729773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183706825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884667,0.00072999514,0.000010946293,0.007438243,0.00041433127,0.0026291024,0.0000309358,0.000016994041,0.0002627958],"genre_scores_gemma":[0.99818265,0.000029356454,0.0010430703,0.0003771363,0.00010515095,0.000024462954,0.00007198726,0.00004281073,0.00012336779],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99125993,0.0044019194,0.0023546617,0.00035309975,0.0012849673,0.0003453921],"domain_scores_gemma":[0.9961033,0.0014425785,0.0011359274,0.00057201355,0.00055022613,0.00019594165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018068525,0.00042563016,0.003710503,0.000750222,0.00008945228,0.000042540214,0.00016589365,0.000080093305,0.00020594185],"category_scores_gemma":[0.0004997963,0.00024193182,0.0029984382,0.0009474171,0.00012594256,0.00012724155,0.00006225063,0.00047004258,0.000008055229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76965034,0.004480573,0.13929398,0.0008554888,0.030274253,0.0020915389,0.014961389,0.0017619627,0.010523411,0.00005724042,0.024463238,0.0015865731],"study_design_scores_gemma":[0.9239116,0.0040112534,0.010673365,0.00078856363,0.0065959413,0.00008907555,0.0035068132,0.000042976462,0.0075660865,0.0000034093778,0.04268632,0.00012462703],"about_ca_topic_score_codex":0.000012040871,"about_ca_topic_score_gemma":0.00004534486,"teacher_disagreement_score":0.15426122,"about_ca_system_score_codex":0.00009476707,"about_ca_system_score_gemma":0.00014746528,"threshold_uncertainty_score":0.9865693},"labels":[],"label_agreement":null},{"id":"W3187886729","doi":"10.1002/ejhf.2330","title":"Functional mitral regurgitation: a proportionate or disproportionate focus of attention?","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Mitral regurgitation; Cardiology; Ventricle; Internal medicine; Stroke volume; Mitral valve; Regurgitation (circulation); Heart failure; Functional mitral regurgitation; Context (archaeology); Ejection fraction","score_opus":0.0224240053555278,"score_gpt":0.2919975841247027,"score_spread":0.2695735787691749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187886729","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04212387,0.0032490334,0.00025154988,0.9510549,0.0015247249,0.00058681105,0.00027797825,0.000035046673,0.00089609105],"genre_scores_gemma":[0.7339661,0.00045588956,0.0192515,0.16056724,0.028434373,0.000032501655,0.0062576486,0.000641508,0.050393246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967297,0.00036416034,0.0011784593,0.00030459047,0.0011646525,0.00025846215],"domain_scores_gemma":[0.9968374,0.000057804504,0.0010571731,0.0003279694,0.0015364066,0.00018326606],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003863039,0.0003129852,0.00079725,0.00028468334,0.00008589413,0.000044809232,0.00009198817,0.00012659853,0.0015897347],"category_scores_gemma":[0.00014883667,0.00022233945,0.003199633,0.00025276543,0.000112392554,0.00015433828,0.00004454548,0.0010163344,0.0000831256],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005301108,0.0002406361,0.018112114,0.00032893135,0.0025592633,0.007881365,0.00001666754,0.000006623665,0.0001469314,0.000009562543,0.9695936,0.00057419855],"study_design_scores_gemma":[0.0033907841,0.00079282874,0.3280448,0.0011510242,0.0024095322,0.004492798,0.00008327932,9.3662015e-7,0.000048917886,0.00003455763,0.6593357,0.00021488244],"about_ca_topic_score_codex":0.000002479314,"about_ca_topic_score_gemma":6.276393e-7,"teacher_disagreement_score":0.79048765,"about_ca_system_score_codex":0.0001037844,"about_ca_system_score_gemma":0.0007253904,"threshold_uncertainty_score":0.99932295},"labels":[],"label_agreement":null},{"id":"W3188522932","doi":"10.1002/ejhf.2320","title":"Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shock","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Cardiogenic shock; Medicine; Shock (circulatory); Heart failure; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.010379565029473783,"score_gpt":0.20876738410925558,"score_spread":0.19838781907978179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188522932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5716697,0.10108959,0.009530287,0.3004298,0.010887393,0.003854829,0.00116939,0.000606128,0.0007629044],"genre_scores_gemma":[0.97086483,0.00005844631,0.01038988,0.013267783,0.004525441,0.000012664038,0.00023057126,0.00045706934,0.00019330083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971712,0.0004253891,0.0009938309,0.00038051256,0.000496295,0.000532756],"domain_scores_gemma":[0.9987023,0.00017076696,0.0002418742,0.00036867516,0.00035571557,0.00016066228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063119887,0.0004758541,0.0011475695,0.00036543474,0.000076173405,0.00016774966,0.00033822499,0.00027280144,0.000047101596],"category_scores_gemma":[0.00015710056,0.0004572158,0.0006697954,0.00019254077,0.000027818278,0.0002418587,0.0000989804,0.0016285775,0.000011928693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024973393,0.000015148561,0.01684804,0.00233895,0.001144896,0.0040748385,0.00068605924,0.008428562,0.0021090307,0.0000035080463,0.9618823,0.002443673],"study_design_scores_gemma":[0.0013708564,0.00014701135,0.003467757,0.00040650327,0.00040816944,0.00078398286,0.00060624833,0.0006246102,0.00043265687,0.00000316918,0.9910797,0.00066932937],"about_ca_topic_score_codex":0.0000035653175,"about_ca_topic_score_gemma":0.000012350114,"teacher_disagreement_score":0.39919513,"about_ca_system_score_codex":0.00021936647,"about_ca_system_score_gemma":0.00011184873,"threshold_uncertainty_score":0.999788},"labels":[],"label_agreement":null},{"id":"W3195826139","doi":"10.1002/ejhf.2328","title":"Cardiac output in severe tricuspid regurgitation: when more is less","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Regurgitation (circulation); Cardiology; Pulmonary hypertension; Internal medicine; Asymptomatic; Tricuspid valve; Heart failure; Cardiac output; Hemodynamics; valvular heart disease","score_opus":0.02362883173337198,"score_gpt":0.2878944893512658,"score_spread":0.26426565761789383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195826139","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027683893,0.009461123,0.000006185871,0.9588619,0.0011154582,0.00036078476,0.00021572036,0.000020260615,0.002274659],"genre_scores_gemma":[0.062073823,0.00087979046,0.005618068,0.87612176,0.025952505,0.000011544428,0.0013961218,0.0005502016,0.027396172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682087,0.0007019655,0.00082472595,0.00038003278,0.0008964013,0.00037600947],"domain_scores_gemma":[0.99817634,0.00008916147,0.000425246,0.0005254744,0.00054378615,0.0002399677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042345788,0.00040982792,0.0012554246,0.0003876437,0.000057059297,0.00009818923,0.00015980907,0.00018981843,0.00025149476],"category_scores_gemma":[0.0000999274,0.00033753001,0.0028165556,0.0002509765,0.00005071198,0.0001338986,0.00007278644,0.0019000403,0.00013157922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091521644,0.000078775796,0.025592953,0.00021880853,0.0011540129,0.01744206,0.00040998816,0.0000040627183,0.0000054240018,4.0874266e-7,0.95319784,0.0018041428],"study_design_scores_gemma":[0.002645696,0.00025512258,0.06485559,0.0013770922,0.0012033058,0.0011897112,0.0005364073,4.240851e-7,0.0000090122985,0.000006616273,0.92765707,0.00026394826],"about_ca_topic_score_codex":0.000009576066,"about_ca_topic_score_gemma":3.9776094e-7,"teacher_disagreement_score":0.08274014,"about_ca_system_score_codex":0.00018906679,"about_ca_system_score_gemma":0.0003921926,"threshold_uncertainty_score":0.9999077},"labels":[],"label_agreement":null},{"id":"W3197520426","doi":"10.1002/ejhf.2339","title":"Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Heart failure; Risk stratification; Intensive care medicine; Cardiac imaging; Internal medicine; Audience measurement; Cardiology; Consensus conference","score_opus":0.009517424356265096,"score_gpt":0.24302433001061494,"score_spread":0.23350690565434984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197520426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89544266,0.00095555204,0.000088025256,0.10253168,0.00013499412,0.00070299907,0.000012802383,0.000007626384,0.00012362648],"genre_scores_gemma":[0.99428135,0.000028818049,0.005288139,0.00025801224,0.00007346405,0.0000018758782,0.0000041802105,0.000033273594,0.00003088421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944332,0.0032687662,0.0011672891,0.00027454188,0.00058766454,0.00026853205],"domain_scores_gemma":[0.9978639,0.0003352598,0.000887828,0.0004175097,0.00041667972,0.000078814795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048391544,0.00024568476,0.0007108339,0.00012094729,0.00014735387,0.000035062363,0.00015954983,0.000034969114,0.000009869285],"category_scores_gemma":[0.0003883815,0.00014365876,0.0003958899,0.00050979666,0.0003257894,0.00011617359,0.0002525558,0.0004228664,6.030332e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007381177,0.0001262337,0.70818746,0.0001405297,0.00088620145,0.000024761297,0.002520993,0.000036173744,0.18990913,0.000011952632,0.09717338,0.00090935465],"study_design_scores_gemma":[0.0073650945,0.0004943622,0.88898087,0.0015917886,0.0010393262,0.0009679895,0.047928173,0.00023609042,0.010042091,0.000034366858,0.041056935,0.00026294173],"about_ca_topic_score_codex":0.00008408566,"about_ca_topic_score_gemma":0.00006842372,"teacher_disagreement_score":0.18079336,"about_ca_system_score_codex":0.0001313919,"about_ca_system_score_gemma":0.00013197893,"threshold_uncertainty_score":0.5858235},"labels":[],"label_agreement":null},{"id":"W3206664673","doi":"10.1002/ejhf.2360","title":"Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Foreign and Commonwealth Office","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Cardiology; Confidence interval; Meta-analysis; Shunt (medical); Hemodynamics; Randomized controlled trial","score_opus":0.0650229140521786,"score_gpt":0.3403516220831899,"score_spread":0.27532870803101134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206664673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017245045,0.9941604,0.0006766411,0.0023504181,0.000039727664,0.0026735018,0.00006241216,0.00001093581,0.000008699905],"genre_scores_gemma":[0.0017239151,0.9941282,0.003598822,0.00017620286,0.00019751019,0.000035162753,0.000046285753,0.00006459563,0.000029301322],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947775,0.0020973063,0.0021203202,0.00043463302,0.0003600333,0.00021023459],"domain_scores_gemma":[0.996999,0.0005574854,0.00089857116,0.00080083584,0.0004904356,0.00025366657],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0034615402,0.0004350872,0.00911255,0.0003634613,0.00008026075,0.00007832841,0.00019266891,0.000096901575,0.00008445366],"category_scores_gemma":[0.00046389928,0.00027840934,0.011168873,0.0006144901,0.000085692125,0.000087242115,0.00006731277,0.0005944751,0.000005117742],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022398435,0.0001223501,0.0000057445877,0.77552897,0.22087044,0.000020663689,0.00008189356,0.0000022343693,0.000002802778,0.000012522523,0.0023968015,0.0009331625],"study_design_scores_gemma":[0.00091367716,0.00024622193,0.000018255783,0.07817097,0.6418752,0.002167343,0.000015203692,9.670495e-7,5.0838514e-7,7.562918e-7,0.27643508,0.00015581874],"about_ca_topic_score_codex":0.0000017611633,"about_ca_topic_score_gemma":0.0000102891145,"teacher_disagreement_score":0.697358,"about_ca_system_score_codex":0.00007325629,"about_ca_system_score_gemma":0.00029813452,"threshold_uncertainty_score":0.9999668},"labels":[],"label_agreement":null},{"id":"W3207522806","doi":"10.1002/ejhf.2362","title":"Can mild to moderate secondary mitral regurgitation be a therapeutic target for symptomatic patients with heart failure with reduced ejection fraction?","year":2021,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Heart failure; Mitral regurgitation; Revascularization; Myocardial infarction","score_opus":0.011920411261407691,"score_gpt":0.26488851809530956,"score_spread":0.25296810683390186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207522806","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37236768,0.00035314282,0.00046413258,0.6240507,0.00045924485,0.0018043742,0.00035136665,0.00005062818,0.00009878647],"genre_scores_gemma":[0.70047337,0.000010287553,0.037813,0.2532775,0.0038817073,0.00007572918,0.0029202253,0.00049354334,0.0010546455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719787,0.00046610757,0.00062257383,0.0004737149,0.00080198183,0.00043776078],"domain_scores_gemma":[0.9975064,0.00009123563,0.00049486797,0.00041199007,0.001177638,0.00031787928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002306603,0.00050771673,0.00096018024,0.0003590266,0.00021638666,0.00017297252,0.000092824295,0.0001426732,0.0001387626],"category_scores_gemma":[0.000040400384,0.00036538937,0.0011321882,0.00027613668,0.00004285739,0.00022960051,0.000018925139,0.0011939835,0.000017375512],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001866514,0.00025781497,0.018354958,0.00041513756,0.0032313738,0.00027317076,0.00018250337,0.00012739809,0.00013161666,5.2143645e-7,0.97500116,0.00015781075],"study_design_scores_gemma":[0.01257428,0.008075184,0.13642776,0.0030302014,0.0045609917,0.0007120513,0.00055890426,0.000016775532,0.00026949632,0.00001937941,0.83301437,0.00074061553],"about_ca_topic_score_codex":0.0000075771654,"about_ca_topic_score_gemma":0.000005121607,"teacher_disagreement_score":0.37077314,"about_ca_system_score_codex":0.0002719433,"about_ca_system_score_gemma":0.0005678602,"threshold_uncertainty_score":0.9998798},"labels":[],"label_agreement":null},{"id":"W3208550556","doi":"10.1002/ejhf.1892","title":"October 2021 at a glance: focus on imaging, biomarkers and comorbidities","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure with preserved ejection fraction; Heart failure; Internal medicine; Cardiology; Ejection fraction; Natriuretic peptide; Body mass index","score_opus":0.011581116218936515,"score_gpt":0.24515559299391665,"score_spread":0.23357447677498014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208550556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58204764,0.0059460346,0.000092992275,0.39192593,0.00060199504,0.00030769722,0.0000125282495,0.000044306835,0.019020857],"genre_scores_gemma":[0.97377473,0.0003797151,0.015658572,0.0022917462,0.00066271983,0.0000012396029,0.000012561327,0.00005482323,0.00716389],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862397,0.00027028928,0.00034299324,0.00019577166,0.00033041983,0.00023654253],"domain_scores_gemma":[0.9991916,0.00005594117,0.000115504496,0.00023772146,0.0001564547,0.00024280397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044926663,0.00017767171,0.00034209734,0.00013499634,0.00010786132,0.00005448362,0.000052321528,0.000017982009,0.0008646798],"category_scores_gemma":[0.00007020266,0.00013550556,0.00016278186,0.00012862342,0.00008135954,0.00009751664,0.00009006922,0.00022304816,0.00020595241],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023889211,0.00015172164,0.028784085,0.00004501043,0.00028224924,0.008506126,0.00025081862,0.0000010033456,0.0051189056,0.00009566817,0.94946706,0.007058434],"study_design_scores_gemma":[0.0028409609,0.00046832915,0.036553543,0.00036294866,0.00015326565,0.0032519884,0.00044412437,0.0000062077625,0.0025526795,0.000022251701,0.9532176,0.00012605243],"about_ca_topic_score_codex":0.0000033440485,"about_ca_topic_score_gemma":0.000009048314,"teacher_disagreement_score":0.3917271,"about_ca_system_score_codex":0.00007088657,"about_ca_system_score_gemma":0.00006548866,"threshold_uncertainty_score":0.94676375},"labels":[],"label_agreement":null},{"id":"W3211468684","doi":"10.1002/ejhf.2381","title":"Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from <scp>DAPA‐HF</scp>","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Defense Acquisition Program Administration; British Heart Foundation; AstraZeneca","keywords":"Heart failure; Medicine; Ejection fraction; Atrial fibrillation; Cardiology; Dapagliflozin; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.011313521802402518,"score_gpt":0.22782552936004627,"score_spread":0.21651200755764374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211468684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858269,0.0014142834,0.00009024179,0.011239426,0.0002980051,0.000219137,0.0000027685808,0.000028487164,0.00088076416],"genre_scores_gemma":[0.98170596,0.0000935898,0.0153498715,0.00027309402,0.0020030818,5.967433e-7,0.000043324748,0.00004239455,0.0004880862],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828804,0.000384288,0.0004592591,0.00027539622,0.0003932952,0.00019970148],"domain_scores_gemma":[0.9990478,0.00013336889,0.00021785995,0.0002132471,0.00020205446,0.00018564597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029565842,0.00019856103,0.00043807694,0.00024145818,0.000090123795,0.000101920545,0.000042847692,0.00005241341,0.00008210218],"category_scores_gemma":[0.00015561281,0.00015647792,0.00014763935,0.00033312873,0.000041714065,0.00038173803,0.000041622403,0.00036129978,0.000056742534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012559352,0.00040764784,0.44684482,0.00022350729,0.00217864,0.0045241383,0.0024123662,0.0014221447,0.12868057,0.00015732617,0.3982609,0.013632019],"study_design_scores_gemma":[0.00567798,0.0011433866,0.20932248,0.00056370714,0.00033206117,0.00038757882,0.0014579712,0.000056864654,0.0044653798,0.00004447153,0.77645344,0.00009471251],"about_ca_topic_score_codex":0.000009518251,"about_ca_topic_score_gemma":0.000048892234,"teacher_disagreement_score":0.37819254,"about_ca_system_score_codex":0.000090550435,"about_ca_system_score_gemma":0.00010017761,"threshold_uncertainty_score":0.6380985},"labels":[],"label_agreement":null},{"id":"W3214295791","doi":"10.1002/ejhf.2378","title":"Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction","year":2021,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Ejection fraction; Guideline; Cardiology; Intensive care medicine; Internal medicine; Pathology","score_opus":0.06936228225469966,"score_gpt":0.37141991648166567,"score_spread":0.302057634226966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214295791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046379766,0.965428,0.00009827334,0.028317936,0.0000944288,0.0013029289,0.000009140238,0.000059961167,0.000051366682],"genre_scores_gemma":[0.0015436772,0.95422095,0.04234688,0.00014544821,0.0014187156,0.000028505787,0.00013978753,0.00013143716,0.000024602192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612945,0.00088393013,0.0014598471,0.0005055946,0.00057669176,0.0004444798],"domain_scores_gemma":[0.99821454,0.0002599721,0.0006619044,0.00023542628,0.0003211203,0.00030701375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029831806,0.00051190937,0.0020723843,0.00026420844,0.00016597938,0.00013833804,0.00009422821,0.00017478138,0.0000641332],"category_scores_gemma":[0.00016224897,0.00035670665,0.00029352383,0.00026209257,0.000068908295,0.00030249724,0.00007889068,0.0012034295,0.0000031355926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072318835,0.000113288166,0.00048691852,0.0040631415,0.0009173422,0.00034437902,0.0005040781,2.9169877e-7,0.00003606861,0.000023270104,0.0224694,0.9709695],"study_design_scores_gemma":[0.0025311706,0.0013360849,0.00036297578,0.029271292,0.00067913835,0.0014377129,0.0033319413,0.000004894712,0.000007859885,0.0000054331877,0.96075106,0.00028042955],"about_ca_topic_score_codex":0.000013656125,"about_ca_topic_score_gemma":0.000059110847,"teacher_disagreement_score":0.97068906,"about_ca_system_score_codex":0.00009540211,"about_ca_system_score_gemma":0.00045255077,"threshold_uncertainty_score":0.9998885},"labels":[],"label_agreement":null},{"id":"W4200146289","doi":"10.1002/ejhf.2403","title":"Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"British Heart Foundation","keywords":"Medicine; Ejection fraction; Heart failure; Diabetes mellitus; Cardiology; Internal medicine; Endocrinology","score_opus":0.0057766189752188404,"score_gpt":0.1992726538769868,"score_spread":0.19349603490176798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200146289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957033,0.000571028,0.000020825124,0.00336163,0.0001380316,0.00014797285,0.0000023820219,0.00001535442,0.000039522372],"genre_scores_gemma":[0.9974406,0.000037936978,0.0019681172,0.00024409378,0.00019273841,7.6579664e-7,0.000010700372,0.00002979569,0.00007526497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986124,0.00039489946,0.0003001392,0.00019233633,0.00032294902,0.00017726021],"domain_scores_gemma":[0.9992311,0.00004419868,0.00010982098,0.00016162486,0.00027820998,0.00017503649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004964442,0.00014115276,0.00037133245,0.00016897178,0.00007353902,0.000060817107,0.000024647587,0.00004408107,0.000060822025],"category_scores_gemma":[0.00014675132,0.00010335118,0.000118445336,0.00020008828,0.000049163078,0.0002811597,0.000032765973,0.00044920188,0.000005250664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011730351,0.00009165174,0.9883183,0.000060991315,0.00012251946,0.00002408224,0.000042202624,0.00001688286,0.00259591,4.703717e-7,0.008326557,0.00028308496],"study_design_scores_gemma":[0.0029530432,0.00074648386,0.8905717,0.0002944569,0.00010709522,0.000068469846,0.00023698216,0.000016268228,0.0015017086,0.0000018715009,0.103403926,0.000097994656],"about_ca_topic_score_codex":0.000002510227,"about_ca_topic_score_gemma":0.000013012578,"teacher_disagreement_score":0.09774664,"about_ca_system_score_codex":0.000032922675,"about_ca_system_score_gemma":0.00004513189,"threshold_uncertainty_score":0.42145386},"labels":[],"label_agreement":null},{"id":"W4200601702","doi":"10.1002/ejhf.1896","title":"December 2021 at a glance: focus on medical treatment, valvular heart disease and prognostic models","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Sacubitril; Ejection fraction; Heart failure; Valsartan; Internal medicine; Enalapril; Clinical endpoint; Cardiology; Heart failure with preserved ejection fraction; Randomized controlled trial; Clinical trial; Blood pressure; Angiotensin-converting enzyme","score_opus":0.019669048179410727,"score_gpt":0.2654408967152047,"score_spread":0.24577184853579398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200601702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65227056,0.0059601003,0.00035496635,0.33772987,0.00028067466,0.00066403416,0.000014733504,0.00005077398,0.0026742937],"genre_scores_gemma":[0.9829404,0.0005879517,0.009745759,0.0023922476,0.00079314323,0.000007580652,0.00002459376,0.00007294301,0.0034354313],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975309,0.0004809471,0.0005019484,0.00035184182,0.0007649427,0.0003694414],"domain_scores_gemma":[0.99813837,0.0001242772,0.00010915979,0.00037220598,0.00018159808,0.0010744013],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049262075,0.00029088944,0.0005614119,0.00013332107,0.00014136622,0.000054513355,0.00007042469,0.00004653181,0.0009820041],"category_scores_gemma":[0.00024829956,0.00020584557,0.00028771078,0.00017473014,0.000080284204,0.00013702437,0.00010217217,0.00028618547,0.0002564058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021214928,0.002839376,0.07714542,0.00022113787,0.001367189,0.0699404,0.0006874636,0.00012643766,0.0018247105,0.00063972117,0.83138233,0.011704323],"study_design_scores_gemma":[0.0090349065,0.0030679908,0.02770173,0.0012276602,0.0009853069,0.0045463913,0.0001413395,0.00029246748,0.00060669775,0.0002580478,0.9518179,0.00031952598],"about_ca_topic_score_codex":0.0000029820446,"about_ca_topic_score_gemma":0.00001918662,"teacher_disagreement_score":0.3353376,"about_ca_system_score_codex":0.00013737254,"about_ca_system_score_gemma":0.00031132883,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W4205306038","doi":"10.1002/ejhf.2422","title":"Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure?","year":2022,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Heart failure; Internal medicine","score_opus":0.018879720746973985,"score_gpt":0.26347327441813917,"score_spread":0.2445935536711652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205306038","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07246699,0.0030079873,0.000051765543,0.92182165,0.0013013337,0.00095881,0.00017140784,0.000028052817,0.00019198563],"genre_scores_gemma":[0.30925632,0.0007212893,0.12608229,0.51117206,0.037737675,0.00002231912,0.0004889147,0.001488861,0.01303026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515355,0.0013103908,0.0012622264,0.00044629455,0.0013042743,0.00052326085],"domain_scores_gemma":[0.997662,0.00006868644,0.00066139863,0.0009245896,0.00036590628,0.00031743548],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013348237,0.0005094551,0.0014041527,0.00043306936,0.00028873284,0.000069258866,0.00042685706,0.00014596742,0.0009509835],"category_scores_gemma":[0.00006601015,0.0003279931,0.001715552,0.00036363554,0.000078401594,0.00010536405,0.00025068902,0.0014087091,0.000032121265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013787401,0.0001535137,0.0008051305,0.00014391025,0.00046390019,0.00025950038,0.0008931362,0.0015608195,0.0101017095,8.7340413e-7,0.9852073,0.00027229858],"study_design_scores_gemma":[0.00097534416,0.0025179917,0.0017054959,0.0006499517,0.0006468174,0.0020601207,0.00049542426,0.000006884996,0.0022985097,0.0000034446105,0.98834294,0.000297079],"about_ca_topic_score_codex":0.000016200604,"about_ca_topic_score_gemma":0.000005176771,"teacher_disagreement_score":0.4106496,"about_ca_system_score_codex":0.00036931707,"about_ca_system_score_gemma":0.00046395214,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W4205589289","doi":"10.1002/ejhf.2421","title":"<scp>Angiotensin–neprilysin</scp> inhibition and renal outcomes across the spectrum of ejection fraction in heart failure","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Valsartan; Medicine; Sacubitril; Enalapril; Ejection fraction; Renal function; Heart failure; Internal medicine; Sacubitril, Valsartan; Hazard ratio; Cardiology; Urology; Angiotensin-converting enzyme; Confidence interval; Blood pressure","score_opus":0.012201872556861622,"score_gpt":0.25415923577256067,"score_spread":0.24195736321569905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205589289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8839907,0.00024237332,0.0002495433,0.11476909,0.00021019124,0.00037692735,0.000007385949,0.00002496106,0.00012882709],"genre_scores_gemma":[0.9926001,0.00002853543,0.005563692,0.00093706977,0.00028874408,0.0000039286015,0.000011948144,0.000038995317,0.00052699435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748105,0.0006725751,0.00068584643,0.00023288408,0.0006036212,0.0003240366],"domain_scores_gemma":[0.9989969,0.00014158314,0.00035161054,0.00027014178,0.000113055066,0.0001266691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019330858,0.00021217977,0.00050628465,0.00030797973,0.0002936435,0.00005007114,0.00007844019,0.00003685552,0.00007498145],"category_scores_gemma":[0.00013933837,0.00015125917,0.00026298323,0.00044281592,0.00011350742,0.00024073549,0.00014604449,0.00077912805,0.000020960248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032609122,0.0007500642,0.2982732,0.000087250664,0.00043360455,0.00084293686,0.0025235708,0.0004871294,0.045666996,0.0001539931,0.6492438,0.0012113962],"study_design_scores_gemma":[0.0025395772,0.0011952199,0.27925044,0.00011936261,0.00012261764,0.001188755,0.0038972327,0.000030961717,0.0020635175,0.000052911277,0.70947224,0.000067157314],"about_ca_topic_score_codex":0.000027586237,"about_ca_topic_score_gemma":0.000047408088,"teacher_disagreement_score":0.11383203,"about_ca_system_score_codex":0.00014379314,"about_ca_system_score_gemma":0.00005871724,"threshold_uncertainty_score":0.616817},"labels":[],"label_agreement":null},{"id":"W4206749065","doi":"10.1002/ejhf.2419","title":"Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in <scp>PARADIGM‐HF</scp>","year":2021,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"British Heart Foundation","keywords":"Sacubitril, Valsartan; Medicine; Valsartan; Sacubitril; Heart failure; Cardiology; Internal medicine; Ejection fraction; Blood pressure","score_opus":0.015557596889745912,"score_gpt":0.27077070707233925,"score_spread":0.25521311018259335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206749065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706436,0.0041602147,0.000026932288,0.0020475509,0.00031291728,0.00013060952,0.000004711497,0.000018704353,0.006234022],"genre_scores_gemma":[0.9982364,0.00007048839,0.00058057526,0.00035962672,0.00052767247,5.22432e-7,0.0000053753406,0.00003421169,0.00018512589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709713,0.0010434974,0.0008334647,0.00020169468,0.0005907894,0.00023342743],"domain_scores_gemma":[0.99803895,0.0006804671,0.00042706428,0.00029701655,0.00026094916,0.00029557495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018402894,0.00019699991,0.0011788812,0.0002940438,0.000052879463,0.00002195169,0.000026971657,0.000043677195,0.000012295877],"category_scores_gemma":[0.004650088,0.00015321033,0.00043618877,0.00056479283,0.000081339545,0.00006521698,0.000037780927,0.00043894572,0.00005173178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050891703,0.0002629449,0.36831418,0.0006507323,0.0013580398,0.048596244,0.0018483906,0.002099368,0.054895695,0.00013393648,0.51956093,0.0017706049],"study_design_scores_gemma":[0.0055661746,0.0025728974,0.13197659,0.002041363,0.00048748837,0.033406597,0.00045487584,0.000012607672,0.10855905,0.00002312843,0.7147651,0.00013413143],"about_ca_topic_score_codex":0.0000014509684,"about_ca_topic_score_gemma":6.483471e-7,"teacher_disagreement_score":0.23633759,"about_ca_system_score_codex":0.000052972588,"about_ca_system_score_gemma":0.00020394124,"threshold_uncertainty_score":0.6247736},"labels":[],"label_agreement":null},{"id":"W4206946749","doi":"10.1002/ejhf.2433","title":"Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in <scp>DAPA‐HF</scp>","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"University of Glasgow; British Heart Foundation; GlaxoSmithKline; Defense Acquisition Program Administration; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Eisai; European Society of Cardiology; Abbott Laboratories","keywords":"Dapagliflozin; Medicine; Uric acid; Heart failure; Internal medicine; Adverse effect; Cardiology; Endocrinology; Diabetes mellitus","score_opus":0.013107804047532425,"score_gpt":0.24428042542651346,"score_spread":0.23117262137898104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206946749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399585,0.00066953636,0.000038640388,0.003237655,0.0005447201,0.00034742308,0.00003588095,0.000033465512,0.0010968153],"genre_scores_gemma":[0.9955064,0.00002651665,0.002839804,0.00065508735,0.00037757092,0.0000038299136,0.000022253407,0.00006512745,0.0005034236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555534,0.001137579,0.0012837377,0.0003088847,0.001305829,0.00040864598],"domain_scores_gemma":[0.99801725,0.00014952797,0.00073634385,0.00043343913,0.00027181188,0.00039163692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021016276,0.00026764296,0.00071973674,0.00037182102,0.00012662039,0.000017219314,0.00042813938,0.000051748495,0.000428276],"category_scores_gemma":[0.00077464577,0.00023038087,0.00024980865,0.0004996891,0.00011879286,0.0003851939,0.00016948882,0.0011903032,0.000030405856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035885273,0.0019608338,0.71482956,0.00012406333,0.00056383165,0.0033891324,0.012302217,0.0010010812,0.18847485,0.00007848861,0.076168925,0.00074816775],"study_design_scores_gemma":[0.010290604,0.004930568,0.76028895,0.0002560613,0.00044290547,0.004159025,0.020233663,0.00009713398,0.017423693,0.00002645796,0.1816158,0.00023515287],"about_ca_topic_score_codex":0.0000060508473,"about_ca_topic_score_gemma":0.0000030357621,"teacher_disagreement_score":0.17105116,"about_ca_system_score_codex":0.00019809978,"about_ca_system_score_gemma":0.0004016261,"threshold_uncertainty_score":0.93946594},"labels":[],"label_agreement":null},{"id":"W4207077001","doi":"10.1002/ejhf.2431","title":"Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the <scp>REPORT‐HF</scp> registry","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cilag; Medical Research Council; National Institutes of Health; Servier; National Medical Research Council; Cytokinetics; National University of Singapore; Boston Scientific Corporation; Amgen; National Heart, Lung, and Blood Institute; Vifor Pharma; Pfizer; Abbott Diagnostics; AstraZeneca; Bristol-Myers Squibb; MyoKardia; Novo Nordisk; United Therapeutics Corporation; Daiichi Sankyo Europe; Agency for Healthcare Research and Quality; Sanofi; American Heart Association","keywords":"Medicine; Heart failure; Interquartile range; Ejection fraction; Internal medicine; Acute coronary syndrome; Confounding; Cardiology; Myocardial infarction","score_opus":0.02315669355557105,"score_gpt":0.2587828568095291,"score_spread":0.23562616325395808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207077001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633092,0.0004769813,0.0005098692,0.034617692,0.0003507414,0.0006083477,0.00003141934,0.000022702614,0.00007299594],"genre_scores_gemma":[0.9837133,0.000019501984,0.014950817,0.00039076593,0.00033467042,0.000015089651,0.0001300377,0.00004619087,0.00039961503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719626,0.00055972644,0.0009377709,0.0002833625,0.0007506539,0.0002722441],"domain_scores_gemma":[0.9979183,0.000692301,0.00068490277,0.00035419225,0.00020792376,0.00014238966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076875027,0.0002436055,0.00058252545,0.00020417476,0.00025024204,0.000046750378,0.0002506558,0.000036181475,0.00007250373],"category_scores_gemma":[0.0004758007,0.00016281156,0.00031980523,0.00033909996,0.000099910176,0.0001937158,0.00012609466,0.00045783992,0.000003984866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111104,0.00047829113,0.38221815,0.000057423036,0.00069811643,0.0006011462,0.0067449436,0.0001087674,0.005268472,0.00023171632,0.60330474,0.00017709563],"study_design_scores_gemma":[0.0025003457,0.0017201476,0.3130428,0.00029391173,0.00035575635,0.00038215693,0.009595719,0.000050587292,0.00059134845,0.00014772872,0.67122257,0.00009692564],"about_ca_topic_score_codex":0.000036207795,"about_ca_topic_score_gemma":0.00003647629,"teacher_disagreement_score":0.06917538,"about_ca_system_score_codex":0.000096441356,"about_ca_system_score_gemma":0.00016283398,"threshold_uncertainty_score":0.66392624},"labels":[],"label_agreement":null},{"id":"W4210520398","doi":"10.1002/ejhf.2333","title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":2134,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Association of Cardiovascular Imaging","keywords":"Kingdom; Ancient history; Economic history; History","score_opus":0.05159503446818506,"score_gpt":0.32719815043164496,"score_spread":0.2756031159634599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210520398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7290695,0.064128354,0.00023186603,0.20507242,0.00041894367,0.0006604386,0.00013726889,0.000016059408,0.00026517245],"genre_scores_gemma":[0.9873049,0.003712495,0.0067740423,0.0005233842,0.001160744,0.000012834571,0.000004567953,0.000032367723,0.0004746195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989826,0.00015244752,0.0003910806,0.00012239187,0.00022508205,0.00012640205],"domain_scores_gemma":[0.99909323,0.00023207151,0.0001608682,0.00014805963,0.00028432213,0.00008147114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052340265,0.00011996421,0.00045441897,0.00008222891,0.00026573412,0.000020492436,0.000019197354,0.0000107169135,0.000034726174],"category_scores_gemma":[0.00009522697,0.000073391006,0.00023339092,0.0001021326,0.00008971068,0.00004001303,0.00005993867,0.000101365185,0.000001833373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028089655,0.00006156795,0.03799688,0.00004285074,0.0011655885,0.000043377517,0.00093263166,0.0001920506,0.0035792592,0.000022882547,0.946895,0.0087870015],"study_design_scores_gemma":[0.001981875,0.0023126104,0.013124373,0.00007008245,0.0005134722,0.0025627133,0.001081552,0.000017290355,0.00048459735,0.0000038495737,0.9777823,0.000065253545],"about_ca_topic_score_codex":0.0000035592095,"about_ca_topic_score_gemma":0.0000025547392,"teacher_disagreement_score":0.25823545,"about_ca_system_score_codex":0.000044197575,"about_ca_system_score_gemma":0.000065446264,"threshold_uncertainty_score":0.29927984},"labels":[],"label_agreement":null},{"id":"W4214483008","doi":"10.1002/ejhf.2463","title":"The response to cardiac resynchronization therapy in <scp>LMNA</scp> cardiomyopathy","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Ejection fraction; Cardiac resynchronization therapy; LMNA; Cardiology; Internal medicine; Cardiomyopathy; Heart failure; Dilated cardiomyopathy; Population; Sudden cardiac death","score_opus":0.013215935343674006,"score_gpt":0.255176415873766,"score_spread":0.24196048053009198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214483008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764398,0.005870781,0.00007599496,0.012640826,0.0006887735,0.00024770945,0.000010050974,0.00002396977,0.004002098],"genre_scores_gemma":[0.9972346,0.00022352258,0.00055970415,0.0005877488,0.0005748688,0.0000036408383,0.0000018180658,0.000036579044,0.0007775601],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964535,0.0021473125,0.00044370632,0.0001447775,0.0005870169,0.00022369009],"domain_scores_gemma":[0.99862087,0.00058996753,0.00014609947,0.0002769114,0.00023770779,0.00012847007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046129134,0.00012175074,0.0004048202,0.00025802862,0.0004014104,0.00004709489,0.000056142406,0.000012558664,0.0000049055884],"category_scores_gemma":[0.0010985762,0.00008738064,0.0002847987,0.0005775092,0.000039364702,0.0000519467,0.000104030165,0.0003861092,0.00003581441],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017062284,0.00004270487,0.059666198,0.000008710029,0.00025074143,0.0003619823,0.006826018,0.0043125073,0.015780374,0.000020212829,0.90548617,0.00553814],"study_design_scores_gemma":[0.0009067727,0.0008346488,0.15021041,0.000032643355,0.000019243262,0.00073022814,0.003868291,0.0000023584223,0.0001866852,0.000003245174,0.8431709,0.000034569064],"about_ca_topic_score_codex":0.0000027418703,"about_ca_topic_score_gemma":7.7593467e-7,"teacher_disagreement_score":0.09054421,"about_ca_system_score_codex":0.00013870824,"about_ca_system_score_gemma":0.00014518309,"threshold_uncertainty_score":0.35632792},"labels":[],"label_agreement":null},{"id":"W4214817612","doi":"10.1002/ejhf.2468","title":"Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Duke Clinical Research Institute; Bayer","keywords":"Medicine; Ejection fraction; Internal medicine; Cardiology; Coronary artery disease; Heart failure; Myocardial infarction; Hazard ratio; Clinical endpoint; Percutaneous coronary intervention; Post-hoc analysis; Clinical trial; Confidence interval","score_opus":0.008822992469338717,"score_gpt":0.22393614101471007,"score_spread":0.21511314854537136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214817612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961353,0.0001974026,0.000036331567,0.002978407,0.00010821262,0.00017897226,0.000007128769,0.000018711247,0.00033953195],"genre_scores_gemma":[0.99835277,0.0000061215965,0.0010833488,0.00031120807,0.00015693782,0.0000017991921,0.000010483644,0.000027895094,0.000049415852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869496,0.00029728314,0.00025738386,0.00016383723,0.00044904652,0.00013749098],"domain_scores_gemma":[0.99938816,0.000035356174,0.00015070276,0.00013032701,0.00014576328,0.00014970607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003146641,0.0001259737,0.00032017444,0.0002041501,0.0001874781,0.0000227135,0.000013219941,0.000009759979,0.000028093213],"category_scores_gemma":[0.000032540556,0.00009405382,0.00006597438,0.00023388099,0.000045521934,0.00016994482,0.000034699286,0.000366704,0.0000069042103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033826192,0.000114393995,0.9536872,0.0000230388,0.000113517024,0.0001948247,0.0002333957,0.00047850932,0.00056973967,8.7837867e-7,0.040980067,0.00022184786],"study_design_scores_gemma":[0.0030033402,0.0017506616,0.8907895,0.00013393202,0.000097857665,0.0015498138,0.0009669821,0.0000043521145,0.000013354022,0.0000012306551,0.10158985,0.000099099176],"about_ca_topic_score_codex":0.0000019787672,"about_ca_topic_score_gemma":0.0000014542956,"teacher_disagreement_score":0.062897645,"about_ca_system_score_codex":0.00008645325,"about_ca_system_score_gemma":0.00006786675,"threshold_uncertainty_score":0.38354033},"labels":[],"label_agreement":null},{"id":"W4220760683","doi":"10.1002/ejhf.2488","title":"Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice","year":2022,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Sacubitril; Heart failure with preserved ejection fraction; Cardiology; Natriuretic peptide; Valsartan; Kidney disease; Clinical trial; Diabetes mellitus; Disease; Endocrinology; Blood pressure","score_opus":0.0824136334599561,"score_gpt":0.35916047150712366,"score_spread":0.27674683804716754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220760683","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028519034,0.0023710143,0.00014131604,0.9656203,0.0001633007,0.002380511,0.000704301,0.000016624312,0.00008363732],"genre_scores_gemma":[0.5197073,0.002345019,0.18889222,0.27911475,0.005053912,0.0002589361,0.0034599167,0.00053799275,0.00062991027],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930593,0.0028584788,0.0026210914,0.00037265275,0.00077276805,0.0003157368],"domain_scores_gemma":[0.9944126,0.0025351567,0.0015068188,0.0006098979,0.000573326,0.00036217025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007461157,0.00033836445,0.0023528526,0.0004159773,0.00010342891,0.000031816606,0.00020567616,0.0001208876,0.00008935519],"category_scores_gemma":[0.0071508856,0.00025360813,0.0010670299,0.0003156528,0.00016406064,0.00016606737,0.00010810487,0.0012583649,9.952154e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007274109,0.0003931213,0.1341667,0.0008472518,0.0027026937,0.00032960434,0.00012879955,0.000017273425,0.00004518265,0.00004129859,0.86037374,0.00022693814],"study_design_scores_gemma":[0.0077883555,0.0018024984,0.053500526,0.00049985683,0.0061045378,0.0001595978,0.00013893339,0.0000071095697,0.000008134501,0.0000072139333,0.9297936,0.0001896597],"about_ca_topic_score_codex":0.00002278426,"about_ca_topic_score_gemma":0.000012611806,"teacher_disagreement_score":0.6865055,"about_ca_system_score_codex":0.00009715734,"about_ca_system_score_gemma":0.0010021059,"threshold_uncertainty_score":0.9999916},"labels":[],"label_agreement":null},{"id":"W4220889425","doi":"10.1002/ejhf.2481","title":"Defining changes in physical limitation from the patient perspective: insights from the <scp>VITALITY‐HFpEF</scp> randomized trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Merck KGaA","keywords":"Medicine; Heart failure; Randomized controlled trial; Internal medicine; Cardiology","score_opus":0.016082565301951585,"score_gpt":0.2528356668306865,"score_spread":0.23675310152873488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220889425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90153843,0.0017600261,0.000037217203,0.09455453,0.0003858523,0.0011092873,0.000019789435,0.000021845031,0.00057303545],"genre_scores_gemma":[0.99492973,0.000038920472,0.0015089457,0.0022253916,0.001080772,0.000034874545,0.00004525546,0.000036139667,0.000099970865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947047,0.003563062,0.00052331854,0.00024166143,0.00074301497,0.00022420697],"domain_scores_gemma":[0.9966845,0.0024393955,0.00034431132,0.0003077882,0.00012257478,0.00010142478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013650135,0.00021273477,0.00063217804,0.000106454696,0.00030637663,0.000073872056,0.00020832587,0.000019071505,0.00006739796],"category_scores_gemma":[0.0009946232,0.00011156513,0.00036970395,0.00026985252,0.00008689637,0.00010763965,0.00016946298,0.0007482228,0.000057785932],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12523736,0.002523084,0.0033197175,0.000015021823,0.0020911917,0.00163432,0.1689926,0.00035278543,0.002558326,0.005326493,0.6846753,0.003273854],"study_design_scores_gemma":[0.40782073,0.0024188424,0.010188231,0.0001625957,0.00064385525,0.000043111235,0.045298826,0.00014581949,0.00013247797,0.0009275269,0.53212523,0.00009271292],"about_ca_topic_score_codex":0.0001424824,"about_ca_topic_score_gemma":0.000092682516,"teacher_disagreement_score":0.2825834,"about_ca_system_score_codex":0.00016462975,"about_ca_system_score_gemma":0.00008903002,"threshold_uncertainty_score":0.4549494},"labels":[],"label_agreement":null},{"id":"W4220962901","doi":"10.1002/ejhf.2492","title":"Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: <scp>1‐year</scp> results from the <scp>CHOICE‐MI</scp> registry","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; St. Paul's Hospital; Montreal Heart Institute","funders":"Deutsche Herzstiftung; British Heart Foundation","keywords":"Medicine; Heart failure; Internal medicine; Mitral valve; Cardiology; Surgery","score_opus":0.014191332240947437,"score_gpt":0.27136660173266075,"score_spread":0.2571752694917133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220962901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354315,0.00056739897,0.000033507815,0.0011995033,0.00032635522,0.00034940275,0.0038311293,0.000010258334,0.00013926768],"genre_scores_gemma":[0.99673384,0.000040344097,0.0015007742,0.000578045,0.00035801245,0.000005054159,0.00051510526,0.000046924866,0.00022189703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981449,0.00030113227,0.0006483633,0.00020926843,0.0004638142,0.0002324803],"domain_scores_gemma":[0.9979187,0.00083526847,0.0005219411,0.00029194646,0.00022963612,0.00020250653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043738005,0.00019333615,0.00046239444,0.000069732065,0.00020147841,0.000042788797,0.00015268677,0.000026741163,0.000013571988],"category_scores_gemma":[0.0006079327,0.00013640363,0.0021064302,0.0000912066,0.00006263338,0.000087222106,0.000053988504,0.00028779745,0.0000045615566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020943307,0.00029515527,0.9467421,0.000036411668,0.0021051285,0.000029607958,0.00102467,0.0000049982655,0.00008842766,0.000006797731,0.048993714,0.00046351648],"study_design_scores_gemma":[0.0070925755,0.0009062136,0.9278754,0.00007559866,0.0016625535,0.000051364594,0.0011363976,0.000001784921,0.000040391627,0.000017837654,0.061111797,0.000028089584],"about_ca_topic_score_codex":0.0000127520525,"about_ca_topic_score_gemma":0.0000015032,"teacher_disagreement_score":0.018866742,"about_ca_system_score_codex":0.000031283522,"about_ca_system_score_gemma":0.000083379295,"threshold_uncertainty_score":0.5562378},"labels":[],"label_agreement":null},{"id":"W4220977210","doi":"10.1002/ejhf.2487","title":"Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a <scp>post‐hoc</scp> analysis of the <scp>ATHENA</scp> trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Relypsa; Abbott Vascular; Servier; Boston Scientific Corporation; Impulse Dynamics; Cytokinetics; Brigham and Women's Hospital; Amgen; Pfizer; AstraZeneca; Bristol-Myers Squibb; Bayer; Daiichi Sankyo Europe; American Regent; Sanofi; American Heart Association","keywords":"Medicine; Dronedarone; Ejection fraction; Cardiology; Heart failure; Internal medicine; Atrial fibrillation; Hazard ratio; Clinical endpoint; Heart failure with preserved ejection fraction; Loop diuretic; Concomitant; Placebo; Confidence interval; Randomized controlled trial; Amiodarone","score_opus":0.029247649540965464,"score_gpt":0.27469908784021574,"score_spread":0.24545143829925029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220977210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875979,0.0009307292,0.00039465658,0.008889927,0.0002997942,0.001768355,0.000040364575,0.000017060293,0.00006124052],"genre_scores_gemma":[0.99434143,0.000092258626,0.0029248067,0.00006941955,0.0017313797,0.0000043626897,0.000028555192,0.00004644232,0.0007613148],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715745,0.0007540375,0.00084590993,0.00025223108,0.00077188923,0.00021848596],"domain_scores_gemma":[0.9967128,0.0012196184,0.001162119,0.0003980257,0.00040333634,0.00010412231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012142671,0.00024510932,0.00085391285,0.00034183418,0.0004201037,0.00005068562,0.00013353463,0.000040446164,0.00003595008],"category_scores_gemma":[0.00035313802,0.00012944076,0.0007958123,0.00087565073,0.0001275688,0.00018124112,0.00005372899,0.00022475285,9.864855e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09735924,0.00049488654,0.62659794,0.0003817689,0.037027895,0.00007544401,0.01153008,0.09903069,0.038615413,0.00026955685,0.08533386,0.0032832248],"study_design_scores_gemma":[0.05404098,0.023303347,0.1266722,0.000102294034,0.009424808,0.00016367772,0.008201085,0.0010657152,0.0013542676,0.000010632172,0.77558523,0.00007576439],"about_ca_topic_score_codex":0.000021780135,"about_ca_topic_score_gemma":0.000035503177,"teacher_disagreement_score":0.69025135,"about_ca_system_score_codex":0.00011874876,"about_ca_system_score_gemma":0.00017404363,"threshold_uncertainty_score":0.5278441},"labels":[],"label_agreement":null},{"id":"W4221036244","doi":"10.1002/ejhf.2493","title":"Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Montreal Heart Institute","funders":"Relypsa; European Regional Development Fund; National Medical Research Council; Abbott Vascular; Servier; Universitair Medisch Centrum Groningen; Medical Research Council; Leids Universitair Medisch Centrum; MyoKardia; Novo Nordisk; Idorsia Pharmaceuticals; Karolinska Institutet; Horizon 2020 Framework Programme; Stockholms Läns Landsting; Health Research Council of New Zealand; Universiteit Leiden; Deutsche Forschungsgemeinschaft; National Heart Foundation of New Zealand; Fondation Leducq; Vetenskapsrådet; Fresenius Medical Care North America; Cytokinetics; Amicus Therapeutics; Ionis Pharmaceuticals; Instituto de Salud Carlos III; Amgen; European Society of Cardiology; Boston Scientific Corporation; Edwards Lifesciences; Bayer HealthCare; European Commission; Sanofi; Ministerio de Ciencia, Innovación y Universidades; AstraZeneca; Pfizer","keywords":"Medicine; Heart failure; Vascular remodelling in the embryo; Ventricle; Ventricular remodeling; Internal medicine; Cardiology; Biomarker; Biology","score_opus":0.038880445440150256,"score_gpt":0.2814340953866018,"score_spread":0.24255364994645154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221036244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009542516,0.98225796,0.000030355484,0.004353329,0.0010303318,0.0021563275,0.00043042868,0.000011481346,0.00018727183],"genre_scores_gemma":[0.018135877,0.9771918,0.002461895,0.00046548023,0.0014859891,0.000005504373,0.00004469913,0.00017865967,0.000030113797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98525906,0.010606932,0.0021908456,0.00048348928,0.0011590399,0.0003006426],"domain_scores_gemma":[0.99478894,0.0011649978,0.002562126,0.0010674829,0.00028782123,0.00012863064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00925155,0.00047934518,0.0032683962,0.00008785552,0.00027478556,0.0000324012,0.00058073044,0.00011107813,0.000024714758],"category_scores_gemma":[0.0004466038,0.0002442583,0.003425431,0.00062998524,0.0001281374,0.000052947722,0.0005306204,0.0012600872,0.0000036512442],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022466146,0.0004159203,0.021549314,0.018343361,0.025240947,0.000046158428,0.005348035,0.0011780232,0.010373817,0.0000036260121,0.75872576,0.15855037],"study_design_scores_gemma":[0.00050608104,0.00031156442,0.0041961097,0.04184473,0.0049294713,0.000047776146,0.0011276563,0.000011438431,0.000018539438,0.0000014895725,0.9467957,0.00020941824],"about_ca_topic_score_codex":0.000074886986,"about_ca_topic_score_gemma":0.0000035505564,"teacher_disagreement_score":0.18806995,"about_ca_system_score_codex":0.00017102025,"about_ca_system_score_gemma":0.00018287185,"threshold_uncertainty_score":0.9960564},"labels":[],"label_agreement":null},{"id":"W4223892578","doi":"10.1002/ejhf.2508","title":"Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from <scp>REPORT‐HF</scp> (international REgistry to assess <scp>medical</scp> Practice with <scp>lOngitudinal obseRvation</scp> for Treatment of Heart Failure)","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Department of Medicine, University of Toronto; Novartis Pharma; Sunnybrook Research Institute; Heart Failure Society of America","keywords":"Medicine; Heart failure; Ejection fraction; Quality of life (healthcare); Psychological intervention; Internal medicine; Physical therapy; Emergency medicine; Nursing","score_opus":0.04347201001812571,"score_gpt":0.33314314337269446,"score_spread":0.28967113335456873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223892578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91185284,0.00029190385,0.024402674,0.059554044,0.0005416885,0.0024188843,0.00072329113,0.00008900045,0.00012566347],"genre_scores_gemma":[0.7581235,0.000030676223,0.23634948,0.0014192545,0.0010185296,0.00031398438,0.0013340265,0.00015138174,0.0012591793],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99107,0.001329041,0.0027085415,0.0010676268,0.003044505,0.0007803192],"domain_scores_gemma":[0.98976123,0.0031890706,0.0024045734,0.0012384269,0.0023226188,0.0010840993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042459434,0.0007485319,0.00215251,0.00086308015,0.00036730507,0.00022226662,0.000571634,0.00016869356,0.00016337642],"category_scores_gemma":[0.005762743,0.00063086324,0.0012653476,0.001154219,0.00020249485,0.0011356327,0.00019117283,0.00049714145,0.000012872872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011323121,0.00604947,0.5434907,0.0002692214,0.016654138,0.0011089302,0.0033692126,0.002106672,0.0069510727,0.00024814787,0.41836792,0.00025221246],"study_design_scores_gemma":[0.007236949,0.006531639,0.26731366,0.00016245812,0.0043678163,0.00036123404,0.007979183,0.00031333847,0.0014996789,0.000021906342,0.70408267,0.00012946961],"about_ca_topic_score_codex":0.0003127814,"about_ca_topic_score_gemma":0.0003635765,"teacher_disagreement_score":0.28571475,"about_ca_system_score_codex":0.00053921517,"about_ca_system_score_gemma":0.0010349563,"threshold_uncertainty_score":0.99961424},"labels":[],"label_agreement":null},{"id":"W4224267136","doi":"10.1002/ejhf.2509","title":"What's all the fuss about a new guideline?","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Heart failure; Intensive care medicine; MEDLINE; Internal medicine; Pathology; Law","score_opus":0.02323631078445452,"score_gpt":0.27797970580910036,"score_spread":0.2547433950246458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224267136","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020808546,0.0035726607,0.00039243585,0.97154444,0.0013145689,0.0004767623,0.0000023670748,0.000050514678,0.001837689],"genre_scores_gemma":[0.67615163,0.0009245354,0.121673234,0.12631033,0.008128099,0.000016061198,0.00006439721,0.00031669816,0.06641503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976661,0.00053375104,0.0006736534,0.00016447713,0.0006684277,0.00029358486],"domain_scores_gemma":[0.99891514,0.000062157895,0.00022873002,0.0003863649,0.00012283713,0.0002847732],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018910436,0.00017608459,0.00031454835,0.0001462049,0.0002335814,0.00012411321,0.00027088416,0.000012505387,0.0023144553],"category_scores_gemma":[0.00007561653,0.00010894213,0.00031231463,0.00021634148,0.000037697457,0.0002485939,0.0002043847,0.0005991676,0.00023661295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013581889,0.00010952046,0.0003319517,0.000007857777,0.0001999784,0.0010476722,0.0007868225,0.00009405491,0.00048105366,0.000092486844,0.9890944,0.0076184245],"study_design_scores_gemma":[0.0020847088,0.0010892127,0.0014546913,0.00006817578,0.00021601528,0.0020980237,0.0024081056,0.000018113109,0.00005073249,0.00002871795,0.99038327,0.00010024946],"about_ca_topic_score_codex":0.000009930091,"about_ca_topic_score_gemma":0.000005734031,"teacher_disagreement_score":0.84523416,"about_ca_system_score_codex":0.0000839116,"about_ca_system_score_gemma":0.00018533149,"threshold_uncertainty_score":0.99859756},"labels":[],"label_agreement":null},{"id":"W4225121800","doi":"10.1002/ejhf.2522","title":"Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Ventricular remodeling","score_opus":0.03260175140151088,"score_gpt":0.3017016111793732,"score_spread":0.2690998597778623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225121800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009910885,0.97964495,0.0000012569542,0.007318425,0.0013345474,0.0013275967,0.00028858907,0.000010060973,0.00016365995],"genre_scores_gemma":[0.005717649,0.99180406,0.00033644633,0.00068360893,0.0013137071,0.0000027914368,0.00001662697,0.00008483638,0.000040263647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9837124,0.012671307,0.002181114,0.0003637032,0.0008314579,0.00024001383],"domain_scores_gemma":[0.99499714,0.0011073427,0.0026272973,0.00085074204,0.0003225688,0.000094885305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011432139,0.00038193786,0.0029736692,0.00005048014,0.00026254947,0.000020357542,0.0005062932,0.00007906544,0.000026551063],"category_scores_gemma":[0.00072074734,0.00017219958,0.0039855414,0.000528594,0.00030170518,0.000051355266,0.00045956622,0.0017048544,0.0000017584821],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006703587,0.0001053391,0.08092156,0.0069340314,0.006250775,0.000031706753,0.00053792115,0.000011935841,0.00008189972,0.0000038721887,0.86770666,0.037347242],"study_design_scores_gemma":[0.000510761,0.0002830213,0.02408985,0.018076712,0.0039910604,0.00009990904,0.0008064326,8.0039405e-7,0.000001399996,0.0000010225011,0.9519971,0.00014190588],"about_ca_topic_score_codex":0.0000113514125,"about_ca_topic_score_gemma":0.000001346282,"teacher_disagreement_score":0.084290445,"about_ca_system_score_codex":0.000113936,"about_ca_system_score_gemma":0.00025461245,"threshold_uncertainty_score":0.7406839},"labels":[],"label_agreement":null},{"id":"W4243610425","doi":"10.1002/ejhf.314","title":"July 2015 at a Glance","year":2015,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Cardiology; Atrial fibrillation; Cardiac resynchronization therapy; QRS complex; Ejection fraction; Clinical trial; Randomization; Cohort","score_opus":0.03514941029933686,"score_gpt":0.2949312897536403,"score_spread":0.2597818794543034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243610425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.758883,0.008941253,0.0003285297,0.03219317,0.001122278,0.00013664468,0.000008448973,0.0000750759,0.19831158],"genre_scores_gemma":[0.98919773,0.000026390373,0.0055680606,0.0006279777,0.0011415255,1.0371024e-7,0.0000010662004,0.000021022073,0.0034161387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900335,0.00015487212,0.00028942784,0.00008104845,0.00034300998,0.00012826108],"domain_scores_gemma":[0.9990541,0.000031173488,0.00013632613,0.00014425835,0.00037684475,0.00025732943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007761675,0.00008658938,0.0003369398,0.00007896097,0.00004917402,0.0000149959715,0.000018434268,0.000013247302,0.000012577207],"category_scores_gemma":[0.000242777,0.00006338971,0.00016395212,0.00010277655,0.000040574767,0.00006160463,0.000043805932,0.00016227693,0.0007519758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017479184,0.000010623848,0.013551681,0.000008042037,0.000056113495,0.00017797173,0.00043604244,0.000027134465,0.00087372796,0.000003034479,0.98451,0.00017081643],"study_design_scores_gemma":[0.0014463573,0.00034798746,0.021060761,0.00009717117,0.000045916386,0.00865576,0.00018690892,0.0000013865449,0.00019402783,0.0000046913133,0.9678978,0.00006125619],"about_ca_topic_score_codex":6.131582e-7,"about_ca_topic_score_gemma":5.390447e-7,"teacher_disagreement_score":0.2303147,"about_ca_system_score_codex":0.000051910156,"about_ca_system_score_gemma":0.0000645548,"threshold_uncertainty_score":0.96653783},"labels":[],"label_agreement":null},{"id":"W4251643608","doi":"10.1016/j.ejheart.2004.04.004","title":"Response from Authors to Letter to the Editor","year":2004,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Internal medicine","score_opus":0.013351896558176441,"score_gpt":0.2563102235267571,"score_spread":0.24295832696858063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251643608","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25624943,0.000047038644,0.00137652,0.74010736,0.0017451666,0.00031739142,0.0000046893806,0.000025606676,0.00012679727],"genre_scores_gemma":[0.7598173,0.000003738917,0.14188224,0.06973793,0.025210466,0.0000051226184,0.0000043493833,0.00008675989,0.0032520853],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981689,0.0004743672,0.00040660397,0.00018171985,0.00049339095,0.0002750384],"domain_scores_gemma":[0.9988452,0.00008131046,0.00007764535,0.00038524583,0.00013402225,0.00047656984],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016863798,0.0001697617,0.0002736572,0.00019090936,0.000111160676,0.00006330516,0.00019709318,0.000026706246,0.00021887773],"category_scores_gemma":[0.00029565798,0.00010029229,0.00018327795,0.00023312407,0.000024204288,0.00008623131,0.000089727975,0.00037181092,0.0027033736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010832305,0.00007860334,0.00024393646,0.0000029749276,0.00008630646,0.00081734895,0.00136999,0.00011963741,0.008171743,0.000009007278,0.9873776,0.000639643],"study_design_scores_gemma":[0.0015242831,0.0014367213,0.016567092,0.00020099142,0.00008568737,0.00011102276,0.00023194803,3.5794878e-7,0.0011438775,0.000008415491,0.9785896,0.00010001663],"about_ca_topic_score_codex":0.0000120970535,"about_ca_topic_score_gemma":0.000013917653,"teacher_disagreement_score":0.6703694,"about_ca_system_score_codex":0.000103717466,"about_ca_system_score_gemma":0.00008686584,"threshold_uncertainty_score":0.99807316},"labels":[],"label_agreement":null},{"id":"W4255739262","doi":"10.1002/ejhf.1596","title":"Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"National Institute for Health and Care Research","keywords":"Empagliflozin; Medicine; Heart failure; Heart failure with preserved ejection fraction; Cardiology; Ejection fraction; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.021955845237664185,"score_gpt":0.25255567663788525,"score_spread":0.23059983140022106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255739262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673605,0.00011914532,0.00020201725,0.00042542868,0.00011876891,0.0023821434,0.000009345079,0.0000027359815,0.000004386146],"genre_scores_gemma":[0.99961996,0.000014065075,0.00022589775,0.00002481705,0.00007801709,0.0000075040407,0.000007152702,0.000015265561,0.000007339153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975275,0.0010790026,0.0003834553,0.00015141797,0.0007753259,0.000083294515],"domain_scores_gemma":[0.9987398,0.00012934375,0.00035298985,0.00022185734,0.0005080554,0.00004799229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020269195,0.00012008269,0.00035802726,0.000087861685,0.0000572955,0.000010947893,0.000034561697,0.000045047156,0.000015063011],"category_scores_gemma":[0.00017685427,0.00006328351,0.00012658698,0.00013080938,0.00010447737,0.0001782518,0.000012420796,0.0002351306,1.6558053e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012431757,0.00022899556,0.9723436,0.0003543568,0.0002606481,8.8380784e-7,0.00018014939,0.0005260405,0.013062991,0.0000015034408,0.0005393045,0.00006977559],"study_design_scores_gemma":[0.04122958,0.004468797,0.93522733,0.0006968498,0.0004962655,0.000014743379,0.00009634116,0.00014611431,0.017314926,0.0000064255723,0.00024159293,0.00006101198],"about_ca_topic_score_codex":0.000018625355,"about_ca_topic_score_gemma":0.00007187669,"teacher_disagreement_score":0.03711624,"about_ca_system_score_codex":0.000050787115,"about_ca_system_score_gemma":0.00017102744,"threshold_uncertainty_score":0.25806266},"labels":[],"label_agreement":null},{"id":"W4280511979","doi":"10.1002/ejhf.2535","title":"Factors associated with health‐related quality of life in heart failure in 23 000 patients from 40 countries: results of the <scp>G‐CHF</scp> research programme","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hamilton Health Sciences; Impact; McMaster University; Population Health Research Institute","funders":"Bayer Canada; Stockholms Läns Landsting; Bayer","keywords":"Medicine; Heart failure; Confidence interval; Quality of life (healthcare); Comorbidity; Internal medicine; Health related quality of life; Physical therapy; Disease","score_opus":0.07429721021115548,"score_gpt":0.31414758877083554,"score_spread":0.23985037855968006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280511979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651714,0.00027474156,0.0000011217469,0.03284566,0.0001293594,0.0012561247,0.00019142871,0.00002053099,0.0001096499],"genre_scores_gemma":[0.9985032,0.000012540196,0.00060769904,0.00032389088,0.000044456265,0.000009222226,0.00013295682,0.000058741705,0.0003073057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9885206,0.0058026486,0.002368717,0.00038135567,0.0021913957,0.00073528383],"domain_scores_gemma":[0.99624133,0.0010065576,0.0012217248,0.0005566361,0.00062859687,0.00034513767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008310278,0.00030249477,0.0012235203,0.0006232478,0.00022186976,0.00003171068,0.00038806687,0.00007386004,0.000080658254],"category_scores_gemma":[0.0026997016,0.00019874108,0.00025925844,0.0016644091,0.00024587294,0.00016337972,0.00027365392,0.0017142927,0.000008105322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062186556,0.001558389,0.8494274,0.00009080075,0.0002714752,0.000051420757,0.006614064,0.000114154085,0.00011095363,0.000015919257,0.14106429,0.00005925407],"study_design_scores_gemma":[0.0119697815,0.003286569,0.82828516,0.00082574633,0.000042543634,0.000005330494,0.007974863,0.000007740408,0.000107222244,0.00001483605,0.14740205,0.00007814427],"about_ca_topic_score_codex":0.0013944346,"about_ca_topic_score_gemma":0.0021351054,"teacher_disagreement_score":0.033331808,"about_ca_system_score_codex":0.00053435756,"about_ca_system_score_gemma":0.00074887724,"threshold_uncertainty_score":0.81044257},"labels":[],"label_agreement":null},{"id":"W4280595574","doi":"10.1002/ejhf.2542","title":"Head‐to‐head comparison between recommendations by the <scp>ESC</scp> and <scp>ACC</scp> / <scp>AHA</scp> / <scp>HFSA</scp> heart failure guidelines","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Guideline; Ejection fraction; Internal medicine; Cardiology; Intensive care medicine; Pathology","score_opus":0.09443273747685921,"score_gpt":0.369412134089355,"score_spread":0.2749793966124958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280595574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055400785,0.91293335,0.00072412426,0.06480312,0.0025512336,0.0072273114,0.00097232347,0.0006191781,0.0046292823],"genre_scores_gemma":[0.0006867193,0.8537085,0.06526536,0.010037437,0.011113951,0.00042352726,0.0037457708,0.0019313575,0.053087365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9804252,0.005257878,0.006291304,0.0022164143,0.0030129238,0.0027963032],"domain_scores_gemma":[0.98217857,0.008408053,0.0031078504,0.0025184902,0.0011412149,0.0026458432],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.008146466,0.0029011518,0.0071358676,0.0020112216,0.0020027785,0.0010523859,0.002081373,0.00066984404,0.00023926792],"category_scores_gemma":[0.007940515,0.002161319,0.002761021,0.0026818644,0.00048805116,0.00082289666,0.0016568268,0.006022759,0.001725553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004332154,0.000580312,0.0021146517,0.0021545563,0.0021532744,0.00044995823,0.0013878377,0.000018804669,0.000032503198,0.00003783952,0.9415954,0.04947056],"study_design_scores_gemma":[0.003162132,0.0026112448,0.0006979025,0.007997796,0.0051161884,0.0026482418,0.0062409737,0.000015635465,0.000028306455,0.00002256207,0.9712315,0.0002274988],"about_ca_topic_score_codex":0.0000924692,"about_ca_topic_score_gemma":0.00013283138,"teacher_disagreement_score":0.064541236,"about_ca_system_score_codex":0.0007482955,"about_ca_system_score_gemma":0.001096615,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W4281254807","doi":"10.1002/ejhf.2534","title":"Distinct pathophysiological pathways in women and men with heart failure","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Population Health Research Institute","funders":"H2020 European Research Council; Medical Research Council; FP7 Ideas: European Research Council; Respicardia; National Medical Research Council; Cytokinetics; Idorsia Pharmaceuticals; British Heart Foundation; National Institute for Health and Care Research; Boston Scientific Corporation; MyoKardia; AstraZeneca; Bristol-Myers Squibb; Servier; European Commission; Amgen","keywords":"Medicine; Heart failure; Ejection fraction; Pathophysiology; Internal medicine; Leptin; Cohort; Endocrinology; Obesity","score_opus":0.01260624466694601,"score_gpt":0.21883870302511751,"score_spread":0.2062324583581715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281254807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950302,0.00021158227,0.000028835786,0.048467252,0.000045758734,0.00036645023,0.000008168738,0.000034420307,0.00053552055],"genre_scores_gemma":[0.9864158,0.000013907736,0.011821121,0.0011261624,0.00018367304,0.00001571895,0.000007899865,0.00004187767,0.00037381178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767196,0.0006608051,0.0004780433,0.0002829684,0.0004878824,0.00041832993],"domain_scores_gemma":[0.99916446,0.000060094055,0.00014955521,0.00024012089,0.000066439316,0.00031931937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001209356,0.0002383117,0.00056383776,0.00023224288,0.00018494698,0.000037165188,0.00012101197,0.000022822202,0.00045899596],"category_scores_gemma":[0.000043577962,0.00016146695,0.00010692367,0.0002897214,0.00010654393,0.00012279829,0.0001998256,0.00068592385,0.000028581677],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045009754,0.0018351671,0.14178029,0.00020609247,0.00037311378,0.011748386,0.0050419243,0.00013576841,0.030129068,0.00033219872,0.79959905,0.004317993],"study_design_scores_gemma":[0.004551452,0.0059992727,0.15694879,0.000109008004,0.000048673683,0.0016971716,0.0031143397,0.000014945139,0.000051678846,0.00006300947,0.8272003,0.00020139672],"about_ca_topic_score_codex":0.0000033197693,"about_ca_topic_score_gemma":0.0000038192784,"teacher_disagreement_score":0.04734109,"about_ca_system_score_codex":0.00016273951,"about_ca_system_score_gemma":0.000091602524,"threshold_uncertainty_score":0.6584431},"labels":[],"label_agreement":null},{"id":"W4283319043","doi":"10.1002/ejhf.2588","title":"Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Toronto General Hospital; Ontario Institute for Cancer Research; Ted Rogers Centre for Heart Research","funders":"Department of Medicine, University of Toronto; Canada First Research Excellence Fund; Canadian Institutes of Health Research; Terry Fox Foundation; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hazard ratio; Internal medicine; Cardiogenic shock; Odds ratio; Heart failure; Gastroenterology; Population; Confidence interval; Ejection fraction; Myocardial infarction","score_opus":0.012861700758917082,"score_gpt":0.22691434007347677,"score_spread":0.2140526393145597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283319043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944478,0.00015486951,0.0000030162062,0.004536229,0.000077933204,0.0002649834,0.00004997629,0.000011140142,0.0004540145],"genre_scores_gemma":[0.9979667,0.0000047757203,0.0006811878,0.0009894663,0.00007596769,0.0000075896064,0.000029127325,0.000042940606,0.00020221111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976742,0.0005575014,0.00043026675,0.00020656097,0.00089171313,0.0002397385],"domain_scores_gemma":[0.99898845,0.000051861858,0.00033742122,0.00020165219,0.00025151498,0.00016910568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005563774,0.00019633514,0.0005588215,0.00014375646,0.00014099333,0.000022581919,0.00009241826,0.000017369903,0.0009541113],"category_scores_gemma":[0.000031055628,0.00012763165,0.00015451243,0.00030508297,0.000044455905,0.00008845228,0.00005352303,0.0004643485,0.000014115872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005829685,0.00075743726,0.9659626,0.000010547735,0.00076505635,0.0015393742,0.0002979534,0.00009559171,0.000011905821,0.000009683079,0.029911954,0.000054958513],"study_design_scores_gemma":[0.0068432256,0.0033374967,0.9641344,0.00015941514,0.00026023455,0.00021854343,0.00009992441,0.0000019198642,0.00009448028,0.000002794414,0.024714667,0.00013291913],"about_ca_topic_score_codex":0.000007767774,"about_ca_topic_score_gemma":0.000016645665,"teacher_disagreement_score":0.0062602567,"about_ca_system_score_codex":0.00022995369,"about_ca_system_score_gemma":0.00014842044,"threshold_uncertainty_score":0.9999592},"labels":[],"label_agreement":null},{"id":"W4283792517","doi":"10.1002/ejhf.2605","title":"BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Health Care Foundation","funders":"Daiichi Sankyo Europe; Heart Care Foundation of India; Vifor Pharma; Servier; Daiichi-Sankyo; Medtronic; Abbott Laboratories","keywords":"Medicine; Guideline; Heart failure; Ejection fraction; Context (archaeology); Internal medicine; Medical prescription; Cardiology; Ambulatory; Emergency medicine; Intensive care medicine; Pathology","score_opus":0.04046947752358966,"score_gpt":0.32678831161182886,"score_spread":0.2863188340882392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283792517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5105156,0.0010900963,0.00050259737,0.48582104,0.00034351964,0.0013615714,0.00004344788,0.00005674357,0.00026544963],"genre_scores_gemma":[0.8709371,0.00006714414,0.112194784,0.013971907,0.0007996731,0.000043275446,0.000014253692,0.0000840778,0.0018877755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735284,0.00047425204,0.00072083494,0.00038408712,0.0006935995,0.00037437148],"domain_scores_gemma":[0.99836403,0.00007348905,0.00018385255,0.00027032595,0.000547213,0.0005610868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017720768,0.00028133317,0.0005255094,0.00043565646,0.00029960857,0.00009426178,0.00014261772,0.000023795857,0.00038337416],"category_scores_gemma":[0.0002828629,0.00023100308,0.00012885372,0.00042486767,0.000049793878,0.00022764664,0.00039341697,0.0004553087,0.000103606355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047704478,0.00013519004,0.0026579618,0.000076087985,0.00045527695,0.00063032564,0.0019010395,0.00011410691,0.03684351,0.00006834339,0.94864875,0.007992361],"study_design_scores_gemma":[0.0031828946,0.0088899955,0.0057329834,0.0002299686,0.0003208323,0.0012561181,0.0011975615,0.000070471055,0.0010680107,0.000029219398,0.97777754,0.00024442936],"about_ca_topic_score_codex":0.000008403304,"about_ca_topic_score_gemma":0.000033433356,"teacher_disagreement_score":0.4718491,"about_ca_system_score_codex":0.00015897606,"about_ca_system_score_gemma":0.00026007136,"threshold_uncertainty_score":0.94200325},"labels":[],"label_agreement":null},{"id":"W4283824390","doi":"10.1002/ejhf.2612","title":"An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Guideline; Heart failure; Intensive care medicine; Kidney disease; Delphi method; Discontinuation; Internal medicine","score_opus":0.023106250209387447,"score_gpt":0.32408043410010184,"score_spread":0.3009741838907144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283824390","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27397123,0.00085159106,0.0011493358,0.7153843,0.0027869544,0.00043956746,0.00014374485,0.000039730534,0.0052335453],"genre_scores_gemma":[0.98455703,0.000083217885,0.011471397,0.0023397608,0.0010034597,0.0000041687867,0.000035625333,0.000043284574,0.00046206347],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825406,0.0005665041,0.00043657603,0.00014473333,0.0003720826,0.00022603762],"domain_scores_gemma":[0.9988354,0.00022737304,0.00031285398,0.0002201014,0.00026352864,0.00014073048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021079616,0.00011216693,0.00019760588,0.000087812296,0.0006319565,0.000064272994,0.00024594655,0.00002105002,0.000148308],"category_scores_gemma":[0.00044212292,0.00007881882,0.00023088985,0.00014659265,0.00007667461,0.00016243053,0.00007322403,0.00084834953,0.00001659213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002463392,0.00079367677,0.003349689,0.00002187711,0.0012716913,0.0010704969,0.0047796485,0.003480724,0.0052264794,0.00054287416,0.9698846,0.0071148574],"study_design_scores_gemma":[0.002602374,0.0010349078,0.000643425,0.000049935566,0.00021097988,0.012123519,0.014314195,0.00021275405,0.000086763655,0.00002103305,0.96860766,0.00009242205],"about_ca_topic_score_codex":0.0000057276507,"about_ca_topic_score_gemma":0.0000023558432,"teacher_disagreement_score":0.7130445,"about_ca_system_score_codex":0.00009558206,"about_ca_system_score_gemma":0.00015262733,"threshold_uncertainty_score":0.4860562},"labels":[],"label_agreement":null},{"id":"W4283833224","doi":"10.1002/ejhf.2613","title":"Guideline‐directed medical therapy in patients undergoing transcatheter edge‐to‐edge repair for secondary mitral regurgitation","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"TOMTEC Imaging Systems; Ono Pharmaceutical; InfraRedx; Abbott Vascular; Medicure; Regeneron Pharmaceuticals; ReCor Medical; Boston Scientific Corporation; AstraZeneca; CSL Behring; Cardinal Health; Amgen; Edwards Lifesciences; Daiichi Sankyo Europe; Sanofi; Pfizer","keywords":"Medicine; Mitral regurgitation; Ejection fraction; Internal medicine; Cardiology; Hazard ratio; Heart failure; Confidence interval","score_opus":0.012735757517487798,"score_gpt":0.29710482270124616,"score_spread":0.2843690651837584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283833224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890471,0.0007264692,0.00008851536,0.008834387,0.00043182675,0.0005375595,0.000047183694,0.000040975654,0.00024599498],"genre_scores_gemma":[0.99176085,0.000020202338,0.004998856,0.0026392043,0.00029777773,0.000010757268,0.00010090588,0.000054658056,0.00011677718],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979586,0.00041016855,0.0006639277,0.00019187342,0.00055282505,0.00022262716],"domain_scores_gemma":[0.9990706,0.00009210558,0.00013718026,0.00016332924,0.00024204196,0.00029477876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089848554,0.0001444351,0.00033355606,0.00022446548,0.00011021718,0.000014901693,0.0000944329,0.000021971551,0.00045549613],"category_scores_gemma":[0.00019700517,0.00012117429,0.0016091141,0.00019370967,0.000017657345,0.00008517399,0.00002713083,0.00031155092,0.000011063879],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067178262,0.0020620725,0.347691,0.0000943662,0.0017918425,0.0003617332,0.0020132652,0.0001421146,0.00023102261,0.000012238978,0.60415566,0.03472685],"study_design_scores_gemma":[0.020808209,0.005901674,0.66681504,0.00020013396,0.00023758653,0.00012818142,0.00043835648,0.000044654305,0.00003667291,0.000020913689,0.30518752,0.00018107033],"about_ca_topic_score_codex":0.0000022165395,"about_ca_topic_score_gemma":0.000002335088,"teacher_disagreement_score":0.319124,"about_ca_system_score_codex":0.0001267789,"about_ca_system_score_gemma":0.00029785396,"threshold_uncertainty_score":0.49873632},"labels":[],"label_agreement":null},{"id":"W4283837356","doi":"10.1002/ejhf.2608","title":"Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Merck Sharp and Dohme; Bayer","keywords":"Medicine; Valsartan; Sacubitril, Valsartan; Sacubitril; Ejection fraction; Heart failure; Hazard ratio; Randomization; Internal medicine; Clinical endpoint; Placebo; Cardiology; Confidence interval; Blood pressure; Randomized controlled trial","score_opus":0.00830172429558037,"score_gpt":0.21843472898191638,"score_spread":0.210133004686336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283837356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911322,0.00009591782,0.000045660876,0.007226892,0.00012057291,0.0012589125,0.000009708115,0.000022512115,0.000087617],"genre_scores_gemma":[0.995991,0.0000076815,0.0033859834,0.00018721195,0.00026462137,0.000009077204,0.00005206812,0.00005304755,0.000049326776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972633,0.0008387305,0.00058993255,0.0002953726,0.00078919914,0.00022345643],"domain_scores_gemma":[0.998756,0.00015191146,0.00041895386,0.0003175757,0.0002119783,0.00014359834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004649682,0.00027458943,0.0007166295,0.00023037924,0.0002443604,0.00003784866,0.00009798922,0.000032647276,0.00011844374],"category_scores_gemma":[0.00003725125,0.00014826003,0.000079670535,0.00059284666,0.00008639297,0.00024119538,0.00004266489,0.0006247649,0.0000054374373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4388621,0.0032267065,0.49804634,0.000059918148,0.001371748,0.00044829838,0.002192577,0.00065479265,0.0053434735,0.00002638234,0.04900246,0.0007652006],"study_design_scores_gemma":[0.12388682,0.021745633,0.5741063,0.00047209207,0.0006726217,0.00011178957,0.0015422197,0.000009266932,0.00056357007,0.0000022002116,0.27663863,0.00024890466],"about_ca_topic_score_codex":0.00005781491,"about_ca_topic_score_gemma":0.000051277937,"teacher_disagreement_score":0.31497526,"about_ca_system_score_codex":0.000169643,"about_ca_system_score_gemma":0.00012849407,"threshold_uncertainty_score":0.6045869},"labels":[],"label_agreement":null},{"id":"W4286685002","doi":"10.1002/ejhf.2630","title":"Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Vifor Pharma","keywords":"Medicine; Heart failure; Etiology; Iron deficiency; Internal medicine; Cardiology; Ischaemic heart disease; Intravenous iron; Intensive care medicine; Randomized controlled trial; Anemia","score_opus":0.008773976843987384,"score_gpt":0.23520216991682225,"score_spread":0.22642819307283485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286685002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001414,0.00045940146,0.0000015275626,0.008795608,0.0001257701,0.00053157384,0.000022149146,0.000005113955,0.00004469549],"genre_scores_gemma":[0.9992412,0.000025472036,0.00034769732,0.00019837271,0.00013453067,0.0000022935458,0.00001297439,0.000028429911,0.000009045878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754214,0.001026459,0.0005757388,0.00019255393,0.00045167527,0.0002114461],"domain_scores_gemma":[0.9986771,0.00041249325,0.000397586,0.00031925528,0.00009488033,0.00009871301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047811444,0.00020153985,0.00052036415,0.00013312722,0.0001442123,0.000010349526,0.00018709918,0.00002986305,0.000115666764],"category_scores_gemma":[0.00011232862,0.000093778835,0.00018321449,0.00026139602,0.00020926415,0.00003932178,0.00008774034,0.0007210859,0.000003682061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15140662,0.012577161,0.71611184,0.000100734265,0.001386521,0.0010853175,0.025846642,0.0018115831,0.025966523,0.00018678242,0.06113186,0.0023884177],"study_design_scores_gemma":[0.05032544,0.040413674,0.9035171,0.00026655002,0.00030325633,0.0003420373,0.0012172577,0.000006150409,0.00028726182,0.000012729846,0.0031528564,0.00015566927],"about_ca_topic_score_codex":0.000073918716,"about_ca_topic_score_gemma":0.000014545425,"teacher_disagreement_score":0.18740527,"about_ca_system_score_codex":0.000097413,"about_ca_system_score_gemma":0.00017701568,"threshold_uncertainty_score":0.38241902},"labels":[],"label_agreement":null},{"id":"W4292791027","doi":"10.1002/ejhf.2652","title":"Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; AstraZeneca; American Regent; Amgen","keywords":"Ejection fraction; Medicine; Internal medicine; Heart failure; Hazard ratio; Cardiology; Dapagliflozin; Clinical endpoint; Confidence interval; Odds ratio; Placebo; Randomized controlled trial; Endocrinology; Diabetes mellitus","score_opus":0.03280294761519501,"score_gpt":0.2400311687853486,"score_spread":0.2072282211701536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292791027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8794937,0.00035045316,0.000048977312,0.11824268,0.0006199391,0.0008226906,0.0000045201487,0.000033519103,0.000383489],"genre_scores_gemma":[0.98381877,0.000016094085,0.004162592,0.0023040157,0.0016463661,0.000018859475,0.000024784147,0.00005347502,0.007955059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739534,0.0008824649,0.00047272016,0.0002346114,0.0007597796,0.0002550967],"domain_scores_gemma":[0.999072,0.0001563374,0.0002871146,0.00020165317,0.00012650774,0.00015637682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016647078,0.00018297137,0.00037409482,0.00021657589,0.0002953222,0.00009094032,0.00008833519,0.000034828994,0.000781945],"category_scores_gemma":[0.00012891808,0.00011794089,0.00014421016,0.00040560376,0.000028333698,0.00025667445,0.00007367144,0.0007208983,0.000029862047],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0155339865,0.00030261895,0.03693375,0.000015944752,0.00032182006,0.00007147657,0.00016724042,0.00037675432,0.001252111,0.0000116244255,0.94473034,0.00028233568],"study_design_scores_gemma":[0.026756896,0.003984349,0.10053603,0.000087694316,0.00026064992,0.00022978078,0.0011902222,0.00004101774,0.000096678246,0.000008486679,0.86668617,0.00012203182],"about_ca_topic_score_codex":0.000029407713,"about_ca_topic_score_gemma":0.000071613256,"teacher_disagreement_score":0.11593867,"about_ca_system_score_codex":0.00035381678,"about_ca_system_score_gemma":0.0001913752,"threshold_uncertainty_score":0.85617495},"labels":[],"label_agreement":null},{"id":"W4292849656","doi":"10.1002/ejhf.2660","title":"Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Post-hoc analysis; Heart failure; Type 2 diabetes; Post hoc; Harmony (color); Internal medicine; Diabetes mellitus; Cardiology; Endocrinology","score_opus":0.006089949227595974,"score_gpt":0.20339512858608577,"score_spread":0.1973051793584898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292849656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98407924,0.0005014173,0.000002582383,0.015004529,0.000084552325,0.00021194638,0.000023043318,0.000016117474,0.00007658583],"genre_scores_gemma":[0.9915265,0.000007255712,0.0059778322,0.0021420016,0.000049254468,0.000002342717,0.00007481213,0.00003571051,0.00018429066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826485,0.00031772154,0.00041631542,0.00022987885,0.0004988498,0.00027240178],"domain_scores_gemma":[0.99918693,0.000063886044,0.00018494549,0.00024868906,0.00013448001,0.00018105135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044804363,0.0002006635,0.00060881884,0.0005131119,0.00010100516,0.00004789128,0.000114575465,0.000013640374,0.0004417366],"category_scores_gemma":[0.00004307522,0.000144516,0.00017446511,0.00059404084,0.000041534247,0.00014918816,0.00014350102,0.0003336653,0.000023427165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032176642,0.00033225896,0.9649788,0.000010860588,0.0014110472,0.00011893112,0.00024488263,0.000054393007,0.00018676798,0.0000029911857,0.0317768,0.0005604765],"study_design_scores_gemma":[0.0041707386,0.003054725,0.87009215,0.000044835273,0.001034818,0.0000034525444,0.00032861516,0.00001076684,0.000025563284,0.000004265529,0.12109967,0.00013041485],"about_ca_topic_score_codex":0.000012122579,"about_ca_topic_score_gemma":0.000026400314,"teacher_disagreement_score":0.09488669,"about_ca_system_score_codex":0.00007504853,"about_ca_system_score_gemma":0.000036852834,"threshold_uncertainty_score":0.58931917},"labels":[],"label_agreement":null},{"id":"W4292851343","doi":"10.1002/ejhf.2661","title":"Right ventricular dysfunction predicts outcome after transcatheter mitral valve repair for primary mitral valve regurgitation","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Hazard ratio; Mitral regurgitation; Confidence interval; Heart failure; Mitral valve; Pulmonary artery; Mitral valve repair; Cohort","score_opus":0.009434613298733999,"score_gpt":0.2612910520585984,"score_spread":0.2518564387598644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292851343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989021,0.005203782,0.00047061237,0.003052629,0.0010079745,0.00078949373,0.00014759557,0.0000681462,0.00023877613],"genre_scores_gemma":[0.9941191,0.0000074239097,0.0035997608,0.000962122,0.0006590042,0.00003124166,0.00014345058,0.00006774684,0.00041016858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978209,0.0003800718,0.00063544046,0.0002600259,0.0006030331,0.0003005382],"domain_scores_gemma":[0.9989696,0.000052454998,0.00024410884,0.0002534221,0.00020988856,0.00027051],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0006729968,0.00021741587,0.00042801717,0.00020187044,0.00018778496,0.000029812772,0.000081114435,0.0000290819,0.00028760178],"category_scores_gemma":[0.000041995707,0.00017669855,0.019010533,0.00015642174,0.000033271863,0.00018701736,0.000029866716,0.0003456094,0.000023043915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007881507,0.002032848,0.84956616,0.000566158,0.01949975,0.002546469,0.00090052537,0.00038004166,0.00039854512,0.000024164347,0.114732675,0.0014711533],"study_design_scores_gemma":[0.006731645,0.002508705,0.8332949,0.00009006904,0.00716778,0.0013132925,0.00017159099,0.000009244615,0.000032709544,0.000029314931,0.14846633,0.00018436108],"about_ca_topic_score_codex":0.0000013080437,"about_ca_topic_score_gemma":2.0329466e-7,"teacher_disagreement_score":0.033733655,"about_ca_system_score_codex":0.00022548232,"about_ca_system_score_gemma":0.000098364006,"threshold_uncertainty_score":0.99081385},"labels":[],"label_agreement":null},{"id":"W4293546866","doi":"10.1002/ejhf.2664","title":"Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Vifor Pharma; Schweizerische Herzstiftung; Ministerio de Economía y Competitividad; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Deutsche Forschungsgemeinschaft; Servier; University of Glasgow; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Novo Nordisk; Teva Pharmaceutical Industries; Boston Scientific Corporation; Fresenius Medical Care North America; European Society of Cardiology; Idorsia Pharmaceuticals; Cytokinetics; Sanofi; Abbott Diagnostics; Universitair Medisch Centrum Groningen; AstraZeneca; Eli Lilly and Company; Amgen; National Science Foundation","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Biomarker; Perspective (graphical)","score_opus":0.05264471447929605,"score_gpt":0.3001561854832855,"score_spread":0.24751147100398943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293546866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025146396,0.88731825,0.00007030769,0.10891566,0.00048579552,0.002569486,0.000075257725,0.000043525455,0.0002702443],"genre_scores_gemma":[0.0141560435,0.9560362,0.023637442,0.00366514,0.0015927936,0.0000619869,0.00027742764,0.00044826284,0.00012467135],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9836068,0.011072834,0.0027149883,0.0006827709,0.0013109609,0.0006116474],"domain_scores_gemma":[0.99399614,0.0014802151,0.0028113516,0.0010800126,0.00043617218,0.00019612063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010026547,0.0007635835,0.003524025,0.00033008787,0.00032015523,0.00005805327,0.00072104076,0.00018488165,0.0002583902],"category_scores_gemma":[0.0013083372,0.00047848708,0.0034481355,0.0017477659,0.00024895457,0.0001330846,0.00040118373,0.0019899632,0.000025164682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089393034,0.00028176638,0.01860614,0.008355393,0.004527578,0.00019605974,0.0005237763,0.000029557556,0.00025890706,0.00003153084,0.9467156,0.02038433],"study_design_scores_gemma":[0.0016869336,0.000314171,0.0070421356,0.04463844,0.0031430363,0.00038289154,0.00090322806,0.0000062524487,0.0000021539113,0.0000045836287,0.94154614,0.0003300501],"about_ca_topic_score_codex":0.00008006012,"about_ca_topic_score_gemma":0.000048302827,"teacher_disagreement_score":0.10525052,"about_ca_system_score_codex":0.0010856898,"about_ca_system_score_gemma":0.000627994,"threshold_uncertainty_score":0.9997667},"labels":[],"label_agreement":null},{"id":"W4294991228","doi":"10.1002/ejhf.2675","title":"Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Heart failure; Surrogate endpoint; Biomarker; Intensive care medicine; Biomarker discovery; Valsartan; Endpoint Determination; Randomized controlled trial; Clinical study design; Internal medicine; Bioinformatics","score_opus":0.10546694690379814,"score_gpt":0.3619022255974795,"score_spread":0.2564352786936813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294991228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032823064,0.86891174,0.00001897704,0.12503962,0.0013630654,0.003834113,0.00014445354,0.000025085916,0.0003347059],"genre_scores_gemma":[0.0026023393,0.986112,0.00704185,0.0020294178,0.0017019461,0.000026825457,0.00009991303,0.00022841406,0.00015730652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.94532305,0.045332745,0.006394123,0.0006876706,0.0016374053,0.000624997],"domain_scores_gemma":[0.987329,0.0042533516,0.006225882,0.0016762367,0.00030165713,0.00021384865],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.04783006,0.0008015036,0.006403414,0.00024202283,0.00025544682,0.00004106589,0.0013615448,0.00029132783,0.00025865238],"category_scores_gemma":[0.003934124,0.0003992477,0.008476891,0.0017399932,0.00046259168,0.000114578055,0.00089092896,0.0028165465,0.000021473912],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001019724,0.0002059979,0.017313479,0.004490397,0.006043009,0.000036265625,0.00015712153,0.0000031382376,0.000056923407,0.0000074655977,0.93194,0.039644238],"study_design_scores_gemma":[0.0023084432,0.0004244658,0.0074869245,0.041956615,0.0059880773,0.00019688913,0.000445955,0.0000010348615,0.0000032049343,0.0000045438574,0.94091284,0.00027100416],"about_ca_topic_score_codex":0.000049930884,"about_ca_topic_score_gemma":0.000058093443,"teacher_disagreement_score":0.1230102,"about_ca_system_score_codex":0.000418177,"about_ca_system_score_gemma":0.0007134693,"threshold_uncertainty_score":0.9998459},"labels":[],"label_agreement":null},{"id":"W4294992557","doi":"10.1002/ejhf.2670","title":"Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université Laval; Population Health Research Institute; Hamilton Health Sciences; University of Toronto; St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Eli Lilly and Company","keywords":"Medicine; Post-hoc analysis; Heart failure; Randomized controlled trial; Internal medicine; Cardiology; Post hoc","score_opus":0.006023277513529365,"score_gpt":0.205660668129868,"score_spread":0.19963739061633862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294992557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693585,0.00234605,0.00001921564,0.026731009,0.00008557449,0.0013832861,0.00003799948,0.000016675034,0.000021688704],"genre_scores_gemma":[0.9928393,0.000039338553,0.005552763,0.0012456364,0.00013231036,0.00001662714,0.000039266986,0.000049037404,0.00008572341],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99590224,0.0017841752,0.0007080716,0.00042179454,0.00085317873,0.0003305643],"domain_scores_gemma":[0.99865925,0.0002605962,0.00024223053,0.00046177604,0.00013592222,0.00024022462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002619726,0.00034532128,0.0018194789,0.00039429442,0.0002653992,0.00014030184,0.00012586522,0.000033034506,0.000092645925],"category_scores_gemma":[0.0001750916,0.00020288736,0.000587427,0.00042913517,0.00019358192,0.00020454398,0.00022900874,0.0005503571,0.000002831139],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122622065,0.00032819906,0.85320944,0.000025109437,0.009832083,0.00011323794,0.0009420907,0.000085106505,0.000037093272,0.000008816278,0.0123370895,0.00045964893],"study_design_scores_gemma":[0.4715169,0.0025864088,0.4172217,0.000093423114,0.005658072,0.000057230423,0.0010825861,0.000017833792,0.000005238434,0.000009774174,0.10152514,0.00022570191],"about_ca_topic_score_codex":0.000071268616,"about_ca_topic_score_gemma":0.00007441876,"teacher_disagreement_score":0.43598777,"about_ca_system_score_codex":0.000048695816,"about_ca_system_score_gemma":0.000053072825,"threshold_uncertainty_score":0.8273506},"labels":[],"label_agreement":null},{"id":"W4295758924","doi":"10.1002/ejhf.2689","title":"Multi‐biomarker approach to predict survival and adverse cardiovascular events among patients with heart failure with preserved ejection fraction","year":2022,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"European Society of Cardiology","keywords":"Medicine; Library science; Gerontology; Computer science","score_opus":0.01579800266555798,"score_gpt":0.2145768749592339,"score_spread":0.1987788722936759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295758924","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4759356,0.000613799,0.006022531,0.5028995,0.0016492177,0.01080341,0.00018692661,0.00037395902,0.0015150536],"genre_scores_gemma":[0.5397949,0.000116729454,0.35703146,0.07717623,0.009809531,0.00035645458,0.0036637152,0.0019912098,0.0100597525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942489,0.0015389824,0.0007493626,0.0007917583,0.0020728447,0.00059812656],"domain_scores_gemma":[0.9977919,0.00005663854,0.0004400322,0.0008010803,0.00048146688,0.00042889765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014100573,0.00069941854,0.0012930026,0.0006575619,0.000304801,0.00007567165,0.0002172053,0.0001927494,0.00019048636],"category_scores_gemma":[0.000066980894,0.0004948886,0.00056756666,0.00045550047,0.00009471349,0.00046978533,0.0001940776,0.0022905793,0.000035139758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095993414,0.00038842778,0.25749964,0.00029504157,0.00262955,0.00063131785,0.00007612773,0.00020460151,0.000013245648,9.0793044e-8,0.73722076,0.00008123563],"study_design_scores_gemma":[0.005760106,0.002146871,0.3013654,0.000432414,0.0013901754,0.00023597243,0.00028373415,0.000019316358,0.0000034001002,1.2411333e-7,0.6880294,0.00033304986],"about_ca_topic_score_codex":0.00005457588,"about_ca_topic_score_gemma":0.000016080403,"teacher_disagreement_score":0.42572328,"about_ca_system_score_codex":0.00030236234,"about_ca_system_score_gemma":0.00012792545,"threshold_uncertainty_score":0.99975026},"labels":[],"label_agreement":null},{"id":"W4296163197","doi":"10.1002/ejhf.2695","title":"Characteristics and Clinical Outcomes of Patients with Acute Heart Failure with a Supranormal Left Ventricular Ejection Fraction","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Novartis Pharma","keywords":"Ejection fraction; Medicine; Cardiology; Heart failure; Internal medicine; Stroke volume","score_opus":0.009252004143010572,"score_gpt":0.2504833766885399,"score_spread":0.24123137254552934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296163197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988389,0.000024604335,0.0002944442,0.010644951,0.00018150444,0.0003957557,0.00002060078,0.000021238857,0.00002786814],"genre_scores_gemma":[0.98357207,0.000015946569,0.015625142,0.00036939108,0.00014990757,0.000002034006,0.00004779481,0.000043450567,0.00017426201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772054,0.0004876974,0.000677149,0.00021559736,0.00067443325,0.00022460954],"domain_scores_gemma":[0.9987712,0.00007718552,0.00045345994,0.00022492724,0.0002677264,0.00020549637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000838853,0.00019851541,0.00063479826,0.0002020497,0.00018946725,0.000036978297,0.000072827635,0.000028878292,0.00028226577],"category_scores_gemma":[0.00004912309,0.00013965367,0.00018566503,0.0001770085,0.00007780607,0.00024519896,0.00007795495,0.0005917829,0.000011269945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010912771,0.00065335754,0.9657908,0.00003262201,0.00078069605,0.00059474737,0.00006243165,0.0000060750913,0.000045026387,0.0000026777132,0.030631268,0.00030899292],"study_design_scores_gemma":[0.003911448,0.0051546423,0.6741993,0.00005528793,0.00066609995,0.0006930644,0.00019860514,0.000004563047,0.000017577595,4.963494e-7,0.31499928,0.000099655335],"about_ca_topic_score_codex":0.000008008177,"about_ca_topic_score_gemma":0.000009810266,"teacher_disagreement_score":0.29159155,"about_ca_system_score_codex":0.00006621771,"about_ca_system_score_gemma":0.000084780004,"threshold_uncertainty_score":0.56949115},"labels":[],"label_agreement":null},{"id":"W4297198936","doi":"10.1002/ejhf.2697","title":"Iron repletion in heart failure: a central chemoreceptor reflex tonic?","year":2022,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Toronto General Hospital; University of Toronto; University Health Network; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Heart failure; Reflex; Chemoreceptor; Tonic (physiology); Cardiology; Internal medicine; Receptor","score_opus":0.016414484503258973,"score_gpt":0.2541099366829141,"score_spread":0.23769545217965513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297198936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071532293,0.0005648889,0.00001307025,0.989317,0.001057205,0.00089068786,0.00002291698,0.000082721286,0.00089826615],"genre_scores_gemma":[0.027339665,0.00034148165,0.096493915,0.831444,0.022581862,0.00005352336,0.0013180793,0.00085174927,0.019575682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938454,0.0013676722,0.0015739397,0.0006988698,0.0014460814,0.001068034],"domain_scores_gemma":[0.9978726,0.00009706295,0.0006464331,0.0008456816,0.00018076066,0.00035749178],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018121599,0.0006977598,0.0014310587,0.0008843248,0.0001648831,0.000111213456,0.00039037678,0.00027101996,0.0061646723],"category_scores_gemma":[0.00015202459,0.00060442695,0.00086592877,0.0005175444,0.0001055822,0.00024736632,0.00023767866,0.004924887,0.00043001125],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003885957,0.00022990839,0.0011846743,0.00029364388,0.00018213382,0.007950303,0.0002845418,0.000009023438,0.00085227174,0.000005487234,0.98807895,0.0005404739],"study_design_scores_gemma":[0.0037362839,0.002360928,0.002185499,0.00069771137,0.00033277567,0.0025516113,0.00024132806,0.000003224327,0.00015518702,0.000005607797,0.98727113,0.00045873006],"about_ca_topic_score_codex":0.000023595478,"about_ca_topic_score_gemma":0.000018527626,"teacher_disagreement_score":0.15787297,"about_ca_system_score_codex":0.00090629514,"about_ca_system_score_gemma":0.00038093756,"threshold_uncertainty_score":0.9996407},"labels":[],"label_agreement":null},{"id":"W4301401104","doi":"10.1002/ejhf.2708","title":"Association of Time-to-Intravenous Furosemide with Mortality in Acute Heart Failure: Data from REPORT-HF","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Impulse Dynamics; Novo Nordisk; Sanofi; Cytokinetics; National University of Singapore; Boston Scientific Corporation; AstraZeneca","keywords":"Medicine; Heart failure; Furosemide; Ejection fraction; Internal medicine; Cardiology","score_opus":0.019658369868128137,"score_gpt":0.26617472861674557,"score_spread":0.24651635874861744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301401104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88507104,0.00012412146,0.0001936426,0.11303167,0.00021460808,0.0006743878,0.0001907705,0.000043351858,0.0004564049],"genre_scores_gemma":[0.9363895,0.000016158203,0.057159793,0.001480733,0.0004908851,0.000007993007,0.00049653044,0.00010904318,0.003849348],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962054,0.000764146,0.0010631483,0.00041585558,0.0011518862,0.00039957592],"domain_scores_gemma":[0.99780995,0.0001267862,0.0006399142,0.0009434605,0.00019504422,0.00028484498],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032780045,0.0002398544,0.00077529775,0.00028962942,0.000110475106,0.000037608403,0.00035072956,0.00003348478,0.0015232663],"category_scores_gemma":[0.0002518095,0.00019908363,0.00014754839,0.00048603886,0.000031890497,0.00022931724,0.00036613696,0.00066283107,0.00017326049],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005144895,0.0005985546,0.16772033,0.00002646779,0.0009986082,0.007439289,0.0003631691,0.00021575806,0.011239942,0.0000021899773,0.81064403,0.00023719012],"study_design_scores_gemma":[0.0028747984,0.0018051906,0.15677623,0.00017176747,0.00067361497,0.001379074,0.00031113595,0.00003941214,0.0004974696,0.000006739682,0.8352726,0.00019192022],"about_ca_topic_score_codex":0.00010196945,"about_ca_topic_score_gemma":0.00014088482,"teacher_disagreement_score":0.111550935,"about_ca_system_score_codex":0.00031566212,"about_ca_system_score_gemma":0.0002568717,"threshold_uncertainty_score":0.99938947},"labels":[],"label_agreement":null},{"id":"W4304620075","doi":"10.1002/ejhf.2713","title":"Reply to the Letter Regarding the Article ‘Clinical Implications of Left Atrial Changes After Optimization of Medical Therapy in Patients with Heart Failure’","year":2022,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Universitair Medisch Centrum Groningen; Rijksuniversiteit Groningen; Università degli Studi di Brescia; Brigham and Women's Hospital","keywords":"Medicine; Heart failure; Cardiology; Medical therapy; Internal medicine; Intensive care medicine","score_opus":0.0183263227598016,"score_gpt":0.2639686109766712,"score_spread":0.2456422882168696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304620075","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07658558,0.00019122289,0.00046431404,0.92160654,0.0005307075,0.0005832211,0.000017842183,0.000008420847,0.0000121195435],"genre_scores_gemma":[0.24187273,0.00022069128,0.0029550977,0.7448949,0.009653217,0.0000091992615,0.000066111104,0.00016018527,0.00016783143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951275,0.0018671304,0.0010116997,0.0002565284,0.0015088203,0.00022832434],"domain_scores_gemma":[0.9980288,0.0002569496,0.00048750185,0.00071510195,0.00039109358,0.00012053664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035377631,0.00020873095,0.00071159174,0.00023776974,0.000092175935,0.000029303566,0.0003300099,0.00012354742,0.0008013685],"category_scores_gemma":[0.00039894023,0.00010353474,0.00074182847,0.00033178367,0.00018177016,0.000059448543,0.00011135648,0.0022012794,0.000008262233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008851492,0.00006506859,0.12183768,0.000018357767,0.00033169234,0.000042050036,0.00026956637,0.00068714615,0.0000067583082,5.67642e-7,0.8754969,0.0003590387],"study_design_scores_gemma":[0.002682074,0.0012488044,0.13092655,0.00021032742,0.00017292179,0.00016814414,0.00007474746,0.0000055150144,0.000013073471,4.7124763e-7,0.8644016,0.00009576387],"about_ca_topic_score_codex":0.000011641154,"about_ca_topic_score_gemma":0.000013788213,"teacher_disagreement_score":0.17671163,"about_ca_system_score_codex":0.000049958697,"about_ca_system_score_gemma":0.00016746523,"threshold_uncertainty_score":0.95635855},"labels":[],"label_agreement":null},{"id":"W4304775502","doi":"10.1002/ejhf.2719","title":"Reply to the letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a <scp>post‐hoc</scp> analysis from the <scp>REWIND</scp> randomized trial’","year":2022,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Heart failure; Medicine; Library science; Population; Gerontology; Cardiovascular health; Internal medicine; Computer science; Environmental health","score_opus":0.009190821161131641,"score_gpt":0.2147468423170082,"score_spread":0.20555602115587654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304775502","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43700215,0.0016485216,0.00006045487,0.55806994,0.00017000765,0.002948898,0.00004178273,0.000033344575,0.000024901621],"genre_scores_gemma":[0.30456826,0.00017256786,0.01322295,0.6756035,0.0040189456,0.00023499122,0.00018193907,0.00042751318,0.0015692934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886117,0.005747137,0.0015643968,0.0010728089,0.002049095,0.0009548928],"domain_scores_gemma":[0.9942089,0.0027418812,0.0006193313,0.0017132821,0.0003358976,0.0003807467],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0071842964,0.0009767764,0.0034048234,0.000663413,0.0007642026,0.0006517952,0.0004986181,0.0001863996,0.000050380026],"category_scores_gemma":[0.001731377,0.00046227395,0.0014956284,0.0009939277,0.00045079357,0.00032795066,0.0005665353,0.0031875707,0.000026180893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005025866,0.000093412156,0.09765994,0.00004581114,0.009042342,0.00033658423,0.002325989,0.00007701321,0.000015590098,0.0000019290203,0.8852771,0.000098414515],"study_design_scores_gemma":[0.13499056,0.0011165799,0.047309387,0.0002549268,0.0074160434,0.00018420057,0.0014515358,0.000012127713,0.000007900028,0.000006129016,0.80710393,0.00014667022],"about_ca_topic_score_codex":0.00025767164,"about_ca_topic_score_gemma":0.0001723773,"teacher_disagreement_score":0.13243389,"about_ca_system_score_codex":0.00012414965,"about_ca_system_score_gemma":0.00013115017,"threshold_uncertainty_score":0.9997829},"labels":[],"label_agreement":null},{"id":"W4306399353","doi":"10.1002/ejhf.2720","title":"Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Relypsa; National Medical Research Council; Medical Research Council; Respicardia; American Regent; National Institutes of Health; Daiichi Sankyo Europe; Abbott Diagnostics; Bayer; Gilead Sciences; Servier; MyoKardia; Novo Nordisk; Impulse Dynamics; Cytokinetics; Boston Scientific Corporation; Bayer HealthCare; Lantheus Medical Imaging; Patient-Centered Outcomes Research Institute; LivaNova; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Vifor Pharma; Pfizer; Edwards Lifesciences; Amgen; Sanofi; Abbott Laboratories; American Heart Association","keywords":"Medicine; Heart failure; GUCY1A3; Ejection fraction; Cardiology; Guanylate cyclase; Internal medicine; GUCY1B3; Guanylate cyclase 2C; Receptor","score_opus":0.017474774056454926,"score_gpt":0.2781897477173685,"score_spread":0.26071497366091356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306399353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1586999,0.78009504,0.00032500114,0.040797044,0.0033856942,0.015326145,0.00017544664,0.00045851857,0.00073723315],"genre_scores_gemma":[0.050406557,0.9233337,0.01825127,0.0008465782,0.003082612,0.00013263084,0.0005473697,0.0012060923,0.0021931722],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947445,0.0016786745,0.0012136664,0.0005665283,0.0011201844,0.0006764487],"domain_scores_gemma":[0.99742097,0.00016567993,0.001208592,0.0007577542,0.00014676883,0.00030022365],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019603746,0.0007279573,0.0018693714,0.0005011761,0.00050577556,0.00014559246,0.00027264265,0.00011160723,0.0005158526],"category_scores_gemma":[0.00008816163,0.0003958891,0.00061027525,0.0009762814,0.000112003094,0.00036207162,0.00014408954,0.0026865609,0.00015710892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058867456,0.004651646,0.1585172,0.007426154,0.006890222,0.0031607163,0.0013852007,0.0014153481,0.000007464565,0.000014698773,0.62653345,0.18411113],"study_design_scores_gemma":[0.0041901544,0.003436139,0.008124595,0.004333313,0.001701479,0.00046105307,0.00031702657,0.000003905015,0.0000021817875,0.0000015395497,0.97704595,0.00038268595],"about_ca_topic_score_codex":0.000036722853,"about_ca_topic_score_gemma":0.00007732561,"teacher_disagreement_score":0.35051244,"about_ca_system_score_codex":0.0006238013,"about_ca_system_score_gemma":0.00035523798,"threshold_uncertainty_score":0.9998493},"labels":[],"label_agreement":null},{"id":"W4307235023","doi":"10.1002/ejhf.2723","title":"Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Heart and Stroke Foundation; Canadian Heart Research Centre; University of Toronto","funders":"National Center on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; Translational Science Center, Wake Forest University; Indian Health Service; National Center for Research Resources; Centers for Disease Control and Prevention; National Institutes of Health; U.S. Department of Veterans Affairs; Massachusetts Institute of Technology; University of Tennessee, Knoxville; University of Pittsburgh; Harvard Catalyst; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; University of Colorado; National Institute of General Medical Sciences; National Institute of Nursing Research; Massachusetts General Hospital","keywords":"Medicine; Hazard ratio; Internal medicine; Heart failure; Glycated hemoglobin; Type 2 diabetes; Confidence interval; Cardiology; Proportional hazards model; Ejection fraction; Blood pressure; Creatinine; Renal function; Framingham Risk Score; Waist; Diabetes mellitus; Body mass index; Endocrinology; Disease","score_opus":0.013950502021763718,"score_gpt":0.2646590447965689,"score_spread":0.25070854277480514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307235023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97621626,0.014223109,0.00003164626,0.008666902,0.00034395006,0.00041024125,0.00008838531,0.000011636724,0.000007845816],"genre_scores_gemma":[0.99374497,0.0009462938,0.0035299123,0.0008202367,0.0008563865,0.0000022789543,0.00004506998,0.00004257624,0.000012282103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934448,0.0040692487,0.0009859839,0.00029076484,0.00081281044,0.00039639382],"domain_scores_gemma":[0.9980574,0.00019015098,0.00047311134,0.00057129806,0.00016436992,0.0005436591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005201217,0.00020963873,0.0014079239,0.00055860047,0.00026162362,0.000031227068,0.0002055655,0.000038235336,0.0001411738],"category_scores_gemma":[0.00029067963,0.0001432725,0.00079430203,0.0012916233,0.00010431986,0.000112348185,0.000110845525,0.0012402362,0.0000054665684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009879931,0.00038703237,0.92997897,0.000075795615,0.0037891872,0.0001496551,0.004294631,0.006348078,0.00031693772,0.0000037656844,0.0403998,0.0043762056],"study_design_scores_gemma":[0.01992921,0.004273674,0.48753837,0.00007874453,0.001713738,0.00017139471,0.005561408,0.00015971731,0.00003138872,0.0000027208155,0.48035368,0.00018595993],"about_ca_topic_score_codex":0.0005225098,"about_ca_topic_score_gemma":0.00016616752,"teacher_disagreement_score":0.4424406,"about_ca_system_score_codex":0.000091024005,"about_ca_system_score_gemma":0.0005666965,"threshold_uncertainty_score":0.58424824},"labels":[],"label_agreement":null},{"id":"W4308294967","doi":"10.1002/ejhf.2716","title":"Association of Post-Vaccination Adverse Reactions After Influenza Vaccine with Mortality and Cardiopulmonary Outcomes in Patients with High-Risk Cardiovascular Disease: The INVESTED Trial","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network","funders":"Relypsa; American Regent; Seqirus; Idorsia Pharmaceuticals; Duke Clinical Research Institute; Cytokinetics; Astellas Pharma; Deutsche Forschungsgemeinschaft; MyoKardia; Novo Nordisk; Verily Life Sciences; Sarepta Therapeutics; AstraZeneca; Amarin Corporation; LivaNova; Boston Scientific Corporation; Bristol-Myers Squibb; CSL Behring; Biogen; U.S. Department of Veterans Affairs; Alnylam Pharmaceuticals; Belvoir Media Group; Daiichi Sankyo Europe; Gilead Sciences; Sanofi Pasteur; Kowa Company; Sanofi; Amgen; National Heart, Lung, and Blood Institute; Sun Pharma; National Institutes of Health; Regeneron Pharmaceuticals","keywords":"Medicine; Hazard ratio; Vaccination; Adverse effect; Internal medicine; Heart failure; Influenza vaccine; Myocardial infarction; Confidence interval; Immunology","score_opus":0.019415791247417418,"score_gpt":0.27151245895377873,"score_spread":0.2520966677063613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308294967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962225,0.0005420509,0.000003221783,0.002320856,0.00006867605,0.0007343285,0.00008310332,0.000008032437,0.000017233417],"genre_scores_gemma":[0.9993717,0.00003431432,0.00019134842,0.00022592352,0.00008777904,0.000017967675,0.0000099979125,0.00002573187,0.00003520688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626917,0.0015517774,0.0005376863,0.00016323235,0.0012965595,0.0001815962],"domain_scores_gemma":[0.9983424,0.00012003015,0.00043347344,0.00032384088,0.00066434446,0.00011591683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023644858,0.0001475008,0.0004975913,0.00023304572,0.00018454381,0.000012990512,0.00008530622,0.000016259031,0.00003122415],"category_scores_gemma":[0.00068883685,0.000086265136,0.00019385398,0.00032365095,0.00003298532,0.00022400453,0.00010131952,0.00065196445,0.0000013001138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027324922,0.00021755909,0.9680155,0.00004122297,0.0018590239,0.00013738811,0.00030509382,0.0014188708,0.000008196968,0.0000012980346,0.000498433,0.0001725097],"study_design_scores_gemma":[0.03300723,0.0019088963,0.950143,0.00006042344,0.00082061515,0.000013978852,0.0003592438,0.0000042224383,0.0000036490874,0.0000024784945,0.013591772,0.00008449052],"about_ca_topic_score_codex":0.00015983723,"about_ca_topic_score_gemma":0.00004699172,"teacher_disagreement_score":0.017872484,"about_ca_system_score_codex":0.00022521897,"about_ca_system_score_gemma":0.0001341888,"threshold_uncertainty_score":0.351779},"labels":[],"label_agreement":null},{"id":"W4309247748","doi":"10.1002/ejhf.2738","title":"<scp>Health‐related</scp> quality of life outcomes in <scp>PARAGON‐HF</scp>","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Respicardia; Sanofi Pasteur; National Institutes of Health; Servier; Moderna; Sarepta Therapeutics; Alnylam Pharmaceuticals; Cytokinetics; American Regent; Sanofi; MyoKardia; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; AstraZeneca; Eli Lilly and Company; Daiichi-Sankyo; Amgen","keywords":"Medicine; Sacubitril; Valsartan; Sacubitril, Valsartan; Confidence interval; Internal medicine; Odds ratio; Ejection fraction; Quality of life (healthcare); Heart failure; Randomization; Randomized controlled trial; Minimal clinically important difference; Cardiology; Blood pressure","score_opus":0.0243482616257864,"score_gpt":0.27686340822486044,"score_spread":0.25251514659907404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309247748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855358,0.003136635,0.00009490772,0.008105458,0.0011543185,0.00028730865,0.000027686156,0.000042710748,0.001615196],"genre_scores_gemma":[0.99436533,0.00015511455,0.0008410195,0.001680803,0.0002556826,0.0000018438866,0.000015283971,0.00007072973,0.002614159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99329793,0.0028432384,0.0018922627,0.00027659896,0.0012511075,0.00043887616],"domain_scores_gemma":[0.9972359,0.0005891177,0.0009118581,0.00048512052,0.00022219453,0.00055580353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006558609,0.0002612629,0.0013451902,0.00054969365,0.00018537897,0.000023203616,0.00024172604,0.000056563582,0.00024200739],"category_scores_gemma":[0.0027775676,0.0002115958,0.0011149999,0.0005920421,0.000102043225,0.00012730174,0.00015159862,0.0016037989,0.00008989067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068464724,0.0006175252,0.6490647,0.00016261538,0.00082740345,0.000689091,0.0040490045,0.001205768,0.001072573,0.00009346054,0.34123695,0.00091241876],"study_design_scores_gemma":[0.0029166457,0.00061063113,0.5122868,0.00006133025,0.000057513585,0.0008302076,0.0045156074,0.00000615562,0.00007608305,0.000008512498,0.47859907,0.000031454092],"about_ca_topic_score_codex":0.000052871383,"about_ca_topic_score_gemma":0.000013418608,"teacher_disagreement_score":0.13736212,"about_ca_system_score_codex":0.00017100271,"about_ca_system_score_gemma":0.00049851404,"threshold_uncertainty_score":0.86286265},"labels":[],"label_agreement":null},{"id":"W4309514269","doi":"10.1002/ejhf.2746","title":"Incidence and Clinical Correlates of <i>de-novo</i> Aortic Regurgitation with a Fully Magnetically Levitated Left Ventricular Assist Device: A MOMENTUM 3 Trial Portfolio Analysis","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"Abbott Laboratories","keywords":"Medicine; Cardiology; Internal medicine; Regurgitation (circulation); Incidence (geometry); Heart failure","score_opus":0.009515703847255372,"score_gpt":0.23800002820521957,"score_spread":0.2284843243579642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309514269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960528,0.00057877647,0.0025202516,0.00038439326,0.0001696511,0.00019114508,0.000008603461,0.000033955053,0.000060451468],"genre_scores_gemma":[0.9965952,0.000010343528,0.003175379,0.00007500918,0.0000756172,0.0000018796529,0.000007700249,0.0000383056,0.000020565894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684906,0.00079334655,0.0012763327,0.00020553627,0.0006267541,0.00024895027],"domain_scores_gemma":[0.9986117,0.00021083762,0.0004702718,0.00023737832,0.00020616694,0.00026364048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027360255,0.00018008272,0.00060057617,0.00030440587,0.00009019177,0.00005244727,0.00024048715,0.00003636284,0.00044756796],"category_scores_gemma":[0.00021537852,0.00015670847,0.00027202594,0.00070027786,0.00007487619,0.00017629637,0.000072650895,0.00062099507,0.0000070037463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051813433,0.0005386115,0.92592233,0.00025647483,0.0036330079,0.0037351402,0.0005481534,0.050176185,0.002268288,0.00013711689,0.006240747,0.0013625736],"study_design_scores_gemma":[0.037557274,0.011865764,0.8567811,0.00040918315,0.008343077,0.0057324464,0.0015615221,0.0398042,0.00036708513,0.00017945883,0.03611684,0.0012820377],"about_ca_topic_score_codex":0.0000014668998,"about_ca_topic_score_gemma":0.0000050467834,"teacher_disagreement_score":0.06914125,"about_ca_system_score_codex":0.000058645943,"about_ca_system_score_gemma":0.00010327228,"threshold_uncertainty_score":0.63903856},"labels":[],"label_agreement":null},{"id":"W4310558456","doi":"10.1002/ejhf.2749","title":"Normal and Excessive Muscle Sympathetic Nerve Activity in Heart Failure: Implications for Future Trials of Therapeutic Autonomic Modulation","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; University of Guelph; Western University; Sinai Health System; Dalhousie University; Toronto General Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Cardiology; Heart rate; Stroke volume; Blood pressure; Body mass index; Ivabradine; Autonomic nervous system","score_opus":0.028164239330874412,"score_gpt":0.28439986370800746,"score_spread":0.25623562437713304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310558456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.904081,0.00034721819,0.0008332028,0.093792446,0.00016448036,0.00069008523,0.000068413625,0.000011225289,0.000011956682],"genre_scores_gemma":[0.9960356,0.000008182164,0.0032035185,0.0002965767,0.00037606602,0.00001764626,0.000008643379,0.000028167264,0.000025638232],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970252,0.0014132458,0.0009835202,0.00021237774,0.00014903687,0.00021663475],"domain_scores_gemma":[0.9985402,0.00040708503,0.0005316634,0.00025386282,0.00013962865,0.00012752843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048187473,0.0001524059,0.0007567566,0.00023488053,0.00016605314,0.000025601525,0.00010711414,0.00004040651,0.00009598962],"category_scores_gemma":[0.00015959966,0.00013183804,0.00031324074,0.00018694406,0.000058110403,0.00019154423,0.00005534129,0.0004693189,0.0000019288489],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054372265,0.0006061218,0.013508562,0.00013476523,0.00017267538,0.00001316587,0.002103491,0.0031662823,0.94125,0.00043356625,0.003090065,0.03497756],"study_design_scores_gemma":[0.0062533244,0.0016490516,0.69234353,0.000096432836,0.0001959534,0.0003291949,0.0010663157,0.0020338376,0.0023323768,0.00032874156,0.29316542,0.00020583259],"about_ca_topic_score_codex":0.000009178103,"about_ca_topic_score_gemma":0.000008031728,"teacher_disagreement_score":0.93891764,"about_ca_system_score_codex":0.00012517844,"about_ca_system_score_gemma":0.0003366529,"threshold_uncertainty_score":0.5376199},"labels":[],"label_agreement":null},{"id":"W4313488361","doi":"10.1002/ejhf.2760","title":"Biomarker Signature and Pathophysiological Pathways in Patients with Chronic Heart Failure and Metabolic Syndrome","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Metabolic syndrome; Medicine; Heart failure; Internal medicine; Biomarker; Insulin resistance; Endocrinology; Cohort; Body mass index; Leptin; Pathophysiology; Obesity; Biology","score_opus":0.009766611386638773,"score_gpt":0.2066544967728383,"score_spread":0.1968878853861995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313488361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953761,0.0014467906,0.0000114362765,0.002769926,0.00012411506,0.00021331843,0.000009289733,0.000036594254,0.000012447032],"genre_scores_gemma":[0.99860525,0.00016613108,0.0007655068,0.00024702388,0.00012730398,9.48812e-7,0.000015493113,0.00003808592,0.000034265762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983728,0.0003932478,0.00033721593,0.00024813358,0.00038236042,0.00026625072],"domain_scores_gemma":[0.999292,0.00004279349,0.000097634525,0.00018988468,0.000120297744,0.00025735627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066416786,0.00020634364,0.00058989815,0.00031768388,0.000077867124,0.00003474862,0.000053983873,0.00007411871,0.00005135958],"category_scores_gemma":[0.000071333816,0.00012504274,0.0001889347,0.00044345972,0.00010703275,0.00012978827,0.00006437478,0.00061461,0.00003573784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000856977,0.00022310269,0.9278501,0.00016342207,0.0005589116,0.0031598872,0.00032027203,0.00007410768,0.017064404,0.000015825508,0.04571611,0.0039968486],"study_design_scores_gemma":[0.003537078,0.0011484316,0.87968624,0.00021089865,0.00008656988,0.001302962,0.00011020874,0.0000090628755,0.000051181265,0.00000392023,0.113722645,0.00013081123],"about_ca_topic_score_codex":0.0000019309366,"about_ca_topic_score_gemma":0.0000036007507,"teacher_disagreement_score":0.06800653,"about_ca_system_score_codex":0.00002612908,"about_ca_system_score_gemma":0.00006140277,"threshold_uncertainty_score":0.5099095},"labels":[],"label_agreement":null},{"id":"W4313488437","doi":"10.1002/ejhf.2764","title":"Heart Failure Related Central Sympathetic Activation: Debunking the ‘Holy Grail’?","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Holy Grail; Heart failure; Medicine; Library science; Internal medicine; Computer science; World Wide Web","score_opus":0.01128573310163615,"score_gpt":0.22875383679856792,"score_spread":0.21746810369693176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313488437","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058634177,0.0004118261,0.000022576647,0.9388152,0.0013924445,0.00034369543,0.000010353098,0.00010955093,0.0002601882],"genre_scores_gemma":[0.4036658,0.00012074698,0.0017811344,0.5530138,0.03359749,0.0000070955834,0.00023712193,0.00058047293,0.0069963327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954501,0.0015737932,0.0009869998,0.00041182735,0.00075172965,0.0008255919],"domain_scores_gemma":[0.9978512,0.0003637139,0.00062114693,0.00065528037,0.00031669455,0.00019195167],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010474877,0.0005076233,0.0010259761,0.00033529347,0.00037940938,0.00009324862,0.0003409536,0.00040348724,0.00024237107],"category_scores_gemma":[0.0002774268,0.00033443343,0.0011973614,0.0005217419,0.0002384667,0.00015553978,0.00010447542,0.007459905,0.0006477068],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007944226,0.00002042707,0.00015476737,0.00008146442,0.00038441486,0.006741291,0.0003132945,0.000077761935,0.0064644767,0.000008077794,0.9854661,0.0002084351],"study_design_scores_gemma":[0.0010256743,0.00071887946,0.007937945,0.0012285676,0.00039882291,0.017314773,0.00011857462,0.0000061049154,0.00030527334,0.00008001146,0.97055674,0.0003086271],"about_ca_topic_score_codex":0.0000026946382,"about_ca_topic_score_gemma":6.088477e-7,"teacher_disagreement_score":0.3858014,"about_ca_system_score_codex":0.00012998427,"about_ca_system_score_gemma":0.00032617114,"threshold_uncertainty_score":0.9999108},"labels":[],"label_agreement":null},{"id":"W4313488947","doi":"10.1002/ejhf.2763","title":"Efficacy of Omecamtiv Mecarbil in Heart Failure with Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide Level: Insights from the GALACTIC-HF Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Servier; Cytokinetics; British Heart Foundation; Amgen","keywords":"Medicine; Heart failure; Internal medicine; Ejection fraction; Hazard ratio; Cardiology; Natriuretic peptide; Clinical endpoint; Atrial fibrillation; Population; Placebo; Confidence interval; Randomized controlled trial","score_opus":0.03824252262840183,"score_gpt":0.29225826302089936,"score_spread":0.2540157403924975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313488947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581926,0.00007220491,0.00009957966,0.039616115,0.00048703232,0.0013080678,0.0000030607926,0.000061604725,0.0001597269],"genre_scores_gemma":[0.9890778,0.000016160886,0.00911055,0.00028916265,0.0011203048,0.000008873148,0.000018193381,0.000075209435,0.00028376022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967185,0.0007938359,0.0009017857,0.00037617979,0.0008307338,0.00037893577],"domain_scores_gemma":[0.9982155,0.0003765328,0.0003858397,0.00043732146,0.00034114887,0.00024368142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012374972,0.0003182143,0.00071680895,0.0006403715,0.00015382664,0.00007980499,0.00019112394,0.00007315955,0.000079084166],"category_scores_gemma":[0.0005734374,0.00020369979,0.00024257106,0.0013964124,0.00006414182,0.0003265392,0.00008439997,0.0007967304,0.00022569852],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11889048,0.0020595638,0.062119495,0.00028134428,0.0015736739,0.0042667273,0.0065092123,0.0008827874,0.19018514,0.00007248841,0.6080851,0.0050740037],"study_design_scores_gemma":[0.068031795,0.012788381,0.27795747,0.0029388384,0.0010007214,0.00094503566,0.008615017,0.00008273994,0.009428903,0.000037732876,0.61755335,0.00062000443],"about_ca_topic_score_codex":0.000061484396,"about_ca_topic_score_gemma":0.000082714156,"teacher_disagreement_score":0.21583797,"about_ca_system_score_codex":0.00018517773,"about_ca_system_score_gemma":0.000246312,"threshold_uncertainty_score":0.8306637},"labels":[],"label_agreement":null},{"id":"W4316466443","doi":"10.1002/ejhf.2777","title":"Cost-Effectiveness of Immediate Initiation of Dapagliflozin in Patients with a History of Heart Failure","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"AstraZeneca","keywords":"Medicine; Heart failure; Dapagliflozin; Cardiology; Internal medicine; Intensive care medicine; Endocrinology; Diabetes mellitus","score_opus":0.021397369517176905,"score_gpt":0.24334492983541933,"score_spread":0.22194756031824242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316466443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978642,0.00018182283,0.000025157937,0.0008034197,0.00015124584,0.00054174976,0.000010760869,0.000010940001,0.0004107345],"genre_scores_gemma":[0.99835086,0.000014258352,0.0013602017,0.00005102761,0.000042645337,0.0000032820042,0.000034746114,0.000028793836,0.00011421329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821866,0.0004404142,0.00059139275,0.00012704746,0.000446801,0.000175691],"domain_scores_gemma":[0.99883074,0.00010848554,0.00043941586,0.00019341367,0.00034065056,0.00008732193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011186578,0.00014078467,0.0005628522,0.00052279385,0.000010272236,0.0000029865355,0.00008716315,0.000026482452,0.000042686934],"category_scores_gemma":[0.00009843762,0.00010813495,0.00012997993,0.00035186956,0.00010043953,0.00015470252,0.000043346463,0.00017814587,0.000015406278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020105408,0.0010620054,0.91912425,0.0011988615,0.0004120601,0.00011760862,0.0010134653,0.00024086997,0.009620915,0.00006007438,0.063927196,0.0012121247],"study_design_scores_gemma":[0.0085785715,0.0032338037,0.9362574,0.0015186005,0.00018739162,0.000005221437,0.00020286265,0.000008732137,0.0022875722,0.0000066527864,0.047618363,0.00009478064],"about_ca_topic_score_codex":0.0000052438754,"about_ca_topic_score_gemma":0.000004546484,"teacher_disagreement_score":0.017133173,"about_ca_system_score_codex":0.00015018541,"about_ca_system_score_gemma":0.000121589444,"threshold_uncertainty_score":0.44096154},"labels":[],"label_agreement":null},{"id":"W4318475934","doi":"10.1002/ejhf.2786","title":"January 2023 at a Glance: Focus on Acute Heart Failure and Medical Therapy","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; Medical therapy; Focus (optics); Cardiology; Internal medicine","score_opus":0.016515557010756843,"score_gpt":0.2753594878849449,"score_spread":0.25884393087418806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318475934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5277548,0.00090397155,0.000021079773,0.46902335,0.0004150054,0.00046242433,0.000011279812,0.00013574878,0.0012723742],"genre_scores_gemma":[0.96029896,0.0029172425,0.013188581,0.009939771,0.0030279371,0.000015160101,0.000058518126,0.00022040454,0.010333437],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701136,0.00041885732,0.0006131417,0.00034878455,0.0010912471,0.0005166093],"domain_scores_gemma":[0.99847627,0.00017868429,0.0001533453,0.00038044984,0.00012341623,0.000687836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015112405,0.00033173812,0.0006583387,0.00039779276,0.00020149437,0.000056067165,0.00017401733,0.00009050934,0.0007609453],"category_scores_gemma":[0.00013344396,0.0002310047,0.00029938453,0.00044942577,0.00012538198,0.00014291704,0.0001601232,0.0006654037,0.0017175934],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054588256,0.00014838632,0.00797399,0.000030108979,0.0003980627,0.005503298,0.00020787538,0.0000022143433,0.0023534826,0.000044158423,0.97871566,0.0040768613],"study_design_scores_gemma":[0.005315857,0.0026722036,0.029164162,0.00043629584,0.00011377699,0.002606073,0.0001779416,0.000018524504,0.000716353,0.000029719598,0.9585492,0.00019986782],"about_ca_topic_score_codex":0.000004347584,"about_ca_topic_score_gemma":0.000015265845,"teacher_disagreement_score":0.4590836,"about_ca_system_score_codex":0.00007812794,"about_ca_system_score_gemma":0.00011331735,"threshold_uncertainty_score":0.9990597},"labels":[],"label_agreement":null},{"id":"W4321748117","doi":"10.1002/ejhf.2798","title":"Personalized Care of Patients with Heart Failure: Are we Ready for a REWOLUTION? Insights from two International Surveys on Healthcare Professionals' Needs and Patients' Perceptions","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Public Health; Libin Cardiovascular Institute of Alberta; University of Ottawa","funders":"Respicardia; Servier; Novo Nordisk; Gedeon Richter; Nestlé Health Science; Impulse Dynamics; Genome Canada; Government of Canada; Vifor Pharma; Ministero della Salute; Pfizer; LivaNova; Boston Scientific Corporation; Sanofi; Amgen; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Heart failure; Health care; Health professionals; Perception; Personalized medicine; Nursing; Cardiology; Bioinformatics; Psychology","score_opus":0.023969762184123736,"score_gpt":0.30005990477758904,"score_spread":0.2760901425934653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321748117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91380703,0.00017584873,0.0001002702,0.08418129,0.00031473284,0.0009847562,0.00035494036,0.00004703569,0.00003409849],"genre_scores_gemma":[0.9886372,0.000044858276,0.009027361,0.00057290326,0.00034103892,0.000014785568,0.000976806,0.00006302455,0.00032200283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973333,0.00069886923,0.0006245889,0.0002890286,0.0007840116,0.00027021],"domain_scores_gemma":[0.99767566,0.00016989364,0.00037241483,0.00025605064,0.0012453473,0.0002806158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046245498,0.00027136703,0.00055025157,0.0005557224,0.00021573843,0.000034276236,0.00012254775,0.0000539809,0.000084827014],"category_scores_gemma":[0.00010915046,0.00019027991,0.00018818793,0.00034942248,0.0000977373,0.00017027467,0.00007270651,0.00033228443,0.000037054102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015428019,0.00081489433,0.72696,0.0002613956,0.0004559426,0.00003194656,0.0066799633,0.000019246352,0.00016214851,0.00019945504,0.26116624,0.0017059437],"study_design_scores_gemma":[0.009279869,0.0022709027,0.625766,0.0011833056,0.00014098948,0.0000053322756,0.006092161,0.000010497842,0.000024371295,0.000020139318,0.3550421,0.00016437098],"about_ca_topic_score_codex":0.000023384415,"about_ca_topic_score_gemma":0.00010939681,"teacher_disagreement_score":0.10119407,"about_ca_system_score_codex":0.00012763972,"about_ca_system_score_gemma":0.00011648707,"threshold_uncertainty_score":0.775939},"labels":[],"label_agreement":null},{"id":"W4321748233","doi":"10.1002/ejhf.2806","title":"February 2023 at a Glance: Focus on Pathophysiology and Treatment","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; General surgery; Internal medicine; Surgery","score_opus":0.015349746695785395,"score_gpt":0.24196688403628475,"score_spread":0.22661713734049935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321748233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98710614,0.00056496484,0.0000072366156,0.011233216,0.00038256525,0.00009747437,0.000005795951,0.000033539094,0.0005690579],"genre_scores_gemma":[0.99432915,0.0013044418,0.00031585564,0.00053412083,0.0009116927,8.53172e-7,0.00000925439,0.00003487151,0.0025597767],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990571,0.00024264827,0.0002232542,0.00013450782,0.00018796694,0.00015453619],"domain_scores_gemma":[0.99948436,0.000045933783,0.00007367385,0.00016897092,0.00005103411,0.00017600982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003338098,0.000117094794,0.00033698283,0.000162796,0.000080430764,0.00000931415,0.000029428642,0.00002649134,0.000109078894],"category_scores_gemma":[0.00004080382,0.00007392904,0.0003127556,0.00014998828,0.000040452367,0.000026411433,0.000029174067,0.00017647687,0.00062717026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016323961,0.00018187007,0.06080486,0.000038666756,0.0007678916,0.007507464,0.0006187242,0.00009335409,0.040756796,0.000020252548,0.83717436,0.05040334],"study_design_scores_gemma":[0.0025270125,0.0023609628,0.5363983,0.00007929277,0.000087040964,0.0014155398,0.00014779788,0.000006585446,0.0005432401,0.000011960953,0.45634934,0.00007293141],"about_ca_topic_score_codex":0.000007038654,"about_ca_topic_score_gemma":0.0000051163415,"teacher_disagreement_score":0.47559345,"about_ca_system_score_codex":0.00006113572,"about_ca_system_score_gemma":0.000031333446,"threshold_uncertainty_score":0.80612135},"labels":[],"label_agreement":null},{"id":"W4322616990","doi":"10.1002/ejhf.2817","title":"Sex Differences in Heart Failure: The Evolving use of Biomarkers","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Gerontology; Library science; Medicine; Computer science","score_opus":0.040666176013210764,"score_gpt":0.2550843334589616,"score_spread":0.21441815744575082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322616990","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015130907,0.0004363044,0.000028450875,0.98297876,0.0005531841,0.00067278324,0.000019018787,0.000053235657,0.00012735899],"genre_scores_gemma":[0.2979198,0.00077369175,0.10152344,0.5487702,0.017500391,0.000043347696,0.0003088048,0.0012853534,0.03187499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497205,0.001451228,0.00140725,0.00040558423,0.0011275071,0.0006363659],"domain_scores_gemma":[0.9975353,0.0006844529,0.00062149845,0.0007185719,0.00026795085,0.00017223868],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019174963,0.0005370074,0.001365332,0.00090643996,0.00011254806,0.0001452625,0.00040678118,0.0002138469,0.00028359838],"category_scores_gemma":[0.00039599775,0.0003311499,0.00068859034,0.00066659093,0.00023155028,0.0002529947,0.0001956247,0.002391656,0.00021637527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000618856,0.00007603444,0.022699201,0.00025115392,0.00061927777,0.003136244,0.0003043471,0.0000031871302,0.00036013618,0.0000020508903,0.9721884,0.0002980653],"study_design_scores_gemma":[0.0013235646,0.0007220435,0.02685051,0.0018924362,0.0003714042,0.0005300165,0.00037892145,0.0000158595,0.00007994947,0.000007684864,0.9675674,0.00026025422],"about_ca_topic_score_codex":0.000063684005,"about_ca_topic_score_gemma":0.00004774846,"teacher_disagreement_score":0.4342086,"about_ca_system_score_codex":0.00012468062,"about_ca_system_score_gemma":0.00021098887,"threshold_uncertainty_score":0.99991405},"labels":[],"label_agreement":null},{"id":"W4323533220","doi":"10.1002/ejhf.2797","title":"Transcatheter Mitral Valve Replacement or Repair for Secondary Mitral Regurgitation: A Propensity Score-Matched Analysis","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; First Nations Health and Social Secretariat of Manitoba; Surgical Specialties (Canada); St. Paul's Hospital; Montreal Heart Institute","funders":"Abbott Vascular; JenaValve; CryoLife; Boston Scientific Corporation; Edwards Lifesciences; Deutsche Herzstiftung; Abbott Laboratories","keywords":"Medicine; Mitral regurgitation; Cardiology; Propensity score matching; Internal medicine; Functional mitral regurgitation; Heart failure; Mitral valve repair; Mitral valve; Mitral valve replacement; Ejection fraction","score_opus":0.03807088767442647,"score_gpt":0.31598137678715416,"score_spread":0.2779104891127277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323533220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926978,0.000496938,0.00021892191,0.0053721103,0.0002086103,0.00063256174,0.000078927886,0.00009182694,0.00020231755],"genre_scores_gemma":[0.99173445,0.00002341018,0.0056800046,0.0005070669,0.00036107632,0.00000936012,0.00011893415,0.000050114617,0.0015155703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980962,0.00025559994,0.00063989084,0.00028940634,0.00040312813,0.00031572045],"domain_scores_gemma":[0.99865043,0.000081299775,0.00023039145,0.00034997083,0.0003606116,0.00032726806],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00094038376,0.00021143751,0.0006793092,0.00033919717,0.00012565171,0.00004794497,0.00008476029,0.000032239863,0.0002713143],"category_scores_gemma":[0.00009930525,0.00014578336,0.013510982,0.00061160617,0.00004732055,0.00015225029,0.0000233158,0.00021175545,0.00007248147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013715243,0.00085093605,0.58279127,0.0005420427,0.08124254,0.0011882003,0.0024743888,0.00020593048,0.00071892893,0.000014794335,0.31402037,0.0022353753],"study_design_scores_gemma":[0.006644473,0.0023982967,0.93112975,0.00020189521,0.01625443,0.00028739375,0.00045328794,0.00004278632,0.000114354545,0.000013885542,0.042266876,0.00019256235],"about_ca_topic_score_codex":0.0000033620518,"about_ca_topic_score_gemma":0.0000047447616,"teacher_disagreement_score":0.3483385,"about_ca_system_score_codex":0.00006989842,"about_ca_system_score_gemma":0.00020305658,"threshold_uncertainty_score":0.99636847},"labels":[],"label_agreement":null},{"id":"W4324021049","doi":"10.1002/ejhf.2819","title":"Autonomic and Respiratory Consequences of Altered Chemoreflex Function: Clinical and Therapeutic Implications in Cardiovascular Diseases","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Cardiorespiratory fitness; Medicine; Baroreflex; Ventilation (architecture); Heart failure; Respiratory system; Autonomic function; Intensive care medicine; Chemoreceptor; Cardiology; Internal medicine; Heart rate variability; Heart rate; Blood pressure; Receptor","score_opus":0.11140351682748756,"score_gpt":0.3666081424933197,"score_spread":0.25520462566583213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324021049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004228793,0.9931254,0.000015874948,0.0019269611,0.00015672408,0.00047243168,0.000031956453,0.000016028958,0.000025877524],"genre_scores_gemma":[0.015579482,0.9829064,0.00032730383,0.00028732765,0.00078332453,0.000007749888,0.000007085926,0.000062405226,0.00003892095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962852,0.0014663266,0.0016458706,0.00030432706,0.00013515096,0.00016312777],"domain_scores_gemma":[0.9983888,0.00045731218,0.0004297536,0.0003991951,0.000103896346,0.00022098777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030821888,0.0002239858,0.0022761233,0.00025706593,0.000046795576,0.000026191443,0.00010407374,0.000096654556,0.000021374453],"category_scores_gemma":[0.00025173684,0.00016639824,0.00075605005,0.00018690937,0.00044202208,0.000054501263,0.000057900295,0.0006500786,0.000015699708],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000650189,0.00013177135,0.0039465106,0.0055599506,0.0020403825,0.0001233711,0.00006674909,0.0000050140507,0.00012283806,0.00010323967,0.0011296776,0.9867055],"study_design_scores_gemma":[0.000993093,0.00038647256,0.035797738,0.004114404,0.0018016868,0.00036542318,0.000030566163,0.0000021660123,8.925843e-7,0.000042166812,0.95634407,0.00012130873],"about_ca_topic_score_codex":0.00000284569,"about_ca_topic_score_gemma":0.0000013983228,"teacher_disagreement_score":0.9865842,"about_ca_system_score_codex":0.000041545354,"about_ca_system_score_gemma":0.000957197,"threshold_uncertainty_score":0.6785523},"labels":[],"label_agreement":null},{"id":"W4324128716","doi":"10.1002/ejhf.2820","title":"Impact of Mitral Regurgitation in Patients with Acute Heart Failure: Insights from the RELAX-AHF-2 Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Novartis","keywords":"Medicine; Heart failure; Hazard ratio; Internal medicine; Ejection fraction; Cardiology; Confidence interval; Mitral regurgitation; Natriuretic peptide; Tolvaptan","score_opus":0.01619525609354331,"score_gpt":0.2931004188694085,"score_spread":0.2769051627758652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324128716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867418,0.00038502438,0.000020111398,0.0119573595,0.00020216875,0.00056029315,0.000017649163,0.000024338211,0.00009127527],"genre_scores_gemma":[0.99759376,0.00005830028,0.0016711233,0.00013381887,0.0003433519,0.000002121732,0.00004589742,0.00005590806,0.00009570542],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99625796,0.00094851607,0.00084610796,0.00022475068,0.0013299012,0.00039274775],"domain_scores_gemma":[0.9978944,0.0005818454,0.0003182417,0.0004046167,0.00043500584,0.00036590276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011075322,0.00020518083,0.00055993604,0.00035521874,0.00007182443,0.00003223347,0.0002723119,0.000085140564,0.000115420466],"category_scores_gemma":[0.0015606052,0.000110294495,0.00037773463,0.0009823283,0.00017786172,0.0002668742,0.00007609659,0.0014049252,0.00014004511],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09935338,0.0013517839,0.28037584,0.00006897508,0.002201357,0.0025175738,0.003733391,0.0001686806,0.008269659,0.0000310321,0.59790486,0.004023496],"study_design_scores_gemma":[0.06508836,0.008435599,0.9098116,0.0033641094,0.00018267393,0.00006826008,0.00018586109,0.000025246627,0.00019898242,0.00005308756,0.012439155,0.00014707209],"about_ca_topic_score_codex":0.000031412572,"about_ca_topic_score_gemma":0.00001890014,"teacher_disagreement_score":0.6294358,"about_ca_system_score_codex":0.00012371596,"about_ca_system_score_gemma":0.0005305019,"threshold_uncertainty_score":0.6103779},"labels":[],"label_agreement":null},{"id":"W4324309252","doi":"10.1002/ejhf.2825","title":"Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors and Angiotensin Receptor–Neprilysin Inhibitors for Heart Failure in Black Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; McMaster University; University of Ottawa","funders":"Amarin Corporation; CSL Behring; Cleveland Clinic; Brigham and Women's Hospital; Belvoir Media Group; Sanofi; AstraZeneca; Daiichi Sankyo Europe; Duke Clinical Research Institute; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Neprilysin; Heart failure; Randomized controlled trial; Pharmacology; Internal medicine; Angiotensin receptor; Renin–angiotensin system; Angiotensin II; Receptor; Cardiology; Enzyme; Blood pressure; Biochemistry","score_opus":0.05451158367022625,"score_gpt":0.3254639968441411,"score_spread":0.2709524131739149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324309252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000414001,0.9680025,0.00002631344,0.010107231,0.00010860243,0.021168409,0.00014631671,0.000022221411,0.0000044245226],"genre_scores_gemma":[0.0007338153,0.9903283,0.007541866,0.0003217306,0.00017837055,0.00023416517,0.00022820038,0.00018120675,0.0002523069],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9772915,0.009473322,0.011259654,0.0006125438,0.000940268,0.00042271608],"domain_scores_gemma":[0.9863868,0.005104153,0.00663234,0.0006584912,0.00087643287,0.00034181916],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.02695595,0.0010000101,0.056225203,0.002489402,0.000052556275,0.000056220437,0.0001915642,0.00021770186,0.00010133438],"category_scores_gemma":[0.006702862,0.0005390229,0.016242152,0.0014674218,0.000281521,0.00015099022,0.00008018069,0.0005654858,0.000012594813],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009510773,0.00064997916,0.000030967265,0.49820858,0.42416763,0.00006943779,0.00037567655,0.0000031890968,0.000011876264,0.000014307101,0.06654393,0.0004136556],"study_design_scores_gemma":[0.084449135,0.0005098609,0.000009039818,0.08883562,0.71539485,0.000022424207,0.000060682574,0.0000026839427,0.000005485559,0.000001504997,0.110420965,0.0002877457],"about_ca_topic_score_codex":0.000010088163,"about_ca_topic_score_gemma":0.000016061376,"teacher_disagreement_score":0.40937296,"about_ca_system_score_codex":0.000080434686,"about_ca_system_score_gemma":0.00019936208,"threshold_uncertainty_score":0.99970615},"labels":[],"label_agreement":null},{"id":"W4324309768","doi":"10.1002/ejhf.2824","title":"Left Ventricular Wall Thickness and Severity of Cardiac Disease in Women and Men with Transthyretin Amyloidosis","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Scuola Superiore Sant'Anna","keywords":"Medicine; Cardiology; Cardiac amyloidosis; Internal medicine; Interventricular septum; Transthyretin; Heart failure; Body surface area; Amyloidosis; Ventricle","score_opus":0.004917829521170566,"score_gpt":0.21161067771952055,"score_spread":0.20669284819835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324309768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935822,0.0024521537,0.000008283162,0.003741317,0.000022827566,0.00013321888,0.000024760111,0.000006163858,0.000029100393],"genre_scores_gemma":[0.9979514,0.0013022627,0.00047315014,0.00011090315,0.000050159597,0.000003260053,0.000009656453,0.000029671082,0.000069521084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872,0.00036624074,0.00029264114,0.00021028085,0.0001835055,0.00022734063],"domain_scores_gemma":[0.9993869,0.000029771263,0.00013339613,0.00017148575,0.00006812369,0.00021033961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061495346,0.00016380294,0.0003124109,0.00010771817,0.00004427899,0.000021716643,0.00010638391,0.00003594684,0.000009646847],"category_scores_gemma":[0.00005105977,0.00012710298,0.00008615894,0.00012999814,0.000104376784,0.000012813636,0.00006447198,0.00013273947,0.000002823091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050804537,0.00011285303,0.97132885,0.0001047454,0.0002487849,0.00035229296,0.00093770167,0.00009058084,0.01953582,0.0000038334315,0.0057688234,0.0010076505],"study_design_scores_gemma":[0.0014667095,0.0005514777,0.9530168,0.000120093646,0.0000722414,0.000081730446,0.00053153816,0.0000074870763,0.0043768426,0.0000093595845,0.039581805,0.00018388362],"about_ca_topic_score_codex":0.000006567547,"about_ca_topic_score_gemma":0.0000044143835,"teacher_disagreement_score":0.03381298,"about_ca_system_score_codex":0.000018202874,"about_ca_system_score_gemma":0.000053254644,"threshold_uncertainty_score":0.5183109},"labels":[],"label_agreement":null},{"id":"W4327601575","doi":"10.1002/ejhf.2828","title":"Patient-Reported Outcome Measures and Patient Engagement in Heart Failure Clinical Trials: Multi-Stakeholder Perspectives","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clinical trial; Reimbursement; Quality of life (healthcare); Patient-reported outcome; Standardization; Consistency (knowledge bases); MEDLINE; Intensive care medicine; Health care; Nursing","score_opus":0.4410554282562671,"score_gpt":0.44988683385607636,"score_spread":0.008831405599809272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327601575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017221752,0.9724273,0.000053143507,0.020266699,0.00097156677,0.0043178285,0.000035824036,0.00013821457,0.00006724425],"genre_scores_gemma":[0.0025039073,0.95925283,0.035565518,0.00059591566,0.0010327329,0.00006207114,0.000051559833,0.0004055619,0.0005299137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97901183,0.011131428,0.0069820443,0.00094681425,0.0012037943,0.00072408933],"domain_scores_gemma":[0.99447316,0.0011411669,0.002420461,0.0007968311,0.00044221382,0.0007261537],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015927276,0.0009900469,0.006137529,0.0012939711,0.00017063583,0.00016071991,0.00022651198,0.00027575358,0.00015654971],"category_scores_gemma":[0.0050851507,0.000665817,0.002223073,0.0006683031,0.00018752512,0.00021103784,0.00033089588,0.0026876077,0.00023559312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028980448,0.0021196753,0.005847356,0.0050998377,0.0045342874,0.0080871405,0.0027830016,0.000005174762,0.0000066916004,0.000021479782,0.42814216,0.5430634],"study_design_scores_gemma":[0.0042591775,0.0019348704,0.0015833612,0.012656323,0.002868676,0.0009559727,0.0038318643,0.0000019663903,8.617405e-7,0.0000017520841,0.9714037,0.0005014531],"about_ca_topic_score_codex":0.00001171426,"about_ca_topic_score_gemma":0.000037502214,"teacher_disagreement_score":0.5432615,"about_ca_system_score_codex":0.00030969418,"about_ca_system_score_gemma":0.00046514886,"threshold_uncertainty_score":0.9996132},"labels":[],"label_agreement":null},{"id":"W4361190273","doi":"10.1002/ejhf.2831","title":"Health Status Across Major Subgroups of Patients with Heart Failure and Preserved Ejection Fraction","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Heart failure; Atrial fibrillation; Ejection fraction; Diabetes mellitus; Cardiology; Body mass index","score_opus":0.011239045207023471,"score_gpt":0.2540013552978048,"score_spread":0.24276231009078136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361190273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930339,0.00020457612,0.00026438254,0.005851905,0.00028284875,0.00026813525,0.000025755784,0.000047998405,0.000020490344],"genre_scores_gemma":[0.9975006,0.000098766606,0.0017402122,0.00019079327,0.00025070092,7.283722e-7,0.000042898315,0.000048786256,0.00012653184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979536,0.0004266911,0.0005085662,0.00019105362,0.0006026536,0.00031741234],"domain_scores_gemma":[0.9986771,0.000042136562,0.00032119936,0.00023456682,0.00039883086,0.0003262149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010853404,0.00016121121,0.0005214568,0.00021945214,0.00016156296,0.000035782934,0.00004484256,0.000042435575,0.00005232177],"category_scores_gemma":[0.000106341446,0.000114268514,0.00023988559,0.00042964017,0.00007155789,0.00024523528,0.000039195947,0.00046848028,0.000030294133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065952446,0.00009803389,0.9281997,0.00013166158,0.00019354413,0.000021324257,0.00022398158,0.000048027927,0.00061320123,9.3943834e-7,0.06925764,0.0005524258],"study_design_scores_gemma":[0.002958363,0.0013144551,0.7322292,0.00016928941,0.000054115902,0.00009963224,0.00096308335,0.000006544292,0.00018276362,8.95674e-7,0.26194635,0.00007532027],"about_ca_topic_score_codex":0.00004884795,"about_ca_topic_score_gemma":0.00004809355,"teacher_disagreement_score":0.19597052,"about_ca_system_score_codex":0.00007041709,"about_ca_system_score_gemma":0.00010091674,"threshold_uncertainty_score":0.46597347},"labels":[],"label_agreement":null},{"id":"W4361271891","doi":"10.1002/ejhf.2834","title":"March 2023 at a Glance: Pathophysiology, Medical Therapy and Devices","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; General surgery; Internal medicine; Surgery","score_opus":0.018672265185925668,"score_gpt":0.23934064769866328,"score_spread":0.22066838251273763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361271891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992836,0.002303956,0.000039682505,0.0040074736,0.00037266238,0.000065256165,0.000006801322,0.000114465736,0.00025370935],"genre_scores_gemma":[0.9976378,0.00038737713,0.00080422283,0.00055757764,0.0004888145,9.985908e-7,0.000004850543,0.00005103371,0.00006731824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857086,0.000270137,0.00039460248,0.00013135481,0.00037414336,0.0002589054],"domain_scores_gemma":[0.9993371,0.00012000184,0.00006612447,0.00015371159,0.000048128426,0.00027495346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012091653,0.00013881373,0.00027686133,0.000115623174,0.00006634345,0.000025290217,0.00023454467,0.000052022264,0.000697295],"category_scores_gemma":[0.00006782979,0.00010820466,0.00008973513,0.00022366556,0.00005213067,0.00010310567,0.00008553077,0.00039912263,0.0006045022],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012918515,0.000049146154,0.030707836,0.00035205815,0.00035385447,0.004786334,0.00049383636,0.0006187211,0.06672056,0.000100519,0.87043047,0.025257472],"study_design_scores_gemma":[0.00094734295,0.00021669616,0.13188659,0.00016171906,0.000012142195,0.00062597485,0.00012364703,0.0016838532,0.00035573775,0.000116391486,0.86363727,0.00023260697],"about_ca_topic_score_codex":4.6270557e-7,"about_ca_topic_score_gemma":0.0000048923976,"teacher_disagreement_score":0.10117876,"about_ca_system_score_codex":0.000016461405,"about_ca_system_score_gemma":0.000022637765,"threshold_uncertainty_score":0.77698547},"labels":[],"label_agreement":null},{"id":"W4361272285","doi":"10.1002/ejhf.2836","title":"Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Echocardiographic Substudy","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Merck KGaA; Bayer","keywords":"Ejection fraction; Medicine; Heart failure; Cardiology; Internal medicine; Ventricular function","score_opus":0.0042809561335021415,"score_gpt":0.21074590812709618,"score_spread":0.20646495199359405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361272285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945752,0.00006185508,0.000022676286,0.0043111327,0.00021829392,0.00075137237,0.0000024549363,0.000032812542,0.000024202911],"genre_scores_gemma":[0.9992658,0.000012915722,0.00034870414,0.00008604201,0.00020414994,0.0000027075957,0.000017568667,0.000040364605,0.000021776228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978784,0.00066799496,0.00035017324,0.00023387883,0.00064334855,0.00022623161],"domain_scores_gemma":[0.9991432,0.000099763005,0.00020524813,0.0002722882,0.00016972159,0.000109771936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088146084,0.00024298242,0.00047359025,0.0004942866,0.00012680634,0.000033983488,0.000060766542,0.000044994915,0.00003114533],"category_scores_gemma":[0.000041482832,0.0001268048,0.00012636333,0.00085670914,0.000059940223,0.0001665398,0.000023835022,0.0004902891,0.000015065959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003852372,0.00014828074,0.969455,0.00009922056,0.0004339738,0.00017866185,0.000144038,0.00033605497,0.0007851146,0.0000026811617,0.02406381,0.0005007739],"study_design_scores_gemma":[0.0064673293,0.013769353,0.91471285,0.00041547383,0.00045436271,0.0001257409,0.00020734507,0.0000068506365,0.0009667443,0.0000021641472,0.06275139,0.00012039051],"about_ca_topic_score_codex":0.000005348748,"about_ca_topic_score_gemma":0.000009750562,"teacher_disagreement_score":0.05474216,"about_ca_system_score_codex":0.00006764039,"about_ca_system_score_gemma":0.000031692456,"threshold_uncertainty_score":0.51709497},"labels":[],"label_agreement":null},{"id":"W4361280886","doi":"10.1002/ejhf.2827","title":"Deep Phenotype Characterization of Hypertensive Response to Exercise: Implications on Functional Capacity and Prognosis Across the Heart Failure Spectrum","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Interquartile range; Cardiology; Heart failure; Internal medicine; Hazard ratio; Ejection fraction; Heart failure with preserved ejection fraction; Confidence interval; Blood pressure; Workload","score_opus":0.02045708842975069,"score_gpt":0.24747542653134966,"score_spread":0.22701833810159897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361280886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9123299,0.00005833253,0.00023222754,0.08686503,0.00014860182,0.00030759754,0.00002368456,0.000023580464,0.000011014135],"genre_scores_gemma":[0.9979261,0.000042064443,0.00059632363,0.00092641904,0.00039852387,0.0000062441873,0.000021652191,0.00003283791,0.000049845214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854267,0.00038243318,0.00036387314,0.00019715332,0.00028391145,0.00022998168],"domain_scores_gemma":[0.9989056,0.00011392559,0.00012884206,0.00030949016,0.00037356585,0.00016859944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010791391,0.00014208163,0.00046461826,0.00015420195,0.0001901457,0.000025152807,0.00008900987,0.000037651644,0.000029905286],"category_scores_gemma":[0.00022975291,0.00009750437,0.00026290753,0.00045869153,0.00010750357,0.000078671364,0.000066793735,0.00027877084,0.000104251696],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062326654,0.00012134489,0.0032571787,0.00005589373,0.00023686874,0.000042077307,0.0018063008,0.0002537963,0.9355081,0.000031410644,0.050660167,0.0017942502],"study_design_scores_gemma":[0.00084938057,0.00069220434,0.93654835,0.00018040057,0.00013141111,0.0006864819,0.0004607201,0.000018459925,0.009648201,0.000020706333,0.05066602,0.00009763466],"about_ca_topic_score_codex":0.0000026582568,"about_ca_topic_score_gemma":0.0000031842824,"teacher_disagreement_score":0.9332912,"about_ca_system_score_codex":0.00002686593,"about_ca_system_score_gemma":0.000055996636,"threshold_uncertainty_score":0.3976113},"labels":[],"label_agreement":null},{"id":"W4361285176","doi":"10.1002/ejhf.2839","title":"Inferior Vena Cava Monitoring in Heart Failure: Don't Wait Until the Last Drop Makes the Cup Run Over","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; University hospital; General surgery; Surgery","score_opus":0.014121125834253302,"score_gpt":0.26831131403054737,"score_spread":0.2541901881962941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361285176","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029652117,0.0024748994,0.000020926398,0.22360574,0.74140435,0.0020282974,0.00007224935,0.00025031622,0.0004911022],"genre_scores_gemma":[0.045634665,0.0008677966,0.0035447935,0.00067494233,0.941357,0.000042031763,0.00009236393,0.0006364738,0.007149941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935416,0.0012526443,0.0015224485,0.0005767366,0.002134593,0.00097196933],"domain_scores_gemma":[0.99628603,0.0011676012,0.00062832964,0.0010889702,0.000457817,0.00037122105],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038596923,0.00081233267,0.0013403753,0.0005756032,0.00040416687,0.00038944118,0.00077672006,0.00030828413,0.00023569698],"category_scores_gemma":[0.0011654042,0.00045943615,0.0007980329,0.00083306484,0.0002385237,0.00028104841,0.0004115495,0.0038818724,0.00083457486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019913392,0.00013615085,0.0063587353,0.00017372491,0.00044056994,0.0015876769,0.0006618376,0.00002816397,0.0003687363,0.0000073318456,0.9895793,0.00045862125],"study_design_scores_gemma":[0.0029540393,0.0007645707,0.013805181,0.0022017984,0.0005090068,0.00016168015,0.000997069,0.000005188813,0.00007108762,0.0000073762667,0.97814006,0.0003829636],"about_ca_topic_score_codex":0.00011740563,"about_ca_topic_score_gemma":0.00031720838,"teacher_disagreement_score":0.2229308,"about_ca_system_score_codex":0.00036453718,"about_ca_system_score_gemma":0.0006380646,"threshold_uncertainty_score":0.9999434},"labels":[],"label_agreement":null},{"id":"W4362522178","doi":"10.1002/ejhf.2847","title":"The Heart Failure Association Endorses the 25in25 Initiative","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Ministero della Salute","keywords":"Medicine; Library science","score_opus":0.020889847152879823,"score_gpt":0.2634808942297788,"score_spread":0.24259104707689894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362522178","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3036747,0.0029995015,0.00005537462,0.6857795,0.0017186727,0.0005057191,0.000025957255,0.00013839819,0.005102144],"genre_scores_gemma":[0.9930107,0.0003554696,0.0004856158,0.0023443538,0.0020082707,0.000003493695,0.0000039141287,0.0000400303,0.0017481489],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975067,0.00091556803,0.00047483924,0.00013008504,0.0006339733,0.0003388551],"domain_scores_gemma":[0.99801135,0.0008467658,0.00030674835,0.00024625537,0.00048247664,0.00010638355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034590934,0.00016184592,0.00036708772,0.00010162012,0.00065153127,0.00010137569,0.00016909433,0.000033578803,0.000028524835],"category_scores_gemma":[0.0014271723,0.00008299789,0.0003955883,0.0004608919,0.000112667236,0.00012813917,0.0001104321,0.00070273405,0.00040786914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000815452,0.000018853385,0.011292874,0.000011502379,0.00029324117,0.00018057592,0.0014027045,0.000011838545,0.001822073,0.00006779033,0.98412716,0.0006898204],"study_design_scores_gemma":[0.0008191168,0.000309358,0.098616324,0.00012788363,0.00014880915,0.00062607025,0.006039804,0.0000029570142,0.0005922222,0.000040750085,0.89259684,0.00007986498],"about_ca_topic_score_codex":0.0000019666263,"about_ca_topic_score_gemma":0.000010566465,"teacher_disagreement_score":0.689336,"about_ca_system_score_codex":0.00008412744,"about_ca_system_score_gemma":0.000106365325,"threshold_uncertainty_score":0.5242469},"labels":[],"label_agreement":null},{"id":"W4362601024","doi":"10.1002/ejhf.2835","title":"9 March 2023, 25in25 Summit: Reducing Heart Failure Mortality by 25% in the Next 25 Years","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hogan; Summit; Medicine; Heart failure; Incidence (geometry); Epidemiology; Population; Demography; Gerontology; Internal medicine; Environmental health; History; Geography; Cartography; Sociology","score_opus":0.0279272668639104,"score_gpt":0.29525852873295505,"score_spread":0.26733126186904466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362601024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9259524,0.00050790724,0.000013934789,0.07167135,0.0007971677,0.0002674066,0.00001643854,0.00003323274,0.0007401765],"genre_scores_gemma":[0.9964053,0.00008663969,0.0010157807,0.0007831494,0.0012475328,0.0000019262607,0.00003902497,0.00004748139,0.00037314536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704736,0.0009344664,0.00062458223,0.00023120013,0.0007764801,0.0003858861],"domain_scores_gemma":[0.9989576,0.00017034175,0.00016618983,0.00037811807,0.00014110288,0.00018665747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035596045,0.00017767525,0.00040644524,0.00023781467,0.00011977657,0.00010415213,0.00021793185,0.000057449037,0.0000992171],"category_scores_gemma":[0.0002948685,0.00012719729,0.00033331692,0.000838479,0.00009978006,0.00022064967,0.00006678739,0.0009667406,0.00045466193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057358888,0.000058455385,0.040572014,0.000052833115,0.000063663545,0.00072450825,0.00081235566,0.000054189477,0.01109654,0.000011338573,0.94579977,0.00069696206],"study_design_scores_gemma":[0.0009204219,0.00013529295,0.4536714,0.00027234553,0.000053196385,0.00013537852,0.0026855927,0.000020257829,0.00007159032,0.0000132716195,0.54191905,0.000102224985],"about_ca_topic_score_codex":0.000036883608,"about_ca_topic_score_gemma":0.000037218342,"teacher_disagreement_score":0.41309938,"about_ca_system_score_codex":0.000053382973,"about_ca_system_score_gemma":0.00012248104,"threshold_uncertainty_score":0.5843911},"labels":[],"label_agreement":null},{"id":"W4366082787","doi":"10.1002/ejhf.2856","title":"Impact of Multimorbidity on Mortality in Heart Failure with Reduced Ejection Fraction: Which Comorbidities Matter Most? An Analysis of PARADIGM-HF and ATMOSPHERE","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Relypsa; Regeneron Pharmaceuticals; National Institutes of Health; MyoKardia; Novo Nordisk; Daiichi Sankyo Europe; Gilead Sciences; Servier; University of Glasgow; British Heart Foundation; Cytokinetics; Ironwood Pharmaceuticals, Incorporated; Respicardia; Celladon Corporation; Sanofi Pasteur; Boston Scientific Corporation; Alnylam Pharmaceuticals; Sanofi; Amgen; National Heart, Lung, and Blood Institute; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Heart failure; Medicine; Ejection fraction; Cardiology; Internal medicine; Atmosphere (unit); Comorbidity","score_opus":0.027649140538342255,"score_gpt":0.3096238264444668,"score_spread":0.2819746859061245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366082787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917627,0.000031672993,0.00003318648,0.0076243794,0.000059121376,0.00030142866,0.000021509646,0.000027802891,0.00013822161],"genre_scores_gemma":[0.9964161,0.000032279895,0.0031646823,0.000095755815,0.00011828251,0.0000026258783,0.000053552838,0.000037265127,0.00007946656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976557,0.00054107176,0.00072825985,0.0002851391,0.0005186676,0.0002711461],"domain_scores_gemma":[0.9986266,0.00008581963,0.00038094568,0.0004254224,0.00026105842,0.00022014443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010174938,0.0002638679,0.00092321925,0.0003885495,0.000069113026,0.00003237846,0.00008338961,0.000059618826,0.0004680913],"category_scores_gemma":[0.000049449685,0.00018833896,0.00026720675,0.0015003935,0.000094272145,0.00032049534,0.000033086166,0.00040697047,0.000029255223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006063696,0.00044789969,0.948976,0.000090144735,0.0015182473,0.00017565733,0.00036188916,0.0035436086,0.0029727104,0.000007237064,0.041198585,0.000101656864],"study_design_scores_gemma":[0.0020191437,0.0028227142,0.9853354,0.000296956,0.0009858251,0.00010202151,0.0009188809,0.00061648246,0.00054999714,0.000004242877,0.0061976775,0.00015064089],"about_ca_topic_score_codex":0.00034523266,"about_ca_topic_score_gemma":0.00042536252,"teacher_disagreement_score":0.036359422,"about_ca_system_score_codex":0.00011219284,"about_ca_system_score_gemma":0.00010775832,"threshold_uncertainty_score":0.768024},"labels":[],"label_agreement":null},{"id":"W4366083577","doi":"10.1002/ejhf.2857","title":"Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Renal function; Hazard ratio; Kidney disease; Heart failure; Internal medicine; Ejection fraction; Dialysis; Confidence interval; Cardiology; Creatinine; Urology; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.018506397207437398,"score_gpt":0.24613449219936187,"score_spread":0.22762809499192446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366083577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9003678,0.00094192737,0.0000023824991,0.09732695,0.0005789431,0.0005363231,0.000063446736,0.000018193523,0.00016406627],"genre_scores_gemma":[0.99646986,0.0001598889,0.00037955673,0.0016083556,0.0009526407,0.0000045991465,0.000038197883,0.000042498967,0.00034440818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975856,0.0006247392,0.0007428292,0.00021652758,0.00053825823,0.00029205746],"domain_scores_gemma":[0.99857044,0.00022156561,0.00029736606,0.0004827576,0.00012449421,0.00030337193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012706004,0.00021738741,0.0006473523,0.00014031363,0.00012395672,0.000053533196,0.00024135956,0.000047239675,0.00009133275],"category_scores_gemma":[0.000452212,0.000119337405,0.00031723635,0.00051645975,0.00015612706,0.00016734927,0.00021364247,0.00041553573,0.000031982057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047991453,0.00021867981,0.078857504,0.000092031434,0.00094657944,0.000068719906,0.0028294604,0.0000615582,0.0054414123,0.000116753195,0.90613663,0.0004315289],"study_design_scores_gemma":[0.021913702,0.0020827865,0.34403834,0.0007599448,0.00040428212,0.000011192169,0.0024977594,0.00001419109,0.001756782,0.00008018287,0.62629825,0.0001425861],"about_ca_topic_score_codex":0.0000480125,"about_ca_topic_score_gemma":0.000047150515,"teacher_disagreement_score":0.27983835,"about_ca_system_score_codex":0.000025823543,"about_ca_system_score_gemma":0.00013092914,"threshold_uncertainty_score":0.48664382},"labels":[],"label_agreement":null},{"id":"W4366462719","doi":"10.1002/ejhf.2855","title":"Detecting the Undetected","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hogan; Heart failure; Medicine; Library science; History; Cardiology; Archaeology","score_opus":0.022184308766604974,"score_gpt":0.2685570678325595,"score_spread":0.24637275906595452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366462719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96921825,0.0005146701,0.000023391334,0.028295446,0.00026500775,0.00012792925,0.000002014177,0.00009308113,0.0014601822],"genre_scores_gemma":[0.9975899,0.000015990061,0.0007061777,0.00043516757,0.00060598,5.2490077e-7,4.7442597e-7,0.00003282188,0.00061298197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879456,0.00026033405,0.0003222291,0.000091234484,0.000314234,0.00021740535],"domain_scores_gemma":[0.9992185,0.00015510034,0.000078545985,0.00019203211,0.00021492262,0.0001408788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088652415,0.0001011641,0.0002025682,0.00014222725,0.00019686605,0.000026274669,0.000100091595,0.000011808061,0.00008531368],"category_scores_gemma":[0.0005155816,0.000060768227,0.00019887144,0.0004896235,0.00007169793,0.00005836906,0.000084331936,0.00039240773,0.00062338315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007499936,0.00013087616,0.034591783,0.00021193267,0.00084794604,0.0067424444,0.0033236898,0.00003116712,0.08510155,0.000022308457,0.772319,0.09592729],"study_design_scores_gemma":[0.0017560641,0.0009146667,0.34045798,0.00032408026,0.0002252018,0.0030775508,0.003449849,0.000116463976,0.0016672862,0.000043906068,0.6478037,0.00016321993],"about_ca_topic_score_codex":8.57374e-7,"about_ca_topic_score_gemma":0.000004583575,"teacher_disagreement_score":0.30586618,"about_ca_system_score_codex":0.000023001789,"about_ca_system_score_gemma":0.000063100495,"threshold_uncertainty_score":0.80125374},"labels":[],"label_agreement":null},{"id":"W4367047896","doi":"10.1002/ejhf.2848","title":"Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Nesiritide; Natriuretic peptide; Internal medicine; Management of heart failure; Cardiology; Intensive care medicine; Brain natriuretic peptide; Neprilysin","score_opus":0.016070343033351465,"score_gpt":0.2515523487717235,"score_spread":0.23548200573837202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367047896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.661575,0.0015851887,0.00004350064,0.33390266,0.00024201527,0.0022861785,0.00023672571,0.000058920185,0.000069776455],"genre_scores_gemma":[0.96473795,0.0009068105,0.031537846,0.0018757108,0.00040150588,0.000043094227,0.000081113365,0.00013028872,0.00028565363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99061096,0.0031839926,0.0022581776,0.0008846512,0.0020967145,0.0009655026],"domain_scores_gemma":[0.9954401,0.0009160253,0.0013455091,0.0013039148,0.00070472446,0.0002896756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008268315,0.0007456823,0.0018241841,0.00022741502,0.00058399106,0.00017365132,0.0007474681,0.00020533659,0.00006715286],"category_scores_gemma":[0.00018544028,0.00046708403,0.0018630568,0.0019189352,0.0012524184,0.00037856618,0.0007911462,0.0013067145,0.000029327053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007767836,0.0002978825,0.13844174,0.00065968704,0.0014147547,0.000014414935,0.008738781,0.00022075264,0.015134867,0.000016958016,0.8348111,0.00017141094],"study_design_scores_gemma":[0.0038294976,0.00088174833,0.1931391,0.0014743923,0.0010020972,0.000094038456,0.051594198,0.00010626038,0.0011333431,0.00004594388,0.7463294,0.00036993623],"about_ca_topic_score_codex":0.00020241407,"about_ca_topic_score_gemma":0.00013949616,"teacher_disagreement_score":0.33202696,"about_ca_system_score_codex":0.00023098345,"about_ca_system_score_gemma":0.00022471785,"threshold_uncertainty_score":0.9997781},"labels":[],"label_agreement":null},{"id":"W4367174564","doi":"10.1002/ejhf.2866","title":"April 2023 at a Glance: Focus on Diagnosis and Comorbidities","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; General surgery; Internal medicine; Surgery","score_opus":0.017594406660001585,"score_gpt":0.2511935644275297,"score_spread":0.23359915776752813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367174564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554899,0.0009715895,5.7115466e-7,0.04116406,0.00039734694,0.00008116716,0.000014426414,0.00003819205,0.0018427835],"genre_scores_gemma":[0.9944671,0.000770491,0.00035875614,0.00058806397,0.0010919047,9.822995e-7,0.0000041794597,0.00002720198,0.0026913455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990593,0.00012133742,0.00025874027,0.0001162906,0.00026351877,0.0001808114],"domain_scores_gemma":[0.9994354,0.000097514516,0.00009667543,0.00013011169,0.0000715859,0.00016871007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033474437,0.0001178344,0.0003119407,0.00011781542,0.00011369553,0.000024350316,0.000049844486,0.00002204594,0.0001877241],"category_scores_gemma":[0.00007347478,0.00007678714,0.0002121918,0.00015325994,0.0000783191,0.000044739718,0.00007701949,0.0002346021,0.00021573668],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020346725,0.000015267191,0.047944497,0.000058626316,0.000099709876,0.0017385007,0.00026470138,0.000009654332,0.001585791,0.000040181894,0.944232,0.003807622],"study_design_scores_gemma":[0.0009368214,0.0007697618,0.35973215,0.00025129507,0.0000478233,0.002084467,0.00030434394,0.0000046437813,0.0007837413,0.00003190314,0.63496697,0.00008604053],"about_ca_topic_score_codex":0.000004085087,"about_ca_topic_score_gemma":0.0000035445375,"teacher_disagreement_score":0.31178766,"about_ca_system_score_codex":0.000029900506,"about_ca_system_score_gemma":0.000018193543,"threshold_uncertainty_score":0.3131289},"labels":[],"label_agreement":null},{"id":"W4367183877","doi":"10.1002/ejhf.2874","title":"Worsening of Chronic Heart Failure: Definition, Epidemiology, Management and Prevention. A Clinical Consensus Statement by the Heart Failure Association of the European Society of Cardiology","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Abbott Vascular; Servier; Stockholms Läns Landsting; Respicardia; Queen's University; Deutsche Forschungsgemeinschaft; University of Glasgow; Pfizer; Moderna; Idorsia Pharmaceuticals; Karolinska Institutet; Impulse Dynamics; Novo Nordisk; MyoKardia; ReCor Medical; British Heart Foundation; Vetenskapsrådet; Cytokinetics; European Commission; Sanofi; Gedeon Richter; LivaNova; Deutsches Zentrum für Herz-Kreislaufforschung; Queen's University Belfast; Boston Scientific Corporation; Helsinn; Alnylam Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Chugai Pharmaceutical; Vifor Pharma; Ministero della Salute; Abbott Laboratories","keywords":"Medicine; Heart failure; Intensive care medicine; Guideline; Diuretic; Epidemiology; Internal medicine; Pathology","score_opus":0.05207939590835027,"score_gpt":0.321903332460545,"score_spread":0.2698239365521947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367183877","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49362242,0.0020738258,0.0011683702,0.49912825,0.0007152493,0.0022196928,0.00009385528,0.00008593292,0.0008924001],"genre_scores_gemma":[0.96042484,0.00059042935,0.03625497,0.00091329275,0.0005115065,0.0000083919,0.00004089609,0.00007041321,0.0011852622],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906611,0.0056442865,0.0022949902,0.00034991006,0.0005710673,0.00047867096],"domain_scores_gemma":[0.9965536,0.0009040678,0.0014488995,0.0005385488,0.00038904892,0.00016581379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014068018,0.0002923807,0.0011471189,0.00014761779,0.00019700137,0.000012424045,0.0002386274,0.000093572264,0.00004103687],"category_scores_gemma":[0.0005026111,0.00018480519,0.0009235453,0.00048795037,0.00044820172,0.00007451452,0.00031609816,0.00066589186,0.000034094523],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007519909,0.00011803811,0.118248366,0.00025338598,0.0012873997,0.000018578958,0.00019318798,0.00013376644,0.0014483649,0.00013657905,0.877483,0.0006041288],"study_design_scores_gemma":[0.0038228077,0.0013820583,0.1900493,0.0007446598,0.00079855224,0.00019222246,0.0016331539,0.000033671746,0.00025094158,0.0001504449,0.80078703,0.00015517038],"about_ca_topic_score_codex":0.000009104102,"about_ca_topic_score_gemma":0.000015488604,"teacher_disagreement_score":0.49821496,"about_ca_system_score_codex":0.00013808794,"about_ca_system_score_gemma":0.00013714562,"threshold_uncertainty_score":0.75361365},"labels":[],"label_agreement":null},{"id":"W4367317352","doi":"10.1002/ejhf.2873","title":"Hyponatraemia and Changes in Natraemia During Hospitalization for Acute Heart Failure and Associations with In-Hospital and Long-Term Outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Abbott Vascular; Servier; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Gedeon Richter; Bayer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim; Edwards Lifesciences; Amgen; Vifor Pharma; Pfizer; ResMed","keywords":"Medicine; Heart failure; Digoxin; Internal medicine; Ejection fraction; Hazard ratio; Diuretic; Acute decompensated heart failure; Hyponatremia; Cardiology; Renal function; Spironolactone; Tolvaptan; Thiazide; Diabetes mellitus; Confidence interval; Endocrinology","score_opus":0.010082340374236944,"score_gpt":0.2561271677111832,"score_spread":0.24604482733694627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367317352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90008515,0.0014675152,0.000020350511,0.097761765,0.00005440764,0.0005159218,0.000051043437,0.000034875953,0.00000897116],"genre_scores_gemma":[0.9974689,0.0004291753,0.00096528226,0.0006169661,0.00025872883,0.000010608853,0.00008364301,0.00007884682,0.00008785774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808526,0.00018090398,0.0005042996,0.00037899116,0.00039253038,0.00045798917],"domain_scores_gemma":[0.9989076,0.00026498898,0.00025138256,0.00022256935,0.00015284702,0.00020057388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005812357,0.00032213875,0.000629571,0.0002835813,0.0002625791,0.0001607531,0.00013282304,0.00011728286,0.000011830875],"category_scores_gemma":[0.00016751779,0.00023346893,0.00011460331,0.00038123317,0.00014523818,0.00033895948,0.00007713325,0.0007010741,0.0000037310256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018866004,0.000073396994,0.9821324,0.00008919317,0.00023122337,0.0003177339,0.0010273538,0.0000058100786,0.006026444,0.000011752057,0.009701633,0.00019441238],"study_design_scores_gemma":[0.0041994224,0.0009932002,0.99107254,0.0005742306,0.00021762775,0.00042503228,0.00067543803,0.000011946279,0.00030537005,0.00002871878,0.0012405972,0.00025589147],"about_ca_topic_score_codex":0.000017284867,"about_ca_topic_score_gemma":0.0012274354,"teacher_disagreement_score":0.09738374,"about_ca_system_score_codex":0.00007044865,"about_ca_system_score_gemma":0.00009046767,"threshold_uncertainty_score":0.9520587},"labels":[],"label_agreement":null},{"id":"W4376641802","doi":"10.1002/ejhf.2886","title":"Clinical Characteristics of Heart Failure with Reduced Ejection Fraction Patients with Rare Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes: A Subgroup Analysis of the PARADIGM-HF Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Medical Research Council; Wellcome Trust; Novartis Pharma; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK","keywords":"Ejection fraction; Medicine; Heart failure; Dilated cardiomyopathy; Internal medicine; Cardiology; Population; Cardiomyopathy","score_opus":0.016987925940503468,"score_gpt":0.2628577836548706,"score_spread":0.24586985771436715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976376,0.000088504945,0.00005703338,0.0010371783,0.00044213643,0.0005940313,0.0000934422,0.00002657379,0.000023495451],"genre_scores_gemma":[0.9990793,0.00007258535,0.0003405193,0.00005973167,0.00029721402,0.000004324694,0.00007512241,0.00004963224,0.000021598707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953479,0.0016617267,0.0015284125,0.000319523,0.00083321356,0.00030919065],"domain_scores_gemma":[0.9971624,0.00020515632,0.0013051517,0.00045068434,0.000736791,0.00013983015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025273943,0.0002743959,0.0016886677,0.00063635426,0.00012334697,0.0000230149,0.00014737155,0.000112014444,0.000013696115],"category_scores_gemma":[0.00048390764,0.00017299216,0.00081125874,0.0029254626,0.00017931621,0.00015511969,0.00006914601,0.00070316554,0.000005000665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017291684,0.00056778354,0.9718962,0.000056540735,0.0033026785,0.00019870226,0.0004568135,0.00014373903,0.003346965,0.0000014073498,0.0021173153,0.0006202223],"study_design_scores_gemma":[0.020674026,0.0026951032,0.96894765,0.0005912321,0.003355569,0.00007514385,0.00056791434,0.000042799194,0.000103426995,0.0000012049098,0.0027809904,0.00016491802],"about_ca_topic_score_codex":0.00001715068,"about_ca_topic_score_gemma":0.000033613367,"teacher_disagreement_score":0.0033823422,"about_ca_system_score_codex":0.00010500556,"about_ca_system_score_gemma":0.00021511204,"threshold_uncertainty_score":0.7054416},"labels":[],"label_agreement":null},{"id":"W4376642279","doi":"10.1002/ejhf.2882","title":"Sex-Specific Analysis of the Rapid Up-Titration of Guideline-Directed Medical Therapies After a Hospitalization for Acute Heart Failure: Insights from the STRONG-HF Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Pfizer; Vifor Pharma; Cytokinetics; Strong; Servier; Amgen; Novo Nordisk; Sanofi; American Heart Association; Roche Diagnostics; Abbott Vascular; Abbott Laboratories; AstraZeneca","keywords":"Medicine; Heart failure; Hazard ratio; Clinical endpoint; Adverse effect; Randomized controlled trial; Confidence interval; Guideline; Internal medicine; Population","score_opus":0.018922306185206433,"score_gpt":0.28001622373599055,"score_spread":0.26109391755078415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376642279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8492785,0.0010705745,0.0032537682,0.14367352,0.00095298083,0.0015674698,0.000081336126,0.0000773789,0.0000444341],"genre_scores_gemma":[0.9908867,0.00017221546,0.0070419,0.00057464023,0.0008741354,0.000017595636,0.00015987077,0.00004788897,0.00022505665],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644744,0.00077960547,0.0013046289,0.00023848565,0.0010078528,0.0002220031],"domain_scores_gemma":[0.9980228,0.00033984592,0.00048818326,0.00050348305,0.00051611825,0.00012956269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014252976,0.000229633,0.0007573967,0.00033848692,0.0001252366,0.00004264572,0.00025935684,0.00007517248,0.00047304566],"category_scores_gemma":[0.00027093987,0.00012122114,0.00079273747,0.0011995094,0.00013599804,0.00014716618,0.000072680596,0.0002515267,0.000013147615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070928475,0.00035978446,0.0071442937,0.000032595257,0.008397127,0.00005535889,0.0038681244,0.00013059442,0.006726151,0.00015891025,0.96374637,0.0022878426],"study_design_scores_gemma":[0.02145254,0.0019063612,0.05189558,0.00029607562,0.004408195,0.000018216571,0.0017179624,0.0011249408,0.0021934633,0.000043525728,0.91473943,0.00020368255],"about_ca_topic_score_codex":0.000011986691,"about_ca_topic_score_gemma":0.00007467987,"teacher_disagreement_score":0.14309889,"about_ca_system_score_codex":0.000038365793,"about_ca_system_score_gemma":0.00015693565,"threshold_uncertainty_score":0.5179518},"labels":[],"label_agreement":null},{"id":"W4376642939","doi":"10.1002/ejhf.2887","title":"Incremental Prognostic Value of Biomarkers in PARADIGM-HF","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Novartis Pharma; British Heart Foundation","keywords":"Medicine; Cystatin C; Heart failure; Internal medicine; Clinical endpoint; GDF15; Biomarker; Creatinine; Renal function; Natriuretic peptide; Cardiology; Oncology; Clinical trial","score_opus":0.012907032987303804,"score_gpt":0.2507425377246766,"score_spread":0.23783550473737278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376642939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863148,0.00042555455,0.0000068586055,0.011689705,0.0002339116,0.00018400831,0.0000029976138,0.000022911188,0.0011193082],"genre_scores_gemma":[0.9976912,0.0000510397,0.00190692,0.00013526953,0.00010630991,3.6457698e-7,0.0000056866916,0.000030152922,0.0000730362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828744,0.00034422983,0.00064770016,0.00012128766,0.0003582408,0.00024110565],"domain_scores_gemma":[0.9993397,0.00007695452,0.00020979665,0.00014032715,0.00006467846,0.00016853983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014675035,0.00012472294,0.0003185336,0.00048701145,0.000031191998,0.000009659107,0.000114504604,0.000043292635,0.0000655888],"category_scores_gemma":[0.00018459295,0.000092000875,0.00018466321,0.00066537835,0.00009798241,0.00007173614,0.000043391166,0.00034109206,0.00012470546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001474101,0.0004936231,0.5565181,0.00036828453,0.0011529877,0.008722952,0.0010924111,0.00011470213,0.17163251,0.00007338736,0.25387585,0.004481076],"study_design_scores_gemma":[0.0050939084,0.0016972856,0.9236946,0.0016988899,0.000181293,0.0024703944,0.0010801582,0.0001653375,0.0049353153,0.000031120704,0.05877516,0.00017652629],"about_ca_topic_score_codex":0.000005687998,"about_ca_topic_score_gemma":0.0000014320801,"teacher_disagreement_score":0.3671765,"about_ca_system_score_codex":0.000036418063,"about_ca_system_score_gemma":0.00010209263,"threshold_uncertainty_score":0.37516868},"labels":[],"label_agreement":null},{"id":"W4377028403","doi":"10.1002/ejhf.2888","title":"Pre-Discharge and Early Post-Discharge Management of Patients Hospitalized for Acute Heart Failure: A Scientific Statement by the Heart Failure Association of the ESC","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Vifor Pharma; Deutsche Forschungsgemeinschaft; Cytokinetics; Boston Scientific Corporation; AstraZeneca; Servier; European Commission; Pfizer; Amgen","keywords":"Medicine; Heart failure; Decompensation; Hospital discharge; Guideline; Intensive care medicine; Management of heart failure; Cardiac decompensation; Acute decompensated heart failure; Internal medicine; Cardiology","score_opus":0.008394209174348794,"score_gpt":0.2527535101538952,"score_spread":0.2443593009795464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377028403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.856932,0.00015114786,0.00007409805,0.13957193,0.0005231933,0.002437333,0.00023877282,0.000040189556,0.000031319236],"genre_scores_gemma":[0.98480934,0.00004707732,0.009011747,0.00043858192,0.00013942759,0.00004656421,0.00011300659,0.00009787167,0.005296358],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957389,0.00056589895,0.0012859679,0.00042303104,0.001368182,0.0006180014],"domain_scores_gemma":[0.9973734,0.00013383392,0.000880475,0.0006188169,0.00075789454,0.00023560369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003133959,0.000371814,0.0007625287,0.00028752207,0.00042050058,0.0001535368,0.00035369146,0.00006902054,0.0000807473],"category_scores_gemma":[0.0001402573,0.00022375898,0.00056018186,0.0007197495,0.00017786576,0.00034793533,0.00030559776,0.0003641393,0.00004513549],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003309895,0.00043130113,0.09717487,0.00030611418,0.0012926611,0.000008407142,0.0011149965,0.0000048929987,0.0092043085,0.000095292955,0.88982975,0.0002064066],"study_design_scores_gemma":[0.0059505943,0.0017001866,0.25725922,0.0005101542,0.0009571729,0.000014784905,0.00074373424,0.00001686584,0.0023917025,0.000026234238,0.730222,0.00020732824],"about_ca_topic_score_codex":0.000012670634,"about_ca_topic_score_gemma":0.000011195729,"teacher_disagreement_score":0.16008437,"about_ca_system_score_codex":0.00013873453,"about_ca_system_score_gemma":0.00009158227,"threshold_uncertainty_score":0.91246265},"labels":[],"label_agreement":null},{"id":"W4377099139","doi":"10.1002/ejhf.2894","title":"Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Surgical Specialties (Canada)","funders":"European Society of Cardiology","keywords":"Medicine; Heart failure; Heart failure with preserved ejection fraction; Internal medicine; Ejection fraction; Cardiology; Diastolic heart failure; Diastole; Polypharmacy; Intensive care medicine; Blood pressure","score_opus":0.023463377156695022,"score_gpt":0.26151897312641176,"score_spread":0.23805559596971673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377099139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88097435,0.00027181444,0.0005266453,0.11486192,0.00049678,0.0023473946,0.00002968817,0.000046469057,0.0004449599],"genre_scores_gemma":[0.99064404,0.000060104234,0.0077940016,0.00081223977,0.00028712463,0.000006450949,0.0000114889035,0.00009240972,0.0002921603],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9878284,0.007871793,0.001737645,0.00046930686,0.0016065184,0.00048633714],"domain_scores_gemma":[0.99548036,0.0006249098,0.0016489651,0.0008679082,0.0012733185,0.00010452458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01845029,0.00036793234,0.00087298476,0.0001885355,0.0005251126,0.00009002202,0.0003655763,0.000072022754,0.000011478824],"category_scores_gemma":[0.0006340406,0.0001834701,0.0007676058,0.0013875733,0.00031926687,0.00023031422,0.0004829979,0.0008104014,0.000018662975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005776862,0.0002996462,0.26756307,0.00028417166,0.0010751716,0.000011910204,0.004548658,0.0053594187,0.05104378,0.000020630585,0.66753083,0.0016850499],"study_design_scores_gemma":[0.0047367867,0.0008880072,0.62424463,0.001707511,0.0005779547,0.00009365956,0.0067096604,0.00036882615,0.0027968567,0.000032730673,0.3576104,0.00023297711],"about_ca_topic_score_codex":0.000040004124,"about_ca_topic_score_gemma":0.00006950355,"teacher_disagreement_score":0.35668156,"about_ca_system_score_codex":0.00033957665,"about_ca_system_score_gemma":0.00018456354,"threshold_uncertainty_score":0.74816936},"labels":[],"label_agreement":null},{"id":"W4377151421","doi":"10.1002/ejhf.2908","title":"Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Heart failure; Hazard ratio; Heart failure with preserved ejection fraction; Confidence interval; Diastole; Proportional hazards model; Blood pressure","score_opus":0.009785176214119862,"score_gpt":0.2847597923648818,"score_spread":0.27497461615076196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377151421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773884,0.0003686349,0.000002380502,0.0010576615,0.000055707565,0.00058745866,0.00017249509,0.000014560526,0.000002284904],"genre_scores_gemma":[0.9994137,0.00007532197,0.0002375412,0.000028695453,0.00009674204,0.0000044654766,0.000077623845,0.00004164255,0.000024259229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977381,0.00046660242,0.0006499156,0.00035277117,0.00052995153,0.0002626373],"domain_scores_gemma":[0.99811465,0.00008119413,0.00050599,0.00045679024,0.00038331538,0.00045807712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039147638,0.00027633732,0.00073244266,0.0004219812,0.00011038932,0.00006433732,0.00008734559,0.00005362655,0.000025437308],"category_scores_gemma":[0.0002638472,0.00018392717,0.0006484216,0.00078180723,0.00019242612,0.0003278258,0.000079084784,0.00034179594,0.0000011588172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010716874,0.00040226858,0.9949608,0.00039521718,0.0013717343,0.000030448235,0.00009092295,0.00005051204,0.0007443836,2.8594235e-7,0.0008088148,0.00007296705],"study_design_scores_gemma":[0.002351259,0.001407648,0.9901628,0.0010880028,0.00449054,0.000047227313,0.00014322659,0.000081136975,0.00003404368,0.000001941624,0.00004199137,0.00015021066],"about_ca_topic_score_codex":0.000025134214,"about_ca_topic_score_gemma":0.000007097611,"teacher_disagreement_score":0.0047979862,"about_ca_system_score_codex":0.00006255142,"about_ca_system_score_gemma":0.00016049402,"threshold_uncertainty_score":0.7500332},"labels":[],"label_agreement":null},{"id":"W4377824561","doi":"10.1002/ejhf.2918","title":"Acute Heart Failure and Valvular Heart Disease: A Scientific Statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; valvular heart disease; Cardiogenic shock; Internal medicine; Cardiology; Observational study; Intensive care medicine; Randomized controlled trial; Myocardial infarction","score_opus":0.010875316927001888,"score_gpt":0.2750319401146032,"score_spread":0.2641566231876013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377824561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951231,0.011806343,0.00013670987,0.031611934,0.00090830046,0.0024445422,0.0017000401,0.000036399342,0.0001247572],"genre_scores_gemma":[0.9981645,0.0004201693,0.00044942487,0.00013846472,0.00034826665,0.000010758127,0.000072238705,0.000083899744,0.00031232773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896617,0.006417779,0.0013087228,0.00042513467,0.0017410126,0.0004456422],"domain_scores_gemma":[0.9950092,0.0005125345,0.0013339849,0.0010473748,0.0019229109,0.00017403801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010912016,0.000343782,0.0014049566,0.00013132363,0.0006236778,0.000099735225,0.0003798381,0.00008172112,0.0000047793756],"category_scores_gemma":[0.0010026563,0.00019273414,0.008925412,0.00069352635,0.00037167643,0.00014228081,0.00039130353,0.0005182462,0.000004933386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042478237,0.00022742519,0.60139614,0.0012986825,0.070694454,0.000045906818,0.0052491897,0.00389113,0.00639777,0.000050077448,0.30987248,0.00045197594],"study_design_scores_gemma":[0.006715894,0.00042223284,0.7356886,0.00090448087,0.024656806,0.00021809555,0.0037623346,0.000026325184,0.00036640157,0.000043148084,0.22695495,0.00024069105],"about_ca_topic_score_codex":0.000020780843,"about_ca_topic_score_gemma":0.0000070336437,"teacher_disagreement_score":0.13429253,"about_ca_system_score_codex":0.00035086356,"about_ca_system_score_gemma":0.00023567579,"threshold_uncertainty_score":0.90015167},"labels":[],"label_agreement":null},{"id":"W4378640462","doi":"10.1002/ejhf.2920","title":"Safety, Tolerability and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure in Elderly Patients: A Sub-Analysis of the STRONG-HF Randomized Clinical Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Clinical endpoint; Confidence interval; Randomized controlled trial; Heart failure; Tolerability; Internal medicine; Guideline; Clinical trial; Adverse effect","score_opus":0.028561783805928203,"score_gpt":0.3454305386261302,"score_spread":0.316868754820202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378640462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547801,0.00010746782,0.00048859353,0.042501844,0.00029334205,0.0017626917,0.000031373635,0.000020207726,0.00001434851],"genre_scores_gemma":[0.9927441,0.00010976633,0.0066974433,0.00013994834,0.00017394831,0.0000082549,0.000057067882,0.000026158179,0.000043326778],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99282223,0.0024713909,0.0033654666,0.00025934345,0.0008503636,0.00023119619],"domain_scores_gemma":[0.9959758,0.001837791,0.0009391818,0.00038602998,0.0006977651,0.00016341137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010078032,0.00021611444,0.0021137153,0.00046469795,0.000053342195,0.000013282027,0.00018331138,0.00009863716,0.00009983956],"category_scores_gemma":[0.0042269,0.0001290871,0.0012559043,0.00089471776,0.0003064535,0.00010176346,0.00008178574,0.00034849436,0.0000016931126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63137144,0.004235323,0.1354796,0.00034364744,0.021701932,0.00004381974,0.0028280206,0.00025926897,0.002174443,0.00020629616,0.18596254,0.01539364],"study_design_scores_gemma":[0.7630748,0.006327064,0.17176507,0.0006199205,0.009394772,0.000014380191,0.00061477843,0.001639891,0.0005188498,0.000039608694,0.04575555,0.00023532065],"about_ca_topic_score_codex":0.00001824468,"about_ca_topic_score_gemma":0.00013046272,"teacher_disagreement_score":0.140207,"about_ca_system_score_codex":0.00003123945,"about_ca_system_score_gemma":0.00023499166,"threshold_uncertainty_score":0.52640194},"labels":[],"label_agreement":null},{"id":"W4379094715","doi":"10.1002/ejhf.2924","title":"Effect of Phosphodiesterase-5 Inhibition on Systemic Right Ventricular Size and Function. A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial: SERVE","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Universitätsspital Zürich; Inselspital, Universitätsspital Bern","keywords":"Medicine; Double blind; Placebo; Randomized controlled trial; Heart failure; Phosphodiesterase; Internal medicine; Cardiology; Enzyme; Biochemistry; Pathology; Biology","score_opus":0.014035084723253202,"score_gpt":0.27271146753519393,"score_spread":0.2586763828119407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379094715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921907,0.0015262376,0.000008748379,0.0021032128,0.00030646363,0.0036984459,0.0000053750023,0.000033232976,0.00012754572],"genre_scores_gemma":[0.99880755,0.00019433373,0.00009338114,0.00011070089,0.00022984306,0.00003679803,0.000014892063,0.000035242363,0.000477266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958523,0.0021960721,0.0008265149,0.00020868535,0.0006465666,0.00026985657],"domain_scores_gemma":[0.9971165,0.0016756651,0.00041445563,0.000204429,0.00028133774,0.00030760487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038082798,0.00023384497,0.0013408411,0.00033814408,0.000105165695,0.00003342966,0.00005612292,0.000049459384,0.00008554927],"category_scores_gemma":[0.0009212946,0.00013319941,0.00052966824,0.00029800116,0.00007289289,0.000116436204,0.000037967817,0.00035488055,0.00013647992],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97914,0.00028919659,0.00028019655,0.0002233306,0.0007887424,0.011937543,0.00003408921,0.00003380869,0.0015421198,0.0000038230673,0.0055819796,0.00014520372],"study_design_scores_gemma":[0.9840042,0.006849495,0.00023048793,0.0012221594,0.00090004347,0.0023811471,0.000062282204,0.00012228184,0.0026342885,0.0000036826677,0.0014970618,0.00009285528],"about_ca_topic_score_codex":0.00000403083,"about_ca_topic_score_gemma":4.317427e-7,"teacher_disagreement_score":0.009556395,"about_ca_system_score_codex":0.0000443819,"about_ca_system_score_gemma":0.00006295006,"threshold_uncertainty_score":0.5431714},"labels":[],"label_agreement":null},{"id":"W4379508906","doi":"10.1002/ejhf.2922","title":"Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Boehringer Ingelheim España","keywords":"Empagliflozin; Medicine; Ejection fraction; Heart failure; Internal medicine; Placebo; Cardiology; Heart failure with preserved ejection fraction; Gastroenterology; Endocrinology; Diabetes mellitus; Type 2 diabetes; Pathology","score_opus":0.010965859758215665,"score_gpt":0.22200402598814864,"score_spread":0.211038166229933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379508906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445933,0.0006005019,0.000005833779,0.0038475783,0.00013681198,0.0008914694,0.0000016860798,0.000020911793,0.00003590014],"genre_scores_gemma":[0.9987363,0.00006728438,0.0007605115,0.00011329893,0.00013770188,0.000006713111,0.000006295583,0.00003087932,0.00014097814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824345,0.0005174023,0.00036163826,0.00018427706,0.0004991014,0.00019411328],"domain_scores_gemma":[0.9991349,0.00017957742,0.00014622955,0.00029719828,0.0001360083,0.00010610431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009380682,0.00017543107,0.00054822536,0.00022620705,0.00007784065,0.00004430889,0.00007836244,0.00003285342,0.0000125691495],"category_scores_gemma":[0.00020434715,0.000101654165,0.00019184574,0.00028246813,0.00006900975,0.00023921009,0.00009370034,0.0002733247,0.000008498679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023404725,0.00021485722,0.9737298,0.00021682327,0.0008840345,0.00012183223,0.00012746741,0.000032268035,0.00011622409,0.0000019518177,0.021806836,0.0004074265],"study_design_scores_gemma":[0.03303095,0.002808732,0.928902,0.00032798477,0.0004581137,0.000008857172,0.00020548873,0.000011490619,0.00012560409,0.000003259411,0.03402891,0.000088651315],"about_ca_topic_score_codex":0.000016892376,"about_ca_topic_score_gemma":0.00001556225,"teacher_disagreement_score":0.044827852,"about_ca_system_score_codex":0.000026872138,"about_ca_system_score_gemma":0.000022522454,"threshold_uncertainty_score":0.41453364},"labels":[],"label_agreement":null},{"id":"W4380729889","doi":"10.1002/ejhf.2928","title":"Association Between a Hospitalization for Heart Failure and the Initiation/Discontinuation of Guideline-Recommended Treatments: An Analysis from the Swedish Heart Failure Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Discontinuation; Medicine; Heart failure; Ejection fraction; Internal medicine; Guideline; Cardiology; Pathology","score_opus":0.020084689271503007,"score_gpt":0.288123749474908,"score_spread":0.26803906020340496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380729889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52922356,0.00018175346,0.0028780294,0.4659378,0.00016067734,0.001328499,0.00018153038,0.0000736882,0.000034445173],"genre_scores_gemma":[0.969207,0.000055642384,0.026215974,0.0014364076,0.001132614,0.000028953149,0.001424234,0.00006438817,0.0004348217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996199,0.0010966377,0.0013275765,0.00033970978,0.0007043596,0.00033269453],"domain_scores_gemma":[0.99694705,0.0007160819,0.0009312315,0.0005142183,0.00071285636,0.00017858719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036618742,0.00030281267,0.00087354623,0.00032902023,0.0003288562,0.0001648167,0.00019896743,0.000090597154,0.000093010596],"category_scores_gemma":[0.00078592583,0.00018423358,0.00057151663,0.0009070444,0.00008585244,0.00045937134,0.00007055968,0.00029294024,0.000021325384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019961578,0.00014952531,0.3133594,0.00002327561,0.0030954622,0.000009493713,0.0012096192,0.00012434792,0.00035830552,0.00007609758,0.68100154,0.00039328766],"study_design_scores_gemma":[0.011395572,0.001300178,0.39012915,0.0002545261,0.008682052,0.000023417435,0.0052795457,0.00073524314,0.00043613475,0.00022020758,0.58125955,0.0002843866],"about_ca_topic_score_codex":0.00008621921,"about_ca_topic_score_gemma":0.0002617851,"teacher_disagreement_score":0.46450138,"about_ca_system_score_codex":0.00014605494,"about_ca_system_score_gemma":0.00010275699,"threshold_uncertainty_score":0.7512827},"labels":[],"label_agreement":null},{"id":"W4380871265","doi":"10.1002/ejhf.2939","title":"Eligibility for Vericiguat in a Real-World Heart Failure Population According to Trial, Guideline and Label Criteria: Data from the Swedish Heart Failure Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"HORIZON EUROPE Framework Programme","keywords":"Medicine; Heart failure; Ejection fraction; Guideline; Population; Internal medicine; Cohort; Clinical trial; Emergency medicine; Environmental health","score_opus":0.092096844304145,"score_gpt":0.39151275965191384,"score_spread":0.29941591534776885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380871265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6149732,0.00016986518,0.00020121224,0.38202807,0.00048062572,0.0018460653,0.00015952271,0.00010407913,0.000037366473],"genre_scores_gemma":[0.8447359,0.00007809943,0.14513764,0.0051693795,0.0032096917,0.00003416511,0.0009648471,0.00015656884,0.000513714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562293,0.00072309904,0.0015999958,0.00076833135,0.00066686753,0.0006187489],"domain_scores_gemma":[0.9970669,0.00050348626,0.00033297663,0.0014005633,0.0002897567,0.00040628185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004963039,0.00042521337,0.0010203727,0.0004257054,0.00029399578,0.00025359422,0.0004822207,0.00008041215,0.00009889455],"category_scores_gemma":[0.0013520344,0.00031017876,0.0002215515,0.000978243,0.00007322871,0.0005465571,0.00051329064,0.00060188165,0.00009564132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030844784,0.00016447478,0.041823532,0.00006878636,0.00012300773,0.00013158777,0.00021693272,0.000019646293,0.0027729317,0.00001568901,0.951023,0.00055592414],"study_design_scores_gemma":[0.01769739,0.0010516937,0.06899421,0.000708247,0.00027350392,0.000098820674,0.0019048671,0.00028973975,0.00007883606,0.00007139911,0.90853846,0.00029284053],"about_ca_topic_score_codex":0.00054633967,"about_ca_topic_score_gemma":0.0023474286,"teacher_disagreement_score":0.37685868,"about_ca_system_score_codex":0.00015141486,"about_ca_system_score_gemma":0.0001522611,"threshold_uncertainty_score":0.99993503},"labels":[],"label_agreement":null},{"id":"W4380872704","doi":"10.1002/ejhf.2921","title":"May 2023 at a Glance: Focus on Pathophysiology, Comorbidities and Devices","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; General surgery; Internal medicine; Surgery","score_opus":0.012659943089290058,"score_gpt":0.2558764084245862,"score_spread":0.24321646533529614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380872704","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021975117,0.0033353611,0.0000060736998,0.0070358105,0.9664654,0.00022223446,0.00019600711,0.000085145184,0.0006788348],"genre_scores_gemma":[0.008237341,0.004382204,0.0003291558,0.00031552633,0.97896826,0.0000018982863,0.00015871423,0.00020085828,0.0074060634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973836,0.0006189599,0.000566687,0.00030155663,0.000852477,0.00027671503],"domain_scores_gemma":[0.9981414,0.00054347684,0.00038243106,0.0003375197,0.0003233092,0.00027188024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154802,0.00033358994,0.0010236682,0.0003067347,0.0001475831,0.00004873451,0.0001309905,0.00022993228,0.00013938015],"category_scores_gemma":[0.0006750347,0.00023383116,0.0006893293,0.00014976664,0.00014763068,0.000053600765,0.00012120377,0.0015799016,0.0005758325],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046269983,0.000027168135,0.00049993943,0.000163768,0.0004398799,0.0016397152,0.00008297974,0.0000046131204,0.00021519062,0.0000013730386,0.9956779,0.0007847789],"study_design_scores_gemma":[0.0018679489,0.0013036807,0.009329279,0.0009630748,0.00032925667,0.00033435412,0.00019700377,6.865578e-7,0.000037666185,0.00000710169,0.98542523,0.00020474296],"about_ca_topic_score_codex":0.000014042094,"about_ca_topic_score_gemma":0.000026182754,"teacher_disagreement_score":0.013737775,"about_ca_system_score_codex":0.00010018862,"about_ca_system_score_gemma":0.00016968374,"threshold_uncertainty_score":0.9535358},"labels":[],"label_agreement":null},{"id":"W4382181403","doi":"10.1002/ejhf.2929","title":"Prevalence, Clinical Characteristics and Outcomes of Heart Failure Patients with or Without Isolated or Combined Mitral and Tricuspid Regurgitation: An Analysis from the ESC-HFA Heart Failure Long-Term Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation; Surgical Specialties (Canada)","funders":"AstraZeneca","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Ejection fraction; Mitral regurgitation; Confidence interval; Odds ratio; Heart failure with preserved ejection fraction","score_opus":0.01902401805837105,"score_gpt":0.32501090204687616,"score_spread":0.3059868839885051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382181403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991388,0.00020406548,0.000020276924,0.0073871366,0.00012945439,0.00051951763,0.00030981848,0.000038986953,0.0000027091044],"genre_scores_gemma":[0.99615216,0.000103915896,0.0024698507,0.00040889427,0.00027959736,0.000002697875,0.00025950396,0.0000616565,0.000261725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966702,0.00077882595,0.0011288531,0.00044472006,0.0006558156,0.00032160617],"domain_scores_gemma":[0.99723524,0.0004184558,0.0006614457,0.0006020404,0.0005539261,0.0005288785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070592924,0.0003698992,0.0013604396,0.00023801588,0.00018384554,0.00013358767,0.00016519436,0.00009348147,0.000112655835],"category_scores_gemma":[0.00035549275,0.0001957933,0.0008663573,0.0007142722,0.00027201138,0.00028543387,0.00008426934,0.00048495288,0.000012537395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004127897,0.00043246022,0.9809991,0.00010413315,0.003408361,0.00019075912,0.00020300612,0.0000026951902,0.000025574516,7.274692e-7,0.010269921,0.0002353659],"study_design_scores_gemma":[0.008155128,0.0036296304,0.9795311,0.0004588851,0.0057496186,0.00011398784,0.00043386474,0.00003780913,0.0000060134435,0.0000014200975,0.0016695946,0.00021294138],"about_ca_topic_score_codex":0.000012129337,"about_ca_topic_score_gemma":0.00003138175,"teacher_disagreement_score":0.008600327,"about_ca_system_score_codex":0.000026856937,"about_ca_system_score_gemma":0.00016299084,"threshold_uncertainty_score":0.7984219},"labels":[],"label_agreement":null},{"id":"W4382197449","doi":"10.1002/ejhf.2944","title":"Knowledge About Self-Efficacy and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"China Scholarship Council; British Heart Foundation","keywords":"Heart failure; Medicine; Ejection fraction; Internal medicine; Cardiology; Fraction (chemistry); Intensive care medicine","score_opus":0.011773230519902563,"score_gpt":0.2611749969870896,"score_spread":0.24940176646718706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382197449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774485,0.000098955854,0.0000122034735,0.021610398,0.00012741261,0.0004570938,0.000001575835,0.000081795166,0.00016203047],"genre_scores_gemma":[0.99193084,0.000041956122,0.007293323,0.00017280263,0.00015708266,0.0000026086752,0.0000103263965,0.000045516954,0.0003455392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852103,0.00025726156,0.00042160563,0.00024052906,0.00029157393,0.00026797559],"domain_scores_gemma":[0.9992517,0.00007306978,0.00013594939,0.00016986894,0.00015101122,0.00021837375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000634158,0.00021611269,0.0004537401,0.0005013847,0.00011150327,0.00005860531,0.000042158907,0.00004370387,0.000027190761],"category_scores_gemma":[0.00007163697,0.00015276732,0.00006789749,0.00038525852,0.000043248943,0.00028009096,0.000051113147,0.00037468315,0.00009004603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035349405,0.00072950224,0.89698887,0.00009912497,0.0001947785,0.00012656618,0.000508447,0.0000057612883,0.0005227581,0.000009938916,0.09861781,0.0018429379],"study_design_scores_gemma":[0.0053126607,0.001353346,0.7335516,0.00024334143,0.00010290347,0.00006447289,0.00025220038,0.000009238333,0.000043804976,0.0000020429645,0.2589563,0.00010803711],"about_ca_topic_score_codex":0.0000040341347,"about_ca_topic_score_gemma":0.000013743115,"teacher_disagreement_score":0.16343725,"about_ca_system_score_codex":0.00007176532,"about_ca_system_score_gemma":0.000045532583,"threshold_uncertainty_score":0.622967},"labels":[],"label_agreement":null},{"id":"W4382240708","doi":"10.1002/ejhf.2946","title":"Heart Failure Diagnosis in the General Community – Who, how and When? A Clinical Consensus Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Statement (logic); Internal medicine; Intensive care medicine","score_opus":0.049227907820356055,"score_gpt":0.30808801822689835,"score_spread":0.2588601104065423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382240708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6915888,0.0001412634,0.00001006545,0.3072481,0.00018585149,0.0006519438,0.000041115476,0.0000141644105,0.00011868107],"genre_scores_gemma":[0.9928997,0.00015969743,0.004618969,0.0015233541,0.00037264355,0.000006400111,0.000009961875,0.00004970078,0.00035956647],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9854325,0.011544564,0.0014524647,0.00024658916,0.00088998704,0.00043386137],"domain_scores_gemma":[0.99656105,0.00105281,0.000968375,0.0008507278,0.0004288613,0.00013816253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012914496,0.0003078034,0.0010883993,0.0001371749,0.0002713367,0.00004148333,0.00048510177,0.000104437604,0.000019596491],"category_scores_gemma":[0.00074330444,0.00016730756,0.000931424,0.0005548645,0.00046650608,0.000092612645,0.00045300103,0.0014281756,0.000009156855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004870399,0.00015795193,0.40085292,0.000111297006,0.00037240665,0.000018421873,0.0016496148,0.00006426501,0.0015039984,0.000018653005,0.5950303,0.00017143265],"study_design_scores_gemma":[0.0024888644,0.00078400574,0.5307726,0.0004187697,0.00031181847,0.0001009415,0.0043560243,0.000021053853,0.0004045354,0.000025401907,0.46020707,0.00010887655],"about_ca_topic_score_codex":0.000072522605,"about_ca_topic_score_gemma":0.00018928063,"teacher_disagreement_score":0.30572474,"about_ca_system_score_codex":0.00010038573,"about_ca_system_score_gemma":0.00016530401,"threshold_uncertainty_score":0.6822604},"labels":[],"label_agreement":null},{"id":"W4382343819","doi":"10.1002/ejhf.2952","title":"Time to Clinical Benefit of Eplerenone Among Patients with Heart Failure and Reduced Ejection Fraction: A Subgroups Analysis from the EMPHASIS-HF Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"University of Glasgow; Pfizer","keywords":"Eplerenone; Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Clinical trial; Spironolactone; Randomized controlled trial","score_opus":0.023205317524609994,"score_gpt":0.2765974650287937,"score_spread":0.2533921475041837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382343819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819677,0.000040804593,0.000058931506,0.017449211,0.00011130274,0.00030048014,0.000012920384,0.000022761997,0.00003592579],"genre_scores_gemma":[0.99654996,0.0000101764335,0.0020064837,0.00040173795,0.0007316118,9.55517e-7,0.000042740394,0.000030198978,0.00022615123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775773,0.00042671617,0.00080107216,0.0002302768,0.00062285457,0.00016135741],"domain_scores_gemma":[0.99830955,0.00025241243,0.0003587764,0.00027099164,0.0005315769,0.00027670118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001231786,0.00015368249,0.00066642213,0.00030573306,0.00012968393,0.00003895416,0.000083127066,0.000060197293,0.0003359694],"category_scores_gemma":[0.00031391354,0.00009302422,0.00030152194,0.0009125695,0.00009474869,0.00015257133,0.000043705066,0.00038875695,0.00011843858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033025168,0.000587677,0.7615186,0.000013589068,0.0020234392,0.00011716287,0.00041228466,0.00030277227,0.0053010467,0.0000029280825,0.19219999,0.0044953697],"study_design_scores_gemma":[0.012188377,0.0023378842,0.914371,0.00012927156,0.0007975059,0.00003121613,0.00021656857,0.00014802453,0.00005760914,0.0000026137186,0.06962862,0.00009128257],"about_ca_topic_score_codex":0.000017068589,"about_ca_topic_score_gemma":0.000025185265,"teacher_disagreement_score":0.15285245,"about_ca_system_score_codex":0.00002607331,"about_ca_system_score_gemma":0.00005472208,"threshold_uncertainty_score":0.37934175},"labels":[],"label_agreement":null},{"id":"W4382344866","doi":"10.1002/ejhf.2953","title":"Optimizing Heart Rate with Ivabradine in Heart Failure with Reduced Ejection Fraction: Insights from a Post-Hoc Analysis of the SHIFT Trial","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Library science; Heart failure; Gerontology; Cardiology; Computer science","score_opus":0.016173495037847742,"score_gpt":0.24762208215547624,"score_spread":0.2314485871176285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382344866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.514491,0.00047555522,0.00010281086,0.4834376,0.0005240879,0.00083200034,0.000033622542,0.000044952252,0.000058352267],"genre_scores_gemma":[0.76467717,0.00018390169,0.017109009,0.19697315,0.019085176,0.000028283577,0.0005834425,0.0007148956,0.0006449714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99199194,0.0036023944,0.0015803596,0.0006741206,0.0015789615,0.0005722253],"domain_scores_gemma":[0.9966709,0.0003194406,0.00092483684,0.0011325432,0.00066738174,0.0002848834],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020811416,0.00060875475,0.0026269984,0.0015115454,0.00022437974,0.00011422408,0.00029414223,0.0003745011,0.00014708457],"category_scores_gemma":[0.00015643393,0.0003678837,0.0015094317,0.0029563066,0.00016233002,0.0003184703,0.00007120171,0.004886548,0.000059109258],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024469765,0.0002597564,0.002223628,0.00033495063,0.0092829205,0.0047521116,0.0014315984,0.0021647976,0.0057409843,0.0000010105726,0.94923085,0.00010762538],"study_design_scores_gemma":[0.022629956,0.0054494743,0.04210412,0.0026825638,0.005238863,0.001061466,0.0008713889,0.00004819024,0.00041902708,0.0000031908467,0.91898483,0.00050691655],"about_ca_topic_score_codex":0.00024901985,"about_ca_topic_score_gemma":0.0004116927,"teacher_disagreement_score":0.28646445,"about_ca_system_score_codex":0.00026118837,"about_ca_system_score_gemma":0.0011009272,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W4382345301","doi":"10.1002/ejhf.2945","title":"Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Heart failure; Ischaemic heart disease; Cardiology; Meta-analysis; Internal medicine; Vaccination; Intensive care medicine; Immunology","score_opus":0.10599814237585677,"score_gpt":0.36142255348102753,"score_spread":0.2554244111051708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382345301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049544917,0.9919237,0.000009018069,0.0015290428,0.00003525474,0.0014365398,0.00007797158,0.000026723383,0.000007291757],"genre_scores_gemma":[0.004536938,0.989624,0.0037071693,0.0010127476,0.00042553846,0.00007269412,0.00008281032,0.00038672218,0.00015137703],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933829,0.002313317,0.0014877404,0.00065704284,0.0016189269,0.0005400934],"domain_scores_gemma":[0.997289,0.00023021922,0.0004868519,0.0007144804,0.000656869,0.000622582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034639672,0.0006769323,0.0055563566,0.0018997015,0.0001669545,0.000074465504,0.00020244876,0.0001020175,0.00006113316],"category_scores_gemma":[0.00074250775,0.00043214706,0.00266711,0.0016230203,0.00010011811,0.0003332291,0.00030090488,0.0013582882,0.00006635609],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001377962,0.00073505944,0.16440259,0.03025609,0.72874916,0.001747859,0.000721981,0.00026497382,0.0000018539506,0.000008571578,0.047895342,0.023838546],"study_design_scores_gemma":[0.0020378798,0.0004425495,0.10441808,0.002099423,0.15559424,0.00009736537,0.000036694073,0.0000013949414,1.191575e-7,0.0000027264778,0.7349546,0.0003149144],"about_ca_topic_score_codex":0.00001429138,"about_ca_topic_score_gemma":0.00001486863,"teacher_disagreement_score":0.6870593,"about_ca_system_score_codex":0.00013314615,"about_ca_system_score_gemma":0.00030384935,"threshold_uncertainty_score":0.999813},"labels":[],"label_agreement":null},{"id":"W4383032924","doi":"10.1002/ejhf.2957","title":"Changes in Mid-Regional Pro-Adrenomedullin During Treatment with Sacubitril/Valsartan","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Sacubitril; Valsartan; Adrenomedullin; Internal medicine; Cardiology; Ejection fraction; Heart failure; Natriuretic peptide; Sacubitril, Valsartan; Troponin T; Vasodilation; Endocrinology; Blood pressure","score_opus":0.04405789464193,"score_gpt":0.2593536169725922,"score_spread":0.2152957223306622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383032924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354136,0.000049795173,6.204978e-7,0.0059899534,0.00009266766,0.00013168225,0.0000058174037,0.000040227642,0.00014789432],"genre_scores_gemma":[0.9982091,0.00016303034,0.00029856618,0.00040372403,0.0004125397,0.0000022393313,0.000001069097,0.000048788523,0.00046095153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983045,0.0004351574,0.00032795136,0.0002888003,0.00026245014,0.00038113617],"domain_scores_gemma":[0.999378,0.0000898413,0.00019128756,0.00015627513,0.000041592622,0.00014298568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002250277,0.0001949012,0.0003693814,0.0002934878,0.00011514509,0.00004492666,0.00022782863,0.000017103066,0.000058631602],"category_scores_gemma":[0.000041840023,0.00013126343,0.0000923211,0.00050519925,0.00010709659,0.00013700216,0.00005615833,0.00026687444,0.0002408239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002630069,0.000094493815,0.0016285591,0.000015557962,0.000006590336,0.0024356532,0.00024206984,0.00020046637,0.99298096,0.000021778535,0.0016206951,0.00049014663],"study_design_scores_gemma":[0.0040760334,0.006904468,0.087993205,0.00039398437,0.000026074762,0.0028438275,0.00037242397,0.000027974884,0.48504606,0.00005256062,0.41180697,0.0004564157],"about_ca_topic_score_codex":0.0000024485732,"about_ca_topic_score_gemma":0.000023629509,"teacher_disagreement_score":0.5079349,"about_ca_system_score_codex":0.000041004016,"about_ca_system_score_gemma":0.000048572947,"threshold_uncertainty_score":0.5352767},"labels":[],"label_agreement":null},{"id":"W4383033052","doi":"10.1002/ejhf.2959","title":"Give a Nudge a Shot: NUDGE-FLU Bridging the Cardiovascular Quality Chasm","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Bridging (networking); Computer security; Computer science","score_opus":0.05185132740228023,"score_gpt":0.28655937158196515,"score_spread":0.2347080441796849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383033052","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013731674,0.0024294565,0.00029861924,0.992351,0.0011186694,0.00086215494,0.000028856957,0.00014909756,0.0013889738],"genre_scores_gemma":[0.006525268,0.00048563533,0.005596697,0.94038814,0.027126037,0.000023246357,0.00018360435,0.00062010105,0.019051261],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932178,0.0022119153,0.001331931,0.0005670016,0.0018536604,0.0008176718],"domain_scores_gemma":[0.99710625,0.00025490855,0.00056412996,0.0013747117,0.00042282743,0.0002771463],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044940794,0.0006728824,0.0016873055,0.00045957512,0.00029504168,0.00017854002,0.0005310543,0.00022377654,0.00023203726],"category_scores_gemma":[0.00030223862,0.00042772002,0.0026097414,0.0004715976,0.00018041545,0.00015377552,0.00025403898,0.0038129007,0.0015527286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006529552,0.000059911054,0.00013600217,0.00033994258,0.0033705912,0.01766107,0.00058958505,0.000013626332,0.000056698,0.000007475942,0.975744,0.0019557837],"study_design_scores_gemma":[0.0023688436,0.00049702567,0.001961306,0.0005015412,0.0017751026,0.0022311162,0.0003258232,0.00000699469,0.000027704582,0.000008799316,0.9899157,0.00037999012],"about_ca_topic_score_codex":0.000042788895,"about_ca_topic_score_gemma":0.000005477969,"teacher_disagreement_score":0.051962852,"about_ca_system_score_codex":0.00021111988,"about_ca_system_score_gemma":0.0002483822,"threshold_uncertainty_score":0.99981743},"labels":[],"label_agreement":null},{"id":"W4383033105","doi":"10.1002/ejhf.2955","title":"A Scoping Review of Heart Failure Transitional Care Quality Indicators and Outcomes for Use in Clinical Care and Research","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Population Health Research Institute; NOSM University; St. Joseph’s Healthcare Hamilton; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; CINAHL; Transitional care; MEDLINE; Clinical trial; Health care; Randomized controlled trial; Intensive care medicine; Psychological intervention; Nursing; Surgery; Pathology","score_opus":0.24018783591191123,"score_gpt":0.5071683424354249,"score_spread":0.2669805065235136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383033105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001077651,0.9856488,0.00000758972,0.009314526,0.000113188355,0.0037002643,0.000102942424,0.000019759897,0.00001529404],"genre_scores_gemma":[0.00020890347,0.97940266,0.019479927,0.00030736421,0.00028029297,0.000039528775,0.00012281963,0.00010673632,0.000051754632],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99185824,0.0034062993,0.0028906998,0.00053290406,0.0008688475,0.00044298315],"domain_scores_gemma":[0.9962385,0.0016931914,0.00064724014,0.000431217,0.00058012764,0.00040971552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007715809,0.00043750028,0.0037797666,0.0010522379,0.0001246959,0.000060795508,0.00017103096,0.00018110144,0.000028621345],"category_scores_gemma":[0.0013510408,0.00031333425,0.0010656337,0.0006485496,0.0002607932,0.00016897937,0.00015419001,0.0013316477,0.00001465905],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001186445,0.0001773497,0.017807532,0.7850625,0.00071431935,0.00040351262,0.0007754961,1.3901484e-7,5.3843445e-7,0.000046281122,0.06227744,0.13261627],"study_design_scores_gemma":[0.0014069488,0.0006768142,0.0028512215,0.36607435,0.00065510534,0.00012272155,0.0006022032,4.007346e-8,2.3806523e-7,0.000001280228,0.6274536,0.00015546977],"about_ca_topic_score_codex":0.000009442878,"about_ca_topic_score_gemma":0.0000900566,"teacher_disagreement_score":0.5651762,"about_ca_system_score_codex":0.00012301323,"about_ca_system_score_gemma":0.00082196377,"threshold_uncertainty_score":0.9999319},"labels":[],"label_agreement":null},{"id":"W4383058872","doi":"10.1002/ejhf.2962","title":"Impact of Comorbidities on Health Status Measured Using the Kansas City Cardiomyopathy Questionnaire in Patients with Heart Failure with Reduced and Preserved Ejection Fraction","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"China Scholarship Council; Servier; University of Glasgow; British Heart Foundation; Cytokinetics; Ironwood Pharmaceuticals, Incorporated; Boston Scientific Corporation; MyoKardia; AstraZeneca; Alnylam Pharmaceuticals; Pfizer; Amgen","keywords":"Medicine; Ejection fraction; Heart failure; Cardiomyopathy; Cardiology; Internal medicine; Physical therapy","score_opus":0.029259067204530483,"score_gpt":0.2864707132908565,"score_spread":0.257211646086326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383058872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883113,0.00009639972,0.000097825105,0.010691404,0.00007337166,0.0006682964,0.000008889344,0.00003508388,0.000017435272],"genre_scores_gemma":[0.9974551,0.000026148602,0.002236476,0.00008732239,0.00011690126,0.0000027442434,0.000014974525,0.00004192699,0.00001840299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975027,0.00082000304,0.00047516555,0.00021238401,0.0006538439,0.00033594048],"domain_scores_gemma":[0.9987992,0.000042739324,0.00034027736,0.00027704428,0.0003364407,0.0002043098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011982284,0.00023168925,0.00053695904,0.00040145082,0.00017396337,0.00004360192,0.000057560952,0.000033003766,0.0000121920475],"category_scores_gemma":[0.00008228729,0.00013121974,0.00013137155,0.0005414107,0.00009502558,0.00026580654,0.000027820097,0.000436036,0.0000040490577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018479708,0.00024920012,0.97765124,0.00010368775,0.00026763947,0.00004107087,0.00059087324,0.001355667,0.00040507843,0.0000022892236,0.017232897,0.00025236225],"study_design_scores_gemma":[0.0042427126,0.0062678764,0.98077613,0.0013811494,0.00011072126,0.000057431043,0.00089449546,0.000055149438,0.000093936236,0.0000032267446,0.005999555,0.00011760824],"about_ca_topic_score_codex":0.00032786178,"about_ca_topic_score_gemma":0.00013579524,"teacher_disagreement_score":0.011233343,"about_ca_system_score_codex":0.00029415704,"about_ca_system_score_gemma":0.0002668667,"threshold_uncertainty_score":0.53509855},"labels":[],"label_agreement":null},{"id":"W4383186630","doi":"10.1002/ejhf.2964","title":"Reply to ‘Vericiguat in Heart Failure with Reduced Ejection Fraction: The Right Choice Above All Else? The Answer May Lie in Time’","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"German; Medicine; Library science; Citation; Ejection fraction; Heart failure; History; Internal medicine; Computer science","score_opus":0.015607394803464718,"score_gpt":0.2596969629695147,"score_spread":0.24408956816605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383186630","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01413154,0.0001317648,0.000019826575,0.9826429,0.0006088272,0.0015123317,0.000007861505,0.000077580706,0.00086735864],"genre_scores_gemma":[0.0158552,0.0000909765,0.007890286,0.92753094,0.013813818,0.00007393231,0.00012859817,0.0004939663,0.034122285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945525,0.0015410109,0.0011544806,0.0006439784,0.0013368985,0.00077112776],"domain_scores_gemma":[0.9975686,0.0004518105,0.00047109777,0.0010340472,0.0002640275,0.00021043557],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002638465,0.00063904404,0.0010277526,0.000816228,0.00019689363,0.00022271785,0.00050790346,0.00021584857,0.000579082],"category_scores_gemma":[0.0002187511,0.00034124192,0.00037867427,0.0012359808,0.00011454896,0.00028521888,0.0001445452,0.0043341722,0.0018807189],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002832239,0.00011539274,0.002527834,0.00006716159,0.00030519726,0.0042558666,0.00038005938,0.00006752944,0.00038764326,0.0000014111033,0.9914341,0.00017456173],"study_design_scores_gemma":[0.0019518685,0.0012496536,0.017822439,0.0013119134,0.00031791147,0.0012693105,0.00030115654,0.0000059116087,0.00010877402,0.000005485078,0.975313,0.00034255208],"about_ca_topic_score_codex":0.00014563887,"about_ca_topic_score_gemma":0.00021403155,"teacher_disagreement_score":0.05511197,"about_ca_system_score_codex":0.00044169716,"about_ca_system_score_gemma":0.00021614053,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W4383872198","doi":"10.1002/ejhf.2954","title":"June 2023 at a Glance: Focus on Worsening Heart Failure, Heart Failure with Preserved Ejection Fraction and Valvular Heart Disease","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; valvular heart disease; Heart failure; Ejection fraction; Cardiology; Internal medicine; Surgery","score_opus":0.00798650476736955,"score_gpt":0.24247296452597256,"score_spread":0.234486459758603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383872198","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24562497,0.0044246553,0.000049269547,0.16814739,0.57779294,0.0024787558,0.00052858406,0.00069048355,0.00026296137],"genre_scores_gemma":[0.08015813,0.00040171898,0.008708473,0.0008660209,0.8967824,0.00003237048,0.00063222833,0.0008753615,0.011543288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935343,0.001029909,0.0012329727,0.0010298513,0.00228622,0.00088669534],"domain_scores_gemma":[0.9957812,0.0006339502,0.00076984265,0.000832463,0.0008585485,0.0011240329],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014926797,0.0009585493,0.0019441822,0.0006313294,0.0006383682,0.00029058012,0.00022115649,0.00046128634,0.00021580196],"category_scores_gemma":[0.000988088,0.00070097804,0.0011086196,0.00069432746,0.00023832967,0.00042942408,0.00026013269,0.0034362234,0.00029883088],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033224272,0.000073528856,0.0072520673,0.00046551964,0.00046456108,0.0009887168,0.00005087181,0.00012958595,0.0020523504,0.0000015859372,0.98515534,0.00004343303],"study_design_scores_gemma":[0.003673879,0.00222603,0.026443817,0.0034920524,0.0007661265,0.0012273564,0.0002981623,0.000016826389,0.00017103263,0.000018240604,0.96098214,0.00068431546],"about_ca_topic_score_codex":0.000074442316,"about_ca_topic_score_gemma":0.00013713446,"teacher_disagreement_score":0.3189895,"about_ca_system_score_codex":0.00039040542,"about_ca_system_score_gemma":0.00043707358,"threshold_uncertainty_score":0.99954414},"labels":[],"label_agreement":null},{"id":"W4384626233","doi":"10.1002/ejhf.2975","title":"Mineralocorticoid Receptor Antagonist Initiation During Admission is Associated with Improved Outcomes Irrespective of Ejection Fraction in Patients with Acute Heart Failure","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Novartis Pharma","keywords":"Medicine; Ejection fraction; Heart failure; Hazard ratio; Internal medicine; Confidence interval; Mineralocorticoid receptor; Cardiology; Guideline; Aldosterone","score_opus":0.009370937809923667,"score_gpt":0.24655692271112076,"score_spread":0.23718598490119708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384626233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332006,0.000009008956,0.000050023165,0.015788859,0.00012744495,0.0005853855,0.000014634179,0.00005973499,0.000044869153],"genre_scores_gemma":[0.9949872,0.000010432932,0.004235487,0.00015802316,0.0000975452,0.0000053071312,0.00007999477,0.000059130627,0.0003669052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791425,0.00028444044,0.00065539347,0.00025805907,0.00058520783,0.00030262987],"domain_scores_gemma":[0.99857175,0.000063680374,0.0005263276,0.00020415822,0.00045766064,0.00017643961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047802794,0.00025619112,0.0005836393,0.0005912208,0.000118672535,0.000036936875,0.00006264536,0.000058830352,0.000096964315],"category_scores_gemma":[0.00016312762,0.00017436463,0.00014055273,0.0007517871,0.000052374497,0.00042735823,0.000034175766,0.00041441998,0.000034565743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002701508,0.000624771,0.9397568,0.000060088318,0.000640393,0.00021240143,0.0004838584,0.00002599395,0.02678011,0.000001963181,0.028570857,0.00014122964],"study_design_scores_gemma":[0.01006779,0.0035692926,0.96788466,0.0007004582,0.00027304073,0.000043132823,0.00055428076,0.000021569362,0.0055162315,0.000001725288,0.011184339,0.0001834537],"about_ca_topic_score_codex":0.000013678723,"about_ca_topic_score_gemma":0.000033511653,"teacher_disagreement_score":0.02812786,"about_ca_system_score_codex":0.00026822876,"about_ca_system_score_gemma":0.00010618285,"threshold_uncertainty_score":0.71103835},"labels":[],"label_agreement":null},{"id":"W4384820130","doi":"10.1002/ejhf.2979","title":"State-of-the-Art Document on Optimal Contemporary Management of Cardiomyopathies","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiovascular Effects of Exercise","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Intensive care medicine; Scope (computer science); Risk stratification; Cardiomyopathy; Hypertrophic cardiomyopathy; Heart failure; Presentation (obstetrics); Disease; Etiology; Sudden cardiac death; Cardiology; Internal medicine; Surgery","score_opus":0.03303742160141517,"score_gpt":0.3007244583616196,"score_spread":0.26768703676020444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384820130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028756232,0.99514997,0.000041572028,0.00053465867,0.0007655894,0.0014113573,0.000032206754,0.000023435452,0.0017536421],"genre_scores_gemma":[0.0008748294,0.9940433,0.0027576613,0.000040134088,0.0003666285,0.00000720448,0.000014696598,0.00020172219,0.0016938086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949986,0.0014820698,0.0016912579,0.0002869047,0.0012812852,0.00025993527],"domain_scores_gemma":[0.99713886,0.0001517048,0.0012218154,0.0010106061,0.00028901725,0.00018798599],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003734535,0.00045071196,0.0033194683,0.0004721639,0.000044905606,0.000027255524,0.0004700948,0.000059735627,0.000019016505],"category_scores_gemma":[0.000108241635,0.00028393895,0.0040697586,0.0004906969,0.0001456598,0.00008131765,0.0003289043,0.0009074324,0.00020364484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004703224,0.00021800095,0.00002069164,0.08519526,0.010840262,0.01346629,0.00015813358,0.00024749612,0.000009827568,0.000028289069,0.40701216,0.48233327],"study_design_scores_gemma":[0.0011267737,0.0007779917,0.00013041543,0.09696208,0.0027399547,0.0013730291,0.000051801362,2.2463155e-7,0.000030755156,0.0000025267748,0.8966261,0.00017831339],"about_ca_topic_score_codex":0.0000014809694,"about_ca_topic_score_gemma":1.4447858e-7,"teacher_disagreement_score":0.48961398,"about_ca_system_score_codex":0.00010828319,"about_ca_system_score_gemma":0.00027671125,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W4385476296","doi":"10.1002/ejhf.2986","title":"Role of Aldosterone in Mid- and Long-Term Left Ventricular Remodelling after Acute Myocardial Infarction: The REMI Study","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux","keywords":"Medicine; Cardiology; Internal medicine; Aldosterone; Myocardial infarction; Ejection fraction; Heart failure; Ventricular remodeling","score_opus":0.013575106530816776,"score_gpt":0.2501885132333561,"score_spread":0.23661340670253933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385476296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890676,0.0008712391,0.000018355093,0.009757083,0.00007222229,0.00017751424,8.342167e-7,0.000007959474,0.00002719136],"genre_scores_gemma":[0.9991651,0.00011437097,0.0002232445,0.00018122823,0.00021798057,3.5212585e-7,0.0000018112389,0.00001797767,0.00007789976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876904,0.00026293588,0.00039705925,0.0001027309,0.00034687697,0.00012138122],"domain_scores_gemma":[0.99948555,0.000032878546,0.00011137097,0.00014695131,0.00013714674,0.00008609333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009216295,0.000088891895,0.00026669863,0.0001877212,0.000044237142,0.000017508157,0.00005512016,0.000021485788,0.000022563863],"category_scores_gemma":[0.0000348253,0.000056677458,0.00009373344,0.00019087689,0.000036985606,0.00008273309,0.00005076343,0.0002696212,0.00001925256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002205167,0.00028786183,0.9144695,0.000040856994,0.0005012697,0.0076017734,0.004043001,0.00051283557,0.059013337,0.0000036382394,0.004305553,0.0070152073],"study_design_scores_gemma":[0.0017171043,0.0006732424,0.981359,0.00019085687,0.00014926275,0.0022914137,0.00045309236,0.0001779493,0.00024203889,0.0000063665166,0.012683611,0.000056084875],"about_ca_topic_score_codex":0.0000015268294,"about_ca_topic_score_gemma":0.0000041259204,"teacher_disagreement_score":0.06688948,"about_ca_system_score_codex":0.00001703695,"about_ca_system_score_gemma":0.000029053323,"threshold_uncertainty_score":0.23112397},"labels":[],"label_agreement":null},{"id":"W4385477564","doi":"10.1002/ejhf.2987","title":"Moving Towards a Comprehensive Heart Failure Management Beyond Ejection Fraction","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Public health; Family medicine; Surgery; Pathology","score_opus":0.02556932429902332,"score_gpt":0.27772727655270624,"score_spread":0.2521579522536829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385477564","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076241656,0.0013165779,0.0006639905,0.9677881,0.0034265474,0.00057767204,0.00003931002,0.0002871603,0.018276503],"genre_scores_gemma":[0.08207024,0.0011273846,0.052586854,0.7598258,0.07878941,0.000017183163,0.00044830935,0.0011546506,0.023980131],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650294,0.00060175324,0.00091792503,0.00041127356,0.0011414409,0.00042469153],"domain_scores_gemma":[0.99795634,0.00014767538,0.00060147257,0.0004196804,0.0007219326,0.0001529072],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00068671035,0.0004500519,0.0012717507,0.00085697306,0.00026042826,0.00012910581,0.000059873742,0.00020746196,0.000053084797],"category_scores_gemma":[0.00009499263,0.00039202964,0.00092487683,0.00046412824,0.000079405414,0.00017346747,0.0001391608,0.002426814,0.0007315829],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008067679,0.000013855159,0.0007511132,0.00038186906,0.000833242,0.0016834593,0.000121905585,0.000069325266,0.00034282397,0.0000013065986,0.9951977,0.0005226983],"study_design_scores_gemma":[0.0010864665,0.00041007547,0.012963071,0.0011788355,0.00059729064,0.0059320875,0.0010694354,0.0000035404432,0.00004919828,0.0000115720195,0.9763989,0.00029954812],"about_ca_topic_score_codex":0.000007681625,"about_ca_topic_score_gemma":0.0000012106451,"teacher_disagreement_score":0.20796223,"about_ca_system_score_codex":0.00021999209,"about_ca_system_score_gemma":0.00008171393,"threshold_uncertainty_score":0.99987465},"labels":[],"label_agreement":null},{"id":"W4385624656","doi":"10.1002/ejhf.2976","title":"July 2023 at a Glance: Heart Failure with Preserved Ejection Fraction and Comorbidities","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Fraction (chemistry); Chromatography","score_opus":0.015268716525431348,"score_gpt":0.2596949888807749,"score_spread":0.24442627235534356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385624656","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02736229,0.0027204382,0.00023124888,0.12624961,0.83711576,0.0030602152,0.00033200282,0.0007258786,0.002202531],"genre_scores_gemma":[0.006555142,0.0012497553,0.02059928,0.0004090503,0.9277851,0.000036357065,0.0007822954,0.0006256001,0.041957404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960101,0.0006076714,0.00084215717,0.0005274737,0.0014819056,0.000530679],"domain_scores_gemma":[0.9973664,0.0004683001,0.0006005678,0.0005000315,0.0006464527,0.00041820205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014392447,0.00058748643,0.001186358,0.0005266954,0.0003091185,0.00018199476,0.00016722432,0.00028684866,0.00022950157],"category_scores_gemma":[0.00045166412,0.00043847034,0.00032283252,0.00035974177,0.00014817307,0.00037065896,0.00018047213,0.001797443,0.00074113905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095203763,0.00011120452,0.0016110346,0.0004869719,0.00060529105,0.0010569722,0.000089704925,0.000009152408,0.00032529293,0.0000011743084,0.9946685,0.00008270746],"study_design_scores_gemma":[0.004047806,0.0029211892,0.0026728758,0.001858111,0.00072706805,0.00039798787,0.00038496155,0.000005491881,0.00008738252,0.0000044049116,0.9865316,0.00036108587],"about_ca_topic_score_codex":0.00003732126,"about_ca_topic_score_gemma":0.00019511417,"teacher_disagreement_score":0.12584056,"about_ca_system_score_codex":0.00031974967,"about_ca_system_score_gemma":0.0002868532,"threshold_uncertainty_score":0.9998067},"labels":[],"label_agreement":null},{"id":"W4385715496","doi":"10.1002/ejhf.2992","title":"Erythropoietic Response After Intravenous Iron in Patients with Heart Failure and Reduced Ejection Fraction with and Without Background Treatment with Sodium–Glucose Cotransporter 2 Inhibitors","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Iron deficiency; Kidney disease; Transferrin saturation; Renal function; Cardiology; Gastroenterology; Anemia","score_opus":0.007940766619801755,"score_gpt":0.22886396072977164,"score_spread":0.22092319410996988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385715496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893724,0.00013727722,0.000013575344,0.0098074125,0.00005638034,0.0005437911,0.000006327596,0.000043786433,0.000019104633],"genre_scores_gemma":[0.99428105,0.00008597448,0.005078331,0.00014600057,0.00014903817,0.00000866918,0.000020813277,0.000089310335,0.00014083144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803007,0.00035791632,0.00043891778,0.00037978106,0.0004492352,0.00034409977],"domain_scores_gemma":[0.9990703,0.000046763937,0.00020208245,0.00022541443,0.00016529638,0.0002901433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042106202,0.0003660973,0.00054298656,0.00035297876,0.00012968037,0.00006862648,0.000032167485,0.00006499883,0.000038347967],"category_scores_gemma":[0.000008361986,0.00021824717,0.000059690083,0.00033405042,0.0002351166,0.00026563168,0.000013531621,0.00041551326,0.000017913837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031173876,0.0007666094,0.9586145,0.0001138349,0.00017176989,0.0011677846,0.0013920898,0.000016212762,0.004322858,3.9288403e-7,0.0014573599,0.0008026933],"study_design_scores_gemma":[0.015736545,0.027798314,0.93568605,0.001357025,0.00031856043,0.0018289647,0.0025912097,0.0000043997043,0.0014606906,0.0000010331205,0.012937397,0.0002798162],"about_ca_topic_score_codex":0.00002106863,"about_ca_topic_score_gemma":0.00009233783,"teacher_disagreement_score":0.027031705,"about_ca_system_score_codex":0.00021009377,"about_ca_system_score_gemma":0.00012978054,"threshold_uncertainty_score":0.8899861},"labels":[],"label_agreement":null},{"id":"W4385715540","doi":"10.1002/ejhf.2994","title":"Artificial Intelligence and Heart Failure: A State-of-the-Art Review","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"Cytokinetics; Sanofi; AstraZeneca; Pfizer; Amgen","keywords":"Heart failure; Medicine; Subclinical infection; Ejection fraction; Intensive care medicine; Disease; Risk stratification; Artificial intelligence; Machine learning; Computer science; Internal medicine","score_opus":0.07638021989989877,"score_gpt":0.3351048306592848,"score_spread":0.258724610759386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385715540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012957873,0.9585082,0.00006749821,0.039268117,0.00039697223,0.0015933672,0.000019103212,0.000042123644,0.00009166093],"genre_scores_gemma":[0.000018459215,0.98935384,0.008045711,0.0006489716,0.000446832,0.00001026985,0.000016227285,0.00014862823,0.0013110436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481237,0.0012003311,0.0023450113,0.00040797403,0.0007889842,0.00044530965],"domain_scores_gemma":[0.9974014,0.0002171076,0.0010204028,0.0007206968,0.0002761205,0.00036423976],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002711621,0.0005830761,0.0029130636,0.00039461954,0.000119142045,0.00005330768,0.00036590575,0.000080592275,0.00012567356],"category_scores_gemma":[0.00042164227,0.0003524904,0.0013527111,0.00090713263,0.00019968327,0.00012261658,0.00030163483,0.0011252314,0.00091504946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018766752,0.000116410156,0.000014787956,0.035589777,0.0005424537,0.0003714603,0.000050723604,4.3941242e-7,0.000008441412,0.00004422082,0.6191592,0.3440833],"study_design_scores_gemma":[0.00012594707,0.0005205583,0.000026737958,0.11003627,0.0021294346,0.0015721904,0.000025105592,4.772636e-7,0.000008797109,0.00003203831,0.8852941,0.00022836946],"about_ca_topic_score_codex":0.0000020314799,"about_ca_topic_score_gemma":0.00001162785,"teacher_disagreement_score":0.34385493,"about_ca_system_score_codex":0.00008740302,"about_ca_system_score_gemma":0.00041916972,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W4385738718","doi":"10.1002/ejhf.2985","title":"Decongestion Strategies In Patients Presenting with Acutely Decompensated Heart Failure: A Worldwide Survey Among Physicians","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Acute decompensated heart failure; Furosemide; Heart failure; Diuretic; Intensive care medicine; Dosing; Diuresis; Internal medicine; Renal function","score_opus":0.01784930756442704,"score_gpt":0.259268719732044,"score_spread":0.24141941216761698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385738718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852459,0.000025710426,0.000056333498,0.01366791,0.00013804443,0.0005409023,0.0000061480196,0.000101415,0.00021762532],"genre_scores_gemma":[0.9913411,0.000009563623,0.007698509,0.00022783173,0.00016689434,0.0000043171653,0.0000837847,0.00007920946,0.00038878224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698126,0.0008211689,0.0007287367,0.0003189341,0.0006027799,0.00054708915],"domain_scores_gemma":[0.99865746,0.0001492004,0.0003100739,0.00030167965,0.00036383144,0.00021772117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015501806,0.00031096223,0.0006199691,0.0006137378,0.00011954495,0.00015033466,0.00015412329,0.000043964763,0.0000581947],"category_scores_gemma":[0.00014399781,0.00024073207,0.0001619441,0.0010680652,0.00009173115,0.00058343285,0.0000796713,0.00052942795,0.00020611536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003529392,0.0002605716,0.8583513,0.00004753683,0.00019194228,0.0005961616,0.00037635677,0.00032664082,0.00026981626,0.000007951221,0.13874237,0.00047641122],"study_design_scores_gemma":[0.003970728,0.00096637086,0.94758,0.0005245824,0.000100823716,0.0000511618,0.0006040094,0.00006521686,0.000142588,0.0000065308136,0.045779563,0.0002084175],"about_ca_topic_score_codex":0.00006421561,"about_ca_topic_score_gemma":0.0011211883,"teacher_disagreement_score":0.09296281,"about_ca_system_score_codex":0.00008607451,"about_ca_system_score_gemma":0.00011933714,"threshold_uncertainty_score":0.9816769},"labels":[],"label_agreement":null},{"id":"W4385827360","doi":"10.1002/ejhf.2997","title":"Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of Cardiology","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); St. Thomas Hospital","funders":"","keywords":"Medicine; Cardiology; Heart failure; Internal medicine; Muscle hypertrophy; Left ventricular hypertrophy; Cardiac amyloidosis; Magnetic resonance imaging; Pressure overload; Cardiac hypertrophy; Cardiac magnetic resonance imaging; Radiology; Blood pressure","score_opus":0.007286354632019189,"score_gpt":0.2155613021436641,"score_spread":0.2082749475116449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954336,0.0008603373,0.000013311182,0.002814621,0.00020248568,0.00044441014,0.00013700753,0.0000050590097,0.000089148896],"genre_scores_gemma":[0.9987215,0.00019451653,0.0009382299,0.00002550944,0.00005831247,0.0000014551752,0.0000062387917,0.000021244568,0.000032986423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970136,0.0010740553,0.00075858313,0.00017742932,0.00078518165,0.0001911293],"domain_scores_gemma":[0.99778914,0.00008540564,0.0009100813,0.00037493283,0.000788524,0.000051899944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027132775,0.00014716249,0.000709701,0.00008727316,0.00010756265,0.000007931622,0.0001631704,0.000019805882,0.0000031945283],"category_scores_gemma":[0.00008591825,0.00008522606,0.0005996432,0.00040165448,0.00034018853,0.000060683822,0.00029269265,0.00019379384,7.961057e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080945974,0.000112527974,0.960151,0.00045523394,0.0010220181,0.000008509999,0.0011114647,0.00027788104,0.0067057684,0.0000038594653,0.029544985,0.00052578084],"study_design_scores_gemma":[0.0015502007,0.00022348798,0.94617903,0.000620505,0.00064613676,0.0000096484,0.0020625961,0.0000069175035,0.0050859037,0.0000039004235,0.043546245,0.00006542126],"about_ca_topic_score_codex":0.0000123209375,"about_ca_topic_score_gemma":0.0000013768469,"teacher_disagreement_score":0.01400126,"about_ca_system_score_codex":0.000053305663,"about_ca_system_score_gemma":0.000048678252,"threshold_uncertainty_score":0.34754178},"labels":[],"label_agreement":null},{"id":"W4385827384","doi":"10.1002/ejhf.2998","title":"Addressing Comorbidities in Heart Failure: When Feeling Better and Living Longer go in the Same Direction","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Feeling; Radiological weapon; University hospital; Family medicine; Surgery; Psychology","score_opus":0.04858363217179489,"score_gpt":0.2781463879682445,"score_spread":0.22956275579644958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827384","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052724157,0.0008952406,0.000019172487,0.945083,0.00050006766,0.00051835703,0.0000055851506,0.000053603606,0.00020078663],"genre_scores_gemma":[0.12951945,0.00051888876,0.041371465,0.79673195,0.021942727,0.000044089,0.00015000765,0.0007103206,0.009011094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955358,0.0016342821,0.0010122163,0.00041148404,0.00079879904,0.0006074547],"domain_scores_gemma":[0.998422,0.0006466213,0.0003220015,0.00039896116,0.00010323855,0.00010716964],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029779018,0.0004725158,0.00093352667,0.0009541995,0.00015289854,0.00028803977,0.00022151164,0.00020570692,0.00014197105],"category_scores_gemma":[0.00024008464,0.00033289337,0.00028318734,0.00032583775,0.00012024046,0.0003083465,0.00014091351,0.0033168946,0.0001481207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028104088,0.000054887372,0.012847714,0.0002783639,0.00010715351,0.0047064708,0.0024278462,0.000007822783,0.00016542306,9.413551e-7,0.9785652,0.0008100727],"study_design_scores_gemma":[0.0010295211,0.0003382611,0.035291743,0.0049343985,0.00018581253,0.0013330389,0.001207973,0.000014004364,0.0000122341335,0.000019282303,0.95535564,0.00027810578],"about_ca_topic_score_codex":0.000059278824,"about_ca_topic_score_gemma":0.00019653798,"teacher_disagreement_score":0.14835107,"about_ca_system_score_codex":0.00017482486,"about_ca_system_score_gemma":0.00008872222,"threshold_uncertainty_score":0.9999123},"labels":[],"label_agreement":null},{"id":"W4386084923","doi":"10.1002/ejhf.3002","title":"Is Palliative Care in Heart Failure Patients Coming Up?","year":2023,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Specialty; Palliative care; Radiological weapon; Public health; Family medicine; Surgery; Nursing","score_opus":0.027932827941370246,"score_gpt":0.2786666864901847,"score_spread":0.25073385854881447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386084923","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012726897,0.0004831518,0.0000115080065,0.984046,0.001207466,0.001002766,0.00007435376,0.00008965722,0.00035820596],"genre_scores_gemma":[0.06441981,0.00022618318,0.03766683,0.86662954,0.013179029,0.00003146427,0.0012170636,0.0010706893,0.015559375],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495006,0.0008508311,0.001413798,0.0006075447,0.0013223982,0.00085537985],"domain_scores_gemma":[0.99763185,0.00017392587,0.0005921895,0.00063951116,0.00066187076,0.00030064603],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073635124,0.0007369437,0.0015094822,0.0010789044,0.00014503713,0.00011849609,0.00035293694,0.0003390196,0.00041035053],"category_scores_gemma":[0.00016615151,0.00060433894,0.0008035967,0.0005814978,0.00009636452,0.00020680927,0.00021542503,0.0037127226,0.001509724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011413371,0.00008674897,0.03636341,0.00049952633,0.0003413725,0.004187514,0.0020412204,0.0000033175622,0.000022810871,9.871869e-7,0.95591325,0.00042570118],"study_design_scores_gemma":[0.004857216,0.0015272148,0.022319794,0.0028759728,0.00036166396,0.00008021794,0.0010527944,0.0000021407757,0.000059998263,0.0000054209886,0.9664106,0.0004469787],"about_ca_topic_score_codex":0.000020744543,"about_ca_topic_score_gemma":0.000047502173,"teacher_disagreement_score":0.11741644,"about_ca_system_score_codex":0.00045679475,"about_ca_system_score_gemma":0.00025556018,"threshold_uncertainty_score":0.9996408},"labels":[],"label_agreement":null},{"id":"W4386151402","doi":"10.1002/ejhf.2990","title":"Baseline Characteristics of Patients Enrolled in the EMPACT-MI Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"Janssen Pharmaceuticals; St. Jude Medical; HLS Therapeutics; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Agency for Healthcare Research and Quality; Vifor Pharma; Pfizer; Moderna; Idorsia Pharmaceuticals; Impulse Dynamics; Medicines Company; Regado Biosciences; Belvoir Media Group; Novo Nordisk; MyoKardia; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; British Heart Foundation; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Empagliflozin; Myocardial infarction; Internal medicine; Heart failure; Cardiology; Ejection fraction; Population; Interquartile range; Diabetes mellitus; Type 2 diabetes; Placebo","score_opus":0.017112991885173567,"score_gpt":0.2542449277176738,"score_spread":0.23713193583250025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386151402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989653,0.000026122403,0.000007818011,0.009098682,0.0002475668,0.00030068096,0.000007727394,0.000008715529,0.0006496749],"genre_scores_gemma":[0.99848783,0.000027579494,0.00031273038,0.00043229744,0.00032659425,0.000001089827,0.000027022748,0.000016621354,0.0003682414],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99854165,0.00037761332,0.0005189276,0.00006977775,0.000344171,0.00014784942],"domain_scores_gemma":[0.9993345,0.00010368264,0.00022507866,0.00016251896,0.00011314223,0.00006105469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017190877,0.00009090907,0.0002994037,0.00020807493,0.000021746806,0.000016522286,0.00011236007,0.000012876993,0.00009665486],"category_scores_gemma":[0.00030817502,0.000053951637,0.0001477022,0.00025287096,0.000023250554,0.000058150137,0.00003142564,0.00017146234,0.00008732568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027261522,0.0031732959,0.17121391,0.00022832585,0.00058799516,0.0018988559,0.0045948313,0.000014798168,0.0010526042,0.000054631044,0.7619182,0.028001059],"study_design_scores_gemma":[0.06400509,0.0044803326,0.6391383,0.0002465194,0.00022024866,0.000011060966,0.0005462496,0.000019330102,0.00011809153,0.000008742877,0.2911135,0.00009256824],"about_ca_topic_score_codex":5.604794e-7,"about_ca_topic_score_gemma":5.859113e-7,"teacher_disagreement_score":0.47080466,"about_ca_system_score_codex":0.000014822568,"about_ca_system_score_gemma":0.000027996599,"threshold_uncertainty_score":0.22000839},"labels":[],"label_agreement":null},{"id":"W4386191518","doi":"10.1002/ejhf.3003","title":"Sex Differences in Long-Term Outcomes Following Acute Heart Failure Hospitalization: Findings from the Get with the Guidelines-Heart Failure Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Population Health Research Institute","funders":"National Institute on Minority Health and Health Disparities; National Institute on Aging; Alnylam Pharmaceuticals; Gilead Sciences; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Duke Clinical Research Institute; Novo Nordisk; Cytokinetics; Sanofi; American Heart Association","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Proportional hazards model; Population; Cardiology","score_opus":0.0281363794632341,"score_gpt":0.2879032371351922,"score_spread":0.2597668576719581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386191518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5987668,0.00024281119,0.00015194718,0.39993906,0.00025780863,0.0005105034,0.000012937972,0.000086361535,0.000031779487],"genre_scores_gemma":[0.98193157,0.00004948691,0.010574203,0.004271328,0.00073220796,0.000016215234,0.00008544586,0.00012113784,0.0022184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99584484,0.0006593668,0.0010766478,0.0005170251,0.0012133451,0.0006887545],"domain_scores_gemma":[0.9978389,0.00042206183,0.00031894745,0.00087549834,0.0002604975,0.00028409273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018492938,0.00056530745,0.0010368621,0.00028497755,0.00043819318,0.00032520038,0.00059831695,0.00010385715,0.00019744124],"category_scores_gemma":[0.00027365691,0.00028329992,0.0005827794,0.00093865057,0.0001760545,0.0004044299,0.00022535195,0.00093580637,0.00025527057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004814443,0.000053427,0.5421718,0.000018741435,0.0004735493,0.0008510201,0.0006311134,0.000016637076,0.00032784973,0.0000093655335,0.45532146,0.00007693207],"study_design_scores_gemma":[0.0028565081,0.00058406364,0.6914174,0.0008551112,0.00052099774,0.00030647332,0.002267703,0.000017759729,0.00012415137,0.000010389088,0.3007377,0.0003017551],"about_ca_topic_score_codex":0.000039595892,"about_ca_topic_score_gemma":0.00026407483,"teacher_disagreement_score":0.39566773,"about_ca_system_score_codex":0.000094412724,"about_ca_system_score_gemma":0.00018094457,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W4386271232","doi":"10.1002/ejhf.3004","title":"August 2023 at a Glance: Focus on Epidemiology and Medical Therapy","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; Public health; General surgery; Internal medicine; Surgery; Pathology","score_opus":0.03952949608684571,"score_gpt":0.31273860092872596,"score_spread":0.27320910484188027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386271232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50093555,0.0012736908,0.000042130672,0.49358627,0.00034292313,0.0002803383,0.0000034017453,0.00008555708,0.003450118],"genre_scores_gemma":[0.96598685,0.0035850857,0.0067667197,0.010053615,0.0019940143,0.0000055007936,0.000019067287,0.00009902466,0.011490148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978612,0.0006427305,0.00052283,0.00020930638,0.00040478268,0.00035915058],"domain_scores_gemma":[0.9987687,0.00034711635,0.00014133814,0.00021924572,0.00006414934,0.0004594472],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028915661,0.00017633116,0.00052266184,0.00023576911,0.00010420961,0.000010170056,0.000100167184,0.000056251498,0.0010272223],"category_scores_gemma":[0.0005000355,0.000114906004,0.00016863651,0.00022167811,0.000104762905,0.000050392693,0.000089062814,0.00039896526,0.001118242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040438425,0.00008424891,0.020841435,0.000020146343,0.00015660813,0.002756588,0.0001021143,0.0000026888142,0.00033968885,0.00016597734,0.96082634,0.014299774],"study_design_scores_gemma":[0.0034175944,0.0019958143,0.08502616,0.00022214314,0.00003606655,0.0011082338,0.00007110678,0.000020040485,0.00009096739,0.00007883883,0.90784043,0.00009262117],"about_ca_topic_score_codex":0.000004336792,"about_ca_topic_score_gemma":0.000007491335,"teacher_disagreement_score":0.48353264,"about_ca_system_score_codex":0.00004727095,"about_ca_system_score_gemma":0.00005687674,"threshold_uncertainty_score":0.999886},"labels":[],"label_agreement":null},{"id":"W4386347321","doi":"10.1002/ejhf.3021","title":"Relationship Between Baseline Electrocardiographic Measurements and Outcomes in Patients with High-Risk Heart Failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Duke Clinical Research Institute; Merck Sharp and Dohme; Bayer","keywords":"Medicine; Heart failure; Interquartile range; Ejection fraction; Cardiology; Internal medicine; Hazard ratio; QRS complex; Sudden death; Natriuretic peptide; Left ventricular hypertrophy; Confidence interval; Blood pressure","score_opus":0.022752414803850426,"score_gpt":0.25478839524980773,"score_spread":0.2320359804459573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386347321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98321354,0.000048142654,0.000083797204,0.0139873745,0.00017888952,0.0023859215,0.0000134008915,0.00007943918,0.000009495657],"genre_scores_gemma":[0.99544066,0.0000051327193,0.0037559376,0.00013684404,0.00046315865,0.000027469632,0.000082871076,0.00007450138,0.0000134503025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943692,0.0022097796,0.0008834681,0.00057420414,0.0014698985,0.0004934344],"domain_scores_gemma":[0.99810094,0.00041031855,0.00041702212,0.00049609155,0.00031955942,0.00025605233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019321793,0.0004934342,0.0010113923,0.00064797985,0.00029523505,0.00013210702,0.00014331134,0.00009147845,0.000009819448],"category_scores_gemma":[0.00028041826,0.00028743187,0.0001466199,0.0022031253,0.000085191925,0.00052914367,0.0000530292,0.0010197049,0.00002800425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011098826,0.0006200502,0.9789062,0.0000146642915,0.00053663994,0.000085655396,0.00028376558,0.00011242121,0.000048859172,0.000001960737,0.008241597,0.000049337617],"study_design_scores_gemma":[0.058931068,0.008623196,0.92375994,0.00030854074,0.00072690693,0.000017090713,0.0010027646,0.0000032629032,0.00003536958,0.00001534945,0.0063022776,0.0002742495],"about_ca_topic_score_codex":0.00031881419,"about_ca_topic_score_gemma":0.0027532002,"teacher_disagreement_score":0.0551463,"about_ca_system_score_codex":0.00029033903,"about_ca_system_score_gemma":0.00017366729,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W4386466601","doi":"10.1002/ejhf.3029","title":"Comorbidities and Clinical Response to Cardiac Resynchronization Therapy: Patient-Level Meta-Analysis from Eight Clinical Trials","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Biosense Webster; National Heart, Lung, and Blood Institute; Respicardia; Idorsia Pharmaceuticals; British Heart Foundation; Merit Medical Systems; Janssen Pharmaceuticals; MyoKardia; Boston Scientific Corporation; Bristol-Myers Squibb; AtriCure; American Heart Association; Sanofi; Servier; Amgen","keywords":"Medicine; Comorbidity; Internal medicine; Heart failure; Cardiac resynchronization therapy; Hazard ratio; Atrial fibrillation; Discontinuation; Cardiology; Coronary artery disease; Confidence interval; Randomized controlled trial; Ejection fraction","score_opus":0.5673672097534903,"score_gpt":0.5134190491623425,"score_spread":0.05394816059114782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386466601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084662816,0.9936273,0.00018052506,0.0025296528,0.0010211581,0.0007062384,0.0009190203,0.000041069165,0.00012842617],"genre_scores_gemma":[0.000487718,0.99270254,0.0031959566,0.0003654733,0.002518184,0.0000047151475,0.000114012684,0.00011780379,0.00049356616],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96319294,0.029863803,0.0053569763,0.00054053555,0.00080290186,0.00024283689],"domain_scores_gemma":[0.98342514,0.012480693,0.0022849354,0.0006604258,0.0006595755,0.00048920984],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.030457873,0.0004962764,0.0137869455,0.0008567184,0.00014917029,0.00012524912,0.00008005848,0.00020444559,0.00007251843],"category_scores_gemma":[0.011734554,0.00030266136,0.012555375,0.00096611265,0.00015137182,0.00007320164,0.00016460342,0.0009321498,0.00021690638],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014041248,0.00007391215,0.0008655591,0.0003292444,0.41474235,0.00026356595,0.0003233138,0.0000073444166,0.0000010584864,0.0000016239535,0.44030637,0.14168154],"study_design_scores_gemma":[0.000631752,0.000729057,0.0025104326,0.0007731621,0.22144154,0.000090714435,0.00011355308,3.428484e-7,2.7432768e-7,0.0000014886303,0.77350944,0.00019826091],"about_ca_topic_score_codex":0.000008317771,"about_ca_topic_score_gemma":0.0000028849447,"teacher_disagreement_score":0.33320305,"about_ca_system_score_codex":0.0000545078,"about_ca_system_score_gemma":0.0003941071,"threshold_uncertainty_score":0.99994254},"labels":[],"label_agreement":null},{"id":"W4386593166","doi":"10.1002/ejhf.3028","title":"Personalized Lifetime Prediction of Survival and Treatment Benefit in Patients with Heart Failure with Reduced Ejection Fraction: The LIFE-HF Model","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Universiteit Gent; Trinity College Dublin; University of Galway; Medical Research Council; National University of Ireland; European Society of Cardiology; Novartis; National Institute for Health and Care Research; Queen Mary University of London","keywords":"Medicine; Heart failure; Ejection fraction; Interquartile range; Hazard ratio; Internal medicine; Cardiology; Proportional hazards model; Natriuretic peptide; Heart failure with preserved ejection fraction; Confidence interval","score_opus":0.017246125171705106,"score_gpt":0.2319916654761153,"score_spread":0.2147455403044102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386593166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677468,0.000066174856,0.00011124579,0.031110955,0.00008019715,0.0006611403,0.00001435744,0.00004470901,0.00016440699],"genre_scores_gemma":[0.9932052,0.000050407572,0.0057306676,0.000121022786,0.00021144081,0.000008729257,0.000034531055,0.00005093511,0.00058705907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981861,0.00024242903,0.00048356765,0.0002451602,0.0005890479,0.00025365566],"domain_scores_gemma":[0.99900913,0.00006103267,0.00023270297,0.00024724848,0.00025038145,0.00019952186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062272686,0.0002464985,0.0005118496,0.00031415565,0.00013202096,0.000034886543,0.00005954685,0.000042597712,0.00005181236],"category_scores_gemma":[0.00003406698,0.00013723795,0.00011550351,0.00045399636,0.00009751751,0.00022649996,0.000027711802,0.00027785284,0.000021679785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006943651,0.0012959507,0.9049973,0.00013252615,0.0012107353,0.00014101621,0.001905678,0.004001423,0.001759059,0.00007598649,0.07627645,0.0012602446],"study_design_scores_gemma":[0.016985878,0.008516343,0.85511106,0.0006260987,0.00067589025,0.00012237116,0.0023050427,0.0010580075,0.00019097906,0.000008282242,0.11418739,0.00021265258],"about_ca_topic_score_codex":0.000017542388,"about_ca_topic_score_gemma":0.000033213255,"teacher_disagreement_score":0.049886215,"about_ca_system_score_codex":0.000108825,"about_ca_system_score_gemma":0.00012061385,"threshold_uncertainty_score":0.5596401},"labels":[],"label_agreement":null},{"id":"W4386704465","doi":"10.1002/ejhf.3033","title":"Assessing the Association Between Genetic and Phenotypic Features of Dilated Cardiomyopathy and Outcome in Patients with Coronary Artery Disease","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; Medical Research Council; Rosetrees Trust; Imperial College London; Sir Jules Thorn Charitable Trust; National Institute for Health and Care Research; National Heart and Lung Institute; British Heart Foundation; Wellcome Trust; Medical Research Council Canada; Israel Cancer Research Fund","keywords":"Medicine; Dilated cardiomyopathy; Cardiology; Internal medicine; Coronary artery disease; Heart failure; Cardiomyopathy; Outcome (game theory); Phenotype; Disease; Association (psychology); Gene; Genetics","score_opus":0.01388714803862337,"score_gpt":0.25233679859499025,"score_spread":0.23844965055636688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386704465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966702,0.0009042979,0.0000092352975,0.0021363893,0.0000653846,0.00015061372,0.000009925597,0.000009352284,0.00004462706],"genre_scores_gemma":[0.9994274,0.000042334228,0.0002558642,0.0000820575,0.00013954713,5.228521e-7,0.0000055328214,0.00001756255,0.000029198109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988153,0.0003092906,0.00032464231,0.00010461847,0.00030777368,0.00013837434],"domain_scores_gemma":[0.9993308,0.0001341203,0.00019990414,0.000103555365,0.00014047908,0.00009112322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007524977,0.00010475521,0.00036583043,0.00012910001,0.0000764449,0.00003287302,0.000037655358,0.000018065339,0.0000010620183],"category_scores_gemma":[0.00014525563,0.00006366929,0.00006729065,0.00019945303,0.00006171837,0.00010593787,0.000054500426,0.00024597291,0.0000012845784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013356187,0.000017624614,0.99541897,0.000050320377,0.00015970918,0.00019703589,0.0004082419,0.000012129503,0.00005967955,6.5837105e-7,0.0010925471,0.002449497],"study_design_scores_gemma":[0.0018819841,0.0002578815,0.9957975,0.00023884437,0.00033397778,0.000052801715,0.0003572572,0.0000015693325,0.000004762011,0.0000056854524,0.0010045774,0.000063145424],"about_ca_topic_score_codex":0.0000012927694,"about_ca_topic_score_gemma":8.009221e-7,"teacher_disagreement_score":0.0027572066,"about_ca_system_score_codex":0.000029105671,"about_ca_system_score_gemma":0.000028916762,"threshold_uncertainty_score":0.25963584},"labels":[],"label_agreement":null},{"id":"W4386705477","doi":"10.1002/ejhf.3031","title":"Heart Failure Patients with Improved Ejection Fraction: Insights from the MECKI Score Database","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Ministero della Salute; AstraZeneca","keywords":"Ejection fraction; Medicine; Heart failure; Cardiology; Internal medicine; Clinical endpoint; Natriuretic peptide; Renal function; Heart transplantation; Transplantation; Kidney disease; Database; Clinical trial","score_opus":0.012908322655450175,"score_gpt":0.22056899097720706,"score_spread":0.2076606683217569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386705477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854832,0.00021478531,0.00061232026,0.012121091,0.0010056109,0.00033358712,0.000029154866,0.00010197631,0.00009825509],"genre_scores_gemma":[0.9948799,0.00003738026,0.0019497761,0.0010607678,0.0016582501,0.0000011852323,0.00016376983,0.000071173105,0.00017779919],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793416,0.00046554662,0.00042911613,0.00025137578,0.0007045731,0.00021520369],"domain_scores_gemma":[0.99850106,0.00009734291,0.00021815121,0.00050357543,0.0004372559,0.0002426068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005125861,0.00021549742,0.00039722145,0.00018903762,0.00027948275,0.00007646112,0.000119425866,0.00004844369,0.0002160496],"category_scores_gemma":[0.00015811538,0.000117413714,0.00038371005,0.00055996457,0.00007137326,0.00033598472,0.00005615556,0.0008446225,0.00035893134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085213466,0.00015768142,0.36638382,0.000026201658,0.0007036963,0.00022674279,0.00030495174,0.00007176433,0.00740391,0.000004658143,0.623002,0.00086245907],"study_design_scores_gemma":[0.0022805992,0.00045546755,0.4270058,0.00019022936,0.0001903234,0.00016186795,0.0006741111,0.00001930525,0.000477605,0.000002029278,0.5684386,0.00010408795],"about_ca_topic_score_codex":0.00003035908,"about_ca_topic_score_gemma":0.00003715926,"teacher_disagreement_score":0.06062196,"about_ca_system_score_codex":0.00006234013,"about_ca_system_score_gemma":0.00010585938,"threshold_uncertainty_score":0.47879925},"labels":[],"label_agreement":null},{"id":"W4386758072","doi":"10.1002/ejhf.3036","title":"Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Statement (logic); Cardiology; Internal medicine; Algorithm; Intensive care medicine; Computer science","score_opus":0.07453152896729641,"score_gpt":0.360294006343419,"score_spread":0.2857624773761226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386758072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65032804,0.00017950674,0.00013196153,0.34745103,0.00040922585,0.0012889545,0.00016825696,0.000034207565,0.000008822201],"genre_scores_gemma":[0.86355364,0.00009077627,0.13345912,0.001433614,0.0010518203,0.00002287658,0.00003343588,0.00011411763,0.00024058748],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939525,0.0019083607,0.0019093164,0.00045446123,0.0011754447,0.0005999312],"domain_scores_gemma":[0.9948392,0.0024222725,0.001040453,0.0006119053,0.0007480275,0.00033817743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004942253,0.00038920462,0.0011577586,0.00018282214,0.00030280495,0.000106029154,0.00022298662,0.00015549059,0.000089738875],"category_scores_gemma":[0.0017355478,0.00024309022,0.0007542325,0.00051042746,0.00027859234,0.00020401954,0.0002541794,0.00087997457,0.00003314584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002595788,0.0003610456,0.3684533,0.000104459796,0.00070372206,0.000049371047,0.00045937183,0.000048109552,0.0015115131,0.000028453604,0.6278411,0.00017993995],"study_design_scores_gemma":[0.005827269,0.0020733129,0.28359818,0.0011897533,0.0012034902,0.00015800448,0.0027734234,0.0003295706,0.002137366,0.000052114516,0.7003873,0.00027021195],"about_ca_topic_score_codex":0.00011945796,"about_ca_topic_score_gemma":0.00012635076,"teacher_disagreement_score":0.34601742,"about_ca_system_score_codex":0.00014020913,"about_ca_system_score_gemma":0.0003631046,"threshold_uncertainty_score":0.9912932},"labels":[],"label_agreement":null},{"id":"W4386878079","doi":"10.1002/ejhf.3037","title":"Phenotype, Outcomes and Natural History of Early-Stage Non-Ischaemic Cardiomyopathy","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; Rosetrees Trust; Imperial College London; Servier; Sir Jules Thorn Charitable Trust; Idorsia Pharmaceuticals; British Heart Foundation; National Institute for Health and Care Research; Wellcome Trust; British Society for Heart Failure; European Society of Cardiology; Israel Cancer Research Fund; Boston Scientific Corporation; MyoKardia; Bristol-Myers Squibb; AstraZeneca; Pfizer; Amgen; Respicardia; Abbott Laboratories","keywords":"Medicine; Internal medicine; Cardiology; Ejection fraction; Mace; Hazard ratio; Interquartile range; Cardiomyopathy; Heart failure; Dilated cardiomyopathy; Confidence interval; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.013032935358539834,"score_gpt":0.23130152977228924,"score_spread":0.2182685944137494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386878079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452996,0.0018127233,0.000058142585,0.0013382384,0.0014732478,0.000097217955,0.000003862265,0.000032901225,0.00065368856],"genre_scores_gemma":[0.99343354,0.0001533986,0.0006197681,0.00018057857,0.00029369473,2.1872727e-7,0.0000032749715,0.00003699993,0.0052785026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987571,0.00018055805,0.00038512397,0.00012644618,0.0003899705,0.00016080619],"domain_scores_gemma":[0.99923646,0.000038866317,0.00016096831,0.00022406157,0.00017487808,0.00016476525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008720687,0.00013401982,0.00052156136,0.00029793315,0.000031575706,0.000008073437,0.00006911362,0.000029486753,0.0000613425],"category_scores_gemma":[0.00010754765,0.00009564332,0.0005132347,0.0001634764,0.00009237299,0.00009156565,0.00005071777,0.00042655758,0.0000778844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042893013,0.000052364077,0.6828645,0.00020970954,0.0010120615,0.0016543297,0.0025422901,0.000051584728,0.022348726,0.00001607249,0.2848266,0.003992824],"study_design_scores_gemma":[0.0012365883,0.00020745005,0.5815601,0.00007415448,0.000116683674,0.00033542194,0.00026301367,0.000008052382,0.00010516097,6.502017e-7,0.4160235,0.0000692564],"about_ca_topic_score_codex":0.000013391066,"about_ca_topic_score_gemma":0.0000015317115,"teacher_disagreement_score":0.13119689,"about_ca_system_score_codex":0.000069698996,"about_ca_system_score_gemma":0.00011586034,"threshold_uncertainty_score":0.39002213},"labels":[],"label_agreement":null},{"id":"W4386878742","doi":"10.1002/ejhf.3039","title":"Non-Cardiac Comorbidities and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights from the STRONG-HF Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Strong","keywords":"Medicine; Heart failure; Comorbidity; Clinical endpoint; Internal medicine; Adverse effect; Incidence (geometry); Stroke (engine); Diabetes mellitus; Surrogate endpoint; Randomized controlled trial; Endocrinology","score_opus":0.02554818312561501,"score_gpt":0.27071851701945676,"score_spread":0.24517033389384174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386878742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668685,0.00016197545,0.000025006637,0.030233597,0.0007006721,0.0019099743,0.000043605254,0.000020450523,0.000036219237],"genre_scores_gemma":[0.9952539,0.00011094414,0.003520683,0.00028674002,0.00037869142,0.000023063998,0.00016026454,0.00004319957,0.00022252052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806154,0.0003647565,0.0007233637,0.00022523268,0.00037203165,0.00025306205],"domain_scores_gemma":[0.99876916,0.00018113705,0.0002630795,0.00025134682,0.00039993454,0.0001353278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050105725,0.00024650196,0.0007275856,0.00021008434,0.000098924706,0.00004858305,0.00008774013,0.000047070487,0.000026385995],"category_scores_gemma":[0.00016204324,0.00015403682,0.0003019176,0.00023275765,0.00009384255,0.0001907742,0.000051032315,0.00018179894,0.000025252364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018290836,0.00067587604,0.107697174,0.00007101246,0.0011318716,0.0000805402,0.005451317,0.000016067072,0.001255876,0.00010447573,0.8623965,0.0028284572],"study_design_scores_gemma":[0.08282527,0.011557697,0.34075078,0.0004337501,0.0005443959,0.0000067485744,0.0042197714,0.000037585858,0.001051333,0.00006125189,0.55828595,0.00022545233],"about_ca_topic_score_codex":0.00006719496,"about_ca_topic_score_gemma":0.000064099935,"teacher_disagreement_score":0.30411056,"about_ca_system_score_codex":0.000094769806,"about_ca_system_score_gemma":0.00009729581,"threshold_uncertainty_score":0.6281439},"labels":[],"label_agreement":null},{"id":"W4387157072","doi":"10.1002/ejhf.3044","title":"Calcium Channel Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"AstraZeneca","keywords":"Medicine; Ejection fraction; Heart failure; Dihydropyridine; Heart failure with preserved ejection fraction; Cardiology; Internal medicine; Calcium channel blocker; Calcium channel; Calcium","score_opus":0.022894646164265876,"score_gpt":0.2547713698385577,"score_spread":0.23187672367429182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627347,0.000061882856,0.00001718905,0.036600124,0.00008118788,0.00045101525,0.0000038380035,0.000038024642,0.000012032406],"genre_scores_gemma":[0.99465585,0.000033559092,0.004466469,0.000298606,0.00010115554,0.000003210857,0.000012598529,0.000041411196,0.00038717096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985617,0.00023748829,0.00037045937,0.00025186664,0.0003188862,0.00025960707],"domain_scores_gemma":[0.99927163,0.00006687462,0.00012404665,0.00016076396,0.00014458253,0.00023209945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005185179,0.00021257589,0.00042624766,0.0004060365,0.00010642198,0.00009052588,0.00003188687,0.000046505542,0.000013221186],"category_scores_gemma":[0.000103198756,0.00014985634,0.000053422435,0.00024802057,0.00005941163,0.00047153013,0.000066278204,0.000327356,0.00001248413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003828446,0.00014045356,0.9469562,0.000059865204,0.0001114606,0.00011200553,0.00015921277,0.0000059672357,0.00075382093,0.0000018283874,0.05119971,0.00011662318],"study_design_scores_gemma":[0.0049179993,0.0013222448,0.9238153,0.00024979486,0.0001116509,0.00007485221,0.0003734191,0.00003442989,0.00013885638,0.0000038234766,0.068826176,0.00013143514],"about_ca_topic_score_codex":0.000027050952,"about_ca_topic_score_gemma":0.000035033005,"teacher_disagreement_score":0.03630152,"about_ca_system_score_codex":0.000036761394,"about_ca_system_score_gemma":0.000023329887,"threshold_uncertainty_score":0.6110964},"labels":[],"label_agreement":null},{"id":"W4387356963","doi":"10.1002/ejhf.3049","title":"Safety of Continuing Mineralocorticoid Receptor Antagonist Treatment in Patients with Heart Failure with Reduced Ejection Fraction and Severe Kidney Disease: Data from Swedish Heart Failure Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biosense Webster; HORIZON EUROPE Framework Programme; Universität Zürich; Servier; Karolinska Institutet; Hjärt-Lungfonden; Mundipharma Medical Company, Basel; Boston Scientific Corporation; Hamilton Health Sciences; Amgen; Cardinal Health; Edwards Lifesciences; Cytokinetics; Sanofi; Novo Nordisk; Teva Pharmaceutical Industries; Stockholms Läns Landsting; ZOLL Medical Corporation; AstraZeneca; Vifor Pharma; Vetenskapsrådet; Pfizer","keywords":"Medicine; Heart failure; Ejection fraction; Hazard ratio; Internal medicine; Kidney disease; Renal function; Dialysis; Cardiology; Mineralocorticoid receptor; Population; Confidence interval; Aldosterone","score_opus":0.014847593303585031,"score_gpt":0.24355323429744916,"score_spread":0.22870564099386412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387356963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97365236,0.00010295393,0.000026909793,0.025341323,0.00010481595,0.00047414302,0.00023450208,0.00003882721,0.000024132307],"genre_scores_gemma":[0.9896901,0.00004920557,0.008243818,0.00026420713,0.00035515832,0.0000020312377,0.0011029256,0.000065835105,0.00022672112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765825,0.00032334673,0.0006920028,0.00042385564,0.0006367269,0.00026583814],"domain_scores_gemma":[0.9981644,0.00007179958,0.00040566068,0.0005362275,0.00036899856,0.00045288863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041705024,0.00028039116,0.00066104246,0.00026588666,0.00011904043,0.000060798342,0.00010670888,0.000058918267,0.00009933497],"category_scores_gemma":[0.00022993614,0.00019549752,0.00008962065,0.00042782398,0.00011205165,0.0004654582,0.000060457707,0.0003948113,0.000023114619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069657103,0.00039834675,0.6711556,0.00007636954,0.00018268812,0.00020745184,0.00019616008,0.000053642027,0.034698773,0.0000014452537,0.2854005,0.0006632978],"study_design_scores_gemma":[0.0062980247,0.0011496672,0.64140856,0.0012438736,0.00018090449,0.00018343794,0.00063253177,0.000094458934,0.00029215298,0.0000010377025,0.3483472,0.0001681766],"about_ca_topic_score_codex":0.000065809,"about_ca_topic_score_gemma":0.000072528346,"teacher_disagreement_score":0.062946655,"about_ca_system_score_codex":0.00013762114,"about_ca_system_score_gemma":0.00027048847,"threshold_uncertainty_score":0.79721576},"labels":[],"label_agreement":null},{"id":"W4387563265","doi":"10.1002/ejhf.3055","title":"Outcomes at One Year in Women with Peripartum Cardiomyopathy: Findings from the ESC EORP PPCM Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Abbott Vascular; Novartis Pharma; Servier; Bayer; Gedeon Richter; British Heart Foundation; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; ResMed","keywords":"Peripartum cardiomyopathy; Medicine; Ejection fraction; Heart failure; Stroke (engine); Internal medicine; Cardiology; Cardiomyopathy","score_opus":0.013881545880032879,"score_gpt":0.2341106609598555,"score_spread":0.22022911507982262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98301965,0.0010345605,0.000024077648,0.014416099,0.00026081747,0.00019490227,0.000012162311,0.000048069083,0.0009896468],"genre_scores_gemma":[0.995453,0.0001255216,0.0017216475,0.00057389325,0.0005441461,0.0000035916826,0.000007290903,0.0000832176,0.0014876758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769956,0.00045356542,0.00045867346,0.00024011085,0.00075383356,0.00039424197],"domain_scores_gemma":[0.9987019,0.00012575515,0.00013890439,0.0007327705,0.00011307862,0.00018764024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018201198,0.00019911936,0.00065758615,0.00014609468,0.000100929115,0.000051095853,0.0002932897,0.000041096777,0.00018039034],"category_scores_gemma":[0.00031732646,0.00012767389,0.0003004013,0.00041437714,0.00012421366,0.00010793417,0.00019220119,0.000670069,0.0004553077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010025402,0.00008636309,0.7974356,0.00007834626,0.0011924467,0.01202684,0.008514506,0.00020427993,0.0021096873,0.000014328432,0.17606626,0.0012688229],"study_design_scores_gemma":[0.0029713768,0.00027968604,0.6435366,0.00092028093,0.00012933006,0.0011087143,0.0019211748,0.0000028452268,0.0001828939,0.000012196796,0.34878936,0.00014548571],"about_ca_topic_score_codex":0.0000072623347,"about_ca_topic_score_gemma":0.000008714555,"teacher_disagreement_score":0.1727231,"about_ca_system_score_codex":0.00018039846,"about_ca_system_score_gemma":0.000086373955,"threshold_uncertainty_score":0.5852211},"labels":[],"label_agreement":null},{"id":"W4387713068","doi":"10.1002/ejhf.3047","title":"September 2023 at a Glance: Focus on Acute Heart Failure and Health Status","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Radiological weapon; Cardiac catheterization; Public health; General surgery; Internal medicine; Cardiology; Surgery; Pathology","score_opus":0.02386042938960948,"score_gpt":0.29768095337510453,"score_spread":0.27382052398549506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387713068","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43989304,0.000977719,0.00003835319,0.5552019,0.00057652296,0.00084375474,0.000044160075,0.00021737644,0.0022072007],"genre_scores_gemma":[0.9342078,0.00090190064,0.03141204,0.008555357,0.0017574454,0.00001250083,0.0000969163,0.0002605934,0.022795472],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714917,0.00031438915,0.0007049103,0.00037669548,0.00068110955,0.00077374594],"domain_scores_gemma":[0.99831295,0.000092782815,0.00024767127,0.00040482363,0.00013275458,0.00080898916],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013868215,0.00034824456,0.00076052226,0.0004425031,0.00025709494,0.00006418444,0.000104877116,0.000053072225,0.00044905857],"category_scores_gemma":[0.000049629965,0.00026278663,0.0002785985,0.0005085241,0.000081105856,0.00015594729,0.00015973496,0.000549444,0.0025346586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024721585,0.00010642455,0.015340559,0.00008271315,0.00031542126,0.0013790894,0.0002818635,0.000010447218,0.00094964355,0.000049727947,0.97991085,0.001326043],"study_design_scores_gemma":[0.0038171886,0.0028034884,0.060951427,0.00045306742,0.00013256546,0.0010289564,0.00028359165,0.000013091043,0.00023064928,0.000023987264,0.9300659,0.0001961341],"about_ca_topic_score_codex":0.000012837765,"about_ca_topic_score_gemma":0.000062934305,"teacher_disagreement_score":0.54664654,"about_ca_system_score_codex":0.00021355385,"about_ca_system_score_gemma":0.00015744277,"threshold_uncertainty_score":0.9999824},"labels":[],"label_agreement":null},{"id":"W4388033147","doi":"10.1002/ejhf.3071","title":"Interaction of Heart Failure and Stroke: A Clinical Consensus Statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Servier; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; Cytokinetics; Alexion Pharmaceuticals; Amarin Corporation; Vifor Pharma; Pfizer; LivaNova; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Edwards Lifesciences; Amgen; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Heart failure; Medicine; Stroke (engine); Statement (logic); Internal medicine; Cardiology","score_opus":0.104742664970564,"score_gpt":0.3398292743980061,"score_spread":0.23508660942744208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72005874,0.00011222121,0.00001371944,0.27844867,0.00055009854,0.00056325056,0.000015198389,0.000020227017,0.00021788575],"genre_scores_gemma":[0.9963825,0.00013673493,0.000792181,0.0012414414,0.00077840977,9.5290517e-7,0.0000036173333,0.00003369952,0.00063047005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99527353,0.0017684383,0.0012073565,0.00023008125,0.0012704695,0.00025011975],"domain_scores_gemma":[0.9962307,0.0018965044,0.0010583368,0.0003396813,0.00037632074,0.00009841883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077672484,0.0002226619,0.00068477535,0.0001308965,0.00026302316,0.00008927337,0.00014600446,0.0000725642,0.000042899446],"category_scores_gemma":[0.0014230651,0.0001145221,0.00043103512,0.00031009514,0.00023616813,0.000098965575,0.00013485062,0.0008167158,0.000019832596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018423593,0.000062001185,0.42085916,0.00009149911,0.00084488746,0.000010694774,0.0010043758,0.00035927433,0.0034052217,0.00043588874,0.5703567,0.00072790147],"study_design_scores_gemma":[0.0052284645,0.0010743736,0.3617673,0.0006299247,0.00038836402,0.000037462563,0.0035513307,0.0001758198,0.00023043003,0.000028779185,0.62677115,0.00011659863],"about_ca_topic_score_codex":0.000015662588,"about_ca_topic_score_gemma":0.00006657889,"teacher_disagreement_score":0.27720726,"about_ca_system_score_codex":0.00014434032,"about_ca_system_score_gemma":0.00010522579,"threshold_uncertainty_score":0.46700758},"labels":[],"label_agreement":null},{"id":"W4388033533","doi":"10.1002/ejhf.3075","title":"Characteristics and Outcomes of Patients with Atrial Versus Ventricular Secondary Tricuspid Regurgitation Undergoing Tricuspid Transcatheter Edge-to-Edge Repair – Results from the TriValve Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; St. Paul's Hospital; Université Laval; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Regurgitation (circulation); Atrial fibrillation; Hazard ratio; Tricuspid valve; Heart failure; Confidence interval","score_opus":0.012771295730342698,"score_gpt":0.26433357247586614,"score_spread":0.25156227674552345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949582,0.00033645766,0.000023509652,0.0032373348,0.00048556714,0.00040010604,0.00045844322,0.00003125051,0.00006912765],"genre_scores_gemma":[0.9983703,0.00007426558,0.000630652,0.0001250944,0.0004620001,0.0000010334876,0.00022913759,0.000041976404,0.00006556179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998014,0.00033442705,0.00070994836,0.00023883105,0.0004995446,0.00020328104],"domain_scores_gemma":[0.9980186,0.0006551605,0.0004724044,0.00034290118,0.00028555188,0.00022535257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059495843,0.00020359804,0.0005394356,0.00016513174,0.000105467254,0.00003657465,0.000099275545,0.000038005026,0.000014033736],"category_scores_gemma":[0.0008066488,0.000120807876,0.001298548,0.0003696666,0.00005406157,0.00010786366,0.000037069494,0.00025569854,0.00001989741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025857823,0.00039004488,0.9172787,0.00011163203,0.004916061,0.0007332553,0.0012422783,0.00003995035,0.000045655735,0.000005860174,0.042679634,0.0066991136],"study_design_scores_gemma":[0.021641064,0.0017469174,0.95898706,0.00024136719,0.0017207436,0.00001878447,0.00030460744,0.0000029246746,0.000018486997,0.0000032934822,0.0151958885,0.00011888036],"about_ca_topic_score_codex":0.0000046471414,"about_ca_topic_score_gemma":0.0000010943209,"teacher_disagreement_score":0.04170835,"about_ca_system_score_codex":0.000051309973,"about_ca_system_score_gemma":0.00013495656,"threshold_uncertainty_score":0.49264023},"labels":[],"label_agreement":null},{"id":"W4388033944","doi":"10.1002/ejhf.3070","title":"October 2023 at a Glance: From Prevention to Diagnosis, Prognosis and Treatment of Acute Decompensation and Comorbidities","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Decompensation; Intensive care medicine; Heart failure; Comorbidity; Internal medicine","score_opus":0.16146552176637918,"score_gpt":0.3916996722637954,"score_spread":0.2302341504974162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033944","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58447754,0.010491202,0.00017990266,0.04993717,0.34635863,0.001629126,0.006749827,0.000048684495,0.00012793494],"genre_scores_gemma":[0.04811274,0.035867732,0.039248746,0.0014547168,0.8667009,0.0002972979,0.0020159378,0.00061846414,0.005683512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949043,0.00079922687,0.0033873476,0.000440049,0.0002144151,0.00025468136],"domain_scores_gemma":[0.99402744,0.0020667044,0.0032026884,0.0002683573,0.00019080029,0.00024402655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0057364665,0.00028760085,0.0014977923,0.00043077514,0.00013974788,0.00011366013,0.00016745883,0.00016672674,0.00016372283],"category_scores_gemma":[0.0015832671,0.00031203235,0.00019827147,0.00012766727,0.000065007494,0.00026855062,0.00009584967,0.00023235542,0.00038282943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057638452,0.00007219471,0.017787023,0.00014498107,0.00039743743,0.00001148731,0.0012665674,0.00000875851,0.000004739081,0.000031938856,0.979982,0.00023520779],"study_design_scores_gemma":[0.0013372586,0.0010673888,0.03604383,0.00069493544,0.00010547338,0.000008308315,0.0002523699,0.000018911638,0.000011437371,0.00022794398,0.95998377,0.0002483611],"about_ca_topic_score_codex":0.0002664259,"about_ca_topic_score_gemma":0.00037497267,"teacher_disagreement_score":0.5363648,"about_ca_system_score_codex":0.00043226458,"about_ca_system_score_gemma":0.00013264893,"threshold_uncertainty_score":0.9999332},"labels":[],"label_agreement":null},{"id":"W4388034165","doi":"10.1002/ejhf.3074","title":"Early Changes in Renal Function During Rapid Up-Titration of Guideline-Directed Medical Therapy Following an Admission for Acute Heart Failure","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Roche Diagnostics","keywords":"Medicine; Guideline; Heart failure; Renal function; Medical therapy; Intensive care medicine; Cardiology; Internal medicine; Pathology","score_opus":0.025095203037526582,"score_gpt":0.30549571241978607,"score_spread":0.28040050938225947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388034165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92467386,0.0002039044,0.00043941094,0.07337237,0.0005175862,0.00062568625,0.0000048617817,0.00013424482,0.000028075427],"genre_scores_gemma":[0.9740948,0.00018221817,0.023127623,0.0006143991,0.0011910942,0.000014453868,0.0001099952,0.00009860592,0.0005667754],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718124,0.0004313422,0.0009441729,0.00028033016,0.00078961777,0.00037327723],"domain_scores_gemma":[0.998779,0.00008167917,0.00025107924,0.00025699372,0.00026973564,0.00036151218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002366868,0.00024354461,0.000588502,0.0006551929,0.0001218728,0.000036211168,0.00013013127,0.00009672098,0.0002740197],"category_scores_gemma":[0.0002500124,0.00018703312,0.00032199998,0.0005594131,0.000035848898,0.00031249778,0.00003996917,0.0003592897,0.000025221103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040893815,0.00047366024,0.011135753,0.00014427846,0.0009878384,0.00096266624,0.0015365356,0.000050729654,0.52087206,0.000024508168,0.44778794,0.011934655],"study_design_scores_gemma":[0.018015811,0.008405609,0.09303502,0.0015505478,0.00045378465,0.00036795108,0.00088728295,0.00046646918,0.024895826,0.000024639106,0.8515188,0.00037823964],"about_ca_topic_score_codex":0.000007794454,"about_ca_topic_score_gemma":0.000052378655,"teacher_disagreement_score":0.4959762,"about_ca_system_score_codex":0.000058162805,"about_ca_system_score_gemma":0.00016455073,"threshold_uncertainty_score":0.76269895},"labels":[],"label_agreement":null},{"id":"W4388035423","doi":"10.1002/ejhf.3076","title":"Incidence, Risk Assessment and Prevention of Sudden Cardiac Death in Cardiomyopathies","year":2023,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiovascular Effects of Exercise","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Incidence (geometry); Heart failure; Sudden cardiac death; Internal medicine; Cardiology; Risk assessment; Cardiomyopathy; Sudden death; Intensive care medicine","score_opus":0.033472856073837286,"score_gpt":0.3492223804015882,"score_spread":0.31574952432775094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388035423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038362965,0.994487,0.00005565081,0.00008701151,0.0003410927,0.0009160383,0.000026942014,0.00001891321,0.00023107699],"genre_scores_gemma":[0.0018954151,0.9921894,0.005109809,0.0000048137363,0.0005705857,0.0000067045803,0.000016207838,0.0001209236,0.00008612086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99392647,0.003339337,0.0013936964,0.00030465497,0.00078302785,0.00025283254],"domain_scores_gemma":[0.9977535,0.00030545265,0.0009754355,0.0005243911,0.0002433464,0.0001978877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008098502,0.00037230467,0.0038396316,0.00092137285,0.00004124448,0.00004111154,0.00018159066,0.000118628355,0.000008406346],"category_scores_gemma":[0.0005226772,0.00028792958,0.002326814,0.0005245695,0.00007594398,0.00014913065,0.00019443709,0.0012807738,0.000025865322],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098782264,0.00011834673,0.0118672205,0.037762117,0.0040236423,0.0053776246,0.00021904358,0.00002439038,0.000015968459,0.000016220874,0.017412834,0.9230638],"study_design_scores_gemma":[0.0011090899,0.00081146054,0.035616048,0.08111976,0.006884364,0.0023714523,0.00010469731,0.0000012317954,0.0000025562326,0.000020082383,0.87167364,0.00028560468],"about_ca_topic_score_codex":0.000017757135,"about_ca_topic_score_gemma":0.0000034264917,"teacher_disagreement_score":0.9227782,"about_ca_system_score_codex":0.00015315453,"about_ca_system_score_gemma":0.00054001,"threshold_uncertainty_score":0.99995726},"labels":[],"label_agreement":null},{"id":"W4388458640","doi":"10.1002/ejhf.3079","title":"Sacubitril/Valsartan Compared to Ramipril in High-Risk Post-Myocardial Infarction Patients Stratified According to Use of Mineralocorticoid Receptor Antagonists: Insight from the PARADISE MI Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Ramipril; Valsartan; Mineralocorticoid receptor; Heart failure; Myocardial infarction; Spironolactone; Internal medicine; Cardiology; Sacubitril, Valsartan; Ivabradine; Aldosterone","score_opus":0.029600779791757865,"score_gpt":0.25806170274014834,"score_spread":0.22846092294839046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388458640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850398,0.000027683072,0.00003368674,0.013507128,0.00065877923,0.00063198805,0.000067878165,0.000019208923,0.000013854531],"genre_scores_gemma":[0.99565846,0.000028356906,0.0023856012,0.0011208269,0.00063860626,0.0000023361697,0.000092095295,0.000035754972,0.00003794278],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972818,0.0007079011,0.0009797792,0.00020211606,0.00060806994,0.00022032332],"domain_scores_gemma":[0.9983585,0.00027975175,0.00033602782,0.00026571847,0.0004727189,0.0002872785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007163115,0.00017309957,0.0006455871,0.00032403308,0.00010071385,0.00006932215,0.00012761132,0.00004455002,0.000043305477],"category_scores_gemma":[0.0012318186,0.00011979999,0.0001940022,0.0006153657,0.00003704273,0.00019717819,0.000059564965,0.00036047495,0.00009591718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07450993,0.0005830631,0.32699758,0.0000191229,0.00032444266,0.00026839433,0.003480706,0.0019478815,0.34267694,0.00002163585,0.2400782,0.009092081],"study_design_scores_gemma":[0.017462289,0.0017092042,0.8701111,0.00024431982,0.000109693385,0.000017790744,0.00049417093,0.000085953834,0.0009939283,0.000004428843,0.108632125,0.00013496536],"about_ca_topic_score_codex":0.0002591377,"about_ca_topic_score_gemma":0.0000722615,"teacher_disagreement_score":0.5431135,"about_ca_system_score_codex":0.000072244016,"about_ca_system_score_gemma":0.00012090906,"threshold_uncertainty_score":0.48853016},"labels":[],"label_agreement":null},{"id":"W4388458875","doi":"10.1002/ejhf.3080","title":"Un(b)locking Therapeutic Options: Potential for Calcium Channel Blockers in Heart Failure with Non-Reduced Left Ventricular Ejection Fraction","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Miller; Cardiology; Library science","score_opus":0.014335010185202245,"score_gpt":0.27140703775733005,"score_spread":0.2570720275721278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388458875","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021173358,0.001962941,0.016916156,0.1765296,0.77552766,0.0072061573,0.00013305768,0.00049566146,0.000055393964],"genre_scores_gemma":[0.121431954,0.000386717,0.058789242,0.00047925735,0.8148664,0.00010897276,0.0010386335,0.00094985793,0.0019489091],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579996,0.00050504087,0.0010973334,0.00061326224,0.0012584974,0.0007259108],"domain_scores_gemma":[0.9975757,0.00026820862,0.0006509949,0.00043930233,0.0007448335,0.000320947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018562456,0.0006415865,0.0011778123,0.0011700515,0.00028860618,0.00015799182,0.00021016311,0.00036966734,0.00006386134],"category_scores_gemma":[0.0002513208,0.0005143821,0.000655572,0.000561538,0.00006810004,0.0003048605,0.000067642315,0.0017784149,0.0001222179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000870296,0.00032986698,0.00016978796,0.00028833494,0.0008507276,0.0012438471,0.00012222496,0.0005240961,0.0016382085,0.0000014231285,0.99373585,0.0002253543],"study_design_scores_gemma":[0.007074789,0.0026116576,0.0007154231,0.001940531,0.0013129781,0.0004752735,0.0007756976,0.00019627769,0.00053228776,0.000010512863,0.98390335,0.0004512204],"about_ca_topic_score_codex":0.000030378022,"about_ca_topic_score_gemma":0.000032938548,"teacher_disagreement_score":0.17605034,"about_ca_system_score_codex":0.0004972994,"about_ca_system_score_gemma":0.00044787768,"threshold_uncertainty_score":0.99973077},"labels":[],"label_agreement":null},{"id":"W4388462111","doi":"10.1002/ejhf.3081","title":"Guideline-Directed Medical Therapy in Severe Heart Failure with Reduced Ejection Fraction: An Analysis from the HELP-HF Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Abbott Vascular; Acceleron; AstraZeneca; Amgen; Vifor Pharma; Abbott Laboratories","keywords":"Medicine; Ejection fraction; Hazard ratio; Heart failure; Internal medicine; Guideline; Cardiology; Valsartan; Confidence interval; Blood pressure; Pathology","score_opus":0.020354348286824777,"score_gpt":0.28651923817946023,"score_spread":0.2661648898926355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388462111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72856325,0.00017926013,0.00025923207,0.2699867,0.00019460545,0.00039194679,0.000008261685,0.00020148906,0.0002152355],"genre_scores_gemma":[0.97214586,0.00018489943,0.021281393,0.003427696,0.0018810438,0.000008417021,0.0002090541,0.00009059011,0.0007710602],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959478,0.0011291469,0.00093334465,0.00041517284,0.0011822438,0.00039230697],"domain_scores_gemma":[0.99807894,0.00017518939,0.0003086741,0.00067649,0.00035873783,0.0004019386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002384841,0.00031458147,0.0007130567,0.00052617484,0.00019592918,0.000100083285,0.00025999825,0.0001079016,0.001341898],"category_scores_gemma":[0.0002409704,0.00018832891,0.00034105204,0.0020228412,0.000091230475,0.0003072773,0.000053158943,0.00092991197,0.00019278371],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000810196,0.00029510073,0.12627287,0.0000104874425,0.001253982,0.0016208444,0.00040194837,0.0003348314,0.001986137,0.0000043482837,0.8646664,0.0023428656],"study_design_scores_gemma":[0.0039464445,0.0011923256,0.20641856,0.00027424886,0.00051908783,0.0005924271,0.0029180674,0.00057840144,0.00023889294,0.00000880468,0.7830933,0.0002194629],"about_ca_topic_score_codex":0.00020395861,"about_ca_topic_score_gemma":0.0006674071,"teacher_disagreement_score":0.266559,"about_ca_system_score_codex":0.00012678232,"about_ca_system_score_gemma":0.00026211445,"threshold_uncertainty_score":0.999571},"labels":[],"label_agreement":null},{"id":"W4388637909","doi":"10.1002/ejhf.3090","title":"Association of Neighbourhood-Level Material Deprivation with Adverse Outcomes and Processes of Care Among Patients with Heart Failure in a Single-Payer Healthcare System: A Population-Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut du Savoir Montfort; University of Ottawa; St. Michael's Hospital; Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network; Montfort Hospital; Women's College Hospital","funders":"Ministry of Long-Term Care; Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Hazard ratio; Interquartile range; Confidence interval; Proportional hazards model; Heart failure; Population; Cohort study; Internal medicine; Demography; Emergency medicine; Environmental health","score_opus":0.01150120439451032,"score_gpt":0.23415341509615636,"score_spread":0.22265221070164604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388637909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940695,0.000010905085,0.000018627701,0.004312694,0.000058894268,0.0014525413,0.000032745094,0.000033787866,0.000010285508],"genre_scores_gemma":[0.9959787,9.412412e-7,0.0037456194,0.00004493338,0.000046177527,0.0000111023155,0.00010120788,0.000044516797,0.000026809983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757195,0.00037884718,0.0007829328,0.00022804464,0.0008084202,0.00022983919],"domain_scores_gemma":[0.9980657,0.000080884776,0.00067804795,0.00019752221,0.0008569472,0.000120899094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006693465,0.0002212089,0.0007216143,0.00046305847,0.00006662758,0.000023649056,0.00006279015,0.000046053075,0.000013462898],"category_scores_gemma":[0.00014264519,0.00015125249,0.00006617475,0.00056675944,0.000026135613,0.00022677807,0.00002916797,0.00016791005,0.0000025029278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060971465,0.0003872213,0.9958459,0.0011188912,0.00021087484,0.000049255723,0.0009112715,0.00014409,0.000052263826,0.0000015260327,0.00061828323,0.00005068527],"study_design_scores_gemma":[0.0064691594,0.0032049303,0.98447657,0.0014417431,0.00031003836,0.0000065984354,0.0035932371,0.0000074440527,0.00010419512,3.4458452e-7,0.00026205482,0.00012369645],"about_ca_topic_score_codex":0.00024057973,"about_ca_topic_score_gemma":0.001750005,"teacher_disagreement_score":0.011369364,"about_ca_system_score_codex":0.00022886579,"about_ca_system_score_gemma":0.00014807183,"threshold_uncertainty_score":0.61678976},"labels":[],"label_agreement":null},{"id":"W4388638069","doi":"10.1002/ejhf.3091","title":"The Use of Mineralocorticoid Receptor Antagonists for Patients with Heart Failure with a Reduced Ejection Fraction: A Time for Reassessment","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Library science; Cardiology; Family medicine","score_opus":0.015598087371509719,"score_gpt":0.26517868609225587,"score_spread":0.24958059872074614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388638069","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08007819,0.0003256455,0.004070895,0.21774445,0.6672756,0.027541675,0.0022709975,0.0005811027,0.00011142115],"genre_scores_gemma":[0.0040430776,0.00020552195,0.44793388,0.00033137674,0.5241474,0.00045246942,0.0035857495,0.0011050757,0.018195461],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962805,0.0003519504,0.0011035901,0.0004689927,0.0012709273,0.00052403065],"domain_scores_gemma":[0.9944441,0.001241812,0.0011695832,0.0005657999,0.0022918414,0.000286916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011073011,0.0005306935,0.0010904033,0.00030378735,0.00034684953,0.00018871401,0.00018233615,0.00017989537,0.000034663903],"category_scores_gemma":[0.0008455459,0.00030578053,0.00046875203,0.00032972993,0.00012657144,0.00030536985,0.000049812,0.0007228791,0.00003996095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006517811,0.0004422849,0.00079263607,0.00033672122,0.0010252412,0.000026320668,0.0000485808,0.000014907834,0.0006306682,0.0000020109708,0.9896998,0.000463036],"study_design_scores_gemma":[0.0076524722,0.012524562,0.0010328469,0.0015849632,0.001151206,0.000028747316,0.00011867666,0.000012034699,0.00011806016,0.0000013787126,0.97547996,0.0002950933],"about_ca_topic_score_codex":0.000013275382,"about_ca_topic_score_gemma":0.00003198218,"teacher_disagreement_score":0.443863,"about_ca_system_score_codex":0.00030186,"about_ca_system_score_gemma":0.00066769327,"threshold_uncertainty_score":0.99993944},"labels":[],"label_agreement":null},{"id":"W4388922027","doi":"10.1002/ejhf.3087","title":"Rationale and Design of the ESC Heart Failure III Registry – Implementation and Discovery","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation; Surgical Specialties (Canada)","funders":"Daiichi Sankyo Europe; Abbott Vascular; Servier; Vifor Pharma; Novartis Pharma; Universität Zürich; Boston Scientific Corporation; European Society of Cardiology; Cytokinetics; Ministero dell’Istruzione, dell’Università e della Ricerca; Teva Pharmaceutical Industries; Agence Nationale de la Recherche; Bayer; Bristol-Myers Squibb; AstraZeneca; Edwards Lifesciences; Amgen","keywords":"Medicine; Heart failure; Clinical trial; Ejection fraction; Guideline; Demographics; Psychological intervention; Intensive care medicine; Internal medicine; Emergency medicine; Pathology","score_opus":0.023335362145855142,"score_gpt":0.2734211606431173,"score_spread":0.25008579849726215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388922027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72400516,0.00048290144,0.0016473912,0.27226922,0.0002218859,0.0011928783,0.000017781225,0.00004051049,0.00012225499],"genre_scores_gemma":[0.9809684,0.00009514267,0.016675051,0.00050279044,0.00023803274,0.0000036799313,0.000012907674,0.000030055498,0.0014739312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985921,0.00030667268,0.0004315916,0.00015064696,0.00034506668,0.0001739182],"domain_scores_gemma":[0.9993029,0.00008745386,0.000197572,0.00020189336,0.00010063209,0.000109527784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009543774,0.00013749335,0.00027554706,0.0001360375,0.00012978062,0.000056328885,0.00006970398,0.000023137405,0.00005521855],"category_scores_gemma":[0.00005537295,0.00008909301,0.00010211551,0.00022698875,0.000097950244,0.0002528801,0.00008918778,0.00018605443,0.0000133246185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001786639,0.00006547631,0.028973514,0.00011897454,0.00019281333,0.00010347036,0.0007243935,0.0000587162,0.02861063,0.0003043058,0.9397846,0.0008844805],"study_design_scores_gemma":[0.0053694732,0.0010530232,0.18304195,0.00043569205,0.00031556113,0.00091054046,0.0044572954,0.00004865008,0.004140004,0.00010162719,0.79994345,0.00018271813],"about_ca_topic_score_codex":0.0000058294327,"about_ca_topic_score_gemma":0.000010147235,"teacher_disagreement_score":0.27176642,"about_ca_system_score_codex":0.00002280605,"about_ca_system_score_gemma":0.000089572175,"threshold_uncertainty_score":0.36331075},"labels":[],"label_agreement":null},{"id":"W4388922100","doi":"10.1002/ejhf.3092","title":"Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Corvia Medical","keywords":"Medicine; Internal medicine; Cardiology; Heart failure; Ejection fraction; Heart failure with preserved ejection fraction; Pulmonary wedge pressure; Obesity; Cardiac output; Body mass index; Cardiomyopathy; Hemodynamics","score_opus":0.021243173639733857,"score_gpt":0.246784455069474,"score_spread":0.22554128142974014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388922100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97073525,0.00024281854,0.00008087292,0.027289845,0.00095472205,0.00040198586,0.0000038654853,0.000072568706,0.00021809478],"genre_scores_gemma":[0.9953319,0.00006075056,0.00083960046,0.00040975926,0.0027392386,0.000002588909,0.000020664727,0.00004763747,0.00054788054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972594,0.001046089,0.0005196976,0.0002533641,0.00070021395,0.0002212561],"domain_scores_gemma":[0.998813,0.00013759252,0.00019813467,0.0004347647,0.0002294424,0.00018707827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001135353,0.0001971948,0.00049614586,0.00023328708,0.00029273165,0.0000637304,0.00013539652,0.00007324732,0.00023873022],"category_scores_gemma":[0.0002484161,0.000114529284,0.00043813107,0.0007452933,0.00006848777,0.00027206982,0.00006512031,0.0010982169,0.00021604775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014769754,0.00040373477,0.11464928,0.000025690551,0.00061371725,0.0007681752,0.00093931286,0.0004739875,0.007812923,0.000009074941,0.8592243,0.00031004223],"study_design_scores_gemma":[0.015579961,0.0010056816,0.32460994,0.00021291089,0.00012427743,0.00033237733,0.0012867344,0.000015045968,0.00061478256,0.000007954598,0.6561023,0.00010804298],"about_ca_topic_score_codex":0.000082712235,"about_ca_topic_score_gemma":0.00016187497,"teacher_disagreement_score":0.20996064,"about_ca_system_score_codex":0.00008563077,"about_ca_system_score_gemma":0.00015818699,"threshold_uncertainty_score":0.47712666},"labels":[],"label_agreement":null},{"id":"W4389452999","doi":"10.1002/ejhf.3102","title":"European Society of Cardiology Core Curriculum for Cardio-Oncology","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Horizon 2020 Framework Programme; Engineering and Physical Sciences Research Council; Ministero della Salute","keywords":"Medicine; Internal medicine; Certification; Oncology; Curriculum; Clinical Oncology; Harmonization; Core curriculum; Standardization; Cancer","score_opus":0.0396532997894854,"score_gpt":0.3068837439280269,"score_spread":0.2672304441385415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389452999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97597975,0.0003418089,0.0032873177,0.014265793,0.00074596924,0.00047119614,0.000031438198,0.00007982746,0.0047969073],"genre_scores_gemma":[0.9863118,0.00018128763,0.010223945,0.0006661543,0.0023105494,0.000001506111,0.00002796976,0.00006430583,0.00021246384],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823844,0.00047873743,0.00058964285,0.00017536715,0.00024901674,0.00026881753],"domain_scores_gemma":[0.9987354,0.000111253314,0.00031101814,0.00022914639,0.00044988538,0.00016327885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025173335,0.0001529534,0.000699536,0.00012609434,0.00008172191,0.0000084544545,0.00013985261,0.00006615036,0.000013613688],"category_scores_gemma":[0.00014219624,0.00012735542,0.0009683114,0.00027622157,0.00012495168,0.00006513876,0.000046386038,0.00040531807,0.000046398476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014047188,0.000034659028,0.003272563,0.0001429984,0.00048075258,0.00021917732,0.00070264906,0.00019722989,0.43109292,0.000034126955,0.5581996,0.005482899],"study_design_scores_gemma":[0.0038185294,0.002043792,0.01201023,0.00020331677,0.00022063238,0.0022353837,0.0017091989,0.00005817346,0.01771381,0.00003164583,0.95981264,0.00014262712],"about_ca_topic_score_codex":9.671115e-7,"about_ca_topic_score_gemma":3.1565983e-7,"teacher_disagreement_score":0.4133791,"about_ca_system_score_codex":0.00006888264,"about_ca_system_score_gemma":0.00013999875,"threshold_uncertainty_score":0.51934034},"labels":[],"label_agreement":null},{"id":"W4389453114","doi":"10.1002/ejhf.3093","title":"Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Maladaptation; Climate change; Global warming; Damages; Natural disaster; Global health; Natural resource economics; Interdependence; Deforestation (computer science); Environmental planning; Environmental resource management; Business; Political science; Medicine; Economic growth; Geography; Health care; Economics; Law; Ecology","score_opus":0.016644928013645234,"score_gpt":0.3158287930744679,"score_spread":0.2991838650608226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389453114","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022953985,0.0038846217,0.000004085342,0.34082508,0.62549514,0.0009870126,0.0015221175,0.00012705458,0.00420089],"genre_scores_gemma":[0.0021718198,0.016213864,0.0018100978,0.00933436,0.96613264,0.0000070676974,0.00020621294,0.00037645164,0.0037474572],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960845,0.00065318,0.00082861667,0.000388417,0.0012288784,0.0008163917],"domain_scores_gemma":[0.99793345,0.00017844321,0.00058216363,0.00038202878,0.00006561769,0.000858314],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0030076508,0.0003575893,0.00060969195,0.0000953616,0.00046862394,0.00011738793,0.0005843065,0.0002255754,0.0031468219],"category_scores_gemma":[0.00055930053,0.0002496247,0.00016681274,0.0005277166,0.000072442665,0.00018598173,0.0005681724,0.0016170709,0.009115023],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007081198,0.000038326474,0.00017405144,0.00008222197,0.00001989865,0.000082573686,0.0006067193,0.000011007505,0.000021475158,8.1306996e-7,0.9974334,0.0014586699],"study_design_scores_gemma":[0.0003703525,0.0011352608,0.0045887684,0.00031257982,0.000053735428,0.00006209248,0.00025141682,8.9582295e-7,0.000002821456,0.00004173684,0.99296445,0.00021590477],"about_ca_topic_score_codex":0.00010375539,"about_ca_topic_score_gemma":0.00015458032,"teacher_disagreement_score":0.34063753,"about_ca_system_score_codex":0.000361432,"about_ca_system_score_gemma":0.00012241321,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W4389670597","doi":"10.1002/ejhf.3096","title":"November 2023 at a Glance: Focus on Cardiogenic Shock, Post-Discharge Outcomes and Cardiomyopathies","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiac Structural Anomalies and Repair","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Institute of Circulatory and Respiratory Health","keywords":"Medicine; Cardiogenic shock; Cardiac catheterization; Radiological weapon; General surgery; Cardiology; Internal medicine; Surgery; Myocardial infarction","score_opus":0.007106003382718086,"score_gpt":0.2435930311559619,"score_spread":0.23648702777324382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389670597","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09804508,0.0058612926,0.0000013937582,0.015561955,0.8771355,0.0004603914,0.0009670387,0.00012604364,0.0018412971],"genre_scores_gemma":[0.03485813,0.0012906928,0.00043688554,0.000335164,0.9450983,0.00000434656,0.00018450162,0.0003539686,0.017438045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622774,0.00042635633,0.0009013457,0.0004894743,0.0014314618,0.00052361883],"domain_scores_gemma":[0.99736476,0.00055939273,0.00048023098,0.0005240674,0.0006337993,0.00043776998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011225016,0.00060536276,0.0019510456,0.00035921903,0.00021836924,0.00008991905,0.00020590465,0.00029822454,0.00010771824],"category_scores_gemma":[0.00094021886,0.00039258227,0.0018282996,0.00022396936,0.000150009,0.000088081164,0.00032762473,0.0017311021,0.00033433328],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005636003,0.000015257492,0.0026552272,0.00022816921,0.0011574762,0.002473048,0.00012961659,0.0000058628407,0.0004381009,0.000002831959,0.9919458,0.00038502936],"study_design_scores_gemma":[0.002298682,0.001209911,0.033937108,0.0007921082,0.0006966153,0.0015117644,0.00015490646,6.0987907e-7,0.000040188654,0.000005087682,0.9589653,0.00038770825],"about_ca_topic_score_codex":0.00003210175,"about_ca_topic_score_gemma":0.000025536036,"teacher_disagreement_score":0.06796276,"about_ca_system_score_codex":0.00018111471,"about_ca_system_score_gemma":0.00022600166,"threshold_uncertainty_score":0.9998526},"labels":[],"label_agreement":null},{"id":"W4390055066","doi":"10.1002/ejhf.3109","title":"Effective Medications can Work Only in Patients Who Take Them: Implications for Post-Acute Heart Failure Care","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Chapel; Library science; Gerontology; Family medicine; Art history; History","score_opus":0.012621809570394204,"score_gpt":0.26834915130962655,"score_spread":0.25572734173923234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390055066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6637179,0.00012768594,0.00016757633,0.3322971,0.00033624805,0.0025855198,0.00016846083,0.00012811102,0.00047141252],"genre_scores_gemma":[0.98477995,0.000021032361,0.012438042,0.0013352766,0.00039221405,0.00006686461,0.00033471623,0.00009298284,0.0005388979],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99789447,0.00029801446,0.00065271277,0.00031656204,0.0003676091,0.00047065143],"domain_scores_gemma":[0.99811053,0.00021229769,0.00021159991,0.00043307265,0.00067982747,0.000352663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006163146,0.0002738159,0.000545756,0.00045795846,0.00021394646,0.00004957836,0.00020106147,0.00006277758,0.000069860565],"category_scores_gemma":[0.00022272687,0.00022045813,0.0003276101,0.0008701685,0.00007323524,0.00014555556,0.00008142945,0.00041280896,0.00020025032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022191406,0.00023371166,0.36519906,0.00008288389,0.00035871443,0.000054647462,0.00203798,0.000017403225,0.0002788509,0.000080164005,0.6263819,0.005052809],"study_design_scores_gemma":[0.0027653244,0.00091631303,0.5908923,0.00029948354,0.0002231004,0.000050643408,0.00074909924,0.0000012056976,0.00004861609,0.000011637237,0.40391573,0.00012649383],"about_ca_topic_score_codex":0.000012812504,"about_ca_topic_score_gemma":0.000108644286,"teacher_disagreement_score":0.3309618,"about_ca_system_score_codex":0.00019442261,"about_ca_system_score_gemma":0.00023522113,"threshold_uncertainty_score":0.89900213},"labels":[],"label_agreement":null},{"id":"W4390055443","doi":"10.1002/ejhf.3114","title":"Independent Prognostic Importance of Blood Urea Nitrogen to Creatinine Ratio in Heart Failure","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"British Heart Foundation","keywords":"Medicine; Creatinine; Blood urea nitrogen; Heart failure; Internal medicine; Cardiology; Urea nitrogen","score_opus":0.01619517244384075,"score_gpt":0.2617421863175157,"score_spread":0.24554701387367497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390055443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9082442,0.00025399422,0.00007261999,0.08998901,0.000120561104,0.0009024946,0.000009725945,0.00006864246,0.0003387425],"genre_scores_gemma":[0.971149,0.000021984562,0.026782386,0.0007684207,0.0003468476,0.000011605372,0.000025653886,0.00007293687,0.00082111446],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969432,0.0003357449,0.0011679634,0.00031382294,0.0007540545,0.00048526467],"domain_scores_gemma":[0.99847585,0.0001092882,0.00029194047,0.00041382833,0.00029007564,0.00041903617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016356099,0.00029717517,0.000769498,0.0007537132,0.00006231772,0.000037460686,0.00019646127,0.000056628818,0.00031207156],"category_scores_gemma":[0.00041846282,0.0002394996,0.00027299885,0.001018765,0.00006053024,0.00017428621,0.00012608797,0.00046694657,0.0003631217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024145456,0.0004741269,0.64809644,0.0001372749,0.00031182915,0.0023224317,0.0006975285,0.00012659367,0.018278569,0.00010566655,0.3289885,0.00021958126],"study_design_scores_gemma":[0.008321376,0.005000408,0.38003397,0.001468226,0.0006795702,0.0014942616,0.0015129981,0.000024921548,0.0069084493,0.00006368837,0.59405994,0.00043219075],"about_ca_topic_score_codex":0.000009258076,"about_ca_topic_score_gemma":0.000074902215,"teacher_disagreement_score":0.26806247,"about_ca_system_score_codex":0.000051815696,"about_ca_system_score_gemma":0.00018729352,"threshold_uncertainty_score":0.976651},"labels":[],"label_agreement":null},{"id":"W4390057148","doi":"10.1002/ejhf.3113","title":"Unraveling Heart Failure Cardiogenic Shock Profiles and Pathways","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Cardiogenic shock; Medicine; Heart failure; Boulevard; Family medicine; Internal medicine; Library science; Myocardial infarction; Engineering","score_opus":0.012486346093827908,"score_gpt":0.21268092791875856,"score_spread":0.20019458182493066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390057148","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011542923,0.005765383,0.00041907298,0.0012926537,0.9792169,0.00046785275,0.00038468395,0.0007049896,0.00020557796],"genre_scores_gemma":[0.07736882,0.00020695526,0.009494901,0.00007517364,0.9116649,0.00000671501,0.00014002046,0.0008975243,0.00014500992],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956492,0.0005519849,0.0013538568,0.0004725543,0.0012968053,0.0006755914],"domain_scores_gemma":[0.9975869,0.0005694957,0.00032965207,0.00054520066,0.0004093953,0.00055937667],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023877537,0.000669796,0.001291784,0.00041603227,0.0001523563,0.00025751817,0.00058850134,0.0004456737,0.000113845745],"category_scores_gemma":[0.00074623077,0.00062018435,0.0005921722,0.00033328115,0.0000634531,0.00028337468,0.00018666888,0.0028040183,0.0005613973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011575501,0.000007994994,0.000109837114,0.00048119182,0.00030498047,0.0005095152,0.000111395246,0.0006975033,0.0023979817,0.0000050694657,0.99521387,0.00014910423],"study_design_scores_gemma":[0.0005367924,0.00016952051,0.00014644764,0.00086762855,0.00019798147,0.00024150425,0.00018871795,0.00013579083,0.00041716138,0.000023850536,0.99648666,0.00058794476],"about_ca_topic_score_codex":0.0000022063416,"about_ca_topic_score_gemma":0.0000079330575,"teacher_disagreement_score":0.06755198,"about_ca_system_score_codex":0.000111819194,"about_ca_system_score_gemma":0.00022398616,"threshold_uncertainty_score":0.99962497},"labels":[],"label_agreement":null},{"id":"W4390106648","doi":"10.1002/ejhf.3120","title":"Real-World Candidacy to Mavacamten in a Contemporary Hypertrophic Obstructive Cardiomyopathy Population","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Ministero della Salute","keywords":"Medicine; Cardiology; Internal medicine; Hypertrophic cardiomyopathy; Ejection fraction; Population; Heart failure; Ventricular outflow tract obstruction; Ventricular outflow tract; Cardiomyopathy; Atrial fibrillation","score_opus":0.031911426787302084,"score_gpt":0.2867174536490647,"score_spread":0.2548060268617626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390106648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844372,0.0004015928,0.000010185588,0.010882616,0.00045117675,0.00028072434,0.000011285841,0.00005328822,0.0034719124],"genre_scores_gemma":[0.9967915,0.00006414297,0.0013758973,0.00036090874,0.00084364694,0.0000030418405,0.000011510598,0.00004682962,0.0005025276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981137,0.00038510223,0.00061426533,0.00021117649,0.0003985321,0.00027725968],"domain_scores_gemma":[0.999123,0.00006473473,0.00015730831,0.00022572836,0.00019978832,0.00022946528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011321276,0.00018228362,0.000667854,0.0008200864,0.00008495903,0.000025711224,0.00009547239,0.000025642497,0.000012718682],"category_scores_gemma":[0.00019412901,0.0001509397,0.00027074225,0.0010286405,0.00003574301,0.00014236575,0.0000941931,0.00039129463,0.00011114136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011386563,0.000055406254,0.79788834,0.000088177665,0.00023637718,0.008969954,0.0026303965,0.00023650347,0.008387283,0.000058098787,0.17714101,0.0031697983],"study_design_scores_gemma":[0.0015930426,0.00038357556,0.88195646,0.00038529513,0.00005565923,0.0006979719,0.0009905538,0.0000045365778,0.00009226799,0.000026640837,0.11367949,0.00013452827],"about_ca_topic_score_codex":0.00021129417,"about_ca_topic_score_gemma":0.00005345778,"teacher_disagreement_score":0.084068105,"about_ca_system_score_codex":0.00013666983,"about_ca_system_score_gemma":0.00009359305,"threshold_uncertainty_score":0.6155142},"labels":[],"label_agreement":null},{"id":"W4390107208","doi":"10.1002/ejhf.3118","title":"Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Roche Diagnostics; Shionogi; Duke Clinical Research Institute; Eisai; Daiichi-Sankyo; Zora Biosciences; Pfizer; Moderna; ARCA Biopharma; Medicines Company; Regado Biosciences; Belvoir Media Group; Novo Nordisk; MyoKardia; Allergan; AstraZeneca; Amarin Corporation; American Heart Association; Intarcia Therapeutics; Ironwood Pharmaceuticals, Incorporated; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; Abbott Laboratories; CSL Behring; Amgen; St. Jude Medical; Kowa Company; Abiomed; Sanofi; National Institutes of Health; Regeneron Pharmaceuticals","keywords":"Medicine; TIMI; Interquartile range; Internal medicine; Hazard ratio; Heart failure; Cardiology; Confidence interval; Body mass index; Natriuretic peptide; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.020731323765873142,"score_gpt":0.28336032233278446,"score_spread":0.2626289985669113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390107208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372476,0.002536271,0.00038750374,0.05809956,0.00022355541,0.0008358683,0.00004256877,0.00015093776,0.00047615523],"genre_scores_gemma":[0.97034365,0.0007243771,0.026787803,0.00051921146,0.0003857702,0.0000038262915,0.00002922277,0.00011624909,0.0010899169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958398,0.00080860755,0.0012261571,0.00053958857,0.0009118903,0.0006739851],"domain_scores_gemma":[0.99752337,0.00027179875,0.0005478769,0.0005589427,0.00040259134,0.0006954373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018893465,0.0005446211,0.0012861647,0.000972358,0.00030065404,0.00016048274,0.00021513274,0.00013681859,0.0002657458],"category_scores_gemma":[0.0003695753,0.0004264918,0.00043197867,0.0008607227,0.00033566586,0.00031410943,0.00020109014,0.00092779443,0.00014294674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008399856,0.00038668685,0.22338423,0.00065687194,0.0022677972,0.0025694172,0.0009871924,0.00039500007,0.062293924,0.000058338497,0.70406216,0.002098386],"study_design_scores_gemma":[0.009511694,0.0033498113,0.26587623,0.0012927805,0.0027673685,0.0015945866,0.0024426077,0.0007253265,0.0038913735,0.00013297601,0.70768356,0.00073166116],"about_ca_topic_score_codex":0.000054471842,"about_ca_topic_score_gemma":0.000040035884,"teacher_disagreement_score":0.05840255,"about_ca_system_score_codex":0.0000759883,"about_ca_system_score_gemma":0.0001853247,"threshold_uncertainty_score":0.9998187},"labels":[],"label_agreement":null},{"id":"W4390113359","doi":"10.1002/ejhf.3112","title":"The Role of Multimorbidity in Patients with Heart Failure Across the Left Ventricular Ejection Fraction Spectrum: Data from the Swedish Heart Failure Registry","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Ejection fraction; Heart failure; Comorbidity; Cardiology; Coronary artery disease; Heart failure with preserved ejection fraction; Population; Proportional hazards model; Kidney disease; Confidence interval","score_opus":0.013624832768366405,"score_gpt":0.24896927813383246,"score_spread":0.23534444536546606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390113359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96608734,0.00045952023,0.000083967076,0.032075457,0.0006398291,0.0004893515,0.00009932399,0.000044914355,0.000020269283],"genre_scores_gemma":[0.99791694,0.00007868121,0.0003996324,0.00026216797,0.0010563358,0.000001470057,0.00016405963,0.000058453257,0.000062281804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963901,0.0010494062,0.00068270427,0.00036007582,0.0011164856,0.00040124432],"domain_scores_gemma":[0.99745184,0.00030109918,0.00042240726,0.0013834055,0.0002884628,0.00015276123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026706979,0.00026290983,0.0005001259,0.00009579442,0.0005393483,0.00014203311,0.0004913866,0.00007942195,0.000093337374],"category_scores_gemma":[0.00047059188,0.00012589649,0.0004115825,0.0006387779,0.00021678556,0.00033629895,0.00020955123,0.0014437877,0.00011295796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039520347,0.00010961163,0.752997,0.000011609866,0.00025901353,0.000049858845,0.00021279219,0.00024246282,0.000498584,0.0000011364485,0.24499218,0.00023056431],"study_design_scores_gemma":[0.0013328313,0.00018218557,0.5220918,0.00013372094,0.000100408215,0.00019268985,0.0027735326,0.000055614037,0.00030576836,0.0000050698095,0.4727443,0.00008207515],"about_ca_topic_score_codex":0.00020967859,"about_ca_topic_score_gemma":0.0005070532,"teacher_disagreement_score":0.23090516,"about_ca_system_score_codex":0.00009384721,"about_ca_system_score_gemma":0.00012377082,"threshold_uncertainty_score":0.62726194},"labels":[],"label_agreement":null},{"id":"W4390120608","doi":"10.1002/ejhf.3106","title":"Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A Clinical Consensus Statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Regurgitation (circulation); Cardiology; Context (archaeology); Intensive care medicine; Internal medicine; Tricuspid Valve Insufficiency; Etiology","score_opus":0.0261816343628828,"score_gpt":0.3297412566560758,"score_spread":0.303559622293193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390120608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593628,0.005382324,0.000010539303,0.033950415,0.00021077298,0.0008967507,0.00013946705,0.000009552795,0.00003740273],"genre_scores_gemma":[0.9966222,0.0021996626,0.0007833092,0.00014519981,0.00011652348,0.0000068486274,0.000012928284,0.000027916663,0.00008542655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910816,0.0063343085,0.0015902185,0.00026043775,0.0004986673,0.00023476164],"domain_scores_gemma":[0.99581,0.0016030876,0.0015493303,0.00043933623,0.0004893974,0.00010889221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007678227,0.00020251675,0.0011206921,0.00011610063,0.00015551508,0.000011810931,0.0001311802,0.00006942894,0.000012161151],"category_scores_gemma":[0.0017777287,0.000111962545,0.0021316088,0.00032931767,0.00038939953,0.000051529663,0.00022688141,0.00036248227,0.0000027299063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038439286,0.00045638284,0.89743686,0.0010386137,0.009978078,0.00006188743,0.00044705963,0.00042638782,0.00067820173,0.00017158582,0.087380566,0.0015400148],"study_design_scores_gemma":[0.0050301775,0.00073232304,0.97808886,0.0014116061,0.0035519835,0.00013079135,0.0009621979,0.000028599503,0.00008216945,0.00015284789,0.009733258,0.00009520373],"about_ca_topic_score_codex":0.00002893342,"about_ca_topic_score_gemma":0.000016364313,"teacher_disagreement_score":0.08065201,"about_ca_system_score_codex":0.00011880175,"about_ca_system_score_gemma":0.00007376484,"threshold_uncertainty_score":0.45657003},"labels":[],"label_agreement":null},{"id":"W4390985431","doi":"10.1002/ejhf.3129","title":"The Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Left Cardiac Remodelling in Heart Failure with Reduced Ejection Fraction: Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Surgical Specialties (Canada)","funders":"","keywords":"Ejection fraction; Medicine; Cardiology; Internal medicine; Heart failure; Cardiac function curve; Confidence interval; End-diastolic volume; Stroke volume","score_opus":0.012219073280015903,"score_gpt":0.2477180501234903,"score_spread":0.2354989768434744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390985431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59129286,0.30849764,0.0004496046,0.09227819,0.0005235026,0.0059988545,0.000018240982,0.00011628727,0.0008248356],"genre_scores_gemma":[0.99749523,0.0010764704,0.0007004353,0.0002188583,0.00009011506,0.000008833828,0.0000063356015,0.000037345126,0.00036637584],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99756956,0.00087176054,0.00075343624,0.00021298413,0.0004303495,0.00016193592],"domain_scores_gemma":[0.9990621,0.00021081975,0.00024150538,0.0002976687,0.00009525688,0.00009264586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027388001,0.0002250554,0.0016584632,0.00032500172,0.0000677406,0.00006543213,0.000059999948,0.000025197452,0.000034740064],"category_scores_gemma":[0.000038893137,0.00010754555,0.00086144503,0.0004487483,0.000042122883,0.00015408342,0.000010993706,0.00037195062,0.000016246988],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016412539,0.00051081466,0.018378912,0.32766265,0.50196964,0.0018367862,0.0014926359,0.0017707982,0.0070253415,0.00009253311,0.13711904,0.00049959874],"study_design_scores_gemma":[0.0015709555,0.005018136,0.0018178979,0.028036274,0.9104586,0.0002664536,0.00036596216,0.000119267126,0.0062477677,0.000004661408,0.04575546,0.0003385526],"about_ca_topic_score_codex":0.0000032025814,"about_ca_topic_score_gemma":0.0000066108987,"teacher_disagreement_score":0.40848896,"about_ca_system_score_codex":0.00005409173,"about_ca_system_score_gemma":0.000022220434,"threshold_uncertainty_score":0.438558},"labels":[],"label_agreement":null},{"id":"W4391139980","doi":"10.1002/ejhf.3149","title":"December 2023 at a Glance: Focus on Medical Therapy in Chronic and Acute Heart Failure","year":2023,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Intensive care medicine; Medical therapy; Cardiology; Internal medicine","score_opus":0.012694266366389732,"score_gpt":0.2873810993936584,"score_spread":0.2746868330272687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391139980","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027023394,0.0072269435,0.000026754602,0.38479573,0.5773076,0.0021619052,0.0001519315,0.00028202758,0.0010237349],"genre_scores_gemma":[0.0077734366,0.011976788,0.0046773055,0.001342242,0.9581874,0.000041690604,0.00033910334,0.000721877,0.014940166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99394554,0.0007965921,0.0012433156,0.00069619564,0.0024763774,0.0008419597],"domain_scores_gemma":[0.99700814,0.00090102974,0.0004007918,0.0006134978,0.00027334664,0.0008032044],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025095185,0.00073944434,0.001629213,0.0007512112,0.00015082114,0.00010087191,0.00034488415,0.00053064164,0.0009007306],"category_scores_gemma":[0.00077036256,0.0005442372,0.00050428923,0.0004979925,0.00021056931,0.00014612653,0.00028203492,0.002874213,0.0012624126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009272476,0.0001723158,0.00045206284,0.00014058668,0.00067823514,0.007930717,0.00013497852,0.0000035631303,0.00024453396,0.0000074754794,0.9875707,0.0017375534],"study_design_scores_gemma":[0.009993256,0.004827117,0.0010387216,0.0027257616,0.00024487005,0.00051569106,0.000051170027,0.0000068667305,0.000070621005,0.00001152475,0.9801133,0.00040110035],"about_ca_topic_score_codex":0.00002528718,"about_ca_topic_score_gemma":0.00058430794,"teacher_disagreement_score":0.3834535,"about_ca_system_score_codex":0.0007474227,"about_ca_system_score_gemma":0.0010056624,"threshold_uncertainty_score":0.9997009},"labels":[],"label_agreement":null},{"id":"W4391229193","doi":"10.1002/ejhf.3150","title":"Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiac resynchronization therapy; Guideline; Implantable cardioverter-defibrillator; Intensive care medicine; Heart disease; Cardiology; Internal medicine; Ejection fraction; Pathology","score_opus":0.026516842664278166,"score_gpt":0.2919952822027765,"score_spread":0.2654784395384983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391229193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97928566,0.0008430248,0.00007264697,0.018337028,0.00034276085,0.00044052923,0.00013481322,0.000022258118,0.0005212826],"genre_scores_gemma":[0.9960867,0.0001645295,0.0025821414,0.0005223432,0.0005074984,8.9663536e-7,0.000024915329,0.0000530628,0.000057915222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925875,0.004491409,0.0015250352,0.00030182392,0.0008165785,0.00027766675],"domain_scores_gemma":[0.99657196,0.001130171,0.0009953842,0.00032756833,0.0008816912,0.00009321379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070376573,0.00025739943,0.0010751626,0.00010550993,0.0001303092,0.000053124542,0.00007228668,0.00007551237,0.0000060435655],"category_scores_gemma":[0.000546447,0.00015218029,0.00054756255,0.00040151045,0.00015755088,0.0001228147,0.000100355326,0.0007531045,0.000010509148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022686712,0.00005261411,0.7145717,0.000044480832,0.0006299052,0.0000035976846,0.0012136202,0.00011585409,0.0037136762,0.0000033871872,0.27917463,0.00024968435],"study_design_scores_gemma":[0.002468591,0.00077601126,0.7801668,0.0007706548,0.00020150506,0.000115757495,0.0013397228,0.000012710888,0.00046109248,0.000004948529,0.21356602,0.00011621029],"about_ca_topic_score_codex":0.00005425196,"about_ca_topic_score_gemma":0.000046894747,"teacher_disagreement_score":0.065608606,"about_ca_system_score_codex":0.00016231778,"about_ca_system_score_gemma":0.00016493919,"threshold_uncertainty_score":0.6205732},"labels":[],"label_agreement":null},{"id":"W4391483192","doi":"10.1002/ejhf.3134","title":"Effect of a Transitional Care Model Following Hospitalization for Heart Failure: 3-Year Outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) Randomized Controlled Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Institute for Work & Health; Institute of Health Services and Policy Research; University of Toronto; Population Health Research Institute; Impact; University of Calgary","funders":"Canadian Institutes of Health Research; Roche Diagnostics; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Heart failure; Hazard ratio; Randomized controlled trial; Transitional care; Confidence interval; Emergency department; Relative risk; Emergency medicine; Internal medicine; Physical therapy; Health care","score_opus":0.007547642622426041,"score_gpt":0.2578355480124821,"score_spread":0.2502879053900561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391483192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92396194,0.0015473267,0.002586381,0.060123738,0.00086309825,0.010619376,0.00015807973,0.00005852978,0.000081538325],"genre_scores_gemma":[0.988928,0.000007752536,0.010314243,0.00021960589,0.00017965943,0.00012360624,0.0000866624,0.000085196305,0.000055248747],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950452,0.0016471863,0.0017306654,0.00034339004,0.00085670094,0.00037687283],"domain_scores_gemma":[0.9982587,0.0005119209,0.00032370223,0.00034113167,0.00039242767,0.00017208258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017561637,0.0004426664,0.002477979,0.00052417547,0.000133545,0.00006338573,0.00015831609,0.00010826372,0.000051318413],"category_scores_gemma":[0.0003460311,0.00026903863,0.003358214,0.00039651507,0.00011953428,0.00027772848,0.000030600815,0.00042625537,0.0000053682],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8454726,0.001414019,0.009411562,0.004079552,0.006137519,0.00022595233,0.025892379,0.0056187464,0.012468583,0.00066207204,0.08803226,0.0005847695],"study_design_scores_gemma":[0.96385944,0.0052321744,0.00040674704,0.0029340864,0.0035306793,0.00005733454,0.003645553,0.001070918,0.0017318608,0.000027138609,0.017170783,0.00033330094],"about_ca_topic_score_codex":0.0000060607967,"about_ca_topic_score_gemma":0.00003362642,"teacher_disagreement_score":0.118386835,"about_ca_system_score_codex":0.00014546528,"about_ca_system_score_gemma":0.0002968411,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4391611556","doi":"10.1002/ejhf.3156","title":"Distinguishing Heart Failure with Reduced Ejection Fraction from Heart Failure with Preserved Ejection Fraction: A Phenomics Approach","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Medical Research Council; National Heart Foundation of New Zealand","keywords":"Ejection fraction; Heart failure; Medicine; Cardiology; Internal medicine; Phenomics; Fraction (chemistry)","score_opus":0.01861379883591372,"score_gpt":0.24632593049895493,"score_spread":0.22771213166304122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391611556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485144,0.001234806,0.024974907,0.021453008,0.0012226519,0.0007906794,0.000029036071,0.0003623097,0.0014182144],"genre_scores_gemma":[0.8700304,0.000023799481,0.12457091,0.00025444131,0.0046498603,0.0000058817263,0.000083145766,0.00019980648,0.00018173142],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625087,0.00060677633,0.0009244704,0.00074244745,0.0009842812,0.00049113866],"domain_scores_gemma":[0.99785566,0.00015013285,0.00041782504,0.0005395019,0.0006294542,0.0004073989],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013682751,0.00051159464,0.00094338896,0.00042651183,0.00045622056,0.0006545254,0.00014879947,0.000180314,0.00012708033],"category_scores_gemma":[0.00016433896,0.00037004138,0.00052786135,0.0007062688,0.00010184449,0.0011085848,0.00006341893,0.0023185967,0.000083488034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045730677,0.0007260411,0.064344674,0.000970076,0.002093109,0.00039069948,0.0012671804,0.015453094,0.4297756,0.000035067387,0.47934106,0.0010303437],"study_design_scores_gemma":[0.0039121094,0.0025666747,0.043467123,0.0052096266,0.001325979,0.007607565,0.007239452,0.007933094,0.005000172,0.000028073262,0.9148097,0.0009004303],"about_ca_topic_score_codex":0.00010421516,"about_ca_topic_score_gemma":0.000030558258,"teacher_disagreement_score":0.43546864,"about_ca_system_score_codex":0.0003855218,"about_ca_system_score_gemma":0.00031304618,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W4391932206","doi":"10.1002/ejhf.3167","title":"Clinical Implications of Subclinical Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Study","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Surgical Specialties (Canada)","funders":"Medical Research Council; Sanofi Genzyme; National Institutes of Health; Servier; Impulse Dynamics; Boston Scientific Corporation; National Medical Research Council; Cytokinetics; Sanofi; Teva Pharmaceutical Industries; Novartis; Amgen; National Heart, Lung, and Blood Institute; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Subclinical infection; Medicine; Heart failure; Ejection fraction; Cardiology; Internal medicine","score_opus":0.028631020490322553,"score_gpt":0.31415749399294274,"score_spread":0.28552647350262017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391932206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96480536,0.00073532714,0.0019891046,0.030767882,0.0009086069,0.00064900966,0.0000031249908,0.000049554837,0.00009203493],"genre_scores_gemma":[0.9976923,0.000072103,0.00084570464,0.0001833987,0.0010192514,0.000003289295,0.000007142782,0.000042273583,0.00013454563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962245,0.0015173734,0.0011739022,0.00030939808,0.000582616,0.00019221645],"domain_scores_gemma":[0.9983778,0.00032582376,0.00024154532,0.0005160991,0.00036305256,0.00017568193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003930343,0.00018393053,0.0005966276,0.00027281177,0.000114828625,0.00006359229,0.00012670606,0.00007988615,0.00017534707],"category_scores_gemma":[0.00032587198,0.00010580861,0.00073133945,0.000601272,0.000113304144,0.00022120998,0.000040394934,0.0013830941,0.0000758511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004955801,0.0006586472,0.92674977,0.000046196474,0.000586997,0.00034047262,0.000105813444,0.00028717043,0.00027649678,0.000010872327,0.0697263,0.0007156595],"study_design_scores_gemma":[0.0017331361,0.0016708223,0.6343486,0.00020776717,0.00037533743,0.0020855716,0.00093513733,0.000033094715,0.000054751046,0.0000053429303,0.35847345,0.000077045726],"about_ca_topic_score_codex":0.000014840849,"about_ca_topic_score_gemma":0.000056777622,"teacher_disagreement_score":0.29240125,"about_ca_system_score_codex":0.00007436817,"about_ca_system_score_gemma":0.00021767037,"threshold_uncertainty_score":0.60089326},"labels":[],"label_agreement":null},{"id":"W4391969972","doi":"10.1002/ejhf.3157","title":"Tricuspid Regurgitation: Frequency, Clinical Presentation, Management and Outcome Among Patients with Severe Left-Sided Valvular Heart Disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II Survey","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Abbott Vascular; Novartis Pharma; Servier; Gedeon Richter; Boston Scientific Japan; Bayer; Boehringer Ingelheim España; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Bristol-Myers Squibb; AstraZeneca; Edwards Lifesciences; Amgen; Vifor Pharma; Pfizer; ResMed","keywords":"Medicine; valvular heart disease; Regurgitation (circulation); Cardiology; Internal medicine; Heart failure; Presentation (obstetrics); Heart disease; Population; Tricuspid Valve Insufficiency; Disease; Surgery","score_opus":0.01946864191702217,"score_gpt":0.3066484377761622,"score_spread":0.28717979585914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391969972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98613375,0.0044788043,0.000042060954,0.0076361904,0.000442109,0.00094674394,0.00019479608,0.000042191317,0.0000833793],"genre_scores_gemma":[0.9966771,0.00010290543,0.00072720385,0.0014122144,0.00035392822,0.0000064591054,0.0003440273,0.00009338424,0.00028280364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950354,0.002009406,0.0011430724,0.00056719827,0.00093438674,0.0003105317],"domain_scores_gemma":[0.99742293,0.00041677218,0.00022419904,0.00057174556,0.00049303484,0.0008713043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096413936,0.00037294644,0.00064015476,0.00022455922,0.00024174844,0.00021652602,0.00016549368,0.000035700417,0.00007129573],"category_scores_gemma":[0.0005845854,0.00023331816,0.00060853566,0.0005450715,0.00017247596,0.0004833651,0.00014666993,0.00053210574,0.000060975475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010765994,0.0005083957,0.95843744,0.00008819384,0.00065668765,0.0018436741,0.00018394501,0.00010264726,0.0000017335882,0.000019221363,0.036937907,0.000143559],"study_design_scores_gemma":[0.0049774824,0.00054211257,0.9783653,0.0009793324,0.001345414,0.000022550557,0.00009283098,0.000032804837,6.2444633e-7,0.0001108518,0.013285877,0.00024480134],"about_ca_topic_score_codex":0.00006990078,"about_ca_topic_score_gemma":0.000018011773,"teacher_disagreement_score":0.02365203,"about_ca_system_score_codex":0.00007505633,"about_ca_system_score_gemma":0.00019512557,"threshold_uncertainty_score":0.95144385},"labels":[],"label_agreement":null},{"id":"W4392110462","doi":"10.1002/ejhf.3162","title":"Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Cardiogenic shock; Medicine; Inotrope; Intensive care medicine; Myocardial infarction; Heart failure; Shock (circulatory); Cardiology; Levosimendan; Contractility; Internal medicine; Cardiac output; Hemodynamics","score_opus":0.02837500826392716,"score_gpt":0.2290519697821137,"score_spread":0.20067696151818654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392110462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97273916,0.025479695,0.00057410484,0.00052079506,0.00033440805,0.000074981304,0.000013179523,0.00004576169,0.00021791285],"genre_scores_gemma":[0.99833214,0.00028016337,0.0011159938,0.000055266795,0.00015815189,2.2732183e-7,0.0000010592427,0.00004657922,0.000010393959],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838734,0.00027970306,0.00066404516,0.00010338383,0.00044331493,0.00012221484],"domain_scores_gemma":[0.9993311,0.00015735834,0.00008292358,0.00016548474,0.000079875565,0.00018321884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009150287,0.00013216956,0.00040191342,0.00013769898,0.000013878513,0.000031305943,0.00017194948,0.000045725275,0.00018017835],"category_scores_gemma":[0.000080284386,0.00010067993,0.00019626044,0.00013177197,0.00006752431,0.00026002465,0.000037389214,0.00035303715,0.000009413352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044736333,0.00025670487,0.09599445,0.0033429267,0.0069148266,0.007830419,0.004479178,0.006478093,0.33429384,0.0013997029,0.4904462,0.048116274],"study_design_scores_gemma":[0.0009058424,0.00043799655,0.012133708,0.0010840946,0.00006184299,0.00092489505,0.00011927985,0.0019276525,0.016004888,0.00003584632,0.966107,0.00025696206],"about_ca_topic_score_codex":0.0000023892085,"about_ca_topic_score_gemma":6.437172e-7,"teacher_disagreement_score":0.47566077,"about_ca_system_score_codex":0.000008385614,"about_ca_system_score_gemma":0.00006526803,"threshold_uncertainty_score":0.41056082},"labels":[],"label_agreement":null},{"id":"W4392235062","doi":"10.1002/ejhf.3173","title":"Apoptosis, a Useful Marker in the Management of Hot-Phase Cardiomyopathy?","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Effects of Exercise","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Fondazione Cassa di Risparmio di Gorizia","keywords":"Medicine; Cardiomyopathy; Ejection fraction; Heart failure; Internal medicine; Myocarditis; Cardiology; Apoptosis; Biopsy; Inflammation; Pathology; Genetics","score_opus":0.01052488090517916,"score_gpt":0.2672716336240536,"score_spread":0.2567467527188744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392235062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97478116,0.012411593,0.0004744392,0.007298688,0.00047124134,0.0005199735,0.0000064063115,0.000023983186,0.0040125162],"genre_scores_gemma":[0.994239,0.0002771413,0.0047436706,0.00019657837,0.00036616882,0.0000022606837,0.0000024872966,0.000045782937,0.00012696399],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776065,0.000664232,0.0005270343,0.00017268973,0.000668073,0.00020731849],"domain_scores_gemma":[0.9991727,0.00007404154,0.00008307236,0.00046955055,0.00009824344,0.00010240759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040446725,0.00016125663,0.0004930254,0.00030590646,0.00002527645,0.00005481609,0.00021499865,0.000023886985,0.00005387668],"category_scores_gemma":[0.00003872358,0.00010269398,0.0007731782,0.00044129934,0.0000584053,0.00011838201,0.00006625837,0.00049623026,0.00007266692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003976686,0.0015889865,0.0050703473,0.0062840977,0.0070628705,0.14099403,0.004522268,0.00033632136,0.027081834,0.00040380884,0.6623323,0.14034645],"study_design_scores_gemma":[0.005551086,0.0011276738,0.05174182,0.005050107,0.0014727814,0.011622507,0.0012251213,0.00004255443,0.0015779214,0.000015354135,0.9203721,0.00020092627],"about_ca_topic_score_codex":0.000002068363,"about_ca_topic_score_gemma":3.6694237e-7,"teacher_disagreement_score":0.25803983,"about_ca_system_score_codex":0.000043739616,"about_ca_system_score_gemma":0.00004655841,"threshold_uncertainty_score":0.4187739},"labels":[],"label_agreement":null},{"id":"W4392463727","doi":"10.1002/ejhf.3190","title":"Effect of Long-Term Tafamidis Treatment on Health-Related Quality of Life in Patients with Transthyretin Amyloid Cardiomyopathy","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pfizer","keywords":"Medicine; Placebo; Internal medicine; Quality of life (healthcare); Clinical endpoint; Randomized controlled trial; Clinical trial; Physical therapy; Alternative medicine","score_opus":0.009153389476974716,"score_gpt":0.2637998828639468,"score_spread":0.2546464933869721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392463727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945375,0.0034804584,0.000023717987,0.0013453636,0.0001228297,0.00037054537,0.000063084415,0.000007894083,0.00004861542],"genre_scores_gemma":[0.9993068,0.0002490268,0.00019022031,0.0000663936,0.000057473804,0.000004299333,0.000049540282,0.00005091195,0.000025329784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966568,0.001551402,0.00097051956,0.00027875567,0.00030867025,0.00023390325],"domain_scores_gemma":[0.998932,0.00010081607,0.0004139134,0.00030479155,0.00008723446,0.00016123567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010384775,0.0002794269,0.0007662211,0.00016744883,0.000030209776,0.000015064141,0.00014943826,0.000058899954,0.00001871556],"category_scores_gemma":[0.000078185076,0.00018554395,0.00038564854,0.0001755327,0.000090273774,0.00001016516,0.000024387598,0.00017772701,0.000008619716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023402465,0.0006151499,0.979956,0.00034373044,0.00069825805,0.0000986607,0.00032189515,0.00020993556,0.0057557845,0.0000040286227,0.0013619474,0.008294404],"study_design_scores_gemma":[0.007359151,0.02660233,0.9212843,0.0007687019,0.00012742782,0.000026500395,0.000039421884,9.192414e-7,0.042024083,6.0043493e-7,0.00154876,0.00021777571],"about_ca_topic_score_codex":0.000030200283,"about_ca_topic_score_gemma":0.000026719988,"teacher_disagreement_score":0.05867163,"about_ca_system_score_codex":0.00008086685,"about_ca_system_score_gemma":0.00013756518,"threshold_uncertainty_score":0.75662625},"labels":[],"label_agreement":null},{"id":"W4392511946","doi":"10.1002/ejhf.3174","title":"Blood Pressure and Intensive Treatment Up-Titration After Acute Heart Failure Hospitalization: Insights from the STRONG-HF Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Roche Diagnostics","keywords":"Medicine; Heart failure; Clinical endpoint; Blood pressure; Internal medicine; Cardiology; Post-hoc analysis; Clinical trial","score_opus":0.012072428707926887,"score_gpt":0.24826337247227642,"score_spread":0.23619094376434954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392511946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7109691,0.02099843,0.0004732533,0.26303825,0.002102897,0.002004239,0.00006432893,0.00014383381,0.00020568883],"genre_scores_gemma":[0.99054784,0.00022506343,0.0045256144,0.0010079897,0.0022065565,0.000017408782,0.00005698366,0.00006610444,0.0013464368],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979741,0.00040369958,0.0005847054,0.00035240783,0.0004402684,0.0002447975],"domain_scores_gemma":[0.99886346,0.00013611368,0.00012450379,0.00034902053,0.00029784953,0.00022903309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025707117,0.0003357278,0.0004924716,0.00014820235,0.0001447611,0.0002885626,0.00009669544,0.000066692846,0.00026775413],"category_scores_gemma":[0.000066692824,0.00019057466,0.00030707513,0.00019919888,0.00009575725,0.00037503283,0.00006108178,0.00035244998,0.000102896476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091212895,0.00058634795,0.0037805755,0.000121047,0.009810071,0.0039270753,0.0082916785,0.00002358973,0.0034062217,0.00058283925,0.958405,0.0019442533],"study_design_scores_gemma":[0.01658817,0.0047649243,0.0050241984,0.00053317717,0.005555313,0.00052413397,0.00095572014,0.00004920228,0.0006691918,0.000033489316,0.96510905,0.00019344004],"about_ca_topic_score_codex":0.000014894574,"about_ca_topic_score_gemma":0.000039780392,"teacher_disagreement_score":0.27957878,"about_ca_system_score_codex":0.000038097693,"about_ca_system_score_gemma":0.00013497533,"threshold_uncertainty_score":0.7771409},"labels":[],"label_agreement":null},{"id":"W4392561073","doi":"10.1002/ejhf.3179","title":"Diuretic Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Relypsa; Respicardia; CSL Limited; Servier; Duke Clinical Research Institute; Novo Nordisk; Cytokinetics; Boston Scientific Corporation; MyoKardia; Gilead Sciences; Merck KGaA; American Regent; Sanofi; Bayer Canada; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Vifor Pharma; Pfizer; Bristol-Myers Squibb Foundation","keywords":"Diuretic; Loop diuretic; Randomization; Medicine; Heart failure; Hazard ratio; Placebo; Furosemide; Ejection fraction; Internal medicine; Randomized controlled trial; Cardiology; Confidence interval","score_opus":0.011915235536495232,"score_gpt":0.23502577292289176,"score_spread":0.22311053738639652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392561073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594818,0.00015753003,0.00006715887,0.03901823,0.00046614168,0.00071927725,0.000004124299,0.000042130523,0.000043656324],"genre_scores_gemma":[0.9924702,0.000011044111,0.0062136385,0.00040957608,0.0006485345,0.0000041338153,0.000015192635,0.000052537187,0.00017511644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981231,0.00040682757,0.00044940104,0.00027904467,0.00053735846,0.00020423105],"domain_scores_gemma":[0.99908537,0.00021047905,0.00011747285,0.00027062185,0.00015182413,0.00016420773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002976049,0.00025573868,0.0004557684,0.00021192932,0.00011380445,0.00024117428,0.000068689355,0.000044587854,0.00007518281],"category_scores_gemma":[0.00007598651,0.00012538549,0.00010619885,0.00030902005,0.0000708243,0.00054247957,0.000032563257,0.00060515065,0.000045175962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016202113,0.00062502164,0.8344098,0.000056102523,0.000832239,0.0006142694,0.0010296488,0.000014362464,0.00049587927,0.00007203789,0.14528401,0.00036456718],"study_design_scores_gemma":[0.02009289,0.0028862162,0.52078897,0.0005947901,0.00030090025,0.00005549314,0.00028036916,0.0000052608366,0.000050908195,0.000008193025,0.45480347,0.00013251505],"about_ca_topic_score_codex":0.00002615242,"about_ca_topic_score_gemma":0.000094593255,"teacher_disagreement_score":0.31362075,"about_ca_system_score_codex":0.00008040991,"about_ca_system_score_gemma":0.00009369917,"threshold_uncertainty_score":0.5113071},"labels":[],"label_agreement":null},{"id":"W4392957618","doi":"10.1002/ejhf.3204","title":"Dissecting the Heart Failure Phenotype Through Phenomics","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Health science; Library science; Family medicine; Medical education","score_opus":0.011396130656257168,"score_gpt":0.2555228405983003,"score_spread":0.24412670994204316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392957618","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017071493,0.0071041486,0.00025902278,0.025664756,0.9625653,0.00041422024,0.00005968273,0.00013212011,0.0020936176],"genre_scores_gemma":[0.0065388344,0.00039013242,0.0036436303,0.00051973574,0.98479337,0.0000015521927,0.00007864618,0.0003467051,0.003687383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957473,0.00064897037,0.0010910929,0.00046810223,0.0015739849,0.0004705473],"domain_scores_gemma":[0.996991,0.00045420043,0.00045527946,0.0007977403,0.0010128664,0.00028895523],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002469876,0.00056956423,0.0012207982,0.00021677032,0.00030339576,0.00029722817,0.00038804903,0.00032531458,0.0003002106],"category_scores_gemma":[0.0014195495,0.00033915232,0.0020647566,0.0004041063,0.00016275853,0.00017945388,0.00017896904,0.0052478057,0.00084560487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018453399,0.000046306504,0.000113696224,0.00022064094,0.0010763241,0.00042447762,0.0006483673,0.00006633632,0.00025413718,0.000014814731,0.9967593,0.00019107205],"study_design_scores_gemma":[0.0011546385,0.00051345595,0.00019875423,0.001173495,0.0013247107,0.0012285669,0.0012612558,0.0000035024968,0.000053506265,0.000034406738,0.99272746,0.00032622388],"about_ca_topic_score_codex":0.00001694779,"about_ca_topic_score_gemma":0.000018255536,"teacher_disagreement_score":0.02514502,"about_ca_system_score_codex":0.00020885064,"about_ca_system_score_gemma":0.00060223765,"threshold_uncertainty_score":0.99993235},"labels":[],"label_agreement":null},{"id":"W4393076332","doi":"10.1002/ejhf.3214","title":"Physician Perceptions, Attitudes, and Strategies Towards Implementing Guideline-Directed Medical Therapy in Heart Failure with Reduced Ejection Fraction. A Survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Guideline; Ejection fraction; Perception; Association (psychology); Cardiology; Internal medicine; Pathology","score_opus":0.0301939904568696,"score_gpt":0.31075803619729514,"score_spread":0.28056404574042554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5937489,0.0014357122,0.00041968556,0.40202752,0.00035611956,0.0017346706,0.00003753394,0.000048068836,0.00019174651],"genre_scores_gemma":[0.99066985,0.00023291982,0.0075799106,0.0009468335,0.00039574216,0.00001614224,0.000012246306,0.00004078387,0.000105550695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525017,0.0023189934,0.0008634395,0.0002708749,0.001007615,0.00028893282],"domain_scores_gemma":[0.997287,0.00069353596,0.00045746262,0.00028826803,0.0011919637,0.00008179154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009397417,0.00023671178,0.00064833957,0.00011227457,0.0002450592,0.0001090975,0.00013915211,0.000092214716,0.00003451811],"category_scores_gemma":[0.0013568908,0.00011638844,0.00022787417,0.00048655047,0.00021275904,0.00033856675,0.00008084073,0.00070168887,0.000001716033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017804422,0.00030204127,0.15961851,0.00033409026,0.0020033831,0.000027141667,0.002239168,0.00012242273,0.011763708,0.00021516511,0.81914264,0.0024512724],"study_design_scores_gemma":[0.0049060434,0.0008040469,0.33317983,0.00069021276,0.0004509017,0.0003809547,0.005326284,0.00020902204,0.00021513813,0.000022251095,0.65367275,0.0001425641],"about_ca_topic_score_codex":0.00046092249,"about_ca_topic_score_gemma":0.0015818737,"teacher_disagreement_score":0.4010807,"about_ca_system_score_codex":0.00024192939,"about_ca_system_score_gemma":0.00097288616,"threshold_uncertainty_score":0.4746183},"labels":[],"label_agreement":null},{"id":"W4393379002","doi":"10.1002/ejhf.3221","title":"Body Mass Index and Cardiorenal Outcomes in the EMPEROR-Preserved Trial: Principal Findings and Meta-Analysis with the DELIVER Trial","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital; McGill University Health Centre","funders":"Relypsa; Abbott Vascular; Cytokinetics; British Heart Foundation; Impulse Dynamics; Amarin Corporation; Servier; University of Glasgow; Moderna; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Amgen; Pfizer","keywords":"Empagliflozin; Medicine; Placebo; Heart failure; Body mass index; Internal medicine; Clinical endpoint; Meta-analysis; Ejection fraction; Cardiology; Clinical trial; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.07333315065106685,"score_gpt":0.32855112109828344,"score_spread":0.2552179704472166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393379002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010001464,0.97687227,0.0000072299085,0.010294286,0.00011256678,0.0024396833,0.000021186612,0.000012449663,0.00023884237],"genre_scores_gemma":[0.044853885,0.9464138,0.0010240331,0.00090104964,0.0010644813,0.00013168452,0.000047989557,0.00021650955,0.0053465646],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627477,0.0015354259,0.0008884426,0.000327363,0.000713777,0.00026023906],"domain_scores_gemma":[0.99868405,0.0002933389,0.00037556008,0.000452676,0.00007183474,0.00012252273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035287235,0.00047098257,0.0035109716,0.0005325104,0.0000870921,0.00028234,0.00030944005,0.00006190722,0.00005644839],"category_scores_gemma":[0.00007385576,0.00016246761,0.0021542115,0.00052613806,0.00011327748,0.00010050348,0.00015288452,0.0009175121,0.0000116732535],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02427883,0.0004633993,0.0014691022,0.004722534,0.88650846,0.0063283485,0.0012699689,0.0000116937645,5.205493e-7,0.00007547927,0.063369215,0.011502438],"study_design_scores_gemma":[0.020735499,0.0010612938,0.0003942384,0.00021112534,0.3967622,0.00007370225,0.00012868585,0.0000011338068,3.8322803e-8,0.0000015100148,0.58051926,0.00011131804],"about_ca_topic_score_codex":0.0000060670973,"about_ca_topic_score_gemma":0.000017664936,"teacher_disagreement_score":0.51715004,"about_ca_system_score_codex":0.000040451294,"about_ca_system_score_gemma":0.0000820591,"threshold_uncertainty_score":0.6625237},"labels":[],"label_agreement":null},{"id":"W4393447739","doi":"10.1002/ejhf.3215","title":"Interatrial Shunt Therapy in Advanced Heart Failure: Outcomes from the Open-Label Cohort of the RELIEVE-HF Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Pennsylvania State University; University of Pennsylvania","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Clinical endpoint; Adverse effect; Cohort; Randomized controlled trial","score_opus":0.02805395987932999,"score_gpt":0.29243398468451565,"score_spread":0.26438002480518563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393447739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93077266,0.0022543618,0.00005995563,0.06114617,0.0043973164,0.0011255163,0.000019276775,0.000023792923,0.00020093721],"genre_scores_gemma":[0.9947816,0.00027078443,0.0014368639,0.0015722053,0.001503681,0.0000040005516,0.000005949357,0.000063802814,0.00036108858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996599,0.0012624699,0.0009638036,0.00026330593,0.00069610676,0.0002152807],"domain_scores_gemma":[0.9985812,0.00033184915,0.00020299392,0.0005979202,0.00016580992,0.00012026858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002716201,0.0002355766,0.0007931633,0.00012251781,0.00009846685,0.00015605614,0.00046960477,0.0000597846,0.00031203934],"category_scores_gemma":[0.00042390937,0.00010876656,0.0008018127,0.00040416684,0.00011072039,0.00021022331,0.00015852205,0.0011160898,0.00004783822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039260935,0.0007927915,0.22219625,0.000041546118,0.0029385572,0.0004221836,0.0022707095,0.00012235652,0.018250547,0.00011124381,0.700735,0.012857899],"study_design_scores_gemma":[0.04445841,0.0011648941,0.13323198,0.000534168,0.00017947661,0.00023929703,0.00043550596,0.000010474181,0.0006893259,0.000015075115,0.81891435,0.00012706629],"about_ca_topic_score_codex":0.0000575824,"about_ca_topic_score_gemma":0.000049022212,"teacher_disagreement_score":0.11817936,"about_ca_system_score_codex":0.000076775126,"about_ca_system_score_gemma":0.0002992491,"threshold_uncertainty_score":0.48489168},"labels":[],"label_agreement":null},{"id":"W4394576992","doi":"10.1002/ejhf.3223","title":"Effects of Sacubitril/Valsartan According to Polypharmacy Status in PARAGON-HF","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Daiichi-Sankyo; Alnylam Pharmaceuticals; AstraZeneca","keywords":"Polypharmacy; Sacubitril, Valsartan; Medicine; Valsartan; Heart failure; Sacubitril; Ejection fraction; Internal medicine; Comorbidity; Cardiology; Intensive care medicine; Blood pressure","score_opus":0.011472262203879516,"score_gpt":0.2912322063508213,"score_spread":0.2797599441469418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394576992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633341,0.004587698,0.00045968097,0.029494392,0.0006682457,0.00069442805,0.000003725255,0.00005316866,0.0007045736],"genre_scores_gemma":[0.98658085,0.00013413581,0.011830344,0.0005631632,0.00039214417,0.00000253846,0.0000021545347,0.000054434113,0.00044026502],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980296,0.0003022326,0.0006675188,0.00020917287,0.0003960481,0.00039542443],"domain_scores_gemma":[0.9991091,0.0001683572,0.000095190175,0.00017629628,0.00008705866,0.00036398493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087111443,0.0002074032,0.0006607147,0.00067051937,0.00003181372,0.000050085073,0.00010745461,0.000023738341,0.000084352505],"category_scores_gemma":[0.00013921155,0.00015721233,0.00023614841,0.0005551043,0.00002788428,0.0001927128,0.0000708223,0.00038746957,0.00020819742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013639481,0.0009358027,0.054563854,0.0025759556,0.0008704565,0.030065594,0.0036962044,0.00012560922,0.31074324,0.000364964,0.54496026,0.04973408],"study_design_scores_gemma":[0.0032192068,0.001578135,0.022919804,0.002812982,0.0003322562,0.00055121834,0.00046686007,0.00003566473,0.024226358,0.000013197064,0.9436496,0.00019472589],"about_ca_topic_score_codex":0.000012935146,"about_ca_topic_score_gemma":0.0000034975053,"teacher_disagreement_score":0.3986893,"about_ca_system_score_codex":0.00010398898,"about_ca_system_score_gemma":0.00013715497,"threshold_uncertainty_score":0.64109325},"labels":[],"label_agreement":null},{"id":"W4394753545","doi":"10.1002/ejhf.3209","title":"Heart Failure and Respiratory Tract Infection: Cause and Consequence of Acute Decompensation?","year":2024,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Berlin Institute of Health","keywords":"Medicine; University hospital; Decompensation; Library science; Family medicine; Internal medicine","score_opus":0.02567936879811382,"score_gpt":0.28548778003091374,"score_spread":0.2598084112327999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394753545","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09147117,0.0017782277,0.000034213008,0.9055617,0.00039415061,0.00050431694,0.000032082287,0.00005126034,0.00017289804],"genre_scores_gemma":[0.29977143,0.0011773068,0.05919022,0.62093717,0.011937254,0.000019784178,0.00015394694,0.00064076495,0.006172103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721736,0.0005573741,0.00094981043,0.0004018896,0.000551466,0.00032210577],"domain_scores_gemma":[0.9985513,0.00014611981,0.00039551972,0.0003711291,0.0002942816,0.00024167004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009899515,0.00043866513,0.00095877727,0.0006067781,0.00009845495,0.00011858596,0.000090164955,0.00021019441,0.0001720755],"category_scores_gemma":[0.000063776046,0.0003437371,0.00029632248,0.00022172734,0.00026801243,0.00023276158,0.00010045376,0.0019311152,0.00008936332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050244642,0.00005230606,0.0057881987,0.0005928331,0.00087509194,0.013261631,0.0001267328,8.092433e-7,0.0010773363,0.000011951077,0.9780187,0.00014414293],"study_design_scores_gemma":[0.001420554,0.0015025982,0.010878451,0.0013943502,0.001730743,0.015408319,0.000038053986,0.000001779075,0.00017182193,0.000032698415,0.967176,0.00024459147],"about_ca_topic_score_codex":0.000010971752,"about_ca_topic_score_gemma":0.000008582114,"teacher_disagreement_score":0.2846245,"about_ca_system_score_codex":0.00007777759,"about_ca_system_score_gemma":0.00024224522,"threshold_uncertainty_score":0.9999015},"labels":[],"label_agreement":null},{"id":"W4394761079","doi":"10.1002/ejhf.3241","title":"Left Atrial to Coronary Sinus Shunting for Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Early Feasibility Study 1-Year Results","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Ottawa","funders":"Edwards Lifesciences","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Coronary sinus; Pulmonary wedge pressure; Hemodynamics; Clinical endpoint; Population; Confidence interval; Adverse effect; Randomized controlled trial","score_opus":0.03573592476379332,"score_gpt":0.29307907738623856,"score_spread":0.2573431526224452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394761079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842153,0.00025342175,0.00038419856,0.012107011,0.0009858379,0.0019043447,0.000036451835,0.0000584939,0.000054949247],"genre_scores_gemma":[0.9897166,0.000014779139,0.006735996,0.00006173176,0.0023996115,0.0000036040904,0.0000117427835,0.000066765875,0.0009891518],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711806,0.00082362315,0.0007794973,0.00038798965,0.0006449657,0.0002458947],"domain_scores_gemma":[0.99833643,0.00024933525,0.00019254841,0.00051790033,0.00048110663,0.00022268275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00198262,0.00025422053,0.0006416292,0.00020205282,0.0001950449,0.00010503366,0.00010346796,0.000053189615,0.000101937585],"category_scores_gemma":[0.0003499416,0.00013359795,0.0008320514,0.00034484817,0.000054454194,0.00020723119,0.000030216659,0.00033514854,0.00003266414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15032451,0.0031270368,0.38435465,0.00049425923,0.009720227,0.0021915538,0.0117632905,0.0045404756,0.018422205,0.0000032306455,0.40340242,0.011656165],"study_design_scores_gemma":[0.011618493,0.024097204,0.40561348,0.00044104306,0.0011966913,0.0019025621,0.0047829626,0.00007147938,0.0011547781,9.554406e-7,0.54892176,0.0001985993],"about_ca_topic_score_codex":0.000042114996,"about_ca_topic_score_gemma":0.00011302204,"teacher_disagreement_score":0.14551933,"about_ca_system_score_codex":0.00020368061,"about_ca_system_score_gemma":0.0002883836,"threshold_uncertainty_score":0.5447966},"labels":[],"label_agreement":null},{"id":"W4394762944","doi":"10.1002/ejhf.3244","title":"Dietary Sodium and Fluid Intake in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Heart failure; Fluid restriction; Sodium; Dietary Sodium; Fluid intake; Homeostasis; Internal medicine; Expert opinion; Intensive care medicine; Dietary salt; Cardiology; Hyponatremia; Blood pressure","score_opus":0.023701504306365362,"score_gpt":0.2928498981427666,"score_spread":0.2691483938364012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394762944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61116827,0.00082439516,0.000007852358,0.38652718,0.0006270476,0.0006848441,0.000020005016,0.000021670101,0.00011871898],"genre_scores_gemma":[0.98921037,0.00007904672,0.008302036,0.0011998666,0.0003745923,0.0000034023553,0.0000042846423,0.000052812324,0.0007735999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497473,0.0016135199,0.001798107,0.00032947733,0.00088862947,0.0003955329],"domain_scores_gemma":[0.9981356,0.00040900832,0.00047764956,0.0005003735,0.00027658176,0.00020075789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004446912,0.00030244433,0.0008551451,0.0002336135,0.00010540135,0.000059916747,0.00021722684,0.00010269757,0.00011312717],"category_scores_gemma":[0.00046145066,0.00017473873,0.0006172293,0.00049703056,0.0002341081,0.00013148504,0.00023721675,0.0010066042,0.000036285266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021389376,0.0003340416,0.19497594,0.000297202,0.0004817554,0.00010492292,0.0006504047,0.000021949489,0.010176325,0.000063763626,0.7921128,0.00056698435],"study_design_scores_gemma":[0.0025546334,0.0010023449,0.18266411,0.0014502187,0.0003875997,0.00026338734,0.0009346993,0.000052653344,0.0017991404,0.000038173523,0.8087049,0.00014810149],"about_ca_topic_score_codex":0.000030368057,"about_ca_topic_score_gemma":0.0002135644,"teacher_disagreement_score":0.3853273,"about_ca_system_score_codex":0.00016797181,"about_ca_system_score_gemma":0.00033903852,"threshold_uncertainty_score":0.7125639},"labels":[],"label_agreement":null},{"id":"W4394846163","doi":"10.1002/ejhf.3229","title":"Reporting Quality of Heart Failure Randomized Controlled Trials 2000–2020: Temporal Trends in Adherence to CONSORT Criteria","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Impact; McMaster University","funders":"","keywords":"Medicine; Consolidated Standards of Reporting Trials; Randomized controlled trial; Randomization; Confidence interval; MEDLINE; Internal medicine; Clinical trial; CINAHL; Psychological intervention","score_opus":0.08095621281048748,"score_gpt":0.3977945957161815,"score_spread":0.316838382905694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394846163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7533867,0.0040828576,0.0009289963,0.23413774,0.0014842415,0.0037124595,0.000033502693,0.0001633838,0.0020701631],"genre_scores_gemma":[0.95245457,0.000036086374,0.043397237,0.0005987711,0.000619252,0.000026349107,0.000018738794,0.0000638873,0.0027851127],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9817153,0.0072062938,0.009172952,0.00048423233,0.0009239356,0.0004972549],"domain_scores_gemma":[0.99466896,0.001586808,0.0024486603,0.0004598654,0.00040195123,0.0004337607],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.053537063,0.00044623515,0.006721451,0.0010444217,0.000071085116,0.00014911254,0.00017123064,0.00008464244,0.0020175013],"category_scores_gemma":[0.011253865,0.00028476582,0.002269512,0.0008132902,0.00013107981,0.00024917728,0.00008502905,0.0007343888,0.00010399032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10821595,0.0006078709,0.012853568,0.0005976406,0.0025568176,0.004817436,0.0025636128,0.000036088062,0.03332193,0.00020057506,0.82963544,0.0045930822],"study_design_scores_gemma":[0.3545743,0.0033119672,0.009450202,0.005215003,0.0019982522,0.0016046374,0.0017612932,0.00013988884,0.0015119719,0.00007366294,0.6197086,0.00065019703],"about_ca_topic_score_codex":0.0000900398,"about_ca_topic_score_gemma":0.000072409886,"teacher_disagreement_score":0.24635835,"about_ca_system_score_codex":0.0001057168,"about_ca_system_score_gemma":0.00041426482,"threshold_uncertainty_score":0.9999604},"labels":[],"label_agreement":null},{"id":"W4394873253","doi":"10.1002/ejhf.3240","title":"Time to Clinical Benefit with Sotagliflozin in Patients with Type 2 Diabetes and Chronic Kidney Disease: Insights from the SCORED Randomized Trial","year":2024,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Anschutz Medical Campus, University of Colorado; University of Toronto; National Institutes of Health; Boston Scientific Corporation; Cleveland Clinic; St. Jude Medical; Pfizer; Daiichi Sankyo Europe; Duke Clinical Research Institute; School of Medicine, Duke University; Bristol-Myers Squibb","keywords":"Medicine; Randomized controlled trial; Kidney disease; Diabetes mellitus; Clinical trial; Type 2 diabetes; Disease; Heart failure; Intensive care medicine; Internal medicine; MEDLINE; Endocrinology","score_opus":0.008256180713946843,"score_gpt":0.2252649292296819,"score_spread":0.21700874851573504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394873253","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53612185,0.0025859426,0.0000012146224,0.45812273,0.0005727475,0.002389272,0.00004679323,0.000025337264,0.00013409332],"genre_scores_gemma":[0.13685784,0.0003380644,0.0037206272,0.8142998,0.030246608,0.00007540692,0.0020745806,0.0007735499,0.011613511],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970549,0.0007689935,0.0008392534,0.00039850216,0.0006340617,0.00030433407],"domain_scores_gemma":[0.99834716,0.00039630296,0.00032258258,0.00039964294,0.00017221636,0.00036210156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006859687,0.00039904926,0.0013479892,0.0002263043,0.000047967034,0.00013653476,0.00020067122,0.000082320716,0.00019591281],"category_scores_gemma":[0.0002499859,0.00018442757,0.00025819577,0.00021932156,0.00019521704,0.00009226659,0.00011618655,0.0012868387,0.00030146638],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16713925,0.00014361153,0.0031280345,0.00007996276,0.0014412204,0.0008824975,0.000072168375,0.0000033808553,9.640585e-7,7.6851165e-7,0.82659644,0.0005117345],"study_design_scores_gemma":[0.34551495,0.00418,0.006850186,0.0030867283,0.0019945875,0.0000013876925,0.0000041070844,0.0000073702818,7.5405984e-7,0.000010153824,0.6381729,0.00017683326],"about_ca_topic_score_codex":0.0000015588204,"about_ca_topic_score_gemma":0.0000028752136,"teacher_disagreement_score":0.39926404,"about_ca_system_score_codex":0.00008287385,"about_ca_system_score_gemma":0.0002641421,"threshold_uncertainty_score":0.7520738},"labels":[],"label_agreement":null},{"id":"W4394961830","doi":"10.1002/ejhf.3236","title":"A Roadmap for Therapeutic Discovery in Pulmonary Hypertension Associated with Left Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation &amp; Right Ventricular Function","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Cilag; HORIZON EUROPE Framework Programme; Nederlandse Federatie van Universitair Medische Centra; Servier; Novo Nordisk Fonden; Genesis Pharma; Novo Nordisk; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ZonMw; European Society of Cardiology; Koninklijke Nederlandse Akademie van Wetenschappen; Deutsche Forschungsgemeinschaft; European Commission; Ministerstvo Zdravotnictví Ceské Republiky; Sanofi; Abiomed; CareDx; British Heart Foundation; Amicus Therapeutics; Cytokinetics; Eli Lilly and Company; U.S. Department of Defense; Deutsches Zentrum für Herz-Kreislaufforschung; National Institutes of Health; Regeneron Pharmaceuticals; National Heart, Lung, and Blood Institute; Acceleron; United Therapeutics Corporation; Bristol-Myers Squibb; AstraZeneca; Vifor Pharma; Ministero della Salute; Pfizer; American Heart Association","keywords":"Medicine; Heart failure; Pulmonary hypertension; Clinical endpoint; Clinical trial; Clinical Practice; Cardiology; Hypertension treatment; Intensive care medicine; Internal medicine; Blood pressure; Physical therapy","score_opus":0.019194169612642663,"score_gpt":0.2404647212937438,"score_spread":0.22127055168110113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394961830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398905,0.0023845728,0.00011469163,0.055750605,0.00040847308,0.0013865513,0.000024962199,0.00001710277,0.000022527993],"genre_scores_gemma":[0.9987307,0.000028953078,0.00025165526,0.00042825544,0.00012589697,0.00001040929,0.000038341157,0.000049392933,0.0003363628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955841,0.0014983346,0.00078279816,0.00037624172,0.0013681342,0.00039042233],"domain_scores_gemma":[0.9980309,0.00054525695,0.0004867222,0.00042580895,0.00040040666,0.00011092551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003471851,0.00027007234,0.00056752,0.0003149256,0.00040970094,0.0001586424,0.00018629766,0.00008448485,0.000019412817],"category_scores_gemma":[0.00029575633,0.00012451866,0.00043488777,0.000810904,0.00023296091,0.00033567267,0.00009276607,0.0007082144,0.000005268872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072834524,0.0035201642,0.733434,0.0006101433,0.002631799,0.0011723316,0.00065657316,0.0016152575,0.19411464,0.0002855713,0.053095933,0.0015801308],"study_design_scores_gemma":[0.005528588,0.001167146,0.8574792,0.005595873,0.00085376616,0.0017822377,0.0005636911,0.0024836406,0.0011574673,0.00040025104,0.1227273,0.0002608465],"about_ca_topic_score_codex":0.000017958477,"about_ca_topic_score_gemma":0.0000755041,"teacher_disagreement_score":0.19295716,"about_ca_system_score_codex":0.0002847155,"about_ca_system_score_gemma":0.0002254985,"threshold_uncertainty_score":0.5077724},"labels":[],"label_agreement":null},{"id":"W4395117037","doi":"10.1002/ejhf.3257","title":"Is it NICE to Measure Natriuretic Peptides After a Hospitalization for Heart Failure?","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Measure (data warehouse); Internal medicine; Natriuretic peptide; Cardiology; Nice; Data mining","score_opus":0.013952275897404184,"score_gpt":0.2780693986505795,"score_spread":0.26411712275317534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395117037","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011193665,0.0051592034,0.0018577098,0.5424543,0.44422066,0.0039764247,0.00031143962,0.00021330715,0.0006875727],"genre_scores_gemma":[0.020151064,0.00019039461,0.08825842,0.0061411075,0.85961866,0.00011731912,0.00024693235,0.0007524222,0.02452365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947502,0.00039460525,0.0014162319,0.00078507746,0.0019301396,0.0007237232],"domain_scores_gemma":[0.99624866,0.0002821408,0.000374903,0.00069849123,0.0016780376,0.00071776536],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022717817,0.0008155658,0.001406859,0.0009012379,0.00014639148,0.00035782013,0.00034832594,0.00038363208,0.00039019965],"category_scores_gemma":[0.0011057595,0.0006503755,0.0012406822,0.00054711994,0.00008786966,0.00026007576,0.0001770883,0.0014533453,0.0013246345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007083714,0.00016102997,0.00015117222,0.0010664278,0.00078175485,0.0006145436,0.00095192593,0.0000053964163,0.00023250187,0.00001369411,0.9951373,0.00017589887],"study_design_scores_gemma":[0.0025833286,0.0034386483,0.000120695426,0.004638916,0.0019569083,0.00019822316,0.00034244265,0.000003847353,0.00010246204,0.000029490071,0.9860366,0.0005484227],"about_ca_topic_score_codex":0.0000056364897,"about_ca_topic_score_gemma":0.000026376187,"teacher_disagreement_score":0.5363132,"about_ca_system_score_codex":0.00035113134,"about_ca_system_score_gemma":0.00065602205,"threshold_uncertainty_score":0.99959475},"labels":[],"label_agreement":null},{"id":"W4396224566","doi":"10.1002/ejhf.3262","title":"Association of Sodium–Glucose Cotransporter 2 Inhibitors with Changes in Comprehensive Geriatric Assessment in Elderly Diabetic Patients with Heart Failure: Data from MAGIC-HF","year":2024,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Diabetes mellitus; Cardiology; Endocrinology","score_opus":0.01173644313318142,"score_gpt":0.22884546109070278,"score_spread":0.21710901795752136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396224566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56051147,0.0006609746,0.000008013692,0.43690163,0.0004052223,0.0010555194,0.0002990614,0.000024023784,0.00013410849],"genre_scores_gemma":[0.84806913,0.00037164736,0.027357671,0.10580174,0.0054205754,0.000032600434,0.009841416,0.0006506733,0.0024545712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604136,0.00055345806,0.0010162339,0.00058566075,0.0012914664,0.00051179685],"domain_scores_gemma":[0.99786794,0.00015664256,0.00085120124,0.0006552234,0.0003432763,0.00012569096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060386525,0.00053856015,0.0013257123,0.00091838336,0.000027388078,0.00009619587,0.00033423063,0.00018041465,0.00014484304],"category_scores_gemma":[0.000018044102,0.0003810166,0.00014693636,0.0005329275,0.000063220745,0.00028176652,0.00012657043,0.0021298768,0.000047053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016322502,0.00034059788,0.29274264,0.00043986255,0.0006956705,0.0014016206,0.0001442587,0.000005772292,0.00009211397,2.4724773e-7,0.7037371,0.00023691039],"study_design_scores_gemma":[0.0063792462,0.0028204508,0.2963155,0.0033164485,0.0013110079,0.0000100833095,0.00013215038,0.0000056809076,0.00006924991,0.0000037176394,0.68931985,0.0003166304],"about_ca_topic_score_codex":0.00004300094,"about_ca_topic_score_gemma":0.0003483218,"teacher_disagreement_score":0.3310999,"about_ca_system_score_codex":0.00036735507,"about_ca_system_score_gemma":0.00019885307,"threshold_uncertainty_score":0.99986416},"labels":[],"label_agreement":null},{"id":"W4396228096","doi":"10.1002/ejhf.3246","title":"Multidisciplinary Care of Peripartum Heart Failure: A Scientific Statement of the Heart Failure Association of the ESC","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Multidisciplinary approach; Heart failure; Pregnancy; Intensive care medicine; Heart disease; Disease; Complication; Disease management; Obstetrics; Surgery; Internal medicine","score_opus":0.021168516538405128,"score_gpt":0.30747598898376083,"score_spread":0.2863074724453557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396228096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001927212,0.985435,0.000010473659,0.007959923,0.0023003106,0.001812209,0.00020215321,0.00002726525,0.00032545463],"genre_scores_gemma":[0.17574306,0.7447395,0.04016159,0.00027602838,0.0054252,0.00009127687,0.00022953482,0.0024015824,0.030932242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912025,0.0027640339,0.0026134185,0.0005561665,0.002386346,0.000477542],"domain_scores_gemma":[0.99445385,0.00015129174,0.0022063807,0.0018276536,0.0011577756,0.00020303126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004149292,0.0006203546,0.0030392022,0.00047848513,0.00020536534,0.00008657685,0.00088003126,0.00021924819,0.0001812003],"category_scores_gemma":[0.0006168274,0.0003486254,0.004821902,0.0013158418,0.0004572564,0.00014037789,0.0008514527,0.0018117462,0.00008797993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006367466,0.00047657362,0.0029281361,0.055171058,0.004385868,0.00020866356,0.005216393,0.000067843364,0.0014473409,0.000049831935,0.9192133,0.010771342],"study_design_scores_gemma":[0.00088260823,0.00030176996,0.0005771991,0.067994,0.0043025305,0.001224935,0.0010945624,0.0000016644639,0.00037814572,0.0000047050585,0.9229955,0.0002423614],"about_ca_topic_score_codex":0.000004186352,"about_ca_topic_score_gemma":0.000026028829,"teacher_disagreement_score":0.24069552,"about_ca_system_score_codex":0.0004715372,"about_ca_system_score_gemma":0.0012134163,"threshold_uncertainty_score":0.9998966},"labels":[],"label_agreement":null},{"id":"W4396731229","doi":"10.1002/ejhf.3281","title":"Metabolomics to Predict Heart Failure Development: A New Frontier?","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Library science; Frontier; Health science; Family medicine; Humanities; Medical education; Political science; Art; Law","score_opus":0.010874957851940318,"score_gpt":0.2506060265082823,"score_spread":0.23973106865634197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396731229","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009791981,0.0074033504,0.0017058041,0.1968168,0.7892299,0.0021167607,0.00012676136,0.00040906286,0.0012123536],"genre_scores_gemma":[0.0003656422,0.00013269453,0.3269754,0.0011115674,0.6396825,0.000010025297,0.00022565867,0.00043065348,0.031065889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936596,0.00047693626,0.0018988247,0.0008480174,0.0021943084,0.0009222735],"domain_scores_gemma":[0.99629396,0.00017944092,0.00045241174,0.0008118169,0.0006785439,0.0015838514],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021800061,0.001012172,0.0020758726,0.0012104312,0.00017817729,0.00036189525,0.0005781473,0.00042136223,0.00051433407],"category_scores_gemma":[0.0006720278,0.0007948968,0.0009467339,0.00062912947,0.00006780251,0.00027457633,0.00042479514,0.0028588548,0.0031857556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040074316,0.00016518879,0.00010001445,0.00038803357,0.0015746403,0.0016466419,0.000674392,0.000008750782,0.00030134042,0.0000071330483,0.9926027,0.0021304006],"study_design_scores_gemma":[0.0029634484,0.0015231981,0.00013962128,0.002652289,0.0015901362,0.00040076542,0.00019911723,0.0000018375918,0.00018506886,0.000011740627,0.98972756,0.00060520804],"about_ca_topic_score_codex":0.000012461568,"about_ca_topic_score_gemma":0.000041814543,"teacher_disagreement_score":0.32526958,"about_ca_system_score_codex":0.0004478929,"about_ca_system_score_gemma":0.0027007111,"threshold_uncertainty_score":0.9994502},"labels":[],"label_agreement":null},{"id":"W4396832690","doi":"10.1002/ejhf.3266","title":"Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Canada Research Chairs; St. Michael's Hospital; University of Toronto; Women's College Hospital","funders":"Bayer","keywords":"Medicine; Ejection fraction; Heart failure; Interquartile range; Internal medicine; Placebo; Cardiology; Natriuretic peptide; Heart failure with preserved ejection fraction; Randomized controlled trial","score_opus":0.017669205232036373,"score_gpt":0.25332608239781246,"score_spread":0.23565687716577607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396832690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91563714,0.00014169408,0.0008467323,0.08097582,0.0006112258,0.001490198,0.000031296087,0.00008389573,0.00018197435],"genre_scores_gemma":[0.97744954,0.000020700749,0.01860704,0.000439776,0.0016002966,0.000009504897,0.000060311762,0.00009233375,0.0017205069],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727005,0.0005701846,0.00078733586,0.00028287488,0.00080365577,0.00028590843],"domain_scores_gemma":[0.99830097,0.00018012806,0.00030697562,0.0004230691,0.00058443565,0.00020441998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012712087,0.00029939608,0.0005949149,0.00023888153,0.00014689831,0.00012474261,0.00013355317,0.000049665618,0.000636664],"category_scores_gemma":[0.000187684,0.00014483112,0.00021695245,0.00046788127,0.0001053535,0.00035506903,0.00004383305,0.0006354398,0.00007584743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06719781,0.0012708408,0.027608557,0.00046719017,0.001196462,0.0007134453,0.0003457115,0.000030281004,0.0012951966,0.000019349156,0.8979655,0.0018896585],"study_design_scores_gemma":[0.017988823,0.008888457,0.043595403,0.00097470236,0.0006666838,0.00022698371,0.00024505547,0.0000462335,0.0003991861,0.0000012432586,0.92679465,0.00017259864],"about_ca_topic_score_codex":0.000006893063,"about_ca_topic_score_gemma":0.000016583328,"teacher_disagreement_score":0.08053605,"about_ca_system_score_codex":0.000072569805,"about_ca_system_score_gemma":0.00026544137,"threshold_uncertainty_score":0.6971024},"labels":[],"label_agreement":null},{"id":"W4396845721","doi":"10.1002/ejhf.3267","title":"Contemporary Guideline-Directed Medical Therapy in De Novo, Chronic, and Worsening Heart Failure Patients: First Data from the TITRATE-HF Study","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ICIN Netherlands Heart Institute; Vifor Pharma; Novo Nordisk; ZonMw; Dutch Cardiovascular Alliance; AstraZeneca; Daiichi Sankyo Europe; Netherlands Heart Institute; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; Heart failure; Interquartile range; Cohort; Guideline; Internal medicine; Canadian Cardiovascular Society; Medical therapy; Outpatient clinic; Cardiology; Pathology","score_opus":0.038896235509579886,"score_gpt":0.3030362104395386,"score_spread":0.2641399749299587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396845721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72948986,0.00808076,0.00010802666,0.26060483,0.00037513248,0.0009868616,0.000033935186,0.00012319656,0.00019741047],"genre_scores_gemma":[0.9895471,0.00022452016,0.0068129683,0.0021341357,0.0009863478,0.000004352846,0.00010529019,0.00007309165,0.00011220367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966836,0.0008259574,0.0009808969,0.00042557615,0.0007425059,0.00034143814],"domain_scores_gemma":[0.9984895,0.0003309985,0.00011986972,0.00060324336,0.000143717,0.00031267217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028964684,0.00029414668,0.00053247734,0.00019064224,0.00013452787,0.00017423826,0.00038360423,0.00006335454,0.00058333867],"category_scores_gemma":[0.00032700732,0.00017781949,0.0001137997,0.00034806711,0.00009555549,0.0003473519,0.00025752536,0.00089307904,0.000090370726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020562914,0.00042364336,0.14638965,0.00002693226,0.0003638177,0.0023067058,0.0009812358,0.0000045120705,0.00013266921,0.0000024717149,0.84709877,0.002063996],"study_design_scores_gemma":[0.00551354,0.0014615501,0.07655969,0.0010554662,0.00010263995,0.0002401011,0.0010706706,0.00047540106,0.000015752441,0.00000393082,0.9133437,0.00015754886],"about_ca_topic_score_codex":0.00015100189,"about_ca_topic_score_gemma":0.0007627658,"teacher_disagreement_score":0.26005724,"about_ca_system_score_codex":0.00010712442,"about_ca_system_score_gemma":0.0005026479,"threshold_uncertainty_score":0.72512686},"labels":[],"label_agreement":null},{"id":"W4396898362","doi":"10.1002/ejhf.3234","title":"Frailty According to the 2019 HFA-ESC Definition in Patients at Risk for Advanced Heart Failure: Insights from the HELP-HF Registry","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Frailty in Older Adults","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Hazard ratio; Confidence interval; Internal medicine; Cohort; Cardiology; Cohort study","score_opus":0.019753994037038175,"score_gpt":0.25700327161847225,"score_spread":0.23724927758143408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396898362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89002055,0.0018410705,0.0005479683,0.10508391,0.0012019125,0.00088763924,0.00018665969,0.000050870887,0.00017942472],"genre_scores_gemma":[0.98129344,0.0000633765,0.013866452,0.0028485458,0.0013548317,0.000009400626,0.00008021586,0.000102374106,0.00038134525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972002,0.0005984904,0.00081595284,0.00038178847,0.0006213033,0.0003822535],"domain_scores_gemma":[0.9978738,0.00073889166,0.0002572393,0.0006152628,0.0002821263,0.00023267439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008863111,0.00029560964,0.0004472741,0.00016438065,0.00027873516,0.00014870784,0.00038406995,0.000071924784,0.00006804992],"category_scores_gemma":[0.0011036793,0.00017214402,0.00032907096,0.000407877,0.00007525166,0.00031689723,0.00016275876,0.0011167481,0.00046378793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008210541,0.00010852563,0.033456124,0.000055954115,0.00013285632,0.000110719186,0.0018435123,0.00021624431,0.0046889563,0.000032609165,0.9546526,0.0038808454],"study_design_scores_gemma":[0.003171946,0.0010360857,0.1331966,0.0019414889,0.00013381502,0.00016314762,0.0010073801,0.000044820063,0.00097277144,0.00015734261,0.8579569,0.00021771663],"about_ca_topic_score_codex":0.000035374807,"about_ca_topic_score_gemma":0.00020513024,"teacher_disagreement_score":0.10223536,"about_ca_system_score_codex":0.00021376718,"about_ca_system_score_gemma":0.00012087845,"threshold_uncertainty_score":0.7019829},"labels":[],"label_agreement":null},{"id":"W4396903204","doi":"10.1002/ejhf.3287","title":"Insulin-Like Growth Factor Binding Protein-7 in Heart Failure: The Challenge of Moving from Risk Prediction to a Biomarker-Guided Management","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Health science; Library science; Medical education","score_opus":0.017691253871898047,"score_gpt":0.2590757160327913,"score_spread":0.24138446216089324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396903204","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14801416,0.0055351406,0.0005014314,0.2637775,0.5650583,0.012885073,0.0019787082,0.0004943237,0.0017553738],"genre_scores_gemma":[0.305074,0.0025772867,0.114303984,0.00056389766,0.5696951,0.00023019064,0.000697297,0.0011996235,0.0056585856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932452,0.0012366315,0.0021009692,0.00079845847,0.0019714239,0.0006473104],"domain_scores_gemma":[0.99713075,0.00035795654,0.00080387475,0.00083181245,0.0004642912,0.00041128532],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0030901572,0.0007579684,0.0013815024,0.0014353817,0.00016010639,0.00017095999,0.00053800014,0.0002947526,0.00018558967],"category_scores_gemma":[0.0006487507,0.0005213963,0.0006926099,0.00087134965,0.00009251779,0.00023575175,0.00047554635,0.0023204393,0.0004126508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046335184,0.00031149705,0.0005506766,0.00075100677,0.0013306487,0.0010133521,0.00093306846,0.0000066152943,0.0014050674,0.000013319912,0.99214274,0.0010786729],"study_design_scores_gemma":[0.0033463978,0.0015071487,0.0018071425,0.0064082867,0.0009063422,0.000034466033,0.0005752636,0.000014949443,0.00021676751,0.000042411066,0.9847835,0.0003573546],"about_ca_topic_score_codex":0.00012662845,"about_ca_topic_score_gemma":0.000097940785,"teacher_disagreement_score":0.2632136,"about_ca_system_score_codex":0.0005014346,"about_ca_system_score_gemma":0.00026750538,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W4396912624","doi":"10.1002/ejhf.3288","title":"Mitral Regurgitation and Heart Failure with Preserved Ejection Fraction: Should we Treat the Muscle, the Valve, or Both?","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Ejection fraction; Internal medicine; Mitral regurgitation; Functional mitral regurgitation; Regurgitation (circulation); Mitral valve","score_opus":0.01851933858183347,"score_gpt":0.3062993468898108,"score_spread":0.28778000830797734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396912624","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07966439,0.04895373,0.00013721052,0.25575796,0.6067184,0.0047553726,0.0007858254,0.0003760856,0.00285098],"genre_scores_gemma":[0.11364343,0.0020903915,0.0018057221,0.00069781934,0.87287,0.00003676627,0.00029181616,0.00045874866,0.008105289],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669623,0.00077936094,0.0005831757,0.0004068567,0.0012256897,0.0003086722],"domain_scores_gemma":[0.99770474,0.00062213966,0.00037912952,0.0005241172,0.0005048727,0.00026501113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086260954,0.00046767027,0.00068655476,0.00018165293,0.00034210616,0.0003912979,0.00016652269,0.0001882004,0.00014769574],"category_scores_gemma":[0.00032244014,0.00020627356,0.0016851709,0.00032367304,0.00015615407,0.00027997937,0.000066105335,0.0018703667,0.00006654568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001257556,0.00010067257,0.0018255155,0.00024138416,0.0018582022,0.00028527473,0.00015057008,0.000013037723,0.000039434424,0.0000016973837,0.99381065,0.00041597223],"study_design_scores_gemma":[0.0024928113,0.0017023442,0.03159233,0.0014659144,0.004812636,0.00059180736,0.0009961813,0.0000042717866,0.000008983897,0.000013112222,0.9561188,0.00020076157],"about_ca_topic_score_codex":0.000026613845,"about_ca_topic_score_gemma":0.000029530287,"teacher_disagreement_score":0.26615158,"about_ca_system_score_codex":0.00014349728,"about_ca_system_score_gemma":0.00043026355,"threshold_uncertainty_score":0.84115916},"labels":[],"label_agreement":null},{"id":"W4398289251","doi":"10.1002/ejhf.3295","title":"How to Tackle Therapeutic Inertia in Heart Failure with Reduced Ejection Fraction. A Scientific Statement of the Heart Failure Association of the ESC","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation; Surgical Specialties (Canada)","funders":"Biosense Webster; Respicardia; Abbott Vascular; Stockholms Läns Landsting; Servier; Karolinska Institutet; Impulse Dynamics; Vifor Pharma; Vetenskapsrådet; Ministero della Salute; Pfizer; LivaNova; Boston Scientific Corporation; Novo Nordisk; Teva Pharmaceutical Industries; Cytokinetics; Sanofi; Amgen; Acceleron; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Heart failure; Guideline; Ejection fraction; Psychological intervention; Clinical Practice; Telemedicine; Intensive care medicine; Physical therapy; Cardiology; Nursing; Health care","score_opus":0.013306421669653372,"score_gpt":0.2527447484744078,"score_spread":0.23943832680475444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398289251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57910126,0.00031001048,0.00019697784,0.41847596,0.0007121814,0.0010792351,0.000010934684,0.000032340533,0.00008110416],"genre_scores_gemma":[0.9896273,0.000007069457,0.0065736338,0.0005666541,0.00024838993,0.000009861508,0.0000046701057,0.000056384786,0.0029060533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643034,0.00084162987,0.00081209885,0.00035181013,0.001184269,0.00037982754],"domain_scores_gemma":[0.9983299,0.000102412785,0.00041196257,0.0005544754,0.00045017805,0.00015108952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023420572,0.00027957137,0.0005425466,0.00046331802,0.00019212022,0.00021998586,0.00022961038,0.00006722125,0.00009947963],"category_scores_gemma":[0.00016890871,0.00015275324,0.00036712372,0.0015057559,0.00010627601,0.00035258758,0.00010192373,0.0007156455,0.0000395378],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025414032,0.0003988665,0.061652653,0.00027157535,0.0004979153,0.000031278716,0.001221777,0.00033932173,0.20580782,0.00007524588,0.7289608,0.00048859406],"study_design_scores_gemma":[0.0014207821,0.00087817543,0.05295781,0.001448665,0.00030125046,0.0001264901,0.0016930636,0.000042903877,0.02129055,0.000017631042,0.9196723,0.00015034321],"about_ca_topic_score_codex":0.00002320215,"about_ca_topic_score_gemma":0.00023406958,"teacher_disagreement_score":0.4179093,"about_ca_system_score_codex":0.00043758765,"about_ca_system_score_gemma":0.0003743736,"threshold_uncertainty_score":0.62290967},"labels":[],"label_agreement":null},{"id":"W4398782523","doi":"10.1002/ejhf.3284","title":"Differences in Presentation, Diagnosis and Management of Heart Failure in Women. A Scientific Statement of the Heart Failure Association of the ESC","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Respicardia; Norgine; Servier; Deutsche Forschungsgemeinschaft; Cytokinetics; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Novo Nordisk; Teva Pharmaceutical Industries; ReCor Medical; Boston Scientific Corporation; Impulse Dynamics; Alnylam Pharmaceuticals; Instituto de Salud Carlos III; Amgen; Vifor Pharma; Pfizer; Abiomed; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Heart failure; Etiology; Presentation (obstetrics); Epidemiology; Intensive care medicine; Scientific evidence; Randomized controlled trial; Statement (logic); MEDLINE; Family medicine; Internal medicine; Surgery","score_opus":0.01587235330767371,"score_gpt":0.26024045352240466,"score_spread":0.24436810021473093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398782523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8750382,0.0005912472,0.000010208797,0.12308244,0.0003012524,0.00090080354,0.000016666647,0.000009195006,0.0000499938],"genre_scores_gemma":[0.9955059,0.0001467185,0.003373586,0.0001424487,0.00005754659,0.00002305839,0.0000027955748,0.000026561676,0.0007213273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963369,0.0007976773,0.0012001337,0.00029361967,0.0010270918,0.00034457396],"domain_scores_gemma":[0.9987117,0.000165686,0.00042824383,0.0003779031,0.00021055127,0.000105902305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002741355,0.00022584047,0.0005973379,0.00044583395,0.0000873538,0.000084111896,0.00023584723,0.000048054815,0.00011480099],"category_scores_gemma":[0.00010636383,0.00013482333,0.00023764488,0.0010466602,0.00018133195,0.00023897334,0.00021125657,0.00038920916,0.000007201145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011288752,0.0005557408,0.7157002,0.0013039337,0.00043337027,0.00004584094,0.0040864167,0.00006310948,0.0042473013,0.00021311436,0.27266052,0.00057752285],"study_design_scores_gemma":[0.0020663396,0.0005109815,0.6581241,0.0039814967,0.00021297719,0.00002583276,0.004733822,0.0000357217,0.0035023047,0.00008090087,0.32659113,0.00013436854],"about_ca_topic_score_codex":0.000031385785,"about_ca_topic_score_gemma":0.00022501232,"teacher_disagreement_score":0.12293999,"about_ca_system_score_codex":0.00024180133,"about_ca_system_score_gemma":0.00013397267,"threshold_uncertainty_score":0.5497936},"labels":[],"label_agreement":null},{"id":"W4399128805","doi":"10.1002/ejhf.3285","title":"Impact of Malnutrition in Patients with Severe Heart Failure","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Malnutrition; Hazard ratio; Heart failure; Confidence interval; Internal medicine; Body mass index; Natriuretic peptide; Incidence (geometry); Logistic regression; Cohort; Cohort study; Clinical endpoint; Clinical trial","score_opus":0.013259588216366728,"score_gpt":0.2875026286020458,"score_spread":0.27424304038567904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399128805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97790354,0.00059236167,0.000053514872,0.020809859,0.00012659699,0.00023953742,0.00001963439,0.000024276264,0.0002306605],"genre_scores_gemma":[0.986604,0.000019416104,0.012632494,0.00034057308,0.00028370495,5.2982904e-7,0.000013424808,0.00004048196,0.00006540989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842113,0.00022738807,0.00058714894,0.000142683,0.00039032823,0.00023131561],"domain_scores_gemma":[0.99918216,0.000040688243,0.00012587057,0.00014427833,0.00028492778,0.00022209581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006089518,0.00014392822,0.0003920752,0.00045368183,0.00003526888,0.00003149328,0.000064437576,0.000035798163,0.00031259732],"category_scores_gemma":[0.0000362403,0.00010041441,0.00019664345,0.00038186487,0.00005266602,0.00021931143,0.000016563914,0.0006468772,0.000051411433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010160068,0.0004671761,0.6982764,0.00076995604,0.00008917789,0.00036995934,0.00029345247,0.000028095383,0.0014823831,0.00003864023,0.29655275,0.00061602605],"study_design_scores_gemma":[0.00540004,0.0036250928,0.8426905,0.0051457267,0.000048733717,0.0011591675,0.0001193448,0.000012281581,0.00010588112,0.000026759928,0.14153954,0.0001269041],"about_ca_topic_score_codex":0.0000040944747,"about_ca_topic_score_gemma":0.0000030149165,"teacher_disagreement_score":0.1550132,"about_ca_system_score_codex":0.000118222175,"about_ca_system_score_gemma":0.0001861849,"threshold_uncertainty_score":0.40947807},"labels":[],"label_agreement":null},{"id":"W4399183405","doi":"10.1002/ejhf.3274","title":"Residual Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair: Insights Into the EuroTR Registry","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Surgical Specialties (Canada)","funders":"Abbott Vascular; Boston Scientific Corporation; Daiichi Sankyo Europe; Siemens Healthineers; Edwards Lifesciences; AstraZeneca; Pfizer","keywords":"Medicine; Regurgitation (circulation); Residual; Cardiology; Internal medicine; Heart failure","score_opus":0.010303811896939914,"score_gpt":0.28486124400535373,"score_spread":0.2745574321084138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399183405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94609314,0.01956088,0.00014284995,0.030891776,0.0009099275,0.0005344839,0.000014182884,0.00012582746,0.0017269352],"genre_scores_gemma":[0.99394494,0.00015072063,0.0013304679,0.0012155499,0.0017501906,0.000009614519,0.000011471645,0.00008444432,0.0015025792],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767244,0.0005345063,0.0006464008,0.00032755217,0.00056095567,0.00025816687],"domain_scores_gemma":[0.99865806,0.00012153065,0.000115073984,0.0004755334,0.00025297832,0.00037680578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006608365,0.00026196698,0.0003940125,0.00031535057,0.00012414338,0.00013841063,0.00014759648,0.000043638433,0.00010681196],"category_scores_gemma":[0.00015721784,0.00015258031,0.0022145326,0.0005095573,0.000069454676,0.00020819099,0.000040029372,0.0004906793,0.00042708908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004172826,0.00067737186,0.013617016,0.00052945263,0.0036454026,0.009542576,0.011436779,0.00004291708,0.0029694336,0.00012214275,0.9274213,0.025822781],"study_design_scores_gemma":[0.0018543577,0.0014586098,0.18021236,0.0008559767,0.001542284,0.0008778871,0.0004339318,0.000009793275,0.00026950813,0.00004279881,0.81223184,0.00021065371],"about_ca_topic_score_codex":0.0000032120793,"about_ca_topic_score_gemma":0.0000017544274,"teacher_disagreement_score":0.16659535,"about_ca_system_score_codex":0.000095738826,"about_ca_system_score_gemma":0.00016369091,"threshold_uncertainty_score":0.6222045},"labels":[],"label_agreement":null},{"id":"W4399434082","doi":"10.1002/ejhf.3286","title":"Percutaneous Repair of Moderate-to-Severe or Severe Functional Mitral Regurgitation in Patients with Symptomatic Heart Failure: Baseline Characteristics of Patients in the RESHAPE-HF2 Trial and Comparison to COAPT and MITRA-FR Trials","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Health Care Foundation","funders":"Abbott Fund","keywords":"Medicine; Heart failure; Functional mitral regurgitation; Mitral regurgitation; Internal medicine; Cardiology; Percutaneous; Regurgitation (circulation); Surgery; Ejection fraction","score_opus":0.01931163033713477,"score_gpt":0.2905938756689213,"score_spread":0.2712822453317865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399434082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967919,0.00020599121,0.000022035494,0.0015260496,0.00013876421,0.0010898494,0.0002072883,0.00000901484,0.000009131404],"genre_scores_gemma":[0.9974565,0.0000114757995,0.002058882,0.00021896724,0.00012227982,0.0000039366564,0.000079164754,0.000030597283,0.000018209998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694824,0.00089690124,0.0011692632,0.00022914443,0.000583088,0.00017335029],"domain_scores_gemma":[0.99857295,0.00047739,0.00025964287,0.00016880786,0.00033777303,0.00018346208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013136021,0.00020604681,0.0008984641,0.00029766437,0.000040574203,0.000051560655,0.00005156181,0.000039049355,0.000037700316],"category_scores_gemma":[0.00072518596,0.00012340274,0.00034640403,0.00029297217,0.00004302731,0.00012994764,0.000027222044,0.00024294728,0.000003912159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12225374,0.0013234271,0.85088813,0.0004519728,0.0007015762,0.0002450991,0.0017067388,0.00020765755,0.00007497457,0.000006829502,0.02058283,0.0015569958],"study_design_scores_gemma":[0.024323637,0.0062176664,0.9639635,0.0014475137,0.0005968909,0.00020644351,0.0004845544,0.0001745708,0.0000064294745,0.0000036432164,0.002438052,0.00013706113],"about_ca_topic_score_codex":0.000010177454,"about_ca_topic_score_gemma":0.000015900338,"teacher_disagreement_score":0.11307538,"about_ca_system_score_codex":0.000059000296,"about_ca_system_score_gemma":0.0001387733,"threshold_uncertainty_score":0.5032218},"labels":[],"label_agreement":null},{"id":"W4399503272","doi":"10.1002/ejhf.3323","title":"Right Heart Failure with Left Ventricular Assist Devices: Preoperative, Perioperative and Postoperative Management Strategies. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Perioperative; Ventricle; Inotrope; Cardiology; Ventricular assist device; Internal medicine; Destination therapy; Hemodynamics; Intensive care medicine; Surgery","score_opus":0.009641374642195827,"score_gpt":0.24020181817778072,"score_spread":0.23056044353558489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399503272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97662956,0.0014130267,0.0004396416,0.019364465,0.00054798194,0.0010079558,0.00007986607,0.000055040906,0.0004624757],"genre_scores_gemma":[0.99369264,0.000009448002,0.0056844554,0.00028530168,0.000116781994,0.000004201292,0.0000038429184,0.00006328201,0.00014007791],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99536973,0.0016525865,0.001385348,0.00035067118,0.00089944596,0.000342189],"domain_scores_gemma":[0.99830365,0.00024085576,0.00039158168,0.00041801177,0.0004719087,0.00017401035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022000466,0.0003764722,0.00071829755,0.00011681359,0.00021539404,0.0002686709,0.00037162082,0.000096075266,0.0002315557],"category_scores_gemma":[0.00008418087,0.00020795579,0.0003514009,0.0004151439,0.000211334,0.00036721758,0.00014204149,0.0010133442,0.000020864603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032128757,0.0007307265,0.5497892,0.0033335546,0.009070567,0.0011331236,0.009026965,0.036947053,0.015947778,0.0064498857,0.3669351,0.00031477082],"study_design_scores_gemma":[0.0025768117,0.0011079567,0.21767849,0.0032253375,0.00086252735,0.0008792288,0.010374785,0.0018604128,0.009383482,0.000048265756,0.7512832,0.0007194973],"about_ca_topic_score_codex":0.000004485006,"about_ca_topic_score_gemma":0.00014437747,"teacher_disagreement_score":0.3843481,"about_ca_system_score_codex":0.00016544535,"about_ca_system_score_gemma":0.00025149534,"threshold_uncertainty_score":0.8480191},"labels":[],"label_agreement":null},{"id":"W4399676925","doi":"10.1002/ejhf.3336","title":"Biologically Active Adrenomedullin as a Marker for Residual Congestion and Early Rehospitalization in Patients Hospitalized for Acute Heart Failure: Data from STRONG-HF","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Adrenomedullin; Heart failure; Natriuretic peptide; Confidence interval; Internal medicine; Cardiology; Urology; Receptor","score_opus":0.029315499111511482,"score_gpt":0.2899158480555676,"score_spread":0.2606003489440561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399676925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370784,0.000084825566,0.00016418057,0.0044171736,0.00037024717,0.0005745946,0.0006304629,0.000031851243,0.000018843428],"genre_scores_gemma":[0.9936341,0.000045031797,0.005352659,0.0004035334,0.00035555728,0.000006572662,0.00009735687,0.00005629474,0.000048899583],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977981,0.00051802036,0.0005669489,0.00061066786,0.00019930486,0.00030698118],"domain_scores_gemma":[0.9987984,0.00047461683,0.00021295674,0.0002485183,0.00013652926,0.0001290012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045055232,0.00022276724,0.00037962143,0.00014163452,0.00010942613,0.00019568915,0.00037092407,0.000058284902,0.00003782344],"category_scores_gemma":[0.00093835685,0.00017456841,0.00010510931,0.00016112276,0.00012645498,0.0005701253,0.00019471685,0.00031807728,0.000025414272],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009613194,0.0006288989,0.03095904,0.00012967165,0.0002680365,0.0002986294,0.0007009165,0.00006820216,0.73679066,0.0014890775,0.21482177,0.004231884],"study_design_scores_gemma":[0.004900671,0.010789856,0.6894107,0.00049302034,0.00015840837,0.00006622934,0.00009107432,0.0002515825,0.0056043547,0.0011669941,0.28655502,0.00051207695],"about_ca_topic_score_codex":0.0000073650504,"about_ca_topic_score_gemma":0.000003512696,"teacher_disagreement_score":0.73118633,"about_ca_system_score_codex":0.000026487129,"about_ca_system_score_gemma":0.00005641203,"threshold_uncertainty_score":0.71186936},"labels":[],"label_agreement":null},{"id":"W4399807455","doi":"10.1002/ejhf.3348","title":"Characterization of Serum Phosphate Levels Over Time with Intravenous Ferric Carboxymaltose Versus Placebo as Treatment for Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Exploratory Prospective Substudy From HEART-FID","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Montréal; Canadian VIGOUR Centre; Montreal Heart Institute","funders":"Daiichi Sankyo Europe; Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; Abbott Vascular; Sanofi; Cytokinetics; American Regent; Amgen; Servier; AstraZeneca","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Placebo; Parathyroid hormone; Gastroenterology; Kidney disease; vitamin D deficiency; Vitamin D and neurology; Cardiology; Calcium; Pathology","score_opus":0.016144985483096536,"score_gpt":0.2596341123431413,"score_spread":0.24348912686004479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399807455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965725,0.0009808115,0.00012873192,0.0010032846,0.00014728877,0.0010060766,0.000075064316,0.000044348766,0.00004192364],"genre_scores_gemma":[0.99785715,0.00004097506,0.0016413766,0.000046329707,0.00018751199,0.000018231887,0.000052030126,0.00007516743,0.00008124875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845994,0.00020738735,0.00037313,0.0003886474,0.00033044108,0.0002404871],"domain_scores_gemma":[0.9991138,0.00005509925,0.00021951851,0.00020366834,0.00021099098,0.00019691885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002495123,0.0003009919,0.000494319,0.00019281165,0.00014900022,0.000080734506,0.00004290481,0.00005308601,0.000039573424],"category_scores_gemma":[0.000017603614,0.00020795535,0.0000912521,0.0002493451,0.000066102824,0.0005469263,0.000011460511,0.00022155429,0.00002021522],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029200861,0.002772388,0.0611236,0.000121554935,0.0011663996,0.0005364893,0.009153697,0.00015524372,0.89299226,0.000018004064,0.0014218473,0.0013376687],"study_design_scores_gemma":[0.03593452,0.07233642,0.76858616,0.0007809741,0.0019063184,0.0011273329,0.0041179224,0.0003763569,0.1081951,0.000027219967,0.0059663625,0.0006452796],"about_ca_topic_score_codex":0.000029346853,"about_ca_topic_score_gemma":0.000042119325,"teacher_disagreement_score":0.78479713,"about_ca_system_score_codex":0.00022314671,"about_ca_system_score_gemma":0.00027531892,"threshold_uncertainty_score":0.84801733},"labels":[],"label_agreement":null},{"id":"W4399829751","doi":"10.1002/ejhf.3347","title":"Diabetic Myocardial Disorder. A Clinical Consensus Statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial &amp; Pericardial Diseases","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Diabetic cardiomyopathy; Diabetes mellitus; Coronary artery disease; Asymptomatic; Cardiomyopathy; Endocrinology","score_opus":0.013705906393013237,"score_gpt":0.2608363162668705,"score_spread":0.24713040987385726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399829751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286147,0.0027558734,0.00007682775,0.06419015,0.0034712339,0.0006460151,0.000046025038,0.000025641795,0.00017356517],"genre_scores_gemma":[0.99706364,0.00026857812,0.000199321,0.00070887833,0.0015712657,0.0000025344182,0.0000037852822,0.000045644985,0.00013634679],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.993686,0.0036201067,0.001040906,0.00025261816,0.0011443713,0.0002559768],"domain_scores_gemma":[0.997756,0.00094409933,0.00044866552,0.0004935676,0.00019477431,0.00016287091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00396537,0.00023259518,0.0008625859,0.00009340604,0.00021609438,0.000084595995,0.00017380221,0.000075128315,0.00003413987],"category_scores_gemma":[0.0012339117,0.000108039494,0.0023481399,0.00035653994,0.0004753764,0.000045136847,0.00014748178,0.0010237478,0.000014102757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015416959,0.00024602708,0.71031624,0.00013677143,0.0037765324,0.000036510497,0.0012822316,0.00039793708,0.00061326276,0.00014344453,0.2769838,0.0045255655],"study_design_scores_gemma":[0.0031832529,0.00028655695,0.41445053,0.0004908931,0.0012560891,0.00012119151,0.00050515257,0.000021589509,0.000023737623,0.000015850936,0.57954746,0.000097678145],"about_ca_topic_score_codex":0.000013061704,"about_ca_topic_score_gemma":0.000013953138,"teacher_disagreement_score":0.3025637,"about_ca_system_score_codex":0.00009539872,"about_ca_system_score_gemma":0.00021403116,"threshold_uncertainty_score":0.44477317},"labels":[],"label_agreement":null},{"id":"W4399982543","doi":"10.1002/ejhf.3342","title":"What's New in Heart Failure? May–June 2024","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Library science; Heart failure; Humanities; Family medicine; Internal medicine; Art","score_opus":0.017051208042220586,"score_gpt":0.2736292731953586,"score_spread":0.256578065153138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399982543","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034315452,0.012896181,0.00027263534,0.946616,0.003867538,0.0006022394,0.0000027583183,0.00014255744,0.001284669],"genre_scores_gemma":[0.7172319,0.0016887911,0.15146661,0.007267614,0.007986092,0.000007900135,0.000030568666,0.00040122657,0.113919266],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972662,0.00033832417,0.000886039,0.0003737657,0.0006201086,0.0005156166],"domain_scores_gemma":[0.9987889,0.000087645276,0.00009419936,0.0003842903,0.00010422739,0.0005407376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013540038,0.0003450058,0.00064941135,0.0007481409,0.000059472783,0.00041424617,0.00017559646,0.000065324675,0.001780651],"category_scores_gemma":[0.00007540121,0.00026401284,0.00043458134,0.0006796364,0.000061581995,0.0009125522,0.00009794773,0.0009248632,0.0022211382],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010659603,0.00013823548,0.0015378176,0.00016724951,0.00018852075,0.0044651874,0.00057005475,0.0000185871,0.0021619897,0.00018564888,0.9855338,0.0049263625],"study_design_scores_gemma":[0.0019409226,0.000771166,0.00269224,0.002627158,0.00018562148,0.002109792,0.0009889526,0.000024731431,0.00041964606,0.00005653218,0.9879659,0.00021735423],"about_ca_topic_score_codex":0.000011296234,"about_ca_topic_score_gemma":0.000060758633,"teacher_disagreement_score":0.93934834,"about_ca_system_score_codex":0.00014684006,"about_ca_system_score_gemma":0.00031546887,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W4399982650","doi":"10.1002/ejhf.3361","title":"C-Reactive Protein, Inflammation and Short-Term Mortality in Acute Heart Failure","year":2024,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Momentum (technical analysis); Internal medicine; Library science; Cardiology","score_opus":0.018960220955705213,"score_gpt":0.27319529989838465,"score_spread":0.25423507894267944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399982650","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2015098,0.00044928826,0.000028115415,0.7961763,0.00032101478,0.0011507539,0.00002115648,0.00006283105,0.00028074117],"genre_scores_gemma":[0.6178305,0.00028939263,0.07810818,0.24427824,0.03840191,0.00017946385,0.0012596109,0.0015234504,0.018129267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99615484,0.0006548227,0.0012025752,0.00056008593,0.0008811577,0.000546519],"domain_scores_gemma":[0.99863744,0.00006751026,0.00029208182,0.00050878216,0.00024387013,0.00025031404],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012363974,0.0006228618,0.0011799755,0.00081345375,0.000077423145,0.00020178562,0.00017663132,0.00030233923,0.00013623385],"category_scores_gemma":[0.0000720242,0.00048405462,0.0004336755,0.0003180019,0.00015579197,0.00039090967,0.00016348631,0.003505436,0.00024244821],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092170914,0.00006148032,0.0066252956,0.0006474256,0.00091754296,0.017471977,0.00033703286,8.942975e-7,0.0051119807,0.000013600457,0.9683396,0.00038097487],"study_design_scores_gemma":[0.001256992,0.00086924754,0.012036587,0.002649009,0.0010419338,0.0021464815,0.00009913813,0.0000041760068,0.0007519047,0.00003327163,0.978741,0.00037024595],"about_ca_topic_score_codex":0.0000096568565,"about_ca_topic_score_gemma":0.0000305272,"teacher_disagreement_score":0.55189806,"about_ca_system_score_codex":0.00023267274,"about_ca_system_score_gemma":0.00020520312,"threshold_uncertainty_score":0.9997611},"labels":[],"label_agreement":null},{"id":"W4399982782","doi":"10.1002/ejhf.3352","title":"Geographical Variation in Patient Characteristics and Outcomes in Heart Failure with Mildly Reduced and Preserved Ejection Fraction","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cilag; Relypsa; National Medical Research Council; Medical Research Council; American Regent; National Heart, Lung, and Blood Institute; Sun Pharma; MyoKardia; Novo Nordisk; Daiichi-Sankyo; University of Glasgow; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; AstraZeneca; Amarin Corporation; Sanofi Pasteur; Celladon Corporation; Amgen; European Society of Cardiology; Boston Scientific Corporation; Esperion Therapeutics; Alnylam Pharmaceuticals; Daiichi Sankyo Europe; Servier; Bayer; Gilead Sciences; British Heart Foundation; Cytokinetics; Brigham and Women's Hospital; Sanofi; Vifor Pharma; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Internal medicine; Fraction (chemistry); Variation (astronomy)","score_opus":0.009803590265533456,"score_gpt":0.24012391932731122,"score_spread":0.23032032906177777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399982782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452467,0.00021534691,0.00010527039,0.05389526,0.00012019941,0.00035698764,0.0000024704896,0.000025984982,0.00003179691],"genre_scores_gemma":[0.9886524,0.00006604346,0.010856958,0.00021700448,0.0001195545,0.000004211105,0.0000073432407,0.00002879232,0.000047707832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985133,0.00029221873,0.0004906609,0.00023524181,0.00027846216,0.00019010591],"domain_scores_gemma":[0.99950004,0.00007045591,0.00009403138,0.00012384665,0.000074645795,0.00013697402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065807323,0.00017497454,0.00037997827,0.0005432893,0.000045262987,0.000098002005,0.000027959906,0.000049449194,0.000030039555],"category_scores_gemma":[0.000072228395,0.00012478886,0.00006334702,0.00029165886,0.000038755214,0.000316599,0.000031004958,0.00048420476,0.000008477502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006243536,0.00041315134,0.96890473,0.00026602976,0.0002198275,0.001235273,0.00081272767,0.000012524794,0.009748126,0.000055224515,0.015295591,0.0024124521],"study_design_scores_gemma":[0.0016136352,0.0013252194,0.8779997,0.0006784877,0.00010019979,0.00042648282,0.00028755964,0.00014943659,0.00008529101,0.000013410321,0.11720602,0.00011452638],"about_ca_topic_score_codex":0.000027915366,"about_ca_topic_score_gemma":0.00005959668,"teacher_disagreement_score":0.101910435,"about_ca_system_score_codex":0.00006548561,"about_ca_system_score_gemma":0.000043934306,"threshold_uncertainty_score":0.5088742},"labels":[],"label_agreement":null},{"id":"W4399982949","doi":"10.1002/ejhf.3260","title":"OPTImal PHARMacological Therapy for Patients with Heart Failure: Rationale and Design of the OPTIPHARM-HF Registry","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Guideline; Medical prescription; Ejection fraction; Observational study; Population; Comorbidity; Internal medicine; Clinical trial; Intensive care medicine; Emergency medicine; Pathology","score_opus":0.024314116540833316,"score_gpt":0.27101072016459754,"score_spread":0.24669660362376422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399982949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79154855,0.0021913042,0.010391341,0.19168544,0.00048607218,0.0034964057,0.000038230195,0.00006778168,0.00009485533],"genre_scores_gemma":[0.8345319,0.00007745036,0.16345619,0.00087742304,0.00038758005,0.000014487881,0.000009416147,0.00004827665,0.000597266],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985501,0.00027320895,0.00039532807,0.00019984452,0.00038002385,0.0002015009],"domain_scores_gemma":[0.9991867,0.00015976778,0.00012767874,0.00015515098,0.00022837697,0.00014235785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007128992,0.00018661961,0.0003184229,0.00009479761,0.00010624972,0.00005928767,0.00011122976,0.000031083626,0.00012648606],"category_scores_gemma":[0.000047898728,0.00009739797,0.00017632113,0.0001615616,0.00012494302,0.00015584253,0.000039702893,0.00027500227,0.000009071873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019994758,0.0005825884,0.009840453,0.00015039198,0.0006557138,0.000097951895,0.00030065357,0.00049597345,0.009393166,0.00009291061,0.9753273,0.0010634096],"study_design_scores_gemma":[0.005943427,0.0040204274,0.014268848,0.00036310812,0.00031094404,0.00024900364,0.00011928829,0.00019164142,0.0020114537,0.00000914015,0.97237694,0.00013577513],"about_ca_topic_score_codex":4.4024816e-7,"about_ca_topic_score_gemma":2.45506e-7,"teacher_disagreement_score":0.19080801,"about_ca_system_score_codex":0.00003314766,"about_ca_system_score_gemma":0.00013647186,"threshold_uncertainty_score":0.3971774},"labels":[],"label_agreement":null},{"id":"W4400095057","doi":"10.1002/ejhf.3353","title":"Left Atrial Enlargement and Biomarker Profiles: Time for Integration of Biomarkers and Echocardiography in Heart Failure Prevention","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine; Biomarker; Left atrial enlargement; Atrial fibrillation","score_opus":0.020021713487637482,"score_gpt":0.30306790131642497,"score_spread":0.2830461878287875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400095057","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.107863195,0.02464821,0.0044153826,0.092784345,0.7543655,0.014193212,0.00082778686,0.00025753674,0.00064483745],"genre_scores_gemma":[0.05911361,0.0015175624,0.09898016,0.00011063167,0.8353005,0.0000056983336,0.0011541556,0.00043075214,0.0033869292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717087,0.00046540945,0.0011727375,0.0003446334,0.00062809343,0.00021824874],"domain_scores_gemma":[0.9984894,0.0003264777,0.00053545414,0.00018554201,0.00033491116,0.00012820549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030617618,0.00032791615,0.00094120944,0.0011694751,0.000053533597,0.00010141642,0.000087997585,0.00021423814,0.00004963408],"category_scores_gemma":[0.00058361486,0.00025992145,0.0007923811,0.00030291258,0.00009319353,0.00020933489,0.00008766902,0.00047353643,0.000009714376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00122365,0.000012301841,0.004593543,0.0007435134,0.00081635005,0.00002255582,0.00013184264,0.0000024075225,0.0028490403,0.00000759643,0.98804843,0.0015487414],"study_design_scores_gemma":[0.004204453,0.0012744146,0.0047622207,0.002192669,0.0009827601,0.000032218843,0.00022422589,0.000053520627,0.00011842685,0.000060963896,0.9858825,0.00021159953],"about_ca_topic_score_codex":0.0000029568284,"about_ca_topic_score_gemma":0.000004826452,"teacher_disagreement_score":0.09456477,"about_ca_system_score_codex":0.000055653596,"about_ca_system_score_gemma":0.0001457416,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W4400130154","doi":"10.1002/ejhf.3371","title":"What's New in Heart Failure? June–July 2024","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Library science; Humanities; Family medicine; Art","score_opus":0.01605040345914346,"score_gpt":0.26922146446779316,"score_spread":0.2531710610086497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400130154","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025809241,0.01896737,0.0003781245,0.9463892,0.0051773125,0.0007765074,0.0000038011522,0.00018795718,0.0023104954],"genre_scores_gemma":[0.64990795,0.0021679383,0.18754543,0.0099388,0.010674624,0.00001057836,0.000036166664,0.0005289717,0.13918956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997225,0.0003407231,0.0009020756,0.00037857125,0.00063306163,0.00052058895],"domain_scores_gemma":[0.99877024,0.00009102752,0.00009672217,0.0003843729,0.0001110237,0.0005465978],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001377536,0.0003499603,0.0006492867,0.0007543463,0.00006292087,0.00044035233,0.00018040749,0.0000666198,0.0012119636],"category_scores_gemma":[0.00008223336,0.0002677028,0.0004509319,0.00067706616,0.000060409766,0.00096381624,0.00009404501,0.0009804093,0.0029094669],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102528305,0.00013406879,0.00083376496,0.00016336395,0.00018434778,0.0041046813,0.0005683296,0.00001883359,0.002002314,0.00010937766,0.98724693,0.004531475],"study_design_scores_gemma":[0.001907237,0.0007724454,0.0020663147,0.002656603,0.0001893309,0.0019890498,0.0006904589,0.000023867568,0.00038967244,0.000060694503,0.98903334,0.00022099089],"about_ca_topic_score_codex":0.000011005324,"about_ca_topic_score_gemma":0.000060995466,"teacher_disagreement_score":0.93645036,"about_ca_system_score_codex":0.00014456616,"about_ca_system_score_gemma":0.0003435252,"threshold_uncertainty_score":0.9999775},"labels":[],"label_agreement":null},{"id":"W4400130834","doi":"10.1002/ejhf.3357","title":"Identifying Reliable Biomarkers for Pulmonary Congestion: Toward a Close Yet Sustainable Heart Failure Follow-Up","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.01748593644760474,"score_gpt":0.28216389289072114,"score_spread":0.2646779564431164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400130834","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094709755,0.011558287,0.00044773205,0.20305738,0.77694374,0.004355618,0.0002838867,0.0004279456,0.0019783096],"genre_scores_gemma":[0.008251086,0.00069780624,0.08769561,0.00082290353,0.7566587,0.00011881176,0.0014187127,0.0010014415,0.14333495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384063,0.00049488246,0.0017285042,0.00096510944,0.0017379409,0.0012329218],"domain_scores_gemma":[0.9955692,0.00049864297,0.0006269535,0.00082030206,0.0017291397,0.0007557302],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004013927,0.0009638907,0.0018144347,0.0011266612,0.00036319892,0.0005800991,0.00047891962,0.0005238138,0.00037045224],"category_scores_gemma":[0.001247388,0.0008069948,0.0015771922,0.0006611592,0.00015657926,0.0005742248,0.00035179374,0.0021908756,0.0008358901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013730697,0.00022039843,0.000095831805,0.0036598435,0.0016542689,0.006562534,0.00026514367,0.0000043451505,0.0002953267,0.00008790393,0.98550004,0.00028129155],"study_design_scores_gemma":[0.0048342594,0.0021585163,0.00005079918,0.0044132187,0.0024878015,0.00074525597,0.0019096463,0.000011891441,0.000089586596,0.00020074425,0.9824565,0.0006417579],"about_ca_topic_score_codex":0.000038540213,"about_ca_topic_score_gemma":0.000013906602,"teacher_disagreement_score":0.20223446,"about_ca_system_score_codex":0.00063107634,"about_ca_system_score_gemma":0.0013323042,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W4400583540","doi":"10.1002/ejhf.3376","title":"European Society of Cardiology Quality Indicators Update for the Care and Outcomes of Adults with Heart Failure. The Heart Failure Association of the ESC","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Guideline; Clinical Practice; Health care; Intensive care medicine; Quality of life (healthcare); Medical emergency; Cardiology; Family medicine; Nursing","score_opus":0.021180777015581506,"score_gpt":0.30438449356272335,"score_spread":0.2832037165471418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400583540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049768826,0.82507056,0.00015612703,0.16285747,0.00073213404,0.005433349,0.0005135164,0.00005704795,0.00020291164],"genre_scores_gemma":[0.16894327,0.78904206,0.03468261,0.0021950053,0.0027352548,0.000096057054,0.00022954131,0.00076492585,0.0013112943],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993247,0.0029149062,0.0019684446,0.00045000238,0.00096942566,0.00045022345],"domain_scores_gemma":[0.9954456,0.0008108337,0.0020244322,0.0009659981,0.00059022673,0.00016288391],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048615704,0.00064555096,0.0029526977,0.00022201841,0.00024408073,0.000053992444,0.000567514,0.00017493563,0.000018860448],"category_scores_gemma":[0.00029763248,0.00026759124,0.002474351,0.0006072358,0.00042191002,0.00010160145,0.00033784617,0.001289365,0.000015358668],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019224756,0.00014673347,0.027272517,0.01964012,0.0081883175,0.00002016569,0.0026706785,0.000013162555,0.00002974207,0.00013347241,0.92368466,0.01800816],"study_design_scores_gemma":[0.0015915458,0.0009332373,0.007770221,0.0067051295,0.0062377327,0.00017420699,0.0027456142,7.901201e-7,0.000018128758,0.00000329229,0.97359735,0.00022272568],"about_ca_topic_score_codex":0.000015037902,"about_ca_topic_score_gemma":0.000044210396,"teacher_disagreement_score":0.16396639,"about_ca_system_score_codex":0.00016372083,"about_ca_system_score_gemma":0.0004165806,"threshold_uncertainty_score":0.99997765},"labels":[],"label_agreement":null},{"id":"W4401117116","doi":"10.1002/ejhf.3397","title":"Biomarker Profiles Associated with Reverse Ventricular Remodelling in Patients with Heart Failure and a Reduced Ejection Fraction: Insights from the Echocardiographic Substudy of the VICTORIA Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Janssen Research and Development; National Medical Research Council; Medical Research Council; Bayer Canada; Natera; Regeneron Pharmaceuticals; National Institutes of Health; CSL Limited; Vifor Pharma; MyoKardia; Novo Nordisk; Daiichi-Sankyo; Abbott Diagnostics; Bayer; Servier; Amgen; National University of Singapore; Siemens Healthineers; Moderna; Boston Scientific Corporation; Cytokinetics; Merck KGaA; European Commission; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; Heart failure; Cardiology; Biomarker; Internal medicine; Fraction (chemistry); Chromatography; Biochemistry","score_opus":0.008038792734199912,"score_gpt":0.20492712378684466,"score_spread":0.19688833105264475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401117116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937768,0.0009875817,0.000021662505,0.0040148622,0.00048249165,0.00066777907,0.00000541199,0.000017895363,0.000025510028],"genre_scores_gemma":[0.99921244,0.000025571022,0.00043396695,0.000058957565,0.00020935934,0.0000015122004,0.000010055274,0.00003441665,0.000013687909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771124,0.0008700615,0.00047754688,0.00021625357,0.0005718867,0.00015298513],"domain_scores_gemma":[0.9990619,0.00012637046,0.0002648192,0.00021434654,0.0002501071,0.00008248544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007433077,0.00018180539,0.00036339674,0.00022117612,0.00013224145,0.00005318098,0.00008849283,0.00008435289,0.000008797283],"category_scores_gemma":[0.000097324046,0.00008045874,0.00019208775,0.0010497267,0.00011042436,0.00016020483,0.000024194109,0.00074672373,0.0000019072083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03940829,0.00085032196,0.90771914,0.00009899791,0.0038592482,0.00074294937,0.0015422908,0.00019882282,0.0066838665,0.0000058455066,0.038715012,0.00017521839],"study_design_scores_gemma":[0.023656474,0.0022139186,0.94776064,0.003844961,0.0008461863,0.00016386161,0.00080835697,0.000105457206,0.0003740655,0.000012402365,0.02004313,0.00017054],"about_ca_topic_score_codex":0.000015492047,"about_ca_topic_score_gemma":0.000011838656,"teacher_disagreement_score":0.040041506,"about_ca_system_score_codex":0.00006171247,"about_ca_system_score_gemma":0.00010843493,"threshold_uncertainty_score":0.32810122},"labels":[],"label_agreement":null},{"id":"W4401204112","doi":"10.1002/ejhf.3340","title":"Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Ted Rogers Centre for Heart Research; Toronto General Hospital; University of Toronto; Mount Sinai Hospital","funders":"Ministero della Salute","keywords":"Medicine; Myocarditis; Immune system; Heart failure; Adverse effect; Immunology; Immune dysregulation; Cancer; Rash; Internal medicine","score_opus":0.058690383981007004,"score_gpt":0.33045284640168343,"score_spread":0.2717624624206764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401204112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057172603,0.9856743,0.000010266217,0.005520959,0.0008025979,0.001943561,0.00020064386,0.000004811223,0.00012556073],"genre_scores_gemma":[0.022218173,0.9715877,0.00059913157,0.00006752859,0.000693726,0.000052844225,0.000008724588,0.00016481311,0.0046073585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99162245,0.003353271,0.0019843564,0.00028146798,0.0024277503,0.0003307018],"domain_scores_gemma":[0.99431604,0.00064622436,0.0017912782,0.0009231565,0.0022527452,0.000070571026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018642707,0.00034648465,0.0030982806,0.00020940625,0.00017806547,0.00005225908,0.00060389104,0.00013654174,0.00009678144],"category_scores_gemma":[0.0006047435,0.0001558364,0.003442666,0.00060170126,0.001041826,0.00006633418,0.00026493557,0.0010216577,0.0000016355261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002772057,0.0007843993,0.0009918091,0.11209521,0.08616723,0.0000562958,0.049279016,0.00038337658,0.05072179,0.00031281015,0.30104077,0.39539525],"study_design_scores_gemma":[0.001982977,0.0004258899,0.000119636796,0.01010607,0.0033828686,0.0001499239,0.0014087027,0.0000031176473,0.0014443444,0.000014786657,0.98084897,0.00011273878],"about_ca_topic_score_codex":0.00006521517,"about_ca_topic_score_gemma":0.00007165488,"teacher_disagreement_score":0.6798082,"about_ca_system_score_codex":0.00084225053,"about_ca_system_score_gemma":0.0043811863,"threshold_uncertainty_score":0.7772037},"labels":[],"label_agreement":null},{"id":"W4401275496","doi":"10.1002/ejhf.3408","title":"Clonal Haematopoiesis is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Princess Margaret Cancer Centre; Hospital for Sick Children; Ontario Institute for Cancer Research; Mount Sinai Hospital; University of Toronto; University Health Network; Toronto General Hospital; Ted Rogers Centre for Heart Research","funders":"","keywords":"Medicine; Internal medicine; Hypertrophic cardiomyopathy; Cardiology; Heart failure; Mace; Troponin; Hazard ratio; Confidence interval; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.007404252586574199,"score_gpt":0.2011179073411407,"score_spread":0.1937136547545665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401275496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234575,0.004691035,0.000082203864,0.0018785071,0.00026997726,0.00030602826,0.000027110234,0.00004240701,0.00035698363],"genre_scores_gemma":[0.9981581,0.000057156903,0.0009621029,0.00026780207,0.0003126146,0.000003071485,0.000010760425,0.000084965104,0.00014345716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729836,0.0004386251,0.0005161244,0.00031662986,0.0010737901,0.00035649913],"domain_scores_gemma":[0.9988704,0.000056449368,0.000122012076,0.00032380995,0.00043308348,0.00019426865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001198749,0.00030224898,0.0010088092,0.00036994432,0.0000945188,0.000024103672,0.00011193845,0.000047018675,0.000033890617],"category_scores_gemma":[0.00009653091,0.00019626127,0.000702351,0.00058749545,0.00009678844,0.00021747014,0.000061844934,0.00061707775,0.00004909829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018687715,0.00036398048,0.93804884,0.0003219463,0.008276449,0.017108982,0.001764179,0.00019875664,0.00009615155,0.0000086916325,0.030590221,0.0013530338],"study_design_scores_gemma":[0.0071479534,0.0017605566,0.89395213,0.0031460105,0.0017548021,0.0023249695,0.00041301316,0.0000045814572,0.00006203357,0.0000040312443,0.08912831,0.00030158993],"about_ca_topic_score_codex":0.0000066218463,"about_ca_topic_score_gemma":0.000003912779,"teacher_disagreement_score":0.05853809,"about_ca_system_score_codex":0.00015829269,"about_ca_system_score_gemma":0.00017003466,"threshold_uncertainty_score":0.8003302},"labels":[],"label_agreement":null},{"id":"W4401366618","doi":"10.1002/ejhf.3409","title":"Ventilation Strategies in Cardiogenic Shock: Insights from the AltShock-2 Registry","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiogenic shock; Hazard ratio; Confidence interval; Mechanical ventilation; Ventilation (architecture); Shock (circulatory); Internal medicine; Prospective cohort study; Cardiology; Myocardial infarction","score_opus":0.010858831006621028,"score_gpt":0.21424299754806622,"score_spread":0.2033841665414452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401366618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97807467,0.016473701,0.0020129804,0.0009504088,0.0011564898,0.000088758265,0.000008619897,0.00010633257,0.0011280541],"genre_scores_gemma":[0.9986352,0.000023699587,0.0006059171,0.000049839666,0.00062579615,4.7462885e-7,0.0000047223107,0.000040517312,0.00001385774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988083,0.000227015,0.00045446414,0.000117487754,0.00025323263,0.00013947912],"domain_scores_gemma":[0.9995333,0.00009332138,0.000047318408,0.00022146397,0.000032617012,0.000071969815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000431558,0.00012711904,0.00019067292,0.00008338605,0.00003467126,0.00018427393,0.0002400242,0.000034317014,0.000108166154],"category_scores_gemma":[0.000022411377,0.000089529654,0.00015986915,0.00020632423,0.000020044974,0.00035421833,0.000023778894,0.0005412651,0.00015582053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001978501,0.00013055898,0.019023208,0.00080277765,0.0019222548,0.01315603,0.010116187,0.20053253,0.14702466,0.0050181686,0.59132546,0.01075034],"study_design_scores_gemma":[0.00037594014,0.00008302081,0.045896437,0.0007631657,0.00009209249,0.00034424008,0.001541661,0.0046010003,0.0018131702,0.00081734604,0.94338036,0.00029156767],"about_ca_topic_score_codex":0.0000035998373,"about_ca_topic_score_gemma":0.00003016185,"teacher_disagreement_score":0.35205492,"about_ca_system_score_codex":0.00004528889,"about_ca_system_score_gemma":0.000055128603,"threshold_uncertainty_score":0.36509135},"labels":[],"label_agreement":null},{"id":"W4401650360","doi":"10.1002/ejhf.3422","title":"Are Mechanical Circulatory Supports the Forgotten Aspect in the Implementation of Therapies for Heart Failure?","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiogenic shock; Heart failure; Decompensation; Internal medicine; Ejection fraction; Cardiology; Myocardial infarction; Incidence (geometry); Population; Heart transplantation; Mortality rate","score_opus":0.02086203005104564,"score_gpt":0.3008162956882472,"score_spread":0.27995426563720155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401650360","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43107644,0.0020969205,0.0010183003,0.56343293,0.00044108872,0.0017564689,0.000021221822,0.00004553322,0.00011109509],"genre_scores_gemma":[0.99213016,0.000024296995,0.005468616,0.0017489385,0.00047278326,0.000013839397,0.000008544725,0.000042651183,0.000090153255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979269,0.00046122313,0.00067474804,0.00018802167,0.00047374688,0.00027537483],"domain_scores_gemma":[0.99907476,0.00020861336,0.00020906607,0.00030382906,0.00012660175,0.00007713345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027760365,0.00018661475,0.00037643986,0.00020683302,0.00009497505,0.00007525864,0.00017867198,0.00003090697,0.00021085996],"category_scores_gemma":[0.0000516094,0.000096210424,0.0003987855,0.00025370056,0.00007311132,0.0001601363,0.000036365185,0.00034809764,0.000024395054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012686684,0.00019624797,0.015654646,0.00026680698,0.00053883775,0.0004834182,0.003613561,0.000006754667,0.0075822915,0.0027280368,0.9659249,0.0028776005],"study_design_scores_gemma":[0.0015078876,0.0009284451,0.055336934,0.00032572757,0.0002884782,0.0006953351,0.011482337,0.000014761113,0.00089607824,0.00028166655,0.92813724,0.00010512045],"about_ca_topic_score_codex":0.000006813575,"about_ca_topic_score_gemma":0.000066422705,"teacher_disagreement_score":0.561684,"about_ca_system_score_codex":0.000058489535,"about_ca_system_score_gemma":0.00011042194,"threshold_uncertainty_score":0.3923347},"labels":[],"label_agreement":null},{"id":"W4401767212","doi":"10.1002/ejhf.3423","title":"Decongestion in Acute Heart Failure: Is It Time to Change Diuretic-Centred Paradigm?","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Pfizer; Vifor Pharma; LivaNova; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Amgen; Edwards Lifesciences; Novo Nordisk; Abbott Vascular; Abbott Laboratories; Sanofi; AstraZeneca; Servier","keywords":"Medicine; Heart failure; Intensive care medicine; Disease; Diuretic; Presentation (obstetrics); Internal medicine; Surgery","score_opus":0.058513986935439945,"score_gpt":0.3245024468755028,"score_spread":0.2659884599400628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401767212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033178032,0.74420387,0.000009289491,0.2529687,0.000524114,0.001867736,0.00004378115,0.00006556118,0.00028379174],"genre_scores_gemma":[0.00010859891,0.9675395,0.015724046,0.004955918,0.0024973364,0.00005155558,0.00012815207,0.00040429056,0.008590642],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99518794,0.0008197918,0.0017670698,0.0006854659,0.0007703658,0.0007693975],"domain_scores_gemma":[0.9978709,0.00012239936,0.00039061104,0.0006892775,0.00013782177,0.00078896305],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010493246,0.000889086,0.0029332575,0.0013705075,0.0000747525,0.00019047702,0.0003479796,0.00020796478,0.0018260158],"category_scores_gemma":[0.00011235595,0.0006433066,0.0012747913,0.00097060716,0.000060000835,0.00024896514,0.0002228193,0.0014014466,0.020820372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058160364,0.00019266158,0.000023323684,0.003000242,0.00086181937,0.003598435,0.0005483699,2.839148e-7,0.000006207702,0.000014120586,0.92769814,0.06399826],"study_design_scores_gemma":[0.0011333352,0.0010799192,0.00005534217,0.032791913,0.004758437,0.0029427856,0.0000659314,0.0000034585512,0.0000030859333,0.000004068322,0.956695,0.00046667983],"about_ca_topic_score_codex":0.000003706406,"about_ca_topic_score_gemma":0.000011665343,"teacher_disagreement_score":0.24801277,"about_ca_system_score_codex":0.0003439337,"about_ca_system_score_gemma":0.0003215699,"threshold_uncertainty_score":0.99960184},"labels":[],"label_agreement":null},{"id":"W4401790159","doi":"10.1002/ejhf.3417","title":"Clinical Characteristics and Outcomes of Patients Aged 80 Years and Over with Heart Failure: Need for Better Treatment","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Health Care Foundation","funders":"British Heart Foundation","keywords":"Medicine; Hazard ratio; Heart failure; Internal medicine; Confidence interval; Ejection fraction; Incidence (geometry); Randomized controlled trial; Cardiology","score_opus":0.01825564169134568,"score_gpt":0.28664608841328765,"score_spread":0.26839044672194196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401790159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747453,0.00020078525,0.000091858514,0.024191348,0.00017558326,0.00052380026,0.000031713116,0.00002144629,0.000018208622],"genre_scores_gemma":[0.963769,0.00006074797,0.034629006,0.0007533869,0.00028500208,0.00000367913,0.000021610422,0.00005550285,0.00042205307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848247,0.0001663949,0.0006498251,0.00022953168,0.00025937703,0.00021240168],"domain_scores_gemma":[0.99917465,0.0001737506,0.00014699409,0.00017967453,0.00009399408,0.00023091797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055716274,0.00022107956,0.00068048196,0.00017565496,0.000045574514,0.00006155319,0.000043092066,0.000041878913,0.00004535932],"category_scores_gemma":[0.000050183473,0.0001384275,0.00021108023,0.00008608303,0.00010775459,0.00013083623,0.00003730725,0.00020258225,0.000009693566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042637755,0.00030970018,0.88409513,0.0001483919,0.00066094776,0.00019769071,0.000295207,1.710696e-7,0.00019053016,0.00001620344,0.10631639,0.0073432634],"study_design_scores_gemma":[0.0034311425,0.0031450612,0.5800527,0.00020175852,0.00039333187,0.000048801165,0.000054961318,0.000005738158,0.000023240116,0.0000032448554,0.41255912,0.000080909325],"about_ca_topic_score_codex":0.0000029320292,"about_ca_topic_score_gemma":0.000006337112,"teacher_disagreement_score":0.30624273,"about_ca_system_score_codex":0.000033521723,"about_ca_system_score_gemma":0.000053017226,"threshold_uncertainty_score":0.5644909},"labels":[],"label_agreement":null},{"id":"W4401961208","doi":"10.1002/ejhf.3412","title":"The Right Heart in Patients with Cancer. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Servier; Cilag; Astellas Pharma; Novo Nordisk; Eisai; Cytokinetics; Amicus Therapeutics; Impulse Dynamics; Fondation Leducq; Gilead Sciences; National Heart Foundation of Australia; BeiGene; Daiichi Sankyo Europe; European Commission; Sanofi; Amgen; Vifor Pharma; Ministero della Salute; Pfizer; Universitair Medisch Centrum Groningen; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Family medicine; Library science; Internal medicine","score_opus":0.010128172348310926,"score_gpt":0.2364705645721796,"score_spread":0.22634239222386868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401961208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85219425,0.0019588005,0.0000085016745,0.14362125,0.0007196056,0.0011838641,0.00002729312,0.0000089205805,0.0002775097],"genre_scores_gemma":[0.9977564,0.000044527063,0.00060852675,0.00024225454,0.000110743815,0.0000086075415,0.000002056567,0.000027634449,0.0011992318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957475,0.0013022867,0.0009163857,0.00021594547,0.001518728,0.0002991342],"domain_scores_gemma":[0.9978497,0.00032002726,0.00052919606,0.00046440327,0.0007573113,0.000079349986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006105197,0.0001985944,0.0005922872,0.0001000262,0.0002787772,0.000072309864,0.00025158603,0.00004443744,0.000040021987],"category_scores_gemma":[0.00021352597,0.000076503726,0.0002775005,0.0005409734,0.0005168624,0.00012514775,0.00014830357,0.00051470584,0.000005407508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012181575,0.00052849663,0.3278321,0.00043072223,0.0015116504,0.000029452862,0.00847233,0.0002694144,0.0025287478,0.0003593413,0.65523577,0.0015838301],"study_design_scores_gemma":[0.003961242,0.00059188536,0.12862882,0.00085439294,0.0003621804,0.000023215192,0.0006417863,0.000025250649,0.0010920801,0.000016935614,0.86372894,0.00007328083],"about_ca_topic_score_codex":0.00006610783,"about_ca_topic_score_gemma":0.000687008,"teacher_disagreement_score":0.20849317,"about_ca_system_score_codex":0.00060767925,"about_ca_system_score_gemma":0.0012108741,"threshold_uncertainty_score":0.31197312},"labels":[],"label_agreement":null},{"id":"W4401963893","doi":"10.1002/ejhf.3432","title":"Glycolysis in heart failure with preserved ejection fraction","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Division of Human Resource Development","keywords":"Internal medicine; Heart failure; Glycolysis; Ejection fraction; Oxidative phosphorylation; Beta oxidation; Mitochondrion; Heart failure with preserved ejection fraction; Medicine; Endocrinology; Adenosine triphosphate; Fatty acid; Cardiology; Oxidative stress; Metabolism; Biochemistry; Chemistry","score_opus":0.008064891949025417,"score_gpt":0.24001701496352607,"score_spread":0.23195212301450066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401963893","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028310962,0.0036213042,0.00059822854,0.019327465,0.9457695,0.001069072,0.00006557509,0.00024507206,0.0009928362],"genre_scores_gemma":[0.030928815,0.00044918206,0.0049803066,0.00017493572,0.9590923,0.000007118755,0.0002020863,0.00038561015,0.0037796246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956533,0.00085947284,0.0009335887,0.00048425948,0.0017216133,0.00034777026],"domain_scores_gemma":[0.9978562,0.00017743124,0.0003906918,0.0005265783,0.00073984714,0.00030925317],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019821688,0.0004599971,0.0012316504,0.0010266689,0.000094104515,0.00017552584,0.00015622747,0.00038864644,0.0003817925],"category_scores_gemma":[0.0005566937,0.00032628982,0.0011291495,0.0007487415,0.00006795528,0.00029698358,0.00006055529,0.0041941004,0.0004194438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088104344,0.000105956155,0.004532034,0.00028953317,0.00080158754,0.0011140401,0.00006374895,0.00011021582,0.000514109,3.647956e-7,0.99144006,0.00014730738],"study_design_scores_gemma":[0.0026945528,0.0012537889,0.004604303,0.0020907389,0.0010223124,0.0010539319,0.00043059798,0.000008763528,0.00012696323,0.0000018643818,0.98641324,0.0002989285],"about_ca_topic_score_codex":0.000051346797,"about_ca_topic_score_gemma":0.00013307815,"teacher_disagreement_score":0.019152531,"about_ca_system_score_codex":0.0003957248,"about_ca_system_score_gemma":0.0005943479,"threshold_uncertainty_score":0.99991894},"labels":[],"label_agreement":null},{"id":"W4402064403","doi":"10.1002/ejhf.3452","title":"Burst Steroid Therapy for Acute Heart Failure: The CORTAHF Randomized, Open-Label, Pilot Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Rijksuniversiteit Groningen; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Heart failure; Randomized controlled trial; Steroid; Open label; Internal medicine; Hormone","score_opus":0.04725770452734225,"score_gpt":0.3327170230920375,"score_spread":0.28545931856469525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402064403","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.104251,0.0071110516,0.0030261127,0.8676125,0.0044250814,0.01223592,0.000052415442,0.0002150451,0.0010709098],"genre_scores_gemma":[0.8286563,0.0015905873,0.12530205,0.015136508,0.011489189,0.00036427763,0.00010629163,0.000578245,0.01677656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960834,0.0011158937,0.0011996467,0.0004235395,0.00064554985,0.0005319695],"domain_scores_gemma":[0.99777675,0.0007542836,0.00026094206,0.0005956596,0.00027885166,0.00033349666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050031003,0.0004444136,0.0013869997,0.00026219228,0.00030482298,0.00070001784,0.00054837327,0.00005187914,0.00035494854],"category_scores_gemma":[0.00020630693,0.00024037433,0.00062021584,0.0003368395,0.00020624053,0.00043440884,0.00015845921,0.00067063404,0.00031030944],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23162156,0.0005215276,0.000020451553,0.0000462534,0.0019523588,0.0003955699,0.00023555143,0.0000017589704,0.0021118592,0.00043291404,0.7608709,0.0017893183],"study_design_scores_gemma":[0.34720716,0.007368668,0.000029362598,0.00029208962,0.0007932007,0.0006075093,0.00010962832,0.000030480747,0.0001946103,0.0000517865,0.6431577,0.00015779996],"about_ca_topic_score_codex":0.000007750446,"about_ca_topic_score_gemma":0.000008790372,"teacher_disagreement_score":0.85247594,"about_ca_system_score_codex":0.00008148924,"about_ca_system_score_gemma":0.00028524053,"threshold_uncertainty_score":0.98021805},"labels":[],"label_agreement":null},{"id":"W4402091733","doi":"10.1002/ejhf.3383","title":"Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Health Care Foundation","funders":"National Institutes of Health; Daiichi-Sankyo; University of Glasgow; Moderna; Sarepta Therapeutics; Respicardia; Sanofi Pasteur; Sun Pharma; Regeneron Pharmaceuticals; Alnylam Pharmaceuticals; MyoKardia; Gilead Sciences; Cytokinetics; American Regent; Sanofi; Bayer; Intas Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Celladon Corporation; Amgen","keywords":"Medicine; Ejection fraction; Hazard ratio; Heart failure; Internal medicine; Atrial fibrillation; Cardiology; Heart failure with preserved ejection fraction; Confidence interval; Myocardial infarction; Bisoprolol; Randomized controlled trial","score_opus":0.014977528607061502,"score_gpt":0.24468411434817994,"score_spread":0.22970658574111844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402091733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573161,0.00038541647,0.000025209583,0.041710157,0.00009576624,0.0004099902,0.000003533144,0.000032216612,0.000021626493],"genre_scores_gemma":[0.98530716,0.00004602904,0.013896001,0.000262679,0.000105040766,0.0000022758757,0.000007638705,0.000041741725,0.0003314258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862283,0.00022677796,0.0003775475,0.0002673579,0.00030067217,0.00020479552],"domain_scores_gemma":[0.99938333,0.00007514162,0.00007838219,0.00014793908,0.00011186962,0.00020333605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004639664,0.000213978,0.0004064328,0.00033943215,0.000077398465,0.0001843583,0.000028027653,0.000037774145,0.00002760197],"category_scores_gemma":[0.000056908724,0.00014303954,0.000062141764,0.00016547038,0.00006027091,0.0006535587,0.00004819486,0.00039441668,0.000009178626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029312356,0.00014054296,0.9498353,0.000111512556,0.00018418887,0.0001748829,0.00012315778,0.0000017360704,0.00057362765,0.00000784323,0.04815037,0.00040370942],"study_design_scores_gemma":[0.0026748204,0.0012114762,0.7673178,0.0004364116,0.00017889659,0.00014171161,0.00015968425,0.000017062532,0.000097948534,0.0000038083003,0.22764944,0.00011098711],"about_ca_topic_score_codex":0.000019009465,"about_ca_topic_score_gemma":0.000033340875,"teacher_disagreement_score":0.18251754,"about_ca_system_score_codex":0.00004539733,"about_ca_system_score_gemma":0.00003144552,"threshold_uncertainty_score":0.58329827},"labels":[],"label_agreement":null},{"id":"W4402308096","doi":"10.1002/ejhf.3443","title":"Development and Validation of a Machine Learning-Based Approach to Identify High-Risk Diabetic Cardiomyopathy Phenotype","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Cohort; Internal medicine; Cardiology; Cardiomyopathy; Diabetes mellitus; Diabetic cardiomyopathy; Heart failure; Endocrinology","score_opus":0.012297680339898611,"score_gpt":0.23554450696395046,"score_spread":0.22324682662405185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402308096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764552,0.0016144351,0.020495974,0.00076022925,0.00034805745,0.00015285518,0.0000041147073,0.000034596218,0.00013455555],"genre_scores_gemma":[0.9808731,0.000027118907,0.018676607,0.00005898521,0.00021505193,7.813294e-7,0.000014567999,0.00003699489,0.00009677546],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984763,0.00039927862,0.0004142319,0.00016828201,0.00041764538,0.00012422373],"domain_scores_gemma":[0.99937654,0.000037359205,0.000102970254,0.00013773881,0.0001580092,0.00018741292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015782635,0.00013003497,0.00036725524,0.0003253668,0.00006413608,0.000048201553,0.000049585837,0.000026087324,0.00003157361],"category_scores_gemma":[0.00014346586,0.000095440075,0.0002430214,0.000269383,0.000029215604,0.00006007398,0.000030196483,0.00041638716,0.000044479744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002573349,0.0012727841,0.49501726,0.0049670874,0.008773006,0.0021595962,0.02001635,0.06969619,0.11753334,0.00016647585,0.071726,0.20609857],"study_design_scores_gemma":[0.0020540187,0.0007276116,0.24564295,0.0006002279,0.00075674505,0.0005440897,0.0003728372,0.0005278172,0.011903111,0.0000029061332,0.7366491,0.00021859434],"about_ca_topic_score_codex":0.000008330482,"about_ca_topic_score_gemma":6.215245e-7,"teacher_disagreement_score":0.6649231,"about_ca_system_score_codex":0.000041067,"about_ca_system_score_gemma":0.000109305845,"threshold_uncertainty_score":0.38919336},"labels":[],"label_agreement":null},{"id":"W4402310087","doi":"10.1002/ejhf.3451","title":"Impact of Age on Clinical Outcomes and Response to Serelaxin in Patients with Acute Heart Failure: An Analysis from the RELAX-AHF-2 Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Clinical endpoint; Placebo; Clinical trial; Internal medicine; Confounding; Randomized controlled trial; Cardiology","score_opus":0.030674336317092623,"score_gpt":0.3789799864970489,"score_spread":0.3483056501799563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402310087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97924274,0.00028575398,0.000041631607,0.019682037,0.00015295424,0.00051513663,0.000044657638,0.000018128858,0.000016985707],"genre_scores_gemma":[0.9964735,0.00004044408,0.0026750714,0.00043928315,0.00020198498,0.0000016333137,0.000013946415,0.000053062286,0.00010110293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938192,0.0030793396,0.0011654494,0.0003832451,0.0011854513,0.00036734782],"domain_scores_gemma":[0.99605066,0.0022065337,0.0001772024,0.00059841934,0.0002060637,0.0007611234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005494341,0.00024797447,0.0009926707,0.00061606016,0.00005396541,0.00007865279,0.00028143136,0.00010750498,0.00016012757],"category_scores_gemma":[0.0036746806,0.00012518466,0.00056949,0.0010719484,0.00018940492,0.00017908226,0.000107612614,0.0019975153,0.000053552398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15015528,0.00076427264,0.8142261,0.000012651585,0.0034086925,0.0024960486,0.00088337227,0.00004996846,0.00035608627,0.000003955244,0.025448028,0.002195531],"study_design_scores_gemma":[0.02382114,0.021065578,0.9462806,0.0017015666,0.00077514426,0.000033495686,0.00008866119,0.000026162214,0.000011057354,0.0000057560724,0.0060706967,0.00012015103],"about_ca_topic_score_codex":0.000051443585,"about_ca_topic_score_gemma":0.00006357777,"teacher_disagreement_score":0.13205448,"about_ca_system_score_codex":0.00012681702,"about_ca_system_score_gemma":0.0004932039,"threshold_uncertainty_score":0.8678321},"labels":[],"label_agreement":null},{"id":"W4402428587","doi":"10.1002/ejhf.3455","title":"The Mayo ATTR-CM Score Versus Other Diagnostic Scores and Cardiac Biomarkers in Patients with Suspected Cardiac Amyloidosis","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Scuola Superiore Sant'Anna","keywords":"Medicine; Cardiac amyloidosis; Transthyretin; Amyloidosis; Internal medicine; Cohort; Cardiomyopathy; Heart failure; Cardiology; Restrictive cardiomyopathy","score_opus":0.006934386373375293,"score_gpt":0.2218465656360715,"score_spread":0.2149121792626962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402428587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98264784,0.013739246,0.000007247306,0.0025077406,0.00062894047,0.000279687,0.000054009608,0.000014477806,0.00012083791],"genre_scores_gemma":[0.997998,0.0010308626,0.0004292101,0.00007881308,0.00028299587,0.000008088132,0.000020256588,0.000081076105,0.00007067962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818546,0.0005145751,0.00036693318,0.00032201357,0.00028354747,0.00032747467],"domain_scores_gemma":[0.9989574,0.00032546683,0.00012743298,0.00031879402,0.00012174247,0.00014917635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004936402,0.00027228933,0.0003034825,0.00012034633,0.00012846402,0.00016158095,0.00020688042,0.000054272477,0.000013477967],"category_scores_gemma":[0.0003091967,0.00017142239,0.0002061423,0.00021808705,0.00019586178,0.000020651829,0.0001097508,0.00022958743,0.000022385922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005684311,0.00006688683,0.94972986,0.000024538684,0.0011197325,0.000064379296,0.000100790225,0.000017112936,0.0014653306,0.000017847526,0.044734355,0.0020907114],"study_design_scores_gemma":[0.0021608793,0.0013654667,0.82466954,0.0002915353,0.00021245488,0.000008142558,0.00022479301,0.0000013431114,0.0018202645,0.000002611956,0.16897944,0.00026355212],"about_ca_topic_score_codex":0.00001610393,"about_ca_topic_score_gemma":0.000033807923,"teacher_disagreement_score":0.12506036,"about_ca_system_score_codex":0.00005183113,"about_ca_system_score_gemma":0.00008126114,"threshold_uncertainty_score":0.69904023},"labels":[],"label_agreement":null},{"id":"W4402527334","doi":"10.1002/ejhf.3464","title":"Timing of Sodium–Glucose Cotransporter 2 Inhibitor Initiation and Post-Discharge Outcomes in Acute Heart Failure with Diabetes: A Population-Based Cohort Study","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Sunnybrook Health Science Centre; McGill University Health Centre; Health Sciences Centre; University Health Network; Ottawa Public Health; University of Toronto; University of Ottawa; Ontario Brain Institute","funders":"Temerty Faculty of Medicine, University of Toronto; Canadian Institutes of Health Research; Health Canada; Servier; University of Toronto; Novo Nordisk; European Society of Cardiology; Ministry of Colleges and Universities; Government of Canada; Alberta Innovates; Heart and Stroke Foundation of Canada; Canadian Cardiovascular Society; Fondation Brain Canada; Canadian Bee Research Fund; Canada First Research Excellence Fund; Canada Research Chairs; AstraZeneca","keywords":"Medicine; Heart failure; Diabetes mellitus; Internal medicine; Cohort; Cardiology; Cohort study; Population; Endocrinology","score_opus":0.009210489063859259,"score_gpt":0.24412213962424578,"score_spread":0.23491165056038651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402527334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990605,0.00019560603,0.000025798321,0.008258111,0.000112628106,0.00071465806,0.000016214963,0.000029356412,0.00004262571],"genre_scores_gemma":[0.9961694,0.0000038934,0.0031974176,0.0003748922,0.00008432744,0.000006589174,0.000051234772,0.000047445195,0.00006478373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836004,0.0001747954,0.0006107697,0.00022441172,0.00041783534,0.00021214242],"domain_scores_gemma":[0.99933374,0.00008224306,0.0001497155,0.00017361986,0.00013602708,0.00012463455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007013893,0.00021503276,0.0005621926,0.0004614599,0.00004227963,0.00006127434,0.000057014237,0.000026662728,0.000078876845],"category_scores_gemma":[0.000027779022,0.00014801846,0.00012626125,0.00023045455,0.000032657223,0.00030300306,0.000018923822,0.00026646734,0.000013018804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012657155,0.00043614878,0.9934232,0.00018007228,0.0005413102,0.00032242556,0.0004989403,0.000013675596,0.0023242452,0.0000047250624,0.0019377645,0.00019088476],"study_design_scores_gemma":[0.0033460988,0.0023707363,0.988525,0.0009521027,0.00080644485,0.000019007373,0.00034432783,0.00008826113,0.00063971116,0.0000018995484,0.0027663663,0.00014009379],"about_ca_topic_score_codex":0.000010266688,"about_ca_topic_score_gemma":0.000045239696,"teacher_disagreement_score":0.007883219,"about_ca_system_score_codex":0.000051857827,"about_ca_system_score_gemma":0.000063129315,"threshold_uncertainty_score":0.60360175},"labels":[],"label_agreement":null},{"id":"W4402852591","doi":"10.1002/ejhf.3444","title":"Translating the 2021 ESC Heart Failure Guideline Recommendations in Daily Practice: Results from a Heart Failure Survey. A Scientific Statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Guideline; Ejection fraction; Internal medicine; Cardiology; Sacubitril; Angiotensin Receptor Blockers; Angiotensin-converting enzyme; Blood pressure; Pathology","score_opus":0.04371058801084942,"score_gpt":0.3115701919175351,"score_spread":0.2678596039066857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402852591","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032547854,0.0017371766,0.000497045,0.9605039,0.0011389856,0.002781145,0.00058038835,0.000028922372,0.00018457958],"genre_scores_gemma":[0.9216332,0.00016141782,0.07096444,0.0042137383,0.0010735006,0.00006138477,0.00019575733,0.00014033663,0.0015562157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98630387,0.007646699,0.0027685016,0.00071029883,0.0019034992,0.00066712656],"domain_scores_gemma":[0.9892702,0.005595075,0.0013843633,0.0011256479,0.0024479215,0.00017679758],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.034941494,0.0004909084,0.0011474832,0.00022670774,0.00074555376,0.000401828,0.00052121835,0.00016294346,0.000088456574],"category_scores_gemma":[0.011210215,0.0002515944,0.00074399327,0.0012776245,0.00047300165,0.00074286957,0.00026573296,0.0015945636,0.00002395351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012047867,0.00023243998,0.0045122695,0.000107865126,0.001007976,0.00002031447,0.0049785264,0.00043866495,0.004029794,0.00011810272,0.98281556,0.0005337183],"study_design_scores_gemma":[0.006734293,0.00048630702,0.005902161,0.0009960132,0.0011257293,0.00025704908,0.009079288,0.00040662597,0.00030507048,0.000061176215,0.974427,0.0002192762],"about_ca_topic_score_codex":0.00054844125,"about_ca_topic_score_gemma":0.0035435741,"teacher_disagreement_score":0.9562902,"about_ca_system_score_codex":0.00054029084,"about_ca_system_score_gemma":0.0015349153,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W4403437993","doi":"10.1002/ejhf.3492","title":"What’s New in Heart Failure? October 2024","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine","score_opus":0.01769884500426409,"score_gpt":0.2724279645992369,"score_spread":0.2547291195949728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403437993","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055022314,0.016524674,0.0003235208,0.92059505,0.0042424384,0.0007348148,0.0000032761511,0.00016983601,0.0023840894],"genre_scores_gemma":[0.7397667,0.0014347152,0.14336517,0.009141438,0.007978973,0.000007671561,0.000026823962,0.00040033675,0.09787815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744517,0.00031227048,0.0008289526,0.00034921296,0.000584839,0.0004795795],"domain_scores_gemma":[0.99886465,0.00008259331,0.00008370908,0.0003576321,0.00010326981,0.0005081263],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012639158,0.00032144837,0.00059651124,0.0006793562,0.00005337331,0.00035831137,0.00015707314,0.000061218874,0.0020040572],"category_scores_gemma":[0.00007220605,0.00024226971,0.00042039627,0.0005974124,0.000053935844,0.0008145039,0.000088203495,0.0008732577,0.0022393616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008876569,0.00012848729,0.0023230866,0.0001392754,0.00017634642,0.0037388625,0.00056259154,0.000016487884,0.0019398547,0.00014952812,0.9859864,0.004750318],"study_design_scores_gemma":[0.0017652363,0.00077103317,0.0042294012,0.0024106482,0.00017034059,0.0019217806,0.0006989115,0.000023375893,0.00036248032,0.000055921257,0.9873883,0.00020254952],"about_ca_topic_score_codex":0.000013735316,"about_ca_topic_score_gemma":0.000062770305,"teacher_disagreement_score":0.9114536,"about_ca_system_score_codex":0.00014229509,"about_ca_system_score_gemma":0.000313201,"threshold_uncertainty_score":0.9989082},"labels":[],"label_agreement":null},{"id":"W4403695199","doi":"10.1002/ejhf.3487","title":"Visit-to-Visit Changes in Heart Rate in Heart Failure: A Pooled Participant-Level Analysis of the PARADIGM-HF and PARAGON-HF Trials","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Novartis","keywords":"Medicine; Heart failure; Hazard ratio; Ejection fraction; Internal medicine; Cardiology; Valsartan; Enalapril; Proportional hazards model; Confidence interval; Heart failure with preserved ejection fraction; Clinical endpoint; Lower risk; Randomized controlled trial; Blood pressure; Angiotensin-converting enzyme","score_opus":0.06601492915721968,"score_gpt":0.32893151035667856,"score_spread":0.2629165811994589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403695199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8410043,0.0049035423,0.00011086408,0.15303004,0.00024380803,0.00062898383,0.00003313207,0.000020647707,0.000024675714],"genre_scores_gemma":[0.994761,0.00026749287,0.0013202295,0.0029946305,0.00046778118,0.00000797515,0.000005725114,0.00006292673,0.000112221154],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9916786,0.004661781,0.0017875708,0.00047097265,0.00073739217,0.0006637027],"domain_scores_gemma":[0.99796134,0.0004898119,0.00024252271,0.0006168384,0.00015954376,0.0005299609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015335791,0.0003479995,0.0023746036,0.0012787534,0.00009183281,0.00011229632,0.00019734289,0.000103210536,0.00012556356],"category_scores_gemma":[0.0008556256,0.00023013946,0.0010088885,0.0026546568,0.00009870221,0.00017181989,0.000107452426,0.0009599443,0.00005949363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004085145,0.0015836129,0.2928693,0.002981059,0.018092334,0.009172882,0.02642141,0.0061390908,0.2961967,0.00038777516,0.3267383,0.015332379],"study_design_scores_gemma":[0.0029154015,0.0009377387,0.59425724,0.00209192,0.0026748062,0.0010373202,0.00090969057,0.000397466,0.003367989,0.000025203906,0.3910686,0.00031662575],"about_ca_topic_score_codex":0.00008215578,"about_ca_topic_score_gemma":0.0006644811,"teacher_disagreement_score":0.30138794,"about_ca_system_score_codex":0.00009513706,"about_ca_system_score_gemma":0.00045756152,"threshold_uncertainty_score":0.93848145},"labels":[],"label_agreement":null},{"id":"W4403762704","doi":"10.1002/ejhf.3485","title":"Applicability of Heart Failure Clinical Practice Guidelines in Low- and Middle-Income Countries","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Clinical Practice; Guideline; Heart failure; Family medicine; Internal medicine; Pathology","score_opus":0.12300173534640348,"score_gpt":0.4703642821423409,"score_spread":0.3473625467959374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403762704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5435565,0.0026664583,0.0006849659,0.45181748,0.0005671906,0.0004910467,0.0000211199,0.000040722112,0.00015448897],"genre_scores_gemma":[0.7961324,0.00038477703,0.19594109,0.005837213,0.0015630404,0.0000018835796,0.0000064876504,0.00006253358,0.000070576556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99286073,0.0012501825,0.0045028264,0.0003844969,0.00072904176,0.0002727068],"domain_scores_gemma":[0.9931865,0.0036839547,0.00072439987,0.00039458633,0.0017135725,0.00029702613],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015739918,0.00022959904,0.0008261568,0.0002413327,0.00004771664,0.000087337845,0.00015294943,0.00009439142,0.00017706395],"category_scores_gemma":[0.024236819,0.0001812594,0.00029606983,0.00038550165,0.0002559141,0.00070929684,0.00012908387,0.0012565657,0.00008794786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055928533,0.0013355466,0.30794853,0.0057077594,0.00086611905,0.0029604863,0.0011832818,0.00013598683,0.0031571905,0.00059024815,0.6544041,0.016117899],"study_design_scores_gemma":[0.0025385432,0.0013329131,0.046552837,0.003298502,0.0003047663,0.002716137,0.0014381487,0.00019154599,0.00014031447,0.00006720926,0.9412525,0.00016658184],"about_ca_topic_score_codex":0.000028306033,"about_ca_topic_score_gemma":0.00004218175,"teacher_disagreement_score":0.44598025,"about_ca_system_score_codex":0.00006358845,"about_ca_system_score_gemma":0.00048516958,"threshold_uncertainty_score":0.98398244},"labels":[],"label_agreement":null},{"id":"W4403897615","doi":"10.1002/ejhf.3501","title":"Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Heart, Lung, and Blood Institute; Merck Sharp and Dohme; Acceleron; Bayer","keywords":"Heart failure; Medicine; Ejection fraction; Clinical endpoint; Internal medicine; Cardiology; Randomized controlled trial; Placebo; Ambulatory; Population; Guideline; Alternative medicine; Pathology","score_opus":0.03544607764145873,"score_gpt":0.29595568005018774,"score_spread":0.260509602408729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403897615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335543,0.0010022883,0.0005309806,0.06159089,0.00067922316,0.0024675936,0.0000051254165,0.00005111533,0.000118494885],"genre_scores_gemma":[0.99344987,0.000010113046,0.005570666,0.00017614612,0.0005021799,0.0000095290525,9.037984e-7,0.000043630596,0.0002369556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967155,0.0010239688,0.0008135762,0.00027412036,0.00073647144,0.00043636037],"domain_scores_gemma":[0.9990244,0.000092123904,0.00015779682,0.00041053287,0.00011392468,0.00020125572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017811815,0.0002699645,0.0006222807,0.00016427977,0.00006740252,0.000069545975,0.00020724458,0.0000344252,0.00014983624],"category_scores_gemma":[0.000087237866,0.00014934324,0.00023648782,0.00074208144,0.00009876609,0.0001824322,0.00008850404,0.00045147812,0.00009007995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03477816,0.0051706596,0.14109372,0.00057734956,0.0027146498,0.0073509687,0.0039885286,0.0020911265,0.0067287544,0.00016248455,0.79281163,0.002531955],"study_design_scores_gemma":[0.07555167,0.02675493,0.103412956,0.002656723,0.0014112433,0.00096422026,0.0016531707,0.00021675271,0.00086140767,0.00001833272,0.7860781,0.00042047218],"about_ca_topic_score_codex":0.0000128910915,"about_ca_topic_score_gemma":0.00013772651,"teacher_disagreement_score":0.061414745,"about_ca_system_score_codex":0.0002715588,"about_ca_system_score_gemma":0.00055481325,"threshold_uncertainty_score":0.6090041},"labels":[],"label_agreement":null},{"id":"W4404079601","doi":"10.1002/ejhf.3499","title":"Long-Term Clinical Outcomes and Healthcare Resource Utilization in Male and Female Patients Following Hospitalization for Heart Failure","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Impact; University of Calgary; Institute for Clinical Evaluative Sciences; McMaster University; Population Health Research Institute","funders":"Ontario Ministry of Health and Long-Term Care; McMaster University; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Medicine; Heart failure; Intensive care medicine; Term (time); Health care; Emergency medicine; Internal medicine; Cardiology","score_opus":0.03779020537627991,"score_gpt":0.33838523956495115,"score_spread":0.30059503418867123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404079601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94714457,0.0015821736,0.00066604244,0.04946994,0.0002867621,0.0007801019,0.0000064347646,0.000036005084,0.00002796705],"genre_scores_gemma":[0.9884001,0.00009628804,0.009906283,0.00079294306,0.00021805511,0.0000047230637,0.000050155722,0.000055455497,0.00047599062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980716,0.00031377448,0.00077097095,0.0003063658,0.00028268946,0.00025456437],"domain_scores_gemma":[0.99925166,0.00013542733,0.00011179189,0.00015715357,0.00010788173,0.00023608118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012155153,0.00020137281,0.0004916627,0.00028528253,0.00009369693,0.00010978014,0.000051330848,0.00006468405,0.000019406736],"category_scores_gemma":[0.00018564903,0.0001576452,0.00022444523,0.00018832022,0.000054405205,0.00027062505,0.000056862045,0.0002697804,0.00000980145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009009205,0.00013023004,0.9628759,0.000341967,0.00010894178,0.00019907595,0.00036111477,0.0000013976357,0.000019245032,0.000067971545,0.03128879,0.004515286],"study_design_scores_gemma":[0.0030579257,0.0013947148,0.76419103,0.0010130297,0.00015619354,0.00010521164,0.00023792511,0.00003441527,0.000011337875,0.0000089949,0.22966239,0.00012683788],"about_ca_topic_score_codex":0.0000026495193,"about_ca_topic_score_gemma":0.000029635099,"teacher_disagreement_score":0.19868486,"about_ca_system_score_codex":0.000051761253,"about_ca_system_score_gemma":0.00005576872,"threshold_uncertainty_score":0.64285845},"labels":[],"label_agreement":null},{"id":"W4404188772","doi":"10.1002/ejhf.3519","title":"Examining the Clinical Role and Educational Preparation of Heart Failure Nurses Across Europe. A Survey of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) of the ESC","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Society of Cardiology; AstraZeneca","keywords":"Heart failure; Medicine; Key (lock); Intensive care medicine; Internal medicine","score_opus":0.030184170337820327,"score_gpt":0.3274685980747401,"score_spread":0.29728442773691977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404188772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9371406,0.0022721507,0.000047235604,0.05881198,0.00043696922,0.0010154669,0.000064659864,0.000007885866,0.00020306789],"genre_scores_gemma":[0.9980183,0.00022290865,0.0010552746,0.0001039084,0.00025544036,0.0000036943802,0.000007926286,0.000037786544,0.0002947109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98934776,0.007805827,0.0013953943,0.00028379873,0.0009185371,0.0002487152],"domain_scores_gemma":[0.995587,0.001541564,0.001298913,0.0005982961,0.0009046267,0.00006958858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01328774,0.00023586908,0.0009880196,0.000059942857,0.0002657909,0.000035793866,0.00028259595,0.00010988809,0.000006098255],"category_scores_gemma":[0.0016394996,0.00011078308,0.0007197595,0.0005133698,0.00076683634,0.00014767941,0.00025123046,0.00068812515,7.8480093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035213243,0.00028766665,0.8412581,0.00047924378,0.003737257,0.0000014008695,0.012423061,0.0003648265,0.0146291135,0.00022022877,0.124952964,0.0012939705],"study_design_scores_gemma":[0.0021118668,0.00036363484,0.94155693,0.001532029,0.0012287765,0.00006484754,0.0038234883,0.00008445462,0.001280132,0.000038038685,0.047820494,0.00009531739],"about_ca_topic_score_codex":0.00005618063,"about_ca_topic_score_gemma":0.000058394064,"teacher_disagreement_score":0.100298785,"about_ca_system_score_codex":0.00007516834,"about_ca_system_score_gemma":0.00033266644,"threshold_uncertainty_score":0.4605292},"labels":[],"label_agreement":null},{"id":"W4404550325","doi":"10.1002/ejhf.3530","title":"Knowledge and Application of ESC/HFA Guidelines in the Management of Advanced Heart Failure","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Guideline; Heart transplantation; Referral; Internal medicine; Intensive care medicine; Emergency medicine; Family medicine; Pathology","score_opus":0.014154853046380906,"score_gpt":0.2663529303625853,"score_spread":0.25219807731620436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404550325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9130426,0.044444513,0.022702541,0.015044533,0.0007987288,0.0010284684,0.000023444278,0.00015739349,0.0027577435],"genre_scores_gemma":[0.98217803,0.00005471802,0.017565312,0.000045450284,0.00010272979,0.0000020323146,0.0000012925656,0.000029692686,0.00002073248],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871516,0.00013308317,0.00070041814,0.00011576687,0.00021205629,0.0001234881],"domain_scores_gemma":[0.99950624,0.00005201079,0.0000782101,0.00021005033,0.0001002115,0.000053287695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001209057,0.000120641685,0.0002442405,0.00013774297,0.000017241335,0.000021896445,0.0002086972,0.000023739165,0.000025155083],"category_scores_gemma":[0.000014079085,0.00008685981,0.0000913125,0.0002895514,0.000034025954,0.00014546879,0.00003741594,0.00024434086,0.000024971394],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014517007,0.00039520062,0.011587216,0.016614519,0.0013473532,0.00076735957,0.0064764894,0.046163987,0.2583884,0.02222267,0.44141123,0.19448039],"study_design_scores_gemma":[0.00038183408,0.00009848555,0.0056561506,0.00090116996,0.00006220022,0.00016527186,0.00080740836,0.0029422576,0.0019417622,0.00014240817,0.98677075,0.0001303173],"about_ca_topic_score_codex":6.373371e-7,"about_ca_topic_score_gemma":0.0000050865824,"teacher_disagreement_score":0.5453595,"about_ca_system_score_codex":0.000014437518,"about_ca_system_score_gemma":0.000011609593,"threshold_uncertainty_score":0.354204},"labels":[],"label_agreement":null},{"id":"W4404551250","doi":"10.1002/ejhf.3515","title":"Effects of Sacubitril/Valsartan According to Background Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction: Insights from PARADIGM-HF","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Heart failure; Enalapril; Sacubitril; Valsartan; Hazard ratio; Ejection fraction; Beta blocker; Sacubitril, Valsartan; Internal medicine; Cardiology; Clinical endpoint; Confidence interval; Randomized controlled trial; Blood pressure; Angiotensin-converting enzyme","score_opus":0.011677663808905114,"score_gpt":0.24696991695314036,"score_spread":0.23529225314423524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404551250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165274,0.001282998,0.0001886982,0.015718365,0.00030137316,0.0007655202,0.0000031968636,0.00003840037,0.000048698945],"genre_scores_gemma":[0.9878713,0.000051616065,0.011108821,0.0003999323,0.00042327857,0.0000056437757,0.000012283629,0.000066944944,0.000060193543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786705,0.00038292832,0.00061371434,0.0003593647,0.00051415403,0.00026280447],"domain_scores_gemma":[0.99903053,0.00017379977,0.00015122896,0.00023566085,0.00014200732,0.00026677866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034800448,0.00030607803,0.0008057858,0.0005458797,0.00008375947,0.000109059896,0.00007841085,0.000060862116,0.00004773485],"category_scores_gemma":[0.000028105767,0.00021177507,0.00015330783,0.00051988283,0.000046145666,0.00043808576,0.000040660532,0.00048206656,0.000048020862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006576364,0.002262199,0.64265305,0.0008963601,0.0024942465,0.0020902625,0.0028557188,0.00006664071,0.112925634,0.00015248061,0.21663074,0.010396289],"study_design_scores_gemma":[0.0067187003,0.005437892,0.58512336,0.0024638395,0.00035874153,0.00009233453,0.00067874626,0.000013234625,0.009317524,0.000029762088,0.38945472,0.0003111485],"about_ca_topic_score_codex":0.000025207679,"about_ca_topic_score_gemma":0.000013703677,"teacher_disagreement_score":0.17282398,"about_ca_system_score_codex":0.000118464006,"about_ca_system_score_gemma":0.00007872791,"threshold_uncertainty_score":0.8635937},"labels":[],"label_agreement":null},{"id":"W4404551391","doi":"10.1002/ejhf.3510","title":"Treat or Not Treat COVID-19 with Combined Renin–Angiotensin System and Neprilysin Inhibition: Have We Found a Solution?","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Myocarditis; Cardiology; Neprilysin; Troponin; Angiotensin II; Myocardial infarction; Receptor","score_opus":0.05557238647370889,"score_gpt":0.3609980218992498,"score_spread":0.3054256354255409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404551391","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16751406,0.0034036078,0.0058334065,0.82076067,0.00028969327,0.0010578205,0.000054794342,0.0003135275,0.00077243656],"genre_scores_gemma":[0.9878892,0.0002992554,0.004324061,0.0022046305,0.00084006746,0.0000034465338,0.000006223072,0.000070854745,0.0043622646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969135,0.00071201165,0.00077693164,0.0004154296,0.00078920013,0.00039294848],"domain_scores_gemma":[0.9961213,0.0021673155,0.00016725434,0.0003296485,0.00038215684,0.0008323135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018724233,0.0002950797,0.00077241124,0.00038350272,0.00027470343,0.00018469666,0.00009586742,0.000057920333,0.00011051269],"category_scores_gemma":[0.0032939527,0.0001735976,0.0002612073,0.00041218693,0.00039041298,0.00020130376,0.00013898908,0.00074645464,0.00009042525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024157472,0.00049472507,0.0071533206,0.004582401,0.001521165,0.08377129,0.0033481934,0.00016372625,0.010450928,0.0004405041,0.85764736,0.0062689143],"study_design_scores_gemma":[0.013454313,0.01203367,0.0130488835,0.0074552316,0.0011302346,0.009206678,0.0010258668,0.0013642635,0.00047615427,0.000034410627,0.9403124,0.00045788882],"about_ca_topic_score_codex":0.000030919466,"about_ca_topic_score_gemma":0.000043765715,"teacher_disagreement_score":0.82037514,"about_ca_system_score_codex":0.00042199632,"about_ca_system_score_gemma":0.000834728,"threshold_uncertainty_score":0.7079104},"labels":[],"label_agreement":null},{"id":"W4404636723","doi":"10.1002/ejhf.3516","title":"State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial &amp; Pericardial Diseases","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"H2020 European Research Council; Instituto de Salud Carlos III; Biotechnology and Biological Sciences Research Council; Directorate for Biological Sciences; National Institutes of Health; Deutsche Krebshilfe; Norges Forskningsråd; Ministero della Salute; Innovative Medicines Initiative; Hartstichting; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; National Institute for Health and Care Research; Bundesministerium für Bildung und Forschung; King's College London; Fondation Leducq; Deutsches Zentrum für Herz-Kreislaufforschung; European Commission; British Heart Foundation; Dutch Cardiovascular Alliance; Deutsche Forschungsgemeinschaft; UK Research and Innovation; Foundation for Cardiovascular Research","keywords":"Heart failure; Medicine; Genetic enhancement; Disease; Modalities; CRISPR; Gene delivery; Genome editing; Bioinformatics; Heart disease; Intensive care medicine; Gene; Cardiology; Internal medicine; Genetics; Biology","score_opus":0.01962384967265613,"score_gpt":0.25667675883705215,"score_spread":0.23705290916439603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404636723","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15245682,0.8416444,0.000060223734,0.0037149098,0.00068067113,0.0012148395,0.00019893155,0.0000037908871,0.000025375602],"genre_scores_gemma":[0.620682,0.37782976,0.0004610939,0.00011693318,0.00063906034,0.000017336308,0.000012527858,0.00011387131,0.00012741958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954543,0.001977293,0.00090542395,0.000383598,0.0010163169,0.000263075],"domain_scores_gemma":[0.99795735,0.0001506628,0.00067340705,0.0008607735,0.00029860524,0.000059204012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004044024,0.0003717002,0.0010785583,0.00008341285,0.0001906744,0.0000985807,0.00051917054,0.00008798319,0.0000027548904],"category_scores_gemma":[0.0002678455,0.00016557453,0.0016221583,0.0003594747,0.00052119733,0.000009228322,0.00027374885,0.0006518512,9.452496e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044605574,0.002325735,0.016278664,0.015053591,0.05069271,0.00004443727,0.054906145,0.07806119,0.23676164,0.00044111355,0.38904384,0.15193038],"study_design_scores_gemma":[0.0009213268,0.00022726247,0.0026376664,0.0017508953,0.0007710727,0.000048281887,0.0006121635,0.000007222881,0.0010962562,0.0000118759945,0.9917349,0.0001810347],"about_ca_topic_score_codex":0.000010494049,"about_ca_topic_score_gemma":0.000049476195,"teacher_disagreement_score":0.6026911,"about_ca_system_score_codex":0.00014100659,"about_ca_system_score_gemma":0.00044186076,"threshold_uncertainty_score":0.67519337},"labels":[],"label_agreement":null},{"id":"W4404780432","doi":"10.1002/ejhf.3525","title":"Reply to ‘Malnutrition and Severe Heart Failure in Real-World Study Settings’","year":2024,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Malnutrition; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.030040013801830988,"score_gpt":0.3154490254627354,"score_spread":0.28540901166090443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404780432","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02372697,0.0005863864,0.000003676923,0.9733097,0.0005712505,0.0010431941,0.000029734978,0.00007626872,0.0006528265],"genre_scores_gemma":[0.020999076,0.00009845449,0.020104708,0.94390255,0.010839983,0.00001021194,0.0000530808,0.00024209805,0.0037498225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954306,0.0010507895,0.0015195989,0.000601168,0.00082326785,0.0005746095],"domain_scores_gemma":[0.9982933,0.00014839685,0.00034204437,0.0004484881,0.00033950963,0.00042826537],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002593893,0.00045076982,0.0011689019,0.0017110106,0.00012887729,0.00018196629,0.00018222637,0.00014990181,0.00018904233],"category_scores_gemma":[0.00014248071,0.0003998233,0.0002497571,0.00073177606,0.00005304709,0.00015791798,0.00013073655,0.005372973,0.00025646706],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016411563,0.0001419973,0.009355327,0.0014860713,0.00006634566,0.009878283,0.00073440437,0.0000010743368,0.00015109307,0.0000024935036,0.9778831,0.00013569176],"study_design_scores_gemma":[0.0025826923,0.0017049053,0.013931417,0.008356456,0.00016234467,0.0052778497,0.00080314005,0.0000016475077,0.000014714267,0.000035282897,0.9668069,0.00032267763],"about_ca_topic_score_codex":0.00003910851,"about_ca_topic_score_gemma":0.00008310423,"teacher_disagreement_score":0.029407127,"about_ca_system_score_codex":0.0002429012,"about_ca_system_score_gemma":0.00021123308,"threshold_uncertainty_score":0.9998454},"labels":[],"label_agreement":null},{"id":"W4404925755","doi":"10.1002/ejhf.3532","title":"The Prognostic Value of the Dandel's Index in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Abbott Vascular; Boston Scientific Corporation; Bristol-Myers Squibb; Edwards Lifesciences; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Cardiology; Internal medicine; Hazard ratio; Logistic regression; Confidence interval; Heart failure; Regurgitation (circulation)","score_opus":0.012871342909905164,"score_gpt":0.25351667990384097,"score_spread":0.2406453369939358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404925755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821471,0.001682446,0.00002678613,0.014987499,0.00029388582,0.000459065,0.000004605362,0.00001662605,0.0003819715],"genre_scores_gemma":[0.9988044,0.000052308125,0.00033706604,0.00028013322,0.00011876033,0.0000019756121,0.000001242691,0.000031402717,0.00037271253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797416,0.00054895616,0.00049234903,0.00015472535,0.00056504924,0.0002647643],"domain_scores_gemma":[0.999009,0.00028793115,0.00007504147,0.00026380413,0.000174064,0.00019016072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009274144,0.00013212781,0.00024481528,0.00018730597,0.000106632615,0.00003440504,0.00019333471,0.000023911136,0.000016476659],"category_scores_gemma":[0.00041361546,0.000060657716,0.00039910525,0.00044555354,0.00006960683,0.0000876216,0.000061070125,0.00049972645,0.000038972885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011487334,0.0010392567,0.9249541,0.00023989072,0.00060332526,0.0025708373,0.0005976644,0.00008111843,0.00092514505,0.000053987893,0.059723932,0.008061972],"study_design_scores_gemma":[0.002312404,0.0020071247,0.91371435,0.0015351591,0.00011484415,0.00046815167,0.00013263851,0.00016084457,0.00013341315,0.00003708367,0.07930637,0.000077611374],"about_ca_topic_score_codex":0.0000023636796,"about_ca_topic_score_gemma":0.0000054983057,"teacher_disagreement_score":0.019582443,"about_ca_system_score_codex":0.000057233778,"about_ca_system_score_gemma":0.00021949457,"threshold_uncertainty_score":0.247355},"labels":[],"label_agreement":null},{"id":"W4405260797","doi":"10.1002/ejhf.3543","title":"Tailored Therapies for Patients Affected by Systemic Sclerosis with Primary Heart Involvement: The Role of Rituximab","year":2024,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Rituximab; Heart failure; Internal medicine; Intensive care medicine; Cardiology; Lymphoma","score_opus":0.00646167408205172,"score_gpt":0.2045273176522162,"score_spread":0.19806564357016448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405260797","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22252715,0.34727314,0.000044920936,0.0049629747,0.4173573,0.0053970907,0.0019523642,0.00018302325,0.00030205253],"genre_scores_gemma":[0.6884414,0.0034213348,0.001098397,0.00034328253,0.30468342,0.00005287992,0.0008641425,0.00052259344,0.0005725487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959766,0.0006539749,0.0012382887,0.000362115,0.0014229703,0.00034600915],"domain_scores_gemma":[0.9966081,0.00043741573,0.0009833649,0.00046704698,0.0012791451,0.00022493453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011875569,0.0004670398,0.0012936669,0.00023870512,0.00014012291,0.00011063687,0.00036045996,0.00024096675,0.00002611854],"category_scores_gemma":[0.000262141,0.0002457296,0.00065606605,0.00027409656,0.00016861189,0.00010690787,0.00007404928,0.0010398766,0.00003072605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009978977,0.00056923635,0.0005609412,0.0014613111,0.0013210982,0.000010505317,0.0004951651,0.000002050434,0.017340284,0.0000011549536,0.9767811,0.00045925772],"study_design_scores_gemma":[0.008460626,0.004205722,0.0012049697,0.037940826,0.0019660615,0.00007778149,0.0011774196,0.0000039407287,0.00060907146,0.0000045913607,0.94404554,0.0003034366],"about_ca_topic_score_codex":0.000008792336,"about_ca_topic_score_gemma":9.100802e-7,"teacher_disagreement_score":0.46591425,"about_ca_system_score_codex":0.0001529205,"about_ca_system_score_gemma":0.00048583077,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W4405335381","doi":"10.1002/ejhf.3551","title":"End-organ Protective Effect of Serelaxin in Patients Hospitalized for Heart Failure: Results of the Biomarker Substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Biomarker; Hazard ratio; Cardiology; Copeptin; Nesiritide; Cystatin C; Population; Tolvaptan; Creatinine; Troponin; Renal function; Placebo; Natriuretic peptide; Confidence interval; Myocardial infarction; Pathology; Vasopressin","score_opus":0.009830633186229586,"score_gpt":0.28240983618041127,"score_spread":0.2725792029941817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405335381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97781694,0.0017109411,0.00004831324,0.016324803,0.00041364468,0.0034793452,0.00011091935,0.000028074839,0.00006704663],"genre_scores_gemma":[0.99663687,0.000053571897,0.0028787828,0.000060790586,0.00007964735,0.000028719596,0.000015239205,0.00013122174,0.00011514252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.991799,0.0026858675,0.0024584027,0.00057276426,0.0017516329,0.00073234853],"domain_scores_gemma":[0.9962795,0.0012291406,0.00064406206,0.00077226997,0.0007073657,0.0003676823],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0070103984,0.0004677197,0.0016036686,0.0009695926,0.00006659668,0.000026684978,0.00056539185,0.00025664349,0.000069983755],"category_scores_gemma":[0.00602729,0.0003055084,0.0007704188,0.001950269,0.00045834365,0.00029233197,0.0002778247,0.0022617772,0.00002352306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037753157,0.0037616708,0.4697406,0.0052580815,0.0031377478,0.00094690244,0.0077308584,0.00007066614,0.26347956,0.000082724095,0.20214437,0.0058936635],"study_design_scores_gemma":[0.045186616,0.021915603,0.7488152,0.040317986,0.0005880343,0.00033220343,0.00044133628,0.00012856901,0.111002155,0.000079700374,0.030649211,0.0005433859],"about_ca_topic_score_codex":0.00006387868,"about_ca_topic_score_gemma":0.00006113191,"teacher_disagreement_score":0.27907458,"about_ca_system_score_codex":0.00026316172,"about_ca_system_score_gemma":0.000622248,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W4405338541","doi":"10.1002/ejhf.3549","title":"Management of Acute Decompensated Valvular Heart Disease","year":2024,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); St. Michael's Hospital","funders":"","keywords":"Medicine; Cardiogenic shock; Heart failure; valvular heart disease; Decompensation; Acute decompensated heart failure; Cardiology; Mitral regurgitation; Internal medicine; Intensive care medicine; Shock (circulatory); Stenosis; Myocardial infarction","score_opus":0.02430777815648688,"score_gpt":0.3680317819448197,"score_spread":0.34372400378833284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405338541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024987536,0.99715984,0.000006443434,0.00088142796,0.0005192453,0.00060254347,0.00020105341,0.000027627717,0.00035191645],"genre_scores_gemma":[0.001074374,0.9953079,0.0020171902,0.000111700436,0.00040911997,0.0000040258474,0.00013524554,0.0001655084,0.00077493594],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721986,0.00044043167,0.001146114,0.0003195119,0.0005982444,0.00027581846],"domain_scores_gemma":[0.9981722,0.00002630402,0.0004393464,0.00054757384,0.0001838911,0.0006306383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045182178,0.00047030082,0.0021182557,0.00036632002,0.000042502314,0.000047494534,0.00018179209,0.000046810568,0.00015318852],"category_scores_gemma":[0.000012519856,0.00031356417,0.006339908,0.0003610442,0.000053205084,0.000060473925,0.00015076881,0.0005232128,0.0006568431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006190999,0.0012953761,0.00086621457,0.10085133,0.07674323,0.07040785,0.000056411525,0.000003409185,0.000003873929,0.00013533563,0.5250926,0.22392525],"study_design_scores_gemma":[0.0008407438,0.00030769402,0.0019914906,0.045477208,0.06882848,0.0009950356,0.000015028864,3.006874e-7,2.9702005e-7,0.0000075918365,0.88135034,0.0001858034],"about_ca_topic_score_codex":5.829681e-7,"about_ca_topic_score_gemma":1.708144e-8,"teacher_disagreement_score":0.3562577,"about_ca_system_score_codex":0.00010382117,"about_ca_system_score_gemma":0.00026106808,"threshold_uncertainty_score":0.99993163},"labels":[],"label_agreement":null},{"id":"W4405409933","doi":"10.1002/ejhf.3558","title":"Tailoring Medical Therapy for Heart Failure with Preserved Ejection Fraction","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Cardiology; Internal medicine; Medical therapy; Intensive care medicine","score_opus":0.018827876067340373,"score_gpt":0.26891727307697083,"score_spread":0.25008939700963045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405409933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79795843,0.003555136,0.009463874,0.1835875,0.001373975,0.001441401,0.000005782102,0.0002866931,0.0023271744],"genre_scores_gemma":[0.97666126,0.00011269418,0.019109828,0.00081223465,0.0018522008,0.000011306173,0.0000146718985,0.00008410335,0.0013417073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985807,0.00013535364,0.0003366232,0.0001954642,0.000526149,0.00022570314],"domain_scores_gemma":[0.9993103,0.0000802097,0.00008468582,0.00016406261,0.00015309532,0.00020761508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009750434,0.00016465082,0.00029306512,0.00021330135,0.00008545797,0.000108059634,0.00008297916,0.000038232203,0.00036815964],"category_scores_gemma":[0.00006444197,0.00010617459,0.00021219355,0.00018567665,0.00003392621,0.0003260459,0.000021544896,0.00037397168,0.0000828442],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012036441,0.0004080883,0.020566598,0.00036841305,0.0012380121,0.00067948835,0.00016605273,0.000039460203,0.0070569273,0.0001489398,0.9528294,0.015294974],"study_design_scores_gemma":[0.002673382,0.0031229402,0.0075386814,0.00088236114,0.00017010653,0.000289597,0.00023123906,0.00013262412,0.0016526887,0.000018818966,0.9831812,0.00010636478],"about_ca_topic_score_codex":0.000001934556,"about_ca_topic_score_gemma":0.0000043534696,"teacher_disagreement_score":0.18277527,"about_ca_system_score_codex":0.00006732912,"about_ca_system_score_gemma":0.00009818813,"threshold_uncertainty_score":0.43296742},"labels":[],"label_agreement":null},{"id":"W4405410038","doi":"10.1002/ejhf.3535","title":"Effect of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction Across the Age Spectrum in PARAGON-HF","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Novartis Pharmaceuticals Corporation","keywords":"Sacubitril, Valsartan; Medicine; Valsartan; Ejection fraction; Heart failure; Hazard ratio; Sacubitril; Internal medicine; Cardiology; Confidence interval; Clinical endpoint; Heart failure with preserved ejection fraction; Population; Adverse effect; Randomized controlled trial; Blood pressure","score_opus":0.010719644154073588,"score_gpt":0.28182401670215235,"score_spread":0.27110437254807873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405410038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94891834,0.0008304043,0.00013120948,0.04874705,0.0002453585,0.00083686644,0.00000393429,0.000042636097,0.0002441862],"genre_scores_gemma":[0.9973668,0.00004267634,0.0016145619,0.00015542273,0.00037305945,0.000006190535,0.000007763423,0.000059668644,0.0003738507],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688846,0.001129412,0.00073577365,0.00029318887,0.0005382348,0.00041492737],"domain_scores_gemma":[0.99903786,0.00026778277,0.00016260248,0.00035311622,0.00006251302,0.000116135394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003258927,0.00028772134,0.00080185453,0.0003719199,0.00007907376,0.000104377,0.00013981402,0.00006233256,0.000106439504],"category_scores_gemma":[0.000105784005,0.0001643161,0.0002541128,0.0007699989,0.00009557358,0.00036031439,0.000055574514,0.000947504,0.0000812891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006869435,0.0011100785,0.51412326,0.002212098,0.00096738373,0.016110044,0.0034652506,0.0011951763,0.041067995,0.00010852294,0.40879762,0.003973109],"study_design_scores_gemma":[0.006317886,0.007896947,0.15272194,0.0033694066,0.0003338215,0.0015806914,0.0012352484,0.0001829371,0.014574533,0.000023199138,0.81146616,0.00029721297],"about_ca_topic_score_codex":0.00006393314,"about_ca_topic_score_gemma":0.00043345874,"teacher_disagreement_score":0.40266857,"about_ca_system_score_codex":0.00016465304,"about_ca_system_score_gemma":0.00008490896,"threshold_uncertainty_score":0.6700616},"labels":[],"label_agreement":null},{"id":"W4405410039","doi":"10.1002/ejhf.3550","title":"The Risk of Death According to Left Ventricular Ejection Fraction and Right Ventricular Dilatation in 17 321 Adults with Heart Failure from 40 High-, Middle- and Low-Income Countries – A Global Congestive Heart Failure (G-CHF) Study","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Heart failure; Hazard ratio; Creatinine; Confidence interval","score_opus":0.005207057756227804,"score_gpt":0.22032862415731136,"score_spread":0.21512156640108354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405410039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900195,0.0028797358,0.0007829378,0.00500778,0.00040750473,0.0008053091,0.00005045464,0.000041530824,0.0000052572555],"genre_scores_gemma":[0.99790883,0.00016647161,0.0013554005,0.000082412844,0.00040985754,0.0000041012645,0.0000160371,0.000041585874,0.000015319249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969828,0.0008329179,0.00068176,0.00044289278,0.0007708193,0.00028876908],"domain_scores_gemma":[0.9985168,0.00026175717,0.00025880564,0.00029031927,0.00040612384,0.00026619658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013818658,0.00032367912,0.0007047529,0.00031126346,0.00028661342,0.00022987972,0.00008362636,0.000086235,0.00003161445],"category_scores_gemma":[0.0002303151,0.00020375442,0.0002511739,0.0005465562,0.000095914555,0.00041945642,0.0000627553,0.0007382619,0.000016822383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016797832,0.00012480484,0.9911437,0.0001110153,0.0007873212,0.001157054,0.000560152,0.0005277648,0.00017448394,0.000010842289,0.0035437015,0.00017935406],"study_design_scores_gemma":[0.0040267115,0.0018289597,0.91599256,0.002191445,0.0008532504,0.0026135885,0.0075948765,0.00013776484,0.00036789622,0.000015193598,0.06413714,0.00024059326],"about_ca_topic_score_codex":0.00028274636,"about_ca_topic_score_gemma":0.00036563692,"teacher_disagreement_score":0.07515114,"about_ca_system_score_codex":0.00021548549,"about_ca_system_score_gemma":0.00012139855,"threshold_uncertainty_score":0.8308864},"labels":[],"label_agreement":null},{"id":"W4405531150","doi":"10.1002/ejhf.3557","title":"Mortality After High-Risk Myocardial Infarction Over the Last 20 Years: Insights from the VALIANT and PARADISE-MI Trials","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Health Care Foundation; Montreal Heart Institute","funders":"Novartis","keywords":"Medicine; Hazard ratio; Myocardial infarction; Proportional hazards model; Confidence interval; Internal medicine; Clinical trial; Lower risk; Heart failure; Cardiology; Conventional PCI","score_opus":0.02789215746193345,"score_gpt":0.3037202688280925,"score_spread":0.27582811136615903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405531150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437534,0.005328735,0.00012411976,0.048954453,0.0011844973,0.00035276,0.00009611362,0.00003138042,0.00017450227],"genre_scores_gemma":[0.9906133,0.000805945,0.00033327795,0.00309965,0.004994594,0.000004937467,0.000010624312,0.00004739302,0.000090315894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515086,0.002955079,0.0007008143,0.00022947592,0.0007528877,0.00021089775],"domain_scores_gemma":[0.9983498,0.00072264124,0.00018335383,0.00039390332,0.00014036035,0.00020996263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035735287,0.0001775563,0.00046879676,0.000115973104,0.0001433709,0.0002851797,0.00015985625,0.000055011722,0.00036093016],"category_scores_gemma":[0.0005645258,0.00008848971,0.00042130964,0.00026071622,0.00022830933,0.00022531477,0.000107272914,0.0011685068,0.00019374838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069712754,0.000046582227,0.02816386,0.000019769644,0.0026639705,0.0010916557,0.001728958,0.00003518424,0.00240092,0.000077928344,0.95798063,0.0050933915],"study_design_scores_gemma":[0.0006720465,0.00018385588,0.45646787,0.000102139835,0.0004279693,0.0001972261,0.00014425442,0.00002076303,0.00006366932,0.00010896837,0.5415503,0.000060988204],"about_ca_topic_score_codex":0.00013229904,"about_ca_topic_score_gemma":0.000017109927,"teacher_disagreement_score":0.428304,"about_ca_system_score_codex":0.0000492828,"about_ca_system_score_gemma":0.00013901091,"threshold_uncertainty_score":0.50766456},"labels":[],"label_agreement":null},{"id":"W4405809532","doi":"10.1002/ejhf.3548","title":"Empagliflozin in Acute Myocardial Infarction in Patients with and Without Type 2 Diabetes: A Pre-Specified Analysis of the EMPACT-MI Trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"Boehringer Ingelheim España; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Myocardial infarction; Heart failure; Type 2 diabetes; Internal medicine; Cardiology; Type 2 Diabetes Mellitus; Clinical trial; Diabetes mellitus; Endocrinology","score_opus":0.008454565064452215,"score_gpt":0.23896585637549836,"score_spread":0.23051129131104614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405809532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731606,0.0002500773,0.0000040047,0.0016881309,0.00020564604,0.00034115964,0.0000043310592,0.000006540303,0.00018404561],"genre_scores_gemma":[0.9994193,0.00002846966,0.0002316683,0.00010302253,0.00008879833,0.0000012908117,0.000006592101,0.000017860953,0.00010304605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988189,0.00022769922,0.0003820336,0.00012961864,0.00030043273,0.00014131701],"domain_scores_gemma":[0.9995643,0.000027826729,0.000118030555,0.00015584812,0.00007173064,0.00006225751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052017387,0.00011512929,0.00039957828,0.00054189377,0.000016036349,0.000036484344,0.00006204998,0.000020277503,0.000028676179],"category_scores_gemma":[0.000036941467,0.00006614265,0.00016568773,0.00086954347,0.00004355361,0.00012853231,0.000037633163,0.00023160846,0.000002890457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010042496,0.00025592223,0.9792334,0.00004048293,0.0040740087,0.000032553995,0.0013162534,0.000112299575,0.00012282512,0.000006949971,0.0029730832,0.0017897113],"study_design_scores_gemma":[0.01499169,0.0022062731,0.972521,0.00037105608,0.0023800111,0.0000016032551,0.00008187961,0.00005666471,0.00003785791,0.0000026583207,0.0072849826,0.00006432351],"about_ca_topic_score_codex":0.0000029641792,"about_ca_topic_score_gemma":0.00001905668,"teacher_disagreement_score":0.006712414,"about_ca_system_score_codex":0.00005050229,"about_ca_system_score_gemma":0.000045161545,"threshold_uncertainty_score":0.2697219},"labels":[],"label_agreement":null},{"id":"W4406185456","doi":"10.1002/ejhf.3573","title":"Registries on Transcatheter Edge-To-Edge Repair in Heart Failure: Current Evidence and Future Perspectives","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; MEDLINE; Mitral regurgitation; Heart failure; Cohort; Clinical trial; Intensive care medicine; Internal medicine","score_opus":0.01579678164331801,"score_gpt":0.3218614018905226,"score_spread":0.3060646202472046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406185456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8101997,0.04041509,0.000032113076,0.147975,0.00055122323,0.00049150747,0.000026645874,0.000043599328,0.00026513764],"genre_scores_gemma":[0.99611354,0.0006344833,0.0015010589,0.0008226623,0.0007284061,0.000003312395,0.0000021504932,0.000027496786,0.00016688212],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998426,0.00033308894,0.00040194107,0.00031047576,0.00029340998,0.00023507584],"domain_scores_gemma":[0.99906033,0.0000852185,0.00008240312,0.00030891382,0.00019304903,0.00027011082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048483626,0.00022178431,0.00046885497,0.00031679202,0.00008346775,0.000040687446,0.0000838809,0.000031298972,0.00003634852],"category_scores_gemma":[0.00016419568,0.00016806196,0.0010203758,0.0003138054,0.000075629934,0.00014234753,0.000035067038,0.00046184915,0.000032463366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024285344,0.001117832,0.3400865,0.00039090877,0.0008624243,0.000412607,0.0037724965,0.000012265334,0.0006661584,0.0003803794,0.6405707,0.009299222],"study_design_scores_gemma":[0.0015180291,0.0008290547,0.49634734,0.0017123474,0.00027186205,0.0001271515,0.0015766784,9.536493e-7,0.00006528244,0.0000138852165,0.49742842,0.00010900595],"about_ca_topic_score_codex":0.0000026746984,"about_ca_topic_score_gemma":0.000003234806,"teacher_disagreement_score":0.18591386,"about_ca_system_score_codex":0.00010799264,"about_ca_system_score_gemma":0.00012994898,"threshold_uncertainty_score":0.68533677},"labels":[],"label_agreement":null},{"id":"W4406236060","doi":"10.1002/ejhf.3511","title":"Heart Failure Outcomes Captured by Adverse Event Reporting in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Observations from the VERTIS CV Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; National Institute on Aging; Pfizer","keywords":"Medicine; Hazard ratio; Heart failure; Internal medicine; MedDRA; Placebo; Adverse effect; Confidence interval; Cardiology; Proportional hazards model; Diabetes mellitus; Type 2 diabetes; Pharmacovigilance; Pathology; Endocrinology","score_opus":0.030356730654667326,"score_gpt":0.25815648150026005,"score_spread":0.22779975084559273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406236060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693624,0.002959385,0.000032036354,0.026822204,0.00018604564,0.0005946701,0.000007428954,0.000015651318,0.000020195414],"genre_scores_gemma":[0.99712956,0.000039548322,0.0012900257,0.0011170421,0.00010952845,0.0000091506845,0.000018751707,0.000026029424,0.00026035294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796784,0.00035363983,0.0008030002,0.00022339138,0.0003712541,0.0002808884],"domain_scores_gemma":[0.99890125,0.00011487826,0.0003146706,0.00039493412,0.00010612092,0.00016813447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011140305,0.00018789386,0.0005590723,0.00007475958,0.00010174262,0.00004608182,0.00009620947,0.000022737704,0.000023128321],"category_scores_gemma":[0.0006181918,0.00011128899,0.0002669408,0.00023923059,0.000062427156,0.0001315141,0.000061091945,0.0002489736,0.0000067285473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009373948,0.00022068927,0.938277,0.000036434794,0.0017617361,0.00015886818,0.00026083624,0.0003507616,0.00067848037,0.0000071308937,0.057009164,0.000301496],"study_design_scores_gemma":[0.014006913,0.00039263366,0.83057994,0.00066253496,0.0010978687,0.000002649059,0.00039253727,0.000036196718,0.000069632755,0.000011014595,0.1526426,0.00010549385],"about_ca_topic_score_codex":0.000020293406,"about_ca_topic_score_gemma":0.000022911583,"teacher_disagreement_score":0.10769707,"about_ca_system_score_codex":0.000053835043,"about_ca_system_score_gemma":0.00009748547,"threshold_uncertainty_score":0.45382333},"labels":[],"label_agreement":null},{"id":"W4406270685","doi":"10.1002/ejhf.3579","title":"Sacubitril/Valsartan Versus Valsartan Initiation in Patients Naïve to Renin–angiotensin System Inhibitors: Insights from PARAGLIDE-HF","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Sherbrooke","funders":"Novartis Pharmaceuticals Corporation","keywords":"Valsartan; Medicine; Sacubitril; Heart failure; Confidence interval; Internal medicine; Clinical endpoint; Ejection fraction; Cardiology; Sacubitril, Valsartan; Randomization; Angiotensin receptor; Renin–angiotensin system; Natriuretic peptide; Angiotensin II; Angiotensin Receptor Blockers; Randomized controlled trial; Urology; Receptor; Blood pressure","score_opus":0.012141056097295828,"score_gpt":0.2481278499805738,"score_spread":0.23598679388327798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406270685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748769,0.00041931059,0.00025330627,0.020636551,0.0014522425,0.00079037173,0.000010372713,0.0000658926,0.0014950633],"genre_scores_gemma":[0.98598844,0.000008019211,0.01249043,0.00068238965,0.0005280705,0.000003960352,0.00004297834,0.000045260676,0.00021046984],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969556,0.00063544244,0.0011224258,0.00035052924,0.0005912287,0.0003448078],"domain_scores_gemma":[0.9984516,0.00014666609,0.00028377396,0.00039780812,0.00041517353,0.0003050031],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005728936,0.0003146993,0.0008870668,0.0008043014,0.000107636435,0.00008068511,0.0001553196,0.0000786086,0.000033700675],"category_scores_gemma":[0.00026244414,0.00026005536,0.00024340906,0.00068572833,0.000032272703,0.00026358746,0.00010109887,0.0004235789,0.00025927724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065860315,0.001345702,0.15138443,0.00017229668,0.0010673872,0.0031227598,0.0030953672,0.00016161359,0.0063911895,0.0006418538,0.8208701,0.0051612463],"study_design_scores_gemma":[0.018003535,0.0027846335,0.34323868,0.0041054925,0.0006013086,0.000025276207,0.0010838212,0.00003768929,0.0033972634,0.000029603794,0.6262762,0.00041647613],"about_ca_topic_score_codex":0.00003786916,"about_ca_topic_score_gemma":0.000053894157,"teacher_disagreement_score":0.19459392,"about_ca_system_score_codex":0.00039784005,"about_ca_system_score_gemma":0.00014442368,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W4406357977","doi":"10.1002/ejhf.3582","title":"Transcatheter Edge-To-Edge Repair in Severe Mitral Regurgitation Following Acute Myocardial Infarction – Aetiology-Based Analysis","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Surgical Specialties (Canada); Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Mitral regurgitation; Cardiology; Internal medicine; Myocardial infarction; Heart failure; Etiology; Functional mitral regurgitation; MitraClip; Ejection fraction","score_opus":0.007467168128223567,"score_gpt":0.29688746397886945,"score_spread":0.2894202958506459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406357977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989263,0.00036811212,0.00074528554,0.008523587,0.00039611687,0.00024860885,0.000024816973,0.000032339845,0.00039814523],"genre_scores_gemma":[0.9942736,0.000008085122,0.003835638,0.0015021362,0.00015656078,0.0000035102864,0.000045497738,0.000019955412,0.00015504133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984218,0.00041479743,0.0004975801,0.00022082982,0.00023187416,0.00021313009],"domain_scores_gemma":[0.9992965,0.000053190553,0.00010106103,0.0002279451,0.00014774209,0.00017357514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056002144,0.00016416093,0.00052879,0.00084010843,0.00006504778,0.000020813903,0.00006224647,0.000044200813,0.00002855938],"category_scores_gemma":[0.00007211914,0.00014002722,0.005053407,0.0008408583,0.00002204488,0.0001101777,0.000013275973,0.00024592932,0.000025975682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015658739,0.00028418406,0.9509038,0.000036624802,0.01659316,0.00043371224,0.00036780638,0.0017279462,0.0014143122,0.000007976794,0.025145328,0.0015193144],"study_design_scores_gemma":[0.004170618,0.00047772902,0.9683632,0.0001986533,0.008914723,0.00004064215,0.0001181468,0.00005188963,0.00004963013,0.0000106976195,0.017492115,0.00011195141],"about_ca_topic_score_codex":0.0000061287465,"about_ca_topic_score_gemma":0.000004632384,"teacher_disagreement_score":0.017459443,"about_ca_system_score_codex":0.00012323544,"about_ca_system_score_gemma":0.00013494777,"threshold_uncertainty_score":0.5710144},"labels":[],"label_agreement":null},{"id":"W4406685256","doi":"10.1002/ejhf.3585","title":"Predicting Survival in Patients with Severe Heart Failure: Risk Score Validation in the HELP-HF Cohort","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Cohort; Internal medicine; Framingham Risk Score; Prognostic model; Cohort study; Risk of mortality; Cardiology; Overall survival; Disease","score_opus":0.00956788466014458,"score_gpt":0.23086148687071276,"score_spread":0.22129360221056818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406685256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626872,0.000073805044,0.0000936828,0.03517925,0.00016637443,0.00094180333,0.0000058277274,0.000024697974,0.0008273476],"genre_scores_gemma":[0.9926387,0.000014477285,0.0062387795,0.00062743865,0.00018052054,0.000006123686,0.000026894635,0.000033198474,0.00023385765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967516,0.0011412615,0.00074861385,0.0002764224,0.00071895757,0.00036314124],"domain_scores_gemma":[0.9989212,0.00014766786,0.00024104177,0.0003600381,0.00021798474,0.00011204706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027888056,0.0002568542,0.00050477753,0.0004468478,0.00012760844,0.00008085606,0.0001898981,0.000047926555,0.00005896032],"category_scores_gemma":[0.00018309147,0.000160828,0.00013888929,0.0007055321,0.000056387416,0.0002724051,0.00006520168,0.0008074064,0.000036790814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036281257,0.00034304085,0.9393242,0.000048683,0.00012556928,0.00014224341,0.00042409616,0.00012387056,0.000020707703,0.000017734315,0.058531057,0.00053600874],"study_design_scores_gemma":[0.005402512,0.00084703945,0.87560683,0.00076522416,0.00018439634,0.000055395154,0.0007382428,0.000012460157,0.00003520092,0.000009137512,0.1162217,0.00012184376],"about_ca_topic_score_codex":0.000049623322,"about_ca_topic_score_gemma":0.00020179056,"teacher_disagreement_score":0.06371733,"about_ca_system_score_codex":0.00013566394,"about_ca_system_score_gemma":0.00013619145,"threshold_uncertainty_score":0.65583754},"labels":[],"label_agreement":null},{"id":"W4407371051","doi":"10.1002/ejhf.3613","title":"Growth Differentiation Factor-15: A Promising Biomarker for Early Detection of Pre-Heart Failure","year":2025,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Medicine; Biomarker; GDF15; Growth factor; Internal medicine; Cardiology; Biochemistry; Receptor; Biology","score_opus":0.008175357781696447,"score_gpt":0.247072556980623,"score_spread":0.23889719919892655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407371051","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23693216,0.0026284035,0.007236456,0.010046633,0.7387608,0.003435945,0.00045169887,0.00017464536,0.00033322716],"genre_scores_gemma":[0.7020096,0.000111439505,0.009232626,0.00007294838,0.28541118,0.000007639964,0.0002496111,0.00027493166,0.002630015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961255,0.0006015593,0.0014251401,0.0004185822,0.0010216172,0.00040758014],"domain_scores_gemma":[0.9960411,0.00040725817,0.0012051298,0.00034682653,0.0017418376,0.0002578259],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011209717,0.0004913899,0.0011185638,0.00083241885,0.000153481,0.000093808005,0.00024995304,0.000674376,0.0000494481],"category_scores_gemma":[0.0014141855,0.00037648412,0.0009608393,0.0003964647,0.00012569918,0.00021027954,0.00006987276,0.0016244685,0.00001160848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021618798,0.00015341294,0.0007936938,0.0012605853,0.0009520643,0.00003207931,0.00021387725,7.4119885e-7,0.08105038,0.0000010159469,0.9125065,0.00087375793],"study_design_scores_gemma":[0.0056400257,0.0025320635,0.027939113,0.0048796083,0.0012767757,0.00014489108,0.00009195301,0.000022374608,0.012879233,0.000016182352,0.94419783,0.00037996555],"about_ca_topic_score_codex":0.000011288994,"about_ca_topic_score_gemma":0.000006714586,"teacher_disagreement_score":0.46507746,"about_ca_system_score_codex":0.0001587061,"about_ca_system_score_gemma":0.0005190086,"threshold_uncertainty_score":0.9998687},"labels":[],"label_agreement":null},{"id":"W4407547225","doi":"10.1002/ejhf.3625","title":"Heart Failure Guideline Implementation in Developing Countries: A Testimony from Syria","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Heart failure; Guideline; Developing country; Intensive care medicine; Internal medicine; Economic growth; Pathology","score_opus":0.014687970028961697,"score_gpt":0.30985583428562186,"score_spread":0.29516786425666014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407547225","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23529832,0.00090162666,0.005678927,0.7559475,0.0005072712,0.00090906443,0.000020977104,0.00008751345,0.00064880727],"genre_scores_gemma":[0.5131655,0.000082999875,0.46891236,0.016480492,0.0006379872,0.000007893719,0.00012383897,0.00006964331,0.0005193035],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972305,0.00034087672,0.0013150602,0.00029395276,0.00043508978,0.00038449248],"domain_scores_gemma":[0.9988277,0.00010611065,0.00023550671,0.0003067308,0.00035748983,0.0001664736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013378457,0.0002810265,0.00061566534,0.0005546373,0.00011003129,0.00008905443,0.00015797655,0.000051047995,0.0006650775],"category_scores_gemma":[0.00011199978,0.00023372845,0.00018567237,0.0005023526,0.00004880058,0.00026082626,0.00009738205,0.00037690316,0.00017022958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000153637,0.00008819698,0.06474741,0.000048077534,0.00019190607,0.0004257007,0.00030692318,0.000026680313,0.0014241325,0.00027961476,0.93122005,0.0010876668],"study_design_scores_gemma":[0.004490635,0.00034118225,0.049078774,0.00075654394,0.00016945638,0.00009881995,0.001030758,0.00002885537,0.00090340106,0.000076732686,0.9428557,0.00016915544],"about_ca_topic_score_codex":0.00009400402,"about_ca_topic_score_gemma":0.00028198943,"teacher_disagreement_score":0.73946697,"about_ca_system_score_codex":0.00026732907,"about_ca_system_score_gemma":0.00046134938,"threshold_uncertainty_score":0.95311695},"labels":[],"label_agreement":null},{"id":"W4407556772","doi":"10.1002/ejhf.3604","title":"Empagliflozin's Anti-Inflammatory Spectrum in Type 2 Diabetes Mellitus: Piecing Together the Puzzle","year":2025,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"Empagliflozin; Medicine; Broad spectrum; Diabetes mellitus; Heart failure; Type 2 diabetes; Type 2 Diabetes Mellitus; Spectrum (functional analysis); Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.006175581370787732,"score_gpt":0.2324845918920742,"score_spread":0.2263090105212865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407556772","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06753307,0.024484925,0.000011513604,0.032804932,0.8615803,0.0012533666,0.000028782728,0.00010358621,0.012199489],"genre_scores_gemma":[0.0547089,0.0033324682,0.0017139433,0.0010707953,0.92397964,0.000007288829,0.000116177085,0.0003048501,0.01476595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696684,0.0005668664,0.00086465885,0.00030627826,0.00080569345,0.0004896494],"domain_scores_gemma":[0.9982464,0.00037099948,0.000442523,0.0005508535,0.0002440369,0.00014520211],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020691792,0.00041048366,0.0009090287,0.00047726277,0.0001074874,0.0001225666,0.00042641524,0.00015009857,0.00019028447],"category_scores_gemma":[0.0004885458,0.00026532487,0.0003721998,0.00035612064,0.000086732936,0.00013070853,0.00017750263,0.0015558879,0.00017773951],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000853183,0.00012305306,0.003421428,0.000251828,0.00054785,0.0006344712,0.00022912212,0.00001656756,0.00008049796,0.000013023552,0.9936345,0.000962319],"study_design_scores_gemma":[0.0017874256,0.00055182655,0.0024315105,0.0022028338,0.00053400936,0.000006271692,0.00020310863,0.0000034322125,0.00017205179,0.000021084572,0.9918788,0.00020765861],"about_ca_topic_score_codex":0.0000034011944,"about_ca_topic_score_gemma":0.000018254934,"teacher_disagreement_score":0.06239929,"about_ca_system_score_codex":0.00018024867,"about_ca_system_score_gemma":0.00032218284,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W4407609290","doi":"10.1002/ejhf.3598","title":"Baseline Characteristics of Contemporary Trial Participants with Heart Failure and Reduced Ejection Fraction: The VICTOR Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Impulse Dynamics; Regeneron Pharmaceuticals; Heart Failure Society of America; Sanofi; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Ejection fraction; Heart failure; Baseline (sea); Internal medicine; Cardiology; Randomized controlled trial","score_opus":0.031022407199283328,"score_gpt":0.2866538436147654,"score_spread":0.2556314364154821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407609290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86466134,0.00023338434,0.0004991965,0.13201003,0.0007271513,0.0014173504,0.000008083533,0.00003334504,0.00041014262],"genre_scores_gemma":[0.9927956,0.000024686855,0.004514207,0.0007477071,0.0011366714,0.000008641841,0.000010815264,0.000028955657,0.0007327275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974551,0.0007582955,0.0009283526,0.00021338841,0.00040720805,0.00023761141],"domain_scores_gemma":[0.9985439,0.00019498933,0.00042913572,0.00031735605,0.00033590972,0.00017868627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019311842,0.00022649637,0.0006885877,0.0002188351,0.00015329581,0.00006188866,0.000089092246,0.000051319264,0.000095433075],"category_scores_gemma":[0.00032100908,0.00013390496,0.00018678515,0.00028886614,0.00012655248,0.00019737451,0.000045744575,0.0004593877,0.000013640722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31544673,0.0010732936,0.010765134,0.00018825103,0.0009384162,0.00027260362,0.00027649038,0.0000030371232,0.007798198,0.00006493736,0.661959,0.0012138806],"study_design_scores_gemma":[0.13305105,0.0063408106,0.012036976,0.0005561107,0.00055026234,0.00013792134,0.0006603434,0.000016589032,0.0010129126,0.0000049268506,0.84550667,0.00012545483],"about_ca_topic_score_codex":0.0000059207614,"about_ca_topic_score_gemma":0.000005425831,"teacher_disagreement_score":0.18354763,"about_ca_system_score_codex":0.000045719124,"about_ca_system_score_gemma":0.00029280558,"threshold_uncertainty_score":0.5460486},"labels":[],"label_agreement":null},{"id":"W4407669598","doi":"10.1002/ejhf.3627","title":"Organ Perfusion Pressure Predicts Outcomes in Cardiogenic Shock Patients","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Interquartile range; Cardiogenic shock; Hazard ratio; Internal medicine; Cardiology; Heart failure; Ejection fraction; Confidence interval; Acute decompensated heart failure; Myocardial infarction; Pulse pressure; Blood pressure; Perfusion; Mean arterial pressure; Shock (circulatory); Central venous pressure; Heart rate","score_opus":0.005385453760060145,"score_gpt":0.19853990749604097,"score_spread":0.19315445373598084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407669598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962005,0.0008299097,0.00023562703,0.0005773018,0.0007868693,0.00014877599,0.000008543342,0.000064347034,0.0011480958],"genre_scores_gemma":[0.99897045,0.000007303435,0.00064348325,0.00013477106,0.00008017313,5.437665e-7,0.000002520738,0.000036142865,0.00012459577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850804,0.00024183207,0.0005915137,0.00013075065,0.0003052176,0.00022264138],"domain_scores_gemma":[0.9994232,0.00004208926,0.00007190987,0.0002355072,0.00010515389,0.00012216024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005426501,0.00016572207,0.00037155356,0.000227985,0.00003768476,0.000034166213,0.00028011645,0.000046241308,0.00014304076],"category_scores_gemma":[0.00011098056,0.00013959434,0.00016121838,0.00023368256,0.000013644471,0.00017832029,0.00006637116,0.0004378931,0.00006502029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019215855,0.00007213648,0.93977636,0.0001369475,0.00017507082,0.00012321101,0.00023455711,0.005198905,0.001902752,0.000020791393,0.050934196,0.0014058526],"study_design_scores_gemma":[0.0014353096,0.00010670247,0.7082079,0.00027542716,0.00008927725,0.000025085543,0.000079829086,0.00050971465,0.00089212647,0.000020130563,0.28816548,0.00019297899],"about_ca_topic_score_codex":7.1885705e-7,"about_ca_topic_score_gemma":0.0000039643855,"teacher_disagreement_score":0.2372313,"about_ca_system_score_codex":0.000040055664,"about_ca_system_score_gemma":0.0000322008,"threshold_uncertainty_score":0.5692492},"labels":[],"label_agreement":null},{"id":"W4407827239","doi":"10.1002/ejhf.3623","title":"Malnutrition and Outcomes in Patients with Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Repair","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Malnutrition; Hazard ratio; Confidence interval; Internal medicine; Heart failure; Regurgitation (circulation); Body mass index; Surgery; Cardiology; Gastroenterology","score_opus":0.005052191433264838,"score_gpt":0.25644439821629744,"score_spread":0.2513922067830326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407827239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955017,0.0006605384,0.00007668152,0.0030511967,0.00007536218,0.00027668747,0.0000069164857,0.000016549206,0.00033435694],"genre_scores_gemma":[0.9971505,0.000036465386,0.0023572082,0.0002850321,0.000036207464,0.0000015117797,0.000011954606,0.0000173757,0.00010373551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989575,0.00018326817,0.0003641333,0.00014247122,0.00022096589,0.0001316498],"domain_scores_gemma":[0.9994392,0.00007583953,0.00011576961,0.000117694784,0.00015361869,0.00009791369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025145084,0.00012849129,0.00033222575,0.00031927868,0.0000443612,0.000023779596,0.000028070248,0.000020699747,0.0000102555705],"category_scores_gemma":[0.0000678171,0.00008752373,0.00089753524,0.00021963308,0.00002360888,0.00014824573,0.000009545916,0.0001486204,0.0000040863565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007797565,0.0004592576,0.99398136,0.00008404104,0.0006688793,0.000048739686,0.000079975915,0.0000065545764,0.00001165296,0.000013593279,0.0023815501,0.0014846579],"study_design_scores_gemma":[0.011906155,0.0011397359,0.9833189,0.00057593617,0.000701446,0.000022386235,0.00013124433,0.000001497538,0.000011122076,0.000020622381,0.0020969904,0.00007395035],"about_ca_topic_score_codex":0.0000015133588,"about_ca_topic_score_gemma":0.0000015742083,"teacher_disagreement_score":0.011126398,"about_ca_system_score_codex":0.00006313078,"about_ca_system_score_gemma":0.000054187505,"threshold_uncertainty_score":0.35691142},"labels":[],"label_agreement":null},{"id":"W4407987804","doi":"10.1002/ejhf.3617","title":"What’s New in Heart Failure? February 2025","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.015549233661552867,"score_gpt":0.2721345570889255,"score_spread":0.2565853234273726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407987804","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.089265965,0.0047256458,0.0004706613,0.9003943,0.0016784657,0.0007440963,0.0000014391775,0.000082588165,0.0026368252],"genre_scores_gemma":[0.7692949,0.0007504577,0.16080695,0.01996862,0.002235246,0.000006766502,0.000022941314,0.00015146488,0.046762645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974537,0.0004155772,0.00091064087,0.00030862907,0.00044691606,0.00046456148],"domain_scores_gemma":[0.9987891,0.00008580937,0.00015295869,0.00044128078,0.00015580413,0.00037508146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011909788,0.00030621246,0.00070895045,0.0007742212,0.00008413026,0.00015629834,0.0002089335,0.00006585292,0.0005346397],"category_scores_gemma":[0.00012851601,0.00024925033,0.00035993647,0.00065725145,0.000059789378,0.00056607206,0.00012257494,0.0007136165,0.00051667844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020072379,0.0002369212,0.019978778,0.00007244004,0.00016487823,0.0008807254,0.0002319963,0.000020207377,0.0016790116,0.0001864424,0.97202075,0.0043271575],"study_design_scores_gemma":[0.0041622627,0.0005840178,0.06410325,0.0015630194,0.00014957107,0.00031149134,0.00082973315,0.0000064012074,0.00062236143,0.00008815219,0.927415,0.00016469538],"about_ca_topic_score_codex":0.000043769945,"about_ca_topic_score_gemma":0.00011649695,"teacher_disagreement_score":0.8804257,"about_ca_system_score_codex":0.00014644476,"about_ca_system_score_gemma":0.00043168908,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W4408026595","doi":"10.1002/ejhf.3618","title":"Clinical Management and Therapeutic Optimization of Patients with Heart Failure with Reduced Ejection Fraction and Low Blood Pressure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Respicardia; Servier; Vifor Pharma; Cytokinetics; Eli Lilly and Company; Edwards Lifesciences; AstraZeneca","keywords":"Medicine; Heart failure; Guideline; Discontinuation; Ejection fraction; Asymptomatic; Blood pressure; Context (archaeology); Intensive care medicine; Management of heart failure; Septic shock; Internal medicine; Cardiology; Sepsis; Pathology","score_opus":0.01221694019461861,"score_gpt":0.276094397671798,"score_spread":0.2638774574771794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408026595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604277,0.00023850995,0.00041754698,0.03697912,0.0002374664,0.0015853023,0.000013619802,0.000015205074,0.00008552528],"genre_scores_gemma":[0.97690445,0.00006912667,0.022211522,0.00038137016,0.00007261698,0.00000459285,0.00000565863,0.000029446916,0.0003212131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960019,0.001376473,0.0013692786,0.0003038936,0.000735305,0.00021315267],"domain_scores_gemma":[0.99736255,0.00023868942,0.0012198053,0.00042056045,0.00065391103,0.00010449275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021272826,0.00024123267,0.0007192573,0.00016736412,0.00013870897,0.000030349662,0.000113767695,0.000094254625,0.000024747418],"category_scores_gemma":[0.00015267475,0.00013336752,0.00022368004,0.00039005122,0.0002368558,0.000104616964,0.00010658928,0.00050470117,8.5296614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012396103,0.0011703831,0.9596496,0.00040143865,0.0022943867,0.000004376688,0.00010793544,0.0008217634,0.0004249154,0.000033058943,0.033386808,0.0004657157],"study_design_scores_gemma":[0.010008112,0.002878539,0.90077347,0.0015953562,0.0037064427,0.00002574494,0.00062984525,0.00016952673,0.0009342026,0.000010023107,0.079125375,0.0001433632],"about_ca_topic_score_codex":0.000007945346,"about_ca_topic_score_gemma":0.000020467542,"teacher_disagreement_score":0.05887613,"about_ca_system_score_codex":0.000046411613,"about_ca_system_score_gemma":0.00014191488,"threshold_uncertainty_score":0.543857},"labels":[],"label_agreement":null},{"id":"W4408370634","doi":"10.1002/ejhf.3440","title":"Quality of Life in Heart Failure. The Heart of the Matter. A Scientific Statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Quality of life (healthcare); Intensive care medicine; Population; Clinical trial; Depression (economics); Physical therapy; Limiting; Internal medicine; Nursing; Environmental health","score_opus":0.014043988866938084,"score_gpt":0.26679109665987405,"score_spread":0.25274710779293597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408370634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200391,0.0005428445,0.00009653719,0.1757977,0.00052282587,0.0016611188,0.00009818989,0.000008487357,0.0012332193],"genre_scores_gemma":[0.9972593,0.000050994826,0.00091682235,0.00063705357,0.0001553183,0.00000488569,0.000005905232,0.000037980415,0.0009317157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9773201,0.018095238,0.0025987653,0.00036618736,0.0011942411,0.00042550403],"domain_scores_gemma":[0.9940739,0.0009216369,0.0028429325,0.0010726482,0.0010109105,0.00007795842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023251787,0.00032903053,0.0016110602,0.0001688701,0.0002563342,0.000028895247,0.00067640224,0.00009542404,0.000024370302],"category_scores_gemma":[0.0012096907,0.00015878073,0.001375868,0.00090732856,0.0010181153,0.00012522195,0.00067106367,0.0008073847,0.000005038568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021333245,0.00018604573,0.63819027,0.00040187413,0.0013585897,0.0000013085391,0.0024518145,0.00037324085,0.02442577,0.00015358067,0.33216685,0.00007733516],"study_design_scores_gemma":[0.004211207,0.0002757689,0.8518379,0.0007800858,0.00058408553,0.000018115912,0.0030846056,0.000009607793,0.0031405136,0.00007747244,0.13586731,0.000113330905],"about_ca_topic_score_codex":0.00011126529,"about_ca_topic_score_gemma":0.00013740237,"teacher_disagreement_score":0.21364765,"about_ca_system_score_codex":0.0002078184,"about_ca_system_score_gemma":0.00037098344,"threshold_uncertainty_score":0.80586517},"labels":[],"label_agreement":null},{"id":"W4408383153","doi":"10.1002/ejhf.3643","title":"The Role of Kidney Disease Progression in Heart Failure Prognosis: Bridging the Evidence Gap for Optimal Management","year":2025,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Bridging (networking); Heart failure; Intensive care medicine; Disease; Disease management; Kidney disease; Cardiology; Management of heart failure; Internal medicine","score_opus":0.01291361413773705,"score_gpt":0.29264707013030505,"score_spread":0.279733455992568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408383153","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010720157,0.027862834,0.0004983027,0.78734845,0.17047817,0.011885121,0.00015954435,0.00013332797,0.00056225696],"genre_scores_gemma":[0.05952467,0.0060032196,0.16752826,0.003120621,0.74919856,0.0010815248,0.0004434282,0.0007346409,0.012365075],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500424,0.0008997257,0.0014077043,0.0005066254,0.0015302972,0.0006514159],"domain_scores_gemma":[0.99648905,0.0008233253,0.00073203444,0.00077978865,0.0006540677,0.0005217595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041749165,0.00053319236,0.00090919115,0.00040208024,0.00035857045,0.00020096092,0.00069439714,0.0001298855,0.000024233033],"category_scores_gemma":[0.002214339,0.00029595883,0.0007389662,0.0004237681,0.00018852059,0.00022723159,0.000369774,0.0012458203,0.00001727339],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015341246,0.00029515798,0.0013661695,0.0011541565,0.00047075292,0.0002424902,0.00016233334,0.000029775538,0.000069260226,0.000061067025,0.98856163,0.006053085],"study_design_scores_gemma":[0.00242404,0.0009662409,0.0005102006,0.017524593,0.001112418,0.000020183803,0.0005896363,0.00006676591,0.000114047165,0.000024708654,0.9764199,0.00022724246],"about_ca_topic_score_codex":0.0000048713337,"about_ca_topic_score_gemma":0.000010028399,"teacher_disagreement_score":0.7842278,"about_ca_system_score_codex":0.0001893501,"about_ca_system_score_gemma":0.0009956134,"threshold_uncertainty_score":0.9999493},"labels":[],"label_agreement":null},{"id":"W4408383416","doi":"10.1002/ejhf.3636","title":"Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Instituto de Salud Carlos III; Biotechnology and Biological Sciences Research Council; Horizon 2020 Framework Programme; Directorate for Biological Sciences; National Institutes of Health; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Ministerio de Ciencia e Innovación; National Heart, Lung, and Blood Institute; Ministero della Salute; Genentech; Deutsche Krebshilfe; Fondation Leducq; European Regional Development Fund; European Commission; Deutsche Forschungsgemeinschaft; UK Research and Innovation; “la Caixa” Foundation; Ministerio de Ciencia, Innovación y Universidades; Università degli Studi di Torino; Ministero dell’Istruzione, dell’Università e della Ricerca; Comunidad de Madrid","keywords":"Medicine; Heart failure; Statement (logic); Cancer therapy; Cancer; Internal medicine; Cardiology","score_opus":0.08046618421815467,"score_gpt":0.31278334737608793,"score_spread":0.23231716315793327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408383416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05721895,0.9084463,0.0000105691,0.030454623,0.0011559675,0.0022273483,0.0001078335,0.0000071886984,0.0003712115],"genre_scores_gemma":[0.47465923,0.5246865,0.000057727728,0.00018190073,0.00023922381,0.000013886829,0.0000041240532,0.000036875466,0.00012050561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99063534,0.0060045924,0.0015826526,0.00040376352,0.0011259306,0.0002476963],"domain_scores_gemma":[0.9944899,0.0011420256,0.002479563,0.00084231875,0.0009856585,0.000060504713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010670176,0.00036909335,0.0021994452,0.00012845393,0.0002650264,0.000023214747,0.0004274461,0.0002844631,0.000011566027],"category_scores_gemma":[0.00046087475,0.00015759813,0.001521389,0.0005163922,0.0012266593,0.000063642525,0.00017141947,0.0014948435,4.1748265e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008884852,0.0037860528,0.0057880785,0.02413323,0.05029914,0.000016790937,0.09217804,0.0039578346,0.10851196,0.012260671,0.07920923,0.61097413],"study_design_scores_gemma":[0.0047588097,0.0012413692,0.0021577151,0.019746952,0.0028654903,0.00005570162,0.0031754593,0.000026463369,0.0053529865,0.00026303087,0.9601152,0.00024082203],"about_ca_topic_score_codex":0.00003224314,"about_ca_topic_score_gemma":0.00003960049,"teacher_disagreement_score":0.880906,"about_ca_system_score_codex":0.0005071023,"about_ca_system_score_gemma":0.0014104742,"threshold_uncertainty_score":0.64944345},"labels":[],"label_agreement":null},{"id":"W4408500171","doi":"10.1002/ejhf.3642","title":"How to Handle Polypharmacy in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Biosense Webster; Servier; University of Glasgow; European Commission; Vifor Pharma; Pfizer; LivaNova; Boston Scientific Corporation; Amgen; Edwards Lifesciences; Alnylam Pharmaceuticals; Novo Nordisk; Teva Pharmaceutical Industries; Bayer; Intas Pharmaceuticals; AstraZeneca; Idorsia Pharmaceuticals; British Heart Foundation; Cytokinetics; Abbott Vascular; Abbott Laboratories","keywords":"Polypharmacy; Medicine; Heart failure; Intensive care medicine; Tolerability; Medical prescription; Adverse effect; Drug; Quality of life (healthcare); Internal medicine; Pharmacology","score_opus":0.04278002057642017,"score_gpt":0.3557567067224014,"score_spread":0.31297668614598123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408500171","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032709814,0.35850725,0.000034276924,0.6296897,0.0020179695,0.0060570696,0.00016953744,0.000041978234,0.00021122127],"genre_scores_gemma":[0.05399081,0.7776722,0.10232184,0.013540101,0.005766748,0.00018813212,0.00013500286,0.00097433827,0.045410853],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892954,0.004688423,0.0033843522,0.00053719763,0.001436547,0.0006580537],"domain_scores_gemma":[0.9949272,0.0008471801,0.0021618537,0.0010781339,0.0006248569,0.00036075778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0057684886,0.00069324404,0.003466124,0.00060340663,0.00015155901,0.00009651705,0.0006761955,0.00022547829,0.00010942012],"category_scores_gemma":[0.0016511737,0.00039234877,0.0024554378,0.0013094983,0.00016732703,0.00011217747,0.0005154355,0.0018878926,0.000053718664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012409917,0.00057639304,0.009818363,0.0044756704,0.0010648548,0.00006707686,0.00015605903,0.000007474967,0.00009269318,0.000028119262,0.9729242,0.010665048],"study_design_scores_gemma":[0.0029939008,0.00070115365,0.0021909222,0.023086464,0.0019698325,0.00017173927,0.0002589677,0.0000011101566,0.00009884909,0.000004237926,0.96825624,0.00026659138],"about_ca_topic_score_codex":0.000024645435,"about_ca_topic_score_gemma":0.00016360897,"teacher_disagreement_score":0.6161496,"about_ca_system_score_codex":0.000497848,"about_ca_system_score_gemma":0.0014877378,"threshold_uncertainty_score":0.99985284},"labels":[],"label_agreement":null},{"id":"W4408644732","doi":"10.1002/ejhf.3629","title":"Guideline-Directed Medical Therapy in Patients with Left Ventricular Assist Device: Don't Forget the Native Heart","year":2025,"lang":"en","type":"editorial","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Guideline; Heart failure; Medical therapy; Cardiology; Internal medicine; Intensive care medicine; Pathology","score_opus":0.005332172362340562,"score_gpt":0.22812749532427015,"score_spread":0.22279532296192958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408644732","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06187512,0.010072446,0.0013794819,0.012850307,0.9091124,0.0024634502,0.0003519531,0.0006947022,0.0012001558],"genre_scores_gemma":[0.26437882,0.00021241358,0.010025328,0.0029118538,0.7201571,0.000021313912,0.00088929513,0.0010052875,0.00039860717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99399275,0.0011584263,0.0015829452,0.00034103522,0.0024464964,0.00047835422],"domain_scores_gemma":[0.9971617,0.0006428471,0.00040681264,0.0004836444,0.0010010261,0.00030395758],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031037661,0.0005341696,0.0009714042,0.0003510252,0.00011220387,0.0001143825,0.00095453084,0.0003495544,0.00032688025],"category_scores_gemma":[0.0013016821,0.00033321607,0.0003159815,0.0004998347,0.00007136991,0.00019416219,0.0000967426,0.003137432,0.000028530514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008568411,0.00007706284,0.0064420155,0.00007322698,0.0003016511,0.00036881704,0.000060972616,0.00032315153,0.0000022879997,0.0000016333312,0.9918974,0.00036611236],"study_design_scores_gemma":[0.002275378,0.00030146993,0.006242384,0.00095368625,0.000068224035,0.00003268209,0.000038888196,0.00016217913,0.000026472373,0.0000066131324,0.9895486,0.00034338215],"about_ca_topic_score_codex":0.0000063487805,"about_ca_topic_score_gemma":0.000060423186,"teacher_disagreement_score":0.20250368,"about_ca_system_score_codex":0.00018821555,"about_ca_system_score_gemma":0.0005506071,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W4408803358","doi":"10.1002/ejhf.3647","title":"Impact of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death Across Cardio-Kidney-Metabolic Diseases: A Meta-Analysis of Randomized Clinical Trials","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Meta-analysis; Odds ratio; Placebo; Mineralocorticoid receptor; Cardiology; Heart failure; Randomized controlled trial; Sudden cardiac death; Confidence interval; Kidney disease; Aldosterone; Pathology","score_opus":0.08525677787108701,"score_gpt":0.41285857831022404,"score_spread":0.327601800439137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408803358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473,0.0071298415,0.00017454555,0.006345118,0.00018147458,0.00070189807,0.0005808808,0.0000066052303,0.00014965591],"genre_scores_gemma":[0.99741477,0.0010106612,0.000841986,0.000261897,0.0002198409,0.000002661034,0.000023746403,0.000021992975,0.00020243935],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9817638,0.013610045,0.003446526,0.0002093884,0.0007715426,0.00019874593],"domain_scores_gemma":[0.99172235,0.0038341808,0.002380628,0.0006015747,0.0011334929,0.00032777962],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02507516,0.000244634,0.0074641434,0.00041878407,0.00006959085,0.000021321508,0.00019585688,0.00006321086,0.00028489743],"category_scores_gemma":[0.021509374,0.00011207003,0.0155059835,0.0007449134,0.0002888318,0.000056682497,0.000053385593,0.0004114861,0.0000054365173],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09000436,0.000901618,0.14646839,0.00007557786,0.6444293,0.00006647225,0.00054510665,0.0007452104,0.022611337,0.00022106664,0.09169846,0.0022331078],"study_design_scores_gemma":[0.045000367,0.0008968606,0.4444914,0.00015416423,0.48264796,0.000024164405,0.0002441866,0.00024792083,0.0011504472,0.000016819735,0.024972817,0.00015291735],"about_ca_topic_score_codex":0.00005915848,"about_ca_topic_score_gemma":0.0000013059554,"teacher_disagreement_score":0.298023,"about_ca_system_score_codex":0.000022787352,"about_ca_system_score_gemma":0.00044747087,"threshold_uncertainty_score":0.9943535},"labels":[],"label_agreement":null},{"id":"W4409119482","doi":"10.1002/ejhf.3635","title":"Cardiac Implantable Electronic and Other Monitoring Devices in Continuous-Flow Left Ventricular Assist Device Patients. A Clinical Consensus Statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Heart Rhythm; Cardiology; Internal medicine; Cardiac resynchronization therapy; Ventricular assist device; Randomized controlled trial; Intensive care medicine; Ejection fraction","score_opus":0.013076168346002325,"score_gpt":0.2630213516909233,"score_spread":0.24994518334492094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409119482","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093016505,0.90046483,0.000014580218,0.0021235824,0.0018165321,0.002057056,0.0002115381,0.000040130864,0.0002552662],"genre_scores_gemma":[0.82046616,0.17618094,0.0010368894,0.0004968766,0.0011909989,0.000017556196,0.000023408084,0.00035851554,0.00022864765],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889626,0.007317407,0.0022679812,0.00027702487,0.00073572877,0.00043927657],"domain_scores_gemma":[0.9959836,0.0013686795,0.0018633998,0.000402845,0.00028663673,0.000094850744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010287143,0.0003880831,0.0018632764,0.00012552802,0.00013744047,0.00009748788,0.00037450073,0.00015638687,0.000008328162],"category_scores_gemma":[0.00084979966,0.00022467476,0.0007496678,0.00037799648,0.000068766785,0.000096647265,0.00019332703,0.0014567678,0.0000055251908],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003790293,0.00012312843,0.9475871,0.0061698454,0.0022215715,0.000015505659,0.0002882297,0.00026550092,0.000015374286,0.00003700708,0.033429686,0.009809157],"study_design_scores_gemma":[0.0011647063,0.00006276767,0.045686115,0.005810308,0.0009678025,0.000066597924,0.000100964666,0.000020185023,0.000019873925,0.0000062256945,0.94587624,0.00021819709],"about_ca_topic_score_codex":0.000012006247,"about_ca_topic_score_gemma":0.000044129327,"teacher_disagreement_score":0.91244656,"about_ca_system_score_codex":0.0003655884,"about_ca_system_score_gemma":0.00022005747,"threshold_uncertainty_score":0.91619706},"labels":[],"label_agreement":null},{"id":"W4409289304","doi":"10.1002/ejhf.3641","title":"Cardiac Rhythm Devices in Heart Failure with Reduced Ejection Fraction – Role, Timing, and Optimal Use in Contemporary Practice. <i>European Journal of Heart Failure</i> Expert Consensus Document","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Servier; Deutsche Forschungsgemeinschaft; Abiomed; European Society of Cardiology; Boston Scientific Corporation; Alnylam Pharmaceuticals; Idorsia Pharmaceuticals; Cytokinetics; Sanofi; Respicardia; Regeneron Pharmaceuticals; Novo Nordisk; Daiichi-Sankyo; Teva Pharmaceutical Industries; Eli Lilly and Company; AstraZeneca; Nipro; Edwards Lifesciences; Amgen","keywords":"Medicine; Heart failure; Guideline; Ejection fraction; Referral; Heart Rhythm; Cardiac resynchronization therapy; Intensive care medicine; Disease management; Cardiology; Medical emergency; Internal medicine; Family medicine","score_opus":0.022912159579590703,"score_gpt":0.2920639151102441,"score_spread":0.2691517555306534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409289304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95291466,0.005901914,0.00018615257,0.03731088,0.00052095955,0.0004350455,0.000006800664,0.00003419107,0.0026893923],"genre_scores_gemma":[0.9670356,0.00019010673,0.030907102,0.0011010924,0.000594908,0.000001604681,0.0000039020524,0.00005709714,0.000108581575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99486905,0.0023400628,0.0014320227,0.00035080416,0.00066973123,0.00033834492],"domain_scores_gemma":[0.99721956,0.0005238254,0.00087404286,0.0002888421,0.00084997516,0.00024374663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035052462,0.00036143934,0.0012332533,0.00084444863,0.0001651573,0.0002055852,0.00004815596,0.000069316535,0.000008762789],"category_scores_gemma":[0.0007439454,0.00029288518,0.0003118616,0.00056946866,0.00015160683,0.00081213494,0.000079052894,0.0010836656,0.000012464559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054219724,0.0002901462,0.22188434,0.00017577515,0.0010322552,0.0016816957,0.0025769419,0.0013744826,0.036580432,0.000014122521,0.7282664,0.0007013969],"study_design_scores_gemma":[0.004844878,0.0012343487,0.092019185,0.0022135442,0.00019371702,0.011331579,0.012519609,0.000011352574,0.0015348196,0.0000017926014,0.8738288,0.00026635217],"about_ca_topic_score_codex":0.00007874666,"about_ca_topic_score_gemma":0.000029322415,"teacher_disagreement_score":0.14556238,"about_ca_system_score_codex":0.00018271215,"about_ca_system_score_gemma":0.00035787254,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W4409462983","doi":"10.1002/ejhf.3667","title":"Late Diagnosis in Cancer Sparks Outrage—So Why Not Heart Failure?","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Outrage; Medicine; Heart failure; Internal medicine; Cancer; Cardiology","score_opus":0.01779124256423512,"score_gpt":0.2811026936717828,"score_spread":0.26331145110754767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409462983","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3169149,0.0017251759,0.00024311004,0.67842025,0.0007180354,0.00067912036,0.000010039061,0.000070226284,0.0012191676],"genre_scores_gemma":[0.9557842,0.00044587842,0.02078033,0.017870663,0.00066459726,0.000025320607,0.00000845278,0.00008040083,0.0043401523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972271,0.00047393003,0.00092919543,0.0003510502,0.00048272652,0.00053605303],"domain_scores_gemma":[0.9987658,0.00011900736,0.00019029005,0.00041247366,0.0002093362,0.00030305187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012167953,0.00034672904,0.0007954024,0.00068829913,0.00013246082,0.00011215059,0.00021152142,0.00009831346,0.00070781016],"category_scores_gemma":[0.0001328249,0.00027789158,0.00037735002,0.0005890318,0.00012215736,0.00024712965,0.00011408017,0.0010467296,0.00020785404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022567276,0.00036650946,0.120857224,0.00012318503,0.00025053966,0.0009487099,0.00026258238,0.00010848408,0.0017262484,0.000107855805,0.8726364,0.002386617],"study_design_scores_gemma":[0.00352783,0.0004623351,0.07647122,0.0012384205,0.00023709256,0.00009337226,0.00016500874,0.000014309158,0.0019587392,0.000019696836,0.9156163,0.0001957231],"about_ca_topic_score_codex":0.00008367639,"about_ca_topic_score_gemma":0.00031312738,"teacher_disagreement_score":0.6605496,"about_ca_system_score_codex":0.00019789617,"about_ca_system_score_gemma":0.0002346274,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W4409855507","doi":"10.1002/ejhf.3662","title":"What's New in Heart Failure? April 2025","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.015189155584635173,"score_gpt":0.27226272701771914,"score_spread":0.25707357143308396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409855507","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0717956,0.004116264,0.000697041,0.9176055,0.0015210226,0.00075412454,0.0000012966433,0.00008387902,0.0034252403],"genre_scores_gemma":[0.7475469,0.0007066441,0.18036906,0.017386723,0.0023414756,0.000006560478,0.000019453099,0.00015129258,0.05147185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974717,0.00039774858,0.0009035207,0.00030604616,0.00045617833,0.00046480144],"domain_scores_gemma":[0.9987731,0.00008475603,0.00015555922,0.0004483983,0.00016804508,0.00037011987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012277088,0.00030239348,0.00071002,0.0007391925,0.00008161381,0.00018228932,0.00021092358,0.00006462031,0.0005521007],"category_scores_gemma":[0.0001473435,0.00024497462,0.00035454545,0.0006643391,0.000060056514,0.00058943575,0.00012106607,0.00068395457,0.0005235541],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019749184,0.00023113545,0.011658237,0.00007400415,0.00016447803,0.00072352984,0.00024446583,0.000023735709,0.0019331995,0.00022509022,0.9791604,0.005364195],"study_design_scores_gemma":[0.004349764,0.0005518399,0.021242805,0.0014638695,0.00015225612,0.0002683041,0.000882456,0.000007762534,0.0007305197,0.00008588719,0.97009957,0.00016494592],"about_ca_topic_score_codex":0.000019263653,"about_ca_topic_score_gemma":0.00007457738,"teacher_disagreement_score":0.9002188,"about_ca_system_score_codex":0.00014580447,"about_ca_system_score_gemma":0.00040627932,"threshold_uncertainty_score":0.9989776},"labels":[],"label_agreement":null},{"id":"W4409855632","doi":"10.1002/ejhf.3619","title":"Remote Pulmonary Artery Pressure-Guided Management of Patients with Heart Failure: A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Clinical trial; Randomized controlled trial; Pulmonary artery; Intracardiac injection; Intensive care medicine; Management of heart failure; Cardiology; Clinical Practice; Ejection fraction; Internal medicine; Physical therapy","score_opus":0.019862317697367914,"score_gpt":0.29293501093397734,"score_spread":0.27307269323660943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409855632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92750835,0.00039070836,0.000021540081,0.07008163,0.00029773748,0.001226429,0.00008081174,0.000011598359,0.00038116967],"genre_scores_gemma":[0.990013,0.000038790473,0.0077374885,0.000676522,0.00006419296,0.0000018493528,0.000010147227,0.000034636687,0.0014233914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943737,0.0017082151,0.0016718819,0.0002997307,0.0015620039,0.00038448986],"domain_scores_gemma":[0.9964402,0.00026024663,0.0010987709,0.00078277395,0.0012159349,0.00020211369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00216056,0.00027039906,0.0008763301,0.00018097801,0.00014238057,0.00001866017,0.00035689655,0.00008109412,0.000061967854],"category_scores_gemma":[0.00032979343,0.0001464494,0.0005577769,0.00053569063,0.00025683214,0.00009084205,0.00027401472,0.0007086182,0.000009183833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013291198,0.001451528,0.68430877,0.0004007491,0.001786477,0.00018630795,0.000039258124,0.00005749324,0.0020257253,0.0000148007,0.3080037,0.0003960671],"study_design_scores_gemma":[0.0050268266,0.0011491979,0.80310255,0.0020469518,0.0007106681,0.00013513173,0.00027135285,0.00004714544,0.0013297652,0.000027535834,0.18604536,0.000107483356],"about_ca_topic_score_codex":0.000015371912,"about_ca_topic_score_gemma":0.0000084751055,"teacher_disagreement_score":0.12195833,"about_ca_system_score_codex":0.00009412397,"about_ca_system_score_gemma":0.00033010435,"threshold_uncertainty_score":0.5972033},"labels":[],"label_agreement":null},{"id":"W4409912113","doi":"10.1002/ejhf.3669","title":"The Efficacy of Finerenone on Hierarchical Composite Endpoint Analysed Using Win Statistics in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Japan Society for the Promotion of Science; Great Britain Sasakawa Foundation; British Heart Foundation; Bayer","keywords":"Medicine; Confidence interval; Heart failure; Ejection fraction; Internal medicine; Odds ratio; Placebo; Clinical endpoint; Randomized controlled trial; Randomization; Cardiology","score_opus":0.0194741233529457,"score_gpt":0.28405668015492014,"score_spread":0.26458255680197446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409912113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900602,0.00007209198,0.0013936696,0.007817993,0.00005402407,0.0005148318,0.00002492354,0.000009364967,0.000052879634],"genre_scores_gemma":[0.954771,0.000014618652,0.044820502,0.00009719985,0.000057465048,0.0000014997308,0.000032686712,0.000021182143,0.00018386824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734,0.00071210135,0.0009388277,0.0002437083,0.00054226595,0.00022307817],"domain_scores_gemma":[0.9982648,0.0004699144,0.00040637198,0.00036307785,0.0003698002,0.00012601826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007634735,0.00021960205,0.0008031434,0.00081839063,0.00012426412,0.00004368731,0.000102266946,0.00004241551,0.00006180896],"category_scores_gemma":[0.0002298692,0.00013148622,0.0001813994,0.0011240778,0.0001334528,0.00010107256,0.000058790632,0.00043187386,0.0000012049512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054415405,0.0045023775,0.8109967,0.00045056237,0.009922524,0.0003040989,0.00065101724,0.009177754,0.020065911,0.00017018974,0.087149285,0.0021941895],"study_design_scores_gemma":[0.008176281,0.0027478617,0.9526167,0.0006060437,0.002083312,0.000009160083,0.00018428364,0.0011166002,0.0010851431,0.0000049863006,0.031241981,0.00012763657],"about_ca_topic_score_codex":0.00002787798,"about_ca_topic_score_gemma":0.0000987369,"teacher_disagreement_score":0.14162003,"about_ca_system_score_codex":0.00008123937,"about_ca_system_score_gemma":0.00012983318,"threshold_uncertainty_score":0.53618526},"labels":[],"label_agreement":null},{"id":"W4410068839","doi":"10.1002/ejhf.3673","title":"Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Respicardia; Abbott Vascular; Servier; Chugai Pharmaceutical; Sphingotec GmbH; Vifor Pharma; Schweizerische Herzstiftung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Idorsia Pharmaceuticals; Impulse Dynamics; Novo Nordisk; Abbott Laboratories; National Institute for Health and Care Research; ReCor Medical; Astellas Pharma; Cytokinetics; Boston Scientific Corporation; Patient-Centered Outcomes Research Institute; Universität Basel; Singulex; Amgen; Edwards Lifesciences; Alnylam Pharmaceuticals; AstraZeneca; Kowa Company; U.S. Department of Defense; Sanofi; National Institutes of Health; Regeneron Pharmaceuticals; Pfizer; Les Laboratories Pierre Fabre; National Science Foundation","keywords":"Medicine; Heart failure; Vasodilation; Nesiritide; Afterload; Preload; Cardiology; Internal medicine; Decompensation; Intensive care medicine; Hemodynamics","score_opus":0.05352921350119626,"score_gpt":0.3110315324551698,"score_spread":0.2575023189539735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410068839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40712485,0.49268523,0.00012346174,0.07975124,0.0037537087,0.015292497,0.00093177473,0.00008428048,0.00025297212],"genre_scores_gemma":[0.2725961,0.6758449,0.044652585,0.0012291736,0.0011781816,0.000052568805,0.00014323847,0.00049060973,0.0038126174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892816,0.0058095558,0.0030017432,0.0005375271,0.00091701886,0.0004525458],"domain_scores_gemma":[0.9950996,0.00042507736,0.0026000778,0.0009604584,0.0007633291,0.00015142994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052356427,0.0005382503,0.0034268475,0.00031931337,0.00013515248,0.000037930695,0.00047154631,0.00019422328,0.000016936609],"category_scores_gemma":[0.0004412498,0.0002754472,0.0017824726,0.00081130187,0.00076227344,0.00016636748,0.0005767459,0.0011157914,0.000004928718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043951516,0.0012244711,0.12270603,0.020481199,0.008547051,0.000088928304,0.0010777933,0.00007949426,0.0025550816,0.000020512367,0.8305495,0.012230445],"study_design_scores_gemma":[0.0021323394,0.0012592206,0.029477842,0.018330613,0.0031155047,0.00009365421,0.00024767383,0.0000040693935,0.00011160748,0.000002677354,0.945019,0.00020579236],"about_ca_topic_score_codex":0.000014953216,"about_ca_topic_score_gemma":0.000032525968,"teacher_disagreement_score":0.18315971,"about_ca_system_score_codex":0.00017605252,"about_ca_system_score_gemma":0.00087129895,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W4410113184","doi":"10.1002/ejhf.3676","title":"Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); St. Thomas Hospital","funders":"National Medical Research Council; Medical Research Council; American Regent; Cytokinetics; Astellas Pharma; Servier; Amgen; Siemens Healthineers; Horizon Therapeutics; Pfizer; Moderna; Impulse Dynamics; Biosense Webster; Novo Nordisk; ReCor Medical; AstraZeneca; Amarin Corporation; Regeneron Pharmaceuticals; Vifor Pharma; LivaNova; Boston Scientific Corporation; Alnylam Pharmaceuticals; European Commission; Circle Cardiovascular Imaging; Society for Cardiovascular Magnetic Resonance; Sanofi; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Heart failure; Obesity; Intensive care medicine; Ejection fraction; Epidemiology; Population; Heart failure with preserved ejection fraction; Internal medicine; Cardiology; Environmental health","score_opus":0.015073620610739458,"score_gpt":0.22999064056251783,"score_spread":0.21491701995177837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410113184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.898208,0.0023570862,0.00020470087,0.09839576,0.00030209305,0.00041638242,0.000016636503,0.000008940539,0.000090400164],"genre_scores_gemma":[0.9977711,0.000022321685,0.0012684856,0.00023205907,0.00009153031,8.6758826e-7,0.0000017723958,0.000016097338,0.0005957586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761915,0.0007839568,0.0005063749,0.00021087886,0.0007164165,0.00016319896],"domain_scores_gemma":[0.9988876,0.00009084894,0.00028226228,0.00028757725,0.00037201977,0.00007968033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002130089,0.00015548886,0.00042015786,0.0001721596,0.00026689243,0.00006348035,0.000109364526,0.00005491772,0.000042463107],"category_scores_gemma":[0.00011941868,0.00008850077,0.00047185933,0.00043204546,0.00028261228,0.0000973375,0.000057959725,0.00048394204,0.0000016093137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001716328,0.0003019162,0.88383454,0.0002482522,0.001232605,0.0000031682785,0.005032342,0.00021837815,0.022125335,0.00047319927,0.08578084,0.00057777733],"study_design_scores_gemma":[0.001777061,0.00013293652,0.6960442,0.00031967674,0.000400896,0.00017110632,0.0046773977,0.00004256598,0.0022976832,0.000054822158,0.2939974,0.000084233405],"about_ca_topic_score_codex":0.0000054667426,"about_ca_topic_score_gemma":0.000030712094,"teacher_disagreement_score":0.2082166,"about_ca_system_score_codex":0.00007357729,"about_ca_system_score_gemma":0.00025224301,"threshold_uncertainty_score":0.36089566},"labels":[],"label_agreement":null},{"id":"W4410143902","doi":"10.1002/ejhf.3678","title":"Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Atrial fibrillation; Heart failure; Regurgitation (circulation); Hazard ratio; Ejection fraction; Confidence interval; Etiology; valvular heart disease","score_opus":0.007973253721890833,"score_gpt":0.26590513805201826,"score_spread":0.2579318843301274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410143902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95101947,0.044636168,0.00006977622,0.0037274328,0.00007911132,0.00022926963,0.000034473192,0.0000058338524,0.00019844266],"genre_scores_gemma":[0.9988399,0.00029503292,0.00043411175,0.0001595266,0.00022267895,0.0000010858141,0.000030008438,0.000006588196,0.000011032463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920756,0.00024516846,0.000281554,0.00011550746,0.000084686035,0.000065521584],"domain_scores_gemma":[0.9991911,0.0002506747,0.0001619923,0.00014505217,0.00018346535,0.000067734276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012449978,0.000090558606,0.00024158602,0.000051697494,0.0000799213,0.000023729212,0.000048474827,0.000024573153,0.000008141869],"category_scores_gemma":[0.000258926,0.000047710728,0.00029452267,0.00011043216,0.00007983929,0.000044758155,0.000033782624,0.00014813569,0.0000013174201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014754479,0.00025797414,0.9194151,0.00018921637,0.002262117,0.00020097844,0.0014444286,0.00001801182,0.002457395,0.00055232586,0.024603028,0.047123935],"study_design_scores_gemma":[0.0022734827,0.00034615985,0.9701033,0.00023130412,0.0006068472,0.0000873495,0.0010093437,0.0000015444663,0.00010160522,0.00032019077,0.02487437,0.000044487937],"about_ca_topic_score_codex":0.0000040065015,"about_ca_topic_score_gemma":5.3819525e-7,"teacher_disagreement_score":0.050688174,"about_ca_system_score_codex":0.000016250224,"about_ca_system_score_gemma":0.00008247817,"threshold_uncertainty_score":0.19455871},"labels":[],"label_agreement":null},{"id":"W4410144058","doi":"10.1002/ejhf.3681","title":"Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart transplantation; Heart failure; Transplantation; Population; Intensive care medicine; Prioritization; European population; Scarcity; Guideline; Internal medicine; Environmental health; Pathology; Management science","score_opus":0.030273050951859493,"score_gpt":0.32558211029080386,"score_spread":0.29530905933894436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410144058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033616838,0.96047807,0.00022920471,0.028764382,0.0039027792,0.002840142,0.00017291681,0.00002072899,0.00023009429],"genre_scores_gemma":[0.02030677,0.9329876,0.029573873,0.0011624697,0.0017211362,0.000039054354,0.00014367496,0.00036110423,0.013704327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99152035,0.0046579535,0.0022556959,0.00027486138,0.0010240413,0.00026712907],"domain_scores_gemma":[0.9960718,0.00047207082,0.0018745956,0.0006040013,0.00088754937,0.00008998174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006806408,0.00030899103,0.0016610583,0.00040919724,0.00013507741,0.00008200403,0.00044530627,0.00010339868,0.000023595705],"category_scores_gemma":[0.0007741803,0.00016582226,0.0007899604,0.001501877,0.000102473634,0.000118603544,0.00008517121,0.0009514301,0.000013606777],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033963987,0.0013386017,0.08563543,0.16247156,0.0025530355,0.00011692834,0.0034809234,0.00072478404,0.004966568,0.0008093705,0.68996376,0.047599427],"study_design_scores_gemma":[0.00078940595,0.00012822887,0.011282498,0.040512078,0.00086784957,0.00018126289,0.00012264779,0.0000027772421,0.00007862531,0.0000022739,0.94591355,0.00011877912],"about_ca_topic_score_codex":0.000017179033,"about_ca_topic_score_gemma":0.00003927462,"teacher_disagreement_score":0.25594985,"about_ca_system_score_codex":0.00023088981,"about_ca_system_score_gemma":0.0012620693,"threshold_uncertainty_score":0.67620355},"labels":[],"label_agreement":null},{"id":"W4410247685","doi":"10.1002/ejhf.3666","title":"Reply to ‘Assessing Heart Failure After Surgical Occlusion of the Left Atrial Appendage’","year":2025,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Appendage; Heart failure; Cardiology; Left atrial appendage occlusion; Atrial Appendage; Internal medicine; Atrial fibrillation; Occlusion; Anatomy; Warfarin","score_opus":0.023759526148435645,"score_gpt":0.29984255708243224,"score_spread":0.2760830309339966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410247685","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012539397,0.00033070036,0.000100843725,0.9836807,0.0019434358,0.0005947544,0.000016390493,0.000029606592,0.000764118],"genre_scores_gemma":[0.11649693,0.000040252973,0.021633238,0.77090186,0.06237833,2.1135111e-7,0.00007430319,0.00027249326,0.028202407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951909,0.001295216,0.001489462,0.00038245934,0.0012362655,0.00040568193],"domain_scores_gemma":[0.9976413,0.0003133108,0.0007458207,0.0007229582,0.00041149338,0.000165111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017946863,0.00042380474,0.0012098223,0.0005221355,0.0001780125,0.00014246318,0.0004128184,0.00021774445,0.0007798281],"category_scores_gemma":[0.0004541541,0.00027142634,0.0017408436,0.0004212064,0.000097704644,0.00019445128,0.0005051117,0.0021623652,0.000110486944],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004251267,0.0000052185064,0.026037542,0.00024146042,0.00018773745,0.0018378762,0.00009785176,0.000030634736,0.00024632466,0.0000030441054,0.9707709,0.00011628148],"study_design_scores_gemma":[0.0018504561,0.00026567222,0.016692847,0.0019277569,0.0005108692,0.0012119127,0.00006928172,0.0000021104365,0.00011725612,0.0000071621917,0.977117,0.00022770221],"about_ca_topic_score_codex":0.0000049707787,"about_ca_topic_score_gemma":0.0000018128687,"teacher_disagreement_score":0.21277891,"about_ca_system_score_codex":0.000093131974,"about_ca_system_score_gemma":0.00030140154,"threshold_uncertainty_score":0.9999738},"labels":[],"label_agreement":null},{"id":"W4410799412","doi":"10.1002/ejhf.3707","title":"Global Heart Failure Epidemiology Versus Enrolment in Pivotal Trials: A Formidable Mismatch","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Representativeness heuristic; Medicine; Epidemiology; Clinical trial; Population; Demography; Environmental health; Internal medicine; Statistics","score_opus":0.18523273088193667,"score_gpt":0.44819951082789244,"score_spread":0.26296677994595574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410799412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5244577,0.0043965913,0.20043066,0.24461669,0.0042151865,0.0037319236,0.00011861381,0.00090481585,0.017127847],"genre_scores_gemma":[0.5230238,0.000038488004,0.47520867,0.0010293386,0.00036241696,0.000012490049,0.0000034331595,0.000049716476,0.00027168143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929773,0.0034108374,0.0023387922,0.00032672405,0.00031268282,0.000633618],"domain_scores_gemma":[0.9955735,0.0027256643,0.0007924281,0.00045835294,0.00025392065,0.0001961146],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0110028535,0.00035066291,0.001519626,0.00029736653,0.000098915945,0.000041792453,0.00048012086,0.00013183425,0.00015094192],"category_scores_gemma":[0.009357312,0.0002845997,0.00045451833,0.00043730557,0.00011762741,0.00034902952,0.00018922848,0.000782355,0.00004466551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013931787,0.00041591492,0.010400856,0.0001764281,0.00025333645,0.00026186704,0.00026409456,0.00020713417,0.002480814,0.049400102,0.93251854,0.002227738],"study_design_scores_gemma":[0.006861375,0.001886466,0.0029856612,0.0012794764,0.00016292685,0.0004952666,0.00096122496,0.000059410122,0.001998051,0.15304062,0.82973355,0.0005359376],"about_ca_topic_score_codex":0.000015317219,"about_ca_topic_score_gemma":0.00013290327,"teacher_disagreement_score":0.274778,"about_ca_system_score_codex":0.00037373704,"about_ca_system_score_gemma":0.00023867119,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W4410898595","doi":"10.1002/ejhf.3692","title":"Lung Ultrasound and Mortality in a Cardiogenic Shock Population: A Prospective Registry-Based Analysis","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Cardiogenic shock; Confidence interval; Univariate analysis; Prospective cohort study; Proportional hazards model; Population; Epidemiology; Cardiology; Multivariate analysis; Myocardial infarction","score_opus":0.01424572989784621,"score_gpt":0.31899901099264033,"score_spread":0.3047532810947941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410898595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912076,0.00041426375,0.002397632,0.0048028324,0.00004512779,0.000255451,0.000012659385,0.000016245707,0.00084821007],"genre_scores_gemma":[0.9885271,0.000016027978,0.010737471,0.000427609,0.00012388123,0.000003224072,0.000016210222,0.0000123958935,0.00013607158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983493,0.00028952485,0.0007281659,0.00023386547,0.00025275117,0.00014640814],"domain_scores_gemma":[0.99873024,0.00034417294,0.00021771516,0.00036422836,0.00021240216,0.00013121805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001147581,0.00012444533,0.0005194329,0.00031428295,0.00006885717,0.000040363844,0.000102485435,0.00004189484,0.000064856315],"category_scores_gemma":[0.0006890813,0.00010506398,0.00031643064,0.0011326455,0.000090717505,0.00007169421,0.000020660373,0.00047009473,0.0000042975666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000854489,0.00010794761,0.9952152,0.000035585777,0.0005811863,0.00004079134,0.000057324723,0.00022772347,0.00072509615,0.00009341427,0.0027794696,0.000050857998],"study_design_scores_gemma":[0.0013160905,0.0001085158,0.99103826,0.00012473355,0.0011774318,0.000092545226,0.0000833745,0.00010253073,0.000066086664,0.00015982227,0.0056510265,0.00007957635],"about_ca_topic_score_codex":0.000030866144,"about_ca_topic_score_gemma":0.00007874101,"teacher_disagreement_score":0.00833984,"about_ca_system_score_codex":0.000111783986,"about_ca_system_score_gemma":0.00012118192,"threshold_uncertainty_score":0.42843845},"labels":[],"label_agreement":null},{"id":"W4410899052","doi":"10.1002/ejhf.3710","title":"Insights into the European Heart Failure Epidemiology","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Epidemiology; Intensive care medicine; MEDLINE; Cardiology; Internal medicine","score_opus":0.02388348851931116,"score_gpt":0.29256761078234833,"score_spread":0.2686841222630372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410899052","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10733237,0.0044226763,0.002125574,0.8651591,0.0009417777,0.0007510543,0.0000012490196,0.00013209392,0.019134097],"genre_scores_gemma":[0.9327865,0.00011166918,0.047461603,0.014538405,0.0011763605,0.0000032654016,0.000009537841,0.000073197625,0.0038394514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398583,0.003680771,0.0011673112,0.00035806274,0.0003405411,0.000467455],"domain_scores_gemma":[0.99796146,0.00040861955,0.00029913126,0.0007170732,0.00029717514,0.00031651312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036688547,0.0003572024,0.00081138813,0.00041540214,0.00034590298,0.00005414667,0.0003894674,0.000056625686,0.0001564317],"category_scores_gemma":[0.00066809996,0.00020994504,0.0005318823,0.0004964082,0.0002367774,0.0001771149,0.00023316599,0.0009342746,0.000783026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011019606,0.00016749756,0.011043827,0.00006643621,0.00038814536,0.0005127975,0.0007119301,0.000026106643,0.002764584,0.0013730518,0.9785121,0.004323333],"study_design_scores_gemma":[0.0018884534,0.00065200566,0.049876567,0.00042207338,0.00027309926,0.0003359696,0.0006466112,0.000010581803,0.00028457056,0.00027597646,0.9451791,0.0001549694],"about_ca_topic_score_codex":0.000012574327,"about_ca_topic_score_gemma":0.000033035343,"teacher_disagreement_score":0.8506207,"about_ca_system_score_codex":0.00009969963,"about_ca_system_score_gemma":0.0001552311,"threshold_uncertainty_score":0.999995},"labels":[],"label_agreement":null},{"id":"W4411078015","doi":"10.1002/ejhf.3719","title":"Cardiac Resynchronization Therapy for Enabling Guideline-Directed Medical Therapy Optimization in Heart Failure","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Medtronic","keywords":"Medicine; Heart failure; Ejection fraction; Cardiac resynchronization therapy; Internal medicine; Cardiology; Odds ratio; Angiotensin receptor; Loop diuretic; Confidence interval; Diuretic; Spironolactone; Angiotensin II; Blood pressure","score_opus":0.01679047048217999,"score_gpt":0.30384949252739196,"score_spread":0.287059022045212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411078015","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2951188,0.06965963,0.24146959,0.37619063,0.004625713,0.00391445,0.000053000214,0.0006930604,0.008275111],"genre_scores_gemma":[0.83434165,0.004169834,0.15231211,0.005477599,0.0028640488,0.00001115117,0.000088102635,0.00012873644,0.00060674537],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975843,0.0005163175,0.0009375749,0.00022368185,0.000498489,0.00023963772],"domain_scores_gemma":[0.99827933,0.00023055123,0.00020332758,0.00021381483,0.0009419365,0.00013105731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002267616,0.0001908423,0.00069847313,0.00046813156,0.00014109064,0.00005151058,0.00004869354,0.000084226944,0.00004248565],"category_scores_gemma":[0.0010383837,0.00015157559,0.0003473607,0.0006383702,0.00006556789,0.00012585301,0.000027458389,0.00031866936,0.0000058806904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091577007,0.000097017146,0.02503555,0.00004744602,0.00035631683,0.000024607181,0.00044979682,0.012105877,0.004169178,0.000046726585,0.9512022,0.005549476],"study_design_scores_gemma":[0.0048217876,0.00035661896,0.0058147707,0.0005388412,0.00003895378,0.00016161513,0.0003468758,0.0009504919,0.0009081149,0.000010847504,0.98591495,0.0001361151],"about_ca_topic_score_codex":0.000004775741,"about_ca_topic_score_gemma":0.0000026470063,"teacher_disagreement_score":0.53922284,"about_ca_system_score_codex":0.00008190026,"about_ca_system_score_gemma":0.00036151928,"threshold_uncertainty_score":0.6181073},"labels":[],"label_agreement":null},{"id":"W4411152771","doi":"10.1002/ejhf.3705","title":"Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function after Mitral Valve Transcatheter Edge-to-Edge Repair","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Research, Development and Innovation Office; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.; Ruhr-Universität Bochum; Magyar Tudományos Akadémia; Deutsche Herzstiftung; Technische Universität München; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; European Commission; Deutsches Zentrum für Herz-Kreislaufforschung","keywords":"Medicine; Interquartile range; Cardiology; Internal medicine; Ejection fraction; Pulmonary artery; Mitral regurgitation; Heart failure; Ventricle","score_opus":0.02760477290809585,"score_gpt":0.28301870691955217,"score_spread":0.2554139340114563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411152771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90128106,0.0012214051,0.092808224,0.0022000126,0.001397431,0.00095721334,0.000011205508,0.000020021153,0.00010345272],"genre_scores_gemma":[0.9968192,0.000014770752,0.002430033,0.00026171797,0.0003688501,0.0000068401487,0.000008204639,0.000020519896,0.00006989513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783456,0.0006315758,0.0007406504,0.00017654612,0.00047271358,0.00014394587],"domain_scores_gemma":[0.99863076,0.000082754574,0.00020715315,0.00032081097,0.0006643002,0.00009423586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032006598,0.00012988424,0.0003631903,0.0002840334,0.000070275724,0.000016501246,0.00008446302,0.000040541538,0.00008774988],"category_scores_gemma":[0.00021513095,0.000083110615,0.002364379,0.000297446,0.000048742695,0.000104649254,0.000013300934,0.00021123831,0.000005550118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06640196,0.0053886827,0.08302609,0.0022643264,0.033284876,0.00035966703,0.010509614,0.037463494,0.12595843,0.0006871549,0.20712483,0.42753088],"study_design_scores_gemma":[0.0057121045,0.012924243,0.35343742,0.0032294265,0.015130819,0.00060527184,0.0031978288,0.0017622197,0.09143749,0.0006599477,0.51128596,0.0006172739],"about_ca_topic_score_codex":0.0000034975312,"about_ca_topic_score_gemma":0.0000067300916,"teacher_disagreement_score":0.42691362,"about_ca_system_score_codex":0.000084797124,"about_ca_system_score_gemma":0.00013566199,"threshold_uncertainty_score":0.33891526},"labels":[],"label_agreement":null},{"id":"W4411351522","doi":"10.1002/ejhf.3703","title":"The Crosstalk Between Immune Activation and Metabolism in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of Alberta","funders":"","keywords":"Crosstalk; Heart failure; Immune system; Medicine; Inflammation; Therapeutic approach; Disease; Heart disease; Bioinformatics; Homeostasis; Maladaptation; Immunology; Internal medicine; Biology","score_opus":0.009324808935488588,"score_gpt":0.2534233928730516,"score_spread":0.244098583937563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411351522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8912351,0.00097327266,0.000060344122,0.10680635,0.0004435183,0.00041168465,0.000015317708,0.000005445058,0.000048957114],"genre_scores_gemma":[0.9977891,0.000025258536,0.0013609468,0.00016839588,0.00016743777,0.000001238095,0.0000026761688,0.0000211976,0.00046378985],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967355,0.0009156171,0.0011033069,0.00019273916,0.0007847579,0.0002680765],"domain_scores_gemma":[0.9980236,0.00023576654,0.00069074554,0.0004445863,0.00054208766,0.00006318627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048522237,0.00016889871,0.0005583793,0.0001772938,0.00042450769,0.00014469365,0.00022474148,0.00006198627,0.00000879262],"category_scores_gemma":[0.00047862864,0.00008582363,0.0004427822,0.0006885169,0.00021689586,0.00018661363,0.00019194082,0.0006804681,0.0000017730408],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015654355,0.000117962445,0.22279088,0.0001593999,0.00035275862,9.4186123e-7,0.0013736436,0.00046704005,0.66295207,0.00012701047,0.11078539,0.00071636465],"study_design_scores_gemma":[0.0013185273,0.000060637354,0.6213128,0.00086474925,0.00014365888,0.000014446636,0.0008467049,0.000029543751,0.03137161,0.000048337522,0.34392262,0.00006638167],"about_ca_topic_score_codex":0.000025948595,"about_ca_topic_score_gemma":0.000036123358,"teacher_disagreement_score":0.6315805,"about_ca_system_score_codex":0.000121291356,"about_ca_system_score_gemma":0.000290841,"threshold_uncertainty_score":0.3499786},"labels":[],"label_agreement":null},{"id":"W4411372608","doi":"10.1002/ejhf.3691","title":"The European Heart Failure Management Resources, Treatment Reimbursement and Activities of Professional and Patient Organizations","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Reimbursement; Medicine; Heart failure; Intensive care medicine; Medical emergency; Nursing; Internal medicine; Health care","score_opus":0.007152930968792898,"score_gpt":0.24207582603576944,"score_spread":0.23492289506697653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411372608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.767571,0.0036098247,0.0001883177,0.22024077,0.0004362734,0.001492244,0.0000121156345,0.00005924467,0.0063902265],"genre_scores_gemma":[0.9786373,0.00042863263,0.015646536,0.00060566346,0.00013290362,0.0000064839332,0.000007199786,0.000045309753,0.0044899685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977821,0.00070956175,0.0006443623,0.00023466889,0.0003714729,0.00025779827],"domain_scores_gemma":[0.99902076,0.000108401095,0.0002326564,0.00032267955,0.00014531468,0.00017021144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007616506,0.00024814086,0.00038828,0.0002513265,0.00038876128,0.0000753328,0.00009909841,0.000024067114,0.000030121824],"category_scores_gemma":[0.000043390897,0.00015045078,0.000110713314,0.0002861628,0.00018069053,0.00010283521,0.00019924334,0.00020669127,0.000008679173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060091,0.0013737694,0.031475198,0.00037577568,0.002179808,0.00067437586,0.0049041845,0.000023618722,0.003698533,0.0017975288,0.8732462,0.07965012],"study_design_scores_gemma":[0.002341584,0.0012379723,0.058498595,0.000634643,0.00036895662,0.00019822632,0.0056850803,0.0000041799385,0.00083665823,0.000023267234,0.93006,0.00011083345],"about_ca_topic_score_codex":0.0000043384507,"about_ca_topic_score_gemma":0.000013067853,"teacher_disagreement_score":0.21963511,"about_ca_system_score_codex":0.00008155357,"about_ca_system_score_gemma":0.00006827054,"threshold_uncertainty_score":0.61352044},"labels":[],"label_agreement":null},{"id":"W4411402867","doi":"10.1002/ejhf.3732","title":"Heart Failure Improvement, Remission, and Recovery: A <i>European Journal of Heart Failure</i> Expert Consensus Document","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Guideline; Intensive care medicine; Psychological intervention; Risk stratification; Therapeutic approach; Internal medicine; Cardiology; Disease; Pathology","score_opus":0.009711302962348211,"score_gpt":0.256395772103974,"score_spread":0.2466844691416258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411402867","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2905961,0.0049225832,0.0010174309,0.69769585,0.0016889505,0.0015300167,0.000019491072,0.00012964016,0.0023999482],"genre_scores_gemma":[0.78141433,0.0005513924,0.1966551,0.014152757,0.0019951488,0.0000062121517,0.00001732328,0.00023442906,0.004973336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936127,0.0015834513,0.002369893,0.00056960125,0.0010678796,0.00079644704],"domain_scores_gemma":[0.99627554,0.0002245323,0.00093709223,0.00075348647,0.00089909474,0.00091025303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044620787,0.00069259596,0.0014774695,0.0008554174,0.0003432158,0.0002748228,0.00037962035,0.00010143625,0.00038317504],"category_scores_gemma":[0.00046771724,0.0005265244,0.0007787824,0.0005640512,0.00024660505,0.00039445783,0.0003274775,0.0012318967,0.00010704873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082771096,0.00037230772,0.0029333525,0.00018484937,0.0006416184,0.0011932915,0.0003660862,0.00001415866,0.061674878,0.000049839946,0.92798895,0.0037529364],"study_design_scores_gemma":[0.008236493,0.0043743164,0.0029600752,0.0021633273,0.0004990809,0.0035046192,0.0016353361,0.0000053530985,0.006480524,0.000060047587,0.96968824,0.0003926195],"about_ca_topic_score_codex":0.000016192982,"about_ca_topic_score_gemma":0.000015600686,"teacher_disagreement_score":0.6835431,"about_ca_system_score_codex":0.00025337117,"about_ca_system_score_gemma":0.0004859419,"threshold_uncertainty_score":0.9997186},"labels":[],"label_agreement":null},{"id":"W4411427080","doi":"10.1002/ejhf.3709","title":"How to Facilitate Seamless Translation from Basic Concepts to New Heart Failure Drugs. A Scientific Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"H2020 European Research Council; Agencia Estatal de Investigación; European Regional Development Fund; Novo Nordisk; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Ministero della Salute; Hartstichting; Alnylam Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; Cytokinetics; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Instituto de Salud Carlos III; Amgen","keywords":"Heart failure; Medicine; Statement (logic); Drug development; Relevance (law); Pharmaceutical industry; Engineering ethics; Human heart; Drug; Cardiology; Pharmacology; Engineering; Political science","score_opus":0.023795161439699734,"score_gpt":0.265945036800215,"score_spread":0.24214987536051524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411427080","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4304264,0.00021340922,0.0011916757,0.56570613,0.0007348386,0.001498415,0.00008828504,0.000024845338,0.00011602223],"genre_scores_gemma":[0.9574731,0.000004447413,0.028961929,0.0021561135,0.00024282628,0.00000785345,0.00001797386,0.00004389129,0.011091864],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954586,0.0010969032,0.0011178309,0.0004417516,0.0014114326,0.00047348012],"domain_scores_gemma":[0.9974976,0.00019200263,0.0004972343,0.0007941671,0.0006745105,0.0003444442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022237445,0.00035234602,0.0007916999,0.00035595402,0.00027544887,0.00018707463,0.0004445395,0.00007914865,0.00014161586],"category_scores_gemma":[0.00032062997,0.00022277562,0.00062242855,0.0012320471,0.00011562375,0.00028633626,0.00018487955,0.000513344,0.000057438778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020023849,0.00018423685,0.01838667,0.00011454261,0.00037443836,0.000005591901,0.005502686,0.00027205594,0.05622485,0.000047725534,0.9167573,0.0019296986],"study_design_scores_gemma":[0.0028155725,0.000441888,0.026282674,0.0011516354,0.0003634434,0.0000072932035,0.0027597547,0.000011619526,0.01827559,0.00004624872,0.9476751,0.00016916252],"about_ca_topic_score_codex":0.00008921354,"about_ca_topic_score_gemma":0.00043156408,"teacher_disagreement_score":0.56355,"about_ca_system_score_codex":0.0003148718,"about_ca_system_score_gemma":0.0005423158,"threshold_uncertainty_score":0.90845263},"labels":[],"label_agreement":null},{"id":"W4411464624","doi":"10.1002/ejhf.3725","title":"Prognostic Value of NT-ProBNP in Patients with Primary Mitral Regurgitation Undergoing Transcatheter Edge-To-Edge Repair","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université Laval","funders":"","keywords":"Medicine; Clinical endpoint; Hazard ratio; Heart failure; Internal medicine; Cardiology; Confidence interval; MitraClip; Atrial fibrillation; Creatinine; Mitral regurgitation; Natriuretic peptide; Randomized controlled trial","score_opus":0.005672602174340282,"score_gpt":0.24974275427023296,"score_spread":0.24407015209589267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411464624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965333,0.00039608366,0.00012282091,0.0014798378,0.00011581564,0.0004593594,0.000008624443,0.000015027785,0.000869178],"genre_scores_gemma":[0.9934694,0.000005631304,0.005987895,0.00034167475,0.000052526255,0.000002034146,0.000017003196,0.000027132486,0.0000966958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869204,0.00021233538,0.00046512255,0.00016187353,0.00029396478,0.00017464059],"domain_scores_gemma":[0.99922353,0.00007222154,0.00013724511,0.00018169801,0.00024780387,0.00013749598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027328017,0.00014110193,0.00036325288,0.00027101493,0.000032347278,0.000012913121,0.000058539346,0.000020708218,0.000009437653],"category_scores_gemma":[0.00009943282,0.00010459855,0.0008324044,0.00027685668,0.000032832926,0.00010748547,0.000017219216,0.00017210167,0.000008863546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001504221,0.00064460776,0.9915695,0.00028339316,0.000705405,0.00006645206,0.0003103369,0.000100664525,0.0001033357,0.00003174754,0.003681129,0.0009991823],"study_design_scores_gemma":[0.0059264214,0.0017422296,0.9881322,0.0019550237,0.0006905944,0.000016096017,0.00011705467,0.0000031502257,0.000046607976,0.000016341512,0.0012724769,0.00008181236],"about_ca_topic_score_codex":0.0000015037882,"about_ca_topic_score_gemma":0.0000013170923,"teacher_disagreement_score":0.005865074,"about_ca_system_score_codex":0.000087610446,"about_ca_system_score_gemma":0.00020583099,"threshold_uncertainty_score":0.4265405},"labels":[],"label_agreement":null},{"id":"W4411491183","doi":"10.1002/ejhf.3731","title":"Implantable Cardioverter-Defibrillators in Ischaemic Versus Non-Ischaemic Heart Failure: Insights from the VICTORIA Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Calgary; University of Alberta Hospital; University of Alberta","funders":"MSD Sharp and Dohme; Bayer","keywords":"Medicine; Internal medicine; Heart failure; Hazard ratio; Cardiology; Ejection fraction; Sudden cardiac death; Implantable cardioverter-defibrillator; Confidence interval; Ischaemic heart disease; Etiology; Decompensation; Cause of death; Disease","score_opus":0.01308264673958131,"score_gpt":0.26630634853772794,"score_spread":0.2532237017981466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411491183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628595,0.0038276205,0.000072858275,0.0063504125,0.004326734,0.00042745206,0.00002341859,0.000041674884,0.02207032],"genre_scores_gemma":[0.9952578,0.0001015629,0.0007928393,0.0005535765,0.0030980206,0.0000017971919,0.00000861282,0.0000407533,0.00014506513],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973228,0.0005632319,0.00090305373,0.00031191262,0.0005502222,0.0003488012],"domain_scores_gemma":[0.9983228,0.000559783,0.00024076941,0.00049005717,0.00022642317,0.0001601676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007566981,0.00030429428,0.0012413803,0.00030121175,0.0002164004,0.000087284716,0.00009549905,0.000084514315,0.000009905654],"category_scores_gemma":[0.00026212423,0.00020748384,0.00057894376,0.0005806089,0.00009805708,0.00018822901,0.00013705343,0.0006971576,0.00011980414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012935259,0.000030412233,0.012451454,0.000019304296,0.00071572245,0.000051378902,0.0010139128,0.000094692994,0.0062017073,0.00003639689,0.9662478,0.00020195577],"study_design_scores_gemma":[0.032972053,0.00050888147,0.019473067,0.00057050405,0.0002769315,0.0005871768,0.0011804606,0.0000040046302,0.0007218442,0.000022463822,0.94349086,0.00019172355],"about_ca_topic_score_codex":0.00008178724,"about_ca_topic_score_gemma":0.00004482062,"teacher_disagreement_score":0.032398265,"about_ca_system_score_codex":0.00014094377,"about_ca_system_score_gemma":0.00027687498,"threshold_uncertainty_score":0.84609455},"labels":[],"label_agreement":null},{"id":"W4411928018","doi":"10.1002/ejhf.3752","title":"Acute Dyspnoea in Cancer Patients: Prevalence of Acute Heart Failure, Resource Use and Diagnostic Accuracy of Natriuretic Peptides","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Alere; European Society of Cardiology; Singulex; Schweizerische Herzstiftung; Universität Basel; National Science Foundation","keywords":"Medicine; Heart failure; Intensive care medicine; Internal medicine; Cancer; Cardiology; Natriuretic peptide","score_opus":0.010424990922868551,"score_gpt":0.26766886078365454,"score_spread":0.257243869860786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411928018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915518,0.0009702531,0.000038966435,0.006870495,0.00009487273,0.00034740087,0.000048266204,0.000008806528,0.000069146816],"genre_scores_gemma":[0.99593145,0.00076812564,0.002525236,0.00052937184,0.00008885014,0.0000022297445,0.0000050221947,0.000026519683,0.00012321357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980721,0.00036824055,0.00078355294,0.00020122567,0.00037248273,0.00020239217],"domain_scores_gemma":[0.99817425,0.0006466874,0.00039877955,0.00024393364,0.00043099825,0.000105334155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058589206,0.00018196755,0.0005663186,0.0003344828,0.000041862633,0.000025168014,0.000134848,0.00006240653,0.000029099032],"category_scores_gemma":[0.0011949502,0.00015624685,0.00018803906,0.0003835137,0.00015402753,0.00030864924,0.000060673116,0.00048396693,0.0000017024221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009270406,0.0004398219,0.4844037,0.0012660188,0.00081449596,0.0001475462,0.0014196166,0.00006573921,0.44943497,0.000060619237,0.05945928,0.001561148],"study_design_scores_gemma":[0.006323215,0.0014271851,0.75493926,0.006784375,0.0009425345,0.00026803068,0.00025046463,0.000012244525,0.1966237,0.000054503817,0.032154493,0.00021998463],"about_ca_topic_score_codex":0.000015447611,"about_ca_topic_score_gemma":0.0000075808443,"teacher_disagreement_score":0.2705356,"about_ca_system_score_codex":0.00006731742,"about_ca_system_score_gemma":0.00016073466,"threshold_uncertainty_score":0.6371562},"labels":[],"label_agreement":null},{"id":"W4412005438","doi":"10.1002/ejhf.3754","title":"Changes in Natriuretic Peptide Levels Following Patiromer-Enabled Optimization of Medical Therapy In Heart Failure: A Post Hoc Analysis of the DIAMOND Study","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of Alberta","funders":"Vifor Pharma","keywords":"Medicine; Heart failure; Natriuretic peptide; Ejection fraction; Clinical endpoint; Internal medicine; Placebo; Post-hoc analysis; Cardiology; Confidence interval; Randomization; Urology; Randomized controlled trial; Pathology","score_opus":0.010933069929906381,"score_gpt":0.2663855455707753,"score_spread":0.2554524756408689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412005438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95414853,0.0012920739,0.000077034005,0.04383463,0.00017297413,0.00038691735,0.000004260113,0.000005856685,0.00007770068],"genre_scores_gemma":[0.9983723,0.00014081437,0.0008467343,0.0005079626,0.000030609794,0.0000017879299,0.0000034851898,0.000021404909,0.00007489223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966594,0.0011121643,0.0009620572,0.00018691561,0.0008521018,0.00022738393],"domain_scores_gemma":[0.99891317,0.00016134138,0.0003314061,0.00028911477,0.00020151577,0.00010343188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024084751,0.00017759009,0.00083909754,0.0012457969,0.000049116486,0.000015584832,0.00027776236,0.00009454407,0.00014477228],"category_scores_gemma":[0.00052855624,0.000112478316,0.00040913603,0.0026219639,0.00008794874,0.00008063799,0.0000736241,0.0007009492,0.0000010500356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009090293,0.0022261562,0.94920784,0.00011874944,0.0031871817,0.0005266733,0.0086363815,0.01706102,0.010731889,0.00001297041,0.006315329,0.0010667833],"study_design_scores_gemma":[0.013480479,0.0024376935,0.9661928,0.0017274147,0.0013356089,0.000052874257,0.008959343,0.0017033323,0.00056114845,0.000008568267,0.0033399716,0.0002007762],"about_ca_topic_score_codex":0.00005546477,"about_ca_topic_score_gemma":0.00064935145,"teacher_disagreement_score":0.044223756,"about_ca_system_score_codex":0.00004921901,"about_ca_system_score_gemma":0.00028459335,"threshold_uncertainty_score":0.45867327},"labels":[],"label_agreement":null},{"id":"W4412414070","doi":"10.1002/ejhf.3737","title":"What's New in Heart Failure? June 2025","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.014210600026225957,"score_gpt":0.2731247278066747,"score_spread":0.2589141277804487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412414070","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040047243,0.0034459594,0.0004973098,0.95128965,0.0017551138,0.0006260037,0.0000010883124,0.00006776111,0.0022698499],"genre_scores_gemma":[0.6122335,0.0009888753,0.23297417,0.02644084,0.003046379,0.0000086517175,0.000027871363,0.0002010164,0.124078676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974846,0.00039008784,0.0009124336,0.0003023531,0.00044738673,0.0004631034],"domain_scores_gemma":[0.99876314,0.00010635921,0.00015604805,0.0004397936,0.0001677564,0.00036687453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012072633,0.00030089187,0.00071878725,0.00076230615,0.00008046283,0.00017510082,0.00020478005,0.00006326934,0.00056947424],"category_scores_gemma":[0.00018222658,0.00024353978,0.00034849407,0.00070379715,0.000060412305,0.0005940875,0.00011593822,0.0006831274,0.0005226228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001921407,0.0002305659,0.0078671,0.00006979688,0.00015916079,0.00074890605,0.00022287162,0.00002108021,0.0018731474,0.00020644524,0.98464483,0.0037639735],"study_design_scores_gemma":[0.004503695,0.00048025697,0.01454459,0.0015315299,0.00015978649,0.0002810663,0.00085304497,0.000006939784,0.0007621958,0.0000801064,0.9766332,0.00016358728],"about_ca_topic_score_codex":0.000016947808,"about_ca_topic_score_gemma":0.000110494875,"teacher_disagreement_score":0.92484885,"about_ca_system_score_codex":0.00013644744,"about_ca_system_score_gemma":0.0003804628,"threshold_uncertainty_score":0.9931264},"labels":[],"label_agreement":null},{"id":"W4412491078","doi":"10.1002/ejhf.3757","title":"Heart Failure Hospitalizations and Clinical Outcomes in Patients Undergoing Tricuspid Transcatheter Edge-To-Edge Repair: Insights from EuroTR","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Surgical Specialties (Canada)","funders":"Edwards Lifesciences; AstraZeneca","keywords":"Medicine; Hazard ratio; Confidence interval; Internal medicine; Cardiology; Heart failure; Cohort; Incidence (geometry); Regurgitation (circulation); Proportional hazards model","score_opus":0.011129998988392913,"score_gpt":0.3045863831716835,"score_spread":0.2934563841832906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412491078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900967,0.0007183852,0.00010106813,0.007901224,0.00044190753,0.0004467753,0.00002966634,0.000036985075,0.00022727001],"genre_scores_gemma":[0.9942939,0.000041495347,0.0035457087,0.0017524626,0.00016675706,0.0000021495778,0.00002355939,0.000041419116,0.00013251782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771094,0.00051131065,0.0009208042,0.00033175992,0.00030002784,0.00022516173],"domain_scores_gemma":[0.9987375,0.00022419749,0.00013939377,0.00031740795,0.00021571014,0.0003657898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002677482,0.00024082046,0.00071066624,0.0003589696,0.00009868114,0.000053830838,0.0000944249,0.00005744394,0.000030426345],"category_scores_gemma":[0.00036983704,0.00018369227,0.0015961835,0.00034359295,0.000052586245,0.00015862272,0.00006359432,0.00035616217,0.000046565237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019792802,0.0007322679,0.96477705,0.000025762165,0.0008119802,0.00006333331,0.0001622008,0.000007937063,0.000010985081,0.000017504355,0.03288084,0.00031219004],"study_design_scores_gemma":[0.0067211133,0.0011141977,0.94898826,0.0005022274,0.00070887053,0.000008135554,0.0001346236,0.0000041164767,0.000006798618,0.000030231862,0.041641753,0.00013967972],"about_ca_topic_score_codex":0.000007556165,"about_ca_topic_score_gemma":0.000019010748,"teacher_disagreement_score":0.015788822,"about_ca_system_score_codex":0.000065550084,"about_ca_system_score_gemma":0.00013418362,"threshold_uncertainty_score":0.74907535},"labels":[],"label_agreement":null},{"id":"W4412493786","doi":"10.1002/ejhf.3753","title":"Prevention of Cancer Therapy-Related Cardiac Dysfunction and Heart Failure in Cancer Patients and Survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Ministero della Salute; Fondation Leducq","keywords":"Medicine; Intensive care medicine; Heart failure; Cancer; Cardiotoxicity; Etiology; Radiation therapy; Internal medicine; Epidemiology; Chemotherapy","score_opus":0.016679549796441463,"score_gpt":0.2887739405749809,"score_spread":0.2720943907785394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412493786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978973,0.0026314915,0.000008565354,0.016593056,0.0004553082,0.0010828968,0.000080240396,0.00000354421,0.00017192941],"genre_scores_gemma":[0.9982102,0.0012482172,0.00008180588,0.00018125837,0.00010595359,0.000007159664,0.0000036503784,0.000020498783,0.00014127912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98933804,0.008039224,0.0015285528,0.00021526466,0.00069600804,0.00018288175],"domain_scores_gemma":[0.99522406,0.00081198633,0.0020672667,0.000270838,0.0015804168,0.000045412846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0106287,0.00018771223,0.0011097435,0.00008527792,0.00010642124,0.000009856446,0.00013254328,0.00015048745,0.000006914986],"category_scores_gemma":[0.0009558128,0.00010367062,0.00048154854,0.00037803856,0.00047256815,0.00006699862,0.00009715394,0.00065250206,1.378881e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007396528,0.00016341229,0.9358607,0.00015665345,0.0020776559,6.41792e-7,0.0033189366,0.00018299057,0.043621648,0.000033952554,0.01164187,0.0022018978],"study_design_scores_gemma":[0.008253424,0.00063978846,0.94757223,0.0007877154,0.00073049864,0.0000110332185,0.0017394791,0.000012275343,0.011950934,0.000096208474,0.028119115,0.00008727836],"about_ca_topic_score_codex":0.0003686305,"about_ca_topic_score_gemma":0.0006957036,"teacher_disagreement_score":0.031670716,"about_ca_system_score_codex":0.00040607058,"about_ca_system_score_gemma":0.00076996506,"threshold_uncertainty_score":0.42275652},"labels":[],"label_agreement":null},{"id":"W4412989235","doi":"10.1002/ejhf.3782","title":"Atrial Cardiomyopathy: From Healthy Atria to Atrial Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Surgical Specialties (Canada)","funders":"British Heart Foundation; National Institute for Health and Care Research; University Hospitals Birmingham NHS Foundation Trust","keywords":"Medicine; Atrial fibrillation; Heart failure; Cardiomyopathy; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.03746755033849203,"score_gpt":0.3424620099072669,"score_spread":0.30499445956877486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412989235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6662889,0.0003409761,0.0001461251,0.32827705,0.0035860206,0.0011511276,0.000060232436,0.000018078023,0.00013145951],"genre_scores_gemma":[0.9858731,0.000028213773,0.0068779,0.0014195141,0.0050565605,3.324275e-7,0.0000064537235,0.00003616194,0.0007017611],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99256665,0.0030415684,0.0026313516,0.0002906352,0.0011425071,0.0003272829],"domain_scores_gemma":[0.99570805,0.0010432415,0.0017231846,0.0006362182,0.0006963837,0.00019293686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059659835,0.00025912846,0.0011791311,0.00022018583,0.00018617675,0.000046204146,0.00039296853,0.00011904113,0.00009778625],"category_scores_gemma":[0.0034100537,0.00015888484,0.002306137,0.00073744945,0.00010741248,0.0000770702,0.00030963417,0.00069085445,0.000031319843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024912823,0.000021917593,0.55838275,0.00005807493,0.0009120647,0.000008940252,0.00021338115,0.00049044914,0.001440388,0.000118609976,0.43539593,0.00046619243],"study_design_scores_gemma":[0.0083371345,0.0006440614,0.25695336,0.0003552718,0.00094691233,0.000010787411,0.0004759853,0.00001471168,0.0003552107,0.00005457373,0.7317327,0.00011929913],"about_ca_topic_score_codex":0.000042692493,"about_ca_topic_score_gemma":0.00007219947,"teacher_disagreement_score":0.32685754,"about_ca_system_score_codex":0.00020645365,"about_ca_system_score_gemma":0.00066721224,"threshold_uncertainty_score":0.6479136},"labels":[],"label_agreement":null},{"id":"W4413282657","doi":"10.1002/ejhf.70010","title":"Transcatheter Tricuspid Valve Replacement Using the LuX-Valve Plus system: 1-Year Compassionate Use Outcomes","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Tricuspid valve; Heart failure; Internal medicine; Valve replacement; Heart valve; Cardiology; Heart valve replacement; Right heart failure; Compassionate Use; Clinical trial; Stenosis","score_opus":0.023760343638836164,"score_gpt":0.31741434217817344,"score_spread":0.29365399853933727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413282657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779064,0.0018514316,0.0009769165,0.0069539,0.0009779109,0.00060582906,0.00003643217,0.000042313386,0.00076459517],"genre_scores_gemma":[0.9965307,0.000025543522,0.0019896827,0.00078653224,0.00018129412,0.0000019738684,0.0000060547527,0.00003725584,0.00044095435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978892,0.0005343965,0.00064391573,0.00020032767,0.00047718425,0.0002549548],"domain_scores_gemma":[0.99876463,0.00012198466,0.00023910207,0.00042163447,0.00025235358,0.00020030502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006743417,0.0002315233,0.0005850215,0.00018922468,0.00020086624,0.00009297051,0.00013945243,0.000028855005,0.00005103495],"category_scores_gemma":[0.000066962195,0.00012821227,0.0036598952,0.00021177587,0.000053345717,0.00012504673,0.000051726296,0.0003202873,0.000042465545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022135805,0.0006967981,0.8515596,0.00041121265,0.013218256,0.00040533076,0.0006954556,0.0006965901,0.00079050526,0.00034561567,0.12828137,0.00068569736],"study_design_scores_gemma":[0.010072194,0.00054481474,0.85815936,0.0016151952,0.006009498,0.0005105752,0.0017866966,0.00012994683,0.00011803736,0.0000062593044,0.120824866,0.00022257023],"about_ca_topic_score_codex":0.000011186705,"about_ca_topic_score_gemma":5.288784e-7,"teacher_disagreement_score":0.008740038,"about_ca_system_score_codex":0.00023469592,"about_ca_system_score_gemma":0.00017139752,"threshold_uncertainty_score":0.5228344},"labels":[],"label_agreement":null},{"id":"W4413299543","doi":"10.1002/ejhf.70003","title":"Identifying and Overcoming Barriers to Referral in Advanced Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Referral; Heart failure; Context (archaeology); Quality of life (healthcare); Intervention (counseling); Intensive care medicine; Stakeholder; MEDLINE; Medical emergency; Family medicine; Nursing; Internal medicine","score_opus":0.02179172612423195,"score_gpt":0.27918936866764693,"score_spread":0.25739764254341496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413299543","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09512988,0.88697577,0.0002592903,0.0081232935,0.0053197863,0.003680636,0.0002633175,0.00009842281,0.00014959581],"genre_scores_gemma":[0.8773837,0.080536366,0.037631817,0.001147062,0.0010007039,0.000074081094,0.000045957197,0.00087842706,0.0013018538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944829,0.0014726034,0.0021407707,0.00039053292,0.0010387963,0.0004744022],"domain_scores_gemma":[0.99756277,0.0002600806,0.00095542497,0.00069714076,0.00025208463,0.0002724885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042768107,0.00044804547,0.0016362478,0.00049479835,0.0002039213,0.00016988732,0.0007799278,0.00014756697,0.000087610235],"category_scores_gemma":[0.0009115285,0.0003092148,0.0007398713,0.0012311862,0.000071245726,0.00034343728,0.00035125512,0.0013324876,0.000012236421],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012366119,0.00031717558,0.04584532,0.111763835,0.003158148,0.00012305393,0.0067117605,0.013351201,0.027459905,0.0004496641,0.7468634,0.043832865],"study_design_scores_gemma":[0.00039335742,0.000047298763,0.0011263897,0.021213064,0.00025396916,0.00004804928,0.00040704006,0.000019061397,0.00034149882,0.00001676378,0.97586536,0.00026815146],"about_ca_topic_score_codex":0.0000037890218,"about_ca_topic_score_gemma":0.0001105484,"teacher_disagreement_score":0.8064394,"about_ca_system_score_codex":0.00042400078,"about_ca_system_score_gemma":0.00044659438,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W4413299573","doi":"10.1002/ejhf.70001","title":"Heart Failure-Attributed Mortality in Europe, 2012–2021","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Demography; Heart failure; Mortality rate; Obesity; Confidence interval; Population; Alcohol consumption; Diabetes mellitus; Internal medicine; Environmental health; Endocrinology","score_opus":0.017990572438588235,"score_gpt":0.2814390571627195,"score_spread":0.26344848472413124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413299573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5200032,0.0020351599,0.0015127307,0.467047,0.0011805556,0.0013268171,0.000031494226,0.0001271328,0.0067359125],"genre_scores_gemma":[0.9448611,0.000110796136,0.04213736,0.00434752,0.0005979576,0.000005544311,0.000038182974,0.00009060864,0.0078109098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99654347,0.0008804887,0.0011162331,0.00036578227,0.0005396718,0.0005543452],"domain_scores_gemma":[0.998268,0.00008817484,0.00020260952,0.0005749488,0.00053159165,0.00033466486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022509103,0.00034684883,0.0008676111,0.0006798048,0.00010428661,0.00006415488,0.0002336637,0.000066663684,0.0006870888],"category_scores_gemma":[0.00035320615,0.00028106786,0.00030398113,0.0013808431,0.00009531527,0.00033416276,0.00015336611,0.000798725,0.0005206703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015680211,0.00045247932,0.11875384,0.00008712262,0.00029534718,0.0016653286,0.00007076625,0.000033049022,0.0031315328,0.00020959572,0.8744371,0.00070701214],"study_design_scores_gemma":[0.0031138458,0.00041542834,0.21310343,0.00052701565,0.00020361833,0.00024037377,0.00013191573,0.000011574319,0.0005667996,0.000017545157,0.7815091,0.00015933966],"about_ca_topic_score_codex":0.000021849402,"about_ca_topic_score_gemma":0.00011531895,"teacher_disagreement_score":0.4626995,"about_ca_system_score_codex":0.0001238579,"about_ca_system_score_gemma":0.00030492758,"threshold_uncertainty_score":0.9999642},"labels":[],"label_agreement":null},{"id":"W4413338414","doi":"10.1002/ejhf.3787","title":"Sodium Zirconium Cyclosilicate, Hyperkalaemia, and Spironolactone Optimization in Heart Failure with Reduced Ejection Fraction: The REALIZE-K Open-Label Run-in Phase","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Toronto Rehabilitation Institute; University of Toronto; University Health Network; Institute for Work & Health; Mount Sinai Hospital","funders":"Ostravská Univerzita v Ostravě; Uniwersytet Łódzki; Brigham and Women's Hospital; University of Toronto; University of Missouri; Universitat de València; University of Glasgow; National Institute for Health and Care Research; Saint Luke's Health System; University of Missouri-Kansas City; Semmelweis Egyetem; Yale University; Sociedade Beneficente Israelita Brasileira Albert Einstein; AstraZeneca","keywords":"Spironolactone; Medicine; Heart failure; Ejection fraction; Sodium; Internal medicine; Zirconium; Hyperkalemia; Phase (matter); Cardiology; Metallurgy; Materials science","score_opus":0.013315027846557559,"score_gpt":0.2826662767131722,"score_spread":0.2693512488666146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413338414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84490323,0.0013099923,0.0011016289,0.14725438,0.00024368364,0.00085436733,0.0000033042475,0.00003221183,0.0042971727],"genre_scores_gemma":[0.98820907,0.00026769942,0.009494668,0.0012800317,0.00013685378,0.00000601181,0.000012109251,0.000042427462,0.00055110804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981398,0.00045897244,0.00063576264,0.00027593772,0.00022441291,0.0002651416],"domain_scores_gemma":[0.99913543,0.0000633628,0.00024037399,0.00027908958,0.00014721039,0.00013450404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009664061,0.00021289963,0.00045483958,0.00038079693,0.0001617524,0.00010673221,0.00017002174,0.000102003316,0.00005878061],"category_scores_gemma":[0.00009321189,0.00013967806,0.00005244988,0.0005960753,0.00012485066,0.0003930449,0.000063469335,0.0010741004,0.000010218883],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017720817,0.007740143,0.13827597,0.00052425487,0.00085595925,0.0014490456,0.0022084792,0.013824679,0.32627255,0.0002023935,0.4839473,0.0069784187],"study_design_scores_gemma":[0.114521615,0.0061823665,0.10873778,0.0050864927,0.0008299675,0.006190493,0.008966927,0.005041396,0.012985303,0.000083358864,0.73035663,0.0010176444],"about_ca_topic_score_codex":0.000060979168,"about_ca_topic_score_gemma":0.00005975597,"teacher_disagreement_score":0.31328723,"about_ca_system_score_codex":0.000109085384,"about_ca_system_score_gemma":0.00022785628,"threshold_uncertainty_score":0.5695906},"labels":[],"label_agreement":null},{"id":"W4413712647","doi":"10.1002/ejhf.70002","title":"Diuretic Resistance and the Efficacy of Hydrochlorothiazide in Acute Decompensated Heart Failure: A Post-Hoc Analysis of the CLOROTIC Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Post-hoc analysis; Heart failure; Hydrochlorothiazide; Diuretic; Acute decompensated heart failure; Internal medicine; Post hoc; Cardiology; Intensive care medicine; Pharmacology; Blood pressure","score_opus":0.0070779591692743515,"score_gpt":0.2549012540345684,"score_spread":0.24782329486529409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413712647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8648559,0.00087263406,0.000046918456,0.13270663,0.00015268436,0.0010807657,0.000006013441,0.000010677637,0.0002677649],"genre_scores_gemma":[0.99412036,0.000059539056,0.0040746294,0.00085906684,0.000067481196,0.0000037425746,0.0000039100673,0.000022164135,0.0007890889],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965533,0.0011915289,0.0012389519,0.00024034991,0.00050508225,0.00027075663],"domain_scores_gemma":[0.99804425,0.0005179938,0.00046794725,0.00059426425,0.00026929672,0.00010621616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020180796,0.00023998764,0.0011511759,0.00061303214,0.00010030828,0.000033100354,0.00028543462,0.000049331717,0.000059301216],"category_scores_gemma":[0.00049789913,0.0001301232,0.0006783713,0.0016082701,0.00036838467,0.000085194006,0.00013953177,0.00047613934,0.000005654105],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45590976,0.004468244,0.10614663,0.0014355989,0.038110226,0.0011978308,0.010675118,0.0010386754,0.034232207,0.00884326,0.33585614,0.0020863065],"study_design_scores_gemma":[0.22903922,0.0033975826,0.44203085,0.0032382105,0.01843219,0.00017094052,0.0012817632,0.00024740634,0.0027109552,0.00014828682,0.29887414,0.00042846365],"about_ca_topic_score_codex":0.000018757008,"about_ca_topic_score_gemma":0.00029923834,"teacher_disagreement_score":0.3358842,"about_ca_system_score_codex":0.000049749695,"about_ca_system_score_gemma":0.00017780239,"threshold_uncertainty_score":0.530627},"labels":[],"label_agreement":null},{"id":"W4413858548","doi":"10.1002/ejhf.3797","title":"Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Surgical Specialties (Canada); St. Michael's Hospital","funders":"Abbott Vascular; Boston Scientific Corporation; AtriCure; Edwards Lifesciences","keywords":"Medicine; Cardiology; Ejection fraction; Internal medicine; Heart failure; Tricuspid valve; Psychological intervention","score_opus":0.010915587118686416,"score_gpt":0.29671015780302185,"score_spread":0.28579457068433545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413858548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899835,0.0046434854,0.00052564684,0.0035138216,0.00052710396,0.00011340213,0.00002278433,0.0000068317404,0.000663423],"genre_scores_gemma":[0.99887514,0.00013502043,0.0003860976,0.00015831538,0.00024992798,4.6486986e-7,0.000023619528,0.000007770374,0.00016362537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992031,0.00008208028,0.0003617274,0.00009394232,0.00020319312,0.00005595377],"domain_scores_gemma":[0.9993275,0.00007118216,0.00021623426,0.00011994084,0.0002076045,0.000057551784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015273679,0.00007943395,0.00019895904,0.00012535641,0.000063507905,0.000028995066,0.00006345421,0.000019749008,0.00008630591],"category_scores_gemma":[0.000088735644,0.00005163557,0.0009591882,0.00010565633,0.000028027554,0.0000914021,0.00003458805,0.0001744736,0.0000065300997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007091266,0.0008710975,0.93678635,0.00010283484,0.005372132,0.00021618781,0.00014430674,0.000058020374,0.0034567988,0.00029713634,0.04458487,0.0074011385],"study_design_scores_gemma":[0.0022484348,0.00023062436,0.93575174,0.00069077994,0.0011519619,0.0001080108,0.0004051194,0.000011811511,0.0007673452,0.00020495064,0.058385227,0.000043976364],"about_ca_topic_score_codex":0.00001484158,"about_ca_topic_score_gemma":0.0000018904669,"teacher_disagreement_score":0.013800359,"about_ca_system_score_codex":0.000051599985,"about_ca_system_score_gemma":0.00003131815,"threshold_uncertainty_score":0.21056373},"labels":[],"label_agreement":null},{"id":"W4413902885","doi":"10.1002/ejhf.70030","title":"High Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis in Older Adults with Carpal Tunnel Syndrome, Heart Failure or Increased Left Ventricular Mass: The CAPTURE Study","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Università degli Studi di Brescia; Università degli Studi di Padova; Scuola Superiore Sant'Anna; Università degli Studi di Ferrara; Università degli Studi di Siena; Pfizer","keywords":"Transthyretin; Medicine; Cardiac amyloidosis; Heart failure; Amyloidosis; Carpal tunnel syndrome; Cardiomyopathy; Internal medicine; Autopsy; Amyloid (mycology); Left ventricular hypertrophy; Restrictive cardiomyopathy; Cardiology; Pathology; Surgery; Blood pressure","score_opus":0.004131681624413233,"score_gpt":0.21574704084222043,"score_spread":0.2116153592178072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413902885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898292,0.0029703425,0.000039878654,0.005979424,0.0001885418,0.00091069617,0.000056565637,0.000011550974,0.000013828173],"genre_scores_gemma":[0.9971032,0.00017566874,0.0019643842,0.0003774187,0.00009846089,0.000013536541,0.00002002633,0.00005868254,0.00018859122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964112,0.0013916187,0.0008089085,0.00048975175,0.0004898657,0.00040864144],"domain_scores_gemma":[0.9983829,0.0001067122,0.00035441853,0.0006636371,0.00033960922,0.00015271144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000933991,0.00042770331,0.00073453796,0.000209243,0.000121560275,0.00004798474,0.00055459415,0.00011687007,0.00007516121],"category_scores_gemma":[0.00017206382,0.0002640842,0.00033572683,0.0004894433,0.0001557538,0.000024633817,0.00009622641,0.0004966166,0.000007394986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016698705,0.0009903439,0.948227,0.00026887635,0.0010160106,0.00086876244,0.00086907804,0.0004937778,0.0144919,0.0000033503106,0.031007461,0.000093605595],"study_design_scores_gemma":[0.006868481,0.0035577992,0.94957554,0.0012362442,0.000769423,0.0005389837,0.004561722,0.0000024744243,0.015015497,0.0000016665227,0.017434489,0.00043768255],"about_ca_topic_score_codex":0.00010024218,"about_ca_topic_score_gemma":0.00016992817,"teacher_disagreement_score":0.013572973,"about_ca_system_score_codex":0.000054703167,"about_ca_system_score_gemma":0.00026716868,"threshold_uncertainty_score":0.99998116},"labels":[],"label_agreement":null},{"id":"W4414070730","doi":"10.1002/ejhf.70026","title":"Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy with Heart Failure: Baseline Characteristics of the PARACHUTE-HF Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Trypanosoma species research and implications","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"Novartis","keywords":"Enalapril; Heart failure; Baseline (sea); Stroke (engine); Cardiomyopathy; Chagas disease; Clinical trial","score_opus":0.01695381475561057,"score_gpt":0.2831221293215862,"score_spread":0.2661683145659756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414070730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91696924,0.0010226348,0.00047890516,0.07895273,0.0006288804,0.0010481443,0.000069456146,0.000023980725,0.000806001],"genre_scores_gemma":[0.9959626,0.00008387014,0.0021062917,0.00032494983,0.0010235457,0.000006133433,0.000012216407,0.000037630296,0.0004427172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683917,0.00082998583,0.0009764989,0.00024364002,0.0006903331,0.00042039566],"domain_scores_gemma":[0.99795425,0.00025553972,0.00034959515,0.00067185477,0.0005344939,0.00023426936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006936916,0.0002320196,0.0008715927,0.00035067863,0.00013111206,0.000053386837,0.00036849498,0.00005640595,0.00011942418],"category_scores_gemma":[0.0008593303,0.00014850502,0.00035054702,0.0008981145,0.0002376637,0.0001446264,0.000116540905,0.0010042605,0.00003047465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08694572,0.0014061306,0.03998615,0.000640122,0.00093486544,0.0005889061,0.0004922189,0.00012722927,0.3134189,0.00074568426,0.5493618,0.005352262],"study_design_scores_gemma":[0.038820304,0.0030976022,0.25090754,0.0007754335,0.00018528804,0.00033237302,0.00020572828,0.000034072058,0.004157306,0.00000611327,0.7013206,0.00015762333],"about_ca_topic_score_codex":0.000009411236,"about_ca_topic_score_gemma":0.00004110252,"teacher_disagreement_score":0.30926156,"about_ca_system_score_codex":0.00024778055,"about_ca_system_score_gemma":0.0013624779,"threshold_uncertainty_score":0.60558593},"labels":[],"label_agreement":null},{"id":"W4414125396","doi":"10.1002/ejhf.70046","title":"Beta-blockers in Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Chronic Obstructive Pulmonary Disease: Cardiovascular and Respiratory Outcomes","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"HORIZON EUROPE Framework Programme; Hjärt-Lungfonden; Deutsche Forschungsgemeinschaft","keywords":"Heart failure; Concomitant; Ejection fraction; COPD; Stroke volume; Respiratory failure","score_opus":0.00725794783124197,"score_gpt":0.2231659973270634,"score_spread":0.21590804949582143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414125396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779344,0.0016486833,0.00006533637,0.01944948,0.00008758693,0.0006995713,0.000003910614,0.000025333868,0.00008567888],"genre_scores_gemma":[0.9938284,0.000028962553,0.005619198,0.00029227708,0.000091214024,0.00000641237,0.0000073915703,0.00003512089,0.000091004826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823076,0.00036867548,0.00040078952,0.00033018662,0.00042556087,0.00024403835],"domain_scores_gemma":[0.99910873,0.000045092762,0.00013873023,0.000286401,0.00019258104,0.00022844959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049922895,0.00026422404,0.00061588746,0.0003778722,0.00012873247,0.000046056026,0.000047305053,0.00003520959,0.000013135211],"category_scores_gemma":[0.000036910897,0.00017828976,0.0001416017,0.00026883688,0.0001271882,0.00030573126,0.000043407497,0.00042204058,0.000004262519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010826081,0.00016411288,0.98578143,0.0001399799,0.0007496925,0.00037719976,0.000045617453,0.00003546371,0.00018203893,0.000011365846,0.010023944,0.0014065253],"study_design_scores_gemma":[0.0046844073,0.00086790085,0.7525577,0.0004979014,0.0005541858,0.000057985162,0.00031752783,0.00000442355,0.000065371445,0.0000029443493,0.24026018,0.00012948482],"about_ca_topic_score_codex":0.000009301324,"about_ca_topic_score_gemma":0.000015320293,"teacher_disagreement_score":0.23322378,"about_ca_system_score_codex":0.00023691573,"about_ca_system_score_gemma":0.00017006727,"threshold_uncertainty_score":0.7270446},"labels":[],"label_agreement":null},{"id":"W4414161332","doi":"10.1002/ejhf.70005","title":"Heart Failure with Preserved Ejection Fraction in Cancer Patients and Survivors. A Scientific Statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure with preserved ejection fraction; Heart failure; Cardiotoxicity; Cancer; Epidemiology; MEDLINE","score_opus":0.01333359300596216,"score_gpt":0.24746073061224985,"score_spread":0.2341271376062877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716076,0.00031290963,0.000032928998,0.026929364,0.00030557852,0.0006851802,0.000018539544,0.0000040316636,0.00010382283],"genre_scores_gemma":[0.9991319,0.00004092075,0.00029525178,0.00025315542,0.00007058407,0.0000051876427,0.0000023485238,0.000014672929,0.00018597176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674493,0.0013790829,0.0006654271,0.000182555,0.00086730835,0.00016070539],"domain_scores_gemma":[0.99764365,0.00018293981,0.0007341951,0.00025335283,0.0011397995,0.000046033954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040424177,0.00014003317,0.0005311456,0.000114407376,0.0001646371,0.000032972705,0.00011140902,0.000078075136,0.000011577338],"category_scores_gemma":[0.00038183038,0.00007585675,0.00017708939,0.0005162031,0.00029046112,0.00017694515,0.00006227741,0.0005197891,2.9966378e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010736339,0.00024606162,0.7783413,0.00030071576,0.00041926414,0.000001197162,0.0027333128,0.0004209106,0.17966306,0.000020830772,0.03645163,0.0003281045],"study_design_scores_gemma":[0.010400941,0.0007230209,0.7082888,0.0014392617,0.00038615154,0.00003782876,0.0029296337,0.00007835936,0.10060105,0.000047763126,0.17494397,0.00012321648],"about_ca_topic_score_codex":0.00029545175,"about_ca_topic_score_gemma":0.0019309736,"teacher_disagreement_score":0.13849233,"about_ca_system_score_codex":0.00053176197,"about_ca_system_score_gemma":0.00076236925,"threshold_uncertainty_score":0.30933484},"labels":[],"label_agreement":null},{"id":"W4414166794","doi":"10.1002/ejhf.70023","title":"Management of Aortic Stenosis and Chronic Heart Failure: A Clinical Consensus Statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Concomitant; Stenosis; Percutaneous; Management of heart failure; Ejection fraction; Valve replacement; Aortic valve stenosis","score_opus":0.012428464532930662,"score_gpt":0.30338540042444495,"score_spread":0.2909569358915143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414166794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697587,0.0037588475,0.000027780716,0.025057083,0.0002650356,0.0008471,0.000078643534,0.0000064742107,0.00020034716],"genre_scores_gemma":[0.99851507,0.00040688532,0.00060504995,0.00011314552,0.00007678118,0.000002218134,0.0000037071652,0.000025341531,0.00025180832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939639,0.0033045784,0.0014993643,0.00021225889,0.00081256166,0.00020731686],"domain_scores_gemma":[0.99728984,0.00034023318,0.0011841282,0.00052744336,0.000569547,0.00008881767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004646757,0.00019292058,0.00091167534,0.00009813181,0.0001325096,0.000026837271,0.00016674881,0.000048051326,0.000017330503],"category_scores_gemma":[0.00043837432,0.00011079129,0.0027920078,0.0002980037,0.0002434356,0.000045081997,0.00023829404,0.0003756146,0.0000020060008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004954994,0.00079944526,0.9254432,0.0016609554,0.021935813,0.000040535073,0.00054472144,0.00029035826,0.0011857975,0.00015776377,0.044873875,0.0025720808],"study_design_scores_gemma":[0.006332786,0.0005632743,0.96217406,0.0025837312,0.008034101,0.00007877313,0.0013601397,0.000020288706,0.00025586376,0.000031094973,0.018468624,0.00009726502],"about_ca_topic_score_codex":0.000025701247,"about_ca_topic_score_gemma":0.0000121423645,"teacher_disagreement_score":0.036730904,"about_ca_system_score_codex":0.00020756655,"about_ca_system_score_gemma":0.00013613746,"threshold_uncertainty_score":0.45179376},"labels":[],"label_agreement":null},{"id":"W4414394366","doi":"10.1002/ejhf.70048","title":"Effect of Glucagon-Like Peptide-1 Receptor Agonists on Heart Failure Outcomes and Cardiovascular Death Across Varying Cardiovascular-Kidney-Metabolic Comorbidity","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heart failure; Comorbidity; Agonist; Receptor; Cause of death; Clinical trial","score_opus":0.010478489879069386,"score_gpt":0.26355908717622095,"score_spread":0.25308059729715154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414394366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148406,0.009102839,0.00015855538,0.006108512,0.0008872402,0.0008719621,0.000029759021,0.00006261757,0.0012944872],"genre_scores_gemma":[0.9934977,0.0004044331,0.004078286,0.0009262183,0.00029295674,0.0000074332247,0.000021223454,0.000073845375,0.00069789734],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962441,0.0011813313,0.00075037207,0.0004559763,0.0008549718,0.0005132879],"domain_scores_gemma":[0.99808145,0.00018011866,0.00020106496,0.0009192747,0.00022817565,0.00038991103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036085243,0.0004753935,0.001991196,0.00030717868,0.00022199382,0.00009982675,0.00023211118,0.00007704095,0.000038262562],"category_scores_gemma":[0.00035504624,0.0003458705,0.00212943,0.0002771293,0.00013880139,0.00018869567,0.00021269382,0.00056088937,0.000056696503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016218906,0.0009226049,0.49202484,0.0029291057,0.045616508,0.0012703233,0.00080270565,0.00063260755,0.005690877,0.00022749422,0.39807087,0.05019017],"study_design_scores_gemma":[0.008000131,0.0016608924,0.07532043,0.0010957475,0.0028855551,0.00014379538,0.00010612109,0.0000054355382,0.007891106,0.000003410528,0.9026347,0.00025272116],"about_ca_topic_score_codex":0.000022119753,"about_ca_topic_score_gemma":0.0000014799531,"teacher_disagreement_score":0.5045638,"about_ca_system_score_codex":0.00007018083,"about_ca_system_score_gemma":0.00009429917,"threshold_uncertainty_score":0.9998993},"labels":[],"label_agreement":null},{"id":"W4414520012","doi":"10.1002/ejhf.70042","title":"Future Development of Arrhythmogenic Risk Scores in Patients with Heart Failure and Inherited Dilated Cardiomyopathy. A Scientific Statement of the Heart Failure Association of the ESC","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Risk stratification; Heart failure; Sudden cardiac death; Population; Genetic testing; Risk assessment; Weakness; Sudden death","score_opus":0.004533606594713999,"score_gpt":0.20595685358904536,"score_spread":0.20142324699433137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414520012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898151,0.0009791964,0.000021525746,0.008010247,0.00042636547,0.00066378625,0.00005298069,0.000007840586,0.000022933586],"genre_scores_gemma":[0.99600345,0.00002187753,0.0036593012,0.000096124735,0.000088041386,0.0000032617638,0.0000059042045,0.0000252759,0.000096747055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963679,0.00090340944,0.0011875579,0.00026885033,0.0009799864,0.0002923094],"domain_scores_gemma":[0.99738204,0.00008239078,0.0009659466,0.00043435433,0.0010522746,0.00008300274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002414544,0.00025851122,0.0008671578,0.00031090382,0.0002620537,0.000035385965,0.00018525925,0.00007085783,0.000008715139],"category_scores_gemma":[0.00027261363,0.00014810207,0.00032225516,0.0011468461,0.00025585448,0.00012514109,0.00023023532,0.0006137989,0.0000010889789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004050809,0.00017059648,0.959065,0.00023791539,0.00047714918,0.000005354017,0.002153578,0.00008491949,0.007449175,0.000004624847,0.029653447,0.00029313558],"study_design_scores_gemma":[0.003507614,0.00029448696,0.8869435,0.0016851728,0.00030125008,0.000030339388,0.0017060755,0.0000023617042,0.006078001,0.000004825678,0.099330075,0.00011627848],"about_ca_topic_score_codex":0.000010555655,"about_ca_topic_score_gemma":0.0001365808,"teacher_disagreement_score":0.07212151,"about_ca_system_score_codex":0.00016447245,"about_ca_system_score_gemma":0.0004611635,"threshold_uncertainty_score":0.60394275},"labels":[],"label_agreement":null},{"id":"W4414580255","doi":"10.1002/ejhf.70057","title":"Acute Heart Failure Care – a Consensus Series of an International Experts' Group","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Vasoactive; Expert opinion; Cardiogenic shock; MEDLINE; Acute kidney injury; Emergency department; Acute care","score_opus":0.010399772617874286,"score_gpt":0.27137653799627703,"score_spread":0.26097676537840275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414580255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77124053,0.0009084357,0.0002868763,0.22093536,0.0014698822,0.0006632038,0.00004188763,0.00010445879,0.0043493803],"genre_scores_gemma":[0.89299375,0.00003370686,0.10430602,0.0010695824,0.0004211686,0.0000031899635,0.000039104965,0.000042311374,0.0010911704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979354,0.00032088318,0.00074648764,0.00025322518,0.000471912,0.00027207157],"domain_scores_gemma":[0.99858445,0.00005359713,0.00021918798,0.00040453183,0.00050974503,0.00022851676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044690593,0.00025781596,0.0005827278,0.0004271405,0.00009923721,0.00005668736,0.00022754469,0.000054178796,0.0002697801],"category_scores_gemma":[0.000093821116,0.00020397353,0.00032955114,0.00024009815,0.00013796714,0.00027546711,0.000109637665,0.0003046178,0.000031540178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019938378,0.00072081253,0.0215556,0.00027851076,0.0019589574,0.0026646783,0.0027032152,0.00002435171,0.054197807,0.0010812219,0.9077065,0.0051144934],"study_design_scores_gemma":[0.0035842587,0.0017575026,0.008048467,0.00050031394,0.00033842243,0.0012904172,0.004963704,0.000007221608,0.0047232416,0.000014319197,0.9746177,0.00015440627],"about_ca_topic_score_codex":0.0000071059612,"about_ca_topic_score_gemma":0.000030277199,"teacher_disagreement_score":0.21986578,"about_ca_system_score_codex":0.00008879263,"about_ca_system_score_gemma":0.00013283294,"threshold_uncertainty_score":0.8317799},"labels":[],"label_agreement":null},{"id":"W4414593705","doi":"10.1002/ejhf.70033","title":"Blood Pressure, Safety and Clinical Efficacy of Vericiguat in Chronic Heart Failure with Reduced Ejection Fraction: Insights from the VICTOR Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"MSD Sharp and Dohme; Bayer Portugal","keywords":"Heart failure; Clinical efficacy; Placebo; Clinical trial; Ejection fraction; Population","score_opus":0.015304685942837935,"score_gpt":0.285607715470699,"score_spread":0.27030302952786106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414593705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94143385,0.0023576268,0.00018967592,0.053739693,0.00051512255,0.0012228136,0.000004792268,0.000031150215,0.00050528883],"genre_scores_gemma":[0.9931049,0.00019620043,0.0049270517,0.00039262496,0.0010313562,0.0000022076604,0.0000090237045,0.000028742566,0.00030793456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714524,0.0009489758,0.0010288297,0.00029652598,0.00037837733,0.00020203617],"domain_scores_gemma":[0.9985286,0.0004581409,0.00032793247,0.00038654494,0.00016428909,0.00013448107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092275074,0.00022576866,0.00071641745,0.00019249693,0.00011656097,0.000041137533,0.00012309423,0.00007769381,0.00009432064],"category_scores_gemma":[0.00021517766,0.00013537132,0.00021851534,0.00039095577,0.00013884301,0.0001785144,0.00006701823,0.00074860675,0.000014016066],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19298966,0.0065535135,0.14380667,0.0005177984,0.011949428,0.0012724209,0.0016494836,0.00042710954,0.026678171,0.0004127917,0.6045955,0.009147453],"study_design_scores_gemma":[0.05449543,0.0037603073,0.18736112,0.00086465897,0.0014725891,0.00006768397,0.00024851496,0.000020777468,0.0006386132,0.0000064813394,0.750953,0.00011081535],"about_ca_topic_score_codex":0.00003337565,"about_ca_topic_score_gemma":0.000098021235,"teacher_disagreement_score":0.14635752,"about_ca_system_score_codex":0.00006379494,"about_ca_system_score_gemma":0.0003219813,"threshold_uncertainty_score":0.5520282},"labels":[],"label_agreement":null},{"id":"W4414662065","doi":"10.1002/ejhf.70020","title":"What's New in Heart Failure? August 2025","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"","score_opus":0.012097298858522001,"score_gpt":0.2585594508921523,"score_spread":0.2464621520336303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414662065","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31092024,0.008829948,0.00035026183,0.65683305,0.0024909538,0.0008992842,0.0000019644187,0.00009958539,0.019574719],"genre_scores_gemma":[0.8669572,0.00045948022,0.04455869,0.011743728,0.0013412625,0.0000030449587,0.000014634286,0.00009104695,0.0748309],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998413,0.00020675766,0.00057329034,0.00019858844,0.000291345,0.0003169728],"domain_scores_gemma":[0.999213,0.000049115206,0.0001187564,0.0002944642,0.000099568264,0.00022512765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006932328,0.0001988526,0.00047522993,0.0004980555,0.000046741807,0.00015205891,0.00016219945,0.00002842551,0.0005147119],"category_scores_gemma":[0.00007848884,0.0001605659,0.00023333957,0.0004273951,0.000038580398,0.00046478017,0.00009279492,0.00041338426,0.00031551064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104862724,0.00019042207,0.018210225,0.000058845057,0.00016293977,0.00041009308,0.00010989569,0.000018480885,0.0009964503,0.000184651,0.972879,0.006674141],"study_design_scores_gemma":[0.0035065876,0.0004424733,0.045638166,0.0013351629,0.00015330446,0.00006147521,0.0006066467,0.0000040446066,0.00057841226,0.0000714576,0.9474942,0.000108036525],"about_ca_topic_score_codex":0.00000936412,"about_ca_topic_score_gemma":0.000032214855,"teacher_disagreement_score":0.6450893,"about_ca_system_score_codex":0.00009265887,"about_ca_system_score_gemma":0.00018599298,"threshold_uncertainty_score":0.65476876},"labels":[],"label_agreement":null},{"id":"W4415268198","doi":"10.1002/ejhf.70073","title":"Artificial Intelligence-Based Echocardiographic Assessment for Monitoring Disease Progression in Transthyretin Cardiac Amyloidosis","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"AstraZeneca","keywords":"Transthyretin; Cardiac amyloidosis; Heart failure; Amyloidosis; Disease; Metric (unit); Atrial fibrillation; Heart disease","score_opus":0.014714043486598499,"score_gpt":0.3108863662363896,"score_spread":0.2961723227497911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415268198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556627,0.0045052376,0.025211427,0.012570709,0.0009778788,0.0008837104,0.000050840004,0.000023182038,0.000114298025],"genre_scores_gemma":[0.97781557,0.00025306412,0.02132507,0.00013093813,0.00035921746,0.000042331583,0.000022198177,0.000036931062,0.000014689314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980114,0.00051274063,0.00062819914,0.00031203896,0.00023500413,0.0003005801],"domain_scores_gemma":[0.99912894,0.000070270646,0.00018664429,0.00028975363,0.00015775113,0.00016662038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009703444,0.00023607297,0.00035200923,0.00030387467,0.0001121876,0.00006486599,0.00024611253,0.000061018745,0.000005918315],"category_scores_gemma":[0.00011584735,0.00020521997,0.0006133618,0.00028078473,0.00007349216,0.000011879428,0.000042812,0.00022169546,0.0000024868214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008557743,0.000567108,0.8896742,0.00012589636,0.0003626858,0.00007871162,0.000051605588,0.0023624972,0.060494237,0.00006663338,0.0055427747,0.039817907],"study_design_scores_gemma":[0.0020928776,0.002070395,0.5122643,0.0017295808,0.0005889157,0.000007938375,0.00067572575,0.00016355167,0.3732861,0.0002487646,0.10612402,0.0007478129],"about_ca_topic_score_codex":0.0000014872123,"about_ca_topic_score_gemma":0.0000020614027,"teacher_disagreement_score":0.37740985,"about_ca_system_score_codex":0.000055469347,"about_ca_system_score_gemma":0.00021724831,"threshold_uncertainty_score":0.83686274},"labels":[],"label_agreement":null},{"id":"W4415424866","doi":"10.1002/ejhf.70069","title":"<i>European Journal of Heart Failure</i> Consensus Statement. Heart Failure Pharmacotherapy for Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Atrial Fibrillation: Review of Evidence and Call to Action","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Surgical Specialties (Canada)","funders":"National Heart, Lung, and Blood Institute; Cardio-Pulmonary Institute; H. Lundbeck A/S; Novo Nordisk; Roche; Deutsche Forschungsgemeinschaft; Eli Lilly and Company; Boehringer Ingelheim España; Daiichi Sankyo Europe; Servier; Horizon Therapeutics; Pfizer; Moderna; Medtronic; Cytokinetics; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Novo Nordisk USA; Bayer HealthCare; European Commission; Sanofi; National Institutes of Health; Regeneron Pharmaceuticals; Novartis; Bristol-Myers Squibb; Boehringer Ingelheim; Amgen","keywords":"Heart failure; Atrial fibrillation; Pharmacotherapy; Concomitant; Context (archaeology); Ejection fraction; Spironolactone; Comorbidity; Cardiac resynchronization therapy; Call to action","score_opus":0.05293365401045189,"score_gpt":0.3493672729555577,"score_spread":0.2964336189451058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415424866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7540092,0.004896503,0.0028068696,0.23465282,0.0007394544,0.0027863765,0.000030175524,0.000043089127,0.000035551337],"genre_scores_gemma":[0.9131453,0.0018402893,0.07963464,0.0026483422,0.0023252557,0.0000016219925,0.000022425242,0.00011152491,0.0002705889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99569803,0.0011680111,0.0016644369,0.00036500065,0.000799279,0.00030523507],"domain_scores_gemma":[0.99597937,0.00044280943,0.0013263619,0.00026827308,0.0016729551,0.00031022323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028972053,0.00037972475,0.0011269774,0.00047168374,0.00022892025,0.000111185655,0.0001043342,0.00005419025,0.000067028],"category_scores_gemma":[0.0005267746,0.0002633686,0.00034785518,0.00053830195,0.00012654302,0.00057040935,0.00005021622,0.00045124048,0.000005533432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012139815,0.000058511738,0.24682112,0.0027879467,0.0009140652,0.000025619738,0.00019772204,0.00041466125,0.039704125,0.000012975671,0.6943025,0.0026209448],"study_design_scores_gemma":[0.010398574,0.0055418513,0.04426376,0.009937147,0.00087616855,0.00039647383,0.00042223113,0.000022165828,0.0021040265,0.00000433088,0.92575175,0.00028152711],"about_ca_topic_score_codex":0.000006610172,"about_ca_topic_score_gemma":0.000012425157,"teacher_disagreement_score":0.23200448,"about_ca_system_score_codex":0.00013247337,"about_ca_system_score_gemma":0.00024781248,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W4415458403","doi":"10.1002/ejhf.70065","title":"Global Registries and Surveys Programme–Heart Failure (GRASP-HF): Rationale, Study Design and Research Implications","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Accreditation; Heart failure; Guideline; Observational study; Health care; MEDLINE; Quality (philosophy); Randomized controlled trial; Clinical trial","score_opus":0.06667783827664923,"score_gpt":0.3548027055291233,"score_spread":0.28812486725247405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415458403","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38639456,0.0025097828,0.012962808,0.59190595,0.0001873708,0.0048305825,0.000017002862,0.00011785424,0.0010740579],"genre_scores_gemma":[0.9264147,0.000065708584,0.07162942,0.00035581645,0.00018618167,0.000025063693,0.000011327569,0.000026216152,0.0012855412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954148,0.0026456374,0.0006127323,0.00036706775,0.00053838344,0.00042136488],"domain_scores_gemma":[0.99813515,0.00031958896,0.00011965542,0.00038916335,0.0007065491,0.0003299095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071693794,0.00022855177,0.00045365677,0.00034985793,0.00042653174,0.00023807325,0.00014311579,0.00004729799,0.00003060062],"category_scores_gemma":[0.000504375,0.00017937114,0.00009584028,0.00079627725,0.0002569113,0.0002123801,0.00016618794,0.0004342912,0.000022518792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017649028,0.0006324544,0.3038791,0.00007493037,0.0003556078,0.0001672383,0.0003004241,0.000007698768,0.00029490382,0.0009703845,0.68697125,0.0061695245],"study_design_scores_gemma":[0.0025363087,0.0017015364,0.46009263,0.00016343378,0.00016588856,0.00037146502,0.0017100264,0.0000060711454,0.00003545151,0.00020834927,0.53290176,0.0001070619],"about_ca_topic_score_codex":0.000024013607,"about_ca_topic_score_gemma":0.00008764324,"teacher_disagreement_score":0.5915502,"about_ca_system_score_codex":0.000104919825,"about_ca_system_score_gemma":0.00032845646,"threshold_uncertainty_score":0.73145425},"labels":[],"label_agreement":null},{"id":"W4415724873","doi":"10.1002/ejhf.70043","title":"<i>European Journal of Heart Failure</i> Expert Consensus Statement on Transcatheter Treatment of Mitral Regurgitation in Heart Failure","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"MitraClip; Heart failure; Mitral regurgitation; Randomized controlled trial; Cardiac resynchronization therapy; Mitral valve; Medical therapy; MEDLINE","score_opus":0.015691198736381258,"score_gpt":0.3109038205465393,"score_spread":0.29521262181015806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415724873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94018704,0.003274986,0.00008925943,0.054868348,0.0004849754,0.0005929283,0.00006448933,0.000017522489,0.00042047413],"genre_scores_gemma":[0.9893985,0.0001634474,0.008820743,0.00095866254,0.000343177,0.0000027665958,0.000019242641,0.00007410322,0.00021937037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952452,0.0014433817,0.0018355638,0.0003119142,0.00073239836,0.0004315124],"domain_scores_gemma":[0.9978323,0.00016654884,0.0006309381,0.0004284219,0.00055168616,0.0003900836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011426278,0.0004342705,0.0011632605,0.0006624173,0.00008819958,0.000057669935,0.00015365779,0.000050313254,0.00010248311],"category_scores_gemma":[0.00008916474,0.0003253519,0.002955461,0.0003515281,0.00015428591,0.00014559177,0.000024059753,0.00040274745,0.000036140118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010691214,0.008307898,0.14818236,0.0004266434,0.0070265853,0.0028359068,0.004907548,0.00080635387,0.05492406,0.00011391702,0.7547291,0.0070484094],"study_design_scores_gemma":[0.027871802,0.0131607875,0.1867644,0.002979196,0.0015282015,0.0013154952,0.0032267547,0.0000066568537,0.01003897,0.000027866778,0.7526741,0.00040578778],"about_ca_topic_score_codex":0.000013899529,"about_ca_topic_score_gemma":0.000009368009,"teacher_disagreement_score":0.053909685,"about_ca_system_score_codex":0.00031500423,"about_ca_system_score_gemma":0.0003485239,"threshold_uncertainty_score":0.99991983},"labels":[],"label_agreement":null},{"id":"W4415724906","doi":"10.1002/ejhf.70064","title":"What's New in Heart Failure? October 2025","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Heart failure; Cardiac resynchronization therapy; Ejection fraction; Biobank; Expert opinion; Psychological intervention; Alcohol consumption; Quality of life (healthcare)","score_opus":0.01464302503957726,"score_gpt":0.2754496146642864,"score_spread":0.26080658962470915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415724906","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08767386,0.0040039164,0.0005442868,0.9016564,0.0015249082,0.00077094877,0.0000013546762,0.00008068717,0.0037436269],"genre_scores_gemma":[0.7424735,0.000634788,0.17096525,0.019821454,0.0023237243,0.000006837311,0.000020401068,0.00015818636,0.06359589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974989,0.00039278268,0.0008921994,0.0003038884,0.0004480924,0.0004641042],"domain_scores_gemma":[0.998789,0.00008359676,0.00014978161,0.00044036345,0.00017205275,0.00036517656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011538501,0.00030291243,0.00069769705,0.000724881,0.000077790515,0.00018090384,0.00019925571,0.00006493479,0.0007213047],"category_scores_gemma":[0.0001366733,0.00024283968,0.0003555034,0.00065276254,0.000058836664,0.00060881674,0.00011629633,0.0006830795,0.0005646035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018435338,0.00023452626,0.015243059,0.000065474625,0.0001668118,0.00073497405,0.0002347101,0.000020447736,0.0017332401,0.00021438069,0.9767145,0.0044535226],"study_design_scores_gemma":[0.0042589535,0.0005105334,0.026455898,0.0014351603,0.00015697144,0.00027613537,0.00077707367,0.0000062066015,0.0006919559,0.00007739643,0.9651889,0.00016476994],"about_ca_topic_score_codex":0.00002144252,"about_ca_topic_score_gemma":0.00008890383,"teacher_disagreement_score":0.881835,"about_ca_system_score_codex":0.00013962816,"about_ca_system_score_gemma":0.00037457648,"threshold_uncertainty_score":0.99027145},"labels":[],"label_agreement":null},{"id":"W4415813145","doi":"10.1002/ejhf.70086","title":"Reply to the Letter Regarding the Article ‘Remote Pulmonary Artery Pressure-Guided Management of Patients with Heart Failure: A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC’","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Statement (logic); Heart failure; Pulmonary artery; Association (psychology); MEDLINE","score_opus":0.015853128034943136,"score_gpt":0.27079210493764144,"score_spread":0.2549389769026983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415813145","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47739366,0.000115237875,0.000138399,0.5197712,0.00039693303,0.0018710598,0.00001853971,0.000015619877,0.00027936156],"genre_scores_gemma":[0.979216,0.000011031668,0.009367923,0.0093902955,0.00020213028,0.0000074154336,0.0000032945534,0.00004421346,0.0017577322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939326,0.0019919996,0.0018693373,0.00035718328,0.0014030173,0.00044585983],"domain_scores_gemma":[0.99641705,0.00036129405,0.0010914052,0.0012717588,0.00072353426,0.00013496615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004560048,0.00032446597,0.00076879904,0.00013754294,0.00027881723,0.000053072068,0.0005260023,0.000060979364,0.000047486294],"category_scores_gemma":[0.0003194752,0.00014542945,0.0006205783,0.00069974415,0.00023546896,0.00010628918,0.00041988696,0.00069888495,0.000016842794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054715434,0.00041524234,0.1984434,0.00018949586,0.0013330508,0.000019912583,0.00030382592,0.00030794425,0.0008855149,0.000058076188,0.7970489,0.00044748854],"study_design_scores_gemma":[0.0024853493,0.0004958195,0.3325416,0.0010984177,0.0009297647,0.000026873493,0.00062099256,0.000039148486,0.001343948,0.00001628421,0.66029644,0.00010536716],"about_ca_topic_score_codex":0.000025906102,"about_ca_topic_score_gemma":0.000030124982,"teacher_disagreement_score":0.5103809,"about_ca_system_score_codex":0.00012198936,"about_ca_system_score_gemma":0.0001510954,"threshold_uncertainty_score":0.5930441},"labels":[],"label_agreement":null},{"id":"W4415824507","doi":"10.1002/ejhf.70079","title":"Urinary Markers in Heart Failure – Types, Timing and Thresholds. <i>European Journal of Heart Failure</i> Expert Consensus Document","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Urinary system; Heart failure; Albuminuria; Kidney disease; Diuretic; Disease; Kidney","score_opus":0.035130232371618074,"score_gpt":0.33863105935545673,"score_spread":0.3035008269838387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415824507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069798605,0.9396128,0.000019571331,0.056090508,0.00076825015,0.0012771692,0.00008879901,0.00004072437,0.0014042049],"genre_scores_gemma":[0.0018058259,0.9329721,0.056858554,0.0029540744,0.002910403,0.000010150923,0.00006569041,0.00052932644,0.0018939013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862253,0.006101648,0.0039507947,0.0007817513,0.0017956804,0.001144814],"domain_scores_gemma":[0.99433535,0.0007868924,0.001628075,0.00101621,0.0008774748,0.0013559762],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00892613,0.0011472802,0.004427113,0.0020665266,0.00024176604,0.00027897992,0.00094278203,0.00027525658,0.0005488316],"category_scores_gemma":[0.0013011172,0.0008832971,0.0015416002,0.0010674739,0.00048041382,0.0003509855,0.00070066535,0.0052097477,0.00017932033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007107189,0.00027698922,0.00042302292,0.005756351,0.00075308525,0.009008765,0.00019635845,0.0000017614069,0.00018199907,0.0000060600405,0.9589522,0.023732692],"study_design_scores_gemma":[0.0035367522,0.0031824324,0.00017679356,0.04507642,0.00078738865,0.049321465,0.00046184918,0.0000012368744,0.000023066572,0.0000043870805,0.89686835,0.00055986055],"about_ca_topic_score_codex":0.000007677504,"about_ca_topic_score_gemma":0.000005986442,"teacher_disagreement_score":0.062083848,"about_ca_system_score_codex":0.00047298544,"about_ca_system_score_gemma":0.0024363887,"threshold_uncertainty_score":0.99936175},"labels":[],"label_agreement":null},{"id":"W4415885203","doi":"10.1002/ejhf.70083","title":"Finerenone in Patients with Severe Heart Failure: The FINEARTS-HF Trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital; Surgical Specialties (Canada)","funders":"Bayer","keywords":"Heart failure; MEDLINE; Randomized controlled trial; Clinical trial; Prospective cohort study","score_opus":0.011646377446890998,"score_gpt":0.25148596794346567,"score_spread":0.23983959049657466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415885203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9230465,0.000306938,0.000010595145,0.0750137,0.00016281901,0.0006333626,0.000009130378,0.000013750299,0.0008031527],"genre_scores_gemma":[0.9935603,0.000010154735,0.0028800627,0.0016608007,0.00021081799,0.0000030018723,0.000014263031,0.000028483208,0.0016320843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779344,0.0005319324,0.00050166243,0.0001993365,0.00062726415,0.00034637845],"domain_scores_gemma":[0.9988332,0.00012508083,0.00011973989,0.00035845768,0.00034912117,0.000214432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000699176,0.00019790334,0.00046176338,0.00026454043,0.00013194651,0.000048578575,0.00017930531,0.000036006822,0.00020763255],"category_scores_gemma":[0.0002484199,0.000103854945,0.00016624623,0.00046093998,0.00009347259,0.00014261155,0.00007533355,0.0007243777,0.00010162395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037606027,0.0017162223,0.2608345,0.00004486941,0.00033757876,0.0023802703,0.00005991291,0.000027264958,0.0002453626,0.000018348544,0.69532824,0.0014014357],"study_design_scores_gemma":[0.06826982,0.0041151666,0.43657774,0.0004852298,0.00009056056,0.0004885557,0.00009441158,0.000008028841,0.000061942956,0.000011848998,0.48968393,0.00011275674],"about_ca_topic_score_codex":0.000008201232,"about_ca_topic_score_gemma":0.000015641635,"teacher_disagreement_score":0.2056443,"about_ca_system_score_codex":0.00005477433,"about_ca_system_score_gemma":0.0002872082,"threshold_uncertainty_score":0.42350817},"labels":[],"label_agreement":null},{"id":"W4415956882","doi":"10.1002/ejhf.70076","title":"Unsupervised Machine Learning for Cardiovascular Disease: A Framework for Future Studies","year":2025,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Agence Nationale de la Recherche; Université de Lorraine","keywords":"Cluster analysis; Unsupervised learning; Clinical Practice; Risk stratification; Personalized medicine; Predictive modelling; Resource (disambiguation)","score_opus":0.20707486293878818,"score_gpt":0.4894961708952026,"score_spread":0.2824213079564144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415956882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032686714,0.97507095,0.009421633,0.0068162745,0.004398127,0.0039816042,0.00022253043,0.0000687742,0.000016813972],"genre_scores_gemma":[0.000009920066,0.95840377,0.030021658,0.00042433594,0.009866937,0.0002441215,0.00008002541,0.00021715628,0.0007320935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889083,0.006403426,0.002756434,0.0005579483,0.00053339486,0.0008405336],"domain_scores_gemma":[0.99034035,0.00520668,0.0013586235,0.00077153393,0.0018715012,0.00045132695],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006180878,0.00065262034,0.0036537359,0.00043376008,0.0016652516,0.000034793848,0.00073085877,0.00035469147,0.000070075155],"category_scores_gemma":[0.008451364,0.0004772213,0.004547236,0.00047152644,0.0000863292,0.000121832614,0.00023007828,0.003991888,0.00009315349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026257307,0.000057329064,0.00024475236,0.24062744,0.004758806,0.0001436834,0.0022378962,0.0001511626,6.1300156e-8,0.0015341582,0.098130055,0.6518521],"study_design_scores_gemma":[0.00023890396,0.00026221914,0.000002096699,0.09198125,0.0029400357,0.00001550629,0.0033517785,0.000020921814,6.0065155e-8,0.00057929876,0.9002794,0.00032851283],"about_ca_topic_score_codex":0.000004876291,"about_ca_topic_score_gemma":0.000012241669,"teacher_disagreement_score":0.80214936,"about_ca_system_score_codex":0.0003228643,"about_ca_system_score_gemma":0.0018323966,"threshold_uncertainty_score":0.9999009},"labels":[],"label_agreement":null},{"id":"W4416056440","doi":"10.1002/ejhf.70093","title":"Sodium–Glucose co-Transporter 2 Inhibitors in Severe Estimated Glomerular Filtration Rate Deterioration Across Cardiovascular-Kidney-Metabolic Conditions: A Pooled Analysis of Randomized Trials","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Janssen Research and Development; Canadian Institutes of Health Research; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Fundação para a Ciência e a Tecnologia; McGill University; Yale University; Eli Lilly and Company","keywords":"Pooled analysis; Renal function; Randomized controlled trial; Heart failure; Meta-analysis","score_opus":0.017992718916347357,"score_gpt":0.30386357078155557,"score_spread":0.2858708518652082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416056440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900762,0.00371327,0.0020341836,0.0025143984,0.00020427517,0.0011635404,0.000069697395,0.000025793568,0.00019868354],"genre_scores_gemma":[0.99676985,0.00036374776,0.0018803368,0.00042387156,0.000081531005,0.000014832953,0.00032910524,0.000020591984,0.00011613147],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947787,0.0024669406,0.0019304029,0.00021864353,0.00038143134,0.00022389328],"domain_scores_gemma":[0.998333,0.0002183907,0.00067090447,0.00030807205,0.00033819376,0.00013144987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008784374,0.00022893808,0.0026860004,0.0009924389,0.00006668126,0.00006847093,0.000093093935,0.000052276013,0.00011595437],"category_scores_gemma":[0.0010014973,0.00017358112,0.0019162393,0.0011777781,0.000099362514,0.00027588083,0.00001622165,0.00019677254,0.000010698864],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11338507,0.0038643726,0.13077272,0.001867612,0.3006682,0.0030099605,0.007030312,0.022311373,0.3064161,0.00037859293,0.06887875,0.041416943],"study_design_scores_gemma":[0.44900623,0.00078923197,0.32193834,0.0031236801,0.11573766,0.000059158854,0.0010988805,0.0015357467,0.055132974,0.00010482153,0.05082952,0.00064375455],"about_ca_topic_score_codex":0.000013225365,"about_ca_topic_score_gemma":0.000010718845,"teacher_disagreement_score":0.33562118,"about_ca_system_score_codex":0.000052533756,"about_ca_system_score_gemma":0.00013041926,"threshold_uncertainty_score":0.7078433},"labels":[],"label_agreement":null},{"id":"W4416061553","doi":"10.1002/ejhf.70090","title":"Adherence to Guideline-Directed Medical Treatments in Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Surgical Specialties (Canada)","funders":"Janssen Research and Development; Agenzia Italiana del Farmaco, Ministero della Salute; Respicardia; National Institutes of Health; Servier; Novo Nordisk; Deutsche Forschungsgemeinschaft; Georg-August-Universität Göttingen; Daiichi-Sankyo; National Institute for Health and Care Research; Idorsia Pharmaceuticals; Impulse Dynamics; British Heart Foundation; Amicus Therapeutics; European Commission; Sanofi; GlaxoSmithKline; Deutsches Zentrum für Herz-Kreislaufforschung; NIHR Leicester Biomedical Research Centre; Boston Scientific Corporation; Alnylam Pharmaceuticals; Edwards Lifesciences; Amgen; Vifor Pharma; Ministero della Salute; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Heart failure; Multidisciplinary approach; Statement (logic); Pharmacotherapy; Limiting; MEDLINE; Health care; Alternative medicine","score_opus":0.022460135441086895,"score_gpt":0.30388477580256684,"score_spread":0.28142464036147996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416061553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73584837,0.0021732354,0.00033122944,0.25898492,0.0008730286,0.0014978406,0.000009318883,0.000023146238,0.00025887543],"genre_scores_gemma":[0.99116236,0.00008448416,0.003143589,0.0045321635,0.00016397714,0.000015089234,0.0000026436885,0.000022266771,0.0008734103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947931,0.001768922,0.0011849751,0.00029662947,0.0016762711,0.00028010047],"domain_scores_gemma":[0.998065,0.00022912676,0.0005119855,0.0006034092,0.00042823513,0.00016227347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058900123,0.00020773517,0.000648783,0.00018300426,0.00020446329,0.000054276945,0.00046561784,0.000058795813,0.00021649881],"category_scores_gemma":[0.00079262006,0.00010715752,0.0004296042,0.001043783,0.00024166927,0.00007495408,0.00011315853,0.0006530493,0.000022519946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006715641,0.00047217798,0.09669479,0.00010923591,0.0010115455,0.00001902125,0.001282807,0.00022795769,0.026544493,0.000102480866,0.86635816,0.0065057795],"study_design_scores_gemma":[0.008980417,0.0004411854,0.0717857,0.00398776,0.00029474928,0.00007138462,0.0008253062,0.00023591549,0.0060585295,0.000050230778,0.9071261,0.00014272223],"about_ca_topic_score_codex":0.000041429517,"about_ca_topic_score_gemma":0.0000642459,"teacher_disagreement_score":0.255314,"about_ca_system_score_codex":0.00015454015,"about_ca_system_score_gemma":0.0004160322,"threshold_uncertainty_score":0.4369757},"labels":[],"label_agreement":null},{"id":"W4416101080","doi":"10.1002/ejhf.70091","title":"Clinical Profiles and Prognostic Impact of Residual Intravascular and Tissue Congestion in Acute Heart Failure","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institutes of Health; Servier; Kowa Company; European Commission; Idorsia Pharmaceuticals; Cytokinetics; British Heart Foundation; Impulse Dynamics; Incyte; Bayer; Bristol-Myers Squibb; AstraZeneca; Novo Nordisk","keywords":"Heart failure; Diuretic; Intravascular volume status; Residual; MEDLINE","score_opus":0.013904845479838194,"score_gpt":0.32315060577634114,"score_spread":0.30924576029650297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416101080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95876175,0.0011506476,0.00008807053,0.03925635,0.00009038623,0.0005666438,0.0000049721525,0.000015861096,0.00006533825],"genre_scores_gemma":[0.97538596,0.00024367859,0.0238419,0.00015379148,0.00015070004,0.0000022771917,0.0000074842233,0.000022366437,0.00019182752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783516,0.0006077716,0.0008363729,0.00023844284,0.0002456187,0.00023663291],"domain_scores_gemma":[0.99905735,0.00018232923,0.00017327309,0.0002054208,0.00017603303,0.00020558308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016426959,0.00020544913,0.0006942105,0.0003605522,0.000045932866,0.000037379028,0.00006708391,0.000069824026,0.000039945866],"category_scores_gemma":[0.0003617833,0.00014803905,0.00015372828,0.00023050033,0.00021327643,0.00015025967,0.000082593164,0.0004660711,0.000008528459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005995439,0.00038947334,0.82067907,0.00026553075,0.0008807432,0.0008113532,0.00032577896,0.000012649301,0.0057521346,0.00014226299,0.1623796,0.007761843],"study_design_scores_gemma":[0.004285781,0.003456105,0.88669866,0.0011924485,0.0005399047,0.00064475264,0.00018840215,0.0000144668165,0.00056397385,0.000034276924,0.102259435,0.00012178103],"about_ca_topic_score_codex":0.000012362781,"about_ca_topic_score_gemma":0.000010602989,"teacher_disagreement_score":0.06601958,"about_ca_system_score_codex":0.00003819103,"about_ca_system_score_gemma":0.00016466573,"threshold_uncertainty_score":0.60368574},"labels":[],"label_agreement":null},{"id":"W4416667894","doi":"10.1002/ejhf.70049","title":"Effects of Semaglutide in Obesity-Related Heart Failure with Preserved Ejection Fraction Across the Age Spectrum: Findings from the STEP-HFpEF Programme","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Institute on Minority Health and Health Disparities; National Institute on Aging; European Society of Cardiology; Horizon Therapeutics; Moderna; Cytokinetics; Esperion Therapeutics; Arrowhead Pharmaceuticals; Novo Nordisk; Dexcom; Alnylam Pharmaceuticals; Gilead Sciences; Amgen; National Heart, Lung, and Blood Institute; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Semaglutide; Heart failure; Heart failure with preserved ejection fraction; Ejection fraction; Body weight; Ventricular function; Cardiac function curve","score_opus":0.006842688268609667,"score_gpt":0.23228290491492476,"score_spread":0.22544021664631508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416667894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96838707,0.0004890172,0.0001316892,0.029569175,0.00016892303,0.0009626894,0.0000024092594,0.000030607454,0.00025842933],"genre_scores_gemma":[0.9964887,0.00002232995,0.0020735336,0.0004830209,0.00011765835,0.000007232423,0.000009278874,0.000030094683,0.0007681542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794555,0.00061273185,0.0005084906,0.00021117895,0.0003842853,0.00033774323],"domain_scores_gemma":[0.99894917,0.0003108281,0.00024380388,0.00032907198,0.00009839654,0.00006871284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011874359,0.00021302764,0.00043981787,0.00012889445,0.00016559957,0.000092875205,0.0002038228,0.0000476425,0.000032092237],"category_scores_gemma":[0.00014817435,0.0001127044,0.00019590057,0.00055967364,0.00011595223,0.00016411707,0.00009151084,0.00069823966,0.000025086507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001042258,0.0011405627,0.84237903,0.00034324583,0.0015022419,0.00071110117,0.001326649,0.00013292547,0.012181136,0.00008701379,0.13744363,0.0017101851],"study_design_scores_gemma":[0.00492594,0.0011594659,0.83227724,0.0016089262,0.0004505173,0.000034507953,0.0012525774,0.00003313361,0.0050866213,0.000056535217,0.15300666,0.00010787681],"about_ca_topic_score_codex":0.00010929091,"about_ca_topic_score_gemma":0.00031311053,"teacher_disagreement_score":0.029086154,"about_ca_system_score_codex":0.000110114976,"about_ca_system_score_gemma":0.000055135937,"threshold_uncertainty_score":0.45959523},"labels":[],"label_agreement":null},{"id":"W4416765865","doi":"10.1002/ejhf.70082","title":"Pharmacological Treatment for Patients with Obesity and Heart Failure: Focus on Glucagon-Like Peptide-1 Receptor Agonists. <i>European Journal of Heart Failure</i> Expert Consensus Document","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Deutsche Forschungsgemeinschaft; Deutsches Zentrum für Herz-Kreislaufforschung","keywords":"Heart failure; Clinical trial; Ejection fraction; Heart failure with preserved ejection fraction; MEDLINE; Obesity; Alternative medicine","score_opus":0.011643463709798805,"score_gpt":0.2573856857318046,"score_spread":0.2457422220220058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416765865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162839,0.0011439592,0.00015772328,0.07912944,0.0008427757,0.0017330599,0.00003406151,0.000053560223,0.00062149344],"genre_scores_gemma":[0.9424658,0.00018738692,0.05200236,0.0035700225,0.00064129813,0.000013524419,0.0000261376,0.00010241839,0.0009910824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959485,0.0009781561,0.0012554782,0.00048046696,0.00071368116,0.0006237171],"domain_scores_gemma":[0.99747944,0.00026207333,0.00066161563,0.0003698862,0.0006446412,0.00058232987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013553258,0.00060772616,0.0011938137,0.0004032557,0.0003078136,0.00017352882,0.00024013128,0.00005926926,0.00013575694],"category_scores_gemma":[0.000106044004,0.0003957622,0.00055512297,0.00025734972,0.0002302886,0.00019138219,0.00012024153,0.0004998949,0.000051800987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004381821,0.0032833188,0.022389987,0.00011761342,0.0020567966,0.00042921212,0.0003557508,0.000025224124,0.0063405945,0.00006899178,0.9552654,0.0052853],"study_design_scores_gemma":[0.022869542,0.022573113,0.019892799,0.0009193165,0.0010165977,0.00021308113,0.0004365178,0.000002949686,0.005665609,0.000018346194,0.92604727,0.0003448667],"about_ca_topic_score_codex":0.0000050948597,"about_ca_topic_score_gemma":0.0000070269607,"teacher_disagreement_score":0.07555942,"about_ca_system_score_codex":0.0003699657,"about_ca_system_score_gemma":0.00020481789,"threshold_uncertainty_score":0.99984944},"labels":[],"label_agreement":null},{"id":"W4416817377","doi":"10.1002/ejhf.70071","title":"Clinical Phenotype and Prognosis of Real-World Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Sanofi Genzyme; Novo Nordisk; Vifor Pharma; Pfizer; Ministero della Salute; Amicus Therapeutics; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Prothena; Boston Scientific Corporation; Alnylam Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; AstraZeneca; Bristol-Myers Squibb","keywords":"Transthyretin; Heart failure; Cardiomyopathy; Cohort; Phenotype; Clinical phenotype; Amyloidosis","score_opus":0.007911085994720606,"score_gpt":0.25248880000446866,"score_spread":0.24457771400974807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416817377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724126,0.00065469206,0.000090392845,0.0011228829,0.00006861638,0.00027832045,0.000020660058,0.0000102899985,0.0005128837],"genre_scores_gemma":[0.9937431,0.00042301274,0.0053066174,0.00020229506,0.00009154185,0.0000029757648,0.000031152722,0.000046150846,0.00015313561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980531,0.00052483106,0.0006392073,0.00032460684,0.00023082441,0.00022744652],"domain_scores_gemma":[0.9987072,0.000051825275,0.0003649966,0.00030144397,0.00042652173,0.00014806679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046363898,0.00026481616,0.0005476651,0.00014472593,0.000071779665,0.000026895637,0.00018420612,0.000059375037,0.000011238723],"category_scores_gemma":[0.000066191824,0.00017843371,0.00017302055,0.00031491506,0.00023108063,0.000014023203,0.000053426837,0.00021102418,0.0000028609848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013318189,0.00034502003,0.986699,0.000036029902,0.0006261427,0.00003568489,0.000041333806,0.000017982793,0.0020234305,0.000007534815,0.0063330946,0.0025029618],"study_design_scores_gemma":[0.0042476887,0.0047075152,0.93683034,0.00028299476,0.00045952376,0.000016646678,0.00007912,9.398095e-7,0.0071069323,0.000001653879,0.04605743,0.00020921411],"about_ca_topic_score_codex":0.000015480306,"about_ca_topic_score_gemma":0.000050682636,"teacher_disagreement_score":0.04986862,"about_ca_system_score_codex":0.000017893797,"about_ca_system_score_gemma":0.00012158079,"threshold_uncertainty_score":0.72763157},"labels":[],"label_agreement":null},{"id":"W4417262318","doi":"10.1002/ejhf.70087","title":"Pharmacologic Pitfalls in Heart Failure: A Guide to Drugs that May Cause or Exacerbate Heart Failure. A European Journal of Heart Failure Expert Consensus Document","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Polypharmacy; Heart failure; Adverse effect; Drug class; MEDLINE; Drug; Health care; Expert opinion","score_opus":0.02387688493317171,"score_gpt":0.31810772169058965,"score_spread":0.29423083675741796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417262318","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27434894,0.0018222679,0.0004135684,0.71829295,0.0015211704,0.0025748955,0.000026440452,0.00018202256,0.0008177202],"genre_scores_gemma":[0.768589,0.0002983362,0.19752176,0.024330437,0.0017447183,0.000031633863,0.000018873558,0.00033157467,0.007133668],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98655045,0.004613129,0.003870148,0.0011094592,0.002031412,0.0018253794],"domain_scores_gemma":[0.99428606,0.0005802444,0.0011012459,0.0012325039,0.0011347505,0.0016652234],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.008031197,0.0013622981,0.002808096,0.0023057715,0.00041374398,0.00046293475,0.00096986233,0.00020020398,0.0015554674],"category_scores_gemma":[0.00069085136,0.0010226999,0.0012970231,0.0017418902,0.00034936538,0.00065491785,0.0006664211,0.0022783175,0.0008150495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002225626,0.0009543723,0.008766921,0.00022742737,0.0010306229,0.006038846,0.0015262001,0.00019086731,0.031736117,0.000046506477,0.9466643,0.0005922474],"study_design_scores_gemma":[0.014671683,0.0040898873,0.0064860694,0.0028332158,0.00068387203,0.0048798854,0.0047267466,0.000010180824,0.008110638,0.000013499532,0.95266014,0.0008341808],"about_ca_topic_score_codex":0.000075504504,"about_ca_topic_score_gemma":0.00022624902,"teacher_disagreement_score":0.6939625,"about_ca_system_score_codex":0.00087758625,"about_ca_system_score_gemma":0.0011282463,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W4417498233","doi":"10.1002/ejhf.70074","title":"Contemporary Medical Therapy for Heart Failure Across the Ejection Fraction Spectrum: The OPTIPHARM-HF Registry","year":2025,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Novo Nordisk; Cytokinetics; Boston Scientific Corporation; Edwards Lifesciences; Teva Pharmaceutical Industries; AstraZeneca; Bayer; American Regent; Servier; Daiichi-Sankyo; Amgen","keywords":"Heart failure; Medical therapy; Ejection fraction; Heart failure with preserved ejection fraction; MEDLINE","score_opus":0.017764183385089286,"score_gpt":0.29503337727320483,"score_spread":0.27726919388811555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417498233","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32347497,0.0057912897,0.018010072,0.6458342,0.0039030646,0.0013338849,0.00001648084,0.00011673776,0.0015192652],"genre_scores_gemma":[0.9888079,0.00033665856,0.00066262216,0.0065741884,0.0024332625,0.0000061132073,0.000009886372,0.00004432079,0.0011250391],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974999,0.0007239202,0.00059838104,0.00022085568,0.00069574616,0.00026121407],"domain_scores_gemma":[0.9985574,0.000254958,0.0002496905,0.0004867842,0.00027702175,0.00017417164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003591116,0.00020753816,0.0004398449,0.000097467986,0.0005272327,0.000116009345,0.00023690314,0.00009915564,0.00017873607],"category_scores_gemma":[0.0004118381,0.00010412669,0.00093780487,0.0003185952,0.00019622176,0.0001562845,0.000044152333,0.001223602,0.000035684403],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000977603,0.00010408731,0.017386042,0.000031101103,0.00059045496,0.00006607235,0.000188847,0.00002818149,0.001469904,0.000028447832,0.9770607,0.0020685538],"study_design_scores_gemma":[0.003379812,0.00043176507,0.046304226,0.0002081992,0.000087659355,0.0017685109,0.0023262512,0.000037956765,0.0013391897,0.000016002152,0.94400513,0.000095266],"about_ca_topic_score_codex":0.000016116182,"about_ca_topic_score_gemma":0.000009163982,"teacher_disagreement_score":0.6653329,"about_ca_system_score_codex":0.000077506826,"about_ca_system_score_gemma":0.000371139,"threshold_uncertainty_score":0.531601},"labels":[],"label_agreement":null}]}